amount,linenumber,linesetting,episodedatasource,detaileddrugcategory,linename,patientid,lineenddate,units,drugcategory,episodedate,linestartdate,route,drugname,ismaintenancetherapy
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/16/2021,mg,antineoplastic,5/21/2021,10/12/2020,Intravenous,bevacizumab,FALSE
80,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,5/9/2016,mg,antineoplastic,2/20/2016,2/28/2016,Intravenous,irinotecan,FALSE
1025,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,12/20/2023,mg,antineoplastic,10/4/2023,9/6/2023,Intravenous,pemetrexed,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/24/2021,mg,antineoplastic,3/14/2021,4/29/2021,Intravenous,paclitaxel protein-bound,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/23/2017,mg,antineoplastic,6/19/2016,6/20/2016,Intravenous,carboplatin,FALSE
324,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/8/2013,mg,antineoplastic,7/8/2013,6/3/2013,Intravenous,paclitaxel,FALSE
384,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/21/2024,mg,antineoplastic,10/24/2024,8/2/2024,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/14/2019,mL,solution-fluid,10/28/2019,9/26/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G262FC43B61CF,8/11/2019,,antineoplastic,6/17/2019,6/20/2019,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,4/17/2022,mg,antineoplastic,12/25/2021,10/21/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/6/2025,mg,antineoplastic,6/23/2022,4/7/2020,Intravenous,pembrolizumab,FALSE
167.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/3/2015,mg,antineoplastic,12/12/2014,9/23/2014,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4C7:4GCD96C:,6/25/2017,,,5/3/2017,4/6/2015,Oral,erlotinib,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/15/2025,mg,antineoplastic,6/20/2024,3/3/2024,Intravenous,pembrolizumab,FALSE
176,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,12/27/2023,mg,antineoplastic,11/30/2023,10/18/2023,Intravenous,carboplatin,FALSE
500,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/3/2017,mg,antineoplastic,9/8/2017,6/30/2017,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,5/31/2023,,antineoplastic,6/5/2023,2/6/2023,Intravenous,bevacizumab-awwb,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1:9FCE6E6G6C,7/22/2020,,antineoplastic,6/26/2020,7/25/2020,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/21/2025,mg,antineoplastic,9/10/2021,4/18/2020,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/29/2024,mL,solution-fluid,2/2/2024,10/30/2023,Intravenous,pemetrexed,FALSE
1540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,7/31/2018,mg,antineoplastic,7/22/2018,8/4/2018,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/16/2019,mg,antineoplastic,5/2/2018,12/19/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,1/31/2025,,antineoplastic,5/23/2024,5/2/2024,Intravenous,paclitaxel protein-bound,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/16/2023,mg,antineoplastic,6/22/2021,12/31/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/10/2022,mg,antineoplastic,9/12/2021,2/1/2020,Intravenous,nivolumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/2/2023,mg,antineoplastic,2/1/2023,9/25/2022,Subcutaneous,azacitidine,FALSE
78,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,12/22/2024,mg,antineoplastic,6/25/2024,5/13/2024,Intravenous,ipilimumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,8/24/2018,mg,antineoplastic,6/25/2018,2/26/2018,Intravenous,nivolumab,FALSE
1.5,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/12/2024,AUC,antineoplastic,10/22/2023,10/16/2023,Intravenous,carboplatin,FALSE
295.4,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/12/2019,mg,antineoplastic,11/21/2018,8/23/2018,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/25/2025,mg,antineoplastic,11/27/2018,1/2/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,10/11/2020,mg,antineoplastic,9/10/2020,7/15/2020,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/28/2024,mg,antineoplastic,3/23/2023,2/21/2023,Intravenous,bevacizumab-awwb,TRUE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/10/2022,mg,antineoplastic,12/1/2021,11/15/2021,Intravenous,fluorouracil,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/30/2024,mg,antineoplastic,12/22/2023,3/31/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/30/2025,,antineoplastic,1/13/2025,2/19/2023,,clinical study drug,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/14/2020,mg,antineoplastic,2/12/2020,3/17/2020,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,10/10/2014,AUC,antineoplastic,1/21/2014,12/25/2013,Intravenous,carboplatin,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/10/2021,mg,antineoplastic,11/14/2021,9/20/2021,Intravenous,carboplatin,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,5/19/2019,mg/m2,antineoplastic,5/5/2019,5/16/2019,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/12/2025,,antineoplastic,11/14/2023,3/3/2023,,clinical study drug,FALSE
789,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,7/11/2012,mg,antineoplastic,5/1/2012,4/18/2012,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Unstructured,,Sotorasib,G3CFD616B13G9,5/19/2022,,,6/8/2022,3/8/2022,Oral,sotorasib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/31/2024,mg,antineoplastic,2/22/2024,12/19/2022,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G1188466C5727,12/10/2014,,,1/14/2015,4/20/2014,Oral,erlotinib,FALSE
990,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G21B4CD9B81B7,5/31/2012,mg,antineoplastic,5/20/2012,5/24/2012,Intravenous,bevacizumab,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,3/13/2014,mg,antineoplastic,1/31/2014,11/3/2013,Intravenous,gemcitabine,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/2/2023,mg,antineoplastic,5/8/2021,12/21/2019,Intravenous,pembrolizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/15/2014,mg,antineoplastic,5/13/2014,1/5/2014,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/20/2019,mg,antineoplastic,10/27/2017,2/28/2016,Intravenous,nivolumab,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G1DCDG73E53FF,6/13/2024,,steroid,7/6/2024,4/20/2024,Intravenous,clinical study drug,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,9/13/2015,mg,antineoplastic,3/13/2015,12/11/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/18/2020,mg,antineoplastic,3/13/2019,1/20/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/22/2022,,,2/25/2022,9/25/2021,Oral,osimertinib,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,6/4/2019,mg,antineoplastic,4/11/2019,4/4/2019,Intravenous,gemcitabine,FALSE
915,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G18E7528ED97:,3/15/2012,mg,antineoplastic,1/8/2012,11/18/2011,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/1/2019,mg,antineoplastic,1/24/2018,5/31/2017,Intravenous,nivolumab,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,11/5/2013,mg,antineoplastic,8/25/2013,3/26/2013,Intravenous,bevacizumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/9/2015,mg/m2,antineoplastic,2/19/2015,10/11/2014,Intravenous,etoposide,FALSE
744,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,10/21/2021,mg,antineoplastic,9/11/2021,8/3/2021,Intravenous,carboplatin,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/22/2025,mg,antineoplastic,8/2/2024,11/14/2022,Intravenous,cisplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/20/2025,mg/m2,antineoplastic,10/22/2024,7/9/2024,Intravenous,gemcitabine,FALSE
231,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/14/2022,mg,antineoplastic,10/2/2021,10/21/2021,Intravenous,carboplatin,FALSE
70,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,8/14/2011,mg,antineoplastic,8/10/2011,8/20/2011,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,12/16/2019,,antineoplastic,10/24/2019,4/13/2019,Oral,hydroxyurea,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/18/2019,mg,antineoplastic,8/31/2018,7/13/2018,Intravenous,pembrolizumab,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1532797B869C,8/8/2023,mg,antineoplastic,8/2/2023,7/18/2023,Intravenous,docetaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G242GD729:FB:,4/26/2024,mg,antineoplastic,4/30/2024,3/24/2024,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,11/3/2022,mg,antineoplastic,9/23/2022,10/21/2021,Intravenous,pemetrexed,TRUE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/24/2025,mg,antineoplastic,1/8/2020,3/25/2019,Intravenous,pemetrexed,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/24/2016,mg,antineoplastic,6/6/2016,5/27/2016,Intravenous,carboplatin,FALSE
450,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3FE:CB6:EG58,5/9/2024,mg,antineoplastic,3/24/2024,3/25/2024,Intravenous,carboplatin,FALSE
848,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/12/2014,mg,antineoplastic,6/3/2013,7/12/2013,Intravenous,bevacizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G16227785C51C,11/28/2021,mg,antineoplastic,12/11/2021,10/28/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G3419F1B75FG6,5/10/2020,mg,antineoplastic,3/25/2020,2/1/2020,Intravenous,pembrolizumab,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/17/2018,mg,antineoplastic,10/21/2017,11/15/2017,Oral,anastrozole,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/10/2025,mg,antineoplastic,5/20/2018,12/30/2016,Intravenous,pembrolizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/15/2016,mg,antineoplastic,6/11/2016,3/3/2016,Intravenous,nivolumab,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/18/2023,mg,antineoplastic,1/26/2023,1/18/2023,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/11/2025,mg,antineoplastic,5/10/2022,2/10/2019,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/30/2025,,antineoplastic,3/26/2020,4/27/2020,Oral,enzalutamide,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G58E33F7EG254,2/17/2020,mg,antineoplastic,12/31/2019,12/24/2019,Intravenous,docetaxel,FALSE
,,ADJUVANT,Unstructured,,Alectinib,G1GECG2D6BB54,3/17/2025,,,3/23/2025,7/9/2021,Oral,alectinib,FALSE
500,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,6/12/2017,mg/m2,antineoplastic,5/3/2017,5/27/2017,Intravenous,pemetrexed,FALSE
232,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,9/8/2017,mg,antineoplastic,9/29/2017,8/9/2017,Intravenous,carboplatin,FALSE
66.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,8/3/2020,mg,antineoplastic,2/7/2020,2/22/2020,Intravenous,paclitaxel,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/25/2025,mg,antineoplastic,6/25/2020,3/12/2019,Intravenous,pemetrexed,FALSE
592,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/20/2016,mg,antineoplastic,9/13/2016,4/21/2016,Intravenous,carboplatin,FALSE
231,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/22/2016,mg,antineoplastic,5/15/2016,11/29/2015,Intravenous,carboplatin,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/21/2025,mg,antineoplastic,4/20/2023,10/4/2022,Intravenous,pemetrexed,TRUE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/24/2022,mg,antineoplastic,8/11/2022,6/30/2022,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/29/2020,mg,antineoplastic,4/14/2019,1/28/2019,Subcutaneous,bortezomib,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/4/2014,mg,antineoplastic,12/30/2013,12/13/2013,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,5/10/2025,mg,antineoplastic,3/6/2025,1/9/2025,Intravenous,pemetrexed,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/3/2015,mg,antineoplastic,2/13/2015,3/1/2015,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/10/2020,mg,antineoplastic,1/4/2017,12/12/2015,Intravenous,nivolumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/9/2013,AUC,antineoplastic,8/24/2012,8/16/2012,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/23/2025,mg,antineoplastic,7/13/2024,7/5/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,4/5/2025,mg,antineoplastic,10/5/2019,5/4/2018,Intravenous,pembrolizumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,4/18/2023,mg,antineoplastic,10/17/2022,6/3/2022,Intravenous,durvalumab,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,4/2/2020,mg,antineoplastic,2/15/2020,1/25/2020,Intravenous,paclitaxel,FALSE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/6/2019,mg/m2,antineoplastic,12/19/2018,1/15/2019,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/16/2022,mg,antineoplastic,2/24/2020,4/4/2017,Intravenous,nivolumab,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,2/19/2014,mg,antineoplastic,11/27/2013,6/16/2013,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G28F814933C3F,1/31/2025,mg,antineoplastic,1/6/2025,8/22/2024,Intravenous,pembrolizumab,TRUE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,11/6/2024,mg,antineoplastic,9/8/2024,8/17/2024,Intravenous,temsirolimus,FALSE
181,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/3/2014,mg,antineoplastic,9/23/2012,10/22/2012,Intravenous,carboplatin,FALSE
233.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/15/2017,mg,antineoplastic,9/29/2017,9/15/2017,Intravenous,carboplatin,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/29/2012,mg,antineoplastic,3/12/2012,12/28/2011,Intravenous,etoposide,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/7/2023,mg,antineoplastic,12/4/2021,10/11/2021,Intravenous,pemetrexed,TRUE
264,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/20/2020,mg,antineoplastic,4/5/2017,3/21/2017,Intravenous,paclitaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/30/2013,mg,antineoplastic,11/8/2012,12/10/2012,Intravenous,vinorelbine,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/5/2015,mg,antineoplastic,10/9/2014,8/16/2014,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/13/2021,,antineoplastic,9/30/2020,7/4/2020,,clinical study drug,FALSE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/28/2017,mg,antineoplastic,8/26/2017,8/10/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/5/2023,,,11/23/2023,12/24/2022,Oral,osimertinib,FALSE
,3,ADVANCED,Unstructured,,Afatinib,G1968F::311C2,1/8/2019,,,10/8/2018,10/27/2018,Oral,afatinib,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/12/2019,mg,antineoplastic,6/30/2018,3/29/2017,Intravenous,pemetrexed,TRUE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/25/2019,mg,antineoplastic,7/30/2018,8/24/2017,Oral,anastrozole,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/8/2015,mg,antineoplastic,2/11/2015,3/15/2015,Intravenous,carboplatin,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,5/5/2024,mg,antineoplastic,1/31/2024,12/28/2023,Intravenous,cisplatin,FALSE
620,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/27/2022,mg,antineoplastic,10/6/2021,9/14/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,8/23/2020,mg,antineoplastic,8/7/2020,7/15/2020,Intravenous,paclitaxel protein-bound,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/2/2022,mg,antineoplastic,7/6/2020,1/30/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/14/2025,mg,antineoplastic,2/22/2025,5/20/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/25/2020,mg,antineoplastic,9/19/2019,4/18/2019,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/7/2024,mg,antineoplastic,2/2/2024,9/26/2023,Intravenous,pembrolizumab,FALSE
173,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/29/2024,mg,antineoplastic,3/25/2024,2/8/2024,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/2/2012,mg,antineoplastic,7/13/2012,3/24/2012,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/13/2021,,antiemetic,7/22/2020,1/21/2020,Intravenous,clinical study drug,FALSE
2500,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,2/4/2021,mg,antineoplastic,11/19/2020,10/2/2020,Intravenous,fluorouracil,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,4/15/2025,mg,antineoplastic,7/1/2024,2/11/2024,Intravenous,pembrolizumab,FALSE
1005,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/21/2025,mg,antineoplastic,4/21/2022,10/7/2021,Intravenous,pemetrexed,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G26C72D6F6G:5,9/22/2020,mg,antineoplastic,9/26/2020,7/17/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/25/2020,mg,antineoplastic,5/27/2020,2/4/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/28/2024,mg,antineoplastic,3/7/2022,5/25/2020,Intravenous,pembrolizumab,TRUE
665,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,3/13/2013,mg,antineoplastic,1/2/2013,11/15/2012,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/30/2024,mg,antineoplastic,4/3/2024,3/20/2023,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G1885B3G8447B,8/10/2022,mg,antineoplastic,8/25/2022,8/25/2022,Intravenous,durvalumab,FALSE
956,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,3/8/2015,mg,antineoplastic,1/3/2015,11/6/2014,Intravenous,bevacizumab,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,5/13/2015,mg,antineoplastic,5/5/2015,2/19/2015,Intravenous,vinorelbine,FALSE
76,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/11/2020,mg,antineoplastic,6/15/2014,4/20/2014,Intravenous,doxorubicin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/12/2020,mg,antineoplastic,5/8/2019,12/10/2015,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/31/2022,mg,antineoplastic,1/2/2022,9/17/2021,Intravenous,pemetrexed,TRUE
350,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/18/2022,mg,antineoplastic,7/25/2021,8/23/2021,Intravenous,amivantamab-vmjw,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/18/2013,mg,antineoplastic,7/9/2012,12/8/2011,Intravenous,etoposide,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/4/2025,mg,antineoplastic,5/2/2025,10/31/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/6/2020,,antineoplastic,4/10/2020,5/10/2020,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/2/2015,mg,antineoplastic,2/19/2015,9/25/2014,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,10/29/2019,mg,antineoplastic,7/15/2019,8/22/2019,Intravenous,pemetrexed,FALSE
400,3,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,8/12/2022,mg,antineoplastic,7/21/2022,9/5/2021,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/24/2022,,antineoplastic,10/3/2017,5/28/2017,Oral,dasatinib,FALSE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/17/2017,mg,antineoplastic,7/10/2017,6/22/2017,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/4/2023,mg,antineoplastic,4/17/2020,12/30/2019,Intravenous,pembrolizumab,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/22/2024,mg,antineoplastic,10/2/2024,8/28/2024,Intravenous,paclitaxel,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,11/9/2021,mg,antineoplastic,9/30/2021,11/10/2021,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/9/2020,mg,antineoplastic,10/8/2019,6/26/2019,Intravenous,pembrolizumab,TRUE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/22/2019,mg,antineoplastic,12/21/2018,10/6/2018,Intravenous,durvalumab,FALSE
1250,1,ADVANCED,Orders,chemotherapy,Capecitabine,G23G4C57:DEB5,10/5/2020,mg/m2,antineoplastic,8/25/2020,9/25/2020,Oral,capecitabine,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,1/15/2017,mg,antineoplastic,12/24/2016,12/26/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G1:78734BCEDB,7/31/2014,,antiemetic,3/15/2014,4/20/2014,Intravenous,clinical study drug,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/15/2019,mg/m2,antineoplastic,2/12/2019,1/28/2019,Intravenous,paclitaxel,FALSE
200,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D168F99BCD4,12/24/2023,mg,antineoplastic,12/22/2023,9/26/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antiemetic,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,2/7/2015,,antiemetic,10/26/2014,10/18/2014,Intravenous,clinical study drug,FALSE
163,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/30/2016,mg,antineoplastic,8/25/2016,5/3/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,12/21/2019,mg,antineoplastic,10/17/2019,10/10/2019,Intravenous,pembrolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/16/2025,mg,antineoplastic,5/16/2020,2/17/2019,Intravenous,pemetrexed,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/17/2015,mg/kg,antineoplastic,10/3/2014,11/11/2014,Intravenous,bevacizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,6/17/2015,mg,antineoplastic,5/7/2015,5/13/2015,Intravenous,carboplatin,FALSE
670,1,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,8/31/2018,mg,antineoplastic,12/14/2017,9/1/2016,Intravenous,rituximab,FALSE
399,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,1/10/2025,mg,antineoplastic,1/4/2025,10/19/2024,Intravenous,carboplatin,FALSE
22.5,3,ADVANCED,Administrations,hormone,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/25/2024,mg,antineoplastic,8/28/2024,6/16/2024,Subcutaneous,leuprolide,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,1/4/2016,mg,antineoplastic,7/22/2015,6/16/2015,Intravenous,paclitaxel protein-bound,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/20/2014,mg,antineoplastic,6/16/2014,4/15/2014,Intravenous,carboplatin,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/14/2021,mg,antineoplastic,1/20/2021,12/21/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/14/2025,mg,antineoplastic,12/6/2024,5/5/2024,Intravenous,pembrolizumab,TRUE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/27/2019,mg,antineoplastic,2/2/2019,2/1/2019,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/10/2015,mg,antineoplastic,2/9/2014,12/24/2013,Intravenous,paclitaxel,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/20/2018,mL,solution-fluid,3/13/2018,12/5/2017,Intravenous,paclitaxel,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/20/2015,mg,antineoplastic,4/11/2015,2/27/2015,Intravenous,carboplatin,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/3/2020,mg,antineoplastic,4/23/2020,2/5/2020,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,5/5/2025,,antiemetic,4/17/2025,11/16/2024,Intravenous,clinical study drug,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,8/19/2021,mL,solution-fluid,6/3/2021,4/15/2021,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,hormone,Bicalutamide,G4992B5EB431G,1/25/2021,,antineoplastic,1/29/2021,9/10/2020,Oral,bicalutamide,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/8/2015,mg,antineoplastic,8/21/2015,6/14/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,4/22/2021,mg,antineoplastic,3/8/2021,1/15/2021,Intravenous,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,7/22/2012,mg,antineoplastic,5/7/2012,4/8/2012,Intravenous,paclitaxel protein-bound,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/12/2025,mg,antineoplastic,1/3/2025,9/14/2022,Intravenous,pemetrexed,TRUE
120,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/2/2023,mg,antineoplastic,11/17/2021,10/8/2021,Intravenous,bendamustine,FALSE
227,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/10/2024,mg,antineoplastic,6/19/2024,5/10/2024,Intravenous,carboplatin,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/13/2017,mg,antineoplastic,12/9/2015,4/14/2015,Intravenous,bevacizumab,TRUE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/10/2022,mg,antineoplastic,6/8/2022,4/23/2022,Intravenous,paclitaxel,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/9/2016,mg,antineoplastic,8/2/2016,5/21/2016,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,12/23/2017,mg,antineoplastic,12/31/2017,10/29/2017,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,8/4/2021,mg,antineoplastic,2/28/2020,12/18/2018,Intravenous,pembrolizumab,TRUE
1400,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/26/2013,mg,antineoplastic,3/1/2013,12/31/2012,Intravenous,gemcitabine,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/27/2021,mg,antineoplastic,1/10/2019,2/14/2018,Intravenous,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/25/2025,mg,antineoplastic,11/28/2017,1/24/2017,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/25/2025,mg,antineoplastic,7/23/2016,7/27/2016,Intravenous,pembrolizumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/8/2017,mg,antineoplastic,10/30/2017,7/19/2017,Intravenous,pemetrexed,FALSE
148,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/5/2023,mg,antineoplastic,10/27/2022,10/3/2022,Intravenous,docetaxel,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/18/2019,mg,antineoplastic,6/14/2019,1/15/2019,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,4/24/2020,mg,antineoplastic,6/3/2017,12/9/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,5/9/2025,mg,antineoplastic,12/22/2024,9/9/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/15/2024,mg,antineoplastic,2/2/2024,5/9/2020,Intravenous,pembrolizumab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,2/27/2025,AUC,antineoplastic,11/9/2022,12/6/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,6/30/2017,,solution-fluid,1/7/2017,12/15/2016,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/17/2025,mg,antineoplastic,12/10/2022,1/30/2019,Intravenous,pemetrexed,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/16/2019,mg,antineoplastic,10/5/2017,8/13/2017,Intravenous,etoposide,FALSE
330,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,12/9/2023,mg,antineoplastic,9/17/2023,8/6/2023,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1GEF44EBD419,4/25/2025,mg,antineoplastic,11/19/2024,11/9/2024,Intravenous,durvalumab,FALSE
418.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39GB9B7D:9:C,2/7/2016,mg,antineoplastic,10/2/2015,10/19/2015,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/27/2020,mg,antineoplastic,6/3/2020,6/24/2020,Subcutaneous,azacitidine,FALSE
263,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/21/2015,mg,antineoplastic,5/25/2015,1/26/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/6/2020,,antineoplastic,2/11/2020,12/27/2019,Intravenous,clinical study drug,FALSE
905,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/10/2020,mg,antineoplastic,3/25/2019,3/13/2019,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G11D1:8:62429,10/5/2015,,antineoplastic,10/10/2015,11/14/2015,,ramucirumab,FALSE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,3/11/2020,mg,antineoplastic,3/13/2020,10/17/2019,Intravenous,carboplatin,FALSE
2600,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,7/16/2022,mg,antineoplastic,10/26/2021,8/4/2021,Intravenous,gemcitabine,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/31/2025,mg,antineoplastic,6/4/2020,2/7/2020,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/3/2017,,solution-fluid,1/29/2017,3/21/2016,Intravenous,clinical study drug,FALSE
128,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,12/11/2021,mg,antineoplastic,10/9/2021,9/16/2021,Intravenous,paclitaxel,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/8/2015,mg,antineoplastic,6/21/2015,3/4/2015,Intravenous,gemcitabine,FALSE
169,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,10/13/2018,mg,antineoplastic,5/2/2014,3/1/2014,Intravenous,docetaxel,FALSE
258,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/14/2022,mg,antineoplastic,1/23/2022,1/25/2022,Intravenous,paclitaxel,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/19/2018,mg,antineoplastic,11/16/2018,9/13/2018,Intravenous,gemcitabine,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,9/30/2014,mg,antineoplastic,6/7/2014,7/29/2014,Intravenous,pemetrexed,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/13/2017,mg,antineoplastic,1/17/2017,11/5/2016,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/28/2022,mg,antineoplastic,10/27/2022,5/12/2020,Intravenous,pembrolizumab,FALSE
1030,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,1/10/2021,mg,antineoplastic,10/24/2020,10/15/2020,Intravenous,pemetrexed,FALSE
2,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,12/17/2012,AUC,antineoplastic,1/10/2013,1/4/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G3419F1B75FG6,6/12/2020,mg,antineoplastic,4/17/2020,2/3/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G38G2BBE55G71,2/20/2025,,,1/30/2025,3/31/2018,Oral,alectinib,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,9/26/2022,mg,antineoplastic,8/7/2022,7/19/2022,Intravenous,carboplatin,FALSE
552.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,5/30/2018,mg,antineoplastic,4/8/2018,2/16/2018,Intravenous,carboplatin,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,8/19/2022,mg,antineoplastic,6/6/2022,5/2/2022,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,12/30/2019,mg,antineoplastic,11/28/2019,11/4/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/27/2017,,antineoplastic,4/24/2017,3/26/2017,Intravenous,pemetrexed,FALSE
1200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,5/25/2012,mg,antineoplastic,5/25/2012,3/31/2012,Intravenous,gemcitabine,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/27/2021,mg/m2,antineoplastic,4/13/2021,3/22/2021,Intravenous,paclitaxel protein-bound,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/4/2023,mg,antineoplastic,11/14/2022,1/24/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/28/2021,mg,antineoplastic,8/15/2020,10/23/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/2/2024,mg,antineoplastic,1/26/2022,5/9/2020,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,2/24/2022,mg,antineoplastic,10/23/2021,9/3/2021,Intravenous,pemetrexed,TRUE
325,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,4/15/2019,mg,antineoplastic,3/5/2019,2/8/2019,Intravenous,paclitaxel,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/13/2024,mg,antineoplastic,2/23/2024,1/11/2024,Intravenous,paclitaxel protein-bound,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2F327FD5:2:3,4/7/2025,mg,antineoplastic,3/5/2025,3/21/2025,Intravenous,ramucirumab,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/10/2023,mg,antineoplastic,5/23/2023,4/19/2023,Intravenous,pemetrexed,FALSE
96,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,11/4/2014,mg,antineoplastic,9/9/2014,9/1/2014,Intravenous,paclitaxel,FALSE
234,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,6/23/2018,mg,antineoplastic,1/5/2018,10/14/2017,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/6/2022,mg,antineoplastic,5/22/2017,4/29/2017,Oral,dasatinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,8/7/2023,mg,antineoplastic,3/23/2023,10/20/2022,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/18/2024,,antineoplastic,1/5/2024,4/4/2023,Intravenous,atezolizumab,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,3/1/2019,mg,antineoplastic,12/30/2018,12/8/2018,Intravenous,paclitaxel,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/24/2017,mg,antineoplastic,5/2/2016,12/15/2015,Intravenous,nivolumab,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/2/2023,mg,antineoplastic,4/29/2021,11/8/2019,Intravenous,pembrolizumab,TRUE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/5/2014,mg,antineoplastic,2/8/2014,11/28/2013,Intravenous,pemetrexed,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/2/2023,mg,antineoplastic,3/4/2021,11/13/2019,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,3/30/2024,,antineoplastic,11/24/2023,9/23/2023,Oral,ivosidenib,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/12/2015,mg,antineoplastic,6/30/2014,1/29/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Unstructured,,"Letrozole,Osimertinib",G31G19E54FC:B,10/2/2023,,,10/4/2020,9/14/2020,Oral,osimertinib,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/25/2020,mg,antineoplastic,4/11/2020,9/29/2019,Intravenous,durvalumab,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/18/2025,mg,antineoplastic,7/20/2020,3/23/2020,Intravenous,pemetrexed,TRUE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/28/2022,mg,antineoplastic,1/4/2022,10/15/2021,Intravenous,carboplatin,FALSE
870,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/16/2020,mg,antineoplastic,4/19/2019,3/20/2019,Intravenous,durvalumab,FALSE
1810,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/21/2019,mg,antineoplastic,7/24/2019,5/15/2019,Intravenous,bevacizumab,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/30/2022,mg,antineoplastic,2/7/2022,1/17/2022,Intravenous,paclitaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,8/5/2021,mg,antineoplastic,1/12/2019,12/19/2018,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Unstructured,,Erlotinib,G147ED4GE76EE,3/21/2020,,,3/19/2020,2/3/2020,Oral,erlotinib,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,11/19/2016,mg,antineoplastic,10/8/2016,7/13/2016,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/4/2025,mg,antineoplastic,11/30/2022,6/15/2022,Intravenous,pembrolizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,8/13/2021,mg,antineoplastic,4/8/2021,2/17/2021,Intravenous,pemetrexed,TRUE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/6/2016,mg,antineoplastic,12/8/2015,8/30/2015,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/6/2023,mg,antineoplastic,2/21/2023,10/11/2022,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/24/2019,mg,antineoplastic,10/28/2019,8/2/2019,Intravenous,etoposide,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/29/2021,mg,antineoplastic,8/19/2019,12/7/2018,Intravenous,pemetrexed,TRUE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,1/17/2014,mg,antineoplastic,11/22/2013,10/13/2013,Intravenous,vinorelbine,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/8/2016,mg,antineoplastic,12/30/2015,11/23/2015,Intravenous,paclitaxel protein-bound,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/1/2023,mg,antineoplastic,7/1/2023,3/28/2023,Subcutaneous,azacitidine,FALSE
1020,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/7/2020,mg,antineoplastic,12/15/2018,12/16/2018,Intravenous,durvalumab,TRUE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G4GE2958C:E1C,4/5/2012,,antiemetic,11/3/2011,7/2/2011,Intravenous,clinical study drug,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,10/26/2019,mg,antineoplastic,9/16/2019,7/26/2019,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/19/2025,mg,antineoplastic,8/8/2024,3/4/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G19D38B88F559,4/14/2020,mg,antineoplastic,4/30/2020,4/10/2020,Intravenous,pembrolizumab,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/3/2024,mg,antineoplastic,9/8/2024,7/20/2024,Intravenous,pembrolizumab,FALSE
280,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,2/23/2019,mg,antineoplastic,12/4/2018,12/17/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/23/2019,,antineoplastic,10/4/2019,9/16/2019,,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/14/2024,mg,antineoplastic,3/8/2023,8/24/2022,Intravenous,pembrolizumab,TRUE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,1/15/2023,mg,antineoplastic,10/12/2022,9/17/2022,Oral,imatinib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/15/2023,mg,antineoplastic,5/29/2023,4/1/2023,Subcutaneous,azacitidine,FALSE
,2,ADVANCED,Orders,hormone,"Anastrozole,Ramucirumab",G1GFD92F489E7,11/19/2023,,antineoplastic,10/3/2023,9/23/2023,Oral,anastrozole,FALSE
535,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FE1DBD491BE,10/2/2017,mg,antineoplastic,10/10/2017,8/14/2017,Intravenous,carboplatin,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/2/2021,mg,antineoplastic,10/10/2020,12/12/2019,Intravenous,durvalumab,TRUE
85,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G359C2E:9E3B7,8/22/2017,mg,antineoplastic,9/28/2017,10/9/2017,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/20/2023,mg,antineoplastic,10/20/2021,5/18/2020,Intravenous,pembrolizumab,FALSE
2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/6/2020,mg,antineoplastic,6/21/2014,3/17/2014,Intravenous,vincristine,FALSE
149,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/23/2024,mg,antineoplastic,12/31/2023,9/27/2023,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/5/2025,mg,antineoplastic,6/3/2017,12/6/2016,Intravenous,nivolumab,FALSE
109,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,4/14/2022,mg,antineoplastic,12/1/2021,12/18/2021,Intravenous,ipilimumab,FALSE
421,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/23/2012,mg,antineoplastic,1/5/2012,8/16/2011,Intravenous,carboplatin,FALSE
85.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,5/2/2018,mg,antineoplastic,8/25/2014,9/2/2014,Intravenous,paclitaxel,FALSE
1650,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/18/2013,mg,antineoplastic,4/15/2012,3/28/2012,Intravenous,gemcitabine,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/15/2017,mg,antineoplastic,3/11/2014,12/10/2013,Intravenous,etoposide,FALSE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G319D776C24D5,5/9/2021,mg,antineoplastic,4/22/2021,4/7/2021,Intravenous,pemetrexed,FALSE
1940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/13/2018,mg,antineoplastic,5/1/2018,3/20/2018,Intravenous,gemcitabine,FALSE
475,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/14/2022,mg,antineoplastic,10/15/2021,6/16/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/17/2024,mg,antineoplastic,1/12/2024,5/5/2020,Intravenous,pembrolizumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/27/2013,mg,antineoplastic,9/28/2012,10/13/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/22/2024,mg,antineoplastic,3/21/2024,3/11/2024,Intravenous,pembrolizumab,FALSE
770,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/11/2014,mg,antineoplastic,3/19/2014,2/2/2014,Intravenous,bevacizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/18/2024,mg,antineoplastic,3/19/2023,3/3/2023,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,5/1/2024,,pain agent,10/28/2023,7/1/2023,Oral,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/22/2022,mg,antineoplastic,8/30/2020,8/26/2020,Intravenous,pembrolizumab,TRUE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/3/2025,mg,antineoplastic,11/29/2022,3/7/2022,Intravenous,atezolizumab,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/12/2013,mg,antineoplastic,6/17/2012,4/11/2012,Intravenous,docetaxel,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,12/14/2024,mg,antineoplastic,6/2/2024,6/1/2024,Intravenous,gemcitabine,FALSE
117,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/9/2021,mg,antineoplastic,7/17/2021,5/21/2021,Intravenous,carboplatin,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/3/2021,mg,antineoplastic,8/7/2021,5/9/2021,Intravenous,carboplatin,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,5/19/2019,mg/m2,antineoplastic,5/15/2019,5/24/2019,Intravenous,cisplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/16/2025,mg,antineoplastic,10/15/2024,12/23/2016,Intravenous,pembrolizumab,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,1/25/2025,mg,antineoplastic,6/12/2023,3/9/2023,Intravenous,paclitaxel protein-bound,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/30/2020,mg,antineoplastic,4/1/2020,10/31/2019,Intravenous,durvalumab,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/14/2016,mg,antineoplastic,8/22/2015,5/31/2015,Intravenous,bevacizumab,FALSE
400,5,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,3/26/2025,mg,antineoplastic,11/9/2024,12/14/2024,Intravenous,pembrolizumab,FALSE
1700,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,10/16/2013,mg,antineoplastic,10/2/2013,8/15/2013,Intravenous,gemcitabine,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/26/2021,mg,antineoplastic,9/7/2020,7/16/2020,Intravenous,doxorubicin,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/6/2021,mg,antineoplastic,1/20/2021,6/17/2020,Intravenous,gemcitabine,FALSE
97,4,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1G54G4GB8B24,10/5/2023,mg,antineoplastic,9/2/2022,7/21/2022,Intravenous,docetaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,2/2/2019,mg,antineoplastic,12/4/2018,4/16/2017,Intravenous,pemetrexed,TRUE
160,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3C:F1C:2BF6C,1/28/2015,mg,antineoplastic,2/12/2015,12/30/2014,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/18/2022,mg,antineoplastic,2/21/2022,8/9/2020,Intravenous,pembrolizumab,TRUE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,5/13/2019,mg/kg,antineoplastic,10/4/2017,8/11/2017,Intravenous,ramucirumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/1/2022,,antineoplastic,3/31/2022,1/6/2022,Intravenous,carboplatin,FALSE
210,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/21/2015,mg,antineoplastic,3/30/2015,1/22/2015,Intravenous,paclitaxel protein-bound,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/6/2025,mg,antineoplastic,8/17/2020,2/20/2019,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/29/2023,mg,antineoplastic,5/5/2023,4/21/2023,Subcutaneous,azacitidine,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,1/26/2024,mg,antineoplastic,12/22/2023,9/14/2023,Intravenous,cisplatin,FALSE
117,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/10/2020,mg,antineoplastic,8/31/2020,5/25/2020,Subcutaneous,azacitidine,FALSE
164,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Leuprolide",G24F:E99C2926,1/14/2024,mg,antineoplastic,12/24/2023,11/2/2023,Intravenous,docetaxel,FALSE
320,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,3/24/2025,mg,antineoplastic,7/28/2024,8/14/2024,Intravenous,paclitaxel,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/18/2016,mg,antineoplastic,4/26/2015,11/27/2014,Intravenous,pemetrexed,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,6/16/2022,mg,antineoplastic,6/27/2022,6/25/2022,Oral,anastrozole,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/23/2022,mg,antineoplastic,4/8/2021,2/26/2021,Intravenous,durvalumab,FALSE
205,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/19/2017,mg,antineoplastic,6/30/2015,6/9/2015,Intravenous,nivolumab,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/26/2022,mg,antineoplastic,5/12/2022,4/9/2022,Intravenous,pemetrexed,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,12/15/2017,mg,antineoplastic,11/15/2017,8/10/2017,Intravenous,carboplatin,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/12/2013,mg/m2,antineoplastic,10/4/2012,7/19/2012,Intravenous,docetaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/6/2025,mg,antineoplastic,8/27/2020,1/24/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/26/2024,mg,antineoplastic,4/5/2024,2/4/2024,Intravenous,pembrolizumab,FALSE
66.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/12/2020,mg,antineoplastic,3/31/2020,2/7/2020,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/17/2022,mg,antineoplastic,8/19/2018,2/11/2016,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,4/14/2015,mg,antineoplastic,12/10/2014,11/12/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/14/2023,mg,antineoplastic,1/28/2022,1/27/2022,Intravenous,pembrolizumab,TRUE
273,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/12/2016,mg,antineoplastic,7/30/2016,7/4/2016,Intravenous,trastuzumab,FALSE
460,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/21/2016,mg,antineoplastic,9/22/2016,7/17/2016,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/28/2024,mL,solution-fluid,7/22/2024,6/21/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/5/2022,mg,antineoplastic,7/16/2021,8/28/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,2/14/2019,mg,antineoplastic,1/11/2019,11/23/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,7/29/2023,mg,antineoplastic,4/18/2023,3/13/2022,Intravenous,pembrolizumab,TRUE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,7/10/2016,mg,antineoplastic,6/29/2016,5/24/2016,Intravenous,paclitaxel,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/27/2024,mg,antineoplastic,5/10/2024,3/20/2024,Intravenous,amivantamab-vmjw,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/30/2021,mg/m2,antineoplastic,9/13/2021,6/26/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/15/2022,mg,antineoplastic,10/20/2020,2/2/2018,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,immunotherapy,Clinical Study Drug,G2C233C2:5B1:,4/20/2025,,antineoplastic,11/22/2024,12/22/2024,Intravenous,clinical study drug,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,8/22/2019,mg,antineoplastic,5/15/2019,5/23/2019,Intravenous,ramucirumab,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/18/2024,mg,antineoplastic,3/3/2024,9/20/2023,Intravenous,nivolumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/20/2024,mg,antineoplastic,12/28/2023,1/25/2024,Intravenous,paclitaxel protein-bound,FALSE
22.5,1,ADVANCED,Administrations,hormone,Leuprolide,G17G71B51EFE2,3/7/2024,mg,antineoplastic,3/31/2024,2/9/2024,Subcutaneous,leuprolide,FALSE
670,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,1/22/2024,mg,antineoplastic,11/10/2023,10/7/2023,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/7/2024,,antineoplastic,11/22/2023,12/3/2023,Intravenous,pemetrexed,FALSE
729,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/8/2025,mg,antineoplastic,1/27/2025,4/24/2024,Intravenous,carboplatin,FALSE
54,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1C32G396:F7G,2/10/2014,mg,antineoplastic,2/17/2014,3/3/2014,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/19/2022,mg,antineoplastic,4/13/2022,7/16/2020,Intravenous,pembrolizumab,TRUE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G369D5G3B91:2,11/17/2024,mg,antineoplastic,10/28/2024,7/20/2024,Intramuscular,leuprolide,FALSE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,7/12/2020,mg,antineoplastic,6/25/2020,5/30/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/13/2025,,antineoplastic,11/2/2021,10/10/2021,Intravenous,pemetrexed,TRUE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/14/2020,mg,antineoplastic,8/7/2020,9/27/2019,Intravenous,durvalumab,FALSE
213,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/22/2022,mg,antineoplastic,11/2/2021,10/4/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/3/2020,mg,antineoplastic,12/10/2019,1/7/2019,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,4/8/2018,mg,antineoplastic,11/21/2017,10/5/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/8/2025,,antineoplastic,2/17/2024,2/5/2023,,clinical study drug,FALSE
740,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G225D5E995642,7/10/2022,mg,antineoplastic,5/9/2022,4/30/2022,Intravenous,durvalumab,TRUE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/4/2025,,antineoplastic,7/6/2024,3/28/2024,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/10/2025,,antineoplastic,1/31/2025,2/23/2023,,clinical study drug,FALSE
439.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,12/12/2018,mg,antineoplastic,11/18/2018,11/1/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/23/2024,mg,antineoplastic,11/4/2023,6/9/2023,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,1/14/2025,mg,antineoplastic,11/5/2024,9/6/2024,Intravenous,nivolumab,TRUE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,1/15/2018,mg,antineoplastic,1/10/2018,2/4/2018,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/24/2023,,antineoplastic,4/17/2023,12/7/2022,,pemetrexed,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/11/2024,mg,antineoplastic,1/19/2024,9/16/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,11/26/2024,mg,antineoplastic,10/19/2024,10/14/2024,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/19/2014,,,4/15/2014,4/16/2014,Oral,erlotinib,FALSE
845,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/5/2017,mg,antineoplastic,2/16/2017,11/14/2016,Intravenous,pemetrexed,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/16/2024,mg,antineoplastic,11/16/2022,11/3/2021,Intravenous,durvalumab,FALSE
,2,ADVANCED,Unstructured,,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/6/2025,,,3/20/2025,6/28/2024,Oral,sotorasib,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,7/1/2024,,antineoplastic,1/23/2024,11/26/2023,,pemetrexed,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/11/2024,mL,solution-fluid,4/4/2024,4/23/2024,Intravenous,paclitaxel,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/19/2014,mg,antineoplastic,8/15/2014,6/20/2014,Intravenous,vinorelbine,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/8/2019,mg,antineoplastic,11/3/2019,8/29/2019,Intravenous,paclitaxel protein-bound,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/29/2019,mg,antineoplastic,7/9/2018,4/9/2018,Intravenous,paclitaxel,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G121:2D8:4E94,8/27/2019,mg,antineoplastic,8/15/2019,7/22/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,7/27/2020,mg,antineoplastic,8/23/2020,4/11/2020,Intravenous,pembrolizumab,TRUE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1978F5FFE:43,8/12/2014,mg,antineoplastic,6/9/2014,6/20/2014,Intravenous,pemetrexed,FALSE
357,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,1/31/2020,mg,antineoplastic,6/8/2013,1/9/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,7/26/2021,mg,antineoplastic,7/6/2021,3/4/2021,Intravenous,pembrolizumab,FALSE
668,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/3/2023,mg,antineoplastic,12/26/2021,9/22/2021,Intravenous,rituximab-pvvr,FALSE
248,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/19/2025,mg,antineoplastic,5/2/2025,12/21/2024,Intravenous,carboplatin,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,12/27/2011,mg,antineoplastic,12/9/2011,12/13/2011,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/27/2025,mg,antineoplastic,4/19/2022,1/12/2017,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/14/2019,mg,antineoplastic,7/31/2018,8/27/2018,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/29/2025,mg,antineoplastic,3/7/2025,4/16/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/4/2019,mg,antineoplastic,11/14/2018,2/4/2018,Intravenous,pembrolizumab,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/3/2025,mg,antineoplastic,4/23/2019,2/2/2019,Intravenous,pemetrexed,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/13/2018,mg,antineoplastic,10/12/2018,8/2/2018,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,3/18/2023,,antineoplastic,12/27/2022,11/21/2022,Intravenous,carboplatin,FALSE
865,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,8/14/2023,mg,antineoplastic,3/21/2023,5/13/2023,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/8/2025,mg,antineoplastic,6/18/2021,2/8/2017,Intravenous,pembrolizumab,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/23/2018,mg,antineoplastic,5/30/2018,3/11/2018,Intravenous,paclitaxel,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,2/2/2024,mg,antineoplastic,1/5/2024,11/8/2023,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G4GE2958C:E1C,4/5/2012,,antiemetic,9/26/2011,7/8/2011,Oral,clinical study drug,FALSE
162,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/22/2019,mg,antineoplastic,1/2/2019,10/28/2018,Intravenous,carboplatin,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/25/2019,mg,antineoplastic,7/26/2019,5/7/2019,Intravenous,paclitaxel,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/7/2025,mg,antineoplastic,10/18/2024,3/11/2024,Intravenous,pemetrexed,TRUE
50,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,4/10/2024,mg,antineoplastic,3/26/2024,2/6/2024,Intravenous,ipilimumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/14/2019,mg,antineoplastic,3/2/2019,2/12/2019,Intravenous,carboplatin,FALSE
178,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG6E1D:B1B7,3/27/2025,mg,antineoplastic,5/5/2025,3/21/2025,Intravenous,carboplatin,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G23:3:B689E33,11/30/2015,mg,antineoplastic,11/5/2015,11/26/2015,Intravenous,carboplatin,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/16/2019,mg,antineoplastic,1/7/2019,12/17/2016,Intramuscular,fulvestrant,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/7/2017,mg,antineoplastic,2/29/2016,5/29/2015,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,7/2/2017,,solution-fluid,2/23/2017,11/25/2016,Intravenous,clinical study drug,FALSE
900,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G49E3CE9E292G,5/2/2020,mg,antineoplastic,11/16/2019,11/6/2019,Intravenous,durvalumab,TRUE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,12/11/2023,mg,antineoplastic,12/6/2023,11/7/2023,Intravenous,paclitaxel,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,10/27/2021,mg,antineoplastic,8/14/2021,9/4/2021,Intravenous,cisplatin,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,7/29/2019,mg,antineoplastic,6/11/2019,4/14/2019,Intravenous,docetaxel,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/25/2022,mg,antineoplastic,4/12/2021,3/26/2021,Intravenous,bevacizumab-awwb,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,1/10/2022,mg,antineoplastic,11/14/2021,9/8/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/26/2021,,steroid,3/12/2020,1/19/2020,Intravenous,clinical study drug,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/25/2016,mg,antineoplastic,7/10/2015,10/29/2014,Intravenous,bevacizumab,TRUE
73,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,8/10/2016,mg,antineoplastic,12/4/2015,10/19/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/11/2023,,antineoplastic,2/8/2023,2/6/2023,Intravenous,carboplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/15/2016,mg,antineoplastic,1/23/2016,11/7/2015,Intravenous,paclitaxel protein-bound,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/16/2023,mL,solution-fluid,2/23/2023,12/30/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G2C4G1G76816F,5/10/2025,,pain agent,11/12/2017,9/13/2017,Oral,clinical study drug,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/25/2022,mg,antineoplastic,3/22/2022,6/2/2021,Intravenous,pembrolizumab,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/23/2020,mg,antineoplastic,5/11/2020,9/23/2019,Intravenous,durvalumab,FALSE
431,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,1/11/2023,mg,antineoplastic,11/26/2022,10/2/2022,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/2/2015,mg,antineoplastic,7/20/2015,4/13/2015,Intravenous,paclitaxel protein-bound,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/23/2025,mg/m2,antineoplastic,2/7/2025,11/15/2024,Intravenous,etoposide,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,1/23/2022,mg,antineoplastic,11/30/2021,11/19/2021,Intravenous,carboplatin,FALSE
626,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/27/2021,mg,antineoplastic,2/22/2021,1/17/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/14/2025,mg,antineoplastic,11/29/2022,9/11/2022,Intravenous,pembrolizumab,TRUE
446,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/20/2015,mg,antineoplastic,12/7/2014,9/28/2014,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/6/2016,mg,antineoplastic,7/1/2016,4/24/2016,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,6/30/2023,mg,antineoplastic,4/2/2023,10/23/2022,Intravenous,pembrolizumab,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/16/2020,mg,antineoplastic,7/5/2020,1/4/2019,Subcutaneous,bortezomib,FALSE
806,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/5/2025,mg,antineoplastic,4/21/2023,1/13/2023,Intravenous,pemetrexed,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,12/11/2019,mg/kg,antineoplastic,11/5/2019,6/10/2019,Intravenous,ramucirumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/21/2019,mg,antineoplastic,5/15/2018,3/9/2018,Intravenous,paclitaxel,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/4/2017,mg,antineoplastic,8/12/2016,6/23/2015,Intravenous,nivolumab,FALSE
198,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,4/28/2022,mg,antineoplastic,3/23/2022,2/17/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,10/31/2023,,solution-fluid,5/15/2023,12/11/2022,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/25/2022,mg,antineoplastic,8/7/2020,1/15/2018,Intravenous,pembrolizumab,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/11/2024,mL,solution-fluid,7/4/2024,5/12/2024,Intravenous,carboplatin,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,4/5/2025,mg,antineoplastic,11/18/2024,11/3/2024,Intravenous,cisplatin,FALSE
1670,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/12/2016,mg,antineoplastic,7/18/2016,3/25/2016,Intravenous,bevacizumab,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/21/2013,mg,antineoplastic,10/26/2013,6/12/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G325BD94D:C:4,4/4/2019,,,1/30/2019,12/9/2018,Oral,osimertinib,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/19/2018,mg,antineoplastic,9/20/2016,7/7/2016,Intravenous,pemetrexed,FALSE
600,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/23/2017,mg,antineoplastic,11/15/2016,9/16/2016,Intravenous,bevacizumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/12/2015,mg,antineoplastic,2/9/2014,1/7/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/27/2024,,antineoplastic,5/12/2024,4/24/2024,Intravenous,gemcitabine,FALSE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,11/17/2017,mg,antineoplastic,9/11/2017,9/6/2017,Intravenous,paclitaxel,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/8/2022,mg,antineoplastic,2/6/2021,3/16/2020,Intravenous,durvalumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/7/2016,mg,antineoplastic,8/10/2014,8/2/2014,Intravenous,etoposide,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,12/1/2023,mg,antineoplastic,5/26/2023,4/14/2023,Intravenous,carboplatin,FALSE
1035,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,12/20/2024,mg,antineoplastic,6/19/2024,3/19/2024,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,Temozolomide,G3DB42DD29B5G,8/22/2021,,antineoplastic,7/1/2021,5/10/2021,Oral,temozolomide,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,12/6/2022,mg,antineoplastic,7/22/2022,2/10/2022,Intravenous,durvalumab,TRUE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/7/2023,mg,antineoplastic,11/4/2023,10/22/2022,Intravenous,durvalumab,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/5/2020,mg,antineoplastic,4/22/2020,9/27/2019,Intravenous,durvalumab,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/6/2025,mg,antineoplastic,9/26/2019,3/19/2019,Intravenous,pemetrexed,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,1/22/2012,mg,antineoplastic,12/31/2011,12/26/2011,Intravenous,docetaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,10/15/2022,mg,antineoplastic,10/12/2021,9/16/2021,Intravenous,durvalumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/24/2015,mg,antineoplastic,4/22/2015,3/18/2015,Intravenous,paclitaxel protein-bound,FALSE
326,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/16/2025,mg,antineoplastic,11/25/2024,8/1/2024,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/2/2013,mg,antineoplastic,1/26/2012,12/30/2011,Intravenous,etoposide,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/23/2025,mg,antineoplastic,10/5/2024,8/31/2024,Intravenous,durvalumab,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/22/2024,mg,antineoplastic,11/11/2023,10/4/2023,Intravenous,durvalumab,TRUE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,9/27/2019,mg,antineoplastic,7/18/2019,6/19/2019,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,10/15/2021,mg,antineoplastic,6/19/2021,3/28/2021,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/15/2019,mg,antineoplastic,9/7/2018,7/12/2018,Intravenous,carboplatin,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/30/2015,mg,antineoplastic,9/19/2015,8/19/2015,Intravenous,bevacizumab,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/5/2021,mg/m2,antineoplastic,8/30/2021,3/9/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/19/2025,mg,antineoplastic,5/20/2019,12/28/2018,Intravenous,pembrolizumab,TRUE
214,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/24/2016,mg,antineoplastic,12/22/2015,12/4/2015,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/2/2013,mg/m2,antineoplastic,8/30/2013,8/8/2013,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G545:2F182DD:,9/17/2017,,antineoplastic,10/16/2017,8/12/2017,,clinical study drug,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,12/9/2020,mg/m2,antineoplastic,10/2/2020,10/31/2020,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/13/2024,mg,antineoplastic,5/4/2024,4/21/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G16:GC1C87FG:,7/11/2017,,,5/27/2017,4/6/2017,Oral,afatinib,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/2/2015,mg,antineoplastic,2/17/2015,8/28/2014,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/19/2025,mg,antineoplastic,10/27/2023,10/21/2023,Intravenous,pembrolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,6/22/2024,mg,antineoplastic,5/29/2024,5/22/2024,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/26/2025,mg,antineoplastic,7/9/2024,8/15/2021,Intravenous,atezolizumab,TRUE
175,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/5/2021,mg/m2,antineoplastic,1/15/2021,10/18/2020,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,2/1/2024,mg,antineoplastic,12/23/2023,1/21/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/17/2024,mg,antineoplastic,10/26/2023,5/28/2020,Intravenous,pembrolizumab,TRUE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/21/2021,mg,antineoplastic,10/25/2021,4/11/2021,Intravenous,vinorelbine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/24/2025,mg,antineoplastic,1/11/2025,6/12/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/13/2023,mg,antineoplastic,6/10/2023,7/4/2022,Intravenous,pembrolizumab,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,11/2/2016,mg,antineoplastic,7/8/2016,6/26/2016,Intravenous,paclitaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/25/2011,mg,antineoplastic,6/30/2011,6/12/2011,Intravenous,etoposide,FALSE
250,,ADJUVANT,Administrations,hormone,Fulvestrant,G286G2E848134,10/27/2016,mg,antineoplastic,11/22/2016,11/3/2016,Intramuscular,fulvestrant,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/1/2024,mg,antineoplastic,9/16/2023,3/19/2022,Intravenous,durvalumab,FALSE
970,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,2/7/2019,mg,antineoplastic,1/16/2019,1/4/2019,Intravenous,pemetrexed,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/12/2014,mg,antineoplastic,12/27/2013,12/20/2013,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/8/2024,mg,antineoplastic,2/13/2024,10/9/2022,Intravenous,pembrolizumab,TRUE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,4/17/2016,mg,antineoplastic,11/21/2015,12/10/2015,Intravenous,docetaxel,FALSE
285,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/25/2013,mg,antineoplastic,12/24/2012,8/31/2012,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,mg,antineoplastic,6/23/2020,5/8/2017,Intravenous,nivolumab,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/22/2020,mg,antineoplastic,6/2/2020,5/18/2020,Intravenous,carboplatin,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,7/5/2019,mg/m2,antineoplastic,5/26/2019,4/24/2019,Intravenous,etoposide,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/18/2013,,antineoplastic,5/13/2013,3/15/2013,Intravenous,vinorelbine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,5/4/2024,,antineoplastic,2/21/2024,1/27/2024,,cisplatin,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/16/2020,mg,antineoplastic,3/18/2020,1/28/2019,Subcutaneous,bortezomib,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/17/2020,mg,antineoplastic,7/1/2020,5/19/2020,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/3/2024,mg,antineoplastic,9/22/2023,2/28/2023,Intravenous,nivolumab,FALSE
374,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,12/30/2021,mg,antineoplastic,5/6/2021,3/15/2021,Intravenous,paclitaxel,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,11/26/2015,mg,antineoplastic,10/2/2015,3/21/2015,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,1/22/2025,,,1/16/2025,9/17/2024,Oral,lorlatinib,FALSE
164,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/5/2023,mg,antineoplastic,4/1/2022,3/6/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G262FC43B61CF,8/16/2019,,antineoplastic,6/23/2019,7/17/2019,,clinical study drug,FALSE
148,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/3/2012,mg,antineoplastic,9/9/2012,3/12/2012,Intravenous,carboplatin,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/17/2013,mg,antineoplastic,7/24/2013,4/30/2013,Intravenous,pemetrexed,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/22/2024,mg,antineoplastic,6/6/2023,1/27/2023,Intravenous,durvalumab,FALSE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/24/2019,mg/m2,antineoplastic,2/22/2019,12/19/2018,Intravenous,pemetrexed,FALSE
200,4,ADVANCED,Administrations,immunotherapy,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,1/20/2025,mg,antineoplastic,1/3/2025,12/9/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/1/2022,mg,antineoplastic,1/21/2021,2/6/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/2/2025,mg,antineoplastic,5/20/2022,6/8/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,1/14/2020,,antineoplastic,9/2/2017,7/21/2017,Intravenous,pemetrexed,TRUE
730,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/22/2024,mg,antineoplastic,9/19/2024,7/14/2024,Intravenous,carboplatin,FALSE
122,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:D34FC71922,11/5/2016,mg,antineoplastic,11/3/2016,10/13/2016,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/27/2024,mg,antineoplastic,8/28/2023,9/24/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,1/19/2017,,antineoplastic,6/19/2016,2/26/2016,Intravenous,clinical study drug,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,7/21/2021,mg,antineoplastic,2/7/2021,10/15/2020,Intravenous,gemcitabine,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/26/2021,mg,antineoplastic,10/27/2021,10/28/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G2G7B3CB6D5C4,8/8/2013,,,2/22/2013,4/2/2013,Oral,erlotinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/24/2019,mg,antineoplastic,8/13/2018,2/19/2018,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/23/2020,mg,antineoplastic,12/11/2019,2/25/2019,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/4/2025,mg,antineoplastic,8/11/2020,4/24/2018,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,12/9/2016,mg,antineoplastic,7/11/2016,7/4/2016,Intravenous,nivolumab,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/1/2021,mg,antineoplastic,5/23/2021,12/10/2020,Intravenous,vinorelbine,FALSE
640,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/17/2025,mg,antineoplastic,7/29/2024,5/1/2024,Intravenous,carboplatin,FALSE
,4,ADVANCED,Unstructured,,"Osimertinib,Trametinib",G31C:9::5EG5D,7/6/2024,,,7/12/2024,7/2/2024,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/29/2024,mg,antineoplastic,4/18/2021,4/23/2020,Intravenous,pembrolizumab,TRUE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,5/3/2012,mg,antineoplastic,8/24/2011,3/20/2011,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Administrations,targeted/biologic,Clinical Study Drug,G579E53D92:75,10/12/2011,,antineoplastic,9/15/2011,9/8/2011,Intravenous,clinical study drug,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/4/2020,mg,antineoplastic,10/30/2019,8/26/2019,Intravenous,durvalumab,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,8/31/2014,mg/m2,antineoplastic,7/7/2014,5/1/2014,Intravenous,docetaxel,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/2/2014,AUC,antineoplastic,2/18/2014,11/7/2013,Intravenous,carboplatin,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/6/2020,mg,antineoplastic,11/22/2019,10/12/2019,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/27/2025,mg,antineoplastic,12/22/2021,1/20/2017,Intravenous,pembrolizumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G34BG69F45EE4,9/11/2019,mg/kg,antineoplastic,2/8/2019,11/8/2018,Intravenous,durvalumab,FALSE
427,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,11/3/2022,mg,antineoplastic,11/20/2022,9/20/2022,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/16/2020,mg,antineoplastic,1/24/2017,1/7/2017,Intravenous,nivolumab,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/14/2024,mg,antineoplastic,8/19/2024,9/15/2024,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/17/2022,mg,antineoplastic,5/3/2017,4/25/2017,Intravenous,nivolumab,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/21/2019,mg/m2,antineoplastic,9/4/2019,9/21/2019,Intravenous,paclitaxel,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,11/8/2013,mg,antineoplastic,7/19/2013,7/16/2013,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/17/2025,mg,antineoplastic,2/14/2023,6/5/2022,Intravenous,pembrolizumab,FALSE
234,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,1/25/2015,mg,antineoplastic,11/13/2014,10/20/2014,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,11/22/2016,,antineoplastic,7/1/2016,4/24/2016,Intravenous,nivolumab,FALSE
117,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/17/2020,mg,antineoplastic,8/31/2020,6/7/2020,Subcutaneous,azacitidine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/15/2020,mg,antineoplastic,9/3/2019,6/13/2019,Intravenous,pembrolizumab,TRUE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,6/4/2024,mg,antineoplastic,1/10/2024,9/14/2023,Intravenous,amivantamab-vmjw,FALSE
575,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/18/2022,mg,antineoplastic,5/22/2021,2/5/2021,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,12/30/2012,mg,antineoplastic,9/8/2012,12/16/2011,Intravenous,etoposide,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,11/20/2016,mg,antineoplastic,7/23/2016,7/16/2016,Intravenous,pemetrexed,FALSE
975,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/24/2023,mg,antineoplastic,4/22/2023,3/27/2023,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/8/2020,mg,antineoplastic,2/18/2019,3/3/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/15/2025,mg,antineoplastic,9/8/2022,1/15/2019,Intravenous,pembrolizumab,TRUE
1,1,ADVANCED,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,8/3/2022,mg,antineoplastic,4/25/2022,4/28/2022,Oral,anastrozole,FALSE
84,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,4/30/2022,mg,antineoplastic,5/11/2022,3/4/2022,Intravenous,paclitaxel,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,10/20/2019,AUC,antineoplastic,8/2/2019,7/9/2019,Intravenous,carboplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,11/21/2019,mg,antineoplastic,9/25/2019,9/21/2019,Intravenous,pemetrexed,FALSE
,,CONCURRENT,Unstructured,,Osimertinib,G15F23FC1G645,1/5/2025,,,4/18/2024,5/15/2024,Oral,osimertinib,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/14/2024,mg,antineoplastic,1/19/2024,10/30/2023,Intravenous,amivantamab-vmjw,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,12/19/2024,mg,antineoplastic,10/2/2024,7/27/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/18/2018,mg,antineoplastic,9/1/2017,7/16/2017,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/13/2020,mg,antineoplastic,10/17/2017,11/26/2015,Intravenous,nivolumab,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/18/2022,mg,antineoplastic,11/17/2022,9/29/2022,Oral,imatinib,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,9/24/2015,mg,antineoplastic,9/25/2015,6/5/2015,Intravenous,nivolumab,FALSE
172,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/16/2023,mg,antineoplastic,5/24/2023,3/29/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/10/2019,mg,antineoplastic,2/27/2019,2/15/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,pain agent,Clinical Study Drug,G14E7662::61C,5/13/2017,,pain agent,6/16/2016,2/17/2016,,clinical study drug,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/1/2022,mg,antineoplastic,3/11/2021,2/10/2021,Intravenous,bevacizumab-awwb,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3E567F5B3:95,10/25/2018,mg,antineoplastic,9/30/2018,8/8/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/5/2023,mg,antineoplastic,3/30/2023,10/24/2021,Intravenous,pembrolizumab,TRUE
114,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,12/27/2012,mg,antineoplastic,2/2/2013,12/7/2012,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/2/2023,mg,antineoplastic,2/10/2022,11/6/2021,Intravenous,pembrolizumab,TRUE
80,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,1/16/2025,mg,antineoplastic,12/7/2024,9/27/2024,Intravenous,ipilimumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/30/2020,mg,antineoplastic,2/8/2018,12/21/2015,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/1/2022,mg,antineoplastic,6/18/2020,2/15/2020,Intravenous,nivolumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/19/2023,mg,antineoplastic,8/6/2023,6/2/2023,Intravenous,pemetrexed,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/8/2015,mg,antineoplastic,2/3/2014,2/7/2014,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,12/6/2021,mL,solution-fluid,11/13/2018,2/21/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,10/17/2019,mg,antineoplastic,5/31/2019,6/2/2019,Intravenous,pembrolizumab,FALSE
610,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,7/11/2022,mg,antineoplastic,4/24/2022,3/21/2022,Intravenous,carboplatin,FALSE
385,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,3/7/2023,mg,antineoplastic,12/17/2022,12/14/2022,Intravenous,paclitaxel,FALSE
510,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/23/2022,mg,antineoplastic,3/31/2022,2/4/2022,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G2141CBEF3GD3,11/7/2022,mL,solution-fluid,10/23/2022,12/11/2022,Intravenous,durvalumab,TRUE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/11/2024,,antineoplastic,9/6/2024,8/23/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/26/2021,mg,antineoplastic,10/17/2021,8/17/2021,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/10/2025,mg,antineoplastic,8/16/2023,7/23/2021,Intravenous,atezolizumab,TRUE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/2/2021,mg/m2,antineoplastic,6/9/2021,3/27/2021,Intravenous,leucovorin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/27/2025,mg,antineoplastic,4/7/2023,7/24/2021,Intravenous,atezolizumab,TRUE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/18/2014,mg,antineoplastic,8/11/2014,7/7/2014,Intravenous,vinorelbine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/12/2025,mg,antineoplastic,2/11/2024,9/1/2021,Intravenous,atezolizumab,TRUE
204,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/6/2020,mg,antineoplastic,5/13/2017,2/22/2017,Intravenous,paclitaxel,FALSE
732,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/21/2017,mg,antineoplastic,7/16/2017,6/25/2017,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,3/4/2024,,antineoplastic,6/21/2023,4/28/2023,Intravenous,atezolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,4/9/2021,mg,antineoplastic,1/12/2021,12/2/2020,Intravenous,cyclophosphamide,FALSE
112,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/11/2013,mg,antineoplastic,6/4/2013,3/31/2013,Intravenous,carboplatin,FALSE
92,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G3DG:2D1DGE8B,6/20/2015,mg,antineoplastic,7/8/2015,6/29/2015,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/18/2024,mg,antineoplastic,6/14/2022,5/11/2020,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,7/10/2017,,solution-fluid,12/10/2016,11/27/2016,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,3/7/2015,,antineoplastic,1/15/2015,2/18/2015,,paclitaxel protein-bound,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/9/2023,,antineoplastic,7/20/2023,3/17/2023,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/15/2013,mg,antineoplastic,4/29/2013,2/25/2013,Intravenous,paclitaxel protein-bound,FALSE
162,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/22/2023,mg,antineoplastic,9/21/2023,8/22/2023,Intravenous,carboplatin,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/27/2024,mg,antineoplastic,8/3/2024,8/11/2024,Intravenous,carboplatin,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/14/2025,mg,antineoplastic,3/29/2025,10/23/2022,Intravenous,pemetrexed,TRUE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/2/2025,mg,antineoplastic,2/4/2025,9/4/2024,Intravenous,durvalumab,TRUE
152,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/17/2023,mg,antineoplastic,5/12/2023,5/13/2023,Intravenous,carboplatin,FALSE
180,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G3:C9BECD3F55,9/13/2020,mg,antineoplastic,7/12/2020,8/8/2020,Intravenous,docetaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,7/16/2024,mg,antineoplastic,12/31/2023,7/23/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G57G45B:D1F17,1/7/2025,,antineoplastic,6/15/2018,12/11/2017,,clinical study drug,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/10/2022,mg/kg,antineoplastic,6/7/2021,2/9/2021,Intravenous,durvalumab,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/11/2014,mg,antineoplastic,1/19/2014,11/13/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,3/25/2024,,antineoplastic,9/24/2023,5/28/2023,Intravenous,clinical study drug,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/16/2025,mg,antineoplastic,3/9/2025,6/1/2023,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/21/2019,mg,antineoplastic,6/21/2017,5/22/2017,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/30/2025,mg,antineoplastic,4/27/2016,11/22/2015,Intravenous,paclitaxel,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/18/2019,mg,antineoplastic,6/30/2019,5/22/2019,Intravenous,docetaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/15/2014,mg,antineoplastic,6/5/2014,7/8/2014,Intravenous,paclitaxel protein-bound,FALSE
210,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G42734BB63:32,8/29/2016,mg,antineoplastic,6/11/2016,5/9/2016,Intravenous,nivolumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/6/2019,mg,antineoplastic,7/11/2018,2/21/2018,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/17/2025,mg,antineoplastic,12/31/2022,1/2/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/19/2025,mg,antineoplastic,2/2/2023,9/2/2022,Intravenous,pembrolizumab,TRUE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,8/31/2022,mg,antineoplastic,7/26/2022,7/31/2022,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/17/2025,mg,antineoplastic,7/11/2018,3/2/2018,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/16/2018,mg,antineoplastic,10/18/2017,8/21/2015,Intravenous,nivolumab,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,8/29/2019,mg,antineoplastic,6/26/2019,5/1/2019,Intravenous,pemetrexed,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/6/2024,mg,antineoplastic,3/11/2024,1/26/2024,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/30/2019,mg,antineoplastic,5/16/2018,4/20/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/1/2025,mg,antineoplastic,1/24/2025,5/20/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/27/2022,,antineoplastic,7/6/2019,5/4/2017,Oral,nilotinib,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/9/2017,,antineoplastic,6/30/2017,8/14/2017,,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,4/8/2023,mg,antineoplastic,1/6/2023,11/27/2022,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/22/2019,mg,antineoplastic,4/5/2018,3/5/2018,Intravenous,nivolumab,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,3/5/2019,mg,antineoplastic,1/19/2019,1/28/2019,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/1/2023,mg,antineoplastic,11/6/2022,9/28/2022,Subcutaneous,azacitidine,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,5/14/2012,,solution-fluid,12/10/2011,9/7/2011,Intravenous,clinical study drug,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/4/2020,mg,antineoplastic,6/26/2018,7/8/2017,Intravenous,pemetrexed,TRUE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,9/8/2017,mg,antineoplastic,9/24/2017,7/13/2017,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/6/2023,mg,antineoplastic,3/22/2021,6/4/2020,Intravenous,pembrolizumab,FALSE
,5,ADVANCED,Orders,hormone,"Everolimus,Exemestane",G19937F58E541,10/27/2014,,antineoplastic,8/1/2014,7/12/2014,Oral,exemestane,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/1/2021,,antineoplastic,3/13/2021,3/2/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Exemestane,G358EF4457D52,7/27/2014,,antineoplastic,7/22/2014,6/28/2014,Oral,exemestane,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/20/2015,mg,antineoplastic,1/2/2015,10/5/2014,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/6/2017,mg,antineoplastic,4/1/2016,3/23/2015,Intravenous,bevacizumab,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/2/2024,mg,antineoplastic,11/15/2024,8/25/2024,Intravenous,pemetrexed,TRUE
770,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/23/2025,mg,antineoplastic,1/19/2024,3/14/2019,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/17/2018,mg/m2,antineoplastic,11/4/2018,7/8/2018,Intravenous,pemetrexed,TRUE
1050,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,3/16/2024,mg,antineoplastic,12/24/2023,12/27/2023,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/22/2025,mg,antineoplastic,11/12/2024,2/23/2024,Intravenous,pembrolizumab,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,11/17/2024,mg,antineoplastic,11/4/2024,8/2/2024,Intravenous,temsirolimus,FALSE
453,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,12/23/2023,mg,antineoplastic,2/4/2024,12/20/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/18/2015,,antineoplastic,10/6/2015,9/22/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/21/2025,mg,antineoplastic,3/3/2019,5/12/2018,Intravenous,pembrolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G184:C43CDE:B,6/7/2017,mg,antineoplastic,7/2/2017,7/20/2017,Intravenous,paclitaxel protein-bound,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/30/2023,mg,antineoplastic,4/13/2018,11/29/2017,Intravenous,nivolumab,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/14/2018,mg,antineoplastic,11/19/2018,7/15/2018,Intravenous,carboplatin,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/13/2016,mg,antineoplastic,3/1/2015,6/10/2014,Intravenous,bevacizumab,FALSE
740,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,12/24/2024,mg,antineoplastic,11/23/2024,9/13/2024,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,7/24/2024,mg,antineoplastic,6/23/2024,6/3/2024,Intravenous,carboplatin,FALSE
670,1,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,7/14/2018,mg,antineoplastic,5/20/2017,10/26/2016,Intravenous,rituximab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/8/2024,mg,antineoplastic,8/13/2023,12/31/2022,Intravenous,nivolumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/11/2016,mg,antineoplastic,10/12/2016,8/24/2016,Intravenous,pemetrexed,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/9/2021,mg,antineoplastic,12/20/2019,11/28/2019,Intravenous,durvalumab,TRUE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,11/29/2021,,antineoplastic,11/1/2018,4/7/2018,,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/3/2025,mg,antineoplastic,7/5/2020,2/11/2018,Intravenous,nivolumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/20/2015,mg,antineoplastic,12/4/2014,10/6/2014,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,7/2/2023,mg,antineoplastic,4/5/2023,4/11/2023,Intravenous,pembrolizumab,FALSE
280,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G381867BDG3G2,11/15/2014,mg,antineoplastic,10/29/2014,12/2/2014,Intravenous,carboplatin,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/24/2021,mg,antineoplastic,2/16/2019,3/25/2018,Intravenous,durvalumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/30/2025,mg,antineoplastic,11/15/2021,2/9/2019,Intravenous,pemetrexed,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,8/14/2014,mg,antineoplastic,8/24/2014,6/11/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/24/2020,mg,antineoplastic,6/11/2018,12/6/2017,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G142964636C93,4/1/2022,mg,antineoplastic,4/14/2022,2/1/2022,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,12/19/2011,mg/m2,antineoplastic,12/17/2011,12/24/2011,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/17/2025,mg,antineoplastic,3/12/2024,5/21/2022,Intravenous,pembrolizumab,FALSE
165,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,9/30/2022,mg,antineoplastic,10/14/2022,8/23/2022,Intravenous,carboplatin,FALSE
130,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G283EB4BF8E72,1/9/2012,mg,antineoplastic,1/23/2012,12/22/2011,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/12/2013,,antineoplastic,5/19/2012,4/14/2012,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/6/2015,mg,antineoplastic,4/25/2014,12/22/2013,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Temozolomide,G3DB42DD29B5G,9/28/2021,,antineoplastic,8/9/2021,5/12/2021,Oral,temozolomide,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/29/2016,mg,antineoplastic,8/15/2016,7/4/2016,Intravenous,necitumumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/21/2021,mg,antineoplastic,8/24/2021,10/18/2019,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/16/2016,mg,antineoplastic,4/20/2016,2/20/2016,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,7/21/2023,mg,antineoplastic,4/22/2023,4/4/2023,Intravenous,pembrolizumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/14/2015,mg,antineoplastic,2/8/2015,3/8/2015,Intravenous,paclitaxel protein-bound,FALSE
46,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3ED9686E8628,5/15/2014,mg,antineoplastic,2/13/2014,2/26/2014,Intravenous,vinorelbine,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,7/14/2021,mg,antineoplastic,5/17/2021,2/8/2021,Intravenous,pemetrexed,TRUE
206.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G2745:9D5G3DG,3/18/2012,mg,antineoplastic,3/25/2012,4/12/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/1/2022,mg,antineoplastic,12/23/2020,8/21/2020,Intravenous,pembrolizumab,TRUE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/6/2022,mg,antineoplastic,4/5/2021,2/21/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/25/2017,,antineoplastic,4/25/2017,2/27/2016,Intravenous,clinical study drug,FALSE
10,1,ADVANCED,Orders,targeted/biologic,"Erlotinib,Ramucirumab",G4725296E3CE4,10/5/2021,mg/kg,antineoplastic,10/15/2021,7/25/2021,Intravenous,ramucirumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/24/2014,mg,antineoplastic,9/30/2014,8/6/2014,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/8/2023,mL,solution-fluid,6/20/2023,12/17/2022,Intravenous,pemetrexed,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/26/2011,mg,antineoplastic,9/3/2011,8/23/2011,Intravenous,etoposide,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4CG4:632GG8E,8/23/2021,,,9/25/2021,5/9/2021,Oral,osimertinib,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,3/22/2017,mg,antineoplastic,12/24/2016,10/30/2016,Intravenous,nivolumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/19/2016,mg,antineoplastic,1/27/2016,1/18/2016,Intravenous,paclitaxel,FALSE
620,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1978F5FFE:43,8/15/2014,mg,antineoplastic,6/15/2014,7/10/2014,Intravenous,bevacizumab,FALSE
5,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/8/2023,AUC,antineoplastic,4/4/2023,3/4/2023,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/8/2021,mL,solution-fluid,4/16/2021,4/9/2021,Intravenous,pemetrexed,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/19/2020,mg,antineoplastic,6/17/2020,12/22/2019,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,3/13/2025,mg,antineoplastic,7/5/2024,9/19/2023,Intravenous,pembrolizumab,FALSE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,10/24/2018,mg,antineoplastic,9/15/2018,9/23/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,7/4/2024,,antineoplastic,8/11/2024,7/20/2024,,gemcitabine,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/25/2025,mg,antineoplastic,4/1/2025,1/27/2025,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/10/2017,,antineoplastic,11/26/2017,7/24/2017,,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/1/2024,mg,antineoplastic,10/14/2023,2/20/2023,Intravenous,nivolumab,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,4/10/2013,mg,antineoplastic,3/15/2013,1/18/2013,Intravenous,paclitaxel,FALSE
128.4,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/10/2019,mg,antineoplastic,9/3/2019,8/4/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/14/2018,mg,antineoplastic,6/20/2015,6/6/2015,Intravenous,carboplatin,FALSE
230,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/3/2013,mg,antineoplastic,7/20/2013,5/10/2013,Intravenous,carboplatin,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/18/2025,mg,antineoplastic,4/23/2024,9/16/2022,Intravenous,pemetrexed,TRUE
622,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,5/17/2024,mg,antineoplastic,4/20/2024,2/28/2024,Intravenous,carboplatin,FALSE
1700,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,4/20/2023,mg,antineoplastic,11/17/2022,10/4/2022,Intravenous,gemcitabine,FALSE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,6/8/2020,mg,antineoplastic,5/22/2020,5/29/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/21/2024,mg,antineoplastic,1/2/2023,10/3/2022,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/22/2023,mg,antineoplastic,6/3/2023,3/28/2023,Intravenous,pembrolizumab,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/25/2024,mg,antineoplastic,4/11/2024,3/6/2024,Intravenous,gemcitabine,FALSE
201,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,11/12/2023,mg,antineoplastic,8/31/2023,9/7/2023,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/2/2020,mg,antineoplastic,1/8/2020,10/21/2019,Intravenous,carboplatin,FALSE
160,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G167G71733G69,11/30/2016,mg,antineoplastic,4/18/2016,3/15/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/13/2025,,antineoplastic,4/25/2024,5/6/2024,Intravenous,paclitaxel protein-bound,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,12/24/2014,mg,antineoplastic,11/14/2014,9/21/2014,Intravenous,carboplatin,FALSE
636,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/1/2025,mg,antineoplastic,1/23/2025,1/10/2025,Intravenous,fluorouracil,FALSE
659,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/23/2016,mg,antineoplastic,5/31/2016,4/26/2016,Intravenous,carboplatin,FALSE
259.8,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G57:2GEC9DD36,12/21/2015,mg,antineoplastic,10/18/2015,11/4/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/6/2020,,antineoplastic,3/14/2018,8/9/2017,Intravenous,pemetrexed,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,8/6/2022,mg,antineoplastic,6/21/2022,9/5/2021,Intravenous,durvalumab,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,1/7/2015,mg,antineoplastic,3/4/2014,1/16/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/4/2019,mg,antineoplastic,3/6/2019,1/21/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/1/2024,mg,antineoplastic,8/13/2023,6/20/2023,Intravenous,pembrolizumab,TRUE
,4,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G46:87GF7FGC9,12/3/2016,,antineoplastic,9/4/2016,10/2/2016,,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/26/2025,mg,antineoplastic,1/9/2020,12/24/2016,Intravenous,pembrolizumab,FALSE
156.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,10/8/2019,mg,antineoplastic,8/25/2019,6/4/2019,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,6/8/2018,mg,antineoplastic,5/10/2018,1/14/2018,Intravenous,pemetrexed,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/26/2019,mg,antineoplastic,3/17/2019,12/27/2018,Intravenous,paclitaxel,FALSE
480,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G2C38B34G8794,10/28/2024,mg,antineoplastic,10/27/2024,8/20/2024,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/7/2015,mg,antineoplastic,1/3/2015,12/3/2014,Intravenous,pemetrexed,FALSE
94,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,10/1/2019,mg,antineoplastic,8/2/2019,7/1/2019,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,9/28/2022,mg,antineoplastic,7/16/2022,11/1/2021,Intravenous,pemetrexed,TRUE
417,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,6/14/2023,mg,antineoplastic,2/26/2023,2/13/2023,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/17/2015,mg,antineoplastic,9/16/2015,3/4/2015,Intravenous,paclitaxel protein-bound,FALSE
950,4,ADVANCED,Administrations,chemotherapy,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,7/25/2016,mg,antineoplastic,6/2/2016,5/2/2016,Intravenous,pemetrexed,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,11/4/2015,mg,antineoplastic,7/28/2015,5/30/2015,Intravenous,nivolumab,FALSE
336,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,11/3/2024,mg,antineoplastic,7/5/2024,6/29/2024,Intravenous,carboplatin,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/2/2021,mg,antineoplastic,9/1/2019,5/22/2019,Intravenous,paclitaxel,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2D168F99BCD4,2/11/2023,AUC,antineoplastic,1/27/2023,2/26/2023,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34927D694398,5/1/2018,mg,antineoplastic,3/25/2018,3/11/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G26B24C7D5G91,5/5/2019,mg,antineoplastic,4/9/2019,5/3/2019,Intravenous,pembrolizumab,FALSE
85,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,9/1/2015,mg,antineoplastic,8/15/2015,7/12/2015,Intravenous,paclitaxel,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/7/2015,mg,antineoplastic,10/7/2014,9/21/2014,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/1/2021,,antiemetic,4/14/2020,1/23/2020,Intravenous,clinical study drug,FALSE
641.8,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/14/2018,mg,antineoplastic,6/21/2018,5/19/2018,Intravenous,carboplatin,FALSE
413,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/10/2023,mg,antineoplastic,5/16/2023,11/13/2022,Intravenous,bevacizumab-bvzr,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,3/18/2025,mg,antineoplastic,2/12/2025,1/20/2025,Intravenous,pembrolizumab,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/10/2015,mg,antineoplastic,10/21/2014,9/1/2014,Intravenous,paclitaxel,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/17/2014,mg,antineoplastic,3/13/2014,12/6/2013,Intravenous,eribulin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/10/2021,mg,antineoplastic,10/1/2020,10/15/2020,Intravenous,durvalumab,FALSE
3,1,ADVANCED,Orders,immunotherapy,Nivolumab,G33E77:6CF7F3,9/14/2017,mg/kg,antineoplastic,5/7/2017,9/1/2016,Intravenous,nivolumab,FALSE
420,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3642135:5B4C,1/21/2019,mg,antineoplastic,1/31/2019,11/25/2018,Intravenous,durvalumab,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/12/2020,mg,antineoplastic,3/29/2020,4/24/2020,Intravenous,carboplatin,FALSE
731.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,8/31/2017,mg,antineoplastic,5/27/2017,4/30/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/30/2022,mg,antineoplastic,10/8/2022,9/21/2022,Intravenous,pembrolizumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2763DEB9848B,4/21/2020,mg,antineoplastic,4/20/2020,3/31/2020,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,2/27/2015,mg,antineoplastic,1/4/2015,6/20/2014,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,8/30/2018,mg,antineoplastic,6/29/2018,10/3/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,5/15/2023,mg,antineoplastic,3/11/2023,3/6/2023,Intravenous,pembrolizumab,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,10/7/2022,mg,antineoplastic,8/4/2022,8/25/2022,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/22/2014,,antineoplastic,11/21/2013,12/10/2013,,pemetrexed,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/27/2016,mg,antineoplastic,7/15/2016,4/2/2016,Intravenous,bevacizumab,TRUE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G128:92:3BD3D,12/24/2021,,steroid,7/21/2021,5/25/2021,Intravenous,clinical study drug,FALSE
855,,ADJUVANT,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/14/2013,mg,antineoplastic,1/9/2013,12/7/2012,Intravenous,rituximab,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/23/2014,mg,antineoplastic,5/6/2014,3/22/2014,Intravenous,paclitaxel,FALSE
742,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,1/7/2014,mg,antineoplastic,11/17/2013,11/16/2013,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,10/8/2019,mg,antineoplastic,6/21/2019,5/20/2019,Intravenous,pemetrexed,TRUE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/3/2021,mg,antineoplastic,12/20/2020,9/18/2020,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/25/2020,,antineoplastic,7/25/2020,5/14/2020,Intravenous,cisplatin,FALSE
1920,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/21/2020,mg,antineoplastic,3/2/2014,4/22/2014,Intravenous,gemcitabine,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/25/2020,mg,antineoplastic,5/5/2019,3/4/2019,Intravenous,durvalumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5:D955C88D97,10/24/2022,mg,antineoplastic,4/14/2019,5/6/2019,Intravenous,pemetrexed,FALSE
500,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,7/24/2014,mg,antineoplastic,8/4/2014,2/28/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/21/2025,mg,antineoplastic,1/17/2025,1/24/2017,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/10/2017,mg,antineoplastic,5/22/2017,8/24/2016,Intravenous,nivolumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13G1125C1G:F,12/24/2019,AUC,antineoplastic,11/9/2019,12/3/2019,Intravenous,carboplatin,FALSE
28,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,9/26/2013,mg,antineoplastic,9/8/2013,8/4/2013,Intravenous,vinorelbine,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/8/2023,mg,antineoplastic,1/16/2023,12/3/2019,Intravenous,pembrolizumab,FALSE
104,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,6/25/2017,mg,antineoplastic,6/21/2017,6/9/2017,Intravenous,paclitaxel,FALSE
486.2,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G163D9B593927,10/27/2014,mg,antineoplastic,9/14/2014,10/1/2014,Intravenous,carboplatin,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,10/10/2015,mg,antineoplastic,5/6/2015,2/26/2015,Intravenous,pemetrexed,TRUE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34927D694398,5/3/2018,mg,antineoplastic,4/20/2018,3/20/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,3/17/2015,,antineoplastic,12/26/2014,7/24/2014,,clinical study drug,FALSE
206,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,12/10/2019,mg,antineoplastic,12/9/2019,10/30/2019,Intravenous,carboplatin,FALSE
40,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,10/12/2013,mg,antineoplastic,9/8/2013,8/23/2013,Intravenous,vinorelbine,FALSE
215,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,6/7/2016,mg,antineoplastic,1/1/2016,11/27/2015,Intravenous,carboplatin,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/22/2013,mg,antineoplastic,3/3/2013,7/4/2012,Intravenous,pemetrexed,FALSE
1040,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G17235672EDGF,9/3/2024,mg,antineoplastic,7/21/2024,7/15/2024,Intravenous,pemetrexed,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/17/2014,mg,antineoplastic,11/19/2014,8/15/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/21/2022,mg,antineoplastic,12/2/2021,12/14/2021,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1C49C5CC7:F7,3/21/2017,mg,antineoplastic,4/15/2017,3/10/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/22/2021,mg,antineoplastic,6/25/2021,4/24/2021,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/26/2023,,antineoplastic,12/21/2022,3/26/2022,Intravenous,pembrolizumab,FALSE
524,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,2/9/2025,mg,antineoplastic,12/8/2024,12/2/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/3/2025,mg,antineoplastic,8/19/2020,4/3/2020,Intravenous,pembrolizumab,FALSE
1288,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G24632:D18158,3/21/2020,mg,antineoplastic,3/4/2020,12/16/2019,Intravenous,gemcitabine,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,5/27/2019,mg,antineoplastic,1/27/2019,1/4/2019,Intravenous,paclitaxel protein-bound,FALSE
20,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,8/18/2024,mg,antineoplastic,8/18/2024,6/6/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/17/2024,mg,antineoplastic,11/23/2021,6/19/2020,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/14/2020,mg,antineoplastic,11/12/2017,3/14/2016,Intravenous,bevacizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,4/16/2021,mg,antineoplastic,10/6/2020,10/28/2020,Intravenous,nivolumab,FALSE
1700,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,4/3/2023,mg,antineoplastic,12/2/2022,9/16/2022,Intravenous,gemcitabine,FALSE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/6/2025,mg,antineoplastic,11/9/2024,9/28/2024,Intravenous,paclitaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/27/2025,mg,antineoplastic,12/19/2023,3/22/2020,Intravenous,pemetrexed,TRUE
190,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/19/2020,mg,antineoplastic,9/7/2016,8/15/2016,Intravenous,nivolumab,FALSE
1089,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G147B:8F3B:52,11/8/2021,mg,antineoplastic,10/31/2021,12/18/2021,Intravenous,bevacizumab-awwb,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/9/2014,mg/m2,antineoplastic,2/7/2014,11/24/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/31/2021,mg,antineoplastic,3/18/2021,10/5/2019,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/20/2025,mg,antineoplastic,10/28/2022,9/9/2022,Oral,anastrozole,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/21/2024,mg,antineoplastic,12/1/2023,9/28/2023,Intravenous,pemetrexed,FALSE
973,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/15/2017,mg,antineoplastic,1/27/2017,12/12/2016,Intravenous,bevacizumab,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/27/2013,mg,antineoplastic,4/5/2012,4/28/2012,Intravenous,paclitaxel,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/15/2012,mg,antineoplastic,2/5/2012,1/16/2012,Intravenous,etoposide,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4:6E57617757,4/14/2025,,,3/24/2025,8/17/2021,Oral,osimertinib,FALSE
345,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,2/29/2012,mg,antineoplastic,3/30/2012,12/3/2011,Intravenous,paclitaxel,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,5/7/2025,mg,antineoplastic,5/18/2025,5/3/2025,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,9/29/2023,mg,antineoplastic,8/12/2023,1/30/2023,Oral,zanubrutinib,FALSE
748,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/16/2024,mg,antineoplastic,2/7/2023,2/14/2023,Intravenous,durvalumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/4/2014,mg,antineoplastic,9/8/2014,6/26/2014,Intravenous,bevacizumab,FALSE
415,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/20/2015,mg,antineoplastic,3/27/2015,2/9/2015,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/27/2023,mg,antineoplastic,6/12/2023,5/20/2023,Intravenous,pemetrexed,FALSE
92,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,1/19/2024,mg,antineoplastic,11/10/2023,10/31/2023,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G1GFD92F489E7,3/28/2023,mg,antineoplastic,3/5/2023,2/14/2023,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/5/2015,mg,antineoplastic,9/29/2014,9/6/2014,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/18/2025,mg,antineoplastic,12/30/2016,12/4/2016,Intravenous,nivolumab,FALSE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,9/30/2017,mg,antineoplastic,9/29/2017,8/29/2017,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/14/2022,mg,antineoplastic,6/19/2019,1/27/2018,Intravenous,pembrolizumab,FALSE
75,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,8/24/2011,mg,antineoplastic,8/21/2011,8/26/2011,Intravenous,cisplatin,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,9/14/2024,mg,antineoplastic,2/5/2024,2/9/2024,Intravenous,paclitaxel,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,12/18/2023,mg,antineoplastic,10/2/2023,5/30/2023,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G555D3D316568,10/2/2018,mg,antineoplastic,7/27/2018,7/4/2018,Intravenous,nivolumab,FALSE
169,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,9/15/2018,mg,antineoplastic,3/9/2014,2/27/2014,Intravenous,docetaxel,FALSE
140,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,1/5/2019,mg,antineoplastic,1/5/2019,12/28/2018,Intravenous,carboplatin,FALSE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,10/25/2018,mg,antineoplastic,9/17/2018,10/9/2018,Intravenous,paclitaxel,FALSE
134,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,3/7/2021,mg,antineoplastic,11/20/2020,11/20/2020,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,4/12/2025,,antineoplastic,8/19/2024,3/22/2024,,pembrolizumab,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/11/2023,mg,antineoplastic,1/28/2023,10/28/2022,Intravenous,durvalumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/3/2025,mg,antineoplastic,2/18/2025,8/21/2021,Intravenous,atezolizumab,TRUE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/10/2015,mg,antineoplastic,1/5/2015,9/27/2014,Intravenous,etoposide,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/7/2023,mg,antineoplastic,5/3/2023,4/13/2023,Subcutaneous,azacitidine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,7/7/2024,,antineoplastic,5/30/2024,5/3/2024,Intravenous,carboplatin,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/8/2024,mg,antineoplastic,7/20/2024,7/15/2024,Intravenous,paclitaxel,FALSE
215.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/21/2023,mg,antineoplastic,5/6/2023,3/23/2023,Intravenous,carboplatin,FALSE
476,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,7/17/2018,mg,antineoplastic,3/5/2018,1/4/2018,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/16/2021,mg,antineoplastic,12/11/2020,8/3/2020,Intravenous,ramucirumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/7/2020,mg,antineoplastic,1/15/2017,1/14/2016,Intravenous,bevacizumab,TRUE
386,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,11/16/2015,mg,antineoplastic,5/18/2015,6/25/2015,Intravenous,ramucirumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/31/2024,mg,antineoplastic,11/21/2021,12/14/2021,Intravenous,durvalumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,9/21/2022,mg,antineoplastic,11/27/2021,10/8/2021,Intravenous,pemetrexed,TRUE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/13/2021,mg,antineoplastic,11/7/2020,10/12/2020,Intravenous,gemcitabine,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,5/1/2022,mg,antineoplastic,11/20/2020,4/10/2020,Intravenous,durvalumab,TRUE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,8/13/2014,mg,antineoplastic,6/30/2013,8/3/2013,Intravenous,bevacizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,1/5/2023,mg,antineoplastic,5/31/2022,6/20/2021,Intravenous,pembrolizumab,FALSE
810,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/8/2025,mg,antineoplastic,8/28/2024,3/18/2024,Intravenous,durvalumab,TRUE
815,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/30/2018,mg,antineoplastic,2/2/2018,1/29/2018,Intravenous,pemetrexed,FALSE
1000,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/7/2017,mg,antineoplastic,5/21/2017,4/2/2017,Intravenous,pemetrexed,FALSE
399,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/13/2024,mg,antineoplastic,2/28/2024,1/25/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,hormone,Anastrozole,G49E8CFG53::D,3/21/2013,,antineoplastic,7/18/2011,7/7/2011,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2GF55749G7G9,1/15/2022,mg,antineoplastic,12/27/2021,12/24/2021,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/29/2016,mg,antineoplastic,1/16/2016,6/23/2015,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/6/2025,mg,antineoplastic,11/13/2024,5/9/2024,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/25/2019,mg,antineoplastic,4/21/2017,4/21/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4C:6:784E1GF,10/6/2017,,,9/14/2017,9/13/2016,Oral,erlotinib,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/15/2024,mg,antineoplastic,8/18/2024,6/1/2024,Intravenous,gemcitabine,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/4/2020,mg,antineoplastic,9/5/2018,3/7/2017,Intravenous,bevacizumab,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/31/2017,mg/kg,antineoplastic,4/1/2017,9/17/2016,Intravenous,bevacizumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/17/2025,mg,antineoplastic,1/4/2022,2/25/2020,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/29/2025,mg,antineoplastic,11/23/2022,1/20/2017,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/8/2022,,antineoplastic,1/13/2022,8/7/2021,Intravenous,amivantamab-vmjw,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/6/2014,mg,antineoplastic,9/10/2012,10/12/2012,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/4/2023,mg,antineoplastic,11/23/2022,1/23/2020,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,4/11/2025,mg,antineoplastic,10/22/2024,1/16/2024,Intravenous,pembrolizumab,FALSE
35,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G36BE14CG117:,5/6/2018,mg,antineoplastic,5/6/2018,4/29/2018,Intravenous,docetaxel,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/27/2024,mg,antineoplastic,4/12/2024,4/19/2024,Intravenous,paclitaxel,FALSE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,3/22/2017,mg,antineoplastic,8/1/2016,5/17/2016,Intravenous,nivolumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/3/2015,mg,antineoplastic,7/5/2015,1/20/2015,Intravenous,paclitaxel protein-bound,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,4/2/2013,mg,antineoplastic,3/11/2013,1/17/2013,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,4/4/2025,mg,antineoplastic,3/19/2025,12/12/2024,Intravenous,nivolumab,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,11/28/2022,mg,antineoplastic,6/5/2022,2/27/2022,Intravenous,durvalumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/16/2020,mg,antineoplastic,4/12/2020,9/25/2019,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/5/2024,mg,antineoplastic,4/30/2024,3/31/2024,Intravenous,pembrolizumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,6/19/2017,mg,antineoplastic,11/29/2016,11/24/2016,Intravenous,nivolumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,6/10/2024,mg,antineoplastic,7/11/2024,3/20/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/19/2023,mg,antineoplastic,2/26/2023,3/21/2023,Intravenous,pembrolizumab,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,6/30/2015,mg,antineoplastic,4/16/2015,3/11/2015,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/25/2025,mg,antineoplastic,11/5/2023,7/20/2023,Intravenous,pembrolizumab,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,1/2/2014,mg/kg,antineoplastic,12/3/2013,11/7/2013,Intravenous,bevacizumab,FALSE
1230,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,2/25/2017,mg,antineoplastic,2/4/2017,12/9/2016,Intravenous,gemcitabine,FALSE
130,4,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2262335C:D62,4/11/2025,mg,antineoplastic,2/14/2025,3/9/2025,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/2/2025,mg,antineoplastic,5/19/2023,8/19/2021,Intravenous,atezolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/14/2025,mg,antineoplastic,10/12/2019,2/14/2018,Intravenous,nivolumab,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,12/29/2015,mg,antineoplastic,11/18/2015,11/2/2015,Intravenous,gemcitabine,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/16/2024,mL,solution-fluid,12/8/2023,11/15/2023,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/28/2018,mg,antineoplastic,7/16/2018,6/7/2018,Intravenous,carboplatin,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G2D168F99BCD4,10/16/2024,,,1/8/2024,1/14/2024,Oral,dabrafenib,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/5/2022,mg,antineoplastic,3/19/2022,10/17/2021,Intravenous,fluorouracil,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/1/2016,mg,antineoplastic,12/12/2015,9/28/2015,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/21/2024,mg,antineoplastic,8/9/2023,11/27/2022,Intravenous,nivolumab,FALSE
174,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/15/2020,mg,antineoplastic,3/23/2020,3/17/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,3/24/2025,mg,antineoplastic,10/18/2024,9/8/2024,Intravenous,pembrolizumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,2/15/2015,mg,antineoplastic,11/12/2014,10/3/2014,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/20/2025,,antineoplastic,2/1/2021,4/24/2020,Oral,enzalutamide,FALSE
840,4,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/9/2021,mg,antineoplastic,11/7/2021,9/28/2021,Intravenous,atezolizumab,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/27/2024,mg,antineoplastic,11/5/2023,8/20/2023,Intravenous,durvalumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G199:3GD5C8:8,3/2/2023,mg,antineoplastic,2/22/2023,1/26/2023,Intravenous,pembrolizumab,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/12/2020,mg,antineoplastic,8/22/2018,12/23/2017,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/8/2025,mg,antineoplastic,9/23/2018,12/26/2016,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/15/2016,mg,antineoplastic,3/16/2015,6/23/2014,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/15/2019,mg,antineoplastic,3/22/2019,2/13/2019,Intravenous,pemetrexed,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/29/2012,mg,antineoplastic,4/2/2012,3/16/2012,Intravenous,carboplatin,FALSE
141,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,10/19/2024,mg,antineoplastic,6/13/2024,7/16/2024,Intravenous,cisplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/15/2023,mg,antineoplastic,12/3/2022,12/8/2022,Intravenous,pembrolizumab,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/20/2024,mg,antineoplastic,12/18/2023,11/11/2023,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/8/2024,mg,antineoplastic,7/16/2024,12/12/2021,Intravenous,nivolumab,TRUE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/20/2017,mg,antineoplastic,6/13/2017,7/10/2017,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,3/30/2025,mg,antineoplastic,1/23/2025,1/15/2025,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/17/2025,mg,antineoplastic,9/5/2024,5/9/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/11/2020,mg,antineoplastic,7/24/2019,1/5/2018,Intravenous,pembrolizumab,TRUE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/6/2021,mL,solution-fluid,1/4/2019,4/5/2018,Intravenous,durvalumab,TRUE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/29/2017,mg,antineoplastic,10/22/2015,5/20/2015,Intravenous,nivolumab,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/29/2017,mg,antineoplastic,6/14/2017,5/11/2017,Intravenous,trastuzumab,FALSE
1115,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/11/2016,mg,antineoplastic,6/11/2016,2/28/2016,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/5/2025,mg,antineoplastic,3/31/2025,1/28/2025,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/2/2023,mg,antineoplastic,2/23/2022,11/8/2021,Intravenous,pembrolizumab,TRUE
424,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,2/2/2020,mg,antineoplastic,12/2/2019,12/21/2019,Intravenous,carboplatin,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/30/2016,mg,antineoplastic,5/20/2015,5/13/2014,Intravenous,bevacizumab,FALSE
234,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/7/2021,mg,antineoplastic,10/26/2021,8/14/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/13/2025,,antineoplastic,7/6/2022,10/30/2021,Intravenous,pembrolizumab,TRUE
795,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,6/3/2016,mg,antineoplastic,3/28/2016,2/20/2016,Intravenous,pemetrexed,FALSE
660,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/11/2022,mg,antineoplastic,3/23/2022,12/22/2021,Intravenous,bevacizumab-bvzr,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/8/2015,mg,antineoplastic,2/10/2014,12/31/2013,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/22/2019,mg,antineoplastic,7/15/2018,4/18/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/21/2025,mg,antineoplastic,2/11/2020,1/28/2018,Intravenous,nivolumab,FALSE
468,2,ADVANCED,Administrations,chemotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,12/8/2024,mg,antineoplastic,8/26/2024,10/4/2024,Intravenous,pemetrexed,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,8/30/2016,mg,antineoplastic,4/27/2016,5/1/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/19/2025,,antineoplastic,7/14/2018,11/6/2017,Intravenous,clinical study drug,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,4/30/2014,mg,antineoplastic,1/4/2014,1/25/2014,Intravenous,carboplatin,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/27/2022,mg,antineoplastic,10/15/2021,6/21/2021,Intravenous,fluorouracil,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/2/2014,mg,antineoplastic,5/20/2013,10/10/2012,Intravenous,gemcitabine,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,4/8/2019,mg,antineoplastic,4/29/2019,12/25/2018,Intravenous,bevacizumab,TRUE
,,NEOADJUVANT,Orders,chemotherapy,Capecitabine,G23ED3EB7B1B2,11/6/2021,,antineoplastic,10/30/2021,10/25/2021,Oral,capecitabine,FALSE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/28/2016,mg,antineoplastic,8/18/2015,5/29/2015,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/16/2025,mg,antineoplastic,4/12/2023,10/2/2022,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Unstructured,,Erlotinib,G34182B94:768,12/8/2017,,,8/25/2017,8/22/2017,Oral,erlotinib,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,3/15/2023,mg,antineoplastic,9/11/2022,5/11/2022,Intravenous,atezolizumab,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,1/1/2020,mg,antineoplastic,8/30/2019,8/9/2019,Intravenous,paclitaxel protein-bound,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/18/2011,mg,antineoplastic,6/22/2011,6/15/2011,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G57G45B:D1F17,2/18/2025,,antineoplastic,4/18/2018,11/24/2017,,clinical study drug,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/30/2014,mg,antineoplastic,7/21/2014,6/14/2014,Intravenous,cisplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,9/7/2024,mg,antineoplastic,7/3/2024,5/3/2024,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/3/2021,mg/m2,antineoplastic,3/24/2021,3/30/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/8/2025,mg,antineoplastic,3/16/2025,1/23/2025,Intravenous,pembrolizumab,FALSE
97,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G14DC7EEE99BF,11/29/2015,mg,antineoplastic,11/25/2015,10/8/2015,Intravenous,nivolumab,FALSE
158,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5344:8G5698G,10/10/2022,mg,antineoplastic,9/6/2022,9/1/2022,Intravenous,cisplatin,FALSE
596,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/4/2013,mg,antineoplastic,8/19/2013,5/18/2013,Intravenous,carboplatin,FALSE
42,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,3/7/2015,mg,antineoplastic,12/14/2014,12/12/2014,Intravenous,vinorelbine,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/10/2017,mg,antineoplastic,2/10/2017,11/4/2016,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/6/2025,mg,antineoplastic,9/28/2023,8/16/2021,Intravenous,atezolizumab,TRUE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G579E53D92:75,10/9/2011,,hematological agent,10/27/2011,9/12/2011,Subcutaneous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/28/2018,mg,antineoplastic,6/17/2017,3/2/2017,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,hormone,Exemestane,G1561187B7F::,3/9/2025,,antineoplastic,11/30/2024,9/11/2024,Oral,exemestane,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/1/2025,mg,antineoplastic,2/26/2025,5/13/2024,Intravenous,pemetrexed,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,10/24/2021,mg,antineoplastic,9/16/2021,4/9/2021,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/18/2022,,antineoplastic,2/26/2022,7/1/2021,Intravenous,amivantamab-vmjw,FALSE
376,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,10/31/2011,mg,antineoplastic,7/29/2011,7/17/2011,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/22/2018,,antineoplastic,6/25/2017,5/31/2017,,clinical study drug,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,9/29/2015,mg,antineoplastic,11/4/2015,5/16/2015,Intravenous,nivolumab,FALSE
368,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/10/2021,mg,antineoplastic,5/13/2021,4/17/2021,Intravenous,carboplatin,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,7/2/2017,mg,antineoplastic,7/7/2017,5/27/2017,Intravenous,cisplatin,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/8/2016,mg/m2,antineoplastic,2/20/2016,3/2/2016,Intravenous,etoposide,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/16/2014,mg/kg,antineoplastic,4/29/2014,11/2/2013,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/21/2018,mg,antineoplastic,8/21/2018,4/5/2017,Intravenous,pembrolizumab,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/30/2022,mg,antineoplastic,7/28/2021,6/25/2021,Intravenous,fluorouracil,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/18/2012,AUC,antineoplastic,6/23/2012,5/6/2012,Intravenous,carboplatin,FALSE
17.2,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/16/2013,mL,antineoplastic,10/20/2013,6/6/2013,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1594:E29D2D9,8/29/2021,,,8/19/2021,9/16/2020,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/27/2024,mg,antineoplastic,1/9/2024,9/23/2022,Intravenous,pembrolizumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/15/2020,mg,antineoplastic,10/14/2019,10/30/2015,Intravenous,nivolumab,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/10/2022,mg,antineoplastic,7/18/2022,4/25/2022,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,11/12/2022,mg,antineoplastic,8/31/2022,10/3/2021,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/30/2025,mg,antineoplastic,1/25/2025,7/23/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/14/2020,mg,antineoplastic,2/3/2017,7/14/2016,Intravenous,nivolumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/4/2025,mg,antineoplastic,6/2/2024,9/20/2022,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,9/24/2023,mg,antineoplastic,5/2/2023,7/6/2022,Intravenous,pembrolizumab,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/27/2025,mg,antineoplastic,3/15/2024,3/6/2024,Intravenous,amivantamab-vmjw,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/8/2018,mg/m2,antineoplastic,8/9/2018,6/30/2018,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/1/2021,mg,antineoplastic,1/12/2021,1/24/2021,Intravenous,bevacizumab-awwb,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,7/25/2024,mg,antineoplastic,6/15/2024,7/11/2024,Intravenous,cisplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/1/2025,mg,antineoplastic,12/8/2018,1/22/2017,Intravenous,nivolumab,FALSE
404,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/12/2017,mg,antineoplastic,1/5/2017,12/27/2016,Intravenous,carboplatin,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,11/12/2021,mg,antineoplastic,9/5/2021,4/8/2021,Intravenous,pemetrexed,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,4/5/2019,mg/m2,antineoplastic,7/25/2017,8/4/2017,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/27/2020,mg,antineoplastic,11/11/2019,8/10/2016,Intravenous,nivolumab,FALSE
900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,5/3/2022,mg,antineoplastic,2/26/2022,1/21/2022,Intravenous,pemetrexed,FALSE
386,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,1/19/2019,mg,antineoplastic,1/21/2019,11/16/2018,Intravenous,carboplatin,FALSE
790,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38D11EG5F826,1/24/2020,mg,antineoplastic,6/5/2016,1/30/2016,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/26/2025,mg,antineoplastic,10/16/2024,8/31/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,8/1/2021,mg,antineoplastic,3/19/2020,11/10/2018,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/27/2025,mg,antineoplastic,8/8/2020,1/1/2017,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,8/17/2017,,solution-fluid,3/31/2017,11/26/2016,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/13/2025,mg,antineoplastic,3/16/2020,2/16/2018,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/20/2022,mg/m2,antineoplastic,11/13/2021,10/17/2021,Intravenous,leucovorin,FALSE
1235,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G88D5G998GE,11/18/2019,mg,antineoplastic,11/6/2019,11/21/2019,Intravenous,pemetrexed,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/3/2019,mg/m2,antineoplastic,2/1/2019,10/27/2018,Intravenous,vinorelbine,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,7/30/2016,mg,antineoplastic,12/19/2015,12/22/2015,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,4/30/2015,mg,antineoplastic,3/27/2015,2/24/2015,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/28/2016,mg,antineoplastic,2/28/2015,12/19/2014,Intravenous,gemcitabine,FALSE
80,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/15/2020,mg,antineoplastic,11/23/2019,8/15/2019,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/23/2020,mg,antineoplastic,6/12/2020,3/18/2020,Intravenous,pembrolizumab,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,3/7/2018,mg,antineoplastic,2/13/2018,11/4/2017,Intravenous,carboplatin,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/15/2021,mg,antineoplastic,10/25/2020,7/22/2020,Intravenous,doxorubicin,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/18/2024,mg,antineoplastic,8/13/2023,8/6/2023,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/9/2018,mg,antineoplastic,5/27/2018,6/23/2018,Intravenous,nivolumab,FALSE
82.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/27/2015,mg,antineoplastic,4/15/2015,4/5/2015,Intravenous,carboplatin,FALSE
100,4,ADVANCED,Administrations,solution-fluid,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,3/4/2025,mL,solution-fluid,11/30/2024,12/2/2024,Intravenous,pembrolizumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Docetaxel",G3D59288727DB,4/28/2019,mL,solution-fluid,4/22/2019,3/14/2019,Intravenous,docetaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/21/2013,mg,antineoplastic,7/30/2012,12/31/2011,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/15/2023,mg,antineoplastic,12/12/2022,7/12/2022,Intravenous,durvalumab,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,11/26/2022,mg,antineoplastic,11/15/2022,11/1/2022,Intravenous,nivolumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/13/2023,mg,antineoplastic,8/5/2023,6/3/2023,Intravenous,paclitaxel,FALSE
306,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,12/1/2024,mg,antineoplastic,7/21/2024,7/22/2024,Intravenous,paclitaxel,FALSE
1750,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/17/2025,mg,antineoplastic,3/3/2025,1/21/2025,Intravenous,amivantamab-vmjw,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,10/12/2013,mg,antineoplastic,9/27/2013,8/9/2013,Intravenous,bevacizumab,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/17/2022,mg,antineoplastic,5/29/2022,4/27/2022,Intravenous,carboplatin,FALSE
434,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/27/2013,mg,antineoplastic,1/29/2013,12/31/2012,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Unstructured,,Afatinib,G26C72D6F6G:5,7/12/2020,,,6/8/2020,4/26/2020,Oral,afatinib,FALSE
1224,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/13/2013,mg,antineoplastic,5/29/2013,11/19/2012,Intravenous,cyclophosphamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/19/2020,mg,antineoplastic,2/13/2018,12/16/2017,Intravenous,pembrolizumab,TRUE
354.6,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18C1EG39143B,9/8/2014,mg,antineoplastic,9/1/2014,8/3/2014,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,11/2/2017,mL,solution-fluid,11/14/2017,7/14/2017,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/22/2018,mg,antineoplastic,12/20/2017,12/15/2017,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/1/2020,mg,antineoplastic,1/28/2016,2/16/2016,Intravenous,bevacizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/17/2025,mg,antineoplastic,8/8/2023,2/8/2017,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/31/2025,mg,antineoplastic,3/24/2020,1/4/2017,Intravenous,pembrolizumab,FALSE
1075,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,2/2/2016,mg,antineoplastic,11/22/2015,9/22/2015,Intravenous,bevacizumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/4/2019,mg,antineoplastic,10/30/2018,1/31/2018,Intravenous,pemetrexed,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,8/10/2017,mg,antineoplastic,7/14/2017,5/15/2017,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,3/27/2019,,,3/1/2019,2/7/2019,Oral,osimertinib,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/25/2021,mL,solution-fluid,5/3/2018,3/4/2018,Intravenous,durvalumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/3/2020,mg,antineoplastic,11/1/2016,11/20/2015,Intravenous,nivolumab,FALSE
585,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/7/2015,mg,antineoplastic,8/23/2015,7/19/2015,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/24/2022,mg,antineoplastic,6/27/2021,5/24/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/16/2019,mg,antineoplastic,11/22/2017,5/24/2017,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/10/2025,mg,antineoplastic,12/21/2019,3/7/2018,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/24/2018,mg,antineoplastic,2/9/2018,2/1/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/19/2025,mg/m2,antineoplastic,1/15/2025,7/21/2024,Intravenous,gemcitabine,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/16/2022,mg,antineoplastic,5/2/2021,2/8/2021,Intravenous,bevacizumab-awwb,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G257D9:2573CF,4/1/2025,mg,antineoplastic,2/23/2025,12/17/2024,Intravenous,durvalumab,TRUE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/5/2011,mg,antineoplastic,4/3/2011,3/27/2011,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/16/2025,,antineoplastic,11/19/2021,10/31/2021,Intravenous,pembrolizumab,TRUE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,1/3/2016,mg,antineoplastic,3/28/2015,3/14/2015,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/22/2025,mg,antineoplastic,1/1/2019,5/2/2018,Intravenous,pembrolizumab,FALSE
503,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/24/2017,mg,antineoplastic,7/30/2017,5/23/2017,Intravenous,carboplatin,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/28/2016,mg,antineoplastic,5/9/2016,5/2/2016,Intravenous,carboplatin,FALSE
750,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/22/2022,mg,antineoplastic,9/11/2021,8/27/2021,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/7/2025,,antineoplastic,10/22/2024,2/21/2023,,clinical study drug,FALSE
54,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1C32G396:F7G,2/21/2014,mg,antineoplastic,3/12/2014,1/22/2014,Intravenous,vinorelbine,FALSE
229.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/9/2015,mg,antineoplastic,3/15/2015,3/8/2015,Intravenous,carboplatin,FALSE
818,,ADJUVANT,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/22/2013,mg,antineoplastic,5/30/2013,12/6/2012,Intravenous,rituximab,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/9/2015,mg,antineoplastic,2/25/2015,11/14/2014,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/12/2022,mg,antineoplastic,5/4/2021,2/19/2021,Intravenous,durvalumab,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,10/30/2019,mg,antineoplastic,4/21/2019,10/2/2018,Intravenous,durvalumab,FALSE
542,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/2/2023,mg,antineoplastic,1/14/2023,2/8/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/22/2025,mg,antineoplastic,7/3/2024,5/3/2024,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/10/2018,mg,antineoplastic,5/3/2018,12/8/2017,Intravenous,pembrolizumab,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/6/2017,mg,antineoplastic,8/17/2016,6/30/2015,Intravenous,nivolumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/1/2024,mg,antineoplastic,8/1/2024,8/26/2024,Intravenous,carboplatin,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,1/22/2024,mg/kg,antineoplastic,10/25/2023,11/9/2023,Intravenous,ramucirumab,FALSE
1055,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/14/2016,mg,antineoplastic,4/14/2015,4/9/2015,Intravenous,pemetrexed,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/26/2021,mg,antineoplastic,1/12/2021,12/29/2020,Intravenous,vinorelbine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,7/25/2018,mg,antineoplastic,5/21/2018,9/24/2017,Intravenous,atezolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,5/24/2016,mg,antineoplastic,3/20/2015,2/12/2015,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,7/29/2012,mg,antineoplastic,5/5/2012,3/7/2012,Intravenous,paclitaxel protein-bound,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/28/2015,mg,antineoplastic,9/8/2014,10/23/2014,Intravenous,etoposide,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/4/2022,mg,antineoplastic,2/24/2022,5/8/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/25/2025,,antineoplastic,3/27/2023,2/3/2023,,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/15/2020,mg,antineoplastic,8/18/2018,7/1/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,10/27/2019,,antineoplastic,6/27/2019,4/5/2019,Oral,hydroxyurea,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/8/2022,mg,antineoplastic,9/14/2019,5/4/2019,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/19/2025,mg,antineoplastic,2/27/2025,11/5/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1E71G:B6G198,3/22/2025,,,2/15/2025,8/22/2024,Oral,osimertinib,FALSE
40,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide,Rituximab",G48842BBE3634,7/5/2013,mg/m2,antineoplastic,5/30/2013,6/8/2013,Intravenous,etoposide,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/30/2019,mg,antineoplastic,8/3/2019,8/21/2019,Intravenous,etoposide,FALSE
736,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,7/8/2015,mg,antineoplastic,5/31/2015,6/19/2015,Intravenous,bevacizumab,FALSE
885,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,1/17/2016,mg,antineoplastic,11/7/2015,11/14/2015,Intravenous,pemetrexed,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/17/2015,mg,antineoplastic,6/3/2014,12/28/2013,Intravenous,paclitaxel,FALSE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/28/2013,mg,antineoplastic,7/18/2012,4/13/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G2D168F99BCD4,1/4/2023,mg,antineoplastic,10/13/2022,8/29/2022,Intravenous,pembrolizumab,TRUE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/3/2023,mg,antineoplastic,7/25/2023,6/26/2023,Intravenous,paclitaxel,FALSE
236,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/19/2016,mg,antineoplastic,3/21/2016,10/23/2015,Intravenous,carboplatin,FALSE
2425,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G177G4:B9E394,3/6/2025,mg,antineoplastic,3/17/2025,2/9/2025,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,5/9/2024,mg,antineoplastic,12/22/2023,2/3/2024,Intravenous,pembrolizumab,FALSE
1229,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/12/2015,mg,antineoplastic,10/28/2014,8/22/2014,Intravenous,bevacizumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/7/2024,mg,antineoplastic,8/31/2023,6/22/2023,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,4/14/2025,,,12/30/2024,12/25/2024,Oral,lorlatinib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/14/2024,,antineoplastic,5/9/2024,3/27/2024,,paclitaxel,FALSE
154.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/4/2015,mg,antineoplastic,8/8/2015,3/18/2015,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/23/2016,mg,antineoplastic,6/12/2015,6/8/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/1/2025,mg,antineoplastic,6/8/2024,8/7/2022,Intravenous,pembrolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3FE:CB6:EG58,5/2/2024,mg,antineoplastic,3/10/2024,2/25/2024,Intravenous,pembrolizumab,FALSE
250,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G21:3143F86E6,2/8/2015,mg,antineoplastic,2/13/2015,1/17/2015,Intravenous,carboplatin,FALSE
366,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/25/2016,mg,antineoplastic,9/15/2016,7/11/2016,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/29/2018,AUC,antineoplastic,6/14/2018,4/17/2018,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/21/2021,mg,antineoplastic,10/21/2020,10/19/2020,Intravenous,nivolumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,11/1/2016,mg,antineoplastic,6/13/2016,6/13/2016,Intravenous,carboplatin,FALSE
1670,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/24/2016,mg,antineoplastic,6/19/2016,2/29/2016,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/3/2015,mg,antineoplastic,4/29/2015,2/2/2015,Intravenous,paclitaxel protein-bound,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/23/2025,,antineoplastic,9/7/2024,6/10/2024,,pembrolizumab,FALSE
1090,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,4/9/2015,mg,antineoplastic,12/29/2014,11/22/2014,Intravenous,pemetrexed,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/19/2019,mg,antineoplastic,9/30/2018,10/7/2018,Intravenous,durvalumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/15/2015,mg,antineoplastic,11/13/2014,10/28/2014,Intravenous,paclitaxel protein-bound,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/5/2024,mg,antineoplastic,7/26/2022,7/12/2020,Intravenous,nivolumab,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/6/2012,mg,antineoplastic,8/14/2012,3/23/2012,Intravenous,carboplatin,FALSE
226,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G18:439734B::,1/20/2016,mg,antineoplastic,12/3/2015,11/1/2015,Intravenous,nivolumab,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/9/2021,mg,antineoplastic,10/29/2020,7/9/2020,Intravenous,doxorubicin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/9/2019,mg,antineoplastic,8/8/2019,7/10/2019,Intravenous,pembrolizumab,FALSE
750,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/15/2024,mg,antineoplastic,11/25/2023,2/2/2023,Intravenous,durvalumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/13/2014,mg,antineoplastic,7/27/2014,5/22/2014,Intravenous,vinorelbine,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/15/2020,mg,antineoplastic,4/1/2020,10/10/2019,Intravenous,durvalumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/20/2017,mg,antineoplastic,1/27/2017,12/14/2016,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,3/22/2021,mg,antineoplastic,2/17/2021,1/5/2021,Intravenous,pembrolizumab,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/3/2014,mg/kg,antineoplastic,8/19/2014,11/19/2013,Intravenous,bevacizumab,FALSE
789,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,6/13/2012,mg,antineoplastic,4/7/2012,4/30/2012,Intravenous,bevacizumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Docetaxel",G3D59288727DB,4/14/2019,mL,solution-fluid,3/7/2019,3/14/2019,Intravenous,docetaxel,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,4/17/2020,mg,antineoplastic,7/1/2019,7/1/2019,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/9/2025,mg,antineoplastic,10/31/2020,2/21/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,8/14/2017,,antineoplastic,3/17/2017,3/14/2017,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/25/2014,mg,antineoplastic,5/21/2014,4/2/2014,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/21/2017,mg,antineoplastic,6/30/2016,6/22/2015,Intravenous,nivolumab,FALSE
228.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/24/2014,mg,antineoplastic,9/22/2014,9/5/2014,Intravenous,carboplatin,FALSE
530,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,6/14/2015,mg,antineoplastic,7/8/2013,8/7/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Alectinib,Clinical Study Drug",G1F9CDC2FCB:5,3/5/2025,,antineoplastic,1/28/2022,3/3/2022,,clinical study drug,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,2/3/2025,mg,antineoplastic,1/14/2025,12/3/2024,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/14/2019,mg,antineoplastic,3/14/2018,1/24/2018,Intravenous,pembrolizumab,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/4/2014,mg,antineoplastic,8/8/2014,5/3/2014,Intravenous,vinorelbine,FALSE
348,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/21/2017,mg,antineoplastic,9/8/2017,7/13/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G46:87GF7FGC9,11/25/2015,,antineoplastic,11/9/2015,7/28/2015,Intravenous,clinical study drug,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/2/2014,AUC,antineoplastic,10/27/2012,10/20/2012,Intravenous,carboplatin,FALSE
1564,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,12/17/2015,mg,antineoplastic,10/19/2015,10/6/2015,Intravenous,bevacizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/8/2022,mg,antineoplastic,8/2/2017,1/12/2016,Intravenous,pemetrexed,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/20/2014,mg,antineoplastic,1/10/2014,12/21/2013,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/15/2019,mg,antineoplastic,11/19/2017,10/20/2017,Intravenous,pembrolizumab,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/30/2013,mg,antineoplastic,6/21/2013,4/6/2013,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/25/2024,mg,antineoplastic,5/19/2024,10/23/2023,Intravenous,pembrolizumab,FALSE
240,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/8/2017,mg,antineoplastic,1/23/2017,12/15/2016,Intravenous,carboplatin,FALSE
500,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,3/13/2025,mg,antineoplastic,12/3/2024,12/3/2024,Intravenous,carboplatin,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/7/2021,mg,antineoplastic,10/3/2018,2/27/2018,Intravenous,durvalumab,TRUE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G17BB6EDG:98F,8/16/2019,mg,antineoplastic,5/27/2019,5/15/2019,Intravenous,atezolizumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/4/2019,mg,antineoplastic,10/6/2019,9/27/2019,Intravenous,cisplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/16/2025,mg,antineoplastic,5/7/2020,2/26/2019,Intravenous,pemetrexed,FALSE
760,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/3/2014,mg,antineoplastic,3/7/2014,2/21/2014,Intravenous,bevacizumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/8/2019,mg,antineoplastic,1/28/2019,1/4/2018,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/13/2022,mg,antineoplastic,3/29/2019,2/2/2016,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/30/2025,mg,antineoplastic,10/8/2024,8/17/2024,Intravenous,pemetrexed,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,4/5/2021,mg,antineoplastic,11/2/2019,10/5/2019,Intravenous,pemetrexed,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/19/2015,mg,antineoplastic,6/23/2015,3/28/2015,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/14/2025,mg,antineoplastic,11/30/2018,3/22/2018,Intravenous,nivolumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/9/2022,mg,antineoplastic,11/24/2021,8/28/2021,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,8/5/2021,mg,antineoplastic,3/21/2019,11/13/2018,Intravenous,pembrolizumab,TRUE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,9/28/2019,mg/m2,antineoplastic,9/22/2019,8/24/2019,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/12/2022,mg,antineoplastic,9/9/2022,9/26/2022,Intravenous,paclitaxel,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,11/6/2018,mg,antineoplastic,4/1/2013,2/18/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/26/2019,,antineoplastic,10/19/2019,9/15/2019,,paclitaxel protein-bound,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,2/28/2023,mg,antineoplastic,11/27/2022,11/23/2022,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G448FDE96D2D6,4/10/2015,mg/m2,antineoplastic,2/18/2015,2/20/2015,Intravenous,paclitaxel protein-bound,FALSE
62.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/2/2021,mg,antineoplastic,5/31/2021,1/4/2021,Intravenous,vinorelbine,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/4/2023,mg,antineoplastic,11/29/2022,10/16/2022,Intravenous,docetaxel,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/1/2020,mg,antineoplastic,12/10/2019,1/28/2019,Intravenous,durvalumab,FALSE
444,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/22/2021,mg,antineoplastic,1/21/2021,12/27/2020,Intravenous,carboplatin,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,7/8/2024,mg,antineoplastic,5/1/2024,3/8/2024,Intravenous,gemcitabine,FALSE
744,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/7/2015,mg,antineoplastic,5/16/2015,5/12/2015,Intravenous,carboplatin,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/16/2022,mg,antineoplastic,11/9/2021,11/5/2021,Intravenous,fluorouracil,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G1DD111EC2E4G,5/16/2021,mL,solution-fluid,3/13/2021,2/26/2021,Intravenous,paclitaxel,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/9/2016,AUC,antineoplastic,7/25/2015,5/14/2014,Intravenous,carboplatin,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/9/2014,mg,antineoplastic,10/27/2014,6/8/2014,Intravenous,vinorelbine,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,10/30/2019,mg,antineoplastic,12/1/2018,9/18/2018,Intravenous,durvalumab,FALSE
177.4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/6/2018,mg,antineoplastic,5/28/2018,4/9/2018,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,10/2/2013,mg,antineoplastic,7/24/2013,4/21/2013,Intravenous,bevacizumab,FALSE
144,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/14/2021,mg,antineoplastic,9/5/2021,8/8/2021,Intravenous,paclitaxel protein-bound,FALSE
844,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/21/2024,mg,antineoplastic,1/3/2024,10/15/2023,Intravenous,durvalumab,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,11/18/2018,mg,antineoplastic,10/30/2018,8/27/2018,Intravenous,pemetrexed,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/23/2025,mg,antineoplastic,3/16/2025,8/22/2024,Intravenous,pemetrexed,TRUE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/23/2024,mg,antineoplastic,10/17/2023,7/6/2023,Intravenous,gemcitabine,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,12/23/2024,mg,antineoplastic,12/27/2024,11/2/2024,Intravenous,pemetrexed,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/20/2023,mg,antineoplastic,9/29/2023,9/1/2023,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,5/20/2024,mg,antineoplastic,3/29/2024,2/6/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,5/18/2025,mg,antineoplastic,4/3/2025,3/19/2025,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G54B7:9:4B62G,1/29/2025,,,12/17/2023,2/3/2024,Oral,osimertinib,FALSE
185.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,3/9/2017,mg,antineoplastic,1/2/2017,12/14/2016,Intravenous,carboplatin,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/10/2022,mg,antineoplastic,7/7/2022,6/10/2022,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/12/2024,mg,antineoplastic,4/15/2023,2/21/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,3/4/2018,mg,antineoplastic,3/8/2018,2/2/2018,Intravenous,pembrolizumab,FALSE
75,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,7/1/2017,mg/m2,antineoplastic,6/28/2017,5/15/2017,Intravenous,cisplatin,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,12/17/2023,mg,antineoplastic,9/23/2023,9/9/2023,Intravenous,paclitaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Irinotecan",G1D61871659DG,8/17/2012,mg,antineoplastic,7/24/2012,8/6/2012,Intravenous,irinotecan,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,4/11/2024,mg,antineoplastic,3/11/2024,3/2/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Unstructured,,Alectinib,G52:6C556E791,8/11/2024,,,8/10/2024,6/24/2024,Oral,alectinib,FALSE
541,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,6/20/2018,mg,antineoplastic,2/12/2018,1/27/2018,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/8/2024,mg,antineoplastic,5/16/2024,4/26/2024,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/27/2023,mg,antineoplastic,10/18/2021,12/30/2019,Intravenous,pembrolizumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/17/2021,mL,solution-fluid,5/30/2018,4/1/2018,Intravenous,durvalumab,TRUE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,11/6/2019,mg,antineoplastic,10/12/2019,8/4/2019,Intravenous,pemetrexed,FALSE
501.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/14/2020,mg,antineoplastic,1/3/2020,12/6/2019,Intravenous,carboplatin,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,2/26/2012,mg,antineoplastic,2/7/2012,1/26/2012,Intravenous,etoposide,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/13/2023,mg,antineoplastic,11/22/2022,10/12/2022,Intravenous,durvalumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,7/5/2024,mg,antineoplastic,1/10/2024,7/28/2023,Intravenous,atezolizumab,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/3/2013,mg,antineoplastic,9/11/2013,5/28/2013,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G46:87GF7FGC9,12/3/2015,,antiemetic,11/14/2015,7/29/2015,Intrajejunal,clinical study drug,FALSE
273,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/10/2016,mg,antineoplastic,10/12/2016,7/2/2016,Intravenous,trastuzumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/6/2023,mg,antineoplastic,7/9/2022,12/2/2019,Intravenous,pembrolizumab,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/7/2016,mg/m2,antineoplastic,8/22/2016,6/9/2016,Intravenous,paclitaxel,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/17/2015,mg,antineoplastic,12/3/2014,8/17/2014,Intravenous,paclitaxel,FALSE
1870,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G24632:D18158,2/28/2020,mg,antineoplastic,12/22/2019,12/18/2019,Intravenous,gemcitabine,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,1/9/2023,mg,antineoplastic,11/10/2022,10/25/2022,Oral,imatinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/22/2016,,antineoplastic,4/9/2016,9/29/2014,Intravenous,pemetrexed,TRUE
645,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46E218G4252C,9/4/2016,mg,antineoplastic,7/18/2016,6/18/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,7/14/2024,mg,antineoplastic,3/29/2024,3/14/2024,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,hormone,Exemestane,G1561187B7F::,2/10/2025,,antineoplastic,10/6/2024,9/26/2024,Oral,exemestane,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/2/2021,mg,antineoplastic,9/22/2021,8/11/2021,Intravenous,paclitaxel protein-bound,FALSE
500,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,11/2/2022,mg,antineoplastic,10/2/2022,7/13/2022,Oral,bosutinib,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/2/2023,,antineoplastic,10/2/2022,9/26/2022,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,4/8/2018,mg/m2,antineoplastic,9/10/2017,10/13/2017,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/2/2019,mg,antineoplastic,4/21/2018,3/24/2018,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/14/2024,mg,antineoplastic,12/27/2022,1/8/2023,Intravenous,nivolumab,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,5/23/2021,mg,antineoplastic,1/2/2021,9/23/2020,Intravenous,gemcitabine,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/20/2018,mg,antineoplastic,4/12/2013,3/20/2013,Intravenous,paclitaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,10/13/2015,mg,antineoplastic,8/6/2015,8/5/2015,Intravenous,paclitaxel protein-bound,FALSE
800,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4DE3DE99E:13,9/13/2015,mg,antineoplastic,1/8/2015,3/6/2015,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Orders,hormone,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/6/2025,,antineoplastic,6/1/2024,5/16/2024,,leuprolide,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,7/3/2017,,antineoplastic,1/8/2017,12/20/2016,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G5:7G3C6E4C81,1/4/2019,,,10/31/2018,10/27/2018,Oral,afatinib,FALSE
385,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4229EB584D67,4/10/2015,mg,antineoplastic,2/11/2015,2/10/2015,Intravenous,carboplatin,FALSE
156,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,10/12/2022,mg,antineoplastic,11/15/2022,9/25/2022,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G14E999899EFC,4/24/2024,mg,antineoplastic,2/28/2024,1/14/2024,Intravenous,cemiplimab,FALSE
553,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,8/27/2024,mg,antineoplastic,6/22/2024,6/24/2024,Intravenous,carboplatin,FALSE
2,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/12/2024,AUC,antineoplastic,10/6/2024,7/9/2024,Intravenous,carboplatin,FALSE
280,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/13/2013,mg,antineoplastic,12/5/2012,1/9/2013,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/23/2022,,antineoplastic,2/18/2022,2/1/2022,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/22/2025,mg,antineoplastic,1/26/2025,5/15/2024,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/1/2022,mg,antineoplastic,10/7/2021,1/13/2016,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,3/22/2018,,antineoplastic,1/28/2018,12/27/2017,Intravenous,clinical study drug,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/28/2023,mg,antineoplastic,1/10/2021,11/13/2019,Intravenous,pembrolizumab,TRUE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/23/2014,mg,antineoplastic,9/11/2013,7/8/2013,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Unstructured,,Crizotinib,G2FF1862EC655,11/22/2013,,,12/30/2013,10/23/2013,Oral,crizotinib,FALSE
552,1,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G53C52948773G,3/6/2024,mg,antineoplastic,1/31/2024,11/1/2023,Intravenous,ramucirumab,FALSE
183.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,2/12/2022,mg,antineoplastic,7/13/2014,7/3/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,2/22/2019,mg,antineoplastic,10/30/2018,12/16/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/12/2022,mg,antineoplastic,3/16/2019,12/16/2017,Intravenous,pembrolizumab,FALSE
480,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,3/9/2019,mg,antineoplastic,8/28/2018,9/9/2018,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/12/2020,mg,antineoplastic,10/17/2019,8/31/2019,Intravenous,pembrolizumab,FALSE
595,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,12/7/2021,mg,antineoplastic,6/8/2018,3/24/2018,Intravenous,durvalumab,TRUE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/24/2020,mg,antineoplastic,5/31/2020,2/5/2020,Intravenous,bevacizumab,FALSE
590,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/13/2021,mg,antineoplastic,7/29/2020,7/24/2020,Intravenous,ramucirumab,FALSE
137,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/20/2020,mg,antineoplastic,2/16/2020,12/8/2019,Intravenous,docetaxel,FALSE
1015,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,6/27/2023,mg,antineoplastic,12/3/2022,11/4/2022,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/8/2025,mg,antineoplastic,10/9/2024,1/19/2017,Intravenous,pembrolizumab,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/1/2014,mg,antineoplastic,10/9/2014,6/13/2014,Intravenous,paclitaxel protein-bound,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,11/28/2013,mg,antineoplastic,10/6/2013,8/28/2013,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/18/2013,mg,antineoplastic,11/18/2012,12/9/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,3/28/2019,mg,antineoplastic,10/21/2018,9/25/2018,Intravenous,pembrolizumab,TRUE
110,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/25/2013,mg,antineoplastic,2/4/2013,2/16/2013,Intravenous,etoposide,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/14/2022,mg,antineoplastic,5/9/2021,4/27/2020,Intravenous,durvalumab,TRUE
500,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,2/25/2025,mg,antineoplastic,11/21/2024,11/4/2024,Intravenous,carboplatin,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/10/2018,AUC,antineoplastic,10/21/2017,10/7/2017,Intravenous,carboplatin,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,10/12/2018,mg,antineoplastic,1/30/2014,1/16/2014,Intravenous,carboplatin,FALSE
385,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,2/18/2023,mg,antineoplastic,3/16/2023,12/15/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/10/2017,,solution-fluid,3/9/2016,3/10/2016,Intravenous,clinical study drug,FALSE
527,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G135B:GEC35G4,5/25/2025,mg,antineoplastic,4/9/2025,4/1/2025,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/14/2022,,antineoplastic,2/21/2022,1/25/2022,,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,5/7/2025,mg,antineoplastic,2/15/2025,4/14/2024,Intravenous,durvalumab,TRUE
720,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/16/2020,mg,antineoplastic,12/21/2019,10/16/2019,Intravenous,pemetrexed,TRUE
136,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/13/2024,mg,antineoplastic,3/9/2024,3/5/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/10/2022,mg,antineoplastic,7/30/2020,8/9/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/20/2023,mg,antineoplastic,8/27/2022,7/2/2022,Intravenous,pembrolizumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/10/2016,mg,antineoplastic,5/22/2016,4/2/2016,Intravenous,paclitaxel,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/2/2025,mL,solution-fluid,6/3/2024,6/19/2024,Intravenous,carboplatin,FALSE
835,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,7/17/2020,mg,antineoplastic,3/19/2020,2/16/2020,Intravenous,pemetrexed,FALSE
810,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/25/2016,mg,antineoplastic,9/30/2016,7/19/2016,Intravenous,gemcitabine,FALSE
35,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G36BE14CG117:,5/8/2018,mg,antineoplastic,3/26/2018,4/12/2018,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,12/17/2022,,antineoplastic,12/18/2022,12/23/2022,Oral,hydroxyurea,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/24/2021,mg,antineoplastic,4/11/2020,12/10/2019,Intravenous,durvalumab,TRUE
234,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11D1:8:62429,9/17/2015,mg,antineoplastic,9/21/2015,7/3/2015,Intravenous,nivolumab,FALSE
82,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/7/2018,mg,antineoplastic,6/24/2018,4/22/2018,Intravenous,paclitaxel,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G121:2D8:4E94,9/4/2019,mg,antineoplastic,8/17/2019,7/14/2019,Intravenous,carboplatin,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,11/5/2023,mg,antineoplastic,8/24/2023,9/2/2023,Intravenous,nivolumab,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/16/2018,mg,antineoplastic,2/22/2018,11/8/2017,Oral,anastrozole,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/6/2025,mg,antineoplastic,2/27/2017,8/8/2016,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/4/2025,mg,antineoplastic,2/5/2024,3/5/2024,Intravenous,pembrolizumab,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/14/2019,mg,antineoplastic,5/28/2013,2/1/2013,Intravenous,carboplatin,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,6/28/2024,mg,antineoplastic,5/13/2024,4/14/2024,Intravenous,paclitaxel,FALSE
414,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,5/16/2024,mg,antineoplastic,11/8/2023,12/7/2023,Intravenous,paclitaxel,FALSE
170,3,ADVANCED,Administrations,chemotherapy,Docetaxel,G1:78734BCEDB,3/19/2015,mg,antineoplastic,1/19/2015,1/29/2015,Intravenous,docetaxel,FALSE
599.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,8/2/2017,mg,antineoplastic,5/17/2017,5/5/2017,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/10/2019,mg,antineoplastic,11/24/2018,12/22/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,glucocorticoid,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/13/2012,,steroid,7/31/2012,4/11/2012,,clinical study drug,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,7/3/2015,mg,antineoplastic,7/18/2014,5/24/2014,Intravenous,pemetrexed,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,10/29/2015,mg,antineoplastic,9/24/2015,11/2/2015,Intravenous,paclitaxel,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,12/12/2023,mg,antineoplastic,1/17/2024,6/16/2023,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/13/2019,mg,antineoplastic,1/30/2019,12/13/2018,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,3/28/2025,mg,antineoplastic,12/5/2024,7/23/2024,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,2/26/2021,mg,antineoplastic,1/31/2020,2/24/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,6/13/2024,,antineoplastic,5/3/2024,4/4/2024,,pembrolizumab,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/4/2015,mg,antineoplastic,1/7/2015,12/11/2014,Intravenous,bevacizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/31/2013,mg,antineoplastic,11/24/2012,12/1/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,7/23/2023,mg,antineoplastic,5/7/2022,2/7/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/6/2025,mg,antineoplastic,7/22/2023,5/30/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/9/2018,,antineoplastic,4/21/2018,5/1/2018,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/16/2022,,antineoplastic,3/12/2019,4/13/2017,Oral,nilotinib,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/15/2024,mg,antineoplastic,9/10/2023,1/12/2023,Intravenous,durvalumab,FALSE
511,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/21/2022,mg,antineoplastic,2/13/2022,12/31/2021,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,5/26/2015,mg,antineoplastic,10/29/2014,10/13/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,2/6/2017,,antineoplastic,9/20/2016,2/21/2016,Intravenous,clinical study drug,FALSE
370.8,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/5/2018,mg,antineoplastic,2/15/2018,12/13/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/27/2025,mg,antineoplastic,3/13/2024,8/30/2022,Intravenous,pembrolizumab,TRUE
240,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/26/2023,mg,antineoplastic,5/14/2023,4/4/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,11/29/2015,,steroid,7/4/2015,7/1/2015,Intrajejunal,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/8/2022,mg,antineoplastic,12/31/2021,3/10/2021,Intravenous,durvalumab,FALSE
1075,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:3B43D3B55G,1/12/2024,mg,antineoplastic,12/12/2023,10/20/2023,Intravenous,pemetrexed,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,6/6/2013,mg,antineoplastic,5/15/2013,3/15/2013,Intravenous,gemcitabine,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/23/2013,mg,antineoplastic,7/24/2013,5/20/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/6/2019,,antineoplastic,10/25/2019,10/3/2019,,carboplatin,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,7/3/2024,mg,antineoplastic,4/30/2024,4/26/2024,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/25/2022,mg,antineoplastic,6/30/2022,4/24/2022,Intravenous,pemetrexed,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/20/2025,mg,antineoplastic,2/16/2025,10/2/2024,Intravenous,durvalumab,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/30/2019,mg,antineoplastic,3/24/2019,11/13/2018,Intravenous,bevacizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,11/21/2014,AUC,antineoplastic,2/12/2014,12/13/2013,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/25/2024,,antineoplastic,12/19/2023,11/16/2023,,carboplatin,FALSE
366,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,11/20/2021,mg,antineoplastic,7/23/2021,7/21/2021,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,7/20/2015,mg,antineoplastic,1/25/2015,12/12/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,8/10/2023,mg,antineoplastic,5/26/2023,4/14/2023,Intravenous,pembrolizumab,FALSE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/23/2017,mg,antineoplastic,7/30/2017,6/2/2017,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/13/2024,mg,antineoplastic,12/27/2023,8/30/2023,Intravenous,nivolumab,FALSE
504.7,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/20/2015,mg,antineoplastic,12/14/2014,10/24/2014,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/4/2025,mg,antineoplastic,8/15/2024,8/7/2024,Intravenous,atezolizumab,TRUE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/31/2024,mg,antineoplastic,11/1/2023,8/5/2023,Intravenous,gemcitabine,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,3/31/2022,mg/kg,antineoplastic,5/5/2021,3/5/2021,Intravenous,durvalumab,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/17/2018,mg,antineoplastic,11/8/2017,11/26/2017,Intravenous,nivolumab,FALSE
342,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,6/25/2016,mg,antineoplastic,5/28/2016,4/16/2016,Intravenous,paclitaxel,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,5/11/2025,mg,antineoplastic,4/5/2025,2/25/2025,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/7/2020,mg,antineoplastic,2/19/2018,12/28/2017,Intravenous,pembrolizumab,TRUE
100,3,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,4/29/2024,mL,solution-fluid,9/29/2020,8/7/2020,Intravenous,nivolumab,FALSE
1700,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,10/24/2013,mg,antineoplastic,9/8/2013,9/27/2013,Intravenous,gemcitabine,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/24/2022,mg,antineoplastic,11/12/2021,9/21/2021,Intravenous,fluorouracil,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/26/2015,mg,antineoplastic,5/17/2014,5/15/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/3/2023,mg,antineoplastic,9/6/2023,9/27/2021,Intravenous,pembrolizumab,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,3/25/2015,mg,antineoplastic,2/14/2015,1/6/2015,Intravenous,carboplatin,FALSE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,11/1/2015,mg,antineoplastic,9/22/2015,7/18/2015,Intravenous,pemetrexed,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/26/2025,mg,antineoplastic,12/18/2019,2/13/2019,Intravenous,pemetrexed,TRUE
594,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,2/21/2016,mg,antineoplastic,2/9/2016,10/26/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/16/2025,mg,antineoplastic,2/24/2018,1/30/2018,Intravenous,nivolumab,FALSE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,3/14/2017,mg,antineoplastic,8/6/2016,5/20/2016,Intravenous,nivolumab,FALSE
588,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,12/13/2015,mg,antineoplastic,12/4/2015,10/23/2015,Intravenous,carboplatin,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/9/2014,mg,antineoplastic,8/19/2014,5/30/2014,Intravenous,paclitaxel protein-bound,FALSE
125,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,2/19/2019,mg,antineoplastic,12/23/2018,1/15/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G41DE1E3BE99:,12/14/2022,,antineoplastic,12/25/2022,12/31/2022,Oral,hydroxyurea,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,11/29/2023,mg,antineoplastic,11/23/2023,10/1/2023,Intravenous,cisplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/6/2018,mg,antineoplastic,9/30/2017,9/6/2017,Intravenous,atezolizumab,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,12/31/2015,mg,antineoplastic,1/20/2016,5/21/2015,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/5/2025,mg,antineoplastic,8/19/2017,1/16/2017,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,11/11/2023,mg,antineoplastic,7/9/2023,6/1/2023,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G49E3CE9E292G,10/5/2019,mL,solution-fluid,9/20/2019,8/25/2019,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/4/2018,mg,antineoplastic,5/7/2018,2/25/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/22/2018,mg,antineoplastic,10/17/2018,7/5/2018,Intravenous,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/23/2025,mg,antineoplastic,10/8/2024,5/11/2024,Intravenous,cemiplimab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/2/2020,mg,antineoplastic,9/23/2017,7/27/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,4/17/2021,mg,antineoplastic,11/25/2018,10/28/2018,Intravenous,pembrolizumab,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/24/2019,mg,antineoplastic,11/11/2017,9/8/2017,Intravenous,etoposide,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G257D9:2573CF,5/6/2025,mg,antineoplastic,4/6/2025,12/18/2024,Intravenous,durvalumab,TRUE
202,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,6/27/2016,mg,antineoplastic,4/28/2016,4/1/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/8/2025,,antineoplastic,7/11/2024,4/13/2024,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/19/2021,,antineoplastic,6/3/2021,4/8/2021,Intravenous,pemetrexed,FALSE
482,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,11/2/2024,mg,antineoplastic,10/15/2024,6/28/2024,Intravenous,carboplatin,FALSE
354,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,8/9/2012,mg,antineoplastic,5/28/2012,4/18/2012,Intravenous,paclitaxel,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/25/2017,mg,antineoplastic,9/15/2017,8/14/2017,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,1/26/2024,,antineoplastic,11/24/2023,10/21/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,4/26/2019,,antineoplastic,4/14/2019,3/17/2019,Intravenous,paclitaxel,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/16/2020,mg,antineoplastic,1/17/2020,10/11/2019,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,11/5/2022,mg,antineoplastic,7/3/2022,10/17/2021,Intravenous,durvalumab,TRUE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/17/2018,mg,antineoplastic,11/25/2017,10/29/2017,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/13/2023,mg,antineoplastic,11/15/2020,3/31/2020,Intravenous,pembrolizumab,TRUE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/2/2022,mg,antineoplastic,4/24/2021,9/21/2020,Intravenous,nivolumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/1/2023,mg,antineoplastic,8/4/2023,5/24/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,1/9/2020,mg,antineoplastic,1/18/2020,11/8/2019,Intravenous,pembrolizumab,FALSE
816,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/18/2025,mg,antineoplastic,2/23/2025,12/26/2024,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/17/2018,mg,antineoplastic,10/12/2016,10/4/2016,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/26/2021,mg,antineoplastic,4/26/2021,5/18/2021,Intravenous,atezolizumab,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/10/2024,mg,antineoplastic,6/19/2024,7/14/2024,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,1/19/2020,mg,antineoplastic,1/19/2020,12/17/2019,Intravenous,carboplatin,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/18/2017,mg,antineoplastic,8/1/2017,9/20/2017,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G37GC233F5FB2,3/17/2025,,,4/26/2025,7/6/2022,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/18/2025,mg,antineoplastic,11/28/2023,1/19/2019,Intravenous,pembrolizumab,TRUE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/29/2017,mg,antineoplastic,8/4/2017,7/3/2017,Intravenous,pemetrexed,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/18/2018,mg,antineoplastic,8/16/2018,7/2/2018,Intravenous,etoposide,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/2/2024,mg,antineoplastic,7/12/2023,3/1/2023,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/1/2023,,antineoplastic,7/8/2023,11/28/2022,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/23/2021,,antineoplastic,6/27/2021,7/10/2021,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/19/2016,mg/m2,antineoplastic,11/25/2015,6/18/2015,Intravenous,pemetrexed,FALSE
668.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/24/2021,mg,antineoplastic,9/22/2019,8/24/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/4/2019,mg,antineoplastic,5/31/2018,1/28/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Pralsetinib,G4C89FC6D8388,5/17/2025,,,4/21/2025,12/23/2024,Oral,pralsetinib,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/27/2025,,solution-fluid,1/10/2018,10/23/2017,Intravenous,clinical study drug,FALSE
1400,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4G53233CD43C,5/5/2025,mg,antineoplastic,3/2/2025,1/24/2025,Intravenous,gemcitabine,FALSE
1050,2,ADVANCED,Orders,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/25/2025,mg,antineoplastic,2/15/2025,1/16/2025,Intravenous,amivantamab-vmjw,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/16/2020,mg,antineoplastic,7/31/2020,3/5/2020,Intravenous,paclitaxel,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,1/20/2015,mg,antineoplastic,2/11/2014,2/2/2014,Intravenous,paclitaxel,FALSE
771,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/17/2013,mg,antineoplastic,9/1/2013,7/10/2013,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G4C4C3G28CF33,3/19/2022,,antineoplastic,11/14/2021,10/11/2021,,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,8/5/2024,mg,antineoplastic,5/5/2024,5/3/2024,Intravenous,pembrolizumab,FALSE
186,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/24/2021,mg,antineoplastic,5/9/2021,1/26/2021,Intravenous,paclitaxel protein-bound,FALSE
156.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,9/7/2019,mg,antineoplastic,5/22/2019,5/31/2019,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/7/2023,mg,antineoplastic,4/12/2021,12/7/2019,Intravenous,pembrolizumab,FALSE
217.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/2/2015,mg,antineoplastic,6/18/2015,4/4/2015,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/16/2025,,antineoplastic,5/23/2024,6/9/2024,,pembrolizumab,FALSE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/27/2024,mg,antineoplastic,8/29/2024,8/18/2024,Intravenous,carboplatin,FALSE
2000,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,9/13/2021,mg,antineoplastic,6/18/2021,6/24/2021,Intravenous,gemcitabine,FALSE
1666,,NEOADJUVANT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/21/2013,mg/m2,antineoplastic,1/20/2013,2/9/2013,Intravenous,mesna,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/22/2019,mg,antineoplastic,10/10/2018,6/15/2018,Intravenous,pemetrexed,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,10/6/2014,mg,antineoplastic,7/8/2014,4/21/2014,Intravenous,carboplatin,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,4/5/2019,mg,antineoplastic,4/15/2019,2/27/2019,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G579E53D92:75,11/23/2011,,antineoplastic,10/8/2011,8/25/2011,Intravenous,clinical study drug,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/27/2014,mg,antineoplastic,7/23/2014,5/15/2014,Intravenous,paclitaxel protein-bound,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/10/2016,mg,antineoplastic,1/22/2016,6/5/2015,Intravenous,pemetrexed,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,1/22/2012,mg/kg,antineoplastic,12/15/2011,12/1/2011,Intravenous,bevacizumab,FALSE
414,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,4/29/2025,mg,antineoplastic,3/6/2025,12/18/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/8/2019,mg,antineoplastic,6/18/2019,3/15/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/24/2025,mg,antineoplastic,9/11/2019,2/18/2018,Intravenous,nivolumab,FALSE
710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12786B9C7G6D,9/5/2018,mg,antineoplastic,8/18/2018,7/22/2018,Intravenous,pemetrexed,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,12/8/2019,mg,antineoplastic,10/11/2019,3/29/2019,Intravenous,ramucirumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/28/2025,mg,antineoplastic,11/16/2020,2/18/2018,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/1/2025,mg,antineoplastic,8/24/2024,1/23/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,4/7/2025,mg,antineoplastic,11/29/2024,7/10/2024,Intravenous,pembrolizumab,TRUE
30,2,ADVANCED,Orders,chemotherapy,Vinorelbine,G2CE6D3C3EFDC,10/12/2013,mg/m2,antineoplastic,10/22/2013,7/5/2013,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,9/20/2020,mg,antineoplastic,9/21/2020,9/6/2020,Intravenous,pembrolizumab,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/10/2013,mg,antineoplastic,10/26/2013,12/1/2012,Intravenous,gemcitabine,FALSE
,,CONCURRENT,Unstructured,,Osimertinib,G15F23FC1G645,1/6/2025,,,11/17/2024,5/17/2024,Oral,osimertinib,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1651E65B5E88,1/21/2018,mg,antineoplastic,12/28/2017,12/17/2017,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/4/2020,mg,antineoplastic,3/14/2020,2/14/2020,Intravenous,paclitaxel,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/29/2015,mg,antineoplastic,12/26/2014,10/20/2014,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/4/2025,mg,antineoplastic,9/19/2024,7/10/2023,Intravenous,pembrolizumab,TRUE
68,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,6/29/2020,mg,antineoplastic,5/1/2020,5/9/2020,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,3/27/2018,mg,antineoplastic,12/21/2017,12/9/2017,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,11/6/2014,AUC,antineoplastic,1/26/2014,12/23/2013,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/11/2025,mg,antineoplastic,7/9/2022,4/20/2020,Subcutaneous,leuprolide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/7/2025,mg,antineoplastic,4/17/2023,1/26/2019,Intravenous,pembrolizumab,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/7/2020,mg,antineoplastic,3/20/2019,2/12/2019,Subcutaneous,bortezomib,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/17/2021,mg,antineoplastic,10/23/2021,9/11/2021,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,"Azacitidine,Venetoclax",G13F761779185,10/1/2023,,antineoplastic,4/28/2023,4/17/2023,Oral,venetoclax,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,5/21/2019,mg,antineoplastic,3/13/2019,1/8/2019,Intravenous,bevacizumab,TRUE
720,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/7/2020,mg,antineoplastic,1/10/2020,10/31/2019,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G132B61FB651B,11/29/2015,,antineoplastic,12/26/2015,10/17/2015,Intravenous,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/20/2025,mg,antineoplastic,3/31/2024,3/3/2024,Intravenous,durvalumab,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/12/2019,mg,antineoplastic,1/2/2019,10/14/2018,Intravenous,durvalumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/20/2025,mg,antineoplastic,7/17/2021,3/6/2020,Intravenous,pemetrexed,TRUE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/24/2014,mg,antineoplastic,3/16/2014,1/10/2014,Intravenous,paclitaxel,FALSE
394,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/13/2014,mg,antineoplastic,10/17/2014,7/31/2014,Intravenous,paclitaxel,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/17/2015,mg,antineoplastic,7/7/2015,8/29/2014,Intravenous,paclitaxel,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,4/27/2019,mg,antineoplastic,3/10/2019,2/11/2019,Intravenous,gemcitabine,FALSE
1100,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3:C9BECD3F55,12/13/2020,mg,antineoplastic,11/13/2020,10/11/2020,Intravenous,ramucirumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/19/2023,mg,antineoplastic,4/12/2023,4/12/2023,Intravenous,atezolizumab,FALSE
176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,4/24/2024,mg,antineoplastic,2/20/2024,1/26/2024,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/13/2021,mg,antineoplastic,5/15/2021,5/27/2021,Intravenous,atezolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,12/12/2021,mg,antineoplastic,10/8/2021,10/10/2021,Intravenous,paclitaxel,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/12/2019,mg,antineoplastic,8/11/2018,7/28/2018,Intravenous,docetaxel,FALSE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,10/17/2017,mg,antineoplastic,9/6/2017,8/15/2017,Intravenous,paclitaxel,FALSE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,4/14/2013,mg,antineoplastic,12/5/2012,1/1/2013,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,3/15/2019,mg,antineoplastic,8/27/2018,5/14/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5:CE:F92EE8D,2/12/2016,,antineoplastic,9/1/2015,6/24/2015,Intravenous,clinical study drug,FALSE
770,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,11/11/2023,mg,antineoplastic,10/20/2023,9/21/2023,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/28/2025,mg,antineoplastic,2/18/2025,6/10/2024,Intravenous,carboplatin,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/31/2019,mg/m2,antineoplastic,10/13/2019,8/19/2019,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/15/2021,mg,antineoplastic,7/17/2021,5/23/2021,Intravenous,pemetrexed,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,9/22/2021,mg,antineoplastic,9/12/2021,7/30/2021,Intravenous,cisplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/11/2024,mg,antineoplastic,12/31/2021,11/24/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/16/2020,mg,antineoplastic,4/23/2020,3/22/2020,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/20/2020,mg,antineoplastic,6/6/2018,7/9/2016,Intravenous,nivolumab,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,3/12/2013,AUC,antineoplastic,12/22/2012,12/21/2012,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/14/2021,mg/m2,antineoplastic,8/24/2021,2/23/2021,Intravenous,oxaliplatin,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/26/2013,mg/m2,antineoplastic,11/7/2013,9/3/2013,Intravenous,etoposide,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,5/29/2020,mg,antineoplastic,8/31/2019,1/29/2019,Subcutaneous,bortezomib,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/1/2016,mg,antineoplastic,2/29/2016,1/19/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,8/16/2020,mg,antineoplastic,6/10/2020,4/19/2020,Intravenous,pembrolizumab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/27/2013,mg/m2,antineoplastic,10/28/2012,7/13/2012,Intravenous,docetaxel,FALSE
790,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/31/2022,mg,antineoplastic,4/1/2022,6/26/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/2/2024,mg,antineoplastic,5/21/2020,4/27/2020,Intravenous,pembrolizumab,TRUE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/2/2024,mg,antineoplastic,7/20/2024,8/3/2024,Intravenous,pembrolizumab,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/10/2017,mg,antineoplastic,5/23/2017,6/5/2017,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/17/2025,mg,antineoplastic,5/28/2024,6/1/2023,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/26/2025,,antineoplastic,2/6/2023,3/26/2020,Oral,enzalutamide,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,9/19/2015,mg,antineoplastic,7/6/2015,7/8/2015,Intravenous,paclitaxel,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/25/2021,mg,antineoplastic,3/24/2021,12/22/2020,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/11/2022,mg,antineoplastic,3/31/2022,4/15/2020,Intravenous,pembrolizumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/8/2015,mg,antineoplastic,6/1/2015,3/28/2015,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Unstructured,,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/6/2025,,,6/1/2024,7/18/2024,Oral,sotorasib,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/24/2023,mg,antineoplastic,8/1/2023,6/7/2023,Intravenous,tremelimumab-actl,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/18/2025,mg,antineoplastic,2/8/2025,9/22/2024,Intravenous,durvalumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/9/2022,mg,antineoplastic,9/18/2017,2/4/2016,Intravenous,pemetrexed,FALSE
123,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,4/8/2024,mg,antineoplastic,4/11/2024,3/1/2024,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/27/2025,mg,antineoplastic,1/29/2025,8/25/2021,Intravenous,atezolizumab,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/6/2013,mg,antineoplastic,1/12/2012,12/31/2011,Intravenous,etoposide,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/10/2015,mg,antineoplastic,7/27/2014,8/16/2014,Intravenous,paclitaxel,FALSE
130,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,2/19/2019,mg/m2,antineoplastic,2/6/2019,2/24/2019,Intravenous,oxaliplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/6/2025,mg/m2,antineoplastic,8/27/2024,6/15/2024,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cetuximab,Irinotecan",G1D61871659DG,7/22/2012,mg/m2,antineoplastic,7/11/2012,6/22/2012,Intravenous,irinotecan,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/20/2024,mg,antineoplastic,2/25/2024,2/12/2024,Intravenous,carboplatin,FALSE
,6,ADVANCED,Unstructured,,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,11/27/2016,,,9/15/2016,8/27/2016,Oral,vemurafenib,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/16/2022,mg,antineoplastic,8/11/2016,1/25/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,9/30/2020,mg,antineoplastic,8/3/2020,7/23/2020,Intravenous,paclitaxel protein-bound,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,3/4/2025,mg,antineoplastic,3/5/2025,12/20/2024,Intravenous,pemetrexed,TRUE
100,2,ADVANCED,Administrations,solution-fluid,Pemetrexed,G49E3CE9E292G,4/9/2023,mL,solution-fluid,7/2/2020,4/25/2020,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/7/2016,mg,antineoplastic,6/6/2016,4/1/2016,Intravenous,pemetrexed,TRUE
605,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/13/2021,mg,antineoplastic,9/10/2020,6/1/2020,Intravenous,carboplatin,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,11/27/2011,mg,antineoplastic,9/30/2011,9/22/2011,Intravenous,paclitaxel,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/9/2018,mg,antineoplastic,1/7/2018,12/20/2017,Intravenous,cisplatin,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/2/2017,mg,antineoplastic,6/21/2017,5/29/2017,Intravenous,carboplatin,FALSE
960,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,4/20/2019,mg,antineoplastic,2/10/2019,1/30/2019,Intravenous,pemetrexed,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,10/29/2019,mg,antineoplastic,4/26/2019,9/14/2018,Intravenous,durvalumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/1/2014,mg,antineoplastic,12/29/2013,10/31/2013,Intravenous,paclitaxel,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G2177D1::DG1E,9/3/2012,mg,antineoplastic,8/7/2012,8/18/2012,Intravenous,vinorelbine,FALSE
950,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G14216G12B:E7,6/3/2020,mg,antineoplastic,12/13/2019,10/10/2019,Intravenous,pemetrexed,TRUE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/15/2018,mg,antineoplastic,10/7/2018,6/7/2018,Intravenous,carboplatin,FALSE
545,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,4/13/2023,mg,antineoplastic,10/19/2022,9/29/2022,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/8/2025,mg,antineoplastic,12/23/2015,12/23/2015,Intravenous,paclitaxel,FALSE
540,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,8/20/2014,mg,antineoplastic,5/1/2014,3/19/2014,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/28/2019,mg,antineoplastic,7/8/2019,6/1/2018,Intravenous,pembrolizumab,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,11/11/2014,mg,antineoplastic,8/14/2014,9/13/2014,Intravenous,paclitaxel,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/18/2017,mg,antineoplastic,10/11/2016,3/23/2015,Intravenous,bevacizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/20/2024,mg,antineoplastic,10/26/2023,1/11/2023,Intravenous,nivolumab,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,3/11/2013,mg/m2,antineoplastic,12/23/2012,12/6/2012,Intravenous,paclitaxel,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/9/2024,mg,antineoplastic,1/6/2023,11/18/2022,Intravenous,durvalumab,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/28/2024,mg,antineoplastic,8/7/2023,5/29/2023,Intravenous,carboplatin,FALSE
610,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/23/2014,mg,antineoplastic,8/17/2013,6/17/2013,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/5/2025,mg,antineoplastic,12/21/2019,2/9/2019,Intravenous,pemetrexed,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,5/9/2025,mg,antineoplastic,4/24/2025,11/8/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/17/2019,mg,antineoplastic,1/11/2019,2/4/2018,Intravenous,pembrolizumab,FALSE
154.6,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,11/29/2017,mg,antineoplastic,10/19/2017,9/2/2017,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/20/2019,,antineoplastic,8/25/2019,8/9/2019,,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,5/5/2025,mg,antineoplastic,8/18/2024,7/29/2024,Intravenous,atezolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/5/2017,mg,antineoplastic,1/17/2017,9/7/2016,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,Pembrolizumab,G1195EGCD:B45,5/9/2024,mL,solution-fluid,5/13/2024,4/22/2024,Intravenous,pembrolizumab,TRUE
415,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/2/2024,mg,antineoplastic,11/23/2023,11/2/2023,Intravenous,carboplatin,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/10/2024,mg,antineoplastic,10/15/2023,10/29/2023,Intravenous,amivantamab-vmjw,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,10/3/2024,mg,antineoplastic,7/26/2024,8/17/2024,Intravenous,paclitaxel,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/20/2025,mg,antineoplastic,8/3/2022,1/16/2022,Intravenous,atezolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/29/2018,mg,antineoplastic,9/27/2018,4/22/2017,Intravenous,pemetrexed,TRUE
310,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G25C3661FG6B9,5/30/2015,mg,antineoplastic,5/26/2015,3/7/2015,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/19/2025,mg,antineoplastic,8/8/2020,2/25/2019,Intravenous,pemetrexed,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/26/2018,mg,antineoplastic,12/12/2017,8/9/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/2/2020,mg,antineoplastic,4/19/2019,12/9/2018,Intravenous,pembrolizumab,TRUE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,11/30/2019,mg,antineoplastic,8/12/2019,5/15/2019,Intravenous,docetaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/24/2025,mg,antineoplastic,9/20/2023,11/18/2021,Intravenous,pembrolizumab,TRUE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,9/7/2024,mg,antineoplastic,6/10/2024,5/20/2024,Intravenous,cemiplimab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,9/12/2019,mg,antineoplastic,9/27/2019,9/10/2019,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/16/2014,mg,antineoplastic,3/24/2014,4/3/2014,Intravenous,paclitaxel protein-bound,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2B4648:BGD83,5/14/2025,mg,antineoplastic,3/20/2025,2/15/2025,Intravenous,durvalumab,FALSE
131,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/21/2024,mg,antineoplastic,11/19/2023,12/4/2023,Intravenous,carboplatin,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/16/2025,mg,antineoplastic,8/13/2020,3/3/2020,Intravenous,pemetrexed,TRUE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/10/2019,mg,antineoplastic,8/30/2017,10/2/2017,Intravenous,etoposide,FALSE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,4/29/2025,mg,antineoplastic,3/18/2025,11/15/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/15/2020,mg,antineoplastic,1/15/2018,12/9/2017,Intravenous,pembrolizumab,TRUE
42,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,2/7/2015,mg,antineoplastic,12/22/2014,11/8/2014,Intravenous,vinorelbine,FALSE
1170,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/12/2024,mg,antineoplastic,5/3/2024,4/27/2024,Intravenous,pemetrexed,FALSE
486.2,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G163D9B593927,10/13/2014,mg,antineoplastic,11/21/2014,10/11/2014,Intravenous,carboplatin,FALSE
379,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,1/20/2018,mg,antineoplastic,9/20/2017,8/16/2017,Intravenous,carboplatin,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/11/2012,mg,antineoplastic,1/29/2012,12/16/2011,Intravenous,carboplatin,FALSE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/11/2019,mg,antineoplastic,1/18/2019,1/11/2019,Intravenous,carboplatin,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/9/2017,,antineoplastic,11/30/2016,11/23/2016,Oral,clinical study drug,FALSE
745,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:B8CFFD1931,4/3/2015,mg,antineoplastic,1/21/2015,10/5/2014,Intravenous,pemetrexed,TRUE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/31/2011,mg,antineoplastic,9/30/2011,8/18/2011,Intravenous,cisplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,2/20/2023,mg,antineoplastic,1/27/2023,4/25/2022,Intravenous,atezolizumab,FALSE
395,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/8/2020,mg,antineoplastic,4/7/2020,2/2/2020,Intravenous,carboplatin,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,11/6/2021,mg,antineoplastic,4/15/2021,4/13/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/24/2025,mg,antineoplastic,11/27/2024,4/6/2023,Intravenous,pembrolizumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/4/2020,mg,antineoplastic,9/19/2019,12/24/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/5/2019,mg,antineoplastic,1/29/2019,2/23/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,3/25/2025,mg,antineoplastic,2/24/2025,2/9/2025,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/21/2025,mg,antineoplastic,12/18/2021,12/15/2021,Intravenous,pembrolizumab,TRUE
,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,9/1/2017,,antineoplastic,7/13/2017,7/11/2017,Intravenous,ramucirumab,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/24/2014,mg,antineoplastic,8/6/2014,6/19/2014,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/28/2020,mg,antineoplastic,8/5/2018,12/6/2017,Intravenous,pemetrexed,TRUE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,9/15/2019,mg,antineoplastic,5/8/2019,3/15/2019,Intravenous,pemetrexed,TRUE
168,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/3/2024,mg,antineoplastic,3/6/2024,3/20/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,10/14/2020,,,7/22/2020,8/6/2020,Oral,trametinib,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/13/2022,mg,antineoplastic,5/17/2022,5/16/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,10/19/2021,,antineoplastic,3/20/2021,1/29/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/31/2025,mg,antineoplastic,12/15/2024,7/23/2024,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,2/7/2017,,antineoplastic,10/25/2016,2/15/2016,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/30/2019,mg,antineoplastic,8/29/2018,6/17/2018,Intravenous,nivolumab,FALSE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,5/26/2015,mg,antineoplastic,3/3/2015,3/1/2015,Intravenous,etoposide,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/18/2015,mg,antineoplastic,4/20/2015,2/19/2015,Intravenous,pemetrexed,FALSE
125,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,4/2/2019,mg,antineoplastic,1/23/2019,12/18/2018,Intravenous,carboplatin,FALSE
141,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/18/2024,mg,antineoplastic,1/17/2024,11/13/2023,Intravenous,carboplatin,FALSE
297,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,2/7/2023,mg,antineoplastic,1/5/2023,11/17/2022,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/10/2025,,antineoplastic,2/20/2025,9/9/2022,Oral,anastrozole,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,11/20/2018,4/12/2017,Oral,nilotinib,FALSE
486,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G324DD277533C,3/4/2020,mg,antineoplastic,2/24/2020,3/13/2020,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/16/2021,mg/m2,antineoplastic,11/1/2021,3/4/2021,Intravenous,oxaliplatin,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/31/2014,mg,antineoplastic,2/3/2014,1/19/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/10/2025,mg,antineoplastic,11/13/2021,4/11/2020,Intravenous,pembrolizumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,3/8/2019,mL,solution-fluid,12/17/2018,1/2/2019,Intravenous,carboplatin,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/25/2015,mg,antineoplastic,9/21/2014,8/26/2014,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/26/2021,mg/m2,antineoplastic,5/1/2021,2/8/2021,Intravenous,oxaliplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,11/5/2020,mg,antineoplastic,3/12/2020,9/14/2019,Intravenous,pembrolizumab,TRUE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/4/2022,mg,antineoplastic,9/21/2021,3/30/2021,Intravenous,bevacizumab-awwb,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/10/2024,mg,antineoplastic,3/3/2022,7/9/2020,Intravenous,ipilimumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/26/2013,mg,antineoplastic,9/6/2012,7/7/2012,Intravenous,pemetrexed,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3B942496:87:,11/3/2012,AUC,antineoplastic,9/23/2012,10/20/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/19/2025,mg,antineoplastic,4/18/2024,10/18/2023,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/24/2018,mg,antineoplastic,9/10/2018,8/1/2018,Intravenous,paclitaxel protein-bound,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,4/30/2022,mg,antineoplastic,3/31/2021,4/16/2020,Intravenous,durvalumab,TRUE
179,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/16/2022,mg,antineoplastic,2/22/2022,1/18/2022,Intravenous,carboplatin,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/30/2020,mg,antineoplastic,4/30/2020,1/2/2020,Intravenous,carboplatin,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,9/12/2022,mg,antineoplastic,3/20/2022,2/8/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/19/2021,,antineoplastic,6/6/2021,4/17/2021,,pembrolizumab,FALSE
1130,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/18/2020,mg,antineoplastic,6/18/2014,2/27/2014,Intravenous,cyclophosphamide,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/29/2025,mg,antineoplastic,8/16/2020,12/14/2016,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/29/2025,mg,antineoplastic,11/14/2023,8/13/2021,Intravenous,atezolizumab,TRUE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,10/1/2021,mg,antineoplastic,5/2/2021,4/22/2021,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,5/3/2025,mg,antineoplastic,3/27/2024,3/17/2024,Intravenous,pembrolizumab,FALSE
441,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,1/13/2022,mg,antineoplastic,11/11/2021,10/12/2021,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DD111EC2E4G,6/10/2021,mg,antineoplastic,4/9/2021,2/26/2021,Intravenous,carboplatin,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/5/2024,mg,antineoplastic,6/18/2024,9/28/2023,Intravenous,durvalumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,9/25/2019,mg,antineoplastic,5/23/2019,6/24/2019,Intravenous,paclitaxel,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,6/17/2024,mg,antineoplastic,4/4/2024,5/23/2023,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/13/2025,mg,antineoplastic,10/21/2023,7/8/2023,Intravenous,pembrolizumab,TRUE
380,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/1/2021,mg,antineoplastic,7/18/2021,4/25/2021,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,1/25/2017,mg,antineoplastic,1/28/2017,10/28/2016,Intravenous,paclitaxel protein-bound,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,4/29/2025,mg,antineoplastic,2/26/2025,3/16/2025,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/15/2012,,steroid,9/9/2011,10/13/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/15/2025,mg,antineoplastic,7/31/2023,4/11/2020,Intravenous,pembrolizumab,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/24/2021,mg,antineoplastic,6/21/2021,10/14/2020,Intravenous,ipilimumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,8/16/2019,mg,antineoplastic,7/1/2019,5/6/2019,Intravenous,pembrolizumab,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,9/12/2013,mg,antineoplastic,4/6/2013,4/3/2013,Intravenous,pemetrexed,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/18/2014,mg,antineoplastic,12/28/2013,11/30/2013,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,2/23/2019,mg,antineoplastic,11/3/2018,6/27/2018,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3867F7D51E3D,3/7/2025,mg,antineoplastic,11/29/2024,11/7/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/22/2022,mg,antineoplastic,9/17/2021,12/19/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1C22CGB1F5C2,10/8/2020,mg,antineoplastic,2/1/2020,11/21/2019,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/20/2023,mg,antineoplastic,2/3/2018,11/12/2017,Intravenous,nivolumab,FALSE
148,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,3/22/2024,mg,antineoplastic,1/27/2024,1/18/2024,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/21/2017,mg,antineoplastic,1/19/2017,8/20/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,6/23/2022,,antineoplastic,5/21/2022,7/1/2022,Oral,hydroxyurea,FALSE
1030,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/25/2020,mg,antineoplastic,11/13/2020,10/13/2020,Intravenous,pemetrexed,FALSE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,2/13/2012,mg,antineoplastic,12/31/2011,11/21/2011,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/8/2019,mg,antineoplastic,3/6/2019,6/18/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/23/2012,,antineoplastic,8/26/2011,6/22/2011,Intravenous,clinical study drug,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/3/2025,mg,antineoplastic,11/25/2019,4/7/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/10/2025,,antineoplastic,6/29/2019,2/3/2019,Intravenous,pembrolizumab,TRUE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,5/6/2020,mg,antineoplastic,4/20/2020,2/13/2020,Intravenous,cisplatin,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,2/17/2019,mg,antineoplastic,2/6/2019,12/17/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/6/2017,,solution-fluid,8/15/2016,3/8/2016,Intravenous,clinical study drug,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/7/2019,mg,antineoplastic,12/26/2018,9/18/2018,Intravenous,durvalumab,FALSE
138,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/7/2024,mg,antineoplastic,5/22/2024,6/18/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,3/31/2025,,antineoplastic,3/14/2024,2/14/2023,,clinical study drug,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/29/2021,mg,antineoplastic,10/25/2020,11/13/2020,Intravenous,oxaliplatin,FALSE
36,4,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/23/2019,mg/m2,antineoplastic,2/21/2019,3/4/2019,Intravenous,docetaxel,FALSE
860,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,2/4/2013,mg,antineoplastic,11/21/2012,11/15/2012,Intravenous,pemetrexed,FALSE
1,1,ADVANCED,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/7/2022,mg,antineoplastic,7/18/2022,5/29/2022,Oral,anastrozole,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/31/2022,mg,antineoplastic,8/7/2014,6/26/2014,Intravenous,paclitaxel,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/16/2018,mg,antineoplastic,3/21/2013,3/22/2013,Intravenous,paclitaxel,FALSE
260,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,9/15/2014,mg,antineoplastic,4/11/2013,3/9/2013,Intravenous,carboplatin,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,5/31/2019,mg,antineoplastic,4/8/2019,3/17/2019,Intravenous,gemcitabine,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,1/22/2013,mg,antineoplastic,12/10/2012,10/29/2012,Intravenous,cisplatin,FALSE
54,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,4/14/2025,mg,antineoplastic,1/13/2025,12/23/2024,Intravenous,ipilimumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/16/2022,mg,antineoplastic,4/2/2021,2/3/2021,Intravenous,atezolizumab,FALSE
,3,ADVANCED,Unstructured,,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,6/12/2024,,,4/27/2024,9/28/2023,Oral,osimertinib,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/25/2018,mL,solution-fluid,7/12/2015,7/3/2015,Intravenous,paclitaxel,FALSE
198,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,2/28/2013,mg,antineoplastic,1/7/2013,11/23/2012,Intravenous,paclitaxel,FALSE
1000,3,ADVANCED,Orders,chemotherapy,Gemcitabine,G2FF2946:4C6F,6/22/2018,mg/m2,antineoplastic,3/28/2018,4/29/2018,Intravenous,gemcitabine,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/30/2022,mg,antineoplastic,11/2/2021,10/3/2021,Intravenous,bendamustine,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/11/2022,,antineoplastic,2/10/2022,3/2/2022,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/16/2025,mL,solution-fluid,10/4/2024,3/23/2024,Intravenous,pembrolizumab,FALSE
1125,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:78734BCEDB,1/11/2015,mg,antineoplastic,10/28/2014,7/12/2014,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/13/2023,mg,antineoplastic,3/30/2023,4/3/2023,Subcutaneous,azacitidine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/10/2020,mg,antineoplastic,4/5/2017,12/12/2016,Intravenous,nivolumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/17/2017,mg,antineoplastic,1/29/2017,12/30/2016,Intravenous,paclitaxel,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/31/2021,mg/m2,antineoplastic,4/20/2021,3/11/2021,Intravenous,oxaliplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/22/2015,mg,antineoplastic,10/30/2014,11/1/2014,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/25/2020,mg,antineoplastic,3/22/2017,3/3/2017,Intravenous,paclitaxel,FALSE
1,1,ADVANCED,Administrations,hormone,Anastrozole,G1F26CECEF:89,3/24/2019,mg,antineoplastic,4/22/2019,4/7/2019,Oral,anastrozole,FALSE
1710,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/27/2013,mg,antineoplastic,1/2/2013,12/27/2012,Intravenous,cyclophosphamide,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G135BB2F5GCDF,5/8/2018,mg,antineoplastic,2/21/2018,3/13/2018,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/18/2023,mg,antineoplastic,10/27/2022,12/9/2022,Intravenous,bevacizumab-awwb,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/8/2016,mg,antineoplastic,7/21/2016,6/16/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,3/19/2015,,solution-fluid,9/4/2014,7/26/2014,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/8/2020,mg,antineoplastic,4/29/2020,1/24/2018,Intravenous,pembrolizumab,TRUE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/22/2022,mg,antineoplastic,11/10/2021,5/11/2017,Oral,nilotinib,FALSE
560.1,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/17/2015,mg,antineoplastic,3/19/2015,11/18/2014,Intravenous,carboplatin,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/18/2014,mg,antineoplastic,12/18/2013,11/14/2013,Intravenous,gemcitabine,FALSE
885,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,3/23/2020,mg,antineoplastic,11/23/2019,11/24/2019,Intravenous,pemetrexed,FALSE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/16/2016,mg,antineoplastic,8/24/2015,5/1/2015,Intravenous,cisplatin,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/9/2018,mg/m2,antineoplastic,10/6/2017,9/1/2017,Intravenous,paclitaxel,FALSE
958,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/10/2017,mg,antineoplastic,12/4/2016,1/2/2017,Intravenous,bevacizumab,FALSE
150,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G289C6438E26:,8/2/2013,mg,antineoplastic,7/19/2013,7/18/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28F814933C3F,12/29/2024,mg,antineoplastic,11/5/2024,7/31/2024,Intravenous,pembrolizumab,TRUE
146,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/12/2024,mg,antineoplastic,3/29/2024,4/17/2024,Intravenous,cisplatin,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,11/15/2016,mg,antineoplastic,6/7/2016,7/19/2016,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/16/2020,mg,antineoplastic,7/26/2019,11/25/2018,Intravenous,pemetrexed,TRUE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/29/2015,mg,antineoplastic,6/11/2014,12/29/2013,Intravenous,paclitaxel,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/2/2015,mg,antineoplastic,7/20/2015,3/5/2015,Intravenous,gemcitabine,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/11/2025,mg,antineoplastic,6/26/2024,3/19/2024,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,3/16/2019,4/26/2017,Intravenous,nivolumab,FALSE
,,NEOADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G1DCDG73E53FF,6/13/2024,,antineoplastic,5/11/2024,4/30/2024,Intravenous,clinical study drug,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/15/2022,mg,antineoplastic,11/4/2021,9/13/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/8/2020,mg,antineoplastic,4/21/2020,9/26/2019,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/17/2020,mg,antineoplastic,11/2/2016,11/5/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/11/2022,mg,antineoplastic,8/30/2021,4/26/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/12/2023,,antineoplastic,8/10/2022,3/8/2022,Intravenous,pembrolizumab,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/18/2022,mg,antineoplastic,3/31/2022,2/19/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,8/31/2021,mg,antineoplastic,6/9/2021,3/20/2021,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,4/8/2021,,antineoplastic,8/20/2020,2/1/2020,Intravenous,clinical study drug,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/12/2023,mg,antineoplastic,6/13/2020,4/28/2020,Intravenous,pemetrexed,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/18/2013,AUC,antineoplastic,6/4/2012,4/3/2012,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/22/2025,mg,antineoplastic,7/18/2018,8/28/2016,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,7/27/2022,mg,antineoplastic,8/5/2022,6/17/2022,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Leuprolide,G369D5G3B91:2,5/5/2024,,antineoplastic,2/23/2024,2/17/2024,Intramuscular,leuprolide,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/26/2019,mg,antineoplastic,4/12/2018,11/3/2016,Intramuscular,fulvestrant,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/23/2025,mg,antineoplastic,12/21/2016,1/4/2017,Intravenous,nivolumab,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/11/2022,mg,antineoplastic,4/11/2022,7/16/2021,Intravenous,bevacizumab-bvzr,FALSE
647,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,4/25/2024,mg,antineoplastic,2/29/2024,3/8/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/21/2024,mg,antineoplastic,6/9/2023,6/2/2023,Intravenous,pembrolizumab,TRUE
100,3,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,5/28/2024,mL,solution-fluid,11/15/2020,8/21/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/5/2023,mg,antineoplastic,5/30/2023,3/6/2022,Intravenous,pembrolizumab,TRUE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G1D41F368EE:G,3/22/2020,mg,antineoplastic,12/18/2019,11/13/2019,Subcutaneous,leuprolide,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/16/2025,mg,antineoplastic,9/11/2024,9/25/2024,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/14/2017,mg,antineoplastic,8/23/2016,8/23/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,5/17/2020,,antineoplastic,1/17/2020,3/5/2020,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/28/2019,mg,antineoplastic,12/19/2018,2/20/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Temozolomide,G4B63:1C9D452,12/3/2016,,antineoplastic,9/1/2016,8/12/2016,,temozolomide,FALSE
304,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/2/2024,mg,antineoplastic,5/9/2024,5/5/2024,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,11/19/2023,mg/m2,antineoplastic,9/27/2023,9/8/2023,Intravenous,gemcitabine,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,1/30/2017,mg,antineoplastic,1/29/2017,9/12/2016,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G2C521EB94C:2,4/11/2023,,,12/30/2020,1/23/2021,Oral,erlotinib,FALSE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G319D776C24D5,7/5/2021,mg,antineoplastic,6/14/2021,4/18/2021,Intravenous,pemetrexed,FALSE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/27/2022,mg,antineoplastic,4/30/2022,2/22/2022,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,1/16/2019,mg,antineoplastic,9/13/2018,7/8/2018,Intravenous,pembrolizumab,FALSE
191,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C88CEG2:289,12/27/2024,mg,antineoplastic,1/19/2025,11/22/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/9/2023,mg,antineoplastic,10/1/2020,5/27/2020,Intravenous,pembrolizumab,FALSE
36,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,5/17/2016,mg,antineoplastic,5/9/2016,4/8/2016,Intravenous,cisplatin,FALSE
130,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,4/25/2025,mg,antineoplastic,11/20/2024,11/24/2024,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,3/8/2019,mg,antineoplastic,12/10/2018,6/20/2018,Intravenous,nivolumab,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,5/19/2022,mg,antineoplastic,5/14/2022,5/9/2022,Intravenous,carboplatin,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,3/18/2012,mg,antineoplastic,3/13/2012,3/9/2012,Intravenous,docetaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/22/2025,mg,antineoplastic,12/20/2023,9/11/2022,Oral,anastrozole,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/14/2022,mg/kg,antineoplastic,3/24/2022,2/20/2021,Intravenous,durvalumab,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/9/2023,mg,antineoplastic,9/19/2023,10/4/2022,Intravenous,durvalumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/7/2021,mL,solution-fluid,7/19/2018,4/5/2018,Intravenous,durvalumab,TRUE
514,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,6/12/2016,mg,antineoplastic,4/25/2016,4/3/2016,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/16/2020,mg,antineoplastic,6/25/2019,12/6/2018,Intravenous,pemetrexed,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/6/2025,mg,antineoplastic,10/28/2024,12/13/2024,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G5792EBE:8EB3,11/19/2012,mg/m2,antineoplastic,12/7/2012,9/26/2012,Intravenous,gemcitabine,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/2/2025,mg,antineoplastic,11/8/2024,4/13/2024,Intravenous,cemiplimab,TRUE
388,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,2/21/2019,mg,antineoplastic,10/27/2018,12/4/2018,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/15/2017,,antineoplastic,7/20/2016,6/9/2016,Intramuscular,fulvestrant,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/4/2025,mg,antineoplastic,9/3/2018,3/20/2018,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/9/2016,mg,antineoplastic,10/18/2015,7/14/2015,Intravenous,carboplatin,FALSE
1476,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,4/4/2022,mg,antineoplastic,1/29/2022,2/2/2022,Intravenous,bevacizumab-awwb,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,4/19/2025,mg,antineoplastic,10/17/2022,2/10/2022,Intravenous,pembrolizumab,TRUE
855,,ADJUVANT,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/20/2013,mg,antineoplastic,11/15/2012,1/9/2013,Intravenous,rituximab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,,antineoplastic,10/6/2020,4/2/2017,Oral,nilotinib,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,4/21/2019,mg,antineoplastic,12/7/2018,7/8/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2F5C96E2545B,5/30/2024,mg,antineoplastic,6/9/2024,6/4/2024,Intravenous,pembrolizumab,FALSE
72,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,11/26/2018,mg,antineoplastic,9/12/2018,10/16/2018,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/4/2025,mg,antineoplastic,10/22/2022,10/15/2022,Intravenous,pemetrexed,TRUE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/3/2014,mg,antineoplastic,4/1/2014,1/2/2014,Intravenous,paclitaxel,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/10/2022,mg,antineoplastic,9/14/2019,5/16/2019,Intravenous,paclitaxel,FALSE
220,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/14/2018,mg,antineoplastic,6/4/2018,4/19/2018,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/9/2021,mg,antineoplastic,3/12/2021,4/21/2021,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/24/2019,mg,antineoplastic,1/27/2018,9/22/2017,Intravenous,pembrolizumab,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/29/2022,mg,antineoplastic,1/12/2022,3/2/2022,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,10/20/2015,mg,antineoplastic,9/11/2015,5/30/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G385EEC4EF993,11/18/2020,,antineoplastic,12/22/2020,12/23/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3GB7EGGB7:9D,3/29/2020,mg,antineoplastic,1/25/2020,1/25/2020,Intravenous,pembrolizumab,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,7/27/2013,mg,antineoplastic,9/5/2013,7/13/2013,Intravenous,etoposide,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/20/2025,mg,antineoplastic,9/29/2019,2/26/2019,Intravenous,pemetrexed,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/9/2015,mg,antineoplastic,9/30/2014,4/27/2014,Intravenous,vinorelbine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/7/2025,mg,antineoplastic,2/8/2021,12/24/2016,Intravenous,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G257D9:2573CF,3/15/2025,mg,antineoplastic,12/24/2024,11/19/2024,Intravenous,durvalumab,TRUE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/2/2016,mg,antineoplastic,8/6/2016,7/2/2016,Intravenous,paclitaxel,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/15/2016,mg,antineoplastic,6/30/2015,6/25/2015,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/29/2025,mg,antineoplastic,3/17/2025,3/25/2024,Intravenous,pembrolizumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,3/4/2014,mg,antineoplastic,8/23/2013,7/16/2013,Intravenous,paclitaxel,FALSE
915,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G18E7528ED97:,3/12/2012,mg,antineoplastic,10/23/2011,11/5/2011,Intravenous,pemetrexed,FALSE
2,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/20/2019,AUC,antineoplastic,11/11/2019,10/18/2019,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/3/2015,mg,antineoplastic,4/17/2014,12/25/2013,Intravenous,paclitaxel,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/30/2021,mg/kg,antineoplastic,9/24/2021,3/23/2021,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1195EGCD:B45,5/15/2024,,antineoplastic,5/28/2024,5/28/2024,,pembrolizumab,TRUE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/26/2021,mg,antineoplastic,10/19/2020,9/15/2020,Intravenous,nivolumab,FALSE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/9/2025,mg,antineoplastic,12/19/2024,9/25/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3CG5712E:B54,4/27/2024,mg,antineoplastic,2/19/2024,2/9/2024,Intravenous,pembrolizumab,TRUE
30,,CONCURRENT,Orders,chemotherapy,Vinorelbine,G13F669ED2119,5/22/2013,mg/m2,antineoplastic,12/25/2012,12/11/2012,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,2/23/2021,,antineoplastic,2/16/2020,3/6/2020,Intravenous,clinical study drug,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,9/22/2022,mg,antineoplastic,9/24/2022,7/11/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/6/2022,,antineoplastic,2/3/2020,4/15/2017,Oral,nilotinib,FALSE
190,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/19/2020,mg,antineoplastic,10/6/2016,6/30/2016,Intravenous,nivolumab,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/10/2018,mg/m2,antineoplastic,11/16/2017,10/23/2017,Intravenous,paclitaxel,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/12/2013,mg,antineoplastic,1/11/2013,1/6/2013,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/1/2025,mg,antineoplastic,1/20/2024,10/11/2023,Intravenous,atezolizumab,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/20/2025,mg,antineoplastic,10/18/2024,6/21/2024,Intravenous,durvalumab,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/31/2022,mg,antineoplastic,3/2/2022,9/23/2021,Intravenous,leucovorin,FALSE
20,2,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,4/14/2014,mg/m2,antineoplastic,3/30/2014,2/17/2014,Intravenous,vinorelbine,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/9/2015,mg,antineoplastic,5/9/2015,1/18/2015,Intravenous,paclitaxel protein-bound,FALSE
472,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/13/2021,mg,antineoplastic,5/1/2021,5/11/2021,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:64BD9C5919,9/22/2021,mg,antineoplastic,8/18/2021,8/20/2021,Intravenous,pemetrexed,FALSE
375,,ADJUVANT,Orders,targeted/biologic,Rituximab,G5545136B977G,10/11/2019,mg/m2,antineoplastic,11/13/2019,10/28/2019,Intravenous,rituximab,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,8/2/2024,,antineoplastic,11/1/2023,4/3/2023,Oral,niraparib,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,3/25/2016,mg,antineoplastic,4/4/2016,11/18/2015,Intravenous,docetaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/5/2020,mg,antineoplastic,6/17/2020,9/19/2019,Intravenous,pembrolizumab,FALSE
85,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,6/19/2015,mg,antineoplastic,5/23/2015,3/28/2015,Intravenous,paclitaxel,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/13/2017,mg,antineoplastic,1/7/2017,12/18/2016,Intravenous,docetaxel,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Paclitaxel",G147ED4GE76EE,11/18/2019,mg/m2,antineoplastic,11/14/2019,10/31/2019,Intravenous,paclitaxel,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/24/2021,mg,antineoplastic,12/22/2020,12/22/2020,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/29/2024,mg,antineoplastic,3/1/2024,9/27/2023,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/1/2024,mg,antineoplastic,10/27/2024,6/15/2024,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/26/2025,mg,antineoplastic,10/15/2024,6/22/2024,Intravenous,carboplatin,FALSE
670,1,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,8/31/2018,mg,antineoplastic,3/6/2018,10/5/2016,Intravenous,rituximab,FALSE
3,1,ADVANCED,Orders,immunotherapy,Nivolumab,G33E77:6CF7F3,9/2/2017,mg/kg,antineoplastic,3/29/2017,8/14/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/3/2017,,solution-fluid,9/30/2016,1/25/2016,Intravenous,clinical study drug,FALSE
84,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,5/23/2022,mg,antineoplastic,3/31/2022,2/25/2022,Intravenous,paclitaxel,FALSE
5,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/28/2013,AUC,antineoplastic,9/5/2013,10/2/2013,Intravenous,carboplatin,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/25/2016,mg,antineoplastic,7/29/2016,5/16/2016,Intravenous,nivolumab,FALSE
166,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,11/14/2022,mg,antineoplastic,9/25/2022,11/17/2022,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/15/2025,,antineoplastic,3/31/2018,10/28/2017,Intravenous,clinical study drug,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Irinotecan",G1D61871659DG,9/3/2012,mg,antineoplastic,7/31/2012,7/7/2012,Intravenous,irinotecan,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/19/2025,mg,antineoplastic,3/17/2023,9/28/2022,Intravenous,pemetrexed,TRUE
975,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/9/2015,mg,antineoplastic,1/24/2015,1/5/2015,Intravenous,pemetrexed,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,7/27/2024,mg,antineoplastic,6/26/2024,6/18/2024,Intravenous,nivolumab,FALSE
,3,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3EC5EB18C676,7/17/2018,,antineoplastic,5/17/2018,3/2/2018,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/25/2020,mg,antineoplastic,4/3/2019,3/18/2019,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,5/18/2016,mg,antineoplastic,9/23/2014,8/19/2014,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/1/2022,mg,antineoplastic,9/3/2022,4/3/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/19/2022,mg,antineoplastic,10/27/2021,1/4/2018,Intravenous,pembrolizumab,FALSE
158,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5344:8G5698G,10/9/2022,mg,antineoplastic,9/11/2022,8/25/2022,Intravenous,cisplatin,FALSE
50,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:D1D2EG5C21,1/23/2015,mg,antineoplastic,2/4/2015,12/13/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,12/10/2015,,steroid,8/12/2015,7/27/2015,Intrajejunal,clinical study drug,FALSE
1780,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/27/2024,mg,antineoplastic,9/17/2023,7/18/2023,Intravenous,gemcitabine,FALSE
100,3,ADVANCED,Administrations,chemotherapy,Paclitaxel,G11B743:8G337,2/10/2017,mg,antineoplastic,1/11/2017,12/19/2016,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/27/2017,mg,antineoplastic,12/23/2016,7/9/2015,Intravenous,nivolumab,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,8/5/2017,,antineoplastic,12/7/2016,11/30/2016,Oral,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,3/8/2022,mg,antineoplastic,12/28/2021,10/18/2021,Intravenous,pembrolizumab,TRUE
1200,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/27/2022,mg/m2,antineoplastic,11/19/2021,10/12/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/18/2025,mg,antineoplastic,1/1/2023,8/17/2022,Intravenous,pembrolizumab,TRUE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/10/2017,mg,antineoplastic,8/29/2016,5/16/2016,Intravenous,paclitaxel protein-bound,FALSE
350,2,ADVANCED,Administrations,immunotherapy,Cemiplimab,G2262335C:D62,11/16/2024,mg,antineoplastic,10/10/2024,9/11/2024,Intravenous,cemiplimab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/1/2021,mg,antineoplastic,7/8/2020,11/23/2019,Intravenous,pembrolizumab,FALSE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,12/4/2019,mg,antineoplastic,10/10/2019,6/24/2019,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/13/2025,mg,antineoplastic,6/10/2024,1/11/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G13GE1E25174F,6/19/2022,mg,antineoplastic,5/2/2022,3/14/2022,Intravenous,pembrolizumab,FALSE
525,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/28/2024,mg,antineoplastic,3/5/2024,1/2/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/9/2025,mg,antineoplastic,10/14/2019,2/11/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/18/2017,,antineoplastic,7/28/2016,2/5/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/17/2020,mg,antineoplastic,7/2/2020,6/14/2020,Intravenous,pembrolizumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/21/2022,mg,antineoplastic,9/30/2021,8/19/2021,Intravenous,amivantamab-vmjw,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,3/28/2017,,solution-fluid,4/11/2017,2/20/2016,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14GFF41D::2B,9/9/2012,mg,antineoplastic,8/24/2012,7/24/2012,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,7/11/2024,,antineoplastic,5/18/2024,3/13/2024,Intravenous,pemetrexed,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/7/2024,mg,antineoplastic,6/26/2024,4/26/2024,Intravenous,cemiplimab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/16/2025,mg,antineoplastic,12/9/2022,1/12/2019,Intravenous,pembrolizumab,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/3/2020,mg/kg,antineoplastic,6/10/2018,2/12/2016,Intravenous,bevacizumab,TRUE
60,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G1G618861EGD9,9/21/2016,mg,antineoplastic,7/25/2016,8/16/2016,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/23/2025,mg,antineoplastic,4/23/2024,3/11/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/30/2025,mg,antineoplastic,6/9/2019,1/1/2019,Intravenous,pembrolizumab,TRUE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/18/2021,mg,antineoplastic,9/1/2020,7/17/2020,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/28/2022,,antineoplastic,3/24/2020,4/29/2017,Oral,nilotinib,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G579E53D92:75,10/22/2011,,antiemetic,8/25/2011,8/16/2011,Intravenous,clinical study drug,FALSE
150,2,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,11/14/2015,mg/m2,antineoplastic,2/9/2015,3/4/2015,Intravenous,paclitaxel protein-bound,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/31/2024,,antineoplastic,11/30/2024,5/2/2024,,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23G13:GCG631,1/10/2018,mg,antineoplastic,11/20/2017,10/4/2017,Intravenous,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,8/25/2012,mg,antineoplastic,3/1/2012,4/7/2012,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1F482136BDE5,3/13/2024,,antineoplastic,3/1/2024,2/17/2024,Oral,anastrozole,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/14/2020,mg,antineoplastic,3/24/2017,12/27/2015,Intravenous,nivolumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/25/2024,mg,antineoplastic,1/12/2024,1/14/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G142964636C93,3/31/2022,mg,antineoplastic,2/5/2022,1/8/2022,Intravenous,pembrolizumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,9/4/2022,mg,antineoplastic,3/22/2022,8/5/2021,Intravenous,pembrolizumab,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,12/24/2024,mg,antineoplastic,1/2/2025,9/20/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/1/2020,mg,antineoplastic,6/13/2020,12/23/2018,Intravenous,pembrolizumab,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/19/2020,mg,antineoplastic,3/26/2020,4/26/2020,Intravenous,paclitaxel,FALSE
1540,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/20/2018,mg,antineoplastic,9/12/2018,8/14/2018,Intravenous,gemcitabine,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,12/4/2018,mg,antineoplastic,6/11/2018,6/15/2018,Intravenous,carboplatin,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/18/2016,mg/kg,antineoplastic,3/28/2016,1/22/2016,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,11/6/2018,mg,antineoplastic,7/14/2018,7/14/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G11D1:8:62429,10/4/2015,,antineoplastic,7/17/2015,7/31/2015,,nivolumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/15/2025,mg,antineoplastic,4/26/2022,3/21/2020,Intravenous,pemetrexed,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/21/2023,mg,antineoplastic,2/26/2023,12/23/2022,Intravenous,atezolizumab,FALSE
204,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/7/2012,mg,antineoplastic,9/2/2012,2/16/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G499EB:16:7F3,8/11/2019,,antineoplastic,3/20/2019,9/2/2018,Intravenous,nivolumab,FALSE
1120,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,10/1/2016,mg,antineoplastic,9/5/2016,8/17/2016,Intravenous,pemetrexed,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/5/2014,mg,antineoplastic,4/4/2014,12/21/2013,Intravenous,carboplatin,FALSE
490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,10/10/2015,mg,antineoplastic,8/6/2015,8/6/2015,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/17/2021,mL,solution-fluid,5/28/2021,4/4/2021,Intravenous,pembrolizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/3/2017,mg,antineoplastic,7/20/2017,8/17/2017,Intravenous,etoposide,FALSE
1224,4,ADVANCED,Administrations,chemotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/26/2024,mg,antineoplastic,10/15/2023,10/6/2023,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/24/2012,,antineoplastic,11/30/2011,8/4/2011,Intravenous,clinical study drug,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/9/2013,mg/m2,antineoplastic,11/1/2013,10/18/2013,Intravenous,etoposide,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/8/2021,mg,antineoplastic,6/16/2021,4/30/2021,Intravenous,pemetrexed,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/1/2024,mg,antineoplastic,7/6/2024,5/3/2024,Intravenous,etoposide,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,11/23/2023,mg,antineoplastic,11/6/2023,11/6/2023,Intravenous,paclitaxel,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/10/2016,mg,antineoplastic,10/24/2015,10/23/2015,Intravenous,etoposide,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,2/23/2022,mg,antineoplastic,5/14/2014,5/20/2014,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/1/2023,mg,antineoplastic,7/9/2023,4/17/2023,Subcutaneous,azacitidine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/27/2025,mg,antineoplastic,10/21/2023,5/8/2023,Intravenous,pembrolizumab,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,3/10/2016,mg,antineoplastic,9/11/2015,8/5/2015,Intravenous,carboplatin,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/24/2014,mg,antineoplastic,4/19/2013,8/29/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/14/2023,mg,antineoplastic,7/23/2022,9/14/2021,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/8/2015,mg,antineoplastic,1/3/2015,11/26/2014,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,6/13/2024,,,10/3/2023,10/30/2023,Oral,osimertinib,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/2/2014,mg/m2,antineoplastic,8/10/2013,9/12/2012,Intravenous,gemcitabine,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/11/2019,mg,antineoplastic,5/9/2019,4/30/2019,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/27/2019,mg,antineoplastic,10/9/2019,7/10/2019,Intravenous,pembrolizumab,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,6/16/2024,mg,antineoplastic,12/5/2023,11/4/2023,Intravenous,nivolumab,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/30/2025,mg,antineoplastic,3/1/2016,12/18/2015,Intravenous,carboplatin,FALSE
370,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,1/24/2024,mg,antineoplastic,12/9/2023,10/18/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/15/2025,mg,antineoplastic,12/25/2024,8/3/2022,Intravenous,pembrolizumab,TRUE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/25/2022,mg,antineoplastic,1/29/2020,1/24/2016,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/11/2020,mg,antineoplastic,6/25/2017,12/6/2015,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,12/27/2016,mg,antineoplastic,6/13/2016,6/14/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,9/24/2022,AUC,antineoplastic,3/25/2022,3/21/2022,Intravenous,carboplatin,FALSE
3,1,ADVANCED,Orders,immunotherapy,Nivolumab,G1CD225858D1:,11/15/2016,mg/kg,antineoplastic,10/29/2016,6/11/2016,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/10/2020,mg,antineoplastic,3/7/2017,6/29/2016,Intravenous,nivolumab,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/28/2012,mg,antineoplastic,10/25/2011,9/5/2011,Intravenous,cetuximab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,8/29/2024,mg,antineoplastic,3/9/2022,6/24/2020,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/27/2018,mg,antineoplastic,3/19/2018,9/2/2017,Intravenous,atezolizumab,FALSE
268,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,1/10/2021,mg,antineoplastic,5/2/2020,1/17/2020,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/23/2020,mg,antineoplastic,5/15/2014,3/12/2014,Intravenous,rituximab,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/2/2022,mg,antineoplastic,6/13/2021,3/14/2021,Intravenous,bevacizumab-awwb,FALSE
460,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,11/11/2021,mg,antineoplastic,7/28/2021,7/12/2021,Intravenous,carboplatin,FALSE
1010,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/4/2025,mg,antineoplastic,11/30/2021,11/4/2021,Intravenous,pemetrexed,TRUE
131,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,7/27/2019,mg,antineoplastic,7/15/2018,6/18/2018,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,12/10/2015,,steroid,10/9/2015,6/29/2015,Intrajejunal,clinical study drug,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/1/2017,mg,antineoplastic,6/24/2017,7/25/2017,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G128:92:3BD3D,12/15/2021,,steroid,5/22/2021,4/17/2021,Intravenous,clinical study drug,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,3/7/2022,mg,antineoplastic,2/10/2022,8/30/2021,Intravenous,pemetrexed,TRUE
109,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G27B37646G3C2,10/2/2019,mg,antineoplastic,8/21/2019,7/26/2019,Intravenous,carboplatin,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/14/2012,mg,antineoplastic,10/18/2012,5/2/2012,Intravenous,carboplatin,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/27/2018,mg,antineoplastic,3/7/2018,11/30/2017,Intravenous,bevacizumab,FALSE
220,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,10/16/2014,mg,antineoplastic,8/13/2014,9/24/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/21/2025,,antineoplastic,6/12/2024,2/25/2023,Intravenous,pemetrexed,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/15/2022,mg,antineoplastic,12/12/2021,11/11/2021,Intravenous,fluorouracil,FALSE
605,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,4/2/2025,mg,antineoplastic,1/22/2025,1/31/2025,Intravenous,carboplatin,FALSE
83,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/4/2016,mg,antineoplastic,7/8/2016,5/29/2016,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,11/7/2022,mg,antineoplastic,12/28/2021,9/17/2021,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,3/3/2016,mg,antineoplastic,8/3/2015,5/31/2015,Intravenous,paclitaxel protein-bound,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,3/26/2020,mg,antineoplastic,8/23/2019,7/26/2019,Intravenous,docetaxel,FALSE
105,1,ADVANCED,Administrations,chemotherapy,Nivolumab,G21BD9C1D75:6,1/21/2019,mg,antineoplastic,6/15/2018,5/29/2018,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/16/2020,mg,antineoplastic,6/19/2020,2/27/2020,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,9/27/2023,mg,antineoplastic,1/18/2023,12/29/2022,Oral,zanubrutinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,6/20/2024,,antineoplastic,3/19/2024,4/29/2024,Intravenous,pemetrexed,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,8/19/2024,mg,antineoplastic,8/31/2024,7/20/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,6/14/2024,mg,antineoplastic,7/12/2024,4/13/2024,Intravenous,pembrolizumab,TRUE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/29/2019,mg,antineoplastic,9/30/2019,6/30/2019,Intravenous,paclitaxel protein-bound,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/10/2022,mg,antineoplastic,9/1/2021,5/8/2021,Intravenous,bevacizumab-bvzr,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/6/2018,mL,solution-fluid,2/9/2018,1/2/2018,Intravenous,paclitaxel,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/16/2011,mg,antineoplastic,7/26/2011,3/23/2011,Intravenous,carboplatin,FALSE
313,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,7/11/2023,mg,antineoplastic,3/20/2023,3/18/2023,Intravenous,paclitaxel,FALSE
162,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/8/2019,mg,antineoplastic,12/16/2018,10/29/2018,Intravenous,carboplatin,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,3/26/2025,mg,antineoplastic,1/15/2025,1/10/2025,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/2/2019,mg,antineoplastic,6/5/2019,4/11/2016,Intravenous,nivolumab,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,2/9/2017,mg,antineoplastic,2/1/2017,1/23/2017,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/31/2020,mg,antineoplastic,4/5/2020,9/23/2019,Intravenous,durvalumab,FALSE
,4,ADVANCED,Unstructured,,Lorlatinib,G3BBG95F1669C,4/3/2023,,,3/29/2023,3/27/2023,Oral,lorlatinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,9/23/2019,mg,antineoplastic,8/25/2019,7/21/2019,Intravenous,pembrolizumab,FALSE
2.9,2,ADVANCED,Administrations,chemotherapy,Eribulin,G19937F58E541,12/6/2013,mg,antineoplastic,11/17/2013,11/17/2013,Intravenous,eribulin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,4/24/2012,,antineoplastic,11/7/2011,8/1/2011,Intravenous,clinical study drug,FALSE
100,3,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,4/29/2024,mL,solution-fluid,9/17/2020,8/20/2020,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/29/2025,mg,antineoplastic,5/7/2018,1/25/2017,Intravenous,pembrolizumab,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/17/2020,mg,antineoplastic,7/6/2020,5/26/2020,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,12/23/2015,mg,antineoplastic,10/6/2015,9/3/2015,Intravenous,pemetrexed,FALSE
500,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,7/9/2017,mg/m2,antineoplastic,7/2/2017,4/29/2017,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1EC14EC2:22:,4/11/2024,mg,antineoplastic,2/27/2024,11/11/2023,Intravenous,durvalumab,TRUE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,2/20/2019,mg,antineoplastic,2/23/2019,10/28/2018,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/30/2025,mg,antineoplastic,1/19/2025,3/18/2024,Intravenous,pembrolizumab,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,3/30/2019,mg/kg,antineoplastic,10/24/2017,7/10/2017,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,3/16/2012,,antineoplastic,10/18/2011,6/28/2011,Intravenous,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G445F26762F72,4/30/2024,mg,antineoplastic,4/19/2024,1/15/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,3/16/2025,,antineoplastic,11/24/2023,2/12/2022,Intravenous,pembrolizumab,TRUE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/20/2025,mg,antineoplastic,10/8/2022,11/29/2021,Intravenous,pembrolizumab,TRUE
348,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/18/2016,mg,antineoplastic,4/21/2016,3/30/2016,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/16/2024,mg,antineoplastic,9/15/2023,8/29/2023,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Orders,antiemetic,Clinical Study Drug,G344BC2:6BGE1,5/2/2012,,antiemetic,12/21/2011,10/16/2011,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/10/2022,mg,antineoplastic,7/18/2020,1/5/2018,Intravenous,pembrolizumab,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/26/2018,mg,antineoplastic,1/7/2018,11/20/2017,Intravenous,bevacizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/31/2023,mg,antineoplastic,5/2/2023,12/20/2022,Intravenous,atezolizumab,FALSE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,6/11/2024,,antiemetic,5/31/2024,5/14/2024,Intravenous,clinical study drug,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/20/2025,mg,antineoplastic,2/7/2025,6/25/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,2/24/2021,,antiemetic,4/11/2020,1/19/2020,Intravenous,clinical study drug,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/3/2025,mg,antineoplastic,7/13/2024,7/15/2024,Intravenous,durvalumab,FALSE
240,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,9/20/2023,mg,antineoplastic,6/28/2023,6/4/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/16/2021,mg,antineoplastic,6/5/2021,5/16/2021,Intravenous,etoposide,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/11/2015,mg/m2,antineoplastic,1/17/2015,2/1/2015,Intravenous,paclitaxel,FALSE
5,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/12/2019,AUC,antineoplastic,8/6/2019,7/4/2019,Intravenous,carboplatin,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/14/2024,mg,antineoplastic,1/25/2024,11/18/2023,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,2/16/2017,mg,antineoplastic,1/12/2017,11/28/2016,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G59G454E1B6B3,10/18/2024,,,7/17/2018,7/21/2018,Oral,osimertinib,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,10/20/2015,mg,antineoplastic,8/5/2015,7/31/2015,Intravenous,gemcitabine,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/25/2018,mg,antineoplastic,3/20/2018,12/19/2017,Intravenous,pemetrexed,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G34BG69F45EE4,7/30/2019,mg/kg,antineoplastic,3/27/2019,9/14/2018,Intravenous,durvalumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/5/2013,AUC,antineoplastic,12/27/2012,7/29/2012,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/19/2019,mg,antineoplastic,2/21/2019,11/12/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/8/2025,mg,antineoplastic,4/12/2019,5/20/2018,Intravenous,pembrolizumab,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/3/2021,mg,antineoplastic,12/29/2020,12/10/2020,Intravenous,paclitaxel,FALSE
436,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,8/6/2012,mg,antineoplastic,6/15/2012,6/18/2012,Intravenous,paclitaxel,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/24/2016,mg,antineoplastic,1/10/2014,1/10/2014,Intravenous,etoposide,FALSE
825,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/19/2017,mg,antineoplastic,10/25/2016,10/21/2016,Intravenous,pemetrexed,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/19/2023,mg,antineoplastic,3/2/2023,1/6/2023,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/26/2022,mg,antineoplastic,1/30/2022,11/17/2021,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,5/28/2020,mg,antineoplastic,2/3/2020,7/13/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/21/2020,mg,antineoplastic,9/9/2019,7/4/2016,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/16/2022,,antineoplastic,3/7/2022,1/13/2022,Intravenous,carboplatin,FALSE
,4,ADVANCED,Unstructured,,Lorlatinib,G3BBG95F1669C,3/4/2023,,,2/21/2023,2/26/2023,Oral,lorlatinib,FALSE
1700,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G11:F93GC6851,5/4/2021,mg,antineoplastic,4/6/2021,1/12/2021,Intravenous,gemcitabine,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/17/2021,mg,antineoplastic,5/24/2020,6/13/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/27/2024,mg,antineoplastic,4/12/2021,6/3/2020,Intravenous,pembrolizumab,TRUE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/11/2020,mg,antineoplastic,2/26/2020,2/14/2019,Subcutaneous,bortezomib,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G43D:C17:25FG,1/30/2016,mg,antineoplastic,10/20/2015,10/25/2015,Intravenous,nivolumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/13/2023,mg,antineoplastic,8/11/2023,5/2/2023,Intravenous,pemetrexed,FALSE
259,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/2/2024,mg,antineoplastic,10/22/2023,9/19/2023,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/22/2016,mg,antineoplastic,4/9/2016,3/25/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/5/2019,mg,antineoplastic,11/26/2018,11/13/2018,Intravenous,pembrolizumab,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/14/2020,mg,antineoplastic,10/23/2020,4/5/2020,Intravenous,docetaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,12/12/2021,mg,antineoplastic,8/8/2021,3/8/2021,Intravenous,durvalumab,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,7/5/2022,mg,antineoplastic,7/3/2022,6/8/2022,Oral,anastrozole,FALSE
722,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/12/2014,mg,antineoplastic,10/4/2014,9/21/2014,Intravenous,carboplatin,FALSE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/6/2018,mg,antineoplastic,9/30/2018,9/25/2018,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/13/2025,mg,antineoplastic,11/25/2024,8/28/2022,Oral,anastrozole,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/10/2015,mg,antineoplastic,11/7/2014,11/12/2014,Intravenous,bevacizumab,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,1/9/2024,mg,antineoplastic,3/13/2023,2/14/2023,Intravenous,cyclophosphamide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/29/2018,mg,antineoplastic,9/28/2017,8/21/2015,Intravenous,nivolumab,FALSE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,11/25/2011,mg,antineoplastic,9/25/2011,9/19/2011,Intravenous,cisplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/10/2025,mg,antineoplastic,8/5/2024,8/18/2022,Intravenous,pembrolizumab,TRUE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/25/2019,mg,antineoplastic,3/26/2019,1/18/2019,Intravenous,paclitaxel protein-bound,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,12/18/2020,mg,antineoplastic,6/30/2020,8/5/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,hormone,"Anastrozole,Ramucirumab",G1GFD92F489E7,11/8/2023,,antineoplastic,12/6/2023,9/16/2023,Oral,anastrozole,FALSE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,1/6/2020,mg,antineoplastic,10/24/2019,8/24/2019,Intravenous,durvalumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,1/23/2023,mg,antineoplastic,4/30/2022,5/12/2022,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G579E53D92:75,11/15/2011,,antiemetic,8/24/2011,7/26/2011,Intravenous,clinical study drug,FALSE
1025,1,LOCOREGIONAL,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,8/13/2012,mg,antineoplastic,5/10/2012,4/18/2012,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/23/2024,mg,antineoplastic,5/18/2024,7/11/2023,Intravenous,pembrolizumab,TRUE
740,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G225D5E995642,8/17/2022,mg,antineoplastic,7/5/2022,4/14/2022,Intravenous,durvalumab,TRUE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,11/19/2011,mg,antineoplastic,9/14/2011,8/2/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/3/2020,mg,antineoplastic,4/16/2019,10/27/2018,Intravenous,pembrolizumab,TRUE
234,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,7/21/2018,mg,antineoplastic,11/8/2017,10/24/2017,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/28/2023,mg,antineoplastic,12/11/2022,8/21/2022,Subcutaneous,azacitidine,FALSE
20,,ADJUVANT,Orders,chemotherapy,Decitabine,G1F5415D1B672,12/17/2018,mg/m2,antineoplastic,10/12/2018,8/26/2018,Intravenous,decitabine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,11/28/2016,mg,antineoplastic,12/9/2014,11/2/2014,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Unstructured,,Alectinib,G19GDC129D136,2/5/2021,,,12/29/2020,8/5/2018,Oral,alectinib,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,2/7/2025,AUC,antineoplastic,1/2/2025,12/12/2024,Intravenous,carboplatin,FALSE
286,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,2/13/2024,mg,antineoplastic,11/23/2023,10/13/2023,Intravenous,carboplatin,FALSE
620,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/22/2024,mg,antineoplastic,2/20/2024,1/21/2024,Intravenous,carboplatin,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/12/2021,mg,antineoplastic,10/12/2019,11/26/2018,Intravenous,pemetrexed,TRUE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/24/2025,mg,antineoplastic,4/19/2024,2/18/2024,Intravenous,amivantamab-vmjw,FALSE
,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/21/2022,,antineoplastic,6/8/2022,5/21/2017,Intravenous,nivolumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/24/2019,mg,antineoplastic,9/18/2019,8/31/2019,Intravenous,etoposide,FALSE
119,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,2/8/2024,mg,antineoplastic,11/27/2023,10/27/2023,Intravenous,carboplatin,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/22/2019,mg,antineoplastic,2/9/2019,1/30/2019,Intravenous,paclitaxel,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/15/2014,mg/kg,antineoplastic,12/31/2013,12/19/2013,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/18/2025,mg,antineoplastic,3/30/2017,12/11/2016,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/17/2023,mg,antineoplastic,5/2/2023,5/25/2023,Intravenous,pembrolizumab,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/22/2014,mg,antineoplastic,4/13/2014,3/13/2014,Intravenous,carboplatin,FALSE
1910,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,2/8/2025,mg,antineoplastic,11/28/2024,12/25/2024,Intravenous,gemcitabine,FALSE
,4,ADVANCED,Orders,hormone,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,1/22/2025,,antineoplastic,1/7/2025,1/23/2025,,enzalutamide,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,3/19/2012,,antineoplastic,7/20/2011,7/30/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/17/2022,mg,antineoplastic,9/2/2021,7/21/2020,Intravenous,pembrolizumab,TRUE
135,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/28/2020,mg,antineoplastic,11/5/2020,11/11/2020,Intravenous,oxaliplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/13/2021,mL,solution-fluid,9/25/2018,3/16/2018,Intravenous,durvalumab,TRUE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/14/2025,mg,antineoplastic,6/10/2024,3/20/2024,Intravenous,pemetrexed,TRUE
840,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2177D1::DG1E,3/5/2012,mg,antineoplastic,12/11/2011,12/25/2011,Intravenous,pemetrexed,TRUE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/17/2019,mg,antineoplastic,5/9/2016,4/11/2016,Intravenous,nivolumab,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,3/21/2024,mg,antineoplastic,10/31/2023,4/22/2023,Intravenous,atezolizumab,FALSE
59.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G2745:9D5G3DG,4/11/2012,mg,antineoplastic,4/14/2012,3/15/2012,Intravenous,docetaxel,FALSE
,,NEOADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G1DCDG73E53FF,6/13/2024,,antineoplastic,6/5/2024,5/31/2024,Intravenous,clinical study drug,FALSE
15,1,ADVANCED,Orders,targeted/biologic,Bevacizumab,G19GDC129D136,8/10/2018,mg/kg,antineoplastic,8/6/2017,7/26/2017,Intravenous,bevacizumab,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/30/2016,mg/kg,antineoplastic,3/24/2016,3/1/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/6/2022,mg,antineoplastic,5/30/2022,4/26/2022,Intravenous,pembrolizumab,FALSE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,1/17/2025,mg,antineoplastic,12/1/2024,10/22/2024,Intravenous,cisplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/12/2019,mg,antineoplastic,5/8/2019,10/12/2018,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/28/2019,mg,antineoplastic,6/20/2018,4/8/2016,Intravenous,nivolumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/21/2018,mL,solution-fluid,1/17/2018,1/24/2018,Intravenous,carboplatin,FALSE
432,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,3/18/2015,mg,antineoplastic,12/9/2014,12/10/2014,Intravenous,carboplatin,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/9/2012,mg,antineoplastic,1/13/2012,9/26/2011,Intravenous,cetuximab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/9/2016,mg,antineoplastic,5/3/2016,1/31/2016,Intravenous,etoposide,FALSE
51,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/26/2024,mg,antineoplastic,3/31/2024,10/21/2023,Intravenous,ipilimumab,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/7/2024,mg,antineoplastic,10/23/2024,8/20/2024,Intravenous,temsirolimus,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,1/19/2025,mg,antineoplastic,10/14/2024,9/26/2024,Intravenous,durvalumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,11/21/2015,mg,antineoplastic,9/24/2015,9/27/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,5/5/2023,mg,antineoplastic,8/29/2022,5/30/2022,Intravenous,nivolumab,FALSE
170,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/10/2019,mg,antineoplastic,5/21/2019,2/7/2019,Intravenous,docetaxel,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/16/2021,mg,antineoplastic,8/4/2020,12/11/2019,Intravenous,durvalumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/28/2025,mg,antineoplastic,7/31/2017,1/14/2017,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,immunotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/23/2024,,antineoplastic,2/21/2023,3/18/2023,Intravenous,nivolumab,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,1/5/2014,mg,antineoplastic,2/16/2014,11/10/2013,Intravenous,carboplatin,FALSE
1275,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/20/2019,mg,antineoplastic,6/8/2019,7/5/2019,Intravenous,pemetrexed,FALSE
1900,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G3CE666498C:9,2/26/2013,mg,antineoplastic,12/22/2012,12/15/2012,Intravenous,gemcitabine,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G21B4CD9B81B7,5/28/2012,mg,antineoplastic,6/14/2012,5/13/2012,Intravenous,pemetrexed,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/24/2019,mg,antineoplastic,10/2/2019,5/23/2019,Intravenous,docetaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,1/15/2025,mg,antineoplastic,9/7/2024,6/26/2024,Intravenous,durvalumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/24/2016,mg,antineoplastic,6/6/2015,11/29/2014,Intravenous,gemcitabine,FALSE
129,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3CG5712E:B54,7/18/2024,mg,antineoplastic,6/14/2024,5/19/2024,Intravenous,docetaxel,FALSE
730,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/25/2024,mg,antineoplastic,7/27/2024,7/6/2024,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,4/22/2025,AUC,antineoplastic,12/4/2024,12/13/2024,Intravenous,carboplatin,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/15/2018,mg,antineoplastic,7/12/2018,4/24/2018,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/26/2024,mg,antineoplastic,8/28/2023,2/25/2022,Intravenous,durvalumab,FALSE
590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,2/1/2013,mg,antineoplastic,11/16/2012,11/5/2012,Intravenous,carboplatin,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/8/2016,mg,antineoplastic,1/10/2016,5/31/2015,Intravenous,bevacizumab,FALSE
800,2,ADVANCED,Orders,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/6/2017,mg,antineoplastic,9/10/2016,7/29/2016,Intravenous,necitumumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/25/2022,,antineoplastic,9/18/2021,4/8/2017,Oral,nilotinib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2B4648:BGD83,5/9/2025,mg,antineoplastic,1/21/2025,1/22/2025,Intravenous,durvalumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/12/2017,mg,antineoplastic,8/21/2017,5/30/2017,Intravenous,carboplatin,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,2/25/2012,mg,antineoplastic,1/8/2012,11/26/2011,Intravenous,paclitaxel,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/3/2024,mg,antineoplastic,7/29/2024,7/24/2024,Intravenous,paclitaxel,FALSE
159,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/22/2024,mg,antineoplastic,6/30/2024,6/14/2024,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/25/2025,mg,antineoplastic,4/3/2025,3/16/2025,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,4/25/2023,,antineoplastic,1/8/2023,11/21/2022,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/8/2016,mg,antineoplastic,9/19/2015,8/24/2015,Intravenous,bevacizumab,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G24167D1DD5FG,2/1/2025,mg,antineoplastic,11/30/2024,10/2/2024,Intravenous,carboplatin,FALSE
616,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G167G71733G69,3/26/2016,mg,antineoplastic,12/13/2015,10/11/2015,Intravenous,pemetrexed,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/9/2015,mg,antineoplastic,11/15/2014,9/6/2014,Intravenous,cisplatin,FALSE
159,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,5/7/2023,mg,antineoplastic,4/20/2023,3/5/2023,Intravenous,cisplatin,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/21/2024,mg,antineoplastic,2/11/2024,11/8/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/14/2025,,antineoplastic,6/10/2024,5/22/2024,Intravenous,paclitaxel protein-bound,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/4/2025,mg,antineoplastic,12/9/2024,7/29/2021,Intravenous,atezolizumab,TRUE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,5/13/2015,mg,antineoplastic,3/25/2015,3/4/2015,Intravenous,pemetrexed,FALSE
114,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,12/28/2021,mg,antineoplastic,9/27/2021,9/27/2021,Intravenous,paclitaxel,FALSE
139,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,9/7/2015,mg,antineoplastic,7/18/2015,5/17/2015,Intravenous,etoposide,FALSE
200,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,2/10/2022,mg/m2,antineoplastic,9/4/2021,8/25/2021,Intravenous,paclitaxel,FALSE
269,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/14/2024,mg,antineoplastic,9/6/2023,9/29/2023,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,2/12/2021,mg,antineoplastic,5/31/2020,3/12/2020,Intravenous,paclitaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,9/18/2020,mg,antineoplastic,9/29/2020,7/25/2020,Intravenous,carboplatin,FALSE
261,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/7/2024,mg,antineoplastic,6/11/2024,2/19/2024,Intravenous,paclitaxel,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/11/2024,mg,antineoplastic,2/15/2023,3/20/2022,Intravenous,durvalumab,FALSE
,,NEOADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G1DCDG73E53FF,6/28/2024,,solution-fluid,6/30/2024,5/21/2024,Intravenous,clinical study drug,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,12/21/2011,mg,antineoplastic,11/2/2011,8/4/2011,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/22/2020,mg,antineoplastic,3/10/2017,11/3/2015,Intravenous,nivolumab,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/9/2025,mg,antineoplastic,12/27/2024,12/6/2024,Intravenous,oxaliplatin,FALSE
114,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,12/12/2018,mg,antineoplastic,1/31/2019,12/7/2018,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/29/2025,mg,antineoplastic,7/4/2024,10/11/2022,Intravenous,pembrolizumab,TRUE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/7/2021,mg/m2,antineoplastic,7/15/2021,2/18/2021,Intravenous,oxaliplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/18/2025,mg,antineoplastic,10/27/2022,7/28/2022,Intravenous,pembrolizumab,TRUE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/22/2013,mg,antineoplastic,11/6/2013,9/11/2013,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,11/10/2021,mg,antineoplastic,4/20/2021,2/16/2021,Intravenous,durvalumab,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/21/2023,mg,antineoplastic,4/10/2020,1/16/2020,Intravenous,docetaxel,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,7/26/2018,mg,antineoplastic,6/27/2018,7/29/2018,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,4/20/2025,mg,antineoplastic,5/22/2024,1/28/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Palbociclib,G286G2E848134,9/17/2016,,antineoplastic,8/9/2016,7/28/2016,Oral,palbociclib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/23/2025,mg,antineoplastic,1/17/2019,5/10/2018,Intravenous,pembrolizumab,FALSE
1590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/2/2013,mg,antineoplastic,7/18/2013,10/21/2012,Intravenous,gemcitabine,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/27/2022,mg,antineoplastic,8/25/2021,5/13/2021,Intravenous,fluorouracil,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/24/2013,mg,antineoplastic,5/27/2013,4/22/2013,Intravenous,pemetrexed,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,1/3/2024,mg,antineoplastic,10/23/2023,7/2/2023,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/25/2020,mg,antineoplastic,11/23/2019,1/20/2019,Intravenous,nivolumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/1/2016,mg,antineoplastic,12/4/2015,4/27/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/29/2020,mg,antineoplastic,12/17/2018,6/22/2016,Intravenous,nivolumab,FALSE
746,,ADJUVANT,Administrations,targeted/biologic,Rituximab,G5545136B977G,8/25/2020,mg,antineoplastic,6/25/2020,6/29/2020,Intravenous,rituximab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/22/2020,,antineoplastic,2/21/2020,12/21/2019,Intravenous,clinical study drug,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/19/2019,mg,antineoplastic,4/1/2018,1/19/2018,Intravenous,pemetrexed,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/3/2015,mg,antineoplastic,8/18/2015,2/20/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/23/2016,mg,antineoplastic,8/24/2015,6/20/2015,Intravenous,paclitaxel protein-bound,FALSE
730,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,12/5/2024,mg,antineoplastic,8/3/2024,8/9/2024,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/26/2024,mg,antineoplastic,6/7/2024,7/4/2024,Intravenous,pembrolizumab,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/2/2020,mg,antineoplastic,11/11/2020,9/10/2020,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/21/2018,mg,antineoplastic,8/11/2018,4/24/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G36G688G4EBD6,10/27/2023,mg,antineoplastic,11/19/2023,9/30/2023,Intravenous,pembrolizumab,TRUE
1540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,7/18/2018,mg,antineoplastic,7/25/2018,6/23/2018,Intravenous,gemcitabine,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,5/3/2025,mg,antineoplastic,1/1/2016,12/24/2015,Intravenous,carboplatin,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/8/2018,mg,antineoplastic,6/20/2018,5/21/2018,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/17/2025,mg,antineoplastic,12/5/2024,3/30/2024,Intravenous,pembrolizumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,4/2/2020,mg,antineoplastic,11/3/2019,9/11/2019,Intravenous,gemcitabine,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/25/2015,mg,antineoplastic,1/19/2015,10/29/2014,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/14/2022,,antineoplastic,11/5/2021,10/5/2021,Intravenous,pembrolizumab,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/16/2012,mg,antineoplastic,3/11/2012,4/6/2012,Intravenous,docetaxel,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/10/2024,mg,antineoplastic,7/16/2024,2/17/2024,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/17/2021,mg,antineoplastic,4/19/2021,3/20/2021,Intravenous,pembrolizumab,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/8/2020,mg,antineoplastic,12/10/2020,9/24/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/9/2022,mg,antineoplastic,6/26/2022,7/31/2022,Intravenous,pembrolizumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/12/2020,mg,antineoplastic,12/10/2019,9/3/2019,Intravenous,gemcitabine,FALSE
110.4,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,2/20/2014,mg,antineoplastic,9/14/2013,6/21/2013,Intravenous,docetaxel,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,1/1/2019,mg,antineoplastic,10/23/2018,7/17/2018,Intravenous,carboplatin,FALSE
432,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/13/2022,mg,antineoplastic,12/22/2021,10/15/2021,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/24/2020,mg,antineoplastic,12/2/2018,6/28/2017,Intravenous,pemetrexed,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/31/2023,mg,antineoplastic,2/9/2022,12/3/2021,Intravenous,durvalumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/23/2023,mg,antineoplastic,2/4/2023,9/19/2022,Subcutaneous,azacitidine,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/21/2025,mg,antineoplastic,8/28/2020,4/4/2019,Intravenous,pemetrexed,FALSE
352,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/24/2025,mg,antineoplastic,1/5/2025,10/27/2024,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/26/2025,mg,antineoplastic,8/17/2022,1/11/2017,Intravenous,pembrolizumab,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/16/2020,mg,antineoplastic,10/18/2019,9/23/2019,Intravenous,pemetrexed,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/11/2023,mg,antineoplastic,3/2/2023,1/14/2023,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G419BEEC19D2C,10/15/2021,mg,antineoplastic,8/14/2021,9/29/2021,Intravenous,pembrolizumab,FALSE
740,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G225D5E995642,8/5/2022,mg,antineoplastic,6/9/2022,5/23/2022,Intravenous,durvalumab,TRUE
840,4,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/24/2021,mg,antineoplastic,11/4/2021,9/1/2021,Intravenous,atezolizumab,FALSE
770,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/20/2021,mg,antineoplastic,9/20/2021,7/25/2021,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,5/15/2025,mg,antineoplastic,12/15/2024,9/24/2024,Intravenous,nivolumab,TRUE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C88CEG2:289,1/14/2025,mg,antineoplastic,10/30/2024,11/21/2024,Intravenous,paclitaxel,FALSE
404,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/22/2016,mg,antineoplastic,2/22/2016,10/19/2015,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/20/2018,mg,antineoplastic,11/20/2016,10/3/2016,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/20/2024,mg,antineoplastic,4/6/2022,3/3/2022,Intravenous,durvalumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/24/2018,mL,solution-fluid,1/14/2018,1/24/2018,Intravenous,paclitaxel,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/11/2021,mg,antineoplastic,5/25/2021,5/12/2021,Intravenous,paclitaxel protein-bound,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/20/2016,mg,antineoplastic,11/15/2015,11/10/2015,Intravenous,paclitaxel protein-bound,FALSE
600,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1G54G4GB8B24,11/2/2023,mg,antineoplastic,10/8/2022,9/14/2022,Intravenous,ramucirumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/6/2023,mg,antineoplastic,11/9/2022,4/25/2022,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/17/2017,mg,antineoplastic,9/27/2017,7/3/2017,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,7/27/2012,mg,antineoplastic,4/29/2012,3/28/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/5/2025,mg,antineoplastic,5/16/2024,7/13/2023,Intravenous,pembrolizumab,TRUE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/27/2015,mg,antineoplastic,6/4/2015,3/23/2015,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/22/2018,mg,antineoplastic,6/1/2018,3/2/2017,Intravenous,pembrolizumab,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,4/1/2016,mg,antineoplastic,12/24/2015,11/19/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/31/2025,mg,antineoplastic,1/23/2025,6/21/2023,Intravenous,pembrolizumab,TRUE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/8/2015,mg,antineoplastic,8/25/2014,8/30/2014,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/26/2019,mg,antineoplastic,12/22/2017,9/1/2017,Intravenous,atezolizumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,4/27/2016,mg,antineoplastic,3/8/2016,2/10/2016,Intravenous,nivolumab,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/9/2018,mg,antineoplastic,1/26/2018,1/7/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/23/2021,mg,antineoplastic,8/9/2019,9/4/2019,Intravenous,pembrolizumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/29/2020,mg,antineoplastic,9/8/2019,2/26/2019,Intravenous,durvalumab,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/10/2025,mg,antineoplastic,11/1/2020,3/7/2020,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/26/2023,mg,antineoplastic,12/1/2020,4/27/2020,Intravenous,pembrolizumab,FALSE
,5,ADVANCED,Orders,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/14/2024,,antineoplastic,9/18/2024,9/10/2024,Intravenous,temsirolimus,FALSE
1650,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G2FF2946:4C6F,5/23/2018,mg,antineoplastic,4/21/2018,4/15/2018,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,3/16/2025,mg,antineoplastic,2/5/2025,8/15/2024,Intravenous,pembrolizumab,FALSE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/23/2017,mg,antineoplastic,1/28/2017,1/29/2017,Intravenous,carboplatin,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/22/2016,mg,antineoplastic,7/13/2015,5/5/2014,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G29C71B44G:B6,7/6/2013,mg/m2,antineoplastic,6/8/2013,6/22/2013,Intravenous,pemetrexed,FALSE
351,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/28/2018,mg,antineoplastic,5/29/2018,5/31/2018,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/11/2021,mg,antineoplastic,12/5/2020,12/21/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/13/2025,mg,antineoplastic,4/23/2025,8/30/2022,Intravenous,pembrolizumab,TRUE
484,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1G54G4GB8B24,10/25/2023,mg,antineoplastic,12/7/2022,8/21/2022,Intravenous,ramucirumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/11/2022,mg,antineoplastic,3/22/2019,2/28/2016,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,1/29/2024,,antineoplastic,3/22/2023,4/10/2023,Intravenous,atezolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/4/2025,mg,antineoplastic,5/31/2022,3/7/2019,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/26/2025,mg,antineoplastic,5/16/2017,7/12/2016,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/24/2021,mg,antineoplastic,9/17/2020,11/13/2018,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,2/2/2018,mg,antineoplastic,11/14/2017,6/8/2017,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,1/16/2018,mg,antineoplastic,11/20/2017,10/8/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/12/2018,mg,antineoplastic,6/11/2017,8/24/2015,Intravenous,nivolumab,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,1/8/2024,mg,antineoplastic,10/3/2023,8/29/2023,Intravenous,cisplatin,FALSE
374,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/24/2022,mg,antineoplastic,5/1/2021,3/19/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G2CG3EF9E5:2B,6/24/2021,,,5/4/2021,11/4/2020,Oral,alectinib,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/21/2025,mg,antineoplastic,8/15/2024,3/2/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/26/2024,mg,antineoplastic,10/12/2020,6/4/2020,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/3/2019,mg,antineoplastic,10/8/2017,7/3/2017,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,3/26/2023,mg/m2,antineoplastic,2/18/2023,11/14/2022,Intravenous,pemetrexed,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/31/2018,mg,antineoplastic,3/20/2013,2/21/2013,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Unstructured,,Erlotinib,G21BD9C1D75:6,4/27/2020,,,4/11/2020,7/2/2019,Oral,erlotinib,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/9/2012,mg,antineoplastic,9/2/2012,5/8/2012,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/7/2020,mg,antineoplastic,10/30/2017,11/23/2015,Intravenous,nivolumab,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G2D168F99BCD4,10/24/2024,,,12/5/2023,12/29/2023,Oral,trametinib,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,4/5/2021,mg,antineoplastic,1/3/2021,12/2/2020,Intravenous,docetaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,4/18/2025,mg,antineoplastic,11/14/2024,1/21/2024,Intravenous,pembrolizumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,1/26/2019,mg,antineoplastic,12/11/2018,11/24/2018,Intravenous,pemetrexed,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/22/2014,mg,antineoplastic,4/26/2014,1/11/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/12/2022,mg,antineoplastic,8/1/2019,12/13/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,6/10/2024,mg,antineoplastic,5/13/2024,2/19/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,3/14/2015,,,3/2/2015,12/15/2014,Oral,crizotinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/7/2023,mg,antineoplastic,8/31/2022,5/27/2020,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/2/2025,mg/m2,antineoplastic,10/11/2024,6/2/2024,Intravenous,pemetrexed,FALSE
159,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,12/29/2023,mg,antineoplastic,11/23/2023,10/13/2023,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/16/2023,mg,antineoplastic,7/18/2020,12/22/2019,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G3CE666498C:9,4/17/2013,mg/m2,antineoplastic,12/16/2012,12/23/2012,Intravenous,gemcitabine,FALSE
360,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/2/2016,mg,antineoplastic,7/23/2016,6/25/2016,Intravenous,paclitaxel,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,12/27/2021,mg,antineoplastic,5/9/2021,3/26/2021,Intravenous,atezolizumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/17/2015,mg,antineoplastic,8/1/2015,7/30/2015,Intravenous,carboplatin,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/1/2015,mg,antineoplastic,6/12/2015,9/5/2014,Intravenous,bevacizumab,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,10/29/2021,,antineoplastic,6/18/2018,2/16/2018,,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/19/2019,mg,antineoplastic,7/16/2017,4/2/2016,Intravenous,nivolumab,FALSE
145,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G18:439734B::,9/19/2015,mg,antineoplastic,9/6/2015,8/6/2015,Intravenous,docetaxel,FALSE
1710,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/27/2013,mg,antineoplastic,1/10/2013,12/15/2012,Intravenous,cyclophosphamide,FALSE
1070,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2763DEB9848B,5/8/2020,mg,antineoplastic,4/26/2020,5/22/2020,Intravenous,pemetrexed,FALSE
48,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17171D313CCE,8/12/2018,mg,antineoplastic,3/6/2018,2/19/2018,Intravenous,docetaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/8/2023,mg,antineoplastic,5/20/2023,8/2/2022,Intravenous,pemetrexed,TRUE
250,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G21:3143F86E6,3/8/2015,mg,antineoplastic,12/21/2014,12/6/2014,Intravenous,carboplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,5/7/2025,mg,antineoplastic,1/24/2025,1/31/2025,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/16/2025,mg,antineoplastic,1/4/2025,4/19/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/26/2025,,,4/11/2025,11/17/2024,Oral,osimertinib,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,11/23/2011,mg,antineoplastic,10/14/2011,9/1/2011,Intravenous,etoposide,FALSE
126,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/19/2014,mg,antineoplastic,1/6/2014,1/13/2014,Intravenous,paclitaxel,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/18/2024,mg,antineoplastic,2/8/2024,2/14/2024,Intravenous,paclitaxel,FALSE
950,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,1/14/2025,mg,antineoplastic,9/5/2024,9/6/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,2/20/2019,mg,antineoplastic,5/3/2018,1/21/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/7/2025,,antineoplastic,2/17/2025,3/24/2024,Intravenous,clinical study drug,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/5/2015,mg,antineoplastic,10/23/2015,7/8/2015,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,12/23/2024,mg,antineoplastic,9/18/2024,7/30/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/24/2025,mg,antineoplastic,12/24/2022,8/1/2022,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/15/2025,mg,antineoplastic,7/24/2017,12/13/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,Sotorasib,G4253CG56F6FC,5/1/2023,,,4/8/2023,2/21/2023,Oral,sotorasib,FALSE
525,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/21/2025,mg,antineoplastic,11/29/2019,4/4/2019,Intravenous,carboplatin,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/26/2025,mg,antineoplastic,11/26/2024,7/30/2024,Intravenous,durvalumab,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/29/2019,mg,antineoplastic,6/15/2019,9/28/2018,Intravenous,durvalumab,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/3/2021,mg,antineoplastic,6/20/2021,5/20/2021,Intravenous,paclitaxel protein-bound,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/1/2019,mg,antineoplastic,9/25/2019,7/18/2019,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38GE:9D51587,8/8/2012,mg,antineoplastic,6/20/2012,3/15/2012,Intravenous,bevacizumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/3/2017,mg/m2,antineoplastic,11/18/2016,9/16/2016,Intravenous,pemetrexed,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/12/2025,mg,antineoplastic,1/11/2017,12/19/2016,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/21/2025,mg,antineoplastic,9/26/2024,4/11/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G344BC2:6BGE1,4/22/2012,,antineoplastic,12/24/2011,10/25/2011,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G1:78734BCEDB,8/30/2014,,antineoplastic,2/28/2014,4/14/2014,Intravenous,clinical study drug,FALSE
391,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,5/11/2025,mg,antineoplastic,2/12/2025,12/29/2024,Intravenous,carboplatin,FALSE
,5,ADVANCED,Orders,hormone,"Everolimus,Exemestane",G19937F58E541,10/27/2014,,antineoplastic,7/27/2014,8/1/2014,Oral,exemestane,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/21/2019,mg,antineoplastic,8/6/2018,7/15/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/12/2014,,solution-fluid,12/2/2013,12/3/2013,Intravenous,clinical study drug,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/10/2019,mg/m2,antineoplastic,1/14/2019,10/24/2018,Intravenous,vinorelbine,FALSE
417,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,6/12/2023,mg,antineoplastic,3/10/2023,3/1/2023,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,3/28/2025,,steroid,4/11/2025,12/23/2024,Intravenous,clinical study drug,FALSE
885,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,12/25/2015,mg,antineoplastic,11/8/2015,10/29/2015,Intravenous,pemetrexed,FALSE
375,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,2/4/2017,mg,antineoplastic,1/2/2017,11/11/2016,Intravenous,carboplatin,FALSE
438,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,10/19/2018,mg,antineoplastic,7/23/2018,5/11/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/18/2015,,antineoplastic,8/22/2015,5/30/2015,Oral,ibrutinib,FALSE
504.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/22/2015,mg,antineoplastic,11/17/2014,10/1/2014,Intravenous,carboplatin,FALSE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/5/2015,mg,antineoplastic,5/23/2014,5/18/2014,Intravenous,vinorelbine,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,6/13/2013,mg,antineoplastic,7/1/2013,2/9/2013,Intravenous,gemcitabine,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/12/2024,mg,antineoplastic,7/3/2022,4/20/2022,Intravenous,durvalumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,6/23/2024,mg,antineoplastic,5/20/2024,5/11/2024,Intravenous,atezolizumab,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/30/2016,mg,antineoplastic,7/17/2016,7/5/2016,Intravenous,carboplatin,FALSE
1075,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/16/2016,mg,antineoplastic,3/5/2016,11/1/2014,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/5/2025,mg,antineoplastic,4/17/2021,1/16/2017,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/20/2018,mg,antineoplastic,1/12/2018,6/13/2017,Intravenous,pembrolizumab,FALSE
144,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/9/2019,mg,antineoplastic,2/11/2019,9/18/2018,Intravenous,carboplatin,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/19/2015,mg,antineoplastic,12/9/2014,5/14/2014,Intravenous,vinorelbine,FALSE
500,3,ADVANCED,Orders,chemotherapy,Pemetrexed,G298FGDFDG8E7,5/1/2023,mg/m2,antineoplastic,2/6/2020,1/16/2020,Intravenous,pemetrexed,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/10/2019,mg,antineoplastic,9/6/2018,9/10/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/18/2022,mg,antineoplastic,8/27/2021,8/12/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/11/2025,mg,antineoplastic,7/19/2023,6/25/2023,Intravenous,pembrolizumab,TRUE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,12/26/2023,mg,antineoplastic,11/30/2023,11/23/2023,Intravenous,carboplatin,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/5/2021,mg,antineoplastic,5/28/2020,6/26/2020,Intravenous,gemcitabine,FALSE
288,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,5/24/2024,mg,antineoplastic,7/18/2023,8/2/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/12/2021,mg,antineoplastic,3/6/2021,11/12/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,5/29/2019,mg,antineoplastic,4/6/2019,3/3/2019,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,5/10/2024,mg,antineoplastic,12/22/2021,12/11/2021,Intravenous,pembrolizumab,FALSE
851.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,1/22/2016,mg,antineoplastic,8/1/2015,7/7/2015,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/8/2022,mg,antineoplastic,12/7/2020,1/6/2016,Intravenous,pemetrexed,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/15/2021,mg,antineoplastic,1/11/2019,3/10/2018,Intravenous,durvalumab,TRUE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,3/1/2016,mg,antineoplastic,5/26/2015,4/16/2015,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/10/2025,mg,antineoplastic,9/24/2024,3/12/2024,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/10/2019,mg,antineoplastic,8/8/2019,7/29/2019,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,5/14/2025,mg,antineoplastic,10/27/2024,8/16/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/18/2024,,antineoplastic,6/1/2024,3/19/2024,,pembrolizumab,FALSE
85,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/3/2023,mg,antineoplastic,2/13/2023,2/9/2023,Intravenous,carboplatin,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/25/2014,mg,antineoplastic,8/3/2014,8/29/2014,Intravenous,pemetrexed,FALSE
450,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/25/2025,mg,antineoplastic,7/17/2020,3/28/2019,Intravenous,carboplatin,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,7/10/2016,mg,antineoplastic,3/25/2016,3/30/2016,Intravenous,paclitaxel,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G121:2D8:4E94,9/4/2019,mg,antineoplastic,8/22/2019,6/29/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/29/2022,mg,antineoplastic,12/2/2021,12/26/2021,Intravenous,pembrolizumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/21/2019,mg,antineoplastic,9/23/2018,8/13/2018,Intravenous,pemetrexed,FALSE
443,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/26/2019,mg,antineoplastic,7/18/2018,6/14/2018,Intravenous,carboplatin,FALSE
668.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/14/2021,mg,antineoplastic,11/1/2019,8/28/2019,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,3/26/2025,mg,antineoplastic,2/1/2025,10/21/2024,Intravenous,durvalumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,8/6/2022,mg,antineoplastic,9/18/2021,9/4/2021,Intravenous,durvalumab,FALSE
118,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/19/2022,mg,antineoplastic,6/24/2022,7/6/2022,Intravenous,carboplatin,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/14/2014,AUC,antineoplastic,1/17/2014,12/29/2013,Intravenous,carboplatin,FALSE
823,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/23/2024,mg,antineoplastic,2/15/2024,10/14/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,2/12/2020,,antineoplastic,2/24/2020,1/1/2020,Intravenous,atezolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,5/31/2023,mg,antineoplastic,7/18/2023,12/9/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/21/2025,mg,antineoplastic,4/21/2023,10/13/2022,Intravenous,pembrolizumab,TRUE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/13/2025,mg,antineoplastic,1/31/2016,1/7/2016,Intravenous,carboplatin,FALSE
117,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/26/2020,mg,antineoplastic,9/20/2020,6/13/2020,Subcutaneous,azacitidine,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,4/3/2016,mg,antineoplastic,1/6/2016,1/20/2016,Intravenous,nivolumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/24/2022,mg,antineoplastic,9/3/2021,8/3/2021,Intravenous,amivantamab-vmjw,FALSE
0,,ADJUVANT,Orders,hormone,Enzalutamide,G214C6EC1517:,4/27/2025,mg,antineoplastic,3/18/2025,1/18/2025,Oral,enzalutamide,FALSE
15.5,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G57DE72B664E8,7/25/2012,mL,antineoplastic,8/8/2012,8/2/2012,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,5/23/2024,mg,antineoplastic,2/1/2024,2/9/2024,Intravenous,pembrolizumab,FALSE
138,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,2/28/2023,mg,antineoplastic,3/2/2023,1/26/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/12/2019,,antineoplastic,5/19/2019,3/12/2019,,docetaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/15/2022,mg,antineoplastic,6/12/2018,12/21/2017,Intravenous,pembrolizumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/1/2018,mg,antineoplastic,10/26/2016,10/3/2016,Intravenous,paclitaxel,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/30/2025,mg,antineoplastic,9/6/2024,10/16/2024,Intravenous,nivolumab,FALSE
1800,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4G53233CD43C,5/3/2025,mg,antineoplastic,2/25/2025,1/4/2025,Intravenous,gemcitabine,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/5/2020,mg,antineoplastic,4/11/2019,3/1/2019,Intravenous,pemetrexed,FALSE
98,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/2/2015,mg,antineoplastic,6/30/2015,6/18/2015,Intravenous,etoposide,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/14/2015,mg,antineoplastic,9/8/2015,7/29/2015,Intravenous,gemcitabine,FALSE
1700,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,5/3/2023,mg,antineoplastic,10/16/2022,8/27/2022,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/10/2025,mg,antineoplastic,10/9/2024,5/4/2024,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/19/2020,mg,antineoplastic,6/21/2016,1/29/2016,Intravenous,bevacizumab,TRUE
1000,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/10/2017,mg,antineoplastic,4/26/2017,3/24/2017,Intravenous,pemetrexed,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/5/2018,mg,antineoplastic,11/10/2018,7/16/2018,Intravenous,paclitaxel,FALSE
350,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,5/6/2025,mg,antineoplastic,1/25/2025,12/5/2024,Intravenous,paclitaxel,FALSE
173,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/9/2014,mg,antineoplastic,8/5/2013,9/2/2012,Intravenous,carboplatin,FALSE
570,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/25/2024,mg,antineoplastic,11/16/2023,11/25/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/13/2025,mg,antineoplastic,1/19/2021,1/19/2017,Intravenous,pembrolizumab,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,9/28/2012,mg/m2,antineoplastic,7/16/2012,5/25/2012,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/17/2019,mg,antineoplastic,2/12/2017,3/5/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/18/2019,mg,antineoplastic,12/2/2018,6/3/2018,Intravenous,nivolumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,7/21/2024,mg,antineoplastic,6/15/2024,5/1/2024,Intravenous,carboplatin,FALSE
269.78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,7/27/2022,mg,antineoplastic,8/11/2022,5/18/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,10/14/2024,,antineoplastic,10/15/2024,7/21/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/27/2025,mg,antineoplastic,2/9/2023,2/26/2020,Intravenous,pembrolizumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/5/2025,mg,antineoplastic,4/22/2018,7/28/2016,Intravenous,pembrolizumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,9/11/2021,mg,antineoplastic,8/16/2021,7/23/2021,Intravenous,paclitaxel,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/16/2021,mg,antineoplastic,1/20/2021,10/20/2020,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/10/2020,mg,antineoplastic,12/23/2019,5/26/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G172GFE717:24,3/21/2020,mg,antineoplastic,1/28/2020,12/28/2019,Intravenous,pembrolizumab,FALSE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,11/24/2017,mg,antineoplastic,8/31/2017,8/17/2017,Intravenous,paclitaxel,FALSE
130,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/30/2013,mg,antineoplastic,7/4/2013,6/17/2013,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/23/2025,mg,antineoplastic,8/22/2024,5/29/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/13/2021,mg,antineoplastic,1/11/2021,11/2/2019,Intravenous,pembrolizumab,FALSE
1666,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/4/2013,mg/m2,antineoplastic,2/13/2013,1/27/2013,Intravenous,ifosfamide,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/24/2019,mg,antineoplastic,8/22/2019,8/26/2019,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,2/9/2019,mg,antineoplastic,11/12/2017,9/21/2017,Intravenous,pembrolizumab,FALSE
45,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G1F:9CFGFGFC1,6/21/2014,mg,antineoplastic,6/7/2014,4/26/2014,Intravenous,cisplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/25/2019,AUC,antineoplastic,8/27/2019,9/18/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,8/28/2022,AUC,antineoplastic,4/19/2022,3/1/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,8/22/2021,,antineoplastic,8/12/2021,6/4/2021,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G4G4D:D9D8152,4/18/2025,mg/m2,antineoplastic,2/18/2025,2/19/2025,Intravenous,gemcitabine,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/1/2013,AUC,antineoplastic,9/1/2012,8/9/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/26/2023,,antineoplastic,1/31/2023,12/15/2022,,pemetrexed,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/19/2016,mg,antineoplastic,11/12/2015,11/30/2015,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3867F7D51E3D,4/2/2025,,antineoplastic,3/14/2025,2/22/2025,Intravenous,clinical study drug,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/4/2021,mg,antineoplastic,7/29/2019,6/30/2019,Intravenous,paclitaxel,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/13/2017,mg,antineoplastic,6/9/2016,5/3/2016,Intravenous,paclitaxel protein-bound,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/7/2024,mg,antineoplastic,1/9/2024,4/22/2022,Intravenous,durvalumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/24/2025,mg,antineoplastic,3/14/2023,2/18/2019,Intravenous,pemetrexed,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/3/2024,mg,antineoplastic,1/8/2024,12/6/2023,Intravenous,nivolumab,FALSE
240,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,11/16/2019,mg,antineoplastic,6/29/2019,6/22/2019,Intravenous,carboplatin,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,3/3/2022,mg,antineoplastic,7/13/2014,7/6/2014,Intravenous,paclitaxel,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/1/2024,mg,antineoplastic,11/8/2023,9/6/2023,Intravenous,amivantamab-vmjw,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/10/2015,mg,antineoplastic,12/25/2014,9/22/2014,Intravenous,cisplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,6/12/2024,mL,solution-fluid,4/28/2024,5/4/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,3/27/2012,,antiemetic,1/1/2012,9/2/2011,Intravenous,clinical study drug,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/9/2020,mg,antineoplastic,6/26/2020,10/1/2019,Intravenous,durvalumab,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3G18D5D62822,6/13/2012,mg,antineoplastic,3/13/2012,11/15/2011,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G15517:BF5DE4,8/13/2023,mg,antineoplastic,2/7/2023,1/20/2023,Intravenous,durvalumab,TRUE
636,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/16/2025,mg,antineoplastic,1/23/2025,12/19/2024,Intravenous,fluorouracil,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/24/2016,mg,antineoplastic,9/6/2016,6/13/2016,Intravenous,nivolumab,FALSE
362,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,6/26/2016,mg,antineoplastic,6/16/2016,3/12/2016,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/11/2020,mg,antineoplastic,4/14/2019,8/8/2017,Intravenous,pemetrexed,TRUE
472,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1D14:53C99:F,4/8/2023,mg,antineoplastic,2/24/2023,2/19/2023,Intravenous,carboplatin,FALSE
1310,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,1/23/2015,mg,antineoplastic,11/13/2014,10/20/2014,Intravenous,gemcitabine,FALSE
1650,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G2FF2946:4C6F,5/18/2018,mg,antineoplastic,6/9/2018,4/14/2018,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,12/26/2016,mg,antineoplastic,10/26/2016,9/23/2016,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/11/2025,mg,antineoplastic,10/25/2024,5/25/2023,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/2/2023,mg,antineoplastic,4/2/2018,10/12/2017,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,1/3/2023,mg,antineoplastic,9/5/2021,6/4/2021,Intravenous,pembrolizumab,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Rituximab",G48842BBE3634,6/3/2013,mg,antineoplastic,6/8/2013,6/3/2013,Intravenous,etoposide,FALSE
482,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/11/2025,mg,antineoplastic,2/1/2020,3/3/2019,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/9/2024,mg,antineoplastic,8/11/2024,7/29/2023,Intravenous,nivolumab,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,3/21/2016,mg,antineoplastic,12/5/2015,11/13/2015,Intravenous,docetaxel,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,4/14/2013,mg/m2,antineoplastic,1/13/2013,12/21/2012,Intravenous,paclitaxel,FALSE
226,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/24/2014,mg,antineoplastic,8/18/2014,8/28/2014,Intravenous,carboplatin,FALSE
555,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,9/16/2023,mg,antineoplastic,8/14/2023,7/27/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/17/2025,mg,antineoplastic,9/20/2022,1/27/2017,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/22/2020,mg,antineoplastic,10/24/2019,11/1/2018,Intravenous,pemetrexed,TRUE
174,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/19/2020,mg,antineoplastic,3/6/2020,2/7/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,6/22/2020,,antineoplastic,4/3/2020,4/26/2020,Intravenous,paclitaxel,FALSE
378,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,11/22/2016,mg,antineoplastic,7/22/2016,7/10/2016,Intravenous,trastuzumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/25/2025,mg,antineoplastic,9/5/2017,1/11/2017,Intravenous,nivolumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/13/2015,mg,antineoplastic,7/31/2015,3/12/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,6/9/2024,mg,antineoplastic,1/20/2024,2/6/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/22/2025,mg,antineoplastic,10/19/2023,9/19/2022,Intravenous,pembrolizumab,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,10/17/2019,mg,antineoplastic,4/18/2019,6/3/2019,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/11/2014,mg,antineoplastic,5/11/2014,3/27/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GD:D13B31BB,11/15/2018,mg,antineoplastic,6/21/2018,6/19/2018,Intravenous,pembrolizumab,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,1/2/2015,mg,antineoplastic,10/12/2014,11/4/2014,Intravenous,etoposide,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,3/23/2021,mg,antineoplastic,12/23/2020,12/14/2020,Intravenous,paclitaxel,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/3/2024,mg,antineoplastic,8/9/2023,2/19/2023,Intravenous,durvalumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/17/2024,mg,antineoplastic,2/17/2024,12/22/2023,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1651E65B5E88,1/24/2018,mg,antineoplastic,1/27/2018,1/23/2018,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1G7:9D7EC1EC,9/22/2021,,antineoplastic,7/26/2021,7/29/2021,,clinical study drug,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,3/5/2025,mg,antineoplastic,2/21/2025,11/23/2024,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/14/2012,,steroid,1/2/2012,9/21/2011,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Unstructured,,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/12/2015,,,8/19/2015,1/21/2015,Oral,erlotinib,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,8/23/2013,mg,antineoplastic,7/26/2013,3/11/2013,Intravenous,carboplatin,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/20/2013,AUC,antineoplastic,12/28/2012,7/15/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,,antineoplastic,2/3/2019,5/26/2017,Oral,nilotinib,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/17/2021,,steroid,8/23/2020,1/23/2020,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1:9FCE6E6G6C,8/25/2019,,antineoplastic,7/2/2019,8/26/2019,Oral,anastrozole,FALSE
226,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G18:439734B::,2/5/2016,mg,antineoplastic,11/7/2015,10/24/2015,Intravenous,nivolumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,7/3/2016,mg,antineoplastic,3/28/2016,2/4/2016,Intravenous,cisplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/18/2017,mg,antineoplastic,8/23/2017,5/25/2017,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/23/2018,mg,antineoplastic,6/16/2018,6/9/2017,Intravenous,pembrolizumab,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/27/2021,mg,antineoplastic,11/3/2020,9/24/2020,Intravenous,gemcitabine,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/28/2018,mg,antineoplastic,10/25/2018,6/25/2018,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/22/2021,mg,antineoplastic,6/28/2021,3/28/2021,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/3/2021,mg,antineoplastic,7/6/2021,4/15/2021,Intravenous,etoposide,FALSE
386,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3::1F4G:66GE,9/18/2022,mg,antineoplastic,9/18/2022,9/25/2022,Intravenous,carboplatin,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/12/2025,mg,antineoplastic,3/25/2016,11/10/2015,Intravenous,carboplatin,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/29/2020,mg,antineoplastic,4/27/2020,1/3/2019,Subcutaneous,bortezomib,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,12/4/2022,mg,antineoplastic,9/23/2022,9/22/2022,Intravenous,pemetrexed,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,7/5/2024,mg,antineoplastic,6/8/2024,4/2/2024,Intravenous,amivantamab-vmjw,FALSE
600,2,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,8/2/2019,mg,antineoplastic,6/8/2019,4/26/2019,Intravenous,leucovorin,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,1/29/2015,mg,antineoplastic,10/25/2014,10/17/2014,Intravenous,paclitaxel,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/5/2022,mg,antineoplastic,2/11/2022,1/24/2022,Intravenous,paclitaxel,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G2177D1::DG1E,9/3/2012,mg,antineoplastic,8/6/2012,6/28/2012,Intravenous,vinorelbine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/13/2025,mg,antineoplastic,4/20/2024,7/13/2023,Intravenous,pembrolizumab,TRUE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,10/6/2017,mg,antineoplastic,9/8/2017,7/17/2017,Intravenous,etoposide,FALSE
60,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,2/1/2023,mg,antineoplastic,1/23/2023,11/27/2022,Intravenous,ipilimumab,TRUE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,2/13/2012,mg,antineoplastic,11/14/2011,1/10/2012,Intravenous,docetaxel,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,3/9/2023,mg,antineoplastic,12/28/2022,11/24/2022,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,6/4/2016,mg,antineoplastic,3/9/2015,2/25/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,hormone,Anastrozole,G175D38G17E84,6/2/2017,,antineoplastic,2/26/2016,2/8/2016,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/23/2021,mg,antineoplastic,3/23/2020,11/2/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G3:D1D2EG5C21,9/15/2014,,,6/8/2014,2/28/2014,Oral,erlotinib,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/15/2015,mg,antineoplastic,9/20/2015,10/4/2015,Intravenous,pemetrexed,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,5/17/2014,mg,antineoplastic,3/2/2014,2/22/2014,Intravenous,docetaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/8/2025,mg,antineoplastic,9/19/2023,6/22/2023,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/1/2015,mg,antineoplastic,10/8/2014,9/10/2014,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,9/24/2019,mg,antineoplastic,8/10/2019,8/8/2019,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,5/5/2018,mg,antineoplastic,1/29/2018,10/14/2017,Intravenous,nivolumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/13/2016,mg,antineoplastic,3/10/2014,12/29/2013,Intravenous,etoposide,FALSE
1280,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,8/1/2015,mg,antineoplastic,6/21/2015,5/30/2015,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G499EB:16:7F3,8/11/2019,,antineoplastic,8/10/2018,7/29/2018,Intravenous,nivolumab,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/11/2012,mg,antineoplastic,11/28/2011,12/19/2011,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G445F26762F72,5/19/2024,mg,antineoplastic,4/13/2024,2/1/2024,Intravenous,durvalumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/3/2025,mg,antineoplastic,7/7/2024,9/14/2023,Intravenous,atezolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,1/29/2020,mg,antineoplastic,7/6/2019,6/7/2019,Intravenous,paclitaxel,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/17/2012,mg,antineoplastic,4/30/2012,2/29/2012,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1FD696E::692,10/17/2024,,antineoplastic,9/5/2024,7/1/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/26/2025,mg,antineoplastic,11/23/2024,7/6/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/19/2020,mg,antineoplastic,3/13/2019,1/12/2019,Intravenous,pembrolizumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/15/2025,mg,antineoplastic,3/13/2025,10/20/2024,Intravenous,durvalumab,TRUE
,1,ADVANCED,Unstructured,,Osimertinib,G5B3B6C1D1B9E,4/15/2025,,,3/25/2020,3/22/2020,Oral,osimertinib,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/22/2015,mL,solution-fluid,3/24/2015,1/31/2015,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/5/2012,mg,antineoplastic,7/5/2012,1/30/2012,Intravenous,carboplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,10/2/2013,mg,antineoplastic,3/4/2013,2/25/2013,Intravenous,paclitaxel protein-bound,FALSE
161,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/16/2023,mg,antineoplastic,12/17/2022,12/8/2022,Intravenous,carboplatin,FALSE
370,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/14/2023,mg,antineoplastic,3/22/2022,3/24/2022,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/10/2019,mg,antineoplastic,9/18/2018,5/31/2018,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/19/2011,mg,antineoplastic,8/1/2011,5/19/2011,Intravenous,etoposide,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/27/2015,mg,antineoplastic,8/12/2015,2/9/2015,Intravenous,gemcitabine,FALSE
5,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/20/2016,mg,antineoplastic,5/15/2016,4/19/2016,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,8/27/2013,mg,antineoplastic,4/17/2013,1/19/2013,Intravenous,bevacizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/14/2014,mg,antineoplastic,3/6/2014,2/26/2014,Intravenous,pemetrexed,FALSE
960,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,2/28/2019,mg,antineoplastic,2/2/2019,1/19/2019,Intravenous,pemetrexed,FALSE
2070,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/22/2013,mg,antineoplastic,5/30/2013,11/13/2012,Intravenous,gemcitabine,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/9/2017,mg,antineoplastic,12/13/2017,9/25/2017,Intravenous,carboplatin,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,7/2/2023,mg,antineoplastic,4/6/2023,3/20/2023,Intravenous,cisplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/8/2019,mg/kg,antineoplastic,10/25/2018,9/4/2018,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/8/2014,,antineoplastic,1/29/2014,12/12/2013,,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/28/2013,mg,antineoplastic,10/20/2012,1/16/2012,Intravenous,etoposide,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,4/22/2025,mg,antineoplastic,7/5/2024,6/2/2024,Intravenous,pemetrexed,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/3/2019,mg,antineoplastic,9/17/2016,3/26/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G2C521EB94C:2,5/27/2023,,,4/20/2023,12/22/2020,Oral,erlotinib,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/10/2020,mg,antineoplastic,8/16/2019,12/29/2018,Intravenous,pemetrexed,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,6/19/2024,mg,antineoplastic,4/21/2024,4/1/2024,Intravenous,paclitaxel,FALSE
127,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/3/2021,mg,antineoplastic,6/30/2021,6/3/2020,Intravenous,docetaxel,FALSE
163.2,5,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Vemurafenib",G4C53C5GC48E:,9/11/2016,mg,antineoplastic,9/14/2016,8/17/2016,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/10/2025,,solution-fluid,12/31/2017,10/31/2017,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/4/2022,,antineoplastic,12/8/2018,5/19/2017,Oral,nilotinib,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/7/2020,mg,antineoplastic,1/4/2020,12/12/2019,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,4/12/2025,,antineoplastic,11/8/2024,10/5/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/23/2018,mg,antineoplastic,6/8/2017,3/28/2017,Intravenous,pembrolizumab,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/6/2021,mg,antineoplastic,5/16/2018,3/23/2018,Intravenous,durvalumab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/17/2016,AUC,antineoplastic,2/28/2015,5/23/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/21/2014,mg,antineoplastic,5/28/2014,4/7/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/15/2025,mg,antineoplastic,4/13/2019,2/1/2018,Intravenous,nivolumab,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,2/23/2023,mg,antineoplastic,4/13/2022,4/5/2022,Intravenous,paclitaxel,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/10/2019,mg,antineoplastic,9/4/2018,7/18/2018,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/20/2014,mg,antineoplastic,5/14/2014,4/17/2014,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G46:87GF7FGC9,12/18/2015,,antiemetic,7/4/2015,8/14/2015,Intrajejunal,clinical study drug,FALSE
54,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1C32G396:F7G,2/13/2014,mg,antineoplastic,3/2/2014,1/26/2014,Intravenous,vinorelbine,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/18/2021,mg,antineoplastic,4/12/2021,4/18/2021,Intravenous,paclitaxel protein-bound,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,4/7/2015,mg,antineoplastic,1/18/2015,1/1/2015,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G226625298DGC,11/5/2021,mg,antineoplastic,7/9/2021,7/17/2021,Intravenous,pembrolizumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/11/2021,mg,antineoplastic,11/10/2020,9/7/2020,Oral,bicalutamide,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/29/2015,mg,antineoplastic,4/10/2015,11/11/2014,Intravenous,pemetrexed,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,4/23/2020,mg,antineoplastic,1/29/2020,12/30/2019,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/12/2024,mg,antineoplastic,5/14/2024,8/27/2023,Intravenous,atezolizumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,3/18/2014,mg,antineoplastic,3/7/2014,1/24/2014,Intravenous,paclitaxel,FALSE
753,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G18:439734B::,10/19/2015,mg,antineoplastic,9/13/2015,9/4/2015,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/7/2019,mg,antineoplastic,8/14/2018,12/31/2017,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,3/28/2025,mg,antineoplastic,11/29/2024,10/7/2024,Intravenous,pemetrexed,TRUE
210,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G42734BB63:32,9/10/2016,mg,antineoplastic,7/18/2016,4/23/2016,Intravenous,nivolumab,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,10/18/2024,mg,antineoplastic,9/5/2024,7/12/2024,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/11/2019,mg,antineoplastic,10/20/2019,9/4/2019,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/23/2025,mg,antineoplastic,11/23/2024,10/22/2024,Intravenous,durvalumab,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/5/2024,mg,antineoplastic,9/12/2024,7/16/2024,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/22/2025,mg,antineoplastic,8/13/2022,1/9/2017,Intravenous,pembrolizumab,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/24/2017,mg,antineoplastic,8/2/2016,5/17/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GE686D11C25,4/7/2015,mg,antineoplastic,4/11/2015,4/13/2015,Intravenous,carboplatin,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/2/2015,mg,antineoplastic,12/23/2014,9/25/2014,Intravenous,docetaxel,FALSE
259,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/25/2016,mg,antineoplastic,3/9/2016,12/1/2015,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/30/2019,mg,antineoplastic,7/21/2019,7/30/2019,Intravenous,trastuzumab,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/3/2019,mg,antineoplastic,11/6/2018,7/13/2018,Intravenous,levoleucovorin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/17/2024,mg,antineoplastic,5/17/2021,4/23/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1CB3B346155D,8/15/2021,mg,antineoplastic,8/8/2021,6/2/2021,Intravenous,pembrolizumab,TRUE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,2/4/2018,mg,antineoplastic,2/20/2018,1/17/2018,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/6/2018,mL,solution-fluid,8/13/2015,6/19/2015,Intravenous,carboplatin,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,2/27/2014,mg,antineoplastic,7/25/2013,7/7/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G241FF877G59G,12/28/2021,,,9/20/2021,9/17/2021,Oral,osimertinib,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,1/27/2015,mg,antineoplastic,1/31/2015,10/21/2014,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/5/2011,mg,antineoplastic,8/10/2011,3/6/2011,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G2C38B34G8794,10/10/2022,,antineoplastic,8/28/2022,10/28/2021,Intravenous,pemetrexed,TRUE
551,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,6/25/2023,mg,antineoplastic,3/22/2023,3/15/2023,Intravenous,pemetrexed,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/18/2025,mg,antineoplastic,1/22/2025,9/20/2024,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/29/2025,mg,antineoplastic,2/2/2025,12/13/2024,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/15/2013,AUC,antineoplastic,6/12/2013,10/20/2012,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/1/2020,mg,antineoplastic,2/13/2020,11/26/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/16/2020,mg,antineoplastic,5/1/2019,12/30/2018,Intravenous,pembrolizumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,11/17/2018,4/25/2017,Oral,nilotinib,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/4/2020,mg,antineoplastic,9/12/2019,9/4/2019,Intravenous,paclitaxel,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,12/1/2023,mg,antineoplastic,10/29/2023,9/21/2023,Intravenous,paclitaxel,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/11/2021,mg,antineoplastic,3/21/2018,3/14/2018,Intravenous,durvalumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/17/2022,mg,antineoplastic,12/2/2020,3/29/2017,Intravenous,nivolumab,FALSE
360,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G545:2F182DD:,10/19/2017,mg,antineoplastic,10/29/2017,10/2/2017,Intravenous,paclitaxel protein-bound,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,5/3/2020,mg,antineoplastic,1/9/2020,12/5/2019,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/16/2021,mL,solution-fluid,3/15/2018,3/27/2018,Intravenous,durvalumab,TRUE
398,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,2/12/2024,mg,antineoplastic,11/23/2023,10/14/2023,Intravenous,paclitaxel,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,12/15/2014,mg,antineoplastic,10/16/2014,9/7/2014,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/1/2025,mg,antineoplastic,4/13/2019,1/8/2017,Intravenous,nivolumab,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/16/2018,mg,antineoplastic,8/29/2018,8/4/2018,Intravenous,bevacizumab,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/26/2023,mg,antineoplastic,10/14/2022,10/19/2022,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GD:D13B31BB,12/17/2018,mg,antineoplastic,5/2/2018,5/2/2018,Intravenous,pembrolizumab,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/4/2015,mg,antineoplastic,10/18/2014,7/31/2014,Intravenous,pemetrexed,FALSE
198.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/23/2017,mg,antineoplastic,10/3/2016,10/25/2016,Intravenous,carboplatin,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/9/2016,mg,antineoplastic,9/28/2015,6/22/2015,Intravenous,pemetrexed,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/10/2021,mg,antineoplastic,12/22/2020,8/30/2020,Intravenous,nivolumab,FALSE
178,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/12/2019,mg,antineoplastic,7/9/2018,4/5/2018,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/20/2020,mg,antineoplastic,4/9/2018,1/9/2018,Intravenous,pemetrexed,TRUE
1200,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,12/24/2022,mg,antineoplastic,12/10/2022,9/24/2022,Intravenous,cyclophosphamide,FALSE
696,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/18/2023,mg,antineoplastic,12/4/2022,11/6/2022,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,mg,antineoplastic,1/8/2018,4/5/2017,Intravenous,nivolumab,FALSE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,11/21/2018,mg,antineoplastic,9/25/2018,9/24/2018,Intravenous,carboplatin,FALSE
159,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/27/2023,mg,antineoplastic,5/6/2023,2/24/2023,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1CB3B346155D,8/19/2021,mg,antineoplastic,6/23/2021,7/9/2021,Intravenous,pembrolizumab,TRUE
150,,ADJUVANT,Orders,targeted/non-biologic,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,4/11/2024,mg,antineoplastic,4/12/2024,3/16/2024,Oral,olutasidenib,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/23/2025,mg,antineoplastic,5/27/2019,2/21/2019,Intravenous,pemetrexed,FALSE
1105,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B11153DEF52,7/10/2021,mg,antineoplastic,6/9/2021,7/16/2021,Intravenous,pemetrexed,FALSE
385,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,1/13/2023,mg,antineoplastic,11/20/2022,10/14/2022,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/17/2025,mg,antineoplastic,5/25/2024,6/2/2024,Intravenous,pemetrexed,TRUE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/20/2022,mg,antineoplastic,9/14/2021,7/22/2021,Intravenous,pembrolizumab,FALSE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/20/2014,mg,antineoplastic,12/28/2013,11/4/2013,Intravenous,pemetrexed,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,7/28/2024,mg,antineoplastic,4/29/2024,5/10/2024,Intravenous,carboplatin,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/22/2019,mg,antineoplastic,7/26/2018,4/5/2018,Intravenous,paclitaxel,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/2/2023,mg,antineoplastic,3/13/2023,4/19/2023,Intravenous,paclitaxel,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/26/2024,mg,antineoplastic,4/10/2024,1/2/2024,Intravenous,cemiplimab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/24/2022,mg,antineoplastic,11/9/2021,7/28/2021,Intravenous,durvalumab,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/19/2015,mg,antineoplastic,2/21/2015,8/29/2014,Intravenous,paclitaxel,FALSE
591,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/8/2023,mg,antineoplastic,1/1/2023,12/26/2022,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/2/2014,mL,solution-fluid,11/12/2013,11/19/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/26/2019,mg,antineoplastic,4/22/2019,4/15/2019,Intravenous,pembrolizumab,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/31/2012,mg,antineoplastic,4/9/2012,3/8/2012,Intravenous,bevacizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,Paclitaxel,G11B743:8G337,3/6/2017,mg,antineoplastic,1/21/2017,1/22/2017,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,5/1/2016,mg,antineoplastic,9/15/2014,8/23/2014,Intravenous,etoposide,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/18/2018,mg,antineoplastic,8/4/2018,7/19/2018,Intravenous,bevacizumab,FALSE
374,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/10/2025,mg,antineoplastic,2/20/2025,2/23/2025,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,10/5/2015,mg,antineoplastic,6/17/2015,6/18/2015,Intravenous,paclitaxel,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/2/2023,mg,antineoplastic,9/25/2022,10/3/2022,Intravenous,bevacizumab-bvzr,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G42D:4D9G6157,1/7/2024,mg/kg,antineoplastic,10/24/2023,8/29/2023,Intravenous,durvalumab,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/6/2025,mg,antineoplastic,4/27/2025,7/1/2024,Intravenous,durvalumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,5/23/2025,mg,antineoplastic,12/31/2024,8/18/2024,Intravenous,pembrolizumab,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/1/2020,mg,antineoplastic,10/5/2019,8/23/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/19/2023,mg,antineoplastic,11/28/2022,10/22/2022,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/8/2018,mg,antineoplastic,11/11/2018,6/15/2018,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/11/2024,mg,antineoplastic,1/31/2024,3/23/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/8/2025,mg,antineoplastic,8/23/2020,1/23/2019,Intravenous,pembrolizumab,TRUE
166,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/14/2019,mg,antineoplastic,10/7/2018,10/14/2018,Intravenous,carboplatin,FALSE
795,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G48EG9E748G84,1/13/2015,mg,antineoplastic,11/11/2014,10/21/2014,Intravenous,bevacizumab,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/14/2020,mg,antineoplastic,7/17/2020,5/20/2020,Subcutaneous,azacitidine,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,5/7/2025,mg,antineoplastic,11/26/2024,12/2/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,11/27/2024,mg,antineoplastic,12/2/2024,6/9/2024,Intravenous,pembrolizumab,FALSE
1093,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1G194ECBE647,3/7/2020,mg,antineoplastic,1/22/2020,1/16/2020,Intravenous,durvalumab,TRUE
230,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,6/9/2022,mg,antineoplastic,4/11/2022,4/8/2022,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/17/2024,mg,antineoplastic,1/7/2021,7/7/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,9/13/2023,mg,antineoplastic,8/16/2023,8/15/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/29/2025,mg,antineoplastic,10/5/2024,3/14/2024,Intravenous,pembrolizumab,TRUE
125,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,7/21/2021,mg,antineoplastic,7/5/2021,3/24/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/31/2025,mg,antineoplastic,9/21/2023,1/6/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/15/2020,mg,antineoplastic,11/29/2019,1/7/2019,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/17/2021,mg,antineoplastic,12/4/2020,10/4/2020,Intravenous,pembrolizumab,FALSE
250.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G2745:9D5G3DG,3/19/2012,mg,antineoplastic,3/22/2012,3/21/2012,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,8/12/2022,mg,antineoplastic,1/28/2022,8/8/2021,Intravenous,durvalumab,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/6/2013,mg,antineoplastic,8/28/2013,12/5/2012,Intravenous,gemcitabine,FALSE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/14/2023,mg,antineoplastic,1/16/2023,11/18/2022,Intravenous,paclitaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,12/2/2015,mg,antineoplastic,6/17/2015,7/24/2015,Intravenous,paclitaxel protein-bound,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/4/2015,mg,antineoplastic,9/16/2014,4/28/2014,Intravenous,vinorelbine,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,12/4/2024,mg,antineoplastic,11/12/2024,9/30/2024,Intravenous,durvalumab,TRUE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/19/2016,mg,antineoplastic,6/10/2015,6/7/2015,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/31/2025,mg,antineoplastic,3/4/2019,2/4/2017,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/14/2020,mg,antineoplastic,3/10/2020,8/27/2019,Intravenous,pembrolizumab,FALSE
340,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/20/2016,mg,antineoplastic,3/23/2016,2/16/2016,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,7/24/2018,mg/m2,antineoplastic,7/20/2018,4/2/2018,Intravenous,pemetrexed,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/24/2023,mg,antineoplastic,8/21/2023,5/6/2023,Intravenous,tremelimumab-actl,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,11/21/2023,mg,antineoplastic,12/22/2023,12/3/2023,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/31/2024,mg,antineoplastic,8/7/2023,2/27/2023,Intravenous,bevacizumab-awwb,TRUE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,7/2/2016,mg,antineoplastic,4/10/2016,1/28/2016,Intravenous,etoposide,FALSE
370.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45388C4DCEFB,6/3/2012,mg,antineoplastic,5/29/2012,4/26/2012,Intravenous,carboplatin,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,1/3/2021,mg/kg,antineoplastic,2/23/2020,3/25/2020,Intravenous,ramucirumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/5/2018,AUC,antineoplastic,12/3/2017,10/12/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/27/2025,,solution-fluid,6/23/2018,12/3/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/26/2023,mg,antineoplastic,8/8/2022,9/23/2021,Intravenous,pembrolizumab,TRUE
202,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,11/4/2021,mg,antineoplastic,8/22/2021,8/16/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,6/27/2017,,solution-fluid,3/15/2017,1/2/2017,Intravenous,clinical study drug,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,1/23/2018,mg,antineoplastic,12/30/2017,12/22/2017,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,4/12/2023,mg,antineoplastic,8/22/2022,8/27/2022,Intravenous,pembrolizumab,FALSE
710,1,ADVANCED,Administrations,targeted/biologic,Ramucirumab,G1GFD92F489E7,11/5/2023,mg,antineoplastic,10/2/2023,8/15/2023,Intravenous,ramucirumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,12/4/2018,mg,antineoplastic,9/16/2018,9/11/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,4/12/2021,mg,antineoplastic,12/25/2018,9/23/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1C3CCC:C44GD,7/19/2022,mg,antineoplastic,12/31/2021,9/3/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/19/2025,mg,antineoplastic,1/9/2025,6/16/2022,Intravenous,pembrolizumab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/1/2013,mg/m2,antineoplastic,10/26/2012,8/10/2012,Intravenous,docetaxel,FALSE
134.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/12/2019,mg,antineoplastic,9/8/2019,8/12/2019,Intravenous,carboplatin,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/14/2022,mg,antineoplastic,5/30/2022,5/18/2022,Intravenous,paclitaxel,FALSE
122,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,6/28/2021,mg,antineoplastic,4/13/2021,4/14/2021,Intravenous,carboplatin,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/12/2014,mg,antineoplastic,3/26/2014,12/19/2013,Intravenous,cisplatin,FALSE
280,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,5/17/2025,mg,antineoplastic,3/16/2025,2/27/2025,Intravenous,amivantamab-vmjw,FALSE
185,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,9/17/2021,mg,antineoplastic,8/22/2021,7/26/2021,Intravenous,paclitaxel protein-bound,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,5/21/2025,mg,antineoplastic,3/7/2025,1/24/2025,Intravenous,carboplatin,FALSE
250,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,2/6/2021,mg,antineoplastic,11/14/2020,10/5/2020,Intravenous,irinotecan,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,3/19/2015,mg,antineoplastic,11/26/2014,10/1/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/15/2022,mg,antineoplastic,11/27/2021,8/7/2020,Intravenous,pembrolizumab,TRUE
93,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,9/3/2016,mg,antineoplastic,1/21/2016,1/3/2016,Intravenous,paclitaxel,FALSE
374,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/16/2022,mg,antineoplastic,2/11/2021,3/9/2021,Intravenous,paclitaxel,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/14/2013,mg,antineoplastic,9/25/2012,10/18/2012,Intravenous,gemcitabine,FALSE
350,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/6/2023,mg,antineoplastic,2/15/2020,12/7/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/1/2020,,antineoplastic,1/3/2020,1/20/2020,Oral,pazopanib,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,Osimertinib,G1169816459CC,3/25/2025,mg,antineoplastic,7/31/2018,7/19/2018,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/17/2023,,antineoplastic,4/14/2023,12/17/2022,,pemetrexed,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/1/2022,,antineoplastic,3/19/2022,2/14/2022,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/27/2017,mg,antineoplastic,7/26/2015,11/25/2014,Intravenous,gemcitabine,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,5/14/2016,mg,antineoplastic,3/16/2016,12/12/2015,Intravenous,nivolumab,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/2/2020,mg,antineoplastic,7/15/2019,11/14/2018,Intravenous,durvalumab,TRUE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,11/10/2015,mg,antineoplastic,8/16/2015,8/19/2015,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/8/2025,mg,antineoplastic,5/4/2023,8/17/2022,Oral,anastrozole,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/29/2022,mg,antineoplastic,8/18/2021,2/14/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1BG11DG4E257,7/27/2021,,,8/15/2021,7/5/2020,Oral,osimertinib,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,4/20/2024,,antineoplastic,9/19/2023,6/17/2023,Intravenous,clinical study drug,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,12/2/2015,mg,antineoplastic,7/7/2015,7/24/2015,Intravenous,gemcitabine,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/22/2016,mg,antineoplastic,1/24/2016,12/21/2015,Intravenous,carboplatin,FALSE
1580,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,5/5/2015,mg,antineoplastic,2/7/2015,12/13/2014,Intravenous,gemcitabine,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/11/2013,mg/m2,antineoplastic,9/14/2012,7/7/2012,Intravenous,docetaxel,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,2/9/2014,mg/m2,antineoplastic,11/26/2013,12/20/2013,Intravenous,paclitaxel,FALSE
539,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/25/2024,mg,antineoplastic,11/13/2023,10/10/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,12/7/2023,mg,antineoplastic,9/27/2023,9/7/2023,Intravenous,pembrolizumab,FALSE
1055,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,5/16/2025,mg,antineoplastic,3/3/2025,12/30/2024,Intravenous,pemetrexed,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253D7G:9C8CE,6/26/2014,mg,antineoplastic,7/5/2014,6/3/2014,Intravenous,pemetrexed,TRUE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/3/2025,mg,antineoplastic,3/5/2025,10/3/2024,Intravenous,durvalumab,FALSE
302,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/15/2023,mg,antineoplastic,4/6/2023,3/26/2023,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/27/2019,mg,antineoplastic,10/20/2017,9/11/2017,Intravenous,etoposide,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/24/2019,mg,antineoplastic,9/25/2019,9/27/2019,Intravenous,etoposide,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/22/2015,mg,antineoplastic,3/11/2015,2/21/2015,Intravenous,carboplatin,FALSE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/20/2019,mg,antineoplastic,11/6/2019,9/30/2019,Intravenous,docetaxel,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/24/2021,mg,antineoplastic,3/26/2021,9/5/2020,Intravenous,nivolumab,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/2/2020,mg,antineoplastic,7/15/2019,3/10/2019,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/2/2023,mg,antineoplastic,11/11/2022,8/22/2022,Subcutaneous,azacitidine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/10/2019,mg,antineoplastic,4/20/2019,3/25/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,5/24/2012,,solution-fluid,10/22/2011,10/14/2011,Intravenous,clinical study drug,FALSE
113,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,11/18/2021,mg,antineoplastic,11/6/2021,11/11/2021,Intravenous,paclitaxel,FALSE
42,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,2/3/2015,mg,antineoplastic,12/11/2014,11/7/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/24/2025,,antineoplastic,4/16/2018,11/8/2017,Intravenous,clinical study drug,FALSE
133,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/17/2024,mg,antineoplastic,4/4/2024,5/21/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/8/2020,mg,antineoplastic,1/5/2017,7/11/2016,Intravenous,nivolumab,FALSE
302,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,4/2/2022,mg,antineoplastic,2/16/2022,12/10/2021,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,2/19/2020,mg,antineoplastic,2/10/2020,11/16/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/16/2025,mg,antineoplastic,5/5/2024,10/6/2023,Intravenous,pembrolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/1/2018,mg,antineoplastic,11/19/2017,12/26/2017,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,7/21/2019,mg,antineoplastic,7/22/2019,2/20/2019,Intravenous,pembrolizumab,TRUE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,9/16/2024,mg,antineoplastic,7/8/2024,6/11/2024,Intravenous,nivolumab,FALSE
775,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3951BC5GBE44,9/26/2023,mg,antineoplastic,6/14/2023,7/2/2023,Intravenous,pemetrexed,FALSE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/27/2023,mg,antineoplastic,1/28/2023,11/5/2022,Intravenous,paclitaxel,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/20/2018,mg,antineoplastic,5/2/2018,5/27/2018,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/11/2025,,antineoplastic,11/9/2024,11/3/2024,Intravenous,paclitaxel,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,9/2/2021,mg,antineoplastic,9/22/2021,8/8/2021,Intravenous,cisplatin,FALSE
6,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/4/2021,AUC,antineoplastic,10/29/2020,9/7/2020,Intravenous,carboplatin,FALSE
0,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,9/20/2020,AUC,antineoplastic,8/14/2020,7/27/2020,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/27/2024,mg,antineoplastic,1/29/2024,12/9/2022,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,2/17/2025,mg,antineoplastic,9/8/2024,8/28/2024,Intravenous,nivolumab,TRUE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/13/2023,,antineoplastic,5/6/2023,4/3/2023,,anastrozole,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,12/22/2018,mg,antineoplastic,6/8/2018,11/5/2017,Intravenous,pembrolizumab,FALSE
757,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,8/31/2019,mg,antineoplastic,3/4/2019,3/9/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/13/2023,mg,antineoplastic,9/8/2022,10/13/2021,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38GE:9D51587,9/12/2012,mg,antineoplastic,3/20/2012,2/20/2012,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/5/2019,,antineoplastic,11/1/2019,9/21/2019,,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/18/2021,AUC,antineoplastic,10/1/2021,8/9/2021,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/22/2021,mg/m2,antineoplastic,10/18/2021,3/11/2021,Intravenous,fluorouracil,FALSE
240,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,8/17/2019,4/28/2017,Intravenous,nivolumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/17/2011,mg,antineoplastic,7/4/2011,3/4/2011,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/30/2024,mg,antineoplastic,3/7/2023,9/28/2022,Intravenous,pembrolizumab,TRUE
225,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,12/13/2022,mg,antineoplastic,11/26/2022,8/24/2022,Intravenous,carboplatin,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/18/2021,mg,antineoplastic,12/11/2021,9/7/2021,Intravenous,paclitaxel,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/18/2020,mg,antineoplastic,1/1/2020,10/13/2019,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/2/2023,,antineoplastic,4/20/2022,3/28/2022,Intravenous,pembrolizumab,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,5/1/2025,mg,antineoplastic,3/16/2025,3/7/2025,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/31/2025,mg,antineoplastic,5/15/2024,4/11/2020,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/11/2024,mg,antineoplastic,12/4/2023,8/14/2023,Intravenous,nivolumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,4/15/2016,mg,antineoplastic,5/28/2014,5/8/2014,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/19/2019,mg,antineoplastic,6/7/2018,1/26/2018,Intravenous,nivolumab,FALSE
1500,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G1G4BC1:B::63,3/15/2022,mg,antineoplastic,1/17/2022,11/22/2021,Intravenous,durvalumab,TRUE
420,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/29/2015,mg,antineoplastic,9/2/2015,9/14/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/29/2019,mg,antineoplastic,3/29/2018,4/1/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/15/2025,mg,antineoplastic,1/15/2024,1/12/2024,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/1/2017,mg,antineoplastic,12/13/2016,12/10/2016,Intravenous,docetaxel,FALSE
65,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/9/2013,mg,antineoplastic,10/6/2012,4/23/2012,Intravenous,docetaxel,FALSE
427.6,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/16/2019,mg,antineoplastic,1/16/2019,12/19/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3::1F4G:66GE,10/23/2022,mg,antineoplastic,9/14/2022,10/1/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,3/31/2017,,antineoplastic,3/24/2016,1/27/2016,Intravenous,clinical study drug,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/20/2022,mg,antineoplastic,7/22/2022,4/26/2022,Intravenous,nivolumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,12/25/2015,mg,antineoplastic,4/1/2015,3/12/2015,Intravenous,pemetrexed,TRUE
191.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/16/2016,mg,antineoplastic,8/16/2016,7/12/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/10/2022,mg,antineoplastic,1/10/2022,12/16/2021,Intravenous,pembrolizumab,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,4/15/2014,mg,antineoplastic,12/15/2013,12/29/2013,Intravenous,carboplatin,FALSE
1075,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/3/2023,mg,antineoplastic,12/30/2019,12/5/2019,Intravenous,pemetrexed,FALSE
885,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,4/20/2020,mg,antineoplastic,11/28/2019,11/24/2019,Intravenous,pemetrexed,FALSE
128,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/6/2021,mg,antineoplastic,11/4/2021,10/10/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/2/2025,,antineoplastic,5/27/2024,2/15/2023,,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/5/2019,mg,antineoplastic,1/14/2018,10/27/2017,Intravenous,pembrolizumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,2/7/2021,mg,antineoplastic,12/6/2020,8/7/2020,Oral,bicalutamide,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/23/2022,mg,antineoplastic,2/24/2022,2/4/2022,Intravenous,carboplatin,FALSE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,11/1/2018,mg,antineoplastic,2/2/2013,3/9/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G1542E4F46G4B,7/2/2021,,,5/4/2020,4/21/2020,Oral,osimertinib,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/13/2021,mg,antineoplastic,10/17/2020,6/12/2020,Intravenous,docetaxel,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/9/2017,mg,antineoplastic,1/28/2016,6/11/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G1:3G:24D:34B,5/12/2025,,,4/3/2018,2/24/2018,Oral,alectinib,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/16/2025,mg,antineoplastic,11/30/2018,2/25/2018,Intravenous,nivolumab,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/6/2019,mg,antineoplastic,12/1/2019,9/17/2019,Intravenous,paclitaxel protein-bound,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/28/2024,mg,antineoplastic,5/9/2022,7/23/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/14/2022,mg,antineoplastic,7/30/2021,4/14/2021,Intravenous,pembrolizumab,TRUE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,1/3/2025,mg,antineoplastic,5/15/2024,5/2/2024,Intravenous,cemiplimab,TRUE
,2,ADVANCED,Orders,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/10/2021,,steroid,9/16/2020,2/27/2020,,clinical study drug,FALSE
,,CONCURRENT,Orders,targeted/non-biologic,Acalabrutinib,G3124B666:88D,3/23/2023,,antineoplastic,5/1/2023,2/24/2023,Oral,acalabrutinib,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/31/2021,mg,antineoplastic,11/12/2021,10/9/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/15/2025,mg,antineoplastic,8/12/2022,5/17/2022,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/14/2025,,antineoplastic,3/22/2018,10/18/2017,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/8/2024,,antineoplastic,3/27/2024,1/4/2024,,cisplatin,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,7/30/2015,mg,antineoplastic,7/19/2015,5/25/2015,Intravenous,etoposide,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,10/29/2020,,,10/8/2020,6/21/2020,Oral,trametinib,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,11/6/2015,mg,antineoplastic,2/9/2015,3/8/2015,Intravenous,paclitaxel protein-bound,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/15/2020,mg,antineoplastic,2/2/2020,1/7/2019,Subcutaneous,bortezomib,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/21/2019,mg,antineoplastic,4/20/2019,10/17/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/4/2022,mg,antineoplastic,8/30/2020,2/3/2018,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/4/2024,mg,antineoplastic,8/3/2024,6/28/2024,Intravenous,paclitaxel,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,5/25/2023,mg,antineoplastic,9/24/2022,5/26/2022,Intravenous,durvalumab,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,10/29/2024,mg,antineoplastic,9/25/2024,5/2/2024,Intravenous,nivolumab,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/8/2025,mg,antineoplastic,11/23/2021,9/28/2021,Intravenous,pemetrexed,TRUE
880,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/25/2019,mg,antineoplastic,6/24/2018,5/31/2018,Intravenous,pemetrexed,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,3/13/2023,mg,antineoplastic,11/25/2022,7/15/2022,Intravenous,durvalumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/8/2016,mg,antineoplastic,9/22/2014,9/1/2014,Intravenous,etoposide,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/1/2019,mg,antineoplastic,12/15/2017,4/9/2017,Intravenous,pemetrexed,TRUE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G266E6248F531,7/11/2018,mg,antineoplastic,5/14/2018,3/1/2018,Intravenous,pemetrexed,TRUE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,1/17/2016,mg,antineoplastic,10/23/2015,10/12/2015,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/19/2023,mg,antineoplastic,9/27/2022,9/29/2022,Subcutaneous,azacitidine,FALSE
520,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/10/2024,mg,antineoplastic,4/29/2024,3/20/2024,Intravenous,carboplatin,FALSE
246.2,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/23/2014,mg,antineoplastic,11/20/2014,7/31/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/9/2025,mg,antineoplastic,4/17/2018,3/16/2018,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/30/2025,,antineoplastic,2/24/2022,3/21/2020,Oral,enzalutamide,FALSE
357,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/4/2019,mg,antineoplastic,2/20/2013,1/13/2013,Intravenous,paclitaxel,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/3/2022,mg,antineoplastic,1/26/2022,7/23/2021,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/7/2020,mg,antineoplastic,10/5/2019,9/21/2019,Intravenous,pembrolizumab,TRUE
146,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/17/2020,mg,antineoplastic,1/9/2020,2/16/2020,Intravenous,cisplatin,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/7/2021,mg,antineoplastic,3/26/2021,12/21/2020,Intravenous,gemcitabine,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/7/2022,mg,antineoplastic,1/17/2022,8/31/2021,Intravenous,paclitaxel,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/19/2018,mg,antineoplastic,6/22/2016,7/14/2016,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,5/6/2019,mg,antineoplastic,3/4/2019,2/28/2019,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/10/2025,mg,antineoplastic,12/28/2024,10/3/2024,Intravenous,pemetrexed,TRUE
164,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,12/2/2024,mg,antineoplastic,7/30/2024,6/23/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/4/2025,mg,antineoplastic,1/1/2024,2/9/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/21/2022,mg,antineoplastic,1/30/2020,12/29/2019,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/9/2025,mg,antineoplastic,4/25/2023,8/12/2022,Intravenous,pembrolizumab,TRUE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,12/26/2015,mg,antineoplastic,5/1/2015,3/11/2015,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/17/2025,mg,antineoplastic,11/6/2024,12/27/2024,Intravenous,pembrolizumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/30/2021,mg/m2,antineoplastic,1/29/2020,8/23/2019,Intravenous,pemetrexed,FALSE
935,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,10/3/2021,mg,antineoplastic,8/1/2021,7/5/2021,Intravenous,pemetrexed,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/14/2024,mg,antineoplastic,3/13/2023,11/23/2022,Intravenous,durvalumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,1/22/2025,mg,antineoplastic,12/1/2024,4/7/2024,Intravenous,cemiplimab,TRUE
1050,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5344:8G5698G,11/19/2022,mg,antineoplastic,9/13/2022,8/10/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,3/27/2025,,antineoplastic,4/9/2025,3/28/2024,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G211B9B8E3:3E,1/17/2025,,antineoplastic,9/19/2024,4/16/2024,Intravenous,durvalumab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G2:737C75FGBF,2/10/2025,,,2/20/2025,1/30/2024,Oral,osimertinib,FALSE
550,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,4/8/2014,mg,antineoplastic,3/1/2014,12/4/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,6/30/2019,mg,antineoplastic,5/14/2019,2/14/2019,Intravenous,pembrolizumab,FALSE
1640,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/15/2015,mg,antineoplastic,4/27/2015,3/31/2015,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/4/2025,mg,antineoplastic,4/7/2024,7/9/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/9/2025,mg,antineoplastic,10/10/2024,8/26/2022,Intravenous,pembrolizumab,TRUE
132,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,1/26/2022,mg,antineoplastic,10/24/2021,9/20/2021,Intravenous,carboplatin,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/31/2017,mg,antineoplastic,11/23/2017,8/4/2017,Intravenous,paclitaxel,FALSE
96,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/23/2021,mg,antineoplastic,1/10/2017,12/22/2016,Intravenous,paclitaxel,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/6/2022,mg/kg,antineoplastic,3/7/2021,3/5/2021,Intravenous,durvalumab,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,3/28/2019,mg,antineoplastic,3/13/2019,1/23/2019,Intravenous,pemetrexed,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/14/2022,mL,solution-fluid,6/13/2022,2/17/2022,Intravenous,nivolumab,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/26/2022,mg,antineoplastic,6/22/2022,5/12/2022,Intravenous,paclitaxel,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/2/2024,mg,antineoplastic,10/13/2023,6/20/2023,Intravenous,gemcitabine,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/11/2024,mg,antineoplastic,7/23/2021,6/24/2020,Intravenous,ipilimumab,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/23/2019,,antineoplastic,9/2/2017,8/24/2017,Oral,anastrozole,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/23/2024,mg,antineoplastic,11/15/2024,5/9/2024,Intravenous,pembrolizumab,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,10/2/2017,mg,antineoplastic,1/29/2017,11/20/2016,Intravenous,etoposide,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,3/17/2019,mg,antineoplastic,5/4/2018,4/25/2018,Intravenous,docetaxel,FALSE
198.9,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G264B2D11BG13,9/20/2016,mg,antineoplastic,10/17/2016,10/14/2016,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/4/2017,mg,antineoplastic,12/10/2015,5/14/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1:F21E8E2D45,4/7/2024,,,4/17/2024,7/11/2023,Oral,osimertinib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,2/26/2023,mg,antineoplastic,9/18/2022,4/19/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/16/2023,mg,antineoplastic,12/17/2022,8/18/2022,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/8/2019,mg,antineoplastic,8/28/2019,7/7/2019,Intravenous,irinotecan,FALSE
695,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/17/2023,mg,antineoplastic,11/23/2022,9/10/2022,Intravenous,pemetrexed,TRUE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,4/19/2021,mg/m2,antineoplastic,4/4/2021,3/5/2021,Intravenous,gemcitabine,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/24/2013,mg,antineoplastic,9/7/2012,12/30/2011,Intravenous,carboplatin,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,11/4/2015,mg,antineoplastic,2/24/2015,1/22/2015,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/8/2023,mL,solution-fluid,2/6/2023,12/22/2022,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/7/2024,mg,antineoplastic,8/31/2023,1/13/2023,Intravenous,nivolumab,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,12/14/2016,mg,antineoplastic,12/22/2016,9/21/2016,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4B6GB9CB3CD4,3/10/2014,,,3/23/2013,2/3/2013,Oral,erlotinib,FALSE
549,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/31/2021,mg,antineoplastic,6/4/2021,5/24/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/2/2025,,,2/3/2025,1/8/2025,Oral,osimertinib,FALSE
,,NEOADJUVANT,Orders,hormone,Anastrozole,G2B4648:BGD83,11/1/2024,,antineoplastic,8/11/2024,9/26/2024,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3G3424ECF92G,2/8/2025,mg,antineoplastic,2/17/2025,2/19/2025,Intravenous,pembrolizumab,FALSE
770,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/10/2018,mg,antineoplastic,8/23/2018,5/14/2018,Intravenous,pemetrexed,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/20/2024,mg,antineoplastic,12/4/2023,9/21/2023,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/16/2024,mg,antineoplastic,5/7/2023,5/21/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/15/2025,mg,antineoplastic,10/6/2023,9/2/2022,Intravenous,pembrolizumab,TRUE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/9/2022,mg,antineoplastic,5/13/2019,1/5/2016,Intravenous,pemetrexed,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/22/2023,mg,antineoplastic,10/31/2023,3/31/2023,Intravenous,gemcitabine,FALSE
3,3,ADVANCED,Orders,immunotherapy,Nivolumab,G46:87GF7FGC9,8/20/2016,mg/kg,antineoplastic,12/13/2015,11/29/2015,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/17/2019,mg,antineoplastic,2/4/2019,3/3/2018,Intravenous,nivolumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/23/2022,mg,antineoplastic,6/19/2021,3/22/2021,Intravenous,atezolizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/1/2024,mg,antineoplastic,11/26/2020,7/22/2020,Intravenous,nivolumab,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/8/2016,mg,antineoplastic,2/23/2016,11/15/2015,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,5/17/2021,mg,antineoplastic,8/17/2020,7/3/2020,Intravenous,pembrolizumab,TRUE
1800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,9/11/2019,mg,antineoplastic,6/20/2019,6/2/2019,Intravenous,bevacizumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,7/25/2018,mg,antineoplastic,7/8/2018,4/25/2018,Intravenous,paclitaxel,FALSE
365,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G168G1C789D7C,6/25/2013,mg,antineoplastic,4/10/2013,4/12/2013,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,3/14/2019,mg,antineoplastic,12/2/2018,5/19/2018,Intravenous,nivolumab,FALSE
1020,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/30/2025,mg,antineoplastic,4/20/2022,11/12/2021,Intravenous,pemetrexed,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,5/10/2019,mg/m2,antineoplastic,3/8/2019,1/25/2019,Intravenous,pemetrexed,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,6/28/2024,,antineoplastic,11/11/2023,5/7/2023,Oral,niraparib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,12/13/2017,mg,antineoplastic,12/10/2017,10/17/2017,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,2/4/2022,mg,antineoplastic,11/9/2021,10/28/2021,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,12/6/2017,,antineoplastic,11/26/2017,10/24/2017,Oral,hydroxyurea,FALSE
145,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/14/2022,mg,antineoplastic,9/10/2022,9/20/2022,Intravenous,carboplatin,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/5/2022,mg,antineoplastic,11/23/2021,11/8/2021,Intravenous,leucovorin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,8/15/2017,,solution-fluid,1/15/2017,12/27/2016,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/26/2017,,solution-fluid,10/15/2016,1/25/2016,Intravenous,clinical study drug,FALSE
381.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,6/9/2015,mg,antineoplastic,12/18/2014,10/12/2014,Intravenous,carboplatin,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,6/2/2022,mg,antineoplastic,3/18/2022,3/1/2022,Intravenous,paclitaxel,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/13/2025,mg,antineoplastic,7/29/2024,11/15/2022,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/9/2025,mg,antineoplastic,2/8/2025,7/27/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/16/2024,mg,antineoplastic,12/7/2023,12/21/2022,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/16/2018,mg,antineoplastic,10/3/2017,8/23/2017,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/28/2025,mg,antineoplastic,12/28/2024,5/26/2023,Intravenous,pembrolizumab,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/19/2012,mg,antineoplastic,6/24/2012,6/14/2012,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/21/2025,mg,antineoplastic,7/11/2024,12/6/2022,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/17/2019,mg,antineoplastic,4/23/2019,3/31/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1F482136BDE5,6/2/2017,,antiemetic,3/26/2017,2/27/2017,Intravenous,clinical study drug,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/22/2022,mg,antineoplastic,10/25/2021,3/1/2021,Intravenous,bevacizumab-awwb,FALSE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,5/23/2015,mg,antineoplastic,3/27/2015,1/26/2015,Intravenous,etoposide,FALSE
180,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G14FD45889171,11/17/2015,mg,antineoplastic,12/9/2015,11/8/2015,Intravenous,nivolumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,4/27/2012,mg,antineoplastic,3/2/2012,1/25/2012,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,3/23/2025,mg,antineoplastic,12/30/2024,1/27/2025,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/15/2025,mg,antineoplastic,9/2/2024,8/28/2023,Intravenous,atezolizumab,FALSE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/2/2016,mg,antineoplastic,3/30/2016,4/15/2016,Intravenous,paclitaxel,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/13/2022,mg/kg,antineoplastic,4/26/2022,2/13/2021,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/8/2025,mg,antineoplastic,2/16/2025,11/23/2024,Intravenous,pembrolizumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,9/24/2017,mg,antineoplastic,8/9/2017,7/31/2017,Intravenous,docetaxel,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/16/2017,mg,antineoplastic,11/16/2016,11/2/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G26F5C48G8168,5/26/2025,,,4/16/2025,4/24/2024,Oral,alectinib,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/11/2024,mg,antineoplastic,7/9/2024,7/19/2024,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/30/2025,mg,antineoplastic,10/3/2023,5/24/2023,Intravenous,pembrolizumab,FALSE
572,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2518G1D763FB,9/16/2024,mg,antineoplastic,8/20/2024,8/7/2024,Intravenous,durvalumab,FALSE
800,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G221C:3FD2EGB,3/11/2019,mg,antineoplastic,3/13/2019,2/19/2019,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/20/2015,mg,antineoplastic,12/2/2014,11/13/2014,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,1/15/2025,mg,antineoplastic,9/11/2024,6/13/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,11/14/2024,,antineoplastic,9/12/2024,9/11/2024,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,5/30/2020,mg,antineoplastic,3/30/2019,1/30/2019,Subcutaneous,bortezomib,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,10/23/2014,mg/m2,antineoplastic,1/12/2014,12/6/2013,Intravenous,paclitaxel,FALSE
550,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,3/26/2025,mg,antineoplastic,8/19/2024,9/4/2024,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/10/2020,mg,antineoplastic,6/25/2019,5/30/2019,Intravenous,carboplatin,FALSE
840,4,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,12/7/2021,mg,antineoplastic,10/10/2021,9/17/2021,Intravenous,atezolizumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/10/2020,mg,antineoplastic,3/22/2020,2/2/2019,Subcutaneous,bortezomib,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G3CG5712E:B54,8/21/2024,mg/kg,antineoplastic,8/17/2024,6/20/2024,Intravenous,ramucirumab,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/4/2021,mg/m2,antineoplastic,6/20/2021,4/2/2021,Intravenous,oxaliplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,9/4/2013,mg,antineoplastic,6/8/2013,2/16/2013,Intravenous,paclitaxel protein-bound,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/26/2011,mg,antineoplastic,9/21/2011,5/6/2011,Intravenous,etoposide,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/1/2017,,solution-fluid,3/20/2017,1/28/2016,Intravenous,clinical study drug,FALSE
546,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/7/2025,mg,antineoplastic,5/3/2024,3/29/2024,Intravenous,carboplatin,FALSE
137,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/13/2020,mg,antineoplastic,4/3/2020,1/7/2020,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/20/2020,mg,antineoplastic,4/21/2020,9/5/2019,Intravenous,pembrolizumab,TRUE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/22/2022,mL,solution-fluid,3/11/2022,2/27/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/19/2022,mg,antineoplastic,5/26/2019,12/27/2017,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/8/2025,mg,antineoplastic,6/26/2023,8/12/2022,Oral,anastrozole,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/26/2020,mg,antineoplastic,7/8/2020,9/26/2019,Intravenous,durvalumab,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/10/2019,mg,antineoplastic,11/13/2018,10/4/2018,Intravenous,bevacizumab,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,2/9/2024,mg,antineoplastic,12/8/2023,9/29/2023,Intravenous,docetaxel,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/19/2016,mg,antineoplastic,5/27/2015,5/23/2014,Intravenous,bevacizumab,FALSE
388,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,3/12/2019,mg,antineoplastic,12/19/2018,11/29/2018,Intravenous,carboplatin,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/2/2022,mg,antineoplastic,7/2/2022,4/26/2022,Intravenous,pemetrexed,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/17/2022,mg,antineoplastic,8/14/2022,6/25/2022,Intravenous,paclitaxel,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/8/2014,mg,antineoplastic,9/21/2013,5/30/2013,Intravenous,bevacizumab,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,3/3/2021,mg,antineoplastic,1/10/2021,11/5/2020,Intravenous,docetaxel,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,9/18/2024,mg,antineoplastic,6/5/2024,5/27/2024,Intravenous,pemetrexed,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/15/2020,mg,antineoplastic,3/31/2020,1/30/2020,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/26/2025,mg,antineoplastic,1/7/2023,4/27/2022,Intravenous,pembrolizumab,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/4/2017,mg,antineoplastic,6/27/2017,4/21/2017,Intravenous,paclitaxel,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/9/2017,mg,antineoplastic,1/19/2014,12/18/2013,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,4/28/2019,mg,antineoplastic,2/14/2019,1/18/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/18/2023,,antineoplastic,3/10/2022,3/2/2022,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/7/2016,mg,antineoplastic,10/8/2015,4/19/2015,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,5/11/2021,mg,antineoplastic,2/2/2021,7/15/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/12/2025,mg,antineoplastic,11/25/2021,2/11/2019,Intravenous,pembrolizumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,3/5/2015,mg,antineoplastic,1/21/2015,11/26/2014,Intravenous,paclitaxel protein-bound,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,4/27/2024,mg,antineoplastic,5/12/2024,4/9/2024,Intravenous,carboplatin,FALSE
660,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,5/23/2022,mg,antineoplastic,4/24/2022,11/20/2021,Intravenous,bevacizumab-bvzr,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/4/2023,mg,antineoplastic,10/5/2022,9/17/2022,Subcutaneous,azacitidine,FALSE
,3,ADVANCED,Unstructured,,"Amivantamab-Vmjw,Osimertinib",G57B5F4B556EG,5/1/2022,,,4/23/2022,3/10/2022,Oral,osimertinib,FALSE
164,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/5/2020,mg,antineoplastic,11/2/2019,10/17/2019,Intravenous,carboplatin,FALSE
75,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,7/29/2011,mg,antineoplastic,8/15/2011,7/16/2011,Intravenous,cisplatin,FALSE
234,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G163D9B593927,11/29/2014,mg,antineoplastic,10/26/2014,10/9/2014,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/15/2022,mg,antineoplastic,7/14/2021,2/5/2020,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/16/2021,mg,antineoplastic,10/21/2020,5/30/2020,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/12/2017,mg,antineoplastic,7/31/2017,7/25/2017,Intravenous,carboplatin,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/12/2013,mg,antineoplastic,9/11/2012,6/8/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,12/17/2022,mg,antineoplastic,4/25/2018,1/20/2018,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/17/2014,mg,antineoplastic,5/13/2014,6/27/2014,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/2/2019,mg,antineoplastic,4/25/2019,4/11/2019,Intravenous,pembrolizumab,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,9/20/2024,mg,antineoplastic,6/23/2024,7/1/2024,Intravenous,pemetrexed,FALSE
636,,ADJUVANT,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/6/2025,mg,antineoplastic,2/1/2025,12/4/2024,Intravenous,leucovorin,FALSE
1102,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,3/14/2020,mg,antineoplastic,12/9/2019,10/13/2019,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/31/2019,mg,antineoplastic,11/13/2017,4/19/2016,Intravenous,nivolumab,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/11/2023,mg,antineoplastic,4/9/2023,3/26/2023,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/14/2022,mg,antineoplastic,8/18/2022,5/27/2022,Intravenous,pemetrexed,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,12/30/2023,mg,antineoplastic,10/4/2023,9/24/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/6/2022,Ea,antineoplastic,2/24/2020,1/6/2018,Intravenous,pembrolizumab,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/30/2020,mg,antineoplastic,8/13/2020,5/6/2020,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/19/2018,,antineoplastic,5/21/2018,4/20/2018,Intravenous,gemcitabine,FALSE
815,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,12/8/2022,mg,antineoplastic,11/12/2022,11/5/2022,Intravenous,pemetrexed,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/16/2023,mg,antineoplastic,9/13/2022,6/3/2022,Intravenous,durvalumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/3/2024,,antineoplastic,1/8/2024,11/11/2023,Intravenous,carboplatin,FALSE
306,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,10/28/2024,mg,antineoplastic,10/23/2024,7/22/2024,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G115873FC55G5,1/20/2021,,,6/7/2020,6/3/2020,Oral,osimertinib,FALSE
960,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,2/27/2019,mg,antineoplastic,3/3/2019,1/28/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/27/2025,,antineoplastic,12/26/2017,10/24/2017,Intravenous,clinical study drug,FALSE
668,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/24/2022,mg,antineoplastic,1/12/2022,9/30/2021,Intravenous,rituximab-pvvr,FALSE
150,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35DE4B3:BCB8,4/24/2019,mg,antineoplastic,10/5/2016,11/22/2016,Intravenous,pembrolizumab,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,5/16/2024,mg,antineoplastic,9/22/2023,5/7/2023,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/21/2024,mg,antineoplastic,10/22/2024,12/9/2023,Intravenous,durvalumab,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/15/2024,mg,antineoplastic,12/11/2023,4/24/2023,Intravenous,atezolizumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,9/11/2020,mL,solution-fluid,7/16/2019,2/5/2019,Intravenous,nivolumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,1/31/2015,mg,antineoplastic,1/10/2015,9/20/2014,Intravenous,docetaxel,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G54368FF4E2E3,4/23/2011,mg/m2,antineoplastic,4/13/2011,6/10/2011,Intravenous,paclitaxel,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,10/28/2019,mg,antineoplastic,10/15/2019,7/28/2019,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,9/24/2022,mg,antineoplastic,7/27/2022,7/21/2022,Intravenous,pemetrexed,TRUE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,9/5/2024,mg,antineoplastic,7/18/2024,5/15/2024,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G29C71B44G:B6,10/22/2013,,,7/13/2013,7/1/2013,Oral,erlotinib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/14/2023,mg/m2,antineoplastic,1/7/2021,4/29/2020,Intravenous,pemetrexed,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/19/2011,mg,antineoplastic,5/27/2011,4/2/2011,Intravenous,carboplatin,FALSE
372,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/23/2021,mg,antineoplastic,2/25/2021,12/28/2020,Intravenous,paclitaxel,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/23/2023,mg,antineoplastic,10/14/2022,12/9/2022,Intravenous,durvalumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/28/2024,mg,antineoplastic,2/10/2024,1/26/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/20/2022,mg,antineoplastic,6/20/2021,4/5/2021,Intravenous,pembrolizumab,TRUE
90,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,2/23/2023,mg,antineoplastic,9/5/2022,6/22/2022,Intravenous,docetaxel,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/23/2014,mg,antineoplastic,3/14/2014,1/21/2014,Intravenous,pemetrexed,FALSE
901,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/19/2023,mg,antineoplastic,4/13/2023,10/28/2022,Intravenous,fluorouracil,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,4/4/2024,mg,antineoplastic,3/7/2024,3/29/2024,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,4/10/2019,mg,antineoplastic,11/16/2018,6/28/2018,Intravenous,nivolumab,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/14/2024,mg,antineoplastic,7/24/2024,9/20/2023,Intravenous,durvalumab,TRUE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/9/2022,mg,antineoplastic,12/25/2019,1/18/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,3/31/2024,,pain agent,5/27/2023,5/11/2023,Oral,clinical study drug,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,3/8/2024,mg,antineoplastic,11/30/2023,10/31/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1:C9B9B392:C,4/20/2015,mg/m2,antineoplastic,5/6/2015,4/21/2015,Intravenous,gemcitabine,FALSE
905,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,1/9/2025,mg,antineoplastic,11/10/2024,12/3/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/17/2024,mg,antineoplastic,9/3/2021,4/24/2020,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,10/19/2020,,,7/14/2020,8/13/2020,Oral,osimertinib,FALSE
5,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/10/2019,AUC,antineoplastic,2/24/2019,1/22/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/26/2025,mg,antineoplastic,10/7/2022,10/17/2022,Intravenous,pembrolizumab,TRUE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,8/31/2022,mg,antineoplastic,12/11/2021,9/20/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/17/2025,mg,antineoplastic,7/20/2024,10/14/2023,Intravenous,pembrolizumab,FALSE
1670,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,6/22/2016,mg,antineoplastic,4/27/2016,3/9/2016,Intravenous,bevacizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,5/8/2025,mg,antineoplastic,1/7/2025,2/20/2024,Intravenous,durvalumab,FALSE
,3,ADVANCED,Unstructured,,Afatinib,G29C71B44G:B6,2/10/2014,,,10/25/2013,9/28/2013,Oral,afatinib,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G46:87GF7FGC9,10/30/2015,,hematological agent,10/11/2015,7/18/2015,Subcutaneous,clinical study drug,FALSE
1500,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/28/2013,mg,antineoplastic,6/23/2013,3/30/2013,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,11/14/2024,,antineoplastic,8/21/2024,8/25/2024,Intravenous,cemiplimab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/21/2024,mg,antineoplastic,6/10/2023,5/30/2023,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/11/2021,mg,antineoplastic,11/3/2020,12/23/2018,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,10/14/2024,mg,antineoplastic,7/19/2024,6/26/2024,Intravenous,pemetrexed,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/20/2018,mg,antineoplastic,12/29/2017,12/25/2017,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/25/2018,mg,antineoplastic,7/31/2017,6/4/2017,Intravenous,nivolumab,FALSE
169.1,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,7/25/2016,mg,antineoplastic,12/11/2015,11/29/2015,Intravenous,carboplatin,FALSE
732,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,5/11/2025,mg,antineoplastic,4/20/2025,3/3/2025,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,10/14/2020,,,9/21/2020,7/11/2020,Oral,dabrafenib,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/28/2021,mg,antineoplastic,11/2/2020,9/2/2020,Oral,bicalutamide,FALSE
98,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/12/2015,mg,antineoplastic,7/29/2015,6/24/2015,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,1/20/2015,mg,antineoplastic,1/26/2015,1/25/2015,Intravenous,paclitaxel protein-bound,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/11/2025,,antineoplastic,7/13/2024,8/2/2022,Oral,anastrozole,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/26/2025,mg,antineoplastic,12/18/2022,12/30/2016,Intravenous,pembrolizumab,FALSE
80,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/4/2022,mg,antineoplastic,11/23/2021,9/25/2021,Intravenous,oxaliplatin,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/31/2016,mg,antineoplastic,8/21/2015,5/6/2015,Intravenous,gemcitabine,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/18/2022,mg,antineoplastic,1/18/2021,2/25/2016,Intravenous,pemetrexed,FALSE
920,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,9/5/2013,mg,antineoplastic,1/29/2013,2/23/2013,Intravenous,pemetrexed,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,1/9/2023,mg,antineoplastic,5/10/2022,3/31/2022,Intravenous,durvalumab,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,6/3/2023,mg,antineoplastic,3/16/2023,2/11/2023,Intravenous,pemetrexed,FALSE
747,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/20/2013,mg,antineoplastic,8/28/2013,6/5/2013,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/18/2023,mg,antineoplastic,7/26/2023,6/4/2023,Intravenous,tremelimumab-actl,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/12/2024,mg,antineoplastic,8/14/2021,6/21/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/12/2025,mg,antineoplastic,11/7/2023,9/4/2022,Intravenous,pembrolizumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,4/19/2025,mg,antineoplastic,4/18/2024,4/26/2024,Intravenous,durvalumab,TRUE
,2,ADVANCED,Unstructured,,"Pemetrexed,Sotorasib",G2C38B34G8794,2/23/2023,,,9/18/2022,10/25/2022,Oral,sotorasib,FALSE
66,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,3/23/2014,mg,antineoplastic,3/18/2014,2/7/2014,Intravenous,paclitaxel,FALSE
195,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/24/2012,mg,antineoplastic,12/23/2011,1/24/2012,Intravenous,etoposide,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/7/2016,mg,antineoplastic,9/2/2015,4/15/2015,Intravenous,nivolumab,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/30/2025,mg,antineoplastic,3/15/2025,2/16/2025,Intravenous,carboplatin,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/30/2018,mg,antineoplastic,7/13/2018,7/16/2018,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,5/1/2020,mg,antineoplastic,10/1/2018,1/9/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/25/2022,mg,antineoplastic,6/12/2019,12/20/2017,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/21/2025,mL,solution-fluid,8/8/2024,5/9/2024,Intravenous,pembrolizumab,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/25/2024,mg,antineoplastic,11/5/2022,4/17/2022,Intravenous,durvalumab,FALSE
940,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,10/9/2024,mg,antineoplastic,7/31/2024,6/12/2024,Intravenous,pemetrexed,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/1/2012,mg,antineoplastic,9/14/2011,8/29/2011,Intravenous,cetuximab,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/12/2019,mg,antineoplastic,6/25/2018,7/4/2018,Other/Miscellaneous,fluorouracil,FALSE
210,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,4/18/2025,mg,antineoplastic,3/26/2025,2/23/2025,Intravenous,carboplatin,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/30/2021,mg,antineoplastic,11/6/2021,9/5/2021,Intravenous,paclitaxel,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/1/2013,mg,antineoplastic,5/29/2013,4/26/2013,Intravenous,paclitaxel,FALSE
583,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/27/2016,mg,antineoplastic,5/28/2016,3/24/2016,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/17/2022,mg,antineoplastic,10/24/2021,10/28/2021,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,10/21/2024,mg,antineoplastic,10/1/2024,9/2/2024,Intravenous,pembrolizumab,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/19/2021,mg,antineoplastic,7/3/2020,6/17/2020,Intravenous,gemcitabine,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/19/2021,mg/m2,antineoplastic,7/12/2021,2/20/2021,Intravenous,oxaliplatin,FALSE
1599,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,2/25/2020,mg,antineoplastic,1/29/2020,12/4/2019,Intravenous,bevacizumab,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,2/15/2021,mg,antineoplastic,4/29/2020,3/14/2020,Intravenous,paclitaxel,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/31/2024,mg,antineoplastic,11/30/2023,12/3/2023,Intravenous,pemetrexed,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/28/2019,mg,antineoplastic,6/27/2019,5/23/2019,Intravenous,paclitaxel,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/29/2025,mg,antineoplastic,11/8/2022,9/8/2022,Intravenous,pemetrexed,TRUE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,8/1/2024,mg,antineoplastic,8/28/2024,5/11/2024,Intravenous,vinorelbine,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,5/29/2021,mg,antineoplastic,6/13/2021,3/13/2021,Intravenous,paclitaxel protein-bound,FALSE
245,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/29/2016,mg,antineoplastic,12/17/2015,11/20/2015,Intravenous,paclitaxel protein-bound,FALSE
630.4,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/12/2015,mg,antineoplastic,11/3/2014,11/21/2014,Intravenous,carboplatin,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,4/20/2020,mg,antineoplastic,1/2/2020,8/1/2019,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/14/2025,mg,antineoplastic,12/6/2023,8/28/2021,Intravenous,atezolizumab,TRUE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/11/2019,mg,antineoplastic,5/19/2019,7/24/2018,Intravenous,pembrolizumab,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,5/5/2024,mg,antineoplastic,3/29/2024,1/10/2024,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/25/2020,mg,antineoplastic,9/19/2020,8/4/2019,Intravenous,pembrolizumab,FALSE
218,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,6/4/2016,mg,antineoplastic,11/9/2015,11/14/2015,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/5/2024,mg,antineoplastic,10/20/2022,12/23/2021,Intravenous,durvalumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/23/2016,mg,antineoplastic,1/8/2016,8/31/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,12/2/2018,mg,antineoplastic,7/17/2018,8/9/2018,Intravenous,pembrolizumab,TRUE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/24/2021,mg,antineoplastic,10/11/2020,8/19/2020,Oral,bicalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,4/29/2021,mg,antineoplastic,2/3/2019,9/15/2018,Intravenous,pembrolizumab,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,8/29/2019,mg,antineoplastic,7/4/2019,6/9/2019,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,5/27/2015,mg/m2,antineoplastic,2/20/2015,9/21/2014,Intravenous,etoposide,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/29/2023,mg,antineoplastic,10/9/2018,10/16/2017,Intravenous,nivolumab,FALSE
328,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/18/2025,mg,antineoplastic,10/1/2024,7/18/2024,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,3/29/2025,mg,antineoplastic,2/25/2025,12/3/2024,Intravenous,pemetrexed,FALSE
170,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/29/2021,mg,antineoplastic,11/24/2020,10/31/2020,Intravenous,irinotecan,FALSE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36:G2D34DE93,12/1/2018,mg,antineoplastic,12/1/2018,12/9/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,3/26/2025,mg,antineoplastic,5/2/2025,1/25/2025,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,11/29/2023,mg,antineoplastic,12/7/2023,10/24/2023,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/16/2020,mg,antineoplastic,6/9/2019,10/25/2018,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Unstructured,,Erlotinib,G21BD9C1D75:6,5/13/2020,,,6/12/2019,6/14/2019,Oral,erlotinib,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,6/24/2013,mg,antineoplastic,7/31/2013,1/26/2013,Intravenous,gemcitabine,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/21/2012,mg,antineoplastic,11/10/2011,10/7/2011,Intravenous,cisplatin,FALSE
690,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/19/2015,mg,antineoplastic,4/13/2015,3/8/2015,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/14/2025,mg,antineoplastic,11/23/2024,1/16/2023,Intravenous,pembrolizumab,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/9/2016,mg,antineoplastic,11/24/2015,5/19/2015,Intravenous,gemcitabine,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,2/6/2022,mg,antineoplastic,6/15/2014,6/3/2014,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/4/2023,mg/m2,antineoplastic,11/1/2022,7/31/2022,Intravenous,pemetrexed,TRUE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/13/2016,mg,antineoplastic,8/17/2015,6/18/2015,Intravenous,bevacizumab,FALSE
935,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,9/27/2021,mg,antineoplastic,7/23/2021,8/19/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/20/2025,mg,antineoplastic,3/15/2024,10/19/2022,Intravenous,pembrolizumab,TRUE
255,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,5/11/2019,mg,antineoplastic,2/19/2019,2/6/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/22/2024,mg,antineoplastic,1/19/2023,4/21/2020,Intravenous,pembrolizumab,TRUE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,5/5/2019,mg/m2,antineoplastic,11/29/2017,8/12/2017,Intravenous,docetaxel,FALSE
497,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,1/24/2012,mg,antineoplastic,3/15/2012,11/15/2011,Intravenous,carboplatin,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,10/13/2021,mg,antineoplastic,7/26/2021,8/3/2021,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,4/25/2025,mg,antineoplastic,12/29/2024,11/27/2024,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,hormone,Bicalutamide,G1E3BGE6C42B6,10/9/2024,,antineoplastic,8/9/2024,7/23/2024,Oral,bicalutamide,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,10/1/2022,,antineoplastic,9/28/2022,8/20/2022,Oral,bosutinib,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/30/2014,mg,antineoplastic,5/5/2014,3/7/2014,Intravenous,carboplatin,FALSE
170,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G44B44661:316,3/14/2016,mg,antineoplastic,3/1/2016,4/1/2016,Intravenous,nivolumab,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/31/2024,mg,antineoplastic,12/9/2023,9/24/2023,Intravenous,durvalumab,FALSE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G579E53D92:75,11/13/2011,,hematological agent,9/2/2011,8/5/2011,Subcutaneous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/6/2024,mg,antineoplastic,6/9/2023,2/9/2023,Intravenous,atezolizumab,TRUE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,10/11/2021,mg,antineoplastic,5/18/2021,7/6/2021,Intravenous,carboplatin,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/16/2016,mg,antineoplastic,4/14/2015,4/29/2015,Intravenous,gemcitabine,FALSE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/21/2017,mg,antineoplastic,7/5/2017,6/20/2017,Intravenous,docetaxel,FALSE
,1,LOCOREGIONAL,Orders,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,3/31/2025,,antineoplastic,1/3/2025,11/15/2024,,clinical study drug,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/6/2025,,antineoplastic,4/12/2025,10/27/2024,Intravenous,pembrolizumab,FALSE
975,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G56B4BCB27428,1/31/2012,mg,antineoplastic,3/8/2012,11/25/2011,Intravenous,pemetrexed,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/20/2015,mg,antineoplastic,4/12/2015,10/18/2014,Intravenous,paclitaxel protein-bound,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/8/2024,mL,solution-fluid,6/1/2024,4/12/2024,Intravenous,carboplatin,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,10/20/2019,mg,antineoplastic,7/22/2019,7/18/2019,Intravenous,carboplatin,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/12/2021,,antineoplastic,11/28/2020,6/23/2020,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/29/2013,mg,antineoplastic,3/24/2013,3/2/2013,Intravenous,paclitaxel protein-bound,FALSE
159,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,1/14/2024,mg,antineoplastic,12/31/2023,10/25/2023,Intravenous,carboplatin,FALSE
376,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,10/26/2011,mg,antineoplastic,10/2/2011,7/22/2011,Intravenous,paclitaxel,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,11/7/2014,mg/m2,antineoplastic,9/14/2014,8/29/2014,Intravenous,paclitaxel,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/3/2025,mg,antineoplastic,4/5/2018,7/11/2016,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/3/2016,mg,antineoplastic,4/2/2015,12/17/2014,Intravenous,gemcitabine,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/14/2024,mg,antineoplastic,3/25/2022,3/13/2022,Intravenous,durvalumab,FALSE
66,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/21/2015,mg,antineoplastic,4/26/2015,2/14/2015,Intravenous,cisplatin,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,2/26/2022,mg,antineoplastic,12/28/2021,9/27/2021,Intravenous,fluorouracil,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/14/2013,mg/m2,antineoplastic,11/28/2012,9/21/2012,Intravenous,paclitaxel protein-bound,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/23/2020,mg,antineoplastic,2/29/2020,12/5/2019,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,2/14/2023,mg,antineoplastic,9/26/2022,5/18/2022,Intravenous,atezolizumab,FALSE
236.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/18/2021,mg,antineoplastic,7/28/2021,6/30/2021,Intravenous,carboplatin,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/7/2024,mg,antineoplastic,9/5/2023,6/22/2023,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19:83254DDF6,8/4/2022,mg,antineoplastic,1/13/2019,1/4/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/11/2025,,antineoplastic,7/16/2023,3/18/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,9/9/2019,mg,antineoplastic,5/31/2019,5/11/2019,Intravenous,pembrolizumab,TRUE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/28/2024,mg,antineoplastic,5/24/2024,4/28/2024,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G445F26762F72,5/13/2024,mg,antineoplastic,5/9/2024,2/1/2024,Intravenous,durvalumab,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/24/2016,mg,antineoplastic,12/2/2014,5/5/2014,Intravenous,bevacizumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/22/2014,mg,antineoplastic,9/29/2014,6/15/2014,Intravenous,vinorelbine,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/12/2021,mg,antineoplastic,2/1/2021,1/10/2021,Intravenous,bevacizumab-awwb,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/7/2021,mg,antineoplastic,6/5/2021,3/31/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,3/28/2025,mg,antineoplastic,5/10/2024,9/5/2022,Intravenous,pembrolizumab,TRUE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G25E1C41F29EC,2/7/2021,mg,antineoplastic,12/19/2015,9/17/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/6/2013,,antineoplastic,4/8/2013,4/2/2013,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/28/2023,mg,antineoplastic,7/18/2023,7/14/2022,Intravenous,pemetrexed,TRUE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/30/2020,mg,antineoplastic,9/26/2019,8/24/2019,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/28/2012,mg,antineoplastic,12/17/2011,12/4/2011,Intravenous,paclitaxel,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/5/2013,mg,antineoplastic,6/12/2013,6/4/2013,Intravenous,paclitaxel,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/15/2025,mg,antineoplastic,4/12/2024,3/17/2024,Intravenous,amivantamab-vmjw,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/1/2015,mg,antineoplastic,10/3/2014,9/2/2014,Intravenous,etoposide,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/9/2019,mg/m2,antineoplastic,5/2/2019,2/10/2019,Intravenous,paclitaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/8/2013,mg,antineoplastic,12/17/2012,10/26/2012,Intravenous,vinorelbine,FALSE
1020,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D5BG82C889G,4/27/2021,mg,antineoplastic,6/6/2021,5/1/2021,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/11/2017,mg,antineoplastic,1/16/2014,1/6/2014,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1B:1G86333FB,7/14/2020,,,7/14/2020,2/20/2019,Oral,osimertinib,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G2DCF3C5B462B,11/25/2022,mL,solution-fluid,11/20/2022,10/16/2022,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/25/2020,mg,antineoplastic,12/20/2019,2/28/2019,Subcutaneous,bortezomib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/15/2025,mg,antineoplastic,5/6/2019,2/6/2017,Intravenous,pembrolizumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,6/21/2017,mg,antineoplastic,4/30/2017,12/13/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,7/25/2017,,antineoplastic,11/8/2016,9/25/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/16/2021,mg/m2,antineoplastic,8/5/2021,2/14/2021,Intravenous,leucovorin,FALSE
160,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,3/25/2015,mg,antineoplastic,3/9/2015,2/12/2015,Intravenous,paclitaxel protein-bound,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/28/2024,mg,antineoplastic,5/31/2024,9/19/2023,Intravenous,durvalumab,TRUE
130,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,3/17/2025,mg,antineoplastic,4/15/2025,12/18/2024,Intravenous,docetaxel,FALSE
1060,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,9/10/2015,mg,antineoplastic,8/25/2015,8/8/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/14/2025,mg,antineoplastic,12/28/2019,1/28/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,3/28/2025,mg,antineoplastic,3/16/2025,12/16/2024,Intravenous,pembrolizumab,TRUE
175,3,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,12/3/2014,mg/m2,antineoplastic,11/15/2014,9/30/2014,Intravenous,paclitaxel,FALSE
497,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,2/16/2012,mg,antineoplastic,2/9/2012,1/13/2012,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/31/2014,mg,antineoplastic,7/13/2014,5/15/2014,Intravenous,paclitaxel protein-bound,FALSE
90,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,1/3/2022,mg/m2,antineoplastic,10/31/2021,10/12/2021,Intravenous,irinotecan,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/22/2016,mg,antineoplastic,2/1/2016,6/28/2015,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,3/3/2022,,antineoplastic,10/6/2021,10/13/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,6/29/2017,,antineoplastic,3/9/2017,2/21/2017,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/24/2024,mg,antineoplastic,9/28/2023,7/8/2023,Intravenous,pembrolizumab,FALSE
805,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/26/2024,mg,antineoplastic,5/11/2024,10/31/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/2/2020,mg,antineoplastic,2/2/2020,5/19/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/8/2019,mg,antineoplastic,7/9/2018,5/10/2018,Intravenous,nivolumab,FALSE
526,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,3/15/2015,mg,antineoplastic,2/27/2015,12/10/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,3/30/2023,mg,antineoplastic,5/12/2022,4/14/2022,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,8/21/2021,mg,antineoplastic,8/12/2021,7/1/2021,Intravenous,carboplatin,FALSE
109,3,ADVANCED,Administrations,chemotherapy,Docetaxel,G164G31958638,11/4/2024,mg,antineoplastic,10/18/2024,10/26/2024,Intravenous,docetaxel,FALSE
181,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/13/2013,mg,antineoplastic,3/22/2013,9/30/2012,Intravenous,carboplatin,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4B1F584CB682,12/21/2015,mg/kg,antineoplastic,1/30/2016,11/16/2015,Intravenous,nivolumab,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,8/11/2024,mL,solution-fluid,5/15/2024,3/22/2024,Intravenous,cisplatin,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,6/19/2021,mg,antineoplastic,4/15/2021,10/31/2020,Intravenous,nivolumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G1CG8EF93777D,4/27/2020,mg/kg,antineoplastic,11/17/2019,10/8/2019,Intravenous,durvalumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,6/21/2017,,antineoplastic,2/9/2017,1/6/2017,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/27/2020,mg,antineoplastic,7/13/2016,2/16/2016,Intravenous,bevacizumab,TRUE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/19/2020,mg,antineoplastic,10/20/2019,9/13/2019,Intravenous,paclitaxel,FALSE
60,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G1G618861EGD9,8/1/2016,mg,antineoplastic,8/5/2016,7/25/2016,Intravenous,cisplatin,FALSE
165.6,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/27/2015,mg,antineoplastic,12/18/2014,11/7/2014,Intravenous,paclitaxel,FALSE
509,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,4/18/2015,mg,antineoplastic,2/5/2015,11/13/2014,Intravenous,pemetrexed,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/18/2023,mg,antineoplastic,12/29/2023,10/20/2022,Intravenous,durvalumab,FALSE
171.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/8/2017,mg,antineoplastic,11/23/2016,9/11/2016,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,12/7/2013,mg,antineoplastic,10/11/2013,7/26/2013,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,12/30/2017,mg,antineoplastic,1/29/2018,11/11/2017,Intravenous,carboplatin,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,3/7/2012,mg,antineoplastic,1/24/2012,1/27/2012,Intravenous,docetaxel,FALSE
770,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,8/24/2018,mg,antineoplastic,7/25/2018,5/5/2018,Intravenous,pemetrexed,FALSE
499.6,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/16/2025,mg,antineoplastic,9/8/2019,2/22/2019,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/22/2022,mg,antineoplastic,12/14/2021,8/23/2021,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/11/2023,,antineoplastic,6/23/2023,3/15/2023,,anastrozole,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G5G8G1EE2EG,8/22/2019,mg,antineoplastic,8/25/2019,8/20/2019,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,12/7/2011,mg,antineoplastic,10/2/2011,8/5/2011,Intravenous,carboplatin,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/3/2012,mg,antineoplastic,11/8/2011,8/23/2011,Intravenous,vinorelbine,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/22/2012,mg,antineoplastic,12/30/2011,9/4/2011,Intravenous,cetuximab,FALSE
,3,ADVANCED,Unstructured,,"Clinical Study Drug,Osimertinib",G3BBG95F1669C,2/23/2023,,,11/14/2022,9/23/2022,Oral,osimertinib,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,11/6/2017,mg,antineoplastic,12/19/2016,12/25/2016,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,1/6/2020,4/20/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/4/2019,mg,antineoplastic,1/26/2019,1/3/2018,Intravenous,pembrolizumab,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,10/2/2024,mg,antineoplastic,5/22/2024,4/30/2024,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/15/2022,,antineoplastic,4/18/2022,5/14/2017,Oral,nilotinib,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/6/2025,mg,antineoplastic,8/28/2024,2/17/2024,Intravenous,amivantamab-vmjw,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/10/2013,mg,antineoplastic,6/30/2012,5/27/2012,Intravenous,gemcitabine,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/7/2013,mg,antineoplastic,9/28/2012,5/19/2012,Intravenous,gemcitabine,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/30/2016,mg,antineoplastic,11/24/2015,11/29/2015,Intravenous,paclitaxel,FALSE
248,,ADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,10/20/2014,mg,antineoplastic,7/15/2014,5/29/2014,Intravenous,ado-trastuzumab emtansine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,3/6/2024,mg,antineoplastic,1/5/2024,12/25/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/23/2024,mg,antineoplastic,12/24/2023,7/10/2023,Intravenous,pembrolizumab,TRUE
65,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/13/2013,mg,antineoplastic,10/4/2012,4/25/2012,Intravenous,docetaxel,FALSE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/22/2015,mg,antineoplastic,4/2/2015,3/16/2015,Intravenous,gemcitabine,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/7/2021,mg,antineoplastic,1/22/2021,10/18/2020,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G1:F129FBCE3F,6/16/2020,,antineoplastic,3/18/2020,2/22/2020,Oral,hydroxyurea,FALSE
832,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,9/16/2021,mg,antineoplastic,8/15/2021,8/31/2021,Intravenous,pemetrexed,FALSE
156,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,9/2/2023,mg,antineoplastic,5/30/2023,5/16/2023,Intravenous,carboplatin,FALSE
25,4,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/11/2019,mg/m2,antineoplastic,2/5/2019,2/26/2019,Intravenous,vinorelbine,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/15/2025,mg,antineoplastic,4/26/2025,5/10/2020,Subcutaneous,leuprolide,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/20/2020,mg,antineoplastic,2/5/2020,2/12/2020,Intravenous,pemetrexed,FALSE
1000,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,4/24/2024,mg,antineoplastic,5/6/2024,3/10/2024,Intravenous,pemetrexed,FALSE
444,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/21/2024,mg,antineoplastic,5/27/2024,3/7/2024,Intravenous,paclitaxel,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/7/2013,mg,antineoplastic,8/28/2013,4/24/2013,Intravenous,pemetrexed,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/26/2025,mg,antineoplastic,1/29/2025,4/1/2024,Intravenous,pemetrexed,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/16/2024,mg,antineoplastic,7/7/2024,6/20/2024,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G142964636C93,4/17/2022,mg,antineoplastic,3/27/2022,2/14/2022,Intravenous,pembrolizumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/13/2025,mg,antineoplastic,3/6/2024,2/24/2024,Intravenous,durvalumab,TRUE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,10/9/2014,mg/m2,antineoplastic,2/7/2014,12/7/2013,Intravenous,paclitaxel,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/20/2014,mg,antineoplastic,5/24/2013,10/18/2012,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G431ECG92273D,12/20/2018,,,1/4/2019,11/3/2018,Oral,afatinib,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/3/2024,mg,antineoplastic,7/24/2024,8/17/2024,Intravenous,paclitaxel,FALSE
271.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/26/2023,mg,antineoplastic,5/8/2023,1/20/2023,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/16/2022,mg,antineoplastic,1/14/2019,4/2/2017,Intravenous,nivolumab,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,8/21/2020,mg,antineoplastic,5/23/2020,5/14/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/26/2019,mg,antineoplastic,8/29/2019,10/2/2019,Intravenous,pembrolizumab,FALSE
280,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,2/16/2019,mg,antineoplastic,1/8/2019,12/6/2018,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/8/2014,mg/m2,antineoplastic,4/25/2014,11/9/2013,Intravenous,pemetrexed,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/11/2017,mg,antineoplastic,6/5/2017,4/24/2017,Intravenous,trastuzumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,4/12/2025,,antineoplastic,2/15/2025,9/14/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,6/22/2024,mg,antineoplastic,5/27/2024,3/17/2024,Intravenous,pembrolizumab,FALSE
2370,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1GDCB:FF9G:1,6/29/2016,mg,antineoplastic,6/9/2016,4/18/2016,Intravenous,gemcitabine,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/18/2022,mg,antineoplastic,6/28/2022,7/8/2022,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/8/2025,mg,antineoplastic,3/17/2025,4/19/2024,Intravenous,pembrolizumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/21/2012,mg,antineoplastic,1/7/2012,11/8/2011,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/18/2025,mg,antineoplastic,7/8/2021,12/18/2016,Intravenous,pembrolizumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/13/2025,mg,antineoplastic,2/26/2025,9/13/2024,Intravenous,durvalumab,TRUE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/1/2025,mg,antineoplastic,1/22/2025,10/28/2024,Intravenous,gemcitabine,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/8/2017,mg,antineoplastic,9/5/2017,7/1/2017,Intravenous,pemetrexed,FALSE
750,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3C:F1C:2BF6C,1/25/2015,mg,antineoplastic,10/22/2014,10/26/2014,Intravenous,carboplatin,FALSE
127,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/29/2021,mg,antineoplastic,5/26/2021,5/29/2020,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/23/2025,mg,antineoplastic,10/18/2021,8/10/2021,Intravenous,atezolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,7/25/2017,4/17/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/27/2024,mg,antineoplastic,7/22/2023,8/24/2022,Intravenous,pembrolizumab,TRUE
75,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,3/21/2014,mg/m2,antineoplastic,1/5/2014,12/21/2013,Intravenous,docetaxel,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,10/18/2018,mg,antineoplastic,10/12/2016,10/17/2016,Intravenous,paclitaxel,FALSE
665,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/7/2021,mg,antineoplastic,12/4/2020,10/30/2020,Intravenous,pemetrexed,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/28/2021,mg,antineoplastic,12/3/2020,12/9/2020,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/19/2025,,antineoplastic,11/23/2023,2/16/2023,,clinical study drug,FALSE
868,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,3/30/2024,mg,antineoplastic,2/3/2024,1/28/2024,Intravenous,carboplatin,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/13/2012,mg,antineoplastic,1/11/2012,11/25/2011,Intravenous,carboplatin,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/8/2016,mg,antineoplastic,7/13/2015,7/17/2015,Intravenous,bevacizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/26/2025,mg,antineoplastic,11/5/2022,1/17/2022,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38579B136B1B,4/28/2025,mg,antineoplastic,3/1/2025,1/14/2025,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/18/2017,mg,antineoplastic,9/4/2017,5/18/2017,Intravenous,pembrolizumab,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/10/2016,mg,antineoplastic,2/26/2015,12/2/2014,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,2/22/2017,mg,antineoplastic,12/30/2016,12/21/2016,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/6/2016,mg,antineoplastic,12/19/2015,4/16/2015,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/13/2022,mg/kg,antineoplastic,3/22/2021,2/18/2021,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G242B854DCE96,4/29/2016,,antineoplastic,5/2/2016,12/13/2015,Intravenous,nivolumab,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,4/5/2013,mg,antineoplastic,5/8/2012,5/6/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,8/29/2020,mg,antineoplastic,5/10/2020,5/26/2020,Intravenous,pembrolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,9/28/2019,mg/kg,antineoplastic,10/6/2019,6/12/2019,Intravenous,durvalumab,TRUE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/30/2011,mg,antineoplastic,5/19/2011,6/15/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/29/2025,mg,antineoplastic,10/8/2019,5/3/2018,Intravenous,pembrolizumab,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/2/2015,mg,antineoplastic,6/22/2015,6/12/2015,Intravenous,etoposide,FALSE
160,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G163D9B593927,9/4/2016,mg,antineoplastic,7/6/2016,7/16/2016,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/8/2025,mg,antineoplastic,8/16/2023,8/13/2021,Intravenous,atezolizumab,TRUE
191.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,3/12/2021,mg,antineoplastic,5/4/2020,5/7/2020,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,3/14/2021,mg,antineoplastic,1/18/2021,12/4/2020,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/1/2020,mg,antineoplastic,1/26/2019,8/13/2016,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,12/1/2014,mg,antineoplastic,5/24/2014,4/15/2014,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/29/2024,mg,antineoplastic,2/3/2024,5/27/2023,Intravenous,carboplatin,FALSE
340,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/31/2016,mg,antineoplastic,9/5/2016,7/7/2016,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,4/17/2017,mg,antineoplastic,12/10/2016,10/28/2016,Intravenous,paclitaxel protein-bound,FALSE
660,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/7/2017,mg,antineoplastic,8/6/2017,7/16/2017,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/18/2022,mg,antineoplastic,7/7/2021,5/31/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/26/2024,mg,antineoplastic,12/17/2021,4/26/2020,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/26/2020,mg,antineoplastic,6/30/2017,8/13/2016,Intravenous,nivolumab,FALSE
89,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,7/14/2021,mg,antineoplastic,2/25/2021,11/15/2020,Intravenous,ipilimumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/7/2019,mg,antineoplastic,12/9/2018,3/30/2016,Intravenous,nivolumab,FALSE
266,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/16/2022,mg,antineoplastic,9/19/2019,6/28/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/8/2023,,antineoplastic,7/5/2023,4/17/2023,,azacitidine,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/29/2015,mg/m2,antineoplastic,2/16/2015,9/28/2014,Intravenous,etoposide,FALSE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G3CE666498C:9,2/21/2013,mg/m2,antineoplastic,12/11/2012,11/25/2012,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/5/2017,,antineoplastic,5/15/2017,3/15/2017,Intravenous,carboplatin,FALSE
196.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/28/2022,mg,antineoplastic,6/3/2014,5/24/2014,Intravenous,carboplatin,FALSE
750,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/22/2024,mg,antineoplastic,8/5/2023,5/20/2023,Intravenous,pemetrexed,FALSE
746,,ADJUVANT,Administrations,targeted/biologic,Rituximab,G5545136B977G,7/21/2020,mg,antineoplastic,8/4/2020,6/17/2020,Intravenous,rituximab,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,7/9/2024,mg,antineoplastic,4/19/2024,3/12/2024,Intravenous,gemcitabine,FALSE
373,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,8/1/2014,mg,antineoplastic,5/10/2014,6/7/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,10/14/2019,mg,antineoplastic,7/15/2019,6/10/2019,Intravenous,pembrolizumab,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/25/2012,mg,antineoplastic,7/3/2012,3/11/2012,Intravenous,docetaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/7/2022,mg,antineoplastic,2/2/2022,11/14/2021,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/8/2024,mg,antineoplastic,6/2/2024,7/30/2023,Intravenous,nivolumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,9/29/2019,mg,antineoplastic,7/9/2019,7/14/2019,Intravenous,pembrolizumab,FALSE
298.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/13/2015,mg,antineoplastic,2/8/2015,1/23/2015,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,9/5/2015,mg,antineoplastic,3/16/2015,3/20/2015,Intravenous,pemetrexed,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/17/2017,mg,antineoplastic,4/26/2016,6/15/2015,Intravenous,nivolumab,FALSE
660,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/10/2019,mg,antineoplastic,8/17/2019,8/29/2019,Intravenous,carboplatin,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/10/2015,mg,antineoplastic,11/23/2014,9/17/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G1F482136BDE5,5/15/2017,,cytoprotective,4/13/2017,2/14/2017,Intramuscular,clinical study drug,FALSE
157,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,2/27/2023,mg,antineoplastic,1/29/2023,2/22/2023,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/12/2024,mg,antineoplastic,6/23/2024,6/19/2024,Intravenous,paclitaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/14/2025,mg,antineoplastic,2/28/2023,2/11/2020,Intravenous,pemetrexed,TRUE
200,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D168F99BCD4,1/15/2024,mg,antineoplastic,11/11/2023,9/17/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/16/2020,mg,antineoplastic,6/20/2019,6/6/2019,Intravenous,pembrolizumab,TRUE
50,5,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3::1:B4F:3D4,2/24/2016,mg,antineoplastic,3/3/2016,3/6/2016,Intravenous,vinorelbine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/9/2021,mg,antineoplastic,6/20/2021,4/26/2021,Intravenous,atezolizumab,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,3/2/2020,mg,antineoplastic,1/30/2020,11/10/2019,Intravenous,paclitaxel,FALSE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/9/2013,mg,antineoplastic,4/18/2013,5/12/2013,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/13/2024,mg,antineoplastic,3/23/2022,11/20/2021,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/2/2019,,antineoplastic,2/25/2019,3/25/2019,,docetaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,3/1/2015,,solution-fluid,10/27/2014,9/10/2014,Intravenous,clinical study drug,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/19/2021,,antineoplastic,10/20/2020,6/15/2020,,clinical study drug,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,1/25/2015,mg,antineoplastic,9/22/2014,9/2/2014,Intravenous,docetaxel,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/7/2019,mg,antineoplastic,7/22/2019,8/24/2019,Intravenous,paclitaxel protein-bound,FALSE
5,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/5/2019,AUC,antineoplastic,3/22/2019,4/10/2019,Intravenous,carboplatin,FALSE
500,3,ADVANCED,Administrations,hormone,Fulvestrant,G272F2D3BB8C2,5/9/2016,mg,antineoplastic,3/31/2016,3/3/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,8/21/2024,mg,antineoplastic,7/29/2024,7/4/2024,Intravenous,paclitaxel protein-bound,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3951BC5GBE44,9/20/2023,mg,antineoplastic,8/2/2023,5/30/2023,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,11/7/2017,mg,antineoplastic,4/29/2017,5/31/2017,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/2/2019,mg,antineoplastic,6/25/2018,4/27/2018,Intravenous,nivolumab,FALSE
,4,ADVANCED,Unstructured,,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,3/14/2022,,,3/10/2022,2/12/2022,Oral,erlotinib,FALSE
,1,ADVANCED,Unstructured,,"Crizotinib,Lorlatinib",G24G49:3G:B1G,3/23/2025,,,4/7/2025,9/22/2024,Oral,lorlatinib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1GEF44EBD419,4/4/2025,mg,antineoplastic,2/11/2025,12/10/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/24/2025,,antineoplastic,4/8/2023,1/26/2023,,clinical study drug,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,12/6/2018,mg/m2,antineoplastic,7/5/2018,6/27/2018,Intravenous,pemetrexed,TRUE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/14/2025,mg,antineoplastic,10/8/2023,5/1/2020,Subcutaneous,leuprolide,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/22/2025,mg,antineoplastic,11/22/2023,8/4/2022,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,12/5/2018,mg,antineoplastic,10/31/2018,9/15/2018,Intravenous,pembrolizumab,FALSE
832,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/7/2020,mg,antineoplastic,10/4/2020,10/24/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/18/2025,mg,antineoplastic,9/13/2018,4/24/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/29/2025,,antineoplastic,12/1/2021,10/10/2021,Intravenous,pemetrexed,TRUE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G16C41789C1C5,5/23/2021,mg,antineoplastic,2/24/2021,2/22/2021,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/19/2025,mg,antineoplastic,11/28/2020,2/3/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,5/6/2024,,antineoplastic,4/8/2024,1/27/2024,,pemetrexed,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/3/2022,mg,antineoplastic,9/1/2022,8/3/2022,Intravenous,paclitaxel,FALSE
544,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/5/2017,mg,antineoplastic,5/2/2017,10/26/2016,Intravenous,bevacizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/24/2023,mg,antineoplastic,7/1/2022,5/2/2022,Intravenous,durvalumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/11/2021,mL,solution-fluid,10/5/2018,3/23/2018,Intravenous,durvalumab,TRUE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,4/21/2020,mg,antineoplastic,2/9/2020,7/15/2019,Intravenous,ramucirumab,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/20/2016,mg,antineoplastic,6/11/2016,6/11/2016,Intravenous,carboplatin,FALSE
485,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,7/13/2016,mg,antineoplastic,4/6/2016,4/10/2016,Intravenous,nivolumab,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,3/3/2022,mg,antineoplastic,2/8/2022,12/24/2021,Intravenous,nivolumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/6/2018,mg,antineoplastic,2/13/2016,10/5/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/31/2025,,,12/24/2022,11/6/2022,Oral,osimertinib,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/15/2016,mg,antineoplastic,10/29/2015,9/30/2015,Intravenous,etoposide,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,3/28/2025,,antiemetic,1/24/2025,11/18/2024,Intravenous,clinical study drug,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4229EB584D67,2/23/2015,mg,antineoplastic,3/20/2015,3/25/2015,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,11/19/2016,mg,antineoplastic,10/27/2016,9/6/2016,Intravenous,pembrolizumab,FALSE
232,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/27/2015,mg,antineoplastic,2/27/2015,3/3/2015,Intravenous,carboplatin,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/10/2020,mg,antineoplastic,8/4/2020,9/24/2019,Intravenous,durvalumab,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,11/12/2019,mg/m2,antineoplastic,8/15/2019,8/6/2019,Intravenous,pemetrexed,FALSE
350,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/9/2023,mg,antineoplastic,2/17/2020,1/19/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/28/2022,mg,antineoplastic,11/12/2021,5/1/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/14/2025,,antineoplastic,7/16/2024,1/30/2023,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G128:92:3BD3D,12/5/2021,,antineoplastic,5/18/2021,5/1/2021,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/16/2025,,antineoplastic,4/5/2022,9/22/2021,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,Osimertinib,G1::2C155D:6E,3/18/2025,,,11/16/2023,9/25/2023,Oral,osimertinib,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/10/2019,mg,antineoplastic,8/8/2018,7/21/2018,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/28/2019,mg,antineoplastic,12/21/2017,3/23/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/3/2025,mg,antineoplastic,3/31/2024,6/2/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/25/2020,mg,antineoplastic,11/27/2019,10/15/2019,Intravenous,pembrolizumab,TRUE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/3/2019,mg,antineoplastic,7/17/2019,12/6/2018,Intravenous,durvalumab,TRUE
680,,NEOADJUVANT,Administrations,targeted/biologic,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/12/2013,mg,antineoplastic,1/7/2013,1/17/2013,Intravenous,rituximab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G14955945B53:,6/14/2023,mg,antineoplastic,5/19/2023,3/24/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38579B136B1B,4/18/2025,mg,antineoplastic,1/4/2025,12/2/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1:9FCE6E6G6C,11/13/2021,,antineoplastic,11/8/2021,10/13/2021,Oral,anastrozole,FALSE
92,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,11/8/2017,mg,antineoplastic,1/31/2017,12/19/2016,Intravenous,cisplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,2/26/2025,mg,antineoplastic,6/10/2022,3/13/2022,Intravenous,pembrolizumab,TRUE
1476,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,5/6/2022,mg,antineoplastic,3/12/2022,1/21/2022,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G24F68:FC41G2,5/22/2023,,,3/28/2023,12/7/2021,Oral,osimertinib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/24/2023,mg,antineoplastic,9/24/2022,8/17/2022,Subcutaneous,azacitidine,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/20/2020,mg,antineoplastic,11/21/2019,1/16/2019,Subcutaneous,bortezomib,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,12/1/2023,mg,antineoplastic,5/26/2023,6/9/2023,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/9/2024,mg,antineoplastic,9/9/2024,7/31/2024,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/5/2025,,antineoplastic,9/18/2024,3/17/2023,Intravenous,pemetrexed,FALSE
739,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,11/19/2018,mg,antineoplastic,9/30/2018,7/30/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/14/2024,mg,antineoplastic,5/17/2023,9/24/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/2/2023,mg,antineoplastic,11/17/2022,3/6/2022,Intravenous,pembrolizumab,TRUE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/3/2023,mg,antineoplastic,3/19/2023,10/26/2022,Intravenous,durvalumab,FALSE
820,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,1/28/2013,mg,antineoplastic,1/11/2013,11/20/2012,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,9/19/2022,,antineoplastic,8/29/2022,8/22/2022,Oral,bosutinib,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,4/10/2021,,antineoplastic,3/14/2021,2/25/2021,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G3B942496:87:,2/1/2013,,,10/30/2012,12/13/2012,Oral,erlotinib,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/19/2025,mg,antineoplastic,11/25/2024,6/5/2024,Intravenous,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,3/16/2023,mg,antineoplastic,7/27/2022,5/7/2022,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/22/2025,mg,antineoplastic,8/6/2024,8/3/2024,Intravenous,pembrolizumab,TRUE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/29/2024,mg,antineoplastic,7/16/2024,6/5/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/6/2025,mg,antineoplastic,1/28/2025,10/15/2024,Intravenous,pembrolizumab,TRUE
108,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/1/2017,mg,antineoplastic,7/3/2016,6/7/2016,Intravenous,paclitaxel,FALSE
785,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,7/17/2023,mg,antineoplastic,3/21/2023,3/22/2023,Intravenous,pemetrexed,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,10/24/2017,mg,antineoplastic,5/21/2017,4/27/2017,Intravenous,gemcitabine,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/24/2012,mg,antineoplastic,1/14/2012,1/6/2012,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/16/2025,mg,antineoplastic,6/5/2020,3/17/2019,Intravenous,pemetrexed,FALSE
4,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/5/2013,AUC,antineoplastic,3/14/2013,2/9/2013,Intravenous,carboplatin,FALSE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/29/2014,mg,antineoplastic,8/6/2014,6/9/2014,Intravenous,vinorelbine,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/28/2022,mg,antineoplastic,8/21/2022,6/16/2022,Intravenous,carboplatin,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/25/2025,mg,antineoplastic,9/2/2024,11/7/2022,Intravenous,pemetrexed,FALSE
27,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,12/26/2014,mg,antineoplastic,1/15/2015,11/19/2014,Intravenous,cisplatin,FALSE
229,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,7/18/2024,mg,antineoplastic,5/14/2024,5/25/2024,Intravenous,carboplatin,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/5/2019,mg,antineoplastic,8/14/2019,8/11/2019,Intravenous,cisplatin,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/2/2013,mg,antineoplastic,4/22/2013,12/1/2012,Intravenous,vinorelbine,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,9/11/2019,mg,antineoplastic,4/14/2019,1/24/2019,Intravenous,pemetrexed,TRUE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/13/2017,mg,antineoplastic,9/30/2016,4/15/2015,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/2/2022,mg,antineoplastic,4/19/2021,4/9/2021,Intravenous,pembrolizumab,TRUE
1500,1,ADVANCED,Orders,immunotherapy,Durvalumab,G439D41E1E1FB,11/7/2022,mg,antineoplastic,6/6/2022,9/15/2021,Intravenous,durvalumab,TRUE
500,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/20/2019,mg/m2,antineoplastic,3/18/2019,4/10/2019,Intravenous,pemetrexed,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/24/2016,mg/m2,antineoplastic,2/6/2016,3/18/2016,Intravenous,etoposide,FALSE
458,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/17/2015,mg,antineoplastic,12/8/2014,11/7/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/12/2025,mg,antineoplastic,1/19/2024,7/20/2023,Intravenous,pembrolizumab,TRUE
815,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,8/21/2024,mg,antineoplastic,8/4/2024,8/7/2024,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/30/2020,mg,antineoplastic,6/16/2019,2/26/2019,Subcutaneous,bortezomib,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/6/2021,mg,antineoplastic,7/5/2021,4/19/2021,Intravenous,carboplatin,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/31/2016,mg,antineoplastic,7/12/2016,7/12/2016,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/5/2025,mg,antineoplastic,10/28/2024,8/13/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/9/2020,mg,antineoplastic,2/17/2019,1/18/2018,Intravenous,pembrolizumab,TRUE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/14/2012,mg,antineoplastic,7/19/2012,6/14/2012,Intravenous,bevacizumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/10/2021,mg,antineoplastic,11/22/2019,11/29/2019,Intravenous,durvalumab,TRUE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/13/2018,mg,antineoplastic,4/5/2016,10/4/2015,Intravenous,nivolumab,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/14/2025,mg,antineoplastic,2/18/2017,12/19/2016,Intravenous,pembrolizumab,FALSE
600,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/19/2019,mg,antineoplastic,11/25/2018,7/22/2018,Intravenous,carboplatin,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/28/2021,mg,antineoplastic,2/10/2021,11/1/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/6/2025,mg,antineoplastic,11/24/2024,4/27/2024,Intravenous,pembrolizumab,TRUE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,2/12/2017,mg,antineoplastic,12/28/2016,12/17/2016,Intravenous,paclitaxel,FALSE
100,5,ADVANCED,Administrations,solution-fluid,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/23/2025,mL,solution-fluid,3/21/2025,2/17/2025,Intravenous,pembrolizumab,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,12/29/2019,mg,antineoplastic,10/12/2019,7/12/2019,Intravenous,docetaxel,FALSE
137,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/27/2020,mg,antineoplastic,12/12/2019,12/7/2019,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G13GE1E25174F,9/8/2022,mg,antineoplastic,8/29/2022,5/8/2022,Intravenous,pembrolizumab,TRUE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/4/2017,mg,antineoplastic,9/18/2017,8/4/2017,Intravenous,paclitaxel,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,12/5/2015,mg,antineoplastic,5/7/2015,2/24/2015,Intravenous,paclitaxel protein-bound,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/16/2016,mg,antineoplastic,12/19/2015,12/29/2015,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,glucocorticoid,Clinical Study Drug,G128:92:3BD3D,11/26/2021,,steroid,4/13/2021,5/8/2021,,clinical study drug,FALSE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/12/2024,mg,antineoplastic,8/26/2024,8/26/2024,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/27/2013,mg,antineoplastic,9/4/2012,12/17/2011,Intravenous,etoposide,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/17/2021,mg,antineoplastic,6/11/2021,6/19/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/3/2023,mg,antineoplastic,2/10/2023,10/7/2021,Intravenous,pembrolizumab,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/30/2016,mg/kg,antineoplastic,8/29/2016,2/28/2016,Intravenous,bevacizumab,TRUE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,5/22/2015,mg,antineoplastic,1/30/2015,10/13/2014,Intravenous,etoposide,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/15/2020,mg,antineoplastic,10/7/2020,5/4/2020,Intravenous,paclitaxel,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/13/2015,mg,antineoplastic,11/1/2014,9/2/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/14/2023,mg,antineoplastic,2/20/2021,4/21/2020,Intravenous,pembrolizumab,TRUE
63.9,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,7/28/2021,mg,antineoplastic,2/15/2021,12/14/2020,Intravenous,vinorelbine,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/10/2021,mg,antineoplastic,11/26/2021,4/13/2021,Intravenous,vinorelbine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,2/14/2023,mg,antineoplastic,11/26/2022,7/20/2022,Intravenous,pembrolizumab,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/9/2023,mg,antineoplastic,12/9/2022,11/18/2022,Intravenous,bevacizumab-bvzr,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/19/2025,,antineoplastic,9/9/2024,4/20/2020,Oral,enzalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,9/23/2020,mg,antineoplastic,7/19/2020,5/12/2020,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/5/2022,mg,antineoplastic,1/6/2018,1/25/2016,Intravenous,pemetrexed,FALSE
1666,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,1/18/2013,mg/m2,antineoplastic,1/25/2013,12/29/2012,Intravenous,ifosfamide,FALSE
308,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,6/18/2023,mg,antineoplastic,3/8/2023,10/11/2022,Intravenous,carboplatin,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,9/30/2017,mg,antineoplastic,9/20/2017,8/28/2017,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,9/24/2019,mg,antineoplastic,9/13/2019,7/13/2019,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,9/11/2024,,antineoplastic,8/24/2024,7/18/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,9/15/2018,mg,antineoplastic,5/15/2018,2/22/2018,Intravenous,pembrolizumab,FALSE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/28/2018,mg,antineoplastic,9/3/2018,4/19/2018,Intravenous,carboplatin,FALSE
1.5,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,11/18/2023,mg,antineoplastic,3/19/2023,1/29/2023,Intravenous,vincristine,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,"Decitabine,Venetoclax",G41DE1E3BE99:,7/2/2024,,antineoplastic,7/23/2024,6/16/2024,Oral,venetoclax,FALSE
790,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3FF9EE1D39::,8/29/2013,mg,antineoplastic,10/7/2013,9/11/2013,Intravenous,pemetrexed,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,5/25/2022,mg,antineoplastic,3/2/2021,3/8/2020,Intravenous,durvalumab,TRUE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/11/2022,mg,antineoplastic,5/9/2021,4/3/2021,Intravenous,bevacizumab-awwb,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/10/2017,mg,antineoplastic,8/24/2016,5/23/2016,Intravenous,paclitaxel protein-bound,FALSE
126,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/12/2014,mg,antineoplastic,1/24/2014,12/23/2013,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/30/2014,mg,antineoplastic,2/27/2014,2/28/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/6/2020,mg,antineoplastic,5/20/2020,4/8/2020,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,8/13/2017,mg,antineoplastic,8/2/2017,6/1/2017,Intravenous,carboplatin,FALSE
825,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/23/2017,mg,antineoplastic,3/18/2017,12/21/2016,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/24/2022,mg,antineoplastic,7/6/2022,6/20/2022,Intravenous,pembrolizumab,FALSE
246,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/13/2021,mg,antineoplastic,12/20/2020,1/7/2021,Intravenous,carboplatin,FALSE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,8/24/2024,mg,antineoplastic,7/28/2024,7/15/2024,Intravenous,gemcitabine,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/20/2013,mg,antineoplastic,8/31/2013,4/9/2013,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,4/15/2012,,antineoplastic,8/19/2011,6/28/2011,Intravenous,clinical study drug,FALSE
644,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,6/28/2017,mg,antineoplastic,7/10/2017,3/17/2017,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/11/2018,mg,antineoplastic,5/10/2017,2/26/2017,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,5/25/2014,mg,antineoplastic,4/23/2014,4/1/2014,Intravenous,pemetrexed,FALSE
137,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5669E21B9D52,3/11/2017,mg,antineoplastic,4/5/2017,2/28/2017,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/21/2021,mg/kg,antineoplastic,7/27/2021,2/12/2021,Intravenous,bevacizumab-awwb,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/24/2023,,antineoplastic,5/22/2023,12/7/2022,Intravenous,clinical study drug,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/18/2020,mg,antineoplastic,5/4/2019,11/4/2015,Intravenous,nivolumab,FALSE
1100,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,8/14/2017,mg,antineoplastic,6/17/2017,4/16/2017,Intravenous,pemetrexed,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/5/2015,mg,antineoplastic,11/29/2015,10/11/2015,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G485C85BECGC4,4/23/2022,,antineoplastic,2/22/2022,12/12/2021,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,8/2/2017,,antineoplastic,7/11/2017,4/11/2017,Intravenous,carboplatin,FALSE
640,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G1:DCBB2BG56F,4/3/2022,mg,antineoplastic,3/24/2022,4/2/2022,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,11/20/2024,mg,antineoplastic,10/25/2024,10/8/2024,Intravenous,pemetrexed,TRUE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/5/2019,mg,antineoplastic,4/13/2017,11/11/2016,Intramuscular,fulvestrant,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,8/30/2024,mg,antineoplastic,6/20/2021,7/17/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/26/2018,mg,antineoplastic,6/6/2015,7/20/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,1/5/2019,mg,antineoplastic,5/9/2018,3/1/2017,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,7/17/2018,mg,antineoplastic,3/17/2018,2/2/2018,Intravenous,pembrolizumab,FALSE
700,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/4/2021,mg,antineoplastic,12/10/2020,11/8/2020,Intravenous,leucovorin,FALSE
743,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G392GC5134FFG,9/14/2020,mg,antineoplastic,9/6/2020,8/15/2020,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/27/2024,mg,antineoplastic,3/9/2024,6/11/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/16/2024,,antineoplastic,6/23/2024,5/22/2024,Intravenous,etoposide,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,3/26/2018,,antineoplastic,12/30/2017,1/23/2018,Intravenous,clinical study drug,FALSE
97,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/19/2017,mg,antineoplastic,11/15/2016,10/6/2016,Intravenous,cisplatin,FALSE
95,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,1/6/2014,mg,antineoplastic,12/8/2013,9/24/2013,Intravenous,cisplatin,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,1/12/2017,mg,antineoplastic,1/30/2017,12/7/2016,Intravenous,pemetrexed,FALSE
,6,ADVANCED,Unstructured,,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,11/16/2016,,,9/26/2016,9/11/2016,Oral,vemurafenib,FALSE
617,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/2/2016,mg,antineoplastic,6/28/2016,6/5/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/18/2022,mg,antineoplastic,9/6/2020,8/11/2020,Intravenous,pembrolizumab,TRUE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/21/2016,mg,antineoplastic,11/7/2014,10/13/2014,Intravenous,bevacizumab,TRUE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G21744:G47B22,10/20/2014,mg,antineoplastic,10/15/2014,8/24/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/12/2020,,antineoplastic,2/20/2018,8/13/2017,Intravenous,pemetrexed,TRUE
1200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,6/2/2012,mg,antineoplastic,4/5/2012,3/3/2012,Intravenous,gemcitabine,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,8/5/2018,mg,antineoplastic,4/22/2018,4/21/2018,Intravenous,paclitaxel,FALSE
325,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/3/2019,mg,antineoplastic,1/27/2019,3/8/2019,Intravenous,paclitaxel,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/15/2016,mg,antineoplastic,8/10/2015,4/30/2015,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/30/2024,mg,antineoplastic,3/23/2022,12/2/2021,Intravenous,durvalumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/4/2024,mg,antineoplastic,3/30/2023,1/13/2022,Intravenous,nivolumab,TRUE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/20/2025,mg,antineoplastic,9/27/2024,10/10/2024,Intravenous,durvalumab,FALSE
124,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,4/5/2017,mg,antineoplastic,2/19/2017,12/3/2016,Intravenous,cisplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,2/28/2023,mg,antineoplastic,6/7/2022,4/19/2022,Intravenous,atezolizumab,FALSE
625,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,6/10/2012,mg,antineoplastic,5/4/2012,4/20/2012,Intravenous,carboplatin,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/6/2018,mg/m2,antineoplastic,12/13/2017,9/7/2017,Intravenous,paclitaxel,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/16/2016,mg,antineoplastic,5/2/2016,11/27/2015,Intravenous,paclitaxel,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/5/2020,mg,antineoplastic,10/21/2019,9/30/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/11/2020,,antineoplastic,2/27/2019,1/4/2019,Subcutaneous,bortezomib,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/10/2022,mg,antineoplastic,3/21/2022,1/11/2022,Intravenous,paclitaxel,FALSE
528.5,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/1/2023,mg,antineoplastic,4/6/2023,5/7/2023,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G257D9:2573CF,4/3/2025,mg,antineoplastic,1/17/2025,11/17/2024,Intravenous,durvalumab,TRUE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,11/28/2021,mg,antineoplastic,7/11/2019,6/27/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,8/30/2020,mg,antineoplastic,9/19/2020,6/16/2020,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,3/20/2025,mg,antineoplastic,3/28/2024,1/26/2024,Intravenous,pembrolizumab,FALSE
195,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/22/2012,mg,antineoplastic,1/31/2012,1/7/2012,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/1/2022,mg,antineoplastic,4/9/2021,1/5/2020,Intravenous,nivolumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/7/2024,mg,antineoplastic,2/14/2024,1/2/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F3:G92:612D,6/7/2018,mg,antineoplastic,5/31/2018,6/14/2018,Intravenous,pembrolizumab,FALSE
185.08,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G359C2E:9E3B7,9/11/2017,mg,antineoplastic,8/24/2017,10/16/2017,Intravenous,carboplatin,FALSE
670,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,2/17/2024,mg,antineoplastic,12/25/2023,10/24/2023,Intravenous,pemetrexed,FALSE
820,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,1/27/2013,mg,antineoplastic,11/27/2012,12/2/2012,Intravenous,pemetrexed,FALSE
925,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G44B44661:316,2/26/2016,mg,antineoplastic,4/3/2015,3/13/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/1/2022,mg,antineoplastic,2/11/2021,1/5/2018,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/15/2025,mL,solution-fluid,6/26/2024,5/5/2024,Intravenous,pembrolizumab,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,6/28/2020,mg,antineoplastic,6/10/2020,5/13/2020,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,2/6/2015,,,1/27/2015,12/12/2014,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,3/31/2025,mg,antineoplastic,12/22/2022,10/23/2022,Intravenous,pembrolizumab,TRUE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,5/2/2015,mg,antineoplastic,1/31/2015,12/17/2014,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,4/5/2025,mg,antineoplastic,3/15/2024,2/9/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G33159ECF97CC,6/1/2019,,,5/15/2018,5/26/2018,Oral,osimertinib,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1F482136BDE5,5/28/2017,,antiemetic,5/31/2017,2/14/2017,Intravenous,clinical study drug,FALSE
480,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G147B:8F3B:52,11/7/2021,mg,antineoplastic,9/26/2021,10/25/2021,Intravenous,pemetrexed,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,3/20/2012,mg,antineoplastic,1/26/2012,2/24/2012,Intravenous,vinorelbine,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/27/2020,mL,solution-fluid,11/2/2019,3/16/2019,Intravenous,nivolumab,FALSE
,,CONCURRENT,Unstructured,,Afatinib,G1B56G7791723,3/10/2022,,,1/16/2022,1/13/2022,Oral,afatinib,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/15/2023,mg,antineoplastic,8/1/2023,5/12/2023,Intravenous,durvalumab,FALSE
675,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,4/19/2017,mg,antineoplastic,11/21/2016,9/7/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/30/2025,,antineoplastic,2/5/2022,10/3/2021,Intravenous,pemetrexed,TRUE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,3/30/2025,mg,antineoplastic,12/12/2024,9/5/2024,Intravenous,durvalumab,TRUE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,12/23/2017,mg,antineoplastic,9/19/2017,8/23/2017,Intravenous,carboplatin,FALSE
845,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,5/1/2025,mg,antineoplastic,4/26/2025,12/12/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G1G:DDC4EED88,7/8/2017,,,8/1/2016,7/31/2015,Oral,erlotinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/3/2021,mg,antineoplastic,8/3/2019,5/25/2019,Intravenous,nivolumab,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,6/23/2022,mg,antineoplastic,12/15/2021,11/29/2021,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,7/10/2019,mg,antineoplastic,1/8/2019,9/10/2017,Oral,anastrozole,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/23/2015,mg,antineoplastic,1/28/2015,1/11/2015,Intravenous,carboplatin,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G287777772FGE,1/13/2023,mg/kg,antineoplastic,3/13/2022,2/27/2022,Intravenous,durvalumab,TRUE
290,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G121:2D8:4E94,9/25/2019,mg,antineoplastic,8/25/2019,6/26/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,8/14/2024,mg,antineoplastic,5/17/2024,5/21/2024,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/1/2025,mg,antineoplastic,6/26/2024,5/4/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,3/10/2022,mg,antineoplastic,2/9/2022,11/2/2021,Intravenous,pembrolizumab,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/22/2014,mg,antineoplastic,12/18/2013,1/26/2014,Intravenous,eribulin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/7/2021,mg,antineoplastic,7/1/2021,10/11/2019,Intravenous,pembrolizumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,3/15/2019,mL,solution-fluid,1/2/2019,11/28/2018,Intravenous,carboplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/9/2013,mg,antineoplastic,5/13/2013,1/19/2013,Intravenous,paclitaxel protein-bound,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3DGG1C5C452:,4/14/2019,mg,antineoplastic,4/10/2019,2/16/2019,Intravenous,durvalumab,FALSE
1137,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/22/2023,mg,antineoplastic,4/1/2023,4/10/2023,Intravenous,bevacizumab-bvzr,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/22/2025,mg,antineoplastic,3/14/2024,2/19/2024,Intravenous,pembrolizumab,FALSE
137,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,8/22/2018,mg,antineoplastic,7/23/2018,7/30/2018,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,1/4/2018,mg,antineoplastic,9/20/2017,9/13/2017,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/27/2022,mg,antineoplastic,3/26/2022,9/20/2021,Intravenous,pemetrexed,TRUE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,2/19/2024,mg,antineoplastic,12/15/2023,12/27/2023,Intravenous,pemetrexed,FALSE
493,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/31/2020,mg,antineoplastic,3/8/2014,4/19/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/23/2025,mg,antineoplastic,4/27/2021,12/16/2016,Intravenous,pembrolizumab,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G43D:C17:25FG,1/11/2016,mg,antineoplastic,10/19/2015,10/17/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/30/2025,mg,antineoplastic,1/19/2025,8/1/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,11/14/2023,,solution-fluid,9/9/2023,11/22/2022,Intravenous,clinical study drug,FALSE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/27/2015,mg,antineoplastic,9/23/2015,7/17/2015,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/1/2020,mg,antineoplastic,8/28/2020,10/15/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/18/2025,mg,antineoplastic,10/18/2024,2/15/2019,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/29/2025,mg,antineoplastic,5/24/2024,5/3/2023,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/12/2023,mg,antineoplastic,10/2/2021,5/26/2020,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/7/2018,mg,antineoplastic,2/2/2016,9/10/2015,Intravenous,nivolumab,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/15/2012,mg,antineoplastic,10/15/2011,8/11/2011,Intravenous,cetuximab,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,8/3/2022,mg,antineoplastic,5/25/2022,4/20/2022,Intravenous,paclitaxel,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/20/2018,mg,antineoplastic,5/30/2018,4/20/2018,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,9/7/2020,mg,antineoplastic,4/13/2020,3/7/2020,Intravenous,paclitaxel,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G3:G28F:1562B,7/25/2017,mg,antineoplastic,8/25/2017,8/13/2017,Intravenous,etoposide,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/9/2019,mg,antineoplastic,1/30/2019,7/16/2018,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,2/26/2019,mg,antineoplastic,1/27/2018,1/24/2018,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,12/16/2023,,antineoplastic,8/27/2023,10/18/2023,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,Erlotinib,G147ED4GE76EE,3/27/2020,,,1/15/2020,2/1/2020,Oral,erlotinib,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/11/2020,mg,antineoplastic,3/15/2020,3/7/2019,Intravenous,nivolumab,FALSE
6,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,3/29/2022,AUC,antineoplastic,3/15/2022,1/8/2022,Intravenous,carboplatin,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,12/24/2015,mg/m2,antineoplastic,12/16/2015,10/5/2015,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Unstructured,,Erlotinib,G166B735:96D2,9/23/2013,,,8/17/2013,8/29/2013,Oral,erlotinib,FALSE
5,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/10/2022,mg/kg,antineoplastic,12/11/2021,10/20/2021,Intravenous,bevacizumab-awwb,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/5/2019,mg,antineoplastic,2/10/2019,11/17/2016,Intramuscular,fulvestrant,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,11/18/2020,mg,antineoplastic,11/10/2020,9/11/2020,Oral,anastrozole,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,12/1/2015,mg,antineoplastic,10/16/2015,6/22/2015,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/18/2019,mg,antineoplastic,2/20/2019,4/13/2016,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/28/2024,mg,antineoplastic,7/31/2024,6/18/2024,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/18/2024,mg,antineoplastic,7/1/2021,5/14/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/14/2017,,solution-fluid,12/4/2016,3/1/2016,Intravenous,clinical study drug,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4ED25F4G24F2,11/15/2018,AUC,antineoplastic,12/3/2018,10/6/2018,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/7/2017,mg,antineoplastic,6/8/2017,5/3/2017,Intravenous,gemcitabine,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/27/2021,,antineoplastic,1/17/2021,7/6/2020,,clinical study drug,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,12/21/2024,mg,antineoplastic,5/3/2023,3/15/2023,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/5/2020,mg,antineoplastic,11/18/2017,1/16/2016,Intravenous,bevacizumab,TRUE
386,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,10/22/2015,mg,antineoplastic,7/24/2015,6/12/2015,Intravenous,ramucirumab,FALSE
331,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,2/27/2023,mg,antineoplastic,12/3/2022,10/25/2022,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/8/2020,mg,antineoplastic,4/22/2018,12/25/2015,Intravenous,nivolumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/11/2024,mL,solution-fluid,2/1/2024,1/10/2024,Intravenous,pemetrexed,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/12/2013,mg,antineoplastic,12/23/2012,10/22/2012,Intravenous,gemcitabine,FALSE
608,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,2/7/2015,mg,antineoplastic,1/20/2015,11/26/2014,Intravenous,carboplatin,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/2/2017,mg,antineoplastic,8/4/2016,6/3/2015,Intravenous,nivolumab,FALSE
,4,ADVANCED,Orders,chemotherapy,"Capecitabine,Fulvestrant",G272F2D3BB8C2,11/9/2017,,antineoplastic,6/9/2016,6/4/2016,Oral,capecitabine,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,11/24/2013,mg,antineoplastic,10/27/2013,8/25/2013,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/23/2020,mg,antineoplastic,8/30/2016,7/2/2016,Intravenous,nivolumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/6/2014,mg,antineoplastic,11/8/2013,11/13/2013,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,10/22/2012,mg,antineoplastic,8/4/2012,8/20/2012,Intravenous,paclitaxel,FALSE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,12/23/2017,mg,antineoplastic,8/8/2016,7/10/2016,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G4FC5:16DD742,8/7/2023,,,7/24/2023,9/15/2021,Oral,trametinib,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/12/2022,mg,antineoplastic,11/30/2021,5/29/2021,Intravenous,pembrolizumab,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,3/7/2018,mg,antineoplastic,12/5/2017,11/30/2017,Intravenous,pemetrexed,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/15/2018,mg,antineoplastic,6/7/2018,5/7/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3698C8B:5EE7,2/14/2022,mg,antineoplastic,12/19/2021,10/4/2021,Intravenous,pembrolizumab,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/10/2024,mg,antineoplastic,10/20/2022,11/18/2021,Intravenous,durvalumab,FALSE
830,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/21/2020,mg,antineoplastic,7/23/2019,3/14/2019,Intravenous,durvalumab,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,12/4/2024,mg,antineoplastic,8/3/2024,5/2/2024,Intravenous,nivolumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,7/29/2021,mg,antineoplastic,4/1/2021,3/23/2021,Intravenous,pemetrexed,TRUE
835,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,8/30/2020,mg,antineoplastic,5/22/2020,3/24/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,7/25/2023,mg,antineoplastic,1/4/2023,3/6/2022,Intravenous,pembrolizumab,TRUE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/17/2023,mg,antineoplastic,9/15/2020,5/24/2020,Intravenous,pemetrexed,FALSE
394,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,2/8/2016,mg,antineoplastic,11/18/2015,10/17/2015,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,12/7/2021,mg,antineoplastic,3/15/2021,3/22/2021,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/27/2024,mg,antineoplastic,2/4/2024,8/22/2023,Intravenous,nivolumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/12/2024,mg,antineoplastic,4/1/2024,3/10/2024,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/28/2015,mg,antineoplastic,2/14/2015,10/3/2014,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/12/2018,mg,antineoplastic,6/22/2018,6/10/2018,Intravenous,nivolumab,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/15/2013,mg,antineoplastic,4/27/2013,4/25/2013,Intravenous,paclitaxel protein-bound,FALSE
560,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/24/2015,mg,antineoplastic,3/18/2015,12/24/2014,Intravenous,carboplatin,FALSE
469,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,7/19/2018,mg,antineoplastic,3/23/2018,1/2/2018,Intravenous,carboplatin,FALSE
482.1,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/6/2025,mg,antineoplastic,4/5/2020,3/18/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/2/2022,mg,antineoplastic,1/23/2022,1/3/2018,Intravenous,pembrolizumab,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/24/2016,mg,antineoplastic,1/21/2015,5/1/2014,Intravenous,bevacizumab,FALSE
,1,LOCOREGIONAL,Unstructured,,Erlotinib,G23E45CE13341,7/11/2013,,,7/15/2013,6/20/2013,Oral,erlotinib,FALSE
175,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/6/2017,mg,antineoplastic,1/5/2016,1/5/2016,Intravenous,nivolumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/15/2025,mg,antineoplastic,1/27/2025,8/20/2022,Oral,anastrozole,FALSE
175,3,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,12/24/2014,mg/m2,antineoplastic,9/19/2014,10/7/2014,Intravenous,paclitaxel,FALSE
45,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,1/7/2023,mg/m2,antineoplastic,12/8/2022,11/13/2022,Intravenous,paclitaxel,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/24/2022,mg,antineoplastic,6/26/2020,6/11/2020,Intravenous,pemetrexed,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/4/2024,mg,antineoplastic,7/20/2022,4/24/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,pain agent,Clinical Study Drug,G14E7662::61C,4/13/2017,,pain agent,2/29/2016,2/17/2016,,clinical study drug,FALSE
900,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G557E997E81G5,7/13/2023,mg,antineoplastic,4/22/2023,3/10/2023,Intravenous,ramucirumab,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/15/2024,mg,antineoplastic,8/19/2023,8/10/2023,Intravenous,durvalumab,TRUE
700,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,3/4/2023,mg,antineoplastic,1/3/2023,11/14/2022,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/14/2021,mL,solution-fluid,6/4/2021,4/26/2021,Intravenous,pemetrexed,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/12/2019,mg,antineoplastic,8/1/2016,3/11/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/20/2022,mg,antineoplastic,1/23/2021,7/28/2020,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/6/2020,mg,antineoplastic,4/5/2017,11/25/2015,Intravenous,nivolumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,4/18/2023,mg,antineoplastic,4/14/2023,4/16/2022,Intravenous,durvalumab,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,10/2/2021,mg,antineoplastic,7/31/2021,4/21/2021,Intravenous,pemetrexed,TRUE
40,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4C88CEG2:289,12/28/2024,mg,antineoplastic,12/25/2024,1/31/2025,Intravenous,docetaxel,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/10/2013,mg,antineoplastic,5/6/2013,4/22/2013,Intravenous,paclitaxel,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/26/2025,mg,antineoplastic,11/22/2019,3/22/2019,Intravenous,pemetrexed,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,7/1/2012,mg,antineoplastic,1/24/2012,1/30/2012,Intravenous,paclitaxel,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/17/2017,mg,antineoplastic,3/21/2016,6/14/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/7/2020,mg,antineoplastic,5/2/2020,6/11/2019,Intravenous,pembrolizumab,TRUE
424,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,8/16/2022,mg,antineoplastic,8/26/2022,7/1/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/14/2019,mg,antineoplastic,7/14/2019,6/21/2019,Intravenous,pembrolizumab,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/7/2025,mg,antineoplastic,3/24/2025,1/28/2025,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,3/19/2025,mg,antineoplastic,2/8/2025,4/9/2024,Intravenous,pembrolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,4/4/2021,mg,antineoplastic,1/15/2021,11/14/2020,Intravenous,nivolumab,FALSE
71,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/5/2025,mg,antineoplastic,11/4/2024,10/3/2024,Intravenous,ipilimumab,TRUE
914,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/5/2023,mg,antineoplastic,1/16/2023,11/20/2022,Intravenous,fluorouracil,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/26/2024,mg,antineoplastic,3/15/2024,10/12/2023,Intravenous,amivantamab-vmjw,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G332:25G93F26,3/20/2025,mg,antineoplastic,4/1/2025,3/29/2025,Intravenous,durvalumab,TRUE
524,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,2/27/2025,mg,antineoplastic,1/9/2025,11/22/2024,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/1/2023,mg,antineoplastic,8/7/2022,8/16/2022,Subcutaneous,azacitidine,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,2/24/2013,mg,antineoplastic,1/28/2013,2/16/2013,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/8/2023,mg,antineoplastic,10/10/2020,1/3/2020,Intravenous,pembrolizumab,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,1/19/2017,mg,antineoplastic,11/14/2016,11/11/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G1F9CDC2FCB:5,1/29/2022,,,1/25/2022,3/26/2021,Oral,alectinib,FALSE
,2,ADVANCED,Unstructured,,"Erlotinib,Osimertinib",G263B3:534B15,4/29/2018,,,11/3/2016,10/7/2016,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,10/20/2019,mg,antineoplastic,8/22/2019,5/19/2019,Intravenous,pembrolizumab,FALSE
384,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/24/2024,mg,antineoplastic,9/2/2024,8/24/2024,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/20/2015,mg,antineoplastic,11/19/2014,10/15/2014,Intravenous,etoposide,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,7/4/2013,mg,antineoplastic,12/23/2012,11/23/2012,Intravenous,vinorelbine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/14/2025,mg,antineoplastic,8/23/2024,12/21/2023,Intravenous,pembrolizumab,FALSE
113.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,2/24/2015,mg,antineoplastic,1/21/2015,12/3/2014,Intravenous,carboplatin,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/2/2018,mg,antineoplastic,1/10/2018,12/21/2017,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,12/3/2021,mL,solution-fluid,3/22/2018,3/26/2018,Intravenous,durvalumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G5722GECG4G16,4/7/2024,mg,antineoplastic,1/16/2024,11/16/2023,Intravenous,durvalumab,TRUE
750,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/24/2022,mg,antineoplastic,11/7/2021,10/12/2021,Intravenous,pemetrexed,FALSE
128,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G7:7E:2641G,4/12/2025,mg,antineoplastic,4/4/2025,4/23/2025,Intravenous,cisplatin,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/8/2014,mg,antineoplastic,4/15/2013,9/7/2012,Intravenous,gemcitabine,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,10/26/2023,mg,antineoplastic,6/9/2023,6/21/2023,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/13/2014,mg/m2,antineoplastic,2/7/2014,11/29/2013,Intravenous,pemetrexed,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/12/2012,mg,antineoplastic,2/1/2012,2/24/2012,Subcutaneous,amifostine,FALSE
1100,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3:C9BECD3F55,12/25/2020,mg,antineoplastic,10/21/2020,9/18/2020,Intravenous,ramucirumab,FALSE
,3,ADVANCED,Unstructured,,Afatinib,G133G3GCBGE3D,4/25/2014,,,5/28/2014,2/7/2014,Oral,afatinib,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/12/2024,mg,antineoplastic,7/3/2024,5/5/2024,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/7/2015,mg,antineoplastic,4/23/2015,5/12/2015,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G4FC5:16DD742,7/26/2023,,,9/5/2021,8/19/2021,Oral,dabrafenib,FALSE
1642,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,4/30/2014,mg,antineoplastic,3/13/2014,3/31/2014,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,12/6/2024,,antineoplastic,10/18/2024,7/1/2024,Intravenous,paclitaxel,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/6/2019,mg,antineoplastic,11/13/2018,8/25/2018,Intravenous,bevacizumab,FALSE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/26/2020,mg,antineoplastic,3/11/2020,2/2/2020,Intravenous,cisplatin,FALSE
243,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/17/2021,mg,antineoplastic,7/13/2019,5/16/2019,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/27/2019,mg,antineoplastic,3/14/2019,2/2/2019,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,5/24/2023,,antineoplastic,1/14/2023,1/22/2023,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/16/2017,mg,antineoplastic,11/26/2014,12/11/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/30/2018,mg,antineoplastic,12/22/2018,6/15/2018,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/13/2017,,antineoplastic,9/19/2017,9/23/2017,Intravenous,carboplatin,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,11/22/2015,mg,antineoplastic,10/16/2015,9/14/2015,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,5/23/2023,mg,antineoplastic,5/11/2023,4/21/2023,Intravenous,carboplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/4/2017,mg,antineoplastic,9/13/2017,5/24/2017,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/16/2022,mg,antineoplastic,7/28/2022,12/28/2017,Intravenous,pembrolizumab,FALSE
527,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,2/10/2015,mg,antineoplastic,12/27/2014,11/24/2014,Intravenous,carboplatin,FALSE
215,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/13/2016,mg,antineoplastic,1/26/2016,11/17/2015,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/24/2011,mg,antineoplastic,10/27/2011,4/1/2011,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/5/2018,mg,antineoplastic,12/10/2016,9/2/2015,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/4/2020,mg,antineoplastic,3/12/2020,7/5/2016,Intravenous,nivolumab,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/7/2012,mg,antineoplastic,3/2/2012,2/4/2012,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,3/29/2023,,antineoplastic,6/28/2020,9/23/2019,Intravenous,pembrolizumab,TRUE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/29/2021,mg,antineoplastic,11/19/2020,9/11/2020,Intravenous,gemcitabine,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/2/2020,mg,antineoplastic,7/30/2017,7/22/2017,Intravenous,pemetrexed,TRUE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/19/2020,mg,antineoplastic,12/15/2019,1/7/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/3/2023,mg,antineoplastic,9/15/2022,4/13/2022,Intravenous,pembrolizumab,FALSE
182,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,6/8/2014,mg,antineoplastic,6/30/2014,3/19/2014,Intravenous,cisplatin,FALSE
1040,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/24/2015,mg,antineoplastic,1/11/2015,11/9/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/6/2025,mg,antineoplastic,3/22/2019,1/31/2019,Intravenous,pembrolizumab,TRUE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,12/14/2022,mg,antineoplastic,11/5/2022,4/12/2022,Intravenous,nivolumab,FALSE
400,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,9/27/2022,mg,antineoplastic,10/19/2022,7/21/2022,Oral,bosutinib,FALSE
167,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,9/28/2019,mg,antineoplastic,8/2/2019,7/18/2019,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/10/2025,,antineoplastic,4/19/2025,10/24/2024,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/7/2022,mg,antineoplastic,4/15/2021,3/23/2021,Intravenous,atezolizumab,FALSE
,,CONCURRENT,Unstructured,,Crizotinib,G2F:C3344EG8G,5/14/2017,,,7/17/2015,8/16/2015,Oral,crizotinib,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3867F7D51E3D,5/10/2025,,antineoplastic,3/22/2025,4/14/2025,Intravenous,clinical study drug,FALSE
487,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,3/3/2021,mg,antineoplastic,2/5/2021,12/25/2020,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/9/2025,mg,antineoplastic,8/11/2024,2/23/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/21/2022,,antineoplastic,2/14/2019,5/6/2017,Oral,nilotinib,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,5/8/2021,mg,antineoplastic,3/9/2021,12/28/2020,Intravenous,carboplatin,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/25/2025,mg,antineoplastic,12/21/2024,11/2/2024,Intravenous,cisplatin,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/22/2021,mg,antineoplastic,6/23/2020,12/30/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/28/2025,mg,antineoplastic,5/23/2024,4/28/2024,Intravenous,pembrolizumab,TRUE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/24/2013,mg,antineoplastic,2/16/2013,9/18/2012,Intravenous,carboplatin,FALSE
350,2,ADVANCED,Administrations,immunotherapy,Cemiplimab,G2262335C:D62,11/25/2024,mg,antineoplastic,11/21/2024,8/19/2024,Intravenous,cemiplimab,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,3/24/2021,mg,antineoplastic,12/15/2020,12/31/2020,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/13/2022,mg,antineoplastic,4/30/2021,3/30/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/2/2020,mg,antineoplastic,4/25/2019,7/24/2016,Intravenous,nivolumab,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,6/1/2018,mg,antineoplastic,5/1/2018,11/14/2017,Intravenous,nivolumab,FALSE
1000,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G289C6438E26:,8/7/2013,mg/m2,antineoplastic,7/15/2013,6/11/2013,Intravenous,gemcitabine,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/25/2021,mg,antineoplastic,4/23/2021,3/27/2021,Intravenous,pemetrexed,TRUE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/3/2018,mL,solution-fluid,7/27/2015,7/15/2015,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/7/2013,mg/m2,antineoplastic,9/17/2012,4/25/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D891287D6B:,11/24/2020,mg,antineoplastic,7/28/2020,7/29/2020,Intravenous,pembrolizumab,FALSE
105,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/27/2013,mg,antineoplastic,6/2/2013,5/6/2013,Intravenous,paclitaxel,FALSE
945,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/22/2020,mg,antineoplastic,2/25/2020,1/9/2020,Intravenous,pemetrexed,FALSE
1131.3,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/14/2015,mg,antineoplastic,1/27/2015,10/30/2014,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G2G76D1E7GG61,2/15/2015,mL,solution-fluid,12/12/2014,12/26/2014,Intravenous,carboplatin,FALSE
228.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/28/2014,mg,antineoplastic,9/22/2014,8/6/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/22/2017,,antineoplastic,8/12/2017,7/28/2017,,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,3/10/2017,mg,antineoplastic,2/11/2017,10/24/2016,Intravenous,nivolumab,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/16/2017,mg,antineoplastic,6/13/2017,5/22/2017,Intravenous,gemcitabine,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,7/23/2023,mg,antineoplastic,4/22/2023,4/28/2023,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,2/5/2019,mg,antineoplastic,2/9/2018,4/20/2017,Intravenous,pemetrexed,TRUE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,5/5/2024,mg,antineoplastic,11/22/2023,10/13/2023,Oral,ivosidenib,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,1/30/2016,mg,antineoplastic,11/26/2015,7/23/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/21/2021,mg,antineoplastic,5/26/2021,1/2/2019,Intravenous,pembrolizumab,TRUE
605,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/1/2020,mg,antineoplastic,10/3/2020,7/1/2020,Intravenous,carboplatin,FALSE
500,3,ADVANCED,Orders,chemotherapy,Pemetrexed,G3G18F3E9E3C8,3/17/2025,mg/m2,antineoplastic,3/7/2025,2/19/2025,Intravenous,pemetrexed,FALSE
129,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,11/28/2019,mg,antineoplastic,10/2/2019,11/8/2019,Intravenous,carboplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/16/2019,mg,antineoplastic,12/19/2018,9/18/2018,Intravenous,durvalumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,11/1/2014,mg,antineoplastic,7/22/2014,7/30/2014,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,5/4/2020,mg,antineoplastic,1/19/2018,1/2/2018,Intravenous,pemetrexed,TRUE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/8/2014,mg,antineoplastic,5/22/2014,12/9/2013,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Selpercatinib,G145E1G:C6189,6/9/2021,,,12/28/2020,12/4/2020,Oral,selpercatinib,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/12/2013,mg,antineoplastic,8/16/2012,12/7/2011,Intravenous,etoposide,FALSE
1550,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/10/2025,mg,antineoplastic,7/7/2024,8/1/2024,Intravenous,gemcitabine,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,11/12/2019,mg,antineoplastic,9/28/2019,8/3/2019,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/20/2025,mg,antineoplastic,8/9/2023,3/2/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/23/2022,mg,antineoplastic,1/28/2022,3/17/2020,Intravenous,pembrolizumab,TRUE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,9/27/2021,mg,antineoplastic,10/17/2021,5/11/2021,Intravenous,pembrolizumab,FALSE
298,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,2/21/2024,mg,antineoplastic,11/15/2023,9/29/2023,Intravenous,paclitaxel,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/21/2025,mg,antineoplastic,3/19/2025,2/5/2025,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,8/17/2024,mg,antineoplastic,8/24/2024,5/14/2024,Intravenous,pembrolizumab,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/14/2015,mg,antineoplastic,10/5/2014,8/29/2014,Intravenous,paclitaxel,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,6/24/2024,mg,antineoplastic,9/28/2023,6/4/2023,Intravenous,pembrolizumab,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,4/10/2013,mg,antineoplastic,1/23/2013,11/27/2012,Intravenous,bevacizumab,TRUE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,12/7/2014,mg,antineoplastic,8/18/2014,8/27/2014,Intravenous,pemetrexed,FALSE
1650,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/20/2017,mg,antineoplastic,12/20/2016,11/21/2016,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,5/10/2025,mg,antineoplastic,4/7/2025,10/13/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/24/2021,mg,antineoplastic,7/18/2021,6/30/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,5/24/2023,mg,antineoplastic,2/22/2023,2/12/2023,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/7/2020,mg,antineoplastic,8/18/2020,5/25/2020,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/4/2019,mg,antineoplastic,2/18/2018,3/6/2016,Intravenous,nivolumab,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/5/2013,mg,antineoplastic,3/2/2012,12/26/2011,Intravenous,carboplatin,FALSE
424,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,11/27/2014,mg,antineoplastic,10/31/2014,9/25/2014,Intravenous,paclitaxel,FALSE
536,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/22/2016,mg,antineoplastic,3/2/2016,3/7/2016,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/17/2019,mg,antineoplastic,9/3/2019,6/10/2019,Intravenous,trastuzumab,FALSE
316,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,5/1/2025,mg,antineoplastic,8/18/2024,7/25/2024,Intravenous,carboplatin,FALSE
265,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,5/6/2025,mg,antineoplastic,2/19/2025,2/18/2025,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/18/2021,mg,antineoplastic,2/26/2021,1/29/2021,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/15/2025,mg,antineoplastic,12/7/2018,2/13/2018,Intravenous,nivolumab,FALSE
778,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G58E33F7EG254,1/8/2020,mg,antineoplastic,1/31/2020,1/27/2020,Intravenous,ramucirumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,7/20/2015,mg,antineoplastic,3/4/2015,2/25/2015,Intravenous,paclitaxel protein-bound,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/24/2025,mg,antineoplastic,8/17/2021,7/14/2021,Intravenous,atezolizumab,TRUE
170,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/23/2025,mg,antineoplastic,11/2/2024,10/11/2024,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/26/2013,mg,antineoplastic,12/24/2011,12/23/2011,Intravenous,etoposide,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/13/2019,mg,antineoplastic,3/2/2018,12/13/2016,Intramuscular,fulvestrant,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/14/2025,mg,antineoplastic,5/24/2020,3/7/2020,Intravenous,pemetrexed,TRUE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,8/30/2013,mg,antineoplastic,7/26/2013,6/28/2013,Intravenous,etoposide,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,7/25/2019,mg,antineoplastic,10/22/2018,6/13/2018,Intravenous,docetaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/18/2022,mg,antineoplastic,6/23/2021,2/24/2021,Intravenous,durvalumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/16/2020,mg,antineoplastic,6/4/2018,1/4/2018,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,6/18/2024,,antineoplastic,4/5/2024,5/3/2024,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/16/2018,mg,antineoplastic,9/16/2017,5/4/2017,Intravenous,nivolumab,FALSE
264,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/26/2023,mg,antineoplastic,2/24/2022,4/22/2022,Intravenous,paclitaxel,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/5/2025,mg,antineoplastic,12/27/2024,5/12/2024,Intravenous,cemiplimab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/19/2013,mg,antineoplastic,5/16/2013,2/19/2013,Intravenous,paclitaxel protein-bound,FALSE
600,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,3/3/2019,mg,antineoplastic,11/13/2018,8/14/2018,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/7/2015,mg,antineoplastic,11/4/2014,10/23/2014,Intravenous,etoposide,FALSE
194,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/29/2024,mg,antineoplastic,8/7/2024,7/8/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/18/2023,mg,antineoplastic,2/12/2023,3/14/2022,Intravenous,pembrolizumab,TRUE
526,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/27/2018,mg,antineoplastic,3/4/2018,12/2/2017,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,4/13/2022,mg,antineoplastic,1/12/2022,2/16/2022,Intravenous,carboplatin,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/14/2020,mg,antineoplastic,9/9/2019,1/30/2019,Intravenous,pemetrexed,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/31/2023,mg,antineoplastic,12/24/2022,10/23/2022,Intravenous,bevacizumab-bvzr,FALSE
80,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2398:2936:C9,12/28/2013,mg/m2,antineoplastic,1/28/2014,2/2/2014,Intravenous,paclitaxel,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/13/2013,mg,antineoplastic,9/26/2012,5/28/2012,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/29/2025,,antineoplastic,2/15/2025,11/2/2024,Intravenous,pembrolizumab,FALSE
1580,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/26/2014,mg,antineoplastic,3/20/2014,3/14/2014,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/14/2025,,antineoplastic,3/21/2025,4/5/2024,Intravenous,clinical study drug,FALSE
1050,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/11/2024,mg,antineoplastic,8/5/2024,3/23/2024,Intravenous,amivantamab-vmjw,FALSE
,,ADJUVANT,Orders,chemotherapy,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,5/2/2024,,antineoplastic,4/18/2024,3/31/2024,Oral,hydroxyurea,FALSE
,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G4F354B:F341F,9/29/2017,,antineoplastic,7/7/2017,6/14/2017,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/23/2023,mg,antineoplastic,3/9/2023,6/6/2022,Intravenous,nivolumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/20/2019,mg,antineoplastic,1/26/2019,2/5/2019,Intravenous,paclitaxel protein-bound,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/18/2022,mg,antineoplastic,12/3/2021,8/30/2021,Intravenous,bendamustine,FALSE
609,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G215817D1B289,12/29/2020,mg,antineoplastic,12/17/2020,1/6/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G26C728549E7G,11/9/2022,,,6/25/2021,6/27/2021,Oral,alectinib,FALSE
43,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,7/3/2023,mg,antineoplastic,11/3/2022,10/1/2022,Intravenous,leucovorin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/23/2023,mg,antineoplastic,12/18/2022,9/26/2022,Subcutaneous,azacitidine,FALSE
352,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/20/2025,mg,antineoplastic,1/16/2025,11/18/2024,Intravenous,paclitaxel,FALSE
404,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/3/2017,mg,antineoplastic,5/18/2017,6/3/2017,Intravenous,trastuzumab,FALSE
486,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,3/2/2021,mg,antineoplastic,1/23/2021,2/3/2021,Intravenous,carboplatin,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2628C28G7613,7/14/2015,mg,antineoplastic,6/1/2015,4/8/2015,Intravenous,pemetrexed,FALSE
340,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,3/15/2013,mg,antineoplastic,2/20/2013,1/13/2013,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/10/2019,mg,antineoplastic,9/3/2017,9/1/2017,Oral,anastrozole,FALSE
,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Durvalumab,Paclitaxel",G4EF93:EF39:7,11/28/2019,,antineoplastic,11/13/2019,11/30/2019,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,10/28/2023,,antineoplastic,7/7/2023,11/27/2022,Intravenous,clinical study drug,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,5/2/2025,mg,antineoplastic,12/15/2015,11/30/2015,Intravenous,carboplatin,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G21:2B8189648,4/29/2019,mg,antineoplastic,5/25/2019,5/25/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G17BG4264193F,4/14/2025,mg,antineoplastic,4/26/2024,3/16/2020,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/23/2024,mL,solution-fluid,2/15/2024,11/18/2023,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/22/2025,mg,antineoplastic,10/5/2020,1/31/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G1969F536B2DD,11/13/2011,,antiemetic,7/14/2011,6/6/2011,Intravenous,clinical study drug,FALSE
72,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,11/25/2018,mg,antineoplastic,10/6/2018,9/27/2018,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,1/25/2025,mg,antineoplastic,1/4/2025,9/18/2024,Intravenous,pemetrexed,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/10/2018,mg,antineoplastic,10/29/2018,9/7/2018,Intravenous,pemetrexed,FALSE
271.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/29/2023,mg,antineoplastic,3/24/2023,1/30/2023,Intravenous,paclitaxel,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,2/9/2020,mg,antineoplastic,12/4/2019,8/30/2019,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/10/2020,mg,antineoplastic,2/22/2018,1/9/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,3/15/2021,,antiemetic,8/10/2020,2/10/2020,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/12/2023,,antineoplastic,1/28/2023,2/22/2023,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,2/2/2020,mg,antineoplastic,9/20/2019,10/26/2019,Intravenous,paclitaxel,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/6/2015,mg,antineoplastic,1/13/2015,8/29/2014,Intravenous,docetaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/13/2021,mL,solution-fluid,1/30/2019,2/21/2018,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/16/2025,,antineoplastic,5/31/2020,4/13/2020,Oral,enzalutamide,FALSE
30,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/16/2019,mg/m2,antineoplastic,12/17/2019,9/28/2019,Intravenous,docetaxel,FALSE
2588,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,6/29/2022,mg,antineoplastic,10/19/2021,8/26/2021,Intravenous,gemcitabine,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/13/2018,mL,solution-fluid,1/10/2018,1/9/2018,Intravenous,carboplatin,FALSE
161,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,11/23/2015,mg,antineoplastic,12/5/2015,10/11/2015,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/13/2025,mg,antineoplastic,5/10/2023,2/17/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/11/2022,mg,antineoplastic,5/19/2022,7/26/2020,Intravenous,pembrolizumab,TRUE
272.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/24/2015,mg,antineoplastic,4/15/2015,2/28/2015,Intravenous,carboplatin,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,1/31/2019,mg,antineoplastic,5/18/2018,4/21/2018,Intravenous,docetaxel,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G32:::74B314F,2/13/2013,mg/m2,antineoplastic,12/9/2012,12/1/2012,Intravenous,docetaxel,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,10/15/2019,mg/kg,antineoplastic,8/9/2019,6/7/2019,Intravenous,durvalumab,TRUE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/13/2012,mg,antineoplastic,11/16/2011,9/13/2011,Intravenous,cetuximab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/26/2018,mg,antineoplastic,5/9/2017,4/16/2017,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,4/18/2025,mg,antineoplastic,3/27/2025,2/8/2025,Intravenous,carboplatin,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/3/2018,mg,antineoplastic,12/14/2015,9/29/2015,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,12/22/2019,mg,antineoplastic,10/31/2019,10/4/2019,Intravenous,paclitaxel,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/19/2023,mg,antineoplastic,4/10/2023,3/17/2023,Intravenous,paclitaxel protein-bound,FALSE
2637,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,7/17/2022,mg,antineoplastic,12/29/2021,9/4/2021,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/15/2021,,antineoplastic,6/1/2021,4/28/2021,,cisplatin,FALSE
1075,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,5/4/2016,mg,antineoplastic,3/31/2016,12/21/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/27/2023,mg,antineoplastic,10/30/2021,10/2/2021,Intravenous,pembrolizumab,TRUE
383,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/31/2024,mg,antineoplastic,1/18/2024,10/11/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/23/2018,,antineoplastic,12/11/2017,10/13/2017,Oral,anastrozole,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/25/2012,mg,antineoplastic,8/11/2011,9/16/2011,Intravenous,vinorelbine,FALSE
500,3,ADVANCED,Orders,chemotherapy,Pemetrexed,G35DE4B3:BCB8,5/15/2019,mg/m2,antineoplastic,6/4/2019,4/25/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2EBF3CF86FF9,10/30/2014,,antineoplastic,11/29/2014,11/28/2014,Intravenous,clinical study drug,FALSE
800,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/16/2023,mg,antineoplastic,5/24/2020,1/19/2020,Intravenous,pemetrexed,FALSE
232,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,12/7/2014,mg,antineoplastic,10/2/2014,9/11/2014,Intravenous,carboplatin,FALSE
416,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/19/2020,mg,antineoplastic,7/14/2020,4/30/2020,Intravenous,carboplatin,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/14/2019,mg,antineoplastic,7/29/2019,8/25/2018,Intravenous,durvalumab,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/26/2021,mg,antineoplastic,10/11/2020,5/19/2020,Intravenous,gemcitabine,FALSE
229,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G35DE4B3:BCB8,11/22/2016,mg,antineoplastic,9/9/2016,7/27/2016,Intravenous,nivolumab,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,3/25/2019,mg,antineoplastic,12/26/2018,11/17/2018,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/16/2017,,antineoplastic,11/20/2016,11/15/2016,Oral,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/12/2025,mg,antineoplastic,4/23/2024,1/26/2024,Intravenous,durvalumab,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/11/2020,mg,antineoplastic,3/18/2019,12/5/2018,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,cytoprotective,Clinical Study Drug,G1F482136BDE5,5/16/2017,,cytoprotective,3/14/2017,2/28/2017,,clinical study drug,FALSE
99,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/12/2015,mg,antineoplastic,7/11/2015,5/5/2015,Intravenous,etoposide,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,9/17/2021,mg/m2,antineoplastic,5/16/2021,3/23/2021,Oral,capecitabine,FALSE
33.8,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,1/10/2014,,antineoplastic,10/6/2013,10/13/2013,Intravenous,vinorelbine,FALSE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/1/2022,mg,antineoplastic,5/17/2022,3/9/2022,Intravenous,nivolumab,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,9/19/2019,mg/kg,antineoplastic,7/2/2019,5/27/2019,Intravenous,durvalumab,TRUE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,3/24/2020,mg,antineoplastic,12/3/2019,11/13/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/12/2025,,antineoplastic,6/13/2022,10/30/2021,Intravenous,pemetrexed,TRUE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/10/2022,mL,solution-fluid,5/21/2022,2/27/2022,Intravenous,nivolumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/11/2015,mg,antineoplastic,12/16/2014,11/22/2014,Intravenous,paclitaxel protein-bound,FALSE
153,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/25/2024,mg,antineoplastic,2/26/2024,1/17/2024,Intravenous,carboplatin,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,7/30/2015,mg,antineoplastic,4/23/2015,2/16/2015,Intravenous,paclitaxel protein-bound,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/3/2025,mg,antineoplastic,9/3/2019,1/7/2019,Intravenous,pemetrexed,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,5/31/2019,mg,antineoplastic,5/6/2019,3/1/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G21BD9C1D75:6,7/5/2019,,,1/11/2019,1/18/2019,Oral,afatinib,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/2/2021,,steroid,8/14/2020,2/8/2020,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/4/2020,mg,antineoplastic,11/10/2019,9/29/2019,Intravenous,pembrolizumab,TRUE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,7/15/2013,mg,antineoplastic,12/31/2012,8/18/2012,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,10/13/2013,mg,antineoplastic,7/30/2013,3/16/2013,Intravenous,bevacizumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/27/2016,mg,antineoplastic,11/24/2015,10/17/2015,Intravenous,etoposide,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/2/2025,mg,antineoplastic,2/6/2025,9/24/2023,Intravenous,atezolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/16/2025,mg,antineoplastic,7/12/2024,1/24/2023,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/24/2023,mg,antineoplastic,12/12/2022,9/5/2022,Subcutaneous,azacitidine,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/29/2019,mg,antineoplastic,5/29/2019,2/1/2019,Intravenous,durvalumab,FALSE
89,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/2/2018,mg,antineoplastic,10/30/2017,9/13/2017,Intravenous,paclitaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,7/17/2013,mg,antineoplastic,6/11/2013,12/4/2012,Intravenous,vinorelbine,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/15/2022,mg,antineoplastic,2/18/2016,2/27/2016,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,Sotorasib,G1ED5EF238G3C,4/10/2025,,,4/7/2025,12/20/2024,Oral,sotorasib,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,3/2/2019,,antineoplastic,11/21/2018,1/4/2019,,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/20/2019,mg,antineoplastic,4/6/2018,8/27/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/22/2020,mg,antineoplastic,8/26/2020,7/4/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/3/2019,mg,antineoplastic,3/15/2019,2/9/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/16/2017,,antineoplastic,11/1/2016,2/23/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/17/2024,mg,antineoplastic,11/24/2022,4/25/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/20/2021,mg,antineoplastic,9/1/2021,8/4/2021,Intravenous,pembrolizumab,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/17/2017,mg,antineoplastic,6/18/2016,1/22/2016,Intravenous,nivolumab,FALSE
775,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3951BC5GBE44,9/8/2023,mg,antineoplastic,7/29/2023,6/27/2023,Intravenous,pemetrexed,FALSE
92,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,4/2/2025,mg,antineoplastic,4/1/2025,2/16/2025,Intravenous,paclitaxel,FALSE
109,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,11/8/2022,mg,antineoplastic,11/23/2022,10/22/2022,Intravenous,carboplatin,FALSE
169,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/11/2016,mg,antineoplastic,4/1/2016,10/27/2015,Intravenous,paclitaxel,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/9/2020,mg,antineoplastic,12/7/2019,10/22/2018,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/18/2025,,,11/2/2024,10/7/2024,Oral,osimertinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,3/1/2022,mg,antineoplastic,5/3/2021,1/13/2021,Intravenous,pembrolizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/10/2012,mg,antineoplastic,1/16/2012,12/25/2011,Intravenous,cisplatin,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/7/2021,mg,antineoplastic,12/22/2020,12/23/2020,Intravenous,gemcitabine,FALSE
385,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,12/2/2022,mg,antineoplastic,12/9/2022,10/6/2022,Intravenous,carboplatin,FALSE
76,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/22/2020,mg,antineoplastic,4/7/2014,4/10/2014,Intravenous,doxorubicin,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/1/2021,mg,antineoplastic,12/27/2018,4/3/2018,Intravenous,durvalumab,TRUE
722,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/11/2014,mg,antineoplastic,10/23/2014,8/1/2014,Intravenous,carboplatin,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,9/8/2014,mg,antineoplastic,8/16/2014,6/13/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/13/2024,,antineoplastic,4/16/2024,3/17/2024,,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/21/2022,mg,antineoplastic,4/2/2022,8/17/2021,Intravenous,durvalumab,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/8/2015,mg,antineoplastic,1/27/2015,3/11/2015,Intravenous,pemetrexed,FALSE
133.2,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/16/2018,mg,antineoplastic,10/1/2017,9/20/2017,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,9/13/2020,mg,antineoplastic,6/5/2020,6/8/2020,Subcutaneous,azacitidine,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/30/2023,mg,antineoplastic,11/15/2019,10/23/2019,Intravenous,pembrolizumab,TRUE
1500,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G1G4BC1:B::63,4/3/2022,mg,antineoplastic,1/11/2022,11/21/2021,Intravenous,durvalumab,TRUE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/1/2019,mg,antineoplastic,7/15/2019,10/8/2018,Intravenous,durvalumab,FALSE
167.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/9/2015,mg,antineoplastic,11/21/2014,10/12/2014,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/7/2023,mg,antineoplastic,1/13/2023,11/23/2022,Intravenous,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,4/23/2020,mg,antineoplastic,3/31/2020,12/20/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12786B9C7G6D,8/8/2018,mg,antineoplastic,7/23/2018,8/6/2018,Intravenous,pembrolizumab,FALSE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,9/29/2019,mg,antineoplastic,8/25/2019,9/2/2019,Intravenous,paclitaxel,FALSE
600,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/12/2019,mg,antineoplastic,6/22/2019,8/4/2019,Intravenous,fluorouracil,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/5/2024,mg,antineoplastic,7/17/2024,7/22/2024,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/27/2016,mg,antineoplastic,2/20/2016,12/2/2015,Intravenous,bevacizumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/4/2019,mg,antineoplastic,7/21/2018,2/5/2018,Intravenous,pemetrexed,FALSE
166,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/11/2020,mg,antineoplastic,2/25/2020,1/12/2020,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/20/2025,,antineoplastic,11/4/2024,10/17/2024,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Orders,targeted/non-biologic,"Decitabine,Venetoclax",G41DE1E3BE99:,8/1/2024,mg,antineoplastic,6/26/2024,7/11/2024,Oral,venetoclax,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/2/2020,mg,antineoplastic,4/7/2020,9/29/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,3/31/2025,,antineoplastic,5/11/2024,2/27/2023,Intravenous,pemetrexed,FALSE
975,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G56B4BCB27428,3/3/2012,mg,antineoplastic,1/31/2012,1/5/2012,Intravenous,pemetrexed,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,2/5/2025,AUC,antineoplastic,12/5/2024,11/30/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G44B44661:316,4/6/2016,,antineoplastic,3/7/2016,3/27/2016,,nivolumab,FALSE
572,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,3/18/2023,mg,antineoplastic,10/21/2022,9/30/2022,Intravenous,carboplatin,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/9/2016,mg,antineoplastic,1/27/2016,7/8/2015,Intravenous,pemetrexed,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/27/2021,mg,antineoplastic,10/17/2020,10/7/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/22/2020,mg,antineoplastic,1/7/2020,1/21/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/10/2022,,antineoplastic,7/26/2020,4/3/2017,Oral,nilotinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/13/2020,mg,antineoplastic,11/30/2019,9/27/2019,Intravenous,pembrolizumab,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/7/2021,mg,antineoplastic,9/20/2020,6/3/2020,Intravenous,gemcitabine,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/3/2023,mg,antineoplastic,1/18/2018,10/15/2017,Intravenous,nivolumab,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,3/27/2013,mg,antineoplastic,12/8/2012,10/25/2012,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,2/27/2024,mg,antineoplastic,1/7/2024,7/25/2023,Intravenous,pembrolizumab,FALSE
1020,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/17/2019,mg,antineoplastic,1/12/2019,12/11/2018,Intravenous,durvalumab,TRUE
153,3,ADVANCED,Administrations,chemotherapy,Docetaxel,G1C32G396:F7G,8/10/2014,mg,antineoplastic,6/8/2014,4/18/2014,Intravenous,docetaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,3/30/2025,mg,antineoplastic,6/8/2024,4/7/2024,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,2/14/2017,,antineoplastic,11/10/2016,12/14/2016,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/14/2014,mg,antineoplastic,12/28/2013,11/30/2013,Intravenous,paclitaxel,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/9/2024,mg,antineoplastic,12/11/2023,11/23/2022,Intravenous,durvalumab,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,3/29/2022,,cytoprotective,4/12/2022,12/31/2021,Intramuscular,clinical study drug,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,10/12/2022,mg,antineoplastic,9/30/2022,8/14/2022,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G1F9BCG13:EFD,10/14/2023,,,2/19/2022,2/28/2022,Oral,osimertinib,FALSE
173,2,ADVANCED,Administrations,chemotherapy,Pembrolizumab,G3EG8DGC9B:1E,7/2/2020,mg,antineoplastic,8/1/2019,7/8/2019,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,6/26/2020,mg,antineoplastic,12/20/2019,7/11/2019,Intravenous,pembrolizumab,FALSE
151,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/5/2024,mg,antineoplastic,9/8/2024,9/8/2024,Intravenous,carboplatin,FALSE
3629,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/26/2025,mg,antineoplastic,1/28/2025,1/7/2025,Other/Miscellaneous,fluorouracil,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5722GECG4G16,5/31/2024,mg,antineoplastic,5/13/2024,4/6/2024,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/21/2025,mg,antineoplastic,7/19/2020,1/21/2017,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,12/10/2012,mg,antineoplastic,11/17/2012,9/25/2012,Intravenous,gemcitabine,FALSE
172,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/28/2023,mg,antineoplastic,6/18/2023,3/21/2023,Intravenous,carboplatin,FALSE
775,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,3/25/2024,mg,antineoplastic,1/6/2024,2/12/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,2/10/2021,mg,antineoplastic,4/15/2020,4/3/2020,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38GE:9D51587,9/18/2012,mg,antineoplastic,6/3/2012,3/13/2012,Intravenous,pemetrexed,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,8/7/2015,mg,antineoplastic,5/17/2015,10/17/2014,Intravenous,paclitaxel protein-bound,FALSE
176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/20/2022,mg,antineoplastic,2/3/2022,3/5/2022,Intravenous,carboplatin,FALSE
950,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,3/2/2025,mg,antineoplastic,10/10/2024,9/10/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/8/2024,mg,antineoplastic,7/17/2024,7/18/2023,Intravenous,pembrolizumab,TRUE
526,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,3/8/2015,mg,antineoplastic,1/15/2015,12/18/2014,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/13/2022,mg,antineoplastic,11/17/2021,10/3/2021,Intravenous,pemetrexed,TRUE
482,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/26/2024,mg,antineoplastic,9/18/2024,6/29/2024,Intravenous,carboplatin,FALSE
757,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/19/2024,mg,antineoplastic,10/7/2023,1/7/2023,Intravenous,durvalumab,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/22/2018,mg,antineoplastic,10/4/2018,8/13/2018,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Administrations,antibody-conjugate,Clinical Study Drug,G177G4:B9E394,4/12/2025,,antineoplastic,5/4/2025,4/5/2025,Intravenous,clinical study drug,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/11/2020,mg,antineoplastic,3/23/2019,1/11/2019,Subcutaneous,bortezomib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,12/27/2016,mg,antineoplastic,7/24/2016,7/23/2016,Intravenous,nivolumab,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/9/2016,mg,antineoplastic,3/3/2016,12/9/2015,Intravenous,carboplatin,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/30/2019,mg,antineoplastic,2/10/2019,7/23/2018,Intravenous,docetaxel,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/21/2025,mg,antineoplastic,12/26/2020,4/6/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3867F7D51E3D,4/11/2025,,antineoplastic,3/12/2025,2/24/2025,Intravenous,clinical study drug,FALSE
400,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,4/9/2025,mg,antineoplastic,1/24/2025,12/17/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/7/2018,mg,antineoplastic,4/12/2018,5/19/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2216DG74F41B,4/30/2024,mg,antineoplastic,3/22/2024,3/13/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/3/2022,mg,antineoplastic,5/19/2022,12/2/2021,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,2/12/2019,mg,antineoplastic,9/8/2018,6/27/2018,Intravenous,nivolumab,FALSE
150,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,5/20/2024,mg,antineoplastic,1/1/2024,12/5/2023,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/22/2025,mg,antineoplastic,8/15/2019,1/13/2019,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,4/3/2019,mg,antineoplastic,1/11/2019,2/8/2019,Intravenous,pembrolizumab,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/29/2015,mg,antineoplastic,7/30/2014,5/30/2014,Intravenous,vinorelbine,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,9/28/2015,mg,antineoplastic,7/17/2015,5/19/2015,Intravenous,nivolumab,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/3/2025,mg,antineoplastic,7/23/2019,3/12/2019,Intravenous,pemetrexed,FALSE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,10/12/2023,mg,antineoplastic,7/4/2023,7/11/2023,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,1/7/2017,mg,antineoplastic,8/28/2016,7/20/2016,Intravenous,nivolumab,FALSE
350,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/17/2023,mg,antineoplastic,12/21/2019,12/12/2019,Intravenous,carboplatin,FALSE
1670,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/18/2016,mg,antineoplastic,4/19/2016,4/10/2016,Intravenous,bevacizumab,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,11/22/2016,mg,antineoplastic,9/5/2016,6/6/2016,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/21/2022,mg,antineoplastic,11/8/2019,5/12/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/30/2024,mg,antineoplastic,6/6/2024,6/18/2023,Intravenous,pembrolizumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/17/2025,mg,antineoplastic,10/17/2021,2/20/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/7/2023,mg,antineoplastic,4/21/2023,2/13/2022,Intravenous,pembrolizumab,TRUE
173,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/20/2014,mg,antineoplastic,7/23/2013,10/12/2012,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/15/2021,mg,antineoplastic,1/23/2021,7/16/2020,Intravenous,ramucirumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/17/2022,,antineoplastic,11/26/2017,4/8/2017,Oral,dasatinib,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,4/27/2016,mg,antineoplastic,9/27/2014,8/29/2014,Intravenous,cisplatin,FALSE
585,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/27/2017,mg,antineoplastic,1/4/2017,10/22/2016,Intravenous,bevacizumab,FALSE
687,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4497G86984C8,4/9/2015,mg,antineoplastic,3/21/2015,3/17/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/7/2025,mg,antineoplastic,1/11/2025,9/13/2022,Intravenous,pembrolizumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/2/2015,mg,antineoplastic,1/14/2015,11/4/2014,Intravenous,paclitaxel protein-bound,FALSE
213,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/5/2021,mg,antineoplastic,12/23/2020,12/14/2020,Intravenous,paclitaxel protein-bound,FALSE
616,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G167G71733G69,4/22/2016,mg,antineoplastic,11/12/2015,11/3/2015,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/4/2024,mg,antineoplastic,8/1/2024,7/1/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/14/2025,mg,antineoplastic,8/30/2021,2/26/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G324DD277533C,2/19/2020,,,2/6/2020,7/14/2019,Oral,osimertinib,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/3/2021,,antineoplastic,2/23/2021,8/2/2020,,clinical study drug,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/15/2015,mg,antineoplastic,10/9/2014,10/30/2014,Intravenous,carboplatin,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/16/2021,mg,antineoplastic,9/23/2020,5/4/2020,Intravenous,gemcitabine,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/28/2021,mg,antineoplastic,7/20/2021,3/27/2021,Intravenous,pemetrexed,FALSE
1040,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/11/2016,mg,antineoplastic,10/17/2015,5/9/2015,Intravenous,pemetrexed,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/23/2025,mg,antineoplastic,7/15/2024,8/30/2022,Intravenous,pemetrexed,TRUE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/19/2019,mg,antineoplastic,11/17/2019,12/25/2018,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,8/6/2017,,antineoplastic,5/23/2017,2/26/2017,Intravenous,pemetrexed,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/6/2025,mg,antineoplastic,12/2/2024,9/13/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/4/2023,mg,antineoplastic,3/15/2023,8/5/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/2/2021,mg,antineoplastic,7/29/2021,10/4/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/23/2025,mg,antineoplastic,8/30/2024,5/24/2023,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,9/5/2022,mg,antineoplastic,6/24/2022,6/27/2022,Intravenous,pemetrexed,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,4/12/2018,AUC,antineoplastic,9/19/2017,10/3/2017,Intravenous,carboplatin,FALSE
475,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/16/2022,mg,antineoplastic,7/29/2021,6/4/2021,Intravenous,carboplatin,FALSE
146,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,5/22/2023,mg,antineoplastic,4/11/2023,3/17/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4::3E61CFBB9,3/25/2025,,,10/30/2024,10/8/2024,Oral,osimertinib,FALSE
50,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,10/28/2023,mg,antineoplastic,7/6/2023,6/29/2023,Intravenous,vinorelbine,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/16/2023,mg,antineoplastic,3/20/2023,2/13/2023,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/10/2024,mg,antineoplastic,5/15/2023,1/3/2023,Intravenous,nivolumab,FALSE
1.7,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/1/2020,mg,antineoplastic,8/12/2014,3/14/2014,Intravenous,vincristine,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,4/12/2024,mg,antineoplastic,4/26/2024,4/14/2024,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/2/2023,mg,antineoplastic,8/27/2021,10/13/2021,Intravenous,bendamustine,FALSE
234,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G163D9B593927,10/11/2014,mg,antineoplastic,11/23/2014,10/8/2014,Intravenous,paclitaxel,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/1/2017,mg,antineoplastic,7/2/2016,4/21/2016,Intravenous,paclitaxel protein-bound,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/7/2022,mg,antineoplastic,5/19/2014,6/8/2014,Intravenous,paclitaxel,FALSE
1140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/17/2022,mg,antineoplastic,2/11/2022,1/6/2022,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G2G7B3CB6D5C4,8/9/2013,,,7/27/2013,4/6/2013,Oral,erlotinib,FALSE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/10/2013,mg,antineoplastic,12/6/2012,12/7/2012,Intravenous,gemcitabine,FALSE
340,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/19/2016,mg,antineoplastic,2/26/2016,12/31/2015,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/2/2025,mL,solution-fluid,4/15/2024,4/26/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/17/2022,,antineoplastic,7/31/2021,8/4/2021,Intravenous,amivantamab-vmjw,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,9/28/2018,mg,antineoplastic,7/10/2018,8/13/2018,Intravenous,carboplatin,FALSE
207,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/21/2023,mg,antineoplastic,9/3/2023,9/23/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/10/2020,mg,antineoplastic,2/26/2020,1/8/2020,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,4/28/2017,mg,antineoplastic,2/7/2017,12/26/2016,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Orders,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,10/19/2023,,antineoplastic,10/8/2023,10/8/2023,Oral,abiraterone,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/19/2016,mg,antineoplastic,3/17/2016,1/14/2016,Intravenous,paclitaxel,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/5/2019,mg,antineoplastic,10/27/2018,6/16/2018,Other/Miscellaneous,fluorouracil,FALSE
136,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G4G53233CD43C,2/26/2025,mg,antineoplastic,11/13/2024,10/29/2024,Intravenous,docetaxel,FALSE
140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,9/26/2024,mg,antineoplastic,4/16/2023,3/28/2023,Intravenous,docetaxel,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,4/18/2015,mg,antineoplastic,3/25/2015,2/21/2015,Intravenous,paclitaxel protein-bound,FALSE
600,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/9/2019,mg,antineoplastic,8/21/2019,6/15/2019,Intravenous,fluorouracil,FALSE
1010,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/19/2025,mg,antineoplastic,12/17/2021,10/29/2021,Intravenous,pemetrexed,TRUE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/20/2024,mg,antineoplastic,10/13/2023,8/2/2023,Intravenous,paclitaxel protein-bound,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/19/2024,mg,antineoplastic,11/6/2023,11/14/2023,Intravenous,paclitaxel,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,8/26/2015,mL,solution-fluid,3/20/2015,3/18/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/8/2023,mg,antineoplastic,9/17/2022,3/6/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/6/2025,mg,antineoplastic,4/13/2025,8/10/2022,Intravenous,pembrolizumab,TRUE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/19/2013,mg,antineoplastic,9/26/2013,5/12/2013,Intravenous,bevacizumab,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/8/2018,mg,antineoplastic,6/23/2018,5/2/2018,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/28/2025,mg,antineoplastic,5/3/2024,4/23/2024,Intravenous,pembrolizumab,FALSE
564,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/2/2020,mg,antineoplastic,3/6/2020,10/3/2019,Intravenous,pemetrexed,TRUE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/19/2022,mg,antineoplastic,9/27/2021,8/18/2021,Intravenous,amivantamab-vmjw,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/6/2019,mg,antineoplastic,4/21/2017,4/6/2016,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/16/2025,mg,antineoplastic,12/10/2020,1/17/2017,Intravenous,pembrolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,4/7/2024,mg,antineoplastic,4/27/2024,4/15/2024,Intravenous,paclitaxel,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/23/2019,mg,antineoplastic,5/10/2017,11/2/2016,Intramuscular,fulvestrant,FALSE
74,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/6/2024,mg,antineoplastic,2/22/2024,4/10/2024,Intravenous,paclitaxel,FALSE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,1/30/2014,mg,antineoplastic,11/17/2013,9/18/2013,Intravenous,vinorelbine,FALSE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,8/23/2024,mg,antineoplastic,5/15/2024,6/26/2024,Intravenous,vinorelbine,FALSE
1000,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G1D84CDE8:C5E,4/7/2015,mg/m2,antineoplastic,5/8/2015,12/7/2014,Intravenous,gemcitabine,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,11/26/2023,mg,antineoplastic,1/5/2024,10/25/2023,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,7/7/2017,mg,antineoplastic,11/18/2016,9/25/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G13GE1E25174F,9/18/2022,mg,antineoplastic,7/29/2022,6/13/2022,Intravenous,pembrolizumab,TRUE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/14/2021,mg,antineoplastic,3/10/2021,9/18/2020,Intravenous,bevacizumab,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/17/2017,,antineoplastic,7/30/2016,4/28/2016,Intramuscular,fulvestrant,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/17/2025,mg,antineoplastic,6/16/2016,11/17/2015,Intravenous,paclitaxel,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/12/2024,mg,antineoplastic,10/15/2023,6/24/2023,Intravenous,pemetrexed,FALSE
1035,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/19/2025,mg,antineoplastic,4/16/2024,4/8/2024,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/26/2024,mg,antineoplastic,3/2/2024,11/7/2023,Intravenous,durvalumab,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3C98:B743F7B,7/31/2014,AUC,antineoplastic,6/7/2013,6/27/2013,Intravenous,carboplatin,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,10/5/2023,mg,antineoplastic,9/20/2023,6/2/2023,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G46:87GF7FGC9,12/26/2015,,antiemetic,10/15/2015,7/9/2015,Intrajejunal,clinical study drug,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/31/2019,mg,antineoplastic,3/13/2019,10/9/2018,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/3/2020,mg,antineoplastic,12/8/2019,10/20/2019,Intravenous,pembrolizumab,TRUE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/17/2024,mg,antineoplastic,5/28/2022,3/8/2022,Intravenous,durvalumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/10/2025,mg/m2,antineoplastic,7/21/2019,2/11/2019,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/26/2022,mg,antineoplastic,7/17/2018,4/2/2017,Intravenous,nivolumab,FALSE
467,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/14/2025,mg,antineoplastic,12/12/2024,12/11/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/21/2020,mg,antineoplastic,8/7/2020,8/30/2019,Intravenous,pembrolizumab,FALSE
595,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,11/10/2016,mg,antineoplastic,9/17/2016,6/17/2016,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Crizotinib,G53C61B2GG71F,4/22/2016,,,2/10/2016,8/25/2015,Oral,crizotinib,FALSE
1300,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,6/8/2015,mg,antineoplastic,7/10/2015,6/30/2015,Intravenous,bevacizumab,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/7/2020,mg,antineoplastic,5/19/2020,5/14/2020,Intravenous,carboplatin,FALSE
2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/27/2020,mg,antineoplastic,3/26/2014,3/23/2014,Intravenous,vincristine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,3/3/2020,mg,antineoplastic,5/23/2019,5/27/2019,Intravenous,pembrolizumab,TRUE
656,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,2/25/2022,mg,antineoplastic,2/4/2022,12/24/2021,Intravenous,pemetrexed,FALSE
569,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,8/4/2014,mg,antineoplastic,6/10/2014,7/16/2014,Intravenous,carboplatin,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,1/18/2017,mg,antineoplastic,12/27/2016,12/17/2016,Intravenous,docetaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/7/2025,mg,antineoplastic,2/3/2022,3/28/2020,Intravenous,pemetrexed,TRUE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G319D776C24D5,7/5/2021,mg,antineoplastic,5/17/2021,4/18/2021,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,5/9/2025,mg,antineoplastic,9/21/2024,9/26/2024,Intravenous,pembrolizumab,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/10/2020,mg,antineoplastic,8/17/2020,9/5/2019,Intravenous,durvalumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/10/2016,AUC,antineoplastic,2/26/2015,5/15/2014,Intravenous,carboplatin,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,4/12/2020,mg,antineoplastic,2/15/2020,11/11/2019,Intravenous,durvalumab,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,5/3/2025,,antineoplastic,4/19/2025,12/17/2024,Intravenous,clinical study drug,FALSE
1155,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/8/2022,mg,antineoplastic,7/21/2022,7/11/2021,Intravenous,bevacizumab-bvzr,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/27/2024,mg,antineoplastic,8/17/2024,9/16/2024,Intravenous,carboplatin,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G13GE1E25174F,5/15/2022,mg,antineoplastic,4/1/2022,3/29/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/7/2025,,antineoplastic,5/10/2022,10/2/2021,Intravenous,pemetrexed,TRUE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,4/7/2021,mg,antineoplastic,2/22/2021,12/31/2020,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/18/2023,mg,antineoplastic,8/28/2022,6/2/2022,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/22/2025,mg,antineoplastic,11/11/2024,1/8/2024,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,4/5/2025,mg,antineoplastic,3/5/2025,2/15/2025,Intravenous,pemetrexed,TRUE
3.8433,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,7/13/2015,AUC,antineoplastic,7/14/2014,6/22/2014,Intravenous,carboplatin,FALSE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/22/2022,mg,antineoplastic,3/28/2022,1/8/2022,Intravenous,carboplatin,FALSE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/1/2012,mg,antineoplastic,9/22/2012,5/8/2012,Intravenous,bevacizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,5/19/2014,mg,antineoplastic,5/1/2014,5/14/2014,Intravenous,carboplatin,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,7/4/2019,mg,antineoplastic,6/10/2019,12/15/2018,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,11/29/2011,mg,antineoplastic,8/22/2011,7/11/2011,Intravenous,carboplatin,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/16/2015,mg,antineoplastic,5/29/2015,3/10/2015,Intravenous,pemetrexed,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/7/2022,mg,antineoplastic,7/20/2022,6/20/2022,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/5/2020,mg,antineoplastic,2/1/2020,12/28/2019,Intravenous,paclitaxel,FALSE
340,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/28/2016,mg,antineoplastic,8/6/2016,6/1/2016,Intravenous,carboplatin,FALSE
5,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/10/2019,AUC,antineoplastic,1/21/2019,1/6/2019,Intravenous,carboplatin,FALSE
197,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/14/2023,mg,antineoplastic,3/23/2023,3/1/2023,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/10/2016,mg,antineoplastic,8/17/2016,7/25/2016,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/15/2015,mg,antineoplastic,7/25/2015,3/18/2015,Intravenous,paclitaxel protein-bound,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/20/2025,mg,antineoplastic,3/20/2025,2/28/2025,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/19/2020,mg,antineoplastic,1/28/2020,8/23/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/24/2023,mg,antineoplastic,12/18/2021,9/30/2021,Intravenous,pembrolizumab,TRUE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/5/2020,mg,antineoplastic,7/20/2019,3/7/2019,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/26/2017,,antineoplastic,12/19/2016,10/25/2016,Oral,clinical study drug,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/29/2023,mg,antineoplastic,11/4/2022,10/10/2022,Intravenous,fluorouracil,FALSE
,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,1/28/2019,,antineoplastic,6/6/2018,3/22/2018,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/4/2018,,antineoplastic,9/8/2018,4/11/2018,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/11/2023,mg,antineoplastic,12/31/2018,11/8/2017,Intravenous,nivolumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,3/2/2020,mg,antineoplastic,11/16/2019,11/25/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/28/2018,mg,antineoplastic,11/16/2018,4/3/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/19/2025,mg,antineoplastic,8/12/2020,1/28/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,Osimertinib,G1169816459CC,4/20/2025,,,3/30/2025,7/23/2018,Oral,osimertinib,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,10/1/2022,mg,antineoplastic,8/17/2022,9/29/2022,Intravenous,carboplatin,FALSE
25,4,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,2/4/2015,mg/m2,antineoplastic,1/10/2015,11/7/2014,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,4/22/2019,,antineoplastic,3/31/2019,3/18/2019,Intravenous,paclitaxel,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,1/3/2012,mg,antineoplastic,11/9/2011,9/11/2011,Intravenous,etoposide,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Capmatinib,G12E5EG31:6:5,10/15/2022,mg,antineoplastic,12/12/2021,2/3/2022,Intravenous,carboplatin,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/22/2016,mg/m2,antineoplastic,2/17/2016,2/17/2016,Intravenous,cisplatin,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/18/2014,mg,antineoplastic,6/22/2014,6/2/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/8/2018,mg,antineoplastic,1/23/2018,6/21/2017,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/14/2018,mg,antineoplastic,12/11/2017,5/18/2017,Intravenous,nivolumab,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,6/25/2012,mg,antineoplastic,5/29/2012,4/25/2012,Intravenous,carboplatin,FALSE
1666,,CONCURRENT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,3/9/2013,mg/m2,antineoplastic,3/20/2013,2/28/2013,Intravenous,mesna,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,4/2/2025,mg,antineoplastic,5/25/2024,3/26/2024,Intravenous,durvalumab,TRUE
370,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/17/2014,mg,antineoplastic,7/7/2014,7/8/2014,Intravenous,carboplatin,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/23/2015,mg,antineoplastic,6/24/2015,5/20/2015,Intravenous,etoposide,FALSE
45,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G1F:9CFGFGFC1,6/30/2014,mg,antineoplastic,5/24/2014,5/24/2014,Intravenous,cisplatin,FALSE
1040,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/12/2016,mg,antineoplastic,9/21/2015,4/7/2015,Intravenous,pemetrexed,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,4/24/2019,mg,antineoplastic,4/11/2019,1/20/2019,Intravenous,pemetrexed,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,8/26/2021,mg,antineoplastic,5/3/2021,4/14/2021,Intravenous,paclitaxel,FALSE
828,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,5/4/2024,mg,antineoplastic,2/1/2024,2/9/2024,Intravenous,carboplatin,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/29/2015,mg,antineoplastic,7/25/2015,8/14/2014,Intravenous,bevacizumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,3/4/2015,mg,antineoplastic,11/11/2014,9/26/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/7/2022,mg,antineoplastic,10/5/2020,7/14/2020,Intravenous,pembrolizumab,TRUE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/17/2014,AUC,antineoplastic,6/1/2014,11/18/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/10/2020,,antineoplastic,8/30/2018,7/20/2017,Intravenous,pemetrexed,TRUE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/30/2020,mg,antineoplastic,6/20/2020,3/18/2020,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,10/16/2014,mg,antineoplastic,4/18/2014,4/22/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/5/2013,mg,antineoplastic,1/14/2013,1/3/2013,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,"Amivantamab-Vmjw,Osimertinib",G57B5F4B556EG,3/20/2022,,,4/16/2022,4/18/2022,Oral,osimertinib,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/6/2022,mg,antineoplastic,6/15/2021,3/12/2021,Intravenous,atezolizumab,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,6/5/2019,mg,antineoplastic,4/20/2019,3/8/2019,Intravenous,gemcitabine,FALSE
206,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/3/2020,mg,antineoplastic,12/13/2019,9/30/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4C7:4GCD96C:,5/1/2017,,,6/11/2017,6/14/2017,Oral,osimertinib,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,7/25/2024,mg,antineoplastic,7/21/2024,6/5/2024,Intravenous,cemiplimab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/16/2013,mg/m2,antineoplastic,11/10/2012,7/24/2012,Intravenous,docetaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/18/2023,mg,antineoplastic,2/4/2022,4/27/2020,Intravenous,pembrolizumab,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G137D67:GFD9F,8/27/2016,mg/kg,antineoplastic,6/18/2016,5/13/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/14/2025,mg,antineoplastic,7/3/2024,3/20/2024,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/9/2020,mg,antineoplastic,2/24/2018,3/4/2016,Intravenous,bevacizumab,TRUE
,1,ADVANCED,Unstructured,,"Erlotinib,Ramucirumab",G4725296E3CE4,10/5/2021,,,8/23/2021,8/8/2021,Oral,erlotinib,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,11/3/2021,mg,antineoplastic,7/19/2021,5/22/2021,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Orders,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,11/1/2023,,antineoplastic,9/2/2023,10/1/2023,Oral,abiraterone,FALSE
110,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,3/27/2014,mg,antineoplastic,9/13/2013,6/26/2013,Intravenous,docetaxel,FALSE
156,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/15/2020,mg,antineoplastic,1/15/2020,11/15/2019,Intravenous,carboplatin,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/15/2022,mg,antineoplastic,6/8/2022,5/7/2022,Intravenous,nivolumab,FALSE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,7/25/2023,mg,antineoplastic,4/3/2023,3/4/2023,Intravenous,durvalumab,TRUE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/18/2025,mg,antineoplastic,10/11/2024,11/5/2024,Intravenous,etoposide,FALSE
184,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/7/2022,mg,antineoplastic,10/29/2022,9/30/2022,Intravenous,carboplatin,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/12/2021,mg,antineoplastic,2/16/2019,3/25/2018,Intravenous,durvalumab,TRUE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,3/31/2020,mg,antineoplastic,3/9/2020,10/6/2019,Intravenous,durvalumab,FALSE
269,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/21/2024,mg,antineoplastic,8/28/2023,9/14/2023,Intravenous,carboplatin,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/22/2017,mL,solution-fluid,7/3/2017,8/6/2017,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/25/2025,mg,antineoplastic,5/14/2018,12/21/2016,Intravenous,nivolumab,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,4/14/2014,mg,antineoplastic,4/3/2014,3/17/2014,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/18/2018,mg,antineoplastic,11/25/2018,7/23/2018,Intravenous,bevacizumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/26/2023,mg,antineoplastic,3/10/2021,12/23/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G1G54G4GB8B24,7/24/2022,,,1/20/2022,2/17/2022,Oral,dabrafenib,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G459D:92E2344,11/1/2019,mg/kg,antineoplastic,11/2/2019,9/29/2018,Intravenous,durvalumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,5/12/2019,mg,antineoplastic,4/15/2019,1/25/2019,Intravenous,paclitaxel protein-bound,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,9/13/2014,mg,antineoplastic,7/30/2014,6/11/2014,Intravenous,pemetrexed,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/19/2020,mg,antineoplastic,1/19/2020,12/9/2019,Intravenous,paclitaxel,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/13/2019,mg,antineoplastic,1/1/2019,10/8/2018,Intravenous,durvalumab,FALSE
806,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/8/2025,mg,antineoplastic,6/19/2023,2/15/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/15/2023,mg,antineoplastic,11/30/2020,4/24/2020,Intravenous,pembrolizumab,TRUE
288,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,1/31/2013,mg,antineoplastic,12/23/2012,10/21/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/27/2025,,antineoplastic,2/28/2024,2/15/2023,Intravenous,pemetrexed,FALSE
50,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,11/8/2023,mg,antineoplastic,7/28/2023,6/13/2023,Intravenous,vinorelbine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/12/2019,mg,antineoplastic,10/11/2018,4/10/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/9/2020,mg,antineoplastic,1/5/2020,1/4/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,11/26/2022,,antineoplastic,12/3/2022,11/3/2022,,pemetrexed,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,2/18/2025,,,7/17/2024,7/31/2024,Oral,dabrafenib,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/24/2025,mg,antineoplastic,10/25/2020,3/23/2020,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,hormone,Anastrozole,G432E:9E:21DC,10/31/2019,,antineoplastic,10/21/2019,10/16/2019,Oral,anastrozole,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,9/15/2018,mg,antineoplastic,6/2/2018,4/11/2018,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/25/2025,mg,antineoplastic,12/4/2024,8/28/2022,Intravenous,pembrolizumab,TRUE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/23/2019,mg,antineoplastic,5/19/2019,5/19/2019,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/29/2020,mg,antineoplastic,4/10/2017,2/23/2016,Intravenous,bevacizumab,TRUE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/20/2022,,antineoplastic,4/9/2022,2/1/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/10/2022,,antineoplastic,6/16/2020,5/10/2017,Oral,nilotinib,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/23/2024,,antineoplastic,10/6/2024,8/23/2024,Intravenous,paclitaxel,FALSE
238,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/20/2024,mg,antineoplastic,2/25/2024,11/19/2023,Intravenous,paclitaxel,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/20/2020,mg,antineoplastic,8/9/2019,7/10/2017,Intravenous,pemetrexed,TRUE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/7/2015,mg,antineoplastic,11/27/2014,9/20/2014,Intravenous,pemetrexed,FALSE
490,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/17/2024,mg,antineoplastic,10/5/2024,7/1/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/26/2025,mg,antineoplastic,7/4/2022,6/12/2022,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/19/2019,mg,antineoplastic,11/9/2018,3/31/2016,Intravenous,nivolumab,FALSE
1650,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/6/2017,mg,antineoplastic,12/2/2016,11/30/2016,Intravenous,gemcitabine,FALSE
475,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/22/2022,mg,antineoplastic,8/13/2021,5/21/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/11/2017,,solution-fluid,4/20/2016,2/22/2016,Intravenous,clinical study drug,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/2/2024,mg,antineoplastic,6/2/2024,11/21/2021,Intravenous,nivolumab,TRUE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/5/2025,,solution-fluid,11/10/2017,11/16/2017,Intravenous,clinical study drug,FALSE
739,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/21/2018,mg,antineoplastic,7/27/2018,7/15/2018,Intravenous,carboplatin,FALSE
167,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/26/2016,mg,antineoplastic,3/1/2016,12/17/2015,Intravenous,paclitaxel,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/25/2024,mg,antineoplastic,3/11/2024,9/22/2023,Intravenous,durvalumab,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/16/2019,mg,antineoplastic,5/16/2017,11/28/2016,Intramuscular,fulvestrant,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G392GC5134FFG,10/22/2020,,antineoplastic,8/11/2020,7/14/2020,Intravenous,durvalumab,TRUE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/17/2025,mg,antineoplastic,11/1/2017,7/29/2016,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G29D9FB:D1D6B,9/26/2020,,antineoplastic,8/27/2020,8/26/2020,,letrozole,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/20/2015,mg,antineoplastic,5/24/2015,3/13/2015,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,7/8/2022,mg,antineoplastic,5/8/2022,4/21/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,1/22/2023,mg,antineoplastic,1/8/2022,4/19/2021,Intravenous,pembrolizumab,TRUE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/20/2014,mg,antineoplastic,2/17/2014,6/11/2013,Intravenous,bevacizumab,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,10/6/2021,mg/m2,antineoplastic,6/24/2021,3/16/2021,Oral,capecitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/8/2020,mg,antineoplastic,6/3/2019,12/19/2017,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/13/2020,mg,antineoplastic,1/23/2018,7/11/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,3/8/2018,mg,antineoplastic,6/28/2017,6/13/2017,Intravenous,nivolumab,FALSE
135.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/11/2019,mg,antineoplastic,8/27/2019,8/5/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/8/2025,,antineoplastic,2/18/2025,10/4/2024,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/28/2023,mg,antineoplastic,3/1/2020,12/12/2019,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,5/30/2012,mg,antineoplastic,3/3/2012,3/30/2012,Intravenous,gemcitabine,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/21/2017,mg,antineoplastic,9/17/2017,7/29/2017,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/21/2023,mg,antineoplastic,7/13/2021,4/25/2020,Intravenous,pembrolizumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/14/2018,mg,antineoplastic,10/31/2018,8/31/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/3/2021,,antineoplastic,1/8/2021,12/9/2020,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2CCC3642E:67,2/13/2020,mg,antineoplastic,1/12/2020,12/8/2019,Intravenous,pembrolizumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/9/2015,mg,antineoplastic,10/11/2014,6/2/2014,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/23/2020,mg,antineoplastic,6/1/2019,1/30/2019,Subcutaneous,bortezomib,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/10/2024,mg,antineoplastic,7/5/2023,5/21/2023,Intravenous,pemetrexed,FALSE
660,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,5/4/2017,mg,antineoplastic,1/25/2017,8/26/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/6/2022,mg,antineoplastic,1/21/2018,2/2/2018,Intravenous,pembrolizumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,4/19/2014,mg,antineoplastic,12/19/2013,12/9/2013,Intravenous,paclitaxel,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,9/4/2020,mg,antineoplastic,7/9/2020,6/16/2020,Subcutaneous,azacitidine,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,5/5/2025,mg,antineoplastic,11/12/2024,9/19/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,3/5/2022,mg,antineoplastic,10/1/2021,10/25/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,2/27/2025,mg,antineoplastic,4/24/2020,3/6/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/26/2024,mg,antineoplastic,3/6/2024,9/9/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,3/21/2025,,,12/10/2024,11/16/2024,Oral,osimertinib,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,6/4/2016,mg,antineoplastic,6/15/2016,4/18/2016,Intravenous,cisplatin,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/3/2015,mg/m2,antineoplastic,2/11/2015,10/14/2014,Intravenous,cisplatin,FALSE
171,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,4/5/2013,mg,antineoplastic,5/6/2012,4/17/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,10/7/2019,mg,antineoplastic,8/21/2019,7/28/2019,Intravenous,pembrolizumab,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/8/2023,mg,antineoplastic,6/27/2023,4/14/2023,Intravenous,paclitaxel,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,11/6/2022,mg,antineoplastic,7/28/2022,8/8/2022,Intravenous,carboplatin,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,5/6/2024,mg,antineoplastic,8/26/2023,5/17/2023,Intravenous,atezolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/12/2024,mg,antineoplastic,6/1/2022,1/12/2022,Intravenous,nivolumab,TRUE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,7/30/2020,mg,antineoplastic,4/30/2020,10/16/2019,Intravenous,durvalumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/12/2022,mL,solution-fluid,4/6/2022,2/19/2022,Intravenous,nivolumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,11/29/2024,mg,antineoplastic,5/30/2024,7/5/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/18/2025,mg,antineoplastic,6/4/2019,4/25/2018,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/17/2019,mg,antineoplastic,10/27/2018,2/1/2018,Intravenous,nivolumab,FALSE
130,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,9/11/2013,mg,antineoplastic,8/23/2013,5/23/2013,Intravenous,paclitaxel,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/16/2015,mg,antineoplastic,11/4/2014,8/8/2014,Intravenous,pemetrexed,FALSE
623,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G1CF3FED3DG,2/2/2018,mg,antineoplastic,12/13/2017,12/29/2017,Intravenous,pemetrexed,FALSE
170,3,ADVANCED,Administrations,chemotherapy,Docetaxel,G1:78734BCEDB,3/24/2015,mg,antineoplastic,1/20/2015,12/27/2014,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,5/28/2020,mg,antineoplastic,5/19/2020,4/6/2020,Intravenous,pembrolizumab,FALSE
500,,ADJUVANT,Orders,chemotherapy,Pemetrexed,G35146C5E4B61,11/26/2015,mg/m2,antineoplastic,5/1/2015,5/17/2015,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/23/2025,mg,antineoplastic,12/30/2021,1/20/2019,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/22/2014,mg/m2,antineoplastic,4/7/2014,12/22/2013,Intravenous,pemetrexed,FALSE
230,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,8/31/2016,mg,antineoplastic,9/15/2016,12/13/2015,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,11/26/2011,mg,antineoplastic,8/21/2011,8/14/2011,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/5/2023,mg,antineoplastic,11/21/2021,1/26/2020,Intravenous,pembrolizumab,FALSE
502,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,2/19/2020,mg,antineoplastic,12/2/2019,12/18/2019,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/18/2021,mL,solution-fluid,12/24/2018,3/16/2018,Intravenous,durvalumab,TRUE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,2/8/2017,mg,antineoplastic,12/30/2016,11/1/2016,Intravenous,pemetrexed,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/10/2025,mg,antineoplastic,11/10/2024,5/18/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,6/26/2018,mg,antineoplastic,6/19/2018,4/17/2018,Intravenous,pembrolizumab,FALSE
220,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,11/2/2014,mg,antineoplastic,9/7/2014,9/18/2014,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G21744:G47B22,11/3/2014,mg,antineoplastic,9/3/2014,9/27/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/18/2024,mg,antineoplastic,11/30/2023,8/21/2022,Intravenous,pembrolizumab,TRUE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/20/2021,mg,antineoplastic,3/6/2021,6/8/2020,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/1/2025,,antineoplastic,1/20/2024,1/22/2023,,clinical study drug,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/26/2020,mg/kg,antineoplastic,8/12/2020,2/14/2020,Intravenous,ramucirumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/18/2020,mg,antineoplastic,9/2/2019,10/9/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,,antineoplastic,5/26/2019,4/15/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,5/6/2025,mg,antineoplastic,3/23/2025,2/16/2025,Intravenous,pembrolizumab,TRUE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/21/2022,mg,antineoplastic,8/17/2020,3/27/2020,Intravenous,durvalumab,TRUE
,2,ADVANCED,Unstructured,,Afatinib,G26534:GEG3:6,11/20/2015,,,9/29/2014,8/4/2014,Oral,afatinib,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,3/19/2018,,antineoplastic,6/23/2017,6/4/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/14/2024,mg,antineoplastic,8/25/2021,6/9/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/20/2025,mg,antineoplastic,1/24/2022,12/28/2018,Intravenous,pembrolizumab,TRUE
61.5,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/6/2021,mg,antineoplastic,7/21/2021,11/6/2020,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/24/2025,mg,antineoplastic,1/3/2025,7/18/2023,Intravenous,pembrolizumab,TRUE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/30/2020,mg,antineoplastic,1/29/2020,1/7/2020,Intravenous,cisplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,12/13/2017,mg,antineoplastic,11/27/2017,8/21/2017,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,8/13/2014,mg,antineoplastic,10/27/2013,6/29/2013,Intravenous,carboplatin,FALSE
680,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3E76E32E795:,6/3/2020,mg,antineoplastic,4/3/2020,3/12/2020,Intravenous,ramucirumab,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,12/23/2011,mg,antineoplastic,12/12/2011,12/29/2011,Intravenous,paclitaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/23/2015,mg,antineoplastic,11/10/2014,10/8/2014,Intravenous,paclitaxel protein-bound,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/12/2022,mg,antineoplastic,5/12/2022,5/31/2022,Intravenous,pemetrexed,FALSE
1095,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pembrolizumab,Pemetrexed",G23G13:GCG631,1/20/2018,mg,antineoplastic,1/25/2018,2/8/2018,Intravenous,pemetrexed,FALSE
200.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/19/2022,mg,antineoplastic,7/17/2022,6/26/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/19/2025,mg,antineoplastic,1/22/2025,7/9/2024,Intravenous,pembrolizumab,TRUE
228,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/14/2021,mg,antineoplastic,12/18/2020,12/13/2020,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/20/2015,mg,antineoplastic,6/8/2015,1/17/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,2/23/2019,mg,antineoplastic,11/19/2018,6/29/2018,Intravenous,pembrolizumab,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,12/4/2024,mg,antineoplastic,5/10/2024,4/23/2024,Intravenous,gemcitabine,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,12/20/2015,mg,antineoplastic,7/17/2015,4/19/2015,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,12/31/2024,,antineoplastic,2/5/2018,10/12/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,11/25/2018,mg,antineoplastic,9/12/2018,7/29/2018,Intravenous,pembrolizumab,FALSE
31.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/5/2014,mg,antineoplastic,3/12/2014,3/14/2014,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,mg,antineoplastic,4/3/2018,5/6/2017,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/22/2020,mg,antineoplastic,4/1/2018,11/17/2015,Intravenous,nivolumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/2/2018,mL,solution-fluid,12/29/2017,1/6/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,1/29/2017,,antineoplastic,2/24/2016,3/25/2016,Intravenous,clinical study drug,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/9/2023,mg,antineoplastic,1/9/2024,11/10/2022,Intravenous,durvalumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,12/17/2021,mg,antineoplastic,11/10/2021,9/19/2021,Intravenous,paclitaxel protein-bound,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/30/2022,mg,antineoplastic,10/24/2021,11/13/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/8/2025,,antineoplastic,6/13/2024,5/11/2024,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/25/2019,mg,antineoplastic,6/30/2017,4/5/2016,Intravenous,nivolumab,FALSE
25,4,ADVANCED,Orders,chemotherapy,Vinorelbine,G557E997E81G5,10/10/2023,mg/m2,antineoplastic,7/30/2023,6/16/2023,Intravenous,vinorelbine,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,12/20/2019,mg,antineoplastic,10/27/2019,9/30/2019,Intravenous,paclitaxel,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/26/2025,mg,antineoplastic,3/28/2025,12/24/2024,Intravenous,gemcitabine,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,4/22/2025,mg,antineoplastic,5/8/2025,4/27/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/24/2020,mg,antineoplastic,8/20/2018,12/15/2017,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/12/2017,mg/m2,antineoplastic,11/14/2016,8/3/2016,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/15/2025,mg,antineoplastic,12/26/2022,12/22/2016,Intravenous,pembrolizumab,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,9/19/2021,mg,antineoplastic,5/24/2021,5/4/2021,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/29/2016,mg,antineoplastic,11/21/2015,5/28/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/30/2025,mg,antineoplastic,1/6/2018,12/15/2016,Intravenous,nivolumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/13/2014,mg,antineoplastic,4/22/2014,2/22/2014,Intravenous,cisplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/31/2020,mg,antineoplastic,9/3/2020,10/2/2020,Nasogastric,bicalutamide,FALSE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/11/2012,mg,antineoplastic,7/4/2012,6/7/2012,Intravenous,bevacizumab,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,4/30/2016,mg,antineoplastic,3/30/2016,10/28/2015,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,3/31/2025,mg,antineoplastic,11/29/2022,8/31/2022,Intravenous,pembrolizumab,TRUE
75,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,6/26/2017,mg/m2,antineoplastic,6/14/2017,4/13/2017,Intravenous,cisplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/20/2016,mg,antineoplastic,9/11/2015,5/6/2015,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/30/2020,mg,antineoplastic,3/21/2020,9/9/2019,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/9/2017,mg,antineoplastic,2/17/2017,8/14/2016,Intravenous,nivolumab,FALSE
41.8,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,7/3/2023,mg,antineoplastic,3/6/2023,11/1/2022,Intravenous,leucovorin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/2/2020,,antineoplastic,2/10/2020,12/30/2019,Intravenous,clinical study drug,FALSE
25,4,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,1/24/2015,mg/m2,antineoplastic,11/18/2014,12/15/2014,Intravenous,vinorelbine,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,6/20/2014,mg,antineoplastic,3/4/2014,1/20/2014,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,2/18/2018,AUC,antineoplastic,11/16/2017,10/1/2017,Intravenous,carboplatin,FALSE
174,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,8/27/2022,mg,antineoplastic,7/4/2022,4/18/2022,Intravenous,carboplatin,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/16/2014,mg,antineoplastic,9/13/2012,9/27/2012,Intravenous,paclitaxel,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/2/2021,mg,antineoplastic,7/25/2021,6/18/2020,Intravenous,gemcitabine,FALSE
930,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/24/2025,mg,antineoplastic,7/28/2024,4/27/2024,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,solution-fluid,Clinical Study Drug,G1F482136BDE5,4/27/2017,,solution-fluid,2/16/2017,2/19/2017,,clinical study drug,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/22/2014,mg,antineoplastic,5/9/2014,4/5/2014,Intravenous,paclitaxel,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/19/2013,mg,antineoplastic,5/4/2013,7/8/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/4/2025,mg,antineoplastic,3/11/2022,9/20/2021,Intravenous,pembrolizumab,TRUE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,1/2/2020,mg,antineoplastic,9/15/2019,6/27/2019,Intravenous,docetaxel,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/25/2014,AUC,antineoplastic,4/29/2014,12/15/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/27/2024,mg,antineoplastic,3/14/2022,6/12/2020,Intravenous,pembrolizumab,TRUE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,2/2/2018,mg,antineoplastic,11/14/2016,7/18/2016,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/8/2018,mg,antineoplastic,8/5/2017,9/22/2015,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/4/2021,mg/m2,antineoplastic,9/30/2021,2/25/2021,Intravenous,fluorouracil,FALSE
360,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,7/19/2018,mg,antineoplastic,9/26/2017,10/8/2017,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/2/2025,mg,antineoplastic,10/14/2023,10/7/2022,Intravenous,pembrolizumab,TRUE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/15/2013,mg,antineoplastic,4/1/2013,11/19/2012,Intravenous,gemcitabine,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/20/2020,mg,antineoplastic,7/7/2020,3/9/2020,Intravenous,bevacizumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38F8684B8FG8,10/24/2015,mg,antineoplastic,10/8/2015,10/2/2015,Intravenous,carboplatin,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,4/8/2025,mg,antineoplastic,12/16/2024,11/21/2024,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,1/13/2022,mg,antineoplastic,12/30/2021,11/24/2021,Intravenous,paclitaxel,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/3/2017,mg,antineoplastic,10/27/2015,7/9/2015,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,4/20/2021,mg,antineoplastic,2/23/2021,5/26/2020,Intravenous,pembrolizumab,TRUE
1000,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G1117E45EE891,7/2/2014,mg/m2,antineoplastic,7/20/2014,7/31/2014,Intravenous,gemcitabine,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,9/20/2024,mg,antineoplastic,3/18/2024,2/14/2024,Intravenous,carboplatin,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,3/17/2015,mg,antineoplastic,12/31/2014,12/21/2014,Intravenous,paclitaxel,FALSE
980,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,11/7/2013,mg,antineoplastic,7/1/2013,3/28/2013,Intravenous,bevacizumab,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/19/2022,mg,antineoplastic,1/17/2022,10/6/2021,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/16/2013,mg,antineoplastic,6/21/2012,11/28/2011,Intravenous,etoposide,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/16/2016,mg,antineoplastic,9/6/2016,4/10/2016,Intravenous,pemetrexed,TRUE
685,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/19/2025,mg,antineoplastic,11/17/2024,10/14/2024,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,10/2/2020,mg,antineoplastic,6/14/2020,7/3/2020,Subcutaneous,azacitidine,FALSE
975,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/31/2023,mg,antineoplastic,4/11/2023,2/27/2023,Intravenous,pemetrexed,FALSE
675,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/18/2016,mg,antineoplastic,11/8/2016,6/28/2016,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/17/2022,,antineoplastic,3/9/2022,5/7/2017,Oral,nilotinib,FALSE
,1,ADVANCED,Unstructured,,"Erlotinib,Ramucirumab",G4725296E3CE4,9/25/2021,,,9/16/2021,8/2/2021,Oral,erlotinib,FALSE
91,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/3/2018,mg,antineoplastic,9/29/2017,9/29/2017,Intravenous,paclitaxel,FALSE
3,3,ADVANCED,Orders,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/30/2016,mg/kg,antineoplastic,1/5/2016,1/11/2016,Intravenous,nivolumab,FALSE
1035,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/25/2018,mg,antineoplastic,8/15/2018,8/2/2018,Intravenous,pemetrexed,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3G18D5D62822,7/15/2012,mg,antineoplastic,1/29/2012,11/20/2011,Intravenous,pemetrexed,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/17/2016,mg,antineoplastic,7/7/2015,11/10/2014,Intravenous,pemetrexed,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,7/24/2020,mg,antineoplastic,5/8/2020,4/10/2020,Intravenous,carboplatin,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/20/2019,mg,antineoplastic,10/24/2019,7/29/2019,Intravenous,etoposide,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/9/2022,mg,antineoplastic,8/15/2022,6/14/2021,Intravenous,pemetrexed,FALSE
980,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/3/2013,mg,antineoplastic,6/15/2013,5/18/2013,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Temozolomide,G4B63:1C9D452,12/1/2016,,antineoplastic,10/19/2016,8/1/2016,,temozolomide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/27/2020,mg,antineoplastic,12/1/2019,4/7/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/15/2018,mg,antineoplastic,11/13/2016,9/17/2015,Intravenous,nivolumab,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2141CBEF3GD3,10/29/2022,,antineoplastic,9/6/2022,9/18/2022,,carboplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/9/2022,mg,antineoplastic,4/24/2020,4/21/2017,Oral,nilotinib,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/23/2020,mg,antineoplastic,2/7/2019,1/28/2019,Subcutaneous,bortezomib,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,5/7/2018,mg,antineoplastic,3/4/2018,12/9/2017,Intravenous,trastuzumab,FALSE
805,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/5/2017,mg,antineoplastic,3/17/2017,4/5/2017,Intravenous,pemetrexed,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,7/3/2023,mg,antineoplastic,6/30/2022,6/14/2022,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/2/2025,mg,antineoplastic,11/18/2024,6/25/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/2/2022,,antineoplastic,5/2/2017,3/29/2017,Oral,dasatinib,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/24/2022,mg,antineoplastic,6/2/2022,5/24/2022,Intravenous,paclitaxel,FALSE
825,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,4/4/2021,mg,antineoplastic,1/14/2021,12/20/2020,Intravenous,pemetrexed,FALSE
1000,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,10/10/2013,mg,antineoplastic,7/20/2013,8/5/2013,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/2/2025,,antineoplastic,6/12/2018,10/17/2017,Intravenous,clinical study drug,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/1/2015,mg,antineoplastic,6/1/2014,12/25/2013,Intravenous,carboplatin,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/27/2012,mg,antineoplastic,12/31/2011,12/1/2011,Intravenous,carboplatin,FALSE
3,3,ADVANCED,Orders,immunotherapy,Nivolumab,G14F3GC2D5E43,10/17/2019,mg/kg,antineoplastic,8/10/2019,7/16/2019,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3E567F5B3:95,10/21/2018,mg,antineoplastic,8/31/2018,9/12/2018,Intravenous,nivolumab,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/13/2025,mg,antineoplastic,3/18/2022,4/11/2020,Subcutaneous,leuprolide,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:64BD9C5919,9/2/2021,mg,antineoplastic,8/15/2021,8/20/2021,Intravenous,pemetrexed,FALSE
550,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,8/11/2012,mg,antineoplastic,4/11/2012,4/12/2012,Intravenous,carboplatin,FALSE
363,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/2/2022,mg,antineoplastic,4/15/2022,4/16/2022,Intravenous,carboplatin,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/17/2022,mg,antineoplastic,10/27/2022,8/27/2022,Intravenous,pemetrexed,FALSE
162,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/6/2012,mg,antineoplastic,6/30/2012,3/20/2012,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/13/2025,mg,antineoplastic,8/24/2023,2/24/2019,Intravenous,pemetrexed,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,4/27/2020,,antineoplastic,11/15/2019,11/2/2019,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/7/2025,mg,antineoplastic,8/28/2024,7/7/2021,Intravenous,atezolizumab,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/5/2025,mg,antineoplastic,9/8/2024,2/17/2024,Intravenous,pembrolizumab,FALSE
288,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,12/13/2024,mg,antineoplastic,9/19/2024,8/15/2024,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/15/2025,mg,antineoplastic,8/16/2024,6/7/2024,Intravenous,carboplatin,FALSE
161,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/4/2016,mg,antineoplastic,1/14/2016,1/26/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/5/2021,,antineoplastic,6/9/2021,4/13/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G4GF74CE8E4:6,7/27/2023,,,5/17/2023,6/12/2023,Oral,osimertinib,FALSE
958,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/11/2017,mg,antineoplastic,2/15/2017,11/29/2016,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/5/2025,mg,antineoplastic,5/8/2020,2/5/2019,Intravenous,pembrolizumab,TRUE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,10/30/2017,mg,antineoplastic,10/31/2017,9/22/2017,Intravenous,paclitaxel,FALSE
2020,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/22/2013,mg,antineoplastic,9/15/2012,6/27/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/4/2025,mg,antineoplastic,12/8/2021,11/10/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/16/2025,,antineoplastic,1/6/2025,2/6/2023,Intravenous,pemetrexed,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/28/2021,mg,antineoplastic,5/14/2021,4/8/2021,Intravenous,cisplatin,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/7/2022,mg,antineoplastic,10/11/2021,10/11/2021,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/3/2025,mg,antineoplastic,10/27/2018,1/9/2017,Intravenous,nivolumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/6/2018,mg,antineoplastic,9/14/2016,9/17/2016,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/13/2019,mg,antineoplastic,2/12/2017,3/22/2016,Intravenous,nivolumab,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,2/17/2025,mg,antineoplastic,8/9/2024,11/26/2022,Intravenous,pemetrexed,FALSE
80,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/13/2022,mg,antineoplastic,2/27/2022,1/28/2022,Intravenous,ipilimumab,FALSE
1666,,CONCURRENT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/1/2013,mg/m2,antineoplastic,3/26/2013,1/31/2013,Intravenous,mesna,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/28/2021,,antineoplastic,7/30/2021,5/18/2021,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Orders,hormone,Abiraterone,G2G419135CEEC,12/28/2023,mg,antineoplastic,12/3/2023,10/28/2023,Oral,abiraterone,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/29/2017,mg,antineoplastic,9/15/2015,6/25/2015,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,5/6/2019,mg,antineoplastic,8/15/2018,8/6/2018,Intravenous,nivolumab,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/31/2023,mg,antineoplastic,5/14/2023,5/27/2023,Intravenous,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/7/2024,mg,antineoplastic,11/11/2023,8/8/2023,Intravenous,atezolizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/8/2022,mg,antineoplastic,10/30/2021,2/22/2021,Intravenous,atezolizumab,FALSE
146,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/13/2013,mg,antineoplastic,4/4/2013,4/11/2013,Intravenous,paclitaxel,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/9/2024,mg,antineoplastic,12/7/2024,8/20/2024,Intravenous,temsirolimus,FALSE
680,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3E76E32E795:,6/11/2020,mg,antineoplastic,5/16/2020,3/7/2020,Intravenous,ramucirumab,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,11/19/2015,mg,antineoplastic,8/22/2015,5/16/2015,Intravenous,pemetrexed,FALSE
560,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,2/15/2015,mg,antineoplastic,12/29/2014,12/23/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/11/2025,,antineoplastic,7/2/2024,5/13/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,2/2/2017,mg,antineoplastic,11/10/2016,11/10/2016,Intravenous,nivolumab,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,3/5/2024,mg,antineoplastic,2/4/2024,1/15/2024,Intravenous,pemetrexed,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/14/2016,mg,antineoplastic,12/26/2015,8/25/2015,Intravenous,etoposide,FALSE
682,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/9/2022,mg,antineoplastic,6/10/2022,5/11/2022,Intravenous,carboplatin,FALSE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/10/2022,mg,antineoplastic,2/1/2022,1/8/2022,Intravenous,carboplatin,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/30/2022,mg,antineoplastic,7/9/2022,7/31/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/15/2016,mg/m2,antineoplastic,6/30/2016,7/3/2016,Intravenous,gemcitabine,FALSE
176,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/28/2012,mg,antineoplastic,6/23/2012,2/21/2012,Intravenous,carboplatin,FALSE
427,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/27/2019,mg,antineoplastic,3/5/2019,2/1/2019,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/18/2015,mL,solution-fluid,6/6/2015,2/23/2015,Intravenous,pemetrexed,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/13/2015,mg,antineoplastic,7/29/2015,7/31/2015,Intravenous,gemcitabine,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/6/2012,mg/m2,antineoplastic,6/19/2012,5/16/2012,Intravenous,paclitaxel,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/12/2016,mg,antineoplastic,9/24/2015,10/23/2015,Intravenous,etoposide,FALSE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,5/4/2024,mg,antineoplastic,2/5/2024,10/3/2023,Oral,ivosidenib,FALSE
459,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,7/13/2018,mg,antineoplastic,1/18/2018,1/19/2018,Intravenous,carboplatin,FALSE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/9/2019,mg/m2,antineoplastic,2/27/2019,1/18/2019,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G1DCDG73E53FF,7/24/2024,,cytoprotective,5/29/2024,4/12/2024,Intramuscular,clinical study drug,FALSE
232.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,11/3/2017,mg,antineoplastic,8/22/2017,9/21/2017,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/15/2021,mg,antineoplastic,10/3/2020,9/8/2020,Oral,bicalutamide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/28/2022,,antineoplastic,11/7/2021,10/12/2021,Intravenous,pembrolizumab,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/20/2024,mg,antineoplastic,7/20/2024,7/2/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,1/3/2017,,antineoplastic,12/15/2016,11/9/2016,Intravenous,carboplatin,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/6/2015,mg,antineoplastic,7/20/2015,8/7/2014,Intravenous,paclitaxel,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,10/26/2017,mg,antineoplastic,10/11/2017,9/24/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/27/2022,,antineoplastic,5/27/2022,5/21/2017,Oral,nilotinib,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/29/2020,mg,antineoplastic,5/16/2020,3/7/2020,Intravenous,carboplatin,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/19/2022,mg,antineoplastic,7/12/2021,7/6/2021,Intravenous,fluorouracil,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/15/2021,mg,antineoplastic,4/27/2021,3/25/2021,Intravenous,pemetrexed,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/4/2022,mg,antineoplastic,1/6/2022,8/24/2021,Intravenous,carboplatin,FALSE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/14/2017,mg,antineoplastic,7/13/2017,5/26/2017,Intravenous,docetaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/17/2025,mg,antineoplastic,2/2/2020,3/4/2019,Intravenous,pemetrexed,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/8/2024,mg,antineoplastic,11/2/2021,7/12/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/21/2022,mg,antineoplastic,12/7/2021,12/20/2021,Intravenous,pembrolizumab,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/19/2022,mg,antineoplastic,6/28/2022,4/22/2022,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/29/2022,mg,antineoplastic,7/19/2022,6/27/2022,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/11/2012,AUC,antineoplastic,3/18/2012,3/1/2012,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/22/2020,mg,antineoplastic,4/25/2017,7/3/2016,Intravenous,nivolumab,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/29/2020,mg,antineoplastic,11/13/2019,4/5/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,2/19/2022,mg,antineoplastic,2/26/2022,9/1/2021,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,4/2/2025,mg,antineoplastic,12/24/2024,10/23/2024,Intravenous,pembrolizumab,FALSE
271,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/20/2021,mg,antineoplastic,6/23/2019,5/15/2019,Intravenous,carboplatin,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,7/11/2023,mg,antineoplastic,1/31/2023,2/15/2023,Intravenous,durvalumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19511695D78G,4/19/2025,mg,antineoplastic,5/25/2025,4/22/2025,Intravenous,carboplatin,FALSE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,12/21/2019,mg,antineoplastic,9/5/2019,7/21/2019,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/27/2025,mg,antineoplastic,11/27/2019,5/3/2018,Intravenous,pembrolizumab,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,12/31/2024,mg,antineoplastic,5/26/2023,4/6/2023,Intravenous,paclitaxel protein-bound,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/20/2014,mg,antineoplastic,4/11/2014,1/1/2014,Intravenous,eribulin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/29/2025,mg,antineoplastic,10/20/2018,12/25/2016,Intravenous,pembrolizumab,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/4/2021,mg,antineoplastic,12/8/2021,4/17/2021,Intravenous,vinorelbine,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/22/2019,mg,antineoplastic,1/13/2019,2/12/2018,Intravenous,pemetrexed,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/27/2023,mg,antineoplastic,11/3/2020,12/28/2019,Intravenous,pembrolizumab,FALSE
114,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/9/2021,mg,antineoplastic,9/11/2021,9/2/2021,Intravenous,paclitaxel,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,7/29/2023,mg,antineoplastic,4/17/2023,4/18/2023,Intravenous,cisplatin,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/12/2015,mL,solution-fluid,5/19/2015,1/31/2015,Intravenous,carboplatin,FALSE
44,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,5/20/2014,mg,antineoplastic,3/18/2014,3/25/2014,Intravenous,vinorelbine,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/24/2011,mg,antineoplastic,6/4/2011,4/27/2011,Intravenous,carboplatin,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/9/2020,mg,antineoplastic,3/31/2020,2/6/2020,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,2/17/2021,mg,antineoplastic,8/3/2020,6/13/2020,Intravenous,docetaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/24/2022,mg,antineoplastic,12/1/2018,1/14/2016,Intravenous,pemetrexed,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,12/27/2015,mg,antineoplastic,10/15/2015,9/17/2015,Intravenous,paclitaxel,FALSE
927,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,12/11/2012,mg,antineoplastic,12/19/2012,11/10/2012,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/13/2023,mg,antineoplastic,9/7/2021,1/6/2020,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,10/1/2015,mg/m2,antineoplastic,8/28/2015,6/17/2015,Intravenous,paclitaxel,FALSE
286,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,4/4/2025,mg,antineoplastic,1/28/2025,12/31/2024,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/12/2022,mg,antineoplastic,9/26/2020,7/27/2020,Intravenous,pembrolizumab,TRUE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/22/2019,mg,antineoplastic,5/18/2019,2/15/2019,Intravenous,durvalumab,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G157317FG3387,6/20/2024,mg,antineoplastic,4/6/2024,5/1/2024,Intravenous,carboplatin,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,9/9/2018,mg/kg,antineoplastic,6/4/2018,2/17/2018,Intravenous,durvalumab,TRUE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,3/22/2025,mg,antineoplastic,12/2/2024,10/16/2024,Intravenous,nivolumab,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/16/2015,mg,antineoplastic,5/9/2015,4/27/2015,Intravenous,etoposide,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/11/2023,mg,antineoplastic,4/30/2023,4/4/2023,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Pembrolizumab",G1934B71378C6,9/13/2024,mg,antineoplastic,1/7/2023,12/10/2022,Intravenous,gemcitabine,FALSE
122,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G319D776C24D5,6/21/2021,mg,antineoplastic,3/11/2021,3/18/2021,Intravenous,cisplatin,FALSE
380,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/8/2021,mg,antineoplastic,5/10/2021,4/15/2021,Intravenous,carboplatin,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/11/2015,mg,antineoplastic,8/19/2014,10/6/2014,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CG8EF93777D,1/26/2022,mg,antineoplastic,10/24/2020,9/15/2020,Intravenous,nivolumab,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/5/2020,mg,antineoplastic,6/14/2020,5/17/2020,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/14/2025,mg,antineoplastic,2/27/2025,10/1/2022,Intravenous,pembrolizumab,TRUE
500,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,11/1/2013,mg,antineoplastic,8/5/2013,6/28/2013,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/12/2025,mg,antineoplastic,7/1/2024,3/21/2024,Subcutaneous,leuprolide,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/24/2022,mg/kg,antineoplastic,2/27/2022,2/3/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/4/2019,mg,antineoplastic,1/10/2018,1/11/2018,Intravenous,pembrolizumab,FALSE
620,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1978F5FFE:43,8/20/2014,mg,antineoplastic,6/6/2014,6/4/2014,Intravenous,bevacizumab,FALSE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,11/11/2015,mg,antineoplastic,11/4/2015,7/13/2015,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/6/2020,mg,antineoplastic,5/8/2019,3/1/2019,Intravenous,pembrolizumab,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/19/2013,mg,antineoplastic,6/6/2012,5/14/2012,Intravenous,docetaxel,FALSE
,4,ADVANCED,Unstructured,,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,3/28/2025,,,5/20/2024,5/28/2024,Oral,osimertinib,FALSE
,,ADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G1F482136BDE5,6/4/2017,,solution-fluid,3/7/2017,3/11/2017,Intravenous,clinical study drug,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/10/2025,mg,antineoplastic,1/20/2025,8/22/2024,Intravenous,pemetrexed,TRUE
,5,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,4/3/2023,,antineoplastic,4/29/2022,4/7/2022,,niraparib,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/31/2021,mg/kg,antineoplastic,3/14/2021,2/19/2021,Intravenous,bevacizumab-awwb,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/14/2024,mg,antineoplastic,5/25/2023,4/24/2022,Intravenous,durvalumab,TRUE
850,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,10/24/2013,mg,antineoplastic,11/3/2013,3/31/2013,Intravenous,pemetrexed,FALSE
1564,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,12/8/2015,mg,antineoplastic,12/4/2015,10/19/2015,Intravenous,bevacizumab,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/11/2019,mg,antineoplastic,10/28/2018,6/9/2018,Intravenous,trastuzumab,FALSE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,5/8/2016,mg,antineoplastic,9/26/2015,12/8/2014,Intravenous,pemetrexed,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,4/27/2016,mg,antineoplastic,3/24/2016,1/8/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/7/2025,mg,antineoplastic,8/26/2024,3/24/2024,Intravenous,pembrolizumab,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,8/31/2013,mg,antineoplastic,9/3/2013,3/4/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/30/2025,mg,antineoplastic,3/20/2024,5/10/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,10/31/2021,mg/m2,antineoplastic,9/22/2021,7/29/2021,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G136E3F9:956D,1/22/2020,mg,antineoplastic,1/21/2020,12/15/2019,Intravenous,pembrolizumab,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/2/2017,mg,antineoplastic,5/24/2017,5/24/2017,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/12/2025,mg,antineoplastic,2/5/2019,1/8/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,1/25/2024,,antineoplastic,12/29/2023,4/2/2023,Intravenous,atezolizumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/13/2013,mg,antineoplastic,2/22/2013,5/26/2012,Intravenous,pemetrexed,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/25/2016,mg,antineoplastic,9/7/2016,6/5/2016,Intravenous,paclitaxel,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/11/2021,mg,antineoplastic,1/5/2021,11/28/2020,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/30/2013,mg,antineoplastic,10/14/2012,11/4/2012,Intravenous,carboplatin,FALSE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/4/2019,mg,antineoplastic,9/19/2019,8/16/2019,Intravenous,carboplatin,FALSE
1050,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5344:8G5698G,10/22/2022,mg,antineoplastic,10/8/2022,9/11/2022,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,3/4/2021,,antiemetic,6/10/2020,1/10/2020,Intravenous,clinical study drug,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/11/2024,mg,antineoplastic,4/13/2022,3/6/2022,Intravenous,durvalumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/7/2020,mg,antineoplastic,12/12/2019,12/16/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/21/2019,AUC,antineoplastic,6/11/2019,1/17/2019,Intravenous,carboplatin,FALSE
480,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,3/10/2019,mg,antineoplastic,9/12/2018,8/23/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/21/2025,,solution-fluid,3/18/2018,11/23/2017,Intravenous,clinical study drug,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/13/2023,mg,antineoplastic,8/2/2023,11/15/2022,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Orders,pain agent,Clinical Study Drug,G14E7662::61C,4/22/2017,,pain agent,3/31/2016,1/22/2016,,clinical study drug,FALSE
286,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Capecitabine",G5724:G6:4ED5,4/18/2025,mg,antineoplastic,2/24/2025,2/7/2025,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,7/21/2024,mg,antineoplastic,4/13/2024,3/27/2024,Intravenous,pembrolizumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/4/2021,mg,antineoplastic,7/16/2020,12/28/2019,Intravenous,durvalumab,TRUE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,4/25/2025,mg,antineoplastic,3/2/2025,11/28/2024,Intravenous,pembrolizumab,FALSE
230,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,7/28/2013,mg,antineoplastic,6/20/2013,6/17/2013,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/13/2022,mg,antineoplastic,8/2/2016,2/27/2016,Intravenous,pemetrexed,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/26/2021,mg,antineoplastic,3/8/2021,11/8/2020,Intravenous,gemcitabine,FALSE
1323,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/30/2015,mg,antineoplastic,1/5/2015,10/16/2014,Intravenous,bevacizumab,FALSE
550,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/12/2024,mg,antineoplastic,7/22/2024,6/28/2024,Intravenous,carboplatin,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/4/2021,mg,antineoplastic,4/24/2021,4/18/2021,Intravenous,paclitaxel protein-bound,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,5/3/2025,mL,solution-fluid,11/18/2024,4/12/2024,Intravenous,pembrolizumab,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/17/2015,mg,antineoplastic,3/2/2015,2/22/2015,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,1/6/2021,mg,antineoplastic,7/15/2020,6/16/2020,Intravenous,pembrolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/19/2024,mg,antineoplastic,2/19/2024,12/12/2021,Intravenous,nivolumab,TRUE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/30/2012,mg,antineoplastic,1/10/2012,10/3/2011,Intravenous,vinorelbine,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/30/2013,mg,antineoplastic,6/29/2013,3/30/2013,Intravenous,paclitaxel protein-bound,FALSE
581.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/3/2018,mg,antineoplastic,5/13/2018,6/6/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/10/2019,,antineoplastic,10/5/2019,8/10/2019,,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/6/2025,mg,antineoplastic,12/1/2024,4/15/2024,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/20/2019,mg,antineoplastic,11/9/2018,10/2/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,3/26/2025,mg,antineoplastic,3/29/2025,9/8/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/22/2018,mg,antineoplastic,12/10/2017,9/17/2015,Intravenous,nivolumab,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,12/30/2012,mg,antineoplastic,3/18/2012,1/16/2012,Intravenous,carboplatin,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3DGG1C5C452:,5/19/2019,mg,antineoplastic,4/7/2019,3/13/2019,Intravenous,durvalumab,FALSE
,,ADJUVANT,Unstructured,,Erlotinib,G2E99628474:8,9/15/2018,,,8/21/2018,9/2/2017,Oral,erlotinib,FALSE
240,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/11/2019,mg,antineoplastic,8/25/2019,6/30/2019,Intravenous,irinotecan,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/12/2019,mg,antineoplastic,10/25/2019,8/1/2019,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/16/2016,,antineoplastic,1/28/2016,1/8/2016,Oral,hydroxyurea,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,8/7/2021,mg,antineoplastic,2/18/2021,9/12/2020,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/13/2023,mg,antineoplastic,9/1/2022,6/8/2020,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,6/13/2024,,antineoplastic,4/24/2024,3/15/2024,,cisplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/4/2013,mg,antineoplastic,7/9/2012,11/23/2011,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/28/2023,,antineoplastic,6/26/2022,4/19/2022,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/14/2022,mg,antineoplastic,12/15/2018,5/27/2017,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,4/26/2024,,antineoplastic,2/2/2024,9/18/2023,Oral,ivosidenib,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/28/2024,mL,solution-fluid,2/13/2024,1/3/2024,Intravenous,pemetrexed,FALSE
152,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G4E68514B7GFD,5/18/2015,mg,antineoplastic,5/5/2015,3/25/2015,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,3/14/2024,,antineoplastic,3/8/2024,2/7/2024,,pemetrexed,FALSE
404,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/13/2016,mg,antineoplastic,1/27/2016,11/27/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/29/2021,mg,antineoplastic,4/24/2021,3/6/2021,Intravenous,pembrolizumab,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/29/2012,mg,antineoplastic,1/19/2012,1/11/2012,Subcutaneous,amifostine,FALSE
,3,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3EC5EB18C676,6/26/2018,,antineoplastic,4/25/2018,2/11/2018,,clinical study drug,FALSE
741,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,2/9/2020,mg,antineoplastic,11/23/2019,12/9/2019,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,5/23/2023,,antineoplastic,4/1/2023,1/24/2023,Intravenous,pemetrexed,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/4/2018,mg,antineoplastic,6/6/2018,6/17/2018,Intravenous,paclitaxel,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/8/2019,mg,antineoplastic,7/3/2019,7/2/2019,Intravenous,paclitaxel protein-bound,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/15/2023,mg,antineoplastic,6/17/2023,7/22/2023,Intravenous,paclitaxel,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/12/2017,mg,antineoplastic,7/5/2016,2/4/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/14/2024,,antineoplastic,6/6/2024,4/5/2024,,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1CB3B346155D,9/4/2021,mg,antineoplastic,7/7/2021,6/27/2021,Intravenous,pembrolizumab,TRUE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/27/2016,mg,antineoplastic,4/10/2015,5/22/2015,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,1/30/2018,mg,antineoplastic,11/13/2017,9/4/2017,Intravenous,nivolumab,FALSE
93,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/15/2016,mg,antineoplastic,12/4/2015,11/23/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/24/2022,mg,antineoplastic,10/30/2021,7/29/2020,Intravenous,pembrolizumab,TRUE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/21/2016,mg,antineoplastic,11/29/2016,6/26/2016,Intravenous,necitumumab,FALSE
164,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,1/26/2024,mg,antineoplastic,10/25/2023,10/8/2023,Intravenous,carboplatin,FALSE
130,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/21/2025,mg,antineoplastic,10/30/2024,9/10/2024,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/2/2024,mg,antineoplastic,12/30/2023,9/22/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/14/2025,,antineoplastic,6/14/2023,2/19/2023,,clinical study drug,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,2/24/2018,mg/m2,antineoplastic,11/18/2017,10/21/2017,Intravenous,paclitaxel,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/27/2024,mg,antineoplastic,3/2/2024,10/23/2023,Intravenous,amivantamab-vmjw,FALSE
,4,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,6/15/2023,,antineoplastic,2/25/2023,2/2/2023,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4C7:4GCD96C:,6/8/2017,,,5/7/2015,3/11/2015,Oral,erlotinib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/25/2024,mg,antineoplastic,9/23/2024,12/29/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/2/2024,mg,antineoplastic,1/25/2021,4/26/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G557E997E81G5,10/15/2022,mg,antineoplastic,3/19/2022,3/8/2022,Intravenous,pembrolizumab,TRUE
790.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,4/12/2015,mg,antineoplastic,2/20/2015,12/7/2014,Intravenous,carboplatin,FALSE
2000,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,9/27/2021,mg,antineoplastic,7/25/2021,6/27/2021,Intravenous,gemcitabine,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/30/2024,mg,antineoplastic,3/27/2023,4/12/2022,Intravenous,durvalumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,5/12/2025,mg,antineoplastic,4/18/2025,2/24/2025,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/14/2021,mg,antineoplastic,9/26/2019,9/4/2019,Intravenous,pembrolizumab,FALSE
600,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,6/20/2020,mg,antineoplastic,4/16/2020,5/29/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/20/2025,mg,antineoplastic,12/20/2024,9/16/2022,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/25/2023,,antineoplastic,5/30/2023,3/11/2023,Intravenous,carboplatin,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/5/2017,mg,antineoplastic,7/1/2017,5/18/2017,Intravenous,trastuzumab,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/22/2020,mg,antineoplastic,8/21/2020,3/1/2020,Intravenous,bevacizumab,FALSE
587,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/21/2020,mg,antineoplastic,9/25/2020,7/14/2020,Intravenous,carboplatin,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/2/2017,mg,antineoplastic,4/17/2017,9/24/2016,Intravenous,cisplatin,FALSE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,3/7/2020,mg,antineoplastic,8/2/2019,7/21/2019,Intravenous,ramucirumab,FALSE
523,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/8/2015,mg,antineoplastic,7/26/2015,4/22/2015,Intravenous,carboplatin,FALSE
1850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,9/7/2018,mg,antineoplastic,6/2/2018,5/21/2018,Intravenous,gemcitabine,FALSE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/29/2013,mg,antineoplastic,8/19/2012,3/29/2012,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/16/2019,mg,antineoplastic,5/21/2019,1/17/2019,Intravenous,paclitaxel,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/18/2020,mg,antineoplastic,5/17/2019,3/26/2019,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,5/11/2025,,antineoplastic,2/26/2025,10/7/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/23/2020,mg,antineoplastic,6/14/2019,5/25/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/7/2022,Ea,antineoplastic,12/27/2019,1/23/2018,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,3/27/2025,mg,antineoplastic,12/14/2024,9/13/2024,Intravenous,nivolumab,TRUE
159,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,9/9/2023,mg,antineoplastic,4/30/2023,6/4/2023,Intravenous,carboplatin,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,4/23/2015,mg,antineoplastic,11/26/2014,11/18/2014,Intravenous,paclitaxel,FALSE
360,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,6/24/2018,mg,antineoplastic,11/23/2017,9/29/2017,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G5:919981B622,8/30/2023,mg,antineoplastic,8/2/2023,5/23/2023,Intravenous,durvalumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/10/2022,mg,antineoplastic,6/7/2020,1/25/2016,Intravenous,pemetrexed,FALSE
172,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/27/2023,mg,antineoplastic,5/3/2023,5/6/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/28/2023,mg,antineoplastic,1/20/2023,12/7/2022,Intravenous,bevacizumab-awwb,FALSE
64,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,4/3/2024,mg,antineoplastic,11/22/2023,11/6/2023,Intravenous,ipilimumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/12/2020,mg,antineoplastic,4/30/2020,1/21/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,12/3/2024,mg,antineoplastic,10/21/2024,8/1/2024,Intravenous,pembrolizumab,FALSE
151.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/1/2018,mg,antineoplastic,10/5/2017,8/7/2017,Intravenous,carboplatin,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,7/9/2016,mg,antineoplastic,5/9/2016,4/8/2016,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,4/24/2022,,steroid,4/4/2022,1/6/2022,Oral,clinical study drug,FALSE
280,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/17/2017,mg,antineoplastic,6/17/2017,4/12/2017,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/1/2024,mg,antineoplastic,7/1/2024,6/6/2024,Intravenous,paclitaxel,FALSE
82.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,6/20/2015,mg,antineoplastic,3/31/2015,4/4/2015,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,5/14/2025,mg,antineoplastic,12/15/2023,5/1/2023,Intravenous,pembrolizumab,FALSE
312,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/13/2016,mg,antineoplastic,8/28/2016,7/13/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/20/2021,,antineoplastic,8/3/2021,5/21/2021,Intravenous,pemetrexed,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/26/2016,mg,antineoplastic,12/3/2015,10/23/2015,Intravenous,etoposide,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,3/31/2022,mg,antineoplastic,4/2/2022,1/18/2022,Intravenous,nivolumab,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,5/10/2019,mg/m2,antineoplastic,6/6/2019,4/23/2019,Intravenous,cisplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/16/2018,mL,solution-fluid,8/15/2015,5/30/2015,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/4/2013,mg,antineoplastic,3/18/2012,12/30/2011,Intravenous,etoposide,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,7/12/2024,mg,antineoplastic,3/12/2024,3/21/2024,Intravenous,carboplatin,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/27/2017,mg,antineoplastic,7/29/2016,2/6/2016,Intravenous,nivolumab,FALSE
96,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,6/23/2015,mg,antineoplastic,5/13/2015,6/21/2015,Intravenous,cisplatin,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,8/13/2024,,antineoplastic,10/29/2023,4/30/2023,,niraparib,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/23/2024,mg,antineoplastic,4/25/2024,4/25/2024,Intravenous,pemetrexed,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/6/2023,mg,antineoplastic,1/7/2023,12/2/2022,Intravenous,carboplatin,FALSE
1050,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G57B5F4B556EG,4/3/2022,mg,antineoplastic,4/29/2022,3/13/2022,Intravenous,amivantamab-vmjw,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/4/2025,mg,antineoplastic,4/4/2025,2/19/2025,Intravenous,pemetrexed,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,6/29/2020,mg,antineoplastic,7/10/2020,5/7/2020,Intravenous,cisplatin,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,4/17/2012,mg,antineoplastic,3/1/2012,2/14/2012,Subcutaneous,amifostine,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,5/30/2022,mg,antineoplastic,5/31/2022,4/11/2022,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/27/2023,mg,antineoplastic,5/7/2023,4/18/2023,Intravenous,tremelimumab-actl,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/17/2022,mg,antineoplastic,5/29/2021,2/19/2016,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/9/2022,mg,antineoplastic,4/10/2020,5/21/2017,Intravenous,nivolumab,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/13/2020,mg,antineoplastic,10/21/2019,9/4/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/20/2017,,antineoplastic,4/14/2017,3/14/2016,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/27/2018,,antineoplastic,6/18/2015,6/11/2015,,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/10/2018,mg,antineoplastic,8/19/2017,3/13/2017,Intravenous,pemetrexed,TRUE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/6/2021,mg,antineoplastic,10/13/2020,9/22/2020,Nasogastric,bicalutamide,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G325BD94D:C:4,4/23/2019,,,5/10/2019,2/6/2019,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,3/25/2025,mg,antineoplastic,2/14/2024,10/15/2023,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/11/2025,mg,antineoplastic,5/30/2021,1/12/2017,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/1/2024,mg,antineoplastic,5/22/2024,5/22/2024,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/20/2022,mg/m2,antineoplastic,8/13/2022,6/1/2022,Intravenous,pemetrexed,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,9/1/2012,mg,antineoplastic,6/20/2012,6/10/2012,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,2/12/2018,mg,antineoplastic,9/28/2017,8/7/2017,Intravenous,nivolumab,FALSE
700,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,3/30/2025,mg,antineoplastic,2/3/2025,1/16/2025,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,8/20/2021,mL,solution-fluid,6/15/2021,4/21/2021,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/22/2019,AUC,antineoplastic,4/23/2019,1/30/2019,Intravenous,carboplatin,FALSE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,6/2/2017,mg,antineoplastic,3/21/2016,12/25/2015,Intravenous,nivolumab,FALSE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/14/2012,mg,antineoplastic,7/27/2012,4/27/2012,Intravenous,bevacizumab,FALSE
139,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/22/2024,mg,antineoplastic,4/11/2024,3/31/2024,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,8/10/2019,mg,antineoplastic,5/21/2019,5/18/2019,Intravenous,pemetrexed,TRUE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,4/17/2019,mg/kg,antineoplastic,7/15/2017,8/5/2017,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,3/23/2021,mg,antineoplastic,2/21/2021,12/15/2020,Intravenous,pembrolizumab,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/8/2020,mg,antineoplastic,5/25/2020,1/29/2019,Subcutaneous,bortezomib,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/9/2014,mg,antineoplastic,5/29/2014,3/6/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/26/2020,mg,antineoplastic,1/13/2020,11/10/2018,Intravenous,pembrolizumab,TRUE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/5/2014,mg,antineoplastic,11/4/2013,12/16/2013,Intravenous,cisplatin,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G3B698C119:F8,7/14/2012,,steroid,5/31/2012,4/28/2012,Intravenous,clinical study drug,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/23/2021,mg,antineoplastic,10/30/2021,8/19/2021,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,8/13/2018,mg,antineoplastic,6/28/2018,3/13/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/10/2025,mg,antineoplastic,6/3/2023,3/2/2020,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/20/2025,mg,antineoplastic,4/12/2023,1/9/2017,Intravenous,pembrolizumab,FALSE
472,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/1/2022,mg,antineoplastic,10/4/2022,9/30/2022,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/3/2016,mg,antineoplastic,4/12/2016,3/16/2016,Intravenous,bevacizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/26/2022,mg,antineoplastic,4/1/2020,12/21/2019,Intravenous,nivolumab,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,11/30/2023,mg,antineoplastic,12/6/2023,11/19/2023,Oral,anastrozole,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G2G22BF9DCG81,7/4/2023,mg,antineoplastic,5/17/2023,4/4/2023,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/27/2020,mg,antineoplastic,12/13/2016,12/13/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,3/3/2020,mg,antineoplastic,1/22/2020,11/18/2019,Intravenous,pembrolizumab,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,10/11/2013,mg,antineoplastic,9/26/2013,7/19/2013,Intravenous,carboplatin,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/25/2025,mg,antineoplastic,5/24/2024,4/1/2024,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,8/29/2024,mg,antineoplastic,5/25/2024,3/15/2023,Intravenous,nivolumab,FALSE
83,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,6/14/2023,mg,antineoplastic,4/20/2023,2/2/2023,Intravenous,cisplatin,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/22/2015,mg,antineoplastic,5/5/2015,8/16/2014,Intravenous,paclitaxel,FALSE
840,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/23/2015,mg,antineoplastic,1/20/2015,10/7/2014,Intravenous,bevacizumab,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/25/2022,mg,antineoplastic,11/20/2022,11/16/2022,Intravenous,pemetrexed,FALSE
277,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/22/2024,mg,antineoplastic,9/13/2023,9/7/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/16/2025,mg,antineoplastic,9/4/2018,12/23/2016,Intravenous,pembrolizumab,FALSE
362,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/11/2021,mg,antineoplastic,8/23/2021,7/23/2021,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,10/2/2021,AUC,antineoplastic,6/23/2021,6/10/2021,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/27/2018,mg,antineoplastic,1/29/2018,11/17/2017,Oral,anastrozole,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/24/2023,,antineoplastic,5/26/2020,10/16/2019,Intravenous,pembrolizumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/25/2025,mg,antineoplastic,7/14/2023,3/6/2019,Intravenous,pemetrexed,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,12/22/2022,mg,antineoplastic,4/5/2022,3/21/2022,Intravenous,durvalumab,TRUE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/6/2023,mg,antineoplastic,3/1/2020,1/21/2020,Intravenous,gemcitabine,FALSE
5,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/3/2019,AUC,antineoplastic,1/6/2019,12/21/2018,Intravenous,carboplatin,FALSE
1140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,6/17/2012,mg,antineoplastic,4/30/2012,4/16/2012,Intravenous,pemetrexed,FALSE
96,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/11/2021,mg,antineoplastic,1/8/2017,1/17/2017,Intravenous,paclitaxel,FALSE
770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,4/12/2013,mg,antineoplastic,4/8/2013,1/8/2013,Intravenous,pemetrexed,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/15/2015,mg,antineoplastic,4/26/2015,4/8/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/21/2025,mg,antineoplastic,3/18/2025,5/5/2024,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/23/2019,mg,antineoplastic,3/14/2019,2/23/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/31/2018,mg,antineoplastic,5/14/2018,4/14/2018,Intravenous,carboplatin,FALSE
795,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,2/16/2018,mg,antineoplastic,1/5/2018,1/30/2018,Intravenous,pemetrexed,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/21/2016,mg,antineoplastic,7/1/2016,5/17/2016,Intravenous,paclitaxel,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/31/2025,mg,antineoplastic,12/8/2024,11/7/2024,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,targeted/non-biologic,Acalabrutinib,G3124B666:88D,3/13/2023,,antineoplastic,2/17/2023,3/23/2023,Oral,acalabrutinib,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,8/16/2014,mg,antineoplastic,7/12/2014,7/9/2014,Intravenous,pemetrexed,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36:G2D34DE93,12/31/2018,mg,antineoplastic,12/3/2018,12/15/2018,Intravenous,paclitaxel,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27D282B7225B,11/28/2021,mg,antineoplastic,8/2/2021,6/15/2021,Intravenous,pemetrexed,TRUE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,5/2/2025,mg,antineoplastic,6/22/2020,3/8/2019,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,7/1/2022,mg,antineoplastic,4/29/2022,3/22/2022,Intravenous,pemetrexed,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,7/9/2016,mg,antineoplastic,4/7/2016,4/6/2016,Intravenous,paclitaxel,FALSE
640,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,8/14/2020,mg,antineoplastic,5/9/2020,5/24/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G17BG4264193F,3/3/2025,mg,antineoplastic,4/13/2024,4/8/2020,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/17/2018,mg,antineoplastic,8/25/2017,2/8/2017,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/13/2020,mg,antineoplastic,5/29/2018,11/29/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/14/2023,,antineoplastic,3/12/2023,4/4/2023,,anastrozole,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/31/2020,mg,antineoplastic,1/1/2018,11/14/2015,Intravenous,nivolumab,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,12/30/2022,mg,antineoplastic,10/21/2022,3/31/2022,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,1/9/2019,mL,solution-fluid,9/20/2017,9/30/2017,Intravenous,etoposide,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/9/2016,,antineoplastic,9/17/2016,3/27/2016,Intravenous,paclitaxel,FALSE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G3::1:B4F:3D4,1/2/2016,mg,antineoplastic,9/23/2015,9/5/2015,Intravenous,nivolumab,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,10/4/2015,mg,antineoplastic,2/23/2015,3/3/2015,Intravenous,pemetrexed,TRUE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,8/9/2017,,antineoplastic,4/28/2017,12/4/2016,Intravenous,clinical study drug,FALSE
152.7,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/4/2017,mg,antineoplastic,8/17/2017,9/12/2017,Intravenous,carboplatin,FALSE
60,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,7/23/2018,mg,antineoplastic,7/4/2018,5/26/2018,Intravenous,cisplatin,FALSE
348,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,8/26/2016,mg,antineoplastic,9/22/2016,6/27/2016,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,6/11/2020,mg,antineoplastic,7/11/2017,11/16/2016,Intravenous,nivolumab,FALSE
1000,4,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,11/12/2023,mg/m2,antineoplastic,3/5/2023,4/11/2023,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/2/2024,,antineoplastic,6/7/2024,5/1/2024,Intravenous,atezolizumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/5/2025,mg,antineoplastic,4/26/2023,8/31/2022,Oral,anastrozole,FALSE
1140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/23/2022,mg,antineoplastic,2/13/2022,1/3/2022,Intravenous,pemetrexed,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/27/2025,mg,antineoplastic,4/17/2025,9/9/2022,Intravenous,pemetrexed,TRUE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/12/2019,mg,antineoplastic,11/19/2018,11/2/2018,Intravenous,durvalumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/25/2020,mg,antineoplastic,4/13/2019,11/11/2018,Intravenous,pemetrexed,TRUE
803,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/13/2025,mg,antineoplastic,12/22/2023,1/17/2023,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G126:384BC665,3/27/2015,mg,antineoplastic,3/2/2015,3/17/2015,Intravenous,pemetrexed,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/29/2016,mg,antineoplastic,10/28/2014,10/15/2014,Intravenous,bevacizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/22/2019,mg,antineoplastic,3/20/2018,10/21/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,6/26/2020,,antineoplastic,5/21/2020,5/13/2020,Intravenous,paclitaxel,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/30/2015,mg,antineoplastic,1/23/2015,2/25/2015,Intravenous,etoposide,FALSE
590,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/5/2021,mg,antineoplastic,8/20/2020,6/26/2020,Intravenous,ramucirumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/23/2018,mg,antineoplastic,9/6/2018,4/27/2017,Intravenous,pemetrexed,TRUE
636,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,4/11/2015,mg,antineoplastic,12/8/2014,10/30/2014,Intravenous,pemetrexed,FALSE
61,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,4/7/2025,mg,antineoplastic,5/3/2025,4/27/2025,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/14/2014,mg/m2,antineoplastic,7/21/2014,7/4/2014,Intravenous,paclitaxel protein-bound,FALSE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/10/2016,mg,antineoplastic,12/7/2015,4/29/2015,Intravenous,gemcitabine,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,5/8/2025,mg,antineoplastic,10/7/2024,9/9/2024,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/13/2018,mg,antineoplastic,9/21/2018,9/14/2018,Intravenous,pembrolizumab,FALSE
433.5,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/23/2016,mg,antineoplastic,6/27/2016,8/2/2016,Intravenous,carboplatin,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/19/2016,mg,antineoplastic,8/29/2015,5/22/2015,Intravenous,nivolumab,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/10/2020,mg,antineoplastic,6/30/2020,1/19/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/24/2022,mg,antineoplastic,5/22/2021,1/14/2018,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/20/2020,mg,antineoplastic,1/16/2020,7/24/2016,Intravenous,nivolumab,FALSE
146,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/4/2019,mg,antineoplastic,10/8/2018,9/26/2018,Intravenous,carboplatin,FALSE
587,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G17235672EDGF,9/2/2024,mg,antineoplastic,7/15/2024,7/20/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/2/2020,mg,antineoplastic,11/20/2018,6/26/2016,Intravenous,nivolumab,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,1/25/2025,mg,antineoplastic,1/6/2025,10/13/2024,Intravenous,etoposide,FALSE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/29/2013,mg,antineoplastic,7/26/2012,8/17/2012,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/2/2025,mg,antineoplastic,5/15/2024,5/10/2024,Intravenous,pembrolizumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/30/2024,mg,antineoplastic,5/20/2024,2/13/2024,Intravenous,amivantamab-vmjw,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/22/2021,mg,antineoplastic,5/3/2021,4/30/2021,Intravenous,vinorelbine,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/1/2024,mg,antineoplastic,10/13/2024,7/19/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/29/2025,,antineoplastic,4/18/2023,2/14/2023,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/31/2025,mg,antineoplastic,2/6/2022,12/14/2016,Intravenous,pembrolizumab,FALSE
60,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,3/23/2023,mg,antineoplastic,2/10/2023,11/7/2022,Intravenous,ipilimumab,TRUE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,9/25/2019,mg,antineoplastic,9/8/2019,6/24/2019,Intravenous,pembrolizumab,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/1/2025,mg,antineoplastic,8/14/2024,4/28/2024,Intravenous,pemetrexed,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/4/2013,mg,antineoplastic,2/19/2012,11/22/2011,Intravenous,etoposide,FALSE
126,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34927D694398,4/21/2018,mg,antineoplastic,4/3/2018,4/16/2018,Intravenous,paclitaxel,FALSE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/17/2016,mg,antineoplastic,11/8/2015,12/23/2014,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/16/2020,mg,antineoplastic,7/10/2019,3/8/2019,Intravenous,nivolumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/16/2019,mg,antineoplastic,3/10/2019,2/5/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/19/2021,mg,antineoplastic,8/30/2021,8/7/2021,Intravenous,pembrolizumab,FALSE
2.9,2,ADVANCED,Administrations,chemotherapy,Eribulin,G19937F58E541,12/4/2013,mg,antineoplastic,10/27/2013,11/25/2013,Intravenous,eribulin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/19/2023,,antineoplastic,7/30/2023,12/10/2022,,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,2/22/2020,,antineoplastic,2/23/2020,2/25/2020,Oral,hydroxyurea,FALSE
,,ADJUVANT,Orders,chemotherapy,Azacitidine,G13F761779185,3/21/2023,,antineoplastic,3/16/2023,8/24/2022,,azacitidine,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/23/2025,mg,antineoplastic,6/23/2024,10/3/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/5/2017,,antineoplastic,4/9/2016,3/6/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/21/2022,mg,antineoplastic,10/3/2019,1/29/2018,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/17/2021,mg,antineoplastic,1/21/2021,12/3/2020,Intravenous,carboplatin,FALSE
171,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/9/2013,mg,antineoplastic,4/27/2012,3/21/2012,Intravenous,carboplatin,FALSE
549,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/7/2021,mg,antineoplastic,6/4/2021,5/11/2021,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/19/2020,mg,antineoplastic,11/3/2019,10/27/2019,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,1/20/2025,mg,antineoplastic,8/14/2024,4/22/2024,Intravenous,cemiplimab,TRUE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/28/2024,mg,antineoplastic,6/9/2023,12/19/2021,Intravenous,nivolumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/18/2024,mg,antineoplastic,3/17/2023,12/11/2022,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/24/2025,mg,antineoplastic,9/1/2024,6/7/2022,Intravenous,pembrolizumab,FALSE
168.6,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/15/2017,mg,antineoplastic,11/17/2016,9/29/2016,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/15/2021,mg,antineoplastic,11/20/2020,11/21/2018,Intravenous,pembrolizumab,TRUE
120,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,3/6/2025,mg,antineoplastic,1/16/2025,12/26/2024,Intravenous,paclitaxel protein-bound,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/2/2019,mg,antineoplastic,2/10/2019,1/3/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,3/9/2015,,antineoplastic,9/13/2014,9/8/2014,,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/11/2025,mg,antineoplastic,2/23/2025,3/30/2024,Intravenous,pemetrexed,FALSE
123,1,ADVANCED,Administrations,chemotherapy,Docetaxel,G3C826F5CD726,5/11/2014,mg,antineoplastic,5/2/2014,4/19/2014,Intravenous,docetaxel,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/16/2025,mg,antineoplastic,6/23/2024,3/8/2024,Intravenous,amivantamab-vmjw,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/12/2014,mg,antineoplastic,9/7/2014,8/29/2014,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,4/11/2023,mg,antineoplastic,12/25/2022,5/12/2022,Intravenous,atezolizumab,FALSE
460,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/17/2024,mg,antineoplastic,12/21/2023,12/1/2023,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1CFE2442E26G,1/17/2014,mg,antineoplastic,11/20/2013,10/29/2013,Intravenous,pemetrexed,TRUE
825,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G15DCCD:D9154,8/14/2023,mg,antineoplastic,6/24/2023,7/27/2023,Intravenous,pemetrexed,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,4/29/2018,mg,antineoplastic,4/27/2018,2/24/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/22/2022,mg,antineoplastic,4/8/2019,1/24/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/19/2025,mg,antineoplastic,4/15/2020,4/16/2018,Intravenous,pembrolizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/12/2025,mg,antineoplastic,6/19/2024,2/20/2024,Intravenous,amivantamab-vmjw,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/5/2017,mg,antineoplastic,1/20/2017,8/18/2016,Intravenous,nivolumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/11/2025,mg,antineoplastic,3/14/2021,1/23/2019,Intravenous,pemetrexed,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,6/1/2015,mg,antineoplastic,8/12/2013,8/13/2013,Intravenous,paclitaxel,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,12/26/2024,mg,antineoplastic,3/27/2023,3/11/2023,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/7/2023,,antineoplastic,3/19/2022,3/27/2022,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/5/2019,mg,antineoplastic,8/2/2018,4/8/2017,Intravenous,pemetrexed,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,4/1/2024,mg,antineoplastic,2/11/2023,4/7/2023,Intravenous,atezolizumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/23/2014,mg,antineoplastic,8/15/2014,4/3/2014,Intravenous,paclitaxel protein-bound,FALSE
113,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,11/8/2021,mg,antineoplastic,12/12/2021,11/29/2021,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/26/2025,mg,antineoplastic,8/23/2018,2/13/2018,Intravenous,nivolumab,FALSE
198,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,2/26/2013,mg,antineoplastic,12/18/2012,11/18/2012,Intravenous,paclitaxel,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/24/2020,mg,antineoplastic,9/16/2018,6/30/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/5/2025,mg,antineoplastic,4/25/2022,9/22/2021,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/6/2018,mg,antineoplastic,4/26/2018,12/18/2017,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/9/2023,mg,antineoplastic,5/30/2023,1/13/2023,Intravenous,nivolumab,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/29/2022,mg,antineoplastic,2/10/2022,1/17/2022,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/16/2023,mg,antineoplastic,6/16/2022,12/20/2019,Intravenous,pembrolizumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,9/27/2019,mg,antineoplastic,9/30/2019,8/28/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G1:78734BCEDB,7/11/2014,,antineoplastic,4/30/2014,4/16/2014,Intravenous,clinical study drug,FALSE
219,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/7/2021,mg,antineoplastic,6/29/2020,6/15/2020,Intravenous,paclitaxel,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/23/2015,mg,antineoplastic,3/15/2015,2/24/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/29/2025,mg,antineoplastic,12/2/2024,6/2/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/3/2013,mg,antineoplastic,2/24/2013,11/20/2012,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/19/2020,mg,antineoplastic,9/19/2016,2/14/2016,Intravenous,bevacizumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G12D5DB79FEED,5/14/2015,mg,antineoplastic,2/20/2015,12/12/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/14/2024,mg,antineoplastic,2/26/2021,5/22/2020,Intravenous,pembrolizumab,TRUE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/2/2021,mg/kg,antineoplastic,7/3/2021,3/3/2021,Intravenous,bevacizumab-awwb,FALSE
1000,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G289C6438E26:,8/5/2013,mg/m2,antineoplastic,7/25/2013,7/8/2013,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/26/2025,mg,antineoplastic,3/3/2023,12/26/2016,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/24/2025,mg,antineoplastic,12/25/2018,1/30/2018,Intravenous,nivolumab,FALSE
1333.5,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/8/2016,mg,antineoplastic,3/31/2015,2/7/2015,Intravenous,bevacizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1EC14EC2:22:,3/29/2024,mg,antineoplastic,12/23/2023,12/3/2023,Intravenous,durvalumab,TRUE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/21/2021,mg,antineoplastic,5/15/2021,3/21/2021,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G4CG4:632GG8E,6/5/2021,,,5/25/2021,1/20/2019,Oral,afatinib,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/22/2013,mg,antineoplastic,3/12/2013,10/8/2012,Intravenous,carboplatin,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/11/2025,mg,antineoplastic,12/2/2024,11/16/2024,Intravenous,gemcitabine,FALSE
230,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/17/2016,mg,antineoplastic,7/24/2016,12/5/2015,Intravenous,nivolumab,FALSE
950,4,ADVANCED,Administrations,chemotherapy,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,8/21/2016,mg,antineoplastic,5/20/2016,6/14/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/1/2025,mg,antineoplastic,7/1/2024,6/28/2023,Intravenous,pembrolizumab,TRUE
66,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/18/2020,mg,antineoplastic,8/16/2014,4/24/2014,Intravenous,doxorubicin,FALSE
22.5,3,ADVANCED,Administrations,hormone,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/2/2025,mg,antineoplastic,5/7/2024,4/27/2024,Subcutaneous,leuprolide,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/27/2023,mg,antineoplastic,1/17/2023,9/7/2022,Subcutaneous,azacitidine,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/19/2021,mg/m2,antineoplastic,11/12/2021,3/17/2021,Intravenous,fluorouracil,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,6/16/2022,mg/kg,antineoplastic,3/17/2022,3/18/2022,Intravenous,bevacizumab-awwb,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,2/27/2025,mg,antineoplastic,5/3/2018,3/21/2018,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/24/2022,mg,antineoplastic,8/24/2018,5/28/2017,Intravenous,nivolumab,FALSE
670,2,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,12/10/2018,mg,antineoplastic,8/7/2018,7/25/2018,Intravenous,rituximab,FALSE
675,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,5/17/2017,mg,antineoplastic,12/2/2016,8/22/2016,Intravenous,pemetrexed,FALSE
152,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/6/2020,mg,antineoplastic,3/2/2020,2/11/2020,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/23/2021,mg,antineoplastic,9/15/2021,9/17/2020,Intravenous,nivolumab,FALSE
465,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/15/2020,mg,antineoplastic,6/30/2020,4/7/2020,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/3/2025,,antineoplastic,3/4/2023,1/25/2023,Intravenous,pemetrexed,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/7/2013,mg,antineoplastic,10/28/2013,10/5/2013,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/4/2020,mg,antineoplastic,10/12/2017,2/21/2016,Intravenous,bevacizumab,TRUE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/22/2020,mg,antineoplastic,6/7/2019,11/26/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2C4G1G76816F,5/7/2025,,antineoplastic,11/27/2017,10/2/2017,Intravenous,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,12/11/2024,mg,antineoplastic,7/15/2024,3/24/2024,Intravenous,pembrolizumab,FALSE
600,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1468E9F5C9CG,1/1/2012,mg,antineoplastic,11/16/2011,11/17/2011,Intravenous,pemetrexed,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,11/1/2016,mg,antineoplastic,10/18/2016,8/9/2016,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/7/2023,,antineoplastic,1/28/2023,10/8/2022,Intravenous,pemetrexed,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/27/2015,mg,antineoplastic,4/9/2015,3/4/2015,Intravenous,paclitaxel protein-bound,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/20/2020,mg,antineoplastic,12/9/2019,3/19/2019,Intravenous,durvalumab,FALSE
172,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/27/2024,mg,antineoplastic,8/13/2024,7/3/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/31/2017,mg,antineoplastic,9/13/2016,9/7/2016,Intravenous,nivolumab,FALSE
146,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,6/26/2023,mg,antineoplastic,4/1/2023,3/24/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G44B44661:316,2/7/2016,,antineoplastic,4/10/2015,3/2/2015,,bevacizumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/21/2015,mg,antineoplastic,8/26/2015,8/13/2015,Intravenous,carboplatin,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/1/2018,mg,antineoplastic,6/1/2018,7/7/2018,Intravenous,etoposide,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/21/2024,,antineoplastic,4/9/2024,5/2/2024,,pembrolizumab,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/10/2016,mg,antineoplastic,9/22/2015,8/28/2015,Intravenous,etoposide,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,9/14/2015,mg,antineoplastic,7/2/2015,8/25/2015,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/8/2024,mg,antineoplastic,2/13/2024,2/25/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,1/15/2024,mg,antineoplastic,9/28/2023,5/17/2023,Intravenous,pembrolizumab,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G266E6248F531,8/12/2018,mg,antineoplastic,3/27/2018,4/12/2018,Intravenous,bevacizumab,TRUE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/5/2022,mg,antineoplastic,12/25/2017,4/21/2017,Oral,dasatinib,FALSE
198,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/30/2012,mg,antineoplastic,5/30/2012,3/8/2012,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/6/2012,mg/m2,antineoplastic,1/7/2012,9/16/2011,Intravenous,cetuximab,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,11/20/2013,mg,antineoplastic,8/25/2013,8/19/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,5/7/2019,mg,antineoplastic,2/19/2019,1/10/2019,Intravenous,pembrolizumab,FALSE
168.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/1/2015,mg,antineoplastic,9/28/2014,10/21/2014,Intravenous,paclitaxel,FALSE
165,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3C:F1C:2BF6C,3/7/2015,mg,antineoplastic,1/29/2015,12/20/2014,Intravenous,pembrolizumab,FALSE
1045,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,10/15/2015,mg,antineoplastic,10/3/2015,7/18/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,11/12/2019,,antineoplastic,11/12/2019,8/24/2019,Intravenous,pembrolizumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/31/2019,mg,antineoplastic,10/15/2016,3/23/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5:CE:F92EE8D,3/27/2016,,antineoplastic,7/27/2015,6/5/2015,Intravenous,clinical study drug,FALSE
135,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,1/11/2019,mg,antineoplastic,1/22/2019,1/15/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,6/17/2022,mg,antineoplastic,1/14/2022,10/29/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/15/2025,mg,antineoplastic,3/2/2024,3/27/2020,Intravenous,pembrolizumab,FALSE
105,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/9/2022,mg,antineoplastic,12/15/2021,10/10/2021,Intravenous,oxaliplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,6/24/2024,,antineoplastic,4/23/2024,3/19/2024,Intravenous,nivolumab,FALSE
130,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,7/17/2013,mg,antineoplastic,8/9/2013,6/30/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/5/2017,,antineoplastic,5/20/2016,1/29/2016,Intravenous,clinical study drug,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,10/2/2019,mg,antineoplastic,9/7/2019,5/12/2019,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/7/2019,mg,antineoplastic,1/26/2019,1/14/2019,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/7/2013,mg,antineoplastic,11/8/2012,1/14/2012,Intravenous,carboplatin,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/5/2019,mg,antineoplastic,8/1/2018,7/3/2018,Intravenous,irinotecan,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,4/7/2022,,steroid,12/27/2021,1/10/2022,Oral,clinical study drug,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/29/2024,mg,antineoplastic,12/25/2023,5/20/2023,Intravenous,pembrolizumab,FALSE
114,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,12/11/2021,mg,antineoplastic,10/4/2021,10/2/2021,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,7/14/2018,mg,antineoplastic,6/27/2018,4/15/2018,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/17/2025,mg,antineoplastic,11/12/2024,1/18/2023,Intravenous,pembrolizumab,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/7/2022,mg,antineoplastic,8/2/2021,6/12/2021,Intravenous,leucovorin,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,5/7/2015,mg,antineoplastic,12/13/2014,12/13/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11G8BG6E719B,3/28/2025,mg,antineoplastic,1/23/2025,12/20/2024,Intravenous,pembrolizumab,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,6/28/2021,mg,antineoplastic,12/22/2020,9/24/2020,Intravenous,durvalumab,FALSE
255,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,7/4/2021,mg,antineoplastic,1/24/2017,12/17/2016,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/18/2024,mg,antineoplastic,7/18/2022,4/9/2022,Intravenous,durvalumab,FALSE
,,ADJUVANT,Unstructured,,Alectinib,G52:6C556E791,7/24/2024,,,7/25/2024,6/28/2024,Oral,alectinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/18/2019,mg,antineoplastic,10/16/2019,8/17/2019,Intravenous,pembrolizumab,FALSE
310,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,3/26/2022,mg,antineoplastic,3/3/2022,3/10/2022,Intravenous,carboplatin,FALSE
840,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G24365CF6:6G7,4/6/2014,mg,antineoplastic,2/22/2014,2/22/2014,Intravenous,pemetrexed,FALSE
524,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/3/2025,mg,antineoplastic,10/19/2024,11/5/2024,Intravenous,carboplatin,FALSE
1344,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/4/2016,mg,antineoplastic,2/15/2015,3/15/2015,Intravenous,bevacizumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/9/2014,mg,antineoplastic,11/2/2014,9/2/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/21/2021,mg,antineoplastic,1/13/2021,1/13/2021,Intravenous,pembrolizumab,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/17/2023,mg,antineoplastic,10/6/2022,10/27/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/7/2018,,antineoplastic,8/8/2015,6/19/2015,,paclitaxel,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/26/2019,mg,antineoplastic,12/10/2017,10/28/2016,Intramuscular,fulvestrant,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/9/2019,mg,antineoplastic,11/8/2018,5/25/2018,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/29/2017,mg,antineoplastic,2/24/2017,4/14/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/1/2021,mg/m2,antineoplastic,10/24/2021,3/20/2021,Intravenous,leucovorin,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,10/28/2016,,antineoplastic,4/24/2016,3/15/2016,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/6/2024,mg,antineoplastic,7/5/2023,4/24/2022,Intravenous,durvalumab,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/16/2025,mg,antineoplastic,2/17/2025,12/14/2024,Intravenous,gemcitabine,FALSE
2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/8/2020,mg,antineoplastic,6/27/2014,4/9/2014,Intravenous,vincristine,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/24/2025,mg,antineoplastic,2/3/2021,3/2/2020,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/23/2020,mg,antineoplastic,5/11/2019,4/5/2019,Intravenous,pembrolizumab,TRUE
500,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,1/15/2015,mg,antineoplastic,10/14/2014,10/22/2014,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/4/2017,mg,antineoplastic,12/11/2015,5/17/2015,Intravenous,nivolumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/1/2015,mg,antineoplastic,7/25/2015,3/20/2015,Intravenous,pemetrexed,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/24/2021,mg,antineoplastic,3/24/2021,10/29/2020,Intravenous,gemcitabine,FALSE
32,,ADJUVANT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,3/11/2014,mg,antineoplastic,1/12/2014,1/18/2014,Intravenous,vinorelbine,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/14/2015,mg,antineoplastic,11/12/2014,10/27/2014,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/10/2022,,antineoplastic,8/1/2021,4/7/2017,Oral,nilotinib,FALSE
550,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,8/9/2012,mg,antineoplastic,4/19/2012,3/30/2012,Intravenous,carboplatin,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,10/29/2024,mg,antineoplastic,9/13/2024,8/5/2024,Intravenous,carboplatin,FALSE
395,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,5/1/2016,mg,antineoplastic,4/19/2016,2/21/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/18/2022,mg,antineoplastic,12/11/2021,11/7/2021,Intravenous,pembrolizumab,FALSE
178,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/6/2012,mg,antineoplastic,4/27/2012,2/22/2012,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,2/17/2019,mg,antineoplastic,6/22/2018,7/10/2018,Intravenous,nivolumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/19/2020,mg,antineoplastic,2/3/2020,10/3/2019,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,4/1/2024,mg,antineoplastic,6/11/2023,3/15/2023,Intravenous,bevacizumab-awwb,TRUE
66,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/17/2015,mg,antineoplastic,3/31/2015,2/15/2015,Intravenous,cisplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/13/2025,mg,antineoplastic,6/15/2017,12/30/2016,Intravenous,pembrolizumab,FALSE
124,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/30/2019,mg,antineoplastic,8/21/2019,8/16/2019,Intravenous,carboplatin,FALSE
700,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,8/4/2014,mg,antineoplastic,3/5/2014,3/27/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G1969F536B2DD,10/27/2011,,antineoplastic,8/27/2011,6/7/2011,Intravenous,clinical study drug,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,8/12/2015,mg,antineoplastic,9/7/2014,6/16/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/27/2017,,antineoplastic,8/17/2017,7/5/2017,,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1:9FCE6E6G6C,2/7/2019,,antineoplastic,2/19/2019,1/16/2019,Oral,anastrozole,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/17/2019,mg,antineoplastic,6/28/2019,6/5/2019,Intravenous,carboplatin,FALSE
587,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/20/2025,mg,antineoplastic,6/16/2019,4/2/2019,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/6/2016,mg,antineoplastic,5/15/2016,5/6/2016,Intravenous,paclitaxel,FALSE
410,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,7/4/2024,mg,antineoplastic,3/10/2024,11/15/2023,Intravenous,carboplatin,FALSE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G3:67CF8FF:28,10/26/2021,,,4/17/2020,5/15/2020,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/6/2022,mg,antineoplastic,10/9/2021,9/28/2021,Intravenous,pembrolizumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/23/2025,mg,antineoplastic,12/12/2024,8/31/2024,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,cytoprotective,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/4/2012,,cytoprotective,4/8/2012,3/11/2012,,clinical study drug,FALSE
1000,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G3C:F1C:2BF6C,1/17/2015,mg/m2,antineoplastic,11/23/2014,10/27/2014,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,4/25/2024,,antineoplastic,4/29/2024,3/19/2024,,paclitaxel,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/3/2022,mg,antineoplastic,4/19/2022,11/20/2021,Intravenous,leucovorin,FALSE
484,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,5/19/2020,mg,antineoplastic,2/13/2020,11/3/2019,Intravenous,carboplatin,FALSE
140,2,ADVANCED,Administrations,chemotherapy,"Paclitaxel Protein-Bound,Pembrolizumab",G5829EBB749DF,4/18/2019,mg,antineoplastic,5/14/2019,4/24/2019,Intravenous,paclitaxel protein-bound,FALSE
735,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,12/16/2023,mg,antineoplastic,10/13/2023,10/12/2023,Intravenous,pemetrexed,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/10/2017,mg,antineoplastic,7/3/2016,6/11/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,10/8/2023,mg,antineoplastic,7/19/2023,5/30/2023,Intravenous,carboplatin,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/24/2020,mg,antineoplastic,11/4/2020,7/10/2020,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/24/2025,mg,antineoplastic,4/23/2022,7/24/2021,Intravenous,atezolizumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G5722GECG4G16,3/1/2024,mg,antineoplastic,10/9/2023,11/7/2023,Intravenous,durvalumab,TRUE
271.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/27/2023,mg,antineoplastic,5/10/2023,2/15/2023,Intravenous,paclitaxel,FALSE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/7/2015,mg,antineoplastic,7/31/2015,7/17/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,1/23/2023,mg,antineoplastic,5/1/2021,4/12/2021,Intravenous,pembrolizumab,TRUE
325,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,4/16/2019,mg,antineoplastic,4/2/2019,2/16/2019,Intravenous,paclitaxel,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/12/2016,mg,antineoplastic,11/13/2015,6/8/2015,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,9/7/2012,mg,antineoplastic,4/22/2012,3/31/2012,Intravenous,paclitaxel protein-bound,FALSE
69,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/28/2018,mg,antineoplastic,8/22/2015,6/24/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,4/2/2025,,antineoplastic,2/17/2022,3/1/2022,Intravenous,pembrolizumab,TRUE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/11/2020,mg,antineoplastic,3/15/2020,2/23/2020,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/24/2025,mg,antineoplastic,3/12/2024,5/21/2023,Intravenous,pembrolizumab,FALSE
575,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/20/2023,mg,antineoplastic,5/19/2023,5/4/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G327B2G171G96,5/30/2022,,antineoplastic,3/11/2020,3/16/2020,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/14/2025,,antineoplastic,9/10/2023,2/11/2023,Intravenous,pemetrexed,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/9/2021,mg,antineoplastic,8/29/2020,12/27/2019,Intravenous,durvalumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,9/12/2020,mg,antineoplastic,4/4/2019,2/6/2019,Intravenous,nivolumab,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/9/2021,mg,antineoplastic,3/21/2021,1/4/2021,Intravenous,vinorelbine,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,3/13/2025,mL,solution-fluid,9/9/2024,4/2/2024,Intravenous,pembrolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/12/2025,mg,antineoplastic,4/2/2021,2/1/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/19/2018,mg,antineoplastic,7/11/2017,8/23/2015,Intravenous,nivolumab,FALSE
202,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,9/17/2018,mg,antineoplastic,4/18/2013,2/5/2013,Intravenous,carboplatin,FALSE
494,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,12/11/2015,mg,antineoplastic,11/17/2015,10/24/2015,Intravenous,carboplatin,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,1/11/2025,mg,antineoplastic,4/12/2023,3/26/2023,Intravenous,paclitaxel protein-bound,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/21/2016,mg,antineoplastic,6/22/2015,5/3/2015,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,10/28/2024,mg,antineoplastic,7/20/2024,6/3/2024,Intravenous,carboplatin,FALSE
172,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/14/2022,mg,antineoplastic,10/22/2021,11/11/2021,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,4/10/2025,mg,antineoplastic,7/22/2024,4/11/2024,Intravenous,durvalumab,TRUE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/11/2016,mg,antineoplastic,6/16/2014,6/24/2014,Intravenous,bevacizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/4/2020,mg,antineoplastic,7/28/2020,9/1/2019,Intravenous,pembrolizumab,FALSE
472,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/24/2025,mg,antineoplastic,10/20/2024,10/23/2022,Intravenous,pemetrexed,TRUE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,10/7/2015,mg,antineoplastic,6/20/2015,2/28/2015,Intravenous,pemetrexed,TRUE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,10/11/2016,mg,antineoplastic,7/21/2016,7/15/2016,Intravenous,carboplatin,FALSE
739,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/17/2018,mg,antineoplastic,8/31/2018,8/19/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/22/2020,mg,antineoplastic,11/7/2019,1/14/2019,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/16/2024,mg,antineoplastic,4/29/2024,7/3/2023,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G43D:C17:25FG,9/7/2015,mg/m2,antineoplastic,7/1/2015,2/20/2015,Intravenous,gemcitabine,FALSE
93,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3E76E32E795:,6/28/2020,mg,antineoplastic,3/14/2020,3/11/2020,Intravenous,docetaxel,FALSE
2500,,NEOADJUVANT,Administrations,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,1/16/2013,mg,antineoplastic,1/2/2013,2/11/2013,Intravenous,mesna,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/8/2024,mg,antineoplastic,7/30/2024,6/10/2024,Intravenous,etoposide,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,4/19/2012,mg,antineoplastic,3/9/2012,2/12/2012,Subcutaneous,amifostine,FALSE
421,2,ADVANCED,Administrations,chemotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,11/17/2024,mg,antineoplastic,11/12/2024,8/20/2024,Intravenous,pemetrexed,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,10/6/2015,mg,antineoplastic,7/28/2015,2/11/2015,Intravenous,gemcitabine,FALSE
1100,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,6/15/2017,mg,antineoplastic,7/3/2017,6/3/2017,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G1B:EDB855:88,5/1/2016,,,3/6/2016,3/29/2016,Oral,erlotinib,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,4/14/2019,mg,antineoplastic,2/1/2019,1/1/2019,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/15/2025,mg,antineoplastic,1/13/2024,4/4/2020,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1CG8EF93777D,1/24/2022,mg,antineoplastic,1/16/2022,1/18/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/27/2023,mg,antineoplastic,9/7/2022,6/25/2022,Intravenous,pembrolizumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/21/2020,mg,antineoplastic,7/11/2019,2/27/2019,Intravenous,durvalumab,FALSE
368,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/3/2021,mg,antineoplastic,5/18/2021,4/22/2021,Intravenous,carboplatin,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,4/9/2025,mg,antineoplastic,2/20/2025,3/1/2024,Intravenous,durvalumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,4/19/2025,mg,antineoplastic,2/17/2025,1/12/2025,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/7/2024,mg,antineoplastic,8/19/2023,3/9/2023,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,3/4/2025,,antineoplastic,1/30/2023,2/2/2022,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/19/2025,mg,antineoplastic,9/19/2018,3/1/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G147ED4GE76EE,2/12/2020,,,12/26/2019,1/3/2020,Oral,afatinib,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/7/2025,mg/m2,antineoplastic,1/16/2025,6/25/2024,Intravenous,gemcitabine,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/4/2020,mg,antineoplastic,1/14/2020,1/11/2019,Subcutaneous,bortezomib,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/12/2014,AUC,antineoplastic,12/16/2013,12/16/2013,Intravenous,carboplatin,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/27/2013,mg/m2,antineoplastic,9/10/2012,8/11/2012,Intravenous,docetaxel,FALSE
233.6,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/14/2017,mg,antineoplastic,12/9/2016,8/12/2016,Intravenous,carboplatin,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/6/2013,mg,antineoplastic,4/8/2013,5/1/2013,Intravenous,paclitaxel,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/16/2012,AUC,antineoplastic,9/7/2012,5/17/2012,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/9/2015,mg,antineoplastic,2/10/2015,10/21/2014,Intravenous,cisplatin,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/12/2013,mg,antineoplastic,11/27/2012,11/12/2012,Intravenous,vinorelbine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/19/2022,mg,antineoplastic,11/19/2017,4/8/2017,Intravenous,nivolumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/21/2014,mL,solution-fluid,2/7/2014,10/30/2013,Intravenous,pemetrexed,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46E218G4252C,8/7/2016,mg,antineoplastic,6/25/2016,5/24/2016,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/1/2022,mg,antineoplastic,8/18/2021,2/13/2021,Intravenous,atezolizumab,FALSE
503,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,1/6/2022,mg,antineoplastic,9/24/2021,7/20/2021,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,3/13/2025,,antineoplastic,11/27/2024,4/14/2024,,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1F8F989D:8C8,12/12/2022,mg,antineoplastic,9/22/2020,9/2/2020,Intravenous,pembrolizumab,FALSE
83,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,6/18/2023,mg,antineoplastic,3/21/2023,2/2/2023,Intravenous,cisplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/19/2024,mg,antineoplastic,5/19/2021,7/4/2020,Intravenous,nivolumab,FALSE
885,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,7/27/2012,mg,antineoplastic,4/5/2012,3/13/2012,Intravenous,bevacizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/30/2022,mg,antineoplastic,3/17/2022,4/15/2017,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/9/2012,mg,antineoplastic,12/5/2011,11/21/2011,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,5/11/2025,mg,antineoplastic,12/27/2024,9/21/2024,Intravenous,pembrolizumab,FALSE
88,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,1/30/2023,mg,antineoplastic,11/14/2022,10/14/2022,Intravenous,paclitaxel,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/14/2023,mg,antineoplastic,1/5/2021,4/25/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/27/2021,mg,antineoplastic,5/3/2020,10/9/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/30/2024,mg,antineoplastic,4/27/2024,3/25/2024,Intravenous,pembrolizumab,FALSE
337,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/27/2018,mg,antineoplastic,8/19/2018,5/28/2018,Intravenous,carboplatin,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/20/2024,mg,antineoplastic,8/12/2023,8/2/2023,Intravenous,gemcitabine,FALSE
184,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/15/2021,mg,antineoplastic,7/2/2020,5/9/2020,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/6/2025,mg,antineoplastic,1/12/2024,10/10/2022,Intravenous,pembrolizumab,TRUE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/16/2025,AUC,antineoplastic,11/3/2024,11/9/2024,Intravenous,carboplatin,FALSE
638,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26B488B88188,1/23/2024,mg,antineoplastic,1/7/2024,2/18/2024,Intravenous,carboplatin,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,6/23/2016,mg,antineoplastic,4/30/2016,3/27/2016,Intravenous,cisplatin,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/5/2024,mg,antineoplastic,2/1/2024,6/11/2023,Intravenous,pemetrexed,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/6/2025,mg,antineoplastic,11/11/2020,3/13/2019,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G24167D1DD5FG,2/7/2025,mg,antineoplastic,10/21/2024,10/4/2024,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,3/28/2025,mg,antineoplastic,8/18/2024,7/13/2024,Intravenous,durvalumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/31/2021,,antineoplastic,7/4/2020,2/25/2020,Intravenous,clinical study drug,FALSE
90,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/15/2022,mg/m2,antineoplastic,12/9/2021,10/8/2021,Intravenous,irinotecan,FALSE
672,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/9/2025,mg,antineoplastic,1/7/2025,12/12/2024,Intravenous,fluorouracil,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,4/9/2012,mg,antineoplastic,3/22/2012,2/3/2012,Intravenous,vinorelbine,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/8/2025,mg,antineoplastic,1/19/2025,8/31/2024,Intravenous,durvalumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/23/2019,mg,antineoplastic,9/27/2017,9/2/2017,Intravenous,atezolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/21/2011,mg,antineoplastic,4/4/2011,3/11/2011,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/12/2023,,antineoplastic,8/9/2023,12/31/2022,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/20/2025,mg,antineoplastic,10/20/2024,9/11/2024,Intravenous,pembrolizumab,TRUE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/15/2022,mg,antineoplastic,10/25/2021,10/24/2021,Intravenous,carboplatin,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/6/2013,AUC,antineoplastic,8/7/2012,7/25/2012,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,5/29/2024,mg,antineoplastic,10/30/2023,8/1/2023,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,7/7/2023,mg,antineoplastic,5/6/2023,3/25/2023,Intravenous,pembrolizumab,FALSE
123,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,12/3/2022,mg,antineoplastic,7/29/2022,6/22/2022,Intravenous,carboplatin,FALSE
315,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,11/24/2020,mg,antineoplastic,2/11/2020,1/16/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,4/1/2024,mg,antineoplastic,2/18/2024,6/11/2020,Intravenous,pembrolizumab,TRUE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,12/5/2014,mg,antineoplastic,6/3/2014,4/10/2014,Intravenous,paclitaxel,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,7/11/2016,mg,antineoplastic,7/3/2016,4/16/2016,Intravenous,cisplatin,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/29/2024,mL,solution-fluid,12/17/2023,11/15/2023,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/1/2024,mg,antineoplastic,5/31/2024,3/7/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/16/2025,mg,antineoplastic,5/10/2024,3/16/2024,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1E3BGE6C42B6,2/24/2025,mg,antineoplastic,3/18/2025,2/23/2025,Intravenous,atezolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,4/27/2025,mg,antineoplastic,1/16/2025,9/19/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/5/2013,mg,antineoplastic,1/30/2013,11/17/2012,Intravenous,paclitaxel protein-bound,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,11/10/2023,mg,antineoplastic,9/15/2023,8/4/2023,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/28/2022,mg,antineoplastic,11/20/2021,12/4/2021,Intravenous,paclitaxel,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,6/23/2015,mg,antineoplastic,8/26/2014,9/13/2014,Intravenous,pemetrexed,FALSE
359,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,1/16/2014,mg,antineoplastic,12/11/2013,12/17/2013,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/14/2014,mg,antineoplastic,8/6/2014,7/23/2014,Intravenous,pemetrexed,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/6/2019,mg,antineoplastic,2/4/2019,7/15/2018,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/10/2019,mL,solution-fluid,9/1/2019,7/19/2019,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/7/2018,mg,antineoplastic,12/22/2017,9/3/2017,Intravenous,atezolizumab,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,3/27/2013,mg,antineoplastic,3/8/2013,2/14/2013,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/11/2025,mg,antineoplastic,7/4/2024,8/20/2021,Intravenous,atezolizumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/31/2025,mg/m2,antineoplastic,5/2/2024,11/11/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/6/2025,mg,antineoplastic,3/6/2021,3/16/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,6/7/2021,mg,antineoplastic,9/19/2018,9/24/2018,Intravenous,pembrolizumab,FALSE
570,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,5/3/2023,mg,antineoplastic,11/6/2022,10/21/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/21/2017,,solution-fluid,7/27/2016,2/29/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/24/2022,mg,antineoplastic,6/5/2022,3/15/2020,Intravenous,pembrolizumab,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/18/2024,mg,antineoplastic,4/27/2022,12/12/2021,Intravenous,durvalumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/16/2024,mg,antineoplastic,8/29/2023,2/3/2023,Intravenous,durvalumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/24/2020,mg,antineoplastic,3/30/2019,10/27/2018,Intravenous,pemetrexed,TRUE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/24/2021,mg,antineoplastic,1/29/2021,12/15/2020,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/24/2025,,antineoplastic,4/30/2024,5/3/2024,Intravenous,pembrolizumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/8/2015,mg,antineoplastic,11/12/2014,9/14/2014,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/11/2025,mg,antineoplastic,5/21/2024,5/2/2024,Intravenous,cemiplimab,TRUE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/13/2020,mg,antineoplastic,8/4/2020,9/27/2019,Intravenous,durvalumab,FALSE
370,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/24/2013,mg,antineoplastic,9/7/2012,4/4/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/11/2024,,antineoplastic,8/17/2023,6/25/2023,Intravenous,gemcitabine,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/19/2024,mg,antineoplastic,9/14/2023,7/10/2023,Intravenous,paclitaxel protein-bound,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G25E1C41F29EC,2/8/2021,mg,antineoplastic,10/9/2015,9/27/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,4/27/2024,mg,antineoplastic,1/30/2024,12/28/2023,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/1/2018,mg,antineoplastic,11/8/2015,8/8/2015,Intravenous,nivolumab,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/5/2021,mg,antineoplastic,5/21/2021,4/6/2021,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/29/2015,,antineoplastic,3/21/2015,3/5/2015,,carboplatin,FALSE
1230,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/27/2017,mg,antineoplastic,2/1/2017,1/14/2017,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/5/2025,mg,antineoplastic,8/30/2023,9/9/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,Sotorasib,G1D2821G451G:,6/9/2024,,,7/27/2024,12/15/2023,Oral,sotorasib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Capecitabine,Docetaxel",G356E75GB3883,10/5/2017,,antineoplastic,10/28/2017,10/16/2017,Oral,capecitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/25/2025,mg,antineoplastic,9/12/2019,4/6/2018,Intravenous,pembrolizumab,FALSE
131,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,7/25/2024,mg,antineoplastic,6/3/2024,6/19/2024,Intravenous,etoposide,FALSE
800,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G4G4D:D9D8152,4/30/2025,mg/m2,antineoplastic,2/28/2025,2/26/2025,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/20/2020,mg,antineoplastic,2/11/2020,8/26/2019,Intravenous,pembrolizumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/23/2025,mg,antineoplastic,11/14/2024,9/9/2024,Intravenous,durvalumab,TRUE
1250,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,5/21/2013,mg,antineoplastic,3/5/2013,1/23/2013,Intravenous,gemcitabine,FALSE
514,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/29/2023,mg,antineoplastic,6/2/2023,1/18/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/11/2023,mg,antineoplastic,3/7/2023,12/20/2022,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/2/2022,mg,antineoplastic,6/3/2021,3/16/2021,Intravenous,atezolizumab,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,9/19/2019,mg/m2,antineoplastic,6/9/2019,5/21/2019,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,12/27/2013,,antineoplastic,12/27/2013,10/19/2013,,clinical study drug,FALSE
470,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G484BED:E686:,1/6/2018,mg,antineoplastic,1/13/2018,12/3/2017,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,4/14/2023,mg,antineoplastic,2/13/2023,4/8/2022,Intravenous,atezolizumab,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,4/27/2017,mg,antineoplastic,2/14/2017,12/19/2016,Intravenous,pemetrexed,FALSE
2052,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G51:G:C712CC6,1/28/2020,mg,antineoplastic,12/2/2019,11/6/2019,Intravenous,gemcitabine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/21/2025,mg,antineoplastic,5/8/2024,6/15/2023,Intravenous,pembrolizumab,TRUE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/11/2015,mg,antineoplastic,3/30/2015,2/10/2015,Intravenous,paclitaxel protein-bound,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/13/2016,mg,antineoplastic,4/16/2016,4/17/2016,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/27/2025,mg,antineoplastic,1/24/2018,7/12/2016,Intravenous,pembrolizumab,FALSE
424,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,10/18/2019,mg,antineoplastic,9/9/2019,10/21/2019,Intravenous,carboplatin,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,12/15/2024,mg,antineoplastic,6/6/2024,6/7/2024,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/23/2016,mg,antineoplastic,9/22/2014,9/21/2014,Intravenous,etoposide,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,12/26/2015,mg,antineoplastic,8/25/2015,4/29/2015,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,4/9/2024,5/22/2023,Intravenous,pembrolizumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/21/2016,mg,antineoplastic,11/13/2015,10/14/2015,Intravenous,etoposide,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/14/2020,mg,antineoplastic,2/9/2020,2/21/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,1/7/2025,mg,antineoplastic,10/20/2024,10/22/2024,Intravenous,pembrolizumab,FALSE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G25BG745::8GE,3/11/2025,,,7/17/2024,6/22/2024,Oral,osimertinib,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G484BED:E686:,11/26/2017,mg,antineoplastic,12/4/2017,1/4/2018,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/23/2023,mg,antineoplastic,12/21/2022,11/21/2022,Intravenous,atezolizumab,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/1/2016,mg,antineoplastic,9/16/2015,7/28/2015,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G257D9:2573CF,4/2/2025,mg,antineoplastic,4/10/2025,12/6/2024,Intravenous,durvalumab,TRUE
1677,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,2/16/2023,mg,antineoplastic,12/28/2022,12/19/2022,Intravenous,bevacizumab-bvzr,FALSE
72,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,5/12/2012,mg/m2,antineoplastic,3/15/2012,1/30/2012,Intravenous,paclitaxel,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,10/26/2015,mg,antineoplastic,9/17/2015,8/27/2015,Intravenous,carboplatin,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/21/2019,mg,antineoplastic,9/20/2019,5/4/2019,Intravenous,carboplatin,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/22/2019,mg,antineoplastic,8/31/2019,8/7/2019,Intravenous,etoposide,FALSE
371,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/11/2016,mg,antineoplastic,6/29/2015,7/28/2015,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/1/2016,,antineoplastic,7/16/2016,3/25/2016,Intravenous,paclitaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/2/2025,mg,antineoplastic,7/20/2023,2/14/2020,Intravenous,pemetrexed,TRUE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,8/5/2023,mg,antineoplastic,5/16/2023,3/1/2023,Intravenous,durvalumab,TRUE
454,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/23/2024,mg,antineoplastic,3/15/2024,11/25/2023,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/1/2024,mg,antineoplastic,7/17/2020,6/22/2020,Intravenous,nivolumab,FALSE
173,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/8/2013,mg,antineoplastic,8/29/2013,10/7/2012,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/21/2025,mg,antineoplastic,3/18/2022,3/17/2019,Intravenous,pemetrexed,FALSE
1107.5,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/1/2015,mg,antineoplastic,10/23/2015,2/16/2015,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/19/2024,,antineoplastic,12/2/2023,11/16/2023,,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/8/2024,mg,antineoplastic,8/16/2024,6/30/2024,Intravenous,pembrolizumab,FALSE
,5,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G4826CB54C27:,5/1/2025,,,12/21/2024,11/29/2024,Oral,osimertinib,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/17/2022,mg,antineoplastic,10/27/2021,12/5/2021,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/26/2016,mg,antineoplastic,8/18/2015,6/10/2015,Intravenous,carboplatin,FALSE
254,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,11/6/2024,mg,antineoplastic,8/28/2024,6/30/2024,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G45DDGFC1G86F,4/15/2016,mg,antineoplastic,4/22/2016,4/2/2016,Intravenous,nivolumab,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/26/2014,mg,antineoplastic,7/10/2014,5/22/2014,Intravenous,carboplatin,FALSE
560,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,1/22/2015,mg,antineoplastic,1/18/2015,2/11/2015,Intravenous,carboplatin,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/7/2012,mg,antineoplastic,6/18/2012,2/23/2012,Intravenous,docetaxel,FALSE
,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/18/2021,mg/m2,antineoplastic,6/23/2021,4/15/2021,Intravenous,paclitaxel protein-bound,FALSE
1130,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/9/2020,mg,antineoplastic,7/12/2014,4/21/2014,Intravenous,cyclophosphamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/11/2025,mg,antineoplastic,3/20/2024,7/28/2022,Intravenous,pembrolizumab,TRUE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/17/2015,mg,antineoplastic,3/23/2015,8/9/2014,Intravenous,bevacizumab,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/29/2020,mg,antineoplastic,4/9/2018,2/18/2017,Intravenous,bevacizumab,FALSE
185,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,12/6/2022,mg,antineoplastic,11/20/2022,11/24/2022,Intravenous,carboplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/6/2022,mg,antineoplastic,3/24/2022,5/1/2017,Oral,nilotinib,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/13/2025,,antineoplastic,12/12/2023,2/2/2023,,clinical study drug,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,12/12/2023,mg,antineoplastic,10/4/2023,9/4/2023,Intravenous,carboplatin,FALSE
45,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,1/15/2013,mg/m2,antineoplastic,12/13/2012,1/16/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G448FDE96D2D6,4/1/2015,mg,antineoplastic,3/7/2015,3/25/2015,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/22/2020,mg,antineoplastic,9/25/2016,1/17/2016,Intravenous,bevacizumab,TRUE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,7/4/2015,mg,antineoplastic,8/10/2013,7/14/2013,Intravenous,paclitaxel,FALSE
390,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,8/10/2014,mg,antineoplastic,4/9/2014,2/4/2014,Intravenous,paclitaxel,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,11/29/2022,mg/m2,antineoplastic,8/23/2022,9/7/2022,Intravenous,paclitaxel,FALSE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/13/2018,mg,antineoplastic,9/23/2018,8/31/2018,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/17/2025,mg,antineoplastic,5/13/2025,3/24/2025,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G57G45B:D1F17,1/27/2025,,antineoplastic,11/24/2017,11/3/2017,,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/27/2022,mg,antineoplastic,9/9/2017,5/13/2017,Intravenous,nivolumab,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/26/2015,mg,antineoplastic,4/11/2015,2/20/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/6/2024,mg,antineoplastic,11/28/2020,4/28/2020,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,9/29/2021,mg/m2,antineoplastic,9/11/2021,2/18/2021,Intravenous,fluorouracil,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/7/2024,,antineoplastic,7/31/2023,4/6/2023,Intravenous,atezolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/10/2025,mg,antineoplastic,12/15/2022,8/9/2021,Intravenous,atezolizumab,TRUE
,2,ADVANCED,Unstructured,,Erlotinib,G5273D::F8155,12/21/2016,,,11/4/2016,10/2/2016,Oral,erlotinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/24/2023,mg,antineoplastic,8/17/2022,5/21/2022,Intravenous,nivolumab,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,5/9/2020,mg,antineoplastic,2/27/2020,10/16/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,11/24/2022,,antineoplastic,10/20/2022,11/27/2022,,cisplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,,antineoplastic,7/13/2021,5/18/2017,Oral,nilotinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,7/21/2024,mg,antineoplastic,5/31/2024,8/11/2023,Intravenous,nivolumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/29/2022,mg,antineoplastic,11/29/2021,11/7/2021,Intravenous,paclitaxel,FALSE
469,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,11/3/2016,mg,antineoplastic,8/26/2016,8/25/2016,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/14/2024,mg,antineoplastic,12/31/2023,12/12/2023,Intravenous,durvalumab,FALSE
100,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,3/5/2013,mg/m2,antineoplastic,1/25/2013,12/19/2012,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,7/6/2018,mg,antineoplastic,4/1/2018,3/9/2018,Intravenous,nivolumab,FALSE
160,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:3B43D3B55G,2/24/2024,mg,antineoplastic,12/2/2023,11/13/2023,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/19/2025,,antineoplastic,3/2/2025,4/6/2020,Oral,enzalutamide,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/29/2021,mg/m2,antineoplastic,7/23/2021,3/18/2021,Intravenous,oxaliplatin,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/3/2021,mg,antineoplastic,6/25/2021,5/10/2021,Intravenous,carboplatin,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/24/2021,mg,antineoplastic,11/30/2020,10/26/2020,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/19/2020,mg,antineoplastic,11/11/2019,7/19/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G58G2E7D9G4E7,6/11/2018,mg,antineoplastic,5/13/2018,3/16/2018,Intravenous,nivolumab,FALSE
186,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/8/2021,mg,antineoplastic,4/12/2021,12/9/2020,Intravenous,paclitaxel protein-bound,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/3/2024,AUC,antineoplastic,10/6/2023,8/24/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/3/2019,,antineoplastic,3/24/2019,2/27/2019,,cisplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/28/2024,mg,antineoplastic,8/28/2024,8/12/2024,Intravenous,pemetrexed,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/21/2021,mg,antineoplastic,9/29/2020,10/21/2020,Intravenous,bevacizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/23/2024,mg,antineoplastic,8/23/2023,3/4/2023,Intravenous,atezolizumab,TRUE
195,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,8/20/2021,mg,antineoplastic,6/20/2021,7/19/2021,Intravenous,paclitaxel protein-bound,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/12/2014,mg,antineoplastic,8/14/2014,9/4/2014,Intravenous,carboplatin,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/13/2021,mg,antineoplastic,12/5/2021,4/15/2021,Intravenous,vinorelbine,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4B1F584CB682,2/4/2016,mg,antineoplastic,11/8/2015,10/16/2015,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,11/5/2023,mg,antineoplastic,9/16/2023,1/4/2023,Oral,zanubrutinib,FALSE
1010,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,11/12/2021,mg,antineoplastic,9/28/2021,7/30/2021,Intravenous,pemetrexed,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,7/5/2021,mg,antineoplastic,3/12/2021,10/14/2020,Intravenous,gemcitabine,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/3/2025,mg,antineoplastic,7/19/2017,8/12/2016,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,9/14/2017,mg,antineoplastic,7/3/2017,7/8/2017,Intravenous,ramucirumab,FALSE
127,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/28/2021,mg,antineoplastic,4/18/2021,6/28/2020,Intravenous,docetaxel,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,12/17/2024,mg,antineoplastic,1/14/2025,9/5/2024,Intravenous,durvalumab,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,1/13/2014,mg/kg,antineoplastic,1/11/2014,11/4/2013,Intravenous,bevacizumab,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/7/2014,AUC,antineoplastic,6/6/2014,12/3/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,5/2/2020,mg,antineoplastic,2/2/2020,1/8/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,3/14/2024,,pain agent,8/26/2023,6/17/2023,Oral,clinical study drug,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/11/2025,mg,antineoplastic,11/22/2023,10/3/2022,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/7/2023,mg,antineoplastic,11/26/2017,10/13/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/24/2025,mg,antineoplastic,6/29/2020,1/27/2019,Intravenous,pembrolizumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,4/18/2024,mg,antineoplastic,8/9/2020,9/9/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/17/2025,mg,antineoplastic,12/10/2022,8/24/2022,Intravenous,pembrolizumab,TRUE
746,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,10/31/2024,mg,antineoplastic,9/13/2024,7/15/2024,Intravenous,pemetrexed,FALSE
287,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,4/8/2025,mg,antineoplastic,6/11/2024,5/30/2024,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,2/3/2015,mg,antineoplastic,3/3/2015,2/27/2015,Intravenous,etoposide,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,3/29/2023,mg,antineoplastic,3/24/2020,11/4/2019,Intravenous,pembrolizumab,TRUE
61.8,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/17/2021,mg,antineoplastic,6/29/2021,12/16/2020,Intravenous,vinorelbine,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/10/2024,mg,antineoplastic,5/15/2024,3/27/2024,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/14/2024,mg,antineoplastic,8/4/2021,6/28/2020,Intravenous,nivolumab,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/13/2020,mg,antineoplastic,11/7/2019,10/1/2019,Intravenous,durvalumab,FALSE
128,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/23/2023,mg,antineoplastic,7/8/2023,3/22/2023,Intravenous,cisplatin,FALSE
692,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/10/2025,mg,antineoplastic,3/3/2023,2/27/2023,Intravenous,carboplatin,FALSE
217.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/18/2013,mg,antineoplastic,6/3/2013,4/28/2013,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,5/4/2025,mg,antineoplastic,11/2/2024,8/30/2024,Intravenous,carboplatin,FALSE
850,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G49E3CE9E292G,3/6/2023,mg,antineoplastic,6/8/2020,4/26/2020,Intravenous,pemetrexed,FALSE
700,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,3/27/2025,mg,antineoplastic,3/25/2025,1/17/2025,Intravenous,carboplatin,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45DDGFC1G86F,11/12/2015,mg,antineoplastic,11/16/2015,11/6/2015,Intravenous,pemetrexed,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/8/2019,mg,antineoplastic,4/6/2018,11/1/2016,Intramuscular,fulvestrant,FALSE
199,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,8/26/2022,mg,antineoplastic,7/5/2022,6/7/2022,Intravenous,carboplatin,FALSE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/5/2024,mg,antineoplastic,8/24/2024,8/4/2024,Intravenous,paclitaxel,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/8/2020,mg,antineoplastic,11/5/2019,1/3/2019,Intravenous,durvalumab,TRUE
,1,ADVANCED,Unstructured,,Erlotinib,G115873FC55G5,5/27/2020,,,3/23/2018,10/3/2017,Oral,erlotinib,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/25/2022,mg,antineoplastic,12/18/2021,10/7/2021,Intravenous,leucovorin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/6/2025,,antineoplastic,9/2/2020,3/30/2020,Oral,enzalutamide,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G21744:G47B22,10/2/2014,mg,antineoplastic,9/29/2014,9/22/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/23/2023,,antineoplastic,4/27/2022,4/22/2022,Intravenous,pembrolizumab,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/6/2022,mg,antineoplastic,12/30/2021,9/9/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/30/2023,mg,antineoplastic,11/14/2022,6/30/2022,Intravenous,pembrolizumab,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,2/9/2017,mg,antineoplastic,1/19/2017,12/16/2016,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/23/2025,mg,antineoplastic,9/16/2024,12/1/2023,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,7/23/2017,,antineoplastic,1/18/2017,10/19/2016,,clinical study drug,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/24/2019,mg,antineoplastic,8/19/2019,6/12/2019,Intravenous,paclitaxel,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,8/13/2016,mg,antineoplastic,4/22/2016,4/1/2016,Intravenous,paclitaxel,FALSE
654,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,3/9/2016,mg,antineoplastic,6/26/2015,7/14/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,5/1/2025,mg,antineoplastic,12/10/2024,9/27/2024,Intravenous,pembrolizumab,TRUE
175,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/21/2017,mg,antineoplastic,2/15/2016,2/5/2016,Intravenous,nivolumab,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,9/17/2024,mg,antineoplastic,7/14/2024,7/13/2024,Intravenous,pemetrexed,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/15/2016,mg,antineoplastic,1/1/2016,7/7/2015,Intravenous,bevacizumab,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/16/2017,mg,antineoplastic,2/13/2017,9/17/2016,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/18/2022,mg,antineoplastic,5/7/2021,12/26/2019,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/28/2020,mg,antineoplastic,9/17/2019,4/21/2019,Intravenous,pembrolizumab,TRUE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G19B:27:ECB43,1/19/2025,,,7/16/2021,6/27/2021,Oral,osimertinib,FALSE
196,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,8/19/2019,mg,antineoplastic,7/17/2019,5/12/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Relugolix,G214C6EC1517:,1/3/2025,,antineoplastic,11/20/2024,10/30/2024,Oral,relugolix,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,1/28/2018,AUC,antineoplastic,9/22/2017,10/2/2017,Intravenous,carboplatin,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Osimertinib,Paclitaxel",G1594:E29D2D9,5/17/2022,mg,antineoplastic,3/4/2022,2/12/2022,Intravenous,paclitaxel,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/17/2019,mg,antineoplastic,2/5/2019,1/18/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/6/2023,mg,antineoplastic,8/15/2022,3/18/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/5/2025,mg,antineoplastic,12/7/2023,8/24/2022,Intravenous,pembrolizumab,TRUE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,5/5/2025,mg,antineoplastic,9/15/2024,7/16/2024,Intravenous,durvalumab,FALSE
857,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/24/2015,mg,antineoplastic,12/10/2014,11/16/2014,Intravenous,carboplatin,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/9/2018,mg,antineoplastic,8/29/2018,5/30/2018,Intravenous,paclitaxel,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/19/2015,mg,antineoplastic,4/1/2015,3/19/2015,Intravenous,cisplatin,FALSE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/19/2021,mg/m2,antineoplastic,4/9/2021,4/10/2021,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Unstructured,,Crizotinib,G53C61B2GG71F,4/25/2016,,,7/2/2015,8/16/2015,Oral,crizotinib,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/17/2024,mg,antineoplastic,6/30/2024,11/8/2023,Intravenous,pemetrexed,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/12/2024,mg,antineoplastic,5/8/2024,10/23/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/24/2022,mg,antineoplastic,11/29/2021,10/2/2021,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/14/2020,mg,antineoplastic,6/22/2016,11/4/2015,Intravenous,nivolumab,FALSE
2588,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,5/22/2022,mg,antineoplastic,10/16/2021,9/1/2021,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,hormone,Bicalutamide,G4992B5EB431G,12/22/2018,,antineoplastic,1/2/2019,12/29/2018,,bicalutamide,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,1/28/2020,mg/m2,antineoplastic,10/28/2019,10/27/2019,Intravenous,paclitaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/23/2022,mg,antineoplastic,4/7/2020,4/23/2020,Intravenous,pemetrexed,TRUE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,4/28/2024,AUC,antineoplastic,5/14/2024,4/6/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/23/2024,,antineoplastic,2/13/2024,4/29/2023,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G455E1367:DG4,7/24/2016,,,6/18/2016,11/5/2015,Oral,erlotinib,FALSE
40,7,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G4C53C5GC48E:,11/28/2016,mg,antineoplastic,10/18/2016,10/11/2016,Intravenous,vinorelbine,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/31/2025,mg,antineoplastic,10/15/2022,3/6/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/24/2023,mg,antineoplastic,9/2/2022,3/19/2020,Intravenous,pembrolizumab,TRUE
375,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/31/2025,mg,antineoplastic,5/8/2019,2/13/2019,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,6/3/2022,mg,antineoplastic,1/16/2022,1/4/2022,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/18/2025,mg,antineoplastic,1/4/2023,12/11/2021,Intravenous,pembrolizumab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/26/2020,mg,antineoplastic,3/15/2019,7/6/2017,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/21/2025,,antineoplastic,2/27/2024,4/22/2020,Oral,enzalutamide,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,5/31/2024,mg,antineoplastic,5/17/2023,5/12/2023,Intravenous,pemetrexed,FALSE
775,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/23/2014,mg,antineoplastic,12/2/2013,11/18/2013,Intravenous,pemetrexed,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/6/2025,mg,antineoplastic,5/18/2024,5/13/2024,Intravenous,cemiplimab,TRUE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/13/2017,mg,antineoplastic,1/15/2017,12/16/2016,Intravenous,docetaxel,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/3/2021,mg,antineoplastic,10/6/2020,10/15/2020,Intravenous,nivolumab,FALSE
750,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/8/2024,mg,antineoplastic,2/15/2024,11/20/2023,Intravenous,pemetrexed,FALSE
750,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/19/2022,mg,antineoplastic,11/13/2021,10/2/2021,Intravenous,pemetrexed,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/7/2015,mg,antineoplastic,3/3/2015,10/11/2014,Intravenous,pemetrexed,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/1/2013,mg,antineoplastic,12/18/2011,12/18/2011,Intravenous,carboplatin,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Osimertinib,Paclitaxel",G1594:E29D2D9,5/12/2022,mg,antineoplastic,3/20/2022,1/29/2022,Intravenous,paclitaxel,FALSE
125,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,7/20/2021,mg,antineoplastic,5/7/2021,5/11/2021,Intravenous,carboplatin,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/27/2013,mg,antineoplastic,4/24/2013,5/4/2013,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/24/2022,mg,antineoplastic,1/15/2021,1/20/2016,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,12/4/2016,mg,antineoplastic,8/29/2016,10/6/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/25/2022,mg,antineoplastic,7/12/2022,5/25/2022,Intravenous,pembrolizumab,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/16/2024,mg,antineoplastic,6/21/2024,5/13/2024,Intravenous,etoposide,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/26/2016,mg,antineoplastic,5/17/2016,4/19/2016,Intravenous,bevacizumab,TRUE
1410,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,3/28/2023,mg,antineoplastic,10/12/2022,9/8/2022,Intravenous,gemcitabine,FALSE
150,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,9/23/2019,mg,antineoplastic,8/7/2019,8/5/2019,Intravenous,carboplatin,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,6/9/2022,mg,antineoplastic,3/20/2022,2/17/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/8/2025,mg,antineoplastic,5/23/2024,5/10/2024,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/23/2025,mg,antineoplastic,12/23/2023,2/5/2017,Intravenous,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3:C9BECD3F55,11/19/2020,mg,antineoplastic,11/4/2020,8/21/2020,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,12/3/2022,mg,antineoplastic,7/13/2018,1/7/2018,Intravenous,pembrolizumab,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,4/5/2025,mg,antineoplastic,11/8/2024,9/17/2024,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,9/7/2019,mg,antineoplastic,5/17/2019,2/18/2019,Intravenous,nivolumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,7/9/2022,mg,antineoplastic,7/7/2022,5/14/2022,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,3/16/2024,,antineoplastic,2/16/2024,1/26/2024,,cisplatin,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,8/11/2012,mg,antineoplastic,4/28/2012,3/13/2012,Intravenous,paclitaxel protein-bound,FALSE
940,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,9/5/2019,mg,antineoplastic,4/14/2019,5/14/2019,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,Sotorasib,G47DG9518GG1E,2/7/2025,,,12/4/2024,10/20/2024,Oral,sotorasib,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G434D7BE:6E1:,12/4/2024,,,1/3/2025,12/7/2024,Oral,osimertinib,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/20/2015,mg,antineoplastic,2/13/2015,1/25/2015,Intravenous,etoposide,FALSE
173,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/3/2024,mg,antineoplastic,2/20/2024,3/12/2024,Intravenous,carboplatin,FALSE
675,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,5/13/2017,mg,antineoplastic,9/28/2016,9/1/2016,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/18/2025,mg,antineoplastic,11/29/2024,3/16/2024,Intravenous,durvalumab,FALSE
693,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,8/2/2023,mg,antineoplastic,1/28/2023,10/13/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/28/2025,mg,antineoplastic,2/7/2025,11/13/2023,Intravenous,pembrolizumab,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/13/2012,mg,antineoplastic,9/7/2012,3/10/2012,Intravenous,docetaxel,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/24/2013,mg,antineoplastic,5/15/2013,1/9/2013,Intravenous,doxorubicin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G5273D::F8155,11/23/2016,,,12/12/2016,11/8/2016,Oral,erlotinib,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,5/13/2016,mg,antineoplastic,5/20/2015,3/1/2015,Intravenous,carboplatin,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,3/29/2020,mg,antineoplastic,4/15/2020,1/11/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3698C8B:5EE7,1/8/2022,mg,antineoplastic,11/23/2021,9/12/2021,Intravenous,pembrolizumab,TRUE
900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,5/22/2022,mg,antineoplastic,4/4/2022,2/12/2022,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/7/2025,,antineoplastic,1/4/2025,9/26/2024,Intravenous,carboplatin,FALSE
248,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,9/6/2024,mg,antineoplastic,6/8/2024,4/12/2024,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/30/2023,mg,antineoplastic,4/2/2023,3/2/2023,Intravenous,cemiplimab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/29/2023,mg,antineoplastic,2/4/2023,9/10/2022,Subcutaneous,azacitidine,FALSE
17.1,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,11/6/2013,mL,antineoplastic,7/9/2013,7/13/2013,Intravenous,vinorelbine,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/20/2013,mg,antineoplastic,5/10/2012,12/14/2011,Intravenous,carboplatin,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,3/29/2019,mg,antineoplastic,3/24/2019,3/4/2019,Intravenous,paclitaxel,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,6/20/2017,mg,antineoplastic,6/16/2017,6/20/2017,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/28/2017,,antineoplastic,7/1/2017,2/23/2017,Intravenous,pemetrexed,FALSE
440,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,5/1/2020,mg,antineoplastic,4/11/2020,3/25/2020,Intravenous,paclitaxel,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/1/2024,mg,antineoplastic,9/12/2024,9/22/2023,Intravenous,durvalumab,TRUE
,4,ADVANCED,Unstructured,,Erlotinib,G18E7528ED97:,6/26/2013,,,8/28/2012,9/15/2012,Oral,erlotinib,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,5/3/2019,mg,antineoplastic,1/23/2019,12/30/2018,Intravenous,bevacizumab,TRUE
1000,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E1C181843G1,6/2/2015,mg,antineoplastic,3/28/2015,4/9/2015,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/16/2025,mg,antineoplastic,8/11/2023,11/27/2021,Intravenous,pembrolizumab,TRUE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/6/2025,mg,antineoplastic,11/10/2024,8/18/2022,Intravenous,pembrolizumab,TRUE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/12/2014,AUC,antineoplastic,8/31/2014,11/1/2013,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/13/2017,mg,antineoplastic,1/17/2015,11/21/2014,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,5/22/2025,mg,antineoplastic,1/31/2025,1/12/2025,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/26/2013,mg,antineoplastic,5/29/2012,4/26/2012,Intravenous,gemcitabine,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,4/9/2019,mg,antineoplastic,2/24/2019,2/5/2019,Intravenous,carboplatin,FALSE
35,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,1/9/2024,mg/m2,antineoplastic,10/7/2023,10/29/2023,Intravenous,docetaxel,FALSE
2,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/24/2013,mg,antineoplastic,1/19/2013,11/21/2012,Intravenous,vincristine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/30/2021,mg,antineoplastic,7/7/2021,4/13/2021,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,10/22/2021,mg,antineoplastic,7/6/2021,7/22/2021,Intravenous,pembrolizumab,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,1/23/2023,mg,antineoplastic,5/17/2022,3/3/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,10/8/2021,mg,antineoplastic,4/23/2021,5/10/2021,Intravenous,pembrolizumab,TRUE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/20/2022,mg,antineoplastic,8/2/2019,1/31/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/11/2022,mg,antineoplastic,5/27/2022,5/1/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,4/15/2012,,solution-fluid,10/8/2011,10/21/2011,Intravenous,clinical study drug,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,12/1/2016,mg,antineoplastic,12/5/2016,10/19/2016,Intravenous,pemetrexed,FALSE
177,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161FDD242EB9,11/14/2011,mg,antineoplastic,8/22/2011,9/16/2011,Intravenous,paclitaxel,FALSE
,5,ADVANCED,Orders,targeted/non-biologic,"Everolimus,Exemestane",G19937F58E541,10/30/2014,,antineoplastic,6/18/2014,6/20/2014,Oral,everolimus,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/5/2024,mg,antineoplastic,5/10/2024,4/1/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/8/2025,mg,antineoplastic,6/26/2023,9/7/2022,Intravenous,pembrolizumab,TRUE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/11/2015,mg,antineoplastic,4/4/2015,3/8/2015,Intravenous,gemcitabine,FALSE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E12EBD52F4D,3/13/2018,mg,antineoplastic,1/21/2018,1/27/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/4/2025,mg,antineoplastic,2/15/2023,8/22/2022,Intravenous,pembrolizumab,TRUE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/20/2013,mg,antineoplastic,8/15/2012,4/23/2012,Intravenous,paclitaxel,FALSE
770,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,11/30/2021,mg,antineoplastic,12/21/2021,8/28/2021,Intravenous,carboplatin,FALSE
137,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,8/24/2018,mg,antineoplastic,6/22/2018,8/9/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,4/24/2018,,antineoplastic,6/23/2017,6/16/2017,Intravenous,clinical study drug,FALSE
2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/10/2020,mg,antineoplastic,5/20/2014,4/1/2014,Intravenous,vincristine,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,5/12/2018,,antineoplastic,9/9/2017,5/3/2017,Intravenous,clinical study drug,FALSE
790,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/9/2022,mg,antineoplastic,3/12/2022,5/28/2021,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,11/1/2019,,antineoplastic,8/8/2019,3/22/2019,Oral,hydroxyurea,FALSE
200,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D168F99BCD4,12/24/2023,mg,antineoplastic,11/30/2023,10/27/2023,Intravenous,pembrolizumab,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/25/2020,mg,antineoplastic,11/6/2018,7/16/2017,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/20/2020,mg,antineoplastic,12/27/2020,10/6/2020,Intravenous,pembrolizumab,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/2/2021,mg/m2,antineoplastic,6/5/2021,3/10/2021,Intravenous,oxaliplatin,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,2/10/2015,,,12/9/2014,11/30/2014,Oral,erlotinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/8/2024,mg,antineoplastic,2/13/2023,12/31/2022,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,8/17/2022,mg,antineoplastic,7/17/2022,6/9/2022,Intravenous,pembrolizumab,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,3/3/2012,mg,antineoplastic,3/19/2012,2/7/2012,Intravenous,vinorelbine,FALSE
213,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/12/2021,mg,antineoplastic,2/12/2021,12/13/2020,Intravenous,paclitaxel protein-bound,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/25/2024,mg,antineoplastic,11/8/2023,3/9/2023,Intravenous,nivolumab,FALSE
195.1,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/25/2018,mg,antineoplastic,9/9/2018,9/7/2018,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/26/2018,mg,antineoplastic,7/26/2018,5/23/2018,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3C:F1C:2BF6C,11/23/2014,mg,antineoplastic,9/16/2014,10/6/2014,Intravenous,carboplatin,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4497G86984C8,4/11/2015,mg,antineoplastic,3/11/2015,2/20/2015,Intravenous,pemetrexed,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G34BG69F45EE4,7/31/2019,mg/kg,antineoplastic,3/15/2019,11/6/2018,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,7/2/2024,mg,antineoplastic,12/2/2023,10/26/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1BG11DG4E257,7/30/2021,,,6/29/2020,6/23/2020,Oral,osimertinib,FALSE
442,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,1/6/2016,mg,antineoplastic,11/29/2015,10/6/2015,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/20/2013,mg/m2,antineoplastic,9/18/2013,9/16/2013,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/22/2025,mg,antineoplastic,8/10/2024,3/28/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,4/12/2018,,antineoplastic,9/3/2017,5/30/2017,Intravenous,clinical study drug,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/5/2012,mg,antineoplastic,5/24/2012,5/2/2012,Intravenous,carboplatin,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,9/21/2013,mg,antineoplastic,10/15/2013,8/11/2013,Intravenous,carboplatin,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,12/1/2015,mg,antineoplastic,9/18/2015,7/15/2015,Intravenous,paclitaxel protein-bound,FALSE
800,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G445B:B:15B5F,11/11/2014,mg/m2,antineoplastic,9/12/2014,10/7/2014,Intravenous,gemcitabine,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/18/2025,mg,antineoplastic,8/30/2023,10/21/2022,Intravenous,pemetrexed,TRUE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,3/21/2025,,antineoplastic,12/23/2024,11/28/2024,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/3/2025,mg,antineoplastic,12/11/2022,3/15/2019,Intravenous,pemetrexed,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/9/2016,mg,antineoplastic,7/13/2015,6/19/2015,Intravenous,bevacizumab,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/10/2019,mg,antineoplastic,9/28/2018,9/13/2018,Intravenous,bevacizumab,FALSE
385,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,12/13/2022,mg,antineoplastic,10/21/2022,9/24/2022,Intravenous,carboplatin,FALSE
652,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G14FD45889171,12/11/2014,mg,antineoplastic,10/21/2014,9/4/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/1/2025,,antineoplastic,9/2/2024,5/2/2024,Intravenous,paclitaxel protein-bound,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/7/2018,mg,antineoplastic,8/9/2016,7/11/2016,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/16/2025,,solution-fluid,4/1/2018,12/8/2017,Intravenous,clinical study drug,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/7/2024,mL,solution-fluid,7/24/2024,5/18/2024,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/10/2023,mg,antineoplastic,6/23/2023,5/11/2023,Subcutaneous,azacitidine,FALSE
518,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,3/3/2021,mg,antineoplastic,3/2/2021,1/24/2021,Intravenous,carboplatin,FALSE
245,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/12/2016,mg,antineoplastic,1/31/2016,11/28/2015,Intravenous,paclitaxel protein-bound,FALSE
61,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,4/29/2025,mg,antineoplastic,5/3/2025,4/4/2025,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/10/2016,AUC,antineoplastic,1/5/2015,10/24/2014,Intravenous,carboplatin,FALSE
145,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,3/6/2024,mg,antineoplastic,1/25/2024,9/29/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/13/2023,mg,antineoplastic,1/21/2023,10/3/2021,Intravenous,pembrolizumab,TRUE
1021,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/31/2020,mg,antineoplastic,5/7/2020,3/22/2020,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Orders,solution-fluid,Clinical Study Drug,G14E7662::61C,5/8/2017,,solution-fluid,8/5/2016,2/1/2016,,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,9/11/2012,mg,antineoplastic,7/11/2012,6/26/2012,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/26/2019,mg/m2,antineoplastic,10/6/2019,7/25/2019,Intravenous,paclitaxel protein-bound,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/28/2021,mg,antineoplastic,2/28/2021,10/1/2020,Intravenous,bevacizumab,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/17/2025,mg,antineoplastic,5/16/2023,9/3/2022,Intravenous,pemetrexed,TRUE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/8/2021,mg,antineoplastic,3/31/2021,4/30/2020,Intravenous,gemcitabine,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,10/4/2017,mg,antineoplastic,2/26/2017,11/23/2016,Intravenous,etoposide,FALSE
61.8,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/19/2021,mg,antineoplastic,7/7/2021,12/18/2020,Intravenous,vinorelbine,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/13/2013,mg/m2,antineoplastic,10/3/2013,7/15/2013,Intravenous,gemcitabine,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/12/2023,mg,antineoplastic,11/14/2022,8/11/2022,Subcutaneous,azacitidine,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/18/2024,mg,antineoplastic,7/26/2021,6/29/2020,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/4/2018,mg,antineoplastic,9/15/2016,10/18/2016,Intravenous,carboplatin,FALSE
448,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/30/2025,mg,antineoplastic,5/15/2020,4/21/2019,Intravenous,carboplatin,FALSE
209.1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,3/5/2014,mg,antineoplastic,1/5/2014,1/26/2014,Intravenous,carboplatin,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,2/19/2024,mg,antineoplastic,10/23/2023,9/23/2023,Intravenous,paclitaxel,FALSE
740,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,1/8/2014,mg,antineoplastic,10/15/2013,10/15/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5:CE:F92EE8D,4/2/2016,,antineoplastic,8/4/2015,7/24/2015,Intravenous,clinical study drug,FALSE
183.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/21/2022,mg,antineoplastic,7/24/2014,6/12/2014,Intravenous,carboplatin,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/29/2025,mg,antineoplastic,4/5/2017,12/12/2016,Intravenous,pembrolizumab,FALSE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,4/6/2020,mg,antineoplastic,8/26/2019,8/17/2019,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,1/30/2022,mg,antineoplastic,11/4/2021,9/3/2021,Intravenous,pembrolizumab,TRUE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/12/2021,mg,antineoplastic,5/2/2020,5/10/2020,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/29/2020,mg,antineoplastic,8/25/2018,6/22/2016,Intravenous,nivolumab,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G266E6248F531,7/22/2018,mg/kg,antineoplastic,6/25/2018,3/6/2018,Intravenous,bevacizumab,TRUE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,2/16/2023,mg,antineoplastic,10/24/2022,8/10/2022,Intravenous,durvalumab,TRUE
455,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/22/2025,mg,antineoplastic,4/7/2020,3/2/2019,Intravenous,carboplatin,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,9/24/2014,mg,antineoplastic,8/26/2014,8/2/2014,Intravenous,carboplatin,FALSE
99,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/7/2015,mg,antineoplastic,6/19/2015,5/18/2015,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/7/2017,mg,antineoplastic,1/9/2017,7/26/2016,Intravenous,nivolumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/22/2025,mg,antineoplastic,9/1/2024,9/8/2024,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,hormone,Leuprolide,G369D5G3B91:2,11/21/2024,,antineoplastic,10/29/2024,6/20/2024,Intramuscular,leuprolide,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/19/2020,mg,antineoplastic,6/10/2019,3/6/2019,Intravenous,durvalumab,FALSE
980,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/24/2013,mg,antineoplastic,6/9/2013,4/21/2013,Intravenous,bevacizumab,FALSE
249,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,8/24/2016,mg,antineoplastic,7/6/2016,6/8/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/28/2020,mg,antineoplastic,2/13/2019,12/27/2017,Intravenous,pembrolizumab,TRUE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,1/30/2020,mg,antineoplastic,1/24/2020,12/11/2019,Intravenous,pemetrexed,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,11/4/2015,mg,antineoplastic,8/16/2015,8/17/2015,Intravenous,carboplatin,FALSE
216,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/13/2016,mg,antineoplastic,3/23/2016,12/18/2015,Intravenous,carboplatin,FALSE
3629,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/28/2025,mg,antineoplastic,2/28/2025,12/20/2024,Other/Miscellaneous,fluorouracil,FALSE
165,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11:F93GC6851,7/4/2021,mg,antineoplastic,5/9/2021,6/5/2021,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,5/12/2012,,antiemetic,12/2/2011,9/19/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,6/5/2021,mg,antineoplastic,2/25/2021,10/4/2020,Intravenous,pembrolizumab,TRUE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/30/2014,mg,antineoplastic,9/9/2014,9/2/2014,Intravenous,paclitaxel,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/29/2016,mg,antineoplastic,12/3/2016,3/17/2016,Intravenous,bevacizumab,TRUE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/3/2020,mg,antineoplastic,5/27/2020,4/17/2020,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,"Fulvestrant,Palbociclib",G286G2E848134,3/5/2019,,antineoplastic,1/26/2017,12/11/2016,Oral,palbociclib,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,9/23/2024,mg,antineoplastic,7/13/2024,8/16/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/28/2020,mg,antineoplastic,1/1/2019,12/10/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23G13:GCG631,1/20/2018,mg,antineoplastic,1/16/2018,10/13/2017,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/8/2021,mg,antineoplastic,10/24/2019,10/4/2019,Intravenous,pemetrexed,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,7/4/2021,mg,antineoplastic,4/15/2021,11/1/2020,Intravenous,bevacizumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/5/2021,mg,antineoplastic,8/23/2020,10/1/2020,Oral,bicalutamide,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/6/2019,mg,antineoplastic,9/19/2018,2/16/2018,Intravenous,pemetrexed,FALSE
740,,ADJUVANT,Administrations,targeted/biologic,Rituximab-Arrx,G2GDF48F:5EGB,9/26/2024,mg,antineoplastic,10/7/2024,9/7/2024,Intravenous,rituximab-arrx,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/4/2025,,antineoplastic,3/16/2025,3/7/2024,Intravenous,clinical study drug,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,1/20/2024,mg,antineoplastic,9/20/2023,9/22/2023,Intravenous,cisplatin,FALSE
185,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/19/2022,mg,antineoplastic,3/3/2022,1/25/2022,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/15/2024,mL,solution-fluid,5/27/2024,4/18/2024,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/1/2019,mg/m2,antineoplastic,12/29/2018,10/28/2018,Intravenous,gemcitabine,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,2/8/2022,mg,antineoplastic,12/24/2021,10/29/2021,Intravenous,paclitaxel,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,7/12/2024,mg,antineoplastic,2/23/2024,2/27/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/7/2020,mg,antineoplastic,4/4/2020,3/1/2020,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,4/6/2025,,antineoplastic,2/18/2025,11/27/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/29/2024,mg,antineoplastic,6/15/2023,5/10/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/23/2021,mg,antineoplastic,6/1/2021,3/26/2021,Intravenous,pembrolizumab,TRUE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,5/2/2025,mg,antineoplastic,3/12/2020,4/19/2019,Intravenous,pemetrexed,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/8/2012,mg,antineoplastic,12/9/2011,9/17/2011,Intravenous,cetuximab,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,3/29/2020,mg,antineoplastic,10/8/2019,7/18/2019,Intravenous,docetaxel,FALSE
110.4,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,3/21/2014,mg,antineoplastic,6/6/2013,6/11/2013,Intravenous,docetaxel,FALSE
450,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/23/2025,mg,antineoplastic,4/26/2019,2/14/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/8/2022,mg,antineoplastic,2/25/2020,2/13/2020,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/27/2018,mg,antineoplastic,1/2/2018,2/23/2017,Intravenous,pembrolizumab,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,5/18/2019,mg,antineoplastic,2/15/2019,3/23/2019,Intravenous,gemcitabine,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/12/2013,mg,antineoplastic,10/21/2012,1/10/2012,Intravenous,etoposide,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/10/2021,mg,antineoplastic,2/2/2021,9/24/2020,Intravenous,gemcitabine,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,8/29/2014,mg,antineoplastic,10/5/2014,9/6/2014,Intravenous,paclitaxel,FALSE
116,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/10/2015,mg,antineoplastic,12/5/2014,9/5/2014,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G1969F536B2DD,10/21/2011,,steroid,6/16/2011,7/19/2011,Intravenous,clinical study drug,FALSE
317,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,10/24/2021,mg,antineoplastic,10/18/2021,10/18/2021,Intravenous,carboplatin,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/15/2021,mg,antineoplastic,10/20/2020,9/9/2020,Intravenous,gemcitabine,FALSE
82,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,11/27/2022,mg,antineoplastic,11/13/2022,12/6/2022,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,8/22/2018,mg,antineoplastic,4/1/2018,3/12/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G1::2C155D:6E,5/5/2025,,,3/20/2025,10/21/2023,Oral,osimertinib,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2F327FD5:2:3,5/2/2025,mg,antineoplastic,4/22/2025,3/30/2025,Intravenous,ramucirumab,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,7/29/2024,mL,solution-fluid,4/19/2024,4/13/2024,Intravenous,cisplatin,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/30/2016,mg,antineoplastic,1/8/2016,12/19/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/14/2020,mg,antineoplastic,12/31/2019,11/14/2018,Intravenous,pembrolizumab,TRUE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/22/2021,mg,antineoplastic,12/20/2020,5/15/2020,Intravenous,gemcitabine,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,5/20/2024,mg,antineoplastic,3/16/2024,1/27/2024,Intravenous,pemetrexed,FALSE
844,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/21/2024,mg,antineoplastic,11/19/2023,10/22/2023,Intravenous,durvalumab,FALSE
98,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,6/23/2015,mg,antineoplastic,6/24/2015,5/16/2015,Intravenous,cisplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/5/2022,mg,antineoplastic,8/4/2020,4/26/2017,Intravenous,nivolumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,5/20/2012,mg,antineoplastic,4/3/2012,1/11/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/16/2016,,antineoplastic,5/8/2016,4/20/2016,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/10/2019,mg,antineoplastic,12/20/2018,5/21/2018,Intravenous,nivolumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/7/2020,mg,antineoplastic,1/23/2020,12/16/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,5/8/2021,mg,antineoplastic,1/28/2021,12/31/2020,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/7/2011,mg,antineoplastic,7/15/2011,5/25/2011,Intravenous,etoposide,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/28/2016,mg,antineoplastic,1/14/2015,10/23/2014,Intravenous,pemetrexed,TRUE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/21/2020,mg,antineoplastic,2/12/2020,9/17/2019,Intravenous,durvalumab,FALSE
,4,ADVANCED,Unstructured,,Osimertinib,G26EFGF738125,12/20/2018,,,12/1/2018,12/5/2018,Oral,osimertinib,FALSE
945,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/30/2020,mg,antineoplastic,2/24/2020,12/25/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/10/2024,,antineoplastic,6/12/2024,6/27/2024,Intravenous,paclitaxel,FALSE
825,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/13/2023,mg,antineoplastic,6/1/2023,3/23/2023,Intravenous,gemcitabine,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,5/19/2022,mg,antineoplastic,6/28/2020,3/11/2020,Intravenous,durvalumab,TRUE
83,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,7/7/2023,mg,antineoplastic,3/31/2023,3/11/2023,Intravenous,cisplatin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/22/2021,mg,antineoplastic,4/4/2021,9/29/2020,Intravenous,durvalumab,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/21/2025,,antiemetic,4/10/2025,11/13/2024,Intravenous,clinical study drug,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/18/2019,mg,antineoplastic,9/4/2019,7/25/2019,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/19/2025,mg,antineoplastic,4/13/2025,9/24/2024,Intravenous,pembrolizumab,TRUE
490,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/16/2012,mg,antineoplastic,7/18/2012,4/2/2012,Intravenous,carboplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G14216G12B:E7,5/20/2020,mg,antineoplastic,10/25/2019,10/8/2019,Intravenous,pemetrexed,TRUE
132,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/11/2020,mg,antineoplastic,2/19/2020,1/11/2020,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,1/7/2025,mg,antineoplastic,9/12/2024,10/27/2024,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/16/2024,mg,antineoplastic,8/17/2023,5/19/2023,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/3/2025,mg,antineoplastic,3/11/2024,3/31/2024,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,6/4/2017,mg,antineoplastic,2/28/2017,12/13/2016,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3CG5712E:B54,4/27/2024,mg,antineoplastic,4/21/2024,4/1/2024,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1C49C5CC7:F7,4/7/2017,mg,antineoplastic,3/5/2017,2/24/2017,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/3/2021,,antiemetic,10/9/2020,2/27/2020,Intravenous,clinical study drug,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,12/3/2017,mg,antineoplastic,7/14/2017,5/25/2017,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/21/2025,mg,antineoplastic,6/5/2020,2/26/2018,Intravenous,nivolumab,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/14/2016,mg,antineoplastic,7/31/2016,5/24/2016,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/23/2022,mg,antineoplastic,4/21/2020,5/23/2017,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/20/2020,mg,antineoplastic,1/12/2018,1/31/2016,Intravenous,bevacizumab,TRUE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/15/2013,mg,antineoplastic,6/2/2013,3/29/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,10/30/2023,,antineoplastic,6/5/2023,12/31/2022,,clinical study drug,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3G18D5D62822,6/24/2012,mg,antineoplastic,12/24/2011,12/25/2011,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/19/2022,mg,antineoplastic,12/17/2021,9/29/2021,Intravenous,bevacizumab-awwb,FALSE
,,NEOADJUVANT,Unstructured,,Crizotinib,G2F:C3344EG8G,8/1/2015,,,7/28/2015,5/7/2015,Oral,crizotinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,12/23/2018,mg,antineoplastic,12/21/2018,11/11/2017,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/16/2024,mg,antineoplastic,5/3/2024,8/18/2023,Intravenous,atezolizumab,FALSE
174,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11B743:8G337,1/7/2017,mg,antineoplastic,6/16/2016,6/28/2016,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/12/2020,mg,antineoplastic,12/25/2015,12/9/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G115873FC55G5,6/22/2020,,,9/20/2017,10/5/2017,Oral,erlotinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/11/2024,mg,antineoplastic,5/22/2023,11/15/2022,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/23/2024,mg,antineoplastic,4/19/2024,12/6/2023,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/23/2025,mg,antineoplastic,1/1/2018,12/4/2016,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/16/2013,mg,antineoplastic,8/7/2013,2/23/2013,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/30/2025,,antineoplastic,10/6/2024,3/15/2023,,clinical study drug,FALSE
272.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/25/2015,mg,antineoplastic,4/4/2015,1/11/2015,Intravenous,carboplatin,FALSE
185.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,3/10/2017,mg,antineoplastic,12/28/2016,10/28/2016,Intravenous,carboplatin,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G137D67:GFD9F,8/20/2016,mg/kg,antineoplastic,7/30/2016,5/20/2016,Intravenous,nivolumab,FALSE
189,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/27/2014,mg,antineoplastic,4/5/2014,3/11/2014,Intravenous,carboplatin,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/29/2024,mg,antineoplastic,10/12/2023,9/16/2023,Intravenous,durvalumab,TRUE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/12/2016,mg,antineoplastic,5/16/2016,5/31/2016,Intravenous,paclitaxel,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/3/2017,mg,antineoplastic,8/31/2017,6/1/2017,Intravenous,gemcitabine,FALSE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/16/2017,mg,antineoplastic,8/22/2017,7/5/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/4/2025,,solution-fluid,2/11/2018,11/23/2017,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,3/11/2025,,antineoplastic,3/28/2025,1/14/2025,Intravenous,pembrolizumab,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G32:::74B314F,2/10/2013,mg/m2,antineoplastic,12/9/2012,12/9/2012,Intravenous,docetaxel,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/25/2025,mg,antineoplastic,3/1/2021,3/10/2020,Intravenous,pemetrexed,TRUE
,,NEOADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G1DCDG73E53FF,6/19/2024,,antineoplastic,4/24/2024,5/8/2024,Intravenous,clinical study drug,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/2/2022,mg,antineoplastic,7/15/2022,7/10/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12DD1599F4EF,10/23/2024,,antineoplastic,8/31/2024,9/10/2024,Intravenous,pemetrexed,FALSE
2030,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,6/15/2013,mg,antineoplastic,9/6/2012,7/25/2012,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,4/14/2025,,antineoplastic,4/19/2024,4/29/2024,,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/23/2018,mg,antineoplastic,8/17/2018,4/15/2018,Intravenous,gemcitabine,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/24/2025,mg,antineoplastic,5/25/2023,4/20/2020,Subcutaneous,leuprolide,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/7/2025,,antineoplastic,5/28/2024,5/8/2024,,paclitaxel,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/27/2015,mg/m2,antineoplastic,2/21/2015,9/8/2014,Intravenous,etoposide,FALSE
100,1,ADVANCED,Administrations,solution-fluid,Pembrolizumab,G4C4C3G28CF33,2/23/2022,mL,solution-fluid,10/16/2021,11/3/2021,Intravenous,pembrolizumab,FALSE
422.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,3/2/2020,mg,antineoplastic,1/28/2020,11/5/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/10/2017,,antineoplastic,2/9/2017,3/2/2016,Intravenous,clinical study drug,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/26/2021,mg,antineoplastic,11/28/2020,9/5/2020,Oral,bicalutamide,FALSE
234,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11D1:8:62429,10/18/2015,mg,antineoplastic,7/29/2015,8/17/2015,Intravenous,nivolumab,FALSE
492,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G164G31958638,9/21/2024,mg,antineoplastic,8/18/2024,8/1/2024,Intravenous,carboplatin,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/20/2020,mg,antineoplastic,10/24/2019,12/6/2018,Intravenous,pemetrexed,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G17BB6EDG:98F,7/22/2019,mg,antineoplastic,7/13/2019,5/20/2019,Intravenous,atezolizumab,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G43D:C17:25FG,12/29/2015,mg,antineoplastic,10/30/2015,10/18/2015,Intravenous,nivolumab,FALSE
360,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,6/27/2018,mg,antineoplastic,12/18/2017,10/7/2017,Intravenous,carboplatin,FALSE
69,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/26/2018,mg,antineoplastic,7/1/2015,7/13/2015,Intravenous,paclitaxel,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/3/2017,mg,antineoplastic,9/19/2017,5/22/2017,Intravenous,gemcitabine,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/27/2020,mg,antineoplastic,6/26/2019,2/16/2019,Intravenous,durvalumab,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/8/2020,mg,antineoplastic,1/11/2020,4/3/2019,Intravenous,durvalumab,FALSE
253,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/15/2019,mg,antineoplastic,7/23/2019,8/31/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/5/2019,mg,antineoplastic,4/18/2019,2/2/2019,Intravenous,pembrolizumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/21/2016,mg,antineoplastic,7/15/2015,6/27/2015,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,2/4/2016,mg,antineoplastic,12/26/2015,12/7/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G26C72D6F6G:5,10/4/2020,mg,antineoplastic,7/28/2020,6/28/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/26/2025,mg,antineoplastic,12/30/2022,4/23/2022,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/27/2020,mg,antineoplastic,11/20/2019,12/16/2019,Intravenous,carboplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,4/9/2016,mg,antineoplastic,1/6/2016,10/23/2015,Intravenous,paclitaxel protein-bound,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/11/2014,mg,antineoplastic,3/7/2014,12/6/2013,Intravenous,carboplatin,FALSE
300,2,LOCOREGIONAL,Administrations,immunotherapy,Nivolumab,G1:63D151:BB3,11/18/2016,mg,antineoplastic,10/8/2016,10/14/2016,Intravenous,nivolumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/27/2025,mg,antineoplastic,11/27/2023,2/19/2020,Intravenous,pemetrexed,TRUE
450,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,3/1/2021,mg,antineoplastic,1/30/2021,1/8/2021,Intravenous,carboplatin,FALSE
1013,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/2/2016,mg,antineoplastic,9/10/2016,7/18/2016,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/2/2020,mg,antineoplastic,12/3/2016,2/11/2016,Intravenous,bevacizumab,TRUE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/14/2020,mg,antineoplastic,7/10/2020,9/23/2019,Intravenous,durvalumab,FALSE
270.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/13/2013,mg,antineoplastic,5/20/2013,6/2/2013,Intravenous,carboplatin,FALSE
1090,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,3/16/2015,mg,antineoplastic,11/28/2014,12/25/2014,Intravenous,pemetrexed,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,4/26/2023,mg,antineoplastic,1/19/2023,5/20/2022,Intravenous,durvalumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/19/2022,mg,antineoplastic,2/22/2017,1/1/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/10/2017,,antineoplastic,4/6/2017,2/16/2016,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,3/30/2025,mg,antineoplastic,9/3/2024,8/17/2024,Intravenous,carboplatin,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/14/2025,mg,antineoplastic,12/21/2024,11/30/2024,Intravenous,etoposide,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/17/2014,mg,antineoplastic,2/9/2014,9/22/2013,Intravenous,gemcitabine,FALSE
324,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,11/28/2013,mg,antineoplastic,6/15/2013,5/14/2013,Intravenous,paclitaxel,FALSE
271.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/5/2023,mg,antineoplastic,2/6/2023,2/14/2023,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/5/2013,mg,antineoplastic,1/6/2013,11/26/2011,Intravenous,etoposide,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,4/13/2025,mg,antineoplastic,3/10/2025,11/29/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/26/2019,,antineoplastic,10/1/2017,9/3/2017,,cisplatin,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/17/2021,mg,antineoplastic,11/14/2020,1/4/2021,Intravenous,gemcitabine,FALSE
200,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,3/2/2023,mg,antineoplastic,11/1/2022,10/19/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/5/2023,mg,antineoplastic,7/31/2023,6/23/2023,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/15/2022,mg/kg,antineoplastic,4/1/2022,2/3/2021,Intravenous,durvalumab,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/5/2023,mg,antineoplastic,7/4/2022,6/21/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G49E3CE9E292G,5/15/2020,,antineoplastic,10/19/2019,10/12/2019,,durvalumab,TRUE
206,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,12/29/2019,mg,antineoplastic,10/20/2019,11/5/2019,Intravenous,carboplatin,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/3/2011,mg,antineoplastic,6/23/2011,6/3/2011,Intravenous,etoposide,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/25/2018,mg,antineoplastic,8/21/2018,6/1/2018,Intravenous,paclitaxel,FALSE
475,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/14/2025,mg,antineoplastic,6/6/2019,2/9/2019,Intravenous,carboplatin,FALSE
170,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G4F354B:F341F,8/18/2017,mg,antineoplastic,7/23/2017,6/5/2017,Intravenous,docetaxel,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,7/8/2023,mg,antineoplastic,6/16/2023,5/6/2023,Intravenous,cisplatin,FALSE
627,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G32GG4C6C:87G,3/22/2021,mg,antineoplastic,12/27/2020,12/30/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,5/4/2025,mg,antineoplastic,3/15/2024,10/31/2023,Intravenous,pembrolizumab,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/3/2024,mg,antineoplastic,4/21/2024,3/21/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/4/2021,mg,antineoplastic,1/11/2020,10/7/2019,Intravenous,pembrolizumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/2/2014,mg,antineoplastic,9/3/2014,7/11/2014,Intravenous,bevacizumab,FALSE
50,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G2CE6D3C3EFDC,9/22/2013,mg,antineoplastic,8/28/2013,7/3/2013,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,hormone,Anastrozole,G49E8CFG53::D,1/23/2013,,antineoplastic,11/24/2012,8/26/2011,Oral,anastrozole,FALSE
380,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G147B:8F3B:52,11/21/2021,mg,antineoplastic,10/26/2021,10/25/2021,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G2G76D1E7GG61,12/30/2014,mL,solution-fluid,1/14/2015,12/15/2014,Intravenous,pemetrexed,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,3/13/2023,mg,antineoplastic,1/22/2023,7/31/2022,Intravenous,durvalumab,TRUE
27,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,2/9/2015,mg,antineoplastic,1/16/2015,11/15/2014,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/9/2017,,antineoplastic,8/3/2017,7/23/2017,,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/10/2020,,antineoplastic,5/4/2020,6/1/2020,Intravenous,cisplatin,FALSE
571,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,7/20/2015,mg,antineoplastic,6/12/2015,6/10/2015,Intravenous,carboplatin,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,10/9/2017,mg,antineoplastic,9/16/2017,7/14/2017,Intravenous,cisplatin,FALSE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,10/25/2022,mg,antineoplastic,10/10/2022,11/2/2022,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,12/19/2020,mg,antineoplastic,6/10/2020,8/24/2019,Intravenous,pembrolizumab,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,12/1/2024,mg,antineoplastic,10/21/2024,7/22/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,7/4/2024,,antineoplastic,4/24/2024,4/11/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/2/2021,mg/m2,antineoplastic,3/14/2021,3/26/2021,Intravenous,leucovorin,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/22/2023,mg,antineoplastic,3/4/2020,1/19/2020,Intravenous,gemcitabine,FALSE
455,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/19/2013,mg,antineoplastic,8/17/2012,7/6/2012,Intravenous,carboplatin,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,4/30/2021,AUC,antineoplastic,5/4/2021,3/16/2021,Intravenous,carboplatin,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/18/2018,mg,antineoplastic,4/23/2016,10/3/2015,Intravenous,nivolumab,FALSE
1540,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/18/2018,mg,antineoplastic,10/3/2018,9/3/2018,Intravenous,gemcitabine,FALSE
,3,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G1G54G4GB8B24,7/31/2022,,,3/2/2022,1/4/2022,Oral,trametinib,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/17/2024,AUC,antineoplastic,2/23/2024,10/25/2023,Intravenous,carboplatin,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/28/2022,mg,antineoplastic,1/16/2022,11/24/2021,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/21/2019,mg,antineoplastic,9/16/2018,7/14/2018,Intravenous,pembrolizumab,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,2/1/2016,mg,antineoplastic,11/6/2015,11/23/2015,Intravenous,gemcitabine,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/30/2025,mg,antineoplastic,3/6/2021,2/22/2019,Intravenous,pemetrexed,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/12/2021,mg,antineoplastic,7/28/2020,6/13/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/8/2025,mg,antineoplastic,1/3/2023,9/29/2022,Intravenous,pembrolizumab,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/24/2024,mg,antineoplastic,1/7/2022,7/19/2020,Intravenous,nivolumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,8/8/2024,mg,antineoplastic,5/25/2024,5/4/2024,Intravenous,paclitaxel,FALSE
60,4,ADVANCED,Administrations,chemotherapy,Doxorubicin Pegylated Liposomal,G19937F58E541,7/31/2014,mg,antineoplastic,6/21/2014,4/28/2014,Intravenous,doxorubicin pegylated liposomal,FALSE
102,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2141CBEF3GD3,11/3/2022,mg,antineoplastic,10/5/2022,9/27/2022,Intravenous,paclitaxel,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,7/24/2022,mg,antineoplastic,6/11/2022,8/19/2021,Intravenous,pembrolizumab,FALSE
940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G24167D1DD5FG,2/5/2025,mg,antineoplastic,12/1/2024,10/14/2024,Intravenous,pemetrexed,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/14/2013,mg,antineoplastic,3/4/2013,11/26/2012,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,4/20/2024,,antineoplastic,9/21/2023,5/5/2023,Intravenous,clinical study drug,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/24/2025,mg,antineoplastic,11/13/2024,12/6/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2F5C96E2545B,7/2/2024,mg,antineoplastic,5/21/2024,6/5/2024,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,4/3/2025,,antineoplastic,1/31/2025,12/15/2024,Intravenous,clinical study drug,FALSE
91,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/21/2017,mg,antineoplastic,9/10/2017,9/10/2017,Intravenous,paclitaxel,FALSE
1476,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,3/14/2022,mg,antineoplastic,3/17/2022,1/14/2022,Intravenous,bevacizumab-awwb,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3DGG1C5C452:,4/11/2019,mg,antineoplastic,3/12/2019,2/26/2019,Intravenous,durvalumab,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1E586G415EF7,3/17/2016,mg,antineoplastic,1/20/2016,3/9/2016,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,8/16/2019,mg,antineoplastic,9/30/2018,8/9/2018,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/29/2023,mg,antineoplastic,2/15/2023,3/20/2023,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,3/6/2020,,antineoplastic,3/6/2019,7/26/2017,Intravenous,pemetrexed,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,4/29/2025,mg,antineoplastic,7/13/2024,5/28/2024,Intravenous,durvalumab,TRUE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/15/2011,mg,antineoplastic,8/26/2011,9/18/2011,Intravenous,cisplatin,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/22/2012,mg,antineoplastic,1/24/2012,12/20/2011,Intravenous,etoposide,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,11/10/2017,mg,antineoplastic,1/29/2017,12/24/2016,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,5/22/2020,mg,antineoplastic,6/30/2020,3/23/2020,Intravenous,pembrolizumab,FALSE
254,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39GB9B7D:9:C,1/19/2016,mg,antineoplastic,10/25/2015,10/26/2015,Intravenous,paclitaxel,FALSE
1301,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G46:87GF7FGC9,8/5/2015,mg,antineoplastic,3/10/2015,3/16/2015,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/4/2024,mg,antineoplastic,12/25/2021,4/22/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/26/2024,mg,antineoplastic,7/16/2023,4/23/2020,Intravenous,pembrolizumab,TRUE
150,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,4/12/2024,mg,antineoplastic,2/25/2024,1/8/2024,Intravenous,cisplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/19/2019,mg,antineoplastic,11/20/2018,8/15/2018,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/31/2024,,antineoplastic,6/29/2024,6/18/2024,,paclitaxel,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/3/2023,mg,antineoplastic,5/17/2023,3/25/2023,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/13/2019,mg,antineoplastic,8/26/2018,6/9/2018,Intravenous,nivolumab,FALSE
180,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/10/2019,mg,antineoplastic,6/24/2018,4/14/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/19/2025,mg,antineoplastic,5/28/2024,3/23/2024,Intravenous,pembrolizumab,FALSE
1075,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/11/2025,mg,antineoplastic,3/6/2023,2/7/2023,Intravenous,pemetrexed,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,6/15/2017,mg,antineoplastic,12/9/2016,1/4/2017,Intravenous,nivolumab,FALSE
340,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/9/2016,mg,antineoplastic,2/29/2016,2/13/2016,Intravenous,nivolumab,FALSE
1632,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/4/2020,mg,antineoplastic,4/10/2020,4/17/2020,Intravenous,bevacizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/1/2013,mg,antineoplastic,6/19/2013,3/16/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/11/2024,,antineoplastic,7/30/2024,7/9/2024,Intravenous,carboplatin,FALSE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/9/2018,mg,antineoplastic,4/4/2013,3/15/2013,Intravenous,carboplatin,FALSE
,2,LOCOREGIONAL,Orders,chemotherapy,Osimertinib,G3:67CF8FF:28,12/18/2021,,antineoplastic,4/11/2020,4/7/2020,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,7/24/2018,mg,antineoplastic,12/15/2017,8/28/2017,Intravenous,atezolizumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/6/2025,mg,antineoplastic,7/24/2018,7/18/2016,Intravenous,pembrolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,11/16/2018,mg,antineoplastic,3/22/2018,12/18/2017,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FD6C9677C56,10/12/2017,mg,antineoplastic,11/12/2017,9/25/2017,Intravenous,paclitaxel,FALSE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,9/16/2024,mg,antineoplastic,6/16/2024,5/27/2024,Intravenous,carboplatin,FALSE
2160,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,2/23/2020,mg,antineoplastic,3/4/2020,10/18/2019,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/6/2014,,solution-fluid,11/9/2013,11/5/2013,Intravenous,clinical study drug,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/25/2019,mg,antineoplastic,9/23/2018,7/28/2018,Intravenous,paclitaxel,FALSE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,3/14/2020,mg,antineoplastic,10/21/2019,7/25/2019,Intravenous,ramucirumab,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,6/6/2020,mg,antineoplastic,6/14/2020,5/25/2020,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/12/2024,mg,antineoplastic,12/22/2022,9/11/2022,Intravenous,pembrolizumab,TRUE
400,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/1/2025,mg,antineoplastic,8/1/2024,7/23/2024,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/30/2015,mg,antineoplastic,7/20/2015,8/5/2015,Intravenous,paclitaxel protein-bound,FALSE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,12/9/2019,mg,antineoplastic,12/4/2019,10/4/2019,Intravenous,durvalumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/4/2025,mg,antineoplastic,1/12/2023,8/25/2021,Intravenous,atezolizumab,TRUE
370,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,9/3/2020,mg,antineoplastic,7/1/2020,5/11/2020,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/23/2023,,antineoplastic,11/25/2022,12/31/2022,,pemetrexed,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/17/2022,mg,antineoplastic,12/25/2021,6/27/2021,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/9/2024,mg,antineoplastic,12/31/2024,10/12/2024,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/24/2017,,antineoplastic,8/31/2016,1/26/2016,Intravenous,clinical study drug,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/17/2014,AUC,antineoplastic,7/12/2014,4/14/2014,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/2/2021,,steroid,10/7/2020,1/29/2020,Intravenous,clinical study drug,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/1/2024,mg,antineoplastic,4/2/2024,9/24/2023,Intravenous,durvalumab,TRUE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/29/2023,mg,antineoplastic,6/11/2023,7/6/2023,Intravenous,paclitaxel,FALSE
840,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2177D1::DG1E,3/15/2012,mg,antineoplastic,12/28/2011,12/21/2011,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/26/2021,,antineoplastic,6/29/2021,4/26/2021,,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/6/2025,mg,antineoplastic,12/30/2023,10/6/2022,Intravenous,pembrolizumab,TRUE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/28/2021,mg,antineoplastic,2/22/2021,10/7/2020,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,5/22/2021,mg,antineoplastic,11/1/2020,9/18/2020,Intravenous,pembrolizumab,TRUE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/12/2020,mg,antineoplastic,8/14/2020,2/3/2020,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/17/2025,mg,antineoplastic,6/20/2023,12/16/2016,Intravenous,pembrolizumab,FALSE
1325,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/24/2015,mg,antineoplastic,1/30/2015,12/30/2014,Intravenous,bevacizumab,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,10/9/2018,mg,antineoplastic,7/14/2018,4/13/2018,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/23/2022,mg,antineoplastic,1/7/2022,4/4/2021,Intravenous,durvalumab,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,11/8/2015,mg,antineoplastic,8/8/2015,7/23/2015,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/5/2025,mg,antineoplastic,7/23/2024,6/17/2024,Intravenous,pembrolizumab,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/7/2019,mg,antineoplastic,1/24/2018,11/1/2016,Intramuscular,fulvestrant,FALSE
260,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/3/2014,mg,antineoplastic,4/21/2013,2/18/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/1/2021,,antineoplastic,3/4/2021,1/21/2021,Intravenous,paclitaxel protein-bound,FALSE
1450,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pembrolizumab,Pemetrexed",G23G13:GCG631,1/20/2018,mg,antineoplastic,12/20/2017,12/25/2017,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Unstructured,,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,3/27/2025,,,2/7/2025,12/29/2024,Oral,tepotinib,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,4/30/2019,mg,antineoplastic,4/5/2019,3/19/2019,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/7/2020,mg,antineoplastic,8/10/2020,6/29/2020,Subcutaneous,azacitidine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/4/2025,mg,antineoplastic,8/3/2019,2/8/2018,Intravenous,nivolumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/13/2014,mg,antineoplastic,9/4/2014,8/1/2014,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,12/19/2023,mg,antineoplastic,8/30/2023,8/29/2023,Intravenous,pemetrexed,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,2/14/2024,mg,antineoplastic,11/2/2023,11/22/2023,Intravenous,cisplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,11/6/2023,mg,antineoplastic,5/28/2023,6/11/2023,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/3/2023,,antineoplastic,12/4/2022,9/10/2022,Intravenous,pemetrexed,FALSE
168.6,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/9/2017,mg,antineoplastic,10/22/2016,9/5/2016,Intravenous,nivolumab,FALSE
60,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G1G618861EGD9,8/25/2016,mg,antineoplastic,7/17/2016,6/23/2016,Intravenous,cisplatin,FALSE
,,NEOADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G1DCDG73E53FF,6/1/2024,,solution-fluid,5/1/2024,5/7/2024,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/20/2019,mg,antineoplastic,8/13/2018,9/16/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,4/23/2020,mg,antineoplastic,1/22/2020,2/11/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/14/2025,mg,antineoplastic,2/12/2023,8/23/2022,Intravenous,pembrolizumab,TRUE
200,2,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/7/2023,mg,antineoplastic,1/12/2022,1/25/2020,Intravenous,pembrolizumab,FALSE
50,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:D1D2EG5C21,2/11/2015,mg,antineoplastic,1/3/2015,11/9/2014,Intravenous,vinorelbine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/18/2024,mg,antineoplastic,11/30/2023,6/8/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G49E3CE9E292G,4/9/2023,,antineoplastic,6/7/2020,4/18/2020,,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,3/25/2016,,antineoplastic,2/20/2016,11/16/2015,Oral,capecitabine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/22/2023,mg,antineoplastic,5/8/2023,3/2/2023,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/1/2017,mg,antineoplastic,7/2/2017,6/12/2017,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/15/2021,mg/m2,antineoplastic,4/25/2021,3/2/2021,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/2/2018,,antineoplastic,4/4/2018,4/20/2018,Intravenous,carboplatin,FALSE
374,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/3/2025,mg,antineoplastic,5/17/2025,1/1/2025,Intravenous,carboplatin,FALSE
268,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,1/5/2021,mg,antineoplastic,7/14/2020,1/19/2020,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/16/2022,mg/kg,antineoplastic,4/4/2021,2/11/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,5/2/2020,mg,antineoplastic,5/12/2019,1/8/2018,Intravenous,pembrolizumab,TRUE
975,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,7/26/2015,mg,antineoplastic,2/10/2015,1/5/2015,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/29/2017,mg,antineoplastic,1/12/2017,4/29/2016,Intravenous,nivolumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/6/2019,mg,antineoplastic,11/6/2019,8/5/2019,Intravenous,cisplatin,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,12/13/2013,mg,antineoplastic,10/21/2013,8/8/2013,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,6/23/2024,,antineoplastic,3/19/2024,4/26/2024,,pemetrexed,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/4/2025,mg,antineoplastic,1/20/2025,7/21/2024,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,1/13/2021,mg,antineoplastic,10/2/2020,8/20/2020,Intravenous,pembrolizumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/14/2011,mg,antineoplastic,4/9/2011,4/29/2011,Intravenous,carboplatin,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,3/29/2025,mg,antineoplastic,12/24/2024,12/18/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,5/2/2024,,pain agent,9/30/2023,5/16/2023,Oral,clinical study drug,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/10/2018,mg,antineoplastic,8/14/2016,9/25/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,8/1/2021,mg,antineoplastic,5/22/2021,2/15/2021,Intravenous,pembrolizumab,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,12/10/2015,mg,antineoplastic,8/8/2015,7/20/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/13/2025,mg,antineoplastic,1/7/2025,12/31/2024,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G1G54G4GB8B24,8/12/2022,,,9/8/2022,1/14/2022,Oral,trametinib,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/21/2019,mg/m2,antineoplastic,9/7/2019,8/2/2019,Intravenous,paclitaxel,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,2/24/2024,mg,antineoplastic,1/31/2024,12/27/2023,Oral,abiraterone,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/8/2021,mg,antineoplastic,4/6/2021,5/14/2020,Intravenous,gemcitabine,FALSE
120,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G24C:63G27686,3/12/2014,mg,antineoplastic,1/6/2014,1/30/2014,Intravenous,paclitaxel protein-bound,FALSE
288.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/16/2015,mg,antineoplastic,11/28/2014,12/18/2014,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G13ED3F1277G4,8/30/2017,mg,antineoplastic,9/3/2017,7/20/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,2/7/2020,mg,antineoplastic,11/2/2019,11/14/2019,Intravenous,pembrolizumab,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/16/2019,mg,antineoplastic,10/1/2018,6/23/2018,Intravenous,pemetrexed,FALSE
132,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/19/2020,mg,antineoplastic,1/29/2020,2/26/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/20/2025,mg,antineoplastic,2/8/2021,2/26/2020,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Clinical Study Drug,Osimertinib",G3BBG95F1669C,1/30/2023,,,1/18/2023,11/6/2022,Oral,osimertinib,FALSE
3629,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/27/2025,mg,antineoplastic,2/4/2025,12/25/2024,Other/Miscellaneous,fluorouracil,FALSE
164,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/16/2020,mg,antineoplastic,8/21/2020,6/2/2020,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,3/29/2024,mg,antineoplastic,6/17/2023,6/12/2023,Intravenous,nivolumab,TRUE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,8/17/2020,mg,antineoplastic,5/22/2020,5/20/2020,Intravenous,pemetrexed,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/24/2021,mg,antineoplastic,5/10/2021,4/18/2021,Intravenous,paclitaxel protein-bound,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/22/2016,mg,antineoplastic,5/19/2016,6/24/2016,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,2/5/2021,mg,antineoplastic,8/10/2020,6/26/2020,Intravenous,docetaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/11/2020,mg,antineoplastic,3/3/2019,1/30/2019,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Paclitaxel",G147ED4GE76EE,1/2/2020,mg/m2,antineoplastic,11/18/2019,11/22/2019,Intravenous,cisplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,12/3/2017,mg,antineoplastic,8/8/2017,4/17/2017,Intravenous,gemcitabine,FALSE
152,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,2/8/2024,mg,antineoplastic,9/9/2023,9/7/2023,Intravenous,cisplatin,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,7/25/2024,,antineoplastic,7/17/2024,7/8/2024,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,3/29/2017,mg,antineoplastic,1/28/2017,11/19/2016,Intravenous,nivolumab,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/24/2019,mg,antineoplastic,7/27/2019,5/10/2019,Intravenous,docetaxel,FALSE
386,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,11/30/2015,mg,antineoplastic,9/29/2015,6/29/2015,Intravenous,ramucirumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/28/2023,mg,antineoplastic,8/23/2021,12/11/2019,Intravenous,pembrolizumab,FALSE
490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/16/2017,mg,antineoplastic,11/14/2017,7/25/2017,Intravenous,carboplatin,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/9/2013,mg,antineoplastic,5/23/2013,1/31/2013,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/24/2018,mg,antineoplastic,3/22/2017,8/27/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/7/2022,mg,antineoplastic,10/24/2021,3/18/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/22/2023,,antineoplastic,1/22/2023,2/2/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,2/4/2019,mg,antineoplastic,11/5/2017,4/9/2017,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,4/25/2024,,antineoplastic,7/26/2023,6/27/2023,Intravenous,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,3/16/2025,mg,antineoplastic,6/13/2024,1/26/2024,Intravenous,durvalumab,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/27/2019,mg,antineoplastic,5/14/2013,2/25/2013,Intravenous,carboplatin,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/10/2021,mg,antineoplastic,5/31/2020,5/29/2020,Intravenous,docetaxel,FALSE
830,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/19/2018,mg,antineoplastic,11/11/2018,7/18/2018,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G46:87GF7FGC9,11/29/2015,,antineoplastic,11/28/2015,7/14/2015,Intravenous,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/11/2016,mg,antineoplastic,4/29/2016,4/11/2016,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,6/17/2015,mg/m2,antineoplastic,6/14/2015,3/4/2015,Intravenous,paclitaxel protein-bound,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3C:F1C:2BF6C,12/16/2014,mg,antineoplastic,11/22/2014,9/8/2014,Intravenous,docetaxel,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,4/20/2025,mg,antineoplastic,2/17/2025,2/15/2025,Intravenous,pemetrexed,FALSE
45,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,10/26/2023,mg,antineoplastic,7/8/2023,6/22/2023,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,2/15/2024,mg,antineoplastic,7/29/2023,8/3/2023,Intravenous,pembrolizumab,FALSE
668,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/10/2022,mg,antineoplastic,9/20/2021,10/3/2021,Intravenous,rituximab-pvvr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/18/2025,mg,antineoplastic,2/9/2025,7/26/2024,Intravenous,pembrolizumab,TRUE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,4/8/2024,mg/m2,antineoplastic,5/13/2024,3/22/2024,Intravenous,paclitaxel,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,12/31/2013,mg,antineoplastic,11/24/2013,10/18/2013,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/11/2025,mg,antineoplastic,3/25/2025,3/29/2024,Intravenous,pembrolizumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/7/2013,AUC,antineoplastic,6/18/2013,4/9/2013,Intravenous,carboplatin,FALSE
726,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,10/31/2011,mg,antineoplastic,9/14/2011,7/11/2011,Intravenous,carboplatin,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/8/2025,mg,antineoplastic,10/24/2019,4/18/2019,Intravenous,pemetrexed,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,3/1/2019,mL,solution-fluid,12/26/2018,12/6/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/19/2022,,antineoplastic,1/14/2022,3/31/2017,Oral,nilotinib,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/8/2020,mg,antineoplastic,6/2/2018,7/4/2017,Intravenous,pemetrexed,TRUE
825,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,4/2/2025,mg,antineoplastic,11/21/2024,12/21/2022,Intravenous,pemetrexed,FALSE
191.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,8/15/2018,mg,antineoplastic,7/27/2018,6/23/2018,Intravenous,carboplatin,FALSE
60,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,6/22/2018,mg,antineoplastic,7/4/2018,4/24/2018,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/14/2021,mg,antineoplastic,6/30/2020,11/14/2019,Intravenous,pembrolizumab,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3C:F1C:2BF6C,1/30/2015,mg,antineoplastic,2/2/2015,1/11/2015,Intravenous,pembrolizumab,FALSE
650,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/19/2021,mg,antineoplastic,10/20/2020,11/5/2020,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G385EEC4EF993,12/12/2020,mg,antineoplastic,11/18/2020,11/25/2020,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/7/2022,mg,antineoplastic,1/4/2020,12/18/2019,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/26/2014,mg,antineoplastic,6/13/2014,3/30/2014,Intravenous,carboplatin,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,11/3/2021,mg,antineoplastic,9/3/2021,8/18/2021,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/5/2020,mg,antineoplastic,8/7/2016,12/9/2015,Intravenous,nivolumab,FALSE
513.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/12/2018,mg,antineoplastic,11/5/2018,9/13/2018,Intravenous,carboplatin,FALSE
336,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/15/2020,mg,antineoplastic,10/2/2019,8/23/2019,Intravenous,carboplatin,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,8/2/2022,mg,antineoplastic,11/5/2021,7/27/2021,Intravenous,pembrolizumab,FALSE
1050,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5344:8G5698G,9/29/2022,mg,antineoplastic,9/11/2022,8/12/2022,Intravenous,pemetrexed,FALSE
49,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G5::D4E74F959,10/25/2013,mg,antineoplastic,11/29/2013,10/14/2013,Intravenous,vinorelbine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/21/2024,mg,antineoplastic,2/14/2023,1/8/2023,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,11/29/2019,mg,antineoplastic,6/11/2019,7/7/2019,Intravenous,ramucirumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/6/2016,mg,antineoplastic,6/16/2016,3/11/2016,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/26/2018,,antineoplastic,7/4/2017,6/24/2017,,clinical study drug,FALSE
230,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/19/2013,mg,antineoplastic,8/17/2013,7/5/2013,Intravenous,carboplatin,FALSE
139,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,9/9/2015,mg,antineoplastic,8/9/2015,6/19/2015,Intravenous,etoposide,FALSE
225,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,6/29/2012,mg,antineoplastic,5/1/2012,4/3/2012,Intravenous,paclitaxel,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/20/2023,mg,antineoplastic,11/16/2022,5/29/2022,Intravenous,durvalumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,4/2/2015,mg,antineoplastic,1/22/2015,2/2/2015,Intravenous,paclitaxel,FALSE
320,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/25/2025,mg,antineoplastic,1/7/2025,12/22/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G46:87GF7FGC9,11/2/2015,,antineoplastic,8/1/2015,7/16/2015,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/19/2019,mg,antineoplastic,9/16/2018,2/15/2018,Intravenous,nivolumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/28/2023,mg,antineoplastic,12/6/2018,10/17/2017,Intravenous,nivolumab,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G15F6:966BBB3,7/29/2016,mg/m2,antineoplastic,5/22/2016,6/26/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2GF55749G7G9,2/8/2022,mg,antineoplastic,1/24/2022,1/18/2022,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/20/2015,mg,antineoplastic,9/16/2014,10/2/2014,Intravenous,pemetrexed,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/8/2024,mg,antineoplastic,1/23/2024,1/27/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/24/2014,mg,antineoplastic,3/22/2014,4/2/2014,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/18/2023,mg,antineoplastic,5/23/2023,9/9/2022,Intravenous,pemetrexed,TRUE
740,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/22/2023,mg,antineoplastic,2/25/2023,12/6/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,4/11/2024,,antineoplastic,8/23/2023,5/20/2023,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/19/2024,mg,antineoplastic,5/24/2023,4/5/2023,Intravenous,atezolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/5/2019,mg,antineoplastic,5/1/2018,4/1/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/17/2025,mg,antineoplastic,10/3/2024,5/25/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/30/2022,,antineoplastic,7/2/2022,5/10/2017,Oral,nilotinib,FALSE
181,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/14/2019,mg,antineoplastic,4/12/2018,2/25/2018,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/2/2017,mg,antineoplastic,12/1/2014,12/9/2014,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/16/2017,,antineoplastic,10/5/2017,7/10/2017,,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,3/4/2025,mg,antineoplastic,12/5/2024,9/24/2024,Intravenous,pembrolizumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/5/2012,AUC,antineoplastic,7/31/2012,5/1/2012,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/19/2016,mg,antineoplastic,12/2/2015,6/4/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/7/2019,mg,antineoplastic,11/23/2019,8/17/2019,Intravenous,pembrolizumab,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/15/2019,mg,antineoplastic,2/11/2019,1/16/2019,Intravenous,paclitaxel,FALSE
438,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/15/2024,mg,antineoplastic,5/23/2024,6/19/2024,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Unstructured,,"Osimertinib,Trametinib",G31C:9::5EG5D,7/23/2024,,,5/23/2024,6/26/2024,Oral,trametinib,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,7/20/2023,5/13/2023,Intravenous,pembrolizumab,FALSE
838,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/25/2015,mg,antineoplastic,12/5/2014,10/5/2014,Intravenous,carboplatin,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,9/17/2015,mg/kg,antineoplastic,8/2/2015,6/7/2015,Intravenous,bevacizumab,FALSE
757,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,10/16/2019,mg,antineoplastic,3/31/2019,2/24/2019,Intravenous,durvalumab,TRUE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,9/18/2022,mg,antineoplastic,7/22/2022,6/18/2022,Intravenous,carboplatin,FALSE
525,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,1/6/2016,mg,antineoplastic,9/5/2015,9/30/2015,Intravenous,carboplatin,FALSE
284,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G164G31958638,10/10/2024,mg,antineoplastic,9/12/2024,8/1/2024,Intravenous,paclitaxel,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/29/2021,mg,antineoplastic,7/29/2018,3/13/2018,Intravenous,durvalumab,TRUE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,7/9/2020,mg,antineoplastic,6/1/2020,5/16/2020,Intravenous,cisplatin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/25/2025,,solution-fluid,1/3/2018,12/5/2017,Intravenous,clinical study drug,FALSE
141.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/11/2019,mg,antineoplastic,8/10/2019,9/15/2019,Intravenous,carboplatin,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,3/31/2016,mg,antineoplastic,1/29/2016,1/23/2016,Intravenous,carboplatin,FALSE
900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,4/4/2022,mg,antineoplastic,2/6/2022,2/3/2022,Intravenous,pemetrexed,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/9/2024,mg,antineoplastic,11/6/2021,7/10/2020,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/10/2022,,antineoplastic,2/3/2022,1/24/2022,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,6/5/2024,,antiemetic,5/29/2024,4/10/2024,Subcutaneous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/17/2025,mg,antineoplastic,8/31/2024,7/2/2024,Intravenous,pembrolizumab,TRUE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,3/3/2019,mg,antineoplastic,3/2/2019,1/10/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/29/2025,mg,antineoplastic,4/7/2024,4/1/2024,Intravenous,pembrolizumab,FALSE
2588,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,7/13/2022,mg,antineoplastic,9/23/2021,9/8/2021,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,10/16/2024,mg,antineoplastic,7/10/2024,7/15/2024,Intravenous,pembrolizumab,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/28/2022,mg,antineoplastic,1/24/2022,11/19/2021,Intravenous,leucovorin,FALSE
93,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,11/7/2023,mg,antineoplastic,10/16/2023,9/14/2023,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/20/2025,mg,antineoplastic,5/27/2019,1/25/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/27/2025,,antineoplastic,2/23/2022,10/31/2021,Intravenous,pemetrexed,TRUE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/27/2022,mg,antineoplastic,11/9/2021,10/18/2021,Intravenous,paclitaxel,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/26/2025,mg,antineoplastic,3/12/2025,4/21/2024,Intravenous,durvalumab,TRUE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/17/2023,mg,antineoplastic,1/28/2023,11/5/2022,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/28/2018,mg,antineoplastic,4/8/2017,3/14/2017,Intravenous,pembrolizumab,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/31/2013,mg,antineoplastic,3/13/2013,8/30/2012,Intravenous,carboplatin,FALSE
51,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,6/7/2024,mg,antineoplastic,3/9/2024,11/7/2023,Intravenous,ipilimumab,FALSE
175,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/21/2017,mg,antineoplastic,2/4/2016,1/31/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1G:94B69FD31,5/1/2025,mg,antineoplastic,9/8/2024,8/20/2024,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,5/25/2025,mg,antineoplastic,2/14/2025,1/28/2025,Intravenous,pemetrexed,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/26/2019,mg,antineoplastic,1/20/2017,11/28/2016,Intramuscular,fulvestrant,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/4/2015,mg,antineoplastic,12/6/2014,10/13/2014,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,5/8/2025,mg,antineoplastic,3/24/2025,10/23/2024,Intravenous,pemetrexed,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/11/2025,mg,antineoplastic,5/10/2024,2/14/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/11/2023,mg,antineoplastic,8/31/2022,8/26/2022,Intravenous,pembrolizumab,TRUE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,11/6/2018,mg,antineoplastic,3/13/2013,3/9/2013,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,4/10/2021,mg/m2,antineoplastic,5/9/2021,4/14/2021,Intravenous,gemcitabine,FALSE
15.5,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G57DE72B664E8,8/27/2012,mL,antineoplastic,7/17/2012,8/24/2012,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G545:2F182DD:,9/16/2017,,solution-fluid,10/1/2017,9/3/2017,Intravenous,clinical study drug,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/30/2020,mL,solution-fluid,3/13/2019,2/28/2019,Intravenous,nivolumab,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/27/2018,mg,antineoplastic,5/6/2018,4/3/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G31C:9::5EG5D,1/5/2023,,,3/10/2019,4/27/2019,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/11/2020,mg,antineoplastic,11/17/2019,10/17/2019,Intravenous,pembrolizumab,TRUE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/23/2016,mg,antineoplastic,8/15/2015,12/8/2014,Intravenous,pemetrexed,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/28/2021,mg,antineoplastic,1/1/2021,10/30/2020,Intravenous,pemetrexed,FALSE
400,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,12/20/2020,mg,antineoplastic,12/30/2020,6/7/2020,Intravenous,pembrolizumab,FALSE
405,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/31/2017,mg,antineoplastic,1/28/2017,12/22/2016,Intravenous,carboplatin,FALSE
683,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/4/2016,mg,antineoplastic,6/24/2015,7/1/2015,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/18/2025,mg,antineoplastic,11/6/2017,1/6/2017,Intravenous,nivolumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/7/2011,mg,antineoplastic,11/3/2011,10/11/2011,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/19/2017,mg,antineoplastic,11/3/2016,4/5/2016,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/8/2024,mg,antineoplastic,12/11/2023,11/27/2023,Intravenous,durvalumab,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/27/2016,mg,antineoplastic,9/12/2015,7/19/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/11/2025,mg,antineoplastic,2/21/2025,12/27/2024,Intravenous,pembrolizumab,FALSE
590,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/9/2021,mg,antineoplastic,10/8/2020,7/11/2020,Intravenous,ramucirumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,11/24/2016,mg,antineoplastic,8/7/2016,6/30/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,"Capmatinib,Erlotinib",G12E5EG31:6:5,11/28/2022,,,11/16/2022,10/17/2022,Oral,capmatinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/8/2018,mg,antineoplastic,11/25/2017,8/17/2015,Intravenous,nivolumab,FALSE
71.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/16/2021,mg,antineoplastic,6/7/2021,6/15/2021,Intravenous,paclitaxel,FALSE
2370,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1GDCB:FF9G:1,6/28/2016,mg,antineoplastic,4/23/2016,4/27/2016,Intravenous,gemcitabine,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,12/19/2012,AUC,antineoplastic,1/12/2013,11/5/2012,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/2/2014,mg,antineoplastic,4/8/2014,1/26/2014,Intravenous,pemetrexed,FALSE
471,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,4/24/2021,mg,antineoplastic,2/17/2021,2/3/2021,Intravenous,carboplatin,FALSE
84,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,6/2/2022,mg,antineoplastic,4/20/2022,2/8/2022,Intravenous,paclitaxel,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,8/21/2018,mg,antineoplastic,5/31/2018,3/29/2018,Intravenous,carboplatin,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,9/28/2018,mg,antineoplastic,8/25/2018,5/31/2018,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/9/2025,mg,antineoplastic,2/11/2024,9/16/2022,Intravenous,pembrolizumab,TRUE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/12/2019,mg,antineoplastic,6/26/2018,7/16/2018,Intravenous,pemetrexed,FALSE
569,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,8/30/2014,mg,antineoplastic,8/7/2014,7/6/2014,Intravenous,carboplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,10/25/2017,mg,antineoplastic,9/21/2017,5/20/2017,Intravenous,gemcitabine,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/27/2017,mg,antineoplastic,7/17/2015,3/14/2015,Intravenous,bevacizumab,TRUE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G58E33F7EG254,2/15/2020,mg,antineoplastic,1/20/2020,1/22/2020,Intravenous,docetaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/2/2020,mg,antineoplastic,1/5/2018,12/16/2017,Intravenous,pemetrexed,TRUE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,9/29/2019,mg,antineoplastic,9/15/2019,8/5/2019,Intravenous,pemetrexed,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Capecitabine,Docetaxel",G356E75GB3883,9/29/2017,mg,antineoplastic,10/28/2017,11/2/2017,Intravenous,docetaxel,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,2/25/2024,mg,antineoplastic,12/19/2023,1/4/2024,Subcutaneous,leuprolide,FALSE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/24/2018,mg,antineoplastic,8/12/2016,6/28/2016,Intravenous,carboplatin,FALSE
1025,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,7/13/2020,mg,antineoplastic,5/23/2020,5/8/2020,Intravenous,pemetrexed,FALSE
183,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/4/2021,mg,antineoplastic,10/19/2021,10/13/2021,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/10/2025,mg,antineoplastic,4/22/2018,1/2/2017,Intravenous,nivolumab,FALSE
757.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4497G86984C8,2/21/2015,mg,antineoplastic,3/11/2015,2/23/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/23/2025,,antineoplastic,7/11/2024,3/11/2023,Intravenous,pemetrexed,FALSE
2200,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/4/2015,mg,antineoplastic,3/19/2015,4/6/2015,Intravenous,gemcitabine,FALSE
448.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/22/2020,mg,antineoplastic,2/12/2020,3/13/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/21/2020,mg,antineoplastic,12/13/2019,10/30/2019,Intravenous,pembrolizumab,TRUE
165.6,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/18/2015,mg,antineoplastic,1/22/2015,10/14/2014,Intravenous,paclitaxel,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/12/2025,mg,antineoplastic,6/28/2024,4/18/2024,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/22/2025,,antineoplastic,11/25/2021,10/4/2021,Intravenous,pembrolizumab,TRUE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/17/2013,mg,antineoplastic,9/5/2013,3/18/2013,Intravenous,paclitaxel protein-bound,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/20/2019,mg,antineoplastic,9/22/2019,9/9/2019,Intravenous,paclitaxel,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,8/3/2021,mg,antineoplastic,9/16/2020,10/12/2020,Intravenous,gemcitabine,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/23/2018,mg,antineoplastic,1/8/2018,12/17/2017,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4ED25F4G24F2,11/26/2018,,,6/13/2018,7/10/2018,Oral,osimertinib,FALSE
630,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,5/12/2012,mg,antineoplastic,5/15/2012,3/11/2012,Intravenous,carboplatin,FALSE
244,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/20/2021,mg,antineoplastic,5/17/2021,4/6/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/21/2025,mg,antineoplastic,6/21/2024,4/25/2023,Intravenous,pembrolizumab,FALSE
670,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,1/26/2024,mg,antineoplastic,12/8/2023,11/13/2023,Intravenous,pemetrexed,FALSE
1075,2,ADVANCED,Administrations,chemotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,9/8/2019,mg,antineoplastic,4/7/2019,1/25/2019,Intravenous,pemetrexed,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/6/2023,mg,antineoplastic,3/25/2023,5/25/2022,Intravenous,durvalumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,6/4/2023,mg,antineoplastic,4/16/2023,3/12/2023,Intravenous,pemetrexed,FALSE
436,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12786B9C7G6D,8/4/2018,AUC,antineoplastic,7/30/2018,8/9/2018,Intravenous,carboplatin,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/26/2013,mg/m2,antineoplastic,12/16/2012,7/25/2012,Intravenous,docetaxel,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,2/27/2012,mg,antineoplastic,2/24/2012,12/7/2011,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/3/2021,mg,antineoplastic,12/8/2020,10/30/2020,Intravenous,pembrolizumab,FALSE
170,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/11/2019,mg,antineoplastic,4/8/2019,3/20/2019,Intravenous,docetaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/31/2023,mg,antineoplastic,6/26/2022,5/26/2020,Intravenous,pembrolizumab,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/18/2022,mg,antineoplastic,1/28/2022,12/1/2021,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/3/2023,mg,antineoplastic,3/5/2023,8/24/2022,Subcutaneous,azacitidine,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,4/20/2015,mg,antineoplastic,3/18/2015,2/8/2015,Intravenous,paclitaxel protein-bound,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,1/30/2020,mg,antineoplastic,6/1/2019,5/22/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G3DG:CFF4F7:G,9/4/2017,,,4/7/2017,5/6/2017,Oral,erlotinib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/6/2023,mg,antineoplastic,10/6/2022,8/15/2022,Subcutaneous,azacitidine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/23/2025,mg,antineoplastic,1/19/2024,12/8/2023,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/4/2022,mg,antineoplastic,8/15/2020,2/28/2016,Intravenous,pemetrexed,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/17/2018,mg,antineoplastic,5/7/2016,8/14/2015,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3:D1D2EG5C21,12/14/2014,,antineoplastic,8/8/2014,8/23/2014,Intravenous,clinical study drug,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/27/2023,mg,antineoplastic,5/10/2023,4/12/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/23/2025,mg,antineoplastic,1/27/2024,7/6/2023,Intravenous,pembrolizumab,TRUE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,4/12/2020,mg,antineoplastic,9/29/2019,7/21/2019,Intravenous,ramucirumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G14E999899EFC,4/30/2024,mg,antineoplastic,1/13/2024,1/13/2024,Intravenous,cemiplimab,FALSE
68,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/11/2020,mg,antineoplastic,6/10/2019,5/18/2019,Intravenous,paclitaxel,FALSE
471,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,4/16/2015,mg,antineoplastic,2/5/2015,12/30/2014,Intravenous,carboplatin,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/24/2024,mg,antineoplastic,2/18/2024,12/17/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,2/2/2015,,antineoplastic,12/2/2014,9/6/2014,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/5/2020,mg,antineoplastic,9/4/2019,1/17/2019,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/9/2011,mg,antineoplastic,7/24/2011,6/21/2011,Intravenous,etoposide,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/24/2024,mg,antineoplastic,10/21/2023,6/19/2023,Intravenous,carboplatin,FALSE
418,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,2/13/2023,mg,antineoplastic,1/13/2023,11/28/2022,Intravenous,carboplatin,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/8/2023,mg,antineoplastic,11/16/2023,12/2/2022,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/1/2017,mg,antineoplastic,1/29/2017,11/4/2016,Intravenous,paclitaxel protein-bound,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/25/2022,mg,antineoplastic,10/4/2020,4/8/2020,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/20/2023,mg,antineoplastic,5/15/2023,10/29/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,2/24/2018,AUC,antineoplastic,12/29/2017,10/26/2017,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,4/26/2023,mg,antineoplastic,5/23/2023,2/26/2023,Intravenous,pemetrexed,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,5/7/2015,mg,antineoplastic,3/10/2015,1/15/2015,Intravenous,paclitaxel protein-bound,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G44B44661:316,3/26/2016,mL,solution-fluid,3/4/2016,3/21/2016,Intravenous,nivolumab,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,8/9/2021,mg,antineoplastic,1/12/2021,10/6/2020,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/17/2022,mL,solution-fluid,12/11/2022,11/2/2022,Intravenous,pemetrexed,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,5/21/2024,mg,antineoplastic,9/17/2020,8/29/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,11/7/2017,mg,antineoplastic,6/18/2017,5/30/2017,Intravenous,pembrolizumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,3/24/2015,mg,antineoplastic,4/8/2015,5/8/2015,Intravenous,paclitaxel,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,10/20/2017,mg,antineoplastic,8/17/2017,7/11/2017,Intravenous,docetaxel,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/10/2025,mg,antineoplastic,3/18/2025,8/20/2024,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,4/2/2016,,antineoplastic,4/25/2016,3/24/2016,Intravenous,carboplatin,FALSE
164,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/5/2019,mg,antineoplastic,3/24/2018,3/26/2018,Intravenous,carboplatin,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,12/16/2024,mg,antineoplastic,4/30/2023,3/4/2023,Intravenous,paclitaxel protein-bound,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5669E21B9D52,4/10/2017,mg,antineoplastic,4/15/2017,2/19/2017,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1B8EF2645E7F,5/1/2015,mg,antineoplastic,4/17/2015,5/3/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/19/2024,mg,antineoplastic,5/14/2021,6/4/2020,Intravenous,pembrolizumab,TRUE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/12/2015,mg,antineoplastic,7/9/2015,3/12/2015,Intravenous,gemcitabine,FALSE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/27/2013,mg,antineoplastic,3/31/2013,12/4/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/30/2023,mg,antineoplastic,7/3/2022,10/2/2021,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G57G45B:D1F17,1/3/2025,,antineoplastic,11/21/2017,11/29/2017,Oral,clinical study drug,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4B1F584CB682,1/17/2016,mg/kg,antineoplastic,12/29/2015,11/14/2015,Intravenous,nivolumab,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/4/2019,mg,antineoplastic,4/20/2019,1/4/2019,Intravenous,paclitaxel,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/27/2021,mg,antineoplastic,12/18/2019,12/8/2019,Intravenous,durvalumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,1/24/2020,mg,antineoplastic,11/5/2019,11/12/2019,Intravenous,pembrolizumab,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/5/2015,mg,antineoplastic,5/27/2015,4/14/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1C22CGB1F5C2,8/24/2020,mg,antineoplastic,1/19/2020,12/26/2019,Intravenous,pembrolizumab,TRUE
712,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/21/2014,mg,antineoplastic,8/14/2014,7/19/2014,Intravenous,carboplatin,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/29/2018,mg,antineoplastic,7/22/2018,6/2/2018,Intravenous,etoposide,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/19/2022,mg,antineoplastic,12/18/2021,6/26/2021,Intravenous,pembrolizumab,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/28/2025,mg,antineoplastic,7/19/2024,4/5/2024,Oral,abiraterone,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/20/2025,mg,antineoplastic,1/22/2021,1/5/2019,Intravenous,pembrolizumab,TRUE
401,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,5/26/2023,mg,antineoplastic,4/6/2023,4/18/2023,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/4/2018,AUC,antineoplastic,5/12/2018,4/11/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/15/2023,mg,antineoplastic,6/19/2023,10/21/2021,Intravenous,pembrolizumab,TRUE
1250,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,9/24/2019,mg,antineoplastic,9/6/2019,5/27/2019,Intravenous,pemetrexed,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/9/2025,mg,antineoplastic,2/3/2025,4/1/2020,Subcutaneous,leuprolide,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,9/12/2023,mg,antineoplastic,9/21/2023,5/22/2023,Intravenous,vinorelbine,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/12/2022,mg,antineoplastic,9/23/2021,3/18/2021,Intravenous,atezolizumab,FALSE
246.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/15/2013,mg,antineoplastic,6/14/2013,4/28/2013,Intravenous,carboplatin,FALSE
304.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/19/2024,mg,antineoplastic,9/8/2024,6/11/2024,Intravenous,paclitaxel,FALSE
1107,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G33:335715B9G,4/19/2025,mg,antineoplastic,2/20/2025,1/26/2025,Intravenous,durvalumab,TRUE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,11/2/2015,mg,antineoplastic,7/15/2015,6/9/2015,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/10/2021,,antineoplastic,5/22/2021,5/4/2021,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/21/2025,mg,antineoplastic,7/30/2020,2/24/2019,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/18/2025,,antineoplastic,11/28/2017,12/4/2017,Intravenous,clinical study drug,FALSE
270,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,6/17/2016,mg,antineoplastic,3/10/2016,3/13/2016,Intravenous,paclitaxel,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/13/2017,mg,antineoplastic,8/16/2015,5/22/2015,Intravenous,nivolumab,FALSE
73,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,8/10/2016,mg,antineoplastic,12/21/2015,11/29/2015,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/28/2017,mg,antineoplastic,11/29/2016,12/8/2016,Intravenous,paclitaxel protein-bound,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,4/26/2022,mg,antineoplastic,4/18/2022,4/25/2022,Intravenous,paclitaxel,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/20/2019,mg,antineoplastic,9/1/2017,8/25/2017,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/26/2023,mg,antineoplastic,8/5/2022,5/30/2020,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/24/2025,mg,antineoplastic,5/16/2024,3/11/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/16/2014,,solution-fluid,1/20/2014,10/28/2013,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,12/2/2024,mg,antineoplastic,10/26/2024,8/2/2024,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CF4D5D1:BF3,11/15/2023,mg,antineoplastic,11/12/2023,11/18/2023,Intravenous,nivolumab,FALSE
551,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,5/23/2023,mg,antineoplastic,5/16/2023,3/28/2023,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/29/2022,mg,antineoplastic,10/16/2021,6/11/2021,Intravenous,bevacizumab-bvzr,FALSE
1068,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,3/10/2021,mg,antineoplastic,11/15/2020,1/2/2021,Intravenous,cyclophosphamide,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/27/2017,mg/m2,antineoplastic,3/16/2017,11/5/2016,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/21/2011,mg,antineoplastic,7/26/2011,4/2/2011,Intravenous,paclitaxel,FALSE
348,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,6/27/2016,mg,antineoplastic,4/20/2016,2/25/2016,Intravenous,paclitaxel,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,7/10/2021,mg,antineoplastic,6/2/2021,6/7/2021,Intravenous,pembrolizumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/20/2012,AUC,antineoplastic,7/9/2012,5/12/2012,Intravenous,carboplatin,FALSE
164,1,LOCOREGIONAL,Administrations,chemotherapy,Docetaxel,G24F:E99C2926,11/17/2023,mg,antineoplastic,12/4/2023,9/24/2023,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,2/16/2021,,antineoplastic,10/11/2020,2/23/2020,Intravenous,clinical study drug,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/12/2020,mg,antineoplastic,3/26/2020,2/3/2019,Subcutaneous,bortezomib,FALSE
240,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,8/18/2023,mg,antineoplastic,9/2/2023,6/7/2023,Intravenous,nivolumab,FALSE
888,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/17/2023,mg,antineoplastic,3/14/2023,2/9/2023,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/4/2025,mg,antineoplastic,8/14/2017,7/12/2016,Intravenous,pembrolizumab,FALSE
491,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/27/2020,mg,antineoplastic,5/31/2020,1/31/2020,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/10/2019,,antineoplastic,9/6/2019,9/6/2019,,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/4/2014,mg,antineoplastic,2/10/2014,11/8/2013,Intravenous,carboplatin,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/14/2014,mg,antineoplastic,1/16/2013,9/21/2012,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/20/2014,mg/m2,antineoplastic,7/16/2014,12/24/2013,Intravenous,pemetrexed,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,11/3/2023,mg,antineoplastic,8/23/2023,8/7/2023,Intravenous,paclitaxel,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,10/30/2020,mg,antineoplastic,11/1/2020,9/9/2020,Intravenous,paclitaxel protein-bound,FALSE
1115,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/3/2016,mg,antineoplastic,3/11/2016,3/11/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/17/2021,mg/m2,antineoplastic,3/29/2021,3/18/2021,Intravenous,leucovorin,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/29/2022,mg,antineoplastic,12/19/2021,8/23/2021,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G18EBC2339CGG,1/10/2015,mg/m2,antineoplastic,1/9/2015,1/9/2015,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G128:92:3BD3D,12/25/2021,,antineoplastic,9/18/2021,5/17/2021,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1:C9B9B392:C,4/23/2015,mg/m2,antineoplastic,4/17/2015,4/2/2015,Intravenous,gemcitabine,FALSE
400,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,1/26/2024,mg,antineoplastic,11/18/2023,11/8/2023,Intravenous,paclitaxel,FALSE
1310,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,1/18/2015,mg,antineoplastic,12/3/2014,10/18/2014,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/12/2022,mg,antineoplastic,8/21/2021,12/17/2019,Intravenous,nivolumab,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/26/2023,mg,antineoplastic,1/1/2023,11/18/2022,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/21/2024,mg,antineoplastic,8/28/2023,5/8/2020,Intravenous,pembrolizumab,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,4/28/2025,mg,antineoplastic,4/22/2025,12/5/2024,Intravenous,pembrolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/10/2025,mg,antineoplastic,7/3/2021,2/24/2019,Intravenous,pemetrexed,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/10/2025,mg,antineoplastic,12/31/2024,1/21/2025,Intravenous,amivantamab-vmjw,FALSE
201,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,4/28/2022,mg,antineoplastic,2/28/2022,2/19/2022,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,Pazopanib,G51:G:C712CC6,7/5/2021,,antineoplastic,4/2/2021,4/18/2021,Oral,pazopanib,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,2/8/2017,mg,antineoplastic,12/2/2016,11/19/2016,Intravenous,paclitaxel protein-bound,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/30/2023,mg,antineoplastic,12/16/2022,11/16/2022,Intravenous,carboplatin,FALSE
425,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1E1BE62:E61G,1/9/2020,mg,antineoplastic,2/1/2020,12/26/2019,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,7/7/2020,mg,antineoplastic,4/12/2020,4/6/2020,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,11/2/2020,mg,antineoplastic,3/9/2020,9/21/2019,Intravenous,durvalumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/1/2014,mg,antineoplastic,4/10/2014,2/19/2014,Intravenous,cisplatin,FALSE
795,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/22/2020,mg,antineoplastic,12/14/2018,11/19/2018,Intravenous,pemetrexed,FALSE
778,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G58E33F7EG254,1/6/2020,mg,antineoplastic,1/9/2020,1/8/2020,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/28/2020,,antineoplastic,7/21/2018,7/13/2017,Intravenous,pemetrexed,TRUE
545,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,6/24/2013,mg,antineoplastic,8/27/2012,7/11/2012,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/23/2023,mg,antineoplastic,2/12/2022,12/16/2019,Intravenous,pembrolizumab,FALSE
28,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,3/29/2015,mg,antineoplastic,3/7/2015,2/28/2015,Intravenous,docetaxel,FALSE
,1,LOCOREGIONAL,Administrations,solution-fluid,Clinical Study Drug,G2C233C2:5B1:,5/2/2025,,solution-fluid,3/18/2025,12/9/2024,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/23/2025,mg,antineoplastic,8/12/2021,8/18/2021,Intravenous,atezolizumab,TRUE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/22/2020,mg,antineoplastic,8/4/2019,2/1/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/7/2022,mg,antineoplastic,2/16/2020,1/30/2020,Intravenous,nivolumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/14/2024,mg,antineoplastic,6/1/2023,1/24/2023,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/14/2024,mg,antineoplastic,4/6/2023,3/21/2023,Intravenous,bevacizumab-awwb,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,8/8/2018,AUC,antineoplastic,6/1/2018,5/3/2018,Intravenous,carboplatin,FALSE
434,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,3/9/2013,mg,antineoplastic,1/3/2013,12/4/2012,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,3/9/2020,mg,antineoplastic,7/28/2018,7/7/2018,Intravenous,durvalumab,FALSE
234,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,6/11/2018,mg,antineoplastic,9/30/2017,11/8/2017,Intravenous,paclitaxel,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/18/2021,mg,antineoplastic,3/28/2021,6/4/2020,Intravenous,gemcitabine,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/17/2019,mg,antineoplastic,12/21/2018,6/14/2018,Intravenous,pemetrexed,FALSE
68,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/6/2024,mg,antineoplastic,9/19/2024,8/7/2024,Intravenous,paclitaxel,FALSE
215,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,7/25/2021,mg,antineoplastic,1/30/2017,12/27/2016,Intravenous,carboplatin,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,4/21/2015,mg,antineoplastic,1/15/2015,12/20/2014,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,9/21/2023,mg,antineoplastic,7/19/2023,8/6/2023,Intravenous,pembrolizumab,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/17/2020,mg,antineoplastic,6/23/2019,5/7/2019,Intravenous,pemetrexed,TRUE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/23/2023,mg,antineoplastic,9/19/2020,11/9/2019,Intravenous,pembrolizumab,TRUE
196,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,4/25/2022,mg,antineoplastic,4/9/2022,2/23/2022,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,4/24/2025,mg,antineoplastic,4/2/2025,10/1/2024,Intravenous,pembrolizumab,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/15/2022,mg/kg,antineoplastic,11/11/2021,7/12/2021,Intravenous,bevacizumab-bvzr,FALSE
,2,ADVANCED,Orders,solution-fluid,Clinical Study Drug,G1CD225858D1:,8/15/2017,,solution-fluid,12/31/2016,1/3/2017,,clinical study drug,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/17/2015,mg,antineoplastic,9/13/2014,9/23/2014,Intravenous,etoposide,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/26/2025,mg,antineoplastic,2/22/2021,3/9/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,4/20/2020,mg,antineoplastic,1/4/2018,12/7/2016,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/12/2024,,antineoplastic,9/5/2024,7/28/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/14/2025,,antineoplastic,7/25/2023,3/16/2023,,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,12/20/2018,mg,antineoplastic,12/18/2018,10/8/2017,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,4/10/2023,mg,antineoplastic,5/17/2022,5/17/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/18/2025,mg,antineoplastic,2/3/2025,10/14/2023,Intravenous,pembrolizumab,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,9/6/2013,mg,antineoplastic,3/9/2013,2/3/2013,Intravenous,paclitaxel protein-bound,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/23/2015,mg,antineoplastic,9/9/2014,9/21/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,1/22/2018,mg,antineoplastic,1/8/2018,2/15/2018,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/7/2022,AUC,antineoplastic,7/25/2022,6/11/2022,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,5/16/2025,mg,antineoplastic,9/14/2024,8/14/2024,Intravenous,atezolizumab,TRUE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,9/16/2024,mg,antineoplastic,6/14/2024,5/10/2024,Intravenous,vinorelbine,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/8/2014,mg,antineoplastic,1/3/2014,12/10/2013,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,3/7/2025,,antineoplastic,10/20/2024,3/17/2024,,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G29D9FB:D1D6B,8/31/2019,,antineoplastic,8/15/2019,9/10/2019,,letrozole,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/12/2017,mg,antineoplastic,7/20/2017,6/5/2017,Intravenous,paclitaxel,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/27/2025,mg,antineoplastic,4/25/2025,4/11/2025,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/26/2014,mg,antineoplastic,11/27/2013,11/5/2013,Intravenous,paclitaxel,FALSE
150,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G289C6438E26:,8/15/2013,mg,antineoplastic,6/19/2013,6/23/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/14/2023,,antineoplastic,2/7/2023,1/12/2023,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,3/3/2019,mg,antineoplastic,10/20/2017,9/7/2017,Intravenous,atezolizumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/27/2019,mg,antineoplastic,8/15/2016,3/15/2016,Intravenous,nivolumab,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/21/2022,mg,antineoplastic,3/12/2018,4/10/2017,Oral,dasatinib,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,4/7/2023,,antineoplastic,8/1/2022,5/3/2022,Intravenous,durvalumab,FALSE
110.4,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,2/10/2014,mg,antineoplastic,8/15/2013,6/14/2013,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/31/2025,mg,antineoplastic,5/31/2021,3/24/2020,Intravenous,pembrolizumab,FALSE
211,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,3/27/2025,mg,antineoplastic,2/6/2025,3/29/2025,Intravenous,carboplatin,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/29/2024,mg,antineoplastic,10/13/2021,7/18/2020,Intravenous,ipilimumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/7/2025,mg,antineoplastic,11/22/2024,7/21/2024,Intravenous,pembrolizumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/22/2020,mg,antineoplastic,10/16/2019,10/8/2019,Intravenous,paclitaxel,FALSE
270,2,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,7/31/2019,mg,antineoplastic,4/27/2019,5/22/2019,Intravenous,irinotecan,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,2/7/2022,mg,antineoplastic,1/26/2021,1/28/2021,Intravenous,pembrolizumab,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/15/2016,mg,antineoplastic,8/29/2016,7/21/2016,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,2/13/2015,mg,antineoplastic,7/24/2014,7/1/2014,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/17/2019,mg,antineoplastic,7/30/2018,2/24/2016,Intravenous,nivolumab,FALSE
1400,2,ADVANCED,Orders,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/21/2025,mg,antineoplastic,12/17/2024,2/7/2024,Intravenous,amivantamab-vmjw,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G44B44661:316,3/26/2016,mL,solution-fluid,2/25/2016,3/17/2016,Intravenous,nivolumab,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G7B3CB6D5C4,4/8/2013,mg,antineoplastic,2/16/2013,3/8/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,5/4/2012,,antineoplastic,12/15/2011,8/11/2011,Intravenous,clinical study drug,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,8/9/2018,mg,antineoplastic,5/7/2018,3/28/2018,Intravenous,pemetrexed,FALSE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,1/16/2014,mg,antineoplastic,9/14/2013,9/22/2013,Intravenous,vinorelbine,FALSE
716,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,5/9/2024,mg,antineoplastic,4/21/2024,2/16/2024,Intravenous,carboplatin,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/3/2020,mg,antineoplastic,1/6/2020,11/26/2019,Intravenous,carboplatin,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/2/2021,mg,antineoplastic,12/21/2020,5/8/2020,Intravenous,gemcitabine,FALSE
470.1,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/19/2025,mg,antineoplastic,9/6/2020,4/8/2019,Intravenous,carboplatin,FALSE
408,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1E586G415EF7,2/13/2016,mg,antineoplastic,3/10/2016,2/2/2016,Intravenous,carboplatin,FALSE
50,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/21/2023,mg/m2,antineoplastic,2/13/2023,2/24/2023,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/3/2016,mg,antineoplastic,5/15/2016,5/8/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/3/2014,mg,antineoplastic,5/27/2014,4/20/2014,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/16/2020,mg,antineoplastic,1/18/2020,12/26/2015,Intravenous,nivolumab,FALSE
588,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,12/16/2015,mg,antineoplastic,10/23/2015,9/20/2015,Intravenous,carboplatin,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,5/2/2015,mg,antineoplastic,5/18/2015,2/24/2015,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/16/2022,mg/kg,antineoplastic,6/1/2021,3/10/2021,Intravenous,durvalumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/19/2015,mg,antineoplastic,7/3/2015,3/10/2015,Intravenous,paclitaxel protein-bound,FALSE
526,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,4/11/2015,mg,antineoplastic,1/6/2015,12/10/2014,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/24/2025,mg,antineoplastic,11/30/2021,4/21/2020,Subcutaneous,leuprolide,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,4/4/2025,mg,antineoplastic,2/20/2025,12/23/2024,Intravenous,oxaliplatin,FALSE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,7/7/2017,mg,antineoplastic,2/21/2016,11/28/2015,Intravenous,nivolumab,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/2/2021,mg,antineoplastic,11/18/2018,3/17/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/8/2025,mg,antineoplastic,12/2/2024,4/14/2024,Intravenous,pembrolizumab,TRUE
,4,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G177G4:B9E394,5/5/2025,,antiemetic,3/27/2025,4/1/2025,Intravenous,clinical study drug,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/18/2019,mg,antineoplastic,5/17/2019,3/7/2019,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,3/12/2024,,antineoplastic,11/1/2023,10/1/2023,Oral,ivosidenib,FALSE
345,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,5/6/2016,mg,antineoplastic,3/2/2016,1/5/2016,Intravenous,nivolumab,FALSE
745,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:B8CFFD1931,3/10/2015,mg,antineoplastic,12/3/2014,9/20/2014,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/22/2023,,antineoplastic,7/21/2023,3/14/2023,Oral,anastrozole,FALSE
179,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:64BD9C5919,10/8/2021,mg,antineoplastic,8/19/2021,8/18/2021,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,5/1/2019,mg,antineoplastic,7/14/2018,6/30/2018,Intravenous,nivolumab,FALSE
80,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/23/2024,mg/m2,antineoplastic,11/4/2023,10/28/2023,Intravenous,paclitaxel,FALSE
165,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11:F93GC6851,5/27/2021,mg,antineoplastic,5/4/2021,4/30/2021,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/10/2016,mg,antineoplastic,7/10/2015,12/21/2014,Intravenous,gemcitabine,FALSE
1476,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,3/23/2022,mg,antineoplastic,2/17/2022,1/25/2022,Intravenous,bevacizumab-awwb,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,3/21/2025,mg,antineoplastic,1/1/2025,10/12/2024,Intravenous,nivolumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/28/2025,mg,antineoplastic,11/3/2024,3/1/2024,Intravenous,durvalumab,TRUE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,8/5/2014,mg,antineoplastic,2/14/2014,1/29/2014,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/12/2024,mg,antineoplastic,6/12/2023,5/28/2020,Intravenous,pembrolizumab,TRUE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/17/2015,mg,antineoplastic,10/24/2014,5/3/2014,Intravenous,vinorelbine,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/31/2015,mg,antineoplastic,3/3/2014,1/27/2014,Intravenous,carboplatin,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,3/21/2024,mg,antineoplastic,1/11/2024,1/24/2024,Intravenous,cisplatin,FALSE
2370,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1GDCB:FF9G:1,6/16/2016,mg,antineoplastic,5/17/2016,5/8/2016,Intravenous,gemcitabine,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,3/2/2016,mg,antineoplastic,11/5/2015,7/17/2015,Intravenous,pemetrexed,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/25/2023,,antineoplastic,7/5/2020,10/5/2019,Intravenous,pembrolizumab,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/28/2024,mg,antineoplastic,7/15/2020,6/9/2020,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/6/2018,mg,antineoplastic,7/6/2017,9/17/2015,Intravenous,nivolumab,FALSE
,5,ADVANCED,Orders,targeted/biologic,"Cisplatin,Gemcitabine,Necitumumab",G5762B778F:95,8/10/2017,,antineoplastic,8/10/2017,8/13/2017,Intravenous,necitumumab,FALSE
468,2,ADVANCED,Administrations,chemotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,11/23/2024,mg,antineoplastic,11/11/2024,9/24/2024,Intravenous,pemetrexed,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/19/2024,mg,antineoplastic,9/24/2024,11/22/2022,Intravenous,nivolumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,6/7/2022,mg,antineoplastic,3/8/2022,11/29/2021,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/23/2025,,antineoplastic,12/4/2024,10/15/2024,Intravenous,pembrolizumab,FALSE
202,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,9/2/2022,mg,antineoplastic,5/14/2022,5/10/2022,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/20/2021,mg,antineoplastic,7/6/2021,4/20/2021,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,6/7/2022,mg,antineoplastic,3/7/2022,11/20/2021,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,6/30/2014,mg,antineoplastic,7/5/2014,3/22/2014,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/5/2025,mg,antineoplastic,1/22/2025,2/29/2020,Intravenous,pembrolizumab,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,3/22/2022,mg,antineoplastic,2/19/2022,12/20/2021,Intravenous,nivolumab,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/21/2021,mg,antineoplastic,12/15/2020,11/3/2020,Intravenous,gemcitabine,FALSE
340,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,5/8/2022,mg,antineoplastic,3/9/2022,1/8/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/22/2025,mg,antineoplastic,7/9/2019,1/23/2019,Intravenous,pembrolizumab,TRUE
1150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,12/25/2024,mg,antineoplastic,9/17/2024,8/1/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel,Ipilimumab,Nivolumab",G1C679D8145C1,6/1/2022,,antineoplastic,4/20/2022,5/19/2022,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,5/16/2025,mg,antineoplastic,1/22/2024,5/13/2023,Intravenous,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G14E999899EFC,4/18/2024,mg,antineoplastic,1/17/2024,12/25/2023,Intravenous,cemiplimab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/27/2014,mg,antineoplastic,7/11/2014,6/25/2014,Intravenous,vinorelbine,FALSE
185.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,2/8/2017,mg,antineoplastic,1/16/2017,12/24/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/16/2025,,antineoplastic,5/21/2023,2/14/2023,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/6/2014,mg,antineoplastic,8/2/2014,3/15/2014,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/23/2025,mg,antineoplastic,5/1/2017,8/28/2016,Intravenous,pembrolizumab,FALSE
,5,ADVANCED,Unstructured,,"Pembrolizumab,Vemurafenib",G4C53C5GC48E:,10/8/2016,,,7/17/2016,7/22/2016,Oral,vemurafenib,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,1/20/2016,mg,antineoplastic,7/1/2015,6/27/2015,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,4/8/2016,,antineoplastic,2/15/2016,12/27/2015,Oral,capecitabine,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/5/2015,mg,antineoplastic,5/9/2015,2/27/2015,Intravenous,paclitaxel protein-bound,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,7/30/2017,mg,antineoplastic,5/14/2017,5/25/2017,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,5/3/2025,,antineoplastic,4/17/2025,3/29/2024,,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/24/2022,,antineoplastic,10/24/2021,9/12/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/10/2024,mg,antineoplastic,6/17/2022,5/19/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,9/11/2022,mg,antineoplastic,5/22/2022,5/18/2022,Intravenous,pembrolizumab,FALSE
484.3,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/22/2018,mg,antineoplastic,12/7/2017,11/24/2017,Intravenous,carboplatin,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/7/2019,mg,antineoplastic,2/14/2019,10/21/2018,Intravenous,bevacizumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/18/2023,mg,antineoplastic,7/4/2022,1/15/2020,Intravenous,pembrolizumab,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,5/18/2025,mg,antineoplastic,3/24/2025,4/20/2025,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/4/2025,mg,antineoplastic,4/25/2024,9/11/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/3/2024,,antineoplastic,5/26/2022,5/24/2022,Intravenous,durvalumab,TRUE
,,ADJUVANT,Unstructured,,Osimertinib,G1B8G131F6FC6,12/2/2019,,,12/17/2019,3/22/2018,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/23/2021,mg,antineoplastic,8/15/2020,10/3/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,3/29/2018,,antineoplastic,12/9/2017,6/13/2017,Intravenous,clinical study drug,FALSE
93,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,2/17/2014,mg,antineoplastic,1/13/2014,1/24/2014,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,9/6/2017,5/5/2017,Intravenous,nivolumab,FALSE
1170,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,6/19/2024,mg,antineoplastic,4/11/2024,4/28/2024,Intravenous,pemetrexed,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,5/1/2014,mg,antineoplastic,3/18/2014,1/24/2014,Intravenous,paclitaxel,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,8/15/2019,mg,antineoplastic,6/6/2019,6/21/2019,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/3/2021,mg,antineoplastic,3/29/2021,1/5/2021,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G25C4B:8:3FF2,3/16/2018,mg,antineoplastic,3/10/2018,2/15/2018,Intravenous,nivolumab,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,6/11/2014,mg,antineoplastic,6/26/2014,4/28/2014,Intravenous,carboplatin,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,10/31/2023,mg,antineoplastic,7/12/2023,11/11/2022,Intravenous,durvalumab,FALSE
97,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,6/29/2015,mg,antineoplastic,7/25/2015,5/5/2015,Intravenous,cisplatin,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/2/2022,mg,antineoplastic,6/12/2019,5/25/2019,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,9/8/2018,mg,antineoplastic,6/13/2018,4/20/2018,Intravenous,paclitaxel,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/8/2024,mg,antineoplastic,12/7/2023,9/19/2023,Intravenous,durvalumab,TRUE
446,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,12/24/2021,mg,antineoplastic,9/19/2021,8/20/2021,Intravenous,carboplatin,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,3/20/2015,mg,antineoplastic,3/15/2015,3/5/2015,Intravenous,paclitaxel protein-bound,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/23/2020,mg,antineoplastic,12/26/2018,8/17/2017,Intravenous,pemetrexed,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/28/2025,mg,antineoplastic,8/15/2020,2/12/2019,Intravenous,pemetrexed,TRUE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/6/2019,mg,antineoplastic,9/22/2018,5/25/2018,Intravenous,trastuzumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,4/23/2025,mg,antineoplastic,2/10/2025,11/25/2024,Intravenous,pemetrexed,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/21/2016,mg,antineoplastic,11/13/2015,9/12/2015,Intravenous,etoposide,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/5/2022,mg,antineoplastic,6/5/2021,5/8/2021,Intravenous,vinorelbine,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,1/12/2015,mg,antineoplastic,12/22/2014,10/9/2014,Intravenous,etoposide,FALSE
137.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G27B37646G3C2,10/28/2019,mg,antineoplastic,8/22/2019,7/5/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,2/26/2019,,antineoplastic,1/26/2019,9/3/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/28/2023,mg,antineoplastic,2/19/2023,8/30/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/25/2020,,antineoplastic,10/5/2017,8/25/2017,Intravenous,pemetrexed,TRUE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/25/2024,mg,antineoplastic,4/3/2024,2/8/2024,Intravenous,cemiplimab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/5/2023,,antineoplastic,9/12/2023,11/28/2022,,pemetrexed,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/4/2016,mg,antineoplastic,6/29/2016,6/24/2016,Intravenous,nivolumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,9/7/2020,mg,antineoplastic,2/25/2020,2/2/2020,Intravenous,paclitaxel,FALSE
152,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,2/13/2020,mg,antineoplastic,3/12/2020,2/14/2020,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/8/2021,mg,antineoplastic,7/4/2021,7/24/2021,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G1G54G4GB8B24,8/2/2022,,,8/19/2022,2/24/2022,Oral,dabrafenib,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/7/2015,mg,antineoplastic,8/18/2015,9/20/2014,Intravenous,paclitaxel,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/15/2015,mg,antineoplastic,12/2/2014,5/17/2014,Intravenous,pemetrexed,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/3/2019,mg/kg,antineoplastic,8/5/2019,8/3/2018,Intravenous,durvalumab,FALSE
500,3,ADVANCED,Administrations,hormone,Fulvestrant,G272F2D3BB8C2,5/19/2016,mg,antineoplastic,4/30/2016,4/3/2016,Intramuscular,fulvestrant,FALSE
185,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,9/18/2021,mg,antineoplastic,7/27/2021,6/19/2021,Intravenous,paclitaxel protein-bound,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/30/2024,,antineoplastic,8/25/2024,7/31/2024,Intravenous,carboplatin,FALSE
117,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,7/14/2023,mg,antineoplastic,6/2/2023,4/1/2023,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,9/28/2012,mg,antineoplastic,8/7/2012,7/12/2012,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Bicalutamide,G4992B5EB431G,1/3/2020,,antineoplastic,10/26/2019,12/10/2019,Oral,bicalutamide,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/3/2024,mg,antineoplastic,10/10/2024,7/23/2024,Intravenous,pemetrexed,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,10/7/2017,mg,antineoplastic,8/5/2017,8/19/2017,Intravenous,cisplatin,FALSE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,6/19/2015,mg,antineoplastic,1/16/2015,3/2/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/10/2022,mg,antineoplastic,7/21/2022,8/26/2020,Intravenous,pembrolizumab,TRUE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CG8EF93777D,2/15/2022,mg,antineoplastic,10/28/2020,9/3/2020,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/13/2024,mg,antineoplastic,5/9/2024,11/3/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/25/2022,,antineoplastic,9/22/2019,5/19/2017,Oral,nilotinib,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,2/4/2025,mg,antineoplastic,8/31/2024,8/22/2024,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/4/2025,mg,antineoplastic,6/30/2020,2/2/2019,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/30/2020,mg,antineoplastic,8/25/2018,10/30/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,5/29/2013,mg,antineoplastic,3/27/2013,1/6/2013,Intravenous,paclitaxel protein-bound,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/9/2017,mg,antineoplastic,5/21/2017,6/2/2017,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/28/2019,mg,antineoplastic,8/15/2017,2/28/2016,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/24/2022,mg,antineoplastic,4/10/2017,2/26/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/8/2025,,antineoplastic,9/21/2024,2/24/2023,,clinical study drug,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/4/2023,mg/m2,antineoplastic,2/3/2021,4/16/2020,Intravenous,pemetrexed,FALSE
454,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,1/14/2021,mg,antineoplastic,6/29/2020,7/1/2020,Intravenous,carboplatin,FALSE
398.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/7/2017,mg,antineoplastic,8/1/2016,6/2/2016,Intravenous,carboplatin,FALSE
104,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,6/11/2017,mg,antineoplastic,6/10/2017,6/26/2017,Intravenous,paclitaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/1/2020,mg,antineoplastic,1/23/2020,2/10/2020,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/7/2025,mg,antineoplastic,12/6/2019,2/8/2018,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,9/30/2022,mg,antineoplastic,10/7/2022,10/6/2022,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/21/2022,mg,antineoplastic,1/13/2017,1/14/2016,Intravenous,pemetrexed,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/11/2014,AUC,antineoplastic,2/8/2014,11/29/2013,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/9/2025,mg,antineoplastic,3/29/2021,3/13/2020,Subcutaneous,leuprolide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,7/22/2019,mg,antineoplastic,4/1/2019,1/19/2019,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,Osimertinib,G2C521EB94C:2,5/20/2025,,,5/13/2025,5/26/2023,Oral,osimertinib,FALSE
,1,ADVANCED,Unstructured,,Crizotinib,G2FF1862EC655,11/27/2013,,,11/23/2013,11/16/2013,Oral,crizotinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/17/2022,mg,antineoplastic,3/7/2021,12/24/2019,Intravenous,nivolumab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G253322FB7:C9,3/4/2023,,,2/20/2022,3/16/2022,Oral,osimertinib,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/23/2013,mg,antineoplastic,12/30/2012,4/13/2012,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/31/2022,mg,antineoplastic,6/5/2022,7/28/2021,Intravenous,durvalumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,12/11/2020,mg,antineoplastic,4/4/2020,9/8/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,2/18/2019,mg,antineoplastic,12/22/2018,1/21/2019,Intravenous,paclitaxel protein-bound,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/5/2025,mg,antineoplastic,1/25/2019,1/25/2017,Intravenous,nivolumab,FALSE
910,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,7/11/2016,mg,antineoplastic,6/5/2016,5/4/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/10/2020,mg,antineoplastic,1/17/2020,6/27/2019,Intravenous,pembrolizumab,TRUE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/17/2022,mg,antineoplastic,1/26/2022,2/28/2022,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G41G38G7991D4,3/30/2025,,,1/15/2025,12/12/2024,Oral,trametinib,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/10/2017,,antineoplastic,4/28/2017,12/4/2016,Intravenous,clinical study drug,FALSE
1075,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:3B43D3B55G,1/20/2024,mg,antineoplastic,10/16/2023,10/15/2023,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/14/2022,,antineoplastic,12/25/2019,4/8/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/7/2019,mg,antineoplastic,3/30/2018,12/11/2017,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/22/2019,mg,antineoplastic,11/10/2018,6/4/2018,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/5/2014,mg,antineoplastic,11/9/2014,8/23/2014,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/17/2020,mg,antineoplastic,2/7/2017,2/12/2016,Intravenous,bevacizumab,TRUE
129,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3CG5712E:B54,7/5/2024,mg,antineoplastic,7/24/2024,6/10/2024,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/20/2025,mg,antineoplastic,12/7/2021,3/12/2020,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/17/2022,mg,antineoplastic,7/25/2021,2/19/2021,Intravenous,durvalumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/23/2021,mL,solution-fluid,12/5/2018,2/17/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2:5874817G9C,7/19/2024,mg,antineoplastic,5/25/2024,5/20/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,Erlotinib,G3CE666498C:9,5/23/2013,,,3/18/2013,4/10/2013,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,1/7/2023,mg,antineoplastic,4/4/2022,5/13/2021,Intravenous,pembrolizumab,TRUE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/26/2015,mL,solution-fluid,5/3/2015,3/20/2015,Intravenous,pemetrexed,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,6/16/2019,mg,antineoplastic,7/4/2019,5/2/2019,Intravenous,fluorouracil,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/19/2025,mg,antineoplastic,2/11/2020,2/19/2019,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Unstructured,,"Osimertinib,Trametinib",G31C:9::5EG5D,8/5/2024,,,7/5/2024,5/20/2024,Oral,osimertinib,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/9/2020,mg,antineoplastic,7/20/2020,12/2/2019,Intravenous,gemcitabine,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/17/2025,mg,antineoplastic,10/17/2024,4/26/2024,Intravenous,pemetrexed,TRUE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/10/2019,mg,antineoplastic,3/23/2019,3/7/2019,Intravenous,carboplatin,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,12/6/2019,mg,antineoplastic,8/20/2019,7/21/2019,Intravenous,docetaxel,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,7/30/2014,mg,antineoplastic,5/15/2014,5/3/2014,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,2/16/2020,mg,antineoplastic,2/15/2020,11/9/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,11/14/2023,,solution-fluid,4/21/2023,11/26/2022,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,8/28/2019,mg,antineoplastic,8/17/2019,5/23/2019,Intravenous,pembrolizumab,TRUE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,10/4/2017,mg,antineoplastic,2/16/2017,1/1/2017,Intravenous,etoposide,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,10/26/2014,mg,antineoplastic,9/24/2014,8/27/2014,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/11/2019,mg,antineoplastic,12/25/2018,7/4/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,8/31/2023,mg,antineoplastic,7/22/2023,8/8/2023,Intravenous,pembrolizumab,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/12/2019,mg,antineoplastic,3/9/2019,11/21/2018,Intravenous,paclitaxel,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/14/2019,mg/kg,antineoplastic,3/18/2019,9/14/2018,Intravenous,durvalumab,FALSE
95,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/27/2017,mg,antineoplastic,1/8/2017,9/19/2016,Intravenous,cisplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/10/2022,mg,antineoplastic,12/6/2021,3/4/2021,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/26/2025,mg/m2,antineoplastic,9/16/2024,7/13/2024,Intravenous,gemcitabine,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/5/2020,mg,antineoplastic,5/17/2019,2/24/2019,Intravenous,durvalumab,FALSE
1086.3,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/20/2016,mg,antineoplastic,10/6/2015,2/9/2015,Intravenous,bevacizumab,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,2/5/2024,mg,antineoplastic,11/24/2023,11/18/2023,Intravenous,pemetrexed,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/29/2014,mg,antineoplastic,11/5/2014,9/10/2014,Intravenous,paclitaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,5/21/2013,mg,antineoplastic,2/26/2013,12/24/2012,Intravenous,carboplatin,FALSE
2500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,1/26/2013,mg,antineoplastic,2/8/2013,2/15/2013,Intravenous,ifosfamide,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/12/2014,mg,antineoplastic,4/17/2014,3/20/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,2/6/2020,mg,antineoplastic,11/27/2019,10/4/2019,Intravenous,pembrolizumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G459D:92E2344,12/5/2019,mg/kg,antineoplastic,11/5/2019,9/20/2018,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/4/2025,mg,antineoplastic,9/14/2022,9/4/2022,Intravenous,pembrolizumab,TRUE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/9/2021,mg,antineoplastic,2/25/2020,11/28/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/7/2015,mg,antineoplastic,9/1/2014,9/30/2014,Intravenous,paclitaxel protein-bound,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/15/2025,mg,antineoplastic,11/3/2019,1/21/2017,Intravenous,pembrolizumab,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,2/2/2022,mg,antineoplastic,6/25/2014,7/3/2014,Intravenous,paclitaxel,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,10/2/2022,mg,antineoplastic,3/8/2022,3/30/2022,Intravenous,paclitaxel,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G31:9DD57G8:5,4/2/2013,mg/m2,antineoplastic,4/17/2013,2/7/2013,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/29/2025,mg,antineoplastic,6/14/2017,12/29/2016,Intravenous,nivolumab,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/22/2016,mg,antineoplastic,1/15/2016,1/14/2016,Intravenous,carboplatin,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,11/30/2014,mg/m2,antineoplastic,1/20/2014,12/26/2013,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/25/2023,mg,antineoplastic,9/2/2021,8/23/2021,Intravenous,bendamustine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/26/2025,mg,antineoplastic,3/10/2018,12/24/2016,Intravenous,pembrolizumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,8/21/2018,mg,antineoplastic,7/3/2018,5/30/2018,Intravenous,cisplatin,FALSE
950,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/17/2024,mg,antineoplastic,12/17/2023,10/28/2023,Intravenous,pemetrexed,FALSE
950,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/31/2024,mg,antineoplastic,2/29/2024,11/4/2023,Intravenous,pemetrexed,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/12/2016,mg,antineoplastic,2/15/2016,11/11/2015,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/11/2016,mg,antineoplastic,1/3/2016,1/4/2016,Intravenous,paclitaxel,FALSE
450,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,2/26/2024,mg,antineoplastic,1/14/2024,1/23/2024,Intravenous,carboplatin,FALSE
253,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/12/2013,mg,antineoplastic,12/12/2012,11/18/2012,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,7/7/2021,,antineoplastic,4/5/2021,3/25/2021,,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G14FD45889171,1/13/2016,mg,antineoplastic,11/19/2015,10/30/2015,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/17/2019,mg,antineoplastic,6/29/2018,6/20/2018,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,2/25/2019,mg,antineoplastic,2/13/2019,12/14/2018,Intravenous,pembrolizumab,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/7/2017,mg,antineoplastic,9/11/2017,9/22/2017,Intravenous,paclitaxel,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,10/22/2024,mg,antineoplastic,6/19/2024,10/4/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,9/4/2021,,antineoplastic,4/29/2021,4/27/2021,,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/16/2022,,antineoplastic,9/27/2021,7/31/2021,Intravenous,amivantamab-vmjw,FALSE
168.6,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/1/2017,mg,antineoplastic,9/8/2016,9/29/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G547F143D3DEG,2/19/2025,,,3/11/2025,10/3/2024,Oral,dabrafenib,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/7/2018,mg,antineoplastic,12/27/2015,9/12/2015,Intravenous,nivolumab,FALSE
775,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,3/11/2022,mg,antineoplastic,1/10/2022,10/5/2021,Intravenous,pemetrexed,FALSE
1093,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1G194ECBE647,2/23/2020,mg,antineoplastic,4/5/2020,12/30/2019,Intravenous,durvalumab,TRUE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,1/22/2025,mg,antineoplastic,10/13/2024,4/26/2024,Intravenous,durvalumab,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,3/20/2023,mg,antineoplastic,2/21/2023,12/9/2022,Intravenous,nivolumab,TRUE
,,ADJUVANT,Unstructured,,Osimertinib,G34182B94:768,2/9/2019,,,12/2/2017,12/27/2017,Oral,osimertinib,FALSE
995,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/7/2024,mg,antineoplastic,7/21/2024,7/18/2024,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,8/15/2019,mg,antineoplastic,5/16/2019,5/7/2019,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1F482136BDE5,9/5/2024,,antineoplastic,9/1/2024,7/20/2024,Oral,anastrozole,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,5/6/2025,mg,antineoplastic,10/14/2024,8/18/2024,Intravenous,atezolizumab,TRUE
,,ADJUVANT,Unstructured,,Osimertinib,G2D284G82G31F,5/1/2025,,,3/20/2025,11/18/2024,Oral,osimertinib,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G1E1C181843G1,4/22/2015,,,11/5/2014,8/29/2014,Oral,erlotinib,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/9/2023,mg,antineoplastic,3/31/2023,11/14/2022,Intravenous,durvalumab,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,12/18/2023,mg,antineoplastic,9/20/2023,9/1/2023,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/30/2019,mg,antineoplastic,2/5/2019,6/22/2018,Intravenous,pembrolizumab,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,10/31/2023,mg,antineoplastic,8/23/2023,9/2/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,7/7/2023,mg,antineoplastic,5/14/2023,3/20/2023,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/24/2025,,antineoplastic,4/11/2021,4/19/2020,Oral,enzalutamide,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/29/2018,mg,antineoplastic,4/26/2018,6/6/2018,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/14/2017,mg,antineoplastic,4/8/2017,11/15/2016,Intravenous,paclitaxel protein-bound,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,6/28/2013,mg,antineoplastic,3/9/2013,1/27/2013,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/13/2023,mg,antineoplastic,2/6/2023,8/24/2022,Subcutaneous,azacitidine,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,4/5/2025,,antineoplastic,12/24/2022,8/12/2022,Oral,anastrozole,FALSE
297.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/10/2017,mg,antineoplastic,6/12/2016,5/2/2016,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/27/2025,mg,antineoplastic,9/22/2024,1/22/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/25/2025,mg,antineoplastic,9/17/2018,4/26/2018,Intravenous,pembrolizumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/4/2023,mg,antineoplastic,1/13/2023,5/18/2022,Intravenous,durvalumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/25/2024,,antineoplastic,8/8/2023,8/15/2023,Intravenous,paclitaxel protein-bound,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/22/2017,mg,antineoplastic,12/22/2016,12/20/2016,Intravenous,docetaxel,FALSE
665,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G54B14B192B6B,2/13/2019,mg,antineoplastic,1/23/2019,2/7/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,8/17/2019,mg,antineoplastic,6/16/2019,4/20/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/23/2024,mg,antineoplastic,1/14/2021,5/23/2020,Intravenous,pembrolizumab,TRUE
140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G47DG9518GG1E,1/11/2025,mg,antineoplastic,1/21/2025,1/26/2025,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/19/2025,,antineoplastic,2/24/2024,3/14/2023,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/13/2024,mg,antineoplastic,6/24/2024,2/22/2024,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/28/2020,mg,antineoplastic,1/25/2019,11/12/2018,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/29/2024,,antineoplastic,4/17/2024,3/21/2024,,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/16/2014,mg/m2,antineoplastic,6/8/2014,12/26/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G353EE82411C:,5/23/2024,mg,antineoplastic,4/6/2024,2/11/2024,Intravenous,pembrolizumab,FALSE
975,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1468E9F5C9CG,12/19/2011,mg,antineoplastic,11/17/2011,10/21/2011,Intravenous,pemetrexed,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/26/2020,mg,antineoplastic,11/3/2019,1/29/2019,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,3/28/2025,mg,antineoplastic,9/9/2024,5/8/2024,Intravenous,pembrolizumab,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,12/3/2019,mg,antineoplastic,9/20/2019,8/31/2019,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,12/30/2012,mg,antineoplastic,10/26/2012,1/19/2012,Intravenous,etoposide,FALSE
100,1,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/21/2013,mg/m2,antineoplastic,5/13/2013,2/25/2013,Intravenous,paclitaxel protein-bound,FALSE
174.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/25/2020,mg,antineoplastic,2/24/2020,3/5/2020,Intravenous,carboplatin,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,5/24/2018,mg,antineoplastic,4/3/2016,9/17/2015,Intravenous,nivolumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/8/2020,mg,antineoplastic,6/21/2019,6/6/2019,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/25/2020,mg,antineoplastic,9/8/2019,10/31/2018,Intravenous,pemetrexed,TRUE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/16/2024,mg,antineoplastic,10/1/2024,8/5/2024,Intravenous,carboplatin,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/29/2019,mg/m2,antineoplastic,11/15/2018,10/27/2018,Intravenous,vinorelbine,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,7/3/2014,mg,antineoplastic,5/8/2014,1/12/2014,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,1/4/2022,mg/m2,antineoplastic,10/26/2021,10/6/2021,Intravenous,leucovorin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/29/2022,,antineoplastic,4/1/2021,5/13/2017,Oral,nilotinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,5/31/2024,mg,antineoplastic,10/18/2023,7/18/2023,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,4/23/2025,,antineoplastic,5/23/2024,3/20/2024,,pembrolizumab,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/17/2022,mg,antineoplastic,12/15/2021,8/25/2021,Intravenous,bevacizumab-awwb,FALSE
66.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/24/2020,mg,antineoplastic,4/10/2020,3/29/2020,Intravenous,paclitaxel,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/1/2018,mg,antineoplastic,10/13/2016,10/1/2016,Intravenous,carboplatin,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/6/2013,mg,antineoplastic,7/21/2013,6/28/2013,Intravenous,etoposide,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,5/5/2025,mg,antineoplastic,9/8/2024,4/13/2024,Intravenous,durvalumab,TRUE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/5/2025,,antineoplastic,11/10/2017,11/10/2017,Intravenous,clinical study drug,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/2/2011,mg,antineoplastic,7/25/2011,5/15/2011,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/19/2018,mg,antineoplastic,8/20/2017,8/29/2015,Intravenous,nivolumab,FALSE
398,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/9/2024,mg,antineoplastic,2/8/2024,1/28/2024,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/22/2012,mg,antineoplastic,2/1/2012,12/14/2011,Intravenous,paclitaxel,FALSE
50,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3G18F3E9E3C8,7/8/2024,mg,antineoplastic,4/22/2024,5/14/2024,Intravenous,ipilimumab,TRUE
403,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,7/3/2020,mg,antineoplastic,3/24/2020,4/24/2020,Intravenous,carboplatin,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/10/2024,mg,antineoplastic,10/26/2023,10/30/2023,Intravenous,nivolumab,FALSE
500,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/18/2020,mg,antineoplastic,7/14/2017,2/21/2017,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,7/23/2024,mL,solution-fluid,4/29/2024,3/17/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G545:2F182DD:,9/23/2017,,solution-fluid,9/1/2017,9/4/2017,Intravenous,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/3/2024,mg,antineoplastic,4/10/2024,3/12/2022,Intravenous,durvalumab,FALSE
,5,ADVANCED,Unstructured,,"Pembrolizumab,Vemurafenib",G4C53C5GC48E:,9/16/2016,,,8/27/2016,8/4/2016,Oral,vemurafenib,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/9/2015,mg,antineoplastic,11/15/2014,9/12/2014,Intravenous,paclitaxel protein-bound,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/28/2023,mg,antineoplastic,4/27/2023,3/5/2023,Intravenous,cemiplimab,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,6/30/2014,mg,antineoplastic,7/1/2014,4/28/2014,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G12D5DB79FEED,4/5/2015,mg/m2,antineoplastic,12/20/2014,1/4/2015,Intravenous,pemetrexed,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/13/2016,mg,antineoplastic,9/27/2015,5/30/2015,Intravenous,pemetrexed,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/6/2022,mg/kg,antineoplastic,11/21/2021,2/23/2021,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/26/2022,mg,antineoplastic,7/1/2020,1/16/2020,Intravenous,nivolumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/27/2019,mg,antineoplastic,10/11/2016,3/31/2016,Intravenous,nivolumab,FALSE
399,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/17/2023,mg,antineoplastic,10/24/2022,11/2/2022,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,2/4/2021,mg,antineoplastic,10/25/2020,9/1/2020,Oral,bicalutamide,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/1/2025,mg,antineoplastic,12/20/2020,2/20/2020,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,2/22/2021,,steroid,12/5/2020,2/7/2020,Intravenous,clinical study drug,FALSE
215.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/11/2015,mg,antineoplastic,4/15/2015,3/31/2015,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,9/9/2019,mg,antineoplastic,2/15/2019,3/7/2019,Intravenous,pemetrexed,TRUE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/15/2013,mg,antineoplastic,9/18/2012,5/5/2012,Intravenous,paclitaxel,FALSE
250,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,8/9/2024,mg,antineoplastic,6/22/2024,5/15/2024,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/1/2024,mg,antineoplastic,7/30/2023,8/12/2023,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/19/2021,mL,solution-fluid,4/7/2021,4/28/2021,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,8/29/2022,mg,antineoplastic,4/16/2022,4/26/2022,Intravenous,pemetrexed,FALSE
770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,3/14/2013,mg,antineoplastic,3/20/2013,1/25/2013,Intravenous,pemetrexed,FALSE
760.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/17/2020,mg,antineoplastic,12/18/2019,11/13/2019,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/22/2023,mg,antineoplastic,12/21/2021,11/6/2021,Intravenous,durvalumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/24/2020,mg,antineoplastic,4/17/2017,11/10/2015,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/17/2016,mg,antineoplastic,7/15/2015,7/19/2015,Intravenous,carboplatin,FALSE
25,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/9/2018,mg/m2,antineoplastic,6/27/2018,4/16/2018,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,12/21/2023,,solution-fluid,2/7/2023,12/25/2022,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/4/2025,mg,antineoplastic,10/13/2022,2/13/2019,Intravenous,pemetrexed,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/10/2019,mg/m2,antineoplastic,12/5/2018,11/13/2018,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/20/2022,mg,antineoplastic,1/29/2018,3/31/2017,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/17/2025,mg/m2,antineoplastic,2/12/2025,7/17/2024,Intravenous,pemetrexed,FALSE
471.87,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G147B:8F3B:52,11/3/2021,mg,antineoplastic,11/28/2021,11/9/2021,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/21/2023,mg,antineoplastic,5/27/2018,11/26/2017,Intravenous,nivolumab,FALSE
802.92,4,ADVANCED,Orders,chemotherapy,Gemcitabine,G11B743:8G337,2/10/2017,mg/m2,antineoplastic,3/13/2017,2/17/2017,Intravenous,gemcitabine,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/23/2020,mg,antineoplastic,9/17/2020,8/8/2020,Oral,bicalutamide,FALSE
1116.3,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/29/2015,mg,antineoplastic,6/18/2015,2/8/2015,Intravenous,bevacizumab,FALSE
588,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,12/7/2015,mg,antineoplastic,12/8/2015,10/5/2015,Intravenous,carboplatin,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,3/6/2012,mg,antineoplastic,1/26/2012,1/10/2012,Intravenous,docetaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/19/2025,mg/m2,antineoplastic,5/9/2025,4/16/2024,Intravenous,pemetrexed,TRUE
975,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/22/2016,mg,antineoplastic,1/26/2016,6/8/2015,Intravenous,pemetrexed,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/16/2021,mL,solution-fluid,3/16/2019,3/31/2018,Intravenous,durvalumab,TRUE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G147B:8F3B:52,11/14/2021,mg,antineoplastic,10/25/2021,12/11/2021,Intravenous,atezolizumab,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,10/15/2015,mL,solution-fluid,5/10/2015,2/28/2015,Intravenous,carboplatin,FALSE
1630,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2:5874817G9C,10/10/2024,mg,antineoplastic,8/2/2024,7/17/2024,Intravenous,gemcitabine,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,4/2/2016,mg,antineoplastic,1/2/2016,8/31/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/28/2024,mg,antineoplastic,1/27/2024,10/9/2022,Intravenous,pembrolizumab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/6/2025,mg,antineoplastic,12/25/2024,6/30/2024,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,10/29/2024,mg,antineoplastic,9/14/2024,8/14/2024,Intravenous,pembrolizumab,FALSE
374,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,6/9/2020,mg,antineoplastic,5/25/2020,3/1/2020,Intravenous,carboplatin,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,12/7/2023,mg,antineoplastic,10/24/2023,3/26/2023,Intravenous,gemcitabine,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/11/2020,mg,antineoplastic,6/16/2020,10/1/2019,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,7/1/2021,mL,solution-fluid,4/23/2021,4/6/2021,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/9/2019,mg,antineoplastic,10/10/2019,9/6/2019,Intravenous,etoposide,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/1/2022,mg/kg,antineoplastic,12/21/2021,1/25/2021,Intravenous,durvalumab,FALSE
744.3,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,10/22/2015,mg,antineoplastic,8/31/2015,7/13/2015,Intravenous,carboplatin,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/4/2016,mg,antineoplastic,8/3/2015,5/4/2015,Intravenous,gemcitabine,FALSE
126,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DD111EC2E4G,5/11/2021,mg,antineoplastic,3/7/2021,4/9/2021,Intravenous,paclitaxel,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,8/6/2013,mg,antineoplastic,6/18/2013,6/17/2013,Intravenous,etoposide,FALSE
166,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,12/2/2022,mg,antineoplastic,10/29/2022,10/6/2022,Intravenous,paclitaxel,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,9/15/2022,mg,antineoplastic,9/6/2022,7/14/2022,Intravenous,carboplatin,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/1/2012,mg,antineoplastic,12/9/2011,11/13/2011,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,antineoplastic,"Clinical Study Drug,Osimertinib",G3BBG95F1669C,2/6/2023,,antineoplastic,9/30/2022,10/12/2022,,clinical study drug,FALSE
482,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/18/2024,mg,antineoplastic,8/2/2024,7/17/2024,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/9/2025,mg,antineoplastic,11/25/2023,9/17/2023,Intravenous,atezolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,5/18/2025,mg,antineoplastic,9/2/2024,5/22/2023,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,7/4/2020,mg,antineoplastic,3/22/2020,3/3/2020,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,11/8/2015,mg,antineoplastic,12/27/2015,10/15/2015,Intravenous,paclitaxel,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/4/2019,mg,antineoplastic,2/27/2019,3/6/2019,Intravenous,paclitaxel,FALSE
72,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/14/2012,mg/m2,antineoplastic,3/5/2012,2/19/2012,Intravenous,paclitaxel,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,12/31/2022,mg,antineoplastic,11/23/2022,10/19/2022,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/1/2021,,antineoplastic,12/11/2020,12/23/2020,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/12/2025,mg,antineoplastic,12/24/2024,9/14/2024,Intravenous,atezolizumab,TRUE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/15/2021,mg,antineoplastic,12/16/2020,12/13/2020,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,hormone,Letrozole,G44DBB13D9C9:,2/11/2019,,antineoplastic,3/2/2019,3/4/2019,Oral,letrozole,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3867F7D51E3D,3/27/2025,,antineoplastic,3/2/2025,3/4/2025,Intravenous,clinical study drug,FALSE
1240,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,11/8/2012,mg,antineoplastic,10/24/2012,8/13/2012,Intravenous,gemcitabine,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/18/2024,mg,antineoplastic,5/15/2024,9/6/2023,Intravenous,atezolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/21/2014,mg,antineoplastic,6/23/2014,4/9/2014,Intravenous,paclitaxel protein-bound,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/20/2017,mg,antineoplastic,7/29/2017,7/27/2017,Intravenous,etoposide,FALSE
219.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/17/2015,mg,antineoplastic,5/4/2015,5/3/2015,Intravenous,carboplatin,FALSE
97,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/5/2017,mg,antineoplastic,11/17/2016,9/16/2016,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/7/2022,mg,antineoplastic,5/28/2021,7/29/2020,Intravenous,pembrolizumab,TRUE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/15/2015,mg,antineoplastic,7/12/2015,7/31/2015,Intravenous,paclitaxel,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/16/2020,mg,antineoplastic,12/12/2019,3/25/2019,Intravenous,durvalumab,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,1/22/2022,mg,antineoplastic,12/1/2021,11/21/2021,Intravenous,carboplatin,FALSE
603,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/12/2022,mg,antineoplastic,11/20/2021,1/4/2022,Intravenous,carboplatin,FALSE
174.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/15/2020,mg,antineoplastic,4/20/2020,2/21/2020,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/29/2019,mg,antineoplastic,4/26/2019,2/18/2019,Intravenous,paclitaxel,FALSE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/17/2016,mg,antineoplastic,6/19/2016,5/21/2016,Intravenous,paclitaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1GEF44EBD419,8/10/2024,mg,antineoplastic,7/16/2024,1/30/2024,Intravenous,durvalumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,3/3/2017,mg,antineoplastic,10/26/2016,12/12/2016,Intravenous,paclitaxel protein-bound,FALSE
93,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3E76E32E795:,7/24/2020,mg,antineoplastic,6/12/2020,4/6/2020,Intravenous,docetaxel,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G485C85BECGC4,3/8/2022,,antineoplastic,2/18/2022,12/17/2021,Intravenous,clinical study drug,FALSE
6,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,2/9/2022,AUC,antineoplastic,10/19/2021,8/28/2021,Intravenous,carboplatin,FALSE
151,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/17/2024,mg,antineoplastic,3/4/2024,1/11/2024,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G25B:66F61266,4/27/2025,mg,antineoplastic,4/1/2025,2/16/2025,Intravenous,pembrolizumab,FALSE
900,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/20/2013,mg/m2,antineoplastic,7/6/2012,4/12/2012,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/4/2023,,antineoplastic,12/26/2022,4/11/2022,Intravenous,durvalumab,FALSE
265,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,3/28/2013,mg,antineoplastic,1/9/2013,12/27/2012,Intravenous,carboplatin,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,6/21/2020,mg,antineoplastic,5/14/2020,3/27/2020,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/7/2019,mL,solution-fluid,11/18/2017,9/26/2017,Intravenous,cisplatin,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5:D955C88D97,11/9/2022,mg,antineoplastic,7/5/2019,4/16/2019,Intravenous,cisplatin,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/7/2024,mg,antineoplastic,8/31/2024,8/26/2024,Intravenous,temsirolimus,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/10/2021,mg,antineoplastic,8/19/2018,4/1/2018,Intravenous,durvalumab,TRUE
80,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/31/2020,mg,antineoplastic,1/27/2020,9/9/2019,Intravenous,docetaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/13/2020,mg,antineoplastic,3/25/2020,1/17/2020,Intravenous,pemetrexed,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/26/2021,mg,antineoplastic,1/8/2021,10/17/2020,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/27/2025,mg,antineoplastic,8/26/2024,3/8/2024,Intravenous,pembrolizumab,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,7/17/2023,mg,antineoplastic,1/26/2023,7/10/2022,Intravenous,durvalumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G17177B5C7D7F,6/8/2022,mg,antineoplastic,2/21/2021,3/21/2021,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/10/2024,mg,antineoplastic,6/15/2024,5/2/2024,Intravenous,atezolizumab,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,6/29/2021,mg,antineoplastic,6/17/2021,5/15/2021,Intravenous,pemetrexed,FALSE
218,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/26/2019,mg,antineoplastic,9/18/2019,9/6/2019,Intravenous,carboplatin,FALSE
385,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,11/11/2015,mg,antineoplastic,9/4/2015,6/25/2015,Intravenous,ramucirumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/29/2024,mg,antineoplastic,11/27/2023,2/21/2023,Intravenous,nivolumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,7/13/2018,AUC,antineoplastic,5/28/2018,5/10/2018,Intravenous,carboplatin,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,11/9/2019,mg,antineoplastic,5/18/2019,4/22/2019,Intravenous,ramucirumab,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/25/2020,mg,antineoplastic,5/17/2019,12/8/2018,Intravenous,durvalumab,TRUE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,3/1/2023,mg,antineoplastic,10/6/2022,9/3/2022,Intravenous,durvalumab,TRUE
5,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/13/2016,mg,antineoplastic,5/2/2016,4/30/2016,Intravenous,paclitaxel,FALSE
148,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/16/2024,mg,antineoplastic,2/10/2024,1/6/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,6/23/2017,mg,antineoplastic,12/12/2016,10/6/2016,Intravenous,nivolumab,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,1/11/2015,mg,antineoplastic,10/20/2014,11/19/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,10/15/2018,mg,antineoplastic,9/11/2018,6/28/2018,Intravenous,pembrolizumab,FALSE
471,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/18/2012,mg,antineoplastic,4/11/2012,12/30/2011,Intravenous,carboplatin,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/25/2017,mg,antineoplastic,4/12/2016,12/31/2015,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/3/2023,mg,antineoplastic,1/11/2023,1/17/2023,Intravenous,nivolumab,FALSE
469,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/10/2016,mg,antineoplastic,7/18/2016,8/30/2016,Intravenous,carboplatin,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/21/2025,mg,antineoplastic,7/17/2023,9/30/2022,Intravenous,pemetrexed,TRUE
96,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,10/12/2014,mg,antineoplastic,9/5/2014,8/24/2014,Intravenous,paclitaxel,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,6/9/2020,mg,antineoplastic,5/13/2020,6/10/2020,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/29/2019,mg,antineoplastic,8/19/2018,2/24/2016,Intravenous,nivolumab,FALSE
670,,NEOADJUVANT,Administrations,targeted/biologic,Rituximab,G27471:8B6217,7/9/2016,mg,antineoplastic,5/24/2016,5/18/2016,Intravenous,rituximab,FALSE
480,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,4/17/2020,mg,antineoplastic,11/23/2019,11/17/2019,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/7/2025,mg,antineoplastic,1/9/2022,8/2/2021,Intravenous,atezolizumab,TRUE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,7/30/2024,mg,antineoplastic,6/12/2024,6/14/2024,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/2/2024,mg,antineoplastic,12/19/2023,7/4/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/13/2025,mg,antineoplastic,11/22/2024,11/8/2024,Intravenous,pembrolizumab,TRUE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,10/19/2017,mg,antineoplastic,9/20/2017,9/22/2017,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/10/2013,mg,antineoplastic,1/29/2012,12/25/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,10/12/2017,mg,antineoplastic,12/1/2016,12/18/2016,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,1/20/2022,mg,antineoplastic,1/15/2022,9/17/2021,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/23/2025,mg,antineoplastic,6/1/2023,5/12/2022,Intravenous,pembrolizumab,FALSE
45,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/5/2024,mg,antineoplastic,4/17/2023,3/6/2023,Intravenous,docetaxel,FALSE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/18/2013,mg,antineoplastic,5/30/2013,3/31/2013,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/19/2024,mg,antineoplastic,6/23/2024,8/3/2023,Intravenous,nivolumab,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,2/10/2019,mg,antineoplastic,2/23/2019,1/20/2019,Intravenous,paclitaxel,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/21/2020,mg,antineoplastic,11/16/2020,10/12/2020,Intravenous,carboplatin,FALSE
80,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/23/2020,mg,antineoplastic,12/7/2019,9/20/2019,Intravenous,docetaxel,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C88CEG2:289,1/16/2025,mg,antineoplastic,12/6/2024,12/21/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/10/2018,mg,antineoplastic,12/25/2016,9/6/2015,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/29/2022,mg,antineoplastic,7/18/2022,7/16/2021,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,2/11/2018,mg,antineoplastic,7/12/2017,6/16/2017,Intravenous,nivolumab,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/1/2019,mg,antineoplastic,3/27/2019,9/27/2018,Intravenous,bevacizumab,FALSE
375,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,2/1/2017,mg,antineoplastic,1/1/2017,12/7/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/14/2024,mg,antineoplastic,10/13/2022,6/15/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/26/2020,mg,antineoplastic,7/13/2019,4/10/2019,Intravenous,pembrolizumab,TRUE
216,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,11/5/2014,mg,antineoplastic,9/17/2014,8/9/2014,Intravenous,carboplatin,FALSE
350,3,ADVANCED,Administrations,immunotherapy,Cemiplimab,G252328CFG4E1,5/30/2024,mg,antineoplastic,1/19/2024,12/25/2023,Intravenous,cemiplimab,FALSE
175,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/14/2018,mg,antineoplastic,8/1/2018,3/19/2018,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/14/2024,mg,antineoplastic,8/15/2022,12/26/2021,Intravenous,nivolumab,TRUE
171,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,3/30/2021,mg,antineoplastic,12/15/2020,1/1/2021,Intravenous,carboplatin,FALSE
552,1,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G53C52948773G,3/29/2024,mg,antineoplastic,1/29/2024,11/6/2023,Intravenous,ramucirumab,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,10/10/2019,mg,antineoplastic,8/6/2019,8/1/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,12/12/2016,,antineoplastic,11/9/2016,4/3/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/11/2025,mg,antineoplastic,10/8/2022,2/21/2020,Intravenous,pembrolizumab,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/14/2012,mg,antineoplastic,6/12/2012,2/14/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,3/17/2015,,solution-fluid,9/1/2014,7/31/2014,Intravenous,clinical study drug,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/31/2021,mg,antineoplastic,11/16/2020,10/23/2020,Intravenous,durvalumab,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,3/27/2022,,cytoprotective,3/22/2022,12/8/2021,Oral,clinical study drug,FALSE
740,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,3/27/2025,mg,antineoplastic,2/2/2025,2/12/2025,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/16/2017,,solution-fluid,3/10/2017,2/6/2016,Intravenous,clinical study drug,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/19/2022,mg,antineoplastic,7/21/2021,4/14/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/17/2020,mg,antineoplastic,8/8/2019,1/15/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/5/2022,mg,antineoplastic,7/13/2020,3/22/2020,Intravenous,pembrolizumab,TRUE
900,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/18/2016,mg,antineoplastic,8/25/2016,7/1/2016,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,1/6/2020,AUC,antineoplastic,11/5/2019,9/22/2019,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,3/30/2021,mg,antineoplastic,9/12/2020,7/6/2020,Intravenous,pembrolizumab,TRUE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/18/2023,mg,antineoplastic,2/19/2023,9/8/2022,Intravenous,pemetrexed,TRUE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/7/2023,mg,antineoplastic,9/29/2022,7/10/2022,Intravenous,durvalumab,FALSE
860,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,3/11/2022,mg,antineoplastic,11/20/2021,12/2/2021,Intravenous,pemetrexed,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,10/12/2018,mg,antineoplastic,6/23/2018,4/7/2018,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,7/25/2018,mg/m2,antineoplastic,7/5/2018,4/26/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/11/2025,,antineoplastic,3/12/2025,2/11/2023,,clinical study drug,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/22/2016,mg,antineoplastic,1/17/2016,1/27/2016,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/4/2022,,antineoplastic,7/31/2019,5/5/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/16/2024,mg,antineoplastic,3/8/2023,10/2/2022,Intravenous,pembrolizumab,TRUE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/6/2024,mg,antineoplastic,8/1/2024,7/13/2024,Intravenous,carboplatin,FALSE
915,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4C:6:784E1GF,2/11/2018,mg,antineoplastic,12/23/2017,1/24/2018,Intravenous,pemetrexed,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,1/22/2019,mg,antineoplastic,11/18/2018,11/27/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G18EBC2339CGG,2/11/2015,AUC,antineoplastic,1/10/2015,2/2/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/26/2019,mg,antineoplastic,5/23/2018,4/21/2016,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/25/2025,mg,antineoplastic,2/6/2025,9/6/2023,Intravenous,atezolizumab,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/20/2021,mg/m2,antineoplastic,7/14/2021,6/14/2021,Intravenous,paclitaxel,FALSE
183,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/29/2019,mg,antineoplastic,4/11/2018,2/14/2018,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/30/2022,mg,antineoplastic,10/9/2021,5/28/2021,Intravenous,pemetrexed,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/1/2020,mg,antineoplastic,3/30/2019,5/7/2019,Intravenous,pemetrexed,TRUE
20,,ADJUVANT,Orders,chemotherapy,Decitabine,G1F5415D1B672,11/22/2018,mg/m2,antineoplastic,8/21/2018,9/17/2018,Intravenous,decitabine,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,8/10/2012,mg,antineoplastic,7/14/2012,6/7/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/2/2025,mg,antineoplastic,9/30/2024,4/11/2024,Intravenous,pembrolizumab,TRUE
590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,11/28/2024,mg,antineoplastic,9/6/2024,7/28/2024,Intravenous,carboplatin,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/3/2021,AUC,antineoplastic,5/17/2021,3/23/2021,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G1G78CEE:7E:3,12/3/2018,mg/m2,antineoplastic,8/18/2018,8/9/2018,Intravenous,pemetrexed,FALSE
131,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,3/3/2024,mg,antineoplastic,12/19/2023,12/20/2023,Intravenous,carboplatin,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/4/2015,mg,antineoplastic,5/27/2015,5/22/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/23/2023,mg,antineoplastic,12/8/2021,10/31/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,10/11/2018,mg,antineoplastic,10/11/2018,6/10/2018,Intravenous,pembrolizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5:D955C88D97,10/12/2022,mg,antineoplastic,6/15/2019,5/1/2019,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,3/24/2018,mg,antineoplastic,1/19/2018,11/3/2017,Intravenous,nivolumab,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/18/2015,mg,antineoplastic,4/5/2015,4/2/2015,Intravenous,gemcitabine,FALSE
564.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/23/2017,mg,antineoplastic,1/27/2017,9/14/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,4/30/2024,mg,antineoplastic,4/6/2024,2/19/2024,Intravenous,pembrolizumab,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/6/2022,mg/kg,antineoplastic,11/12/2021,2/22/2021,Intravenous,durvalumab,FALSE
1000,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/23/2025,mg,antineoplastic,5/6/2024,2/25/2024,Intravenous,amivantamab-vmjw,FALSE
500,3,ADVANCED,Orders,chemotherapy,Pemetrexed,G1CC41:D:7C48,2/21/2021,mg/m2,antineoplastic,2/4/2021,2/18/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/2/2025,mg,antineoplastic,9/2/2024,4/23/2024,Intravenous,pembrolizumab,TRUE
346,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,6/7/2024,mg,antineoplastic,1/19/2024,2/28/2024,Intravenous,paclitaxel,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G21B4CD9B81B7,5/17/2012,mg,antineoplastic,5/21/2012,6/9/2012,Intravenous,carboplatin,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/5/2019,mg,antineoplastic,3/31/2019,2/16/2019,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/27/2025,mg,antineoplastic,8/3/2020,4/4/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Lorlatinib,G26C728549E7G,3/15/2023,,,1/30/2023,11/12/2022,Oral,lorlatinib,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/20/2019,mg,antineoplastic,9/23/2018,8/20/2018,Intravenous,carboplatin,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/15/2019,mg,antineoplastic,7/19/2019,12/11/2018,Intravenous,durvalumab,TRUE
800,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/11/2025,mg,antineoplastic,9/17/2024,9/19/2024,Intravenous,bevacizumab-bvzr,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/16/2024,mg,antineoplastic,12/13/2023,10/27/2023,Intravenous,nivolumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,1/23/2023,mg,antineoplastic,4/9/2022,3/30/2022,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/5/2023,,antineoplastic,12/8/2022,11/3/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,7/17/2021,mg,antineoplastic,2/23/2021,3/11/2021,Intravenous,pembrolizumab,TRUE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/21/2018,mg,antineoplastic,10/29/2018,9/30/2018,Intravenous,paclitaxel,FALSE
475.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/18/2017,mg,antineoplastic,6/6/2016,5/3/2016,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,3/11/2025,mg,antineoplastic,9/20/2024,4/30/2024,Intravenous,durvalumab,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,3/16/2015,mg,antineoplastic,12/6/2014,11/1/2014,Intravenous,paclitaxel,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/12/2014,mg,antineoplastic,10/26/2014,7/8/2014,Intravenous,paclitaxel protein-bound,FALSE
450,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/26/2024,mg,antineoplastic,3/17/2024,11/21/2023,Intravenous,carboplatin,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G2471D2GFG2E4,8/15/2017,mg/kg,antineoplastic,4/5/2017,7/28/2016,Intravenous,nivolumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,3/4/2014,mg,antineoplastic,12/6/2013,12/6/2013,Intravenous,paclitaxel,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,7/8/2021,mg,antineoplastic,11/9/2020,11/21/2020,Intravenous,nivolumab,FALSE
26,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/27/2015,mg,antineoplastic,7/4/2014,5/19/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,7/18/2017,,antineoplastic,10/7/2016,9/30/2016,Intravenous,nivolumab,FALSE
445,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,2/24/2024,mg,antineoplastic,1/8/2024,11/14/2023,Intravenous,carboplatin,FALSE
75,5,ADVANCED,Orders,chemotherapy,"Cisplatin,Gemcitabine,Necitumumab",G5762B778F:95,8/1/2017,mg/m2,antineoplastic,6/19/2017,7/11/2017,Intravenous,cisplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/30/2025,mg,antineoplastic,9/27/2024,4/13/2024,Intravenous,pembrolizumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/18/2015,mg,antineoplastic,12/11/2014,11/29/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,1/31/2019,mg,antineoplastic,11/9/2018,7/12/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G21:2B8189648,5/24/2019,mg,antineoplastic,5/2/2019,5/11/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/12/2024,mg,antineoplastic,9/21/2024,8/19/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,8/25/2024,mg,antineoplastic,8/7/2024,6/19/2024,Intravenous,paclitaxel protein-bound,FALSE
865,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,8/15/2023,mg,antineoplastic,5/31/2023,3/20/2023,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/22/2022,mg,antineoplastic,9/22/2019,2/9/2016,Intravenous,pemetrexed,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/19/2016,mg,antineoplastic,2/10/2016,12/18/2015,Intravenous,carboplatin,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/20/2024,mg,antineoplastic,8/12/2023,6/16/2023,Intravenous,pemetrexed,FALSE
647,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/6/2013,mg,antineoplastic,6/4/2013,5/11/2013,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/30/2023,mg,antineoplastic,7/24/2022,11/21/2021,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,5/5/2025,mg,antineoplastic,2/18/2025,4/22/2024,Intravenous,durvalumab,TRUE
1000,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,3/27/2019,mg/m2,antineoplastic,1/23/2019,1/19/2019,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/31/2019,mg,antineoplastic,11/21/2017,10/22/2017,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/18/2015,mg,antineoplastic,4/18/2015,4/8/2015,Intravenous,paclitaxel protein-bound,FALSE
357,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/7/2018,mg,antineoplastic,5/9/2018,5/31/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/10/2025,mg,antineoplastic,1/14/2025,8/18/2022,Intravenous,pembrolizumab,TRUE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/5/2016,mg,antineoplastic,2/10/2016,11/4/2015,Intravenous,nivolumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,9/10/2024,AUC,antineoplastic,8/22/2024,7/6/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/2/2025,mg,antineoplastic,5/17/2023,8/11/2022,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/17/2022,,antineoplastic,12/23/2020,5/21/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,4/20/2025,mg,antineoplastic,4/30/2025,4/12/2025,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/13/2025,mg,antineoplastic,1/17/2024,2/5/2024,Intravenous,durvalumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,1/4/2024,mg,antineoplastic,10/11/2023,10/1/2023,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Docetaxel,G1153B156D:49,1/24/2014,mg,antineoplastic,11/26/2013,12/5/2013,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/2/2023,mg,antineoplastic,12/27/2022,7/16/2022,Intravenous,pembrolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/19/2025,mg,antineoplastic,12/10/2024,6/30/2023,Intravenous,pembrolizumab,TRUE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/10/2023,mg,antineoplastic,10/4/2022,8/11/2022,Subcutaneous,azacitidine,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/26/2022,mg,antineoplastic,3/10/2022,5/21/2021,Intravenous,bevacizumab-bvzr,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,2/27/2016,mg,antineoplastic,12/16/2015,10/19/2015,Intravenous,paclitaxel protein-bound,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,4/2/2022,mg,antineoplastic,4/13/2021,3/31/2021,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/2/2016,mg,antineoplastic,9/21/2014,8/20/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/1/2022,,antineoplastic,11/3/2021,8/31/2021,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,11/17/2013,mg,antineoplastic,11/18/2013,7/24/2013,Intravenous,bevacizumab,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/20/2025,mg,antineoplastic,5/22/2024,3/25/2024,Oral,abiraterone,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/21/2020,mg,antineoplastic,4/29/2017,10/29/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,2/15/2019,mg,antineoplastic,9/23/2018,7/14/2018,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/8/2020,mg,antineoplastic,12/8/2015,11/21/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/28/2025,,antineoplastic,7/29/2024,12/6/2022,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,11/2/2016,AUC,antineoplastic,9/9/2016,6/15/2016,Intravenous,carboplatin,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/9/2024,mg,antineoplastic,3/1/2024,1/3/2024,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,4/9/2025,mg,antineoplastic,4/21/2025,3/29/2025,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/5/2020,mg,antineoplastic,11/17/2015,12/12/2015,Intravenous,nivolumab,FALSE
443,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E12EBD52F4D,4/4/2018,mg,antineoplastic,2/25/2018,2/19/2018,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/17/2021,mg,antineoplastic,5/6/2021,4/16/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/24/2025,mg,antineoplastic,9/9/2024,4/30/2024,Intravenous,pembrolizumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,2/1/2021,mg,antineoplastic,9/22/2020,10/2/2020,Oral,bicalutamide,FALSE
451,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,5/12/2025,mg,antineoplastic,1/17/2025,11/5/2024,Intravenous,carboplatin,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/3/2018,mg,antineoplastic,5/22/2018,10/24/2017,Intravenous,nivolumab,FALSE
238.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/9/2013,mg,antineoplastic,7/14/2013,4/30/2013,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/28/2025,mg,antineoplastic,10/16/2024,2/13/2024,Intravenous,amivantamab-vmjw,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3B26D:2G114C,3/28/2018,,antineoplastic,1/6/2018,2/8/2018,Intravenous,clinical study drug,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/21/2016,mg,antineoplastic,8/30/2016,6/30/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G49E3CE9E292G,4/18/2023,,antineoplastic,4/9/2020,5/21/2020,,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,7/18/2019,mg,antineoplastic,3/16/2019,3/1/2019,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/28/2022,mg,antineoplastic,11/18/2021,6/15/2020,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/15/2021,mg,antineoplastic,11/24/2020,9/21/2020,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/4/2018,mg,antineoplastic,4/18/2016,10/4/2015,Intravenous,nivolumab,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/3/2021,mg,antineoplastic,9/13/2020,7/3/2020,Intravenous,doxorubicin,FALSE
1200,2,ADVANCED,Orders,immunotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/23/2020,mg,antineoplastic,4/18/2020,3/17/2020,Intravenous,atezolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/22/2024,mg,antineoplastic,1/5/2024,8/25/2023,Intravenous,atezolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/25/2025,mg,antineoplastic,11/16/2020,1/2/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/22/2025,,antineoplastic,8/15/2024,3/11/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/5/2021,mg,antineoplastic,8/18/2021,5/20/2021,Intravenous,pembrolizumab,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G266E6248F531,7/30/2018,mg,antineoplastic,5/9/2018,3/6/2018,Intravenous,pemetrexed,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/16/2023,mg,antineoplastic,7/17/2020,3/31/2020,Intravenous,pemetrexed,TRUE
240,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,8/30/2023,mg,antineoplastic,5/16/2023,5/10/2023,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/20/2024,mg,antineoplastic,9/3/2024,7/24/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,12/5/2024,mg,antineoplastic,9/11/2024,7/17/2024,Intravenous,pembrolizumab,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,12/1/2022,mg,antineoplastic,4/29/2022,5/8/2022,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,2/28/2019,mg,antineoplastic,10/10/2018,6/21/2018,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/14/2017,mg,antineoplastic,6/23/2017,5/11/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/8/2025,,antineoplastic,11/11/2024,6/3/2024,Intravenous,pembrolizumab,FALSE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,5/1/2012,mg,antineoplastic,12/6/2011,3/18/2011,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,11/3/2019,,antineoplastic,2/22/2019,2/28/2019,Oral,hydroxyurea,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G36BE14CG117:,4/9/2018,mg,antineoplastic,4/28/2018,4/17/2018,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/23/2023,mg,antineoplastic,5/3/2023,5/10/2023,Subcutaneous,azacitidine,FALSE
915,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1D14:53C99:F,5/18/2023,mg,antineoplastic,3/16/2023,3/7/2023,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/7/2025,mg/m2,antineoplastic,11/7/2024,7/1/2024,Intravenous,gemcitabine,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,4/2/2019,mg,antineoplastic,2/9/2019,1/10/2019,Intravenous,paclitaxel,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/18/2020,mg/kg,antineoplastic,4/5/2018,1/26/2016,Intravenous,bevacizumab,TRUE
,4,ADVANCED,Orders,glucocorticoid,Clinical Study Drug,G177G4:B9E394,4/30/2025,,steroid,4/14/2025,4/4/2025,,clinical study drug,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/2/2022,,antineoplastic,5/26/2022,3/20/2022,,ipilimumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,7/30/2018,mg,antineoplastic,6/6/2018,6/1/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/28/2022,,antineoplastic,7/7/2020,4/3/2017,Oral,nilotinib,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3B26D:2G114C,5/1/2018,,antineoplastic,1/30/2018,12/19/2017,Intravenous,clinical study drug,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,7/31/2020,mg,antineoplastic,6/17/2020,9/25/2019,Intravenous,durvalumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,6/25/2024,mg,antineoplastic,6/25/2024,3/24/2024,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/17/2025,,steroid,4/27/2025,1/4/2025,Intravenous,clinical study drug,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/30/2022,mg/m2,antineoplastic,8/28/2022,5/22/2022,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/29/2018,mg,antineoplastic,5/12/2018,12/13/2017,Intravenous,pembrolizumab,FALSE
654,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G88D5G998GE,11/27/2019,mg,antineoplastic,12/5/2019,10/25/2019,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,5/8/2025,mg,antineoplastic,12/27/2024,11/29/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
179,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/2/2023,mg,antineoplastic,4/20/2023,4/9/2023,Intravenous,paclitaxel protein-bound,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/10/2018,mg,antineoplastic,7/23/2018,6/16/2018,Intravenous,paclitaxel protein-bound,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/15/2022,mg,antineoplastic,7/30/2022,6/28/2022,Intravenous,paclitaxel,FALSE
315,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/26/2020,mg,antineoplastic,2/25/2020,1/28/2020,Intravenous,carboplatin,FALSE
105,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,9/13/2013,mg,antineoplastic,5/9/2013,4/30/2013,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/13/2020,mg,antineoplastic,11/4/2016,12/13/2015,Intravenous,nivolumab,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/21/2023,mg,antineoplastic,7/30/2022,6/30/2022,Intravenous,durvalumab,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/8/2024,mg,antineoplastic,1/24/2024,8/13/2023,Intravenous,durvalumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/27/2025,mg,antineoplastic,1/13/2020,1/26/2017,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/21/2017,mg,antineoplastic,7/9/2017,7/12/2016,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/22/2014,mg,antineoplastic,4/10/2014,3/19/2014,Intravenous,carboplatin,FALSE
582,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/13/2024,mg,antineoplastic,5/6/2024,3/13/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/19/2025,mg,antineoplastic,9/25/2024,9/11/2022,Intravenous,pembrolizumab,TRUE
490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,10/12/2015,mg,antineoplastic,11/5/2015,9/20/2015,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/18/2021,,steroid,9/18/2020,1/16/2020,Intravenous,clinical study drug,FALSE
489.6,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/7/2022,mg,antineoplastic,10/28/2021,10/23/2021,Intravenous,leucovorin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/20/2024,mg,antineoplastic,10/27/2023,3/27/2022,Intravenous,durvalumab,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,7/10/2023,mg,antineoplastic,5/21/2023,4/4/2023,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,8/9/2023,mg,antineoplastic,8/12/2023,6/21/2023,Intravenous,carboplatin,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,3/16/2021,mg,antineoplastic,1/16/2021,12/18/2020,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/2/2025,mg,antineoplastic,1/19/2024,9/11/2023,Intravenous,atezolizumab,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/14/2014,mg,antineoplastic,8/31/2014,8/2/2014,Intravenous,paclitaxel,FALSE
167,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G19E:EBC916F5,4/24/2022,mg,antineoplastic,3/14/2022,4/7/2022,Intravenous,docetaxel,FALSE
348,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/27/2016,mg,antineoplastic,4/7/2016,3/14/2016,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/2/2017,,antineoplastic,6/21/2017,3/11/2017,Intravenous,pemetrexed,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/9/2016,mg,antineoplastic,12/20/2014,6/1/2014,Intravenous,bevacizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/2/2025,mg,antineoplastic,4/15/2024,1/31/2024,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,4/11/2016,mg/m2,antineoplastic,4/20/2016,12/25/2015,Oral,capecitabine,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/20/2020,mg,antineoplastic,10/9/2017,12/25/2015,Intravenous,nivolumab,FALSE
541,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G54F545489E59,11/17/2023,mg,antineoplastic,6/15/2023,3/16/2023,Intravenous,ramucirumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/8/2025,mg,antineoplastic,8/2/2024,9/30/2022,Oral,anastrozole,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,6/27/2015,mg,antineoplastic,5/19/2015,4/6/2015,Intravenous,paclitaxel protein-bound,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/15/2018,mg,antineoplastic,2/5/2018,1/27/2018,Intravenous,paclitaxel,FALSE
510,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,11/8/2016,mg,antineoplastic,9/20/2016,8/15/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,4/25/2023,mg,antineoplastic,4/10/2023,2/17/2023,Intravenous,pembrolizumab,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G266E6248F531,7/1/2018,mg,antineoplastic,4/19/2018,4/7/2018,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,7/16/2020,,antineoplastic,9/6/2020,7/13/2020,Oral,hydroxyurea,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/21/2025,mg,antineoplastic,5/12/2017,8/21/2016,Intravenous,pembrolizumab,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,10/23/2015,mg,antineoplastic,9/4/2015,7/21/2015,Intravenous,bevacizumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,2/25/2019,mL,solution-fluid,12/28/2018,11/11/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,6/23/2024,mg,antineoplastic,5/2/2024,3/10/2024,Intravenous,pembrolizumab,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/6/2016,mg,antineoplastic,1/24/2016,1/29/2016,Intravenous,paclitaxel,FALSE
303,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,10/14/2021,mg,antineoplastic,9/23/2021,9/20/2021,Intravenous,carboplatin,FALSE
179,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:64BD9C5919,9/7/2021,mg,antineoplastic,8/12/2021,8/8/2021,Intravenous,cisplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,10/19/2012,mg,antineoplastic,9/2/2012,8/23/2012,Intravenous,paclitaxel,FALSE
474.7,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/5/2015,mg,antineoplastic,11/18/2014,10/27/2014,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,3/24/2025,mg,antineoplastic,12/7/2024,11/23/2024,Intravenous,durvalumab,FALSE
30,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,8/9/2016,mg,antineoplastic,8/26/2016,8/8/2016,Intravenous,docetaxel,FALSE
200,5,ADVANCED,Administrations,immunotherapy,"Leuprolide,Pembrolizumab",G17G71B51EFE2,5/1/2025,mg,antineoplastic,3/14/2025,1/24/2025,Intravenous,pembrolizumab,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/12/2020,mg,antineoplastic,6/1/2020,1/22/2019,Subcutaneous,bortezomib,FALSE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/28/2013,mg,antineoplastic,5/7/2013,12/1/2012,Intravenous,gemcitabine,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/31/2025,mg,antineoplastic,6/14/2024,4/19/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1C9B158617B6,3/13/2014,mg/m2,antineoplastic,12/6/2011,11/14/2011,Intravenous,paclitaxel,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/18/2023,mg,antineoplastic,12/29/2020,10/27/2019,Intravenous,pembrolizumab,TRUE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,11/23/2019,mg,antineoplastic,9/26/2019,7/22/2019,Intravenous,ramucirumab,FALSE
131,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,10/31/2024,mg,antineoplastic,8/17/2024,8/20/2024,Intravenous,carboplatin,FALSE
180,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3:C9BECD3F55,12/26/2020,mg,antineoplastic,10/16/2020,10/13/2020,Intravenous,docetaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161FDD242EB9,11/20/2011,mg,antineoplastic,9/21/2011,10/8/2011,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/1/2015,mg,antineoplastic,3/25/2014,12/27/2013,Intravenous,paclitaxel,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/13/2019,mg,antineoplastic,10/6/2019,1/3/2019,Intravenous,durvalumab,TRUE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/30/2021,mg,antineoplastic,9/25/2021,9/9/2021,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/26/2025,,antineoplastic,1/14/2025,3/15/2023,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G128:92:3BD3D,11/21/2021,,antiemetic,6/8/2021,5/16/2021,Intravenous,clinical study drug,FALSE
5,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/20/2019,AUC,antineoplastic,9/14/2019,7/16/2019,Intravenous,carboplatin,FALSE
381.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/3/2015,mg,antineoplastic,3/18/2015,10/4/2014,Intravenous,carboplatin,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/4/2018,mg,antineoplastic,8/6/2018,7/27/2018,Intravenous,cisplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,5/8/2023,mg,antineoplastic,3/1/2023,3/13/2023,Intravenous,pemetrexed,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,9/21/2019,mg,antineoplastic,8/11/2019,9/15/2019,Intravenous,carboplatin,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,10/16/2024,mg,antineoplastic,7/28/2024,8/2/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/9/2021,mg,antineoplastic,6/4/2020,11/26/2018,Intravenous,pembrolizumab,TRUE
,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/28/2024,,antineoplastic,7/5/2023,7/16/2023,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/6/2023,,antineoplastic,3/25/2023,2/4/2023,Intravenous,nivolumab,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,5/30/2013,mg,antineoplastic,11/14/2012,3/27/2012,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/13/2024,mg,antineoplastic,5/18/2023,2/8/2023,Intravenous,bevacizumab-awwb,TRUE
392,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,1/3/2024,mg,antineoplastic,11/13/2023,10/1/2023,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,11/25/2016,mg,antineoplastic,10/27/2016,7/18/2016,Intravenous,nivolumab,FALSE
5,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,2/6/2021,AUC,antineoplastic,12/29/2020,11/5/2020,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/25/2024,,antineoplastic,1/11/2024,10/24/2023,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/8/2024,mg,antineoplastic,5/20/2024,11/14/2023,Intravenous,durvalumab,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,4/28/2017,mg,antineoplastic,4/2/2017,4/12/2017,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/21/2025,,antineoplastic,12/8/2023,2/26/2023,,clinical study drug,FALSE
,4,ADVANCED,Unstructured,,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/21/2024,,,11/29/2024,5/19/2024,Oral,osimertinib,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G121:2D8:4E94,8/30/2019,mg,antineoplastic,7/25/2019,6/10/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/1/2020,mg,antineoplastic,1/20/2017,7/8/2016,Intravenous,nivolumab,FALSE
492,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G164G31958638,10/16/2024,mg,antineoplastic,8/13/2024,8/20/2024,Intravenous,carboplatin,FALSE
131,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,6/23/2024,mg,antineoplastic,5/29/2024,6/3/2024,Intravenous,etoposide,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/26/2025,mg,antineoplastic,9/14/2024,5/17/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/14/2025,mg,antineoplastic,2/17/2025,7/14/2023,Intravenous,pembrolizumab,TRUE
404,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/25/2016,mg,antineoplastic,1/1/2016,12/11/2015,Intravenous,carboplatin,FALSE
795,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,6/12/2016,mg,antineoplastic,4/3/2016,3/23/2016,Intravenous,pemetrexed,FALSE
696,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,1/21/2023,mg,antineoplastic,1/2/2023,10/16/2022,Intravenous,pemetrexed,FALSE
500,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,10/15/2022,mg,antineoplastic,8/29/2022,8/4/2022,Oral,bosutinib,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/19/2025,mg,antineoplastic,1/13/2024,5/8/2022,Intravenous,pembrolizumab,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/20/2016,mg,antineoplastic,4/13/2015,9/14/2014,Intravenous,pemetrexed,TRUE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/10/2025,mg,antineoplastic,12/29/2024,10/12/2024,Intravenous,etoposide,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/16/2024,mg,antineoplastic,6/5/2024,7/1/2024,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,12/14/2022,mg,antineoplastic,11/22/2022,11/14/2022,Intravenous,pemetrexed,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/30/2023,mg,antineoplastic,6/18/2019,10/20/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/18/2025,mg,antineoplastic,3/15/2023,8/11/2022,Intravenous,pembrolizumab,TRUE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/7/2016,mg,antineoplastic,9/24/2015,5/23/2015,Intravenous,bevacizumab,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,4/13/2017,mg,antineoplastic,1/25/2017,1/14/2017,Intravenous,carboplatin,FALSE
115,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/8/2023,mg,antineoplastic,11/21/2023,9/2/2023,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/13/2023,mg,antineoplastic,1/30/2023,9/15/2022,Subcutaneous,azacitidine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/4/2025,mg,antineoplastic,9/24/2023,9/13/2022,Intravenous,pembrolizumab,TRUE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/29/2015,mg,antineoplastic,8/22/2015,8/22/2015,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,9/15/2015,mg,antineoplastic,8/13/2015,5/8/2015,Intravenous,nivolumab,FALSE
527,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,1/25/2023,mg,antineoplastic,1/19/2023,1/2/2023,Intravenous,carboplatin,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/29/2025,mg/m2,antineoplastic,11/1/2024,11/11/2024,Intravenous,paclitaxel,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,3/2/2013,mg,antineoplastic,6/29/2012,4/2/2012,Intravenous,docetaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,7/6/2013,mg,antineoplastic,5/26/2013,11/16/2012,Intravenous,vinorelbine,FALSE
535,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FE1DBD491BE,10/23/2017,mg,antineoplastic,8/28/2017,8/20/2017,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/25/2020,mg,antineoplastic,7/23/2017,12/24/2015,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/4/2022,mg,antineoplastic,11/26/2021,5/28/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G24C:63G27686,1/29/2014,,solution-fluid,11/7/2013,12/23/2013,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/11/2025,mg,antineoplastic,1/29/2020,2/7/2018,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,11/25/2016,mg,antineoplastic,10/26/2016,7/3/2016,Intravenous,nivolumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/19/2015,mg,antineoplastic,6/18/2015,4/5/2015,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/17/2025,mg,antineoplastic,10/7/2023,6/13/2023,Intravenous,pembrolizumab,TRUE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,1/3/2025,mg/m2,antineoplastic,1/3/2025,11/3/2024,Intravenous,gemcitabine,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/23/2018,mg,antineoplastic,11/29/2017,11/22/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/2/2024,mg,antineoplastic,3/4/2024,12/16/2023,Intravenous,pembrolizumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/10/2023,mg,antineoplastic,6/27/2020,1/26/2020,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,4/24/2018,mg,antineoplastic,3/6/2018,10/6/2017,Intravenous,nivolumab,FALSE
248,,ADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,9/6/2014,mg,antineoplastic,6/29/2014,5/25/2014,Intravenous,ado-trastuzumab emtansine,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/13/2023,mg,antineoplastic,6/14/2023,4/23/2023,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,8/22/2014,mg,antineoplastic,6/23/2014,4/17/2014,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/29/2024,mg,antineoplastic,10/25/2022,4/5/2022,Intravenous,durvalumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/4/2025,mg,antineoplastic,9/30/2018,12/21/2016,Intravenous,nivolumab,FALSE
1,1,ADVANCED,Administrations,hormone,Anastrozole,G1F26CECEF:89,4/21/2019,mg,antineoplastic,4/14/2019,4/5/2019,Oral,anastrozole,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/19/2013,mg,antineoplastic,9/4/2013,4/6/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,5/1/2020,mg,antineoplastic,10/29/2018,1/1/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,8/6/2017,,solution-fluid,4/27/2017,12/17/2016,Intravenous,clinical study drug,FALSE
1240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/6/2020,mg,antineoplastic,12/7/2019,1/1/2020,Intravenous,pemetrexed,FALSE
383,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/12/2017,mg,antineoplastic,4/9/2017,2/7/2017,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/13/2025,mg,antineoplastic,9/14/2024,4/26/2024,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3867F7D51E3D,2/18/2025,mg,antineoplastic,3/4/2025,10/23/2024,Intravenous,pembrolizumab,TRUE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/15/2023,mg,antineoplastic,6/5/2023,3/3/2023,Intravenous,paclitaxel protein-bound,FALSE
327,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,1/23/2024,mg,antineoplastic,1/5/2024,11/3/2023,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,4/18/2016,mg,antineoplastic,4/25/2014,3/13/2014,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/27/2019,mg,antineoplastic,11/18/2018,10/22/2017,Intravenous,atezolizumab,FALSE
25,4,ADVANCED,Orders,chemotherapy,Vinorelbine,G2177D1::DG1E,8/24/2012,mg/m2,antineoplastic,8/23/2012,8/6/2012,Intravenous,vinorelbine,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,11/12/2021,mg,antineoplastic,5/30/2021,4/2/2021,Intravenous,pemetrexed,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/23/2025,mg,antineoplastic,8/4/2023,9/1/2022,Oral,anastrozole,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/17/2021,mg,antineoplastic,5/28/2021,9/8/2020,Intravenous,nivolumab,FALSE
245.7,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,6/16/2016,mg,antineoplastic,3/2/2016,12/7/2015,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G163D9B593927,9/14/2016,mg,antineoplastic,8/19/2016,6/9/2016,Intravenous,nivolumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/22/2018,mg,antineoplastic,6/28/2018,8/3/2018,Intravenous,cisplatin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G2E8B56477B83,5/13/2014,,,6/27/2014,3/1/2014,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/15/2018,mg,antineoplastic,12/5/2017,3/5/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,4/7/2018,,antineoplastic,10/31/2017,6/25/2017,Intravenous,clinical study drug,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/28/2012,mg,antineoplastic,3/24/2012,4/29/2012,Intravenous,carboplatin,FALSE
191.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,6/27/2018,mg,antineoplastic,5/14/2018,4/14/2018,Intravenous,carboplatin,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,1/4/2022,mg,antineoplastic,10/5/2021,10/22/2021,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/6/2018,,antineoplastic,1/28/2018,10/27/2017,Oral,anastrozole,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,2/18/2018,mg,antineoplastic,12/15/2017,7/8/2017,Intravenous,nivolumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/21/2023,mg,antineoplastic,12/8/2022,8/17/2022,Subcutaneous,azacitidine,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/26/2021,mg,antineoplastic,6/6/2021,4/22/2021,Intravenous,paclitaxel protein-bound,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,9/28/2023,mg,antineoplastic,9/11/2023,5/25/2023,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/4/2025,,antineoplastic,7/1/2023,2/19/2023,Intravenous,pemetrexed,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,5/3/2024,mg,antineoplastic,10/16/2023,6/3/2023,Intravenous,nivolumab,TRUE
2010,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,6/15/2013,mg,antineoplastic,9/27/2012,6/19/2012,Intravenous,gemcitabine,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,4/11/2022,mg,antineoplastic,2/22/2022,1/14/2022,Intravenous,nivolumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/7/2023,mg,antineoplastic,7/26/2023,6/21/2023,Intravenous,paclitaxel,FALSE
432,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/13/2024,mg,antineoplastic,10/21/2023,10/10/2023,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/5/2025,mg,antineoplastic,7/7/2022,7/21/2021,Intravenous,atezolizumab,TRUE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,9/13/2015,mg,antineoplastic,6/29/2015,6/12/2015,Intravenous,paclitaxel,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/20/2025,mg,antineoplastic,9/2/2020,3/22/2020,Intravenous,pemetrexed,TRUE
43,1,ADVANCED,Administrations,chemotherapy,Selpercatinib,G145E1G:C6189,6/16/2021,mg,antineoplastic,11/3/2020,12/23/2020,Intravenous,vinorelbine,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/30/2016,mg,antineoplastic,6/8/2014,6/2/2014,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/17/2017,mg,antineoplastic,5/18/2017,7/22/2016,Intravenous,nivolumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/26/2022,mg,antineoplastic,1/8/2022,8/20/2021,Intravenous,amivantamab-vmjw,FALSE
,4,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,6/22/2023,,,12/29/2022,1/14/2023,Oral,alectinib,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/14/2022,mg,antineoplastic,8/1/2020,4/28/2017,Oral,nilotinib,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,5/7/2024,mg,antineoplastic,2/3/2024,12/30/2023,Intravenous,paclitaxel protein-bound,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/8/2020,mg,antineoplastic,6/7/2014,4/14/2014,Intravenous,rituximab,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,7/14/2024,,antineoplastic,5/11/2023,5/11/2023,,niraparib,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,1/29/2017,mg,antineoplastic,3/2/2017,11/3/2016,Intravenous,carboplatin,FALSE
1095,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/26/2023,mg,antineoplastic,3/3/2020,2/6/2020,Intravenous,gemcitabine,FALSE
385,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,12/22/2022,mg,antineoplastic,11/6/2022,10/28/2022,Intravenous,carboplatin,FALSE
1540,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/28/2018,mg,antineoplastic,8/12/2018,7/23/2018,Intravenous,gemcitabine,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,5/14/2016,mg,antineoplastic,3/11/2016,1/6/2016,Intravenous,nivolumab,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/9/2018,mg,antineoplastic,7/14/2018,7/6/2018,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/24/2023,mg,antineoplastic,8/25/2022,3/2/2022,Intravenous,pembrolizumab,TRUE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/19/2021,mg,antineoplastic,3/13/2021,4/13/2021,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,11/29/2013,mg/m2,antineoplastic,9/25/2013,7/22/2013,Intravenous,gemcitabine,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,5/30/2012,mg,antineoplastic,2/21/2012,2/6/2012,Intravenous,paclitaxel,FALSE
190.5,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,8/13/2018,mg,antineoplastic,7/6/2018,7/23/2018,Intravenous,carboplatin,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/29/2016,mg,antineoplastic,12/23/2015,9/27/2015,Intravenous,etoposide,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/9/2016,mg,antineoplastic,6/24/2015,5/3/2015,Intravenous,carboplatin,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/16/2024,mg,antineoplastic,8/7/2022,7/30/2020,Intravenous,ipilimumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/31/2022,mg,antineoplastic,3/28/2021,2/15/2021,Intravenous,docetaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,Paclitaxel,G247F67418GGD,6/20/2013,mg/m2,antineoplastic,6/22/2013,7/19/2013,Intravenous,paclitaxel,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,4/6/2012,mg,antineoplastic,3/3/2012,1/24/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/14/2025,,antineoplastic,5/8/2018,12/1/2017,Intravenous,clinical study drug,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,3/22/2025,mg,antineoplastic,2/3/2025,1/13/2025,Intravenous,pembrolizumab,FALSE
606,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,5/1/2015,mg,antineoplastic,3/11/2015,2/2/2015,Intravenous,carboplatin,FALSE
540,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,7/29/2021,mg,antineoplastic,4/30/2021,4/30/2021,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/9/2023,mg,antineoplastic,10/26/2022,9/11/2022,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/21/2016,mg,antineoplastic,9/2/2016,6/20/2016,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,7/8/2019,mg,antineoplastic,9/30/2018,8/28/2017,Oral,anastrozole,FALSE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G3::1:B4F:3D4,11/12/2015,mg,antineoplastic,11/23/2015,10/14/2015,Intravenous,nivolumab,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/12/2015,mg,antineoplastic,7/23/2015,8/28/2014,Intravenous,paclitaxel,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,9/16/2022,mg,antineoplastic,9/8/2022,8/18/2022,Intravenous,carboplatin,FALSE
660,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/27/2023,mg,antineoplastic,11/29/2022,9/21/2021,Intravenous,rituximab-pvvr,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/9/2013,mg,antineoplastic,12/27/2012,9/30/2012,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/28/2013,mg,antineoplastic,4/12/2012,1/9/2012,Intravenous,etoposide,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,,antineoplastic,4/28/2022,5/6/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,11/4/2023,mg,antineoplastic,5/1/2023,4/22/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/17/2012,,antineoplastic,9/6/2011,10/27/2011,Intravenous,clinical study drug,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/13/2012,mg,antineoplastic,5/28/2012,5/28/2012,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/6/2023,mg,antineoplastic,3/21/2019,10/17/2017,Intravenous,nivolumab,FALSE
888,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,7/8/2023,mg,antineoplastic,4/11/2023,1/29/2023,Intravenous,pemetrexed,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/18/2025,mg,antineoplastic,12/23/2023,3/1/2023,Intravenous,pembrolizumab,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/12/2023,mg,antineoplastic,4/12/2023,3/3/2023,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/6/2014,mg,antineoplastic,6/23/2014,3/20/2014,Intravenous,paclitaxel protein-bound,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,11/12/2017,mL,solution-fluid,9/30/2017,7/20/2017,Intravenous,carboplatin,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/12/2017,mg,antineoplastic,10/12/2017,7/5/2017,Intravenous,docetaxel,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/25/2023,mg,antineoplastic,4/18/2023,4/30/2023,Intravenous,paclitaxel,FALSE
255,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/15/2016,mg,antineoplastic,2/9/2016,11/9/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Tepotinib,G278ED563CF9F,6/15/2023,,,6/3/2023,11/6/2022,Oral,tepotinib,FALSE
6,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,12/16/2014,AUC,antineoplastic,12/11/2014,10/2/2014,Intravenous,carboplatin,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,12/30/2021,mg,antineoplastic,12/23/2021,12/5/2021,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/30/2024,mg,antineoplastic,7/29/2023,12/30/2021,Intravenous,nivolumab,TRUE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/8/2023,mg,antineoplastic,10/18/2022,9/9/2022,Subcutaneous,azacitidine,FALSE
125,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,8/10/2021,mg,antineoplastic,5/21/2021,3/28/2021,Intravenous,carboplatin,FALSE
262,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,12/31/2019,mg,antineoplastic,11/2/2019,10/25/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/12/2022,,antineoplastic,7/2/2019,5/24/2017,Oral,nilotinib,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/16/2014,mg,antineoplastic,9/22/2014,9/18/2014,Intravenous,carboplatin,FALSE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/3/2017,mg,antineoplastic,3/27/2017,1/25/2017,Intravenous,carboplatin,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,9/4/2015,mg,antineoplastic,5/7/2015,6/4/2015,Intravenous,etoposide,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/16/2019,mg,antineoplastic,11/29/2018,5/26/2018,Intravenous,pemetrexed,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/2/2023,mL,solution-fluid,7/9/2023,11/29/2022,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Orders,immunotherapy,Durvalumab,G212D32:BD3B6,10/20/2021,mg,antineoplastic,10/24/2021,10/10/2021,Intravenous,durvalumab,TRUE
219,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/21/2022,mg,antineoplastic,7/16/2022,6/10/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/8/2018,mg,antineoplastic,10/16/2018,7/6/2018,Intravenous,pembrolizumab,TRUE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/11/2022,mg,antineoplastic,7/23/2021,4/29/2021,Intravenous,vinorelbine,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G26D38EC278C1,8/16/2019,mg,antineoplastic,4/10/2019,2/15/2019,Intravenous,atezolizumab,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G157317FG3387,6/25/2024,mg,antineoplastic,4/14/2024,5/7/2024,Intravenous,pemetrexed,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/18/2018,mg,antineoplastic,6/27/2016,8/23/2015,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/3/2025,mg,antineoplastic,8/5/2017,1/19/2017,Intravenous,nivolumab,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,10/17/2019,mg,antineoplastic,6/28/2019,7/3/2019,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,immunotherapy,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,2/7/2025,,antineoplastic,12/27/2024,1/1/2025,,pembrolizumab,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,6/1/2013,mg,antineoplastic,4/14/2013,12/10/2012,Intravenous,doxorubicin,FALSE
101,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,8/13/2020,mg,antineoplastic,5/11/2020,4/6/2020,Intravenous,cisplatin,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/29/2016,mg,antineoplastic,8/6/2015,7/3/2015,Intravenous,bevacizumab,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/26/2025,mg,antineoplastic,4/29/2020,3/25/2020,Intravenous,pemetrexed,TRUE
74,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/29/2024,mg,antineoplastic,4/5/2024,4/9/2024,Intravenous,paclitaxel,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/22/2023,mg,antineoplastic,10/20/2023,10/18/2023,Intravenous,paclitaxel,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/13/2025,mg,antineoplastic,8/1/2017,9/8/2016,Intravenous,pembrolizumab,FALSE
790,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,7/1/2014,mg,antineoplastic,2/5/2014,3/24/2014,Intravenous,carboplatin,FALSE
177,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161FDD242EB9,12/5/2011,mg,antineoplastic,10/19/2011,9/20/2011,Intravenous,paclitaxel,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,11/2/2018,mg,antineoplastic,12/25/2017,12/26/2017,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/11/2023,mg,antineoplastic,7/21/2023,10/15/2021,Intravenous,pembrolizumab,TRUE
360,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/5/2016,mg,antineoplastic,8/12/2016,6/22/2016,Intravenous,paclitaxel,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/28/2024,mg,antineoplastic,4/4/2024,3/29/2024,Intravenous,amivantamab-vmjw,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/29/2019,mg,antineoplastic,2/18/2018,2/1/2018,Intravenous,pemetrexed,FALSE
1223,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/1/2014,mg,antineoplastic,10/24/2012,9/16/2012,Intravenous,gemcitabine,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/6/2016,AUC,antineoplastic,6/10/2015,6/5/2014,Intravenous,carboplatin,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/5/2024,mg,antineoplastic,4/21/2024,4/29/2024,Intravenous,nivolumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/30/2021,mg,antineoplastic,5/3/2020,12/22/2019,Intravenous,durvalumab,TRUE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/16/2021,,steroid,6/21/2020,1/24/2020,Intravenous,clinical study drug,FALSE
3629,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/30/2025,mg,antineoplastic,11/21/2024,12/28/2024,Other/Miscellaneous,fluorouracil,FALSE
264,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,9/14/2015,mg,antineoplastic,6/27/2015,6/10/2015,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/8/2025,mg,antineoplastic,9/18/2024,1/28/2024,Intravenous,pembrolizumab,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,3/11/2021,mg,antineoplastic,1/18/2021,12/4/2020,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/24/2025,,solution-fluid,1/18/2018,10/15/2017,Intravenous,clinical study drug,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/19/2025,mg,antineoplastic,11/12/2021,10/31/2021,Intravenous,pemetrexed,TRUE
400,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,1/23/2021,mg,antineoplastic,10/3/2020,5/2/2020,Intravenous,pembrolizumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/12/2017,mg,antineoplastic,4/26/2016,6/2/2016,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/30/2021,mg,antineoplastic,5/16/2021,4/8/2021,Intravenous,pembrolizumab,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/8/2021,mg,antineoplastic,1/24/2021,12/21/2020,Intravenous,paclitaxel,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1C19:B29DB3F,6/13/2021,mg,antineoplastic,3/5/2015,3/6/2015,Intravenous,carboplatin,FALSE
15,3,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,12/16/2014,mg/kg,antineoplastic,9/28/2014,10/13/2014,Intravenous,bevacizumab,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/17/2021,mg,antineoplastic,5/19/2021,10/23/2020,Intravenous,durvalumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/8/2016,mg,antineoplastic,11/8/2015,12/18/2015,Intravenous,carboplatin,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,9/5/2013,mg,antineoplastic,4/26/2013,5/11/2013,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/8/2020,mg,antineoplastic,1/13/2020,1/18/2019,Subcutaneous,bortezomib,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,9/15/2022,mg,antineoplastic,6/29/2022,5/11/2022,Intravenous,pemetrexed,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,7/28/2018,mg,antineoplastic,6/1/2018,6/2/2018,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38GE:9D51587,8/21/2012,mg,antineoplastic,3/13/2012,2/10/2012,Intravenous,pemetrexed,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/20/2013,mg,antineoplastic,1/9/2013,9/14/2012,Intravenous,gemcitabine,FALSE
620,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/23/2014,mg,antineoplastic,9/4/2014,8/11/2014,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,4/22/2025,,antineoplastic,11/25/2024,4/22/2024,,pembrolizumab,FALSE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,8/25/2016,mg,antineoplastic,4/13/2016,5/12/2016,Intravenous,paclitaxel,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/26/2016,mg,antineoplastic,8/16/2015,11/2/2014,Intravenous,pemetrexed,FALSE
482,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,8/27/2021,mg,antineoplastic,7/10/2021,6/2/2021,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,10/22/2023,mg,antineoplastic,7/6/2023,6/1/2023,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/8/2025,mg,antineoplastic,7/16/2018,5/1/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/24/2015,,antineoplastic,1/19/2015,3/8/2015,Intravenous,etoposide,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,12/16/2023,mg/kg,antineoplastic,10/31/2023,9/14/2023,Intravenous,ramucirumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,2/3/2017,mg,antineoplastic,12/5/2016,9/22/2016,Intravenous,nivolumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,8/10/2019,mg,antineoplastic,7/9/2019,4/6/2019,Intravenous,docetaxel,FALSE
405,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/16/2013,mg,antineoplastic,7/28/2012,7/27/2012,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/14/2021,mg/kg,antineoplastic,11/5/2021,2/22/2021,Intravenous,bevacizumab-awwb,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/10/2024,mg,antineoplastic,2/17/2023,6/17/2020,Intravenous,pembrolizumab,TRUE
900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,5/4/2022,mg,antineoplastic,2/11/2022,1/31/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,2/28/2025,mg,antineoplastic,9/21/2023,3/11/2020,Intravenous,pembrolizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/8/2024,mg,antineoplastic,7/12/2021,6/28/2020,Intravenous,nivolumab,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,4/10/2013,mg,antineoplastic,1/20/2013,11/27/2012,Intravenous,bevacizumab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,8/4/2024,mg,antineoplastic,6/27/2024,6/6/2024,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/28/2025,mg,antineoplastic,2/12/2022,12/28/2016,Intravenous,pembrolizumab,FALSE
156,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,6/16/2023,mg,antineoplastic,3/29/2023,4/23/2023,Intravenous,cisplatin,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/8/2016,mg,antineoplastic,7/13/2015,7/11/2015,Intravenous,pemetrexed,FALSE
634,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,11/6/2016,mg,antineoplastic,7/13/2016,5/24/2016,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/30/2025,mg,antineoplastic,11/8/2020,1/24/2017,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/12/2022,mg,antineoplastic,11/12/2021,1/8/2020,Intravenous,nivolumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/15/2017,mg,antineoplastic,12/20/2013,12/24/2013,Intravenous,etoposide,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/17/2023,mg,antineoplastic,8/2/2023,10/7/2022,Intravenous,durvalumab,FALSE
670,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/26/2022,mg,antineoplastic,12/19/2021,8/22/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/5/2025,mg,antineoplastic,3/28/2022,1/18/2017,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/31/2016,mg,antineoplastic,4/23/2015,6/14/2014,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/24/2025,mg,antineoplastic,3/28/2025,4/24/2023,Intravenous,pembrolizumab,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/5/2023,mg,antineoplastic,10/19/2022,11/16/2022,Intravenous,fluorouracil,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,5/5/2025,mg,antineoplastic,10/3/2024,2/14/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,10/31/2014,AUC,antineoplastic,10/23/2014,9/11/2014,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,6/14/2014,mg,antineoplastic,5/4/2014,5/16/2014,Intravenous,pemetrexed,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,4/8/2020,mg,antineoplastic,2/7/2020,10/20/2019,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,9/6/2018,mg,antineoplastic,9/23/2017,7/28/2017,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,4/2/2025,mg,antineoplastic,3/8/2025,8/13/2022,Oral,anastrozole,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G34182B94:768,1/23/2019,,,1/29/2019,11/18/2017,Oral,osimertinib,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/24/2018,mL,solution-fluid,1/7/2018,1/21/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Tamoxifen,G1B:584419G11,6/26/2012,,antineoplastic,7/30/2012,6/11/2012,Oral,tamoxifen,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/14/2025,mg,antineoplastic,4/16/2021,1/7/2019,Intravenous,pembrolizumab,TRUE
820,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,4/2/2017,mg,antineoplastic,1/28/2017,2/5/2017,Intravenous,pemetrexed,FALSE
385,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,5/28/2018,mg,antineoplastic,2/9/2018,2/3/2018,Intravenous,carboplatin,FALSE
45,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/18/2024,mg,antineoplastic,3/28/2023,3/21/2023,Intravenous,docetaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,4/15/2016,,antineoplastic,12/23/2015,11/12/2015,Oral,capecitabine,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,7/4/2019,mg,antineoplastic,1/16/2019,12/16/2018,Intravenous,paclitaxel,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/9/2016,mg,antineoplastic,10/9/2015,5/14/2015,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/18/2020,mg,antineoplastic,8/10/2017,12/15/2015,Intravenous,nivolumab,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/9/2022,mg,antineoplastic,9/19/2022,5/26/2022,Intravenous,nivolumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G381867BDG3G2,11/4/2014,mg,antineoplastic,12/2/2014,11/11/2014,Intravenous,pemetrexed,FALSE
800,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G47DG9518GG1E,1/19/2025,mg,antineoplastic,12/27/2024,12/14/2024,Intravenous,ramucirumab,FALSE
304,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,7/28/2024,mg,antineoplastic,6/17/2024,5/2/2024,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/18/2023,mg,antineoplastic,9/19/2021,10/19/2021,Intravenous,pemetrexed,TRUE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G3B698C119:F8,7/23/2012,,antiemetic,7/29/2012,6/8/2012,Intravenous,clinical study drug,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G242GD729:FB:,5/2/2024,mg,antineoplastic,4/14/2024,2/8/2024,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/22/2023,mg,antineoplastic,10/25/2023,10/10/2023,Intravenous,paclitaxel,FALSE
440.7,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/31/2025,mg,antineoplastic,7/17/2020,4/14/2019,Intravenous,carboplatin,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,4/21/2025,mg,antineoplastic,4/3/2025,1/25/2025,Intravenous,cisplatin,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,12/15/2024,mg,antineoplastic,7/17/2022,5/31/2022,Intravenous,cisplatin,FALSE
471,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/30/2012,AUC,antineoplastic,3/1/2012,12/29/2011,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/31/2019,mg,antineoplastic,5/1/2018,4/22/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,12/21/2024,mg,antineoplastic,10/15/2024,9/19/2024,Intravenous,pembrolizumab,TRUE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/9/2024,mg,antineoplastic,8/29/2022,4/19/2022,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,7/10/2024,mg,antineoplastic,1/21/2024,6/28/2023,Intravenous,pembrolizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,4/15/2025,mg,antineoplastic,4/23/2025,3/12/2025,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,8/28/2018,mg,antineoplastic,2/22/2018,3/5/2018,Intravenous,pembrolizumab,FALSE
1025,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,1/12/2024,mg,antineoplastic,12/31/2023,9/1/2023,Intravenous,pemetrexed,FALSE
285,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,12/5/2014,mg,antineoplastic,9/5/2014,9/15/2014,Intravenous,carboplatin,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,8/28/2019,mg/kg,antineoplastic,7/21/2019,6/22/2019,Intravenous,durvalumab,TRUE
743,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G392GC5134FFG,9/27/2020,mg,antineoplastic,8/26/2020,8/6/2020,Intravenous,durvalumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,11/16/2015,mg,antineoplastic,4/17/2015,2/27/2015,Intravenous,pemetrexed,TRUE
1610,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,7/11/2014,mg,antineoplastic,5/14/2014,3/5/2014,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/28/2022,,antineoplastic,11/26/2018,4/17/2017,Oral,nilotinib,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,9/16/2021,mg,antineoplastic,6/29/2021,5/12/2021,Intravenous,pemetrexed,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/3/2013,mg,antineoplastic,5/25/2013,10/22/2012,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/1/2023,mg,antineoplastic,2/4/2023,7/10/2022,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1F482136BDE5,5/30/2017,,antineoplastic,3/4/2017,3/15/2017,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,12/15/2019,,antineoplastic,1/16/2020,12/1/2019,Oral,anastrozole,FALSE
93,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3E76E32E795:,6/26/2020,mg,antineoplastic,4/14/2020,4/8/2020,Intravenous,docetaxel,FALSE
200,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/28/2019,mg,antineoplastic,3/30/2019,1/27/2019,Intravenous,pembrolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/10/2025,mg,antineoplastic,6/22/2019,2/8/2019,Intravenous,pemetrexed,TRUE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/15/2024,mg,antineoplastic,7/14/2024,11/17/2022,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,Bicalutamide,G4992B5EB431G,5/3/2019,,antineoplastic,5/30/2019,5/8/2019,,bicalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,4/8/2021,mg,antineoplastic,9/18/2020,9/29/2020,Intravenous,pembrolizumab,TRUE
130,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/9/2013,mg,antineoplastic,6/28/2013,7/4/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/6/2025,,antineoplastic,9/5/2024,3/8/2023,,clinical study drug,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/7/2013,mg,antineoplastic,11/1/2012,12/12/2011,Intravenous,etoposide,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,7/15/2017,,antineoplastic,11/13/2016,11/17/2016,,clinical study drug,FALSE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4826CB54C27:,5/23/2020,mg,antineoplastic,4/9/2020,2/27/2020,Intravenous,carboplatin,FALSE
103,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/14/2015,mg,antineoplastic,11/6/2014,8/16/2014,Intravenous,carboplatin,FALSE
612,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/7/2016,mg,antineoplastic,8/11/2016,4/22/2016,Intravenous,carboplatin,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/14/2020,mg,antineoplastic,8/31/2020,7/7/2020,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G11B743:8G337,6/16/2016,mg,antineoplastic,4/18/2015,3/20/2015,Intravenous,pemetrexed,TRUE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/12/2024,mg,antineoplastic,1/18/2024,9/6/2023,Intravenous,durvalumab,FALSE
130,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/12/2013,mg,antineoplastic,1/6/2012,12/20/2011,Intravenous,etoposide,FALSE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,11/20/2016,mg,antineoplastic,8/28/2016,5/15/2016,Intravenous,paclitaxel,FALSE
443,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/9/2019,mg,antineoplastic,7/20/2018,5/25/2018,Intravenous,carboplatin,FALSE
146,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/22/2013,mg,antineoplastic,4/23/2013,3/29/2013,Intravenous,paclitaxel,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/4/2023,mg,antineoplastic,8/29/2023,9/9/2023,Intravenous,paclitaxel,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/26/2019,mg,antineoplastic,6/14/2018,12/3/2016,Intramuscular,fulvestrant,FALSE
283,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,7/5/2013,mg,antineoplastic,7/27/2012,8/31/2012,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/27/2015,mg,antineoplastic,4/11/2015,3/9/2015,Intravenous,paclitaxel protein-bound,FALSE
15,,ADJUVANT,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,12/24/2015,mg/kg,antineoplastic,12/16/2015,6/8/2015,Intravenous,bevacizumab,FALSE
680,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3E76E32E795:,7/24/2020,mg,antineoplastic,4/19/2020,3/15/2020,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/17/2023,mg,antineoplastic,3/7/2023,12/2/2022,Intravenous,carboplatin,FALSE
191,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,3/30/2022,mg,antineoplastic,3/5/2022,1/21/2022,Intravenous,carboplatin,FALSE
1690,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/17/2013,mg,antineoplastic,12/23/2012,8/27/2012,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,4/26/2025,mg,antineoplastic,3/2/2025,1/13/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,4/25/2024,,antineoplastic,4/20/2024,5/6/2024,,carboplatin,FALSE
241,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/7/2016,mg,antineoplastic,11/11/2015,12/7/2015,Intravenous,nivolumab,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/8/2024,mg,antineoplastic,11/5/2024,11/18/2023,Intravenous,durvalumab,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/28/2013,mg,antineoplastic,5/27/2013,5/18/2013,Intravenous,carboplatin,FALSE
78,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/3/2024,mg,antineoplastic,10/23/2024,5/30/2024,Intravenous,ipilimumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,2/14/2020,mg,antineoplastic,12/20/2019,1/14/2020,Intravenous,paclitaxel,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/11/2014,mg,antineoplastic,4/29/2014,4/20/2014,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,3/30/2023,mg,antineoplastic,10/19/2022,9/20/2022,Subcutaneous,azacitidine,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/23/2022,mg,antineoplastic,11/23/2021,10/15/2021,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/2/2023,mg,antineoplastic,8/4/2020,12/12/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,7/26/2018,,antineoplastic,5/17/2018,4/15/2018,Intravenous,carboplatin,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,12/22/2015,mg,antineoplastic,12/11/2015,12/5/2015,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/15/2018,mg,antineoplastic,3/20/2017,8/21/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/6/2012,,antineoplastic,11/8/2011,11/1/2011,,clinical study drug,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/15/2019,mg,antineoplastic,4/5/2018,4/8/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/27/2023,,antineoplastic,6/13/2022,4/3/2022,Intravenous,pembrolizumab,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/22/2022,mg,antineoplastic,5/30/2022,5/20/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/31/2021,mg,antineoplastic,10/27/2021,11/13/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19D38B88F559,3/31/2020,mg,antineoplastic,4/17/2020,3/5/2020,Intravenous,pembrolizumab,FALSE
1110,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/11/2021,mg,antineoplastic,3/5/2021,12/20/2020,Intravenous,gemcitabine,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/1/2021,mg,antineoplastic,4/2/2021,11/29/2020,Intravenous,gemcitabine,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/22/2022,mg,antineoplastic,6/9/2021,3/21/2021,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/3/2020,mg,antineoplastic,5/22/2020,1/21/2020,Intravenous,pembrolizumab,FALSE
0,,ADJUVANT,Orders,hormone,Enzalutamide,G214C6EC1517:,5/9/2025,mg,antineoplastic,2/16/2025,1/23/2025,Oral,enzalutamide,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/27/2020,mg,antineoplastic,9/18/2019,11/24/2018,Intravenous,durvalumab,TRUE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/15/2025,mg,antineoplastic,7/6/2023,9/27/2022,Oral,anastrozole,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/26/2018,mg,antineoplastic,1/6/2017,8/11/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1C22CGB1F5C2,8/25/2020,mg,antineoplastic,12/12/2019,12/26/2019,Intravenous,pembrolizumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/2/2025,mg,antineoplastic,1/15/2023,3/14/2019,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/15/2017,mg,antineoplastic,5/1/2017,7/22/2016,Intravenous,nivolumab,FALSE
520,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/19/2023,mg,antineoplastic,4/7/2023,4/15/2023,Intravenous,carboplatin,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,8/4/2022,mg,antineoplastic,9/15/2021,8/23/2021,Intravenous,pembrolizumab,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/16/2015,mg,antineoplastic,10/20/2014,8/31/2014,Intravenous,carboplatin,FALSE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/21/2017,mg,antineoplastic,7/21/2017,7/23/2017,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G475BB:CGC731,4/20/2025,,antineoplastic,12/6/2022,8/27/2021,Intravenous,atezolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,8/24/2019,mg/kg,antineoplastic,8/15/2019,6/2/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/20/2021,mg,antineoplastic,3/31/2021,11/15/2019,Intravenous,pembrolizumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/20/2021,mL,solution-fluid,6/30/2018,2/26/2018,Intravenous,durvalumab,TRUE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/23/2025,mg,antineoplastic,5/21/2024,4/19/2024,Intravenous,pembrolizumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,1/25/2024,mg,antineoplastic,10/13/2023,11/11/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,2/27/2024,mg,antineoplastic,11/11/2023,9/28/2023,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,3/25/2025,,steroid,1/16/2025,12/30/2024,Intravenous,clinical study drug,FALSE
164,1,LOCOREGIONAL,Administrations,chemotherapy,Docetaxel,G24F:E99C2926,11/6/2023,mg,antineoplastic,10/15/2023,11/13/2023,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,4/4/2025,,antineoplastic,1/14/2023,3/3/2022,Intravenous,pembrolizumab,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/25/2024,mg,antineoplastic,4/12/2021,6/24/2020,Intravenous,nivolumab,FALSE
810,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/15/2025,mg,antineoplastic,9/12/2024,3/26/2024,Intravenous,durvalumab,TRUE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/13/2022,mg,antineoplastic,10/29/2021,6/21/2021,Intravenous,fluorouracil,FALSE
1590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/19/2013,mg,antineoplastic,8/6/2013,9/15/2012,Intravenous,gemcitabine,FALSE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/10/2014,mg,antineoplastic,12/30/2013,12/22/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,3/8/2022,mg,antineoplastic,1/17/2022,11/26/2021,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G46:87GF7FGC9,12/26/2015,,hematological agent,10/4/2015,7/14/2015,Subcutaneous,clinical study drug,FALSE
95,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,12/4/2013,mg,antineoplastic,9/29/2013,10/12/2013,Intravenous,cisplatin,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,6/19/2023,mg/m2,antineoplastic,6/3/2023,4/22/2023,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/24/2023,mg,antineoplastic,6/27/2023,3/27/2023,Subcutaneous,azacitidine,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/24/2017,mg,antineoplastic,7/18/2017,4/28/2017,Intravenous,paclitaxel,FALSE
350,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/28/2024,mg,antineoplastic,9/30/2023,10/21/2023,Intravenous,amivantamab-vmjw,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/19/2015,mg,antineoplastic,10/7/2015,9/20/2015,Intravenous,pemetrexed,FALSE
1025,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,6/11/2015,mg,antineoplastic,5/31/2015,7/5/2015,Intravenous,pemetrexed,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/29/2019,mg,antineoplastic,2/22/2019,2/9/2019,Intravenous,durvalumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/21/2013,mg/m2,antineoplastic,6/15/2012,3/22/2012,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/3/2025,mg,antineoplastic,7/26/2024,6/11/2024,Intravenous,carboplatin,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,1/6/2012,mg,antineoplastic,11/3/2011,8/10/2011,Intravenous,paclitaxel,FALSE
17.2,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/2/2013,mL,antineoplastic,10/26/2013,6/29/2013,Intravenous,vinorelbine,FALSE
750,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/10/2024,mg,antineoplastic,1/22/2024,1/13/2023,Intravenous,durvalumab,FALSE
306,1,ADVANCED,Administrations,chemotherapy,Osimertinib,G4::3E61CFBB9,3/27/2025,mg,antineoplastic,11/3/2024,10/24/2024,Intravenous,paclitaxel,FALSE
6,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,10/28/2020,AUC,antineoplastic,9/29/2020,10/20/2020,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/28/2023,mg,antineoplastic,2/23/2023,12/19/2022,Intravenous,atezolizumab,FALSE
593,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,11/24/2014,mg,antineoplastic,12/19/2014,10/8/2014,Intravenous,carboplatin,FALSE
214,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/23/2021,mg,antineoplastic,8/23/2021,6/27/2021,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/7/2024,mg,antineoplastic,9/30/2021,6/2/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/13/2021,mg,antineoplastic,4/6/2020,11/11/2019,Intravenous,pembrolizumab,FALSE
340,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/3/2016,mg,antineoplastic,9/2/2016,6/2/2016,Intravenous,carboplatin,FALSE
1400,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4G53233CD43C,4/6/2025,mg,antineoplastic,2/21/2025,1/29/2025,Intravenous,gemcitabine,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/26/2014,mg,antineoplastic,7/3/2014,5/24/2014,Intravenous,vinorelbine,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/26/2024,mg,antineoplastic,4/22/2024,12/29/2023,Intravenous,paclitaxel protein-bound,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1E1BE62:E61G,1/24/2020,mg,antineoplastic,12/26/2019,1/20/2020,Intravenous,pemetrexed,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/19/2025,mg,antineoplastic,11/17/2024,11/10/2024,Intravenous,cisplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G14216G12B:E7,5/26/2020,mg,antineoplastic,1/3/2020,11/11/2019,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/28/2018,mg,antineoplastic,12/6/2017,3/17/2017,Intravenous,pemetrexed,TRUE
139,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/19/2015,mg,antineoplastic,9/9/2015,5/18/2015,Intravenous,etoposide,FALSE
30,3,ADVANCED,Orders,chemotherapy,Vinorelbine,G1D:B49GGG719,9/18/2018,mg/m2,antineoplastic,8/10/2017,5/8/2017,Intravenous,vinorelbine,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/16/2015,mg,antineoplastic,10/21/2014,9/7/2014,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,10/12/2023,mg,antineoplastic,4/13/2023,1/26/2023,Oral,zanubrutinib,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/19/2017,,solution-fluid,5/31/2016,2/10/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/21/2020,mg,antineoplastic,5/23/2018,1/14/2018,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,Crizotinib,G183BG5B65678,1/10/2020,,,12/19/2019,2/4/2019,Oral,crizotinib,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,1/31/2014,mg,antineoplastic,11/21/2013,9/22/2013,Intravenous,gemcitabine,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/17/2025,mg,antineoplastic,4/29/2024,3/25/2024,Intravenous,durvalumab,TRUE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/26/2019,mg,antineoplastic,4/18/2016,3/23/2016,Intravenous,nivolumab,FALSE
160,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G167G71733G69,10/12/2016,mg,antineoplastic,5/28/2016,5/11/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/13/2019,mg,antineoplastic,9/22/2018,5/30/2018,Intravenous,pembrolizumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/22/2019,mg,antineoplastic,2/8/2019,1/11/2019,Intravenous,paclitaxel protein-bound,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,8/5/2024,,antineoplastic,11/12/2023,4/23/2023,Oral,niraparib,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/8/2016,mg,antineoplastic,1/28/2016,12/14/2015,Intravenous,bevacizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/12/2024,mg,antineoplastic,8/19/2023,7/11/2023,Intravenous,pembrolizumab,FALSE
116,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/10/2015,mg,antineoplastic,12/3/2014,8/9/2014,Intravenous,paclitaxel,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/28/2016,mg,antineoplastic,9/9/2015,6/5/2015,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Bevacizumab,Pembrolizumab,Pemetrexed",G23G13:GCG631,1/11/2018,mg,antineoplastic,2/11/2018,2/7/2018,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/18/2025,mg,antineoplastic,2/4/2023,1/27/2023,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,3/20/2023,mg,antineoplastic,11/21/2022,9/26/2022,Subcutaneous,azacitidine,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/12/2025,mg,antineoplastic,7/17/2021,12/28/2018,Intravenous,pembrolizumab,TRUE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/3/2024,mg,antineoplastic,8/6/2024,5/29/2024,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/1/2019,,antineoplastic,11/3/2019,9/25/2019,,pembrolizumab,FALSE
396,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/23/2024,mg,antineoplastic,8/3/2024,8/24/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1EE49EC392G6,6/17/2024,mg,antineoplastic,6/5/2023,3/28/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/23/2025,,antineoplastic,4/18/2024,5/11/2024,Intravenous,pemetrexed,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/13/2020,mg,antineoplastic,10/11/2019,9/9/2019,Intravenous,durvalumab,FALSE
167.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/27/2015,mg,antineoplastic,11/15/2014,10/7/2014,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/14/2024,mg,antineoplastic,8/1/2023,4/11/2023,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,9/12/2018,mg,antineoplastic,9/4/2017,10/6/2017,Intravenous,atezolizumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,12/30/2019,mg,antineoplastic,1/23/2019,2/25/2019,Intravenous,durvalumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/11/2019,mg/kg,antineoplastic,9/23/2018,7/29/2018,Intravenous,durvalumab,FALSE
794,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2E14:97G:FFD,5/29/2019,mg,antineoplastic,3/22/2019,4/25/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/16/2017,,solution-fluid,6/6/2016,2/28/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/8/2021,mg,antineoplastic,10/30/2019,11/13/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/28/2025,,,5/13/2023,4/13/2023,Oral,sotorasib,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,3/27/2024,mg,antineoplastic,12/10/2023,5/26/2023,Intravenous,nivolumab,TRUE
1000,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,3/9/2016,mg/m2,antineoplastic,12/12/2015,11/30/2015,Oral,capecitabine,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,1/28/2015,mg,antineoplastic,10/19/2014,10/17/2014,Intravenous,carboplatin,FALSE
757,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/25/2024,mg,antineoplastic,9/15/2023,2/23/2023,Intravenous,durvalumab,FALSE
350,3,ADVANCED,Administrations,immunotherapy,Cemiplimab,G252328CFG4E1,4/26/2024,mg,antineoplastic,1/27/2024,1/22/2024,Intravenous,cemiplimab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/12/2020,mg,antineoplastic,6/20/2017,1/28/2016,Intravenous,bevacizumab,TRUE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,10/4/2023,mg,antineoplastic,8/2/2023,6/14/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/21/2025,mg,antineoplastic,12/6/2024,3/17/2020,Intravenous,pembrolizumab,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/10/2016,mg,antineoplastic,6/1/2016,4/13/2016,Intravenous,carboplatin,FALSE
485,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,7/19/2016,mg,antineoplastic,5/2/2016,4/28/2016,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,4/16/2025,,,3/31/2025,6/20/2024,Oral,osimertinib,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/18/2012,mg,antineoplastic,9/22/2011,9/14/2011,Intravenous,cetuximab,FALSE
193,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,9/20/2021,mg,antineoplastic,8/20/2021,6/18/2021,Intravenous,carboplatin,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/5/2022,mg,antineoplastic,6/29/2021,3/4/2021,Intravenous,bevacizumab-awwb,FALSE
810.7,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,10/6/2015,mg,antineoplastic,8/24/2015,7/27/2015,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,7/31/2021,mL,solution-fluid,6/19/2021,3/29/2021,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/11/2016,mg,antineoplastic,2/19/2016,5/5/2015,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/22/2024,,antineoplastic,11/5/2023,11/10/2023,Intravenous,carboplatin,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/26/2021,mg,antineoplastic,7/3/2021,3/26/2021,Intravenous,paclitaxel protein-bound,FALSE
1087.5,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/21/2015,mg,antineoplastic,8/31/2015,1/28/2015,Intravenous,bevacizumab,FALSE
124,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/10/2024,mg,antineoplastic,3/12/2024,3/27/2024,Intravenous,carboplatin,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/24/2019,mg/m2,antineoplastic,11/10/2018,10/17/2018,Intravenous,vinorelbine,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,8/21/2024,mg,antineoplastic,7/8/2024,6/24/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G4FC5:16DD742,8/1/2023,,,9/6/2021,9/5/2021,Oral,trametinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/9/2025,,antineoplastic,3/17/2024,2/9/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/4/2022,mg,antineoplastic,10/24/2018,1/17/2018,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/5/2020,mg,antineoplastic,3/18/2020,4/13/2020,Intravenous,atezolizumab,FALSE
743,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G392GC5134FFG,9/21/2020,mg,antineoplastic,8/11/2020,7/16/2020,Intravenous,durvalumab,TRUE
868,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46E218G4252C,8/7/2016,mg,antineoplastic,5/25/2016,6/18/2016,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/11/2020,mg,antineoplastic,4/19/2019,2/6/2019,Subcutaneous,bortezomib,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/12/2013,mg,antineoplastic,12/6/2012,12/27/2012,Intravenous,doxorubicin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,3/27/2025,mg,antineoplastic,3/25/2025,10/2/2024,Intravenous,pembrolizumab,TRUE
80,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/26/2013,mg/m2,antineoplastic,7/14/2013,6/6/2013,Intravenous,paclitaxel,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,9/7/2024,mg,antineoplastic,7/25/2024,6/5/2024,Intravenous,carboplatin,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,10/8/2024,mg,antineoplastic,9/23/2022,4/24/2022,Intravenous,durvalumab,TRUE
271.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/24/2023,mg,antineoplastic,2/4/2023,2/4/2023,Intravenous,paclitaxel,FALSE
1700,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G11:F93GC6851,5/4/2021,mg,antineoplastic,1/31/2021,2/3/2021,Intravenous,gemcitabine,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/15/2015,mg,antineoplastic,11/10/2014,9/18/2014,Intravenous,docetaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/29/2025,mg,antineoplastic,6/20/2024,4/21/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G12E3G252G92G,4/19/2015,,,2/25/2014,2/11/2014,Oral,erlotinib,FALSE
400,2,ADVANCED,Orders,immunotherapy,Pembrolizumab,G517B45372B5D,12/3/2020,mg,antineoplastic,11/27/2020,5/22/2020,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/5/2019,mL,solution-fluid,9/13/2017,9/22/2017,Intravenous,etoposide,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/4/2020,mg,antineoplastic,7/18/2020,5/31/2020,Intravenous,carboplatin,FALSE
600,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,11/2/2021,mg,antineoplastic,10/24/2021,10/16/2021,Intravenous,pemetrexed,FALSE
1115,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/19/2020,mg,antineoplastic,12/7/2019,1/11/2020,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G2CG3EF9E5:2B,6/28/2021,,,5/24/2021,4/29/2021,Oral,alectinib,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/2/2015,mg,antineoplastic,2/12/2015,8/31/2014,Intravenous,etoposide,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Pemetrexed",G1D:B49GGG719,11/22/2016,mg/kg,antineoplastic,9/23/2016,7/2/2016,Intravenous,bevacizumab,TRUE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/3/2023,mg,antineoplastic,12/18/2022,9/15/2022,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1:C9B9B392:C,4/28/2015,mg/m2,antineoplastic,3/19/2015,5/4/2015,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/7/2025,mg,antineoplastic,11/26/2023,1/27/2017,Intravenous,pembrolizumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/14/2014,mg,antineoplastic,2/28/2014,1/3/2014,Intravenous,cisplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,1/13/2016,mg,antineoplastic,6/20/2015,6/24/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/27/2018,mg,antineoplastic,7/24/2018,4/13/2018,Intravenous,carboplatin,FALSE
5,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,11/18/2020,AUC,antineoplastic,8/25/2020,1/17/2020,Intravenous,carboplatin,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,7/5/2015,mg,antineoplastic,3/25/2015,1/9/2015,Intravenous,paclitaxel protein-bound,FALSE
2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/9/2020,mg,antineoplastic,7/21/2014,2/25/2014,Intravenous,vincristine,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1G7:9D7EC1EC,9/3/2021,,antineoplastic,7/16/2021,7/17/2021,,clinical study drug,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/21/2025,mg,antineoplastic,3/18/2025,10/22/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/8/2025,mg,antineoplastic,10/7/2020,4/1/2020,Intravenous,pembrolizumab,FALSE
379,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/13/2024,mg,antineoplastic,12/29/2023,11/4/2023,Intravenous,carboplatin,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/26/2017,mg,antineoplastic,6/30/2016,4/18/2016,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/17/2020,mg,antineoplastic,1/13/2020,7/22/2016,Intravenous,nivolumab,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,4/25/2016,mg,antineoplastic,1/24/2016,11/14/2015,Intravenous,ramucirumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/2/2023,,antineoplastic,12/9/2022,11/27/2022,,pemetrexed,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/6/2020,mg,antineoplastic,11/5/2019,10/22/2019,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,hormone,Exemestane,G358EF4457D52,8/8/2014,,antineoplastic,7/26/2014,7/21/2014,Oral,exemestane,FALSE
995,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,5/23/2016,mg,antineoplastic,4/29/2016,3/18/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/5/2022,mg,antineoplastic,3/2/2022,12/21/2021,Intravenous,pembrolizumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/2/2021,mg,antineoplastic,11/5/2020,9/14/2020,Oral,bicalutamide,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/13/2021,,antiemetic,1/21/2020,1/27/2020,Intravenous,clinical study drug,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/9/2017,mL,solution-fluid,8/5/2017,7/1/2017,Intravenous,carboplatin,FALSE
360,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,6/17/2018,mg,antineoplastic,12/11/2017,9/30/2017,Intravenous,carboplatin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,8/9/2021,mg,antineoplastic,2/19/2021,9/20/2020,Intravenous,durvalumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/12/2025,mg,antineoplastic,9/3/2024,3/8/2024,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,7/13/2024,mg,antineoplastic,4/6/2024,4/25/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3CG5712E:B54,4/27/2024,mg,antineoplastic,4/29/2024,3/4/2024,Intravenous,pembrolizumab,TRUE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/10/2025,mg,antineoplastic,12/26/2024,9/19/2024,Intravenous,durvalumab,TRUE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3C98:B743F7B,7/26/2014,mg/m2,antineoplastic,5/23/2013,5/25/2013,Intravenous,pemetrexed,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/15/2014,mg,antineoplastic,10/28/2014,8/28/2014,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,5/15/2025,mg,antineoplastic,7/9/2024,4/29/2023,Intravenous,pembrolizumab,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/14/2024,mg,antineoplastic,3/10/2024,12/21/2023,Intravenous,cisplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,7/23/2024,mL,solution-fluid,6/4/2024,3/11/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/19/2025,mg,antineoplastic,8/28/2023,1/25/2019,Intravenous,pembrolizumab,TRUE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G17BB6EDG:98F,8/22/2019,mg,antineoplastic,6/12/2019,6/9/2019,Intravenous,atezolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/14/2018,mg,antineoplastic,9/23/2015,8/14/2015,Intravenous,nivolumab,FALSE
636,,ADJUVANT,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/12/2025,mg,antineoplastic,2/17/2025,11/21/2024,Intravenous,leucovorin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/19/2011,mg,antineoplastic,4/19/2011,4/18/2011,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,6/26/2023,,,6/8/2023,1/11/2023,Oral,alectinib,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,1/2/2025,mg,antineoplastic,5/16/2022,5/6/2022,Intravenous,cisplatin,FALSE
95,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/24/2017,mg,antineoplastic,1/12/2017,9/9/2016,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,1/25/2023,,antineoplastic,11/7/2022,11/15/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1FD696E::692,11/23/2024,,antineoplastic,7/18/2024,6/4/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G1:3G:24D:34B,5/14/2025,,,5/28/2024,3/29/2018,Oral,alectinib,FALSE
259,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/1/2016,mg,antineoplastic,1/14/2016,12/9/2015,Intravenous,nivolumab,FALSE
1125,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:78734BCEDB,12/27/2014,mg,antineoplastic,8/5/2014,7/13/2014,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/9/2019,mg,antineoplastic,4/24/2018,4/19/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/17/2021,mg,antineoplastic,12/20/2018,12/16/2018,Intravenous,pembrolizumab,TRUE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/28/2013,mg,antineoplastic,5/11/2012,3/31/2012,Intravenous,gemcitabine,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,4/19/2020,mg,antineoplastic,3/19/2020,12/23/2019,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/16/2020,mg,antineoplastic,10/8/2020,9/26/2020,Nasogastric,bicalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/18/2019,mg,antineoplastic,8/22/2019,7/22/2019,Intravenous,pembrolizumab,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/7/2023,mg,antineoplastic,2/1/2023,10/21/2022,Intravenous,fluorouracil,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/9/2016,mg,antineoplastic,3/1/2015,10/3/2014,Intravenous,bevacizumab,TRUE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/7/2023,mg,antineoplastic,5/10/2023,4/23/2023,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Orders,hormone,Anastrozole,G1GFD92F489E7,1/24/2023,,antineoplastic,2/2/2023,1/23/2023,Oral,anastrozole,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/4/2016,mg,antineoplastic,8/26/2014,6/28/2014,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,7/30/2018,mg,antineoplastic,4/22/2018,2/21/2018,Intravenous,pemetrexed,FALSE
76,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/11/2020,mg,antineoplastic,6/11/2014,3/16/2014,Intravenous,doxorubicin,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/4/2018,,antineoplastic,7/17/2018,8/7/2018,Intravenous,pembrolizumab,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/25/2023,mg,antineoplastic,5/30/2023,12/14/2022,Intravenous,pemetrexed,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/7/2024,mg,antineoplastic,2/26/2023,4/8/2022,Intravenous,durvalumab,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,7/6/2013,mg,antineoplastic,6/23/2013,1/28/2013,Intravenous,gemcitabine,FALSE
815,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/16/2018,mg,antineoplastic,2/26/2018,12/19/2017,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/26/2024,mL,solution-fluid,9/6/2024,4/26/2024,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/2/2025,mg,antineoplastic,11/26/2024,10/10/2023,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5:CE:F92EE8D,3/24/2016,,antineoplastic,10/5/2015,7/29/2015,Intravenous,clinical study drug,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/18/2025,mg,antineoplastic,9/18/2023,3/21/2020,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Unstructured,,Osimertinib,G17DC5G:4GB26,12/21/2020,,,8/29/2020,9/8/2020,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G365D2:FDG53F,4/10/2025,mg,antineoplastic,4/29/2025,2/5/2025,Intravenous,pembrolizumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,8/14/2024,mg,antineoplastic,6/1/2024,4/29/2024,Intravenous,carboplatin,FALSE
970,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,1/28/2019,mg,antineoplastic,11/26/2018,11/7/2018,Intravenous,pemetrexed,FALSE
1650,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G2FF2946:4C6F,5/23/2018,mg,antineoplastic,5/8/2018,3/12/2018,Intravenous,gemcitabine,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,4/23/2025,mg,antineoplastic,9/17/2024,7/26/2024,Intravenous,durvalumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/28/2015,mg,antineoplastic,5/14/2015,2/21/2015,Intravenous,carboplatin,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/3/2019,mg,antineoplastic,3/5/2019,2/18/2019,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,4/19/2025,mg,antineoplastic,5/11/2025,7/31/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/15/2019,mg,antineoplastic,9/21/2019,10/6/2019,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/27/2015,mg,antineoplastic,1/26/2014,1/24/2014,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/9/2023,mg,antineoplastic,4/21/2023,8/13/2022,Subcutaneous,azacitidine,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,1/18/2017,mg,antineoplastic,12/23/2016,11/23/2016,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/17/2025,mg,antineoplastic,9/23/2019,3/23/2018,Intravenous,nivolumab,FALSE
126,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G24365CF6:6G7,4/5/2014,mg,antineoplastic,3/15/2014,3/8/2014,Intravenous,cisplatin,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/28/2014,mg,antineoplastic,12/4/2013,10/30/2013,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/16/2025,mg,antineoplastic,9/28/2020,2/12/2018,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/10/2025,mg,antineoplastic,9/19/2019,1/13/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/4/2024,mg,antineoplastic,5/20/2023,4/27/2020,Intravenous,pembrolizumab,TRUE
284,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G164G31958638,10/14/2024,mg,antineoplastic,8/4/2024,7/25/2024,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,5/8/2025,mg,antineoplastic,4/28/2025,10/24/2024,Intravenous,pembrolizumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,10/20/2017,mg,antineoplastic,9/11/2017,7/20/2017,Intravenous,docetaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/18/2016,mg,antineoplastic,12/9/2015,10/27/2015,Intravenous,pemetrexed,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,2/21/2025,mg,antineoplastic,12/8/2024,10/19/2024,Intravenous,pemetrexed,FALSE
1509,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1D:B49GGG719,12/27/2016,mg,antineoplastic,11/29/2016,8/6/2016,Intravenous,bevacizumab,TRUE
120,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,5/1/2024,mg,antineoplastic,3/15/2024,3/12/2024,Intravenous,ipilimumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/21/2025,mg,antineoplastic,5/11/2024,2/15/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,4/12/2019,mg,antineoplastic,3/27/2019,1/17/2019,Intravenous,pembrolizumab,FALSE
1,1,ADVANCED,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/25/2022,mg,antineoplastic,5/24/2022,5/17/2022,Oral,anastrozole,FALSE
590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,9/6/2024,mg,antineoplastic,7/1/2024,6/26/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:EECBFBEGD,7/19/2022,mg,antineoplastic,6/9/2022,6/16/2022,Intravenous,pembrolizumab,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/12/2013,mg,antineoplastic,3/23/2013,11/12/2012,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/14/2024,,antineoplastic,4/24/2024,4/15/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G133G3GCBGE3D,1/22/2014,,,6/5/2013,6/2/2013,Oral,erlotinib,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,3/20/2025,mg,antineoplastic,10/5/2024,8/31/2024,Intravenous,durvalumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/20/2023,mg,antineoplastic,10/3/2023,9/14/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/12/2024,,antineoplastic,6/3/2024,4/17/2024,Intravenous,etoposide,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,8/31/2024,mg,antineoplastic,7/21/2024,6/17/2024,Intravenous,carboplatin,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/24/2021,,antineoplastic,2/28/2021,7/22/2020,,clinical study drug,FALSE
156,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,6/20/2023,mg,antineoplastic,6/11/2023,4/22/2023,Intravenous,cisplatin,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/31/2013,mg,antineoplastic,5/21/2013,5/3/2013,Intravenous,paclitaxel,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,7/18/2016,mg,antineoplastic,6/6/2016,3/29/2016,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,4/12/2025,mg,antineoplastic,3/17/2025,3/24/2025,Intravenous,carboplatin,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/30/2021,mg,antineoplastic,7/20/2020,12/17/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,3/26/2019,mg,antineoplastic,9/19/2018,10/16/2018,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,3/20/2025,,antineoplastic,1/5/2025,12/10/2024,Intravenous,pembrolizumab,FALSE
265,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/20/2015,mg,antineoplastic,4/28/2015,2/2/2015,Intravenous,carboplatin,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/2/2025,mg,antineoplastic,4/2/2024,2/24/2024,Intravenous,amivantamab-vmjw,FALSE
404,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/23/2016,mg,antineoplastic,4/3/2016,10/26/2015,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,11/12/2022,mg,antineoplastic,10/8/2021,10/26/2021,Intravenous,pemetrexed,TRUE
400,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/20/2013,mg,antineoplastic,11/30/2012,10/24/2012,Intravenous,carboplatin,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,3/6/2019,mg,antineoplastic,1/13/2019,11/20/2018,Intravenous,paclitaxel,FALSE
347.4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,5/4/2019,mg,antineoplastic,5/16/2019,3/15/2019,Intravenous,carboplatin,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/19/2025,mg,antineoplastic,1/26/2024,9/26/2022,Intravenous,pemetrexed,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,10/14/2022,mg,antineoplastic,4/10/2022,11/1/2021,Intravenous,durvalumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,6/15/2020,mg,antineoplastic,8/21/2019,7/31/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,,antineoplastic,7/19/2021,5/27/2017,Oral,nilotinib,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/28/2025,mg,antineoplastic,5/5/2023,2/25/2023,Intravenous,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/8/2023,mg,antineoplastic,7/21/2023,5/24/2023,Intravenous,durvalumab,FALSE
487,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/29/2016,mg,antineoplastic,1/11/2016,9/26/2015,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/19/2021,mg/m2,antineoplastic,5/14/2021,2/21/2021,Intravenous,oxaliplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/18/2025,,antineoplastic,7/23/2019,2/2/2019,Intravenous,pembrolizumab,TRUE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,4/18/2024,mL,solution-fluid,3/18/2024,3/21/2024,Intravenous,pembrolizumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/14/2024,mg,antineoplastic,9/27/2022,12/21/2021,Intravenous,durvalumab,FALSE
180,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/29/2016,AUC,antineoplastic,9/11/2016,6/13/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,9/24/2020,mg,antineoplastic,7/21/2020,7/15/2020,Intravenous,paclitaxel protein-bound,FALSE
376,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,11/4/2011,mg,antineoplastic,12/14/2011,7/25/2011,Intravenous,paclitaxel,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,10/29/2018,mg,antineoplastic,11/9/2016,10/1/2016,Intravenous,carboplatin,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/26/2018,mg,antineoplastic,9/22/2018,7/3/2018,Intravenous,etoposide,FALSE
200,2,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,7/28/2023,mg,antineoplastic,5/15/2023,5/27/2023,Intravenous,pembrolizumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/5/2015,mg,antineoplastic,3/15/2014,1/17/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/15/2021,mg,antineoplastic,6/3/2021,5/23/2021,Intravenous,etoposide,FALSE
110,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/25/2025,mg,antineoplastic,12/23/2024,8/21/2024,Intravenous,paclitaxel,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,11/10/2017,mg,antineoplastic,10/24/2017,9/12/2017,Intravenous,carboplatin,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,6/30/2023,mg,antineoplastic,5/23/2023,6/13/2023,Intravenous,paclitaxel,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/8/2025,mg,antineoplastic,12/10/2022,10/6/2022,Intravenous,pemetrexed,TRUE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,12/12/2017,mg,antineoplastic,11/24/2017,11/25/2017,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,11/8/2020,mg,antineoplastic,9/5/2020,9/1/2020,Intravenous,pemetrexed,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/8/2019,mg,antineoplastic,1/15/2019,6/30/2018,Other/Miscellaneous,fluorouracil,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/27/2025,mg,antineoplastic,8/27/2020,12/19/2016,Intravenous,pembrolizumab,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/20/2020,mg,antineoplastic,5/27/2020,6/14/2020,Intravenous,carboplatin,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/14/2016,mg,antineoplastic,7/21/2015,5/23/2015,Intravenous,bevacizumab,FALSE
670,1,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,8/28/2018,mg,antineoplastic,7/25/2017,10/14/2016,Intravenous,rituximab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G11F2659368B9,4/26/2025,,,4/12/2025,12/24/2023,Oral,osimertinib,FALSE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Irinotecan",G1D61871659DG,7/13/2012,mg/m2,antineoplastic,8/2/2012,7/24/2012,Intravenous,cetuximab,FALSE
145,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/18/2016,mg,antineoplastic,12/24/2015,11/13/2015,Intravenous,carboplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/2/2019,mg,antineoplastic,7/7/2019,10/22/2018,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,8/24/2019,mg,antineoplastic,3/2/2019,3/1/2019,Intravenous,nivolumab,FALSE
900,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G557E997E81G5,5/22/2023,mg,antineoplastic,5/12/2023,4/26/2023,Intravenous,ramucirumab,FALSE
166,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,1/18/2023,mg,antineoplastic,4/18/2022,2/28/2022,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/16/2025,mg,antineoplastic,12/21/2023,2/1/2023,Intravenous,pembrolizumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5:1C6DEC2:1:,12/2/2017,mg,antineoplastic,11/10/2017,11/7/2017,Intravenous,carboplatin,FALSE
372,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/29/2021,mg,antineoplastic,11/14/2020,11/9/2020,Intravenous,carboplatin,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/1/2024,mg,antineoplastic,12/1/2023,12/3/2023,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/13/2025,mg,antineoplastic,9/21/2024,6/27/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/22/2025,mg,antineoplastic,10/11/2023,5/21/2022,Intravenous,pembrolizumab,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,3/31/2025,mg/m2,antineoplastic,11/28/2024,12/1/2024,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,8/10/2020,,antineoplastic,6/14/2020,5/4/2020,Intravenous,pemetrexed,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/29/2011,mg,antineoplastic,8/28/2011,10/6/2011,Intravenous,etoposide,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/5/2015,,antineoplastic,12/18/2015,5/2/2015,Oral,ibrutinib,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G4GE2958C:E1C,4/13/2012,,steroid,9/16/2011,6/15/2011,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/4/2020,mg,antineoplastic,7/18/2018,6/28/2016,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/20/2015,mg,antineoplastic,12/18/2014,10/31/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/3/2025,mg,antineoplastic,9/27/2024,4/1/2020,Intravenous,pembrolizumab,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,5/11/2019,mg,antineoplastic,3/26/2019,12/11/2018,Intravenous,bevacizumab,TRUE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/18/2014,mg,antineoplastic,7/11/2014,7/3/2014,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1GEF44EBD419,8/6/2024,mg,antineoplastic,2/14/2024,3/8/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/23/2017,,antineoplastic,2/17/2017,3/20/2016,Intravenous,clinical study drug,FALSE
1040,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,6/18/2016,mg,antineoplastic,2/10/2015,1/14/2015,Intravenous,pemetrexed,FALSE
79,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,2/16/2023,mg,antineoplastic,10/14/2022,7/21/2022,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/15/2019,mg,antineoplastic,10/14/2018,1/12/2018,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/8/2020,mg,antineoplastic,5/11/2016,12/20/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/26/2020,,antineoplastic,9/15/2019,3/1/2019,Subcutaneous,bortezomib,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/21/2021,mg,antineoplastic,5/21/2019,12/6/2018,Intravenous,pemetrexed,TRUE
925,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/1/2015,mg,antineoplastic,6/22/2015,2/22/2015,Intravenous,pemetrexed,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/12/2016,mg,antineoplastic,8/12/2015,7/8/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,3/1/2022,mg,antineoplastic,11/13/2021,10/4/2021,Intravenous,pembrolizumab,FALSE
718,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/16/2024,mg,antineoplastic,3/4/2024,1/30/2024,Intravenous,carboplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/9/2019,mg,antineoplastic,1/23/2019,10/30/2018,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/12/2020,mg,antineoplastic,12/29/2017,7/2/2016,Intravenous,nivolumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/12/2025,mg,antineoplastic,10/1/2024,5/20/2024,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/26/2025,mg,antineoplastic,12/31/2024,10/19/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/9/2023,mg,antineoplastic,4/21/2022,9/14/2021,Intravenous,pembrolizumab,TRUE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,9/1/2022,mg,antineoplastic,5/10/2022,5/19/2022,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/20/2022,mg,antineoplastic,4/29/2022,4/16/2020,Intravenous,pembrolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,1/20/2024,mg,antineoplastic,12/26/2023,12/16/2023,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/10/2022,,antineoplastic,2/4/2022,2/8/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/2/2025,,antineoplastic,10/18/2023,2/12/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,3/16/2025,mg,antineoplastic,2/3/2025,8/11/2024,Intravenous,pembrolizumab,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/4/2019,mg/m2,antineoplastic,11/13/2018,10/13/2018,Intravenous,gemcitabine,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/24/2018,mg,antineoplastic,6/24/2018,4/17/2018,Intravenous,carboplatin,FALSE
129,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3CG5712E:B54,7/4/2024,mg,antineoplastic,5/22/2024,5/17/2024,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/28/2021,,antineoplastic,4/11/2021,3/19/2021,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,12/20/2012,mg,antineoplastic,11/12/2012,10/12/2012,Intravenous,bevacizumab,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/26/2024,mL,solution-fluid,10/5/2024,5/19/2024,Intravenous,pembrolizumab,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/30/2020,mg,antineoplastic,4/19/2020,2/26/2020,Intravenous,bevacizumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/28/2025,mg,antineoplastic,3/28/2024,3/22/2024,Intravenous,durvalumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/30/2022,mg,antineoplastic,6/15/2020,4/21/2020,Intravenous,pembrolizumab,FALSE
122,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G319D776C24D5,6/14/2021,mg,antineoplastic,4/23/2021,4/11/2021,Intravenous,cisplatin,FALSE
690,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/21/2015,mg,antineoplastic,4/7/2015,2/6/2015,Intravenous,carboplatin,FALSE
400,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,9/21/2022,mg,antineoplastic,9/22/2022,9/3/2022,Oral,bosutinib,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/17/2025,mg,antineoplastic,7/26/2023,7/21/2023,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/23/2019,mg,antineoplastic,1/19/2019,4/8/2016,Intravenous,nivolumab,FALSE
1100,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3:C9BECD3F55,12/21/2020,mg,antineoplastic,11/18/2020,8/20/2020,Intravenous,ramucirumab,FALSE
520,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/24/2024,mg,antineoplastic,5/1/2024,3/5/2024,Intravenous,carboplatin,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/11/2019,mg,antineoplastic,5/6/2019,10/13/2018,Intravenous,durvalumab,FALSE
475,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/18/2022,mg,antineoplastic,6/11/2021,6/29/2021,Intravenous,carboplatin,FALSE
318,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11DC:E9G171F,5/4/2020,mg,antineoplastic,5/21/2020,4/15/2020,Intravenous,paclitaxel,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/3/2024,mg,antineoplastic,7/9/2022,4/23/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2F5C96E2545B,7/18/2024,mg,antineoplastic,5/22/2024,4/12/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,5/8/2018,,antineoplastic,8/17/2017,5/21/2017,Intravenous,clinical study drug,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,11/22/2017,mg,antineoplastic,11/30/2017,8/17/2017,Intravenous,paclitaxel,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,2/24/2024,mg,antineoplastic,12/5/2023,1/21/2024,Intravenous,pemetrexed,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/2/2013,mg,antineoplastic,10/6/2013,11/22/2012,Intravenous,gemcitabine,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,5/19/2024,mg,antineoplastic,2/9/2024,5/31/2023,Intravenous,pembrolizumab,FALSE
116,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/8/2015,mg,antineoplastic,11/22/2014,7/25/2014,Intravenous,paclitaxel,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253D7G:9C8CE,8/7/2014,mg,antineoplastic,6/17/2014,5/31/2014,Intravenous,pemetrexed,TRUE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/12/2021,mg,antineoplastic,6/15/2021,10/23/2020,Intravenous,durvalumab,FALSE
686,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,5/23/2012,mg,antineoplastic,5/22/2012,5/1/2012,Intravenous,carboplatin,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/2/2024,mg,antineoplastic,3/15/2024,10/23/2023,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,1/20/2025,,,10/25/2024,10/31/2024,Oral,lorlatinib,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/2/2019,mg,antineoplastic,8/7/2018,3/22/2017,Intravenous,pemetrexed,TRUE
1000,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,1/11/2017,mg,antineoplastic,1/17/2017,11/5/2016,Intravenous,pemetrexed,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,5/31/2020,mg,antineoplastic,6/14/2020,2/16/2019,Subcutaneous,bortezomib,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/17/2024,mg,antineoplastic,8/22/2022,4/9/2022,Intravenous,durvalumab,TRUE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/28/2025,mg,antineoplastic,2/13/2024,10/28/2022,Intravenous,pemetrexed,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/16/2025,mg,antineoplastic,4/13/2025,2/25/2024,Intravenous,pembrolizumab,FALSE
629,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/2/2022,mg,antineoplastic,5/14/2022,5/12/2022,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,4/18/2024,mg,antineoplastic,8/21/2020,8/4/2020,Intravenous,nivolumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/2/2016,mg,antineoplastic,12/28/2015,4/19/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,1/22/2025,mg,antineoplastic,12/20/2024,10/22/2024,Intravenous,pembrolizumab,FALSE
95,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/25/2017,mg,antineoplastic,2/11/2017,9/22/2016,Intravenous,cisplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/28/2021,mg,antineoplastic,10/16/2020,9/12/2020,Oral,bicalutamide,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/25/2021,mg,antineoplastic,5/30/2021,4/22/2021,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G344BC2:6BGE1,5/19/2012,,antineoplastic,3/9/2012,10/24/2011,Intravenous,clinical study drug,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/28/2011,mg,antineoplastic,8/29/2011,9/7/2011,Intravenous,etoposide,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/14/2025,mg,antineoplastic,12/30/2017,9/9/2016,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G217694659D6F,7/2/2022,,,5/4/2021,5/12/2021,Oral,alectinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/25/2023,mg,antineoplastic,3/23/2023,3/2/2023,Intravenous,pembrolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/2/2024,mg,antineoplastic,3/23/2022,1/15/2022,Intravenous,nivolumab,TRUE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/18/2020,mg,antineoplastic,2/18/2020,8/30/2019,Intravenous,durvalumab,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,5/27/2019,mg/m2,antineoplastic,6/10/2019,4/18/2019,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/20/2020,,antineoplastic,4/28/2018,11/14/2016,Intravenous,nivolumab,FALSE
1010,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,10/25/2021,mg,antineoplastic,8/14/2021,8/19/2021,Intravenous,pemetrexed,FALSE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,9/11/2024,mg,antineoplastic,6/27/2024,5/26/2024,Intravenous,pemetrexed,FALSE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/27/2023,mg,antineoplastic,11/16/2022,11/6/2022,Intravenous,carboplatin,FALSE
489,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,7/14/2023,mg,antineoplastic,3/24/2023,3/18/2023,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/4/2012,mg,antineoplastic,4/8/2012,2/26/2012,Intravenous,carboplatin,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G2:5874817G9C,10/10/2024,AUC,antineoplastic,9/9/2024,7/6/2024,Intravenous,carboplatin,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,11/1/2015,mg,antineoplastic,8/24/2015,7/2/2015,Intravenous,paclitaxel,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/2/2023,mg,antineoplastic,4/6/2022,2/26/2022,Intravenous,paclitaxel,FALSE
910,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,6/23/2016,mg,antineoplastic,4/21/2016,3/25/2016,Intravenous,pemetrexed,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/5/2020,mg,antineoplastic,9/9/2019,9/10/2019,Intravenous,paclitaxel,FALSE
1125,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,4/11/2025,mg,antineoplastic,5/12/2024,4/15/2024,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/31/2017,mg,antineoplastic,2/16/2017,8/14/2016,Intravenous,nivolumab,FALSE
,3,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,12/28/2021,,,10/15/2021,9/4/2021,Oral,osimertinib,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/13/2022,mL,solution-fluid,3/20/2022,2/4/2022,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/31/2024,mL,solution-fluid,3/10/2024,3/16/2024,Intravenous,pemetrexed,FALSE
1055,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/8/2016,mg,antineoplastic,3/22/2015,4/13/2015,Intravenous,pemetrexed,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/29/2023,mg,antineoplastic,1/31/2023,8/30/2022,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/4/2020,mg,antineoplastic,12/17/2018,1/16/2018,Intravenous,pembrolizumab,TRUE
1590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/14/2013,mg,antineoplastic,8/8/2013,10/18/2012,Intravenous,gemcitabine,FALSE
234,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,6/7/2016,mg,antineoplastic,3/22/2016,12/8/2015,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/13/2025,mg,antineoplastic,6/9/2023,2/4/2023,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/31/2018,mg/m2,antineoplastic,10/1/2017,10/6/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G3B1F6B561ED5,3/11/2021,,hematological agent,10/23/2020,2/1/2020,Subcutaneous,clinical study drug,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/18/2024,mg,antineoplastic,4/27/2024,3/11/2024,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/23/2015,mg,antineoplastic,3/12/2015,11/16/2014,Intravenous,pemetrexed,FALSE
43,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/8/2023,mg,antineoplastic,12/23/2022,9/29/2022,Intravenous,leucovorin,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/24/2014,mg,antineoplastic,7/31/2014,8/24/2014,Intravenous,paclitaxel,FALSE
43.6,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/10/2023,mg,antineoplastic,10/11/2022,9/21/2022,Intravenous,leucovorin,FALSE
351,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,7/10/2024,mg,antineoplastic,5/6/2024,3/17/2024,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/23/2015,mg,antineoplastic,1/31/2015,1/25/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/13/2021,,antineoplastic,5/28/2021,3/24/2021,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/23/2019,mg,antineoplastic,10/6/2017,5/16/2017,Intravenous,nivolumab,FALSE
1100,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,7/13/2017,mg,antineoplastic,6/22/2017,4/29/2017,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/7/2022,mg,antineoplastic,11/14/2021,1/23/2016,Intravenous,pemetrexed,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,8/16/2016,mg,antineoplastic,7/22/2016,7/16/2016,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/4/2016,,,9/1/2016,5/26/2016,Oral,afatinib,FALSE
,4,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,6/17/2023,,antineoplastic,3/19/2023,1/5/2023,Intravenous,pemetrexed,FALSE
92,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2CCC3642E:67,2/10/2020,mg,antineoplastic,2/12/2020,3/17/2020,Intravenous,docetaxel,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/19/2017,mg,antineoplastic,3/27/2016,3/5/2015,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/8/2025,mg,antineoplastic,11/21/2018,4/26/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G24C:63G27686,1/11/2014,,solution-fluid,1/17/2014,12/6/2013,Intravenous,clinical study drug,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,9/2/2020,mg,antineoplastic,6/25/2020,7/2/2020,Subcutaneous,azacitidine,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,11/30/2017,,antineoplastic,1/9/2017,5/2/2016,Intramuscular,fulvestrant,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/4/2023,mg,antineoplastic,1/18/2023,7/24/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,3/6/2020,,antineoplastic,1/21/2020,2/7/2020,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/20/2021,mg,antineoplastic,6/29/2021,6/9/2021,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/28/2014,mg,antineoplastic,7/31/2014,7/16/2014,Intravenous,carboplatin,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/10/2022,mg,antineoplastic,1/27/2022,10/29/2021,Intravenous,fluorouracil,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,4/1/2025,mg,antineoplastic,1/24/2025,1/1/2025,Intravenous,cisplatin,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/8/2025,AUC,antineoplastic,11/28/2024,9/26/2024,Intravenous,carboplatin,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/22/2016,mg,antineoplastic,5/23/2016,4/8/2016,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/8/2025,mg,antineoplastic,7/19/2024,9/28/2023,Intravenous,atezolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/19/2018,mg,antineoplastic,10/26/2017,5/4/2017,Intravenous,pemetrexed,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/29/2024,mg,antineoplastic,4/23/2022,6/18/2020,Intravenous,nivolumab,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/10/2014,mg,antineoplastic,1/5/2014,11/30/2013,Intravenous,cisplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/21/2016,mg,antineoplastic,3/12/2014,12/12/2013,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/22/2021,mg,antineoplastic,6/29/2019,12/25/2018,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/31/2020,mg,antineoplastic,12/26/2016,6/21/2016,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/20/2013,mg,antineoplastic,8/17/2013,2/6/2013,Intravenous,bevacizumab,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/17/2022,mg,antineoplastic,7/30/2022,7/8/2022,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,4/9/2020,mg,antineoplastic,9/10/2018,8/13/2018,Intravenous,durvalumab,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/3/2021,mg,antineoplastic,9/22/2021,8/12/2021,Intravenous,paclitaxel,FALSE
1144,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1E586G415EF7,2/27/2016,mg,antineoplastic,3/11/2016,2/9/2016,Intravenous,bevacizumab,FALSE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/7/2016,mg,antineoplastic,2/3/2016,4/18/2015,Intravenous,gemcitabine,FALSE
424,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,1/1/2015,mg,antineoplastic,10/28/2014,10/26/2014,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/25/2021,mL,solution-fluid,5/29/2021,3/31/2021,Intravenous,carboplatin,FALSE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/25/2013,mg,antineoplastic,4/16/2013,4/9/2013,Intravenous,carboplatin,FALSE
64,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,4/4/2024,mg,antineoplastic,11/6/2023,11/2/2023,Intravenous,ipilimumab,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/15/2019,mg,antineoplastic,9/17/2018,6/13/2018,Other/Miscellaneous,fluorouracil,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/29/2025,mg,antineoplastic,12/27/2024,11/2/2024,Intravenous,nivolumab,TRUE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/30/2019,mg,antineoplastic,10/6/2019,10/17/2019,Intravenous,docetaxel,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/14/2021,mg,antineoplastic,11/27/2021,9/22/2021,Intravenous,paclitaxel,FALSE
555,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1532797B869C,9/15/2023,mg,antineoplastic,7/16/2023,6/30/2023,Intravenous,ramucirumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/18/2017,,antineoplastic,7/9/2017,7/27/2017,,paclitaxel,FALSE
446.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/27/2020,mg,antineoplastic,5/11/2020,2/13/2020,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/18/2020,mg,antineoplastic,4/27/2014,3/2/2014,Intravenous,rituximab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/3/2020,mg,antineoplastic,11/24/2019,1/5/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,4/23/2021,mg,antineoplastic,12/13/2020,9/18/2020,Intravenous,pembrolizumab,TRUE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/6/2020,mg,antineoplastic,1/25/2020,9/28/2019,Intravenous,durvalumab,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,1/26/2022,mg,antineoplastic,11/15/2021,10/12/2021,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/11/2019,mg,antineoplastic,6/5/2019,3/1/2019,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/7/2022,mg,antineoplastic,3/19/2022,3/25/2021,Intravenous,durvalumab,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,5/26/2024,mg,antineoplastic,5/22/2024,4/30/2023,Intravenous,pembrolizumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/6/2023,mg,antineoplastic,1/25/2022,1/18/2020,Intravenous,pembrolizumab,FALSE
64,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,4/1/2024,mg,antineoplastic,2/2/2024,10/16/2023,Intravenous,ipilimumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/23/2018,,antineoplastic,1/22/2018,1/30/2018,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,4/21/2025,mg,antineoplastic,3/2/2025,10/22/2024,Intravenous,durvalumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/1/2015,mg,antineoplastic,5/23/2014,12/27/2013,Intravenous,paclitaxel,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/1/2016,mg,antineoplastic,9/6/2015,5/13/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/1/2020,mg,antineoplastic,8/27/2018,12/19/2017,Intravenous,pembrolizumab,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/8/2013,mg,antineoplastic,8/5/2012,1/15/2012,Intravenous,etoposide,FALSE
92,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,2/11/2012,mg,antineoplastic,11/26/2011,12/22/2011,Intravenous,paclitaxel,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/24/2015,mg,antineoplastic,3/13/2015,3/17/2015,Intravenous,cisplatin,FALSE
96.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,3/14/2015,mg,antineoplastic,1/4/2015,12/27/2014,Intravenous,carboplatin,FALSE
565,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G126:384BC665,3/23/2015,mg,antineoplastic,3/3/2015,2/16/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/29/2025,mg,antineoplastic,7/25/2023,4/27/2022,Intravenous,pembrolizumab,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/30/2019,mg,antineoplastic,11/16/2018,6/28/2018,Other/Miscellaneous,fluorouracil,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,4/23/2015,mg,antineoplastic,4/26/2015,5/1/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,7/24/2012,,antineoplastic,3/28/2012,4/15/2012,,clinical study drug,FALSE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/25/2023,mg,antineoplastic,4/22/2023,5/2/2023,Intravenous,carboplatin,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/1/2018,AUC,antineoplastic,9/27/2017,9/3/2017,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,6/26/2017,mg/m2,antineoplastic,6/7/2017,6/8/2017,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/7/2019,mg,antineoplastic,2/17/2019,9/24/2018,Intravenous,carboplatin,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,1/12/2016,mg,antineoplastic,12/1/2015,10/9/2015,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/29/2023,mg,antineoplastic,5/31/2023,4/21/2023,Intravenous,tremelimumab-actl,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,2/28/2019,mg,antineoplastic,6/17/2018,3/21/2018,Intravenous,docetaxel,FALSE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/12/2013,mg,antineoplastic,5/23/2013,2/23/2013,Intravenous,bevacizumab,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,12/25/2019,mg,antineoplastic,7/24/2019,4/22/2019,Intravenous,ramucirumab,FALSE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,12/23/2017,mg,antineoplastic,6/19/2016,6/6/2016,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,2/28/2025,mg,antineoplastic,7/11/2019,3/6/2018,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/5/2017,mg,antineoplastic,10/12/2017,6/30/2017,Intravenous,carboplatin,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/31/2020,mg,antineoplastic,7/13/2018,3/16/2017,Intravenous,bevacizumab,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/22/2016,mg,antineoplastic,6/3/2015,10/19/2014,Intravenous,pemetrexed,TRUE
770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,3/12/2013,mg,antineoplastic,4/28/2013,2/23/2013,Intravenous,pemetrexed,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,1/12/2022,mg,antineoplastic,9/16/2021,9/20/2021,Intravenous,paclitaxel,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,3/27/2021,mg,antineoplastic,2/9/2021,10/17/2020,Intravenous,pemetrexed,FALSE
242.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,5/29/2023,mg,antineoplastic,4/12/2023,4/24/2023,Intravenous,carboplatin,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/16/2024,mg,antineoplastic,3/20/2024,3/3/2024,Intravenous,gemcitabine,FALSE
411,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/9/2020,mg,antineoplastic,5/20/2020,5/1/2020,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/30/2023,mg,antineoplastic,12/26/2022,12/6/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/15/2014,mg/m2,antineoplastic,4/9/2014,4/28/2014,Intravenous,paclitaxel,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,5/5/2020,mg,antineoplastic,1/17/2020,10/21/2019,Intravenous,durvalumab,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,9/14/2024,mg,antineoplastic,4/29/2024,4/26/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/23/2019,mg,antineoplastic,1/26/2019,1/10/2019,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/24/2014,mg,antineoplastic,7/16/2014,4/3/2014,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G118F63B281FD,6/19/2011,,antineoplastic,5/11/2011,4/23/2011,,clinical study drug,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G57G45B:D1F17,1/28/2025,,antineoplastic,12/9/2017,10/22/2017,Oral,clinical study drug,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/28/2016,mg,antineoplastic,4/4/2016,3/4/2016,Intravenous,cisplatin,FALSE
54,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,3/13/2025,mg,antineoplastic,2/12/2025,9/3/2024,Intravenous,ipilimumab,FALSE
1325,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,9/4/2015,mg,antineoplastic,3/22/2015,1/10/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/14/2025,mg,antineoplastic,6/25/2024,5/30/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,Osimertinib,G44785496DGE9,4/6/2025,,,1/5/2025,8/15/2024,Oral,osimertinib,FALSE
80,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,2/11/2025,mg,antineoplastic,9/26/2024,8/31/2024,Intravenous,ipilimumab,TRUE
880,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,5/8/2020,mg,antineoplastic,1/14/2020,10/26/2019,Intravenous,pemetrexed,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/10/2015,mg,antineoplastic,5/28/2014,1/8/2014,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/18/2025,mg,antineoplastic,10/17/2024,12/6/2023,Intravenous,pembrolizumab,FALSE
40,7,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G4C53C5GC48E:,12/1/2016,mg,antineoplastic,10/31/2016,10/24/2016,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/25/2021,mg,antineoplastic,12/9/2018,11/12/2018,Intravenous,pembrolizumab,TRUE
255,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,8/10/2016,mg,antineoplastic,5/24/2016,5/8/2016,Intravenous,nivolumab,FALSE
795,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/18/2020,mg,antineoplastic,1/28/2019,11/24/2018,Intravenous,pemetrexed,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/24/2024,mg,antineoplastic,12/27/2023,1/13/2024,Intravenous,paclitaxel,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3C98:B743F7B,6/17/2014,mg/m2,antineoplastic,7/23/2013,7/14/2013,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4DE3DE99E:13,11/3/2015,mg,antineoplastic,10/19/2015,9/16/2015,Intravenous,pembrolizumab,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,2/5/2023,mg,antineoplastic,12/22/2022,7/28/2022,Intravenous,durvalumab,TRUE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,10/25/2024,mg,antineoplastic,8/1/2024,10/21/2023,Intravenous,durvalumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/27/2016,AUC,antineoplastic,8/18/2016,5/31/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/17/2023,mg,antineoplastic,8/28/2022,4/15/2022,Intravenous,pembrolizumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/29/2024,mg,antineoplastic,10/26/2023,7/1/2023,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/20/2019,mg,antineoplastic,7/7/2017,6/17/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/9/2024,mg,antineoplastic,9/8/2021,6/4/2020,Intravenous,pembrolizumab,TRUE
865,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,8/8/2023,mg,antineoplastic,5/22/2023,5/10/2023,Intravenous,pemetrexed,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,11/1/2019,mg,antineoplastic,7/12/2019,8/21/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/6/2019,,antineoplastic,2/26/2019,8/9/2018,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/16/2022,mg,antineoplastic,8/2/2022,5/28/2022,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/14/2025,mg,antineoplastic,8/17/2024,7/14/2024,Intravenous,pemetrexed,FALSE
1750,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/8/2025,mg,antineoplastic,2/28/2025,2/5/2025,Intravenous,amivantamab-vmjw,FALSE
45,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G57DE72B664E8,7/27/2012,mg,antineoplastic,7/14/2012,8/12/2012,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G149B7C41:236,7/17/2023,,antineoplastic,5/2/2023,6/21/2023,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/2/2018,mg,antineoplastic,10/16/2015,9/9/2015,Intravenous,nivolumab,FALSE
740,,ADJUVANT,Administrations,targeted/biologic,Rituximab-Arrx,G2GDF48F:5EGB,9/26/2024,mg,antineoplastic,10/4/2024,9/29/2024,Intravenous,rituximab-arrx,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,3/14/2023,mg,antineoplastic,10/10/2022,11/7/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/10/2025,mg,antineoplastic,9/28/2023,8/24/2022,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/8/2020,mg,antineoplastic,5/18/2018,8/3/2016,Intravenous,nivolumab,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,2/5/2018,mg,antineoplastic,7/5/2016,7/8/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/2/2022,,antineoplastic,11/19/2021,9/22/2021,Intravenous,carboplatin,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/25/2022,mg,antineoplastic,9/12/2021,8/29/2021,Intravenous,amivantamab-vmjw,FALSE
276,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,8/25/2020,mg,antineoplastic,8/5/2020,6/25/2020,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/11/2015,mg,antineoplastic,12/2/2014,8/26/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/16/2018,,antineoplastic,6/10/2015,6/29/2015,,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/16/2025,mg,antineoplastic,2/10/2025,6/19/2023,Intravenous,pembrolizumab,TRUE
340,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,3/16/2013,mg,antineoplastic,1/14/2013,1/7/2013,Intravenous,carboplatin,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/6/2016,mg,antineoplastic,10/19/2014,9/4/2014,Intravenous,bevacizumab,TRUE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/28/2024,mg,antineoplastic,9/10/2024,7/15/2024,Intravenous,cisplatin,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/21/2016,mg,antineoplastic,11/11/2015,6/8/2015,Intravenous,nivolumab,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/3/2015,mg,antineoplastic,10/29/2014,8/15/2014,Intravenous,paclitaxel,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/10/2022,mg,antineoplastic,11/18/2021,9/18/2021,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/11/2022,mg,antineoplastic,4/26/2022,6/28/2021,Intravenous,pembrolizumab,FALSE
1137,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/24/2023,mg,antineoplastic,4/8/2023,4/11/2023,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,6/19/2019,mg,antineoplastic,4/23/2019,3/12/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/7/2023,mg,antineoplastic,3/31/2022,3/9/2022,Intravenous,pembrolizumab,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/15/2020,mg,antineoplastic,11/28/2019,1/14/2019,Subcutaneous,bortezomib,FALSE
835,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G161297FC6EC1,12/8/2014,mg,antineoplastic,1/8/2015,11/2/2014,Intravenous,pemetrexed,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/6/2019,mg,antineoplastic,8/19/2018,6/14/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/21/2025,mg,antineoplastic,9/20/2023,9/8/2022,Intravenous,pembrolizumab,TRUE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/25/2012,mg,antineoplastic,12/18/2011,12/8/2011,Intravenous,paclitaxel protein-bound,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/7/2025,mg,antineoplastic,12/13/2022,2/16/2019,Intravenous,pemetrexed,FALSE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/2/2015,mg,antineoplastic,7/23/2015,6/13/2015,Intravenous,paclitaxel,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,7/7/2023,mg,antineoplastic,4/18/2023,3/10/2023,Intravenous,paclitaxel,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,9/17/2014,mg,antineoplastic,10/1/2014,6/24/2014,Intravenous,pemetrexed,FALSE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/16/2019,mg,antineoplastic,10/31/2019,10/20/2019,Intravenous,docetaxel,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/15/2015,mg,antineoplastic,11/25/2014,10/16/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/10/2022,mg,antineoplastic,9/29/2020,1/26/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1B:1G86333FB,7/16/2020,,,2/4/2019,2/25/2019,Oral,osimertinib,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,11/14/2023,mg,antineoplastic,4/3/2023,2/19/2023,Intravenous,rituximab-arrx,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/24/2022,mg,antineoplastic,12/6/2018,12/13/2017,Intravenous,pembrolizumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/13/2016,mg,antineoplastic,4/13/2015,10/13/2014,Intravenous,bevacizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/28/2022,mg/m2,antineoplastic,3/14/2021,4/17/2020,Intravenous,pemetrexed,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/30/2016,mg,antineoplastic,11/14/2016,8/6/2016,Intravenous,necitumumab,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,3/2/2021,mg,antineoplastic,2/2/2021,11/21/2020,Intravenous,paclitaxel,FALSE
15,3,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,11/28/2014,mg/kg,antineoplastic,11/3/2014,10/5/2014,Intravenous,bevacizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/4/2024,mg,antineoplastic,3/24/2024,11/18/2022,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,7/15/2023,mg,antineoplastic,6/25/2023,1/29/2023,Intravenous,durvalumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/28/2025,mg,antineoplastic,10/5/2023,7/22/2023,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,6/17/2020,mg,antineoplastic,6/2/2020,4/13/2020,Intravenous,pembrolizumab,FALSE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/27/2022,mg,antineoplastic,3/30/2022,1/24/2022,Intravenous,nivolumab,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/10/2019,mg,antineoplastic,8/3/2019,5/29/2019,Intravenous,paclitaxel protein-bound,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/16/2019,mg,antineoplastic,4/11/2016,4/5/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/6/2025,,antineoplastic,9/14/2024,2/15/2023,,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/10/2020,mg,antineoplastic,10/29/2016,3/9/2016,Intravenous,bevacizumab,TRUE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,9/7/2016,mg,antineoplastic,8/18/2016,8/2/2016,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/21/2015,mg,antineoplastic,12/9/2014,11/2/2014,Intravenous,carboplatin,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/31/2017,mg,antineoplastic,3/21/2017,1/4/2017,Intravenous,paclitaxel,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,8/22/2021,mg,antineoplastic,5/17/2021,5/12/2021,Intravenous,paclitaxel,FALSE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/26/2024,mg,antineoplastic,8/11/2024,8/19/2024,Intravenous,paclitaxel,FALSE
347.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,10/15/2019,mg,antineoplastic,8/2/2019,7/11/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,9/6/2024,mg,antineoplastic,8/4/2024,6/14/2024,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/18/2019,mg,antineoplastic,9/21/2018,8/28/2017,Intravenous,atezolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/25/2024,mg,antineoplastic,4/18/2024,2/16/2023,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,10/24/2020,mg,antineoplastic,9/28/2020,8/21/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G3::1:B4F:3D4,7/2/2015,,,6/20/2015,5/25/2014,Oral,erlotinib,TRUE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/9/2017,mg,antineoplastic,3/9/2017,11/9/2016,Intravenous,docetaxel,FALSE
840,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G24365CF6:6G7,3/16/2014,mg,antineoplastic,3/15/2014,3/19/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Docetaxel,Ipilimumab,Nivolumab",G1C679D8145C1,4/29/2022,,antineoplastic,6/3/2022,4/20/2022,Intravenous,nivolumab,FALSE
133,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G2628C28G7613,3/30/2016,mg,antineoplastic,4/4/2016,5/1/2016,Intravenous,nivolumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,10/28/2018,mg,antineoplastic,9/23/2016,8/27/2016,Intravenous,paclitaxel,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/2/2019,mg/m2,antineoplastic,5/18/2019,4/1/2019,Intravenous,etoposide,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/23/2018,mg,antineoplastic,7/13/2015,7/22/2015,Intravenous,paclitaxel,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/19/2019,mg,antineoplastic,2/25/2019,10/9/2018,Intravenous,durvalumab,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,7/28/2017,mg,antineoplastic,10/14/2016,9/29/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/28/2019,,antineoplastic,9/24/2019,10/5/2019,,paclitaxel protein-bound,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/18/2016,mg,antineoplastic,5/11/2014,6/14/2014,Intravenous,carboplatin,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/1/2016,mg,antineoplastic,5/4/2015,4/30/2015,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/13/2023,,antineoplastic,11/2/2023,12/8/2022,,pemetrexed,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,5/31/2024,mg,antineoplastic,3/28/2024,2/13/2024,Intravenous,pemetrexed,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/16/2022,mg,antineoplastic,12/23/2021,8/25/2021,Intravenous,paclitaxel,FALSE
263,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/22/2015,mg,antineoplastic,8/1/2015,1/14/2015,Intravenous,carboplatin,FALSE
238,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,2/26/2024,mg,antineoplastic,2/25/2024,11/22/2023,Intravenous,paclitaxel,FALSE
524,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,3/18/2023,mg,antineoplastic,11/19/2022,11/4/2022,Intravenous,carboplatin,FALSE
486,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45DDGFC1G86F,11/15/2015,mg,antineoplastic,10/9/2015,12/7/2015,Intravenous,carboplatin,FALSE
90,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G54F545489E59,11/9/2023,mg,antineoplastic,4/9/2023,2/19/2023,Intravenous,docetaxel,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3DGG1C5C452:,3/21/2019,mg,antineoplastic,4/3/2019,2/3/2019,Intravenous,durvalumab,FALSE
660,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/25/2023,mg,antineoplastic,12/30/2022,10/19/2021,Intravenous,rituximab-pvvr,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,4/23/2024,,antineoplastic,8/16/2023,5/13/2023,Intravenous,clinical study drug,FALSE
495.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/25/2015,mg,antineoplastic,10/14/2014,10/12/2014,Intravenous,carboplatin,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/8/2025,mg,antineoplastic,12/8/2024,11/28/2024,Intravenous,etoposide,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/28/2023,mg,antineoplastic,4/15/2023,11/29/2022,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/8/2025,mg,antineoplastic,9/26/2019,3/21/2018,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,"Letrozole,Osimertinib",G31G19E54FC:B,9/28/2023,,antineoplastic,3/9/2023,10/22/2020,Oral,letrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,5/19/2019,mg,antineoplastic,3/11/2019,1/8/2019,Intravenous,pembrolizumab,FALSE
228,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,11/28/2021,mg,antineoplastic,11/17/2021,10/26/2021,Intravenous,carboplatin,FALSE
600,3,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/13/2019,mg,antineoplastic,8/27/2019,7/5/2019,Intravenous,leucovorin,FALSE
,3,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3EC5EB18C676,6/18/2018,,antineoplastic,3/31/2018,1/20/2018,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,10/29/2022,mg,antineoplastic,2/23/2018,1/19/2018,Intravenous,pembrolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,3/16/2024,mg,antineoplastic,2/11/2024,12/22/2023,Intravenous,paclitaxel,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/18/2020,mg,antineoplastic,9/27/2019,9/7/2019,Intravenous,durvalumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/28/2014,mg,antineoplastic,4/29/2014,2/28/2014,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/8/2014,AUC,antineoplastic,4/21/2014,3/24/2014,Intravenous,carboplatin,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/20/2020,mg,antineoplastic,11/1/2017,3/15/2017,Intravenous,bevacizumab,FALSE
1272,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Erlotinib",G168G1C789D7C,3/1/2014,mg,antineoplastic,1/29/2014,3/13/2014,Intravenous,bevacizumab,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/15/2020,mg,antineoplastic,2/9/2020,2/29/2020,Intravenous,bevacizumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/4/2024,mg,antineoplastic,11/8/2022,12/9/2021,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,4/29/2025,,antineoplastic,1/14/2025,9/27/2024,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,9/14/2019,mg,antineoplastic,9/25/2018,8/15/2018,Intravenous,nivolumab,FALSE
80,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,12/30/2024,mg,antineoplastic,1/8/2025,9/26/2024,Intravenous,ipilimumab,TRUE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/18/2015,mg,antineoplastic,2/19/2015,9/21/2014,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/26/2024,mg,antineoplastic,6/12/2024,5/3/2024,Intravenous,pembrolizumab,FALSE
170,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G44B44661:316,3/31/2016,mg,antineoplastic,3/9/2016,2/23/2016,Intravenous,nivolumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/9/2015,mg,antineoplastic,4/15/2014,1/20/2014,Intravenous,carboplatin,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/7/2014,mg/kg,antineoplastic,2/8/2014,12/22/2013,Intravenous,bevacizumab,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/20/2021,mg/kg,antineoplastic,7/14/2021,3/21/2021,Intravenous,bevacizumab-awwb,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/13/2022,mg,antineoplastic,10/7/2021,2/16/2021,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,2/24/2025,,antineoplastic,3/26/2023,3/13/2022,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/21/2025,mg,antineoplastic,2/27/2024,7/13/2021,Intravenous,atezolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,5/23/2019,mg,antineoplastic,5/18/2019,12/25/2018,Intravenous,pembrolizumab,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,11/22/2023,mg,antineoplastic,7/14/2023,6/11/2023,Intravenous,pemetrexed,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,2/10/2025,mg/m2,antineoplastic,12/8/2024,12/14/2024,Intravenous,paclitaxel,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/24/2014,mg,antineoplastic,12/20/2012,9/7/2012,Intravenous,gemcitabine,FALSE
585,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/16/2017,mg,antineoplastic,2/16/2017,10/22/2016,Intravenous,bevacizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,12/2/2020,mg,antineoplastic,4/30/2014,3/17/2014,Intravenous,rituximab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,3/27/2025,,steroid,4/20/2025,12/4/2024,Intravenous,clinical study drug,FALSE
217.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,10/2/2013,mg,antineoplastic,4/25/2013,4/23/2013,Intravenous,carboplatin,FALSE
1870,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G24632:D18158,3/15/2020,mg,antineoplastic,12/31/2019,12/14/2019,Intravenous,gemcitabine,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Docetaxel",G3D59288727DB,4/4/2019,mL,solution-fluid,2/25/2019,1/28/2019,Intravenous,cisplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/10/2024,mL,solution-fluid,2/1/2024,1/20/2024,Intravenous,cisplatin,FALSE
592,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,1/3/2014,mg,antineoplastic,11/15/2013,10/14/2013,Intravenous,pemetrexed,FALSE
232.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/5/2017,mg,antineoplastic,8/7/2017,8/4/2017,Intravenous,carboplatin,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,1/31/2025,mg,antineoplastic,12/2/2024,10/26/2024,Intravenous,etoposide,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/16/2023,mg,antineoplastic,12/11/2022,9/30/2022,Intravenous,bevacizumab-bvzr,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,4/30/2021,mg,antineoplastic,12/17/2020,12/10/2020,Intravenous,gemcitabine,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/9/2012,mg,antineoplastic,5/27/2012,5/20/2012,Intravenous,paclitaxel,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/14/2016,mg/m2,antineoplastic,8/7/2016,6/10/2016,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/3/2016,mg,antineoplastic,1/8/2016,5/15/2015,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/10/2025,mg,antineoplastic,6/25/2019,3/10/2019,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,4/30/2024,mL,solution-fluid,4/28/2024,4/19/2024,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/5/2021,mg,antineoplastic,7/4/2019,5/5/2019,Intravenous,nivolumab,FALSE
100,5,ADVANCED,Administrations,solution-fluid,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/20/2025,mL,solution-fluid,2/14/2025,1/30/2025,Intravenous,pembrolizumab,FALSE
920,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G168G1C789D7C,6/10/2013,mg,antineoplastic,5/4/2013,4/19/2013,Intravenous,pemetrexed,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/18/2025,mg,antineoplastic,9/23/2019,3/26/2019,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/21/2019,mL,solution-fluid,10/4/2017,8/11/2017,Intravenous,etoposide,FALSE
1320,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G46:87GF7FGC9,7/19/2015,mg,antineoplastic,5/25/2015,3/21/2015,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,6/11/2024,mg,antineoplastic,3/3/2024,1/27/2024,Intravenous,pembrolizumab,FALSE
920,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G168G1C789D7C,7/24/2013,mg,antineoplastic,6/28/2013,5/16/2013,Intravenous,pemetrexed,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,3/30/2016,mg,antineoplastic,1/22/2016,1/18/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/8/2025,mg,antineoplastic,1/17/2025,9/18/2022,Intravenous,pembrolizumab,TRUE
3000,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/24/2020,mg,antineoplastic,11/16/2020,11/15/2020,Intravenous,fluorouracil,FALSE
373,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,7/19/2014,mg,antineoplastic,6/3/2014,5/18/2014,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/9/2020,mg,antineoplastic,12/28/2016,8/9/2016,Intravenous,nivolumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,4/16/2016,mg,antineoplastic,1/25/2016,10/27/2015,Intravenous,paclitaxel protein-bound,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/1/2025,mL,solution-fluid,11/10/2024,6/7/2024,Intravenous,pembrolizumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,6/21/2017,mg,antineoplastic,1/6/2017,11/27/2016,Intravenous,nivolumab,FALSE
235,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/1/2016,mg,antineoplastic,5/1/2016,11/12/2015,Intravenous,nivolumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G4F354B:F341F,9/11/2017,,antineoplastic,8/10/2017,7/19/2017,Intravenous,docetaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/17/2021,mg,antineoplastic,9/13/2021,8/11/2021,Intravenous,paclitaxel protein-bound,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/2/2014,AUC,antineoplastic,8/14/2013,10/11/2012,Intravenous,carboplatin,FALSE
345,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GDCB:FF9G:1,4/21/2016,mg,antineoplastic,2/11/2016,2/26/2016,Intravenous,nivolumab,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/27/2024,mg,antineoplastic,12/28/2023,10/6/2023,Intravenous,durvalumab,TRUE
606,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,4/19/2025,mg,antineoplastic,2/20/2025,1/29/2025,Intravenous,carboplatin,FALSE
1065,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G54B14B192B6B,2/17/2019,mg,antineoplastic,1/3/2019,2/25/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/4/2025,mg,antineoplastic,7/20/2021,3/21/2020,Intravenous,pembrolizumab,FALSE
306,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,10/31/2024,mg,antineoplastic,8/31/2024,6/29/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,5/1/2021,mg,antineoplastic,1/29/2019,10/6/2018,Intravenous,pembrolizumab,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/10/2013,mg,antineoplastic,9/16/2012,5/19/2012,Intravenous,docetaxel,FALSE
462,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/11/2016,mg,antineoplastic,8/13/2016,7/14/2016,Intravenous,paclitaxel,FALSE
584.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/1/2021,mg,antineoplastic,1/17/2021,12/4/2020,Intravenous,carboplatin,FALSE
825,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,4/12/2021,mg,antineoplastic,1/27/2021,1/24/2021,Intravenous,pemetrexed,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/10/2021,mg,antineoplastic,11/3/2021,10/2/2021,Intravenous,paclitaxel,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,7/15/2015,mg,antineoplastic,8/22/2014,6/30/2014,Intravenous,pemetrexed,FALSE
98,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/3/2015,mg,antineoplastic,7/9/2015,5/3/2015,Intravenous,etoposide,FALSE
80,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G13D3F29D3FFF,3/5/2014,mg,antineoplastic,12/14/2013,10/29/2013,Intravenous,cisplatin,FALSE
,3,ADVANCED,Unstructured,,Alectinib,G53C61B2GG71F,6/9/2016,,,6/6/2016,4/17/2016,Oral,alectinib,FALSE
142.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,10/28/2019,mg,antineoplastic,9/18/2019,8/15/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/2/2025,mg,antineoplastic,6/28/2024,12/19/2023,Intravenous,pembrolizumab,FALSE
885,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,4/2/2020,mg,antineoplastic,1/13/2020,10/23/2019,Intravenous,pemetrexed,FALSE
352,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,5/8/2025,mg,antineoplastic,12/5/2024,11/14/2024,Intravenous,paclitaxel,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/1/2020,mg,antineoplastic,5/19/2020,10/6/2019,Intravenous,durvalumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/4/2025,mg,antineoplastic,2/27/2024,3/10/2024,Intravenous,amivantamab-vmjw,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,5/29/2019,AUC,antineoplastic,1/31/2019,1/7/2019,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/2/2020,mg,antineoplastic,2/23/2018,1/18/2018,Intravenous,pemetrexed,TRUE
372,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/2/2022,mg,antineoplastic,2/12/2022,3/20/2022,Intravenous,paclitaxel,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,11/3/2013,AUC,antineoplastic,8/27/2013,8/30/2013,Intravenous,carboplatin,FALSE
480,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,4/9/2020,mg,antineoplastic,12/8/2019,12/9/2019,Intravenous,carboplatin,FALSE
175,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,12/29/2014,mg/m2,antineoplastic,1/21/2015,9/30/2014,Intravenous,paclitaxel,FALSE
4.4,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,2/20/2023,mg,antineoplastic,2/3/2023,3/11/2023,Intravenous,paclitaxel,FALSE
309,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/10/2023,mg,antineoplastic,11/14/2022,12/2/2022,Intravenous,carboplatin,FALSE
274,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,11/7/2022,mg,antineoplastic,7/29/2022,7/18/2022,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/30/2019,mg,antineoplastic,9/4/2019,6/25/2018,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,3/26/2024,mL,solution-fluid,2/12/2024,1/4/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/11/2013,mg,antineoplastic,11/27/2012,12/31/2012,Intravenous,paclitaxel protein-bound,FALSE
45,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G57DE72B664E8,8/15/2012,mg,antineoplastic,8/17/2012,8/16/2012,Intravenous,vinorelbine,FALSE
159.3,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,4/4/2021,mg,antineoplastic,12/12/2020,12/17/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G263B3:534B15,11/8/2016,,,10/28/2016,9/3/2014,Oral,erlotinib,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/22/2025,mg,antineoplastic,1/1/2025,9/6/2024,Intravenous,durvalumab,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/28/2019,mg,antineoplastic,1/23/2019,12/7/2018,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/31/2014,,antineoplastic,11/20/2013,11/7/2013,,cisplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,3/2/2025,mg,antineoplastic,12/19/2024,12/17/2024,Intravenous,paclitaxel,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/1/2019,mg,antineoplastic,2/13/2019,7/13/2018,Intravenous,docetaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/18/2023,mg,antineoplastic,2/11/2023,9/27/2022,Subcutaneous,azacitidine,FALSE
163.2,5,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Vemurafenib",G4C53C5GC48E:,10/16/2016,mg,antineoplastic,7/19/2016,8/6/2016,Intravenous,pembrolizumab,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/24/2024,mg,antineoplastic,3/24/2024,6/13/2023,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/11/2025,mg,antineoplastic,7/16/2024,3/30/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,8/21/2024,mg,antineoplastic,8/8/2024,6/19/2024,Intravenous,pembrolizumab,FALSE
63.6,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/4/2021,mg,antineoplastic,3/7/2021,11/16/2020,Intravenous,vinorelbine,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/16/2014,mg,antineoplastic,5/25/2014,6/4/2014,Intravenous,paclitaxel,FALSE
105,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3951BC5GBE44,9/23/2023,mg,antineoplastic,6/18/2023,7/4/2023,Intravenous,cisplatin,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,3/22/2012,mg,antineoplastic,2/23/2012,1/27/2012,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/23/2025,mg,antineoplastic,5/24/2020,4/21/2018,Intravenous,pembrolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/6/2018,mg,antineoplastic,4/16/2018,12/8/2017,Intravenous,pemetrexed,FALSE
816,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/17/2025,mg,antineoplastic,5/6/2025,1/13/2025,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/9/2025,mg/m2,antineoplastic,11/19/2024,8/4/2024,Intravenous,gemcitabine,FALSE
351,2,ADVANCED,Administrations,chemotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,12/1/2024,mg,antineoplastic,12/1/2024,10/12/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/29/2023,,antineoplastic,5/8/2023,1/13/2023,Intravenous,clinical study drug,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/19/2025,mg,antineoplastic,5/30/2021,2/12/2020,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G2CG3EF9E5:2B,5/28/2021,,,6/27/2021,6/20/2021,Oral,lorlatinib,FALSE
50,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/1/2024,mg,antineoplastic,6/17/2023,7/8/2023,Intravenous,cisplatin,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/5/2016,mg,antineoplastic,10/11/2016,7/1/2016,Intravenous,necitumumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/29/2024,mg,antineoplastic,3/22/2024,8/20/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,8/26/2020,mg,antineoplastic,7/14/2020,5/9/2020,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/15/2016,mg,antineoplastic,6/19/2015,5/23/2014,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/9/2018,mg,antineoplastic,3/4/2018,9/24/2015,Intravenous,nivolumab,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/9/2024,mg,antineoplastic,7/24/2024,5/13/2024,Intravenous,carboplatin,FALSE
200,4,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,4/24/2021,mg,antineoplastic,3/15/2021,4/17/2021,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G325BD94D:C:4,1/28/2019,,,9/5/2018,8/20/2018,Oral,afatinib,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,11/13/2018,mg,antineoplastic,12/10/2017,12/21/2017,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/20/2024,,antineoplastic,1/31/2024,3/27/2023,Intravenous,atezolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/10/2020,mg,antineoplastic,2/15/2016,12/1/2015,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/22/2022,mg,antineoplastic,11/21/2020,1/22/2016,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/30/2014,mg,antineoplastic,5/5/2014,3/26/2014,Intravenous,pemetrexed,FALSE
803,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/15/2025,mg,antineoplastic,8/22/2023,2/20/2023,Intravenous,pemetrexed,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,8/27/2011,mg,antineoplastic,8/4/2011,7/4/2011,Intravenous,docetaxel,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,4/9/2013,mg,antineoplastic,2/20/2013,2/5/2013,Intravenous,paclitaxel,FALSE
1610,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/6/2014,mg,antineoplastic,4/11/2014,2/14/2014,Intravenous,gemcitabine,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,2/1/2025,mg,antineoplastic,6/20/2024,6/6/2024,Intravenous,durvalumab,TRUE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/31/2019,mg,antineoplastic,5/23/2019,3/7/2019,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:2GG784D6FD,4/4/2025,mg,antineoplastic,3/2/2025,3/1/2025,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/11/2020,,antineoplastic,4/11/2020,4/11/2020,Intravenous,carboplatin,FALSE
20,,ADJUVANT,Orders,chemotherapy,Decitabine,G1F5415D1B672,11/28/2018,mg/m2,antineoplastic,9/17/2018,9/25/2018,Intravenous,decitabine,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/16/2023,,antineoplastic,10/23/2022,10/27/2022,Intravenous,docetaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,4/22/2020,mg,antineoplastic,2/26/2020,12/16/2019,Intravenous,pemetrexed,FALSE
855,,ADJUVANT,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/28/2013,mg,antineoplastic,4/15/2013,12/6/2012,Intravenous,rituximab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,7/23/2016,mg,antineoplastic,5/26/2016,5/9/2016,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/9/2024,,antineoplastic,2/17/2024,11/27/2023,,carboplatin,FALSE
223,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/13/2018,mg,antineoplastic,10/24/2016,9/24/2015,Intravenous,nivolumab,FALSE
540,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,6/22/2021,mg,antineoplastic,5/3/2021,4/14/2021,Intravenous,pemetrexed,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,3/16/2020,mg,antineoplastic,1/15/2020,12/9/2019,Intravenous,pemetrexed,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/11/2025,mg,antineoplastic,3/13/2025,7/27/2024,Intravenous,durvalumab,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/16/2021,mg,antineoplastic,1/4/2021,12/3/2020,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1E3BGE6C42B6,10/21/2024,AUC,antineoplastic,10/30/2024,10/3/2024,Intravenous,carboplatin,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,5/11/2022,mg,antineoplastic,4/25/2022,4/24/2022,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/16/2025,mg,antineoplastic,7/9/2017,12/19/2016,Intravenous,nivolumab,FALSE
489,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,7/3/2023,mg,antineoplastic,4/10/2023,4/12/2023,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/28/2013,mg/m2,antineoplastic,10/28/2013,9/24/2013,Intravenous,etoposide,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/22/2022,,antineoplastic,6/24/2020,4/15/2017,Oral,nilotinib,FALSE
591,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,11/18/2021,mg,antineoplastic,10/5/2021,10/13/2021,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/12/2013,mg,antineoplastic,6/12/2012,12/23/2011,Intravenous,etoposide,FALSE
250.2,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,6/17/2016,mg,antineoplastic,12/17/2015,1/2/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/4/2021,mg,antineoplastic,9/1/2019,8/20/2019,Intravenous,pembrolizumab,FALSE
309,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/19/2024,mg,antineoplastic,8/17/2024,6/30/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,11/28/2022,mg,antineoplastic,10/3/2021,3/31/2020,Intravenous,pembrolizumab,TRUE
17.2,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/30/2013,mL,antineoplastic,9/7/2013,8/4/2013,Intravenous,vinorelbine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/7/2025,mg,antineoplastic,3/11/2020,1/30/2017,Intravenous,pembrolizumab,FALSE
42,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,10/1/2018,mg,antineoplastic,5/14/2018,5/4/2018,Intravenous,docetaxel,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/10/2016,mg,antineoplastic,9/30/2015,5/28/2015,Intravenous,gemcitabine,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/19/2024,mL,solution-fluid,11/24/2023,10/15/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/8/2025,,antineoplastic,7/25/2024,3/18/2023,,clinical study drug,FALSE
130,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G38C61:99G266,4/8/2023,mg,antineoplastic,4/5/2023,2/7/2023,Intravenous,docetaxel,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G47CG7D:EEG,7/1/2018,AUC,antineoplastic,5/10/2018,5/18/2018,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/31/2014,mg,antineoplastic,11/9/2013,10/25/2013,Intravenous,pemetrexed,FALSE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/16/2017,mg,antineoplastic,3/16/2017,1/17/2017,Intravenous,carboplatin,FALSE
289,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/20/2015,mg,antineoplastic,3/5/2015,12/27/2014,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/28/2018,mg,antineoplastic,5/5/2018,4/25/2018,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,glucocorticoid,Clinical Study Drug,G1F482136BDE5,4/10/2017,,steroid,3/26/2017,2/20/2017,,clinical study drug,FALSE
720,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,11/27/2015,mg,antineoplastic,10/27/2015,9/1/2015,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,3/3/2019,,antineoplastic,4/9/2018,5/12/2018,,clinical study drug,FALSE
144,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1FE4F243:1FG,5/13/2025,mg,antineoplastic,5/10/2025,5/11/2025,Intravenous,cisplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/6/2024,mg,antineoplastic,7/5/2024,5/30/2024,Intravenous,pemetrexed,FALSE
571,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G14FD45889171,10/17/2014,mg,antineoplastic,8/21/2014,10/9/2014,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G2D2EC6C91F3C,10/1/2018,,,9/24/2018,7/9/2018,Oral,osimertinib,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/28/2020,mg,antineoplastic,1/2/2020,1/25/2020,Intravenous,pemetrexed,FALSE
1312,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,10/5/2015,mg,antineoplastic,7/4/2015,7/23/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/19/2025,mg,antineoplastic,8/28/2022,3/24/2020,Intravenous,pembrolizumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/15/2020,mg,antineoplastic,4/26/2018,12/23/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/28/2025,mg,antineoplastic,12/30/2022,6/15/2022,Intravenous,pembrolizumab,FALSE
234,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G555D3D316568,7/12/2018,mg,antineoplastic,10/25/2017,11/16/2017,Intravenous,paclitaxel,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,5/28/2023,mg,antineoplastic,4/15/2023,3/27/2023,Intravenous,paclitaxel,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/31/2019,mg/kg,antineoplastic,8/3/2019,7/27/2018,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,4/6/2012,,antiemetic,12/19/2011,10/9/2011,Intravenous,clinical study drug,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,9/12/2021,mg,antineoplastic,5/8/2021,4/23/2021,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/28/2025,mg,antineoplastic,3/17/2016,1/1/2016,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,7/17/2024,mg,antineoplastic,4/20/2024,8/23/2023,Intravenous,atezolizumab,FALSE
,1,LOCOREGIONAL,Orders,hormone,Anastrozole,G22F:D77B6329,1/10/2018,,antineoplastic,1/31/2018,12/21/2017,Oral,anastrozole,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G132B61FB651B,12/30/2015,,antineoplastic,12/27/2015,10/29/2015,Intravenous,clinical study drug,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1GEF44EBD419,8/21/2024,mg,antineoplastic,5/3/2024,1/31/2024,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/25/2024,mg,antineoplastic,9/12/2024,9/4/2024,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/10/2025,,antineoplastic,10/18/2024,10/28/2024,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/26/2024,mg,antineoplastic,1/24/2021,7/6/2020,Intravenous,nivolumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,8/30/2021,mg,antineoplastic,6/17/2021,6/16/2021,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/7/2025,mg,antineoplastic,5/26/2024,9/30/2023,Intravenous,atezolizumab,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,4/18/2019,mg,antineoplastic,1/8/2019,2/17/2019,Intravenous,pemetrexed,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,9/28/2021,mg/kg,antineoplastic,5/16/2021,2/9/2021,Intravenous,bevacizumab-awwb,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/1/2021,,antiemetic,2/3/2020,1/12/2020,Intravenous,clinical study drug,FALSE
520,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/31/2024,mg,antineoplastic,4/21/2024,3/25/2024,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/3/2020,mL,solution-fluid,1/25/2020,3/14/2019,Intravenous,nivolumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/4/2024,mg,antineoplastic,1/28/2022,12/16/2021,Intravenous,nivolumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/1/2025,mg,antineoplastic,3/17/2017,12/23/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,9/12/2020,mg,antineoplastic,10/1/2019,10/8/2019,Intravenous,pembrolizumab,TRUE
85,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,12/7/2015,mg,antineoplastic,8/9/2015,8/25/2015,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/11/2023,mg,antineoplastic,6/27/2020,12/12/2019,Intravenous,pembrolizumab,FALSE
353,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/20/2016,mg,antineoplastic,7/29/2016,3/13/2016,Intravenous,carboplatin,FALSE
740,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G225D5E995642,7/15/2022,mg,antineoplastic,7/20/2022,5/6/2022,Intravenous,durvalumab,TRUE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/11/2020,mg,antineoplastic,4/23/2020,2/12/2019,Subcutaneous,bortezomib,FALSE
168.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/26/2015,mg,antineoplastic,11/11/2014,10/25/2014,Intravenous,paclitaxel,FALSE
650,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,5/4/2017,mg,antineoplastic,5/1/2017,8/25/2016,Intravenous,pemetrexed,FALSE
1710,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/12/2013,mg,antineoplastic,2/20/2013,11/29/2012,Intravenous,cyclophosphamide,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,2/12/2020,mg,antineoplastic,10/31/2019,12/21/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G115873FC55G5,1/26/2021,,,12/20/2020,6/28/2020,Oral,osimertinib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/27/2023,mg,antineoplastic,5/1/2023,3/26/2023,Subcutaneous,azacitidine,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,7/16/2017,mg,antineoplastic,7/22/2017,6/14/2017,Intravenous,pemetrexed,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,12/13/2015,mg,antineoplastic,9/1/2015,6/17/2015,Intravenous,paclitaxel protein-bound,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,2/20/2025,AUC,antineoplastic,1/14/2025,12/1/2024,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28F814933C3F,4/3/2025,mg,antineoplastic,2/14/2025,1/2/2025,Intravenous,pemetrexed,FALSE
712,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,11/2/2017,mg,antineoplastic,6/15/2017,6/6/2017,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/11/2023,mg,antineoplastic,4/22/2023,8/6/2022,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/15/2025,mg,antineoplastic,5/24/2018,1/25/2018,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/17/2024,mg,antineoplastic,12/19/2023,7/25/2023,Intravenous,atezolizumab,FALSE
150,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,1/30/2020,mg,antineoplastic,11/27/2019,10/18/2019,Intravenous,paclitaxel,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/4/2022,mg,antineoplastic,11/23/2022,9/23/2022,Oral,imatinib,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/21/2016,mg,antineoplastic,11/21/2014,11/25/2014,Intravenous,carboplatin,FALSE
1005,4,ADVANCED,Administrations,chemotherapy,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,8/21/2016,mg,antineoplastic,5/23/2016,6/21/2016,Intravenous,pemetrexed,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/8/2016,mg,antineoplastic,3/4/2016,12/19/2015,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G45DDGFC1G86F,5/30/2016,mg,antineoplastic,5/10/2016,4/22/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/27/2021,,steroid,2/12/2020,2/20/2020,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/13/2025,mg,antineoplastic,10/23/2021,2/4/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/29/2019,mg,antineoplastic,8/15/2019,6/12/2019,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/15/2025,mg,antineoplastic,8/10/2023,2/2/2023,Intravenous,pembrolizumab,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Osimertinib,Paclitaxel",G1594:E29D2D9,4/23/2022,mg,antineoplastic,4/4/2022,3/7/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3EC2153F:341,5/31/2020,mg,antineoplastic,6/7/2020,5/10/2020,Intravenous,pembrolizumab,FALSE
1015,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G137D67:GFD9F,10/24/2016,mg,antineoplastic,8/23/2016,8/9/2016,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/6/2020,mg,antineoplastic,1/14/2020,8/2/2019,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/28/2025,mg,antineoplastic,9/14/2017,12/26/2016,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/30/2020,mg,antineoplastic,8/16/2020,5/1/2020,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/1/2024,mg,antineoplastic,2/2/2024,3/5/2023,Intravenous,nivolumab,FALSE
482,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,11/16/2024,mg,antineoplastic,7/19/2024,7/15/2024,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,4/3/2024,mg,antineoplastic,12/21/2023,12/24/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/30/2018,mg,antineoplastic,8/26/2017,4/20/2017,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/21/2017,AUC,antineoplastic,7/15/2017,6/21/2017,Intravenous,carboplatin,FALSE
62.1,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/16/2021,mg,antineoplastic,5/19/2021,11/17/2020,Intravenous,vinorelbine,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/24/2024,mg,antineoplastic,7/25/2023,1/12/2023,Intravenous,durvalumab,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,2/20/2019,mg,antineoplastic,1/16/2019,11/27/2018,Intravenous,paclitaxel,FALSE
170,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1594:E29D2D9,5/27/2022,mg,antineoplastic,5/18/2022,4/1/2022,Intravenous,nivolumab,FALSE
546,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,3/9/2023,mg,antineoplastic,3/13/2023,1/14/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Exemestane,G358EF4457D52,6/1/2016,,antineoplastic,6/15/2016,6/27/2016,Oral,exemestane,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/7/2025,mg,antineoplastic,3/26/2025,4/8/2024,Intravenous,pembrolizumab,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/8/2019,mg/m2,antineoplastic,11/23/2018,10/14/2018,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,3/23/2023,mg,antineoplastic,6/11/2022,5/11/2022,Intravenous,nivolumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/28/2021,mg,antineoplastic,8/4/2021,6/21/2021,Intravenous,paclitaxel,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G25E1C41F29EC,1/14/2021,mg/kg,antineoplastic,3/16/2016,8/27/2015,Intravenous,nivolumab,FALSE
569,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,10/23/2016,mg,antineoplastic,6/12/2016,7/25/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/10/2023,,antineoplastic,3/16/2023,2/6/2023,Intravenous,paclitaxel,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/20/2017,mg,antineoplastic,12/26/2016,11/18/2016,Intravenous,carboplatin,FALSE
915,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G18E7528ED97:,3/27/2012,mg,antineoplastic,1/29/2012,10/10/2011,Intravenous,pemetrexed,FALSE
568,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,10/24/2024,mg,antineoplastic,8/30/2024,7/1/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,3/14/2024,,antineoplastic,6/24/2023,5/22/2023,Intravenous,clinical study drug,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G472C99B8G373,6/21/2018,mg,antineoplastic,5/19/2018,5/29/2018,Intravenous,pembrolizumab,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,7/24/2019,mg,antineoplastic,5/3/2019,8/30/2017,Oral,anastrozole,FALSE
549,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,9/20/2021,mg,antineoplastic,9/15/2021,6/6/2021,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,4/14/2015,mg,antineoplastic,11/26/2014,10/6/2014,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/16/2023,mg,antineoplastic,10/21/2022,6/4/2020,Intravenous,pembrolizumab,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,3/29/2023,mg,antineoplastic,7/9/2020,2/7/2020,Intravenous,docetaxel,FALSE
875,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G49E3CE9E292G,3/28/2023,mg,antineoplastic,7/20/2020,5/29/2020,Intravenous,pemetrexed,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/20/2021,mg,antineoplastic,2/16/2021,8/25/2020,Intravenous,nivolumab,FALSE
845,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/12/2017,mg,antineoplastic,1/16/2017,1/2/2017,Intravenous,pemetrexed,FALSE
6,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/14/2021,AUC,antineoplastic,10/25/2020,9/28/2020,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/22/2020,mg,antineoplastic,7/25/2019,8/2/2016,Intravenous,nivolumab,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,4/4/2018,mg,antineoplastic,8/18/2014,9/8/2014,Intravenous,carboplatin,FALSE
1.5,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/28/2024,AUC,antineoplastic,9/29/2023,10/21/2023,Intravenous,carboplatin,FALSE
494,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/5/2021,mg,antineoplastic,9/2/2021,9/18/2021,Intravenous,carboplatin,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/14/2025,mg,antineoplastic,10/6/2023,9/28/2022,Intravenous,pemetrexed,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,5/14/2025,mg,antineoplastic,3/8/2025,1/25/2025,Intravenous,pemetrexed,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/19/2018,mg/m2,antineoplastic,10/28/2017,9/14/2017,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/8/2017,mg,antineoplastic,3/19/2015,11/1/2014,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/2/2015,mg,antineoplastic,5/20/2015,3/5/2015,Intravenous,paclitaxel protein-bound,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/8/2022,mg,antineoplastic,9/22/2022,5/29/2022,Intravenous,nivolumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/28/2015,mg,antineoplastic,3/26/2014,1/26/2014,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/22/2023,mg,antineoplastic,9/12/2022,12/18/2021,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/31/2016,mg,antineoplastic,6/28/2015,11/26/2014,Intravenous,gemcitabine,FALSE
1020,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,2/20/2023,mg,antineoplastic,2/14/2023,12/27/2022,Intravenous,pemetrexed,FALSE
2000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/5/2013,mg,antineoplastic,7/5/2012,7/1/2012,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G3:G1:CC15DG9,4/9/2024,,antineoplastic,4/8/2024,1/28/2024,Intravenous,pembrolizumab,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/24/2016,mg,antineoplastic,7/23/2014,5/19/2014,Intravenous,carboplatin,FALSE
260,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,5/6/2015,mg,antineoplastic,4/7/2015,3/14/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/30/2025,mg,antineoplastic,7/30/2024,9/26/2022,Intravenous,pembrolizumab,TRUE
42,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/29/2018,mg,antineoplastic,6/10/2018,4/22/2018,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/8/2025,mg,antineoplastic,2/23/2023,8/25/2021,Intravenous,atezolizumab,TRUE
160,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/19/2022,mg,antineoplastic,6/7/2021,3/10/2021,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13G1125C1G:F,12/20/2019,mg,antineoplastic,12/20/2019,12/21/2019,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,4/11/2025,mg,antineoplastic,2/22/2025,8/25/2024,Intravenous,durvalumab,FALSE
925,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,10/12/2013,mg,antineoplastic,11/6/2013,9/9/2013,Intravenous,pemetrexed,FALSE
225.3,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/4/2016,mg,antineoplastic,8/20/2015,6/29/2015,Intravenous,carboplatin,FALSE
92,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,3/7/2025,mg,antineoplastic,4/10/2025,1/30/2025,Intravenous,paclitaxel,FALSE
925,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,10/28/2013,mg,antineoplastic,8/16/2013,8/7/2013,Intravenous,pemetrexed,FALSE
126,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,5/12/2024,mg,antineoplastic,2/1/2024,1/25/2024,Intravenous,carboplatin,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/24/2021,mg,antineoplastic,11/1/2020,10/3/2020,Intravenous,ipilimumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,3/5/2015,,antineoplastic,1/11/2015,1/12/2015,,carboplatin,FALSE
183,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/6/2021,mg,antineoplastic,10/29/2021,10/30/2021,Intravenous,paclitaxel protein-bound,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,11/24/2019,mg,antineoplastic,9/17/2019,9/16/2019,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/11/2016,mg,antineoplastic,5/22/2016,6/28/2016,Intravenous,carboplatin,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/5/2025,mg,antineoplastic,2/3/2025,9/27/2024,Intravenous,durvalumab,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,2/15/2019,mg,antineoplastic,2/16/2019,1/5/2019,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/6/2025,mg,antineoplastic,3/3/2025,8/23/2023,Intravenous,atezolizumab,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,8/6/2022,mg,antineoplastic,6/24/2022,5/10/2022,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,3/5/2019,,antineoplastic,12/1/2018,12/22/2018,,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G177G4:B9E394,3/26/2024,mg,antineoplastic,2/15/2024,12/8/2023,Intravenous,pembrolizumab,TRUE
1049,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,2/18/2023,mg,antineoplastic,6/7/2022,4/15/2022,Intravenous,pemetrexed,FALSE
114,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/30/2021,mg,antineoplastic,10/12/2021,9/25/2021,Intravenous,paclitaxel,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/13/2023,mg,antineoplastic,7/29/2018,11/17/2017,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/17/2022,mg,antineoplastic,3/5/2018,1/28/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/21/2025,mg,antineoplastic,5/4/2025,2/21/2025,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G579E53D92:75,10/14/2011,,antineoplastic,8/2/2011,9/12/2011,Intravenous,clinical study drug,FALSE
527,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,1/26/2023,mg,antineoplastic,1/1/2023,11/26/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/2/2021,,antineoplastic,4/10/2021,5/3/2021,,pemetrexed,FALSE
75,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Leuprolide",G24F:E99C2926,2/4/2024,mg/m2,antineoplastic,12/8/2023,11/22/2023,Intravenous,docetaxel,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/27/2024,mg,antineoplastic,3/6/2023,4/25/2022,Intravenous,durvalumab,TRUE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/16/2024,mL,solution-fluid,3/21/2024,3/27/2024,Intravenous,pembrolizumab,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/4/2022,mg,antineoplastic,5/23/2021,6/4/2021,Intravenous,leucovorin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/26/2020,mg,antineoplastic,4/2/2020,12/24/2019,Intravenous,carboplatin,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/19/2020,mg,antineoplastic,1/5/2020,12/17/2019,Intravenous,paclitaxel,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/31/2014,mg,antineoplastic,6/6/2014,4/29/2014,Intravenous,carboplatin,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,2/7/2019,mg,antineoplastic,1/4/2019,12/10/2018,Intravenous,paclitaxel,FALSE
1020,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/3/2019,mg,antineoplastic,1/14/2019,11/8/2018,Intravenous,durvalumab,TRUE
397,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38F8684B8FG8,11/8/2015,mg,antineoplastic,9/25/2015,10/3/2015,Intravenous,paclitaxel,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,5/20/2014,mg,antineoplastic,2/24/2014,12/2/2013,Intravenous,eribulin,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/27/2025,,solution-fluid,5/18/2018,10/28/2017,Intravenous,clinical study drug,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,4/21/2023,mg,antineoplastic,5/13/2022,5/27/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Unstructured,,Sotorasib,G3CFD616B13G9,5/21/2022,,,2/13/2022,3/4/2022,Oral,sotorasib,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/26/2020,mg,antineoplastic,3/4/2020,12/4/2019,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/30/2025,mg,antineoplastic,12/1/2024,8/26/2023,Intravenous,atezolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/17/2020,mg,antineoplastic,2/7/2017,11/30/2016,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/27/2025,mg,antineoplastic,8/27/2023,1/22/2017,Intravenous,pembrolizumab,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/28/2019,mg,antineoplastic,4/22/2019,2/14/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,5/6/2024,,antineoplastic,11/27/2023,7/3/2023,Intravenous,clinical study drug,FALSE
400,3,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/4/2024,mg,antineoplastic,8/27/2023,7/18/2023,Intravenous,pembrolizumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,3/20/2021,mg,antineoplastic,2/25/2021,2/3/2021,Intravenous,carboplatin,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/2/2018,mg,antineoplastic,6/16/2018,5/3/2018,Intravenous,paclitaxel,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/15/2023,mg,antineoplastic,5/26/2023,11/8/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/12/2022,mg,antineoplastic,12/13/2021,7/10/2020,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G128:92:3BD3D,12/24/2021,,antineoplastic,7/9/2021,4/18/2021,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,3/20/2022,mg,antineoplastic,4/4/2021,2/24/2021,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/19/2020,mg,antineoplastic,7/6/2019,12/9/2018,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,cytoprotective,Clinical Study Drug,G1969F536B2DD,11/18/2011,,cytoprotective,9/19/2011,6/1/2011,Intrajejunal,clinical study drug,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/11/2019,mg,antineoplastic,4/11/2019,4/11/2019,Intravenous,carboplatin,FALSE
67,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG6E1D:B1B7,5/2/2025,mg,antineoplastic,4/13/2025,4/27/2025,Intravenous,paclitaxel,FALSE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,12/24/2013,mg,antineoplastic,11/11/2013,8/29/2013,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/3/2019,mg,antineoplastic,2/16/2019,1/22/2019,Intravenous,pembrolizumab,FALSE
28,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/24/2013,mg,antineoplastic,8/31/2013,7/21/2013,Intravenous,vinorelbine,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/28/2019,mg,antineoplastic,11/24/2018,11/11/2018,Intravenous,carboplatin,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/3/2024,mg,antineoplastic,7/17/2024,4/30/2024,Intravenous,etoposide,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/23/2023,mg,antineoplastic,4/18/2023,3/11/2023,Intravenous,cemiplimab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/25/2017,,antineoplastic,7/5/2017,8/6/2017,,carboplatin,FALSE
622,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/25/2024,mg,antineoplastic,1/12/2024,12/17/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,10/1/2019,mg,antineoplastic,6/7/2019,7/27/2019,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/19/2024,mg,antineoplastic,6/1/2024,4/23/2024,Intravenous,pembrolizumab,FALSE
880,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/15/2012,mg,antineoplastic,6/28/2012,2/29/2012,Intravenous,bevacizumab,FALSE
615,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G25C3661FG6B9,7/2/2015,mg,antineoplastic,5/1/2015,4/4/2015,Intravenous,pemetrexed,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,6/24/2012,mg,antineoplastic,5/4/2012,4/26/2012,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G485C85BECGC4,4/15/2022,,antiemetic,5/1/2022,1/21/2022,Intravenous,clinical study drug,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/7/2016,mg,antineoplastic,9/30/2014,7/30/2014,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,5/8/2023,,antineoplastic,2/9/2023,12/1/2022,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/6/2019,mg,antineoplastic,1/3/2019,11/29/2018,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,antibody-conjugate,Clinical Study Drug,G177G4:B9E394,4/11/2025,,antineoplastic,4/27/2025,3/5/2025,,clinical study drug,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,9/29/2020,mg,antineoplastic,8/7/2020,7/6/2020,Subcutaneous,azacitidine,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/2/2019,mg,antineoplastic,8/8/2019,8/19/2019,Intravenous,paclitaxel protein-bound,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/12/2016,mg,antineoplastic,8/15/2015,5/18/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/26/2022,mg,antineoplastic,12/5/2021,2/6/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/2/2022,mg,antineoplastic,7/25/2021,4/26/2020,Intravenous,pembrolizumab,TRUE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/12/2020,mg,antineoplastic,7/22/2020,9/2/2019,Intravenous,durvalumab,FALSE
1080,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/13/2016,mg,antineoplastic,9/16/2015,2/1/2015,Intravenous,bevacizumab,FALSE
675,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/20/2016,mg,antineoplastic,12/6/2016,7/28/2016,Intravenous,gemcitabine,FALSE
400,5,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,3/12/2025,mg,antineoplastic,1/12/2025,11/3/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/16/2025,mg,antineoplastic,12/11/2024,6/29/2024,Intravenous,pembrolizumab,TRUE
660,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,4/10/2017,mg,antineoplastic,1/26/2017,8/21/2016,Intravenous,pemetrexed,FALSE
395,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1ED5EF238G3C,7/22/2024,mg,antineoplastic,7/28/2024,7/23/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/18/2019,mg,antineoplastic,8/2/2018,2/19/2018,Intravenous,nivolumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/11/2024,mg,antineoplastic,3/16/2022,6/24/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/29/2018,mg,antineoplastic,8/28/2018,3/19/2017,Intravenous,pembrolizumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,Osimertinib,G1169816459CC,4/2/2025,mg,antineoplastic,7/25/2018,8/11/2018,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,Afatinib,G29C71B44G:B6,3/6/2014,,,2/24/2014,9/28/2013,Oral,afatinib,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,5/1/2024,mg,antineoplastic,3/31/2024,2/6/2024,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/14/2022,mg,antineoplastic,5/16/2020,2/3/2020,Intravenous,nivolumab,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,4/18/2023,mg,antineoplastic,3/8/2023,2/19/2023,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/15/2020,mg,antineoplastic,5/29/2014,2/28/2014,Intravenous,rituximab,FALSE
200,2,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,8/7/2023,mg,antineoplastic,4/2/2023,5/1/2023,Intravenous,pembrolizumab,FALSE
93,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,3/4/2014,mg,antineoplastic,2/2/2014,12/28/2013,Intravenous,paclitaxel,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,8/5/2013,mg,antineoplastic,8/11/2013,7/1/2013,Intravenous,cisplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/1/2022,mg,antineoplastic,11/20/2018,4/30/2017,Oral,nilotinib,FALSE
40,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,11/23/2013,mg,antineoplastic,9/1/2013,8/24/2013,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/26/2020,mg,antineoplastic,3/25/2020,1/6/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,4/28/2024,,antineoplastic,3/17/2024,4/21/2024,,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/22/2019,mg,antineoplastic,8/22/2018,5/12/2018,Intravenous,nivolumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/27/2022,mg,antineoplastic,6/15/2021,3/10/2021,Intravenous,docetaxel,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/9/2024,mg,antineoplastic,4/2/2024,3/31/2023,Intravenous,atezolizumab,FALSE
342,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,7/20/2016,mg,antineoplastic,7/15/2016,5/6/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,3/19/2025,mg,antineoplastic,6/7/2024,10/31/2023,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,1/10/2015,,antineoplastic,10/20/2014,8/27/2014,Intravenous,clinical study drug,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,9/4/2017,4/29/2017,Oral,dasatinib,FALSE
54,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,5/3/2025,mg,antineoplastic,11/2/2024,10/11/2024,Intravenous,ipilimumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/20/2025,mg,antineoplastic,10/5/2022,7/25/2021,Intravenous,atezolizumab,TRUE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/24/2017,mg,antineoplastic,9/23/2016,4/6/2015,Intravenous,bevacizumab,TRUE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/25/2013,mg/m2,antineoplastic,7/13/2012,8/12/2012,Intravenous,docetaxel,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,3/29/2013,mg,antineoplastic,10/28/2012,11/28/2012,Intravenous,bevacizumab,TRUE
1165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,4/8/2022,mg,antineoplastic,12/9/2021,1/10/2022,Intravenous,pemetrexed,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,9/17/2021,mg/m2,antineoplastic,9/11/2021,8/15/2021,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,7/19/2020,mg,antineoplastic,5/28/2019,2/3/2019,Intravenous,nivolumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/5/2022,mg,antineoplastic,7/21/2022,8/19/2022,Intravenous,paclitaxel,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,12/31/2019,mg,antineoplastic,9/12/2019,1/30/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/23/2025,mg,antineoplastic,4/21/2024,12/28/2018,Intravenous,pembrolizumab,TRUE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,9/13/2013,mg,antineoplastic,4/1/2013,3/9/2013,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/6/2017,mg,antineoplastic,3/3/2017,7/3/2015,Intravenous,nivolumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/19/2024,mg,antineoplastic,6/19/2024,12/19/2021,Intravenous,nivolumab,TRUE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/24/2025,mg,antineoplastic,6/3/2024,8/25/2022,Oral,anastrozole,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/29/2019,mg,antineoplastic,7/16/2019,5/26/2019,Intravenous,pemetrexed,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/7/2021,mg,antineoplastic,1/30/2021,5/25/2020,Intravenous,gemcitabine,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,3/29/2015,mg,antineoplastic,1/9/2015,12/18/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,8/5/2019,mg,antineoplastic,7/4/2019,4/27/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/8/2022,mg,antineoplastic,6/15/2020,1/17/2020,Intravenous,nivolumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,mg,antineoplastic,6/11/2019,4/8/2017,Oral,nilotinib,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/8/2015,mg,antineoplastic,8/23/2014,9/13/2014,Intravenous,paclitaxel,FALSE
200,5,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3:C9BECD3F55,4/29/2021,mg,antineoplastic,3/22/2021,2/1/2021,Intravenous,pembrolizumab,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/21/2021,AUC,antineoplastic,4/14/2021,3/29/2021,Intravenous,carboplatin,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/18/2019,mg,antineoplastic,12/24/2018,7/16/2018,Intravenous,docetaxel,FALSE
2.9,2,ADVANCED,Administrations,chemotherapy,Eribulin,G19937F58E541,12/30/2013,mg,antineoplastic,12/25/2013,10/19/2013,Intravenous,eribulin,FALSE
850,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/21/2012,mg,antineoplastic,5/21/2012,3/5/2012,Intravenous,bevacizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,7/5/2024,mg,antineoplastic,3/2/2024,7/25/2023,Intravenous,atezolizumab,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/10/2017,mg,antineoplastic,4/7/2016,1/16/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G3:G1:CC15DG9,2/27/2024,,antineoplastic,2/24/2024,2/2/2024,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/18/2019,mL,solution-fluid,10/16/2017,8/31/2017,Intravenous,etoposide,FALSE
375,,ADJUVANT,Orders,targeted/biologic,Rituximab,G5545136B977G,11/12/2019,mg/m2,antineoplastic,11/23/2019,10/4/2019,Intravenous,rituximab,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,1/24/2015,mg,antineoplastic,2/12/2014,12/31/2013,Intravenous,cisplatin,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,4/6/2024,mg,antineoplastic,4/13/2024,4/7/2024,Intravenous,paclitaxel,FALSE
571,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,9/8/2022,mg,antineoplastic,6/7/2022,5/8/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G193F989CDC3D,11/10/2017,,,3/24/2016,3/28/2016,Oral,erlotinib,FALSE
259.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,5/22/2023,mg,antineoplastic,5/22/2023,4/11/2023,Intravenous,carboplatin,FALSE
406,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G13GE1E25174F,5/7/2022,mg,antineoplastic,4/5/2022,4/6/2022,Intravenous,carboplatin,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,4/13/2015,mg,antineoplastic,1/8/2015,12/3/2014,Intravenous,paclitaxel,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,10/8/2019,mg,antineoplastic,6/22/2019,6/21/2019,Intravenous,paclitaxel,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/15/2019,mg,antineoplastic,10/14/2019,9/5/2019,Intravenous,etoposide,FALSE
825,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2FF1862EC655,1/16/2014,mg,antineoplastic,1/18/2014,11/30/2013,Intravenous,pemetrexed,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/30/2017,mL,solution-fluid,8/23/2017,7/26/2017,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/28/2023,mg,antineoplastic,7/29/2020,5/24/2020,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/2/2013,mg,antineoplastic,4/1/2012,1/5/2012,Intravenous,etoposide,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/22/2018,mL,solution-fluid,7/17/2015,7/17/2015,Intravenous,paclitaxel,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/7/2016,mg,antineoplastic,6/25/2015,7/8/2015,Intravenous,carboplatin,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G3:G28F:1562B,8/24/2017,mg,antineoplastic,8/15/2017,7/18/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/23/2024,mg,antineoplastic,10/13/2021,5/16/2020,Intravenous,pembrolizumab,TRUE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/13/2019,mg,antineoplastic,2/27/2019,2/17/2019,Intravenous,pemetrexed,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,9/1/2019,mg/kg,antineoplastic,7/18/2019,5/15/2019,Intravenous,durvalumab,TRUE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,4/25/2015,mg,antineoplastic,3/17/2015,4/5/2015,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,12/21/2024,mg,antineoplastic,10/26/2024,8/5/2024,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/25/2014,mg,antineoplastic,10/13/2014,9/4/2014,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,5/27/2015,mg,antineoplastic,4/27/2015,4/16/2015,Intravenous,carboplatin,FALSE
81,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,2/22/2024,mg,antineoplastic,1/8/2024,10/12/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/5/2022,,antineoplastic,1/23/2019,5/12/2017,Oral,nilotinib,FALSE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/30/2023,mg,antineoplastic,12/5/2022,11/10/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,11/6/2024,,antineoplastic,8/12/2024,7/10/2024,Intravenous,pembrolizumab,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/21/2013,mg,antineoplastic,7/30/2013,7/12/2013,Intravenous,vinorelbine,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,4/5/2025,mg/m2,antineoplastic,11/15/2022,12/11/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1:D34FC71922,5/3/2015,,antineoplastic,4/29/2015,3/8/2015,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:2GG784D6FD,4/1/2025,mg,antineoplastic,4/16/2025,2/12/2025,Intravenous,pembrolizumab,TRUE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,9/9/2021,mg,antineoplastic,4/14/2021,3/9/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,5/25/2024,,antineoplastic,4/3/2024,5/3/2024,Oral,olutasidenib,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/30/2025,mg,antineoplastic,5/28/2019,3/13/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/1/2013,mg,antineoplastic,3/17/2013,12/4/2012,Intravenous,paclitaxel protein-bound,FALSE
72,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,7/10/2012,mg/m2,antineoplastic,2/1/2012,2/22/2012,Intravenous,paclitaxel,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/24/2025,mg,antineoplastic,11/1/2024,4/9/2024,Intravenous,durvalumab,TRUE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/26/2024,mg,antineoplastic,12/2/2023,11/26/2023,Intravenous,nivolumab,FALSE
590,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,1/14/2021,mg,antineoplastic,9/14/2020,7/17/2020,Intravenous,ramucirumab,FALSE
1300,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,12/8/2012,mg,antineoplastic,10/2/2012,9/19/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/23/2025,mg,antineoplastic,12/23/2023,6/29/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/10/2019,,antineoplastic,11/3/2019,8/15/2019,,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/28/2019,mg,antineoplastic,1/15/2017,4/5/2016,Intravenous,nivolumab,FALSE
800,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G4G4D:D9D8152,3/31/2025,mg/m2,antineoplastic,2/27/2025,2/11/2025,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/5/2025,mg,antineoplastic,3/13/2020,2/15/2019,Intravenous,pembrolizumab,TRUE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,1/15/2020,mg,antineoplastic,12/17/2019,9/9/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/24/2025,mg,antineoplastic,11/1/2021,2/9/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/23/2025,,antineoplastic,12/20/2024,3/6/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G14E7662::61C,4/21/2017,,antineoplastic,3/9/2016,3/13/2016,,clinical study drug,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/21/2014,mg,antineoplastic,10/3/2014,6/15/2014,Intravenous,paclitaxel protein-bound,FALSE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/17/2012,mg,antineoplastic,8/23/2012,4/21/2012,Intravenous,bevacizumab,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/3/2019,mg/m2,antineoplastic,7/21/2019,7/25/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/20/2022,mg,antineoplastic,10/6/2020,1/10/2020,Intravenous,nivolumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/25/2017,mg,antineoplastic,5/5/2016,6/2/2015,Intravenous,nivolumab,FALSE
198,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,2/11/2017,mg,antineoplastic,11/17/2016,12/18/2016,Intravenous,carboplatin,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/6/2019,mg,antineoplastic,10/14/2018,11/25/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/24/2025,,antineoplastic,5/21/2024,2/23/2023,,clinical study drug,FALSE
1093,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1G194ECBE647,3/16/2020,mg,antineoplastic,2/15/2020,12/30/2019,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/11/2025,,antineoplastic,7/30/2024,4/14/2024,Intravenous,carboplatin,FALSE
630,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,1/21/2024,mg,antineoplastic,11/23/2023,10/3/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,4/9/2021,,antineoplastic,3/2/2020,2/5/2020,Intravenous,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/27/2022,mg,antineoplastic,6/8/2016,1/7/2016,Intravenous,pemetrexed,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,8/13/2014,mg,antineoplastic,10/30/2013,7/25/2013,Intravenous,carboplatin,FALSE
82.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,6/2/2015,mg,antineoplastic,4/7/2015,3/17/2015,Intravenous,carboplatin,FALSE
371,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/12/2022,mg,antineoplastic,2/17/2022,12/8/2021,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/8/2018,mg,antineoplastic,12/8/2017,9/16/2017,Intravenous,pemetrexed,FALSE
1020,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/13/2020,mg,antineoplastic,1/25/2019,12/11/2018,Intravenous,durvalumab,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/5/2024,mg,antineoplastic,5/18/2022,11/25/2021,Intravenous,durvalumab,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/6/2018,mL,solution-fluid,7/28/2015,5/28/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/17/2025,mg,antineoplastic,8/10/2023,9/6/2022,Intravenous,pembrolizumab,TRUE
750,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,8/28/2015,mg,antineoplastic,5/11/2015,2/22/2015,Intravenous,carboplatin,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/2/2021,mg,antineoplastic,9/3/2021,9/17/2021,Intravenous,paclitaxel,FALSE
93,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,1/31/2014,mg,antineoplastic,1/12/2014,12/16/2013,Intravenous,paclitaxel,FALSE
1670,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/19/2016,mg,antineoplastic,4/29/2016,3/20/2016,Intravenous,bevacizumab,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/11/2020,mg,antineoplastic,6/9/2019,6/16/2019,Intravenous,pemetrexed,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,12/7/2019,mg,antineoplastic,9/23/2019,10/15/2019,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/6/2018,mg,antineoplastic,8/25/2017,3/24/2017,Intravenous,pembrolizumab,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/23/2018,mg,antineoplastic,12/2/2018,6/15/2018,Intravenous,paclitaxel,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/14/2020,mg,antineoplastic,10/26/2019,10/10/2019,Intravenous,durvalumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G127F7CE9C111,4/12/2025,mg,antineoplastic,1/31/2025,2/12/2025,Intravenous,pemetrexed,FALSE
457.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,8/21/2015,mg,antineoplastic,6/13/2015,5/28/2015,Intravenous,carboplatin,FALSE
1400,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1665E:E6:E1:,11/17/2013,mg,antineoplastic,4/28/2013,2/1/2013,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/5/2025,,antineoplastic,3/28/2024,3/14/2024,Intravenous,clinical study drug,FALSE
1015,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,6/8/2018,mg,antineoplastic,2/25/2018,2/11/2018,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/12/2019,AUC,antineoplastic,1/24/2019,12/27/2018,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,12/8/2015,mg,antineoplastic,6/11/2015,3/1/2015,Intravenous,pemetrexed,TRUE
167,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,3/5/2024,mg,antineoplastic,2/14/2024,11/19/2023,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/5/2025,mg,antineoplastic,10/31/2024,8/28/2021,Intravenous,atezolizumab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/10/2020,mg,antineoplastic,1/13/2018,7/14/2017,Intravenous,pemetrexed,TRUE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/5/2020,mg,antineoplastic,2/1/2020,9/21/2019,Intravenous,pemetrexed,TRUE
161,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,3/22/2016,mg,antineoplastic,12/14/2015,12/20/2015,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/26/2019,mg,antineoplastic,6/24/2019,6/5/2019,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/29/2025,mg,antineoplastic,8/15/2018,1/25/2017,Intravenous,nivolumab,FALSE
103,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/23/2020,mg,antineoplastic,6/8/2020,1/7/2020,Intravenous,docetaxel,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/8/2017,mg,antineoplastic,4/20/2017,4/24/2017,Intravenous,carboplatin,FALSE
450,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/19/2025,mg,antineoplastic,1/30/2019,3/10/2019,Intravenous,carboplatin,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/23/2014,mg,antineoplastic,3/16/2014,1/7/2014,Intravenous,eribulin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/13/2024,,antineoplastic,8/13/2024,6/19/2024,Intravenous,paclitaxel protein-bound,FALSE
578,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,11/22/2020,mg,antineoplastic,2/19/2020,2/6/2020,Intravenous,pemetrexed,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/26/2024,mg,antineoplastic,5/22/2021,6/24/2020,Intravenous,ipilimumab,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/11/2025,,antineoplastic,3/19/2018,10/15/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,4/24/2025,mg,antineoplastic,2/24/2025,2/23/2025,Intravenous,pembrolizumab,TRUE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/11/2022,mg,antineoplastic,9/2/2021,7/5/2021,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,11/28/2022,mg,antineoplastic,11/22/2020,3/19/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,10/8/2021,mg,antineoplastic,8/10/2021,9/9/2021,Intravenous,pembrolizumab,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/6/2024,mg,antineoplastic,9/13/2024,8/27/2024,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,5/12/2025,,antineoplastic,2/21/2025,11/29/2024,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,hormone,Clinical Study Drug,G4992B5EB431G,1/15/2020,,antineoplastic,2/7/2020,1/25/2020,,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/22/2025,,antineoplastic,2/1/2023,3/10/2023,,clinical study drug,FALSE
180,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/19/2018,mg,antineoplastic,5/22/2018,2/15/2018,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,8/4/2021,mg,antineoplastic,4/14/2021,4/16/2021,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,4/19/2025,mg,antineoplastic,1/25/2025,1/9/2025,Intravenous,pembrolizumab,FALSE
540,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,8/12/2021,mg,antineoplastic,4/29/2021,4/23/2021,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/15/2020,mg,antineoplastic,10/15/2016,11/21/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,3/22/2023,mg,antineoplastic,11/14/2022,11/27/2022,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/24/2022,mg,antineoplastic,12/9/2017,1/22/2016,Intravenous,pemetrexed,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/23/2021,mg,antineoplastic,1/6/2021,9/26/2020,Intravenous,ipilimumab,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/28/2025,mg,antineoplastic,12/14/2024,10/3/2022,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,Lorlatinib,G26C728549E7G,2/18/2023,,,9/29/2022,11/14/2022,Oral,lorlatinib,FALSE
74,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,5/2/2024,mg,antineoplastic,3/1/2024,2/23/2024,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,4/25/2022,,cytoprotective,3/16/2022,12/11/2021,Oral,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/5/2022,mg,antineoplastic,7/30/2018,4/11/2017,Intravenous,nivolumab,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/1/2024,mg,antineoplastic,1/16/2023,3/14/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/4/2024,,antineoplastic,5/22/2024,6/6/2024,Intravenous,etoposide,FALSE
175,3,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,1/3/2015,mg/m2,antineoplastic,11/1/2014,10/8/2014,Intravenous,paclitaxel,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/10/2021,mg,antineoplastic,12/4/2020,5/14/2020,Intravenous,docetaxel,FALSE
40,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/13/2018,mg,antineoplastic,10/15/2018,7/7/2018,Intravenous,cisplatin,FALSE
409,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,6/16/2020,mg,antineoplastic,3/26/2020,4/9/2020,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,6/1/2019,mg,antineoplastic,2/17/2019,1/31/2019,Intravenous,carboplatin,FALSE
0,3,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,3/8/2023,mg,antineoplastic,10/18/2022,11/9/2022,Intravenous,bevacizumab-bvzr,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,12/4/2024,mg,antineoplastic,10/30/2024,9/16/2024,Intravenous,pembrolizumab,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,3/8/2016,mg,antineoplastic,9/15/2015,6/26/2015,Intravenous,paclitaxel,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/26/2025,mg,antineoplastic,12/5/2015,1/3/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/10/2022,,antineoplastic,8/13/2021,8/11/2021,Intravenous,amivantamab-vmjw,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,3/27/2024,,antineoplastic,3/28/2024,2/10/2024,,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,11/8/2023,mg,antineoplastic,5/26/2023,11/19/2022,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4BFGE1G7646C,4/18/2020,,,4/14/2020,12/6/2019,Oral,osimertinib,FALSE
483,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/7/2025,mg,antineoplastic,1/27/2020,2/25/2019,Intravenous,carboplatin,FALSE
735,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/15/2021,mg,antineoplastic,10/9/2021,9/11/2021,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/18/2025,mg,antineoplastic,3/14/2025,4/29/2024,Intravenous,carboplatin,FALSE
575,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,4/12/2025,mg,antineoplastic,9/14/2024,9/1/2024,Intravenous,durvalumab,FALSE
1050,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/14/2024,mg,antineoplastic,9/23/2023,10/29/2023,Intravenous,amivantamab-vmjw,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/21/2025,mg,antineoplastic,11/18/2019,2/11/2018,Intravenous,nivolumab,FALSE
99.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/20/2021,mg,antineoplastic,3/27/2021,4/23/2021,Intravenous,paclitaxel,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/5/2017,mg,antineoplastic,4/23/2017,4/23/2017,Intravenous,paclitaxel,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/5/2025,mg,antineoplastic,12/5/2024,6/29/2024,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,4/18/2020,mg,antineoplastic,9/10/2018,6/25/2018,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,4/3/2025,mg,antineoplastic,2/9/2025,11/28/2024,Intravenous,etoposide,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,11/21/2019,mg,antineoplastic,7/16/2019,7/4/2019,Intravenous,paclitaxel,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/11/2021,mg,antineoplastic,8/4/2020,5/29/2020,Intravenous,gemcitabine,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/16/2021,mg,antineoplastic,11/29/2021,10/15/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/26/2019,mg,antineoplastic,2/24/2019,2/14/2019,Intravenous,carboplatin,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/26/2024,mg,antineoplastic,2/26/2024,2/14/2024,Intravenous,paclitaxel,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,5/16/2015,mg,antineoplastic,2/28/2015,1/21/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/25/2020,mg,antineoplastic,8/29/2019,1/1/2019,Intravenous,pembrolizumab,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/9/2022,mg,antineoplastic,10/3/2022,8/17/2022,Intravenous,carboplatin,FALSE
775,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/26/2024,mg,antineoplastic,3/11/2024,1/10/2024,Intravenous,pemetrexed,FALSE
900,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,12/22/2023,mg,antineoplastic,12/29/2023,12/26/2023,Intravenous,pemetrexed,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,6/28/2019,mg,antineoplastic,9/15/2018,2/9/2018,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/16/2025,mg,antineoplastic,2/10/2025,8/13/2024,Intravenous,atezolizumab,TRUE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/3/2023,mg,antineoplastic,6/17/2020,4/27/2020,Intravenous,carboplatin,FALSE
,4,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,7/8/2023,,,5/16/2023,1/23/2023,Oral,capmatinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/10/2019,mg,antineoplastic,3/4/2019,3/8/2016,Intravenous,nivolumab,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,9/15/2013,mg,antineoplastic,8/2/2013,4/25/2013,Intravenous,pemetrexed,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/19/2024,mg,antineoplastic,6/1/2024,5/31/2024,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/12/2025,,antineoplastic,3/17/2023,1/25/2023,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G1F482136BDE5,4/16/2017,,solution-fluid,3/16/2017,2/9/2017,Intravenous,clinical study drug,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,5/28/2023,mg,antineoplastic,5/22/2023,4/16/2023,Intravenous,paclitaxel protein-bound,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/18/2024,mg,antineoplastic,6/10/2024,4/8/2023,Intravenous,nivolumab,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/17/2019,mg,antineoplastic,7/18/2018,6/7/2018,Intravenous,fluorouracil,FALSE
775,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/31/2022,mg,antineoplastic,10/26/2021,9/10/2021,Intravenous,pemetrexed,FALSE
167,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,3/25/2023,mg,antineoplastic,2/1/2023,2/26/2023,Intravenous,cisplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,12/9/2023,,antineoplastic,2/14/2023,1/6/2023,,clinical study drug,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,12/4/2017,mg,antineoplastic,7/14/2017,5/13/2017,Intravenous,trastuzumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Pemetrexed,G49E3CE9E292G,3/9/2023,mL,solution-fluid,8/6/2020,5/6/2020,Intravenous,pemetrexed,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/25/2025,mg,antineoplastic,11/19/2023,9/26/2022,Oral,anastrozole,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/1/2023,mL,solution-fluid,5/19/2023,11/23/2022,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/24/2025,mg,antineoplastic,7/28/2018,1/27/2018,Intravenous,nivolumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,9/12/2021,mg,antineoplastic,8/30/2021,7/2/2021,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,2/6/2025,mg,antineoplastic,11/20/2024,7/9/2024,Intravenous,pembrolizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/6/2017,mg,antineoplastic,2/14/2017,12/8/2016,Intravenous,cisplatin,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/3/2013,AUC,antineoplastic,8/10/2012,7/12/2012,Intravenous,carboplatin,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/21/2024,mg,antineoplastic,10/19/2023,10/6/2023,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/26/2022,mg,antineoplastic,11/17/2019,2/20/2016,Intravenous,pemetrexed,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/20/2012,mg,antineoplastic,12/13/2011,10/1/2011,Intravenous,vinorelbine,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/22/2025,mg,antineoplastic,3/12/2021,2/6/2019,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/19/2014,mg,antineoplastic,1/5/2014,10/28/2013,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,4/13/2021,AUC,antineoplastic,12/15/2019,9/11/2019,Intravenous,carboplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/14/2017,mg,antineoplastic,9/19/2017,5/22/2017,Intravenous,gemcitabine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/7/2025,mg,antineoplastic,3/4/2025,7/3/2023,Intravenous,pembrolizumab,TRUE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,1/4/2013,mg/kg,antineoplastic,1/12/2013,12/7/2012,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/12/2025,mg,antineoplastic,3/22/2025,6/20/2024,Intravenous,pembrolizumab,FALSE
540,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,11/20/2016,mg,antineoplastic,8/24/2016,4/29/2016,Intravenous,bevacizumab,FALSE
376,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,12/7/2011,mg,antineoplastic,10/24/2011,8/21/2011,Intravenous,paclitaxel,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,9/2/2024,mg,antineoplastic,8/4/2024,7/14/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/17/2021,mg,antineoplastic,5/23/2021,5/29/2021,Intravenous,pembrolizumab,FALSE
115,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,4/30/2015,mg,antineoplastic,2/26/2015,3/22/2015,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/2/2019,mg,antineoplastic,7/23/2019,8/20/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/6/2018,mg,antineoplastic,7/20/2018,5/15/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/26/2020,mg,antineoplastic,6/7/2020,10/1/2019,Intravenous,pembrolizumab,TRUE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/20/2016,mg,antineoplastic,10/30/2015,5/17/2015,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2C4G1G76816F,5/13/2025,,antineoplastic,9/29/2017,9/19/2017,Intravenous,clinical study drug,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/4/2020,mg,antineoplastic,7/30/2019,11/8/2015,Intravenous,nivolumab,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/11/2020,mg,antineoplastic,1/27/2020,10/30/2019,Intravenous,durvalumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/17/2024,mg,antineoplastic,2/21/2024,12/18/2023,Intravenous,durvalumab,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3E76E32E795:,4/25/2020,mg,antineoplastic,4/4/2020,1/2/2020,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/25/2018,,antineoplastic,8/12/2015,7/7/2015,,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/23/2018,mg,antineoplastic,7/16/2017,5/7/2017,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/29/2023,mg,antineoplastic,11/18/2022,1/7/2023,Intravenous,atezolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/31/2020,mg,antineoplastic,7/13/2019,2/26/2019,Intravenous,pembrolizumab,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/24/2019,mg,antineoplastic,9/24/2018,7/12/2018,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/6/2019,mg,antineoplastic,1/19/2017,2/23/2016,Intravenous,nivolumab,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,8/6/2018,mg,antineoplastic,5/2/2017,6/11/2017,Intravenous,vinorelbine,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/20/2016,mg,antineoplastic,10/2/2016,3/6/2016,Intravenous,bevacizumab,TRUE
209.1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,3/17/2014,mg,antineoplastic,2/17/2014,1/2/2014,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/21/2021,mg,antineoplastic,7/2/2021,4/8/2021,Intravenous,pembrolizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/16/2024,mg,antineoplastic,10/9/2021,7/8/2020,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/16/2025,mg,antineoplastic,9/21/2024,9/17/2023,Intravenous,atezolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,4/12/2025,mg,antineoplastic,3/24/2025,12/12/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,3/26/2019,mg,antineoplastic,10/12/2017,6/7/2017,Intravenous,nivolumab,FALSE
182,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,6/21/2014,mg,antineoplastic,5/22/2014,4/5/2014,Intravenous,cisplatin,FALSE
,2,ADVANCED,Unstructured,,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/9/2023,,,12/2/2022,12/27/2022,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,5/1/2020,mg,antineoplastic,2/24/2020,12/12/2019,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/30/2016,mg,antineoplastic,3/17/2014,12/11/2013,Intravenous,cisplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,9/20/2017,mg,antineoplastic,1/21/2017,1/12/2017,Intravenous,etoposide,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,9/9/2015,mg,antineoplastic,5/12/2015,4/29/2015,Intravenous,cisplatin,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,3/18/2024,mg,antineoplastic,1/25/2024,1/3/2024,Intravenous,cisplatin,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/17/2021,mg,antineoplastic,6/18/2021,5/20/2021,Intravenous,carboplatin,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,3/1/2025,,,7/28/2024,6/27/2024,Oral,trametinib,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,3/17/2023,mg,antineoplastic,12/29/2022,11/11/2022,Intravenous,nivolumab,TRUE
1900,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,9/27/2021,mg,antineoplastic,8/4/2021,7/25/2021,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/17/2020,mg,antineoplastic,4/22/2017,2/8/2016,Intravenous,bevacizumab,TRUE
770,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,12/8/2023,mg,antineoplastic,9/11/2023,8/7/2023,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,4/2/2025,mg,antineoplastic,12/6/2024,10/20/2024,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/16/2022,mg,antineoplastic,5/9/2018,2/26/2016,Intravenous,pemetrexed,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/4/2025,mg,antineoplastic,4/9/2017,12/27/2016,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/15/2020,mg,antineoplastic,3/21/2019,8/5/2016,Intravenous,nivolumab,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/12/2021,mg,antineoplastic,10/10/2018,2/18/2018,Intravenous,durvalumab,TRUE
103,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,7/4/2020,mg,antineoplastic,5/10/2020,6/23/2020,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/22/2022,mg,antineoplastic,4/15/2017,4/16/2017,Oral,dasatinib,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/28/2020,mg,antineoplastic,7/31/2020,2/2/2020,Intravenous,bevacizumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/13/2021,mg,antineoplastic,6/28/2020,11/24/2019,Intravenous,durvalumab,TRUE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/13/2023,mg,antineoplastic,7/29/2023,10/15/2022,Intravenous,durvalumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,10/9/2024,AUC,antineoplastic,8/18/2024,6/26/2024,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/16/2025,mg,antineoplastic,3/1/2023,1/28/2019,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/23/2022,mg,antineoplastic,6/8/2021,6/15/2020,Intravenous,pembrolizumab,FALSE
1000,,ADJUVANT,Orders,hormone,Abiraterone,G2G419135CEEC,1/11/2024,mg,antineoplastic,10/31/2023,10/23/2023,Oral,abiraterone,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,12/2/2023,,antineoplastic,7/6/2023,12/7/2022,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/14/2017,mg,antineoplastic,12/27/2016,11/2/2016,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/16/2015,AUC,antineoplastic,5/23/2015,2/23/2015,Intravenous,carboplatin,FALSE
529,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/28/2022,mg,antineoplastic,6/5/2022,11/28/2021,Intravenous,pemetrexed,FALSE
80,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/21/2020,mg,antineoplastic,2/26/2020,8/11/2019,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,7/18/2019,,antineoplastic,2/9/2018,8/6/2017,Oral,anastrozole,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,9/2/2022,mg,antineoplastic,11/2/2021,6/29/2021,Intravenous,bevacizumab-bvzr,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/16/2018,mL,solution-fluid,2/18/2018,12/20/2017,Intravenous,carboplatin,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/7/2023,mg,antineoplastic,11/11/2023,9/19/2022,Intravenous,durvalumab,FALSE
,,NEOADJUVANT,Unstructured,,Osimertinib,G1G9455D2D9G7,1/14/2024,,,8/29/2023,9/8/2023,Oral,osimertinib,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/7/2020,mg,antineoplastic,12/6/2019,8/23/2019,Intravenous,durvalumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G215817D1B289,1/21/2021,mg,antineoplastic,1/4/2021,2/5/2021,Intravenous,nivolumab,FALSE
259.8,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G57:2GEC9DD36,1/8/2016,mg,antineoplastic,11/28/2015,10/28/2015,Intravenous,nivolumab,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,3/11/2025,mg,antineoplastic,1/22/2025,9/26/2024,Intravenous,durvalumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/19/2019,mg,antineoplastic,3/25/2016,3/30/2016,Intravenous,nivolumab,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G19GDC129D136,7/14/2018,mg,antineoplastic,8/18/2017,7/13/2017,Intravenous,bevacizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,7/15/2020,mg,antineoplastic,8/30/2019,1/19/2019,Intravenous,nivolumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1F482136BDE5,5/10/2017,,antineoplastic,4/2/2017,3/26/2017,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/23/2025,,antineoplastic,12/22/2021,10/14/2021,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/15/2015,,antineoplastic,5/24/2015,3/17/2015,,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/13/2023,,antineoplastic,8/28/2023,1/13/2023,,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,1/10/2018,mg,antineoplastic,8/5/2017,6/30/2017,Intravenous,nivolumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/11/2013,mg,antineoplastic,4/17/2013,5/5/2013,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,3/22/2012,mg,antineoplastic,3/3/2012,2/16/2012,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/23/2024,mg,antineoplastic,8/8/2020,7/7/2020,Intravenous,nivolumab,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/26/2024,mg,antineoplastic,9/10/2024,8/28/2024,Intravenous,carboplatin,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/2/2017,mg,antineoplastic,7/4/2017,5/28/2017,Intravenous,paclitaxel,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,4/13/2019,mg,antineoplastic,4/29/2019,3/5/2019,Intravenous,paclitaxel,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/14/2016,mg/m2,antineoplastic,10/24/2016,6/16/2016,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/8/2014,mg,antineoplastic,5/23/2014,2/19/2014,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/20/2024,mg,antineoplastic,11/3/2023,10/9/2023,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/30/2022,mg,antineoplastic,6/5/2020,12/22/2019,Intravenous,nivolumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,2/6/2015,mg,antineoplastic,10/24/2014,10/2/2014,Intravenous,docetaxel,FALSE
71.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/18/2021,mg,antineoplastic,6/13/2021,5/20/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G1:DCBB2BG56F,3/9/2022,mg,antineoplastic,4/23/2022,3/1/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/9/2025,mg,antineoplastic,6/25/2024,3/25/2020,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/14/2023,mg,antineoplastic,4/16/2018,11/10/2017,Intravenous,nivolumab,FALSE
67,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG6E1D:B1B7,4/2/2025,mg,antineoplastic,4/11/2025,5/11/2025,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3B26D:2G114C,3/30/2018,,antineoplastic,3/23/2018,12/15/2017,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G27D282B7225B,12/14/2021,,antineoplastic,7/14/2021,7/23/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/7/2023,mg,antineoplastic,7/12/2023,9/29/2021,Intravenous,pembrolizumab,TRUE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,3/8/2013,mg,antineoplastic,12/27/2012,1/15/2013,Intravenous,gemcitabine,FALSE
800,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,3/23/2022,mg,antineoplastic,2/8/2022,11/26/2021,Intravenous,pemetrexed,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/27/2025,mg,antineoplastic,12/31/2015,11/24/2015,Intravenous,paclitaxel,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/7/2020,mg,antineoplastic,8/22/2019,11/28/2018,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/31/2017,mg,antineoplastic,3/21/2017,10/25/2016,Intravenous,paclitaxel protein-bound,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/7/2024,mg,antineoplastic,4/7/2022,12/20/2021,Intravenous,durvalumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/13/2021,mg,antineoplastic,9/6/2020,10/1/2020,Oral,bicalutamide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/3/2017,mg,antineoplastic,5/18/2017,4/8/2016,Intravenous,nivolumab,FALSE
193,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/21/2020,mg,antineoplastic,9/15/2019,9/10/2019,Intravenous,carboplatin,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/28/2013,mg,antineoplastic,7/29/2013,11/23/2012,Intravenous,gemcitabine,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/11/2015,mg,antineoplastic,4/29/2015,10/14/2014,Intravenous,paclitaxel protein-bound,FALSE
400,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/18/2025,mg,antineoplastic,3/20/2025,6/10/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,10/3/2021,mg,antineoplastic,9/5/2021,9/5/2021,Intravenous,pembrolizumab,FALSE
1070,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1D:B49GGG719,11/20/2016,mg,antineoplastic,9/17/2016,7/25/2016,Intravenous,pemetrexed,TRUE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/3/2018,mL,solution-fluid,3/7/2018,12/6/2017,Intravenous,carboplatin,FALSE
103,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,6/1/2020,mg,antineoplastic,5/7/2020,5/3/2020,Intravenous,paclitaxel,FALSE
668,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/30/2022,mg,antineoplastic,11/10/2021,10/2/2021,Intravenous,rituximab-pvvr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G172GFE717:24,4/2/2020,mg,antineoplastic,2/23/2020,1/8/2020,Intravenous,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,9/17/2012,mg,antineoplastic,4/8/2012,2/18/2012,Intravenous,paclitaxel protein-bound,FALSE
640,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/22/2018,mg,antineoplastic,6/17/2018,6/12/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,10/8/2013,mg,antineoplastic,2/4/2013,3/2/2013,Intravenous,paclitaxel protein-bound,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,9/29/2021,mg/kg,antineoplastic,9/23/2021,3/21/2021,Intravenous,bevacizumab-awwb,FALSE
511,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/10/2022,mg,antineoplastic,1/29/2022,12/21/2021,Intravenous,carboplatin,FALSE
198,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,10/19/2021,mg,antineoplastic,8/5/2021,9/18/2021,Intravenous,paclitaxel,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/18/2012,mg,antineoplastic,11/25/2011,8/8/2011,Intravenous,vinorelbine,FALSE
460,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,6/18/2023,mg,antineoplastic,11/27/2022,10/21/2022,Intravenous,carboplatin,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,3/31/2012,mg,antineoplastic,2/8/2012,1/18/2012,Intravenous,vinorelbine,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,10/30/2019,mg/m2,antineoplastic,10/16/2019,8/10/2019,Intravenous,pemetrexed,FALSE
1000,2,LOCOREGIONAL,Orders,chemotherapy,Gemcitabine,G51CG28FB981G,4/27/2025,mg/m2,antineoplastic,2/9/2025,12/1/2024,Intravenous,gemcitabine,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,5/7/2013,mg,antineoplastic,3/30/2013,2/12/2013,Intravenous,carboplatin,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,2/25/2019,mg,antineoplastic,6/29/2018,4/15/2018,Intravenous,docetaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/24/2013,mg,antineoplastic,8/9/2012,12/5/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11G8BG6E719B,2/15/2025,mg,antineoplastic,12/22/2024,12/6/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/3/2020,mg,antineoplastic,7/21/2019,7/16/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/2/2019,mg,antineoplastic,9/26/2018,6/14/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,3/2/2019,mg,antineoplastic,8/3/2018,7/23/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/13/2025,mg,antineoplastic,5/26/2024,6/6/2023,Intravenous,pembrolizumab,TRUE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/18/2012,mg,antineoplastic,4/13/2012,4/12/2012,Intravenous,docetaxel,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/27/2018,mg,antineoplastic,10/1/2016,7/31/2016,Intravenous,pemetrexed,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/17/2025,mg,antineoplastic,10/5/2024,4/7/2024,Intravenous,pemetrexed,TRUE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/27/2021,mg,antineoplastic,8/19/2020,6/3/2020,Intravenous,gemcitabine,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,8/16/2018,mg,antineoplastic,5/10/2018,4/10/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G29D9FB:D1D6B,8/11/2016,,antineoplastic,9/19/2016,7/28/2016,,letrozole,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,4/20/2024,mg,antineoplastic,1/21/2021,9/3/2020,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/3/2022,,antineoplastic,3/10/2022,2/5/2022,Intravenous,carboplatin,FALSE
182,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,6/28/2014,mg,antineoplastic,5/6/2014,4/24/2014,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3::1F4G:66GE,9/25/2022,AUC,antineoplastic,9/7/2022,9/15/2022,Intravenous,carboplatin,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/11/2014,mg,antineoplastic,10/7/2014,7/20/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,4/3/2024,mg,antineoplastic,3/5/2024,11/22/2023,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/18/2022,mg,antineoplastic,7/2/2022,4/19/2022,Intravenous,ipilimumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/22/2025,mg,antineoplastic,11/1/2024,10/17/2024,Intravenous,pemetrexed,TRUE
297,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/18/2023,mg,antineoplastic,12/5/2022,11/17/2022,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,solution-fluid,Durvalumab,G49E3CE9E292G,5/22/2020,mL,solution-fluid,10/17/2019,10/28/2019,Intravenous,durvalumab,TRUE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,11/28/2014,mg,antineoplastic,2/11/2014,1/22/2014,Intravenous,cisplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/22/2013,mg/m2,antineoplastic,1/5/2013,9/27/2012,Intravenous,gemcitabine,FALSE
523,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/30/2020,mg,antineoplastic,6/16/2017,4/8/2017,Intravenous,carboplatin,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/8/2018,mg,antineoplastic,5/13/2018,6/14/2018,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3EC5EB18C676,6/28/2018,,antineoplastic,4/20/2018,3/5/2018,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/2/2019,mg,antineoplastic,9/2/2018,5/31/2018,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,Cisplatin,G1G618861EGD9,9/3/2016,mg/m2,antineoplastic,8/5/2016,7/20/2016,Intravenous,cisplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/10/2023,mg,antineoplastic,6/3/2020,3/13/2020,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,11/14/2018,mg,antineoplastic,8/15/2018,8/12/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,9/10/2018,mg,antineoplastic,7/27/2018,7/5/2018,Intravenous,pembrolizumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,9/17/2015,mg,antineoplastic,6/30/2015,3/14/2015,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/11/2021,,steroid,9/6/2020,2/8/2020,Intravenous,clinical study drug,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/13/2025,mg,antineoplastic,9/19/2022,3/28/2020,Subcutaneous,leuprolide,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/10/2023,mg,antineoplastic,11/28/2022,9/13/2022,Subcutaneous,azacitidine,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/18/2025,mg,antineoplastic,2/11/2024,2/12/2020,Intravenous,pemetrexed,TRUE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,7/21/2019,mg,antineoplastic,3/7/2019,3/9/2019,Intravenous,durvalumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/12/2014,mg,antineoplastic,5/13/2014,6/13/2014,Intravenous,paclitaxel,FALSE
440,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/22/2020,mg,antineoplastic,4/16/2020,2/21/2020,Intravenous,paclitaxel,FALSE
1350,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/27/2013,mg,antineoplastic,4/24/2013,3/17/2013,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3::1F4G:66GE,9/7/2022,mg/m2,antineoplastic,9/9/2022,8/26/2022,Intravenous,pemetrexed,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/27/2025,mg,antineoplastic,1/28/2016,12/11/2015,Intravenous,paclitaxel,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/16/2021,mg,antineoplastic,9/10/2021,7/24/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/24/2023,mg,antineoplastic,3/30/2023,4/3/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/13/2017,,solution-fluid,5/26/2016,1/24/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,4/9/2022,mg,antineoplastic,11/3/2021,11/11/2021,Intravenous,pembrolizumab,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/10/2024,mg,antineoplastic,9/3/2024,7/15/2024,Intravenous,gemcitabine,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/19/2019,mL,solution-fluid,8/15/2019,8/12/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/21/2014,AUC,antineoplastic,2/4/2014,11/12/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/18/2012,,antineoplastic,11/7/2011,9/7/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/17/2023,mg,antineoplastic,9/22/2022,7/27/2022,Intravenous,pembrolizumab,FALSE
301,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,2/15/2024,mg,antineoplastic,12/5/2023,11/19/2023,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G16C41789C1C5,6/8/2021,mg,antineoplastic,4/19/2021,1/29/2021,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/20/2018,mg,antineoplastic,1/28/2018,3/12/2017,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/12/2011,mg,antineoplastic,7/13/2011,5/22/2011,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,2/28/2025,mg,antineoplastic,3/26/2020,2/1/2018,Intravenous,nivolumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/20/2015,mg,antineoplastic,11/26/2014,10/23/2014,Intravenous,cisplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/21/2025,mg,antineoplastic,10/27/2020,4/6/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,1/23/2020,,antineoplastic,12/10/2017,8/8/2017,Intravenous,pemetrexed,TRUE
660,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/27/2023,mg,antineoplastic,6/4/2022,9/14/2021,Intravenous,rituximab-pvvr,FALSE
695,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/30/2023,mg,antineoplastic,11/29/2022,8/11/2022,Intravenous,pemetrexed,TRUE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/3/2012,mg,antineoplastic,4/22/2012,5/12/2012,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/9/2022,mg,antineoplastic,5/2/2016,1/11/2016,Intravenous,pemetrexed,FALSE
660,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,6/1/2017,mg,antineoplastic,3/29/2017,10/10/2016,Intravenous,pemetrexed,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/5/2020,mg,antineoplastic,11/2/2019,9/6/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/6/2025,mg,antineoplastic,11/4/2023,6/4/2022,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/10/2019,mg,antineoplastic,2/8/2018,9/22/2017,Intravenous,pembrolizumab,FALSE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,3/28/2012,mg,antineoplastic,10/13/2011,3/18/2011,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/27/2017,,antineoplastic,10/30/2017,9/26/2017,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/24/2025,,antineoplastic,9/4/2023,1/22/2023,,clinical study drug,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,5/22/2021,,antineoplastic,7/22/2020,8/10/2020,,niraparib,FALSE
1632,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,3/15/2025,mg,antineoplastic,6/24/2024,4/23/2024,Intravenous,bevacizumab-awwb,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G2G76D1E7GG61,2/19/2015,mL,solution-fluid,12/1/2014,12/4/2014,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/18/2013,mg,antineoplastic,11/15/2012,1/14/2012,Intravenous,carboplatin,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/20/2024,mg,antineoplastic,7/27/2024,10/4/2023,Intravenous,durvalumab,FALSE
2000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/20/2013,mg,antineoplastic,7/20/2012,7/26/2012,Intravenous,gemcitabine,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/21/2017,mg,antineoplastic,7/11/2016,5/7/2016,Intravenous,paclitaxel protein-bound,FALSE
1130,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/29/2020,mg,antineoplastic,7/20/2014,4/11/2014,Intravenous,cyclophosphamide,FALSE
600,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,7/28/2019,mg,antineoplastic,6/25/2019,4/20/2019,Intravenous,ramucirumab,FALSE
105,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/12/2022,mg,antineoplastic,10/19/2021,11/6/2021,Intravenous,oxaliplatin,FALSE
668,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,4/1/2023,mg,antineoplastic,2/9/2023,11/20/2022,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3:C9BECD3F55,11/18/2020,mg,antineoplastic,9/20/2020,8/17/2020,Intravenous,docetaxel,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/11/2022,mg,antineoplastic,3/5/2022,1/11/2022,Intravenous,paclitaxel,FALSE
366,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/2/2021,mg,antineoplastic,11/1/2021,8/7/2021,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,4/24/2025,mg,antineoplastic,3/1/2025,2/25/2025,Intravenous,carboplatin,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/5/2016,mg,antineoplastic,8/7/2015,4/19/2015,Intravenous,nivolumab,FALSE
832,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,10/7/2021,mg,antineoplastic,10/6/2021,8/30/2021,Intravenous,pemetrexed,FALSE
2000,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,10/8/2021,mg,antineoplastic,7/25/2021,7/16/2021,Intravenous,gemcitabine,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/21/2011,mg,antineoplastic,9/30/2011,9/10/2011,Intravenous,paclitaxel,FALSE
980,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G5:919981B622,9/21/2023,mg,antineoplastic,6/1/2023,7/22/2023,Intravenous,durvalumab,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/29/2013,mg,antineoplastic,3/20/2013,1/15/2013,Intravenous,paclitaxel protein-bound,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G266E6248F531,8/8/2018,mg,antineoplastic,6/5/2018,4/21/2018,Intravenous,bevacizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/28/2025,mg,antineoplastic,2/15/2025,7/18/2021,Intravenous,atezolizumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/22/2020,mg,antineoplastic,7/4/2019,12/24/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/29/2021,,antineoplastic,7/12/2021,6/30/2021,Intravenous,pemetrexed,FALSE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/30/2013,mg,antineoplastic,10/3/2012,7/27/2012,Intravenous,gemcitabine,FALSE
35,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/17/2013,mg/m2,antineoplastic,9/9/2012,5/6/2012,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/28/2021,mg,antineoplastic,7/25/2019,6/7/2019,Intravenous,nivolumab,FALSE
660,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/3/2022,mg,antineoplastic,5/30/2022,12/20/2021,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,10/23/2021,mg/m2,antineoplastic,9/28/2021,8/3/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,12/3/2021,mg,antineoplastic,9/25/2021,9/5/2021,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/22/2025,mg,antineoplastic,8/22/2024,5/6/2023,Intravenous,pembrolizumab,FALSE
1015,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,7/24/2018,mg,antineoplastic,2/13/2018,1/23/2018,Intravenous,pemetrexed,FALSE
371,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,5/21/2022,mg,antineoplastic,12/10/2021,12/9/2021,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/14/2023,,antineoplastic,12/22/2022,10/8/2022,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/18/2020,mg,antineoplastic,3/6/2020,2/19/2020,Intravenous,carboplatin,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,6/8/2023,mg,antineoplastic,5/26/2023,4/14/2023,Intravenous,pemetrexed,FALSE
1564,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,11/24/2015,mg,antineoplastic,11/27/2015,10/28/2015,Intravenous,bevacizumab,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/14/2023,mg,antineoplastic,7/5/2020,5/8/2020,Intravenous,pemetrexed,FALSE
315,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G25C3661FG6B9,5/22/2015,mg,antineoplastic,3/25/2015,3/4/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/10/2024,mg,antineoplastic,4/8/2024,9/4/2023,Intravenous,nivolumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/16/2024,mg,antineoplastic,4/28/2023,2/8/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,4/23/2024,,pain agent,8/17/2023,6/18/2023,Oral,clinical study drug,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,9/22/2022,mg,antineoplastic,1/26/2022,10/31/2021,Intravenous,pemetrexed,TRUE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/20/2025,,steroid,12/12/2024,12/17/2024,Intravenous,clinical study drug,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/12/2016,mg,antineoplastic,12/30/2015,12/25/2015,Intravenous,paclitaxel,FALSE
265,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/24/2024,mg,antineoplastic,9/23/2023,8/31/2023,Intravenous,carboplatin,FALSE
15,4,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,4/6/2022,mg/kg,antineoplastic,12/27/2021,1/15/2022,Intravenous,bevacizumab-bvzr,FALSE
1055,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,1/21/2016,mg,antineoplastic,6/22/2015,5/5/2015,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/22/2025,mg,antineoplastic,4/23/2024,3/14/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/1/2022,mg,antineoplastic,6/24/2022,6/1/2022,Intravenous,pembrolizumab,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/15/2022,mg,antineoplastic,3/5/2021,3/5/2021,Intravenous,bevacizumab-awwb,FALSE
226,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G18:439734B::,12/31/2015,mg,antineoplastic,11/11/2015,9/24/2015,Intravenous,nivolumab,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/13/2018,mg,antineoplastic,5/14/2018,6/7/2018,Intravenous,etoposide,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/12/2024,mg,antineoplastic,7/10/2024,7/26/2024,Intravenous,paclitaxel protein-bound,FALSE
1030,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,10/11/2020,mg,antineoplastic,8/9/2020,7/10/2020,Intravenous,pemetrexed,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/18/2017,mg,antineoplastic,11/8/2016,6/22/2015,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,7/29/2023,mg,antineoplastic,5/28/2023,4/28/2023,Intravenous,pembrolizumab,FALSE
22.5,,NEOADJUVANT,Administrations,hormone,Leuprolide,G1D41F368EE:G,3/7/2019,mg,antineoplastic,3/6/2019,2/16/2019,Subcutaneous,leuprolide,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/25/2023,mg,antineoplastic,6/18/2022,5/30/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/15/2020,mg,antineoplastic,11/6/2019,12/7/2018,Intravenous,pembrolizumab,TRUE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/10/2015,mg,antineoplastic,9/13/2015,8/24/2014,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/13/2021,mg/m2,antineoplastic,4/27/2021,3/24/2021,Intravenous,fluorouracil,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/20/2016,mg,antineoplastic,9/4/2016,8/4/2016,Intravenous,necitumumab,FALSE
510,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,10/22/2016,mg,antineoplastic,8/26/2016,9/22/2016,Intravenous,carboplatin,FALSE
130,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,12/1/2018,mg,antineoplastic,9/12/2018,9/24/2018,Intravenous,carboplatin,FALSE
72,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/5/2018,mg,antineoplastic,10/4/2018,10/19/2018,Intravenous,paclitaxel,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/10/2015,mg,antineoplastic,12/6/2014,11/6/2014,Intravenous,bevacizumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/23/2022,mg,antineoplastic,12/19/2021,7/3/2021,Intravenous,amivantamab-vmjw,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,12/29/2022,,antineoplastic,10/29/2022,10/15/2022,Intravenous,bevacizumab-awwb,FALSE
360,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G287777772FGE,1/4/2023,mg,antineoplastic,12/29/2022,1/3/2023,Intravenous,paclitaxel,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,9/16/2015,mg,antineoplastic,6/5/2015,5/25/2015,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/16/2021,mL,solution-fluid,5/5/2021,4/3/2021,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/11/2019,mg,antineoplastic,11/12/2016,4/3/2016,Intravenous,nivolumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,8/9/2015,mg,antineoplastic,4/2/2015,9/28/2014,Intravenous,paclitaxel protein-bound,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,10/4/2016,mg,antineoplastic,11/21/2014,10/21/2014,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/25/2025,mg,antineoplastic,4/20/2019,2/7/2019,Intravenous,pembrolizumab,TRUE
128,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/1/2023,mg,antineoplastic,6/2/2023,5/9/2023,Intravenous,cisplatin,FALSE
2,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/24/2013,AUC,antineoplastic,9/11/2013,5/16/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/16/2018,,antineoplastic,6/7/2015,6/30/2015,,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/13/2024,mg,antineoplastic,12/28/2023,12/11/2023,Intravenous,durvalumab,FALSE
1025,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,1/4/2024,mg,antineoplastic,12/10/2023,8/28/2023,Intravenous,pemetrexed,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/26/2022,mg,antineoplastic,9/13/2021,6/21/2021,Intravenous,pemetrexed,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/17/2019,mg,antineoplastic,8/8/2018,6/30/2018,Intravenous,fluorouracil,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/30/2018,,antineoplastic,7/16/2017,5/31/2017,,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/16/2023,mg,antineoplastic,10/30/2022,10/24/2022,Intravenous,atezolizumab,FALSE
600,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,7/23/2018,mg,antineoplastic,5/27/2018,5/6/2018,Intravenous,pemetrexed,FALSE
50,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/14/2013,mg/m2,antineoplastic,8/14/2013,6/15/2013,Intravenous,etoposide,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/26/2024,mg,antineoplastic,5/12/2023,12/5/2021,Intravenous,nivolumab,TRUE
160,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:3B43D3B55G,3/7/2024,mg,antineoplastic,10/30/2023,11/9/2023,Intravenous,cisplatin,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,3/10/2022,mg,antineoplastic,12/23/2021,11/15/2021,Intravenous,pemetrexed,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G2745:9D5G3DG,4/8/2012,mg,antineoplastic,3/15/2012,3/20/2012,Intravenous,docetaxel,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/19/2013,mg,antineoplastic,5/18/2012,5/14/2012,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/25/2019,mg,antineoplastic,12/8/2018,5/28/2018,Intravenous,nivolumab,FALSE
43,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/12/2023,mg,antineoplastic,1/17/2023,10/6/2022,Intravenous,leucovorin,FALSE
945,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,12/8/2016,mg,antineoplastic,8/15/2016,5/31/2016,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,5/30/2018,mg,antineoplastic,2/17/2017,8/7/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,10/15/2019,,antineoplastic,8/13/2019,8/29/2019,,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,11/5/2018,mg,antineoplastic,3/19/2013,2/22/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/6/2015,,antineoplastic,7/25/2015,3/20/2015,,pemetrexed,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,4/19/2015,mg,antineoplastic,4/22/2015,5/7/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/7/2025,mg,antineoplastic,8/31/2024,4/24/2024,Intravenous,pembrolizumab,FALSE
47,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3ED9686E8628,6/8/2014,mg,antineoplastic,2/6/2014,1/26/2014,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/27/2025,,antineoplastic,11/28/2024,3/3/2023,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,1/24/2018,4/23/2017,Intravenous,nivolumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/10/2023,mg,antineoplastic,5/27/2020,9/22/2019,Intravenous,pembrolizumab,TRUE
1090,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,3/1/2024,mg,antineoplastic,1/19/2024,1/25/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/3/2025,,antineoplastic,10/15/2017,11/7/2017,Intravenous,clinical study drug,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/20/2017,mg,antineoplastic,8/1/2017,4/13/2017,Intravenous,trastuzumab,FALSE
550.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,4/8/2018,mg,antineoplastic,2/24/2018,2/26/2018,Intravenous,carboplatin,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/27/2016,mg,antineoplastic,12/20/2015,10/8/2015,Intravenous,etoposide,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/29/2025,mg,antineoplastic,7/17/2024,4/8/2024,Intravenous,pemetrexed,FALSE
248,,ADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,8/26/2014,mg,antineoplastic,7/21/2014,5/17/2014,Intravenous,ado-trastuzumab emtansine,FALSE
199,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,6/9/2022,mg,antineoplastic,2/9/2022,1/7/2022,Intravenous,carboplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/26/2019,mg,antineoplastic,8/31/2018,7/25/2018,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/27/2024,mg,antineoplastic,10/18/2023,11/29/2022,Intravenous,nivolumab,FALSE
37,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,5/8/2016,mg,antineoplastic,4/6/2016,4/8/2016,Intravenous,cisplatin,FALSE
464.4,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/4/2015,mg,antineoplastic,1/17/2015,11/15/2014,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,3/21/2020,mg,antineoplastic,1/3/2020,12/7/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/10/2013,AUC,antineoplastic,12/26/2012,10/24/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,8/3/2020,,antineoplastic,4/29/2019,2/23/2019,,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/12/2018,mg,antineoplastic,11/5/2017,9/20/2015,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/2/2025,mg,antineoplastic,3/2/2024,2/6/2017,Intravenous,pembrolizumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,5/6/2016,mg,antineoplastic,4/26/2014,5/6/2014,Intravenous,paclitaxel,FALSE
174,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,8/6/2022,mg,antineoplastic,6/26/2022,5/26/2022,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,10/27/2021,mg,antineoplastic,2/1/2021,12/18/2020,Intravenous,paclitaxel protein-bound,FALSE
231,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/13/2016,mg,antineoplastic,5/29/2016,12/4/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,6/21/2022,mg,antineoplastic,3/31/2021,7/31/2020,Intravenous,pembrolizumab,TRUE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/11/2013,mg,antineoplastic,4/18/2013,5/12/2013,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,5/11/2025,mg,antineoplastic,2/25/2025,3/1/2025,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/13/2016,mg,antineoplastic,12/14/2014,12/4/2014,Intravenous,gemcitabine,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/20/2012,mg,antineoplastic,4/20/2012,4/24/2012,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/22/2025,mg,antineoplastic,8/26/2024,3/10/2024,Intravenous,durvalumab,TRUE
83,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/22/2023,mg,antineoplastic,2/5/2023,3/16/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/19/2025,mg,antineoplastic,7/27/2020,4/1/2020,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/18/2023,,antineoplastic,11/16/2022,9/20/2022,Intravenous,carboplatin,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,4/2/2018,mg/m2,antineoplastic,9/14/2014,8/7/2014,Intravenous,paclitaxel,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/12/2014,mg,antineoplastic,3/7/2014,1/18/2014,Intravenous,cisplatin,FALSE
1075,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/13/2023,mg,antineoplastic,3/9/2020,1/29/2020,Intravenous,pemetrexed,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,12/25/2024,mg,antineoplastic,9/13/2024,4/30/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27456:36F5D8,6/13/2019,mg,antineoplastic,7/6/2019,7/9/2019,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/25/2024,mg,antineoplastic,8/8/2022,3/13/2022,Intravenous,durvalumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/19/2023,mg,antineoplastic,7/8/2023,11/23/2022,Intravenous,atezolizumab,FALSE
1600,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,6/10/2022,mg,antineoplastic,6/13/2022,3/24/2022,Intravenous,bevacizumab-awwb,FALSE
150,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/12/2013,mg,antineoplastic,4/28/2013,5/15/2013,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/14/2021,mg/kg,antineoplastic,8/25/2021,4/2/2021,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,10/31/2024,,antineoplastic,10/9/2024,6/15/2024,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/22/2022,mg,antineoplastic,1/3/2022,6/28/2021,Intravenous,pembrolizumab,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,11/24/2022,mg,antineoplastic,10/16/2022,5/19/2022,Intravenous,nivolumab,FALSE
380,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/28/2021,mg,antineoplastic,6/20/2021,5/5/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,4/14/2022,,cytoprotective,12/25/2021,1/23/2022,Intramuscular,clinical study drug,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/13/2023,mg,antineoplastic,2/1/2019,10/26/2017,Intravenous,nivolumab,FALSE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/26/2013,mg,antineoplastic,12/22/2012,1/7/2013,Intravenous,gemcitabine,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/20/2023,mg,antineoplastic,9/29/2023,9/8/2023,Intravenous,paclitaxel,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,12/13/2023,mg/kg,antineoplastic,10/25/2023,10/1/2023,Intravenous,ramucirumab,FALSE
125,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,8/27/2021,mg,antineoplastic,8/29/2021,10/4/2021,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/15/2015,mg,antineoplastic,7/19/2015,2/26/2015,Intravenous,paclitaxel protein-bound,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G26D38EC278C1,6/27/2019,mg,antineoplastic,3/12/2019,2/15/2019,Intravenous,atezolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/8/2013,mg,antineoplastic,12/17/2012,11/25/2011,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/23/2019,mg,antineoplastic,7/18/2018,2/20/2018,Intravenous,nivolumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/16/2023,mg,antineoplastic,2/1/2023,6/1/2022,Intravenous,durvalumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/10/2025,mg,antineoplastic,2/11/2023,8/9/2022,Oral,anastrozole,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/15/2024,mg,antineoplastic,12/28/2022,12/12/2021,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/16/2025,mg,antineoplastic,10/24/2022,9/26/2022,Intravenous,pembrolizumab,TRUE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/12/2016,mg,antineoplastic,1/11/2016,1/11/2016,Intravenous,carboplatin,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/4/2016,mg,antineoplastic,12/23/2015,1/27/2016,Intravenous,paclitaxel,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,2/10/2023,mg,antineoplastic,10/23/2022,7/31/2022,Intravenous,durvalumab,TRUE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,5/23/2015,mg,antineoplastic,2/17/2015,2/19/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/19/2020,mg,antineoplastic,7/30/2018,1/5/2018,Intravenous,pembrolizumab,TRUE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/10/2025,mg,antineoplastic,9/7/2020,2/8/2020,Intravenous,pemetrexed,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/16/2020,mg,antineoplastic,5/26/2020,8/11/2016,Intravenous,nivolumab,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/24/2024,mg,antineoplastic,4/20/2024,4/15/2024,Intravenous,pemetrexed,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/2/2023,mg,antineoplastic,3/17/2023,2/22/2023,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G557E997E81G5,8/29/2022,mg,antineoplastic,3/4/2022,1/29/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/21/2020,mg,antineoplastic,11/4/2019,12/14/2018,Intravenous,pembrolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1FG3GD3:9D:3,5/8/2025,mg/kg,antineoplastic,1/12/2025,9/5/2024,Intravenous,durvalumab,FALSE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/16/2024,mg,antineoplastic,9/29/2024,6/28/2024,Intravenous,gemcitabine,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,8/7/2012,mg,antineoplastic,4/19/2012,3/18/2012,Intravenous,carboplatin,FALSE
500,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/20/2017,mg,antineoplastic,10/7/2017,7/17/2017,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4725296E3CE4,3/4/2022,,,9/19/2021,9/15/2021,Oral,erlotinib,TRUE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,2/19/2020,mg,antineoplastic,9/20/2018,8/13/2018,Intravenous,durvalumab,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/31/2020,mg,antineoplastic,7/24/2020,7/15/2020,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/26/2023,mg,antineoplastic,6/6/2020,6/9/2020,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/14/2022,mg,antineoplastic,11/6/2018,5/26/2017,Intravenous,nivolumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1978F5FFE:43,9/7/2014,mg,antineoplastic,7/20/2014,7/3/2014,Intravenous,pemetrexed,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/16/2013,mg,antineoplastic,5/26/2013,4/3/2013,Intravenous,paclitaxel,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/29/2018,mL,solution-fluid,6/4/2015,7/16/2015,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/17/2021,mg,antineoplastic,2/19/2021,12/6/2018,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/20/2012,,steroid,1/8/2012,10/18/2011,Intravenous,clinical study drug,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/17/2025,mg,antineoplastic,8/27/2024,5/6/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/8/2025,mg,antineoplastic,6/13/2021,3/22/2020,Intravenous,pembrolizumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,3/29/2023,mg,antineoplastic,4/29/2020,1/28/2020,Intravenous,gemcitabine,FALSE
240,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/17/2019,mg,antineoplastic,7/22/2019,8/4/2019,Intravenous,irinotecan,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/3/2014,AUC,antineoplastic,4/5/2014,12/1/2013,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/30/2016,mg,antineoplastic,6/23/2016,6/23/2016,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/23/2015,mg,antineoplastic,5/15/2015,2/21/2015,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,3/18/2020,mg,antineoplastic,1/19/2020,1/17/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,4/7/2021,mg,antineoplastic,2/7/2021,12/18/2020,Intravenous,pembrolizumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/24/2015,mg,antineoplastic,12/11/2014,10/2/2014,Intravenous,paclitaxel,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,3/4/2020,mg,antineoplastic,12/18/2019,11/12/2019,Intravenous,paclitaxel,FALSE
794,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2E14:97G:FFD,4/11/2019,mg,antineoplastic,4/29/2019,4/4/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/21/2023,mg,antineoplastic,5/7/2021,5/1/2020,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G5792EBE:8EB3,1/4/2013,mg/m2,antineoplastic,11/3/2012,9/12/2012,Intravenous,gemcitabine,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/20/2022,mg,antineoplastic,1/3/2022,8/7/2021,Intravenous,amivantamab-vmjw,FALSE
593.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G173G:4FD7E,2/26/2014,mg,antineoplastic,12/25/2013,2/15/2014,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,5/11/2019,mg,antineoplastic,4/22/2019,2/2/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/7/2025,mg,antineoplastic,11/9/2024,3/23/2024,Intravenous,pembrolizumab,TRUE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/8/2024,mg,antineoplastic,4/30/2024,9/26/2023,Intravenous,durvalumab,TRUE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,1/17/2020,mg,antineoplastic,9/25/2019,8/28/2019,Intravenous,durvalumab,FALSE
525,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,11/10/2015,mg,antineoplastic,10/9/2015,8/10/2015,Intravenous,carboplatin,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,10/7/2013,mg,antineoplastic,9/30/2013,4/4/2013,Intravenous,pemetrexed,FALSE
950,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G298FGDFDG8E7,4/27/2023,mg,antineoplastic,1/16/2020,12/15/2019,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/11/2016,mg,antineoplastic,10/18/2016,3/1/2016,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/31/2024,,antineoplastic,3/24/2023,3/15/2023,Intravenous,docetaxel,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/9/2018,mg,antineoplastic,9/11/2016,8/25/2015,Intravenous,nivolumab,FALSE
113,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/27/2019,mg,antineoplastic,9/30/2017,8/18/2017,Intravenous,cisplatin,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11DC:E9G171F,5/11/2020,mg,antineoplastic,5/13/2020,4/3/2020,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,3/5/2025,mg,antineoplastic,2/20/2025,1/28/2025,Intravenous,pembrolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/13/2025,mg,antineoplastic,9/14/2022,2/12/2019,Intravenous,pemetrexed,FALSE
564.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/10/2019,mg,antineoplastic,11/22/2018,10/27/2018,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/10/2022,,antineoplastic,8/18/2019,5/14/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,9/27/2024,mg,antineoplastic,8/26/2024,7/27/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/2/2025,,antineoplastic,6/15/2024,6/16/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,targeted/non-biologic,"Decitabine,Venetoclax",G41DE1E3BE99:,6/26/2024,mg,antineoplastic,7/28/2024,7/11/2024,Oral,venetoclax,FALSE
900,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G557E997E81G5,7/11/2023,mg,antineoplastic,4/2/2023,3/19/2023,Intravenous,ramucirumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/24/2025,mg,antineoplastic,11/25/2024,9/27/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/19/2018,mg,antineoplastic,3/23/2017,4/19/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,10/22/2020,,antineoplastic,10/24/2020,9/13/2020,Oral,anastrozole,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/23/2015,mg,antineoplastic,8/5/2015,3/27/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/14/2025,mg,antineoplastic,5/29/2024,4/23/2024,Intravenous,pembrolizumab,FALSE
1005,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,2/1/2019,mg,antineoplastic,4/18/2017,3/8/2017,Intravenous,pemetrexed,TRUE
400,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/28/2025,mg,antineoplastic,1/15/2025,6/23/2024,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/16/2024,mg,antineoplastic,1/27/2024,5/31/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/12/2025,mg,antineoplastic,6/25/2018,4/12/2018,Intravenous,pembrolizumab,FALSE
527,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,1/21/2023,mg,antineoplastic,12/12/2022,11/30/2022,Intravenous,carboplatin,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/19/2017,mg,antineoplastic,1/16/2017,10/5/2016,Intravenous,paclitaxel protein-bound,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/22/2019,mg,antineoplastic,2/16/2017,10/28/2016,Intramuscular,fulvestrant,FALSE
435,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/17/2016,mg,antineoplastic,10/13/2015,9/3/2015,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,11/21/2016,mg,antineoplastic,10/27/2016,8/31/2016,Intravenous,cisplatin,FALSE
260,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,2/8/2015,mg,antineoplastic,10/20/2014,9/13/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,6/1/2019,mg,antineoplastic,3/7/2019,3/25/2019,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,1/23/2012,AUC,antineoplastic,11/30/2011,12/20/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/8/2025,mg,antineoplastic,8/20/2022,2/18/2019,Intravenous,pembrolizumab,TRUE
492,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,10/13/2015,mg,antineoplastic,9/11/2015,9/11/2015,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/1/2025,mg,antineoplastic,2/16/2025,1/6/2017,Intravenous,pembrolizumab,FALSE
1280,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/12/2013,mg,antineoplastic,4/17/2013,12/8/2012,Intravenous,cyclophosphamide,FALSE
85,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,6/13/2015,mg,antineoplastic,5/13/2015,3/24/2015,Intravenous,paclitaxel,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,6/20/2018,mg,antineoplastic,3/26/2018,12/11/2017,Intravenous,nivolumab,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,7/4/2024,mg,antineoplastic,4/24/2024,4/21/2024,Intravenous,gemcitabine,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,5/6/2016,mg,antineoplastic,12/13/2015,10/24/2015,Intravenous,docetaxel,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3EC2153F:341,7/12/2020,mg,antineoplastic,6/11/2020,6/6/2020,Intravenous,carboplatin,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/11/2021,mg,antineoplastic,2/15/2019,2/21/2018,Intravenous,durvalumab,TRUE
90,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,2/2/2021,mg,antineoplastic,9/20/2020,6/16/2020,Intravenous,docetaxel,FALSE
1180,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/4/2023,mg,antineoplastic,10/17/2022,11/14/2022,Intravenous,cyclophosphamide,FALSE
1666,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/15/2013,mg/m2,antineoplastic,1/26/2013,1/17/2013,Intravenous,ifosfamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/3/2023,mg,antineoplastic,6/10/2023,2/8/2022,Intravenous,pembrolizumab,TRUE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/10/2017,mg,antineoplastic,8/30/2017,5/7/2017,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GE686D11C25,3/28/2015,mg,antineoplastic,3/30/2015,2/20/2015,Intravenous,carboplatin,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,3/25/2014,mg,antineoplastic,2/26/2014,2/19/2014,Intravenous,docetaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/23/2016,mg,antineoplastic,3/4/2015,5/6/2014,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/26/2025,mg/m2,antineoplastic,3/28/2025,11/17/2024,Intravenous,pemetrexed,TRUE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/8/2014,mg/m2,antineoplastic,12/5/2014,8/3/2014,Intravenous,paclitaxel,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/8/2016,mg,antineoplastic,4/8/2015,12/4/2014,Intravenous,pemetrexed,FALSE
464,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/30/2021,mg,antineoplastic,10/3/2021,7/22/2021,Intravenous,carboplatin,FALSE
1025,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,7/25/2020,mg,antineoplastic,4/15/2020,4/10/2020,Intravenous,pemetrexed,FALSE
449,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/11/2025,mg,antineoplastic,12/4/2020,4/9/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4ED25F4G24F2,11/1/2018,,,11/10/2018,5/15/2018,Oral,osimertinib,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/25/2021,mg/m2,antineoplastic,4/23/2021,3/29/2021,Intravenous,leucovorin,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/17/2023,,antineoplastic,7/9/2023,2/21/2023,,anastrozole,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/10/2020,mg,antineoplastic,3/6/2018,4/4/2017,Intravenous,bevacizumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/11/2023,mg,antineoplastic,9/23/2020,12/17/2019,Intravenous,pembrolizumab,FALSE
22.5,,NEOADJUVANT,Administrations,hormone,Leuprolide,G53D3D6874EB3,4/1/2023,mg,antineoplastic,2/13/2023,1/27/2023,Subcutaneous,leuprolide,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/4/2020,,antineoplastic,1/22/2019,8/8/2017,Intravenous,pemetrexed,TRUE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/17/2017,mg,antineoplastic,7/5/2017,5/15/2017,Intravenous,trastuzumab,FALSE
640,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,1/19/2024,mg,antineoplastic,12/2/2023,1/10/2024,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,3/26/2025,,antiemetic,1/25/2025,1/2/2025,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,8/11/2021,,antineoplastic,4/15/2021,2/14/2021,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,4/11/2024,,antineoplastic,1/25/2024,10/28/2023,Oral,ivosidenib,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/9/2025,mg,antineoplastic,4/30/2025,8/23/2024,Intravenous,atezolizumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/19/2025,mg,antineoplastic,4/27/2020,2/12/2019,Intravenous,pemetrexed,TRUE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,7/23/2020,mg,antineoplastic,2/7/2020,2/12/2019,Intravenous,nivolumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/17/2024,mg,antineoplastic,2/25/2024,11/23/2023,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,8/22/2020,,antineoplastic,8/8/2020,6/4/2020,Intravenous,cisplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/25/2024,mg,antineoplastic,1/17/2024,3/28/2023,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/15/2022,,antineoplastic,3/28/2022,2/23/2022,Intravenous,carboplatin,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Rituximab",G48842BBE3634,7/8/2013,mg,antineoplastic,6/7/2013,7/3/2013,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,7/29/2018,mg,antineoplastic,7/10/2018,3/17/2018,Intravenous,nivolumab,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/16/2020,mg,antineoplastic,5/29/2020,9/7/2019,Intravenous,durvalumab,FALSE
,2,ADVANCED,Unstructured,,Alectinib,G19GDC129D136,1/10/2021,,,6/30/2018,8/1/2018,Oral,alectinib,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G7:7E:2641G,4/30/2025,mg,antineoplastic,5/10/2025,4/28/2025,Intravenous,pemetrexed,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,11/19/2023,mg,antineoplastic,1/1/2024,11/23/2023,Intravenous,carboplatin,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/10/2014,mg,antineoplastic,5/7/2014,4/4/2014,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,5/5/2019,mg,antineoplastic,8/12/2018,5/12/2018,Intravenous,nivolumab,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,7/9/2016,mg,antineoplastic,5/1/2016,5/5/2016,Intravenous,cisplatin,FALSE
114,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/2/2021,mg,antineoplastic,9/25/2021,8/27/2021,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/3/2016,,antineoplastic,6/26/2016,5/10/2016,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,6/23/2014,mg,antineoplastic,6/18/2014,4/29/2014,Intravenous,paclitaxel,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,4/13/2015,mg,antineoplastic,1/11/2015,10/30/2014,Intravenous,paclitaxel,FALSE
320,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/30/2025,mg,antineoplastic,8/10/2024,8/4/2024,Intravenous,paclitaxel,FALSE
485,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,8/8/2016,mg,antineoplastic,5/23/2016,5/28/2016,Intravenous,carboplatin,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/4/2016,mg,antineoplastic,2/6/2016,9/6/2014,Intravenous,bevacizumab,TRUE
172,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/4/2019,mg,antineoplastic,7/27/2018,3/14/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/1/2024,mg,antineoplastic,11/14/2023,6/29/2023,Intravenous,pembrolizumab,FALSE
201,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,3/3/2023,mg,antineoplastic,11/4/2022,9/25/2022,Intravenous,carboplatin,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,12/23/2013,mg/kg,antineoplastic,11/1/2013,11/10/2013,Intravenous,bevacizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/18/2025,mg,antineoplastic,11/25/2018,1/27/2017,Intravenous,nivolumab,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/17/2021,,antineoplastic,7/24/2020,7/30/2020,,clinical study drug,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/19/2022,,antineoplastic,3/17/2022,2/3/2022,Intravenous,paclitaxel,FALSE
230,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,6/4/2022,mg,antineoplastic,5/1/2022,3/18/2022,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/4/2018,mg,antineoplastic,3/4/2018,9/26/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/13/2025,mg,antineoplastic,10/31/2024,10/15/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/27/2025,mg,antineoplastic,4/7/2022,3/29/2020,Intravenous,pembrolizumab,FALSE
338,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,3/13/2025,mg,antineoplastic,4/18/2024,5/9/2024,Intravenous,carboplatin,FALSE
114,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,1/19/2019,mg,antineoplastic,1/7/2019,12/11/2018,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1DCDG73E53FF,7/13/2024,,antineoplastic,5/28/2024,4/7/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,1/11/2019,mg,antineoplastic,7/7/2018,2/26/2017,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/13/2025,,steroid,1/15/2025,12/8/2024,Intravenous,clinical study drug,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/25/2016,mg,antineoplastic,9/5/2015,7/17/2015,Intravenous,carboplatin,FALSE
1100,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G56CF8BF38D:7,10/7/2014,mg,antineoplastic,11/16/2013,11/25/2013,Intravenous,pemetrexed,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/18/2022,mg,antineoplastic,12/23/2021,2/9/2021,Intravenous,atezolizumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,1/6/2025,mg,antineoplastic,10/11/2024,9/18/2024,Intravenous,pemetrexed,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/8/2015,mg,antineoplastic,9/16/2015,5/4/2015,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/13/2021,,antineoplastic,4/5/2021,4/7/2021,,pemetrexed,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/22/2016,mg,antineoplastic,11/10/2015,5/26/2015,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/13/2022,mg,antineoplastic,8/4/2021,2/22/2016,Intravenous,pemetrexed,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/21/2025,mg,antineoplastic,2/11/2019,2/27/2019,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/13/2017,mg,antineoplastic,9/20/2017,6/21/2017,Intravenous,pemetrexed,FALSE
66.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/19/2020,mg,antineoplastic,2/29/2020,2/4/2020,Intravenous,paclitaxel,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/14/2013,mg,antineoplastic,8/14/2013,4/26/2013,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/18/2025,mg,antineoplastic,3/25/2020,3/16/2019,Intravenous,pemetrexed,FALSE
372,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,4/1/2023,mg,antineoplastic,1/5/2023,11/10/2022,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/21/2018,mg,antineoplastic,9/16/2018,8/26/2018,Intravenous,pemetrexed,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,3/21/2020,mg,antineoplastic,12/22/2019,1/27/2020,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/15/2022,mg,antineoplastic,3/10/2021,2/22/2021,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/7/2025,,solution-fluid,11/18/2017,11/16/2017,Intravenous,clinical study drug,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,4/6/2018,mg,antineoplastic,9/14/2014,8/4/2014,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,3/28/2025,,antineoplastic,11/23/2024,12/3/2024,Intravenous,clinical study drug,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5669E21B9D52,4/24/2017,mg,antineoplastic,3/5/2017,2/26/2017,Intravenous,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/20/2012,mg,antineoplastic,4/13/2012,4/6/2012,Intravenous,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,11/10/2023,mg,antineoplastic,1/29/2023,11/23/2022,Intravenous,atezolizumab,FALSE
436,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,8/28/2012,mg,antineoplastic,8/2/2012,5/15/2012,Intravenous,paclitaxel,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/29/2021,mg,antineoplastic,5/24/2021,4/10/2021,Intravenous,pemetrexed,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/19/2023,mg,antineoplastic,2/4/2023,6/4/2022,Intravenous,durvalumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,4/8/2025,mg,antineoplastic,2/2/2022,12/27/2021,Intravenous,pembrolizumab,TRUE
1520,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,7/12/2024,mg,antineoplastic,8/22/2024,8/8/2024,Intravenous,gemcitabine,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,5/15/2025,mg,antineoplastic,3/11/2022,1/15/2022,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,2/19/2024,mg,antineoplastic,2/29/2024,7/23/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/16/2025,mg,antineoplastic,11/27/2019,5/31/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/2/2025,mg,antineoplastic,11/2/2023,9/15/2022,Intravenous,pembrolizumab,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/7/2013,mg,antineoplastic,10/11/2012,12/19/2011,Intravenous,etoposide,FALSE
820,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/11/2014,mg,antineoplastic,9/23/2014,3/27/2014,Intravenous,pemetrexed,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/19/2021,mg,antineoplastic,12/30/2020,10/25/2020,Intravenous,fluorouracil,FALSE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G579E53D92:75,11/12/2011,,hematological agent,7/31/2011,8/30/2011,Subcutaneous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/18/2019,mg,antineoplastic,7/26/2018,5/3/2018,Intravenous,nivolumab,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/28/2024,mg,antineoplastic,5/21/2023,4/17/2022,Intravenous,durvalumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/28/2022,mg,antineoplastic,6/13/2019,4/9/2017,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14::E36GD8C6,4/18/2019,AUC,antineoplastic,5/6/2019,4/11/2019,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,3/14/2024,mg,antineoplastic,3/9/2024,11/3/2023,Oral,ivosidenib,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/3/2022,mg,antineoplastic,3/13/2022,2/27/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,6/12/2022,mg,antineoplastic,4/27/2022,11/15/2021,Intravenous,pembrolizumab,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/16/2025,mg,antineoplastic,5/28/2020,3/21/2019,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/13/2021,mg/m2,antineoplastic,12/5/2019,9/8/2019,Intravenous,pemetrexed,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,1/18/2016,mg,antineoplastic,11/20/2015,11/4/2015,Intravenous,gemcitabine,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/20/2023,mg,antineoplastic,7/3/2023,12/5/2022,Intravenous,durvalumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,10/1/2019,mg,antineoplastic,6/30/2019,7/1/2019,Intravenous,paclitaxel,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/6/2012,mg,antineoplastic,5/2/2012,4/16/2012,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/9/2024,mg,antineoplastic,10/23/2023,2/19/2023,Intravenous,bevacizumab-awwb,TRUE
1500,3,ADVANCED,Administrations,immunotherapy,"Anastrozole,Durvalumab",G1885B3G8447B,3/25/2025,mg,antineoplastic,9/8/2022,8/10/2022,Intravenous,durvalumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/18/2013,mg,antineoplastic,4/13/2012,12/25/2011,Intravenous,etoposide,FALSE
810,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/9/2017,mg,antineoplastic,10/6/2016,6/21/2016,Intravenous,gemcitabine,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/28/2025,mg,antineoplastic,12/8/2019,2/14/2019,Intravenous,pemetrexed,TRUE
400,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,10/29/2013,mg,antineoplastic,7/31/2013,7/9/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/11/2025,,antineoplastic,8/3/2019,2/1/2019,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,7/13/2021,,antineoplastic,6/27/2021,5/29/2021,Intravenous,pemetrexed,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/20/2024,mg,antineoplastic,3/23/2024,8/24/2023,Intravenous,durvalumab,TRUE
680,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/12/2022,mg,antineoplastic,8/4/2022,4/4/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,2/26/2025,mg,antineoplastic,10/28/2023,6/21/2023,Intravenous,pembrolizumab,TRUE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,2/22/2017,mg,antineoplastic,6/1/2016,6/29/2016,Intravenous,nivolumab,FALSE
1350,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/25/2013,mg,antineoplastic,2/17/2013,2/20/2013,Intravenous,bevacizumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,10/4/2024,mg,antineoplastic,3/24/2023,4/2/2022,Intravenous,durvalumab,TRUE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/25/2025,mg,antineoplastic,8/14/2022,3/26/2020,Intravenous,pemetrexed,TRUE
370.8,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,7/16/2018,mg,antineoplastic,2/21/2018,1/21/2018,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/26/2023,mg,antineoplastic,12/27/2017,11/2/2017,Intravenous,nivolumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/24/2024,mg,antineoplastic,11/23/2020,6/18/2020,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,12/13/2015,,antineoplastic,7/6/2015,4/3/2015,Oral,ibrutinib,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,2/27/2024,mg,antineoplastic,4/4/2024,12/11/2023,Oral,abiraterone,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,11/6/2016,,antineoplastic,9/1/2016,5/11/2016,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/18/2025,mg,antineoplastic,3/16/2025,1/29/2025,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/11/2013,mg,antineoplastic,4/15/2012,1/15/2012,Intravenous,etoposide,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/18/2024,mg,antineoplastic,11/11/2024,9/23/2024,Intravenous,temsirolimus,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/23/2020,mg,antineoplastic,6/16/2020,6/13/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/10/2020,mg,antineoplastic,12/2/2019,10/21/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,3/24/2024,,antineoplastic,11/1/2023,6/13/2023,Intravenous,clinical study drug,FALSE
348,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/16/2024,mg,antineoplastic,7/17/2024,4/26/2024,Intravenous,paclitaxel,FALSE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,8/4/2016,mg,antineoplastic,4/5/2016,3/13/2016,Intravenous,carboplatin,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/9/2022,mg,antineoplastic,1/26/2022,8/8/2021,Intravenous,amivantamab-vmjw,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/5/2017,mg,antineoplastic,5/11/2017,12/7/2016,Intravenous,nivolumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/10/2023,mg,antineoplastic,3/5/2023,5/28/2022,Intravenous,durvalumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/8/2019,mg,antineoplastic,3/29/2019,12/10/2018,Intravenous,paclitaxel protein-bound,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/14/2022,mg,antineoplastic,9/3/2020,9/25/2020,Intravenous,ipilimumab,FALSE
168.6,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/6/2017,mg,antineoplastic,8/20/2016,8/24/2016,Intravenous,nivolumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/27/2023,mg,antineoplastic,10/5/2023,6/3/2023,Intravenous,durvalumab,FALSE
750,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,12/30/2013,mg,antineoplastic,12/29/2013,9/29/2013,Intravenous,bevacizumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/25/2024,mg,antineoplastic,8/12/2024,6/18/2024,Intravenous,paclitaxel protein-bound,FALSE
60,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,2/22/2023,mg,antineoplastic,12/12/2022,12/6/2022,Intravenous,ipilimumab,TRUE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/6/2020,mg,antineoplastic,4/11/2020,1/18/2019,Subcutaneous,bortezomib,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G2G22BF9DCG81,5/27/2023,mg,antineoplastic,4/21/2023,4/26/2023,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,4/12/2018,mg/m2,antineoplastic,12/9/2017,9/1/2017,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,12/18/2017,mg,antineoplastic,11/30/2017,9/12/2017,Intravenous,pembrolizumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/18/2012,mg,antineoplastic,2/11/2012,1/2/2012,Intravenous,etoposide,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/19/2016,mg,antineoplastic,9/28/2015,10/29/2014,Intravenous,bevacizumab,TRUE
1200,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,11/13/2023,mg,antineoplastic,2/27/2023,1/10/2023,Intravenous,cyclophosphamide,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/26/2015,mg,antineoplastic,4/17/2015,9/29/2014,Intravenous,paclitaxel protein-bound,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/2/2019,mg,antineoplastic,12/3/2018,11/29/2018,Intravenous,pemetrexed,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/24/2020,mg,antineoplastic,6/25/2020,6/25/2020,Intravenous,carboplatin,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/12/2024,mg,antineoplastic,8/29/2023,7/26/2023,Intravenous,paclitaxel protein-bound,FALSE
2020,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,6/28/2013,mg,antineoplastic,9/18/2012,8/10/2012,Intravenous,gemcitabine,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G42D:4D9G6157,12/17/2023,mg/kg,antineoplastic,9/7/2023,8/25/2023,Intravenous,durvalumab,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/5/2014,mg,antineoplastic,9/14/2014,5/24/2014,Intravenous,vinorelbine,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/27/2020,mg,antineoplastic,4/21/2020,9/16/2019,Intravenous,durvalumab,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/24/2024,mg,antineoplastic,7/2/2024,4/29/2024,Intravenous,paclitaxel,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/25/2018,mg,antineoplastic,3/22/2018,10/30/2017,Intravenous,trastuzumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/17/2023,mg,antineoplastic,6/19/2023,4/9/2023,Intravenous,atezolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/30/2019,mg,antineoplastic,5/17/2017,3/26/2016,Intravenous,nivolumab,FALSE
251,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1E3BGE6C42B6,10/12/2024,mg,antineoplastic,10/17/2024,10/26/2024,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G177G4:B9E394,4/22/2025,,solution-fluid,4/21/2025,4/13/2025,Intravenous,clinical study drug,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,10/23/2018,mg,antineoplastic,7/31/2018,8/7/2018,Intravenous,carboplatin,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,2/19/2013,mg,antineoplastic,2/5/2013,1/26/2013,Intravenous,carboplatin,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/18/2020,mg,antineoplastic,6/1/2020,3/8/2020,Intravenous,carboplatin,FALSE
442,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,10/28/2024,mg,antineoplastic,8/26/2024,8/6/2024,Intravenous,carboplatin,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/24/2024,mg,antineoplastic,7/3/2023,8/14/2023,Intravenous,gemcitabine,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/1/2024,mg,antineoplastic,10/19/2024,9/9/2024,Intravenous,temsirolimus,FALSE
179,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:64BD9C5919,8/26/2021,mg,antineoplastic,8/20/2021,7/28/2021,Intravenous,cisplatin,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,7/23/2024,mg,antineoplastic,6/12/2024,5/20/2024,Intravenous,etoposide,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,4/9/2017,mg,antineoplastic,6/24/2016,3/19/2015,Intravenous,bevacizumab,TRUE
524,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,9/1/2024,mg,antineoplastic,8/13/2024,8/28/2024,Intravenous,carboplatin,FALSE
1040,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/13/2015,mg,antineoplastic,2/5/2015,11/17/2014,Intravenous,pemetrexed,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/18/2013,mg,antineoplastic,6/23/2012,3/31/2012,Intravenous,gemcitabine,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/12/2023,mg,antineoplastic,3/30/2022,4/9/2022,Intravenous,paclitaxel,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/8/2022,mg,antineoplastic,3/17/2022,2/23/2022,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/2/2019,mg,antineoplastic,8/28/2018,9/24/2017,Intravenous,atezolizumab,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/8/2018,AUC,antineoplastic,10/14/2017,10/21/2017,Intravenous,carboplatin,FALSE
183,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,12/25/2021,mg,antineoplastic,10/1/2021,9/7/2021,Intravenous,paclitaxel protein-bound,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/10/2020,mL,solution-fluid,5/10/2019,2/10/2019,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/19/2017,AUC,antineoplastic,2/16/2015,12/7/2014,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/7/2020,mg,antineoplastic,6/1/2020,9/20/2019,Intravenous,durvalumab,FALSE
156,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,7/24/2023,mg,antineoplastic,7/3/2023,4/22/2023,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G39C1C9BC249D,8/6/2017,mg,antineoplastic,8/27/2017,8/28/2017,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/18/2025,,antineoplastic,12/18/2024,3/19/2020,Oral,enzalutamide,FALSE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,2/13/2017,mg,antineoplastic,6/19/2016,6/17/2016,Intravenous,nivolumab,FALSE
629,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2262335C:D62,3/4/2025,mg,antineoplastic,2/3/2025,3/5/2025,Intravenous,ramucirumab,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G2D2EC6C91F3C,8/26/2018,,,8/6/2018,6/28/2018,Oral,osimertinib,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/5/2024,mg,antineoplastic,7/26/2024,8/18/2023,Intravenous,durvalumab,TRUE
108,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/12/2017,mg,antineoplastic,7/3/2016,6/22/2016,Intravenous,paclitaxel,FALSE
201,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,7/26/2015,mg,antineoplastic,6/28/2015,7/26/2015,Intravenous,carboplatin,FALSE
465,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/5/2014,mg,antineoplastic,5/14/2014,3/11/2014,Intravenous,carboplatin,FALSE
431,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,7/7/2015,mg,antineoplastic,3/13/2015,4/9/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/8/2022,,antineoplastic,1/19/2022,9/26/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/11/2025,mg,antineoplastic,10/15/2024,9/21/2022,Intravenous,pembrolizumab,TRUE
600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,7/26/2015,mg,antineoplastic,1/29/2015,12/27/2014,Intravenous,carboplatin,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,1/28/2024,mg,antineoplastic,12/9/2023,9/28/2023,Intravenous,carboplatin,FALSE
157,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/22/2024,mg,antineoplastic,6/7/2024,5/9/2024,Intravenous,carboplatin,FALSE
748,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/25/2024,mg,antineoplastic,1/18/2023,2/8/2023,Intravenous,durvalumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/16/2017,mg,antineoplastic,1/16/2017,11/16/2016,Intravenous,carboplatin,FALSE
795,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/21/2020,mg,antineoplastic,2/24/2019,12/4/2018,Intravenous,pemetrexed,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,11/25/2017,mg,antineoplastic,9/21/2017,9/8/2017,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/15/2020,mg,antineoplastic,4/16/2018,2/12/2016,Intravenous,bevacizumab,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,5/31/2020,mg,antineoplastic,3/11/2019,2/9/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/6/2025,mg,antineoplastic,1/26/2024,9/1/2022,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/9/2025,mg,antineoplastic,4/18/2024,12/31/2016,Intravenous,pembrolizumab,FALSE
394.8,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,12/19/2019,mg,antineoplastic,10/15/2019,9/18/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G44E794G323GG,2/13/2017,,,10/10/2016,9/7/2016,Oral,erlotinib,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/7/2023,mL,solution-fluid,6/10/2023,12/22/2022,Intravenous,pemetrexed,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/29/2020,mg,antineoplastic,1/21/2019,11/25/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/4/2020,,antineoplastic,5/6/2020,5/14/2020,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/25/2025,mg,antineoplastic,12/19/2021,2/26/2019,Intravenous,pemetrexed,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,12/24/2015,mg,antineoplastic,8/31/2015,5/14/2015,Intravenous,pemetrexed,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/12/2022,mg/kg,antineoplastic,7/1/2021,3/4/2021,Intravenous,durvalumab,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,9/18/2021,mg,antineoplastic,3/7/2021,12/9/2020,Intravenous,vinorelbine,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/14/2016,mg,antineoplastic,7/2/2016,6/10/2016,Intravenous,carboplatin,FALSE
495,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/23/2012,mg,antineoplastic,11/20/2011,9/15/2011,Intravenous,cetuximab,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,6/26/2024,mg,antineoplastic,5/13/2024,3/15/2024,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G24167D1DD5FG,5/5/2025,mg,antineoplastic,1/6/2025,1/10/2025,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/19/2019,mg,antineoplastic,5/13/2019,6/8/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G1968F::311C2,7/6/2018,,,6/26/2018,8/5/2013,Oral,erlotinib,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/8/2020,mg,antineoplastic,6/27/2020,2/4/2020,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,mg,antineoplastic,4/28/2022,4/2/2017,Intravenous,nivolumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/10/2023,mg,antineoplastic,8/18/2023,5/28/2023,Intravenous,durvalumab,FALSE
495,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2628C28G7613,6/5/2015,mg,antineoplastic,3/30/2015,4/26/2015,Intravenous,carboplatin,FALSE
346,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,4/22/2024,mg,antineoplastic,2/22/2024,2/11/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/4/2012,,antineoplastic,12/21/2011,10/9/2011,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/7/2025,mg,antineoplastic,4/25/2020,12/30/2016,Intravenous,pembrolizumab,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/10/2014,mg/m2,antineoplastic,1/20/2014,11/3/2013,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/5/2021,mg,antineoplastic,8/27/2021,7/16/2021,Intravenous,pemetrexed,FALSE
445,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/23/2024,mg,antineoplastic,1/15/2024,11/10/2023,Intravenous,carboplatin,FALSE
825,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/25/2023,mg,antineoplastic,4/18/2023,4/8/2023,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/17/2018,mg,antineoplastic,5/16/2017,4/15/2017,Intravenous,pemetrexed,TRUE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/16/2019,mg,antineoplastic,12/29/2018,9/14/2018,Intravenous,carboplatin,FALSE
582,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,6/27/2024,mg,antineoplastic,6/20/2024,4/10/2024,Intravenous,paclitaxel,FALSE
71,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,10/8/2024,mg,antineoplastic,8/26/2024,8/22/2024,Intravenous,ipilimumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/14/2025,mg,antineoplastic,8/14/2022,2/21/2020,Intravenous,pemetrexed,TRUE
246,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,8/31/2016,mg,antineoplastic,3/4/2016,11/3/2015,Intravenous,nivolumab,FALSE
308,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/11/2016,mg,antineoplastic,7/26/2016,4/30/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/24/2021,mg,antineoplastic,6/19/2021,3/28/2021,Intravenous,pembrolizumab,FALSE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,9/26/2024,mg,antineoplastic,7/28/2024,6/22/2024,Intravenous,vinorelbine,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/3/2016,mg,antineoplastic,11/9/2014,5/27/2014,Intravenous,pemetrexed,FALSE
2600,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,5/18/2022,mg,antineoplastic,12/16/2021,8/23/2021,Intravenous,gemcitabine,FALSE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,12/30/2013,mg,antineoplastic,12/23/2013,9/22/2013,Intravenous,vinorelbine,FALSE
820,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,12/30/2024,mg,antineoplastic,8/18/2024,8/8/2024,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/13/2020,mg,antineoplastic,5/5/2016,11/4/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/16/2025,,antineoplastic,10/21/2021,9/26/2021,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G1G7:9D7EC1EC,9/20/2021,,antineoplastic,8/1/2021,6/24/2021,,clinical study drug,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/31/2022,mg,antineoplastic,11/7/2021,10/5/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/26/2025,mg,antineoplastic,5/2/2023,1/14/2019,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G26D38EC278C1,7/16/2019,mg,antineoplastic,5/30/2019,3/5/2019,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/17/2024,,antineoplastic,7/8/2024,7/1/2024,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/7/2023,,antineoplastic,1/8/2023,10/4/2022,Intravenous,bevacizumab-awwb,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,8/26/2018,,antineoplastic,6/22/2018,8/3/2018,Intravenous,carboplatin,FALSE
1045,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/19/2025,mg,antineoplastic,9/23/2024,6/24/2024,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G25B:66F61266,4/30/2025,mg,antineoplastic,1/7/2025,1/12/2025,Intravenous,pembrolizumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/4/2015,mg,antineoplastic,9/30/2014,9/29/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,1/28/2023,mg,antineoplastic,5/22/2022,3/31/2022,Intravenous,pembrolizumab,FALSE
333,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,12/4/2022,mg,antineoplastic,11/11/2022,10/19/2022,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/31/2021,mg,antineoplastic,10/2/2021,6/29/2021,Intravenous,carboplatin,FALSE
255,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,7/23/2021,mg,antineoplastic,1/13/2017,12/6/2016,Intravenous,carboplatin,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,2/23/2013,mg/m2,antineoplastic,1/31/2013,1/18/2013,Intravenous,paclitaxel,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,6/30/2013,mg,antineoplastic,3/21/2013,6/28/2012,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/21/2013,mg,antineoplastic,8/25/2013,4/16/2013,Intravenous,bevacizumab,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/30/2019,mg,antineoplastic,5/20/2019,6/16/2019,Intravenous,paclitaxel protein-bound,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,1/3/2024,mg,antineoplastic,10/13/2023,11/12/2023,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/15/2016,mg,antineoplastic,12/21/2014,11/20/2014,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/18/2024,mg,antineoplastic,5/16/2023,12/19/2022,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/21/2025,mg,antineoplastic,7/20/2019,1/16/2019,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G22CF9C794236,4/28/2025,,antineoplastic,1/1/2025,12/7/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,4/16/2012,,antineoplastic,9/16/2011,7/5/2011,Intravenous,clinical study drug,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/6/2019,mg,antineoplastic,5/9/2019,11/27/2018,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G3G18D5D62822,6/26/2012,mg/m2,antineoplastic,3/28/2012,11/18/2011,Intravenous,pemetrexed,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,6/5/2018,mg,antineoplastic,3/15/2018,11/20/2017,Intravenous,nivolumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/8/2013,AUC,antineoplastic,10/5/2013,8/10/2013,Intravenous,carboplatin,FALSE
491,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/19/2020,mg,antineoplastic,5/10/2020,1/24/2020,Intravenous,pemetrexed,FALSE
1950,6,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,11/22/2016,mg,antineoplastic,8/25/2016,9/19/2016,Intravenous,gemcitabine,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,6/7/2023,mg,antineoplastic,7/3/2023,3/15/2023,Intravenous,atezolizumab,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/29/2019,mg,antineoplastic,7/18/2018,5/28/2018,Other/Miscellaneous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/13/2021,mg,antineoplastic,5/5/2019,11/13/2018,Intravenous,pembrolizumab,TRUE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G53D3D6874EB3,7/24/2023,mg,antineoplastic,4/13/2023,4/22/2023,Subcutaneous,leuprolide,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,10/7/2024,mg,antineoplastic,2/22/2023,5/19/2022,Intravenous,durvalumab,TRUE
350,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,9/24/2013,mg,antineoplastic,9/13/2013,8/17/2013,Intravenous,carboplatin,FALSE
871,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/17/2015,mg,antineoplastic,12/11/2014,12/24/2014,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/18/2013,mg,antineoplastic,12/26/2012,12/7/2012,Intravenous,paclitaxel protein-bound,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/18/2025,mg,antineoplastic,1/13/2025,2/12/2025,Intravenous,amivantamab-vmjw,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/1/2023,mg,antineoplastic,6/4/2023,4/3/2023,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/27/2025,mg,antineoplastic,9/18/2024,4/15/2024,Intravenous,pemetrexed,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/8/2018,mg,antineoplastic,12/17/2018,6/10/2018,Intravenous,paclitaxel,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/13/2024,mg,antineoplastic,9/20/2023,6/8/2023,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/9/2024,mg,antineoplastic,11/10/2023,7/8/2023,Intravenous,pembrolizumab,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/19/2023,mg,antineoplastic,6/28/2023,3/22/2023,Intravenous,gemcitabine,FALSE
1075,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/25/2025,mg,antineoplastic,3/21/2023,2/22/2023,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/22/2024,,antineoplastic,4/15/2023,2/15/2023,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,4/14/2021,,antineoplastic,7/6/2020,2/22/2020,Intravenous,clinical study drug,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/12/2013,mg/m2,antineoplastic,6/18/2013,4/13/2013,Intravenous,paclitaxel,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/13/2024,mg,antineoplastic,2/28/2023,4/3/2022,Intravenous,durvalumab,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/2/2015,mg,antineoplastic,9/6/2015,8/7/2015,Intravenous,gemcitabine,FALSE
950,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G14216G12B:E7,6/9/2020,mg,antineoplastic,11/18/2019,11/20/2019,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,10/26/2023,,antineoplastic,3/4/2023,1/3/2023,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G545:2F182DD:,9/12/2017,,antineoplastic,9/1/2017,9/3/2017,,paclitaxel protein-bound,FALSE
151,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35DE4B3:BCB8,5/15/2019,mg,antineoplastic,11/15/2016,10/6/2016,Intravenous,pembrolizumab,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/10/2017,mg,antineoplastic,10/9/2015,4/8/2015,Intravenous,bevacizumab,TRUE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/30/2015,mg,antineoplastic,9/27/2014,5/30/2014,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,9/21/2018,mg,antineoplastic,3/21/2013,3/16/2013,Intravenous,carboplatin,FALSE
317.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/12/2020,mg,antineoplastic,11/25/2019,9/24/2019,Intravenous,carboplatin,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/30/2020,mg,antineoplastic,9/24/2020,10/4/2020,Intravenous,paclitaxel protein-bound,FALSE
945,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3G18D5D62822,6/6/2012,mg,antineoplastic,1/30/2012,11/21/2011,Intravenous,pemetrexed,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/29/2014,mg,antineoplastic,9/16/2014,9/8/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/24/2018,mg,antineoplastic,10/9/2018,7/29/2018,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/25/2022,mg,antineoplastic,5/14/2021,5/30/2020,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/31/2024,mg,antineoplastic,8/16/2023,3/8/2023,Intravenous,atezolizumab,TRUE
88,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/14/2023,mg,antineoplastic,10/24/2022,9/21/2022,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/17/2020,mg,antineoplastic,10/11/2019,3/2/2019,Subcutaneous,bortezomib,FALSE
775,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/20/2022,mg,antineoplastic,1/11/2022,10/1/2021,Intravenous,pemetrexed,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,11/1/2014,mg/kg,antineoplastic,8/9/2014,12/7/2013,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1C22CGB1F5C2,9/17/2020,mg,antineoplastic,2/7/2020,11/12/2019,Intravenous,pembrolizumab,TRUE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,7/20/2020,mg,antineoplastic,5/20/2020,4/23/2020,Intravenous,cisplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,9/23/2021,mg,antineoplastic,7/25/2021,8/27/2021,Intravenous,carboplatin,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/23/2014,mg,antineoplastic,10/24/2014,5/17/2014,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G133G3GCBGE3D,2/16/2014,,,11/7/2013,6/10/2013,Oral,erlotinib,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G17DC5G:4GB26,12/20/2020,,,11/8/2020,7/26/2020,Oral,osimertinib,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,12/2/2024,mg,antineoplastic,7/6/2022,5/23/2022,Intravenous,cisplatin,FALSE
129,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,12/18/2012,mg,antineoplastic,11/24/2012,11/6/2012,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/23/2020,mg,antineoplastic,10/14/2019,1/9/2019,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/3/2014,,antineoplastic,1/2/2014,11/8/2013,,pemetrexed,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,4/12/2023,mg,antineoplastic,2/12/2023,2/16/2023,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/6/2023,mg,antineoplastic,1/9/2023,11/20/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,5/17/2025,mg,antineoplastic,10/7/2024,10/10/2024,Intravenous,pembrolizumab,TRUE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/18/2020,mg,antineoplastic,9/6/2020,5/22/2020,Intravenous,paclitaxel,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/6/2018,mg,antineoplastic,7/26/2018,7/5/2018,Intravenous,etoposide,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/6/2015,mg,antineoplastic,3/16/2015,9/30/2014,Intravenous,pemetrexed,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,5/11/2019,mg,antineoplastic,1/21/2019,1/28/2019,Intravenous,pemetrexed,FALSE
200,,NEOADJUVANT,Administrations,chemotherapy,Carboplatin,G21:3143F86E6,1/5/2015,mg,antineoplastic,11/25/2014,11/23/2014,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/11/2019,mg,antineoplastic,6/4/2019,5/17/2019,Intravenous,carboplatin,FALSE
1540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,8/30/2018,mg,antineoplastic,8/19/2018,6/22/2018,Intravenous,gemcitabine,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,4/7/2016,mg,antineoplastic,2/4/2016,11/15/2015,Intravenous,docetaxel,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/27/2021,mg,antineoplastic,3/14/2020,12/5/2019,Intravenous,durvalumab,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/18/2017,,solution-fluid,4/16/2016,3/14/2016,Intravenous,clinical study drug,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,7/5/2021,mg,antineoplastic,5/1/2021,10/28/2020,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/19/2017,mg,antineoplastic,4/24/2017,5/3/2016,Intravenous,nivolumab,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/31/2021,mg,antineoplastic,12/11/2020,10/22/2020,Intravenous,nivolumab,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/18/2015,mg,antineoplastic,8/4/2015,7/31/2015,Intravenous,paclitaxel,FALSE
390,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,8/29/2014,mg,antineoplastic,4/8/2014,3/14/2014,Intravenous,paclitaxel,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/2/2019,mg,antineoplastic,7/12/2018,7/21/2018,Intravenous,levoleucovorin,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/11/2022,mg,antineoplastic,3/5/2022,1/13/2022,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,6/4/2024,,antiemetic,6/5/2024,4/19/2024,Subcutaneous,clinical study drug,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,9/22/2015,mg,antineoplastic,7/24/2015,5/21/2015,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/31/2025,mg,antineoplastic,3/11/2025,4/26/2024,Intravenous,pembrolizumab,FALSE
2052,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G51:G:C712CC6,1/2/2020,mg,antineoplastic,11/15/2019,11/3/2019,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,5/8/2025,mg,antineoplastic,3/7/2025,9/20/2023,Intravenous,pembrolizumab,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/17/2015,mg,antineoplastic,3/2/2015,1/13/2015,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/3/2025,,antineoplastic,2/11/2023,3/20/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/23/2022,,antineoplastic,10/28/2021,10/12/2021,Intravenous,paclitaxel,FALSE
100,5,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,12/20/2023,mg/m2,antineoplastic,11/14/2023,10/7/2023,Intravenous,etoposide,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/8/2021,mg,antineoplastic,3/26/2021,5/10/2021,Intravenous,pemetrexed,FALSE
1200,2,ADVANCED,Orders,immunotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/27/2020,mg,antineoplastic,4/23/2020,3/29/2020,Intravenous,atezolizumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,10/29/2019,mg,antineoplastic,11/8/2019,9/15/2019,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/10/2024,mg,antineoplastic,4/22/2024,9/4/2023,Intravenous,nivolumab,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/20/2016,mg,antineoplastic,5/14/2016,3/17/2016,Intravenous,bevacizumab,TRUE
380,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/17/2014,mg,antineoplastic,12/31/2013,1/27/2014,Intravenous,carboplatin,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,10/9/2019,mg,antineoplastic,8/31/2019,8/25/2019,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,12/1/2021,,antineoplastic,4/12/2018,2/21/2018,,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/28/2020,mg,antineoplastic,8/30/2019,4/17/2019,Intravenous,pembrolizumab,TRUE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/14/2020,mg,antineoplastic,2/7/2020,1/29/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,3/29/2025,mg,antineoplastic,12/16/2024,8/8/2022,Intravenous,pembrolizumab,TRUE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/17/2015,mg,antineoplastic,6/26/2015,5/2/2015,Intravenous,etoposide,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,12/9/2011,mg,antineoplastic,9/8/2011,8/19/2011,Intravenous,pemetrexed,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,4/23/2024,mg,antineoplastic,3/11/2024,10/21/2023,Intravenous,nivolumab,FALSE
273,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/28/2016,mg,antineoplastic,9/15/2016,6/20/2016,Intravenous,trastuzumab,FALSE
17.2,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,11/22/2013,mL,antineoplastic,8/12/2013,7/7/2013,Intravenous,vinorelbine,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,2/12/2024,mg,antineoplastic,11/18/2023,10/22/2023,Intravenous,paclitaxel,FALSE
743,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G392GC5134FFG,10/14/2020,mg,antineoplastic,8/20/2020,7/5/2020,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,3/3/2020,,antineoplastic,1/29/2018,7/20/2017,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,Osimertinib,G17:EF9E52451,8/30/2024,,,8/27/2024,8/21/2021,Oral,osimertinib,FALSE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/27/2020,mg,antineoplastic,8/2/2020,4/12/2020,Intravenous,carboplatin,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/6/2021,mg,antineoplastic,6/9/2021,5/4/2020,Intravenous,gemcitabine,FALSE
155,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/13/2021,mg,antineoplastic,12/17/2020,9/21/2020,Intravenous,oxaliplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,7/4/2024,mg,antineoplastic,9/18/2023,9/3/2023,Intravenous,atezolizumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/5/2023,mg,antineoplastic,4/28/2023,2/3/2023,Intravenous,carboplatin,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/19/2024,mg,antineoplastic,12/11/2023,10/9/2023,Intravenous,durvalumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/4/2022,mg,antineoplastic,9/27/2021,1/14/2020,Intravenous,nivolumab,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/8/2023,mg,antineoplastic,9/3/2023,8/29/2023,Intravenous,carboplatin,FALSE
129,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3CG5712E:B54,7/20/2024,mg,antineoplastic,6/22/2024,6/6/2024,Intravenous,docetaxel,FALSE
372,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/2/2021,mg,antineoplastic,2/8/2021,12/22/2020,Intravenous,paclitaxel,FALSE
295,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/22/2014,mg,antineoplastic,1/19/2014,12/7/2013,Intravenous,carboplatin,FALSE
342,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,6/17/2016,mg,antineoplastic,6/26/2016,5/27/2016,Intravenous,paclitaxel,FALSE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,3/14/2020,mg,antineoplastic,9/3/2019,7/5/2019,Intravenous,ramucirumab,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,4/5/2013,AUC,antineoplastic,1/23/2013,11/26/2012,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/17/2025,mg,antineoplastic,7/19/2024,2/24/2023,Intravenous,pembrolizumab,FALSE
715,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,3/7/2013,mg,antineoplastic,10/16/2012,10/31/2012,Intravenous,carboplatin,FALSE
289,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/6/2015,mg,antineoplastic,2/8/2015,12/8/2014,Intravenous,paclitaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/19/2023,mg,antineoplastic,11/29/2020,12/13/2019,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/5/2025,mg,antineoplastic,8/27/2022,7/10/2021,Intravenous,atezolizumab,TRUE
345,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/16/2021,mg,antineoplastic,5/31/2021,4/12/2021,Intravenous,carboplatin,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/7/2020,mg,antineoplastic,10/23/2019,11/10/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/20/2018,mg,antineoplastic,10/24/2018,4/8/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/29/2025,mg,antineoplastic,9/17/2022,9/2/2022,Intravenous,pembrolizumab,TRUE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,1/30/2025,mg,antineoplastic,12/24/2024,9/25/2024,Intravenous,cisplatin,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/1/2022,mg,antineoplastic,7/3/2022,6/27/2022,Intravenous,carboplatin,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,5/27/2021,mg,antineoplastic,3/24/2021,12/9/2020,Intravenous,nivolumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,5/12/2024,mg,antineoplastic,2/11/2024,2/9/2024,Intravenous,paclitaxel,FALSE
710,1,ADVANCED,Administrations,targeted/biologic,Ramucirumab,G1GFD92F489E7,11/13/2023,mg,antineoplastic,10/2/2023,7/13/2023,Intravenous,ramucirumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/19/2023,mg,antineoplastic,1/14/2023,8/22/2022,Subcutaneous,azacitidine,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/26/2012,mg,antineoplastic,3/19/2012,2/18/2012,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,hormone,Anastrozole,G175D38G17E84,6/25/2017,,antineoplastic,9/10/2016,1/28/2016,Oral,anastrozole,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/21/2025,mg,antineoplastic,4/11/2019,2/10/2018,Intravenous,nivolumab,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,5/8/2019,mg/m2,antineoplastic,6/1/2019,4/8/2019,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/26/2017,mg,antineoplastic,12/5/2016,9/20/2016,Intravenous,nivolumab,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/2/2023,mg,antineoplastic,6/12/2022,4/9/2022,Intravenous,durvalumab,FALSE
285,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G2D5B71G65F2G,4/23/2016,mg,antineoplastic,3/10/2016,2/29/2016,Intravenous,nivolumab,FALSE
605,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/4/2017,mg,antineoplastic,8/7/2017,6/5/2017,Intravenous,trastuzumab,FALSE
219.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FD6C9677C56,11/28/2017,mg,antineoplastic,10/25/2017,10/21/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/16/2023,mg,antineoplastic,10/25/2022,9/30/2021,Intravenous,pembrolizumab,TRUE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,5/6/2014,mg,antineoplastic,4/12/2014,2/14/2014,Intravenous,carboplatin,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,11/22/2024,mg,antineoplastic,5/21/2024,5/24/2024,Intravenous,gemcitabine,FALSE
354,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/20/2016,mg,antineoplastic,6/26/2016,3/28/2016,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/22/2016,mg,antineoplastic,5/22/2015,12/4/2014,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/25/2025,mg,antineoplastic,4/25/2024,12/25/2016,Intravenous,pembrolizumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/24/2018,mg,antineoplastic,6/28/2018,6/13/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,2/11/2015,,,3/10/2015,11/28/2014,Oral,afatinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/13/2024,mg,antineoplastic,9/22/2023,7/20/2023,Intravenous,nivolumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/21/2014,mg/m2,antineoplastic,12/17/2013,12/28/2013,Intravenous,pemetrexed,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/30/2024,mg,antineoplastic,12/3/2023,8/9/2023,Intravenous,durvalumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/28/2017,mg,antineoplastic,3/19/2016,6/1/2015,Intravenous,nivolumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/8/2014,mg,antineoplastic,1/10/2014,10/30/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,6/25/2024,mg,antineoplastic,4/29/2024,4/3/2024,Intravenous,pembrolizumab,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/23/2019,mg,antineoplastic,12/6/2018,6/24/2018,Intravenous,levoleucovorin,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,8/30/2011,mg,antineoplastic,8/22/2011,7/6/2011,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/12/2025,,antineoplastic,1/27/2024,1/28/2023,,clinical study drug,FALSE
825,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,2/2/2025,mg,antineoplastic,10/24/2024,8/10/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/26/2021,mg,antineoplastic,10/17/2021,9/7/2021,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/31/2012,mg,antineoplastic,10/10/2012,5/30/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/29/2025,mg,antineoplastic,12/12/2024,4/28/2024,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/13/2022,mg,antineoplastic,12/20/2021,6/17/2021,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,11/11/2020,,,7/14/2020,7/22/2020,Oral,dabrafenib,FALSE
210,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,3/1/2025,mg,antineoplastic,3/12/2025,3/24/2025,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166FBC749F7D,4/19/2013,mg,antineoplastic,3/29/2013,4/22/2013,Intravenous,carboplatin,FALSE
523,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/15/2025,mg,antineoplastic,3/2/2019,4/17/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/1/2021,,antiemetic,8/29/2020,2/23/2020,Intravenous,clinical study drug,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/13/2023,mg,antineoplastic,4/14/2023,4/6/2022,Intravenous,durvalumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/18/2015,mg,antineoplastic,7/13/2015,3/6/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/3/2023,mg,antineoplastic,5/14/2021,4/11/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/13/2020,mg,antineoplastic,7/22/2019,11/11/2018,Intravenous,pembrolizumab,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/25/2024,mg,antineoplastic,7/18/2022,7/8/2020,Intravenous,nivolumab,FALSE
167,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/22/2019,mg,antineoplastic,2/17/2019,3/3/2019,Intravenous,cisplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/11/2017,,antineoplastic,11/7/2016,2/24/2016,Intravenous,clinical study drug,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/21/2024,mg,antineoplastic,5/2/2023,4/25/2023,Intravenous,atezolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/23/2022,mg,antineoplastic,3/10/2022,2/22/2021,Intravenous,durvalumab,FALSE
401,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,1/19/2025,mg,antineoplastic,12/26/2024,10/10/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/21/2025,mg,antineoplastic,7/7/2019,5/21/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/25/2022,,antineoplastic,1/5/2022,3/29/2017,Oral,nilotinib,FALSE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,12/8/2015,mg,antineoplastic,6/4/2015,7/25/2015,Intravenous,pemetrexed,TRUE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,11/12/2019,mg,antineoplastic,8/21/2019,7/28/2019,Intravenous,paclitaxel,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,5/8/2015,mg,antineoplastic,3/25/2015,3/15/2015,Intravenous,vinorelbine,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/24/2018,mg,antineoplastic,7/5/2018,4/24/2018,Intravenous,carboplatin,FALSE
658,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,12/6/2016,mg,antineoplastic,7/22/2016,7/22/2016,Intravenous,carboplatin,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,5/11/2015,mg,antineoplastic,2/11/2015,1/11/2015,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/5/2021,mg/kg,antineoplastic,5/25/2021,4/6/2021,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Orders,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,5/7/2018,,antineoplastic,5/23/2017,6/25/2017,,clinical study drug,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/27/2022,mg,antineoplastic,9/26/2021,3/21/2021,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/2/2025,mg,antineoplastic,11/10/2024,7/23/2024,Intravenous,pembrolizumab,TRUE
468,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/18/2020,mg,antineoplastic,7/18/2020,6/2/2020,Intravenous,carboplatin,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/4/2016,mg,antineoplastic,6/24/2016,6/20/2016,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,1/1/2012,mg,antineoplastic,9/22/2011,7/14/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/14/2020,mg,antineoplastic,4/18/2020,2/4/2020,Intravenous,pembrolizumab,FALSE
479.2,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G24632:D18158,3/9/2020,mg,antineoplastic,11/13/2019,11/10/2019,Intravenous,carboplatin,FALSE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,2/7/2012,mg,antineoplastic,1/2/2012,12/30/2011,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/27/2025,,antineoplastic,10/5/2023,2/25/2023,Intravenous,pemetrexed,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,12/20/2016,mg,antineoplastic,12/30/2016,12/17/2016,Intravenous,paclitaxel,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/15/2021,mg/kg,antineoplastic,2/25/2021,3/20/2021,Intravenous,bevacizumab-awwb,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/4/2022,mg,antineoplastic,11/26/2021,10/16/2021,Intravenous,bevacizumab-awwb,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G1E1C181843G1,4/18/2015,,,9/17/2014,10/26/2014,Oral,erlotinib,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/6/2025,mg,antineoplastic,1/14/2025,12/7/2024,Intravenous,oxaliplatin,FALSE
1950,7,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G4C53C5GC48E:,10/28/2016,mg,antineoplastic,11/15/2016,10/20/2016,Intravenous,gemcitabine,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/14/2018,mg,antineoplastic,8/30/2018,6/2/2018,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,12/14/2023,mg,antineoplastic,1/7/2024,12/5/2023,Oral,anastrozole,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/19/2013,mg,antineoplastic,1/31/2013,3/27/2012,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/13/2020,mg,antineoplastic,11/23/2018,6/19/2016,Intravenous,nivolumab,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,12/9/2014,mg,antineoplastic,11/1/2014,11/1/2014,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,8/28/2019,mg,antineoplastic,5/19/2019,4/22/2019,Intravenous,pembrolizumab,TRUE
398,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,5/17/2012,mg,antineoplastic,5/11/2012,5/5/2012,Intravenous,carboplatin,FALSE
130,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,10/11/2018,mg,antineoplastic,9/6/2018,10/17/2018,Intravenous,carboplatin,FALSE
1,1,ADVANCED,Orders,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,5/11/2025,mg/kg,antineoplastic,2/28/2025,10/20/2024,Intravenous,ipilimumab,TRUE
524,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1D14:53C99:F,5/1/2023,mg,antineoplastic,5/9/2023,2/5/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/19/2023,mg,antineoplastic,5/30/2022,10/17/2021,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/14/2020,mg,antineoplastic,12/8/2019,9/13/2019,Intravenous,pembrolizumab,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/22/2019,mg,antineoplastic,4/21/2019,1/18/2019,Intravenous,paclitaxel,FALSE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/30/2018,mg,antineoplastic,9/15/2016,7/22/2016,Intravenous,carboplatin,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/27/2015,mg,antineoplastic,3/20/2015,2/22/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/18/2021,,antineoplastic,6/5/2021,5/3/2021,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/29/2014,mg,antineoplastic,7/15/2014,4/15/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/12/2025,mg,antineoplastic,2/26/2022,10/1/2021,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/11/2021,mg/m2,antineoplastic,5/19/2021,3/24/2021,Intravenous,fluorouracil,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,6/24/2020,mg,antineoplastic,6/6/2020,3/25/2020,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/13/2020,mg,antineoplastic,2/20/2017,12/27/2016,Intravenous,nivolumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/2/2024,mg,antineoplastic,6/1/2022,4/3/2022,Intravenous,durvalumab,TRUE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G4656G51E4EG7,11/29/2018,mg,antineoplastic,11/30/2018,11/1/2018,Intravenous,paclitaxel protein-bound,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,1/31/2019,mL,solution-fluid,9/9/2017,8/11/2017,Intravenous,etoposide,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,7/25/2019,mg,antineoplastic,5/12/2019,4/17/2019,Intravenous,docetaxel,FALSE
386,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,1/21/2019,mg,antineoplastic,1/3/2019,12/22/2018,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/9/2019,mg,antineoplastic,6/14/2017,3/27/2016,Intravenous,nivolumab,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/3/2019,mg,antineoplastic,9/22/2018,8/6/2018,Intravenous,carboplatin,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/5/2022,mg,antineoplastic,4/26/2021,5/5/2021,Intravenous,vinorelbine,FALSE
66,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/21/2015,mg,antineoplastic,5/8/2015,3/3/2015,Intravenous,cisplatin,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/28/2020,mg,antineoplastic,4/22/2020,3/20/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,3/11/2024,mg,antineoplastic,11/30/2023,6/9/2023,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,11/23/2023,6/13/2023,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/8/2025,mg,antineoplastic,11/27/2021,8/6/2021,Intravenous,atezolizumab,TRUE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,7/1/2021,mg,antineoplastic,1/27/2021,11/14/2020,Intravenous,nivolumab,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,7/7/2023,mg,antineoplastic,6/8/2023,4/19/2023,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G2C4G1G76816F,5/2/2025,,steroid,10/2/2017,9/15/2017,Intravenous,clinical study drug,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/6/2020,mg,antineoplastic,10/21/2019,2/13/2019,Intravenous,durvalumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/29/2023,mg,antineoplastic,3/9/2023,8/7/2022,Subcutaneous,azacitidine,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/17/2019,mg,antineoplastic,4/2/2019,12/31/2018,Intravenous,paclitaxel,FALSE
127,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/23/2021,mg,antineoplastic,3/28/2021,5/27/2020,Intravenous,docetaxel,FALSE
41,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/4/2023,mg,antineoplastic,2/24/2023,10/8/2022,Intravenous,leucovorin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/13/2019,mg,antineoplastic,7/11/2018,8/31/2017,Intravenous,atezolizumab,FALSE
350,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,4/8/2025,mg,antineoplastic,8/26/2024,6/22/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/29/2022,mg,antineoplastic,8/15/2022,6/28/2022,Intravenous,pembrolizumab,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/15/2013,mg,antineoplastic,12/1/2012,10/9/2012,Intravenous,gemcitabine,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/21/2013,mg,antineoplastic,1/4/2013,12/5/2012,Intravenous,vinorelbine,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/8/2025,mg,antineoplastic,4/8/2024,10/28/2022,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G1:F129FBCE3F,3/3/2021,,antineoplastic,12/26/2020,12/26/2020,Oral,hydroxyurea,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/23/2020,mg,antineoplastic,10/5/2019,9/15/2019,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/13/2018,mg,antineoplastic,5/23/2016,9/5/2015,Intravenous,nivolumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,4/8/2015,mg,antineoplastic,3/14/2015,1/21/2015,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,6/1/2020,mg,antineoplastic,8/31/2019,6/30/2019,Intravenous,pembrolizumab,FALSE
940,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,9/11/2024,mg,antineoplastic,7/31/2024,7/10/2024,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Orders,pain agent,Clinical Study Drug,G177G4:B9E394,4/2/2025,,pain agent,3/19/2025,3/29/2025,,clinical study drug,FALSE
1688,1,LOCOREGIONAL,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,9/21/2016,mg,antineoplastic,9/5/2016,8/24/2016,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G58G2E7D9G4E7,5/28/2018,mg,antineoplastic,6/12/2018,5/9/2018,Intravenous,nivolumab,FALSE
265,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,3/17/2013,mg,antineoplastic,2/4/2013,11/29/2012,Intravenous,carboplatin,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/19/2020,mg,antineoplastic,12/24/2019,11/10/2019,Intravenous,paclitaxel,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/9/2025,mg,antineoplastic,1/29/2017,1/17/2017,Intravenous,pembrolizumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/19/2020,mg,antineoplastic,6/24/2019,1/5/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,9/3/2019,mg,antineoplastic,5/31/2019,1/18/2019,Intravenous,pembrolizumab,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/11/2020,mg,antineoplastic,3/18/2019,2/2/2019,Subcutaneous,bortezomib,FALSE
1500,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/16/2013,mg,antineoplastic,4/17/2013,4/16/2013,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/19/2025,mg,antineoplastic,8/19/2020,2/20/2020,Intravenous,pembrolizumab,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/25/2018,mg,antineoplastic,8/12/2018,9/2/2018,Intravenous,carboplatin,FALSE
665,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/16/2020,mg,antineoplastic,9/27/2020,11/1/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/26/2024,mg,antineoplastic,2/11/2024,7/16/2023,Intravenous,pembrolizumab,TRUE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,1/2/2022,mg,antineoplastic,9/10/2021,9/7/2021,Intravenous,carboplatin,FALSE
237,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,12/7/2014,mg,antineoplastic,9/1/2014,8/1/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/16/2015,,antineoplastic,6/23/2015,5/28/2015,Oral,ibrutinib,FALSE
182,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/5/2024,mg,antineoplastic,8/12/2024,7/29/2024,Intravenous,carboplatin,FALSE
970,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,2/25/2019,mg,antineoplastic,12/3/2018,11/22/2018,Intravenous,pemetrexed,FALSE
180,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,10/21/2022,mg,antineoplastic,10/26/2022,12/5/2022,Intravenous,carboplatin,FALSE
424,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,3/19/2023,mg,antineoplastic,1/30/2023,11/28/2022,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/21/2024,mg,antineoplastic,4/23/2024,10/2/2023,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/19/2025,mg,antineoplastic,8/14/2023,2/19/2023,Intravenous,pembrolizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/9/2024,mg,antineoplastic,8/29/2021,6/25/2020,Intravenous,nivolumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/17/2025,mg/m2,antineoplastic,1/15/2025,10/23/2024,Intravenous,etoposide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/2/2022,mg,antineoplastic,9/27/2020,12/17/2019,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/12/2019,mg/m2,antineoplastic,8/9/2019,7/4/2019,Intravenous,paclitaxel protein-bound,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/13/2024,mg,antineoplastic,11/16/2024,10/15/2024,Intravenous,pemetrexed,TRUE
712,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/6/2014,mg,antineoplastic,8/23/2014,6/17/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/29/2023,mg,antineoplastic,6/5/2020,4/28/2020,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/17/2025,mg/m2,antineoplastic,3/14/2025,4/12/2024,Intravenous,pemetrexed,TRUE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/9/2016,mg,antineoplastic,4/1/2016,2/29/2016,Intravenous,etoposide,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/3/2025,,antineoplastic,1/16/2018,12/6/2017,Intravenous,clinical study drug,FALSE
42,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/24/2018,mg,antineoplastic,5/29/2018,4/9/2018,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/15/2022,mg,antineoplastic,6/8/2019,6/24/2019,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3867F7D51E3D,4/14/2025,mg,antineoplastic,12/11/2024,12/11/2024,Intravenous,pembrolizumab,TRUE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/23/2014,mg,antineoplastic,5/16/2014,3/20/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,12/23/2015,,antineoplastic,11/30/2015,5/7/2015,Oral,ibrutinib,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/13/2023,mg,antineoplastic,4/29/2023,3/13/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/7/2023,mg,antineoplastic,9/27/2022,3/14/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,2/21/2019,mg,antineoplastic,11/2/2018,9/18/2018,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/27/2024,mg,antineoplastic,4/7/2024,10/15/2023,Intravenous,pembrolizumab,FALSE
1564,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,12/24/2015,mg,antineoplastic,10/22/2015,11/3/2015,Intravenous,bevacizumab,FALSE
500,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/22/2016,mg,antineoplastic,7/1/2016,3/4/2016,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/5/2025,mg,antineoplastic,10/18/2024,12/3/2024,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/7/2013,mg/m2,antineoplastic,2/7/2013,1/1/2013,Intravenous,paclitaxel protein-bound,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/17/2012,mg,antineoplastic,3/5/2012,2/7/2012,Intravenous,etoposide,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,7/24/2019,,antineoplastic,2/18/2019,9/7/2017,Oral,anastrozole,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,3/13/2024,mg,antineoplastic,10/10/2023,6/16/2023,Intravenous,nivolumab,TRUE
1000,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,7/14/2023,mg,antineoplastic,5/2/2023,5/4/2023,Intravenous,pemetrexed,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/15/2021,mg,antineoplastic,4/1/2018,3/12/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/13/2023,mg,antineoplastic,12/3/2022,9/19/2021,Intravenous,pembrolizumab,TRUE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/29/2019,mg,antineoplastic,1/15/2019,1/16/2019,Intravenous,paclitaxel,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/14/2024,mg,antineoplastic,1/15/2023,4/29/2022,Intravenous,durvalumab,TRUE
816,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,2/9/2018,mg,antineoplastic,8/16/2016,7/12/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/10/2018,mg,antineoplastic,5/26/2018,5/2/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G17BG4264193F,3/8/2025,mg,antineoplastic,12/31/2021,4/7/2020,Intravenous,pembrolizumab,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,7/20/2013,mg,antineoplastic,3/19/2013,2/13/2013,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,Temozolomide,G3DB42DD29B5G,10/18/2021,,antineoplastic,9/1/2021,6/11/2021,Oral,temozolomide,FALSE
2050,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G57:2GEC9DD36,12/6/2015,mg,antineoplastic,11/26/2015,11/21/2015,Intravenous,gemcitabine,FALSE
270,2,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,7/19/2019,mg,antineoplastic,6/30/2019,4/22/2019,Intravenous,irinotecan,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,3/12/2025,mg,antineoplastic,12/9/2024,10/15/2024,Intravenous,durvalumab,FALSE
585,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/18/2015,mg,antineoplastic,9/18/2015,6/9/2015,Intravenous,carboplatin,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/23/2017,mg,antineoplastic,9/26/2016,9/21/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G1F9BCG13:EFD,11/16/2023,,,11/2/2023,4/5/2022,Oral,osimertinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,1/2/2019,mg,antineoplastic,9/5/2018,6/8/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G3B1F6B561ED5,2/22/2021,,hematological agent,11/18/2020,1/8/2020,Subcutaneous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/23/2025,,antineoplastic,7/1/2023,1/19/2023,Intravenous,pemetrexed,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Decitabine,Venetoclax",G41DE1E3BE99:,7/18/2024,mg,antineoplastic,7/7/2024,6/22/2024,Intravenous,decitabine,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,4/2/2017,mg,antineoplastic,6/18/2015,4/30/2015,Intravenous,bevacizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/16/2018,mg,antineoplastic,10/13/2017,6/8/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/22/2019,mg,antineoplastic,5/18/2019,5/30/2019,Intravenous,pembrolizumab,FALSE
255,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,2/4/2015,mg,antineoplastic,11/21/2014,9/6/2014,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/30/2022,mg,antineoplastic,7/15/2021,5/28/2021,Intravenous,pembrolizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/1/2022,mg,antineoplastic,6/14/2021,4/26/2017,Intravenous,nivolumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/2/2021,mg,antineoplastic,5/12/2020,11/26/2019,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/28/2024,mg,antineoplastic,2/2/2024,2/23/2024,Intravenous,pembrolizumab,FALSE
540,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,9/24/2016,mg,antineoplastic,5/11/2016,5/3/2016,Intravenous,bevacizumab,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/24/2024,mg,antineoplastic,11/1/2023,8/15/2023,Intravenous,durvalumab,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/29/2019,mg,antineoplastic,10/6/2019,9/21/2019,Intravenous,paclitaxel protein-bound,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/22/2015,mg,antineoplastic,9/20/2015,7/12/2015,Intravenous,paclitaxel protein-bound,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/5/2024,mg,antineoplastic,3/26/2024,8/18/2023,Intravenous,durvalumab,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/5/2022,mg,antineoplastic,4/21/2021,2/20/2021,Intravenous,ramucirumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/15/2023,mg,antineoplastic,2/5/2023,8/28/2022,Intravenous,pembrolizumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/3/2019,mg,antineoplastic,10/24/2019,9/27/2019,Intravenous,etoposide,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/28/2025,mg,antineoplastic,2/14/2023,10/25/2022,Intravenous,pemetrexed,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/17/2020,mg,antineoplastic,10/22/2019,2/7/2019,Subcutaneous,bortezomib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/9/2025,mg,antineoplastic,6/9/2018,1/28/2017,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,3/29/2025,mg,antineoplastic,3/12/2024,2/23/2024,Intravenous,pembrolizumab,FALSE
277,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/21/2025,mg,antineoplastic,1/9/2025,12/29/2024,Intravenous,bevacizumab-bvzr,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,1/7/2016,mg,antineoplastic,10/4/2015,9/8/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/5/2025,mg,antineoplastic,8/26/2022,6/7/2022,Intravenous,pembrolizumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/25/2022,mg,antineoplastic,7/13/2021,3/30/2017,Oral,nilotinib,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/18/2021,mg,antineoplastic,9/5/2021,7/2/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,5/9/2025,mg,antineoplastic,12/11/2024,8/1/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,6/5/2019,mg,antineoplastic,5/8/2019,11/16/2018,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G485C85BECGC4,3/30/2022,,antiemetic,2/19/2022,12/12/2021,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/25/2021,,antineoplastic,3/28/2021,4/12/2021,,carboplatin,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,9/5/2014,mg,antineoplastic,7/2/2014,6/17/2014,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,1/26/2017,mg,antineoplastic,11/27/2016,11/19/2016,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19511695D78G,5/25/2025,mg,antineoplastic,3/28/2025,4/30/2025,Intravenous,pembrolizumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/13/2019,mg,antineoplastic,3/23/2019,1/15/2019,Intravenous,paclitaxel protein-bound,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/19/2024,mg,antineoplastic,6/27/2024,5/20/2024,Intravenous,carboplatin,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/10/2020,mg,antineoplastic,9/24/2019,9/9/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G25C3661FG6B9,3/19/2015,,,4/1/2015,9/2/2014,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/31/2022,mg,antineoplastic,12/26/2021,1/24/2018,Intravenous,pembrolizumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/24/2024,,antineoplastic,11/10/2023,11/30/2023,Intravenous,carboplatin,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/25/2014,mg,antineoplastic,8/24/2014,8/29/2014,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/27/2024,mg,antineoplastic,6/21/2023,11/17/2021,Intravenous,nivolumab,TRUE
165,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3:C9BECD3F55,12/30/2020,mg,antineoplastic,12/15/2020,8/20/2020,Intravenous,docetaxel,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,4/8/2017,mg,antineoplastic,9/24/2015,4/17/2015,Intravenous,bevacizumab,TRUE
925,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,9/15/2013,mg,antineoplastic,10/12/2013,7/26/2013,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/19/2018,mg,antineoplastic,10/12/2018,9/10/2018,Intravenous,pembrolizumab,FALSE
1632,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/21/2020,mg,antineoplastic,4/4/2020,4/7/2020,Intravenous,bevacizumab,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/28/2025,mg,antineoplastic,4/8/2024,3/18/2024,Subcutaneous,leuprolide,FALSE
1035,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,6/10/2016,mg,antineoplastic,6/11/2015,3/4/2015,Intravenous,pemetrexed,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/15/2015,mg,antineoplastic,6/15/2014,1/2/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/18/2022,,antineoplastic,10/10/2021,9/23/2021,Intravenous,pemetrexed,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/25/2023,mg,antineoplastic,9/10/2023,9/8/2023,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Orders,hormone,Anastrozole,G2B4648:BGD83,9/29/2024,,antineoplastic,9/30/2024,10/3/2024,Oral,anastrozole,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/27/2019,mg,antineoplastic,3/7/2019,11/26/2018,Intravenous,carboplatin,FALSE
236,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/28/2016,mg,antineoplastic,4/3/2016,11/7/2015,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/26/2020,mg,antineoplastic,1/7/2018,7/21/2017,Intravenous,pemetrexed,TRUE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/19/2022,mg,antineoplastic,10/6/2019,4/12/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/17/2017,AUC,antineoplastic,7/5/2017,5/26/2017,Intravenous,carboplatin,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,12/5/2022,mg,antineoplastic,9/24/2022,8/16/2022,Intravenous,pemetrexed,FALSE
,,CONCURRENT,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/3/2025,,antineoplastic,12/31/2024,11/6/2024,Oral,anastrozole,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,12/5/2024,mg,antineoplastic,7/12/2024,7/17/2024,Intravenous,carboplatin,FALSE
1000,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,6/25/2024,mg,antineoplastic,5/9/2024,5/29/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,12/4/2018,mg,antineoplastic,8/15/2018,6/27/2018,Intravenous,pembrolizumab,TRUE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/9/2016,mg,antineoplastic,1/15/2016,12/13/2015,Intravenous,bevacizumab,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/20/2019,mg,antineoplastic,1/29/2018,10/30/2016,Intramuscular,fulvestrant,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,2/25/2015,mg,antineoplastic,8/4/2014,6/21/2014,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/18/2022,,antineoplastic,11/16/2020,4/23/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/18/2019,mg,antineoplastic,9/1/2019,7/3/2019,Intravenous,pembrolizumab,FALSE
50,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:D1D2EG5C21,2/15/2015,mg,antineoplastic,12/17/2014,12/21/2014,Intravenous,vinorelbine,FALSE
419,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,10/24/2024,mg,antineoplastic,8/3/2024,7/18/2024,Intravenous,carboplatin,FALSE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,10/20/2015,mg,antineoplastic,8/22/2015,7/19/2015,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/16/2018,mg,antineoplastic,11/18/2017,2/7/2017,Intravenous,pembrolizumab,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/26/2022,mg,antineoplastic,2/28/2022,2/27/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/1/2019,,antineoplastic,10/27/2018,10/10/2018,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/15/2025,mg,antineoplastic,3/24/2025,8/12/2024,Intravenous,atezolizumab,TRUE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/6/2022,mg,antineoplastic,12/2/2022,9/19/2022,Oral,imatinib,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,8/15/2013,mg,antineoplastic,3/18/2013,3/26/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4ED3922EEE48,10/29/2022,,,10/21/2022,4/29/2019,Oral,osimertinib,FALSE
125,,ADJUVANT,Administrations,chemotherapy,"Docetaxel,Leuprolide",G53D3D6874EB3,10/14/2023,mg,antineoplastic,8/28/2023,7/30/2023,Intravenous,docetaxel,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/13/2014,mg,antineoplastic,11/6/2014,9/21/2014,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/20/2018,mg,antineoplastic,10/15/2017,3/2/2017,Intravenous,pembrolizumab,FALSE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/18/2019,mg,antineoplastic,8/28/2019,7/17/2019,Intravenous,paclitaxel,FALSE
463,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,12/12/2024,mg,antineoplastic,9/19/2024,8/25/2024,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/9/2025,mg,antineoplastic,7/26/2022,2/5/2022,Intravenous,atezolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/14/2013,,antineoplastic,4/3/2013,3/31/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,3/29/2017,,antineoplastic,2/20/2016,3/11/2016,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/24/2022,mg,antineoplastic,3/21/2020,1/25/2020,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,6/4/2019,mg/m2,antineoplastic,3/15/2019,2/19/2019,Intravenous,pemetrexed,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,10/3/2016,mg,antineoplastic,11/23/2015,9/25/2014,Intravenous,bevacizumab,TRUE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,9/20/2023,mg,antineoplastic,8/19/2023,5/21/2023,Intravenous,vinorelbine,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/15/2019,mg,antineoplastic,11/3/2018,6/28/2018,Intravenous,trastuzumab,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/14/2015,mg,antineoplastic,11/12/2014,9/10/2014,Intravenous,pemetrexed,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/16/2021,mg,antineoplastic,5/14/2021,9/5/2020,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,10/22/2018,mg,antineoplastic,7/19/2018,7/30/2018,Intravenous,paclitaxel,FALSE
163,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/18/2016,mg,antineoplastic,6/27/2016,5/17/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/29/2025,mg,antineoplastic,6/2/2023,9/25/2022,Intravenous,pembrolizumab,TRUE
40,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/12/2018,mg,antineoplastic,9/16/2018,7/6/2018,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/12/2020,,antineoplastic,5/11/2020,5/30/2020,Intravenous,paclitaxel,FALSE
183,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,1/20/2023,mg,antineoplastic,4/5/2022,3/16/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/24/2019,mg,antineoplastic,10/28/2019,8/16/2019,Intravenous,pembrolizumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,4/15/2021,3/29/2017,Oral,nilotinib,FALSE
,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/16/2020,,antineoplastic,10/11/2020,8/21/2020,Oral,bicalutamide,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/5/2019,mg,antineoplastic,3/27/2019,12/10/2018,Intravenous,durvalumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,8/31/2024,mg,antineoplastic,6/28/2024,4/16/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/17/2025,mg,antineoplastic,10/2/2024,6/14/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/18/2025,mg,antineoplastic,5/26/2023,9/12/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/5/2021,mg,antineoplastic,5/1/2021,4/26/2021,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/30/2025,mg,antineoplastic,11/26/2022,8/15/2021,Intravenous,atezolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/14/2020,mg,antineoplastic,3/15/2020,8/3/2019,Intravenous,pembrolizumab,FALSE
400,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/13/2019,mg/m2,antineoplastic,1/2/2019,5/27/2018,Intravenous,pemetrexed,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/5/2020,mg,antineoplastic,5/10/2019,1/7/2019,Subcutaneous,bortezomib,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,5/4/2019,AUC,antineoplastic,3/1/2019,2/27/2019,Intravenous,carboplatin,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/9/2020,mg,antineoplastic,6/18/2020,2/27/2019,Subcutaneous,bortezomib,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/5/2025,mg,antineoplastic,11/11/2024,8/8/2024,Intravenous,pemetrexed,TRUE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/30/2019,mg,antineoplastic,5/1/2018,11/13/2016,Intramuscular,fulvestrant,FALSE
198,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,3/31/2013,mg,antineoplastic,3/5/2013,11/28/2012,Intravenous,paclitaxel,FALSE
43,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/25/2023,mg,antineoplastic,10/21/2022,10/31/2022,Intravenous,leucovorin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38GE:9D51587,8/21/2012,mg,antineoplastic,5/22/2012,4/3/2012,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/1/2025,mg,antineoplastic,1/25/2025,4/1/2024,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/25/2024,mg,antineoplastic,9/28/2023,10/20/2023,Intravenous,pembrolizumab,FALSE
,,NEOADJUVANT,Orders,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,10/15/2023,,antineoplastic,9/18/2023,9/9/2023,Intramuscular,leuprolide,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/20/2019,mg,antineoplastic,9/7/2017,12/3/2016,Intramuscular,fulvestrant,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/24/2019,mg/m2,antineoplastic,6/6/2019,4/22/2019,Intravenous,etoposide,FALSE
6,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/12/2022,AUC,antineoplastic,10/23/2021,10/12/2021,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/8/2014,mL,solution-fluid,11/30/2013,11/17/2013,Intravenous,cisplatin,FALSE
480,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/2/2016,mg,antineoplastic,9/10/2016,7/10/2016,Intravenous,carboplatin,FALSE
792,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/25/2018,mg,antineoplastic,9/14/2018,10/7/2018,Intravenous,pemetrexed,FALSE
1310,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,1/25/2015,mg,antineoplastic,2/25/2015,12/7/2014,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/7/2022,mg,antineoplastic,1/22/2021,7/23/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,1/24/2023,mg,antineoplastic,5/11/2022,4/2/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/15/2025,mg,antineoplastic,4/14/2025,6/17/2022,Intravenous,pembrolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/29/2024,mg,antineoplastic,12/14/2023,12/8/2021,Intravenous,nivolumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/26/2018,mg,antineoplastic,9/18/2017,6/10/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/5/2025,mg,antineoplastic,6/1/2024,5/29/2024,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,9/11/2018,mg,antineoplastic,4/17/2013,3/11/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/28/2020,,antineoplastic,12/24/2019,12/24/2019,Intravenous,clinical study drug,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,6/23/2024,mg,antineoplastic,12/17/2023,5/25/2023,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/10/2025,mg,antineoplastic,4/21/2024,2/4/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,1/11/2018,mg,antineoplastic,9/3/2017,8/13/2017,Intravenous,nivolumab,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/5/2021,mg,antineoplastic,1/12/2021,6/17/2020,Intravenous,gemcitabine,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/31/2020,mg,antineoplastic,3/19/2020,11/3/2019,Intravenous,durvalumab,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1F482136BDE5,4/10/2017,,antiemetic,3/8/2017,2/14/2017,Intravenous,clinical study drug,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,2/1/2015,mg,antineoplastic,2/18/2015,11/6/2014,Intravenous,vinorelbine,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/20/2023,mg,antineoplastic,6/19/2021,1/16/2020,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/10/2018,mg,antineoplastic,1/8/2018,9/5/2015,Intravenous,nivolumab,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/26/2024,mg,antineoplastic,4/21/2023,3/5/2022,Intravenous,durvalumab,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,3/26/2022,mg,antineoplastic,4/29/2022,3/28/2022,Oral,anastrozole,FALSE
2550,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,7/10/2022,mg,antineoplastic,11/4/2021,8/27/2021,Intravenous,gemcitabine,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/28/2022,mg,antineoplastic,3/26/2022,11/9/2021,Intravenous,fluorouracil,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,9/17/2019,mg,antineoplastic,9/2/2019,2/7/2019,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/9/2025,mg,antineoplastic,1/27/2025,1/9/2024,Intravenous,pembrolizumab,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/19/2020,mg,antineoplastic,3/9/2020,12/14/2019,Intravenous,gemcitabine,FALSE
,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,6/13/2024,,antineoplastic,6/8/2024,6/11/2024,Intravenous,nivolumab,FALSE
443.8,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G11:E1E83E6:D,4/9/2019,mg,antineoplastic,5/19/2019,5/1/2019,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/4/2021,,antineoplastic,8/15/2020,2/11/2020,Intravenous,clinical study drug,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/13/2024,mg,antineoplastic,12/22/2023,12/23/2023,Intravenous,pemetrexed,FALSE
104,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/15/2017,mg,antineoplastic,5/29/2017,5/22/2017,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/24/2014,mg,antineoplastic,11/9/2014,9/14/2014,Intravenous,pemetrexed,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Decitabine,Venetoclax",G41DE1E3BE99:,6/6/2024,mg,antineoplastic,7/11/2024,6/7/2024,Intravenous,decitabine,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/13/2023,mg,antineoplastic,2/13/2023,8/3/2022,Subcutaneous,azacitidine,FALSE
958,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/6/2017,mg,antineoplastic,12/4/2016,12/19/2016,Intravenous,bevacizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/15/2022,mg,antineoplastic,1/13/2022,1/10/2022,Intravenous,pemetrexed,FALSE
115,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,10/24/2022,mg,antineoplastic,9/22/2022,10/6/2022,Intravenous,carboplatin,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/7/2014,mg,antineoplastic,8/22/2013,7/4/2013,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/5/2025,,antineoplastic,3/2/2025,1/29/2023,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/17/2022,mg,antineoplastic,5/28/2021,8/11/2020,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/6/2020,mg,antineoplastic,9/25/2017,11/28/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23G13:GCG631,12/31/2017,mg,antineoplastic,11/7/2017,10/16/2017,Intravenous,pembrolizumab,FALSE
61.5,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/26/2021,mg,antineoplastic,8/17/2021,12/1/2020,Intravenous,vinorelbine,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/5/2014,mg,antineoplastic,4/20/2014,2/17/2014,Intravenous,docetaxel,FALSE
204,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/4/2020,mg,antineoplastic,6/1/2017,3/18/2017,Intravenous,paclitaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/20/2023,mg,antineoplastic,7/18/2023,5/30/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,12/30/2016,,antineoplastic,3/27/2016,2/29/2016,Intravenous,clinical study drug,FALSE
486,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,6/1/2024,mg,antineoplastic,3/18/2024,3/11/2024,Intravenous,paclitaxel,FALSE
576.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,3/28/2019,mg,antineoplastic,3/15/2019,2/21/2019,Intravenous,carboplatin,FALSE
160,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G167G71733G69,10/20/2016,mg,antineoplastic,5/14/2016,5/7/2016,Intravenous,nivolumab,FALSE
96,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,3/24/2015,mg,antineoplastic,11/28/2014,11/15/2014,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,3/29/2015,mg,antineoplastic,1/30/2015,12/28/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/19/2025,mg,antineoplastic,11/17/2024,4/8/2020,Intravenous,pembrolizumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G13D3F29D3FFF,2/20/2014,mg,antineoplastic,11/27/2013,10/21/2013,Intravenous,cisplatin,FALSE
750,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/19/2024,mg,antineoplastic,12/16/2023,1/19/2023,Intravenous,durvalumab,FALSE
,4,ADVANCED,Orders,chemotherapy,"Hydroxyurea,Imatinib",G14E7662::61C,12/3/2022,,antineoplastic,10/19/2022,11/12/2022,Oral,hydroxyurea,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/25/2016,mg,antineoplastic,3/22/2016,4/14/2016,Intravenous,bevacizumab,TRUE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/28/2016,mg,antineoplastic,10/18/2014,9/15/2014,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,1/26/2019,,antineoplastic,8/8/2018,3/31/2018,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,11/30/2022,mg,antineoplastic,10/1/2020,4/13/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,5/2/2025,mg,antineoplastic,9/5/2024,10/8/2023,Intravenous,pembrolizumab,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/30/2014,mg,antineoplastic,6/30/2014,7/14/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,6/8/2024,mg,antineoplastic,2/23/2024,2/2/2024,Intravenous,pembrolizumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/20/2025,mg,antineoplastic,5/24/2023,1/29/2020,Intravenous,pemetrexed,TRUE
178,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/27/2023,mg,antineoplastic,12/23/2022,11/27/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/16/2025,mg,antineoplastic,2/1/2025,6/17/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,10/4/2020,mg,antineoplastic,8/22/2020,8/5/2020,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G177G4:B9E394,5/5/2025,,steroid,3/22/2025,3/2/2025,Intravenous,clinical study drug,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G57:2GEC9DD36,1/3/2016,mg,antineoplastic,12/19/2015,11/17/2015,Intravenous,cisplatin,FALSE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/2/2014,mg,antineoplastic,6/12/2014,5/9/2014,Intravenous,vinorelbine,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/24/2024,mg,antineoplastic,3/25/2023,1/25/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,hormone,Anastrozole,G49E8CFG53::D,2/24/2013,,antineoplastic,12/4/2012,7/24/2011,Oral,anastrozole,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/28/2019,mg,antineoplastic,11/16/2018,3/5/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/8/2025,,antineoplastic,1/19/2024,1/24/2023,,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/8/2025,mg,antineoplastic,12/21/2024,5/15/2023,Intravenous,pembrolizumab,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/9/2014,mg,antineoplastic,4/22/2013,10/7/2012,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/14/2023,mg,antineoplastic,4/15/2020,9/29/2019,Intravenous,pembrolizumab,TRUE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/8/2018,mg,antineoplastic,10/21/2018,9/15/2018,Intravenous,paclitaxel,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/18/2015,mg/m2,antineoplastic,2/4/2015,9/1/2014,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/1/2022,mg,antineoplastic,9/9/2017,5/8/2017,Intravenous,nivolumab,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/13/2014,mg,antineoplastic,10/11/2013,6/9/2013,Intravenous,bevacizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/11/2022,mg,antineoplastic,8/2/2022,10/13/2021,Intravenous,pemetrexed,TRUE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/17/2016,mg,antineoplastic,12/5/2015,11/23/2015,Intravenous,bevacizumab,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/9/2016,mg/kg,antineoplastic,3/24/2015,5/5/2014,Intravenous,bevacizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,8/6/2024,mL,solution-fluid,5/22/2024,4/3/2024,Intravenous,pemetrexed,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,6/19/2024,mg/m2,antineoplastic,5/27/2024,4/11/2024,Intravenous,pemetrexed,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,8/20/2021,mg,antineoplastic,7/18/2021,7/12/2021,Intravenous,paclitaxel,FALSE
1102,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/14/2020,mg,antineoplastic,10/6/2019,10/28/2019,Intravenous,bevacizumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/10/2022,mL,solution-fluid,4/7/2022,1/22/2022,Intravenous,nivolumab,FALSE
62.1,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/20/2021,mg,antineoplastic,6/27/2021,12/4/2020,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/10/2022,mg,antineoplastic,12/6/2021,5/7/2021,Intravenous,pembrolizumab,TRUE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,2/27/2022,mg,antineoplastic,10/25/2021,10/26/2021,Intravenous,fluorouracil,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,8/3/2024,mg,antineoplastic,8/4/2024,5/27/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,6/26/2017,,antineoplastic,4/14/2017,12/27/2016,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,chemotherapy,"Bevacizumab-Bvzr,Capecitabine",G5724:G6:4ED5,5/17/2025,,antineoplastic,2/8/2025,3/15/2025,Oral,capecitabine,FALSE
660,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/10/2022,mg,antineoplastic,5/25/2022,8/20/2021,Intravenous,rituximab-pvvr,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/21/2025,mg,antineoplastic,3/12/2021,1/18/2017,Intravenous,pembrolizumab,FALSE
1010,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/29/2025,mg,antineoplastic,4/1/2022,9/22/2021,Intravenous,pemetrexed,TRUE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,2/18/2015,mg,antineoplastic,6/24/2014,6/11/2014,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/14/2016,mg,antineoplastic,4/26/2016,4/4/2016,Intravenous,pemetrexed,TRUE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/6/2025,mg,antineoplastic,10/24/2020,3/3/2019,Intravenous,pemetrexed,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,11/30/2014,mg,antineoplastic,1/21/2014,1/25/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/22/2025,mg,antineoplastic,10/26/2023,3/10/2020,Intravenous,pembrolizumab,FALSE
317,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G243C3G2697F5,5/27/2015,mg,antineoplastic,6/9/2015,6/13/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/14/2024,mg,antineoplastic,11/5/2023,5/31/2023,Intravenous,pembrolizumab,TRUE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,11/12/2023,mg,antineoplastic,9/27/2023,12/10/2022,Oral,zanubrutinib,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,8/12/2023,mg,antineoplastic,7/10/2023,6/25/2023,Intravenous,carboplatin,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G27C8FF:88CEC,5/24/2020,mg,antineoplastic,4/29/2020,5/7/2020,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/13/2025,,antineoplastic,6/12/2024,3/8/2023,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/12/2014,mg,antineoplastic,8/27/2014,3/9/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G485C85BECGC4,4/10/2022,,antiemetic,2/1/2022,1/14/2022,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,5/4/2025,mg,antineoplastic,1/14/2025,9/2/2024,Intravenous,atezolizumab,TRUE
105,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/11/2020,mg,antineoplastic,9/12/2019,8/15/2019,Intravenous,docetaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/3/2017,,solution-fluid,6/25/2016,3/7/2016,Intravenous,clinical study drug,FALSE
388.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,3/3/2015,mg,antineoplastic,11/30/2014,10/26/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/8/2018,mg,antineoplastic,1/12/2018,3/29/2017,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/8/2025,,steroid,3/1/2025,12/15/2024,Intravenous,clinical study drug,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/21/2015,mg,antineoplastic,4/25/2014,1/22/2014,Intravenous,carboplatin,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/24/2024,mg,antineoplastic,10/16/2023,10/27/2023,Intravenous,amivantamab-vmjw,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/17/2025,,antineoplastic,5/21/2023,3/15/2023,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/24/2025,mg,antineoplastic,7/10/2024,5/15/2024,Intravenous,pemetrexed,TRUE
100,1,ADVANCED,Administrations,solution-fluid,Durvalumab,G49E3CE9E292G,5/17/2020,mL,solution-fluid,12/12/2019,10/22/2019,Intravenous,durvalumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/28/2023,mg,antineoplastic,6/3/2023,5/23/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/28/2016,,antineoplastic,5/14/2016,9/15/2014,Intravenous,pemetrexed,TRUE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/18/2014,mg/kg,antineoplastic,3/6/2014,11/6/2013,Intravenous,bevacizumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/9/2019,mg,antineoplastic,10/17/2016,4/2/2016,Intravenous,nivolumab,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/17/2012,mg,antineoplastic,5/13/2012,3/18/2012,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G26D38EC278C1,7/26/2019,mg,antineoplastic,6/23/2019,2/10/2019,Intravenous,atezolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,1/5/2021,mg,antineoplastic,5/31/2020,6/11/2020,Intravenous,pembrolizumab,FALSE
404,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/26/2017,mg,antineoplastic,11/22/2016,11/21/2016,Intravenous,carboplatin,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/12/2019,mg,antineoplastic,8/22/2018,7/18/2018,Intravenous,fluorouracil,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G11B743:8G337,6/27/2016,mg,antineoplastic,3/17/2015,4/8/2015,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/3/2025,mg,antineoplastic,12/16/2024,4/25/2024,Intravenous,pembrolizumab,FALSE
50,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/15/2022,mL,solution-fluid,3/1/2022,2/10/2022,Intravenous,ipilimumab,FALSE
960,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1FE4F243:1FG,4/22/2025,mg,antineoplastic,4/3/2025,3/23/2025,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/2/2013,mg,antineoplastic,7/31/2012,1/5/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1F8F989D:8C8,12/31/2022,mg,antineoplastic,9/14/2020,9/14/2020,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1:9FCE6E6G6C,5/8/2025,,,6/19/2023,7/16/2023,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/15/2025,,antineoplastic,2/21/2025,1/24/2023,,clinical study drug,FALSE
129,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/13/2018,mg,antineoplastic,10/9/2018,10/14/2018,Intravenous,carboplatin,FALSE
432,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/17/2013,mg,antineoplastic,5/17/2012,4/23/2012,Intravenous,carboplatin,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/16/2016,mg,antineoplastic,4/13/2016,12/13/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,7/1/2023,mg,antineoplastic,4/15/2023,4/3/2023,Intravenous,pembrolizumab,FALSE
400,2,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,7/21/2023,mg,antineoplastic,7/20/2023,5/19/2023,Intravenous,pembrolizumab,FALSE
616,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G167G71733G69,3/14/2016,mg,antineoplastic,1/2/2016,10/24/2015,Intravenous,pemetrexed,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/22/2012,mg,antineoplastic,5/17/2012,2/21/2012,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/13/2021,mg,antineoplastic,2/20/2021,9/30/2020,Intravenous,nivolumab,FALSE
225,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,6/13/2012,mg,antineoplastic,4/20/2012,3/26/2012,Intravenous,paclitaxel,FALSE
248,,ADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,9/8/2014,mg,antineoplastic,4/26/2014,4/15/2014,Intravenous,ado-trastuzumab emtansine,FALSE
860,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,1/23/2014,mg,antineoplastic,12/23/2013,11/18/2013,Intravenous,carboplatin,FALSE
200,4,ADVANCED,Administrations,immunotherapy,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,2/26/2025,mg,antineoplastic,12/18/2024,11/26/2024,Intravenous,pembrolizumab,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/23/2025,mg,antineoplastic,3/22/2025,7/28/2024,Intravenous,durvalumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,10/9/2024,mg,antineoplastic,8/1/2024,7/6/2024,Intravenous,nivolumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,1/6/2025,mg,antineoplastic,8/4/2024,4/7/2024,Intravenous,cemiplimab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/27/2019,AUC,antineoplastic,10/6/2019,6/27/2019,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/5/2019,mL,solution-fluid,9/21/2019,8/10/2019,Intravenous,pembrolizumab,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/6/2022,mg/kg,antineoplastic,8/21/2021,2/18/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/30/2025,mg,antineoplastic,5/3/2022,2/15/2019,Intravenous,pembrolizumab,TRUE
1229,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/16/2015,mg,antineoplastic,8/30/2014,7/31/2014,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,,antineoplastic,12/23/2021,4/7/2017,Oral,nilotinib,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/9/2022,mg,antineoplastic,7/23/2021,3/24/2021,Intravenous,ramucirumab,FALSE
2,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/1/2023,mg,antineoplastic,12/20/2022,10/5/2022,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,12/21/2015,,antineoplastic,8/28/2015,4/15/2015,Oral,ibrutinib,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/3/2021,,antiemetic,4/28/2020,3/5/2020,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/22/2025,mg,antineoplastic,12/27/2019,2/20/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,2/5/2015,,,1/8/2015,12/2/2014,Oral,afatinib,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/13/2015,mg,antineoplastic,10/29/2014,8/6/2014,Intravenous,carboplatin,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,11/7/2013,mg,antineoplastic,9/2/2013,8/10/2013,Intravenous,carboplatin,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/13/2015,mg,antineoplastic,12/14/2014,4/29/2014,Intravenous,vinorelbine,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/23/2012,mg,antineoplastic,9/8/2012,5/4/2012,Intravenous,carboplatin,FALSE
1300,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,11/27/2012,mg,antineoplastic,9/5/2012,8/18/2012,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/10/2019,,antineoplastic,9/12/2017,8/20/2017,,cisplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/20/2016,mg,antineoplastic,2/16/2016,11/24/2015,Intravenous,pemetrexed,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/11/2020,mg/kg,antineoplastic,9/13/2020,3/13/2020,Intravenous,ramucirumab,FALSE
15,4,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,3/18/2022,mg/kg,antineoplastic,2/9/2022,2/13/2022,Intravenous,bevacizumab-bvzr,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,6/15/2024,mg,antineoplastic,3/19/2024,10/24/2023,Intravenous,nivolumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/26/2020,mg,antineoplastic,1/4/2020,2/1/2019,Subcutaneous,bortezomib,FALSE
245,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/19/2016,mg,antineoplastic,12/30/2015,11/16/2015,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/2/2025,mg,antineoplastic,8/27/2024,2/4/2024,Intravenous,pembrolizumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,7/19/2016,mg,antineoplastic,4/18/2016,3/15/2016,Intravenous,paclitaxel,FALSE
,1,LOCOREGIONAL,Unstructured,,"Carboplatin,Crizotinib,Pemetrexed",G1D4DE:C3C41C,3/21/2025,,,3/4/2024,1/17/2024,Oral,crizotinib,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/1/2021,mg,antineoplastic,12/25/2019,1/1/2020,Intravenous,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/21/2025,mg,antineoplastic,4/9/2018,1/4/2017,Intravenous,nivolumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/4/2013,AUC,antineoplastic,12/14/2012,8/4/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/21/2024,,antineoplastic,4/4/2024,10/29/2023,,pemetrexed,FALSE
90,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/18/2022,mg/m2,antineoplastic,10/6/2021,10/20/2021,Intravenous,irinotecan,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/6/2022,mg,antineoplastic,12/5/2017,5/15/2017,Intravenous,nivolumab,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,1/2/2023,mg,antineoplastic,11/13/2022,10/5/2022,Oral,imatinib,FALSE
113,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,10/1/2021,mg,antineoplastic,5/29/2021,6/9/2021,Intravenous,carboplatin,FALSE
404,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/30/2016,mg,antineoplastic,11/5/2015,10/18/2015,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,9/29/2019,mg,antineoplastic,8/1/2019,5/1/2019,Intravenous,carboplatin,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,5/14/2017,mg,antineoplastic,4/23/2017,4/14/2017,Intravenous,carboplatin,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/21/2014,mg,antineoplastic,3/18/2014,2/19/2014,Intravenous,docetaxel,FALSE
845,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/6/2017,mg,antineoplastic,12/6/2016,11/22/2016,Intravenous,pemetrexed,FALSE
456,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,4/15/2025,mg,antineoplastic,2/1/2025,11/5/2024,Intravenous,carboplatin,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/10/2024,mg,antineoplastic,8/9/2024,7/9/2024,Intravenous,paclitaxel,FALSE
1500,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,5/3/2013,mg,antineoplastic,1/13/2013,2/17/2013,Intravenous,gemcitabine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/1/2025,mg,antineoplastic,6/11/2022,8/7/2021,Intravenous,atezolizumab,TRUE
,,NEOADJUVANT,Administrations,growth factor,Clinical Study Drug,G1DCDG73E53FF,7/20/2024,,hematological agent,6/10/2024,5/8/2024,Subcutaneous,clinical study drug,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/9/2020,mg,antineoplastic,5/27/2020,4/17/2020,Intravenous,paclitaxel protein-bound,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/24/2024,mg,antineoplastic,10/2/2023,6/16/2023,Intravenous,pemetrexed,FALSE
1140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/29/2022,mg,antineoplastic,12/10/2021,12/8/2021,Intravenous,pemetrexed,FALSE
957,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/11/2025,mg,antineoplastic,5/4/2025,8/26/2024,Intravenous,durvalumab,TRUE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,1/19/2018,mg,antineoplastic,11/1/2017,11/1/2017,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/24/2025,mg,antineoplastic,5/16/2023,5/22/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/22/2023,,antineoplastic,11/30/2022,12/29/2022,,clinical study drug,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/10/2024,mg,antineoplastic,5/22/2024,11/12/2023,Intravenous,durvalumab,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/1/2018,mg,antineoplastic,1/2/2018,12/27/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/16/2022,,antineoplastic,2/21/2022,2/27/2022,,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/1/2022,mg,antineoplastic,11/8/2018,5/3/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/26/2022,mg,antineoplastic,4/26/2021,1/29/2020,Intravenous,nivolumab,FALSE
1880,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G557E997E81G5,3/28/2023,mg,antineoplastic,9/14/2022,9/2/2022,Intravenous,gemcitabine,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/3/2021,mg,antineoplastic,7/31/2021,7/21/2021,Intravenous,carboplatin,FALSE
1640,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,10/29/2015,mg,antineoplastic,4/17/2015,3/26/2015,Intravenous,gemcitabine,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/2/2025,mg,antineoplastic,6/23/2024,7/28/2024,Intravenous,pemetrexed,FALSE
140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,8/17/2024,mg,antineoplastic,7/3/2023,3/3/2023,Intravenous,docetaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/20/2022,,antineoplastic,1/28/2022,2/4/2022,Intravenous,carboplatin,FALSE
110,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,5/15/2025,mg,antineoplastic,1/12/2025,8/27/2024,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G57G45B:D1F17,2/2/2025,,antineoplastic,5/2/2018,10/18/2017,,clinical study drug,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/15/2025,mg,antineoplastic,5/13/2020,1/24/2019,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/18/2021,,antineoplastic,4/4/2020,3/1/2020,Intravenous,clinical study drug,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,5/27/2019,mg,antineoplastic,1/27/2019,1/29/2019,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,4/17/2025,mg,antineoplastic,3/25/2022,3/9/2022,Intravenous,pembrolizumab,TRUE
354,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/8/2017,mg,antineoplastic,11/6/2017,8/8/2017,Intravenous,paclitaxel,FALSE
888,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/28/2019,mg,antineoplastic,9/4/2018,6/25/2018,Intravenous,pemetrexed,FALSE
54,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,3/20/2025,mg,antineoplastic,3/6/2025,9/20/2024,Intravenous,ipilimumab,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,4/2/2022,mg,antineoplastic,1/16/2022,12/29/2021,Intravenous,nivolumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,6/28/2014,mg,antineoplastic,2/24/2014,12/20/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/12/2023,,antineoplastic,3/17/2023,1/19/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/28/2021,mg,antineoplastic,5/10/2021,10/22/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/23/2022,mg,antineoplastic,6/10/2022,5/15/2022,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,4/5/2024,mg,antineoplastic,11/23/2023,4/9/2023,Intravenous,bevacizumab-awwb,TRUE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,11/11/2017,,antineoplastic,11/12/2016,6/24/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/28/2024,mg,antineoplastic,5/14/2024,6/5/2023,Intravenous,pembrolizumab,TRUE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/2/2024,mg,antineoplastic,2/7/2023,12/23/2021,Intravenous,nivolumab,TRUE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/8/2025,mg,antineoplastic,8/13/2019,4/17/2019,Intravenous,pemetrexed,FALSE
148,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,5/29/2024,mg,antineoplastic,2/12/2024,2/4/2024,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Orders,chemotherapy,Pemetrexed,G35146C5E4B61,11/6/2015,mg/m2,antineoplastic,5/7/2015,4/3/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/11/2025,mg,antineoplastic,9/14/2024,12/30/2018,Intravenous,pembrolizumab,TRUE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/2/2016,mg,antineoplastic,6/7/2016,3/17/2016,Intravenous,cisplatin,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/20/2013,AUC,antineoplastic,10/17/2012,8/16/2012,Intravenous,carboplatin,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/28/2013,mg,antineoplastic,11/26/2012,12/15/2012,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/16/2025,mg,antineoplastic,11/23/2020,3/18/2020,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/31/2019,mg,antineoplastic,9/2/2018,11/3/2017,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/11/2014,mg,antineoplastic,6/16/2014,3/31/2014,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/5/2025,mg,antineoplastic,12/5/2022,8/7/2022,Oral,anastrozole,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,5/2/2024,,antineoplastic,9/23/2023,6/20/2023,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G128:92:3BD3D,11/22/2021,,hematological agent,6/18/2021,4/24/2021,Subcutaneous,clinical study drug,FALSE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/10/2013,mg,antineoplastic,10/30/2012,11/5/2012,Intravenous,bevacizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,8/13/2021,mg,antineoplastic,7/15/2021,7/13/2021,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G157317FG3387,10/4/2024,mg,antineoplastic,7/13/2024,5/27/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,8/25/2022,mg,antineoplastic,5/24/2022,7/11/2022,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,4/3/2021,mg,antineoplastic,5/28/2020,6/2/2020,Intravenous,pembrolizumab,TRUE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Irinotecan",G1D61871659DG,8/7/2012,mg/m2,antineoplastic,7/29/2012,7/2/2012,Intravenous,cetuximab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/29/2025,mg,antineoplastic,6/9/2020,4/21/2018,Intravenous,pembrolizumab,FALSE
50,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,10/28/2023,mg,antineoplastic,6/4/2023,7/13/2023,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,12/1/2019,mg,antineoplastic,8/30/2019,8/14/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,12/28/2022,,,10/17/2022,11/7/2022,Oral,alectinib,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,3/31/2013,mg,antineoplastic,3/4/2013,1/21/2013,Intravenous,pemetrexed,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/12/2013,mg,antineoplastic,4/29/2012,4/17/2012,Intravenous,paclitaxel,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/12/2013,AUC,antineoplastic,12/24/2012,8/6/2012,Intravenous,carboplatin,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/21/2011,mg,antineoplastic,10/26/2011,9/29/2011,Intravenous,etoposide,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4725296E3CE4,4/28/2022,,,3/3/2022,10/9/2021,Oral,erlotinib,TRUE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/18/2018,mg,antineoplastic,5/19/2018,5/2/2018,Intravenous,paclitaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/5/2011,mg,antineoplastic,8/25/2011,3/19/2011,Intravenous,paclitaxel,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Osimertinib,Paclitaxel",G1594:E29D2D9,5/4/2022,mg,antineoplastic,2/22/2022,2/13/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/13/2025,,antineoplastic,4/14/2022,10/5/2021,Intravenous,pembrolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,7/25/2018,mg/kg,antineoplastic,7/1/2018,3/24/2018,Intravenous,durvalumab,TRUE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,12/2/2013,mg,antineoplastic,9/20/2013,10/1/2013,Intravenous,carboplatin,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/14/2024,mg,antineoplastic,3/20/2024,3/19/2024,Intravenous,paclitaxel,FALSE
780,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G493:D:293BE2,2/1/2013,mg,antineoplastic,3/18/2013,3/21/2013,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/15/2012,mg,antineoplastic,3/30/2012,5/7/2012,Intravenous,carboplatin,FALSE
1096.3,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/8/2015,mg,antineoplastic,8/11/2015,2/11/2015,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,hormone,Exemestane,G358EF4457D52,6/11/2015,,antineoplastic,5/27/2015,6/19/2015,Oral,exemestane,FALSE
1630,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2:5874817G9C,8/30/2024,mg,antineoplastic,8/3/2024,7/22/2024,Intravenous,gemcitabine,FALSE
455,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,4/7/2025,mg,antineoplastic,3/19/2025,1/25/2025,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/26/2019,AUC,antineoplastic,8/30/2019,8/17/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/22/2021,,antineoplastic,8/18/2021,5/26/2021,Intravenous,pemetrexed,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/2/2019,mg,antineoplastic,3/28/2019,11/17/2018,Intravenous,bevacizumab,FALSE
306,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,11/24/2024,mg,antineoplastic,8/18/2024,6/25/2024,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,2/6/2018,mg,antineoplastic,9/3/2017,9/12/2017,Intravenous,pemetrexed,FALSE
6,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/3/2021,AUC,antineoplastic,12/2/2020,10/23/2020,Intravenous,carboplatin,FALSE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/20/2016,mg,antineoplastic,5/13/2016,6/10/2016,Intravenous,paclitaxel,FALSE
1650,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,6/1/2022,mg,antineoplastic,4/27/2022,3/7/2022,Intravenous,bevacizumab-awwb,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/12/2025,mg,antineoplastic,2/9/2018,1/13/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/28/2025,mg,antineoplastic,4/27/2022,1/21/2019,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/28/2025,mg,antineoplastic,6/17/2023,1/15/2017,Intravenous,pembrolizumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/1/2013,AUC,antineoplastic,9/4/2012,8/11/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,9/27/2020,mg,antineoplastic,12/14/2019,9/6/2019,Intravenous,pembrolizumab,TRUE
288.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/20/2015,mg,antineoplastic,1/17/2015,11/9/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/12/2025,mg,antineoplastic,11/4/2018,4/29/2018,Intravenous,pembrolizumab,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,6/29/2024,mg,antineoplastic,4/18/2024,4/5/2024,Intravenous,paclitaxel,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,1/13/2012,mg,antineoplastic,9/11/2011,7/26/2011,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,7/11/2017,,antineoplastic,11/27/2016,10/28/2016,,clinical study drug,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,5/23/2019,mg,antineoplastic,3/25/2019,2/22/2019,Intravenous,carboplatin,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/6/2024,mg,antineoplastic,11/19/2023,11/2/2023,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,6/22/2023,mg,antineoplastic,5/6/2023,2/14/2023,Intravenous,atezolizumab,FALSE
159,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/11/2020,mg,antineoplastic,9/1/2020,4/25/2020,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,1/20/2019,mL,solution-fluid,8/25/2017,8/14/2017,Intravenous,cisplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/13/2021,mg,antineoplastic,7/23/2021,6/7/2021,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/16/2020,mg,antineoplastic,12/8/2020,8/28/2020,Oral,bicalutamide,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,5/4/2025,mg,antineoplastic,12/22/2024,12/2/2024,Intravenous,paclitaxel,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/27/2018,mg,antineoplastic,5/19/2018,6/15/2018,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,3/14/2025,mL,solution-fluid,2/25/2025,5/10/2024,Intravenous,pembrolizumab,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,9/7/2013,mg,antineoplastic,3/19/2013,2/21/2013,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/7/2020,mg,antineoplastic,11/18/2018,1/16/2016,Intravenous,bevacizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/22/2022,mg,antineoplastic,8/16/2021,5/19/2020,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,11/26/2013,mg/m2,antineoplastic,10/11/2012,10/26/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G36G688G4EBD6,11/4/2023,mg,antineoplastic,10/25/2023,8/30/2023,Intravenous,pembrolizumab,TRUE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/30/2013,mg,antineoplastic,6/18/2013,1/2/2013,Intravenous,gemcitabine,FALSE
816,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/1/2025,mg,antineoplastic,1/9/2025,1/1/2025,Intravenous,pemetrexed,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/4/2021,mg,antineoplastic,8/21/2019,1/4/2019,Intravenous,pemetrexed,TRUE
115,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/15/2023,mg,antineoplastic,11/16/2023,9/14/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/19/2024,mg,antineoplastic,12/6/2024,6/15/2024,Intravenous,pembrolizumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,2/20/2019,mg,antineoplastic,11/18/2018,12/6/2018,Intravenous,pemetrexed,FALSE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G1D41F368EE:G,8/7/2019,mg,antineoplastic,8/13/2019,7/17/2019,Subcutaneous,leuprolide,FALSE
670,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/24/2015,mg,antineoplastic,12/21/2014,1/5/2015,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/4/2018,mg,antineoplastic,6/1/2017,7/27/2017,Intravenous,pembrolizumab,FALSE
762,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/20/2020,mg,antineoplastic,3/25/2017,3/4/2017,Intravenous,bevacizumab,FALSE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,12/14/2019,mg,antineoplastic,10/23/2019,9/7/2019,Intravenous,durvalumab,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/11/2017,mg,antineoplastic,6/23/2017,5/7/2017,Intravenous,carboplatin,FALSE
300,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,1/13/2025,mg,antineoplastic,12/27/2024,11/15/2024,Intravenous,paclitaxel,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,5/20/2021,mg,antineoplastic,11/26/2020,11/2/2020,Intravenous,nivolumab,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,5/4/2019,mg/m2,antineoplastic,1/3/2018,8/16/2017,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/13/2021,mg,antineoplastic,2/11/2021,11/28/2020,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,3/12/2025,mg,antineoplastic,5/13/2022,2/15/2022,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,2/4/2022,mg/m2,antineoplastic,11/4/2021,10/2/2021,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/15/2022,mg,antineoplastic,10/11/2017,5/4/2017,Oral,dasatinib,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,6/19/2024,mg,antineoplastic,5/24/2024,4/26/2024,Intravenous,gemcitabine,FALSE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/6/2012,mg/m2,antineoplastic,11/29/2011,10/2/2011,Intravenous,cetuximab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,4/29/2024,mg,antineoplastic,5/1/2024,2/19/2024,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/18/2023,mg,antineoplastic,11/20/2022,5/18/2022,Intravenous,nivolumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,12/5/2016,mg,antineoplastic,9/4/2016,7/16/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/28/2023,mg,antineoplastic,3/29/2023,8/20/2022,Intravenous,pembrolizumab,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/30/2024,mg,antineoplastic,6/18/2024,6/14/2024,Intravenous,gemcitabine,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/8/2024,mg,antineoplastic,3/24/2024,9/11/2023,Intravenous,durvalumab,FALSE
350,3,ADVANCED,Administrations,immunotherapy,Cemiplimab,G252328CFG4E1,5/24/2024,mg,antineoplastic,2/24/2024,1/28/2024,Intravenous,cemiplimab,FALSE
1910,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,2/18/2025,mg,antineoplastic,1/20/2025,12/17/2024,Intravenous,gemcitabine,FALSE
200,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,5/2/2019,mg,antineoplastic,12/25/2018,1/6/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/19/2024,mg,antineoplastic,8/3/2022,6/16/2020,Intravenous,pembrolizumab,TRUE
172,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,11/12/2015,mg,antineoplastic,11/14/2015,9/12/2015,Intravenous,carboplatin,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,10/3/2017,mg,antineoplastic,6/13/2016,1/13/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G1:641727397B,5/22/2025,,,4/7/2025,2/29/2024,Oral,alectinib,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/19/2021,mg,antineoplastic,10/18/2021,10/24/2021,Intravenous,carboplatin,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G7:9D7EC1EC,8/7/2022,mg,antineoplastic,4/12/2022,7/27/2021,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,5/17/2024,mg,antineoplastic,2/13/2022,11/17/2021,Intravenous,pembrolizumab,FALSE
480,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,1/31/2017,mg,antineoplastic,1/25/2017,10/25/2016,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,11/23/2023,,antineoplastic,12/20/2023,11/13/2023,Oral,anastrozole,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/31/2025,mg,antineoplastic,4/24/2025,4/13/2025,Intravenous,pemetrexed,FALSE
736,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,12/29/2013,mg,antineoplastic,1/11/2014,12/5/2013,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/24/2024,mg,antineoplastic,10/22/2023,7/13/2023,Intravenous,pembrolizumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,4/16/2022,mg,antineoplastic,2/12/2022,11/28/2021,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,10/23/2020,mg,antineoplastic,9/16/2020,8/27/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,targeted/biologic,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,9/6/2012,,antineoplastic,8/19/2012,4/19/2012,,clinical study drug,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,6/30/2020,mg,antineoplastic,6/18/2020,4/21/2020,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/31/2022,mg,antineoplastic,10/4/2022,6/30/2022,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/30/2019,mg,antineoplastic,8/30/2017,3/26/2016,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/14/2025,mg,antineoplastic,12/9/2023,8/25/2021,Intravenous,atezolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/18/2025,mg,antineoplastic,10/17/2023,9/22/2022,Intravenous,pembrolizumab,TRUE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/30/2023,mg,antineoplastic,6/11/2023,4/28/2023,Intravenous,carboplatin,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/28/2018,mg,antineoplastic,2/7/2018,10/18/2017,Intravenous,nivolumab,FALSE
237.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,8/25/2021,mg,antineoplastic,7/19/2021,6/17/2021,Intravenous,carboplatin,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/5/2025,mg,antineoplastic,12/10/2020,4/1/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/12/2020,mg,antineoplastic,7/18/2017,6/23/2016,Intravenous,nivolumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/5/2018,mg,antineoplastic,6/5/2018,4/24/2018,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/22/2022,mg,antineoplastic,11/15/2021,7/2/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,1/21/2024,mg,antineoplastic,9/1/2023,7/29/2023,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G26D38EC278C1,8/6/2019,mg,antineoplastic,7/29/2019,2/21/2019,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G344BC2:6BGE1,5/10/2012,,antineoplastic,11/27/2011,10/7/2011,Intravenous,clinical study drug,FALSE
544,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/23/2017,mg,antineoplastic,5/2/2017,10/13/2016,Intravenous,bevacizumab,FALSE
2200,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/5/2020,mg,antineoplastic,10/5/2019,10/19/2019,Intravenous,gemcitabine,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/31/2016,mg,antineoplastic,3/6/2016,9/5/2014,Intravenous,bevacizumab,TRUE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/2/2020,mg,antineoplastic,12/24/2019,10/30/2019,Intravenous,paclitaxel,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,12/19/2023,mg,antineoplastic,7/13/2023,7/15/2023,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,1/19/2020,,antineoplastic,4/14/2019,6/29/2017,Intravenous,pemetrexed,TRUE
271.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/5/2015,mg,antineoplastic,1/29/2015,2/13/2015,Intravenous,carboplatin,FALSE
200,5,ADVANCED,Administrations,immunotherapy,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/10/2025,mg,antineoplastic,3/14/2025,1/7/2025,Intravenous,pembrolizumab,FALSE
745,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,3/2/2023,mg,antineoplastic,12/6/2022,11/7/2022,Intravenous,pemetrexed,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4497G86984C8,3/29/2015,mg,antineoplastic,4/8/2015,2/21/2015,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2BEFF41G59F1,12/21/2024,mg,antineoplastic,11/16/2024,11/26/2024,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,2/1/2025,mg,antineoplastic,10/16/2024,8/14/2024,Intravenous,nivolumab,TRUE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/6/2024,mg,antineoplastic,5/28/2024,4/1/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23F23C5G7BFD,1/10/2019,mg,antineoplastic,1/19/2019,9/28/2018,Intravenous,pembrolizumab,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,3/30/2019,mg,antineoplastic,3/22/2019,1/11/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,8/17/2022,AUC,antineoplastic,6/6/2022,2/28/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,6/27/2021,mg,antineoplastic,3/16/2021,3/16/2021,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/15/2018,mg,antineoplastic,1/15/2017,9/2/2015,Intravenous,nivolumab,FALSE
1.5,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/14/2024,AUC,antineoplastic,10/26/2023,10/29/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,8/22/2020,,antineoplastic,2/26/2019,2/7/2019,,nivolumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/17/2016,mg,antineoplastic,1/4/2016,9/29/2014,Intravenous,bevacizumab,TRUE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/17/2025,mg/m2,antineoplastic,12/22/2024,10/16/2024,Intravenous,paclitaxel,FALSE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/9/2019,mg/m2,antineoplastic,2/14/2019,1/8/2019,Intravenous,pemetrexed,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,2/13/2014,mg,antineoplastic,10/6/2013,7/4/2013,Intravenous,bevacizumab,FALSE
233.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,11/2/2017,mg,antineoplastic,9/16/2017,8/1/2017,Intravenous,carboplatin,FALSE
1800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/11/2019,mg,antineoplastic,8/6/2019,5/8/2019,Intravenous,bevacizumab,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/29/2016,mg,antineoplastic,7/24/2016,6/25/2016,Intravenous,paclitaxel,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,5/28/2014,mg,antineoplastic,2/25/2014,1/29/2014,Intravenous,eribulin,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/15/2020,mg,antineoplastic,2/26/2020,2/3/2020,Intravenous,paclitaxel,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,8/5/2013,mg,antineoplastic,8/5/2012,7/20/2012,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/20/2019,mg,antineoplastic,12/16/2018,11/4/2018,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/11/2025,mg,antineoplastic,11/1/2024,8/17/2022,Intravenous,pembrolizumab,TRUE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,8/13/2016,mg,antineoplastic,6/3/2016,3/8/2016,Intravenous,paclitaxel,FALSE
875,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,7/15/2024,mg,antineoplastic,7/31/2024,7/3/2024,Intravenous,pemetrexed,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/14/2021,mg,antineoplastic,7/17/2021,5/8/2020,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G55C5E563EFC3,6/21/2014,,,4/8/2012,4/8/2012,Oral,erlotinib,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/3/2024,mg,antineoplastic,3/10/2024,10/2/2023,Intravenous,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1C49C5CC7:F7,4/11/2017,mg,antineoplastic,4/9/2017,3/18/2017,Intravenous,nivolumab,FALSE
,,ADJUVANT,Unstructured,,Erlotinib,G34182B94:768,12/11/2017,,,10/1/2017,9/14/2017,Oral,erlotinib,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/13/2025,,steroid,2/8/2025,11/21/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/25/2025,mg,antineoplastic,11/1/2024,7/20/2024,Intravenous,pembrolizumab,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/13/2015,mg,antineoplastic,8/19/2015,8/7/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/1/2025,,solution-fluid,8/25/2018,11/20/2017,Intravenous,clinical study drug,FALSE
500,,CONCURRENT,Orders,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/18/2012,mg,antineoplastic,2/29/2012,1/24/2012,Subcutaneous,amifostine,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/11/2015,mg,antineoplastic,10/9/2014,5/26/2014,Intravenous,vinorelbine,FALSE
366,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,11/30/2021,mg,antineoplastic,11/7/2021,8/17/2021,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,5/16/2025,,antineoplastic,10/22/2024,10/9/2024,Intravenous,durvalumab,FALSE
240.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/17/2013,mg,antineoplastic,6/17/2013,4/25/2013,Intravenous,carboplatin,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/5/2025,mg,antineoplastic,10/15/2021,1/29/2020,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,7/18/2024,AUC,antineoplastic,8/13/2023,6/22/2023,Intravenous,carboplatin,FALSE
313.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,5/20/2019,mg,antineoplastic,3/8/2019,2/23/2019,Intravenous,carboplatin,FALSE
113,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/10/2019,mg,antineoplastic,8/23/2017,8/12/2017,Intravenous,cisplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/14/2025,mg,antineoplastic,7/5/2022,2/25/2019,Intravenous,pemetrexed,FALSE
631,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/2/2013,mg,antineoplastic,8/27/2013,4/25/2013,Intravenous,carboplatin,FALSE
371,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/12/2022,mg,antineoplastic,4/1/2022,12/18/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/6/2025,,antineoplastic,7/4/2020,4/12/2020,Oral,enzalutamide,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/1/2022,,antineoplastic,1/4/2020,5/16/2017,Oral,nilotinib,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/26/2025,mg,antineoplastic,6/9/2019,12/29/2018,Intravenous,pemetrexed,TRUE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/15/2024,mg,antineoplastic,4/15/2024,9/3/2023,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G1969F536B2DD,11/1/2011,,antineoplastic,8/7/2011,6/21/2011,Intravenous,clinical study drug,FALSE
920,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,10/16/2024,mg,antineoplastic,6/7/2024,5/21/2024,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,6/23/2017,,antineoplastic,12/1/2016,12/2/2016,,clinical study drug,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/6/2022,mg,antineoplastic,6/25/2022,5/20/2022,Intravenous,paclitaxel,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/7/2023,mg,antineoplastic,10/24/2020,5/15/2020,Intravenous,pemetrexed,FALSE
600,1,ADVANCED,Administrations,targeted/biologic,"Erlotinib,Ramucirumab",G4725296E3CE4,9/15/2021,mg,antineoplastic,8/18/2021,9/14/2021,Intravenous,ramucirumab,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/22/2019,mg,antineoplastic,2/24/2019,10/7/2018,Intravenous,durvalumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/19/2025,mg,antineoplastic,1/5/2023,1/31/2020,Intravenous,pemetrexed,TRUE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/21/2021,mg,antineoplastic,9/10/2020,11/24/2019,Intravenous,durvalumab,TRUE
128,4,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/3/2021,mg,antineoplastic,11/2/2021,10/21/2021,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/26/2019,mg,antineoplastic,9/7/2019,8/30/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G4936::B67G17,1/29/2020,,,3/10/2019,1/26/2019,Oral,afatinib,FALSE
215,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,4/4/2016,mg,antineoplastic,4/2/2014,3/18/2014,Intravenous,carboplatin,FALSE
160,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G167G71733G69,10/30/2016,mg,antineoplastic,5/19/2016,4/21/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G147B:8F3B:52,12/10/2021,mg,antineoplastic,11/8/2021,10/30/2021,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/19/2025,mg,antineoplastic,4/8/2024,3/8/2024,Intravenous,carboplatin,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/9/2016,mg,antineoplastic,2/26/2015,9/29/2014,Intravenous,pemetrexed,TRUE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/10/2019,mg,antineoplastic,10/4/2017,12/2/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/4/2020,mg,antineoplastic,5/28/2020,8/26/2019,Intravenous,pembrolizumab,TRUE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/16/2014,mg,antineoplastic,3/14/2014,3/18/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/10/2025,mg,antineoplastic,1/22/2025,5/18/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,11/7/2017,mg,antineoplastic,7/25/2017,5/20/2017,Intravenous,pembrolizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/2/2022,mg,antineoplastic,11/9/2020,4/25/2017,Intravenous,nivolumab,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,11/22/2022,mg,antineoplastic,8/25/2022,9/12/2022,Intravenous,carboplatin,FALSE
578,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G17235672EDGF,9/7/2024,mg,antineoplastic,7/24/2024,7/21/2024,Intravenous,carboplatin,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,3/9/2019,mg,antineoplastic,8/18/2018,9/6/2018,Intravenous,paclitaxel,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,7/18/2021,mg,antineoplastic,10/3/2020,9/9/2020,Intravenous,gemcitabine,FALSE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/6/2024,mg,antineoplastic,7/3/2024,6/29/2024,Intravenous,cisplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/9/2022,mg,antineoplastic,8/10/2021,5/28/2021,Intravenous,pembrolizumab,FALSE
226,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/2/2014,mg,antineoplastic,9/4/2014,8/2/2014,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/16/2020,mg,antineoplastic,6/19/2017,8/15/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/27/2023,mg,antineoplastic,3/3/2023,5/24/2022,Intravenous,nivolumab,FALSE
491,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/7/2020,mg,antineoplastic,5/26/2020,2/17/2020,Intravenous,pemetrexed,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,9/20/2018,mg,antineoplastic,6/26/2017,5/31/2017,Intravenous,vinorelbine,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,11/12/2015,AUC,antineoplastic,9/8/2015,7/20/2015,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,5/13/2024,mg,antineoplastic,10/30/2020,8/24/2020,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,10/14/2022,mg,antineoplastic,10/23/2022,8/24/2022,Intravenous,paclitaxel,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/2/2024,mL,solution-fluid,6/7/2024,6/13/2024,Intravenous,paclitaxel,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/25/2015,mg,antineoplastic,3/27/2015,9/20/2014,Intravenous,bevacizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,10/30/2021,mg,antineoplastic,10/12/2021,6/25/2021,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,7/27/2012,mg,antineoplastic,5/27/2012,3/4/2012,Intravenous,paclitaxel protein-bound,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/19/2015,mg,antineoplastic,4/8/2015,10/15/2014,Intravenous,paclitaxel protein-bound,FALSE
1200,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/27/2022,mg/m2,antineoplastic,11/4/2021,10/21/2021,Intravenous,fluorouracil,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/14/2015,mg,antineoplastic,8/20/2015,7/10/2015,Intravenous,paclitaxel protein-bound,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/25/2025,mg,antineoplastic,1/13/2025,6/6/2024,Intravenous,pemetrexed,FALSE
72,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/22/2018,mg,antineoplastic,11/7/2018,8/24/2018,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/11/2016,,antineoplastic,6/18/2016,4/13/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/16/2024,mg,antineoplastic,11/26/2023,6/6/2023,Intravenous,pembrolizumab,TRUE
582,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/15/2024,mg,antineoplastic,4/24/2024,3/26/2024,Intravenous,paclitaxel,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/12/2023,mg,antineoplastic,10/2/2023,9/3/2023,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,1/23/2016,mg,antineoplastic,11/16/2015,12/14/2015,Intravenous,docetaxel,FALSE
105,1,ADVANCED,Administrations,chemotherapy,Nivolumab,G21BD9C1D75:6,1/5/2019,mg,antineoplastic,5/25/2018,5/27/2018,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,4/6/2018,mg,antineoplastic,2/13/2018,11/1/2017,Intravenous,nivolumab,FALSE
85.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,3/21/2018,mg,antineoplastic,8/15/2014,8/29/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/7/2022,mg,antineoplastic,1/12/2021,12/17/2017,Intravenous,pembrolizumab,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,12/3/2014,mg,antineoplastic,5/6/2014,4/4/2014,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/3/2017,mg,antineoplastic,3/15/2017,11/30/2016,Intravenous,paclitaxel protein-bound,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/11/2022,mg,antineoplastic,11/24/2022,10/5/2022,Oral,imatinib,FALSE
800,4,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,4/7/2021,mg,antineoplastic,4/14/2021,3/24/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/27/2025,mg,antineoplastic,5/19/2025,8/26/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/13/2018,mg,antineoplastic,10/26/2017,4/21/2017,Intravenous,pembrolizumab,FALSE
1666,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/14/2013,mg/m2,antineoplastic,3/3/2013,3/10/2013,Intravenous,ifosfamide,FALSE
70,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G4G98:8D426E2,9/19/2011,mg,antineoplastic,8/11/2011,8/28/2011,Intravenous,cisplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,5/21/2024,mg,antineoplastic,1/29/2024,3/3/2024,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/19/2017,,antineoplastic,11/17/2016,5/20/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/22/2025,mg,antineoplastic,8/10/2023,8/9/2022,Intravenous,pembrolizumab,TRUE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/9/2024,mg,antineoplastic,8/3/2024,5/19/2024,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/16/2016,mg,antineoplastic,8/21/2015,9/6/2015,Intravenous,pemetrexed,FALSE
108,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48796B29723B,6/16/2013,mg,antineoplastic,6/22/2013,6/17/2013,Intravenous,paclitaxel,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,8/11/2016,mg,antineoplastic,9/14/2016,7/4/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,1/19/2017,,antineoplastic,3/19/2016,3/7/2016,Intravenous,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/19/2022,mg,antineoplastic,10/12/2018,2/8/2016,Intravenous,pemetrexed,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/12/2023,mg,antineoplastic,9/15/2023,2/26/2023,Intravenous,gemcitabine,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G3B698C119:F8,6/14/2012,,antineoplastic,6/19/2012,5/7/2012,Intravenous,clinical study drug,FALSE
563,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/5/2022,mg,antineoplastic,5/14/2021,4/3/2021,Intravenous,carboplatin,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,4/3/2025,mg,antineoplastic,11/20/2024,8/31/2024,Intravenous,durvalumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4ED25F4G24F2,11/19/2018,mg/m2,antineoplastic,11/30/2018,10/11/2018,Intravenous,pemetrexed,FALSE
159,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/18/2023,mg,antineoplastic,3/22/2023,2/11/2023,Intravenous,cisplatin,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,6/1/2015,mg,antineoplastic,4/24/2015,3/30/2015,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/29/2020,mg,antineoplastic,10/4/2019,12/16/2017,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,2/27/2023,mg,antineoplastic,3/10/2023,11/30/2022,Intravenous,atezolizumab,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,10/23/2019,mg,antineoplastic,3/9/2019,10/8/2018,Intravenous,durvalumab,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/2/2024,mg,antineoplastic,4/11/2024,2/25/2024,Intravenous,cisplatin,FALSE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,10/27/2024,mg,antineoplastic,9/9/2024,7/20/2024,Intravenous,paclitaxel,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/10/2024,mg,antineoplastic,2/11/2023,11/29/2022,Intravenous,durvalumab,FALSE
825,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/6/2020,mg,antineoplastic,8/23/2019,4/2/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/22/2025,,antineoplastic,9/6/2023,3/19/2023,,clinical study drug,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/17/2014,mg,antineoplastic,12/19/2014,7/21/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G56B734583C17,1/3/2024,,,12/2/2023,1/29/2021,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/28/2025,,antineoplastic,10/14/2024,2/16/2023,,clinical study drug,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/31/2022,mg,antineoplastic,2/10/2019,4/27/2017,Oral,nilotinib,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/15/2025,,antineoplastic,6/20/2024,1/27/2023,,clinical study drug,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/14/2012,AUC,antineoplastic,3/7/2012,1/18/2012,Intravenous,carboplatin,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/12/2018,mg/m2,antineoplastic,10/31/2017,9/10/2017,Intravenous,paclitaxel,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/22/2025,mg,antineoplastic,11/13/2024,10/12/2024,Intravenous,durvalumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,8/15/2022,mg/m2,antineoplastic,6/27/2022,6/9/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/8/2022,mg,antineoplastic,10/31/2021,1/4/2018,Intravenous,pembrolizumab,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,12/23/2022,mg,antineoplastic,12/22/2022,9/23/2022,Intravenous,nivolumab,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,11/22/2019,mg,antineoplastic,9/23/2019,7/21/2019,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,4/30/2023,,antineoplastic,11/20/2022,11/2/2022,Intravenous,pemetrexed,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/21/2023,mg,antineoplastic,6/18/2021,11/8/2019,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,5/5/2018,mg,antineoplastic,3/1/2018,11/22/2017,Intravenous,nivolumab,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,3/25/2018,mg,antineoplastic,10/10/2014,9/8/2014,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,2/5/2020,mg,antineoplastic,7/18/2019,5/17/2019,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/26/2020,,antineoplastic,12/18/2019,1/26/2020,Oral,pazopanib,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G14E999899EFC,5/6/2024,mg,antineoplastic,4/17/2024,12/20/2023,Intravenous,cemiplimab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/5/2025,mg,antineoplastic,7/3/2023,7/9/2023,Intravenous,pembrolizumab,TRUE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/2/2013,mg,antineoplastic,4/21/2013,10/9/2012,Intravenous,carboplatin,FALSE
400,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/11/2020,mg,antineoplastic,11/18/2020,11/17/2020,Intravenous,leucovorin,FALSE
970,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,8/5/2023,mg,antineoplastic,3/25/2023,3/21/2023,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/17/2025,mg,antineoplastic,10/21/2021,2/1/2017,Intravenous,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/10/2021,mg,antineoplastic,1/15/2022,10/23/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/7/2017,,antineoplastic,6/26/2016,3/2/2016,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/11/2015,,antineoplastic,5/27/2015,1/28/2015,,carboplatin,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/16/2020,mg,antineoplastic,10/14/2019,11/18/2018,Intravenous,pemetrexed,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/19/2025,mg,antineoplastic,5/10/2020,3/24/2020,Subcutaneous,leuprolide,FALSE
404,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/3/2017,mg,antineoplastic,1/13/2017,11/11/2016,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/7/2024,,antineoplastic,7/18/2023,7/25/2023,Intravenous,gemcitabine,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/3/2018,mg,antineoplastic,5/2/2018,5/1/2018,Intravenous,paclitaxel,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/15/2014,mg,antineoplastic,10/21/2013,10/25/2013,Intravenous,gemcitabine,FALSE
225,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,7/3/2013,mg,antineoplastic,8/17/2012,8/19/2012,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,5/10/2025,mg,antineoplastic,4/6/2025,10/20/2024,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Unstructured,,Capmatinib,G15:19EG3849:,11/6/2021,,,9/23/2021,10/28/2021,Oral,capmatinib,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/20/2025,mg,antineoplastic,6/14/2024,3/23/2024,Intravenous,pemetrexed,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/2/2013,mg,antineoplastic,6/5/2013,7/15/2013,Intravenous,cisplatin,FALSE
1580,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,7/13/2014,mg,antineoplastic,4/21/2014,3/31/2014,Intravenous,gemcitabine,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/23/2023,mg,antineoplastic,6/1/2023,5/9/2023,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,3/20/2025,mg,antineoplastic,4/1/2025,9/16/2023,Intravenous,atezolizumab,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,3/27/2025,mg,antineoplastic,5/26/2024,4/13/2024,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/13/2016,mg,antineoplastic,11/20/2015,12/3/2015,Intravenous,bevacizumab,FALSE
665,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/22/2021,mg,antineoplastic,11/19/2020,10/11/2020,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,2/27/2025,mg,antineoplastic,10/23/2024,2/1/2024,Intravenous,pembrolizumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/25/2020,mg,antineoplastic,11/10/2019,2/9/2019,Subcutaneous,bortezomib,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,1/13/2022,mg,antineoplastic,1/13/2022,11/23/2021,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,5/31/2017,4/7/2017,Intravenous,nivolumab,FALSE
414,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,10/31/2024,mg,antineoplastic,9/30/2024,9/11/2024,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/17/2017,mg,antineoplastic,8/8/2017,7/9/2017,Intravenous,carboplatin,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/19/2014,mg,antineoplastic,5/23/2014,3/4/2014,Intravenous,carboplatin,FALSE
177.4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/17/2018,mg,antineoplastic,6/3/2018,4/14/2018,Intravenous,carboplatin,FALSE
,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,2/21/2019,,antineoplastic,6/9/2018,3/27/2018,Intravenous,docetaxel,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/7/2016,mg,antineoplastic,8/1/2016,5/3/2016,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/19/2025,mg,antineoplastic,9/8/2023,6/14/2023,Intravenous,pembrolizumab,TRUE
634.5,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/7/2018,mg,antineoplastic,8/8/2018,5/21/2018,Intravenous,carboplatin,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,9/20/2018,mg,antineoplastic,8/12/2017,6/15/2017,Intravenous,vinorelbine,FALSE
1540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,7/27/2018,mg,antineoplastic,7/19/2018,6/23/2018,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,2/17/2019,mg,antineoplastic,8/26/2018,7/18/2018,Intravenous,nivolumab,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G3C:F1C:2BF6C,12/29/2014,AUC,antineoplastic,12/19/2014,11/9/2014,Intravenous,carboplatin,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/19/2019,mg,antineoplastic,9/21/2018,7/18/2018,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/18/2025,,antineoplastic,5/17/2024,5/1/2024,Intravenous,carboplatin,FALSE
793,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/22/2024,mg,antineoplastic,12/6/2023,10/7/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/18/2025,mg,antineoplastic,5/15/2023,6/1/2023,Intravenous,pembrolizumab,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/25/2016,mg,antineoplastic,12/5/2015,9/26/2015,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/24/2022,,,9/12/2021,10/7/2021,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/2/2025,,antineoplastic,10/22/2021,1/27/2019,Intravenous,pembrolizumab,TRUE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/4/2023,mg,antineoplastic,1/13/2023,7/3/2022,Intravenous,durvalumab,FALSE
558.7,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/18/2025,mg,antineoplastic,6/13/2019,4/12/2019,Intravenous,carboplatin,FALSE
328,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/27/2025,mg,antineoplastic,10/16/2024,7/25/2024,Intravenous,carboplatin,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,3/6/2014,mg,antineoplastic,4/1/2014,1/25/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,10/29/2024,mg,antineoplastic,9/15/2024,9/5/2024,Intravenous,pembrolizumab,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,10/3/2019,mg,antineoplastic,6/23/2019,6/18/2019,Intravenous,paclitaxel,FALSE
584.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/16/2021,mg,antineoplastic,12/23/2020,10/25/2020,Intravenous,carboplatin,FALSE
820,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,2/4/2013,mg,antineoplastic,2/20/2013,12/3/2012,Intravenous,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/10/2025,mg,antineoplastic,3/17/2020,2/8/2019,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/17/2024,mg,antineoplastic,3/29/2024,4/16/2023,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/26/2020,mg,antineoplastic,9/8/2019,9/7/2019,Intravenous,pembrolizumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,7/17/2017,mg,antineoplastic,7/4/2017,6/14/2017,Intravenous,carboplatin,FALSE
1067,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,8/31/2022,mg,antineoplastic,5/22/2022,5/12/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,3/7/2025,,antineoplastic,7/5/2023,3/8/2022,Intravenous,pembrolizumab,TRUE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,11/30/2023,mg,antineoplastic,10/20/2023,10/17/2023,Intravenous,paclitaxel,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/11/2014,mg/m2,antineoplastic,4/25/2014,12/8/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/6/2022,,antineoplastic,7/12/2022,4/2/2017,Oral,nilotinib,FALSE
1,1,ADVANCED,Administrations,hormone,Anastrozole,G1F26CECEF:89,3/3/2019,mg,antineoplastic,3/25/2019,3/3/2019,Oral,anastrozole,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,11/16/2023,mg,antineoplastic,8/18/2023,6/10/2023,Intravenous,pemetrexed,FALSE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/19/2024,mg,antineoplastic,7/21/2024,7/13/2024,Intravenous,carboplatin,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,5/7/2018,mg,antineoplastic,9/11/2014,9/1/2014,Intravenous,carboplatin,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/7/2025,mg,antineoplastic,12/19/2024,12/25/2024,Intravenous,gemcitabine,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/18/2024,mg,antineoplastic,3/2/2024,4/7/2022,Intravenous,durvalumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/16/2015,mg,antineoplastic,6/26/2015,4/4/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/28/2025,mg,antineoplastic,7/5/2023,7/8/2023,Intravenous,pembrolizumab,TRUE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/27/2016,mg,antineoplastic,8/12/2015,7/7/2015,Intravenous,pemetrexed,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/5/2013,mg,antineoplastic,5/10/2013,5/17/2013,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G44E794G323GG,1/26/2017,,,1/29/2017,8/31/2016,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/17/2020,mg,antineoplastic,3/9/2019,12/22/2018,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/11/2025,mg,antineoplastic,2/11/2023,7/29/2021,Intravenous,atezolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/25/2024,mg,antineoplastic,3/6/2023,5/7/2020,Intravenous,pembrolizumab,TRUE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/5/2012,mg,antineoplastic,8/19/2012,5/7/2012,Intravenous,bevacizumab,FALSE
975,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G193F989CDC3D,4/25/2016,mg,antineoplastic,3/14/2016,3/20/2016,Intravenous,bevacizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/19/2025,mg,antineoplastic,12/13/2023,7/15/2021,Intravenous,atezolizumab,TRUE
116,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/10/2021,mg,antineoplastic,7/10/2021,6/15/2021,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,4/3/2023,mg,antineoplastic,11/18/2022,5/26/2022,Intravenous,docetaxel,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,4/21/2022,,antineoplastic,7/7/2021,6/26/2021,,niraparib,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/1/2020,mg,antineoplastic,8/27/2019,3/12/2019,Intravenous,durvalumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/27/2014,mg,antineoplastic,7/22/2014,7/14/2014,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/15/2020,mg,antineoplastic,11/7/2018,7/18/2016,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/29/2025,mg,antineoplastic,2/22/2025,5/19/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5:1C6DEC2:1:,11/29/2017,mg,antineoplastic,10/27/2017,11/29/2017,Intravenous,pembrolizumab,FALSE
138,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/28/2024,mg,antineoplastic,1/11/2024,9/22/2023,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1195EGCD:B45,7/5/2024,mg,antineoplastic,6/10/2024,4/26/2024,Intravenous,pembrolizumab,TRUE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,1/5/2024,mg,antineoplastic,12/25/2023,10/21/2023,Intravenous,carboplatin,FALSE
40,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/7/2024,mg/m2,antineoplastic,10/7/2024,8/9/2024,Intravenous,paclitaxel protein-bound,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,6/29/2018,mg,antineoplastic,2/16/2018,11/23/2017,Intravenous,nivolumab,FALSE
473,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,2/7/2016,mg,antineoplastic,10/9/2015,11/4/2015,Intravenous,carboplatin,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/9/2020,mg,antineoplastic,6/9/2019,2/10/2019,Intravenous,durvalumab,FALSE
248,,ADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,8/28/2014,mg,antineoplastic,8/28/2014,5/16/2014,Intravenous,ado-trastuzumab emtansine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/1/2025,mg,antineoplastic,6/5/2022,8/26/2021,Intravenous,atezolizumab,TRUE
371,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,5/27/2023,mg,antineoplastic,3/30/2023,4/24/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,4/5/2025,,antineoplastic,12/28/2024,10/2/2024,Intravenous,durvalumab,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,1/28/2018,mg,antineoplastic,10/19/2017,9/8/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/1/2023,mg,antineoplastic,12/23/2022,3/19/2020,Intravenous,pembrolizumab,TRUE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,10/10/2022,mg,antineoplastic,4/29/2022,2/15/2022,Intravenous,paclitaxel,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,8/22/2019,mg,antineoplastic,7/15/2019,6/12/2019,Intravenous,carboplatin,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/1/2016,mg,antineoplastic,1/23/2015,6/2/2014,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,7/17/2020,mg,antineoplastic,4/17/2020,4/17/2020,Intravenous,pembrolizumab,FALSE
97.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G135BB2F5GCDF,5/19/2018,mg,antineoplastic,3/6/2018,3/7/2018,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/10/2011,mg,antineoplastic,5/14/2011,4/14/2011,Intravenous,paclitaxel,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/20/2021,mg,antineoplastic,12/15/2020,11/9/2020,Intravenous,bevacizumab,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,10/1/2016,mg,antineoplastic,5/11/2016,10/24/2014,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,7/11/2020,mg,antineoplastic,10/4/2019,8/24/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Temozolomide",G4DE3DE99E:13,1/25/2016,,antineoplastic,12/9/2015,12/26/2015,Oral,temozolomide,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,6/2/2024,mg,antineoplastic,12/4/2023,11/12/2023,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/9/2022,,antineoplastic,10/14/2021,7/29/2021,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/16/2025,mg,antineoplastic,2/24/2020,4/11/2018,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/10/2022,mg,antineoplastic,2/26/2020,2/22/2016,Intravenous,pemetrexed,FALSE
79,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,4/4/2016,mg,antineoplastic,3/25/2016,3/21/2016,Intravenous,irinotecan,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/28/2019,mg/kg,antineoplastic,6/25/2019,8/4/2018,Intravenous,durvalumab,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/13/2024,mg,antineoplastic,9/9/2020,8/1/2020,Intravenous,ipilimumab,FALSE
166,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,1/2/2021,mg,antineoplastic,3/31/2020,3/11/2020,Intravenous,docetaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/24/2024,mg,antineoplastic,3/18/2023,3/25/2023,Intravenous,nivolumab,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/2/2015,mg,antineoplastic,6/25/2015,6/23/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/12/2025,mg,antineoplastic,7/31/2019,4/9/2018,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,7/8/2018,mg,antineoplastic,1/21/2018,12/7/2017,Intravenous,pembrolizumab,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/28/2015,mg,antineoplastic,4/18/2015,2/8/2015,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/19/2021,mg,antineoplastic,9/2/2020,9/18/2020,Oral,bicalutamide,FALSE
620,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/29/2014,mg,antineoplastic,9/30/2014,8/1/2014,Intravenous,bevacizumab,FALSE
1000,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/11/2022,mg,antineoplastic,1/9/2022,3/22/2021,Intravenous,bevacizumab-awwb,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/15/2020,mg,antineoplastic,2/20/2019,10/26/2018,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,9/29/2024,mg,antineoplastic,7/9/2024,8/10/2024,Intravenous,carboplatin,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,4/6/2022,mg,antineoplastic,10/26/2021,9/6/2021,Intravenous,paclitaxel,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,3/26/2019,mg/m2,antineoplastic,9/13/2017,6/22/2017,Intravenous,docetaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G332:25G93F26,4/20/2025,mg,antineoplastic,3/8/2025,2/19/2025,Intravenous,durvalumab,TRUE
620,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,7/28/2020,mg,antineoplastic,6/17/2020,6/2/2020,Intravenous,pemetrexed,FALSE
247,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,4/20/2025,mg,antineoplastic,12/20/2024,11/3/2024,Intravenous,carboplatin,FALSE
620,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,11/24/2014,mg,antineoplastic,9/1/2014,7/23/2014,Intravenous,bevacizumab,FALSE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/25/2014,mg,antineoplastic,8/31/2013,6/7/2013,Intravenous,bevacizumab,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/16/2024,mg,antineoplastic,5/27/2024,10/6/2023,Intravenous,durvalumab,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,4/17/2020,mg,antineoplastic,9/11/2019,7/19/2019,Intravenous,docetaxel,FALSE
742,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,8/14/2024,mg,antineoplastic,8/17/2024,5/9/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,5/6/2012,,antineoplastic,1/28/2012,7/14/2011,Intravenous,clinical study drug,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,9/14/2021,mg,antineoplastic,8/13/2021,8/16/2021,Intravenous,carboplatin,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/4/2013,AUC,antineoplastic,11/4/2012,7/16/2012,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/16/2020,mg,antineoplastic,9/27/2018,8/7/2017,Intravenous,pemetrexed,TRUE
542,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/22/2021,mg,antineoplastic,10/2/2021,8/20/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/29/2020,mg,antineoplastic,8/17/2020,8/1/2019,Intravenous,pembrolizumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/1/2016,mg,antineoplastic,5/31/2015,9/28/2014,Intravenous,bevacizumab,TRUE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/12/2018,mg,antineoplastic,9/21/2018,10/8/2018,Intravenous,carboplatin,FALSE
400,5,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,4/17/2025,mg,antineoplastic,2/3/2025,12/9/2024,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,4/30/2021,,antineoplastic,7/12/2020,7/28/2020,,clinical study drug,FALSE
213.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/20/2015,mg,antineoplastic,7/27/2015,3/16/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/10/2022,mg,antineoplastic,6/17/2022,5/10/2022,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/22/2025,mg,antineoplastic,4/5/2025,10/14/2024,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/2/2023,mg,antineoplastic,12/1/2022,5/4/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/25/2025,,antineoplastic,8/23/2024,3/20/2023,,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/8/2019,mg,antineoplastic,6/13/2018,5/17/2018,Intravenous,nivolumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/3/2013,mg,antineoplastic,6/2/2012,12/25/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/10/2025,mg,antineoplastic,4/15/2025,2/24/2025,Intravenous,pembrolizumab,FALSE
160.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,3/9/2019,mg,antineoplastic,12/31/2018,12/16/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/17/2023,mg,antineoplastic,4/19/2023,8/22/2022,Intravenous,pembrolizumab,TRUE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/8/2020,mg,antineoplastic,4/12/2020,3/18/2020,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G242GD729:FB:,5/30/2024,mg,antineoplastic,3/18/2024,3/17/2024,Intravenous,pembrolizumab,FALSE
255,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,8/29/2016,mg,antineoplastic,12/22/2015,12/24/2015,Intravenous,nivolumab,FALSE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,7/8/2023,mg,antineoplastic,3/28/2023,3/4/2023,Intravenous,durvalumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/19/2025,mg,antineoplastic,10/14/2024,7/9/2023,Intravenous,pembrolizumab,TRUE
653.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,3/8/2017,mg,antineoplastic,4/11/2017,1/10/2017,Intravenous,carboplatin,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,9/17/2017,mg,antineoplastic,8/4/2017,7/29/2017,Intravenous,cisplatin,FALSE
1426.5,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/3/2015,mg,antineoplastic,10/9/2014,11/2/2014,Intravenous,bevacizumab,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/2/2025,mg,antineoplastic,2/20/2024,9/8/2022,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,2/10/2015,mg,antineoplastic,1/1/2015,2/1/2015,Intravenous,paclitaxel protein-bound,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G157317FG3387,6/28/2024,mg,antineoplastic,6/6/2024,5/13/2024,Intravenous,pemetrexed,FALSE
1680,3,ADVANCED,Administrations,immunotherapy,"Anastrozole,Atezolizumab",G1GFD92F489E7,12/24/2023,mg,antineoplastic,12/8/2023,12/8/2023,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G2D168F99BCD4,2/15/2023,mg,antineoplastic,8/23/2022,9/27/2022,Intravenous,pembrolizumab,TRUE
980,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1CFE2442E26G,12/10/2013,mg,antineoplastic,11/1/2013,11/20/2013,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/3/2018,mg,antineoplastic,6/27/2017,2/8/2017,Intravenous,pembrolizumab,FALSE
320,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,3/11/2015,mg,antineoplastic,2/4/2015,10/19/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/10/2025,mg,antineoplastic,6/20/2023,1/26/2019,Intravenous,pembrolizumab,TRUE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/3/2013,mg,antineoplastic,9/13/2012,7/8/2012,Intravenous,gemcitabine,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/13/2025,mg,antineoplastic,6/8/2024,4/24/2024,Intravenous,pemetrexed,TRUE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/10/2022,mg,antineoplastic,11/19/2018,4/28/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,11/29/2022,mg,antineoplastic,7/20/2020,3/28/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,3/4/2024,mg,antineoplastic,11/21/2023,6/13/2023,Intravenous,pembrolizumab,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/15/2021,mg,antineoplastic,2/24/2021,1/6/2021,Intravenous,carboplatin,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/2/2024,mg,antineoplastic,3/10/2023,2/3/2023,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,1/11/2025,mg,antineoplastic,9/17/2024,5/28/2024,Intravenous,durvalumab,TRUE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/29/2017,mg,antineoplastic,5/27/2016,5/5/2016,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G126:384BC665,3/12/2015,mg,antineoplastic,4/15/2015,3/28/2015,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,7/15/2016,mg,antineoplastic,6/22/2016,3/18/2016,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/8/2021,mg,antineoplastic,4/8/2019,11/29/2018,Intravenous,pemetrexed,TRUE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/17/2024,mg,antineoplastic,8/16/2024,7/7/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/21/2025,,antineoplastic,7/6/2024,6/21/2024,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,10/23/2024,mg,antineoplastic,8/21/2024,8/12/2024,Intravenous,nivolumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/18/2022,mg,antineoplastic,6/22/2022,6/2/2022,Intravenous,paclitaxel,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/17/2025,mg,antineoplastic,11/19/2020,3/17/2020,Subcutaneous,leuprolide,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,3/31/2013,AUC,antineoplastic,12/7/2012,11/25/2012,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,11/21/2016,mg,antineoplastic,7/20/2015,5/27/2015,Intravenous,pemetrexed,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/23/2017,mg,antineoplastic,5/10/2017,5/30/2017,Intravenous,trastuzumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/7/2024,mg,antineoplastic,4/18/2022,12/12/2021,Intravenous,durvalumab,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,2/2/2021,mg,antineoplastic,9/22/2020,10/25/2020,Intravenous,oxaliplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/27/2020,mg,antineoplastic,12/16/2019,9/13/2019,Intravenous,durvalumab,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/12/2023,mg,antineoplastic,3/21/2023,10/29/2022,Intravenous,durvalumab,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/13/2024,mg,antineoplastic,7/7/2023,4/13/2023,Intravenous,atezolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/18/2016,mg,antineoplastic,6/17/2016,6/9/2016,Intravenous,carboplatin,FALSE
450,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,5/13/2020,mg,antineoplastic,4/11/2020,3/1/2020,Intravenous,carboplatin,FALSE
689,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,4/23/2024,mg,antineoplastic,2/19/2024,1/31/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3E567F5B3:95,11/4/2018,mg,antineoplastic,10/4/2018,8/7/2018,Intravenous,nivolumab,FALSE
668.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/22/2021,mg,antineoplastic,10/9/2019,9/5/2019,Intravenous,carboplatin,FALSE
5,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/25/2019,AUC,antineoplastic,3/3/2019,1/24/2019,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/28/2014,mg/m2,antineoplastic,1/25/2014,12/6/2013,Intravenous,pemetrexed,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,4/27/2019,mg,antineoplastic,3/2/2019,1/31/2019,Intravenous,pemetrexed,FALSE
870,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,1/25/2012,mg,antineoplastic,1/1/2012,12/17/2011,Intravenous,pemetrexed,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/8/2019,mg/kg,antineoplastic,11/18/2018,9/12/2018,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/29/2023,mg,antineoplastic,7/11/2023,2/19/2022,Intravenous,pembrolizumab,TRUE
722,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/22/2013,mg,antineoplastic,9/2/2013,8/2/2013,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Methotrexate,G298FGDFDG8E7,1/16/2020,,antineoplastic,11/4/2019,11/10/2019,Oral,methotrexate,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G18C1EG39143B,8/11/2014,,,4/22/2013,3/18/2013,Oral,erlotinib,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4B6GB9CB3CD4,3/15/2014,,,3/29/2014,3/6/2013,Oral,erlotinib,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,2/23/2015,mg,antineoplastic,12/24/2014,12/1/2014,Intravenous,paclitaxel,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,5/20/2025,mg,antineoplastic,4/24/2025,4/4/2025,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,10/2/2024,mg,antineoplastic,8/2/2024,6/5/2024,Intravenous,pemetrexed,FALSE
130,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G166B735:96D2,10/25/2013,mg,antineoplastic,9/27/2013,9/9/2013,Intravenous,docetaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/27/2024,mg,antineoplastic,9/23/2022,12/13/2021,Intravenous,nivolumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,5/2/2023,mg,antineoplastic,10/15/2022,5/4/2022,Intravenous,nivolumab,FALSE
130,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,3/16/2019,mg/m2,antineoplastic,2/18/2019,2/8/2019,Intravenous,oxaliplatin,FALSE
322.4,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/12/2016,mg,antineoplastic,8/20/2015,6/4/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,1/6/2023,,antineoplastic,11/28/2022,11/8/2022,Intravenous,carboplatin,FALSE
99,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/24/2015,mg,antineoplastic,5/13/2015,6/23/2015,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23F23C5G7BFD,11/28/2018,mg,antineoplastic,11/12/2018,11/5/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/13/2016,,,12/22/2015,1/19/2015,Oral,afatinib,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/25/2023,mg,antineoplastic,12/31/2022,6/19/2022,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/4/2021,mg,antineoplastic,5/4/2019,6/26/2019,Intravenous,nivolumab,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/21/2018,mg,antineoplastic,5/29/2018,4/25/2018,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/31/2021,mg/m2,antineoplastic,12/14/2019,9/22/2019,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/24/2025,mg,antineoplastic,1/3/2018,11/29/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/15/2024,mg,antineoplastic,11/11/2023,7/10/2023,Intravenous,pembrolizumab,TRUE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/2/2022,mg/kg,antineoplastic,8/12/2021,3/4/2021,Intravenous,durvalumab,FALSE
179,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/1/2019,mg,antineoplastic,6/23/2018,2/18/2018,Intravenous,carboplatin,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/3/2022,mg,antineoplastic,3/16/2022,11/15/2021,Intravenous,pemetrexed,FALSE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/14/2012,mg,antineoplastic,12/31/2011,11/18/2011,Intravenous,paclitaxel protein-bound,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,12/4/2017,mg,antineoplastic,8/16/2017,5/2/2017,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/21/2025,mg,antineoplastic,9/12/2024,7/29/2021,Intravenous,atezolizumab,TRUE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5:1C6DEC2:1:,12/12/2017,mg,antineoplastic,12/14/2017,11/27/2017,Intravenous,pemetrexed,FALSE
492,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/22/2015,mg,antineoplastic,10/21/2015,8/30/2015,Intravenous,paclitaxel,FALSE
100,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,3/8/2013,mg/m2,antineoplastic,1/28/2013,2/6/2013,Intravenous,etoposide,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/26/2017,mg,antineoplastic,12/18/2013,11/22/2013,Intravenous,etoposide,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/22/2025,mg,antineoplastic,8/4/2016,7/24/2016,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,4/8/2018,AUC,antineoplastic,10/14/2014,8/24/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,6/2/2020,mg,antineoplastic,5/7/2020,2/28/2020,Intravenous,pembrolizumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,2/24/2024,mg,antineoplastic,12/10/2023,11/16/2023,Intravenous,paclitaxel,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/10/2020,mg,antineoplastic,1/11/2020,1/22/2019,Intravenous,durvalumab,FALSE
590,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,9/8/2013,mg,antineoplastic,4/27/2013,2/16/2013,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/9/2025,mg/m2,antineoplastic,3/12/2025,4/2/2024,Intravenous,pemetrexed,TRUE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,8/20/2013,mg,antineoplastic,4/6/2013,1/19/2013,Intravenous,bevacizumab,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/5/2025,mg,antineoplastic,3/17/2025,10/3/2024,Intravenous,nivolumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,1/29/2019,mg,antineoplastic,12/15/2018,12/31/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/15/2020,mg,antineoplastic,11/3/2019,10/9/2019,Intravenous,pembrolizumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,11/2/2018,mg,antineoplastic,9/12/2018,7/27/2018,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/3/2025,mg,antineoplastic,10/28/2024,3/5/2024,Intravenous,pemetrexed,FALSE
205.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/3/2020,mg,antineoplastic,11/21/2019,11/14/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/19/2022,mg,antineoplastic,11/27/2020,12/29/2019,Intravenous,nivolumab,FALSE
15,1,ADVANCED,Orders,targeted/biologic,Bevacizumab,G247F67418GGD,3/28/2012,mg/kg,antineoplastic,5/15/2011,4/6/2011,Intravenous,bevacizumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,8/18/2023,mg,antineoplastic,8/6/2023,7/19/2023,Intravenous,paclitaxel,FALSE
402,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/20/2024,mg,antineoplastic,1/19/2024,10/22/2023,Intravenous,carboplatin,FALSE
209,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/28/2016,mg,antineoplastic,11/24/2015,11/30/2015,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/30/2025,mg,antineoplastic,2/25/2022,7/8/2021,Intravenous,atezolizumab,TRUE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/24/2022,mg,antineoplastic,10/21/2021,6/26/2021,Intravenous,leucovorin,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/18/2019,mg,antineoplastic,4/12/2019,3/8/2019,Intravenous,paclitaxel,FALSE
2000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,6/23/2013,mg,antineoplastic,7/18/2012,8/10/2012,Intravenous,gemcitabine,FALSE
711,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/22/2024,mg,antineoplastic,10/29/2023,10/4/2023,Intravenous,durvalumab,TRUE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,1/22/2017,mg,antineoplastic,11/30/2016,12/18/2016,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/14/2023,,antineoplastic,10/20/2023,11/22/2022,Intravenous,clinical study drug,FALSE
,3,ADVANCED,Unstructured,,"Osimertinib,Paclitaxel",G1594:E29D2D9,4/10/2022,,,1/14/2022,3/10/2022,Oral,osimertinib,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,4/10/2017,mg,antineoplastic,4/23/2016,3/6/2015,Intravenous,bevacizumab,TRUE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,3/13/2022,,steroid,3/16/2022,1/22/2022,Oral,clinical study drug,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/16/2022,mg,antineoplastic,2/7/2022,11/18/2021,Intravenous,fluorouracil,FALSE
130,4,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2262335C:D62,3/24/2025,mg,antineoplastic,3/16/2025,2/25/2025,Intravenous,docetaxel,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/10/2018,mg,antineoplastic,1/29/2018,12/24/2017,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,10/5/2024,mg,antineoplastic,6/15/2024,7/9/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,6/21/2017,,antineoplastic,11/11/2016,10/5/2016,Intravenous,nivolumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/16/2023,mg,antineoplastic,5/14/2023,5/13/2023,Subcutaneous,azacitidine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/23/2018,mg,antineoplastic,8/29/2017,6/28/2017,Intravenous,pembrolizumab,FALSE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/12/2012,mg,antineoplastic,12/29/2011,12/21/2011,Intravenous,paclitaxel protein-bound,FALSE
116,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/15/2015,mg,antineoplastic,5/23/2014,1/3/2014,Intravenous,carboplatin,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,6/20/2016,mg,antineoplastic,5/20/2016,3/28/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/25/2025,mg,antineoplastic,10/25/2024,6/5/2024,Intravenous,pembrolizumab,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/10/2013,mg,antineoplastic,3/22/2013,3/29/2012,Intravenous,pemetrexed,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/20/2025,mg,antineoplastic,2/4/2025,5/8/2024,Intravenous,pemetrexed,TRUE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,mg,antineoplastic,2/28/2021,4/25/2017,Oral,nilotinib,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/25/2018,mg,antineoplastic,2/20/2018,12/16/2017,Intravenous,cisplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/1/2017,mg,antineoplastic,12/24/2016,11/30/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,11/6/2021,,antineoplastic,4/4/2021,4/6/2021,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/24/2023,mg,antineoplastic,3/26/2021,1/30/2020,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/15/2011,mg,antineoplastic,9/15/2011,5/7/2011,Intravenous,etoposide,FALSE
115,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/17/2015,mg,antineoplastic,4/19/2015,3/19/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D891287D6B:,11/23/2020,mg,antineoplastic,10/31/2020,8/10/2020,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,6/8/2024,mg,antineoplastic,7/7/2024,8/18/2023,Intravenous,atezolizumab,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/31/2023,mg,antineoplastic,9/28/2022,5/12/2022,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/8/2024,,antineoplastic,8/18/2024,7/24/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,10/28/2017,mg,antineoplastic,7/11/2017,5/23/2017,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/11/2023,mg,antineoplastic,1/22/2023,8/3/2022,Subcutaneous,azacitidine,FALSE
371.2,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,3/16/2013,mg,antineoplastic,2/24/2013,12/26/2012,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,7/24/2017,,antineoplastic,12/12/2016,12/2/2016,,clinical study drug,FALSE
,3,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G4826CB54C27:,5/1/2024,,,6/12/2024,12/11/2021,Oral,osimertinib,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,7/11/2023,mg,antineoplastic,4/23/2023,3/8/2023,Intravenous,pemetrexed,FALSE
122,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,8/11/2021,mg,antineoplastic,5/27/2021,4/6/2021,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/27/2024,mg,antineoplastic,2/15/2023,4/20/2022,Intravenous,durvalumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,10/19/2019,mg,antineoplastic,8/19/2019,7/16/2019,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/12/2025,mg,antineoplastic,3/7/2024,9/1/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/18/2025,mg,antineoplastic,9/27/2021,10/1/2021,Intravenous,pembrolizumab,TRUE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/6/2021,mg,antineoplastic,5/21/2021,10/3/2020,Intravenous,gemcitabine,FALSE
259.8,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G57:2GEC9DD36,12/30/2015,mg,antineoplastic,9/17/2015,10/5/2015,Intravenous,nivolumab,FALSE
490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/12/2015,mg,antineoplastic,10/26/2015,9/14/2015,Intravenous,carboplatin,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,9/29/2018,mg,antineoplastic,7/27/2018,5/20/2018,Intravenous,etoposide,FALSE
671,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,7/31/2017,mg,antineoplastic,4/1/2017,3/30/2017,Intravenous,carboplatin,FALSE
248,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/25/2021,mg,antineoplastic,6/9/2019,7/1/2019,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,4/7/2025,mg,antineoplastic,8/10/2022,12/20/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/1/2025,mg,antineoplastic,10/5/2024,6/5/2023,Intravenous,pembrolizumab,TRUE
525,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,2/8/2024,mg,antineoplastic,11/17/2023,10/14/2023,Intravenous,carboplatin,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,4/28/2013,mg,antineoplastic,4/1/2013,12/7/2012,Intravenous,doxorubicin,FALSE
441.78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,8/4/2022,mg,antineoplastic,6/8/2022,5/2/2022,Intravenous,carboplatin,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/11/2014,mg,antineoplastic,7/27/2014,6/18/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/25/2022,Ea,antineoplastic,5/29/2020,1/20/2018,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/23/2018,mg,antineoplastic,4/7/2018,1/18/2018,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/26/2016,mg,antineoplastic,1/1/2016,10/30/2015,Intravenous,pemetrexed,FALSE
1035,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/3/2018,mg,antineoplastic,8/4/2018,7/14/2018,Intravenous,pemetrexed,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/2/2018,mg,antineoplastic,12/27/2017,1/25/2018,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/9/2021,mL,solution-fluid,5/4/2021,4/26/2021,Intravenous,pemetrexed,FALSE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,8/30/2024,mg,antineoplastic,8/12/2024,6/16/2024,Intravenous,cisplatin,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,5/6/2016,mg,antineoplastic,2/11/2016,10/23/2015,Intravenous,ramucirumab,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/21/2020,mg,antineoplastic,7/16/2020,5/25/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/18/2018,mg,antineoplastic,3/1/2018,3/30/2017,Intravenous,pembrolizumab,FALSE
428,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/5/2023,mg,antineoplastic,2/18/2023,10/28/2022,Intravenous,bevacizumab-bvzr,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,6/12/2017,mg,antineoplastic,9/11/2016,8/12/2016,Intravenous,nivolumab,FALSE
442,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,1/10/2016,mg,antineoplastic,12/5/2015,11/15/2015,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/23/2020,mg,antineoplastic,12/10/2017,12/16/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,2/10/2015,,antineoplastic,10/4/2014,9/3/2014,,clinical study drug,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/27/2014,mg/m2,antineoplastic,5/9/2014,12/11/2013,Intravenous,pemetrexed,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/3/2022,mg,antineoplastic,1/28/2022,10/1/2021,Intravenous,paclitaxel,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,12/17/2019,mg,antineoplastic,11/20/2019,12/13/2019,Oral,anastrozole,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,1/2/2023,mg,antineoplastic,11/21/2022,7/5/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/5/2023,mg,antineoplastic,8/3/2023,7/31/2022,Intravenous,pembrolizumab,TRUE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2141CBEF3GD3,10/21/2022,mL,solution-fluid,8/27/2022,9/7/2022,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/6/2014,mg,antineoplastic,6/12/2014,5/9/2014,Intravenous,paclitaxel,FALSE
523,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/17/2020,mg,antineoplastic,6/1/2017,4/17/2017,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/21/2020,,antineoplastic,9/15/2019,1/16/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G177G4:B9E394,3/12/2024,mg,antineoplastic,1/17/2024,12/3/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,3/9/2025,,antineoplastic,9/14/2023,3/8/2022,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/20/2022,mg,antineoplastic,5/16/2021,2/3/2020,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/11/2022,,antineoplastic,8/22/2021,8/26/2021,Intravenous,amivantamab-vmjw,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,9/30/2023,mg,antineoplastic,10/20/2023,8/11/2023,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,9/28/2015,mg,antineoplastic,2/19/2015,3/8/2015,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/9/2019,mg,antineoplastic,12/10/2017,2/24/2016,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/3/2025,mg,antineoplastic,12/27/2017,8/12/2016,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/29/2016,mg,antineoplastic,5/26/2016,2/26/2016,Intravenous,pemetrexed,TRUE
180,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G3:C9BECD3F55,9/29/2020,mg,antineoplastic,9/2/2020,7/10/2020,Intravenous,docetaxel,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/14/2021,mg,antineoplastic,6/3/2021,6/23/2020,Intravenous,gemcitabine,FALSE
500,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,3/10/2024,mg,antineoplastic,2/27/2024,12/31/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/22/2025,mg,antineoplastic,4/22/2024,5/22/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/27/2025,mg,antineoplastic,12/13/2018,1/29/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/12/2019,,antineoplastic,4/14/2019,3/13/2019,,cisplatin,FALSE
745,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:B8CFFD1931,3/4/2015,mg,antineoplastic,9/15/2014,9/2/2014,Intravenous,pemetrexed,TRUE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/29/2017,mg,antineoplastic,6/25/2017,6/1/2017,Intravenous,carboplatin,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/25/2024,mg,antineoplastic,3/24/2024,3/20/2024,Intravenous,paclitaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/12/2015,mg,antineoplastic,4/26/2015,3/6/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,9/21/2023,mg,antineoplastic,12/5/2022,8/4/2022,Intravenous,pembrolizumab,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,5/19/2019,mg/m2,antineoplastic,7/24/2017,6/28/2017,Intravenous,docetaxel,FALSE
550,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,5/26/2016,mg,antineoplastic,5/6/2016,3/5/2016,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/8/2025,,antineoplastic,5/10/2024,2/27/2023,,clinical study drug,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,10/28/2018,mg,antineoplastic,8/17/2018,7/29/2018,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G136E3F9:956D,1/21/2020,mg,antineoplastic,1/13/2020,1/24/2020,Intravenous,pembrolizumab,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/24/2018,mg,antineoplastic,8/23/2018,8/3/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,4/19/2018,,antineoplastic,1/4/2018,5/10/2017,Intravenous,clinical study drug,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/3/2022,mg,antineoplastic,1/29/2022,10/12/2021,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,4/13/2018,mg/m2,antineoplastic,10/22/2017,10/10/2017,Intravenous,paclitaxel,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/30/2014,mg,antineoplastic,8/24/2013,7/6/2013,Intravenous,pemetrexed,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,2/22/2020,mg,antineoplastic,6/13/2019,5/31/2019,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/3/2014,mL,solution-fluid,1/7/2014,10/27/2013,Intravenous,pemetrexed,FALSE
165.6,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/11/2015,mg,antineoplastic,1/5/2015,11/13/2014,Intravenous,paclitaxel,FALSE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/12/2013,mg,antineoplastic,8/12/2012,5/9/2012,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,8/12/2020,,antineoplastic,3/4/2020,1/24/2019,,nivolumab,FALSE
,,ADJUVANT,Administrations,targeted/biologic,Clinical Study Drug,G579E53D92:75,11/20/2011,,antineoplastic,9/7/2011,7/28/2011,Intravenous,clinical study drug,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/2/2023,mg,antineoplastic,5/22/2023,3/27/2023,Intravenous,pemetrexed,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/16/2024,mg,antineoplastic,11/17/2023,12/19/2021,Intravenous,nivolumab,TRUE
526.88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,9/24/2022,mg,antineoplastic,8/20/2022,5/1/2022,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/6/2017,,antineoplastic,1/19/2017,6/16/2016,Intramuscular,fulvestrant,FALSE
395,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,2/21/2025,mg,antineoplastic,11/27/2024,11/17/2024,Intravenous,carboplatin,FALSE
480,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G2C38B34G8794,11/26/2024,mg,antineoplastic,9/18/2024,9/10/2024,Intravenous,nivolumab,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,4/12/2022,,steroid,3/19/2022,1/7/2022,Intravenous,clinical study drug,FALSE
526,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,2/13/2023,mg,antineoplastic,4/14/2022,5/16/2022,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/1/2022,mg,antineoplastic,7/17/2021,5/24/2021,Intravenous,bevacizumab-bvzr,FALSE
945,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G3G18D5D62822,11/3/2011,mg,antineoplastic,10/15/2011,9/7/2011,Intravenous,pemetrexed,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/25/2020,mg,antineoplastic,5/26/2020,5/29/2020,Intravenous,pemetrexed,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,4/1/2022,mg,antineoplastic,1/25/2022,2/5/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,4/24/2012,,solution-fluid,9/27/2011,9/2/2011,,clinical study drug,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,10/29/2015,mg,antineoplastic,7/8/2015,1/18/2015,Intravenous,pemetrexed,TRUE
480,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,12/7/2024,mg,antineoplastic,10/6/2024,7/18/2024,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/17/2025,mg,antineoplastic,11/1/2024,6/5/2024,Intravenous,carboplatin,FALSE
432.4,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/7/2013,mg,antineoplastic,4/16/2012,3/19/2012,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/30/2020,mg,antineoplastic,3/17/2017,12/26/2016,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/25/2023,mg,antineoplastic,9/22/2022,6/4/2022,Intravenous,nivolumab,FALSE
1500,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/18/2013,mg,antineoplastic,5/14/2013,3/29/2013,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G128:92:3BD3D,12/9/2021,,antiemetic,7/16/2021,5/1/2021,Intravenous,clinical study drug,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,12/22/2015,mg,antineoplastic,11/24/2015,7/1/2015,Intravenous,bevacizumab,FALSE
164,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/1/2024,mg,antineoplastic,8/22/2024,7/11/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/22/2024,mg,antineoplastic,6/24/2024,5/31/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/11/2017,,antineoplastic,7/8/2016,2/14/2016,Intravenous,clinical study drug,FALSE
265,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,3/26/2013,mg,antineoplastic,12/11/2012,12/23/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,5/2/2021,mg,antineoplastic,10/31/2020,10/1/2020,Intravenous,pembrolizumab,TRUE
66,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,4/14/2014,mg,antineoplastic,4/18/2014,3/4/2014,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/13/2021,mg,antineoplastic,8/31/2021,6/23/2021,Intravenous,pemetrexed,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/22/2014,mg,antineoplastic,3/24/2014,12/18/2013,Intravenous,paclitaxel,FALSE
101,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,7/9/2020,mg,antineoplastic,5/4/2020,3/9/2020,Intravenous,cisplatin,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/6/2021,,steroid,2/21/2020,1/29/2020,Intravenous,clinical study drug,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,9/29/2021,mg,antineoplastic,8/25/2021,8/2/2021,Intravenous,carboplatin,FALSE
238,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,9/7/2021,mg,antineoplastic,7/6/2021,6/12/2021,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/9/2020,mg,antineoplastic,7/25/2018,2/11/2016,Intravenous,bevacizumab,TRUE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,4/8/2012,,antiemetic,11/29/2011,10/7/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/24/2019,mg,antineoplastic,11/24/2018,10/10/2018,Intravenous,pembrolizumab,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/16/2025,mg,antineoplastic,4/3/2025,12/4/2024,Intravenous,gemcitabine,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,8/25/2017,mg,antineoplastic,4/20/2017,4/24/2017,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/15/2025,mg,antineoplastic,6/17/2019,1/25/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,3/12/2025,mg,antineoplastic,1/17/2025,10/13/2023,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/3/2025,mg,antineoplastic,5/16/2024,2/19/2023,Intravenous,pembrolizumab,FALSE
1630,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,5/14/2015,mg,antineoplastic,4/10/2015,12/30/2014,Intravenous,gemcitabine,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,6/5/2022,mg,antineoplastic,1/24/2022,1/28/2022,Intravenous,paclitaxel,FALSE
400,3,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/12/2024,mg,antineoplastic,11/19/2023,6/21/2023,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/12/2018,,antineoplastic,12/24/2017,1/6/2018,,paclitaxel,FALSE
1650,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/27/2013,mg,antineoplastic,6/2/2012,5/4/2012,Intravenous,gemcitabine,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/13/2014,mg/m2,antineoplastic,3/29/2014,3/25/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/29/2024,mg,antineoplastic,3/3/2021,6/3/2020,Intravenous,pembrolizumab,TRUE
800,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/12/2017,mg,antineoplastic,11/8/2016,10/7/2016,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/14/2024,mg,antineoplastic,3/26/2024,6/27/2023,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/9/2025,mg,antineoplastic,11/1/2021,2/3/2017,Intravenous,pembrolizumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/23/2024,mg,antineoplastic,9/1/2024,7/14/2024,Intravenous,carboplatin,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,7/2/2021,mg,antineoplastic,3/29/2021,11/13/2020,Intravenous,nivolumab,FALSE
688,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/5/2024,mg,antineoplastic,4/9/2024,2/10/2024,Intravenous,carboplatin,FALSE
152,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G4E68514B7GFD,4/18/2015,mg,antineoplastic,4/29/2015,3/20/2015,Intravenous,docetaxel,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/27/2024,mg,antineoplastic,2/7/2024,10/12/2023,Intravenous,amivantamab-vmjw,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/4/2025,,antineoplastic,1/4/2024,2/11/2023,,clinical study drug,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,12/13/2016,mg,antineoplastic,11/11/2016,9/14/2016,Intravenous,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G44B44661:316,3/27/2016,mg,antineoplastic,4/9/2015,2/25/2015,Intravenous,pemetrexed,FALSE
370,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,10/2/2020,mg,antineoplastic,7/31/2020,6/30/2020,Intravenous,carboplatin,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/29/2020,mg,antineoplastic,3/16/2020,1/5/2020,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/7/2023,,antineoplastic,10/11/2022,9/20/2022,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/6/2025,mg,antineoplastic,3/25/2019,2/9/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/1/2013,,antineoplastic,5/18/2013,3/8/2013,Intravenous,vinorelbine,FALSE
660,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,4/16/2017,mg,antineoplastic,12/14/2016,9/2/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/6/2025,,antineoplastic,3/5/2024,3/3/2023,,clinical study drug,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/27/2025,mg,antineoplastic,5/11/2024,4/10/2024,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/13/2020,mg,antineoplastic,7/2/2020,7/31/2016,Intravenous,nivolumab,FALSE
136,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/15/2014,mg,antineoplastic,11/21/2012,10/8/2012,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/23/2017,,antineoplastic,8/15/2017,6/23/2017,,paclitaxel,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/13/2021,mg,antineoplastic,6/9/2020,6/6/2020,Intravenous,gemcitabine,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/14/2019,mg,antineoplastic,10/7/2019,7/28/2019,Intravenous,paclitaxel protein-bound,FALSE
128,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/28/2023,mg,antineoplastic,5/12/2023,3/15/2023,Intravenous,cisplatin,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,8/3/2014,mg,antineoplastic,5/17/2014,5/10/2014,Intravenous,paclitaxel,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/25/2012,mg,antineoplastic,7/19/2012,2/21/2012,Intravenous,carboplatin,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/5/2017,mg,antineoplastic,6/28/2016,6/6/2016,Intravenous,paclitaxel protein-bound,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,3/1/2024,mg,antineoplastic,11/21/2023,9/24/2023,Intravenous,paclitaxel,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,9/30/2024,mg,antineoplastic,6/17/2024,6/16/2024,Intravenous,carboplatin,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/6/2022,mg,antineoplastic,9/30/2021,9/26/2021,Intravenous,paclitaxel,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/14/2012,mg,antineoplastic,4/19/2012,3/20/2012,Intravenous,paclitaxel,FALSE
180,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G14FD45889171,12/18/2015,mg,antineoplastic,10/16/2015,11/5/2015,Intravenous,nivolumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/21/2024,mg,antineoplastic,7/6/2022,5/28/2022,Intravenous,durvalumab,TRUE
950,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/8/2024,mg,antineoplastic,10/14/2023,10/23/2023,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/9/2025,mg,antineoplastic,9/6/2024,6/26/2024,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C88CEG2:289,2/1/2025,mg,antineoplastic,12/22/2024,11/18/2024,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,1/4/2016,mg,antineoplastic,10/12/2015,10/6/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/20/2013,mg,antineoplastic,1/30/2013,12/3/2012,Intravenous,paclitaxel protein-bound,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/9/2022,mg,antineoplastic,6/18/2021,2/24/2021,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/7/2023,mg,antineoplastic,11/17/2022,2/13/2022,Intravenous,pembrolizumab,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/23/2023,mg,antineoplastic,12/22/2021,12/26/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/27/2025,mg,antineoplastic,3/7/2023,9/22/2022,Intravenous,pembrolizumab,TRUE
85,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,2/7/2023,mg,antineoplastic,1/13/2023,11/10/2022,Intravenous,paclitaxel,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/4/2017,mg,antineoplastic,4/22/2016,2/12/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/26/2023,mg,antineoplastic,10/16/2022,10/19/2021,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/31/2020,mg,antineoplastic,11/8/2017,12/18/2015,Intravenous,nivolumab,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/29/2018,mg,antineoplastic,6/5/2018,4/21/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,6/22/2024,,antineoplastic,3/19/2024,3/16/2024,Intravenous,nivolumab,FALSE
131,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,4/25/2025,mg,antineoplastic,12/10/2024,11/22/2024,Intravenous,docetaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/8/2025,mg,antineoplastic,4/17/2024,5/6/2024,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/29/2023,mg,antineoplastic,1/19/2020,12/7/2019,Intravenous,pembrolizumab,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,10/9/2013,mg,antineoplastic,6/7/2013,3/26/2013,Intravenous,pemetrexed,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/26/2014,mg,antineoplastic,4/23/2014,12/27/2013,Intravenous,eribulin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/29/2022,,antineoplastic,3/3/2022,2/10/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/17/2025,mg,antineoplastic,3/23/2025,3/22/2024,Intravenous,pembrolizumab,TRUE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/27/2020,mg,antineoplastic,6/15/2020,4/8/2020,Intravenous,docetaxel,FALSE
186,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/23/2022,mg,antineoplastic,2/19/2022,3/1/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/22/2022,mg,antineoplastic,6/1/2018,12/21/2017,Intravenous,pembrolizumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/7/2015,mg,antineoplastic,12/27/2014,10/29/2014,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,3/29/2015,mg,antineoplastic,1/18/2015,12/5/2014,Intravenous,bevacizumab,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,1/16/2019,mg,antineoplastic,7/19/2017,10/24/2016,Intramuscular,fulvestrant,FALSE
468,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/19/2021,mg,antineoplastic,4/17/2021,4/25/2021,Intravenous,carboplatin,FALSE
500,3,ADVANCED,Orders,targeted/non-biologic,Bosutinib,G14E7662::61C,10/31/2022,mg,antineoplastic,8/24/2022,8/28/2022,Oral,bosutinib,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,11/18/2015,mg,antineoplastic,8/1/2015,3/19/2015,Intravenous,pemetrexed,TRUE
500,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,6/15/2017,mg/m2,antineoplastic,7/7/2017,5/9/2017,Intravenous,pemetrexed,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,6/29/2014,mg,antineoplastic,5/15/2014,4/28/2014,Intravenous,carboplatin,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,11/19/2011,mg,antineoplastic,10/15/2011,10/13/2011,Intravenous,etoposide,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/10/2020,mg,antineoplastic,1/14/2019,1/31/2019,Subcutaneous,bortezomib,FALSE
125,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4DE3DE99E:13,12/30/2015,mg,antineoplastic,9/16/2015,10/10/2015,Intravenous,pembrolizumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G459D:92E2344,12/11/2020,mg/kg,antineoplastic,12/3/2020,12/8/2020,Intravenous,durvalumab,FALSE
223,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/23/2024,mg,antineoplastic,8/30/2023,6/25/2023,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,10/14/2020,mg,antineoplastic,8/4/2020,8/7/2020,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1CD225858D1:,8/4/2017,,antineoplastic,12/4/2016,12/30/2016,,clinical study drug,FALSE
195,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/9/2012,mg,antineoplastic,2/2/2012,1/19/2012,Intravenous,etoposide,FALSE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,5/8/2015,mg,antineoplastic,2/1/2015,3/6/2015,Intravenous,etoposide,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/13/2025,mg,antineoplastic,1/9/2019,12/28/2018,Intravenous,pemetrexed,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,11/18/2021,mg,antineoplastic,5/15/2021,2/21/2021,Intravenous,durvalumab,FALSE
550,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,4/12/2014,mg,antineoplastic,3/7/2014,1/5/2014,Intravenous,carboplatin,FALSE
268,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,7/23/2015,mg,antineoplastic,6/20/2015,7/1/2015,Intravenous,paclitaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/28/2013,mg,antineoplastic,3/27/2013,12/4/2012,Intravenous,vinorelbine,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G11B743:8G337,5/17/2016,mg,antineoplastic,4/12/2015,3/14/2015,Intravenous,bevacizumab,TRUE
1070,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1D:B49GGG719,11/21/2016,mg,antineoplastic,11/13/2016,7/3/2016,Intravenous,pemetrexed,TRUE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,7/20/2024,,antiemetic,4/20/2024,4/29/2024,Subcutaneous,clinical study drug,FALSE
250,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,9/7/2024,mg,antineoplastic,5/19/2024,4/21/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/24/2017,mg,antineoplastic,11/16/2016,4/4/2016,Intravenous,nivolumab,FALSE
350,2,ADVANCED,Administrations,immunotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,11/18/2024,mg,antineoplastic,9/19/2024,9/27/2024,Intravenous,cemiplimab,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/10/2015,mg,antineoplastic,9/20/2014,8/25/2014,Intravenous,paclitaxel,FALSE
1143,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/7/2019,mg,antineoplastic,10/16/2018,11/12/2018,Intravenous,bevacizumab,FALSE
1800,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4G53233CD43C,4/11/2025,mg,antineoplastic,2/16/2025,1/31/2025,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/8/2017,,antineoplastic,8/30/2017,7/12/2017,,paclitaxel,FALSE
201,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,7/31/2016,mg,antineoplastic,4/8/2016,4/6/2016,Intravenous,carboplatin,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,12/18/2013,mg,antineoplastic,8/31/2013,10/16/2013,Intravenous,vinorelbine,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/10/2023,mg,antineoplastic,5/24/2023,11/15/2022,Intravenous,atezolizumab,FALSE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,12/16/2019,mg,antineoplastic,11/19/2019,7/25/2019,Intravenous,ramucirumab,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,7/26/2019,mg,antineoplastic,7/22/2019,5/15/2019,Intravenous,ramucirumab,FALSE
116.25,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/18/2015,mg,antineoplastic,3/18/2014,1/27/2014,Intravenous,carboplatin,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,8/30/2022,mg,antineoplastic,2/17/2022,3/1/2022,Intravenous,paclitaxel,FALSE
1750,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/4/2025,mg,antineoplastic,4/23/2025,1/25/2025,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/28/2025,mg,antineoplastic,7/18/2023,9/27/2022,Intravenous,pembrolizumab,TRUE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G163D9B593927,9/5/2016,mg,antineoplastic,9/17/2016,6/26/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/7/2025,mg,antineoplastic,7/23/2024,8/25/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/24/2025,mg,antineoplastic,11/27/2024,3/31/2020,Intravenous,pembrolizumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/4/2018,mg,antineoplastic,11/20/2015,8/22/2015,Intravenous,nivolumab,FALSE
413,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/14/2023,mg,antineoplastic,4/13/2023,10/15/2022,Intravenous,bevacizumab-bvzr,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/20/2016,,antineoplastic,4/29/2016,4/16/2016,Intravenous,paclitaxel,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/6/2016,mg/m2,antineoplastic,9/11/2016,6/20/2016,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G324DD277533C,2/6/2020,,,6/25/2019,8/6/2019,Oral,osimertinib,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,9/8/2012,mg,antineoplastic,5/23/2012,4/9/2012,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G3B698C119:F8,8/9/2012,,antineoplastic,5/9/2012,5/8/2012,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/18/2024,mg,antineoplastic,7/22/2024,6/17/2024,Intravenous,pembrolizumab,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/13/2022,mg,antineoplastic,11/19/2020,4/13/2020,Intravenous,durvalumab,TRUE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,7/1/2020,mg,antineoplastic,9/28/2019,10/8/2019,Intravenous,carboplatin,FALSE
629,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2262335C:D62,4/25/2025,mg,antineoplastic,3/5/2025,3/8/2025,Intravenous,ramucirumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,12/13/2022,mg,antineoplastic,10/21/2022,9/14/2022,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/18/2025,mg,antineoplastic,4/3/2025,5/4/2024,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/29/2022,mg,antineoplastic,1/28/2019,2/23/2016,Intravenous,pemetrexed,FALSE
665,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/2/2021,mg,antineoplastic,12/10/2020,9/23/2020,Intravenous,pemetrexed,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/22/2025,mg,antineoplastic,11/9/2020,4/1/2019,Intravenous,pemetrexed,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G193F52G:DDG7,7/13/2024,mg,antineoplastic,6/1/2024,6/1/2024,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G1G78CEE:7E:3,10/25/2018,mg/m2,antineoplastic,9/21/2018,8/25/2018,Intravenous,pemetrexed,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,3/31/2016,mg,antineoplastic,12/30/2015,12/16/2015,Intravenous,paclitaxel,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/11/2024,mg,antineoplastic,2/24/2021,6/9/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/19/2024,mg,antineoplastic,11/19/2023,6/19/2023,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/19/2024,mg,antineoplastic,10/15/2023,3/20/2023,Intravenous,bevacizumab-awwb,TRUE
541,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G54F545489E59,11/4/2023,mg,antineoplastic,5/18/2023,2/16/2023,Intravenous,ramucirumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/20/2019,mg,antineoplastic,3/1/2019,3/4/2019,Intravenous,docetaxel,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/12/2013,AUC,antineoplastic,7/8/2012,6/26/2012,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,10/31/2015,mg,antineoplastic,6/26/2015,7/29/2015,Intravenous,paclitaxel protein-bound,FALSE
220.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,7/30/2015,mg,antineoplastic,4/18/2015,3/20/2015,Intravenous,carboplatin,FALSE
463,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,11/15/2024,mg,antineoplastic,8/25/2024,8/13/2024,Intravenous,carboplatin,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,1/2/2012,mg,antineoplastic,12/14/2011,8/11/2011,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Osimertinib",G3BBG95F1669C,9/22/2022,,,1/4/2022,12/5/2021,Oral,osimertinib,FALSE
591.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/10/2017,mg,antineoplastic,6/3/2016,6/2/2016,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/9/2022,,antineoplastic,9/17/2019,5/16/2017,Oral,nilotinib,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/27/2018,mg,antineoplastic,11/18/2018,7/22/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,6/29/2020,mg,antineoplastic,4/10/2020,3/12/2020,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/8/2013,mg,antineoplastic,9/16/2012,1/15/2012,Intravenous,etoposide,FALSE
168.4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/4/2018,mg,antineoplastic,4/8/2018,4/28/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1:D34FC71922,6/19/2015,,antineoplastic,3/24/2015,3/8/2015,,clinical study drug,FALSE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/23/2025,mg,antineoplastic,11/14/2024,9/28/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G13GE1E25174F,9/23/2022,mg,antineoplastic,5/13/2022,6/12/2022,Intravenous,pembrolizumab,TRUE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/25/2017,mg,antineoplastic,5/19/2016,5/25/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G31C:9::5EG5D,12/21/2022,,,12/29/2022,3/13/2019,Oral,osimertinib,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/20/2025,mg,antineoplastic,5/20/2016,11/23/2015,Intravenous,paclitaxel,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/10/2025,mg,antineoplastic,1/22/2025,8/28/2022,Intravenous,pembrolizumab,TRUE
675,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,6/25/2013,mg,antineoplastic,6/19/2012,6/30/2012,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/21/2024,mg,antineoplastic,10/21/2024,9/22/2024,Intravenous,carboplatin,FALSE
146,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/13/2024,mg,antineoplastic,6/27/2024,4/6/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1983:3F:98B7,6/25/2020,mg,antineoplastic,6/29/2020,7/11/2020,Intravenous,pembrolizumab,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,2/4/2023,mg,antineoplastic,11/14/2022,10/26/2022,Intravenous,nivolumab,TRUE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/5/2020,mg,antineoplastic,3/13/2019,3/24/2019,Intravenous,pemetrexed,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,3/16/2016,mg,antineoplastic,2/7/2016,11/30/2015,Intravenous,carboplatin,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/13/2023,mg,antineoplastic,12/12/2022,4/26/2022,Intravenous,durvalumab,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,12/21/2021,mg,antineoplastic,1/15/2022,10/8/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G23G13:GCG631,1/9/2018,mg,antineoplastic,12/8/2017,11/2/2017,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4725296E3CE4,10/17/2022,,,10/30/2022,3/23/2022,Oral,osimertinib,FALSE
104,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,8/7/2017,mg,antineoplastic,6/21/2017,6/15/2017,Intravenous,paclitaxel,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/5/2023,mg,antineoplastic,5/10/2023,4/12/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,7/9/2021,mg,antineoplastic,6/23/2021,2/24/2021,Intravenous,pembrolizumab,TRUE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/7/2017,mg,antineoplastic,11/2/2016,9/15/2016,Intravenous,paclitaxel protein-bound,FALSE
762,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/23/2020,mg,antineoplastic,4/9/2017,3/23/2017,Intravenous,bevacizumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/16/2024,mg,antineoplastic,6/9/2022,4/30/2022,Intravenous,durvalumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/25/2020,mg,antineoplastic,3/12/2019,12/15/2015,Intravenous,nivolumab,FALSE
400,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/8/2018,mg,antineoplastic,8/2/2018,5/12/2018,Intravenous,carboplatin,FALSE
318,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,5/11/2024,mg,antineoplastic,3/28/2024,1/31/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/22/2025,mg,antineoplastic,6/13/2019,1/3/2019,Intravenous,pembrolizumab,TRUE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,7/10/2021,mg,antineoplastic,11/19/2020,10/26/2020,Intravenous,gemcitabine,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G5G8G1EE2EG,9/4/2019,mg,antineoplastic,9/13/2019,8/23/2019,Intravenous,pemetrexed,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/16/2019,mg,antineoplastic,8/27/2019,8/19/2019,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,2/27/2025,mg,antineoplastic,1/13/2024,3/29/2020,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,8/27/2020,mg,antineoplastic,7/29/2020,6/22/2020,Intravenous,atezolizumab,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,7/31/2019,mg,antineoplastic,8/6/2019,10/3/2018,Intravenous,durvalumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/13/2014,mg,antineoplastic,9/27/2014,8/17/2014,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/2/2018,mg,antineoplastic,9/1/2018,8/15/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/20/2021,mg/m2,antineoplastic,3/19/2021,3/23/2021,Intravenous,leucovorin,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/5/2020,mg,antineoplastic,6/2/2020,3/23/2020,Intravenous,carboplatin,FALSE
71.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,10/9/2021,mg,antineoplastic,5/26/2021,5/13/2021,Intravenous,paclitaxel,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/20/2018,mg,antineoplastic,6/14/2018,5/3/2018,Intravenous,pemetrexed,FALSE
448,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/3/2025,mg,antineoplastic,11/21/2019,4/2/2019,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/29/2016,mg,antineoplastic,12/15/2015,10/30/2015,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/5/2013,,antineoplastic,3/6/2013,3/18/2013,Intravenous,vinorelbine,FALSE
227.2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/30/2016,mg,antineoplastic,9/24/2016,8/4/2016,Intravenous,carboplatin,FALSE
448,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/19/2025,mg,antineoplastic,9/25/2020,4/16/2019,Intravenous,carboplatin,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/20/2014,mg,antineoplastic,10/9/2014,8/26/2014,Intravenous,paclitaxel,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/19/2024,mg,antineoplastic,6/11/2024,8/18/2023,Intravenous,durvalumab,FALSE
130,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,9/11/2013,mg,antineoplastic,7/31/2013,6/19/2013,Intravenous,paclitaxel,FALSE
175,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/20/2021,mg/m2,antineoplastic,2/10/2021,9/15/2020,Intravenous,paclitaxel,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,3/5/2015,mg,antineoplastic,2/12/2015,12/21/2014,Intravenous,carboplatin,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G7B3CB6D5C4,2/27/2013,mg,antineoplastic,1/22/2013,2/16/2013,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/16/2021,mg/m2,antineoplastic,2/19/2021,3/15/2021,Intravenous,fluorouracil,FALSE
1600,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4ED3922EEE48,11/8/2022,mg,antineoplastic,10/11/2022,9/22/2022,Intravenous,gemcitabine,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,10/16/2023,mg,antineoplastic,8/3/2023,5/13/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/23/2021,mg,antineoplastic,12/5/2019,10/31/2019,Intravenous,pembrolizumab,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/21/2021,mL,solution-fluid,3/6/2019,4/6/2018,Intravenous,durvalumab,TRUE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,4/15/2018,,antineoplastic,12/29/2017,2/11/2018,Intravenous,clinical study drug,FALSE
260,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/15/2014,mg,antineoplastic,4/1/2013,4/9/2013,Intravenous,carboplatin,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/24/2020,mg,antineoplastic,2/8/2020,8/29/2019,Intravenous,gemcitabine,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/3/2024,mg,antineoplastic,7/9/2021,6/27/2020,Intravenous,ipilimumab,FALSE
1770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,1/12/2025,mg,antineoplastic,11/21/2024,11/17/2024,Intravenous,gemcitabine,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/23/2025,mg,antineoplastic,9/10/2024,2/18/2023,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1554C84G3CD2,11/1/2023,mg,antineoplastic,6/15/2023,6/20/2023,Intravenous,pembrolizumab,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/22/2021,mg,antineoplastic,2/8/2021,1/21/2021,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/27/2023,mg,antineoplastic,2/24/2023,11/26/2022,Intravenous,pembrolizumab,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/8/2022,mg,antineoplastic,10/10/2021,6/1/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,5/16/2021,mg,antineoplastic,3/24/2019,10/29/2018,Intravenous,pembrolizumab,FALSE
194,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,8/14/2016,mg,antineoplastic,4/10/2016,3/30/2016,Intravenous,carboplatin,FALSE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/7/2020,mg,antineoplastic,10/16/2019,11/5/2019,Intravenous,docetaxel,FALSE
266,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/19/2021,mg,antineoplastic,7/15/2019,5/10/2019,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/8/2025,mg,antineoplastic,5/26/2019,2/9/2017,Intravenous,pembrolizumab,FALSE
40,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/26/2018,mg,antineoplastic,11/5/2018,7/28/2018,Intravenous,cisplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,5/2/2025,mg,antineoplastic,11/14/2024,9/28/2024,Intravenous,pembrolizumab,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/24/2023,mg,antineoplastic,2/3/2023,2/14/2023,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G46:87GF7FGC9,12/5/2016,,antineoplastic,9/18/2016,9/12/2016,,clinical study drug,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/15/2018,mg,antineoplastic,10/5/2017,8/4/2017,Intravenous,carboplatin,FALSE
645,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,4/6/2023,mg,antineoplastic,1/17/2023,11/30/2022,Intravenous,pemetrexed,FALSE
152.7,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/8/2017,mg,antineoplastic,9/15/2017,9/4/2017,Intravenous,carboplatin,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/2/2020,mg,antineoplastic,12/13/2019,11/29/2018,Intravenous,pemetrexed,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/15/2019,mg,antineoplastic,4/5/2019,1/15/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/21/2022,mg,antineoplastic,6/26/2021,1/3/2020,Intravenous,nivolumab,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/14/2018,mg,antineoplastic,5/2/2018,5/15/2018,Intravenous,carboplatin,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,11/5/2023,mg,antineoplastic,10/5/2023,9/12/2023,Intravenous,paclitaxel,FALSE
297,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/5/2023,mg,antineoplastic,11/23/2022,11/3/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/20/2019,mg,antineoplastic,10/20/2019,9/27/2019,Intravenous,pembrolizumab,FALSE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,12/4/2015,mg,antineoplastic,8/8/2015,5/7/2015,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,2/1/2021,mg,antineoplastic,6/10/2020,4/11/2020,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,4/20/2025,,antineoplastic,9/4/2024,10/7/2024,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/4/2019,mg,antineoplastic,4/1/2019,7/2/2018,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/16/2014,mg,antineoplastic,4/18/2014,5/2/2014,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G4G4D:D9D8152,5/8/2025,mg/m2,antineoplastic,3/20/2025,1/30/2025,Intravenous,gemcitabine,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/22/2025,mg,antineoplastic,8/31/2020,3/9/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/6/2021,mg,antineoplastic,9/3/2020,10/28/2019,Intravenous,pembrolizumab,FALSE
,,NEOADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G3B698C119:F8,7/24/2012,,solution-fluid,6/14/2012,4/22/2012,Intrajejunal,clinical study drug,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,8/12/2022,mg,antineoplastic,7/30/2022,6/26/2022,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/28/2025,,antineoplastic,1/24/2022,4/24/2020,Oral,enzalutamide,FALSE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,6/14/2023,mg,antineoplastic,6/16/2023,2/15/2023,Intravenous,durvalumab,TRUE
450,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,5/31/2020,mg,antineoplastic,4/27/2020,3/27/2020,Intravenous,carboplatin,FALSE
277,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/10/2025,mg,antineoplastic,12/29/2024,11/27/2024,Intravenous,bevacizumab-bvzr,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5669E21B9D52,4/29/2017,mg,antineoplastic,3/29/2017,3/28/2017,Intravenous,carboplatin,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/19/2011,mg,antineoplastic,6/27/2011,6/6/2011,Intravenous,carboplatin,FALSE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/10/2012,mg,antineoplastic,11/17/2011,11/21/2011,Intravenous,carboplatin,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,6/16/2014,mg,antineoplastic,12/29/2013,12/14/2013,Intravenous,bevacizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,7/19/2012,mg,antineoplastic,5/5/2012,4/13/2012,Intravenous,carboplatin,FALSE
145,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/30/2024,mg,antineoplastic,5/26/2024,5/16/2024,Intravenous,carboplatin,FALSE
5,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/11/2013,AUC,antineoplastic,11/21/2012,12/7/2011,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/29/2017,mg,antineoplastic,10/4/2016,4/16/2015,Intravenous,bevacizumab,TRUE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/15/2024,mg,antineoplastic,3/25/2024,10/1/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,12/1/2024,mg,antineoplastic,9/5/2024,8/31/2024,Intravenous,pembrolizumab,FALSE
1632,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,3/22/2025,mg,antineoplastic,4/18/2024,6/2/2024,Intravenous,bevacizumab-awwb,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,10/20/2023,,antineoplastic,11/2/2023,1/26/2023,Oral,zanubrutinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/13/2014,mg/m2,antineoplastic,10/30/2014,5/30/2014,Intravenous,paclitaxel protein-bound,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,8/31/2024,mg,antineoplastic,9/28/2020,7/19/2020,Intravenous,ipilimumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/30/2020,mg,antineoplastic,9/16/2019,11/27/2015,Intravenous,nivolumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/30/2025,mg,antineoplastic,3/9/2025,10/16/2024,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/8/2025,mg,antineoplastic,8/18/2024,7/23/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/26/2025,mg,antineoplastic,7/1/2020,2/24/2020,Intravenous,pembrolizumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1E35BD845958,5/19/2015,mg,antineoplastic,2/28/2015,12/12/2014,Intravenous,pemetrexed,TRUE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/6/2016,mg,antineoplastic,6/16/2016,6/25/2016,Intravenous,paclitaxel,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/23/2019,mg/m2,antineoplastic,1/28/2019,11/5/2018,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/17/2016,mg,antineoplastic,8/15/2015,5/25/2015,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G437:CB1EF9DB,11/15/2023,mg,antineoplastic,11/5/2023,11/19/2023,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/22/2016,mg,antineoplastic,12/17/2013,12/19/2013,Intravenous,cisplatin,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/19/2020,mg,antineoplastic,3/1/2018,1/20/2016,Intravenous,bevacizumab,TRUE
480,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3:67CF8FF:28,5/9/2020,mg,antineoplastic,1/23/2020,11/30/2019,Intravenous,carboplatin,FALSE
376,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,10/23/2011,mg,antineoplastic,7/9/2011,7/28/2011,Intravenous,paclitaxel,FALSE
606.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,4/22/2017,mg,antineoplastic,2/5/2017,12/15/2016,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/18/2011,mg,antineoplastic,6/25/2011,4/5/2011,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/19/2022,mg,antineoplastic,5/25/2020,12/29/2019,Intravenous,nivolumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,Paclitaxel,G1G5771EC2C8F,2/12/2018,mg,antineoplastic,2/15/2018,2/10/2018,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/12/2025,mg,antineoplastic,8/14/2024,7/9/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/6/2024,,antineoplastic,7/21/2024,6/12/2024,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/19/2018,mg,antineoplastic,8/15/2018,8/5/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/17/2024,mg,antineoplastic,10/23/2023,8/19/2022,Intravenous,pembrolizumab,TRUE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,5/19/2019,mg/kg,antineoplastic,12/3/2017,8/7/2017,Intravenous,ramucirumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,5/5/2025,mg,antineoplastic,12/21/2022,2/21/2022,Intravenous,atezolizumab,FALSE
148,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/1/2020,mg,antineoplastic,2/8/2020,2/17/2020,Intravenous,carboplatin,FALSE
660,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/19/2020,mg,antineoplastic,11/15/2019,11/17/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/3/2025,mg,antineoplastic,3/22/2025,4/20/2024,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,2/10/2024,mg,antineoplastic,3/19/2024,12/26/2023,Intravenous,pembrolizumab,FALSE
176,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/9/2012,mg,antineoplastic,4/3/2012,4/11/2012,Intravenous,carboplatin,FALSE
175,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/19/2018,mg,antineoplastic,7/20/2018,3/23/2018,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/25/2025,mg,antineoplastic,1/9/2018,12/28/2016,Intravenous,nivolumab,FALSE
540,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,11/4/2016,mg,antineoplastic,7/3/2016,5/24/2016,Intravenous,bevacizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G147D:E6:68B1,11/21/2024,mg,antineoplastic,9/10/2024,7/27/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/21/2021,mg,antineoplastic,12/8/2020,11/28/2020,Intravenous,pembrolizumab,FALSE
1010,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/3/2023,mg,antineoplastic,3/15/2023,12/31/2022,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,4/10/2022,,cytoprotective,1/20/2022,12/29/2021,Oral,clinical study drug,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/6/2014,mg,antineoplastic,10/20/2014,7/18/2014,Intravenous,paclitaxel,FALSE
2487,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1FFE6DDFB4DE,8/8/2023,mg,antineoplastic,7/17/2023,8/10/2023,Intravenous,gemcitabine,FALSE
344,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G42B4F:55::6F,8/6/2020,mg,antineoplastic,8/12/2020,8/5/2020,Intravenous,paclitaxel,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,11/15/2023,mg,antineoplastic,6/19/2023,4/5/2023,Intravenous,gemcitabine,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,10/10/2021,mg,antineoplastic,7/8/2021,5/17/2021,Intravenous,pemetrexed,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/24/2025,mg,antineoplastic,2/18/2025,3/28/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/25/2021,mg,antineoplastic,3/20/2019,12/5/2018,Intravenous,pembrolizumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,3/31/2025,mg,antineoplastic,4/22/2024,2/29/2024,Intravenous,durvalumab,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/22/2019,mg,antineoplastic,8/12/2018,11/24/2016,Intramuscular,fulvestrant,FALSE
129,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/9/2020,mg,antineoplastic,10/27/2019,9/21/2019,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/24/2016,AUC,antineoplastic,5/29/2015,6/14/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/25/2025,mg,antineoplastic,4/23/2025,8/28/2024,Intravenous,pembrolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/6/2024,mg,antineoplastic,11/12/2023,6/9/2023,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/24/2025,mg,antineoplastic,3/6/2024,1/14/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,9/24/2021,mg,antineoplastic,9/14/2021,8/25/2021,Intravenous,pembrolizumab,FALSE
72,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/4/2018,mg,antineoplastic,10/22/2018,9/13/2018,Intravenous,paclitaxel,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,5/15/2012,mg,antineoplastic,6/17/2012,1/30/2012,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/3/2025,mg,antineoplastic,5/9/2024,3/15/2024,Intravenous,pemetrexed,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/26/2014,mg,antineoplastic,11/19/2013,10/9/2013,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/19/2024,mg,antineoplastic,8/16/2023,6/8/2020,Intravenous,pembrolizumab,TRUE
160.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,3/30/2019,mg,antineoplastic,1/24/2019,12/27/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/31/2022,,antineoplastic,5/24/2022,5/29/2022,Oral,anastrozole,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,5/26/2025,mg/m2,antineoplastic,8/6/2024,7/21/2024,Intravenous,pemetrexed,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/25/2021,mg,antineoplastic,10/10/2021,8/24/2021,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/19/2025,,antineoplastic,6/23/2023,3/4/2023,,clinical study drug,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,10/18/2019,mg/kg,antineoplastic,6/12/2019,6/16/2019,Intravenous,durvalumab,TRUE
552,1,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G53C52948773G,2/27/2024,mg,antineoplastic,12/7/2023,11/24/2023,Intravenous,ramucirumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/9/2025,mg,antineoplastic,4/13/2024,4/4/2024,Intravenous,pembrolizumab,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,5/1/2014,mg,antineoplastic,2/8/2014,1/22/2014,Intravenous,eribulin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/23/2025,mg,antineoplastic,10/7/2023,2/16/2023,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,12/7/2017,mg,antineoplastic,1/15/2017,3/28/2016,Intravenous,nivolumab,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,6/24/2018,,antineoplastic,2/2/2018,12/19/2017,Intravenous,pembrolizumab,FALSE
50,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/26/2023,mg/m2,antineoplastic,3/21/2023,2/25/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/25/2018,mg,antineoplastic,7/4/2018,3/7/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/30/2018,mg,antineoplastic,10/16/2018,8/18/2018,Intravenous,pembrolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/8/2025,mg,antineoplastic,12/15/2015,1/7/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,5/5/2024,mg,antineoplastic,9/3/2023,9/14/2022,Intravenous,pembrolizumab,TRUE
273,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/14/2022,mg,antineoplastic,7/9/2019,6/10/2019,Intravenous,carboplatin,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/18/2019,mg,antineoplastic,9/2/2018,7/11/2018,Intravenous,levoleucovorin,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/20/2025,mg,antineoplastic,5/21/2019,2/17/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/31/2020,mg,antineoplastic,3/16/2018,8/3/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,9/17/2017,mg,antineoplastic,7/25/2017,6/19/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G27D282B7225B,12/3/2021,,antineoplastic,7/24/2021,7/9/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/20/2025,mg,antineoplastic,6/19/2023,6/5/2022,Intravenous,pembrolizumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/22/2020,mL,solution-fluid,1/7/2020,2/12/2019,Intravenous,nivolumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/9/2025,mg,antineoplastic,9/11/2019,3/13/2019,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/25/2024,mg,antineoplastic,10/18/2023,5/28/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/16/2025,mg,antineoplastic,12/29/2023,11/10/2023,Intravenous,pembrolizumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/8/2013,mg,antineoplastic,10/2/2013,9/13/2013,Intravenous,paclitaxel,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/22/2013,mg,antineoplastic,4/9/2013,3/3/2013,Intravenous,paclitaxel protein-bound,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/22/2020,mg,antineoplastic,7/28/2019,10/23/2018,Intravenous,pemetrexed,TRUE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/11/2016,mg,antineoplastic,10/11/2016,3/17/2016,Intravenous,pemetrexed,TRUE
760,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/12/2024,mg,antineoplastic,5/2/2024,4/9/2024,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/28/2025,mg,antineoplastic,11/29/2024,5/27/2024,Intravenous,pemetrexed,TRUE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/17/2022,mg/kg,antineoplastic,2/16/2021,3/18/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,9/12/2023,mg,antineoplastic,5/16/2022,3/16/2022,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G46:87GF7FGC9,12/25/2015,,antiemetic,10/1/2015,7/20/2015,Intrajejunal,clinical study drug,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/22/2021,mg,antineoplastic,6/20/2019,6/8/2019,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,mg,antineoplastic,9/6/2019,4/25/2017,Oral,nilotinib,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/1/2014,mg,antineoplastic,4/24/2013,10/25/2012,Intravenous,gemcitabine,FALSE
1045,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/10/2025,mg,antineoplastic,10/4/2024,7/23/2024,Intravenous,pemetrexed,FALSE
90,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,12/30/2020,mg,antineoplastic,8/9/2020,8/9/2020,Intravenous,docetaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G2G22BF9DCG81,6/25/2023,mg,antineoplastic,4/21/2023,3/28/2023,Intravenous,pembrolizumab,FALSE
304,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/19/2024,mg,antineoplastic,7/6/2024,5/11/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/2/2025,,antineoplastic,5/21/2019,1/8/2019,Intravenous,pembrolizumab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/19/2020,mg,antineoplastic,1/23/2018,7/21/2017,Intravenous,pemetrexed,TRUE
194,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17171D313CCE,7/6/2018,mg,antineoplastic,3/14/2018,2/7/2018,Intravenous,carboplatin,FALSE
2563,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,6/24/2022,mg,antineoplastic,8/26/2021,8/7/2021,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,10/27/2020,mg,antineoplastic,12/5/2020,9/17/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/7/2025,,antineoplastic,7/7/2024,2/6/2023,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,2/28/2025,mg,antineoplastic,4/22/2021,4/18/2020,Intravenous,pembrolizumab,FALSE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/18/2020,mg,antineoplastic,4/4/2020,5/28/2020,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/16/2024,mg,antineoplastic,2/20/2024,9/15/2023,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/22/2023,,antineoplastic,3/9/2022,4/24/2022,Intravenous,paclitaxel,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,1/24/2016,mg,antineoplastic,12/11/2015,10/27/2015,Intravenous,bevacizumab,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/28/2016,mg,antineoplastic,6/7/2015,5/2/2015,Intravenous,carboplatin,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/30/2025,mg,antineoplastic,1/8/2023,2/17/2020,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,solution-fluid,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/23/2012,,solution-fluid,4/7/2012,3/28/2012,,clinical study drug,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/8/2023,mg,antineoplastic,11/14/2022,9/16/2022,Subcutaneous,azacitidine,FALSE
689,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/19/2025,mg,antineoplastic,4/15/2023,2/9/2023,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/7/2023,mg,antineoplastic,7/4/2023,10/28/2022,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,9/1/2022,mg,antineoplastic,12/4/2021,7/12/2021,Intravenous,pemetrexed,FALSE
780,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4ECBF26D2579,8/29/2014,mg,antineoplastic,7/3/2014,8/29/2014,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,5/17/2019,mg,antineoplastic,1/20/2019,6/23/2018,Intravenous,nivolumab,FALSE
45,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,9/7/2024,mg,antineoplastic,3/20/2023,2/11/2023,Intravenous,docetaxel,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/11/2012,mg,antineoplastic,11/18/2012,4/27/2012,Intravenous,bevacizumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,9/6/2024,mg,antineoplastic,5/14/2024,5/9/2024,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,mg,antineoplastic,3/28/2021,5/25/2017,Intravenous,nivolumab,FALSE
324,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,11/10/2013,mg,antineoplastic,7/3/2013,5/13/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,11/3/2019,mg,antineoplastic,9/23/2019,9/29/2019,Intravenous,pembrolizumab,FALSE
27,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,2/6/2015,mg,antineoplastic,12/30/2014,11/10/2014,Intravenous,cisplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,5/16/2016,mg,antineoplastic,10/4/2014,8/29/2014,Intravenous,cisplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,12/4/2015,mg,antineoplastic,3/12/2015,2/25/2015,Intravenous,paclitaxel protein-bound,FALSE
360,1,ADVANCED,Orders,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/4/2025,mg,antineoplastic,2/12/2025,9/17/2024,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/23/2025,mg,antineoplastic,10/7/2023,8/1/2022,Intravenous,pembrolizumab,TRUE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/4/2017,mg,antineoplastic,6/26/2017,6/4/2017,Intravenous,docetaxel,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/23/2021,mg,antineoplastic,1/11/2017,12/19/2016,Intravenous,carboplatin,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/21/2020,mg,antineoplastic,11/8/2018,2/24/2017,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/7/2021,,antineoplastic,5/11/2021,5/7/2021,,pemetrexed,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/17/2014,mg/kg,antineoplastic,12/10/2013,12/9/2013,Intravenous,bevacizumab,FALSE
782.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/15/2016,mg,antineoplastic,6/26/2015,6/4/2015,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/15/2024,mg,antineoplastic,6/7/2022,7/16/2020,Intravenous,nivolumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,2/13/2015,mg,antineoplastic,10/21/2014,9/25/2014,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/5/2025,,antineoplastic,9/1/2023,2/16/2023,,clinical study drug,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/5/2018,mg,antineoplastic,10/2/2018,10/14/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/7/2023,mg,antineoplastic,12/5/2022,2/26/2022,Intravenous,pembrolizumab,TRUE
452,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,5/1/2016,mg,antineoplastic,5/4/2016,1/20/2016,Intravenous,carboplatin,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/31/2020,mg,antineoplastic,5/6/2020,5/4/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/14/2021,mg,antineoplastic,6/16/2021,5/27/2021,Intravenous,etoposide,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,10/13/2015,mg,antineoplastic,10/31/2015,7/13/2015,Intravenous,paclitaxel protein-bound,FALSE
1070,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/22/2025,mg,antineoplastic,6/2/2023,2/20/2023,Intravenous,pemetrexed,FALSE
325,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/8/2014,mg,antineoplastic,11/24/2013,12/6/2013,Intravenous,paclitaxel,FALSE
85,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,6/5/2015,mg,antineoplastic,5/8/2015,3/25/2015,Intravenous,paclitaxel,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/14/2025,mg,antineoplastic,1/18/2024,9/25/2022,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Unstructured,,"Alectinib,Osimertinib",G3BBG95F1669C,11/14/2022,,,11/4/2022,12/5/2021,Oral,osimertinib,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,11/5/2023,mg,antineoplastic,7/15/2023,6/6/2023,Intravenous,vinorelbine,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/15/2025,mg,antineoplastic,6/14/2024,6/1/2024,Intravenous,pemetrexed,TRUE
70,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/31/2020,mg,antineoplastic,12/16/2019,10/27/2019,Intravenous,paclitaxel,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/18/2024,mg,antineoplastic,7/30/2024,6/23/2024,Intravenous,gemcitabine,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/30/2025,mg,antineoplastic,4/8/2024,3/28/2024,Oral,abiraterone,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/21/2017,mg,antineoplastic,1/17/2017,9/19/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/12/2024,mg,antineoplastic,8/22/2024,6/14/2024,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/30/2019,mL,solution-fluid,9/30/2019,8/14/2019,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/12/2013,mg,antineoplastic,8/15/2012,1/9/2012,Intravenous,etoposide,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/19/2024,mg,antineoplastic,7/18/2024,7/12/2024,Intravenous,gemcitabine,FALSE
,,NEOADJUVANT,Administrations,growth factor,Clinical Study Drug,G1DCDG73E53FF,6/28/2024,,hematological agent,7/13/2024,4/29/2024,Subcutaneous,clinical study drug,FALSE
156,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/17/2020,mg,antineoplastic,5/12/2020,6/14/2020,Intravenous,cisplatin,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,5/1/2020,mg,antineoplastic,4/14/2020,10/11/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/14/2025,,antineoplastic,7/22/2023,3/1/2023,,clinical study drug,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/26/2020,mg,antineoplastic,11/14/2019,11/19/2018,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/28/2019,mg,antineoplastic,9/19/2019,9/16/2019,Intravenous,pembrolizumab,FALSE
469,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/11/2020,mg,antineoplastic,8/11/2020,2/16/2020,Intravenous,ramucirumab,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,8/3/2018,mg,antineoplastic,7/18/2018,5/12/2018,Intravenous,carboplatin,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,3/11/2016,mg,antineoplastic,10/17/2015,8/25/2015,Intravenous,carboplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/25/2019,mg/kg,antineoplastic,3/26/2019,7/31/2018,Intravenous,durvalumab,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/9/2024,mg,antineoplastic,9/30/2024,11/18/2023,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/31/2022,mg,antineoplastic,4/20/2022,6/7/2020,Intravenous,pembrolizumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/4/2020,mg,antineoplastic,3/20/2019,1/24/2019,Intravenous,durvalumab,FALSE
128,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,8/3/2023,mg,antineoplastic,6/1/2023,3/31/2023,Intravenous,cisplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,7/2/2014,mg,antineoplastic,3/15/2014,1/9/2014,Intravenous,cisplatin,FALSE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,10/21/2015,mg,antineoplastic,6/19/2015,6/16/2015,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,hormone,"Letrozole,Osimertinib",G31G19E54FC:B,10/22/2023,,antineoplastic,12/20/2021,9/12/2020,Oral,letrozole,FALSE
198,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19DB44:G31G8,2/27/2013,mg,antineoplastic,11/28/2012,11/25/2012,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,4/29/2025,mg,antineoplastic,5/15/2025,12/29/2024,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/11/2025,mg,antineoplastic,8/21/2023,5/29/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/6/2025,,antineoplastic,6/14/2023,2/24/2023,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/23/2017,AUC,antineoplastic,3/22/2015,10/22/2014,Intravenous,carboplatin,FALSE
1336,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,2/14/2015,mg,antineoplastic,10/29/2014,10/27/2014,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,1/20/2017,,antineoplastic,6/14/2016,2/9/2016,Intravenous,clinical study drug,FALSE
,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Durvalumab,Paclitaxel",G4EF93:EF39:7,12/7/2019,,antineoplastic,11/7/2019,11/27/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/8/2025,,antineoplastic,12/23/2024,3/29/2024,Intravenous,clinical study drug,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/21/2020,mg,antineoplastic,1/15/2019,11/13/2018,Intravenous,pemetrexed,TRUE
358,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D5BG82C889G,6/13/2021,mg,antineoplastic,5/1/2021,6/6/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,10/4/2022,mg,antineoplastic,2/23/2022,2/28/2022,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,2/22/2021,mg,antineoplastic,5/5/2020,5/9/2020,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Nintedanib,G2848BE3831EF,12/21/2022,,antineoplastic,12/21/2022,1/15/2023,Oral,nintedanib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/25/2023,mg,antineoplastic,9/9/2022,8/11/2022,Subcutaneous,azacitidine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,12/6/2017,mg,antineoplastic,5/3/2017,5/11/2016,Intravenous,nivolumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/29/2020,mg,antineoplastic,11/18/2020,10/11/2020,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/30/2018,mg/m2,antineoplastic,6/21/2018,7/12/2018,Intravenous,paclitaxel protein-bound,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/8/2014,mg,antineoplastic,12/6/2013,11/20/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/5/2023,mg,antineoplastic,8/5/2022,2/23/2022,Intravenous,pembrolizumab,TRUE
503,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,12/6/2021,mg,antineoplastic,9/5/2021,8/10/2021,Intravenous,durvalumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/24/2011,mg,antineoplastic,7/12/2011,5/15/2011,Intravenous,etoposide,FALSE
178,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/14/2023,mg,antineoplastic,2/9/2023,12/2/2022,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G128:92:3BD3D,11/20/2021,,antineoplastic,7/9/2021,4/9/2021,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/8/2025,mg,antineoplastic,12/24/2019,2/8/2018,Intravenous,nivolumab,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G47DB481E783:,3/2/2025,mg,antineoplastic,2/8/2025,1/16/2025,Intravenous,ramucirumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/30/2014,mg,antineoplastic,10/16/2014,6/27/2014,Intravenous,vinorelbine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/4/2024,mg,antineoplastic,3/31/2024,4/28/2024,Intravenous,pembrolizumab,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/8/2014,mg,antineoplastic,9/5/2014,7/10/2014,Intravenous,cisplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,,antineoplastic,3/13/2021,4/7/2017,Oral,nilotinib,FALSE
404,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,10/12/2021,mg,antineoplastic,9/26/2021,8/25/2021,Intravenous,carboplatin,FALSE
792,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G48EG9E748G84,1/17/2015,mg,antineoplastic,12/4/2014,11/23/2014,Intravenous,bevacizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,mg,antineoplastic,10/2/2019,3/29/2017,Intravenous,nivolumab,FALSE
745,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,6/8/2023,mg,antineoplastic,2/6/2023,3/7/2023,Intravenous,pemetrexed,FALSE
770,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/14/2021,mg,antineoplastic,9/3/2021,8/26/2021,Intravenous,carboplatin,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,3/26/2014,mg,antineoplastic,4/16/2014,2/10/2014,Intravenous,docetaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G2G1D1B:745EG,3/18/2021,mg,antineoplastic,11/29/2020,12/1/2020,Intravenous,cyclophosphamide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/30/2020,mg,antineoplastic,11/22/2018,7/10/2016,Intravenous,nivolumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/12/2025,mg,antineoplastic,6/12/2021,2/17/2020,Intravenous,pemetrexed,TRUE
75,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G557E997E81G5,6/26/2023,mg,antineoplastic,5/4/2023,4/29/2023,Intravenous,docetaxel,FALSE
980,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,11/10/2013,mg,antineoplastic,6/22/2013,4/5/2013,Intravenous,bevacizumab,FALSE
840,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2177D1::DG1E,3/29/2012,mg,antineoplastic,1/25/2012,11/13/2011,Intravenous,pemetrexed,TRUE
1028.57,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G5722GECG4G16,7/9/2024,mg/m2,antineoplastic,6/7/2024,3/25/2024,Intravenous,gemcitabine,FALSE
357,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/26/2016,mg,antineoplastic,7/26/2015,5/28/2015,Intravenous,carboplatin,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,7/19/2024,mg,antineoplastic,6/19/2024,5/12/2024,Intravenous,nivolumab,FALSE
1048,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/3/2016,mg,antineoplastic,8/22/2016,7/2/2016,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G59243DC543:8,10/14/2024,,,10/4/2024,6/30/2024,Oral,lorlatinib,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,3/2/2022,mg,antineoplastic,10/26/2021,11/14/2021,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,Pazopanib,G51:G:C712CC6,7/1/2021,,antineoplastic,3/10/2021,3/29/2021,Oral,pazopanib,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/11/2022,,antineoplastic,10/5/2020,5/9/2017,Oral,nilotinib,FALSE
693,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/7/2023,mg,antineoplastic,1/15/2023,11/21/2022,Intravenous,pemetrexed,FALSE
383.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/23/2019,mg,antineoplastic,7/31/2019,6/19/2019,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/20/2025,mg,antineoplastic,1/22/2022,2/2/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,4/17/2019,mg,antineoplastic,4/15/2019,2/5/2019,Intravenous,pembrolizumab,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,8/27/2024,mg,antineoplastic,7/19/2024,7/6/2024,Intravenous,paclitaxel,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,5/25/2025,mg,antineoplastic,11/21/2024,12/14/2024,Intravenous,gemcitabine,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/26/2019,mg,antineoplastic,9/17/2019,10/3/2019,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,7/22/2019,mg,antineoplastic,7/17/2019,5/11/2019,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,1/18/2025,mg,antineoplastic,2/8/2025,10/17/2024,Intravenous,pemetrexed,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/3/2019,mg/m2,antineoplastic,2/18/2019,12/26/2018,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,12/25/2016,mg,antineoplastic,6/7/2016,5/13/2016,Intravenous,carboplatin,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/8/2012,mg,antineoplastic,8/7/2012,4/24/2012,Intravenous,paclitaxel,FALSE
5,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,9/17/2019,AUC,antineoplastic,9/5/2019,7/14/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G1969F536B2DD,11/6/2011,,antineoplastic,5/25/2011,6/13/2011,Intravenous,clinical study drug,FALSE
80,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,9/30/2024,mg,antineoplastic,6/20/2024,7/11/2024,Intravenous,ipilimumab,FALSE
162,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,3/19/2019,mg,antineoplastic,11/25/2018,9/18/2018,Intravenous,carboplatin,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/6/2014,mg,antineoplastic,11/12/2014,6/13/2014,Intravenous,cisplatin,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G26D38EC278C1,7/22/2019,mg,antineoplastic,3/22/2019,2/13/2019,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/29/2019,mg,antineoplastic,4/6/2019,3/11/2019,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/15/2015,mg,antineoplastic,6/6/2015,3/5/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,5/1/2024,mg,antineoplastic,11/29/2023,9/29/2022,Intravenous,pembrolizumab,TRUE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,2/5/2022,mg,antineoplastic,10/2/2021,10/13/2021,Intravenous,paclitaxel,FALSE
2450,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G3B26D:2G114C,4/1/2019,mg,antineoplastic,2/1/2019,3/4/2019,Intravenous,gemcitabine,FALSE
150,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/6/2020,mg,antineoplastic,9/1/2019,10/16/2019,Intravenous,paclitaxel,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/17/2018,mg,antineoplastic,2/18/2018,11/4/2017,Intravenous,pemetrexed,FALSE
734,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/15/2024,mg,antineoplastic,10/10/2023,9/26/2023,Intravenous,pemetrexed,FALSE
585,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,7/5/2014,mg,antineoplastic,5/24/2014,6/5/2014,Intravenous,bevacizumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/5/2023,mg,antineoplastic,4/26/2020,2/5/2020,Intravenous,gemcitabine,FALSE
789,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,7/11/2012,mg,antineoplastic,5/30/2012,4/26/2012,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/28/2020,mg,antineoplastic,11/10/2020,5/18/2019,Intravenous,pembrolizumab,TRUE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/26/2024,mg,antineoplastic,8/23/2024,6/19/2024,Intravenous,gemcitabine,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/28/2015,mg,antineoplastic,4/14/2015,8/13/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/17/2021,mg/m2,antineoplastic,10/4/2021,3/20/2021,Intravenous,leucovorin,FALSE
915,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G18E7528ED97:,3/24/2012,mg,antineoplastic,11/14/2011,10/3/2011,Intravenous,pemetrexed,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/4/2013,AUC,antineoplastic,10/23/2012,8/2/2012,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/2/2012,mg,antineoplastic,5/22/2012,3/29/2012,Intravenous,pemetrexed,FALSE
276,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,2/27/2013,mg,antineoplastic,12/11/2012,10/12/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,8/19/2019,mg,antineoplastic,5/17/2019,4/24/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/30/2012,,antineoplastic,1/2/2012,8/12/2011,Intravenous,clinical study drug,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/20/2024,mg,antineoplastic,1/10/2021,6/23/2020,Intravenous,ipilimumab,FALSE
506.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,12/25/2018,mg,antineoplastic,9/22/2018,10/6/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Crizotinib,G1B59D86EEB5E,5/14/2020,,,5/11/2020,1/30/2020,Oral,crizotinib,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/1/2016,mg,antineoplastic,6/21/2016,7/11/2016,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/20/2021,mL,solution-fluid,5/20/2018,3/8/2018,Intravenous,durvalumab,TRUE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/16/2013,mg/m2,antineoplastic,10/6/2013,10/14/2013,Intravenous,etoposide,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/5/2021,mg,antineoplastic,1/10/2021,11/11/2020,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/22/2025,mg,antineoplastic,11/21/2023,1/1/2017,Intravenous,pembrolizumab,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/11/2020,mg,antineoplastic,8/2/2020,6/1/2020,Intravenous,paclitaxel protein-bound,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/22/2019,mg,antineoplastic,2/2/2019,12/19/2018,Intravenous,paclitaxel,FALSE
271.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/23/2015,mg,antineoplastic,3/10/2015,1/8/2015,Intravenous,carboplatin,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/18/2022,mg,antineoplastic,4/9/2022,1/15/2022,Intravenous,paclitaxel,FALSE
56,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,12/24/2019,mg,antineoplastic,11/17/2019,9/28/2019,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,1/10/2015,mg,antineoplastic,1/31/2015,9/24/2014,Intravenous,carboplatin,FALSE
634,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,5/4/2021,mg,antineoplastic,2/9/2021,2/2/2021,Intravenous,pemetrexed,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5:D955C88D97,10/9/2022,mg,antineoplastic,5/18/2019,5/31/2019,Intravenous,cisplatin,FALSE
1000,,ADJUVANT,Administrations,chemotherapy,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,3/11/2024,mg,antineoplastic,2/4/2024,12/29/2023,Intravenous,pemetrexed,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/9/2025,mg,antineoplastic,11/4/2024,11/19/2024,Intravenous,etoposide,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/21/2022,mg,antineoplastic,9/8/2021,6/30/2021,Intravenous,pemetrexed,FALSE
432.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/24/2017,mg,antineoplastic,8/19/2016,5/3/2016,Intravenous,carboplatin,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/29/2015,mg,antineoplastic,1/25/2014,1/28/2014,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,5/11/2021,mg,antineoplastic,1/27/2021,11/6/2020,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Nintedanib,G2848BE3831EF,11/5/2023,,antineoplastic,11/8/2023,10/24/2023,Oral,nintedanib,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/1/2024,mL,solution-fluid,4/16/2024,4/20/2024,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,7/1/2023,mg,antineoplastic,8/31/2022,7/20/2022,Intravenous,durvalumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,6/4/2017,mg,antineoplastic,12/17/2016,10/23/2016,Intravenous,paclitaxel protein-bound,FALSE
620,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,4/13/2025,mg,antineoplastic,3/23/2025,4/26/2025,Intravenous,durvalumab,FALSE
234,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/14/2016,mg,antineoplastic,2/11/2016,12/10/2015,Intravenous,carboplatin,FALSE
99.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/30/2021,mg,antineoplastic,5/3/2021,3/19/2021,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/3/2024,,antineoplastic,6/26/2024,6/15/2024,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/15/2020,mg,antineoplastic,7/20/2019,6/27/2019,Intravenous,paclitaxel,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/6/2025,mg,antineoplastic,1/4/2021,2/17/2020,Intravenous,pemetrexed,TRUE
300,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,5/9/2025,mg,antineoplastic,4/17/2025,1/23/2025,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/29/2020,mg,antineoplastic,12/22/2019,12/16/2019,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/26/2019,mg,antineoplastic,9/28/2018,5/7/2017,Intravenous,pemetrexed,TRUE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/1/2025,mL,solution-fluid,6/26/2024,5/9/2024,Intravenous,pembrolizumab,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,10/17/2019,mg/kg,antineoplastic,10/13/2019,6/17/2019,Intravenous,durvalumab,TRUE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/8/2012,mg,antineoplastic,8/6/2012,2/24/2012,Intravenous,docetaxel,FALSE
152,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35DE4B3:BCB8,5/9/2019,mg,antineoplastic,12/3/2016,11/9/2016,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/28/2025,,antineoplastic,2/19/2024,1/30/2023,,clinical study drug,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/2/2020,mg,antineoplastic,7/20/2019,2/21/2019,Subcutaneous,bortezomib,FALSE
2,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/10/2013,mg,antineoplastic,4/15/2013,11/16/2012,Intravenous,vincristine,FALSE
,3,ADVANCED,Unstructured,,Alectinib,G3E12EBD52F4D,8/18/2018,,,6/27/2018,5/10/2018,Oral,alectinib,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G15F6:966BBB3,6/29/2016,AUC,antineoplastic,5/14/2016,5/25/2016,Intravenous,carboplatin,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/14/2021,mg,antineoplastic,8/22/2021,8/28/2020,Intravenous,ipilimumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/2/2022,mg,antineoplastic,6/13/2022,4/8/2022,Intravenous,paclitaxel,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/13/2022,mg,antineoplastic,12/26/2018,4/4/2017,Oral,nilotinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/23/2020,mg,antineoplastic,7/17/2019,3/10/2019,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/5/2025,mg,antineoplastic,1/4/2018,12/29/2016,Intravenous,pembrolizumab,FALSE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,4/28/2019,mg,antineoplastic,3/1/2019,12/30/2018,Intravenous,bevacizumab,TRUE
830,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,4/9/2012,mg,antineoplastic,5/16/2011,5/3/2011,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G4GE2958C:E1C,4/29/2012,,steroid,9/7/2011,6/30/2011,Intrajejunal,clinical study drug,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/29/2016,mg,antineoplastic,11/14/2015,9/21/2014,Intravenous,bevacizumab,TRUE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/1/2014,mg,antineoplastic,3/21/2014,12/29/2013,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G24F68:FC41G2,4/28/2023,,,12/28/2021,1/4/2022,Oral,osimertinib,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G217694659D6F,9/22/2022,,,8/24/2022,8/11/2022,Oral,lorlatinib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,9/3/2024,,antineoplastic,7/26/2024,6/24/2024,Intravenous,paclitaxel,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,11/4/2019,mg,antineoplastic,8/20/2019,7/5/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,12/10/2021,mg,antineoplastic,8/12/2021,9/9/2021,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/16/2013,mg,antineoplastic,3/28/2012,12/15/2011,Intravenous,etoposide,FALSE
,3,ADVANCED,Unstructured,,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,4/27/2025,,,5/11/2025,12/5/2024,Oral,tepotinib,FALSE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/20/2015,mg,antineoplastic,6/3/2014,6/4/2014,Intravenous,vinorelbine,FALSE
664,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,11/6/2016,mg,antineoplastic,10/2/2016,7/2/2016,Intravenous,carboplatin,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,6/29/2017,,antineoplastic,11/20/2016,11/6/2016,Oral,clinical study drug,FALSE
200,2,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/24/2022,mg/m2,antineoplastic,10/30/2021,11/24/2021,Intravenous,leucovorin,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/20/2016,mg,antineoplastic,4/27/2016,11/4/2015,Intravenous,paclitaxel,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/24/2015,mg,antineoplastic,12/16/2014,5/31/2014,Intravenous,vinorelbine,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/17/2023,mg,antineoplastic,5/9/2022,4/29/2022,Intravenous,durvalumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/20/2025,mg,antineoplastic,1/12/2025,1/29/2023,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,11/21/2019,mg,antineoplastic,10/5/2019,8/11/2019,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/13/2023,mg,antineoplastic,4/18/2023,3/24/2023,Subcutaneous,azacitidine,FALSE
179,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,7/16/2023,mg,antineoplastic,4/11/2023,2/23/2023,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/17/2019,mg,antineoplastic,6/15/2018,3/16/2017,Intravenous,pemetrexed,TRUE
230,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/4/2016,mg,antineoplastic,7/23/2016,11/13/2015,Intravenous,nivolumab,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/1/2012,mg,antineoplastic,3/24/2012,2/17/2012,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/19/2024,mg,antineoplastic,6/18/2023,8/19/2022,Intravenous,pembrolizumab,TRUE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/20/2016,mg,antineoplastic,8/8/2016,7/13/2016,Intravenous,necitumumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/26/2023,mg,antineoplastic,10/19/2022,9/7/2022,Intravenous,pembrolizumab,TRUE
,1,LOCOREGIONAL,Administrations,immunotherapy,Clinical Study Drug,G2C233C2:5B1:,5/17/2025,,antineoplastic,1/15/2025,11/7/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/18/2025,mg,antineoplastic,3/10/2023,3/23/2020,Intravenous,pembrolizumab,FALSE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/19/2018,mg,antineoplastic,9/19/2018,6/15/2018,Intravenous,carboplatin,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/16/2020,mg,antineoplastic,8/5/2020,3/16/2020,Intravenous,docetaxel,FALSE
289,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,7/7/2023,mg,antineoplastic,7/25/2023,4/2/2023,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/11/2022,mg,antineoplastic,11/2/2020,9/18/2020,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/31/2022,mg,antineoplastic,7/28/2021,6/12/2020,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/1/2013,mg,antineoplastic,5/20/2012,12/4/2011,Intravenous,etoposide,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19:83254DDF6,8/10/2022,mg,antineoplastic,1/16/2019,1/31/2019,Intravenous,carboplatin,FALSE
191,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,1/2/2017,mg,antineoplastic,11/2/2016,11/17/2016,Intravenous,carboplatin,FALSE
484,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1G54G4GB8B24,10/13/2023,mg,antineoplastic,10/2/2022,7/25/2022,Intravenous,ramucirumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/7/2014,,antineoplastic,1/10/2014,11/15/2013,,cisplatin,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/3/2018,mg,antineoplastic,1/13/2018,11/22/2017,Intravenous,nivolumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/24/2022,mg,antineoplastic,8/25/2021,7/10/2021,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,9/21/2017,mg,antineoplastic,12/5/2016,12/13/2016,Intravenous,carboplatin,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,5/27/2019,mg,antineoplastic,4/12/2019,4/25/2019,Intravenous,carboplatin,FALSE
870,3,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,2/16/2020,mg,antineoplastic,10/24/2019,11/22/2019,Intravenous,pemetrexed,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/2/2023,mg,antineoplastic,11/22/2022,12/21/2019,Intravenous,pembrolizumab,FALSE
259.5,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,10/4/2013,mg,antineoplastic,7/12/2013,4/18/2013,Intravenous,carboplatin,FALSE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/10/2016,mg,antineoplastic,8/22/2015,11/18/2014,Intravenous,pemetrexed,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/17/2016,AUC,antineoplastic,1/19/2015,10/25/2014,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/20/2024,mg,antineoplastic,4/2/2023,11/27/2021,Intravenous,nivolumab,TRUE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/13/2021,mg,antineoplastic,9/13/2019,6/5/2019,Intravenous,carboplatin,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/20/2023,mg,antineoplastic,5/31/2019,11/13/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/5/2025,mg,antineoplastic,9/18/2024,6/20/2023,Intravenous,pembrolizumab,TRUE
1000,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G3C:F1C:2BF6C,1/25/2015,mg/m2,antineoplastic,12/7/2014,10/23/2014,Intravenous,gemcitabine,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/9/2020,mg,antineoplastic,3/7/2019,6/28/2017,Intravenous,pemetrexed,TRUE
352.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G13GE1E25174F,5/12/2022,mg,antineoplastic,4/21/2022,5/6/2022,Intravenous,carboplatin,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/4/2023,mg,antineoplastic,3/10/2023,11/10/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,2/16/2021,mg,antineoplastic,11/24/2019,10/5/2019,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,3/1/2024,mg,antineoplastic,1/19/2024,1/8/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/18/2015,,antineoplastic,4/22/2015,6/1/2015,Oral,ibrutinib,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,7/2/2023,mg,antineoplastic,4/20/2023,4/28/2023,Intravenous,cisplatin,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/28/2018,mg,antineoplastic,7/5/2018,6/25/2018,Intravenous,cisplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/26/2019,mg,antineoplastic,7/11/2019,5/9/2019,Intravenous,carboplatin,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,8/27/2014,mg,antineoplastic,8/13/2014,3/27/2014,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/24/2019,mg,antineoplastic,7/20/2017,4/22/2016,Intravenous,nivolumab,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,4/17/2020,mg,antineoplastic,3/11/2020,12/15/2019,Intravenous,carboplatin,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/11/2014,mg,antineoplastic,11/6/2014,6/1/2014,Intravenous,vinorelbine,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/25/2024,mg,antineoplastic,3/15/2022,12/22/2021,Intravenous,durvalumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/25/2020,mg,antineoplastic,9/22/2020,8/24/2020,Oral,bicalutamide,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/12/2022,mg,antineoplastic,2/15/2019,2/11/2016,Intravenous,pemetrexed,FALSE
228,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,11/19/2021,mg,antineoplastic,11/25/2021,11/12/2021,Intravenous,carboplatin,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,7/7/2019,mg,antineoplastic,4/26/2019,1/15/2019,Intravenous,durvalumab,FALSE
,,CONCURRENT,Unstructured,,Afatinib,G1B56G7791723,2/26/2022,,,3/1/2022,2/23/2022,Oral,afatinib,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,4/5/2025,mg,antineoplastic,3/24/2025,3/5/2025,Intravenous,carboplatin,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,10/20/2016,mg,antineoplastic,10/30/2016,7/9/2016,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/5/2023,mg,antineoplastic,4/28/2023,9/10/2022,Subcutaneous,azacitidine,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/11/2013,mg,antineoplastic,9/10/2012,4/17/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/13/2025,mg,antineoplastic,6/21/2023,5/27/2022,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,6/6/2023,mg,antineoplastic,11/3/2022,10/17/2022,Intravenous,pembrolizumab,FALSE
770,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/14/2017,mg,antineoplastic,6/16/2017,10/12/2016,Intravenous,pemetrexed,FALSE
757,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,9/22/2019,mg,antineoplastic,5/30/2019,3/5/2019,Intravenous,durvalumab,TRUE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,3/9/2015,mg,antineoplastic,1/17/2015,11/21/2014,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,10/29/2022,mg,antineoplastic,1/8/2022,10/27/2021,Intravenous,durvalumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/15/2021,mg,antineoplastic,8/20/2021,6/24/2021,Intravenous,paclitaxel,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/13/2019,mg,antineoplastic,6/3/2019,2/20/2019,Intravenous,paclitaxel,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/1/2023,mg,antineoplastic,8/20/2022,6/17/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/4/2025,mg,antineoplastic,10/17/2024,11/28/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/4/2025,,antineoplastic,7/22/2024,4/30/2024,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/14/2025,mg,antineoplastic,2/10/2024,3/27/2024,Intravenous,pemetrexed,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/11/2014,mg,antineoplastic,6/10/2014,3/9/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/3/2021,mg,antineoplastic,11/10/2020,10/24/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/18/2021,mg,antineoplastic,9/15/2021,9/14/2021,Intravenous,pembrolizumab,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,9/4/2021,mg,antineoplastic,9/21/2021,9/1/2021,Intravenous,cisplatin,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,9/11/2024,mg,antineoplastic,8/22/2024,7/22/2024,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G5G8G1EE2EG,8/30/2019,mg,antineoplastic,9/13/2019,9/13/2019,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,3/11/2022,,steroid,4/6/2022,12/15/2021,Oral,clinical study drug,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,6/18/2013,mg,antineoplastic,3/21/2013,12/7/2012,Intravenous,vinorelbine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,6/29/2017,mg,antineoplastic,12/15/2016,8/22/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,8/23/2020,,antineoplastic,7/11/2019,2/14/2019,,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,5/8/2021,mg,antineoplastic,11/9/2020,10/2/2020,Intravenous,nivolumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/19/2020,mg,antineoplastic,12/22/2018,11/4/2018,Intravenous,pemetrexed,TRUE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/27/2013,mg,antineoplastic,10/12/2012,8/7/2012,Intravenous,gemcitabine,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/5/2025,mg,antineoplastic,11/15/2020,2/1/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/12/2019,mg,antineoplastic,11/23/2018,2/21/2018,Intravenous,nivolumab,FALSE
228.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/12/2014,mg,antineoplastic,11/16/2014,8/23/2014,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/26/2025,mg,antineoplastic,2/26/2020,2/26/2019,Intravenous,pemetrexed,TRUE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/30/2018,mg,antineoplastic,7/13/2018,6/7/2018,Intravenous,etoposide,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/5/2018,mg,antineoplastic,3/6/2016,8/13/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/23/2020,,antineoplastic,5/26/2020,5/4/2020,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/6/2019,mg,antineoplastic,10/7/2017,8/16/2017,Intravenous,etoposide,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/25/2024,mg,antineoplastic,5/5/2024,2/27/2022,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/28/2022,mg,antineoplastic,7/12/2020,1/3/2020,Intravenous,nivolumab,FALSE
832,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,9/24/2021,mg,antineoplastic,7/21/2021,7/28/2021,Intravenous,pemetrexed,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/10/2025,mg,antineoplastic,5/18/2020,3/26/2020,Intravenous,pemetrexed,TRUE
435,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,4/15/2022,mg,antineoplastic,12/30/2021,1/17/2022,Intravenous,carboplatin,FALSE
740,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,12/10/2013,mg,antineoplastic,10/29/2013,9/20/2013,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,5/14/2025,mg,antineoplastic,1/6/2025,11/20/2024,Intravenous,pemetrexed,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,7/20/2020,mg,antineoplastic,5/25/2020,6/11/2020,Intravenous,cisplatin,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,7/17/2018,mg/kg,antineoplastic,2/13/2018,3/16/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/17/2022,mg,antineoplastic,12/31/2020,1/22/2018,Intravenous,pembrolizumab,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/15/2020,mg,antineoplastic,4/3/2020,5/6/2020,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,3/28/2018,mg,antineoplastic,11/13/2017,10/26/2017,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G2DCF3C5B462B,1/8/2023,mL,solution-fluid,10/8/2022,10/13/2022,Intravenous,cisplatin,FALSE
1137,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,7/28/2023,mg,antineoplastic,5/25/2023,2/19/2023,Intravenous,bevacizumab-bvzr,FALSE
500,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,2/20/2025,mg,antineoplastic,2/6/2025,11/25/2024,Intravenous,carboplatin,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/13/2017,mg,antineoplastic,7/30/2017,7/17/2017,Intravenous,etoposide,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,7/2/2020,mg,antineoplastic,5/16/2020,3/22/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,3/20/2023,mg,antineoplastic,2/2/2023,1/22/2023,Intravenous,pembrolizumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,9/3/2019,mg,antineoplastic,7/4/2019,4/29/2019,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/10/2025,mg/m2,antineoplastic,7/29/2024,6/28/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,1/21/2025,mg,antineoplastic,10/21/2024,9/29/2024,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/31/2022,,antineoplastic,12/8/2022,10/1/2022,Oral,imatinib,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/26/2021,mg,antineoplastic,1/25/2019,11/7/2018,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/11/2021,mg,antineoplastic,9/6/2019,11/17/2018,Intravenous,pembrolizumab,TRUE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/16/2020,mg,antineoplastic,11/18/2019,8/21/2019,Intravenous,durvalumab,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/21/2024,mg,antineoplastic,2/24/2024,11/13/2023,Intravenous,durvalumab,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/10/2013,mg,antineoplastic,5/19/2012,4/9/2012,Intravenous,paclitaxel,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/1/2018,mg,antineoplastic,1/27/2016,9/20/2015,Intravenous,nivolumab,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/28/2014,mg/kg,antineoplastic,6/2/2014,12/10/2013,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G47CG7D:EEG,7/20/2018,mg/m2,antineoplastic,7/1/2018,5/15/2018,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G15517:BF5DE4,7/31/2023,mg,antineoplastic,12/19/2022,12/3/2022,Intravenous,durvalumab,TRUE
1000,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/7/2017,mg,antineoplastic,3/17/2017,4/14/2017,Intravenous,pemetrexed,FALSE
736,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/25/2025,mg,antineoplastic,2/11/2025,4/6/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/25/2025,mg,antineoplastic,10/17/2018,4/17/2018,Intravenous,pembrolizumab,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/28/2022,mg,antineoplastic,6/30/2021,6/23/2021,Intravenous,bevacizumab-bvzr,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/28/2015,mL,solution-fluid,5/25/2015,2/15/2015,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/10/2022,mg,antineoplastic,1/29/2019,4/10/2017,Intravenous,nivolumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/14/2016,mg,antineoplastic,11/7/2015,10/8/2015,Intravenous,etoposide,FALSE
1325,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/5/2015,mg,antineoplastic,2/16/2015,1/6/2015,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/11/2017,mg,antineoplastic,3/18/2017,8/27/2016,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/12/2019,mg,antineoplastic,10/2/2017,4/15/2017,Intravenous,pemetrexed,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/4/2019,mg,antineoplastic,4/25/2019,3/16/2016,Intravenous,nivolumab,FALSE
1145,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/8/2015,mg,antineoplastic,6/5/2015,1/24/2015,Intravenous,bevacizumab,FALSE
217.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/27/2015,mg,antineoplastic,5/7/2015,4/9/2015,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/23/2019,mg,antineoplastic,5/22/2019,3/7/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1:F21E8E2D45,3/21/2024,,,6/18/2023,6/16/2023,Oral,osimertinib,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,11/2/2015,mg,antineoplastic,9/19/2015,2/11/2015,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D891287D6B:,12/10/2020,mg,antineoplastic,9/23/2020,7/1/2020,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,1/25/2015,mg,antineoplastic,10/1/2014,8/31/2014,Intravenous,docetaxel,FALSE
450,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/20/2020,mg,antineoplastic,3/16/2020,3/17/2020,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,12/20/2020,mg,antineoplastic,3/20/2020,9/3/2019,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/16/2016,mg,antineoplastic,8/13/2016,6/22/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,7/28/2023,mg,antineoplastic,5/16/2023,3/11/2022,Intravenous,pembrolizumab,TRUE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,3/7/2025,mg,antineoplastic,10/27/2024,11/13/2024,Intravenous,pemetrexed,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,11/10/2013,mg,antineoplastic,10/18/2013,6/19/2013,Intravenous,pemetrexed,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,5/26/2015,mg,antineoplastic,5/2/2015,3/5/2015,Intravenous,vinorelbine,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/17/2021,mg,antineoplastic,9/14/2020,5/31/2020,Intravenous,docetaxel,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/31/2015,mg,antineoplastic,5/14/2015,6/9/2015,Intravenous,cisplatin,FALSE
98,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,10/28/2017,mg,antineoplastic,9/30/2017,8/17/2017,Intravenous,paclitaxel,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/25/2021,mg,antineoplastic,10/25/2021,9/5/2021,Intravenous,paclitaxel,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,11/11/2015,mg,antineoplastic,5/16/2015,2/22/2015,Intravenous,pemetrexed,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/21/2024,mg,antineoplastic,5/6/2023,2/20/2023,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/19/2019,mg,antineoplastic,9/16/2017,4/29/2017,Intravenous,pemetrexed,TRUE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/6/2018,mg,antineoplastic,11/19/2018,10/13/2018,Intravenous,carboplatin,FALSE
384,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/1/2024,mg,antineoplastic,10/5/2024,7/30/2024,Intravenous,paclitaxel,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/25/2025,mL,solution-fluid,4/10/2024,5/8/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/30/2024,mg,antineoplastic,5/4/2023,12/11/2022,Intravenous,nivolumab,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/13/2017,mg,antineoplastic,7/21/2016,4/25/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/25/2019,mg,antineoplastic,8/16/2019,7/19/2019,Intravenous,pembrolizumab,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,10/20/2019,mg,antineoplastic,8/8/2019,7/6/2019,Intravenous,carboplatin,FALSE
185.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,1/31/2017,mg,antineoplastic,12/21/2016,11/27/2016,Intravenous,carboplatin,FALSE
108,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,12/13/2016,mg,antineoplastic,6/30/2016,4/29/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/4/2020,mg,antineoplastic,4/16/2020,6/1/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G59243DC543:8,10/24/2024,,,7/24/2024,8/19/2024,Oral,alectinib,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/8/2013,mg,antineoplastic,10/2/2013,9/10/2013,Intravenous,paclitaxel,FALSE
1316,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/17/2015,mg,antineoplastic,3/17/2015,11/9/2014,Intravenous,bevacizumab,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/23/2017,mg,antineoplastic,7/11/2016,4/18/2016,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,4/7/2025,mg,antineoplastic,3/25/2025,3/21/2025,Intravenous,carboplatin,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BG:7FD7572:,11/24/2017,mg,antineoplastic,10/10/2017,8/22/2017,Intravenous,carboplatin,FALSE
486.6,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,12/25/2014,mg,antineoplastic,11/30/2014,10/18/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/22/2020,mg,antineoplastic,9/21/2020,5/12/2019,Intravenous,pembrolizumab,TRUE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/16/2016,mg,antineoplastic,6/4/2016,7/17/2016,Intravenous,paclitaxel,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,3/1/2021,mg,antineoplastic,1/22/2021,12/21/2020,Intravenous,paclitaxel,FALSE
760,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/6/2024,mg,antineoplastic,5/27/2024,3/20/2024,Intravenous,carboplatin,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/16/2022,mg,antineoplastic,10/2/2021,9/2/2021,Intravenous,paclitaxel,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/23/2017,mg,antineoplastic,4/29/2017,4/22/2017,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Orders,glucocorticoid,Clinical Study Drug,G1DCDG73E53FF,7/1/2024,,steroid,4/17/2024,6/3/2024,,clinical study drug,FALSE
620,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,7/13/2020,mg,antineoplastic,5/22/2020,4/23/2020,Intravenous,pemetrexed,FALSE
790,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/20/2020,mg,antineoplastic,3/6/2016,2/26/2016,Intravenous,pemetrexed,TRUE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/19/2020,mL,solution-fluid,6/1/2019,3/4/2019,Intravenous,nivolumab,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/12/2016,mg,antineoplastic,11/17/2014,12/3/2014,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Capmatinib,Erlotinib",G12E5EG31:6:5,11/5/2022,,,11/14/2022,9/25/2022,Oral,erlotinib,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/8/2017,mg,antineoplastic,10/10/2016,9/30/2016,Intravenous,paclitaxel,FALSE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,10/31/2018,mg,antineoplastic,10/21/2018,9/1/2018,Intravenous,paclitaxel,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G24167D1DD5FG,4/26/2025,mg,antineoplastic,5/10/2025,2/3/2025,Intravenous,durvalumab,TRUE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/4/2025,mg,antineoplastic,4/23/2016,12/3/2015,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/31/2018,AUC,antineoplastic,10/14/2017,10/7/2017,Intravenous,carboplatin,FALSE
613,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1GG86B599E79,4/20/2015,mg,antineoplastic,12/21/2014,11/8/2014,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/13/2015,mg,antineoplastic,8/20/2015,4/10/2015,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/19/2014,mg,antineoplastic,4/26/2014,4/4/2014,Intravenous,paclitaxel protein-bound,FALSE
,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,11/29/2024,,antineoplastic,6/19/2024,6/9/2024,,pembrolizumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,9/16/2018,mg,antineoplastic,8/8/2018,8/23/2018,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/17/2023,mg,antineoplastic,6/14/2023,5/4/2023,Subcutaneous,azacitidine,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/3/2022,,antineoplastic,3/11/2022,1/11/2022,Intravenous,paclitaxel,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,7/29/2023,mg,antineoplastic,6/9/2023,5/27/2023,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/8/2022,mg,antineoplastic,4/14/2022,7/1/2021,Intravenous,pembrolizumab,FALSE
1642,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,5/13/2014,mg,antineoplastic,3/13/2014,3/11/2014,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/15/2017,mg,antineoplastic,1/17/2017,10/5/2016,Intravenous,nivolumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/14/2024,mg,antineoplastic,1/26/2021,7/16/2020,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/27/2017,mg,antineoplastic,2/14/2017,4/4/2016,Intravenous,nivolumab,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/5/2024,mg,antineoplastic,4/7/2024,2/20/2024,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,2/26/2020,mg,antineoplastic,6/8/2019,6/8/2019,Intravenous,paclitaxel,FALSE
660,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,4/17/2022,mg,antineoplastic,2/14/2022,1/12/2022,Intravenous,carboplatin,FALSE
288.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,5/2/2015,mg,antineoplastic,11/30/2014,11/22/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,5/2/2021,mg,antineoplastic,3/22/2021,12/29/2020,Intravenous,pembrolizumab,FALSE
489.6,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/18/2022,mg,antineoplastic,11/9/2021,10/10/2021,Intravenous,leucovorin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G266E6248F531,7/23/2018,mg,antineoplastic,4/16/2018,2/28/2018,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/6/2025,,antineoplastic,2/20/2025,3/1/2023,,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,2/3/2018,mg,antineoplastic,9/21/2017,7/8/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/11/2018,mg,antineoplastic,3/28/2017,3/22/2017,Intravenous,pembrolizumab,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,2/15/2013,mg,antineoplastic,3/13/2013,3/1/2013,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G579E53D92:75,11/17/2011,,steroid,10/5/2011,8/26/2011,Intravenous,clinical study drug,FALSE
1650,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G2FF2946:4C6F,7/8/2018,mg,antineoplastic,5/23/2018,4/15/2018,Intravenous,gemcitabine,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/25/2025,mg,antineoplastic,1/17/2016,12/19/2015,Intravenous,carboplatin,FALSE
376,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/17/2020,mg,antineoplastic,9/5/2020,5/23/2020,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,5/17/2024,6/19/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/14/2012,,antineoplastic,11/17/2011,10/18/2011,Intravenous,clinical study drug,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,4/11/2024,mg,antineoplastic,5/8/2024,2/23/2024,Intravenous,nivolumab,FALSE
750,2,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,6/9/2014,mg/m2,antineoplastic,4/29/2014,2/23/2014,Intravenous,gemcitabine,FALSE
2,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,6/4/2013,mg,antineoplastic,4/26/2013,11/16/2012,Intravenous,vincristine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/16/2024,mg,antineoplastic,11/23/2023,8/18/2023,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/20/2020,,antineoplastic,7/7/2020,5/31/2020,Intravenous,pemetrexed,FALSE
870,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/3/2020,mg,antineoplastic,2/21/2019,3/22/2019,Intravenous,durvalumab,FALSE
467.2,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/30/2025,mg,antineoplastic,9/21/2019,3/17/2019,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/30/2023,,,1/10/2023,11/6/2022,Oral,alectinib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/8/2021,,antineoplastic,6/2/2021,5/14/2021,Intravenous,pembrolizumab,FALSE
528,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,1/2/2023,mg,antineoplastic,5/12/2022,4/5/2022,Intravenous,carboplatin,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/12/2023,mg,antineoplastic,6/29/2023,7/17/2023,Intravenous,paclitaxel,FALSE
60,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G1G618861EGD9,8/9/2016,mg,antineoplastic,8/15/2016,8/1/2016,Intravenous,cisplatin,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/25/2022,mg,antineoplastic,3/13/2022,8/16/2021,Intravenous,amivantamab-vmjw,FALSE
243,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/3/2021,mg,antineoplastic,6/24/2019,6/27/2019,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G517B45372B5D,5/22/2020,mg,antineoplastic,5/28/2020,3/22/2020,Intravenous,pemetrexed,FALSE
698,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/11/2016,mg,antineoplastic,6/26/2015,6/4/2015,Intravenous,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/22/2025,mg,antineoplastic,1/13/2020,2/9/2019,Intravenous,pemetrexed,TRUE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/19/2019,mg/kg,antineoplastic,5/5/2019,9/14/2018,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/13/2021,mg,antineoplastic,9/28/2019,5/4/2019,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel,Ipilimumab,Nivolumab",G1C679D8145C1,4/17/2022,,antineoplastic,5/16/2022,5/12/2022,Intravenous,docetaxel,FALSE
2220,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1B2469295BGE,3/7/2014,mg,antineoplastic,1/18/2014,2/6/2014,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/16/2022,mg,antineoplastic,11/4/2020,1/29/2018,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/15/2019,mg,antineoplastic,8/24/2018,8/28/2017,Intravenous,atezolizumab,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/4/2021,mg,antineoplastic,11/20/2020,8/6/2020,Intravenous,doxorubicin,FALSE
416,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,12/15/2021,mg,antineoplastic,11/8/2021,8/27/2021,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/30/2019,mg,antineoplastic,6/26/2018,7/12/2018,Intravenous,irinotecan,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/16/2020,mg,antineoplastic,10/10/2019,10/4/2019,Intravenous,pemetrexed,TRUE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/17/2024,mg,antineoplastic,4/12/2022,11/25/2021,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,8/3/2024,mg,antineoplastic,5/3/2024,4/25/2024,Intravenous,pembrolizumab,TRUE
800,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G445B:B:15B5F,12/5/2014,mg/m2,antineoplastic,10/9/2014,9/20/2014,Intravenous,gemcitabine,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/16/2024,mg,antineoplastic,9/20/2023,9/21/2023,Intravenous,nivolumab,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/6/2019,mg,antineoplastic,2/26/2019,1/27/2019,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,1/28/2018,AUC,antineoplastic,11/9/2017,9/4/2017,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/2/2025,,antineoplastic,12/28/2023,3/23/2020,Oral,enzalutamide,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/13/2025,mg,antineoplastic,1/14/2024,9/9/2023,Intravenous,atezolizumab,FALSE
500,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/18/2013,mg,antineoplastic,10/15/2013,7/18/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,1/19/2024,mg,antineoplastic,7/28/2023,7/26/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,5/4/2019,mg,antineoplastic,1/16/2019,12/25/2018,Intravenous,pembrolizumab,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/13/2016,mg,antineoplastic,7/22/2015,5/1/2015,Intravenous,gemcitabine,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,5/30/2012,mg,antineoplastic,3/27/2012,1/20/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/9/2015,,antineoplastic,3/17/2015,2/20/2015,,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/12/2017,mg,antineoplastic,1/29/2014,1/9/2014,Intravenous,cisplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/15/2020,mg,antineoplastic,11/1/2019,9/10/2019,Intravenous,durvalumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,4/12/2021,AUC,antineoplastic,12/27/2019,9/14/2019,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,5/20/2025,mg,antineoplastic,2/16/2025,12/17/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,2/15/2024,mg,antineoplastic,12/28/2023,10/14/2023,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/10/2022,,antineoplastic,3/7/2022,3/4/2022,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/17/2016,mg,antineoplastic,8/24/2016,7/8/2016,Intravenous,carboplatin,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/13/2019,mg,antineoplastic,8/20/2019,6/22/2019,Intravenous,carboplatin,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,4/17/2018,mg,antineoplastic,5/30/2018,3/22/2018,Intravenous,pemetrexed,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/2/2017,mg,antineoplastic,8/1/2016,5/30/2016,Intravenous,paclitaxel protein-bound,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/22/2023,mg,antineoplastic,6/1/2023,3/22/2023,Intravenous,paclitaxel,FALSE
950,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,2/4/2025,mg,antineoplastic,12/23/2024,10/28/2024,Intravenous,pemetrexed,FALSE
433,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/6/2013,mg,antineoplastic,3/22/2012,4/11/2012,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/19/2025,mg,antineoplastic,11/12/2024,6/17/2024,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/24/2019,mg,antineoplastic,10/15/2019,7/30/2019,Intravenous,cisplatin,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G31:9DD57G8:5,3/15/2013,AUC,antineoplastic,3/19/2013,3/27/2013,Intravenous,carboplatin,FALSE
144,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/3/2017,mg,antineoplastic,11/2/2017,8/13/2017,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,3/12/2017,,antineoplastic,3/7/2017,3/20/2017,Oral,hydroxyurea,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/13/2020,mg,antineoplastic,3/25/2020,1/30/2020,Intravenous,pemetrexed,FALSE
394,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,12/28/2023,mg,antineoplastic,12/22/2023,10/11/2023,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/7/2022,mg,antineoplastic,2/10/2018,4/19/2017,Oral,dasatinib,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/16/2013,mg,antineoplastic,10/25/2012,7/9/2012,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/26/2021,mg,antineoplastic,1/16/2021,12/17/2020,Intravenous,cisplatin,FALSE
,1,LOCOREGIONAL,Administrations,immunotherapy,Clinical Study Drug,G2C233C2:5B1:,4/30/2025,,antineoplastic,4/24/2025,12/29/2024,Intravenous,clinical study drug,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/8/2020,mg,antineoplastic,8/29/2019,4/1/2019,Intravenous,durvalumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G2D5B71G65F2G,3/15/2016,mg,antineoplastic,9/8/2015,8/4/2015,Intravenous,docetaxel,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/20/2024,mg,antineoplastic,8/29/2024,8/30/2024,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Unstructured,,Afatinib,G26C72D6F6G:5,8/6/2020,,,4/7/2020,4/8/2020,Oral,afatinib,FALSE
600,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/30/2019,mg,antineoplastic,7/30/2019,7/16/2019,Intravenous,fluorouracil,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/20/2025,mg,antineoplastic,2/28/2016,11/14/2015,Intravenous,carboplatin,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/13/2019,mg,antineoplastic,4/20/2018,2/24/2018,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/29/2025,mg,antineoplastic,7/30/2024,4/13/2024,Intravenous,pembrolizumab,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/23/2012,mg,antineoplastic,2/29/2012,1/11/2012,Subcutaneous,amifostine,FALSE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,8/31/2017,mg,antineoplastic,8/16/2017,6/1/2017,Intravenous,docetaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/3/2024,mg,antineoplastic,4/7/2024,4/3/2023,Intravenous,nivolumab,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/25/2016,mg,antineoplastic,7/4/2016,6/8/2016,Intravenous,paclitaxel,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/1/2025,mg,antineoplastic,11/22/2019,2/24/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/28/2020,mg,antineoplastic,2/24/2020,12/22/2018,Intravenous,pembrolizumab,FALSE
237.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,8/2/2021,mg,antineoplastic,6/25/2021,6/12/2021,Intravenous,carboplatin,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,3/7/2013,mg,antineoplastic,5/15/2012,4/4/2012,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,7/26/2018,,antineoplastic,8/4/2018,8/4/2018,Intravenous,gemcitabine,FALSE
65,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/21/2022,mg,antineoplastic,2/6/2022,2/12/2022,Intravenous,paclitaxel,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,7/3/2015,mg,antineoplastic,7/12/2013,7/10/2013,Intravenous,paclitaxel,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/3/2025,mg,antineoplastic,5/14/2017,12/13/2016,Intravenous,pembrolizumab,FALSE
311,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,11/11/2024,mg,antineoplastic,10/13/2024,7/21/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/9/2019,mg,antineoplastic,4/26/2019,2/24/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,11/20/2019,mg,antineoplastic,11/8/2019,10/7/2019,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,3/24/2025,mL,solution-fluid,4/23/2025,3/24/2024,Intravenous,pembrolizumab,FALSE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/19/2018,mg,antineoplastic,4/30/2018,3/26/2018,Intravenous,paclitaxel,FALSE
158,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,11/22/2019,mg,antineoplastic,11/23/2019,10/1/2019,Intravenous,carboplatin,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,9/19/2018,mg,antineoplastic,6/18/2018,4/19/2018,Intravenous,carboplatin,FALSE
547,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,12/31/2014,mg,antineoplastic,11/7/2014,8/18/2014,Intravenous,carboplatin,FALSE
1165,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,4/13/2016,mg,antineoplastic,1/3/2016,12/10/2015,Intravenous,bevacizumab,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/15/2019,mg,antineoplastic,11/8/2018,6/21/2018,Other/Miscellaneous,fluorouracil,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,4/23/2020,mg,antineoplastic,3/6/2018,12/27/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,4/17/2021,,antineoplastic,7/6/2020,2/6/2020,Intravenous,clinical study drug,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,8/17/2016,mg,antineoplastic,4/23/2016,4/14/2016,Intravenous,paclitaxel,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/8/2021,mg,antineoplastic,11/18/2020,9/27/2020,Oral,bicalutamide,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,5/23/2022,mg,antineoplastic,1/5/2022,11/7/2021,Intravenous,pemetrexed,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/28/2023,mg,antineoplastic,7/1/2018,12/4/2017,Intravenous,nivolumab,FALSE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/19/2013,mg,antineoplastic,5/19/2013,4/6/2013,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Nivolumab,G35DE4B3:BCB8,10/27/2016,mg,antineoplastic,9/22/2016,9/10/2016,Intravenous,pemetrexed,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,7/29/2021,mg,antineoplastic,2/7/2021,10/4/2020,Intravenous,gemcitabine,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,4/6/2025,AUC,antineoplastic,4/22/2024,12/2/2022,Intravenous,carboplatin,FALSE
104,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/19/2017,mg,antineoplastic,5/26/2017,6/3/2017,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/29/2016,mg,antineoplastic,9/29/2015,8/21/2015,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/18/2020,mg,antineoplastic,12/31/2019,6/26/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/17/2024,mg,antineoplastic,6/21/2023,9/14/2022,Intravenous,pembrolizumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,9/26/2024,mg,antineoplastic,10/8/2024,7/28/2024,Intravenous,pemetrexed,FALSE
1430,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/4/2020,mg,antineoplastic,3/15/2014,3/18/2014,Intravenous,cyclophosphamide,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/3/2019,mg,antineoplastic,7/6/2018,3/2/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/6/2022,,antineoplastic,8/10/2020,4/15/2017,Oral,nilotinib,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/29/2021,mg,antineoplastic,7/21/2021,5/3/2020,Intravenous,gemcitabine,FALSE
815,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,11/6/2022,mg,antineoplastic,11/8/2022,10/31/2022,Intravenous,pemetrexed,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/17/2015,mg,antineoplastic,3/30/2015,2/2/2015,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G1:F129FBCE3F,5/26/2020,,antineoplastic,2/22/2020,3/8/2020,Oral,hydroxyurea,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/13/2025,mg,antineoplastic,9/7/2021,5/6/2020,Subcutaneous,leuprolide,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,5/27/2019,mg,antineoplastic,6/4/2019,3/28/2019,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/9/2020,mg,antineoplastic,11/25/2019,3/6/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,4/3/2021,,antineoplastic,10/24/2020,2/16/2020,Intravenous,clinical study drug,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/19/2012,mg,antineoplastic,4/5/2012,3/9/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/8/2020,mg,antineoplastic,5/31/2020,6/12/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,10/28/2022,mg,antineoplastic,10/4/2018,12/31/2017,Intravenous,pembrolizumab,FALSE
68,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,9/15/2021,mg,antineoplastic,9/27/2021,9/7/2021,Intravenous,paclitaxel,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/26/2016,mg,antineoplastic,11/29/2015,9/3/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/8/2021,mg,antineoplastic,3/19/2020,10/12/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,9/6/2017,,antineoplastic,7/17/2017,7/5/2017,Intravenous,ramucirumab,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,3/22/2025,,,3/24/2025,6/30/2024,Oral,trametinib,FALSE
1940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/25/2018,mg,antineoplastic,7/15/2018,4/16/2018,Intravenous,gemcitabine,FALSE
578.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,5/24/2022,mg,antineoplastic,3/29/2022,1/3/2022,Intravenous,carboplatin,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/3/2016,mg,antineoplastic,8/11/2016,7/11/2016,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/9/2025,mg,antineoplastic,9/28/2024,6/3/2024,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,2/4/2017,,antineoplastic,12/28/2016,12/20/2016,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,5/18/2023,,antineoplastic,4/5/2023,2/12/2023,Intravenous,bevacizumab-awwb,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/23/2019,mg,antineoplastic,11/23/2018,10/16/2018,Intravenous,pembrolizumab,FALSE
411,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,2/24/2023,mg,antineoplastic,1/11/2023,11/24/2022,Intravenous,carboplatin,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,10/4/2024,mg,antineoplastic,3/19/2023,5/22/2022,Intravenous,durvalumab,TRUE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/9/2024,mg,antineoplastic,11/5/2023,6/27/2023,Intravenous,paclitaxel protein-bound,FALSE
420,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,11/18/2014,mg,antineoplastic,12/31/2014,10/26/2014,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/27/2020,mg,antineoplastic,6/14/2018,12/24/2015,Intravenous,nivolumab,FALSE
263,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/12/2015,mg,antineoplastic,6/4/2015,2/18/2015,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G128:92:3BD3D,12/28/2021,,antiemetic,4/1/2021,4/1/2021,Intravenous,clinical study drug,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/17/2021,mg,antineoplastic,7/25/2021,9/27/2020,Intravenous,durvalumab,FALSE
900,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38GE:9D51587,8/22/2012,mg,antineoplastic,2/23/2012,2/17/2012,Intravenous,bevacizumab,FALSE
174,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,8/7/2023,mg,antineoplastic,4/19/2023,5/5/2023,Intravenous,carboplatin,FALSE
795,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,4/22/2016,mg,antineoplastic,4/5/2016,2/19/2016,Intravenous,pemetrexed,FALSE
85,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,4/24/2015,mg,antineoplastic,4/19/2015,5/14/2015,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,9/21/2022,mg,antineoplastic,4/21/2022,9/14/2021,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/1/2025,mg,antineoplastic,1/20/2020,2/21/2019,Intravenous,pembrolizumab,TRUE
110,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G47DB481E783:,3/28/2025,mg,antineoplastic,3/7/2025,1/22/2025,Intravenous,docetaxel,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,12/2/2015,mg,antineoplastic,3/15/2015,1/30/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,3/26/2024,,pain agent,10/18/2023,6/17/2023,Oral,clinical study drug,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,9/27/2023,mg,antineoplastic,12/18/2022,12/19/2022,Intravenous,atezolizumab,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/20/2020,mg,antineoplastic,5/11/2020,10/7/2019,Intravenous,durvalumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/11/2018,mL,solution-fluid,2/11/2018,12/30/2017,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/6/2024,,antineoplastic,2/12/2024,2/4/2024,,cisplatin,FALSE
71,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/17/2025,mg,antineoplastic,1/17/2025,9/21/2024,Intravenous,ipilimumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/29/2013,mg,antineoplastic,7/13/2013,2/11/2013,Intravenous,paclitaxel protein-bound,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/30/2025,mg,antineoplastic,3/27/2025,10/29/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,4/27/2020,mg,antineoplastic,1/19/2020,1/28/2020,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/12/2019,mg,antineoplastic,12/30/2018,9/15/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,9/9/2020,mg,antineoplastic,9/4/2020,4/20/2020,Intravenous,pembrolizumab,TRUE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,1/28/2019,mg,antineoplastic,1/12/2019,1/3/2019,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/8/2024,mg,antineoplastic,12/23/2023,7/26/2023,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Orders,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/25/2025,mg,antineoplastic,4/17/2025,9/24/2024,Intravenous,nivolumab,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,7/14/2021,,antineoplastic,6/12/2021,3/19/2021,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,Pembrolizumab,G1195EGCD:B45,6/1/2024,mL,solution-fluid,4/22/2024,6/18/2024,Intravenous,pembrolizumab,TRUE
582,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/7/2024,mg,antineoplastic,1/21/2024,2/3/2024,Intravenous,carboplatin,FALSE
567,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,2/22/2024,mg,antineoplastic,12/7/2023,11/2/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,4/19/2025,mg,antineoplastic,3/17/2025,8/11/2024,Intravenous,pembrolizumab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,7/4/2013,mg/m2,antineoplastic,12/17/2012,6/27/2012,Intravenous,docetaxel,FALSE
545,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,12/16/2014,mg,antineoplastic,10/25/2014,10/12/2014,Intravenous,carboplatin,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/25/2023,mg,antineoplastic,8/19/2023,7/27/2023,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,1/20/2021,mg,antineoplastic,6/13/2020,5/17/2020,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,1/31/2017,mg,antineoplastic,1/21/2017,11/9/2016,Intravenous,docetaxel,FALSE
240,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/11/2019,mg,antineoplastic,6/26/2019,8/3/2019,Intravenous,irinotecan,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/6/2022,mg,antineoplastic,7/14/2021,5/22/2021,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/25/2020,mg,antineoplastic,11/6/2019,12/18/2017,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G1969F536B2DD,11/16/2011,,antiemetic,7/4/2011,7/4/2011,Intravenous,clinical study drug,FALSE
180,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G14FD45889171,12/7/2015,mg,antineoplastic,10/8/2015,11/8/2015,Intravenous,nivolumab,FALSE
609,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,5/11/2024,mg,antineoplastic,1/28/2024,2/3/2024,Intravenous,carboplatin,FALSE
45,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,1/29/2023,mg/m2,antineoplastic,12/12/2022,10/5/2022,Intravenous,paclitaxel,FALSE
404,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/9/2017,mg,antineoplastic,1/31/2017,11/9/2016,Intravenous,carboplatin,FALSE
596,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/17/2016,mg,antineoplastic,6/17/2016,5/30/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/14/2020,mg,antineoplastic,1/13/2019,12/14/2018,Intravenous,pembrolizumab,TRUE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/18/2025,mg,antineoplastic,9/25/2024,9/10/2023,Intravenous,atezolizumab,FALSE
200,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,1/11/2023,mg,antineoplastic,11/1/2022,10/23/2022,Intravenous,carboplatin,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/22/2024,mg,antineoplastic,1/23/2024,10/31/2023,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/27/2025,mg,antineoplastic,6/19/2022,1/16/2017,Intravenous,pembrolizumab,FALSE
400,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,4/29/2022,mg,antineoplastic,2/16/2022,3/2/2022,Intravenous,pembrolizumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/29/2020,mg,antineoplastic,10/12/2019,10/10/2019,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/4/2025,,antineoplastic,2/16/2018,11/4/2017,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/2/2020,mg,antineoplastic,5/20/2017,1/31/2016,Intravenous,bevacizumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/12/2024,mg,antineoplastic,11/1/2024,12/10/2023,Intravenous,durvalumab,FALSE
74,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,4/30/2024,mg,antineoplastic,4/11/2024,2/22/2024,Intravenous,paclitaxel,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/12/2022,mg,antineoplastic,2/19/2022,12/13/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/9/2025,mg,antineoplastic,3/14/2024,4/8/2020,Intravenous,pembrolizumab,FALSE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,11/27/2019,mg,antineoplastic,12/9/2019,10/26/2019,Intravenous,docetaxel,FALSE
465,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/6/2014,mg,antineoplastic,5/24/2014,4/9/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/30/2019,mg,antineoplastic,5/15/2017,4/5/2016,Intravenous,nivolumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/7/2025,mg,antineoplastic,1/22/2025,11/23/2024,Intravenous,durvalumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/5/2014,mg,antineoplastic,12/25/2013,11/26/2013,Intravenous,carboplatin,FALSE
320,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,3/22/2025,mg,antineoplastic,2/7/2025,12/14/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,10/4/2022,mg,antineoplastic,4/22/2022,2/4/2022,Intravenous,pembrolizumab,FALSE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,5/23/2017,mg,antineoplastic,3/16/2016,12/3/2015,Intravenous,nivolumab,FALSE
360,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/1/2016,mg,antineoplastic,7/10/2016,7/4/2016,Intravenous,paclitaxel,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/22/2024,mg,antineoplastic,4/24/2024,3/11/2024,Intravenous,gemcitabine,FALSE
131,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,7/2/2024,mg,antineoplastic,5/2/2024,4/29/2024,Intravenous,etoposide,FALSE
112,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/23/2023,mg,antineoplastic,2/23/2023,2/24/2023,Intravenous,carboplatin,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/21/2025,mg,antineoplastic,5/21/2022,2/18/2020,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/2/2020,,antineoplastic,5/31/2020,5/4/2020,Intravenous,cisplatin,FALSE
201,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,7/9/2016,mg,antineoplastic,4/5/2016,4/21/2016,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/16/2021,mg,antineoplastic,12/20/2018,12/5/2018,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/26/2025,mg,antineoplastic,11/29/2024,5/30/2023,Intravenous,pembrolizumab,FALSE
1035,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,12/17/2024,mg,antineoplastic,5/25/2024,5/6/2024,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/21/2018,mg,antineoplastic,8/7/2018,5/29/2018,Intravenous,gemcitabine,FALSE
130,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,4/21/2019,mg,antineoplastic,3/13/2019,2/27/2019,Intravenous,carboplatin,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/15/2012,mg,antineoplastic,12/9/2011,8/21/2011,Intravenous,vinorelbine,FALSE
184,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,6/28/2023,mg,antineoplastic,6/21/2023,6/2/2023,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/26/2021,mg,antineoplastic,7/7/2021,5/2/2021,Intravenous,pembrolizumab,FALSE
88,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,1/28/2023,mg,antineoplastic,10/17/2022,10/22/2022,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,4/18/2019,mg,antineoplastic,12/21/2018,8/18/2018,Intravenous,nivolumab,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,4/2/2024,mg,antineoplastic,3/30/2024,2/28/2024,Intravenous,carboplatin,FALSE
485,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,2/7/2019,mg,antineoplastic,2/8/2019,11/18/2018,Intravenous,pemetrexed,FALSE
313,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,8/10/2013,mg,antineoplastic,2/28/2013,2/6/2013,Intravenous,carboplatin,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4C88CEG2:289,1/25/2025,mg,antineoplastic,2/3/2025,1/20/2025,Intravenous,carboplatin,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/15/2014,mg,antineoplastic,9/24/2014,5/22/2014,Intravenous,vinorelbine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,2/1/2018,mg,antineoplastic,10/5/2017,5/28/2017,Intravenous,nivolumab,FALSE
90,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G54F545489E59,10/3/2023,mg,antineoplastic,4/18/2023,3/6/2023,Intravenous,docetaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/5/2016,mg,antineoplastic,4/1/2015,4/9/2015,Intravenous,carboplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/11/2019,mg,antineoplastic,9/24/2018,7/25/2018,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,6/4/2012,mg,antineoplastic,4/3/2012,3/8/2012,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/3/2025,mg,antineoplastic,7/2/2023,8/5/2021,Intravenous,atezolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,3/30/2025,,antineoplastic,9/16/2023,3/26/2022,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/10/2021,mg/m2,antineoplastic,8/1/2021,3/20/2021,Intravenous,fluorouracil,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2F327FD5:2:3,3/14/2025,mg,antineoplastic,3/29/2025,4/17/2025,Intravenous,docetaxel,FALSE
245,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,3/3/2021,mg,antineoplastic,12/21/2020,12/17/2020,Intravenous,carboplatin,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,11/30/2024,mg,antineoplastic,10/20/2024,9/13/2024,Intravenous,durvalumab,TRUE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/15/2025,mg,antineoplastic,9/11/2024,3/30/2024,Intravenous,amivantamab-vmjw,FALSE
1500,1,ADVANCED,Orders,immunotherapy,Durvalumab,G212D32:BD3B6,10/2/2021,mg,antineoplastic,9/24/2021,8/27/2021,Intravenous,durvalumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,7/30/2024,mg,antineoplastic,3/20/2023,2/23/2023,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/29/2025,mg,antineoplastic,6/12/2016,12/4/2015,Intravenous,paclitaxel,FALSE
1540,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/10/2018,mg,antineoplastic,8/23/2018,8/25/2018,Intravenous,gemcitabine,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,8/18/2018,mg/kg,antineoplastic,3/26/2018,2/14/2018,Intravenous,durvalumab,TRUE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/18/2022,mg/kg,antineoplastic,7/12/2021,2/6/2021,Intravenous,durvalumab,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/2/2021,mg,antineoplastic,10/24/2021,9/23/2021,Intravenous,paclitaxel,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/14/2024,mg,antineoplastic,1/22/2024,1/17/2024,Intravenous,paclitaxel,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/20/2018,mg,antineoplastic,7/10/2015,6/29/2015,Intravenous,carboplatin,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/23/2022,mg,antineoplastic,1/4/2022,8/24/2021,Intravenous,paclitaxel,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/7/2016,mg,antineoplastic,1/8/2016,1/14/2016,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,9/12/2024,mg,antineoplastic,6/28/2024,6/18/2024,Intravenous,cemiplimab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,8/24/2024,mg,antineoplastic,6/3/2024,6/18/2024,Intravenous,paclitaxel,FALSE
153,3,ADVANCED,Administrations,chemotherapy,Docetaxel,G1C32G396:F7G,8/19/2014,mg,antineoplastic,4/21/2014,6/12/2014,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/5/2025,mg,antineoplastic,11/11/2024,8/11/2024,Intravenous,pembrolizumab,TRUE
117,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/23/2020,mg,antineoplastic,8/27/2020,6/20/2020,Subcutaneous,azacitidine,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,7/8/2018,,antineoplastic,2/21/2018,12/24/2017,Intravenous,pemetrexed,FALSE
1540,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/29/2018,mg,antineoplastic,8/22/2018,7/25/2018,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/12/2021,mg,antineoplastic,10/21/2019,11/21/2018,Intravenous,pembrolizumab,TRUE
200,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/25/2023,mg,antineoplastic,11/15/2022,11/1/2022,Intravenous,carboplatin,FALSE
218,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/29/2016,mg,antineoplastic,12/10/2015,10/28/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/4/2022,mg,antineoplastic,2/5/2021,12/21/2019,Intravenous,nivolumab,FALSE
110.4,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,2/8/2014,mg,antineoplastic,7/30/2013,6/3/2013,Intravenous,docetaxel,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/27/2014,mg,antineoplastic,7/8/2014,6/3/2014,Intravenous,paclitaxel protein-bound,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,8/12/2022,mg/m2,antineoplastic,5/22/2022,6/12/2022,Intravenous,pemetrexed,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,8/3/2018,mg/kg,antineoplastic,6/12/2018,4/7/2018,Intravenous,durvalumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/5/2016,mg,antineoplastic,7/30/2014,8/19/2014,Intravenous,etoposide,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,2/7/2023,mg,antineoplastic,1/14/2023,10/22/2022,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/10/2025,mg,antineoplastic,6/12/2024,5/17/2024,Intravenous,cemiplimab,TRUE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,8/1/2021,mg,antineoplastic,12/27/2019,12/5/2018,Intravenous,pemetrexed,TRUE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/26/2022,mg/kg,antineoplastic,7/18/2021,3/14/2021,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,8/26/2022,mg,antineoplastic,8/28/2022,6/27/2022,Intravenous,bevacizumab-awwb,TRUE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/3/2020,mg,antineoplastic,4/26/2020,4/9/2020,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/21/2015,mg,antineoplastic,2/4/2015,2/17/2015,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cetuximab,Irinotecan",G1D61871659DG,7/17/2012,mg/m2,antineoplastic,6/26/2012,7/19/2012,Intravenous,irinotecan,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/9/2025,mg,antineoplastic,6/30/2023,8/11/2021,Intravenous,atezolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/28/2020,mg,antineoplastic,12/12/2015,12/18/2015,Intravenous,nivolumab,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/31/2021,mg,antineoplastic,8/10/2020,5/6/2020,Intravenous,docetaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/20/2024,mg,antineoplastic,4/10/2024,4/1/2024,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/9/2022,mg,antineoplastic,10/27/2020,10/13/2020,Intravenous,nivolumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/24/2015,mg,antineoplastic,9/29/2015,2/23/2015,Intravenous,paclitaxel protein-bound,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,9/14/2014,mg,antineoplastic,8/21/2014,9/21/2014,Intravenous,carboplatin,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G177G4:B9E394,4/23/2025,,antineoplastic,4/8/2025,4/24/2025,Intravenous,clinical study drug,FALSE
950,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,4/29/2013,mg,antineoplastic,1/7/2013,11/22/2012,Intravenous,bevacizumab,TRUE
170,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/26/2025,mg,antineoplastic,10/27/2024,9/17/2024,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,3/29/2025,mg,antineoplastic,12/29/2024,4/11/2024,Intravenous,pembrolizumab,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/1/2019,mg,antineoplastic,9/11/2018,6/7/2018,Intravenous,levoleucovorin,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,12/3/2014,mg/m2,antineoplastic,2/6/2014,1/5/2014,Intravenous,paclitaxel,FALSE
500,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/8/2024,mg,antineoplastic,5/29/2024,5/30/2023,Intravenous,pemetrexed,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/10/2024,mg,antineoplastic,12/26/2023,4/25/2023,Intravenous,atezolizumab,FALSE
1500,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G1G4BC1:B::63,3/9/2022,mg,antineoplastic,2/17/2022,11/16/2021,Intravenous,durvalumab,TRUE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/14/2024,mg,antineoplastic,10/26/2022,4/9/2022,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,5/13/2025,mg,antineoplastic,12/19/2024,11/14/2024,Intravenous,nivolumab,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/23/2022,mg,antineoplastic,10/14/2021,9/20/2021,Intravenous,carboplatin,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/23/2014,mg,antineoplastic,11/18/2013,6/29/2013,Intravenous,bevacizumab,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,6/14/2023,mg,antineoplastic,6/7/2023,12/23/2022,Intravenous,durvalumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G35DGE621BE1E,12/16/2024,mg/kg,antineoplastic,11/6/2024,11/13/2023,Intravenous,durvalumab,FALSE
495.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/15/2015,mg,antineoplastic,10/5/2014,9/25/2014,Intravenous,carboplatin,FALSE
600,3,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/27/2019,mg,antineoplastic,9/20/2019,6/20/2019,Intravenous,leucovorin,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,5/24/2023,mg,antineoplastic,4/28/2023,7/12/2022,Intravenous,durvalumab,FALSE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,11/19/2018,mg,antineoplastic,10/2/2018,9/23/2018,Intravenous,carboplatin,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,12/24/2024,mg,antineoplastic,6/17/2022,4/22/2022,Intravenous,cisplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/28/2023,mg,antineoplastic,7/21/2023,4/27/2023,Subcutaneous,azacitidine,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/29/2023,mL,solution-fluid,10/28/2023,11/27/2022,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/24/2025,mg,antineoplastic,10/6/2017,8/30/2016,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,3/20/2017,mg,antineoplastic,10/28/2016,11/14/2016,Intravenous,nivolumab,FALSE
166.5,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,9/4/2019,mg,antineoplastic,7/19/2019,5/18/2019,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,2/26/2020,mg,antineoplastic,1/14/2020,12/24/2019,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,3/3/2017,,antineoplastic,2/13/2017,2/13/2017,Oral,hydroxyurea,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/14/2020,mg,antineoplastic,10/2/2019,11/20/2018,Intravenous,pembrolizumab,TRUE
60,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/12/2018,mg,antineoplastic,9/24/2018,6/9/2018,Intravenous,cisplatin,FALSE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,6/25/2017,mg,antineoplastic,1/30/2016,12/29/2015,Intravenous,nivolumab,FALSE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/22/2022,mg,antineoplastic,8/26/2022,6/9/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G545:2F182DD:,10/17/2017,,antineoplastic,8/20/2017,8/31/2017,,clinical study drug,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/24/2020,mg,antineoplastic,11/5/2019,10/7/2019,Intravenous,paclitaxel,FALSE
803,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/10/2025,mg,antineoplastic,9/2/2023,2/19/2023,Intravenous,pemetrexed,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/7/2017,mg,antineoplastic,1/11/2017,2/23/2017,Intravenous,paclitaxel,FALSE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,6/21/2023,mg,antineoplastic,5/15/2023,3/14/2023,Intravenous,durvalumab,TRUE
,2,ADVANCED,Orders,hormone,Exemestane,G272F2D3BB8C2,4/7/2016,,antineoplastic,1/26/2016,1/30/2016,Oral,exemestane,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1:C9B9B392:C,5/23/2015,AUC,antineoplastic,5/17/2015,5/1/2015,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,4/6/2025,mg,antineoplastic,10/11/2024,1/28/2024,Intravenous,pembrolizumab,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,6/23/2021,mg,antineoplastic,3/17/2021,10/22/2020,Intravenous,nivolumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/15/2020,mg,antineoplastic,3/25/2020,12/26/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/7/2025,,antineoplastic,5/15/2024,3/30/2024,Intravenous,paclitaxel protein-bound,FALSE
740,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,1/5/2025,mg,antineoplastic,12/8/2024,10/25/2024,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/27/2025,mg,antineoplastic,10/19/2024,10/15/2024,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,9/1/2019,mg,antineoplastic,10/5/2018,9/8/2018,Intravenous,nivolumab,FALSE
164,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/28/2024,mg,antineoplastic,9/16/2024,7/5/2024,Intravenous,cisplatin,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/28/2023,,antineoplastic,8/11/2023,12/22/2022,Intravenous,clinical study drug,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,5/26/2015,mg,antineoplastic,10/2/2014,9/29/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/23/2025,,antineoplastic,12/20/2024,3/19/2024,Intravenous,clinical study drug,FALSE
298,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/21/2024,mg,antineoplastic,1/18/2024,11/13/2023,Intravenous,paclitaxel,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/13/2018,mg,antineoplastic,12/12/2017,11/13/2017,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/29/2021,mg/m2,antineoplastic,6/1/2021,3/4/2021,Intravenous,leucovorin,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4B1F584CB682,2/12/2016,mg,antineoplastic,10/17/2015,10/2/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/25/2015,,antineoplastic,9/22/2015,4/22/2015,Oral,ibrutinib,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,10/24/2021,,antineoplastic,2/9/2018,4/1/2018,,durvalumab,TRUE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/10/2024,mg,antineoplastic,10/3/2024,8/1/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/14/2022,mg,antineoplastic,11/14/2020,12/26/2019,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,2/3/2023,mg,antineoplastic,11/4/2022,10/31/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/24/2024,mg,antineoplastic,12/16/2022,9/13/2022,Intravenous,pembrolizumab,TRUE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/16/2014,AUC,antineoplastic,8/23/2014,12/1/2013,Intravenous,carboplatin,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/20/2013,mg,antineoplastic,4/22/2012,4/4/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/4/2022,mg,antineoplastic,8/23/2021,10/3/2021,Intravenous,pembrolizumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/13/2019,mg,antineoplastic,5/30/2016,4/8/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G325BD94D:C:4,12/9/2018,,,1/10/2019,8/23/2018,Oral,afatinib,FALSE
115,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,5/4/2015,mg,antineoplastic,3/20/2015,3/12/2015,Intravenous,paclitaxel protein-bound,FALSE
112,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/21/2021,mg,antineoplastic,5/21/2021,5/14/2021,Intravenous,cisplatin,FALSE
225,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,5/23/2012,mg,antineoplastic,4/30/2012,4/15/2012,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,1/23/2021,mg,antineoplastic,2/16/2020,1/20/2020,Intravenous,pembrolizumab,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,3/28/2014,mg,antineoplastic,2/14/2014,1/9/2014,Intravenous,docetaxel,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,9/3/2018,mg/kg,antineoplastic,8/3/2018,2/26/2018,Intravenous,durvalumab,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/13/2017,,solution-fluid,11/25/2016,2/16/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/23/2020,mg,antineoplastic,5/11/2018,12/20/2017,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/13/2025,mg,antineoplastic,12/29/2024,4/13/2024,Intravenous,pembrolizumab,FALSE
585,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,7/2/2014,mg,antineoplastic,5/3/2014,5/13/2014,Intravenous,bevacizumab,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/28/2022,mg/kg,antineoplastic,11/28/2021,2/8/2021,Intravenous,durvalumab,FALSE
166.1,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/8/2017,mg,antineoplastic,4/23/2017,5/8/2017,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,9/14/2024,mg,antineoplastic,6/19/2024,6/26/2024,Intravenous,atezolizumab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/12/2013,mg/m2,antineoplastic,11/27/2012,7/6/2012,Intravenous,docetaxel,FALSE
552,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/6/2016,mg,antineoplastic,9/1/2015,7/7/2015,Intravenous,pemetrexed,FALSE
229,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/23/2016,mg,antineoplastic,12/13/2015,12/7/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/12/2022,mg,antineoplastic,11/27/2020,1/19/2020,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/26/2025,mg,antineoplastic,2/19/2018,2/14/2018,Intravenous,nivolumab,FALSE
89,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/5/2017,mg,antineoplastic,10/1/2017,8/28/2017,Intravenous,paclitaxel,FALSE
1650,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G2FF2946:4C6F,6/11/2018,mg,antineoplastic,4/7/2018,4/4/2018,Intravenous,gemcitabine,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,5/9/2025,mg,antineoplastic,8/19/2024,7/15/2024,Intravenous,pemetrexed,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,8/29/2024,mg,antineoplastic,6/8/2020,7/20/2020,Intravenous,ipilimumab,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G557E997E81G5,6/29/2023,mg,antineoplastic,5/3/2023,5/2/2023,Intravenous,docetaxel,FALSE
606,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/22/2019,mg,antineoplastic,2/15/2013,2/28/2013,Intravenous,carboplatin,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/21/2013,mg,antineoplastic,5/15/2013,4/30/2013,Intravenous,paclitaxel,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,12/2/2017,mg,antineoplastic,5/13/2016,3/24/2016,Intravenous,nivolumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,9/12/2020,mg,antineoplastic,12/20/2019,2/9/2019,Intravenous,nivolumab,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,10/28/2022,mg,antineoplastic,10/12/2022,4/28/2022,Intravenous,nivolumab,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/27/2019,mg,antineoplastic,12/8/2018,6/30/2018,Intravenous,trastuzumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/22/2023,mg/m2,antineoplastic,3/13/2021,6/6/2020,Intravenous,pemetrexed,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,6/23/2021,mg,antineoplastic,1/16/2021,12/1/2020,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/12/2018,mg,antineoplastic,1/1/2018,2/28/2017,Intravenous,pembrolizumab,FALSE
585,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,10/26/2015,mg,antineoplastic,9/22/2015,6/9/2015,Intravenous,carboplatin,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/8/2019,mg,antineoplastic,9/4/2019,9/23/2019,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/17/2024,mg,antineoplastic,6/5/2023,1/5/2023,Intravenous,nivolumab,FALSE
93,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/10/2018,mg,antineoplastic,4/20/2018,4/21/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/14/2015,,antineoplastic,12/14/2014,11/29/2014,,pemetrexed,FALSE
99,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/15/2015,mg,antineoplastic,7/11/2015,6/14/2015,Intravenous,etoposide,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/27/2023,mg,antineoplastic,8/17/2022,1/8/2020,Intravenous,pembrolizumab,FALSE
501,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,4/17/2016,mg,antineoplastic,3/23/2016,2/24/2016,Intravenous,carboplatin,FALSE
616,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,4/1/2022,mg,antineoplastic,1/10/2022,11/8/2021,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/22/2025,mg,antineoplastic,3/8/2024,7/26/2021,Intravenous,atezolizumab,TRUE
615,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,10/29/2024,mg,antineoplastic,8/10/2024,8/28/2024,Intravenous,carboplatin,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/7/2019,mg,antineoplastic,6/22/2018,3/6/2018,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/12/2021,mL,solution-fluid,6/30/2018,2/18/2018,Intravenous,durvalumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/16/2025,mg,antineoplastic,1/2/2022,3/3/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/20/2023,,antineoplastic,2/7/2023,1/9/2023,Intravenous,paclitaxel,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/17/2018,mg,antineoplastic,11/26/2016,10/6/2016,Intravenous,paclitaxel,FALSE
1000,4,ADVANCED,Administrations,chemotherapy,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,8/21/2016,mg,antineoplastic,7/4/2016,6/3/2016,Intravenous,pemetrexed,FALSE
514,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,12/16/2013,mg,antineoplastic,10/27/2013,9/23/2013,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G5722GECG4G16,2/23/2024,mg,antineoplastic,2/1/2024,11/12/2023,Intravenous,durvalumab,TRUE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/31/2017,mL,solution-fluid,7/12/2017,7/1/2017,Intravenous,paclitaxel,FALSE
855,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/15/2015,mg,antineoplastic,11/26/2014,10/20/2014,Intravenous,carboplatin,FALSE
860,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G166B735:96D2,8/17/2013,mg,antineoplastic,1/9/2013,1/11/2013,Intravenous,pemetrexed,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/6/2013,mg,antineoplastic,12/5/2012,10/21/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G499EB:16:7F3,9/11/2019,,antineoplastic,9/13/2018,8/26/2018,Intravenous,nivolumab,FALSE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/18/2014,mg,antineoplastic,12/24/2013,10/30/2013,Intravenous,pemetrexed,FALSE
580,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4GE2BD8C57D9,1/1/2019,mg,antineoplastic,1/27/2019,1/30/2019,Intravenous,ramucirumab,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G39GB9B7D:9:C,9/6/2017,mg,antineoplastic,2/17/2016,1/18/2016,Intravenous,nivolumab,FALSE
1122,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4229EB584D67,4/22/2015,mg,antineoplastic,2/23/2015,3/30/2015,Intravenous,bevacizumab,FALSE
500,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/20/2021,mg,antineoplastic,11/19/2020,10/10/2020,Intravenous,leucovorin,FALSE
50,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/23/2022,mL,solution-fluid,4/1/2022,2/15/2022,Intravenous,ipilimumab,FALSE
103,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/9/2015,mg,antineoplastic,11/14/2014,9/14/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/26/2025,mg,antineoplastic,6/14/2023,5/12/2023,Intravenous,pembrolizumab,FALSE
27,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,1/24/2015,mg,antineoplastic,1/14/2015,11/30/2014,Intravenous,cisplatin,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/11/2021,mg,antineoplastic,7/4/2021,5/10/2021,Intravenous,paclitaxel protein-bound,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,4/29/2019,mg,antineoplastic,8/5/2018,7/27/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,9/18/2023,mg,antineoplastic,8/31/2022,8/14/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/30/2022,mg,antineoplastic,4/29/2021,2/9/2018,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,11/22/2016,mg,antineoplastic,10/5/2016,6/11/2016,Intravenous,nivolumab,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,5/23/2022,mg,antineoplastic,4/28/2022,4/7/2022,Intravenous,paclitaxel,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/27/2019,mg,antineoplastic,5/12/2019,4/16/2019,Intravenous,docetaxel,FALSE
250,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G21:3143F86E6,2/18/2015,mg,antineoplastic,2/18/2015,1/11/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,4/28/2024,,antineoplastic,11/1/2023,5/26/2023,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/29/2024,mg,antineoplastic,8/30/2023,9/28/2022,Intravenous,pembrolizumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/8/2025,mg/m2,antineoplastic,3/31/2025,7/15/2024,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Administrations,pain agent,Clinical Study Drug,G177G4:B9E394,5/10/2025,,pain agent,3/12/2025,3/2/2025,Oral,clinical study drug,FALSE
260,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/29/2025,mg,antineoplastic,8/19/2024,9/15/2024,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,11/2/2015,mg,antineoplastic,9/10/2015,5/10/2015,Intravenous,nivolumab,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Clinical Study Drug,G2C233C2:5B1:,4/5/2025,,antineoplastic,1/3/2025,12/6/2024,,clinical study drug,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/27/2025,mg/m2,antineoplastic,12/5/2024,5/30/2024,Intravenous,pemetrexed,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,12/16/2015,mg,antineoplastic,12/22/2015,10/9/2015,Intravenous,gemcitabine,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/20/2022,mg,antineoplastic,11/10/2022,10/8/2022,Intravenous,paclitaxel,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,9/30/2020,mg,antineoplastic,8/10/2020,6/11/2020,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/14/2021,mg,antineoplastic,10/9/2021,9/15/2021,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/6/2018,mg,antineoplastic,12/8/2017,9/10/2017,Intravenous,atezolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/14/2025,mg,antineoplastic,11/6/2017,1/28/2017,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,12/27/2017,mg,antineoplastic,10/5/2017,9/7/2017,Intravenous,nivolumab,FALSE
,3,ADVANCED,Unstructured,,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/16/2016,,,6/4/2016,12/22/2015,Oral,vemurafenib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/24/2021,mg,antineoplastic,11/1/2019,10/25/2019,Intravenous,pembrolizumab,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/30/2025,mg,antineoplastic,5/20/2020,4/18/2019,Intravenous,pemetrexed,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,3/20/2025,mg,antineoplastic,2/20/2016,12/1/2015,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,7/10/2014,mg/m2,antineoplastic,7/15/2014,5/4/2014,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/2/2022,mg,antineoplastic,1/10/2018,1/8/2016,Intravenous,pemetrexed,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/24/2024,mg,antineoplastic,9/5/2024,7/27/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/10/2025,,antineoplastic,11/28/2024,2/18/2023,,clinical study drug,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/4/2023,mg,antineoplastic,10/26/2022,5/7/2022,Intravenous,durvalumab,FALSE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,3/14/2024,mg,antineoplastic,3/13/2024,10/24/2023,Oral,ivosidenib,FALSE
227.3,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/18/2019,mg,antineoplastic,9/29/2019,8/10/2019,Intravenous,carboplatin,FALSE
500,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/28/2024,mg,antineoplastic,5/22/2024,6/19/2023,Intravenous,pemetrexed,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/21/2018,mg,antineoplastic,7/12/2015,6/7/2015,Intravenous,paclitaxel,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/9/2021,mg,antineoplastic,1/1/2021,9/20/2020,Intravenous,gemcitabine,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/12/2021,mg,antineoplastic,12/8/2019,11/17/2018,Intravenous,pemetrexed,TRUE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/21/2015,mg,antineoplastic,7/28/2015,7/22/2015,Intravenous,paclitaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/19/2019,mg,antineoplastic,4/21/2019,2/10/2019,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,mg,antineoplastic,8/14/2017,5/12/2017,Oral,dasatinib,FALSE
900,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G32GG4C6C:87G,4/1/2021,mg,antineoplastic,2/9/2021,12/30/2020,Intravenous,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,3/28/2025,mg,antineoplastic,10/10/2023,8/17/2023,Intravenous,atezolizumab,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G419BEEC19D2C,10/11/2021,mg,antineoplastic,9/15/2021,8/13/2021,Intravenous,pemetrexed,FALSE
495,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,9/1/2024,mg,antineoplastic,9/12/2024,6/22/2024,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/4/2021,mg,antineoplastic,4/21/2021,3/15/2021,Oral,anastrozole,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,12/7/2014,mg,antineoplastic,9/28/2014,8/22/2014,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antiemetic,Clinical Study Drug,G344BC2:6BGE1,4/30/2012,,antiemetic,10/18/2011,9/17/2011,,clinical study drug,FALSE
625,1,ADVANCED,Administrations,chemotherapy,Capmatinib,G12E5EG31:6:5,10/6/2022,mg,antineoplastic,2/3/2022,2/1/2022,Intravenous,pemetrexed,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/5/2020,mg,antineoplastic,3/21/2020,1/24/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/13/2025,mg,antineoplastic,1/15/2025,8/14/2024,Intravenous,pembrolizumab,TRUE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,2/20/2019,mg,antineoplastic,1/15/2019,12/18/2018,Intravenous,paclitaxel,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,3/26/2025,mg,antineoplastic,8/16/2024,6/28/2024,Intravenous,durvalumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/17/2025,mg,antineoplastic,9/25/2024,2/11/2023,Intravenous,pembrolizumab,FALSE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/29/2023,mg,antineoplastic,2/26/2023,11/16/2022,Intravenous,paclitaxel,FALSE
516,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,10/6/2021,mg,antineoplastic,9/30/2021,6/23/2021,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/4/2019,mg,antineoplastic,2/9/2019,1/3/2019,Intravenous,paclitaxel protein-bound,FALSE
1000,,NEOADJUVANT,Orders,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,11/9/2023,mg,antineoplastic,10/2/2023,9/6/2023,Oral,abiraterone,FALSE
145,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,4/19/2016,mg,antineoplastic,1/9/2016,12/13/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,4/3/2025,mg,antineoplastic,6/18/2019,4/30/2018,Intravenous,pembrolizumab,FALSE
660,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/30/2022,mg,antineoplastic,4/25/2022,11/25/2021,Intravenous,bevacizumab-bvzr,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/18/2025,mg,antineoplastic,9/19/2020,1/29/2019,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/9/2024,mg,antineoplastic,11/16/2023,4/15/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G4GF74CE8E4:6,7/20/2023,,,7/17/2023,7/3/2023,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,11/18/2024,mg,antineoplastic,7/27/2024,8/25/2024,Intravenous,pembrolizumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,11/25/2017,mL,solution-fluid,9/21/2017,8/3/2017,Intravenous,paclitaxel,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,4/25/2025,mg,antineoplastic,3/2/2025,10/9/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,8/1/2021,mg,antineoplastic,5/23/2021,3/8/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/22/2024,mg,antineoplastic,1/13/2024,1/14/2024,Intravenous,pembrolizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,8/27/2017,mg,antineoplastic,8/25/2017,7/6/2017,Intravenous,etoposide,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/15/2023,mg,antineoplastic,4/14/2023,9/30/2022,Subcutaneous,azacitidine,FALSE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/20/2016,mg,antineoplastic,7/16/2016,6/9/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G2CG3EF9E5:2B,5/6/2021,,,11/21/2020,12/7/2020,Oral,alectinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,12/21/2021,mg,antineoplastic,9/3/2021,8/29/2021,Intravenous,pembrolizumab,FALSE
139,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,9/6/2015,mg,antineoplastic,9/16/2015,5/11/2015,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/18/2018,mg,antineoplastic,10/16/2017,6/3/2017,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/25/2021,,antineoplastic,11/13/2020,1/7/2020,Intravenous,clinical study drug,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/6/2023,mg,antineoplastic,12/11/2017,11/7/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/24/2018,mg,antineoplastic,7/6/2018,3/21/2018,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/17/2025,mg,antineoplastic,9/1/2022,2/16/2022,Intravenous,atezolizumab,FALSE
541,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G54F545489E59,10/25/2023,mg,antineoplastic,4/22/2023,2/17/2023,Intravenous,ramucirumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/24/2020,mg,antineoplastic,12/26/2019,11/20/2018,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,2/17/2021,mg,antineoplastic,3/13/2020,2/6/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/22/2024,mg,antineoplastic,11/12/2023,6/1/2020,Intravenous,pembrolizumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/2/2023,mg,antineoplastic,7/3/2018,10/9/2017,Intravenous,nivolumab,FALSE
115,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,11/22/2023,mg,antineoplastic,12/7/2023,9/29/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G272F2D3BB8C2,1/26/2016,mg/m2,antineoplastic,10/8/2013,9/24/2013,Intravenous,gemcitabine,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/4/2025,AUC,antineoplastic,1/3/2021,4/2/2019,Intravenous,carboplatin,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,3/3/2014,mg/kg,antineoplastic,12/25/2013,6/13/2013,Intravenous,bevacizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G25B:66F61266,4/22/2025,mg,antineoplastic,5/1/2025,2/8/2025,Intravenous,pembrolizumab,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,11/23/2023,mg,antineoplastic,7/29/2023,11/20/2022,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/13/2025,mg,antineoplastic,12/5/2024,10/5/2024,Intravenous,durvalumab,FALSE
555.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,4/8/2018,mg,antineoplastic,4/3/2018,3/5/2018,Intravenous,carboplatin,FALSE
773,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/26/2023,mg,antineoplastic,2/9/2023,11/23/2022,Intravenous,carboplatin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/10/2021,mg,antineoplastic,12/13/2020,8/29/2020,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/2/2022,,antineoplastic,11/21/2022,12/2/2022,,cisplatin,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,10/20/2015,mg,antineoplastic,10/4/2015,7/16/2015,Intravenous,carboplatin,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/16/2025,mg,antineoplastic,1/14/2025,7/11/2024,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/13/2020,mg,antineoplastic,4/13/2020,8/15/2016,Intravenous,nivolumab,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/5/2019,mg,antineoplastic,10/26/2018,7/5/2018,Intravenous,trastuzumab,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,12/2/2012,mg,antineoplastic,8/11/2012,5/9/2012,Intravenous,carboplatin,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/28/2015,mg,antineoplastic,12/7/2014,12/29/2014,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,9/13/2017,mg,antineoplastic,11/15/2016,9/21/2016,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/29/2020,mg,antineoplastic,2/6/2017,12/5/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G172GFE717:24,4/26/2020,mg,antineoplastic,3/19/2020,12/24/2019,Intravenous,pembrolizumab,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/2/2011,mg,antineoplastic,8/17/2011,8/6/2011,Intravenous,paclitaxel,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4B1F584CB682,2/8/2016,mg,antineoplastic,10/3/2015,10/20/2015,Intravenous,nivolumab,FALSE
300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/27/2022,mg,antineoplastic,11/5/2021,11/21/2021,Intravenous,bevacizumab-awwb,FALSE
,,NEOADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,1/3/2019,,antineoplastic,1/7/2019,12/16/2018,,bortezomib,FALSE
573,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,1/23/2023,mg,antineoplastic,12/17/2022,10/22/2022,Intravenous,carboplatin,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/9/2023,mg,antineoplastic,3/12/2023,1/1/2023,Intravenous,pemetrexed,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/26/2016,mg,antineoplastic,8/5/2015,7/6/2015,Intravenous,bevacizumab,FALSE
795,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/4/2017,mg,antineoplastic,12/24/2016,9/12/2016,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/28/2023,,antineoplastic,9/9/2023,11/10/2022,,pemetrexed,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/11/2017,mg,antineoplastic,12/26/2016,7/13/2016,Intravenous,necitumumab,FALSE
2500,,NEOADJUVANT,Administrations,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/21/2013,mg,antineoplastic,1/13/2013,1/6/2013,Intravenous,mesna,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3E567F5B3:95,10/23/2018,mg,antineoplastic,10/15/2018,8/10/2018,Intravenous,nivolumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/1/2017,mg,antineoplastic,2/22/2017,11/25/2016,Intravenous,nivolumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/3/2011,mg,antineoplastic,8/30/2011,9/1/2011,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/13/2025,mg,antineoplastic,5/18/2022,1/18/2019,Intravenous,pembrolizumab,TRUE
691,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,8/19/2020,mg,antineoplastic,7/21/2020,7/27/2020,Intravenous,carboplatin,FALSE
572,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2518G1D763FB,9/10/2024,mg,antineoplastic,9/16/2024,7/8/2024,Intravenous,durvalumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,6/10/2023,mg,antineoplastic,4/12/2023,4/12/2023,Intravenous,paclitaxel,FALSE
480,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G2C38B34G8794,11/25/2024,mg,antineoplastic,8/31/2024,8/30/2024,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,10/4/2017,,antineoplastic,10/6/2017,8/10/2017,,paclitaxel,FALSE
394,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/17/2014,mg,antineoplastic,8/31/2014,8/1/2014,Intravenous,paclitaxel,FALSE
726,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,12/13/2011,mg,antineoplastic,10/4/2011,9/1/2011,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/17/2016,,antineoplastic,5/10/2016,5/7/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3E76E32E795:,3/19/2020,mg,antineoplastic,2/26/2020,12/1/2019,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G1969F536B2DD,11/1/2011,,antiemetic,6/28/2011,6/30/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,7/14/2024,mg,antineoplastic,4/28/2024,3/27/2024,Intravenous,pembrolizumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/30/2024,mg,antineoplastic,9/6/2024,7/17/2024,Intravenous,pemetrexed,FALSE
314,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,11/26/2022,mg,antineoplastic,10/20/2022,9/11/2022,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/29/2013,mg,antineoplastic,9/3/2012,12/4/2011,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/9/2020,mg,antineoplastic,4/19/2020,2/4/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,11/1/2022,mg,antineoplastic,10/25/2022,6/16/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/20/2022,mg,antineoplastic,3/25/2022,4/18/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/11/2021,,antineoplastic,6/15/2021,5/10/2021,,carboplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,11/16/2017,mL,solution-fluid,10/11/2017,7/2/2017,Intravenous,paclitaxel,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,6/5/2024,mg,antineoplastic,12/20/2023,11/5/2023,Intravenous,amivantamab-vmjw,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/12/2014,mg,antineoplastic,10/7/2014,8/28/2014,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,2/13/2019,mg,antineoplastic,10/12/2017,9/21/2017,Intravenous,etoposide,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/26/2020,mg,antineoplastic,8/20/2018,12/28/2017,Intravenous,pemetrexed,TRUE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/2/2022,,antineoplastic,11/19/2021,8/15/2021,Intravenous,amivantamab-vmjw,FALSE
1900,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,10/9/2021,mg,antineoplastic,7/15/2021,7/13/2021,Intravenous,gemcitabine,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,11/16/2015,mg,antineoplastic,11/24/2015,3/25/2015,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,8/5/2023,mg,antineoplastic,5/23/2023,10/18/2022,Intravenous,pembrolizumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/27/2025,mg,antineoplastic,3/16/2017,7/26/2016,Intravenous,pembrolizumab,FALSE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,12/1/2015,mg,antineoplastic,9/23/2015,7/3/2015,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G24C:63G27686,2/11/2014,,antineoplastic,12/22/2013,11/28/2013,,clinical study drug,FALSE
738,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,1/23/2014,mg,antineoplastic,1/10/2014,10/28/2013,Intravenous,carboplatin,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/27/2024,mg/m2,antineoplastic,4/14/2024,4/19/2024,Intravenous,pemetrexed,FALSE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,7/3/2018,mg,antineoplastic,6/29/2018,4/20/2018,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,10/16/2018,mg,antineoplastic,4/13/2014,3/6/2014,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/12/2013,mg,antineoplastic,9/2/2012,12/9/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/26/2025,mg,antineoplastic,2/22/2019,4/6/2018,Intravenous,pembrolizumab,FALSE
300,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/30/2020,mg,antineoplastic,10/28/2020,11/9/2020,Intravenous,fluorouracil,FALSE
2,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/27/2023,mg,antineoplastic,12/17/2022,11/8/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/4/2020,,antineoplastic,6/2/2020,11/15/2019,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,4/26/2021,mg,antineoplastic,3/25/2021,12/15/2020,Intravenous,paclitaxel,FALSE
608,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2628C28G7613,10/25/2015,mg,antineoplastic,9/28/2015,6/7/2015,Intravenous,pemetrexed,TRUE
500,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,11/12/2020,mg/m2,antineoplastic,7/4/2020,3/1/2020,Intravenous,pemetrexed,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/29/2016,mg,antineoplastic,7/13/2014,6/9/2014,Intravenous,bevacizumab,FALSE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/11/2015,mg,antineoplastic,6/12/2015,3/18/2015,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/21/2024,,antineoplastic,9/1/2024,8/3/2024,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/9/2020,mg,antineoplastic,7/19/2020,5/18/2020,Subcutaneous,azacitidine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,4/4/2025,mg,antineoplastic,5/1/2024,1/9/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/1/2020,mg,antineoplastic,10/23/2017,11/9/2015,Intravenous,nivolumab,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/10/2018,mg,antineoplastic,1/24/2018,10/19/2017,Intravenous,trastuzumab,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,10/18/2024,mg,antineoplastic,7/23/2024,6/26/2024,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/2/2016,AUC,antineoplastic,8/12/2016,6/17/2016,Intravenous,carboplatin,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/2/2019,mg/m2,antineoplastic,9/4/2019,7/30/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,5/16/2021,mg,antineoplastic,11/12/2020,11/14/2020,Intravenous,nivolumab,FALSE
480,1,ADVANCED,Orders,immunotherapy,Nivolumab,G1E2B6::D8477,4/3/2024,mg,antineoplastic,9/7/2023,5/21/2023,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,3/11/2019,mg,antineoplastic,10/15/2018,9/22/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,immunotherapy,"Paclitaxel Protein-Bound,Pembrolizumab",G5829EBB749DF,6/4/2019,,antineoplastic,4/6/2019,5/4/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,1/25/2023,mg,antineoplastic,10/29/2022,11/11/2022,Intravenous,pembrolizumab,FALSE
439,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,2/12/2020,mg,antineoplastic,1/1/2020,11/25/2019,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/13/2020,mg,antineoplastic,2/16/2020,12/30/2019,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/24/2020,mg,antineoplastic,4/11/2017,7/22/2016,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/17/2023,mg,antineoplastic,3/27/2023,3/3/2023,Intravenous,pembrolizumab,FALSE
1400,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1665E:E6:E1:,12/18/2013,mg,antineoplastic,5/8/2013,2/17/2013,Intravenous,gemcitabine,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/12/2014,mg,antineoplastic,8/19/2014,6/24/2014,Intravenous,carboplatin,FALSE
636,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/15/2025,mg,antineoplastic,12/30/2024,11/25/2024,Intravenous,fluorouracil,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/24/2016,mg,antineoplastic,7/13/2015,5/31/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,4/26/2020,mg,antineoplastic,8/4/2017,12/27/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G36G688G4EBD6,11/22/2023,mg,antineoplastic,10/17/2023,10/16/2023,Intravenous,pembrolizumab,TRUE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/6/2023,mg,antineoplastic,5/3/2022,1/10/2020,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,5/18/2025,mg,antineoplastic,11/20/2024,1/8/2024,Intravenous,pembrolizumab,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/26/2013,mg,antineoplastic,8/11/2012,7/25/2012,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/9/2023,mL,solution-fluid,9/8/2023,11/7/2022,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/25/2022,mg,antineoplastic,6/18/2022,8/14/2021,Intravenous,durvalumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/4/2020,mg,antineoplastic,5/23/2020,8/8/2019,Intravenous,pembrolizumab,FALSE
485,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/24/2016,mg,antineoplastic,3/30/2016,3/23/2016,Intravenous,nivolumab,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/30/2015,mg,antineoplastic,3/29/2015,10/10/2014,Intravenous,pemetrexed,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/25/2025,mg,antineoplastic,9/28/2024,3/14/2024,Intravenous,amivantamab-vmjw,FALSE
270.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/20/2021,mg,antineoplastic,10/3/2019,6/17/2019,Intravenous,carboplatin,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1532797B869C,7/23/2023,mg,antineoplastic,7/5/2023,7/28/2023,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,8/2/2017,,solution-fluid,2/20/2017,11/28/2016,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Unstructured,,Sotorasib,G1D2821G451G:,6/6/2024,,,12/1/2023,12/26/2023,Oral,sotorasib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/20/2020,mg,antineoplastic,7/15/2020,5/17/2019,Intravenous,pembrolizumab,TRUE
259.8,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G57:2GEC9DD36,11/22/2015,mg,antineoplastic,11/25/2015,10/13/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/19/2023,mg,antineoplastic,4/30/2023,11/6/2021,Intravenous,pembrolizumab,TRUE
363.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,8/2/2015,mg,antineoplastic,11/2/2014,9/22/2014,Intravenous,carboplatin,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,9/1/2022,mg,antineoplastic,7/3/2021,5/31/2021,Intravenous,bevacizumab-bvzr,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,3/5/2024,mg,antineoplastic,2/28/2024,12/30/2023,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,8/8/2013,mg,antineoplastic,2/12/2013,1/2/2013,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/20/2025,,antineoplastic,2/21/2023,4/21/2020,Oral,enzalutamide,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,11/3/2015,,steroid,12/1/2015,8/2/2015,Intrajejunal,clinical study drug,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,11/5/2021,mg,antineoplastic,6/13/2021,2/2/2021,Intravenous,durvalumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5:CE:F92EE8D,2/14/2016,,antineoplastic,8/11/2015,7/14/2015,Intravenous,clinical study drug,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,7/25/2018,mg/kg,antineoplastic,7/27/2018,4/11/2018,Intravenous,durvalumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/25/2015,mg,antineoplastic,1/2/2015,11/15/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/18/2025,mg,antineoplastic,1/13/2025,2/4/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/12/2024,mg,antineoplastic,4/14/2024,10/10/2022,Intravenous,pembrolizumab,TRUE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/7/2020,mg,antineoplastic,12/4/2019,3/16/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/26/2025,mg,antineoplastic,5/8/2022,9/18/2021,Intravenous,pembrolizumab,TRUE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/26/2023,mg,antineoplastic,9/29/2022,12/16/2019,Intravenous,pembrolizumab,FALSE
235,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/15/2016,mg,antineoplastic,5/21/2016,11/1/2015,Intravenous,nivolumab,FALSE
286,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/4/2025,mg,antineoplastic,2/3/2025,12/31/2024,Intravenous,bevacizumab-bvzr,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,10/7/2015,mg,antineoplastic,6/23/2015,7/10/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/2/2025,,antineoplastic,11/8/2021,11/2/2021,Intravenous,pemetrexed,TRUE
1075,2,ADVANCED,Administrations,chemotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,8/15/2019,mg,antineoplastic,8/29/2019,3/3/2019,Intravenous,pemetrexed,FALSE
855,,ADJUVANT,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,6/4/2013,mg,antineoplastic,4/26/2013,11/29/2012,Intravenous,rituximab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/24/2022,mg,antineoplastic,2/21/2019,4/5/2017,Intravenous,nivolumab,FALSE
940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G24167D1DD5FG,2/10/2025,mg,antineoplastic,10/5/2024,10/26/2024,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/1/2024,mg,antineoplastic,4/27/2024,5/18/2023,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,4/3/2025,,antineoplastic,12/24/2024,9/21/2022,Oral,anastrozole,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,2/18/2025,,antineoplastic,8/12/2023,3/18/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,1/15/2019,mg,antineoplastic,10/27/2018,12/1/2018,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,7/15/2024,mg,antineoplastic,6/13/2024,7/5/2023,Intravenous,pembrolizumab,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,3/24/2016,mg,antineoplastic,1/11/2016,1/20/2016,Intravenous,paclitaxel,FALSE
218,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/23/2012,mg,antineoplastic,4/8/2012,3/25/2012,Intravenous,carboplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,7/29/2019,mg,antineoplastic,6/1/2019,10/17/2018,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/16/2019,mg,antineoplastic,4/4/2018,3/10/2018,Intravenous,nivolumab,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,9/27/2021,mg/m2,antineoplastic,6/3/2021,2/16/2021,Intravenous,oxaliplatin,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/10/2012,mg/m2,antineoplastic,5/22/2012,4/30/2012,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,1/5/2023,mg,antineoplastic,12/20/2022,10/7/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/4/2022,mg,antineoplastic,2/22/2022,7/25/2020,Intravenous,pembrolizumab,TRUE
186,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4C88CEG2:289,2/13/2025,mg,antineoplastic,12/17/2024,1/4/2025,Intravenous,carboplatin,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,10/8/2018,mg,antineoplastic,8/3/2018,7/9/2018,Intravenous,carboplatin,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,4/7/2020,mg,antineoplastic,2/3/2020,11/3/2019,Intravenous,durvalumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/24/2023,mL,solution-fluid,6/11/2023,11/13/2022,Intravenous,pemetrexed,FALSE
83,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/16/2016,mg,antineoplastic,6/23/2016,5/18/2016,Intravenous,paclitaxel,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/12/2020,mg,antineoplastic,6/11/2019,3/5/2019,Intravenous,pemetrexed,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/9/2014,mg,antineoplastic,8/16/2014,4/24/2014,Intravenous,vinorelbine,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/6/2018,mg,antineoplastic,11/15/2017,8/8/2017,Intravenous,pemetrexed,FALSE
75,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/29/2020,mg,antineoplastic,3/10/2020,9/6/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/21/2025,,antineoplastic,11/11/2024,2/9/2023,,clinical study drug,FALSE
185.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,1/28/2017,mg,antineoplastic,12/23/2016,12/8/2016,Intravenous,carboplatin,FALSE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/27/2016,mg,antineoplastic,9/30/2015,5/29/2015,Intravenous,cisplatin,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/7/2024,mg,antineoplastic,7/9/2024,11/5/2023,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/7/2025,mg,antineoplastic,7/19/2019,2/27/2018,Intravenous,nivolumab,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G485C85BECGC4,4/14/2022,,antiemetic,1/18/2022,1/20/2022,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/10/2025,mg,antineoplastic,5/7/2018,1/25/2018,Intravenous,nivolumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/22/2021,mg,antineoplastic,5/19/2021,4/5/2021,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/11/2017,,antineoplastic,7/11/2016,2/3/2016,Intravenous,clinical study drug,FALSE
497,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,2/25/2012,mg,antineoplastic,12/26/2011,12/1/2011,Intravenous,carboplatin,FALSE
424,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,3/28/2022,mg,antineoplastic,2/19/2022,2/21/2022,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G485C85BECGC4,3/7/2022,,steroid,3/20/2022,1/15/2022,Intravenous,clinical study drug,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,1/1/2022,mg,antineoplastic,10/21/2021,8/22/2021,Intravenous,paclitaxel,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/1/2017,mg,antineoplastic,4/7/2015,10/27/2014,Intravenous,carboplatin,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/15/2019,mg,antineoplastic,8/27/2018,6/15/2018,Intravenous,trastuzumab,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,10/14/2021,mg/m2,antineoplastic,4/17/2021,3/28/2021,Oral,capecitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/2/2018,mg,antineoplastic,1/2/2017,8/17/2015,Intravenous,nivolumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/14/2023,mg,antineoplastic,8/26/2023,6/12/2023,Intravenous,paclitaxel,FALSE
213,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G174FDF7E16C9,1/1/2016,mg,antineoplastic,1/25/2016,2/11/2016,Intravenous,nivolumab,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,2/6/2024,mg,antineoplastic,11/29/2023,6/16/2023,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G161:GEG632G8,12/31/2019,mg,antineoplastic,8/13/2019,7/22/2019,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,6/19/2024,mg,antineoplastic,5/26/2024,3/12/2024,Intravenous,pembrolizumab,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/17/2016,mg,antineoplastic,4/1/2016,11/29/2015,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/31/2025,mg,antineoplastic,8/30/2024,5/1/2024,Intravenous,pembrolizumab,FALSE
1280,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,6/4/2013,mg,antineoplastic,4/15/2013,11/19/2012,Intravenous,cyclophosphamide,FALSE
494,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,12/26/2015,mg,antineoplastic,11/1/2015,9/26/2015,Intravenous,carboplatin,FALSE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/24/2018,mg,antineoplastic,9/26/2018,5/7/2018,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/12/2021,mg/m2,antineoplastic,10/10/2021,4/3/2021,Intravenous,oxaliplatin,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/10/2024,mg,antineoplastic,8/21/2024,7/20/2024,Intravenous,paclitaxel,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,12/10/2022,mg,antineoplastic,12/24/2022,3/3/2022,Intravenous,durvalumab,TRUE
,3,ADVANCED,Unstructured,,Erlotinib,G2177D1::DG1E,8/21/2012,,,7/11/2012,7/11/2012,Oral,erlotinib,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/6/2020,mg,antineoplastic,6/11/2019,5/14/2019,Intravenous,pemetrexed,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/29/2022,mg,antineoplastic,3/13/2022,11/24/2021,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/14/2021,mg,antineoplastic,12/22/2020,2/5/2021,Intravenous,pemetrexed,FALSE
1850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,9/17/2018,mg,antineoplastic,5/26/2018,5/23/2018,Intravenous,gemcitabine,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,5/25/2015,mg,antineoplastic,4/1/2015,3/24/2015,Intravenous,paclitaxel protein-bound,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/24/2015,mg,antineoplastic,12/18/2014,8/30/2014,Intravenous,etoposide,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,4/25/2015,mg,antineoplastic,4/13/2015,2/11/2015,Intravenous,pemetrexed,FALSE
163,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/22/2013,mg,antineoplastic,8/16/2012,4/16/2012,Intravenous,paclitaxel,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/17/2020,mg,antineoplastic,3/18/2020,12/17/2019,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/10/2018,mg,antineoplastic,11/9/2017,9/2/2017,Intravenous,pemetrexed,FALSE
1540,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,12/2/2015,mg,antineoplastic,8/11/2015,8/8/2015,Intravenous,gemcitabine,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/16/2022,mg,antineoplastic,12/2/2021,1/1/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,9/15/2021,mg,antineoplastic,9/26/2021,7/30/2021,Intravenous,pembrolizumab,FALSE
145,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/14/2016,mg,antineoplastic,1/7/2016,11/10/2015,Intravenous,carboplatin,FALSE
210,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G564F8B8:FB1E,2/4/2023,mg,antineoplastic,12/15/2022,12/10/2022,Intravenous,paclitaxel protein-bound,FALSE
60,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,12/3/2022,mg,antineoplastic,11/10/2022,10/18/2022,Intravenous,ipilimumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/9/2017,mg,antineoplastic,1/20/2017,9/5/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,4/18/2025,mg,antineoplastic,6/20/2024,12/30/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/21/2025,mg,antineoplastic,6/12/2024,3/7/2024,Intravenous,pembrolizumab,TRUE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/7/2025,mg,antineoplastic,2/27/2025,5/3/2024,Intravenous,pemetrexed,TRUE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/25/2019,mg,antineoplastic,10/7/2019,8/3/2019,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/6/2014,mg,antineoplastic,8/30/2013,7/29/2013,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,1/8/2024,mg,antineoplastic,12/10/2023,12/2/2023,Oral,anastrozole,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/1/2021,mg,antineoplastic,7/15/2021,5/19/2021,Intravenous,pembrolizumab,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,12/10/2024,mg,antineoplastic,4/18/2022,5/19/2022,Intravenous,cisplatin,FALSE
915,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1D14:53C99:F,3/30/2023,mg,antineoplastic,4/15/2023,1/28/2023,Intravenous,pemetrexed,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G1:DCBB2BG56F,3/28/2022,mg,antineoplastic,3/24/2022,2/28/2022,Intravenous,cisplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/10/2025,mg,antineoplastic,3/15/2022,7/8/2021,Intravenous,atezolizumab,TRUE
1075,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/31/2023,mg,antineoplastic,1/11/2020,1/29/2020,Intravenous,pemetrexed,FALSE
442,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,6/5/2015,mg,antineoplastic,5/2/2015,4/9/2015,Intravenous,carboplatin,FALSE
844,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/12/2024,mg,antineoplastic,11/11/2023,10/3/2023,Intravenous,durvalumab,FALSE
635,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,5/2/2024,mg,antineoplastic,3/23/2024,2/20/2024,Intravenous,carboplatin,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,7/27/2017,mg,antineoplastic,6/13/2017,4/22/2017,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/17/2012,,steroid,11/7/2011,10/11/2011,Intravenous,clinical study drug,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/29/2020,mg/kg,antineoplastic,11/15/2020,2/21/2020,Intravenous,ramucirumab,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,10/20/2021,mg,antineoplastic,9/8/2021,9/3/2021,Intravenous,cisplatin,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/12/2024,mg,antineoplastic,5/29/2023,2/5/2023,Intravenous,durvalumab,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/2/2019,mg/m2,antineoplastic,5/3/2019,3/5/2019,Intravenous,paclitaxel,FALSE
352,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,5/26/2025,mg,antineoplastic,1/8/2025,11/5/2024,Intravenous,paclitaxel,FALSE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/14/2016,mg,antineoplastic,1/23/2016,6/8/2015,Intravenous,gemcitabine,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/28/2024,mg,antineoplastic,8/19/2023,3/20/2023,Intravenous,atezolizumab,TRUE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/24/2016,mg,antineoplastic,2/1/2015,6/11/2014,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,2/2/2019,,antineoplastic,7/30/2018,5/8/2018,,clinical study drug,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/2/2020,mg,antineoplastic,1/27/2020,11/25/2019,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,7/25/2013,mg,antineoplastic,1/14/2013,1/25/2013,Intravenous,bevacizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/13/2025,mg,antineoplastic,11/9/2023,7/11/2023,Intravenous,pembrolizumab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G158118CE1E2C,12/19/2017,AUC,antineoplastic,12/29/2017,1/29/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/4/2025,mg,antineoplastic,5/2/2023,10/12/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G365D2:FDG53F,4/4/2025,mg,antineoplastic,3/27/2025,2/9/2025,Intravenous,pembrolizumab,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/19/2019,mg,antineoplastic,2/1/2019,3/7/2019,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,3/7/2024,,antineoplastic,8/30/2023,3/21/2023,Intravenous,atezolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/22/2025,mg,antineoplastic,10/9/2023,1/13/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,9/6/2024,mg,antineoplastic,5/9/2024,5/14/2024,Intravenous,pembrolizumab,FALSE
273,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/9/2016,mg,antineoplastic,9/29/2016,7/3/2016,Intravenous,trastuzumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1E3BGE6C42B6,4/8/2025,mg,antineoplastic,2/9/2025,2/8/2025,Intravenous,atezolizumab,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,8/14/2021,mg,antineoplastic,6/11/2021,9/12/2020,Intravenous,durvalumab,FALSE
469,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,11/5/2016,mg,antineoplastic,11/7/2016,8/12/2016,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/14/2019,mg,antineoplastic,4/29/2018,3/15/2016,Intravenous,nivolumab,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/25/2015,mg,antineoplastic,8/9/2015,7/14/2015,Intravenous,paclitaxel,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,4/3/2015,mg,antineoplastic,2/22/2015,1/28/2015,Intravenous,paclitaxel protein-bound,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/17/2016,mg,antineoplastic,2/15/2014,12/22/2013,Intravenous,etoposide,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/13/2017,mg,antineoplastic,2/9/2017,12/29/2016,Intravenous,paclitaxel,FALSE
50,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G2CE6D3C3EFDC,9/1/2013,mg,antineoplastic,8/8/2013,6/9/2013,Intravenous,vinorelbine,FALSE
1400,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1665E:E6:E1:,12/26/2013,mg,antineoplastic,3/16/2013,2/4/2013,Intravenous,gemcitabine,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,5/12/2024,mg,antineoplastic,8/10/2022,4/25/2022,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/14/2025,,antineoplastic,10/28/2024,2/15/2024,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/31/2025,mg,antineoplastic,9/20/2018,2/23/2018,Intravenous,nivolumab,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,4/1/2025,mg,antineoplastic,3/25/2025,8/29/2024,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,8/24/2024,,antineoplastic,7/21/2024,7/23/2024,Intravenous,paclitaxel protein-bound,FALSE
500,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G1G78CEE:7E:3,10/30/2018,mg/m2,antineoplastic,9/24/2018,7/27/2018,Intravenous,pemetrexed,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,10/20/2017,mg,antineoplastic,7/31/2017,5/16/2017,Intravenous,gemcitabine,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,1/6/2015,mg,antineoplastic,10/15/2014,12/5/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Unstructured,,Sotorasib,G28:58D343FCF,1/8/2023,,,7/6/2022,8/22/2022,Oral,sotorasib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/10/2025,mg,antineoplastic,4/7/2023,2/27/2020,Intravenous,pembrolizumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,5/9/2019,mg,antineoplastic,12/20/2018,12/6/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D891287D6B:,11/27/2020,mg,antineoplastic,8/21/2020,7/6/2020,Intravenous,pembrolizumab,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/29/2019,mg/m2,antineoplastic,6/30/2019,5/9/2019,Intravenous,etoposide,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/10/2020,mg,antineoplastic,1/16/2020,12/7/2019,Intravenous,carboplatin,FALSE
165,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/19/2024,mg,antineoplastic,5/10/2024,2/23/2024,Intravenous,carboplatin,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,11/3/2012,AUC,antineoplastic,7/25/2012,6/16/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/28/2022,,,1/21/2022,10/5/2021,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,3/21/2020,mg,antineoplastic,1/21/2020,12/23/2019,Intravenous,pembrolizumab,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/20/2025,mg,antineoplastic,9/12/2024,10/16/2024,Intravenous,durvalumab,FALSE
940,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,10/25/2024,mg,antineoplastic,9/6/2024,6/28/2024,Intravenous,pemetrexed,FALSE
140,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,11/17/2019,mg,antineoplastic,8/24/2019,7/12/2019,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/10/2025,mg,antineoplastic,11/27/2023,4/1/2020,Intravenous,pembrolizumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/19/2023,mg,antineoplastic,9/3/2023,8/31/2023,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,mg,antineoplastic,3/23/2021,4/11/2017,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G58E8F29:9:45,11/15/2014,,antineoplastic,11/3/2014,10/24/2014,Oral,anastrozole,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/25/2024,mg,antineoplastic,2/27/2024,10/31/2023,Intravenous,paclitaxel,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/14/2025,mg,antineoplastic,6/4/2022,2/3/2022,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/1/2025,mg,antineoplastic,1/30/2023,2/2/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,4/16/2020,mg,antineoplastic,9/11/2017,11/16/2016,Intravenous,nivolumab,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/15/2015,mg,antineoplastic,5/9/2015,2/18/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/4/2025,mg,antineoplastic,6/1/2020,1/16/2019,Intravenous,pembrolizumab,TRUE
99,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,2/3/2024,mg,antineoplastic,11/13/2023,11/10/2023,Intravenous,carboplatin,FALSE
100,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,1/31/2013,mg/m2,antineoplastic,3/13/2013,1/13/2013,Intravenous,etoposide,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,4/6/2025,mg,antineoplastic,1/2/2025,11/25/2024,Intravenous,durvalumab,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/13/2024,mg,antineoplastic,2/2/2024,7/1/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/26/2012,,steroid,11/17/2011,10/24/2011,Intravenous,clinical study drug,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,5/16/2025,mg,antineoplastic,4/8/2025,12/17/2024,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/5/2020,mg,antineoplastic,5/21/2018,12/8/2017,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Unstructured,,Alectinib,G51:CGD7GD6C4,1/16/2025,,,8/8/2018,6/23/2018,Oral,alectinib,FALSE
,4,ADVANCED,Unstructured,,Afatinib,G3::1:B4F:3D4,2/11/2016,,,12/16/2015,11/29/2015,Oral,afatinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/7/2025,mg,antineoplastic,10/4/2017,1/16/2017,Intravenous,nivolumab,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,6/4/2022,mg,antineoplastic,4/16/2021,3/31/2021,Intravenous,ramucirumab,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/7/2021,mg,antineoplastic,11/14/2020,11/29/2020,Intravenous,vinorelbine,FALSE
1000,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,8/27/2017,mg,antineoplastic,7/23/2017,6/5/2017,Intravenous,ramucirumab,FALSE
132,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,8/30/2021,mg,antineoplastic,8/28/2021,9/4/2021,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/13/2025,mg,antineoplastic,1/23/2025,5/30/2024,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/12/2020,mg,antineoplastic,4/20/2020,2/13/2020,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/21/2022,,antineoplastic,7/6/2020,5/11/2017,Oral,nilotinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,7/15/2021,,antineoplastic,6/4/2021,4/13/2021,,cisplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/16/2025,mg,antineoplastic,11/25/2024,9/19/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/27/2018,AUC,antineoplastic,1/15/2018,9/14/2017,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/3/2022,mg/kg,antineoplastic,4/8/2022,3/2/2021,Intravenous,durvalumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,6/25/2022,mg,antineoplastic,9/4/2021,9/9/2021,Intravenous,durvalumab,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/14/2023,mg,antineoplastic,4/28/2023,4/23/2023,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/18/2021,mL,solution-fluid,3/9/2019,2/14/2018,Intravenous,durvalumab,TRUE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,1/14/2025,mg,antineoplastic,12/22/2024,8/25/2024,Intravenous,nivolumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/6/2025,,antineoplastic,2/10/2025,11/21/2024,Intravenous,carboplatin,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/11/2014,mg,antineoplastic,7/14/2014,7/1/2014,Intravenous,pemetrexed,FALSE
2,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,8/17/2024,AUC,antineoplastic,9/18/2024,7/4/2024,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,7/29/2015,mg,antineoplastic,7/26/2015,5/30/2015,Intravenous,pemetrexed,FALSE
61,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,5/4/2025,mg,antineoplastic,3/23/2025,5/7/2025,Intravenous,paclitaxel,FALSE
264,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,9/8/2016,mg,antineoplastic,4/14/2016,5/29/2016,Intravenous,nivolumab,FALSE
660,,ADJUVANT,Administrations,targeted/biologic,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/28/2023,mg,antineoplastic,2/8/2022,10/14/2021,Intravenous,rituximab-pvvr,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/29/2018,AUC,antineoplastic,1/6/2018,9/27/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/13/2022,,antineoplastic,9/4/2021,5/25/2017,Oral,nilotinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/29/2017,mg,antineoplastic,12/16/2016,7/25/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/11/2019,,antineoplastic,10/1/2017,9/21/2017,,etoposide,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/10/2018,,antineoplastic,7/18/2018,5/7/2018,Intravenous,carboplatin,FALSE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/23/2016,mg,antineoplastic,12/3/2015,12/1/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/18/2025,mg,antineoplastic,1/12/2019,2/14/2019,Intravenous,pembrolizumab,TRUE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/22/2023,mg,antineoplastic,5/12/2019,11/25/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/17/2020,,antineoplastic,5/28/2020,11/25/2019,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/6/2020,mg,antineoplastic,4/17/2017,8/13/2016,Intravenous,nivolumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/16/2022,mg,antineoplastic,7/30/2022,6/7/2022,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,9/10/2013,mg,antineoplastic,7/15/2013,2/28/2013,Intravenous,paclitaxel protein-bound,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/7/2020,mg,antineoplastic,12/9/2018,11/5/2018,Intravenous,pemetrexed,TRUE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/14/2017,mg,antineoplastic,2/3/2017,11/16/2016,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,4/14/2025,mg,antineoplastic,12/11/2024,5/19/2024,Intravenous,durvalumab,TRUE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,9/30/2021,mg,antineoplastic,7/10/2021,4/24/2021,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,8/21/2021,mg,antineoplastic,4/17/2021,4/5/2021,Intravenous,pembrolizumab,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,1/4/2025,mg,antineoplastic,9/6/2024,4/13/2024,Intravenous,cemiplimab,TRUE
450,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/13/2024,mg,antineoplastic,6/3/2023,6/18/2023,Intravenous,carboplatin,FALSE
181,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/6/2013,mg,antineoplastic,10/21/2012,9/18/2012,Intravenous,carboplatin,FALSE
184,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/29/2020,mg,antineoplastic,9/21/2019,10/15/2019,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/14/2017,mg,antineoplastic,11/23/2015,6/28/2015,Intravenous,nivolumab,FALSE
392,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,4/30/2024,mg,antineoplastic,3/20/2024,2/24/2024,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/23/2020,mg,antineoplastic,1/16/2018,1/24/2018,Intravenous,pemetrexed,TRUE
441,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,1/10/2022,mg,antineoplastic,12/28/2021,11/21/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/13/2025,mg,antineoplastic,1/11/2021,3/15/2020,Intravenous,pembrolizumab,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,4/7/2025,mg/m2,antineoplastic,12/16/2024,11/27/2024,Intravenous,paclitaxel,FALSE
108,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,2/1/2017,mg,antineoplastic,7/16/2016,6/26/2016,Intravenous,paclitaxel,FALSE
825,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,4/4/2021,mg,antineoplastic,4/8/2021,1/30/2021,Intravenous,pemetrexed,FALSE
166,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/19/2019,mg,antineoplastic,11/7/2018,10/25/2018,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/22/2022,mg,antineoplastic,7/25/2021,3/19/2021,Intravenous,atezolizumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,9/18/2024,mg,antineoplastic,7/21/2024,7/21/2024,Intravenous,paclitaxel,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16B34C4BF7EB,4/5/2015,mg,antineoplastic,12/27/2014,10/31/2014,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/22/2020,mg,antineoplastic,11/2/2016,8/1/2016,Intravenous,nivolumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/27/2014,mg,antineoplastic,7/25/2014,5/26/2014,Intravenous,vinorelbine,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,10/10/2023,mg,antineoplastic,8/16/2023,7/12/2023,Intravenous,carboplatin,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Docetaxel",G168G1C789D7C,2/18/2014,mg,antineoplastic,1/12/2014,6/25/2013,Intravenous,bevacizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/31/2016,mg,antineoplastic,1/31/2016,6/1/2015,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/3/2018,AUC,antineoplastic,9/9/2017,9/6/2017,Intravenous,carboplatin,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/21/2024,mg,antineoplastic,11/15/2023,7/9/2023,Intravenous,gemcitabine,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/11/2018,mg,antineoplastic,10/13/2018,6/10/2018,Intravenous,paclitaxel,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,12/17/2013,mg,antineoplastic,11/24/2013,10/6/2013,Intravenous,vinorelbine,FALSE
158,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,8/16/2024,mg,antineoplastic,4/20/2024,4/25/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,8/10/2023,AUC,antineoplastic,5/17/2023,5/15/2023,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/27/2020,mg,antineoplastic,9/11/2017,6/28/2016,Intravenous,nivolumab,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/25/2021,mg,antineoplastic,7/31/2020,6/5/2020,Intravenous,gemcitabine,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,9/6/2020,mg,antineoplastic,6/6/2020,2/22/2020,Intravenous,carboplatin,FALSE
1940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/9/2018,mg,antineoplastic,7/10/2018,4/17/2018,Intravenous,gemcitabine,FALSE
190,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/1/2020,mg,antineoplastic,10/9/2016,6/27/2016,Intravenous,nivolumab,FALSE
80,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/9/2024,mg/m2,antineoplastic,11/24/2023,11/4/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/24/2023,mg,antineoplastic,4/20/2022,4/13/2022,Intravenous,pembrolizumab,FALSE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/11/2016,mg,antineoplastic,1/27/2016,6/2/2015,Intravenous,gemcitabine,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/23/2022,mg,antineoplastic,10/29/2021,5/14/2021,Intravenous,bevacizumab-bvzr,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/2/2019,mg/m2,antineoplastic,9/11/2019,9/8/2019,Intravenous,paclitaxel,FALSE
185,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,8/13/2021,mg,antineoplastic,6/29/2021,7/24/2021,Intravenous,paclitaxel protein-bound,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/28/2022,mg,antineoplastic,4/24/2022,12/29/2021,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G226G4F43C6FE,3/5/2017,mg,antineoplastic,11/18/2016,10/23/2016,Intravenous,nivolumab,FALSE
1000,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,8/18/2017,mg,antineoplastic,7/21/2017,7/1/2017,Intravenous,ramucirumab,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/15/2024,mg,antineoplastic,8/25/2023,9/5/2023,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G29D9FB:D1D6B,9/15/2016,,antineoplastic,6/29/2016,8/2/2016,,letrozole,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/24/2020,mg,antineoplastic,2/14/2020,7/21/2016,Intravenous,nivolumab,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/28/2023,,antineoplastic,12/22/2022,9/26/2022,Intravenous,docetaxel,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/19/2025,mg,antineoplastic,7/10/2023,5/4/2020,Subcutaneous,leuprolide,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,3/2/2014,mg,antineoplastic,8/10/2013,6/18/2013,Intravenous,paclitaxel,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/10/2024,mg,antineoplastic,5/31/2024,10/4/2023,Intravenous,durvalumab,TRUE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/3/2021,mg,antineoplastic,11/27/2021,10/19/2021,Intravenous,paclitaxel,FALSE
1150,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/18/2016,mg,antineoplastic,11/25/2015,12/3/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/7/2025,mg,antineoplastic,10/1/2021,12/30/2018,Intravenous,pembrolizumab,TRUE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/17/2019,mg,antineoplastic,11/7/2017,11/19/2016,Intramuscular,fulvestrant,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/7/2021,mg,antineoplastic,8/16/2019,5/12/2019,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/19/2022,,antineoplastic,6/18/2020,5/5/2017,Oral,nilotinib,FALSE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/21/2014,mg,antineoplastic,12/1/2013,6/22/2013,Intravenous,bevacizumab,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/15/2025,mg,antineoplastic,7/1/2024,3/12/2024,Intravenous,pemetrexed,TRUE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/18/2018,mg,antineoplastic,12/17/2017,11/12/2017,Intravenous,trastuzumab,FALSE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/24/2013,mg,antineoplastic,11/26/2012,8/28/2012,Intravenous,gemcitabine,FALSE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,3/4/2020,mg,antineoplastic,11/27/2019,10/24/2019,Intravenous,carboplatin,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/4/2013,mg,antineoplastic,9/12/2013,12/12/2012,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/5/2017,mg,antineoplastic,9/26/2016,7/4/2015,Intravenous,nivolumab,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,12/15/2023,5/17/2023,Intravenous,pemetrexed,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/16/2025,mg,antineoplastic,12/18/2024,6/17/2024,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/28/2013,mg/m2,antineoplastic,11/9/2013,8/11/2013,Intravenous,gemcitabine,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,5/14/2021,mg,antineoplastic,5/13/2021,11/10/2020,Intravenous,gemcitabine,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,5/3/2025,mg,antineoplastic,12/5/2024,1/3/2025,Intravenous,docetaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/31/2025,mg,antineoplastic,3/23/2024,1/17/2024,Intravenous,pembrolizumab,FALSE
66,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,5/19/2014,mg,antineoplastic,3/25/2014,3/15/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/25/2015,,antineoplastic,10/15/2015,5/12/2015,Oral,ibrutinib,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/13/2021,mg,antineoplastic,5/7/2021,4/30/2021,Intravenous,pembrolizumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/19/2023,mg,antineoplastic,6/3/2023,4/15/2023,Intravenous,paclitaxel,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/24/2025,mg,antineoplastic,3/4/2025,10/14/2024,Intravenous,pemetrexed,TRUE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/26/2014,mg,antineoplastic,4/7/2014,1/1/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/21/2025,mg,antineoplastic,3/11/2023,9/2/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/4/2025,mg,antineoplastic,9/13/2023,5/23/2023,Intravenous,pembrolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/22/2025,mg,antineoplastic,3/31/2025,6/7/2023,Intravenous,pembrolizumab,TRUE
454,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/30/2025,mg,antineoplastic,10/10/2020,3/11/2019,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1E35BD845958,5/16/2015,mg,antineoplastic,3/15/2015,1/3/2015,Intravenous,pemetrexed,TRUE
50,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/10/2022,mL,solution-fluid,5/13/2022,3/12/2022,Intravenous,ipilimumab,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/28/2015,mg,antineoplastic,11/6/2014,11/17/2014,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/20/2022,mg,antineoplastic,6/16/2022,12/23/2021,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,5/4/2024,mg,antineoplastic,1/9/2024,2/7/2024,Intravenous,paclitaxel protein-bound,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/28/2019,mg,antineoplastic,10/17/2019,7/28/2019,Intravenous,paclitaxel protein-bound,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/29/2019,mg,antineoplastic,6/22/2019,1/19/2019,Intravenous,pemetrexed,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/21/2019,mg,antineoplastic,4/14/2018,9/30/2017,Intravenous,atezolizumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,4/25/2016,mg,antineoplastic,4/27/2014,3/23/2014,Intravenous,paclitaxel,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,1/24/2014,mg,antineoplastic,11/24/2013,9/7/2013,Intravenous,vinorelbine,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/8/2021,mg/m2,antineoplastic,8/17/2021,4/8/2021,Intravenous,oxaliplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/26/2019,mg,antineoplastic,6/12/2018,6/10/2018,Intravenous,pembrolizumab,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/22/2015,mg,antineoplastic,8/23/2015,7/30/2014,Intravenous,bevacizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/5/2025,mg,antineoplastic,2/13/2025,11/12/2024,Intravenous,etoposide,FALSE
533,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,2/11/2023,mg,antineoplastic,6/24/2022,5/19/2022,Intravenous,carboplatin,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/8/2021,mg,antineoplastic,10/5/2020,5/18/2020,Intravenous,gemcitabine,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/20/2019,mg,antineoplastic,9/30/2018,12/6/2016,Intramuscular,fulvestrant,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,9/24/2021,mg,antineoplastic,8/10/2021,8/26/2021,Intravenous,cisplatin,FALSE
96,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,2/11/2017,mg,antineoplastic,12/22/2016,11/2/2016,Intravenous,carboplatin,FALSE
75,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G557E997E81G5,7/10/2023,mg,antineoplastic,5/29/2023,4/27/2023,Intravenous,docetaxel,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/24/2019,mg,antineoplastic,10/14/2019,8/7/2019,Intravenous,paclitaxel protein-bound,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,5/12/2016,mg,antineoplastic,1/9/2016,12/2/2015,Intravenous,ramucirumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/4/2020,mg,antineoplastic,12/18/2016,12/27/2015,Intravenous,nivolumab,FALSE
1665,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1B2469295BGE,3/1/2014,mg,antineoplastic,1/29/2014,2/26/2014,Intravenous,gemcitabine,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/10/2019,mg,antineoplastic,11/26/2018,12/10/2016,Intramuscular,fulvestrant,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/28/2021,mg,antineoplastic,8/10/2021,4/1/2021,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,8/4/2016,mg,antineoplastic,8/16/2016,7/3/2016,Intravenous,carboplatin,FALSE
1102,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/1/2020,mg,antineoplastic,11/21/2019,9/9/2019,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/19/2025,mg,antineoplastic,11/28/2023,9/3/2022,Intravenous,pembrolizumab,TRUE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G448FDE96D2D6,3/15/2015,mg,antineoplastic,3/9/2015,3/17/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/16/2025,mg,antineoplastic,2/14/2025,10/1/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G3B942496:87:,12/19/2012,,,1/23/2013,11/1/2012,Oral,erlotinib,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/30/2023,mg,antineoplastic,2/22/2023,12/2/2022,Intravenous,pembrolizumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/27/2019,mg/kg,antineoplastic,6/30/2019,8/21/2018,Intravenous,durvalumab,FALSE
427,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/21/2019,mg,antineoplastic,1/31/2019,1/12/2019,Intravenous,carboplatin,FALSE
74,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,5/25/2024,mg,antineoplastic,3/6/2024,2/18/2024,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,1/9/2019,mg,antineoplastic,5/20/2018,3/21/2017,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,12/27/2022,,antineoplastic,11/28/2022,9/13/2022,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/23/2020,mg,antineoplastic,8/17/2016,1/22/2016,Intravenous,bevacizumab,TRUE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,7/9/2020,mg,antineoplastic,5/21/2020,4/19/2020,Intravenous,carboplatin,FALSE
1035,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,12/12/2024,mg,antineoplastic,7/15/2024,3/14/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/5/2015,,antineoplastic,5/20/2015,3/19/2015,,pemetrexed,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,5/17/2025,,antineoplastic,11/17/2024,10/11/2024,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/7/2025,mg,antineoplastic,2/5/2025,3/26/2024,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/14/2013,mg,antineoplastic,2/4/2013,1/11/2013,Intravenous,paclitaxel protein-bound,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/17/2021,mg,antineoplastic,7/3/2019,6/7/2019,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/9/2021,mL,solution-fluid,9/14/2018,2/19/2018,Intravenous,durvalumab,TRUE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,2/28/2023,mg,antineoplastic,12/18/2022,12/27/2022,Intravenous,nivolumab,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/8/2021,mg,antineoplastic,1/14/2021,9/19/2020,Intravenous,bevacizumab,FALSE
45,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,9/9/2024,mg,antineoplastic,3/7/2023,2/8/2023,Intravenous,docetaxel,FALSE
1072.5,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,6/17/2023,mg,antineoplastic,7/20/2023,4/3/2023,Intravenous,bevacizumab-bvzr,FALSE
,4,ADVANCED,Administrations,pain agent,Clinical Study Drug,G177G4:B9E394,4/29/2025,,pain agent,4/12/2025,3/29/2025,Oral,clinical study drug,FALSE
129,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/15/2020,mg,antineoplastic,12/12/2019,10/17/2019,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/24/2025,mg,antineoplastic,6/21/2018,8/12/2016,Intravenous,pembrolizumab,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/14/2023,mg,antineoplastic,2/16/2020,1/25/2020,Intravenous,docetaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/23/2025,mg/m2,antineoplastic,9/18/2024,6/21/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/8/2025,mg,antineoplastic,4/20/2019,4/22/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/15/2021,,steroid,4/28/2020,1/27/2020,Intravenous,clinical study drug,FALSE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/3/2024,mg,antineoplastic,8/14/2024,7/14/2024,Intravenous,carboplatin,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,1/16/2015,mg,antineoplastic,1/30/2014,1/30/2014,Intravenous,cisplatin,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/21/2013,mg,antineoplastic,5/8/2013,5/22/2013,Intravenous,paclitaxel,FALSE
742,,ADJUVANT,Administrations,targeted/biologic,Rituximab,G1EG8767G6BG4,12/13/2018,mg,antineoplastic,12/11/2018,12/3/2018,Intravenous,rituximab,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,3/25/2014,mg,antineoplastic,4/6/2014,3/3/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/16/2012,,antineoplastic,7/20/2011,6/22/2011,Intravenous,clinical study drug,FALSE
376,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,1/3/2013,mg,antineoplastic,12/24/2012,12/4/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/21/2021,,antineoplastic,6/15/2021,6/10/2021,Intravenous,pemetrexed,FALSE
243,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/31/2021,mg,antineoplastic,7/6/2019,6/20/2019,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G5792EBE:8EB3,12/7/2012,mg/m2,antineoplastic,12/17/2012,8/25/2012,Intravenous,gemcitabine,FALSE
2000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/9/2019,mg,antineoplastic,6/10/2019,6/1/2019,Intravenous,bevacizumab,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/22/2020,mg,antineoplastic,6/24/2020,2/21/2020,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G15DCCD:D9154,7/26/2023,mg,antineoplastic,6/18/2023,6/16/2023,Intravenous,pembrolizumab,FALSE
1025,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G49E3CE9E292G,3/1/2023,mg,antineoplastic,5/23/2020,6/6/2020,Intravenous,pemetrexed,FALSE
22.5,4,ADVANCED,Administrations,hormone,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,4/12/2024,mg,antineoplastic,2/13/2024,3/27/2024,Subcutaneous,leuprolide,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/7/2022,mg,antineoplastic,4/26/2020,2/27/2016,Intravenous,pemetrexed,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/13/2018,AUC,antineoplastic,10/4/2017,10/14/2017,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/20/2020,mg,antineoplastic,3/3/2017,12/30/2016,Intravenous,nivolumab,FALSE
535,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,3/1/2013,mg,antineoplastic,1/28/2013,10/27/2012,Intravenous,carboplatin,FALSE
1770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,2/26/2025,mg,antineoplastic,1/22/2025,10/17/2024,Intravenous,gemcitabine,FALSE
136,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G24632:D18158,12/20/2019,mg,antineoplastic,7/20/2019,4/25/2019,Intravenous,docetaxel,FALSE
507.4,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/23/2025,mg,antineoplastic,5/21/2019,3/9/2019,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/19/2017,mg,antineoplastic,7/22/2015,5/26/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,10/2/2023,mg,antineoplastic,6/20/2023,4/26/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/10/2023,,antineoplastic,2/25/2023,3/1/2022,Intravenous,pembrolizumab,FALSE
830,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Temozolomide",G4DE3DE99E:13,1/25/2016,mg,antineoplastic,12/18/2015,12/19/2015,Intravenous,gemcitabine,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/22/2023,mg,antineoplastic,3/8/2023,4/7/2023,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/14/2020,mg,antineoplastic,4/24/2017,12/15/2015,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/17/2017,mg,antineoplastic,1/22/2014,1/13/2014,Intravenous,cisplatin,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/4/2020,mg,antineoplastic,10/31/2019,1/15/2019,Intravenous,durvalumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,9/22/2018,mg,antineoplastic,7/15/2018,7/7/2018,Intravenous,carboplatin,FALSE
15,4,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,1/23/2015,mg/kg,antineoplastic,12/25/2014,11/21/2014,Intravenous,bevacizumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/11/2019,mg,antineoplastic,11/14/2019,9/11/2019,Intravenous,paclitaxel protein-bound,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/11/2018,mg,antineoplastic,9/21/2018,6/14/2018,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,12/15/2024,mg,antineoplastic,11/9/2024,7/22/2024,Intravenous,pembrolizumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/30/2020,mg,antineoplastic,9/27/2020,10/4/2020,Intravenous,irinotecan,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/11/2022,mg,antineoplastic,9/22/2017,5/28/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/22/2020,mg,antineoplastic,9/15/2017,12/12/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,4/23/2025,mg,antineoplastic,3/29/2025,2/14/2025,Intravenous,pembrolizumab,TRUE
190,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/5/2012,mg,antineoplastic,12/26/2011,1/6/2012,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/31/2014,,antineoplastic,11/8/2013,10/21/2013,,clinical study drug,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/26/2025,mg,antineoplastic,12/25/2021,2/28/2020,Intravenous,pemetrexed,TRUE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/23/2018,mg,antineoplastic,1/26/2018,12/13/2017,Intravenous,paclitaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/7/2025,mg,antineoplastic,8/10/2023,2/27/2020,Intravenous,pemetrexed,TRUE
1840,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G24632:D18158,4/5/2020,mg,antineoplastic,3/7/2020,1/4/2020,Intravenous,gemcitabine,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/19/2025,mg,antineoplastic,2/5/2025,3/10/2024,Intravenous,durvalumab,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/10/2018,mL,solution-fluid,6/23/2015,7/24/2015,Intravenous,carboplatin,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,8/20/2020,mg,antineoplastic,8/21/2020,5/14/2020,Intravenous,pemetrexed,FALSE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,3/7/2025,mg,antineoplastic,12/9/2024,11/3/2024,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/24/2018,mg,antineoplastic,7/12/2017,5/4/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/1/2025,mg,antineoplastic,9/14/2024,9/8/2024,Intravenous,pembrolizumab,TRUE
66,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,4/1/2014,mg,antineoplastic,2/6/2014,2/22/2014,Intravenous,paclitaxel,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,11/14/2023,mg,antineoplastic,10/19/2023,8/23/2023,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G175D3C95:34G,6/29/2019,,,4/25/2019,5/28/2019,Oral,osimertinib,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/28/2021,AUC,antineoplastic,4/9/2021,4/8/2021,Intravenous,carboplatin,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/13/2021,mg,antineoplastic,10/7/2018,2/20/2018,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,5/23/2013,,antineoplastic,3/3/2013,3/27/2013,Intravenous,vinorelbine,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/10/2012,mg,antineoplastic,1/2/2012,1/2/2012,Intravenous,carboplatin,FALSE
1642,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,4/14/2014,mg,antineoplastic,2/21/2014,3/20/2014,Intravenous,gemcitabine,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,11/11/2023,mg,antineoplastic,1/22/2023,1/26/2023,Oral,zanubrutinib,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,4/10/2025,mg,antineoplastic,4/15/2025,3/30/2025,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,8/1/2023,mg,antineoplastic,5/21/2023,3/22/2023,Intravenous,atezolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/15/2024,mg,antineoplastic,12/13/2023,6/29/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/10/2025,mg,antineoplastic,6/13/2024,6/2/2022,Intravenous,pembrolizumab,FALSE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/6/2013,mg,antineoplastic,4/26/2013,5/26/2013,Intravenous,carboplatin,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/20/2024,mg,antineoplastic,11/7/2023,9/20/2023,Intravenous,paclitaxel,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/10/2012,mg,antineoplastic,2/6/2012,2/6/2012,Subcutaneous,amifostine,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/19/2021,mg,antineoplastic,10/24/2021,4/9/2021,Intravenous,pembrolizumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/4/2017,mg,antineoplastic,2/6/2017,1/11/2017,Intravenous,paclitaxel,FALSE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,6/13/2017,mg,antineoplastic,2/6/2016,12/31/2015,Intravenous,nivolumab,FALSE
183.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,3/5/2022,mg,antineoplastic,6/18/2014,6/8/2014,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,4/27/2024,mg,antineoplastic,1/19/2024,6/9/2023,Intravenous,nivolumab,TRUE
410,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/6/2024,mg,antineoplastic,1/22/2024,11/19/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/10/2024,mg,antineoplastic,6/1/2020,5/26/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/4/2025,mg,antineoplastic,3/11/2024,1/6/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,7/9/2024,mg,antineoplastic,9/24/2023,5/28/2023,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G46:87GF7FGC9,12/21/2015,,antineoplastic,8/14/2015,7/19/2015,Intravenous,clinical study drug,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45388C4DCEFB,7/2/2012,mg,antineoplastic,6/3/2012,6/19/2012,Intravenous,paclitaxel,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,7/1/2024,mg,antineoplastic,10/31/2023,10/5/2023,Intravenous,pemetrexed,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,4/19/2017,mg,antineoplastic,1/4/2017,11/27/2016,Intravenous,paclitaxel protein-bound,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/25/2023,mg,antineoplastic,2/4/2023,11/28/2022,Intravenous,durvalumab,FALSE
1295,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,8/17/2013,mg,antineoplastic,2/3/2013,3/22/2013,Intravenous,bevacizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/3/2020,mg,antineoplastic,12/26/2020,10/20/2020,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/21/2017,,antineoplastic,8/16/2017,7/31/2017,,paclitaxel,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/25/2013,mg,antineoplastic,3/1/2012,11/22/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/5/2025,mg,antineoplastic,7/6/2023,9/11/2022,Intravenous,pembrolizumab,TRUE
455.3,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/28/2025,mg,antineoplastic,3/17/2020,4/17/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/17/2025,mg,antineoplastic,6/30/2024,12/29/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,1/17/2025,,antineoplastic,9/7/2024,9/18/2024,Intravenous,pemetrexed,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,7/2/2013,mg,antineoplastic,2/2/2013,3/6/2013,Intravenous,gemcitabine,FALSE
395,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/12/2017,mg,antineoplastic,3/28/2017,2/22/2017,Intravenous,carboplatin,FALSE
131,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,9/18/2019,mg,antineoplastic,8/2/2018,6/27/2018,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/3/2019,mg,antineoplastic,4/10/2017,3/21/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,7/15/2017,,antineoplastic,9/22/2016,10/6/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/29/2025,,antineoplastic,9/17/2024,6/6/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/19/2020,mg,antineoplastic,3/19/2016,12/25/2015,Intravenous,nivolumab,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/12/2015,AUC,antineoplastic,1/16/2015,1/30/2015,Intravenous,carboplatin,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/24/2022,mg,antineoplastic,6/29/2021,6/15/2021,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/17/2016,mg,antineoplastic,11/7/2015,7/9/2015,Intravenous,carboplatin,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,3/17/2019,mg,antineoplastic,12/29/2018,12/10/2018,Intravenous,paclitaxel,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,4/9/2015,mg,antineoplastic,5/1/2015,3/20/2015,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/1/2025,mg,antineoplastic,7/26/2018,1/31/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,4/22/2025,mg,antineoplastic,8/17/2023,6/18/2023,Intravenous,pembrolizumab,TRUE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/23/2016,mg,antineoplastic,8/28/2014,5/5/2014,Intravenous,bevacizumab,FALSE
110.4,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Docetaxel",G168G1C789D7C,1/28/2014,mg,antineoplastic,9/22/2013,6/8/2013,Intravenous,docetaxel,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G4CG4:632GG8E,6/10/2021,,,12/20/2018,12/10/2018,Oral,afatinib,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/9/2023,,antineoplastic,12/8/2022,4/11/2022,Intravenous,durvalumab,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/8/2022,mg,antineoplastic,8/18/2022,6/25/2022,Intravenous,pemetrexed,FALSE
176,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,6/16/2024,mg,antineoplastic,4/20/2024,4/27/2024,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,7/7/2021,,antineoplastic,4/22/2021,5/4/2021,,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,9/30/2020,mg,antineoplastic,1/18/2020,9/10/2019,Intravenous,pembrolizumab,TRUE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/7/2023,mg,antineoplastic,3/29/2021,9/23/2019,Intravenous,pembrolizumab,TRUE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,6/29/2015,mg,antineoplastic,9/2/2013,7/18/2013,Intravenous,paclitaxel,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/13/2024,mg,antineoplastic,6/22/2024,9/12/2023,Intravenous,durvalumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,3/21/2025,mL,solution-fluid,4/30/2024,4/17/2024,Intravenous,pembrolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/13/2018,mg,antineoplastic,8/6/2015,6/28/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/12/2025,,antineoplastic,5/6/2023,2/8/2023,,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G555D3D316568,9/29/2018,mg,antineoplastic,8/7/2018,8/5/2018,Intravenous,nivolumab,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3B942496:87:,11/22/2012,mg/m2,antineoplastic,10/31/2012,10/27/2012,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G1CD225858D1:,7/29/2017,,solution-fluid,2/27/2017,1/9/2017,Intravenous,clinical study drug,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,3/23/2021,mg,antineoplastic,11/6/2020,11/22/2020,Intravenous,pemetrexed,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Rituximab",G48842BBE3634,6/25/2013,mg/d,antineoplastic,6/3/2013,5/22/2013,Other/Miscellaneous,cisplatin,FALSE
480,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/9/2025,mg,antineoplastic,10/11/2020,4/11/2019,Intravenous,carboplatin,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/4/2016,mg,antineoplastic,8/20/2016,6/18/2016,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/8/2018,mg,antineoplastic,3/2/2018,9/18/2015,Intravenous,nivolumab,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,5/24/2019,mg/m2,antineoplastic,2/12/2019,12/28/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G257459B7FF:E,10/16/2019,,,9/26/2019,3/20/2018,Oral,osimertinib,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4E68514B7GFD,4/8/2015,mg,antineoplastic,4/2/2015,2/1/2015,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/10/2019,mL,solution-fluid,10/19/2019,9/24/2019,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G13D3F29D3FFF,3/29/2014,mg,antineoplastic,11/27/2013,11/24/2013,Intravenous,cisplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/2/2015,mg,antineoplastic,1/20/2015,9/4/2014,Intravenous,cisplatin,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/17/2015,mg,antineoplastic,2/8/2015,9/3/2014,Intravenous,bevacizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/15/2013,mg/m2,antineoplastic,11/2/2013,7/13/2013,Intravenous,gemcitabine,FALSE
138,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/28/2024,mg,antineoplastic,11/28/2023,9/26/2023,Intravenous,carboplatin,FALSE
,5,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,12/11/2023,AUC,antineoplastic,11/30/2023,10/13/2023,Intravenous,carboplatin,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,12/2/2020,mg,antineoplastic,6/22/2020,4/30/2020,Intravenous,paclitaxel protein-bound,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/6/2019,mg,antineoplastic,4/12/2019,1/15/2019,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/15/2020,mg,antineoplastic,12/21/2019,12/19/2019,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,3/26/2023,mg,antineoplastic,3/24/2023,8/29/2022,Subcutaneous,azacitidine,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/31/2022,,antineoplastic,7/21/2020,4/2/2017,Oral,nilotinib,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,4/1/2025,,antineoplastic,3/11/2025,9/2/2024,Intravenous,durvalumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/4/2022,mg,antineoplastic,5/17/2021,3/9/2021,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,10/29/2018,,antineoplastic,11/5/2018,10/30/2018,Oral,hydroxyurea,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/26/2013,mg,antineoplastic,10/17/2013,10/3/2013,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/12/2023,mg,antineoplastic,1/20/2023,10/18/2022,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/9/2014,,antineoplastic,2/13/2014,12/3/2013,Intravenous,clinical study drug,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,10/3/2012,mg,antineoplastic,8/21/2012,7/6/2012,Intravenous,paclitaxel,FALSE
307,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/15/2018,mg,antineoplastic,6/25/2017,6/1/2017,Intravenous,carboplatin,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/13/2013,mg,antineoplastic,6/27/2013,6/5/2012,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/25/2013,mg/m2,antineoplastic,8/27/2013,8/24/2013,Intravenous,gemcitabine,FALSE
3.6,,ADJUVANT,Orders,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,9/12/2014,mg/kg,antineoplastic,10/9/2014,4/11/2014,Intravenous,ado-trastuzumab emtansine,FALSE
75,6,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,4/20/2021,mg,antineoplastic,8/30/2020,9/3/2020,Intravenous,docetaxel,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Temozolomide",G4DE3DE99E:13,2/15/2016,mg,antineoplastic,11/28/2015,12/30/2015,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/19/2025,mg/m2,antineoplastic,11/18/2024,6/24/2024,Intravenous,gemcitabine,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,12/3/2017,mg,antineoplastic,5/15/2017,4/17/2017,Intravenous,gemcitabine,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,4/20/2016,mg,antineoplastic,2/11/2016,2/2/2016,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/23/2020,mg,antineoplastic,9/1/2017,2/7/2016,Intravenous,bevacizumab,TRUE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G25B:66F61266,4/14/2025,mg,antineoplastic,2/25/2025,1/22/2025,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G4C4C3G28CF33,2/9/2022,,antineoplastic,12/13/2021,10/10/2021,,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/18/2020,mg,antineoplastic,12/21/2019,12/16/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GE686D11C25,4/28/2015,mg,antineoplastic,4/10/2015,4/8/2015,Intravenous,carboplatin,FALSE
,,CONCURRENT,Unstructured,,Crizotinib,G2F:C3344EG8G,4/8/2017,,,3/19/2017,8/7/2015,Oral,crizotinib,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/12/2021,mg/m2,antineoplastic,11/1/2021,9/25/2021,Intravenous,paclitaxel,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,7/31/2024,mg/m2,antineoplastic,8/16/2024,8/9/2024,Intravenous,pemetrexed,FALSE
774,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/22/2015,mg,antineoplastic,1/27/2015,11/2/2014,Intravenous,carboplatin,FALSE
175,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,1/22/2015,mg/m2,antineoplastic,12/18/2014,8/25/2014,Intravenous,paclitaxel,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/19/2020,mg,antineoplastic,1/28/2019,11/29/2015,Intravenous,nivolumab,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/20/2020,mg,antineoplastic,3/14/2020,1/26/2020,Intravenous,gemcitabine,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/20/2022,mg,antineoplastic,12/17/2021,8/11/2021,Intravenous,durvalumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/17/2018,mg,antineoplastic,8/3/2018,6/27/2018,Intravenous,cisplatin,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/10/2017,mg,antineoplastic,2/22/2014,11/29/2013,Intravenous,etoposide,FALSE
22.5,2,ADVANCED,Administrations,hormone,Leuprolide,G4G1G16FE1GF8,10/8/2014,mg,antineoplastic,7/24/2014,7/10/2014,Intramuscular,leuprolide,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,3/20/2023,mg,antineoplastic,10/22/2022,5/11/2022,Intravenous,atezolizumab,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,11/6/2024,mg,antineoplastic,5/5/2024,4/16/2024,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,11/21/2020,,antineoplastic,11/26/2020,12/6/2020,Oral,hydroxyurea,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,10/11/2024,mg,antineoplastic,7/27/2024,7/3/2024,Intravenous,pembrolizumab,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,4/16/2013,mg,antineoplastic,3/12/2013,2/27/2013,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/16/2024,,antineoplastic,7/22/2023,5/10/2023,Intravenous,atezolizumab,FALSE
1000,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,6/23/2024,mg,antineoplastic,6/9/2024,5/13/2024,Intravenous,pemetrexed,FALSE
683,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/28/2015,mg,antineoplastic,5/15/2015,3/16/2015,Intravenous,carboplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,7/21/2024,mg,antineoplastic,6/10/2024,6/8/2024,Intravenous,carboplatin,FALSE
516,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,10/27/2021,mg,antineoplastic,8/26/2021,7/6/2021,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,2/1/2015,mg,antineoplastic,12/1/2014,9/23/2014,Intravenous,cisplatin,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,11/26/2023,mg,antineoplastic,1/16/2024,11/9/2023,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,8/9/2019,mg,antineoplastic,6/28/2019,5/30/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/15/2018,mg,antineoplastic,12/29/2017,3/16/2017,Intravenous,pembrolizumab,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/17/2021,mg,antineoplastic,8/13/2020,6/6/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/20/2021,mg/m2,antineoplastic,7/26/2021,4/1/2021,Intravenous,leucovorin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/4/2021,mg,antineoplastic,7/19/2021,3/20/2021,Intravenous,paclitaxel protein-bound,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/12/2020,mg,antineoplastic,7/21/2020,6/10/2020,Intravenous,pemetrexed,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/24/2024,mg,antineoplastic,4/29/2023,3/14/2022,Intravenous,durvalumab,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,6/15/2019,mg,antineoplastic,11/28/2018,11/28/2018,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,5/17/2025,mg,antineoplastic,4/4/2025,2/5/2025,Intravenous,carboplatin,FALSE
810,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/13/2017,mg,antineoplastic,9/2/2016,8/1/2016,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/2/2023,mg,antineoplastic,5/27/2021,3/22/2020,Intravenous,pembrolizumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/26/2025,mg,antineoplastic,7/27/2024,2/2/2024,Intravenous,durvalumab,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/25/2022,mg,antineoplastic,5/26/2017,5/28/2017,Oral,dasatinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,7/4/2020,mg,antineoplastic,7/6/2019,8/3/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/30/2018,mg,antineoplastic,5/28/2017,9/11/2015,Intravenous,nivolumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,1/19/2016,mg,antineoplastic,11/30/2015,11/10/2015,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/14/2021,mg,antineoplastic,10/27/2021,8/20/2021,Intravenous,carboplatin,FALSE
569,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,8/8/2014,mg,antineoplastic,9/6/2014,7/15/2014,Intravenous,carboplatin,FALSE
1295,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,8/7/2013,mg,antineoplastic,3/3/2013,2/26/2013,Intravenous,bevacizumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,2/2/2019,mg,antineoplastic,1/3/2019,12/22/2018,Intravenous,paclitaxel,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/15/2017,mg,antineoplastic,5/5/2016,6/2/2015,Intravenous,nivolumab,FALSE
1140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,6/19/2012,mg,antineoplastic,4/29/2012,3/26/2012,Intravenous,pemetrexed,FALSE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,11/10/2019,mg,antineoplastic,7/21/2019,8/2/2019,Intravenous,paclitaxel,FALSE
1350,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/22/2016,mg,antineoplastic,3/30/2015,2/22/2015,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,7/15/2021,,antineoplastic,5/30/2021,2/18/2021,Intravenous,pemetrexed,TRUE
179,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,7/21/2023,mg,antineoplastic,4/1/2023,2/26/2023,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/19/2025,mg,antineoplastic,11/29/2019,2/7/2018,Intravenous,nivolumab,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/12/2023,mg,antineoplastic,10/27/2022,10/19/2022,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,9/12/2021,mg,antineoplastic,9/11/2021,3/21/2021,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/15/2016,mg,antineoplastic,12/24/2015,7/6/2015,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,2/15/2023,mg,antineoplastic,3/4/2023,7/25/2022,Intravenous,docetaxel,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1CFE2442E26G,1/2/2014,mg,antineoplastic,1/17/2014,11/13/2013,Intravenous,bevacizumab,TRUE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/25/2022,,antineoplastic,6/6/2019,3/29/2017,Oral,nilotinib,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/11/2025,,antineoplastic,2/16/2023,2/2/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/6/2019,mg,antineoplastic,4/20/2018,1/26/2018,Intravenous,pembrolizumab,FALSE
185,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,8/14/2016,mg,antineoplastic,5/8/2016,4/11/2016,Intravenous,carboplatin,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,12/28/2024,mg,antineoplastic,5/22/2023,2/20/2023,Intravenous,paclitaxel protein-bound,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,8/17/2018,mg,antineoplastic,1/14/2018,10/3/2017,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,8/15/2021,mg,antineoplastic,9/9/2021,3/3/2021,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,5/16/2012,,solution-fluid,3/22/2012,10/24/2011,Intravenous,clinical study drug,FALSE
910,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,7/10/2016,mg,antineoplastic,6/15/2016,4/17/2016,Intravenous,pemetrexed,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/18/2016,mg/kg,antineoplastic,3/11/2016,3/12/2016,Intravenous,bevacizumab,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/22/2023,mg,antineoplastic,7/24/2023,11/23/2022,Intravenous,pemetrexed,FALSE
965,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/15/2025,mg,antineoplastic,9/9/2020,3/17/2019,Intravenous,pemetrexed,FALSE
364,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,3/12/2022,mg,antineoplastic,1/13/2022,10/3/2021,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,7/20/2024,,antiemetic,4/16/2024,5/18/2024,Intravenous,clinical study drug,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/15/2025,mg,antineoplastic,8/8/2022,8/9/2022,Oral,anastrozole,FALSE
2600,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,5/31/2022,mg,antineoplastic,12/10/2021,8/10/2021,Intravenous,gemcitabine,FALSE
179,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,4/3/2023,mg,antineoplastic,2/2/2023,10/16/2022,Intravenous,carboplatin,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG899C7446,11/27/2024,mg,antineoplastic,12/29/2024,12/24/2024,Intravenous,pemetrexed,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,1/9/2022,mg,antineoplastic,6/25/2019,5/15/2019,Intravenous,paclitaxel,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/22/2021,mg,antineoplastic,12/28/2020,12/15/2020,Intravenous,vinorelbine,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,9/24/2024,mg,antineoplastic,8/21/2024,8/1/2024,Intravenous,paclitaxel,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/25/2015,mg,antineoplastic,10/25/2015,6/28/2015,Intravenous,paclitaxel protein-bound,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,12/18/2014,mg,antineoplastic,8/28/2014,8/17/2014,Intravenous,paclitaxel,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,7/14/2013,mg,antineoplastic,7/10/2013,5/15/2013,Intravenous,paclitaxel protein-bound,FALSE
400,5,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,3/18/2025,mg,antineoplastic,3/14/2025,12/16/2024,Intravenous,pembrolizumab,FALSE
722,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/22/2014,mg,antineoplastic,9/12/2014,7/24/2014,Intravenous,carboplatin,FALSE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,7/31/2024,mg,antineoplastic,5/27/2024,5/4/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/25/2025,mg,antineoplastic,9/27/2024,10/21/2024,Intravenous,pembrolizumab,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,4/12/2024,mg,antineoplastic,1/11/2024,10/31/2023,Intravenous,nivolumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/16/2013,AUC,antineoplastic,9/10/2012,7/20/2012,Intravenous,carboplatin,FALSE
770,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/23/2014,mg,antineoplastic,3/23/2014,3/12/2014,Intravenous,bevacizumab,FALSE
670,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,1/16/2024,mg,antineoplastic,10/2/2023,10/7/2023,Intravenous,pemetrexed,FALSE
543,2,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/6/2022,mg,antineoplastic,3/23/2021,2/27/2021,Intravenous,carboplatin,FALSE
167,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/20/2016,mg,antineoplastic,1/8/2016,12/10/2015,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,Relugolix,G214C6EC1517:,12/23/2024,,antineoplastic,1/11/2025,11/10/2024,Oral,relugolix,FALSE
206.8,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,7/19/2016,mg,antineoplastic,11/22/2015,12/10/2015,Intravenous,carboplatin,FALSE
5,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,1/13/2022,mg/kg,antineoplastic,11/8/2021,10/7/2021,Intravenous,bevacizumab-awwb,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/21/2024,mg,antineoplastic,7/12/2023,1/8/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/11/2024,mg,antineoplastic,7/20/2024,6/24/2024,Intravenous,pembrolizumab,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,2/17/2014,mg,antineoplastic,1/20/2014,12/26/2013,Intravenous,paclitaxel,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,7/29/2015,mg,antineoplastic,1/9/2015,1/11/2015,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,4/21/2025,mg,antineoplastic,4/19/2025,4/21/2025,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4ED3922EEE48,6/6/2019,mg,antineoplastic,2/19/2019,3/7/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/16/2025,,antineoplastic,12/15/2024,11/24/2024,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/27/2020,mg,antineoplastic,10/18/2016,8/12/2016,Intravenous,nivolumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/29/2023,mg,antineoplastic,2/26/2019,12/7/2017,Intravenous,nivolumab,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/12/2021,mg,antineoplastic,5/2/2021,6/5/2020,Intravenous,gemcitabine,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,6/14/2024,mg,antineoplastic,6/7/2023,5/16/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,2/27/2025,mg,antineoplastic,3/3/2020,3/3/2020,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,6/30/2014,mg,antineoplastic,4/17/2014,4/8/2014,Intravenous,carboplatin,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/22/2020,mg,antineoplastic,9/3/2019,2/9/2019,Intravenous,durvalumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/16/2020,mg,antineoplastic,6/22/2019,6/19/2019,Intravenous,paclitaxel,FALSE
180,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G14FD45889171,11/26/2015,mg,antineoplastic,11/15/2015,10/1/2015,Intravenous,nivolumab,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/14/2020,mg,antineoplastic,8/6/2020,5/9/2020,Intravenous,paclitaxel protein-bound,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/12/2023,mg,antineoplastic,3/29/2023,8/27/2022,Subcutaneous,azacitidine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G12D5DB79FEED,4/5/2015,mg,antineoplastic,2/14/2015,12/7/2014,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G22FG21G231E9,6/3/2023,,,6/14/2022,6/4/2022,Oral,osimertinib,FALSE
1040,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17169D3:3667,7/3/2023,mg,antineoplastic,6/6/2023,5/20/2023,Intravenous,pemetrexed,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/8/2023,mg,antineoplastic,7/25/2023,7/13/2023,Intravenous,paclitaxel,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46E218G4252C,9/6/2016,mg,antineoplastic,5/12/2016,6/8/2016,Intravenous,carboplatin,FALSE
259,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/26/2024,mg,antineoplastic,10/21/2023,8/31/2023,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/3/2025,mg,antineoplastic,2/8/2025,7/14/2024,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/22/2020,mg,antineoplastic,3/7/2020,3/24/2020,Intravenous,carboplatin,FALSE
1900,1,LOCOREGIONAL,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,10/7/2021,mg,antineoplastic,8/26/2021,7/13/2021,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/24/2025,mg,antineoplastic,11/7/2018,2/20/2018,Intravenous,nivolumab,FALSE
156.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,8/30/2019,mg,antineoplastic,5/26/2019,5/27/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/6/2018,,antineoplastic,9/28/2017,6/21/2017,,clinical study drug,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/30/2021,,steroid,6/22/2020,2/1/2020,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/11/2020,mg,antineoplastic,6/25/2019,5/12/2019,Intravenous,pembrolizumab,TRUE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1151G7416919,3/24/2014,mg,antineoplastic,3/16/2014,3/3/2014,Intravenous,carboplatin,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/9/2025,mg,antineoplastic,11/6/2024,9/20/2024,Intravenous,nivolumab,FALSE
97,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/4/2024,mg,antineoplastic,5/29/2024,6/6/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,6/7/2019,mg,antineoplastic,3/14/2019,11/30/2018,Intravenous,pembrolizumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G5829EBB749DF,4/9/2019,mg,antineoplastic,3/8/2019,1/14/2019,Intravenous,paclitaxel protein-bound,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27:46:6B7F9E,3/13/2020,mg,antineoplastic,2/20/2020,12/12/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/16/2022,mg,antineoplastic,4/7/2022,7/13/2020,Intravenous,pembrolizumab,TRUE
565,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G126:384BC665,3/5/2015,mg,antineoplastic,2/3/2015,2/22/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,1/28/2019,mg,antineoplastic,8/1/2018,3/9/2018,Intravenous,nivolumab,FALSE
995,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G58C6E1DD1D13,1/26/2023,mg,antineoplastic,11/13/2022,11/16/2022,Intravenous,pemetrexed,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/13/2017,mL,solution-fluid,10/26/2017,8/6/2017,Intravenous,carboplatin,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/5/2012,mg,antineoplastic,9/7/2011,8/15/2011,Intravenous,vinorelbine,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/2/2022,mg,antineoplastic,3/29/2021,4/3/2021,Intravenous,durvalumab,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,3/31/2025,mg,antineoplastic,4/27/2025,11/10/2024,Intravenous,gemcitabine,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/21/2013,mg/m2,antineoplastic,11/25/2012,7/13/2012,Intravenous,docetaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/18/2023,mg,antineoplastic,2/25/2022,1/28/2020,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,5/17/2025,mg,antineoplastic,2/17/2025,11/15/2024,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,6/1/2013,mg/m2,antineoplastic,3/28/2013,12/16/2012,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/17/2022,,antineoplastic,4/24/2022,2/25/2022,,nivolumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/16/2013,mg,antineoplastic,3/31/2012,12/28/2011,Intravenous,etoposide,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,7/2/2013,mg,antineoplastic,6/2/2013,11/21/2012,Intravenous,vinorelbine,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/12/2015,mg,antineoplastic,7/12/2015,7/17/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/8/2019,mg,antineoplastic,8/21/2018,3/29/2016,Intravenous,nivolumab,FALSE
810,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/26/2017,mg,antineoplastic,9/30/2016,11/3/2016,Intravenous,pemetrexed,FALSE
130,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/22/2012,mg,antineoplastic,1/21/2012,11/10/2011,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/8/2023,mg,antineoplastic,5/30/2022,3/8/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/28/2025,mg,antineoplastic,2/26/2025,3/28/2024,Intravenous,pembrolizumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,10/4/2019,AUC,antineoplastic,8/12/2019,9/15/2019,Intravenous,carboplatin,FALSE
259.8,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G57:2GEC9DD36,11/26/2015,mg,antineoplastic,10/24/2015,9/22/2015,Intravenous,nivolumab,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/6/2015,mg,antineoplastic,7/31/2014,5/28/2014,Intravenous,vinorelbine,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,11/22/2018,mg,antineoplastic,1/21/2018,12/9/2017,Intravenous,cisplatin,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/20/2018,mg,antineoplastic,2/9/2018,10/26/2017,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/7/2024,mg,antineoplastic,2/26/2024,12/24/2022,Intravenous,nivolumab,FALSE
955,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,7/25/2015,mg,antineoplastic,6/3/2015,6/21/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21953622CB66,7/3/2019,mg,antineoplastic,6/2/2019,2/8/2019,Intravenous,pembrolizumab,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,9/12/2012,mg,antineoplastic,6/27/2012,2/16/2012,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/15/2024,mg,antineoplastic,4/16/2024,8/14/2023,Intravenous,nivolumab,FALSE
1020,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,4/3/2023,mg,antineoplastic,1/16/2023,1/26/2023,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,5/5/2021,mg,antineoplastic,4/15/2021,6/3/2020,Intravenous,pembrolizumab,TRUE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,4/1/2021,mg,antineoplastic,12/20/2020,6/6/2020,Intravenous,pembrolizumab,TRUE
1075,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/16/2016,mg,antineoplastic,1/18/2016,11/15/2014,Intravenous,pemetrexed,FALSE
895,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,5/20/2023,mg,antineoplastic,6/16/2023,6/29/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/6/2024,mg,antineoplastic,10/14/2023,11/2/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/22/2019,mg,antineoplastic,1/7/2018,5/11/2017,Intravenous,nivolumab,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,2/10/2015,mg,antineoplastic,11/19/2014,9/29/2014,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/15/2022,mg,antineoplastic,9/2/2017,4/7/2017,Oral,dasatinib,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,4/24/2025,mg,antineoplastic,2/21/2025,3/16/2025,Intravenous,paclitaxel,FALSE
1300,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,9/23/2019,mg,antineoplastic,5/26/2019,6/20/2019,Intravenous,pemetrexed,FALSE
217.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/3/2015,mg,antineoplastic,6/10/2015,3/6/2015,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,12/27/2024,mg,antineoplastic,12/4/2024,5/13/2024,Intravenous,durvalumab,TRUE
100,1,ADVANCED,Administrations,solution-fluid,"Bevacizumab,Pemetrexed",G44B44661:316,2/4/2016,mL,solution-fluid,3/26/2015,3/28/2015,Intravenous,bevacizumab,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/22/2018,mg,antineoplastic,6/2/2018,3/24/2018,Intravenous,carboplatin,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/20/2016,mg,antineoplastic,2/1/2016,12/4/2015,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G475BB:CGC731,3/24/2025,mg,antineoplastic,5/8/2024,8/16/2021,Intravenous,atezolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/7/2022,mg,antineoplastic,8/24/2021,1/29/2020,Intravenous,nivolumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/9/2016,mg,antineoplastic,6/2/2016,5/20/2016,Intravenous,paclitaxel,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/28/2015,mg,antineoplastic,1/1/2015,1/2/2015,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G17:EF9E52451,8/14/2024,,,8/26/2021,7/25/2021,Oral,osimertinib,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/11/2021,mg,antineoplastic,10/8/2021,9/10/2021,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/19/2024,mg,antineoplastic,11/4/2021,7/31/2020,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/11/2019,mg,antineoplastic,2/19/2018,2/6/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,10/24/2022,mg,antineoplastic,7/4/2018,1/13/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/12/2017,,antineoplastic,3/28/2016,3/3/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G54B14B192B6B,2/13/2019,mg,antineoplastic,2/20/2019,2/15/2019,Intravenous,pembrolizumab,FALSE
531,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G161297FC6EC1,12/31/2014,mg,antineoplastic,1/16/2015,11/8/2014,Intravenous,carboplatin,FALSE
6,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,1/28/2021,AUC,antineoplastic,2/12/2021,10/5/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G12E3G252G92G,4/21/2015,,,3/27/2015,2/8/2014,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/8/2025,mg,antineoplastic,2/5/2025,10/30/2024,Intravenous,pembrolizumab,TRUE
735,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G48EG9E748G84,11/25/2014,mg,antineoplastic,12/14/2014,12/10/2014,Intravenous,pemetrexed,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/21/2025,mg,antineoplastic,2/28/2023,8/30/2022,Intravenous,pemetrexed,TRUE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/28/2022,mg,antineoplastic,7/21/2021,6/15/2021,Intravenous,bevacizumab-bvzr,FALSE
128,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/24/2024,mg,antineoplastic,9/6/2024,8/10/2024,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,6/17/2019,mg/m2,antineoplastic,4/29/2019,1/23/2019,Intravenous,paclitaxel,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/11/2016,mg,antineoplastic,3/17/2016,10/4/2014,Intravenous,bevacizumab,TRUE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/17/2022,mg,antineoplastic,11/9/2021,11/1/2021,Intravenous,carboplatin,FALSE
139,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/7/2015,mg,antineoplastic,7/2/2015,5/10/2015,Intravenous,etoposide,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,4/9/2014,mg,antineoplastic,2/17/2014,3/28/2014,Intravenous,carboplatin,FALSE
187,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/22/2014,mg,antineoplastic,3/7/2014,2/25/2014,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,5/9/2025,,antineoplastic,1/14/2025,8/29/2024,Intravenous,durvalumab,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3EC5EB18C676,6/22/2017,mg/m2,antineoplastic,6/11/2016,6/22/2016,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/19/2023,mg,antineoplastic,12/8/2022,11/6/2022,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G46:87GF7FGC9,12/26/2015,,antiemetic,10/2/2015,8/5/2015,Intrajejunal,clinical study drug,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4:6E57617757,5/1/2025,,,6/26/2021,6/30/2021,Oral,osimertinib,FALSE
45,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G1F:9CFGFGFC1,5/26/2014,mg,antineoplastic,6/21/2014,4/21/2014,Intravenous,cisplatin,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,8/20/2023,mg,antineoplastic,7/27/2023,6/18/2023,Intravenous,paclitaxel,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,2/4/2015,mg,antineoplastic,2/1/2015,5/25/2014,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/16/2018,mg,antineoplastic,2/11/2018,9/9/2015,Intravenous,nivolumab,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,12/15/2023,mg,antineoplastic,3/10/2023,3/6/2023,Intravenous,cyclophosphamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/8/2023,mg,antineoplastic,7/20/2022,3/1/2022,Intravenous,pembrolizumab,FALSE
500,4,ADVANCED,Administrations,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/28/2017,mg,antineoplastic,5/26/2016,6/20/2016,Intramuscular,fulvestrant,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,,antineoplastic,12/30/2020,4/5/2017,Oral,nilotinib,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/17/2015,mg,antineoplastic,11/1/2014,7/29/2014,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/7/2012,mg,antineoplastic,3/2/2012,2/2/2012,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,5/7/2015,mg,antineoplastic,6/2/2015,5/1/2015,Intravenous,carboplatin,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/12/2016,AUC,antineoplastic,3/10/2016,5/29/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,7/22/2024,mg,antineoplastic,6/21/2024,5/4/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,12/31/2019,mg,antineoplastic,10/13/2019,9/21/2019,Intravenous,pembrolizumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/23/2015,mg,antineoplastic,3/14/2015,1/28/2015,Intravenous,carboplatin,FALSE
1272,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,9/4/2015,mg,antineoplastic,9/5/2015,8/28/2015,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G46:87GF7FGC9,12/17/2015,,antineoplastic,9/21/2015,7/15/2015,Intravenous,clinical study drug,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/3/2015,mg,antineoplastic,11/12/2014,11/6/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G579E53D92:75,11/21/2011,,steroid,9/6/2011,9/5/2011,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1GFD92F489E7,2/28/2023,,antineoplastic,1/15/2023,1/12/2023,Oral,anastrozole,FALSE
770,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/2/2025,mg,antineoplastic,1/12/2024,2/25/2019,Intravenous,pemetrexed,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/28/2016,mg,antineoplastic,12/18/2014,10/25/2014,Intravenous,bevacizumab,TRUE
700,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G11:1G4CE9G7B,5/3/2019,mg,antineoplastic,1/31/2019,1/27/2019,Intravenous,bevacizumab,TRUE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4F:7C5268:G1,4/8/2025,mg,antineoplastic,4/12/2025,4/13/2025,Intravenous,carboplatin,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/22/2013,mg,antineoplastic,4/19/2013,5/3/2013,Intravenous,paclitaxel,FALSE
500,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/25/2013,mg,antineoplastic,9/28/2013,6/21/2013,Intravenous,carboplatin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/5/2021,mg,antineoplastic,11/20/2020,9/27/2020,Intravenous,durvalumab,FALSE
1137,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,8/4/2023,mg,antineoplastic,2/16/2023,3/22/2023,Intravenous,bevacizumab-bvzr,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/18/2023,,antineoplastic,1/18/2023,1/2/2023,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G5722GECG4G16,3/24/2024,mg,antineoplastic,2/3/2024,10/18/2023,Intravenous,durvalumab,TRUE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,3/29/2022,mg/kg,antineoplastic,3/13/2022,3/14/2021,Intravenous,durvalumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/30/2024,mg,antineoplastic,11/29/2023,12/22/2021,Intravenous,nivolumab,TRUE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/30/2025,mg,antineoplastic,6/14/2018,9/1/2016,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/28/2018,mg,antineoplastic,8/14/2018,7/3/2018,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,9/16/2020,mg,antineoplastic,5/26/2020,4/10/2020,Intravenous,pembrolizumab,TRUE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/25/2019,mg,antineoplastic,8/22/2019,9/15/2019,Intravenous,etoposide,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/9/2018,mg/m2,antineoplastic,9/29/2017,9/11/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,5/7/2018,,antineoplastic,3/13/2018,12/14/2017,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/3/2024,mg,antineoplastic,2/21/2024,8/12/2023,Intravenous,nivolumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/23/2017,mg,antineoplastic,3/20/2017,11/19/2016,Intravenous,nivolumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/25/2013,mg,antineoplastic,7/10/2012,1/6/2012,Intravenous,etoposide,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,7/16/2020,,antineoplastic,6/2/2019,3/10/2019,,nivolumab,FALSE
390,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,7/9/2014,mg,antineoplastic,6/22/2014,2/28/2014,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,7/27/2020,mL,solution-fluid,10/23/2019,1/19/2019,Intravenous,nivolumab,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/8/2018,mg/m2,antineoplastic,12/2/2017,10/9/2017,Intravenous,paclitaxel,FALSE
3,2,ADVANCED,Orders,immunotherapy,Nivolumab,G1D:B49GGG719,5/17/2017,mg/kg,antineoplastic,5/22/2017,11/12/2016,Intravenous,nivolumab,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/5/2019,mg,antineoplastic,7/29/2019,7/22/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,7/21/2015,,,12/17/2014,12/20/2014,Oral,erlotinib,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/10/2023,mg,antineoplastic,5/18/2023,4/12/2023,Intravenous,paclitaxel protein-bound,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,4/20/2024,mg,antineoplastic,2/9/2024,2/9/2024,Intravenous,paclitaxel,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/15/2022,mg,antineoplastic,2/13/2022,11/6/2021,Intravenous,pemetrexed,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,9/17/2015,mg,antineoplastic,7/4/2015,3/18/2015,Intravenous,pemetrexed,FALSE
1230,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/16/2017,mg,antineoplastic,1/10/2017,1/4/2017,Intravenous,gemcitabine,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/22/2021,mg,antineoplastic,2/13/2021,11/4/2020,Intravenous,bevacizumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,1/24/2025,mg,antineoplastic,2/10/2025,1/5/2025,Intravenous,paclitaxel protein-bound,FALSE
63,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/6/2015,mg,antineoplastic,2/27/2015,3/18/2015,Intravenous,paclitaxel,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48796B29723B,6/11/2013,mg,antineoplastic,7/7/2013,6/22/2013,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/14/2025,mg,antineoplastic,5/24/2022,1/21/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/20/2025,mg,antineoplastic,5/6/2018,6/1/2018,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G547F143D3DEG,2/12/2025,,,9/28/2024,8/31/2024,Oral,trametinib,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,1/19/2020,mg,antineoplastic,10/20/2019,10/3/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/6/2025,mg,antineoplastic,8/4/2024,5/11/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/28/2022,,antineoplastic,4/23/2020,4/30/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,10/10/2018,mg,antineoplastic,6/21/2018,5/21/2018,Intravenous,pembrolizumab,FALSE
524,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,2/6/2025,mg,antineoplastic,1/24/2025,10/26/2024,Intravenous,carboplatin,FALSE
1250,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G53C52948773G,4/5/2024,mg/m2,antineoplastic,4/4/2024,3/19/2024,Intravenous,gemcitabine,FALSE
463,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,11/28/2024,mg,antineoplastic,11/18/2024,9/12/2024,Intravenous,carboplatin,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/29/2022,mg,antineoplastic,6/2/2022,5/13/2022,Intravenous,carboplatin,FALSE
297,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/21/2015,mg,antineoplastic,2/4/2015,12/3/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G24C:63G27686,2/4/2014,,antineoplastic,1/17/2014,12/22/2013,,clinical study drug,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/8/2024,mg,antineoplastic,2/28/2024,8/27/2023,Intravenous,durvalumab,FALSE
290,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,3/12/2020,mg,antineoplastic,2/19/2020,2/24/2020,Intravenous,irinotecan,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/17/2025,mg,antineoplastic,10/8/2023,10/20/2023,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,5/12/2025,mg,antineoplastic,2/12/2025,2/25/2025,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,cytoprotective,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/31/2012,,cytoprotective,4/2/2012,3/14/2012,,clinical study drug,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/18/2021,mg,antineoplastic,12/11/2020,1/5/2021,Intravenous,gemcitabine,FALSE
770,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/11/2025,mg,antineoplastic,10/18/2023,2/18/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,1/1/2019,mg,antineoplastic,5/11/2018,4/7/2017,Intravenous,pembrolizumab,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G215817D1B289,1/9/2021,mg,antineoplastic,1/17/2021,2/12/2021,Intravenous,pemetrexed,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/14/2023,mg,antineoplastic,11/11/2022,10/26/2022,Intravenous,bevacizumab-bvzr,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/8/2013,mg,antineoplastic,3/17/2012,1/8/2012,Intravenous,etoposide,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/1/2021,mg,antineoplastic,3/13/2021,9/28/2020,Intravenous,nivolumab,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/2/2022,mg,antineoplastic,6/18/2021,4/21/2021,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4C3G28CF33,2/5/2022,mg,antineoplastic,12/14/2021,12/5/2021,Intravenous,pembrolizumab,FALSE
1126.3,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/27/2016,mg,antineoplastic,7/8/2015,2/19/2015,Intravenous,bevacizumab,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,9/22/2014,mg,antineoplastic,8/17/2014,9/6/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,11/21/2015,,steroid,9/26/2015,8/7/2015,Intrajejunal,clinical study drug,FALSE
350,1,ADVANCED,Administrations,immunotherapy,Cemiplimab,G4484725BB423,2/6/2025,mg,antineoplastic,1/4/2025,5/14/2024,Intravenous,cemiplimab,TRUE
602,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G161297FC6EC1,1/21/2015,mg,antineoplastic,12/8/2014,10/30/2014,Intravenous,carboplatin,FALSE
319,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,10/26/2022,mg,antineoplastic,5/14/2022,5/24/2022,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/22/2020,mg,antineoplastic,8/30/2016,11/2/2015,Intravenous,nivolumab,FALSE
71.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,10/10/2021,mg,antineoplastic,7/4/2021,5/17/2021,Intravenous,paclitaxel,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/26/2014,mg,antineoplastic,4/16/2014,4/1/2014,Intravenous,paclitaxel,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/14/2025,mg,antineoplastic,7/24/2024,7/15/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/14/2025,mg,antineoplastic,5/6/2020,3/29/2020,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/28/2024,mg,antineoplastic,10/23/2024,9/20/2024,Intravenous,pemetrexed,TRUE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/25/2022,mg,antineoplastic,4/29/2017,5/5/2017,Intravenous,nivolumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/19/2017,mg,antineoplastic,8/19/2015,5/19/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/12/2022,mg,antineoplastic,12/8/2020,4/26/2020,Intravenous,pembrolizumab,TRUE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/27/2021,mL,solution-fluid,4/26/2018,3/30/2018,Intravenous,durvalumab,TRUE
600,2,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,6/19/2019,mg,antineoplastic,5/10/2019,6/10/2019,Intravenous,leucovorin,FALSE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,8/17/2024,mg,antineoplastic,8/17/2024,7/5/2024,Intravenous,gemcitabine,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,10/28/2015,mg,antineoplastic,7/30/2015,7/25/2015,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/24/2022,mg,antineoplastic,7/30/2020,1/4/2016,Intravenous,pemetrexed,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,9/30/2020,mg,antineoplastic,6/4/2020,6/19/2020,Subcutaneous,azacitidine,FALSE
1102,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,1/30/2020,mg,antineoplastic,3/4/2020,10/22/2019,Intravenous,bevacizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,11/6/2021,mg,antineoplastic,9/1/2021,8/15/2021,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,3/7/2019,,,3/24/2019,2/11/2019,Oral,osimertinib,FALSE
250,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,8/18/2016,mg,antineoplastic,6/17/2016,4/12/2016,Intravenous,nivolumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/18/2023,mg,antineoplastic,10/25/2021,12/16/2019,Intravenous,pembrolizumab,FALSE
103,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/12/2015,mg,antineoplastic,11/2/2014,9/12/2014,Intravenous,carboplatin,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,7/12/2021,mg,antineoplastic,11/4/2020,11/18/2020,Intravenous,nivolumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/25/2023,mg,antineoplastic,12/18/2021,10/4/2021,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/30/2024,mg,antineoplastic,7/26/2023,3/28/2023,Intravenous,bevacizumab-awwb,TRUE
211.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,9/6/2015,mg,antineoplastic,4/16/2015,5/2/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/2/2018,,antineoplastic,6/7/2017,5/29/2017,,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/16/2015,,antineoplastic,1/1/2015,11/18/2014,,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,12/25/2021,mg,antineoplastic,10/25/2021,7/30/2021,Intravenous,pembrolizumab,FALSE
22.5,,NEOADJUVANT,Administrations,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,12/2/2023,mg,antineoplastic,9/8/2023,10/8/2023,Subcutaneous,leuprolide,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/18/2021,mg,antineoplastic,5/27/2021,5/21/2021,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/31/2017,mg,antineoplastic,6/15/2017,4/7/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G484BED:E686:,11/29/2017,,,10/6/2016,9/21/2016,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,7/24/2024,mg,antineoplastic,4/13/2024,4/1/2024,Intravenous,pembrolizumab,FALSE
930,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2E8B56477B83,4/18/2014,mg,antineoplastic,9/27/2013,9/7/2013,Intravenous,pemetrexed,FALSE
950,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G14216G12B:E7,6/4/2020,mg,antineoplastic,3/14/2020,11/21/2019,Intravenous,pemetrexed,TRUE
500,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,10/22/2013,mg,antineoplastic,6/22/2013,7/10/2013,Intravenous,carboplatin,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/13/2021,mg,antineoplastic,5/28/2019,11/22/2018,Intravenous,pemetrexed,TRUE
800,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1CC41:D:7C48,9/3/2020,mg,antineoplastic,7/6/2020,7/19/2020,Intravenous,pemetrexed,TRUE
,1,LOCOREGIONAL,Administrations,immunotherapy,Clinical Study Drug,G2C233C2:5B1:,4/25/2025,,antineoplastic,3/26/2025,11/7/2024,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,2/19/2015,,solution-fluid,10/11/2014,8/21/2014,Intravenous,clinical study drug,FALSE
436,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,9/27/2012,mg,antineoplastic,7/30/2012,5/20/2012,Intravenous,paclitaxel,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/16/2021,mg,antineoplastic,8/5/2018,3/5/2018,Intravenous,durvalumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/10/2018,AUC,antineoplastic,9/18/2017,10/22/2017,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,12/7/2022,mg,antineoplastic,7/19/2022,7/26/2022,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/7/2016,mg,antineoplastic,1/14/2016,1/23/2016,Intravenous,paclitaxel,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/15/2016,mg,antineoplastic,7/27/2014,5/30/2014,Intravenous,carboplatin,FALSE
958,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/8/2017,mg,antineoplastic,1/25/2017,12/21/2016,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Unstructured,,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,2/22/2023,,,10/30/2022,10/22/2022,Oral,osimertinib,FALSE
219.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FD6C9677C56,11/14/2017,mg,antineoplastic,11/4/2017,10/6/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G3EC5EB18C676,2/9/2018,,antineoplastic,5/30/2017,7/1/2017,Intravenous,nivolumab,FALSE
378,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/22/2016,mg,antineoplastic,6/22/2015,6/27/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/25/2025,mg,antineoplastic,5/10/2020,1/28/2019,Intravenous,pembrolizumab,TRUE
350,2,ADVANCED,Administrations,immunotherapy,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,12/18/2024,mg,antineoplastic,9/28/2024,9/16/2024,Intravenous,cemiplimab,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G26EFGF738125,7/31/2018,,,5/28/2018,10/6/2017,Oral,afatinib,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,7/4/2013,mg,antineoplastic,4/18/2013,12/13/2012,Intravenous,bevacizumab,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/24/2021,mg,antineoplastic,6/3/2021,11/2/2020,Intravenous,bevacizumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG899C7446,1/9/2025,mg,antineoplastic,12/26/2024,11/20/2024,Intravenous,carboplatin,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,11/29/2022,mg,antineoplastic,11/11/2022,3/4/2022,Intravenous,durvalumab,TRUE
690,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,3/23/2022,mg,antineoplastic,3/11/2022,3/10/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,12/3/2024,mg,antineoplastic,7/24/2024,6/26/2024,Intravenous,pembrolizumab,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2628C28G7613,6/29/2015,mg,antineoplastic,5/7/2015,3/13/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,12/9/2018,mg,antineoplastic,9/12/2018,5/11/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G1969F536B2DD,10/28/2011,,antineoplastic,8/21/2011,6/15/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,2/26/2019,mg,antineoplastic,1/29/2019,12/14/2018,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,8/25/2024,mg,antineoplastic,2/26/2023,12/1/2022,Intravenous,nivolumab,FALSE
554,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/7/2018,mg,antineoplastic,4/12/2018,4/15/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G432E:9E:21DC,1/17/2021,,antineoplastic,1/2/2021,1/27/2021,Oral,anastrozole,FALSE
931,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2351BF:22F4G,8/26/2012,mg,antineoplastic,6/13/2012,6/28/2012,Intravenous,carboplatin,FALSE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/9/2014,mg,antineoplastic,12/23/2013,12/17/2013,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,"Bevacizumab,Erlotinib",G168G1C789D7C,3/19/2014,,,4/16/2014,1/27/2014,Oral,erlotinib,FALSE
516,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,5/15/2019,mg,antineoplastic,5/14/2019,3/25/2019,Intravenous,carboplatin,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/26/2019,mg,antineoplastic,8/12/2019,8/30/2019,Intravenous,etoposide,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/11/2019,mg,antineoplastic,6/24/2018,7/10/2018,Intravenous,levoleucovorin,FALSE
100,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,10/21/2022,mg,antineoplastic,6/10/2022,4/15/2022,Intravenous,ipilimumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/28/2016,mg,antineoplastic,4/11/2014,1/16/2014,Intravenous,etoposide,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/17/2015,mg,antineoplastic,10/31/2014,8/17/2014,Intravenous,carboplatin,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,12/18/2014,mg,antineoplastic,12/8/2014,12/3/2014,Intravenous,etoposide,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/10/2024,mg,antineoplastic,10/9/2023,7/19/2023,Intravenous,paclitaxel protein-bound,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/12/2022,mg,antineoplastic,1/27/2022,6/17/2021,Intravenous,pemetrexed,FALSE
326,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,3/1/2022,mg,antineoplastic,1/19/2022,1/16/2022,Intravenous,nivolumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/5/2017,mL,solution-fluid,7/18/2017,6/26/2017,Intravenous,paclitaxel,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,2/5/2017,mg,antineoplastic,12/27/2013,11/22/2013,Intravenous,etoposide,FALSE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,4/20/2025,mg,antineoplastic,11/16/2024,12/22/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/10/2019,mg,antineoplastic,6/29/2019,6/4/2019,Intravenous,carboplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/7/2024,mg,antineoplastic,3/16/2024,12/20/2021,Intravenous,nivolumab,TRUE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,12/2/2016,,antineoplastic,5/11/2016,4/23/2016,Intravenous,nivolumab,FALSE
86,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,11/12/2022,mg,antineoplastic,11/12/2022,10/20/2022,Intravenous,paclitaxel,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,5/10/2024,mg,antineoplastic,12/13/2023,11/2/2023,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,hormone,"Eribulin,Exemestane",G19937F58E541,5/20/2014,,antineoplastic,12/29/2013,12/22/2013,Oral,exemestane,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Pemetrexed,G49E3CE9E292G,3/28/2023,mL,solution-fluid,5/31/2020,4/18/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,7/1/2023,mg,antineoplastic,5/8/2023,3/31/2023,Intravenous,pembrolizumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,10/30/2018,mg,antineoplastic,9/16/2016,9/6/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/30/2012,,antineoplastic,10/27/2011,7/23/2011,Intravenous,clinical study drug,FALSE
350,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,9/29/2013,mg,antineoplastic,8/10/2013,8/3/2013,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/2/2016,mg,antineoplastic,3/10/2016,11/11/2015,Intravenous,bevacizumab,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,8/5/2017,,antineoplastic,11/19/2016,11/15/2016,,clinical study drug,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/10/2022,mg,antineoplastic,7/29/2022,6/25/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/4/2021,mg/m2,antineoplastic,6/28/2021,2/28/2021,Intravenous,leucovorin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/11/2022,mg,antineoplastic,9/25/2019,1/10/2018,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/14/2023,mg,antineoplastic,1/13/2021,5/17/2020,Intravenous,pembrolizumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/24/2015,mL,solution-fluid,5/18/2015,2/25/2015,Intravenous,pemetrexed,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3GB7EGGB7:9D,3/9/2020,mg,antineoplastic,1/28/2020,2/14/2020,Intravenous,carboplatin,FALSE
93,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/9/2016,mg,antineoplastic,11/21/2015,1/6/2016,Intravenous,paclitaxel,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,12/25/2017,mg,antineoplastic,11/9/2017,9/14/2017,Intravenous,carboplatin,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/7/2019,mg,antineoplastic,11/17/2018,9/22/2018,Intravenous,durvalumab,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,5/3/2016,mg,antineoplastic,5/18/2015,11/18/2014,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/5/2020,mg,antineoplastic,4/16/2020,3/18/2020,Intravenous,carboplatin,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,10/4/2020,mg,antineoplastic,8/10/2020,5/31/2020,Subcutaneous,azacitidine,FALSE
670,1,ADVANCED,Administrations,targeted/biologic,Rituximab,G27471:8B6217,7/23/2018,mg,antineoplastic,1/5/2017,10/6/2016,Intravenous,rituximab,FALSE
19.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13G1125C1G:F,11/10/2019,mg,antineoplastic,12/24/2019,12/14/2019,Intravenous,paclitaxel,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/13/2019,mg/m2,antineoplastic,1/25/2019,10/14/2018,Intravenous,gemcitabine,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/23/2025,AUC,antineoplastic,8/18/2020,4/17/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,5/3/2016,mg,antineoplastic,3/30/2015,3/3/2015,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/19/2025,mg,antineoplastic,6/3/2024,4/28/2024,Intravenous,pembrolizumab,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,6/20/2013,mg,antineoplastic,5/17/2013,4/20/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Pralsetinib,G4C89FC6D8388,5/8/2025,,,12/22/2024,12/19/2024,Oral,pralsetinib,FALSE
1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,3/11/2016,mg,antineoplastic,12/3/2015,1/27/2016,Intravenous,paclitaxel,FALSE
980,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,10/6/2020,mg,antineoplastic,8/22/2014,3/13/2014,Intravenous,cyclophosphamide,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/4/2023,mg,antineoplastic,9/7/2023,11/30/2022,Intravenous,atezolizumab,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,6/9/2021,mg,antineoplastic,12/31/2020,11/10/2020,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/10/2025,mg,antineoplastic,9/22/2020,4/2/2020,Intravenous,pembrolizumab,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,1/21/2019,mg,antineoplastic,7/14/2018,5/16/2018,Intravenous,docetaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/4/2015,mg,antineoplastic,1/5/2015,9/13/2014,Intravenous,etoposide,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/30/2020,mg,antineoplastic,1/22/2017,11/8/2015,Intravenous,nivolumab,FALSE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,2/20/2012,mg/m2,antineoplastic,8/24/2011,9/23/2011,Intravenous,cetuximab,FALSE
340,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,4/23/2013,mg,antineoplastic,3/14/2013,2/14/2013,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/19/2014,mg/m2,antineoplastic,12/19/2012,10/18/2012,Intravenous,gemcitabine,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,6/21/2014,mg,antineoplastic,5/8/2014,1/23/2014,Intravenous,bevacizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,5/4/2025,mg,antineoplastic,1/29/2025,1/14/2025,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/8/2014,,antineoplastic,1/7/2014,12/15/2013,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/21/2025,mg,antineoplastic,8/21/2022,6/6/2022,Intravenous,pembrolizumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5669E21B9D52,4/19/2017,mg,antineoplastic,4/7/2017,3/14/2017,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,5/4/2025,mg,antineoplastic,7/10/2020,3/27/2020,Subcutaneous,leuprolide,FALSE
1270,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G35DB7G1CE73D,8/20/2015,mg,antineoplastic,6/18/2015,7/19/2015,Intravenous,bevacizumab,FALSE
250,,ADJUVANT,Administrations,hormone,Fulvestrant,G286G2E848134,11/12/2016,mg,antineoplastic,10/18/2016,9/29/2016,Intramuscular,fulvestrant,FALSE
323,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,12/14/2015,mg,antineoplastic,11/14/2015,10/11/2015,Intravenous,paclitaxel,FALSE
22.5,,ADJUVANT,Orders,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/18/2025,mg,antineoplastic,3/15/2025,3/18/2024,Intramuscular,leuprolide,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/16/2025,mg,antineoplastic,6/30/2024,3/18/2024,Intravenous,pembrolizumab,FALSE
465,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/20/2014,mg,antineoplastic,3/11/2014,4/21/2014,Intravenous,carboplatin,FALSE
51,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/11/2024,mg,antineoplastic,5/25/2024,10/4/2023,Intravenous,ipilimumab,FALSE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/17/2018,mg/m2,antineoplastic,10/13/2017,10/10/2017,Intravenous,paclitaxel,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,12/24/2019,mg/m2,antineoplastic,12/19/2019,10/30/2019,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G158118CE1E2C,1/23/2018,mg,antineoplastic,12/9/2017,12/29/2017,Intravenous,pemetrexed,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,11/25/2015,mg,antineoplastic,8/27/2015,7/4/2015,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G127F7CE9C111,4/4/2025,mg,antineoplastic,3/31/2025,4/16/2025,Intravenous,durvalumab,TRUE
195,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G27B37646G3C2,9/11/2019,mg,antineoplastic,8/25/2019,7/11/2019,Intravenous,paclitaxel protein-bound,FALSE
32,,ADJUVANT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,3/8/2014,mg,antineoplastic,1/30/2014,1/25/2014,Intravenous,vinorelbine,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/27/2022,mg,antineoplastic,7/25/2022,5/2/2022,Intravenous,carboplatin,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,11/28/2014,mg,antineoplastic,1/13/2014,1/1/2014,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/30/2023,mg,antineoplastic,10/13/2017,10/19/2017,Intravenous,nivolumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,12/31/2024,mg,antineoplastic,11/2/2024,10/22/2024,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/24/2025,mg,antineoplastic,1/9/2025,8/21/2024,Intravenous,atezolizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/25/2023,,antineoplastic,2/19/2023,12/6/2022,,pemetrexed,FALSE
530,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,1/18/2015,mg,antineoplastic,10/7/2014,9/20/2014,Intravenous,carboplatin,FALSE
66.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,8/4/2020,mg,antineoplastic,3/14/2020,3/2/2020,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/8/2024,,antineoplastic,12/7/2023,11/14/2023,,carboplatin,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,1/28/2016,mg,antineoplastic,1/7/2016,12/7/2015,Intravenous,bevacizumab,FALSE
386,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,3/8/2022,mg,antineoplastic,12/24/2021,11/4/2021,Intravenous,paclitaxel,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/30/2024,mg,antineoplastic,12/8/2023,10/12/2023,Intravenous,amivantamab-vmjw,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,3/29/2023,mg,antineoplastic,9/1/2022,8/23/2022,Subcutaneous,azacitidine,FALSE
901,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/24/2023,mg,antineoplastic,3/14/2023,11/20/2022,Intravenous,fluorouracil,FALSE
855,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,9/24/2017,mg,antineoplastic,7/23/2017,5/20/2017,Intravenous,pemetrexed,FALSE
600,3,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,8/21/2019,mg,antineoplastic,7/25/2019,7/25/2019,Intravenous,leucovorin,FALSE
95,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,1/31/2014,mg,antineoplastic,9/30/2013,9/22/2013,Intravenous,cisplatin,FALSE
156,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,3/9/2020,mg,antineoplastic,12/14/2019,11/25/2019,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,8/1/2019,mg,antineoplastic,3/1/2018,9/17/2017,Oral,anastrozole,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/14/2014,mg,antineoplastic,3/3/2014,3/1/2014,Intravenous,cisplatin,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,1/31/2019,mg,antineoplastic,9/8/2018,8/3/2018,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/24/2016,mg,antineoplastic,7/25/2015,5/7/2014,Intravenous,pemetrexed,FALSE
5.12,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,10/25/2022,mg,antineoplastic,8/9/2022,8/7/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/13/2024,mg,antineoplastic,12/17/2023,9/22/2022,Intravenous,pembrolizumab,TRUE
232,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/8/2016,mg,antineoplastic,6/10/2016,11/26/2015,Intravenous,nivolumab,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,4/29/2016,mg,antineoplastic,12/4/2015,10/29/2015,Intravenous,ramucirumab,FALSE
160,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,3/27/2015,mg,antineoplastic,3/9/2015,3/11/2015,Intravenous,paclitaxel protein-bound,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/20/2019,mg,antineoplastic,2/25/2019,2/8/2019,Intravenous,docetaxel,FALSE
371.5,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,3/21/2013,mg,antineoplastic,2/25/2013,12/14/2012,Intravenous,carboplatin,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,1/14/2017,mg,antineoplastic,11/17/2016,9/1/2016,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/6/2025,mg,antineoplastic,11/12/2024,7/8/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/28/2017,,solution-fluid,1/14/2017,2/19/2016,Intravenous,clinical study drug,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/15/2024,mg,antineoplastic,8/26/2024,6/28/2024,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/17/2023,mg,antineoplastic,3/16/2020,10/8/2019,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,7/29/2020,,antineoplastic,8/28/2020,6/23/2020,Intravenous,pemetrexed,FALSE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,10/2/2024,mg,antineoplastic,7/19/2024,6/13/2024,Intravenous,cisplatin,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/11/2014,mg/kg,antineoplastic,2/21/2014,12/28/2013,Intravenous,bevacizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/19/2023,mg,antineoplastic,5/11/2021,4/23/2020,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,8/29/2013,mg/m2,antineoplastic,4/28/2013,2/20/2013,Intravenous,paclitaxel protein-bound,FALSE
1400,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1665E:E6:E1:,12/24/2013,mg,antineoplastic,3/28/2013,3/1/2013,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,11/3/2023,mg,antineoplastic,12/23/2022,11/3/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,4/9/2025,mg,antineoplastic,3/25/2025,2/14/2025,Intravenous,pembrolizumab,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,11/11/2015,mg,antineoplastic,12/1/2015,4/30/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,8/30/2020,mg,antineoplastic,8/6/2020,7/1/2020,Intravenous,paclitaxel protein-bound,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,11/6/2022,mg,antineoplastic,8/24/2022,6/28/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,4/20/2025,mg,antineoplastic,3/9/2025,8/14/2024,Intravenous,pembrolizumab,TRUE
492,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/16/2015,mg,antineoplastic,9/20/2015,10/2/2015,Intravenous,paclitaxel,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,7/25/2020,mg,antineoplastic,4/28/2020,5/26/2020,Intravenous,paclitaxel,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,5/5/2016,mg,antineoplastic,10/24/2015,11/10/2015,Intravenous,ramucirumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/26/2017,mg,antineoplastic,3/11/2014,1/8/2014,Intravenous,etoposide,FALSE
750,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,2/26/2015,mg,antineoplastic,1/1/2015,12/30/2014,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G455E1367:DG4,6/26/2016,,,12/10/2015,11/27/2015,Oral,erlotinib,FALSE
1140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,6/11/2012,mg,antineoplastic,5/15/2012,4/4/2012,Intravenous,pemetrexed,FALSE
151,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/18/2024,mg,antineoplastic,5/21/2024,3/4/2024,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38GE:9D51587,9/12/2012,mg,antineoplastic,7/25/2012,3/7/2012,Intravenous,pemetrexed,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,2/23/2014,mg,antineoplastic,8/29/2013,7/26/2013,Intravenous,paclitaxel,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/18/2025,mg,antineoplastic,1/2/2023,2/17/2022,Intravenous,atezolizumab,FALSE
252,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,11/8/2024,mg,antineoplastic,9/24/2024,8/19/2024,Intravenous,paclitaxel,FALSE
70,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,1/25/2020,mg,antineoplastic,11/27/2019,10/28/2019,Intravenous,paclitaxel,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/4/2024,mg,antineoplastic,10/15/2021,7/26/2020,Intravenous,ipilimumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/23/2023,mg,antineoplastic,10/25/2022,5/27/2022,Intravenous,durvalumab,FALSE
855,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,3/14/2025,mg,antineoplastic,3/12/2025,1/3/2025,Intravenous,pemetrexed,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/12/2023,mg,antineoplastic,8/3/2022,1/18/2020,Intravenous,pembrolizumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,2/27/2012,mg,antineoplastic,3/20/2012,1/24/2012,Intravenous,etoposide,FALSE
500,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,11/25/2014,mg,antineoplastic,12/16/2014,10/12/2014,Intravenous,carboplatin,FALSE
190.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,11/23/2011,mg,antineoplastic,12/3/2011,11/6/2011,Intravenous,carboplatin,FALSE
399,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,7/10/2015,mg,antineoplastic,5/13/2015,9/26/2014,Intravenous,carboplatin,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/1/2014,mg,antineoplastic,11/8/2014,7/13/2014,Intravenous,vinorelbine,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/5/2015,mg,antineoplastic,8/2/2014,6/2/2014,Intravenous,vinorelbine,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/20/2016,mg,antineoplastic,8/4/2015,5/6/2015,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,6/2/2014,mg,antineoplastic,4/10/2014,5/4/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/18/2024,mg,antineoplastic,11/29/2024,8/24/2024,Intravenous,pembrolizumab,TRUE
170,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G4F354B:F341F,8/10/2017,mg,antineoplastic,6/10/2017,7/9/2017,Intravenous,docetaxel,FALSE
820,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,2/11/2013,mg,antineoplastic,1/24/2013,11/20/2012,Intravenous,pemetrexed,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3DGG1C5C452:,4/27/2019,mg,antineoplastic,2/13/2019,1/29/2019,Intravenous,durvalumab,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G2D168F99BCD4,10/20/2024,,,10/26/2024,1/6/2024,Oral,dabrafenib,FALSE
213,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,8/13/2021,mg,antineoplastic,8/19/2021,7/26/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/6/2019,mg,antineoplastic,2/10/2018,12/26/2017,Intravenous,pembrolizumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,5/19/2022,mg,antineoplastic,12/5/2021,12/5/2021,Intravenous,pembrolizumab,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,10/10/2015,mg,antineoplastic,9/1/2015,6/25/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/28/2020,mg,antineoplastic,7/12/2019,1/29/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,11/19/2022,mg,antineoplastic,11/19/2022,9/15/2022,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/6/2019,AUC,antineoplastic,3/12/2019,1/10/2019,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,12/28/2019,mg,antineoplastic,11/30/2019,10/6/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/25/2025,mg,antineoplastic,3/21/2025,10/1/2022,Intravenous,pembrolizumab,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,4/13/2025,mg,antineoplastic,3/13/2025,2/16/2025,Intravenous,pemetrexed,TRUE
1650,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,5/27/2022,mg,antineoplastic,5/31/2022,3/28/2022,Intravenous,bevacizumab-awwb,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,9/8/2018,mg,antineoplastic,6/13/2017,5/6/2017,Intravenous,vinorelbine,FALSE
136,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/9/2019,mg,antineoplastic,7/9/2019,8/7/2019,Intravenous,paclitaxel protein-bound,FALSE
93,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,8/29/2016,mg,antineoplastic,1/13/2016,12/31/2015,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/20/2025,mg,antineoplastic,1/5/2025,7/22/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,8/3/2024,,antineoplastic,6/23/2024,4/12/2024,Intravenous,cisplatin,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/21/2017,mg,antineoplastic,6/23/2016,5/7/2016,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/10/2023,,antineoplastic,1/15/2023,12/30/2022,,clinical study drug,FALSE
265,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,7/11/2016,mg,antineoplastic,7/15/2016,5/20/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,4/12/2018,,antineoplastic,12/22/2017,1/10/2018,Intravenous,clinical study drug,FALSE
1940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/19/2018,mg,antineoplastic,8/30/2018,4/1/2018,Intravenous,gemcitabine,FALSE
124,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/8/2017,mg,antineoplastic,2/9/2017,11/28/2016,Intravenous,cisplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/18/2025,mg,antineoplastic,5/6/2021,1/25/2017,Intravenous,pembrolizumab,FALSE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/20/2017,mg,antineoplastic,7/18/2017,6/29/2017,Intravenous,docetaxel,FALSE
945,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3E464G5769E:,3/21/2020,mg,antineoplastic,3/27/2020,12/27/2019,Intravenous,pemetrexed,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/15/2025,mg,antineoplastic,7/4/2024,6/23/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/17/2022,,antineoplastic,2/17/2022,9/12/2021,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/9/2020,mg,antineoplastic,4/18/2019,1/30/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/5/2020,mg,antineoplastic,10/27/2017,7/15/2016,Intravenous,nivolumab,FALSE
860,5,ADVANCED,Administrations,chemotherapy,Pemetrexed,G166B735:96D2,11/10/2013,mg,antineoplastic,10/27/2013,10/10/2013,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/2/2025,,antineoplastic,9/18/2023,3/3/2023,,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/7/2025,,antineoplastic,8/10/2024,3/30/2024,Intravenous,paclitaxel protein-bound,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/16/2025,mg,antineoplastic,11/4/2024,10/18/2024,Intravenous,nivolumab,TRUE
490,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/17/2020,mg,antineoplastic,5/14/2020,3/6/2020,Intravenous,carboplatin,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/1/2022,mg/kg,antineoplastic,10/17/2021,3/7/2021,Intravenous,durvalumab,FALSE
370.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45388C4DCEFB,5/18/2012,mg,antineoplastic,5/24/2012,6/10/2012,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,1/26/2025,mg,antineoplastic,10/30/2024,11/2/2024,Intravenous,pemetrexed,FALSE
200,5,ADVANCED,Administrations,immunotherapy,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/11/2025,mg,antineoplastic,1/10/2025,2/24/2025,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/16/2025,mg,antineoplastic,3/1/2024,6/15/2023,Intravenous,pembrolizumab,TRUE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/11/2021,mg,antineoplastic,5/18/2021,11/27/2020,Intravenous,vinorelbine,FALSE
1107,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G33:335715B9G,5/18/2025,mg,antineoplastic,1/24/2025,1/27/2025,Intravenous,durvalumab,TRUE
416,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/27/2021,mg,antineoplastic,12/9/2021,10/1/2021,Intravenous,carboplatin,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/13/2021,mg/m2,antineoplastic,7/24/2021,3/12/2021,Intravenous,oxaliplatin,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/30/2025,mg,antineoplastic,7/5/2024,5/3/2024,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/7/2025,mg,antineoplastic,6/17/2024,5/7/2024,Intravenous,pembrolizumab,FALSE
1340,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G161:GEG632G8,7/30/2019,mg,antineoplastic,5/1/2019,6/9/2019,Intravenous,pemetrexed,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/30/2024,mg,antineoplastic,3/31/2024,12/31/2021,Intravenous,nivolumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G12D5DB79FEED,4/11/2015,mg/m2,antineoplastic,1/3/2015,1/2/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/18/2017,,antineoplastic,5/8/2016,3/10/2016,Intravenous,clinical study drug,FALSE
800,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Temozolomide",G4DE3DE99E:13,3/4/2016,mg,antineoplastic,1/7/2016,11/27/2015,Intravenous,gemcitabine,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/1/2025,mg,antineoplastic,11/22/2015,1/9/2016,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/4/2025,mg,antineoplastic,10/25/2024,3/7/2024,Intravenous,amivantamab-vmjw,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/31/2022,,antineoplastic,1/14/2022,7/15/2021,Intravenous,amivantamab-vmjw,FALSE
670,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/19/2022,mg,antineoplastic,2/2/2022,8/19/2021,Intravenous,carboplatin,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/7/2018,mg,antineoplastic,1/26/2018,10/31/2017,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,3/21/2019,mg,antineoplastic,12/10/2018,12/24/2018,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/8/2024,mg,antineoplastic,6/27/2024,4/24/2024,Intravenous,cemiplimab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/8/2025,mg,antineoplastic,5/14/2023,7/23/2021,Intravenous,atezolizumab,TRUE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/16/2019,mg,antineoplastic,5/24/2019,6/27/2019,Intravenous,carboplatin,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,8/1/2012,mg,antineoplastic,7/20/2012,3/27/2012,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1G:2:8D7GC6F,11/27/2024,,,7/28/2023,6/28/2023,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/4/2018,,antineoplastic,6/2/2018,3/30/2018,Intravenous,gemcitabine,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,3/8/2020,mg,antineoplastic,7/10/2019,12/27/2018,Intravenous,pemetrexed,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/24/2015,mg,antineoplastic,9/3/2015,7/24/2014,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/19/2019,mg,antineoplastic,9/8/2018,4/12/2016,Intravenous,nivolumab,FALSE
95,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/30/2017,mg,antineoplastic,1/10/2017,10/16/2016,Intravenous,cisplatin,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,10/27/2023,,antineoplastic,11/13/2023,11/24/2022,Intravenous,clinical study drug,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/13/2021,mg,antineoplastic,3/13/2021,1/12/2021,Intravenous,paclitaxel protein-bound,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/4/2014,mg,antineoplastic,10/25/2014,7/12/2014,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G17FC44B51E:3,2/12/2015,,antineoplastic,2/28/2015,1/19/2015,Oral,letrozole,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/10/2021,mg,antineoplastic,10/26/2021,10/8/2021,Intravenous,carboplatin,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,9/22/2018,mg,antineoplastic,7/21/2018,4/22/2018,Intravenous,docetaxel,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/28/2018,mg,antineoplastic,10/27/2018,5/9/2018,Intravenous,paclitaxel,FALSE
696,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/11/2023,mg,antineoplastic,12/20/2022,10/9/2022,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,3/18/2025,mg,antineoplastic,7/28/2024,3/31/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/20/2018,mg,antineoplastic,4/28/2018,9/19/2015,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,7/1/2024,mg,antineoplastic,3/18/2024,8/4/2023,Intravenous,atezolizumab,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,9/17/2022,mg,antineoplastic,5/25/2022,7/11/2022,Intravenous,bevacizumab-awwb,TRUE
489.6,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/14/2022,mg,antineoplastic,11/22/2021,9/23/2021,Intravenous,leucovorin,FALSE
1393.5,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/19/2015,mg,antineoplastic,11/29/2014,11/12/2014,Intravenous,bevacizumab,FALSE
103,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/29/2020,mg,antineoplastic,5/29/2020,12/28/2019,Intravenous,docetaxel,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,5/28/2014,mg,antineoplastic,5/4/2014,12/15/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/31/2025,mg,antineoplastic,5/18/2024,4/8/2024,Intravenous,pembrolizumab,TRUE
167.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/3/2015,mg,antineoplastic,11/23/2014,10/19/2014,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/22/2016,mg,antineoplastic,7/22/2015,12/14/2014,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,5/5/2023,mg,antineoplastic,3/17/2023,4/29/2022,Intravenous,nivolumab,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G419BEEC19D2C,10/1/2021,mg,antineoplastic,8/17/2021,10/9/2021,Intravenous,carboplatin,FALSE
975,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G56B4BCB27428,3/13/2012,mg,antineoplastic,1/9/2012,11/25/2011,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/11/2020,mg,antineoplastic,8/9/2020,6/17/2019,Intravenous,pembrolizumab,TRUE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/12/2020,mg,antineoplastic,4/21/2020,4/20/2020,Intravenous,paclitaxel protein-bound,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/16/2025,mg,antineoplastic,11/26/2019,12/31/2016,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/1/2020,mg,antineoplastic,8/24/2019,2/17/2019,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/23/2017,mg,antineoplastic,10/25/2016,8/19/2016,Intravenous,nivolumab,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11:F93GC6851,6/28/2021,mg,antineoplastic,5/29/2021,5/25/2021,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/9/2015,mg,antineoplastic,7/19/2015,2/11/2015,Intravenous,paclitaxel protein-bound,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,10/22/2024,mg,antineoplastic,1/30/2024,3/27/2023,Intravenous,nivolumab,FALSE
155,,ADJUVANT,Administrations,chemotherapy,"Docetaxel,Leuprolide",G53D3D6874EB3,10/17/2023,mg,antineoplastic,7/8/2023,8/4/2023,Intravenous,docetaxel,FALSE
183.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/19/2016,mg,antineoplastic,7/17/2016,6/25/2016,Intravenous,carboplatin,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/7/2015,mg,antineoplastic,3/8/2015,9/22/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/4/2025,mg,antineoplastic,7/11/2022,1/22/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/17/2022,mg,antineoplastic,12/3/2021,11/21/2021,Intravenous,pembrolizumab,FALSE
500,3,ADVANCED,Administrations,hormone,Fulvestrant,G272F2D3BB8C2,4/28/2016,mg,antineoplastic,4/21/2016,4/21/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/31/2025,mg,antineoplastic,9/20/2023,6/15/2023,Intravenous,pembrolizumab,TRUE
171,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G51:G:C712CC6,1/1/2020,mg,antineoplastic,12/15/2019,11/4/2019,Intravenous,docetaxel,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/1/2014,mg,antineoplastic,8/8/2014,8/25/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,2/2/2023,mg,antineoplastic,1/25/2023,11/9/2022,Intravenous,pembrolizumab,FALSE
288.3,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,11/8/2015,mg,antineoplastic,4/21/2015,1/23/2015,Intravenous,carboplatin,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/15/2014,mg,antineoplastic,4/16/2014,4/21/2014,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/9/2025,mg,antineoplastic,11/12/2024,10/4/2024,Intravenous,pembrolizumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,7/23/2021,mg,antineoplastic,5/4/2021,4/4/2021,Intravenous,paclitaxel,FALSE
560,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,3/26/2025,mg,antineoplastic,4/6/2025,12/15/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/13/2021,,antineoplastic,4/13/2021,1/24/2021,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G2G76D1E7GG61,1/25/2015,mL,solution-fluid,11/17/2014,11/22/2014,Intravenous,pemetrexed,FALSE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/27/2014,mg,antineoplastic,8/5/2013,7/7/2013,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/7/2025,,antineoplastic,9/3/2020,4/4/2020,Oral,enzalutamide,FALSE
394,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/4/2014,mg,antineoplastic,10/27/2014,8/26/2014,Intravenous,paclitaxel,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,10/21/2017,mg,antineoplastic,9/24/2017,5/2/2017,Intravenous,gemcitabine,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/3/2022,mg,antineoplastic,12/3/2022,10/25/2022,Oral,imatinib,FALSE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,12/6/2024,mg,antineoplastic,9/4/2024,8/10/2024,Intravenous,carboplatin,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/21/2013,mg,antineoplastic,8/31/2013,12/31/2012,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/3/2019,,antineoplastic,8/19/2019,7/23/2019,,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/6/2024,mL,solution-fluid,2/21/2024,12/31/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/5/2020,mg,antineoplastic,1/9/2020,10/17/2019,Intravenous,pembrolizumab,TRUE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/8/2015,mg,antineoplastic,2/25/2014,1/13/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3EC2153F:341,5/25/2020,mg,antineoplastic,6/1/2020,5/12/2020,Intravenous,paclitaxel protein-bound,FALSE
542,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G161297FC6EC1,12/21/2014,mg,antineoplastic,12/15/2014,12/1/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,5/1/2018,,antineoplastic,6/3/2017,5/19/2017,Intravenous,clinical study drug,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/13/2019,mg,antineoplastic,9/20/2019,7/5/2019,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/25/2016,mg,antineoplastic,8/24/2016,4/1/2016,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/13/2019,mg,antineoplastic,6/18/2018,12/29/2017,Intravenous,pembrolizumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,12/29/2013,AUC,antineoplastic,12/26/2013,10/26/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/16/2025,mg,antineoplastic,2/4/2022,10/5/2021,Intravenous,pembrolizumab,TRUE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/25/2014,AUC,antineoplastic,10/14/2014,11/13/2013,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Durvalumab,Paclitaxel",G4EF93:EF39:7,12/29/2019,,antineoplastic,12/22/2019,11/9/2019,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/1/2017,mg,antineoplastic,1/20/2017,7/3/2015,Intravenous,nivolumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/9/2020,mg,antineoplastic,5/31/2020,2/3/2020,Intravenous,paclitaxel,FALSE
298,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/5/2024,mg,antineoplastic,12/2/2023,11/7/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,12/18/2018,mg,antineoplastic,11/25/2018,8/18/2018,Intravenous,pembrolizumab,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,6/9/2024,mg,antineoplastic,10/27/2023,8/14/2023,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/16/2025,,solution-fluid,2/6/2018,11/16/2017,Intravenous,clinical study drug,FALSE
131,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,3/15/2025,mg,antineoplastic,1/28/2025,12/24/2024,Intravenous,docetaxel,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/25/2022,mg,antineoplastic,8/28/2022,7/20/2022,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,6/12/2023,mg,antineoplastic,4/18/2023,2/28/2023,Intravenous,pemetrexed,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/23/2020,mg,antineoplastic,1/31/2020,3/17/2019,Intravenous,durvalumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/7/2025,mg,antineoplastic,10/10/2022,1/20/2022,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G33159ECF97CC,5/4/2019,,,6/8/2019,7/8/2018,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/30/2025,,antineoplastic,11/25/2024,2/20/2023,,clinical study drug,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/12/2019,mg,antineoplastic,10/12/2019,7/29/2019,Intravenous,etoposide,FALSE
,3,ADVANCED,Unstructured,,Alectinib,G3E12EBD52F4D,7/31/2018,,,7/26/2018,6/8/2018,Oral,alectinib,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/2/2025,mg,antineoplastic,4/22/2025,8/20/2023,Intravenous,atezolizumab,FALSE
280,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,2/12/2019,mg,antineoplastic,12/7/2018,1/4/2019,Intravenous,carboplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/20/2022,mg,antineoplastic,11/9/2020,4/2/2017,Oral,nilotinib,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/31/2021,mg,antineoplastic,10/24/2020,8/29/2020,Oral,bicalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,4/7/2024,mg,antineoplastic,2/7/2024,9/29/2023,Intravenous,pembrolizumab,FALSE
209,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/30/2022,mg,antineoplastic,11/18/2021,10/24/2021,Intravenous,carboplatin,FALSE
386,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,3/15/2022,mg,antineoplastic,12/18/2021,11/20/2021,Intravenous,paclitaxel,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/18/2017,mg,antineoplastic,1/21/2016,4/23/2015,Intravenous,bevacizumab,TRUE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/14/2023,mg,antineoplastic,10/20/2023,10/12/2022,Intravenous,durvalumab,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,9/4/2018,mg,antineoplastic,12/13/2017,8/18/2017,Intravenous,atezolizumab,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/25/2024,mg,antineoplastic,1/14/2024,4/2/2023,Intravenous,atezolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/12/2016,mg,antineoplastic,11/8/2015,8/26/2015,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/8/2025,mg,antineoplastic,1/16/2023,7/27/2021,Intravenous,atezolizumab,TRUE
95,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,7/19/2013,mg,antineoplastic,8/19/2013,6/18/2013,Intravenous,cisplatin,FALSE
88,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/25/2023,mg,antineoplastic,11/4/2022,10/7/2022,Intravenous,paclitaxel,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,11/26/2024,mg,antineoplastic,12/16/2024,10/9/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,3/29/2025,mg,antineoplastic,10/16/2024,7/18/2024,Intravenous,pembrolizumab,TRUE
2,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/19/2013,AUC,antineoplastic,7/6/2013,5/21/2013,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/9/2023,mg,antineoplastic,3/29/2018,10/9/2017,Intravenous,nivolumab,FALSE
775,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/13/2014,mg,antineoplastic,2/19/2014,11/19/2013,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,4/18/2017,mg,antineoplastic,2/26/2017,12/22/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,2/16/2023,,antineoplastic,10/11/2022,4/23/2022,Intravenous,pembrolizumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/22/2013,mg,antineoplastic,4/10/2012,12/1/2011,Intravenous,etoposide,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/22/2014,mg,antineoplastic,8/5/2014,6/5/2014,Intravenous,paclitaxel protein-bound,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,5/2/2019,mg,antineoplastic,6/24/2018,7/10/2018,Intravenous,irinotecan,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G3B698C119:F8,7/28/2012,,steroid,4/22/2012,6/2/2012,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,9/1/2022,mg/m2,antineoplastic,4/12/2022,7/17/2021,Intravenous,pemetrexed,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/16/2025,mg,antineoplastic,6/23/2019,3/22/2019,Intravenous,pemetrexed,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/16/2024,mg,antineoplastic,7/10/2020,7/21/2020,Intravenous,nivolumab,FALSE
5,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,10/2/2019,AUC,antineoplastic,8/8/2019,6/27/2019,Intravenous,carboplatin,FALSE
290,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,1/11/2019,mg,antineoplastic,3/4/2019,12/8/2018,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/17/2018,mg,antineoplastic,4/15/2013,3/13/2013,Intravenous,paclitaxel,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/27/2015,mg,antineoplastic,12/21/2014,10/31/2014,Intravenous,bevacizumab,FALSE
1040,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/9/2016,mg,antineoplastic,10/10/2015,4/21/2015,Intravenous,pemetrexed,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/18/2024,mg,antineoplastic,12/7/2023,5/19/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/13/2023,mg,antineoplastic,1/31/2022,10/5/2021,Intravenous,pembrolizumab,TRUE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,11/8/2021,mg,antineoplastic,9/29/2021,5/6/2021,Intravenous,pemetrexed,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,3/12/2019,mg,antineoplastic,1/1/2019,12/9/2018,Intravenous,paclitaxel,FALSE
96,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/4/2021,mg,antineoplastic,2/1/2017,12/13/2016,Intravenous,paclitaxel,FALSE
28,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,5/13/2015,mg,antineoplastic,3/13/2015,2/23/2015,Intravenous,docetaxel,FALSE
467,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/12/2025,mg,antineoplastic,1/6/2025,12/7/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/4/2023,mg,antineoplastic,12/30/2020,5/12/2020,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/19/2025,mg,antineoplastic,5/27/2020,1/27/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/6/2025,mg,antineoplastic,8/10/2024,3/5/2020,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/3/2025,mg,antineoplastic,5/19/2024,9/29/2023,Intravenous,atezolizumab,FALSE
835,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G161297FC6EC1,12/9/2014,mg,antineoplastic,1/15/2015,10/30/2014,Intravenous,pemetrexed,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/6/2024,mg,antineoplastic,2/17/2024,4/5/2023,Intravenous,atezolizumab,FALSE
270,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,6/7/2016,mg,antineoplastic,3/25/2016,2/13/2016,Intravenous,paclitaxel,FALSE
710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,9/20/2024,mg,antineoplastic,8/4/2024,8/9/2024,Intravenous,pemetrexed,FALSE
179,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,5/25/2023,mg,antineoplastic,3/1/2023,3/18/2023,Intravenous,paclitaxel protein-bound,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/2/2022,mg,antineoplastic,10/24/2016,1/2/2016,Intravenous,pemetrexed,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/16/2017,mg,antineoplastic,12/22/2016,12/10/2016,Intravenous,docetaxel,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/4/2018,mg/m2,antineoplastic,9/15/2017,10/25/2017,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/6/2021,mg,antineoplastic,10/11/2021,11/1/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,10/29/2023,mg,antineoplastic,7/15/2023,5/25/2023,Intravenous,pembrolizumab,TRUE
171.5,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,3/14/2021,mg,antineoplastic,12/31/2020,12/27/2020,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/25/2025,mg,antineoplastic,9/17/2024,6/24/2023,Intravenous,pembrolizumab,TRUE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/10/2016,mg,antineoplastic,6/29/2016,5/31/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/18/2016,,,2/22/2015,3/5/2015,Oral,afatinib,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,5/25/2023,mg,antineoplastic,4/26/2023,3/20/2023,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,4/1/2014,mg,antineoplastic,3/31/2014,1/3/2014,Intravenous,carboplatin,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/3/2021,mg,antineoplastic,9/13/2020,9/27/2020,Oral,bicalutamide,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/10/2020,mg,antineoplastic,6/8/2020,8/4/2016,Intravenous,nivolumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,Paclitaxel,G1G5771EC2C8F,3/3/2018,mg,antineoplastic,3/8/2018,2/6/2018,Intravenous,paclitaxel,FALSE
1176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,11/2/2023,mg,antineoplastic,8/19/2023,9/27/2023,Intravenous,gemcitabine,FALSE
68,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,11/6/2024,mg,antineoplastic,9/22/2024,8/7/2024,Intravenous,paclitaxel,FALSE
665,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,2/21/2013,mg,antineoplastic,11/15/2012,11/29/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26B488B88188,3/5/2024,mg,antineoplastic,2/18/2024,12/22/2023,Intravenous,pembrolizumab,FALSE
45,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G1F:9CFGFGFC1,6/1/2014,mg,antineoplastic,5/2/2014,6/2/2014,Intravenous,cisplatin,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,12/2/2015,mg,antineoplastic,7/30/2015,7/11/2015,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/22/2022,mg,antineoplastic,3/15/2021,1/24/2020,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/11/2019,mg,antineoplastic,1/3/2019,3/24/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G51:CGD7GD6C4,2/28/2025,,,6/7/2018,6/15/2018,Oral,alectinib,FALSE
500,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,10/20/2016,mg,antineoplastic,6/26/2016,6/4/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/20/2018,mg,antineoplastic,8/20/2018,2/26/2017,Intravenous,pembrolizumab,FALSE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3ED9686E8628,7/10/2013,mg,antineoplastic,7/31/2012,8/4/2012,Intravenous,gemcitabine,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/30/2021,mg,antineoplastic,11/23/2020,8/22/2020,Oral,bicalutamide,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/27/2014,mg,antineoplastic,9/28/2014,8/22/2014,Intravenous,carboplatin,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CFGEG188695,3/31/2025,mg,antineoplastic,3/24/2025,2/26/2025,Intravenous,paclitaxel,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/19/2023,mg,antineoplastic,9/28/2021,10/13/2021,Intravenous,bendamustine,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,9/30/2017,mg,antineoplastic,8/26/2017,9/1/2017,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G33E55:63F87C,4/20/2025,,,3/25/2025,4/25/2024,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/20/2025,mg,antineoplastic,10/2/2021,2/17/2019,Intravenous,pembrolizumab,TRUE
594,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,12/16/2016,mg,antineoplastic,9/28/2016,7/21/2016,Intravenous,carboplatin,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/11/2023,mg,antineoplastic,2/26/2023,5/3/2022,Intravenous,durvalumab,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/31/2013,mg,antineoplastic,2/14/2013,12/25/2012,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,6/29/2017,,antineoplastic,7/2/2017,6/8/2017,Oral,hydroxyurea,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/4/2024,mL,solution-fluid,11/22/2023,12/1/2023,Intravenous,pemetrexed,FALSE
499,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/9/2023,mg,antineoplastic,4/8/2023,1/22/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G1F9CDC2FCB:5,2/17/2022,,,3/31/2021,4/26/2021,Oral,alectinib,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,7/16/2015,mg,antineoplastic,5/28/2014,7/9/2014,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G3316B72:E:48,1/15/2024,,antineoplastic,11/30/2023,1/2/2024,Oral,anastrozole,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/4/2011,mg,antineoplastic,6/14/2011,3/30/2011,Intravenous,paclitaxel,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,10/1/2014,AUC,antineoplastic,9/11/2014,7/25/2014,Intravenous,carboplatin,FALSE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/26/2023,mg,antineoplastic,1/6/2023,11/9/2022,Intravenous,fluorouracil,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/22/2018,mg,antineoplastic,10/25/2018,8/18/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G2D168F99BCD4,1/12/2023,mg,antineoplastic,10/11/2022,9/10/2022,Intravenous,pembrolizumab,TRUE
417,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,5/9/2023,mg,antineoplastic,5/7/2023,2/14/2023,Intravenous,carboplatin,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/22/2025,mg,antineoplastic,3/5/2020,2/18/2020,Intravenous,pemetrexed,TRUE
216,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,5/11/2020,mg,antineoplastic,11/10/2019,8/23/2019,Intravenous,carboplatin,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,3/26/2019,mg,antineoplastic,4/20/2019,3/24/2019,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1554C84G3CD2,11/11/2023,mg,antineoplastic,10/3/2023,5/28/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/23/2020,,antineoplastic,3/28/2019,8/4/2017,Intravenous,pemetrexed,TRUE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,5/22/2015,mg,antineoplastic,9/17/2014,10/24/2014,Intravenous,cisplatin,FALSE
881,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,6/9/2024,mg,antineoplastic,3/25/2024,2/8/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/27/2021,mg,antineoplastic,8/12/2021,10/11/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,11/4/2019,mg,antineoplastic,10/13/2019,8/12/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,12/18/2023,,solution-fluid,5/27/2023,12/16/2022,Intravenous,clinical study drug,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/13/2014,mg,antineoplastic,4/28/2014,4/17/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G211B9B8E3:3E,2/18/2025,,antineoplastic,5/15/2024,5/18/2024,Intravenous,durvalumab,FALSE
82.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,6/14/2015,mg,antineoplastic,4/23/2015,3/16/2015,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/17/2020,,antineoplastic,8/30/2020,8/12/2020,Nasogastric,bicalutamide,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G217694659D6F,6/22/2022,,,7/7/2022,5/10/2021,Oral,alectinib,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/9/2012,mg,antineoplastic,5/23/2012,4/20/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/14/2016,,antineoplastic,7/1/2016,10/11/2014,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/21/2024,,antineoplastic,4/27/2024,5/4/2024,,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/1/2023,mg,antineoplastic,3/8/2023,11/19/2022,Intravenous,pembrolizumab,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,4/30/2021,mg,antineoplastic,1/20/2021,12/16/2020,Intravenous,carboplatin,FALSE
832,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E16D::267DF,10/15/2021,mg,antineoplastic,10/2/2021,8/3/2021,Intravenous,pemetrexed,FALSE
206,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37973D8B1C9F,12/5/2019,mg,antineoplastic,10/25/2019,11/18/2019,Intravenous,carboplatin,FALSE
50,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:D1D2EG5C21,1/22/2015,mg,antineoplastic,12/18/2014,12/24/2014,Intravenous,vinorelbine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,2/23/2023,mg,antineoplastic,1/15/2023,9/4/2022,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,11/18/2023,mg,antineoplastic,2/23/2023,2/28/2023,Intravenous,rituximab-arrx,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/11/2020,mg,antineoplastic,11/22/2019,2/11/2019,Intravenous,pembrolizumab,FALSE
141,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G4C65C839C5CC,11/26/2016,mg,antineoplastic,10/8/2016,9/16/2016,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/20/2025,,antineoplastic,4/17/2023,3/1/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,6/2/2021,mg,antineoplastic,5/9/2021,8/14/2020,Intravenous,pembrolizumab,TRUE
368,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/15/2021,mg,antineoplastic,5/4/2021,4/20/2021,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/20/2025,mg,antineoplastic,5/15/2024,8/29/2022,Intravenous,pembrolizumab,TRUE
249.9,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/8/2016,mg,antineoplastic,1/3/2016,12/30/2015,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/18/2025,mg,antineoplastic,3/20/2017,1/15/2017,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,11/15/2024,mg,antineoplastic,8/20/2024,8/9/2024,Intravenous,pemetrexed,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,5/20/2019,mg/kg,antineoplastic,9/27/2017,8/5/2017,Intravenous,ramucirumab,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,1/10/2019,mg,antineoplastic,10/28/2018,7/26/2018,Intravenous,carboplatin,FALSE
288,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,11/4/2024,mg,antineoplastic,9/20/2024,9/14/2024,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G128:92:3BD3D,11/28/2021,,antineoplastic,6/17/2021,4/16/2021,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G14955945B53:,7/10/2023,mg,antineoplastic,5/4/2023,3/22/2023,Intravenous,pembrolizumab,TRUE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/13/2018,mL,solution-fluid,2/2/2018,12/4/2017,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/29/2020,mg,antineoplastic,7/16/2017,7/13/2016,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G2:1CGCB76E,5/2/2021,mg,antineoplastic,10/31/2020,6/10/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/23/2020,mg,antineoplastic,7/29/2020,6/30/2019,Intravenous,pembrolizumab,TRUE
735,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,9/28/2014,mg,antineoplastic,8/2/2014,6/5/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/31/2021,mg/m2,antineoplastic,4/10/2021,3/12/2021,Intravenous,leucovorin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/16/2013,mg,antineoplastic,9/12/2012,12/22/2011,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,immunotherapy,"Ipilimumab,Nivolumab",G1411E9::FGC8,6/22/2023,,antineoplastic,6/7/2023,6/20/2023,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/17/2020,mg,antineoplastic,12/24/2019,9/24/2019,Intravenous,pembrolizumab,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,2/23/2016,mg,antineoplastic,9/27/2015,9/19/2015,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/24/2017,mg,antineoplastic,7/24/2017,7/18/2017,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,4/13/2025,mg,antineoplastic,1/6/2025,11/18/2024,Intravenous,pembrolizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/6/2022,mg,antineoplastic,8/22/2021,8/11/2021,Intravenous,amivantamab-vmjw,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/10/2017,,antineoplastic,12/15/2016,1/26/2016,Intravenous,clinical study drug,FALSE
394,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,11/28/2014,mg,antineoplastic,8/28/2014,8/5/2014,Intravenous,paclitaxel,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,9/5/2023,mg,antineoplastic,7/21/2023,4/13/2023,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3::1F4G:66GE,10/28/2022,mg,antineoplastic,9/16/2022,8/12/2022,Intravenous,pemetrexed,FALSE
366,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/25/2015,mg,antineoplastic,11/1/2014,10/1/2014,Intravenous,carboplatin,FALSE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,8/3/2018,mg,antineoplastic,5/16/2018,5/22/2018,Intravenous,pemetrexed,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,10/31/2018,mg,antineoplastic,9/9/2016,10/8/2016,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,5/4/2024,,antineoplastic,4/10/2024,4/29/2024,Oral,ivosidenib,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/22/2020,mg,antineoplastic,6/3/2020,2/28/2020,Intravenous,carboplatin,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/17/2024,mg,antineoplastic,4/4/2024,3/2/2024,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/23/2022,,antineoplastic,10/29/2022,10/14/2022,,pemetrexed,FALSE
1386,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/5/2015,mg,antineoplastic,12/4/2014,9/27/2014,Intravenous,bevacizumab,FALSE
173,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/15/2013,mg,antineoplastic,6/7/2012,4/26/2012,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/25/2020,mg,antineoplastic,11/18/2017,7/12/2017,Intravenous,pemetrexed,TRUE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/15/2022,mg,antineoplastic,6/11/2021,5/9/2021,Intravenous,fluorouracil,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,6/26/2015,mg,antineoplastic,5/26/2015,5/20/2015,Intravenous,carboplatin,FALSE
1200,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Temozolomide",G4DE3DE99E:13,2/6/2016,mg,antineoplastic,2/6/2016,12/11/2015,Intravenous,gemcitabine,FALSE
1115,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/12/2016,mg,antineoplastic,4/17/2016,2/20/2016,Intravenous,pemetrexed,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/3/2024,mg,antineoplastic,6/28/2024,5/3/2024,Intravenous,paclitaxel,FALSE
125,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4DE3DE99E:13,12/9/2015,mg,antineoplastic,9/15/2015,9/11/2015,Intravenous,pembrolizumab,FALSE
2,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2398:2936:C9,1/25/2014,AUC,antineoplastic,2/2/2014,1/26/2014,Intravenous,carboplatin,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/12/2016,mg/m2,antineoplastic,3/10/2016,2/5/2016,Intravenous,etoposide,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,11/27/2014,mg,antineoplastic,9/24/2014,8/17/2014,Intravenous,carboplatin,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/22/2021,mg,antineoplastic,5/18/2021,4/27/2021,Intravenous,pemetrexed,FALSE
500,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G1G78CEE:7E:3,11/4/2018,mg/m2,antineoplastic,9/5/2018,7/18/2018,Intravenous,pemetrexed,FALSE
108,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GE686D11C25,4/19/2015,mg,antineoplastic,4/6/2015,4/1/2015,Intravenous,paclitaxel,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/15/2021,mL,solution-fluid,10/18/2018,2/22/2018,Intravenous,durvalumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,12/17/2021,mg,antineoplastic,4/16/2021,1/23/2021,Intravenous,durvalumab,FALSE
816,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/4/2025,mg,antineoplastic,2/12/2025,12/31/2024,Intravenous,pemetrexed,FALSE
580,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/31/2022,mg,antineoplastic,3/1/2022,3/22/2022,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,8/25/2018,,antineoplastic,5/24/2018,5/24/2018,Oral,hydroxyurea,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/9/2017,mg,antineoplastic,11/28/2016,9/6/2016,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,1/18/2025,mg/m2,antineoplastic,10/20/2024,10/23/2024,Intravenous,etoposide,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,7/29/2022,mg,antineoplastic,7/4/2022,7/31/2022,Oral,anastrozole,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/3/2025,mg,antineoplastic,2/27/2025,8/5/2024,Intravenous,pemetrexed,TRUE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14::E36GD8C6,5/11/2019,mg/m2,antineoplastic,4/25/2019,4/6/2019,Intravenous,paclitaxel,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/25/2021,mg,antineoplastic,6/24/2019,5/3/2019,Intravenous,paclitaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,12/31/2018,mg,antineoplastic,12/28/2018,10/4/2018,Intravenous,pemetrexed,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,1/2/2024,mg,antineoplastic,10/12/2023,8/16/2023,Intravenous,paclitaxel,FALSE
162,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,10/17/2022,mg,antineoplastic,9/25/2022,9/4/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/18/2022,mg,antineoplastic,3/27/2020,3/19/2020,Intravenous,pembrolizumab,TRUE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/24/2021,mg,antineoplastic,6/29/2021,5/5/2021,Intravenous,paclitaxel protein-bound,FALSE
221,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/15/2020,mg,antineoplastic,8/8/2020,5/1/2020,Intravenous,paclitaxel,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/21/2025,mg,antineoplastic,10/28/2024,4/29/2024,Intravenous,pemetrexed,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/6/2020,mg,antineoplastic,4/25/2017,7/1/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/15/2025,,antineoplastic,3/4/2025,1/28/2023,Intravenous,pemetrexed,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/22/2020,mg,antineoplastic,11/26/2020,10/5/2020,Intravenous,pemetrexed,FALSE
1800,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5722GECG4G16,7/3/2024,mg,antineoplastic,5/9/2024,2/14/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,9/7/2020,mg,antineoplastic,6/26/2020,5/30/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/4/2022,mg,antineoplastic,2/3/2022,11/20/2021,Intravenous,pembrolizumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/28/2012,mg,antineoplastic,2/1/2012,1/14/2012,Intravenous,etoposide,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/10/2016,mg,antineoplastic,3/1/2015,5/7/2014,Intravenous,pemetrexed,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/12/2015,mg,antineoplastic,7/13/2015,2/24/2015,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/7/2013,,antineoplastic,4/13/2013,2/19/2013,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,5/4/2025,mg,antineoplastic,4/15/2016,1/5/2016,Intravenous,paclitaxel,FALSE
51,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,7/12/2024,mg,antineoplastic,6/13/2024,5/28/2024,Intravenous,ipilimumab,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,2/3/2020,,antineoplastic,11/29/2017,8/20/2017,Intravenous,pemetrexed,TRUE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G1D41F368EE:G,5/22/2019,mg,antineoplastic,4/16/2019,5/26/2019,Subcutaneous,leuprolide,FALSE
651,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46E218G4252C,9/18/2016,mg,antineoplastic,5/17/2016,6/22/2016,Intravenous,pemetrexed,FALSE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/21/2018,mg,antineoplastic,4/21/2018,5/3/2018,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14GFF41D::2B,8/10/2012,mg,antineoplastic,7/7/2012,8/14/2012,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,5/17/2023,mg,antineoplastic,12/6/2019,10/10/2019,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/7/2018,mg,antineoplastic,12/27/2017,8/30/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/26/2022,Ea,antineoplastic,10/18/2019,12/12/2017,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/20/2023,mg,antineoplastic,9/8/2022,9/1/2022,Subcutaneous,azacitidine,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,1/10/2025,,antineoplastic,8/14/2018,10/12/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,7/26/2018,mg,antineoplastic,6/4/2018,5/21/2018,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/13/2016,mg,antineoplastic,2/7/2016,5/7/2015,Intravenous,nivolumab,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/23/2020,mg,antineoplastic,5/25/2019,3/9/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28F814933C3F,2/13/2025,mg,antineoplastic,8/17/2024,8/20/2024,Intravenous,pembrolizumab,TRUE
175,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,10/6/2020,mg/m2,antineoplastic,10/1/2020,10/9/2020,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/2/2025,mg,antineoplastic,8/3/2018,3/17/2018,Intravenous,nivolumab,FALSE
500,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/18/2024,mg,antineoplastic,6/15/2024,6/19/2023,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,5/4/2025,,,3/26/2025,12/31/2024,Oral,lorlatinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/5/2025,mg,antineoplastic,4/4/2025,9/26/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,4/24/2019,mg,antineoplastic,4/27/2019,2/14/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/10/2020,mg,antineoplastic,4/21/2019,7/15/2016,Intravenous,nivolumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/4/2015,mg,antineoplastic,8/9/2014,8/20/2014,Intravenous,paclitaxel,FALSE
150,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,3/29/2024,mg,antineoplastic,1/20/2024,11/12/2023,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,12/7/2017,mg,antineoplastic,8/30/2017,9/13/2017,Intravenous,pemetrexed,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/30/2018,mg,antineoplastic,8/28/2017,8/30/2017,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/8/2016,mg,antineoplastic,8/20/2016,4/21/2016,Intravenous,bevacizumab,TRUE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G46:87GF7FGC9,11/14/2015,,hematological agent,9/11/2015,7/24/2015,Subcutaneous,clinical study drug,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,9/7/2012,mg,antineoplastic,4/24/2012,3/15/2012,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/2/2025,mg,antineoplastic,8/24/2023,2/2/2019,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Administrations,immunotherapy,"Anastrozole,Atezolizumab",G1GFD92F489E7,12/19/2023,,antineoplastic,11/8/2023,10/18/2023,Intravenous,atezolizumab,FALSE
,,ADJUVANT,Orders,hormone,"Letrozole,Osimertinib",G31G19E54FC:B,9/25/2023,,antineoplastic,9/18/2020,9/19/2020,Oral,letrozole,FALSE
676,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,8/20/2024,mg,antineoplastic,9/6/2024,8/1/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,11/10/2019,mg,antineoplastic,10/21/2019,8/2/2019,Intravenous,pembrolizumab,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/12/2025,mg,antineoplastic,12/31/2024,11/3/2024,Intravenous,pemetrexed,TRUE
1666,,NEOADJUVANT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/19/2013,mg/m2,antineoplastic,2/12/2013,2/4/2013,Intravenous,mesna,FALSE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,12/2/2015,mg,antineoplastic,8/11/2015,5/10/2015,Intravenous,docetaxel,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,9/12/2021,mg,antineoplastic,8/4/2021,4/9/2021,Intravenous,pemetrexed,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/25/2020,mg,antineoplastic,2/19/2018,7/27/2017,Intravenous,pemetrexed,TRUE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/16/2020,mg,antineoplastic,2/10/2020,1/6/2020,Intravenous,paclitaxel,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/20/2014,AUC,antineoplastic,7/24/2014,11/7/2013,Intravenous,carboplatin,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/31/2017,mg,antineoplastic,6/13/2016,4/11/2016,Intravenous,nivolumab,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,8/1/2019,mg,antineoplastic,4/11/2019,9/19/2018,Intravenous,durvalumab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G1DD111EC2E4G,4/22/2021,mL,solution-fluid,4/3/2021,4/2/2021,Intravenous,carboplatin,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G2F8618:5DF1:,5/17/2014,mg,antineoplastic,5/14/2014,5/29/2014,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,1/19/2016,mg,antineoplastic,11/13/2015,7/21/2015,Intravenous,bevacizumab,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/22/2023,mg,antineoplastic,11/6/2019,9/17/2019,Intravenous,pembrolizumab,TRUE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,3/6/2013,mg,antineoplastic,2/12/2013,2/10/2013,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,1/25/2020,mg,antineoplastic,9/17/2017,1/24/2016,Intravenous,bevacizumab,TRUE
388,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,1/20/2021,mg,antineoplastic,10/20/2020,10/6/2020,Intravenous,carboplatin,FALSE
96,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/20/2021,mg,antineoplastic,2/13/2017,12/9/2016,Intravenous,paclitaxel,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,9/11/2024,mg,antineoplastic,7/25/2024,6/25/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,12/1/2022,mg,antineoplastic,8/18/2018,2/3/2018,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/31/2022,mg,antineoplastic,10/11/2019,4/13/2017,Intravenous,nivolumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,12/29/2019,mg,antineoplastic,11/16/2019,2/16/2019,Intravenous,durvalumab,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,3/12/2021,mg,antineoplastic,11/17/2020,11/12/2020,Intravenous,paclitaxel,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/2/2025,mg,antineoplastic,3/1/2025,4/18/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,9/16/2018,mg,antineoplastic,6/30/2018,4/6/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/9/2019,mg,antineoplastic,3/15/2019,3/6/2019,Intravenous,pembrolizumab,TRUE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/9/2020,mg,antineoplastic,2/20/2020,10/5/2019,Intravenous,durvalumab,FALSE
1300,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,10/30/2013,mg,antineoplastic,8/3/2013,7/29/2013,Intravenous,gemcitabine,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,11/19/2019,mg,antineoplastic,9/26/2019,6/18/2019,Intravenous,docetaxel,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,4/1/2016,mg,antineoplastic,2/10/2015,12/13/2014,Intravenous,pemetrexed,FALSE
390,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,3/22/2023,mg,antineoplastic,12/22/2022,12/1/2022,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/18/2025,mg,antineoplastic,10/26/2020,1/17/2017,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/4/2023,mg,antineoplastic,9/19/2022,8/9/2022,Subcutaneous,azacitidine,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/6/2021,AUC,antineoplastic,9/7/2021,7/16/2021,Intravenous,carboplatin,FALSE
707,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3CG5712E:B54,7/24/2024,mg,antineoplastic,5/19/2024,5/28/2024,Intravenous,ramucirumab,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/23/2016,mg,antineoplastic,11/20/2016,7/10/2016,Intravenous,necitumumab,FALSE
493,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/8/2025,mg,antineoplastic,8/30/2019,4/3/2019,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/27/2025,mg,antineoplastic,3/24/2025,7/17/2024,Intravenous,pembrolizumab,FALSE
245,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/6/2016,mg,antineoplastic,4/3/2016,12/18/2015,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/1/2025,mg/m2,antineoplastic,11/10/2024,7/18/2024,Intravenous,gemcitabine,FALSE
795,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,3/3/2015,mg,antineoplastic,11/29/2014,10/3/2014,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/30/2018,mg,antineoplastic,11/18/2017,6/23/2017,Intravenous,pembrolizumab,FALSE
857,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,5/1/2015,mg,antineoplastic,2/15/2015,12/1/2014,Intravenous,carboplatin,FALSE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,12/19/2014,,antineoplastic,10/8/2014,9/13/2014,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/17/2024,mg,antineoplastic,5/27/2023,2/28/2023,Intravenous,atezolizumab,TRUE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/3/2022,mg,antineoplastic,9/15/2022,8/13/2022,Intravenous,paclitaxel,FALSE
840,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,8/1/2012,mg,antineoplastic,5/28/2012,3/5/2012,Intravenous,bevacizumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/2/2018,mg/m2,antineoplastic,9/29/2017,10/23/2017,Intravenous,paclitaxel,FALSE
400,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,3/30/2023,mg,antineoplastic,11/1/2020,9/25/2019,Intravenous,pembrolizumab,TRUE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2628C28G7613,5/10/2016,mg,antineoplastic,1/16/2016,10/20/2015,Intravenous,docetaxel,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,1/31/2014,mg,antineoplastic,11/17/2013,9/30/2013,Intravenous,vinorelbine,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/18/2023,mg,antineoplastic,5/24/2023,4/5/2023,Subcutaneous,azacitidine,FALSE
760,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2628C28G7613,6/18/2015,mg,antineoplastic,3/26/2015,3/25/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1FD696E::692,10/18/2024,,antineoplastic,7/27/2024,5/26/2024,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/12/2025,,antineoplastic,2/15/2025,11/6/2024,Intravenous,pembrolizumab,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/4/2025,mg,antineoplastic,11/27/2023,10/10/2022,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38579B136B1B,5/8/2025,mg,antineoplastic,4/1/2025,12/20/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/28/2023,mg,antineoplastic,5/26/2023,9/11/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,hormone,Clinical Study Drug,G118F63B281FD,6/16/2011,,antineoplastic,6/7/2011,5/2/2011,Intramuscular,clinical study drug,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/24/2013,mg/m2,antineoplastic,7/23/2012,6/27/2012,Intravenous,docetaxel,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/6/2024,mg,antineoplastic,7/22/2024,8/10/2023,Intravenous,durvalumab,FALSE
1040,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GE686D11C25,2/9/2016,mg,antineoplastic,9/15/2015,4/16/2015,Intravenous,pemetrexed,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/2/2023,mg,antineoplastic,2/20/2021,1/8/2020,Intravenous,pembrolizumab,FALSE
254,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39GB9B7D:9:C,1/29/2016,mg,antineoplastic,12/5/2015,11/8/2015,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,antiemetic,Clinical Study Drug,G177G4:B9E394,5/10/2025,,antiemetic,5/7/2025,3/29/2025,,clinical study drug,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/29/2024,mg,antineoplastic,11/13/2023,10/13/2023,Intravenous,pembrolizumab,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,11/12/2014,mg,antineoplastic,8/4/2014,9/22/2014,Intravenous,paclitaxel,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/16/2020,mg,antineoplastic,3/23/2020,8/30/2019,Intravenous,gemcitabine,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,8/14/2017,mg,antineoplastic,6/26/2017,5/13/2017,Intravenous,cisplatin,FALSE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/8/2024,mg,antineoplastic,7/6/2024,5/8/2024,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,5/17/2019,mg,antineoplastic,1/15/2019,2/20/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/6/2017,,solution-fluid,3/19/2016,3/6/2016,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,4/16/2023,,antineoplastic,10/14/2022,4/5/2022,Intravenous,durvalumab,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G2F327FD5:2:3,3/22/2025,mg,antineoplastic,3/25/2025,3/4/2025,Intravenous,docetaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/15/2025,mg,antineoplastic,2/19/2019,1/26/2017,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/28/2016,mg,antineoplastic,1/28/2015,5/1/2014,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/20/2023,,antineoplastic,5/2/2023,11/29/2022,,pemetrexed,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,3/1/2014,mg,antineoplastic,10/10/2013,7/28/2013,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/23/2025,mg,antineoplastic,1/16/2025,3/21/2024,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,11/23/2023,mg,antineoplastic,11/15/2023,12/8/2023,Oral,anastrozole,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,4/23/2025,mg,antineoplastic,3/6/2025,10/9/2024,Intravenous,pembrolizumab,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/25/2014,mg,antineoplastic,9/16/2014,8/12/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/21/2024,mg,antineoplastic,11/6/2024,8/4/2024,Intravenous,pembrolizumab,FALSE
1590,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,9/11/2015,mg,antineoplastic,4/30/2015,3/3/2015,Intravenous,gemcitabine,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/12/2020,mg,antineoplastic,8/8/2020,5/8/2020,Intravenous,carboplatin,FALSE
798,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2G38:E36D42B,1/24/2025,mg,antineoplastic,11/3/2024,10/19/2024,Intravenous,durvalumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/6/2025,mg,antineoplastic,2/9/2019,1/27/2018,Intravenous,nivolumab,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/5/2016,mg,antineoplastic,8/12/2015,4/15/2015,Intravenous,gemcitabine,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,7/18/2013,mg,antineoplastic,1/15/2013,12/18/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/16/2025,mg,antineoplastic,4/11/2023,4/21/2022,Intravenous,pembrolizumab,FALSE
564.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/4/2019,mg,antineoplastic,1/27/2019,10/28/2018,Intravenous,carboplatin,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/1/2025,mg,antineoplastic,4/23/2024,3/20/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G485C85BECGC4,3/14/2022,,antineoplastic,1/24/2022,1/3/2022,Intravenous,clinical study drug,FALSE
2.28,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/26/2014,mg,antineoplastic,6/1/2014,1/9/2014,Intravenous,eribulin,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,5/23/2025,mg,antineoplastic,6/6/2024,7/8/2024,Intravenous,carboplatin,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,8/6/2021,mg,antineoplastic,11/7/2020,9/1/2020,Intravenous,durvalumab,FALSE
22.5,5,ADVANCED,Administrations,hormone,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/11/2025,mg,antineoplastic,2/1/2025,2/17/2025,Subcutaneous,leuprolide,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,5/7/2025,mg,antineoplastic,3/28/2025,9/17/2024,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/4/2025,,antineoplastic,7/4/2024,11/24/2022,Intravenous,cisplatin,FALSE
,,ADJUVANT,Unstructured,,Alectinib,G1GECG2D6BB54,3/27/2025,,,6/13/2021,7/12/2021,Oral,alectinib,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/6/2017,mg,antineoplastic,6/21/2016,4/17/2015,Intravenous,bevacizumab,TRUE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/27/2022,mg,antineoplastic,2/22/2019,5/3/2017,Oral,nilotinib,FALSE
136,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G4G53233CD43C,1/20/2025,mg,antineoplastic,11/13/2024,11/1/2024,Intravenous,docetaxel,FALSE
304,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/5/2025,mg,antineoplastic,3/17/2025,2/16/2025,Intravenous,carboplatin,FALSE
161,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/19/2023,mg,antineoplastic,1/21/2023,11/20/2022,Intravenous,carboplatin,FALSE
320,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/8/2025,mg,antineoplastic,11/30/2024,8/13/2024,Intravenous,paclitaxel,FALSE
101,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,8/6/2020,mg,antineoplastic,4/27/2020,3/17/2020,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/12/2025,mg,antineoplastic,7/8/2018,3/25/2018,Intravenous,nivolumab,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,5/30/2022,mg,antineoplastic,6/1/2022,5/10/2022,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,12/23/2017,mg,antineoplastic,8/25/2017,8/4/2017,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,7/31/2024,mg,antineoplastic,5/30/2024,3/7/2024,Intravenous,pembrolizumab,FALSE
1632,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab,Carboplatin,Paclitaxel",G3D:24E398DDF,6/8/2020,mg,antineoplastic,4/24/2020,3/18/2020,Intravenous,bevacizumab,FALSE
187,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/22/2022,mg,antineoplastic,2/14/2022,1/25/2022,Intravenous,carboplatin,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,4/24/2025,mg,antineoplastic,12/12/2024,10/25/2024,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,7/21/2016,mg,antineoplastic,5/24/2016,4/27/2016,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/15/2020,mg,antineoplastic,3/20/2020,10/20/2019,Intravenous,durvalumab,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,11/3/2016,,antineoplastic,5/13/2016,5/10/2016,Intravenous,nivolumab,FALSE
185,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/3/2022,mg,antineoplastic,3/26/2022,2/14/2022,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,targeted/biologic,"Erlotinib,Ramucirumab",G4725296E3CE4,10/4/2021,mg,antineoplastic,8/29/2021,9/12/2021,Intravenous,ramucirumab,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/10/2024,mg,antineoplastic,7/30/2024,5/30/2024,Intravenous,carboplatin,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,10/23/2023,mg,antineoplastic,5/24/2023,6/1/2023,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,8/3/2017,,antineoplastic,11/17/2016,11/14/2016,Oral,clinical study drug,FALSE
,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/26/2021,,antineoplastic,9/21/2020,8/30/2020,Oral,bicalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/11/2025,mg,antineoplastic,3/8/2025,2/13/2019,Intravenous,pembrolizumab,TRUE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/20/2016,mg,antineoplastic,11/1/2015,12/25/2014,Intravenous,pemetrexed,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/7/2020,mg,antineoplastic,6/22/2018,3/1/2017,Intravenous,bevacizumab,FALSE
800,1,ADVANCED,Orders,chemotherapy,Gemcitabine,G4G4D:D9D8152,4/28/2025,mg/m2,antineoplastic,4/9/2025,2/11/2025,Intravenous,gemcitabine,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/6/2020,mg,antineoplastic,8/1/2016,11/23/2015,Intravenous,nivolumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,1/29/2025,mg,antineoplastic,11/28/2024,11/29/2024,Intravenous,pemetrexed,FALSE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,3/21/2017,mg,antineoplastic,8/19/2016,5/14/2016,Intravenous,nivolumab,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/9/2018,mg,antineoplastic,7/3/2016,8/13/2015,Intravenous,nivolumab,FALSE
60,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G1G618861EGD9,8/11/2016,mg,antineoplastic,8/29/2016,7/10/2016,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/4/2023,mg,antineoplastic,10/22/2022,8/4/2022,Intravenous,pembrolizumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/23/2020,mg,antineoplastic,4/26/2019,2/10/2019,Intravenous,nivolumab,FALSE
1.5,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,12/4/2023,mg,antineoplastic,2/22/2023,1/8/2023,Intravenous,vincristine,FALSE
,2,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,10/1/2020,,,8/18/2020,6/23/2020,Oral,osimertinib,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G2C38B34G8794,9/26/2022,,antineoplastic,1/17/2022,9/13/2021,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/13/2018,mg,antineoplastic,6/24/2015,6/1/2015,Intravenous,carboplatin,FALSE
92,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,9/28/2017,mg,antineoplastic,2/2/2017,1/7/2017,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,2/1/2017,,antineoplastic,1/19/2017,11/5/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,10/15/2021,mg,antineoplastic,9/23/2021,8/7/2021,Intravenous,pembrolizumab,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/15/2023,mg,antineoplastic,4/12/2020,3/13/2020,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/2/2025,mg,antineoplastic,1/14/2017,12/21/2016,Intravenous,nivolumab,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,4/30/2019,mg,antineoplastic,5/15/2019,3/5/2019,Intravenous,paclitaxel,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/24/2014,mg,antineoplastic,11/4/2014,9/7/2014,Intravenous,paclitaxel,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/19/2023,mg,antineoplastic,3/24/2023,2/11/2023,Intravenous,cemiplimab,FALSE
145.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3842BD:23EG:,11/7/2017,mg,antineoplastic,10/21/2017,11/2/2017,Intravenous,carboplatin,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/28/2021,mg,antineoplastic,5/26/2021,8/29/2020,Intravenous,ipilimumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G47CG7D:EEG,6/9/2018,AUC,antineoplastic,7/14/2018,5/20/2018,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/22/2025,mg,antineoplastic,6/25/2021,4/19/2020,Subcutaneous,leuprolide,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/9/2019,mg,antineoplastic,8/11/2018,2/18/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/5/2025,,antineoplastic,7/30/2024,4/7/2024,Intravenous,paclitaxel protein-bound,FALSE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,10/5/2024,mg,antineoplastic,7/14/2024,7/25/2024,Intravenous,gemcitabine,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G36BE14CG117:,4/11/2018,mg,antineoplastic,4/18/2018,4/1/2018,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/2/2024,mg,antineoplastic,10/18/2023,12/17/2022,Intravenous,nivolumab,FALSE
164,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/12/2024,mg,antineoplastic,7/10/2024,6/3/2024,Intravenous,cisplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1CC41:D:7C48,8/26/2020,mg,antineoplastic,8/6/2020,7/26/2020,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Unstructured,,"Bevacizumab,Erlotinib",G168G1C789D7C,3/14/2014,,,3/20/2014,2/16/2014,Oral,erlotinib,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/18/2022,mg,antineoplastic,6/17/2017,5/24/2017,Oral,dasatinib,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/25/2024,mg,antineoplastic,2/5/2023,5/3/2022,Intravenous,durvalumab,TRUE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/1/2022,mg,antineoplastic,10/19/2021,3/31/2021,Intravenous,vinorelbine,FALSE
1,1,ADVANCED,Administrations,hormone,Anastrozole,G1F26CECEF:89,3/4/2019,mg,antineoplastic,3/22/2019,3/10/2019,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/22/2019,mg,antineoplastic,3/17/2019,1/29/2019,Intravenous,pembrolizumab,TRUE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/23/2015,mg,antineoplastic,5/25/2015,3/14/2015,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/4/2024,mg,antineoplastic,10/23/2022,2/25/2022,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/1/2025,mg,antineoplastic,1/24/2025,3/16/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G1542E4F46G4B,4/26/2020,,,5/1/2020,3/21/2018,Oral,afatinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/21/2019,mg,antineoplastic,12/19/2018,6/23/2018,Intravenous,nivolumab,FALSE
390,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,8/3/2014,mg,antineoplastic,5/24/2014,2/25/2014,Intravenous,paclitaxel,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/16/2020,mg,antineoplastic,9/29/2017,12/24/2015,Intravenous,nivolumab,FALSE
45,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G1F:9CFGFGFC1,6/13/2014,mg,antineoplastic,5/6/2014,6/7/2014,Intravenous,cisplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G199:3GD5C8:8,3/14/2023,mg,antineoplastic,2/19/2023,1/26/2023,Intravenous,pembrolizumab,TRUE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/5/2020,mg,antineoplastic,10/5/2020,2/13/2020,Intravenous,docetaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/9/2025,mg,antineoplastic,5/27/2022,1/27/2017,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,3/10/2016,mg,antineoplastic,11/8/2015,8/17/2015,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,6/24/2016,mg,antineoplastic,4/3/2015,1/19/2015,Intravenous,pemetrexed,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/24/2021,mL,solution-fluid,10/4/2018,2/23/2018,Intravenous,durvalumab,TRUE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/23/2019,mg/m2,antineoplastic,1/17/2019,10/23/2018,Intravenous,gemcitabine,FALSE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,2/22/2017,mg,antineoplastic,11/22/2016,12/4/2016,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/22/2014,,antineoplastic,12/29/2013,11/9/2013,,clinical study drug,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,9/11/2012,mg,antineoplastic,4/21/2012,2/28/2012,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/23/2025,,antineoplastic,4/30/2024,4/29/2024,Intravenous,pembrolizumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,3/21/2023,mg,antineoplastic,6/3/2022,4/17/2022,Intravenous,atezolizumab,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/13/2023,mg,antineoplastic,11/2/2023,9/4/2023,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/10/2025,mg,antineoplastic,7/27/2024,4/3/2024,Intravenous,amivantamab-vmjw,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/15/2019,mg,antineoplastic,4/24/2019,3/10/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/13/2024,mg,antineoplastic,9/9/2024,8/17/2024,Intravenous,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,12/11/2024,mg,antineoplastic,10/7/2024,6/4/2024,Intravenous,durvalumab,TRUE
860,5,ADVANCED,Administrations,chemotherapy,Pemetrexed,G166B735:96D2,11/6/2013,mg,antineoplastic,11/2/2013,9/27/2013,Intravenous,pemetrexed,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/3/2011,mg,antineoplastic,8/16/2011,4/17/2011,Intravenous,carboplatin,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/25/2024,mg,antineoplastic,4/28/2024,3/21/2024,Intravenous,pemetrexed,FALSE
313,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,4/19/2019,mg,antineoplastic,4/15/2019,3/11/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/22/2025,,antineoplastic,4/8/2023,2/23/2023,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/12/2014,mg,antineoplastic,1/19/2014,10/29/2013,Intravenous,paclitaxel,FALSE
174,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11B743:8G337,1/21/2017,mg,antineoplastic,6/11/2016,7/10/2016,Intravenous,nivolumab,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/20/2018,mg,antineoplastic,1/5/2018,11/28/2017,Intravenous,nivolumab,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,8/7/2016,mg,antineoplastic,6/10/2016,3/7/2016,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,1/2/2018,mg,antineoplastic,11/8/2017,7/12/2017,Intravenous,nivolumab,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/2/2024,mg,antineoplastic,6/14/2024,4/12/2024,Intravenous,cisplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/9/2012,,antineoplastic,10/31/2011,10/16/2011,Intravenous,clinical study drug,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/4/2025,mg,antineoplastic,1/10/2025,1/26/2024,Intravenous,pembrolizumab,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,1/22/2017,mg,antineoplastic,11/23/2016,12/2/2016,Intravenous,paclitaxel,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,12/15/2023,mg,antineoplastic,12/17/2023,7/13/2023,Intravenous,nivolumab,FALSE
560,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,10/26/2023,mg,antineoplastic,3/8/2023,4/10/2023,Intravenous,carboplatin,FALSE
129,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/26/2019,mg,antineoplastic,10/7/2019,9/10/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/20/2022,mg,antineoplastic,7/6/2021,1/2/2018,Intravenous,pembrolizumab,FALSE
160,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,3/12/2015,mg,antineoplastic,1/22/2015,2/25/2015,Intravenous,paclitaxel protein-bound,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/18/2023,mg,antineoplastic,6/9/2023,10/10/2022,Intravenous,durvalumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,5/31/2024,mg,antineoplastic,9/4/2023,7/18/2023,Intravenous,atezolizumab,FALSE
125,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G153G5833D6D1,3/29/2019,mg,antineoplastic,1/26/2019,1/17/2019,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/28/2013,mg,antineoplastic,6/7/2013,2/16/2013,Intravenous,paclitaxel protein-bound,FALSE
830,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/20/2020,mg,antineoplastic,7/4/2019,2/9/2019,Intravenous,durvalumab,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,3/31/2020,mg,antineoplastic,9/16/2019,6/28/2019,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,8/6/2018,mg,antineoplastic,1/3/2018,9/20/2017,Intravenous,atezolizumab,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/7/2020,mg,antineoplastic,4/24/2019,7/5/2017,Intravenous,pemetrexed,TRUE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/30/2018,mg,antineoplastic,9/28/2018,4/30/2018,Intravenous,carboplatin,FALSE
683,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,9/8/2015,mg,antineoplastic,4/19/2015,4/23/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12DD1599F4EF,10/19/2024,,antineoplastic,7/30/2024,8/13/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,5/15/2021,,antineoplastic,3/10/2021,4/1/2021,Oral,anastrozole,FALSE
815,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,11/11/2022,mg,antineoplastic,10/22/2022,11/2/2022,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/22/2023,mg,antineoplastic,3/15/2023,3/13/2023,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,12/29/2016,mg,antineoplastic,1/9/2014,11/25/2013,Intravenous,cisplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,6/22/2015,mg,antineoplastic,4/14/2015,5/9/2015,Intravenous,carboplatin,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,1/13/2014,mg,antineoplastic,11/3/2013,11/3/2013,Intravenous,paclitaxel,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,3/19/2024,mg,antineoplastic,3/24/2024,2/3/2024,Intravenous,pemetrexed,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/25/2023,mg,antineoplastic,4/15/2020,1/10/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,2/2/2025,,antineoplastic,8/2/2024,5/16/2024,Intravenous,paclitaxel protein-bound,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,7/8/2018,mg,antineoplastic,7/16/2018,8/8/2018,Intravenous,paclitaxel,FALSE
32,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,3/25/2014,mg,antineoplastic,5/13/2014,3/30/2014,Intravenous,docetaxel,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/22/2022,mg,antineoplastic,7/27/2021,2/17/2021,Intravenous,bevacizumab-awwb,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/20/2024,mg,antineoplastic,8/28/2024,4/27/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/21/2025,mg,antineoplastic,9/21/2020,3/25/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Capmatinib,G15:19EG3849:,11/25/2021,,,12/5/2021,9/27/2021,Oral,capmatinib,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G2:737C75FGBF,2/2/2025,,,3/8/2024,2/29/2024,Oral,osimertinib,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/4/2021,mg,antineoplastic,10/7/2021,9/12/2021,Intravenous,carboplatin,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,2/25/2013,mg/m2,antineoplastic,1/1/2013,1/8/2013,Intravenous,paclitaxel,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,4/29/2025,mg,antineoplastic,4/13/2025,9/9/2024,Intravenous,durvalumab,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,4/22/2023,mg,antineoplastic,2/9/2023,5/28/2022,Intravenous,durvalumab,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,10/24/2015,mg,antineoplastic,8/13/2015,7/25/2015,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/30/2024,mg,antineoplastic,9/24/2024,8/3/2024,Intravenous,pembrolizumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/5/2016,mg,antineoplastic,8/24/2015,7/4/2015,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/17/2023,mg,antineoplastic,2/24/2022,6/12/2020,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,2/11/2015,,antineoplastic,8/17/2014,9/1/2014,,clinical study drug,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/18/2020,mg,antineoplastic,11/10/2020,9/23/2020,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/16/2016,mg,antineoplastic,12/23/2014,6/17/2014,Intravenous,pemetrexed,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/16/2024,mg,antineoplastic,5/23/2024,4/6/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,12/14/2023,mg,antineoplastic,11/8/2023,9/30/2023,Intravenous,pembrolizumab,FALSE
386,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57FE598G618G,3/2/2019,mg,antineoplastic,1/17/2019,12/22/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Crizotinib,G183BG5B65678,2/9/2020,,,2/13/2019,3/11/2019,Oral,crizotinib,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/5/2019,mg,antineoplastic,5/8/2019,2/20/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/16/2017,,antineoplastic,12/6/2016,2/10/2016,Intravenous,clinical study drug,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/15/2024,,antineoplastic,11/12/2023,10/16/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1:D34FC71922,5/24/2015,,antineoplastic,1/25/2015,2/4/2015,,clinical study drug,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,3/15/2013,AUC,antineoplastic,1/14/2013,12/11/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/18/2022,mg,antineoplastic,4/1/2022,1/21/2018,Intravenous,pembrolizumab,FALSE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/8/2023,mg,antineoplastic,11/28/2022,10/15/2022,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/17/2022,mg,antineoplastic,7/11/2017,4/25/2017,Oral,dasatinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,5/13/2021,mg,antineoplastic,12/18/2020,11/12/2020,Intravenous,nivolumab,FALSE
572,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2518G1D763FB,9/16/2024,mg,antineoplastic,9/7/2024,8/8/2024,Intravenous,durvalumab,FALSE
484,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2:5874817G9C,10/3/2024,mg,antineoplastic,7/3/2024,6/18/2024,Intravenous,carboplatin,FALSE
400,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/30/2018,mg,antineoplastic,7/8/2018,5/28/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/19/2020,mg,antineoplastic,1/20/2020,10/10/2019,Intravenous,pembrolizumab,FALSE
146,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/13/2019,mg,antineoplastic,11/16/2018,10/25/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/4/2025,,antineoplastic,4/19/2023,3/10/2023,,clinical study drug,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/17/2017,mg,antineoplastic,7/7/2017,6/27/2017,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/2/2014,mg,antineoplastic,3/29/2014,3/28/2014,Intravenous,paclitaxel protein-bound,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,12/4/2014,mg,antineoplastic,4/11/2014,5/2/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/31/2024,mg,antineoplastic,11/1/2020,6/9/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/21/2025,,antineoplastic,10/2/2024,3/20/2024,Intravenous,clinical study drug,FALSE
1640,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,10/21/2015,mg,antineoplastic,3/4/2015,3/2/2015,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G58G2E7D9G4E7,6/20/2018,mg,antineoplastic,4/5/2018,4/18/2018,Intravenous,nivolumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,4/19/2024,mg,antineoplastic,7/18/2023,5/16/2023,Intravenous,nivolumab,TRUE
1090,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/15/2020,mg,antineoplastic,2/14/2020,12/20/2019,Intravenous,pemetrexed,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/11/2016,mg,antineoplastic,6/16/2016,10/20/2014,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/21/2024,mg,antineoplastic,6/26/2023,3/18/2023,Intravenous,bevacizumab-awwb,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,4/5/2019,mg,antineoplastic,9/27/2018,12/22/2017,Intravenous,pembrolizumab,FALSE
290.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,12/24/2019,mg,antineoplastic,9/14/2019,9/20/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FD6C9677C56,11/24/2017,mg,antineoplastic,10/1/2017,11/18/2017,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/14/2025,,antineoplastic,5/7/2018,11/6/2017,Intravenous,clinical study drug,FALSE
835,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/24/2012,mg,antineoplastic,2/23/2012,1/16/2012,Intravenous,bevacizumab,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,6/7/2016,mg,antineoplastic,12/26/2015,12/2/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,3/30/2019,mg,antineoplastic,7/17/2017,6/20/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/29/2014,mg,antineoplastic,6/21/2014,3/21/2014,Intravenous,paclitaxel protein-bound,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,12/6/2012,mg/m2,antineoplastic,12/24/2012,11/21/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/13/2025,mg,antineoplastic,12/13/2024,11/5/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/14/2018,,antineoplastic,8/14/2017,9/16/2017,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,7/22/2024,mg,antineoplastic,6/3/2024,5/3/2024,Intravenous,pembrolizumab,FALSE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/27/2011,mg,antineoplastic,10/3/2011,7/28/2011,Intravenous,cisplatin,FALSE
2070,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/9/2013,mg,antineoplastic,6/19/2013,12/21/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,4/2/2024,mg,antineoplastic,10/10/2022,6/15/2020,Intravenous,pembrolizumab,TRUE
1165,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G45DDGFC1G86F,12/20/2015,mg,antineoplastic,12/1/2015,11/28/2015,Intravenous,bevacizumab,FALSE
233,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/4/2016,mg,antineoplastic,6/8/2016,12/20/2015,Intravenous,nivolumab,FALSE
158,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,1/15/2024,mg,antineoplastic,11/30/2023,11/28/2023,Intravenous,carboplatin,FALSE
2140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/14/2021,mg,antineoplastic,8/7/2020,5/26/2020,Intravenous,gemcitabine,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/12/2018,mg,antineoplastic,9/2/2018,6/14/2018,Intravenous,etoposide,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/4/2012,mg,antineoplastic,10/16/2011,10/4/2011,Intravenous,vinorelbine,FALSE
523,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,5/3/2025,mg,antineoplastic,3/22/2019,3/30/2019,Intravenous,carboplatin,FALSE
558,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,3/29/2023,mg,antineoplastic,1/17/2023,1/7/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/19/2025,mg,antineoplastic,8/21/2024,9/20/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/13/2023,mg,antineoplastic,7/20/2023,8/26/2022,Intravenous,pembrolizumab,TRUE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/1/2014,mg,antineoplastic,12/10/2013,10/15/2013,Intravenous,gemcitabine,FALSE
416,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/7/2025,mg,antineoplastic,1/12/2025,1/25/2025,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,3/23/2023,mg,antineoplastic,12/18/2022,9/21/2022,Subcutaneous,azacitidine,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/9/2015,mg,antineoplastic,12/11/2014,10/11/2014,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1G:2:8D7GC6F,11/9/2024,,,11/24/2024,7/9/2023,Oral,osimertinib,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,2/14/2014,mg,antineoplastic,10/16/2013,7/15/2013,Intravenous,paclitaxel,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/21/2023,mg,antineoplastic,2/18/2023,12/27/2022,Intravenous,pemetrexed,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/8/2014,mg/kg,antineoplastic,5/28/2014,11/5/2013,Intravenous,bevacizumab,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/12/2015,mg,antineoplastic,4/19/2015,2/20/2015,Intravenous,carboplatin,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/29/2025,mg,antineoplastic,3/8/2020,4/1/2019,Intravenous,pemetrexed,FALSE
268,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/26/2020,mg,antineoplastic,5/13/2020,3/7/2020,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/21/2012,mg,antineoplastic,4/18/2012,5/13/2012,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/10/2025,,antineoplastic,2/26/2024,3/6/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/2/2019,mg,antineoplastic,9/12/2019,5/21/2019,Intravenous,pembrolizumab,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/20/2012,mg,antineoplastic,11/25/2011,11/16/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/6/2025,mg,antineoplastic,1/4/2025,10/24/2024,Intravenous,pembrolizumab,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/9/2016,mg,antineoplastic,8/2/2016,8/14/2016,Intravenous,necitumumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,7/23/2024,mg,antineoplastic,7/23/2023,7/13/2023,Intravenous,nivolumab,FALSE
900,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,10/2/2017,mg,antineoplastic,8/4/2017,7/11/2017,Intravenous,ramucirumab,FALSE
500,1,LOCOREGIONAL,Administrations,chemotherapy,Pemetrexed,G591:2784957C,12/12/2013,mg,antineoplastic,11/17/2013,10/26/2013,Intravenous,pemetrexed,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,6/19/2023,mg,antineoplastic,5/5/2023,3/1/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/30/2025,,antineoplastic,11/25/2024,10/16/2024,Intravenous,carboplatin,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,3/27/2020,mg,antineoplastic,12/6/2019,8/7/2019,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/17/2024,mg,antineoplastic,2/22/2022,6/2/2020,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/21/2018,mg,antineoplastic,10/25/2017,2/15/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,4/23/2022,,cytoprotective,2/27/2022,12/3/2021,Oral,clinical study drug,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11D1:8:62429,3/19/2014,mg,antineoplastic,2/24/2014,1/30/2014,Intravenous,paclitaxel,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/30/2023,mg,antineoplastic,9/19/2023,9/30/2022,Intravenous,durvalumab,FALSE
222,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/21/2015,mg,antineoplastic,7/20/2015,6/28/2015,Intravenous,carboplatin,FALSE
825,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,1/10/2025,mg,antineoplastic,12/1/2024,8/15/2024,Intravenous,pemetrexed,FALSE
115,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,11/2/2023,mg,antineoplastic,11/16/2023,9/23/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,10/6/2012,mg,antineoplastic,8/23/2012,7/17/2012,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G49E3CE9E292G,4/14/2020,mg,antineoplastic,11/15/2019,11/19/2019,Intravenous,durvalumab,TRUE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/3/2019,mg,antineoplastic,3/19/2018,1/29/2018,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Capmatinib,G278ED563CF9F,11/4/2023,,,5/25/2023,6/19/2023,Oral,capmatinib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,5/11/2024,,antineoplastic,4/1/2024,3/13/2024,,carboplatin,FALSE
27,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G163D9B593927,1/16/2015,mg,antineoplastic,1/11/2015,11/21/2014,Intravenous,cisplatin,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G173G:4FD7E,1/25/2014,mg,antineoplastic,2/17/2014,12/25/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28F814933C3F,2/21/2025,mg,antineoplastic,11/7/2024,7/31/2024,Intravenous,pembrolizumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,1/9/2025,mg,antineoplastic,12/9/2024,6/18/2024,Intravenous,durvalumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/12/2015,mg,antineoplastic,1/9/2016,8/23/2015,Intravenous,pemetrexed,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/19/2015,mg,antineoplastic,9/11/2014,6/9/2014,Intravenous,vinorelbine,FALSE
1250,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,3/29/2013,mg,antineoplastic,2/10/2013,1/15/2013,Intravenous,gemcitabine,FALSE
308,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/20/2016,mg,antineoplastic,7/11/2016,4/27/2016,Intravenous,paclitaxel,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/31/2025,mg,antineoplastic,12/30/2024,11/27/2024,Intravenous,etoposide,FALSE
30,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/16/2020,mg/m2,antineoplastic,11/20/2019,10/11/2019,Intravenous,docetaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,12/17/2023,,solution-fluid,9/19/2023,12/30/2022,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,10/2/2022,mg,antineoplastic,8/9/2022,7/19/2022,Intravenous,pemetrexed,TRUE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/1/2014,mg,antineoplastic,11/1/2014,7/18/2014,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G4FCB886B34DC,6/21/2023,,,6/8/2023,12/3/2022,Oral,osimertinib,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,1/12/2015,mg,antineoplastic,9/20/2014,8/12/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/24/2018,mg,antineoplastic,10/17/2018,8/13/2018,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/8/2021,,steroid,3/29/2020,1/24/2020,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/15/2018,mg,antineoplastic,7/31/2018,4/1/2018,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/23/2025,mg,antineoplastic,10/30/2022,3/17/2020,Subcutaneous,leuprolide,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/4/2018,mg,antineoplastic,4/29/2018,12/14/2017,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/18/2025,mg,antineoplastic,6/11/2020,2/2/2018,Intravenous,nivolumab,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G52:6C556E791,7/10/2024,mL,solution-fluid,4/25/2024,3/17/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/14/2025,mg,antineoplastic,12/26/2022,10/8/2022,Intravenous,pembrolizumab,TRUE
680,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/4/2016,mg,antineoplastic,8/12/2015,8/5/2015,Intravenous,carboplatin,FALSE
655,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/26/2013,mg,antineoplastic,4/30/2013,4/23/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/15/2025,mg,antineoplastic,4/1/2022,3/28/2020,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/16/2019,mg,antineoplastic,2/4/2018,3/7/2016,Intravenous,nivolumab,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,1/6/2012,mg,antineoplastic,1/11/2012,11/29/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/23/2022,mg,antineoplastic,12/19/2021,12/21/2021,Intravenous,pembrolizumab,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G135BB2F5GCDF,6/25/2018,mg,antineoplastic,3/15/2018,3/10/2018,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,4/25/2023,mg,antineoplastic,6/8/2022,4/29/2022,Intravenous,nivolumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/15/2025,mg,antineoplastic,11/5/2024,3/31/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,7/24/2018,mg,antineoplastic,5/10/2018,5/22/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G217694659D6F,9/19/2022,,,7/7/2022,7/4/2022,Oral,alectinib,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,5/20/2016,mg,antineoplastic,12/28/2015,1/13/2016,Intravenous,carboplatin,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,11/24/2015,mg,antineoplastic,10/16/2015,8/29/2015,Intravenous,bevacizumab,FALSE
1070,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1D:B49GGG719,12/16/2016,mg,antineoplastic,10/22/2016,8/3/2016,Intravenous,pemetrexed,TRUE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/28/2017,mg,antineoplastic,1/9/2017,12/28/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/11/2018,mg,antineoplastic,11/23/2017,9/18/2017,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/8/2020,,antineoplastic,8/22/2019,1/6/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/28/2021,mg,antineoplastic,4/28/2021,11/11/2019,Intravenous,pembrolizumab,FALSE
175,4,ADVANCED,Orders,chemotherapy,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,1/8/2015,mg/m2,antineoplastic,11/10/2014,11/16/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G353EE82411C:,5/24/2024,mg,antineoplastic,3/14/2024,4/5/2024,Intravenous,pembrolizumab,FALSE
372,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,4/12/2024,mg,antineoplastic,12/4/2023,11/23/2023,Intravenous,paclitaxel,FALSE
129,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/6/2025,mg,antineoplastic,12/7/2024,12/3/2024,Intravenous,oxaliplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/15/2020,mg,antineoplastic,4/18/2019,7/5/2016,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/14/2023,mg,antineoplastic,5/26/2023,4/20/2023,Intravenous,pemetrexed,FALSE
385,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,3/11/2023,mg,antineoplastic,1/18/2023,1/14/2023,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/16/2025,mg,antineoplastic,10/4/2024,8/27/2022,Oral,anastrozole,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/14/2025,mg,antineoplastic,11/2/2024,7/23/2024,Intravenous,pembrolizumab,FALSE
1580,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,3/24/2015,mg,antineoplastic,3/4/2015,12/14/2014,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/19/2024,mg,antineoplastic,9/2/2023,8/14/2023,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,12/26/2018,mg,antineoplastic,6/7/2018,9/29/2017,Intravenous,pembrolizumab,FALSE
668,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,3/31/2013,mg,antineoplastic,5/2/2013,1/9/2013,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,7/17/2020,mL,solution-fluid,7/13/2019,2/7/2019,Intravenous,nivolumab,FALSE
97,4,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1G54G4GB8B24,9/14/2023,mg,antineoplastic,10/26/2022,9/9/2022,Intravenous,docetaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,3/30/2025,mg,antineoplastic,4/26/2022,3/14/2022,Intravenous,pembrolizumab,TRUE
810,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/21/2020,mg,antineoplastic,7/13/2020,3/18/2019,Intravenous,durvalumab,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/14/2020,mg,antineoplastic,11/1/2018,7/31/2017,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Unstructured,,Osimertinib,G37GC233F5FB2,4/12/2025,,,7/18/2022,6/5/2022,Oral,osimertinib,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,4/20/2024,mg/m2,antineoplastic,4/27/2024,3/11/2024,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/18/2020,mg,antineoplastic,4/24/2020,2/11/2020,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G1C3D332:5G66,5/28/2022,mg,antineoplastic,6/1/2022,5/4/2022,Intravenous,pembrolizumab,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/10/2023,mg,antineoplastic,7/27/2022,5/10/2022,Intravenous,durvalumab,FALSE
285,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2:737C75FGBF,3/2/2024,mg,antineoplastic,12/1/2023,10/29/2023,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,4/8/2025,mg,antineoplastic,6/7/2024,1/21/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/2/2021,mg,antineoplastic,6/23/2021,4/21/2021,Intravenous,etoposide,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/24/2015,mg/m2,antineoplastic,3/7/2015,9/25/2014,Intravenous,cisplatin,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/23/2024,mg,antineoplastic,7/26/2024,4/24/2024,Intravenous,nivolumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/11/2022,mg,antineoplastic,3/30/2019,5/20/2017,Oral,nilotinib,FALSE
130,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,5/8/2025,mg,antineoplastic,3/27/2025,11/28/2024,Intravenous,docetaxel,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/3/2018,mg,antineoplastic,7/19/2016,9/13/2015,Intravenous,nivolumab,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/25/2022,mg,antineoplastic,3/9/2022,2/11/2022,Intravenous,carboplatin,FALSE
330,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/26/2018,mg,antineoplastic,9/27/2017,9/27/2017,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Unstructured,,Afatinib,G1B56G7791723,2/14/2022,,,9/9/2021,9/18/2021,Oral,afatinib,FALSE
210,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G42734BB63:32,9/20/2016,mg,antineoplastic,5/13/2016,5/31/2016,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/6/2023,mg,antineoplastic,6/4/2023,12/22/2022,Intravenous,atezolizumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,9/10/2020,mL,solution-fluid,6/23/2019,3/19/2019,Intravenous,nivolumab,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,10/8/2023,mg,antineoplastic,7/8/2023,6/26/2023,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,8/6/2019,mg,antineoplastic,7/16/2019,5/4/2019,Intravenous,ramucirumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,2/28/2022,mg,antineoplastic,9/21/2021,7/29/2021,Intravenous,amivantamab-vmjw,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/24/2014,,antineoplastic,1/11/2014,11/15/2013,,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G158118CE1E2C,1/29/2018,mg,antineoplastic,1/31/2018,12/30/2017,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/10/2024,mg,antineoplastic,12/9/2022,12/17/2022,Intravenous,nivolumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,10/31/2014,mg,antineoplastic,4/3/2014,5/9/2014,Intravenous,carboplatin,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/23/2020,mg,antineoplastic,6/21/2019,1/4/2019,Subcutaneous,bortezomib,FALSE
1125,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:78734BCEDB,1/2/2015,mg,antineoplastic,7/31/2014,8/14/2014,Intravenous,pemetrexed,FALSE
480,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,5/14/2019,mg,antineoplastic,3/30/2019,2/21/2019,Intravenous,carboplatin,FALSE
795,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,1/17/2018,mg,antineoplastic,2/3/2018,1/17/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/6/2025,mg,antineoplastic,5/2/2020,1/24/2019,Intravenous,pembrolizumab,TRUE
150,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,4/9/2024,mg,antineoplastic,12/29/2023,10/28/2023,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/11/2016,mg,antineoplastic,7/30/2016,4/24/2016,Intravenous,pemetrexed,TRUE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/12/2023,mg,antineoplastic,5/14/2023,4/21/2023,Intravenous,paclitaxel,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14361:3FBBE:,9/18/2018,mg,antineoplastic,6/17/2018,5/25/2018,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/18/2025,mg,antineoplastic,12/21/2024,1/30/2023,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,11/2/2024,mg,antineoplastic,10/8/2024,10/6/2024,Intravenous,pemetrexed,TRUE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/21/2019,mL,solution-fluid,9/23/2019,9/16/2019,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/4/2016,mg,antineoplastic,7/27/2015,7/23/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,2/26/2019,mg,antineoplastic,6/26/2018,1/30/2018,Intravenous,pembrolizumab,FALSE
100,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,1/20/2013,mg/m2,antineoplastic,2/8/2013,2/11/2013,Intravenous,etoposide,FALSE
491,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,1/8/2021,mg,antineoplastic,6/27/2020,2/16/2020,Intravenous,pemetrexed,FALSE
152.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/29/2020,mg,antineoplastic,12/28/2019,12/2/2019,Intravenous,carboplatin,FALSE
532,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,3/1/2023,mg,antineoplastic,4/13/2023,1/28/2023,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,10/16/2017,mg/m2,antineoplastic,7/21/2017,6/14/2017,Intravenous,pemetrexed,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/24/2014,mg,antineoplastic,5/4/2014,2/17/2014,Intravenous,cisplatin,FALSE
340,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,5/4/2016,mg,antineoplastic,5/5/2016,1/4/2016,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,5/1/2025,,antineoplastic,4/26/2025,9/8/2024,Intravenous,durvalumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,9/17/2021,mg,antineoplastic,5/4/2021,3/24/2021,Intravenous,paclitaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,4/10/2025,mg,antineoplastic,12/20/2024,8/18/2024,Intravenous,durvalumab,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G484BED:E686:,12/30/2017,,,12/1/2017,10/13/2016,Oral,erlotinib,FALSE
559,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,7/9/2016,mg,antineoplastic,3/10/2016,3/15/2016,Intravenous,carboplatin,FALSE
400,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,5/16/2024,mg,antineoplastic,2/6/2024,6/6/2023,Intravenous,pembrolizumab,FALSE
358,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,7/26/2018,mg,antineoplastic,6/10/2018,5/29/2018,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,10/24/2014,AUC,antineoplastic,4/9/2014,3/18/2014,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,3/24/2025,mg,antineoplastic,11/18/2024,1/10/2024,Intravenous,pembrolizumab,FALSE
303,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G168G1C789D7C,7/23/2013,mg,antineoplastic,4/30/2013,4/1/2013,Intravenous,carboplatin,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/1/2015,mg,antineoplastic,12/30/2014,8/5/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,10/22/2024,mg,antineoplastic,7/29/2024,7/9/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/26/2020,mg,antineoplastic,9/6/2016,12/17/2015,Intravenous,nivolumab,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/14/2019,mg,antineoplastic,11/21/2018,7/20/2018,Intravenous,levoleucovorin,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/29/2016,mg,antineoplastic,10/13/2015,6/27/2015,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/13/2025,mg,antineoplastic,4/17/2025,7/11/2021,Intravenous,atezolizumab,TRUE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/5/2020,mg,antineoplastic,1/3/2019,8/24/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/1/2025,mg,antineoplastic,8/13/2019,1/15/2019,Intravenous,pembrolizumab,TRUE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/5/2019,mg,antineoplastic,4/18/2019,3/8/2019,Intravenous,carboplatin,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/5/2025,mg,antineoplastic,8/1/2024,10/14/2023,Intravenous,atezolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/14/2017,mg,antineoplastic,12/18/2016,12/31/2016,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/14/2018,mL,solution-fluid,6/29/2015,7/20/2015,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/12/2019,mg,antineoplastic,9/5/2019,7/18/2019,Intravenous,carboplatin,FALSE
533,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F3:G92:612D,5/2/2018,mg,antineoplastic,5/1/2018,5/10/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/11/2018,,antineoplastic,7/12/2015,6/17/2015,,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G1:F129FBCE3F,3/26/2021,,antineoplastic,12/30/2020,1/10/2021,Oral,hydroxyurea,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/9/2025,mg,antineoplastic,4/5/2025,3/2/2020,Intravenous,pembrolizumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/6/2016,mg,antineoplastic,10/30/2014,10/6/2014,Intravenous,bevacizumab,TRUE
125,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/5/2019,mg,antineoplastic,8/25/2019,7/25/2019,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/31/2021,mg/m2,antineoplastic,4/23/2021,3/3/2021,Intravenous,fluorouracil,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/22/2024,mg,antineoplastic,2/14/2024,10/31/2023,Intravenous,nivolumab,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/13/2014,mg,antineoplastic,4/6/2014,4/5/2014,Intravenous,carboplatin,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/4/2015,mg,antineoplastic,11/13/2014,9/9/2014,Intravenous,paclitaxel protein-bound,FALSE
140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,9/21/2024,mg,antineoplastic,6/12/2023,3/24/2023,Intravenous,docetaxel,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/12/2023,mg,antineoplastic,8/24/2021,1/5/2020,Intravenous,pembrolizumab,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/14/2019,mg,antineoplastic,8/25/2018,6/20/2018,Intravenous,trastuzumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G135BB2F5GCDF,1/20/2019,mg,antineoplastic,12/7/2018,5/14/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/6/2018,mg,antineoplastic,9/8/2018,7/17/2018,Intravenous,pembrolizumab,TRUE
41,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/14/2023,mg,antineoplastic,3/20/2023,10/3/2022,Intravenous,leucovorin,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/8/2013,mg,antineoplastic,7/13/2012,5/12/2012,Intravenous,docetaxel,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/24/2014,mg,antineoplastic,9/21/2014,6/12/2014,Intravenous,vinorelbine,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,1/27/2015,mg,antineoplastic,1/16/2015,10/17/2014,Intravenous,paclitaxel protein-bound,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/30/2019,mg,antineoplastic,10/15/2018,7/1/2018,Intravenous,levoleucovorin,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,11/5/2019,mg,antineoplastic,9/23/2019,7/6/2019,Intravenous,carboplatin,FALSE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,12/19/2013,mg,antineoplastic,10/6/2013,9/1/2013,Intravenous,vinorelbine,FALSE
672,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,11/13/2014,mg,antineoplastic,11/6/2014,11/1/2014,Intravenous,carboplatin,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/22/2017,mg,antineoplastic,5/27/2017,5/27/2017,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/20/2025,mg,antineoplastic,3/28/2025,7/23/2023,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/23/2024,mg,antineoplastic,11/12/2023,4/4/2023,Intravenous,atezolizumab,TRUE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/17/2014,mg,antineoplastic,5/8/2014,6/9/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/2/2025,mg/m2,antineoplastic,12/12/2024,8/1/2024,Intravenous,gemcitabine,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/7/2020,mg,antineoplastic,3/15/2019,1/25/2019,Intravenous,durvalumab,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,9/18/2024,mg,antineoplastic,2/12/2024,2/5/2024,Intravenous,carboplatin,FALSE
498,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,4/7/2021,mg,antineoplastic,3/19/2021,12/24/2020,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,11/3/2024,mg,antineoplastic,8/5/2024,7/14/2024,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/9/2025,mg,antineoplastic,6/25/2024,2/20/2024,Intravenous,durvalumab,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/7/2016,mg,antineoplastic,12/3/2015,12/10/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,8/15/2020,mg,antineoplastic,6/18/2020,7/4/2020,Intravenous,pembrolizumab,FALSE
75,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Pemetrexed,Ramucirumab",G12D5DB79FEED,4/22/2015,mg/m2,antineoplastic,5/13/2015,3/29/2015,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/25/2020,mg,antineoplastic,5/26/2018,6/26/2016,Intravenous,nivolumab,FALSE
210,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,1/24/2021,mg,antineoplastic,11/29/2020,11/17/2020,Intravenous,irinotecan,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/9/2021,mL,solution-fluid,4/18/2018,2/13/2018,Intravenous,durvalumab,TRUE
467,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,2/23/2025,mg,antineoplastic,12/5/2024,11/15/2024,Intravenous,carboplatin,FALSE
330,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,11/26/2023,mg,antineoplastic,9/14/2023,9/23/2023,Intravenous,carboplatin,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/2/2016,mg,antineoplastic,7/9/2016,7/12/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/17/2021,mg,antineoplastic,1/21/2020,11/12/2019,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/18/2020,mg,antineoplastic,4/2/2020,7/5/2016,Intravenous,nivolumab,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/22/2013,mg,antineoplastic,8/9/2012,5/17/2012,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1F482136BDE5,4/15/2017,,antineoplastic,4/28/2017,1/30/2017,Intravenous,clinical study drug,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/20/2017,mg,antineoplastic,8/4/2017,8/24/2017,Intravenous,etoposide,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/9/2022,,antineoplastic,5/31/2019,5/7/2017,Oral,nilotinib,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/11/2022,mg,antineoplastic,3/4/2022,12/19/2021,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,2/12/2019,mg,antineoplastic,9/15/2018,5/27/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/13/2025,,solution-fluid,4/21/2018,10/18/2017,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G327B2G171G96,5/3/2022,,antineoplastic,4/8/2020,3/10/2020,Intravenous,durvalumab,TRUE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/22/2024,mg,antineoplastic,6/1/2021,6/6/2020,Intravenous,nivolumab,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,6/7/2023,mg,antineoplastic,4/22/2023,4/4/2023,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/13/2025,mL,solution-fluid,10/21/2024,5/4/2024,Intravenous,pembrolizumab,FALSE
322.4,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/20/2016,mg,antineoplastic,8/15/2016,8/8/2016,Intravenous,carboplatin,FALSE
146,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,6/30/2023,mg,antineoplastic,5/2/2023,3/8/2023,Intravenous,carboplatin,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,1/8/2017,mg,antineoplastic,1/30/2017,11/11/2016,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/27/2020,mg,antineoplastic,7/23/2018,8/10/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/24/2022,mg,antineoplastic,7/23/2022,6/8/2022,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1CFE2442E26G,1/15/2014,mg,antineoplastic,11/26/2013,10/28/2013,Intravenous,bevacizumab,TRUE
,1,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G59243DC543:8,9/14/2024,,,7/6/2024,8/8/2024,Oral,alectinib,FALSE
74,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,5/18/2024,mg,antineoplastic,3/5/2024,4/19/2024,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/20/2023,mg,antineoplastic,10/14/2022,9/3/2022,Subcutaneous,azacitidine,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/30/2021,mg,antineoplastic,8/22/2019,6/11/2019,Intravenous,paclitaxel,FALSE
206.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,2/11/2022,mg,antineoplastic,7/18/2014,5/28/2014,Intravenous,carboplatin,FALSE
345,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/7/2021,mg,antineoplastic,5/29/2021,3/20/2021,Intravenous,carboplatin,FALSE
270,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,7/11/2016,mg,antineoplastic,4/9/2016,2/20/2016,Intravenous,paclitaxel,FALSE
115,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1532797B869C,8/31/2023,mg,antineoplastic,8/10/2023,7/25/2023,Intravenous,docetaxel,FALSE
114,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/7/2013,mg,antineoplastic,12/26/2012,12/10/2012,Intravenous,doxorubicin,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G2C521EB94C:2,4/27/2025,,,6/7/2023,5/14/2023,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/2/2023,mg,antineoplastic,7/26/2022,2/19/2022,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Administrations,solution-fluid,Clinical Study Drug,G1F482136BDE5,4/5/2017,,solution-fluid,3/28/2017,2/14/2017,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3F2D34C5366D,5/22/2022,,antineoplastic,8/8/2021,6/14/2021,,clinical study drug,FALSE
2210,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/11/2020,mg,antineoplastic,10/8/2019,8/25/2019,Intravenous,gemcitabine,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/2/2012,mg,antineoplastic,2/1/2012,1/31/2012,Intravenous,carboplatin,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/8/2013,mg,antineoplastic,7/11/2013,1/2/2013,Intravenous,gemcitabine,FALSE
375,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,12/31/2016,mg,antineoplastic,12/22/2016,12/22/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,10/14/2018,mg,antineoplastic,6/3/2018,3/12/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,12/19/2022,mg,antineoplastic,12/6/2022,10/23/2022,Intravenous,pembrolizumab,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/16/2016,mg,antineoplastic,5/31/2015,11/3/2014,Intravenous,pemetrexed,TRUE
130,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/2/2018,mg,antineoplastic,11/3/2018,9/27/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1GC7B8314B6D,6/1/2023,,,5/22/2023,11/6/2020,Oral,osimertinib,FALSE
680,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Irinotecan",G1D61871659DG,7/17/2012,mg,antineoplastic,6/16/2012,7/18/2012,Intravenous,cetuximab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,3/8/2015,mg,antineoplastic,12/13/2014,10/6/2014,Intravenous,carboplatin,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/29/2023,mg,antineoplastic,3/10/2020,3/3/2020,Intravenous,gemcitabine,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/3/2022,mg,antineoplastic,11/8/2022,10/5/2022,Intravenous,pemetrexed,FALSE
950,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46:6C69:D9:C,8/5/2024,mg,antineoplastic,7/6/2024,5/8/2024,Intravenous,pemetrexed,FALSE
492,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GB6D5C:448G,11/10/2015,mg,antineoplastic,10/22/2015,8/23/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1651E65B5E88,1/21/2018,mg,antineoplastic,1/9/2018,1/13/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,9/9/2020,mg,antineoplastic,7/23/2020,6/10/2020,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/11/2024,mg,antineoplastic,5/3/2024,8/24/2023,Intravenous,nivolumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G14216G12B:E7,5/3/2020,mg/m2,antineoplastic,12/10/2019,11/19/2019,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,9/24/2024,mg,antineoplastic,7/29/2024,8/15/2024,Intravenous,pembrolizumab,FALSE
2637,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,7/12/2022,mg,antineoplastic,1/19/2022,8/11/2021,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,7/10/2018,mg,antineoplastic,4/5/2018,1/7/2018,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,3/29/2021,,steroid,6/7/2020,3/6/2020,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/31/2019,,antineoplastic,10/10/2019,8/24/2019,,carboplatin,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,8/27/2018,mg,antineoplastic,5/12/2018,5/10/2018,Intravenous,pemetrexed,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/2/2020,mg,antineoplastic,8/2/2019,11/10/2015,Intravenous,nivolumab,FALSE
103,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,6/29/2020,mg,antineoplastic,6/27/2020,6/23/2020,Intravenous,paclitaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/22/2025,mg,antineoplastic,8/16/2024,1/10/2023,Intravenous,pembrolizumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/4/2019,mg,antineoplastic,4/25/2018,3/26/2018,Intravenous,paclitaxel,FALSE
616,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G167G71733G69,3/31/2016,mg,antineoplastic,12/24/2015,10/13/2015,Intravenous,pemetrexed,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/21/2016,mg,antineoplastic,4/18/2016,4/6/2016,Intravenous,paclitaxel,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/8/2024,mg,antineoplastic,8/24/2023,4/2/2023,Intravenous,atezolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/10/2025,mg,antineoplastic,9/2/2024,3/29/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/9/2019,mg,antineoplastic,3/15/2018,3/25/2018,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Orders,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,5/12/2025,mg,antineoplastic,2/14/2025,11/20/2024,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,4/12/2024,,antineoplastic,1/12/2021,8/21/2020,,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,9/12/2014,AUC,antineoplastic,9/14/2014,9/6/2014,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/27/2019,mg,antineoplastic,3/26/2019,2/5/2019,Intravenous,paclitaxel,FALSE
146,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,6/27/2024,mg,antineoplastic,4/30/2024,5/1/2024,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,9/30/2020,mg,antineoplastic,7/4/2020,8/27/2019,Intravenous,pembrolizumab,TRUE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,6/26/2019,mg/m2,antineoplastic,3/21/2019,2/14/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G1G:DDC4EED88,7/25/2017,,,7/25/2015,6/21/2015,Oral,erlotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,3/27/2023,mg,antineoplastic,1/9/2023,1/9/2023,Intravenous,pembrolizumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/18/2022,mg,antineoplastic,7/12/2020,4/1/2017,Intravenous,nivolumab,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/5/2019,mg,antineoplastic,11/18/2019,9/30/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,7/13/2024,,antineoplastic,7/30/2024,7/29/2024,,paclitaxel protein-bound,FALSE
555,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,6/10/2022,mg,antineoplastic,6/1/2022,4/15/2022,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/14/2022,mg,antineoplastic,4/3/2020,4/11/2017,Intravenous,nivolumab,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/7/2021,mg,antineoplastic,9/5/2020,9/4/2020,Oral,bicalutamide,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G1F482136BDE5,4/21/2017,,cytoprotective,2/16/2017,2/20/2017,Intramuscular,clinical study drug,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/10/2019,mg,antineoplastic,8/30/2018,9/5/2018,Intravenous,paclitaxel,FALSE
432,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/18/2013,mg,antineoplastic,7/16/2012,3/27/2012,Intravenous,carboplatin,FALSE
354,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,9/2/2012,mg,antineoplastic,4/19/2012,5/3/2012,Intravenous,paclitaxel,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/9/2021,mg/m2,antineoplastic,3/13/2021,3/3/2021,Intravenous,oxaliplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/9/2024,mg,antineoplastic,8/22/2024,9/7/2024,Intravenous,pembrolizumab,TRUE
100,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,1/30/2020,mg,antineoplastic,12/8/2019,9/10/2019,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/28/2024,mg,antineoplastic,1/26/2023,12/9/2021,Intravenous,nivolumab,TRUE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/20/2020,mg,antineoplastic,8/3/2019,11/12/2018,Intravenous,durvalumab,TRUE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/9/2023,mg,antineoplastic,3/27/2023,12/28/2022,Intravenous,atezolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,3/14/2023,mg,antineoplastic,5/22/2022,5/2/2022,Intravenous,nivolumab,FALSE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/15/2023,mg,antineoplastic,4/13/2023,3/7/2023,Intravenous,carboplatin,FALSE
71,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G11E67B3F9DC7,4/9/2025,mg,antineoplastic,9/4/2024,9/29/2024,Intravenous,ipilimumab,TRUE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/28/2023,,antineoplastic,6/15/2023,12/15/2022,,clinical study drug,FALSE
955,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1E35BD845958,5/2/2015,mg,antineoplastic,1/16/2015,12/8/2014,Intravenous,pemetrexed,TRUE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,8/1/2024,mg,antineoplastic,3/31/2024,2/12/2024,Intravenous,amivantamab-vmjw,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/19/2023,mg,antineoplastic,12/8/2022,8/4/2022,Subcutaneous,azacitidine,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/24/2025,,antiemetic,2/4/2025,12/27/2024,Intravenous,clinical study drug,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/18/2013,AUC,antineoplastic,2/27/2013,10/5/2012,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/28/2022,mg,antineoplastic,12/7/2017,1/14/2016,Intravenous,pemetrexed,FALSE
461,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,3/5/2018,mg,antineoplastic,3/5/2018,11/17/2017,Intravenous,carboplatin,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/13/2021,mg,antineoplastic,9/19/2020,5/6/2020,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,3/1/2019,mg,antineoplastic,11/19/2018,10/6/2017,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G545:2F182DD:,9/28/2017,,antineoplastic,8/3/2017,9/15/2017,,clinical study drug,FALSE
980,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,4/9/2013,mg,antineoplastic,4/5/2013,10/11/2012,Intravenous,bevacizumab,TRUE
57,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,10/15/2017,mg,antineoplastic,6/29/2017,6/8/2017,Intravenous,docetaxel,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/15/2014,mg/m2,antineoplastic,6/27/2014,12/27/2013,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,5/4/2025,,antineoplastic,9/12/2023,4/17/2020,Oral,enzalutamide,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/10/2023,mg,antineoplastic,6/16/2023,6/25/2022,Intravenous,durvalumab,FALSE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/5/2016,mg,antineoplastic,6/6/2016,4/15/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/18/2020,mg,antineoplastic,5/16/2020,2/26/2020,Intravenous,paclitaxel,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,5/30/2023,mg,antineoplastic,5/21/2023,3/25/2023,Intravenous,paclitaxel protein-bound,FALSE
100,1,ADVANCED,Administrations,solution-fluid,Pembrolizumab,G4C4C3G28CF33,3/1/2022,mL,solution-fluid,12/8/2021,10/14/2021,Intravenous,pembrolizumab,FALSE
,2,LOCOREGIONAL,Orders,chemotherapy,Osimertinib,G3:67CF8FF:28,11/15/2021,,antineoplastic,4/25/2020,4/8/2020,Intravenous,paclitaxel protein-bound,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/20/2025,mg,antineoplastic,3/17/2019,1/25/2019,Intravenous,pemetrexed,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/27/2013,mg,antineoplastic,11/1/2012,12/26/2011,Intravenous,etoposide,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/19/2023,mg,antineoplastic,11/12/2023,10/27/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/23/2022,mg,antineoplastic,3/4/2018,1/31/2018,Intravenous,pembrolizumab,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,5/11/2025,mg,antineoplastic,12/6/2024,9/27/2024,Intravenous,nivolumab,FALSE
145,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,4/1/2012,mg,antineoplastic,3/26/2012,1/16/2012,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,2/11/2020,mg,antineoplastic,10/10/2019,4/22/2019,Intravenous,pembrolizumab,TRUE
2200,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/5/2015,mg,antineoplastic,3/31/2015,2/22/2015,Intravenous,gemcitabine,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,10/21/2024,mg/m2,antineoplastic,7/2/2024,7/25/2024,Intravenous,pemetrexed,FALSE
274,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,9/23/2022,mg,antineoplastic,9/13/2022,6/8/2022,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/16/2022,,antineoplastic,3/7/2022,3/1/2022,Intravenous,paclitaxel,FALSE
100,4,ADVANCED,Administrations,solution-fluid,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,2/1/2025,mL,solution-fluid,2/12/2025,1/24/2025,Intravenous,pembrolizumab,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,12/8/2017,mg,antineoplastic,10/28/2017,5/27/2017,Intravenous,trastuzumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/7/2025,,antineoplastic,10/17/2024,1/27/2023,Intravenous,pemetrexed,FALSE
400,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2262335C:D62,4/6/2025,mg,antineoplastic,3/9/2025,2/11/2025,Intravenous,ramucirumab,FALSE
1229,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/23/2015,mg,antineoplastic,11/2/2014,8/1/2014,Intravenous,bevacizumab,FALSE
1550,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/26/2025,mg,antineoplastic,7/12/2024,7/3/2024,Intravenous,gemcitabine,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,3/27/2025,,antiemetic,2/19/2025,11/13/2024,Intravenous,clinical study drug,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/21/2025,mg,antineoplastic,5/6/2024,3/6/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/6/2021,mg,antineoplastic,5/25/2021,3/7/2021,Intravenous,pembrolizumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/19/2025,mg,antineoplastic,9/18/2024,9/18/2024,Intravenous,pemetrexed,TRUE
900,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/5/2016,mg,antineoplastic,9/20/2016,6/26/2016,Intravenous,carboplatin,FALSE
350,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,3/30/2025,mg,antineoplastic,1/4/2025,1/12/2025,Intravenous,amivantamab-vmjw,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/29/2016,mg,antineoplastic,2/8/2015,11/12/2014,Intravenous,pemetrexed,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,4/30/2025,mg,antineoplastic,9/4/2024,7/22/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,3/23/2024,,antineoplastic,12/28/2023,6/28/2023,Intravenous,clinical study drug,FALSE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G1G78CEE:7E:3,9/4/2018,mg/kg,antineoplastic,5/29/2018,3/23/2018,Intravenous,durvalumab,TRUE
980,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,5/1/2013,mg,antineoplastic,3/10/2013,11/10/2012,Intravenous,bevacizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/6/2025,mg/m2,antineoplastic,10/4/2024,7/16/2024,Intravenous,gemcitabine,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/28/2023,mg,antineoplastic,11/17/2022,12/10/2022,Intravenous,pemetrexed,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/16/2013,mg/m2,antineoplastic,10/17/2013,9/24/2013,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,5/8/2025,mg,antineoplastic,10/6/2024,4/29/2024,Intravenous,pembrolizumab,TRUE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,11/9/2017,mg,antineoplastic,1/21/2017,1/3/2017,Intravenous,etoposide,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/6/2024,mg,antineoplastic,9/21/2023,10/8/2023,Intravenous,paclitaxel,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13CCC275:E7G,6/18/2012,mg,antineoplastic,5/14/2012,4/26/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1G9455D2D9G7,3/31/2025,,,1/25/2024,1/13/2024,Oral,osimertinib,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/14/2013,AUC,antineoplastic,11/5/2012,8/21/2012,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/7/2015,mg,antineoplastic,1/12/2015,9/9/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/20/2025,,antineoplastic,2/23/2023,3/10/2023,Intravenous,carboplatin,FALSE
22.5,3,ADVANCED,Administrations,hormone,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/2/2024,mg,antineoplastic,11/23/2024,5/7/2024,Subcutaneous,leuprolide,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/5/2023,mg,antineoplastic,7/8/2023,4/1/2023,Subcutaneous,azacitidine,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,12/23/2019,mg,antineoplastic,2/9/2019,12/30/2018,Intravenous,durvalumab,TRUE
446,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/29/2020,mg,antineoplastic,2/27/2020,3/8/2020,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/10/2015,mg,antineoplastic,7/29/2015,7/26/2015,Intravenous,carboplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/14/2019,mg/kg,antineoplastic,9/27/2018,9/6/2018,Intravenous,durvalumab,FALSE
609,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G517B45372B5D,5/1/2020,mg,antineoplastic,3/16/2020,4/21/2020,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/3/2022,mg,antineoplastic,7/19/2019,2/2/2016,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/11/2018,mg,antineoplastic,9/12/2018,6/17/2018,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Administrations,cytoprotective,Clinical Study Drug,G485C85BECGC4,4/5/2022,,cytoprotective,12/14/2021,12/17/2021,Oral,clinical study drug,FALSE
980,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G1E589EBD8F93,4/16/2013,mg,antineoplastic,2/14/2013,11/16/2012,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,9/30/2018,mg,antineoplastic,2/10/2018,2/1/2018,Intravenous,pembrolizumab,FALSE
22.5,2,ADVANCED,Administrations,hormone,"Docetaxel,Leuprolide",G24F:E99C2926,1/9/2024,mg,antineoplastic,12/21/2023,12/16/2023,Subcutaneous,leuprolide,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/22/2025,mg,antineoplastic,7/13/2024,1/12/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,10/24/2012,mg,antineoplastic,8/19/2012,7/29/2012,Intravenous,carboplatin,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/5/2024,mg,antineoplastic,12/30/2021,7/27/2020,Intravenous,ipilimumab,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,11/23/2018,mg,antineoplastic,9/30/2016,10/13/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/22/2025,,antineoplastic,12/22/2024,2/28/2023,,clinical study drug,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/11/2024,mg,antineoplastic,11/21/2023,10/22/2023,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,3/8/2016,mg,antineoplastic,10/22/2015,10/19/2015,Intravenous,pemetrexed,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,3/27/2025,,antineoplastic,4/19/2025,12/18/2024,Intravenous,clinical study drug,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2C2DDG:4G:32,9/26/2013,mg,antineoplastic,4/1/2013,1/24/2013,Intravenous,paclitaxel protein-bound,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,2/14/2019,mg,antineoplastic,3/16/2018,10/8/2017,Intravenous,pembrolizumab,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,10/16/2021,mg,antineoplastic,8/9/2021,4/17/2021,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/18/2025,mg,antineoplastic,4/25/2024,4/10/2024,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,3/9/2018,4/23/2017,Intravenous,nivolumab,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/13/2025,,antiemetic,3/30/2025,12/29/2024,Intravenous,clinical study drug,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,6/25/2023,mg,antineoplastic,4/29/2023,5/11/2023,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1CG8EF93777D,1/22/2022,mg,antineoplastic,3/8/2022,1/28/2022,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/5/2017,mg,antineoplastic,12/24/2016,11/20/2016,Intravenous,docetaxel,FALSE
925,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,10/31/2013,mg,antineoplastic,8/28/2013,8/17/2013,Intravenous,pemetrexed,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,11/11/2017,mg,antineoplastic,12/13/2016,11/25/2016,Intravenous,etoposide,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/31/2012,mg,antineoplastic,6/12/2012,3/1/2012,Intravenous,docetaxel,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/23/2013,mg,antineoplastic,5/22/2013,4/26/2013,Intravenous,carboplatin,FALSE
192,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/15/2022,mg,antineoplastic,6/21/2022,5/27/2022,Intravenous,carboplatin,FALSE
176,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/16/2024,mg,antineoplastic,5/27/2024,3/17/2024,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G22GF5E64E49D,5/9/2023,,antineoplastic,3/9/2023,2/10/2023,Intravenous,pemetrexed,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/20/2018,mg,antineoplastic,3/3/2018,12/28/2017,Intravenous,carboplatin,FALSE
142,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,5/15/2015,mg,antineoplastic,5/7/2015,4/1/2015,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G2E8B56477B83,5/15/2014,,,4/3/2014,3/22/2014,Oral,erlotinib,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,4/13/2025,mg,antineoplastic,1/11/2025,11/5/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/12/2025,,antineoplastic,11/17/2021,9/19/2021,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Unstructured,,Osimertinib,G1D:61B997689,8/12/2018,,,8/2/2018,8/20/2018,Oral,osimertinib,FALSE
318,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,4/3/2024,mg,antineoplastic,3/2/2024,3/26/2024,Intravenous,paclitaxel,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Pembrolizumab",G1934B71378C6,10/4/2024,mg,antineoplastic,1/16/2023,1/24/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/29/2025,mg,antineoplastic,11/25/2024,4/10/2024,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/26/2022,,antineoplastic,11/10/2021,8/22/2021,Intravenous,paclitaxel,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/15/2019,mg,antineoplastic,12/24/2018,9/23/2018,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/19/2025,mg,antineoplastic,3/11/2019,2/7/2018,Intravenous,nivolumab,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/9/2020,mg,antineoplastic,8/19/2018,7/19/2017,Intravenous,pemetrexed,TRUE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/15/2023,mg,antineoplastic,5/16/2023,4/27/2023,Subcutaneous,azacitidine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/25/2022,mg,antineoplastic,10/9/2021,1/26/2020,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,1/12/2018,mg,antineoplastic,12/3/2017,6/15/2017,Intravenous,nivolumab,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/6/2024,mg,antineoplastic,9/15/2024,10/15/2023,Intravenous,durvalumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/31/2017,mg,antineoplastic,4/2/2014,1/6/2014,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3F2D34C5366D,4/1/2022,,antineoplastic,9/18/2021,7/11/2021,,clinical study drug,FALSE
765,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,11/18/2021,mg,antineoplastic,9/23/2021,8/4/2021,Intravenous,carboplatin,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,5/19/2025,mg,antineoplastic,3/24/2022,1/17/2022,Intravenous,atezolizumab,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,3/31/2025,mg,antineoplastic,10/3/2024,7/31/2024,Intravenous,pemetrexed,TRUE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,4/20/2020,mg,antineoplastic,1/25/2020,12/12/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/5/2021,mg,antineoplastic,5/3/2021,4/6/2021,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/21/2011,mg,antineoplastic,4/19/2011,3/7/2011,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G3B1F6B561ED5,4/2/2021,,hematological agent,11/29/2020,1/23/2020,Subcutaneous,clinical study drug,FALSE
118,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/11/2022,mg,antineoplastic,8/23/2022,6/23/2022,Intravenous,carboplatin,FALSE
150,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/4/2013,mg,antineoplastic,4/6/2012,12/1/2011,Intravenous,carboplatin,FALSE
985,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,4/7/2016,mg,antineoplastic,4/24/2016,4/1/2016,Intravenous,pemetrexed,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,9/26/2012,mg/m2,antineoplastic,7/31/2012,4/30/2012,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,12/4/2015,AUC,antineoplastic,5/18/2015,1/22/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,11/1/2020,mg,antineoplastic,2/15/2020,10/9/2019,Intravenous,pembrolizumab,TRUE
80,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/31/2022,mg,antineoplastic,3/19/2022,3/5/2022,Intravenous,ipilimumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/31/2020,mg,antineoplastic,9/1/2019,12/10/2017,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1F482136BDE5,5/7/2017,,antineoplastic,5/14/2017,3/24/2017,Intravenous,clinical study drug,FALSE
1240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,8/9/2020,mg,antineoplastic,3/17/2020,12/24/2019,Intravenous,pemetrexed,FALSE
209.1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,2/4/2014,mg,antineoplastic,2/22/2014,12/23/2013,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,12/25/2019,mg,antineoplastic,6/24/2019,7/30/2019,Intravenous,docetaxel,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,6/26/2019,mg,antineoplastic,5/3/2019,2/11/2019,Intravenous,carboplatin,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,1/28/2019,mL,solution-fluid,12/3/2018,11/16/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/23/2024,,antineoplastic,3/28/2024,4/21/2024,,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,2/19/2017,,antineoplastic,11/27/2016,12/20/2016,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/27/2025,mg,antineoplastic,9/8/2021,1/30/2019,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,9/30/2021,AUC,antineoplastic,6/20/2021,5/20/2021,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G57B5F4B556EG,3/15/2022,,antineoplastic,3/8/2022,3/12/2022,Intravenous,amivantamab-vmjw,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/29/2024,mg,antineoplastic,9/16/2020,6/24/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G3419F1B75FG6,6/10/2020,mg,antineoplastic,3/10/2020,3/25/2020,Intravenous,pembrolizumab,FALSE
1950,7,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G4C53C5GC48E:,12/10/2016,mg,antineoplastic,11/4/2016,10/11/2016,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/17/2025,mg,antineoplastic,9/26/2024,7/25/2024,Intravenous,pembrolizumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/11/2024,mg,antineoplastic,7/14/2023,1/29/2023,Intravenous,durvalumab,FALSE
1.5,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,11/21/2023,mg,antineoplastic,1/22/2023,2/22/2023,Intravenous,vincristine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/21/2025,mg,antineoplastic,8/9/2019,5/19/2018,Intravenous,pembrolizumab,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/4/2023,mg,antineoplastic,5/19/2020,6/6/2020,Intravenous,carboplatin,FALSE
79,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,4/4/2016,mg,antineoplastic,2/19/2016,3/31/2016,Intravenous,irinotecan,FALSE
144,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,9/27/2014,mg,antineoplastic,8/20/2014,8/14/2014,Intravenous,paclitaxel,FALSE
151,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35DE4B3:BCB8,5/8/2019,mg,antineoplastic,11/5/2016,10/1/2016,Intravenous,pembrolizumab,FALSE
6,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/31/2022,AUC,antineoplastic,11/24/2021,9/23/2021,Intravenous,carboplatin,FALSE
970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,11/5/2016,mg,antineoplastic,6/23/2016,6/10/2016,Intravenous,pemetrexed,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/28/2012,mg,antineoplastic,2/2/2012,1/10/2012,Subcutaneous,amifostine,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/5/2024,mg,antineoplastic,2/17/2022,12/21/2021,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/7/2016,mg,antineoplastic,8/4/2014,9/16/2014,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G31G19E54FC:B,2/4/2024,,antineoplastic,1/30/2024,1/28/2024,Oral,letrozole,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/20/2018,mg,antineoplastic,11/15/2018,7/23/2018,Intravenous,paclitaxel,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,5/1/2015,mg,antineoplastic,3/10/2015,11/24/2014,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/25/2020,mg,antineoplastic,8/18/2017,7/27/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/14/2020,mg,antineoplastic,11/13/2019,1/20/2018,Intravenous,pembrolizumab,TRUE
200,5,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3:C9BECD3F55,4/8/2021,mg,antineoplastic,4/6/2021,2/15/2021,Intravenous,pembrolizumab,FALSE
169,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/3/2016,mg,antineoplastic,4/6/2016,10/22/2015,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G1:B8CFFD1931,3/2/2015,mg/m2,antineoplastic,10/2/2014,8/15/2014,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/6/2025,mg,antineoplastic,3/15/2025,8/30/2022,Intravenous,pembrolizumab,TRUE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,3/24/2025,mg,antineoplastic,5/30/2022,3/2/2020,Intravenous,pemetrexed,TRUE
96,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/30/2021,mg,antineoplastic,12/21/2016,1/4/2017,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,1/26/2020,mg,antineoplastic,2/9/2017,2/3/2016,Intravenous,bevacizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,6/29/2020,,antineoplastic,6/15/2020,5/27/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,11/6/2022,mg,antineoplastic,9/20/2022,7/24/2022,Intravenous,paclitaxel,FALSE
665,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/11/2025,mg,antineoplastic,6/21/2023,3/10/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/19/2025,mg,antineoplastic,8/18/2023,4/26/2022,Intravenous,pembrolizumab,FALSE
85,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,1/19/2023,mg,antineoplastic,3/21/2022,4/1/2022,Intravenous,paclitaxel,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D7ED2233C43,9/27/2021,mg,antineoplastic,10/6/2021,7/31/2021,Intravenous,carboplatin,FALSE
299,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,8/18/2023,mg,antineoplastic,6/2/2023,4/29/2023,Intravenous,carboplatin,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/24/2025,mg,antineoplastic,3/10/2017,1/9/2017,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/14/2020,mg,antineoplastic,8/8/2016,11/17/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G1:78734BCEDB,7/31/2014,,steroid,4/12/2014,4/1/2014,Intravenous,clinical study drug,FALSE
265,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G137D67:GFD9F,8/3/2016,mg,antineoplastic,7/4/2016,5/9/2016,Intravenous,nivolumab,FALSE
945,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,2/20/2020,mg,antineoplastic,12/17/2019,12/18/2019,Intravenous,pemetrexed,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/13/2016,mg,antineoplastic,6/14/2015,5/25/2015,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Unstructured,,Capmatinib,G278ED563CF9F,11/26/2023,,,9/26/2023,7/10/2023,Oral,capmatinib,FALSE
45,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D:2:59GC48E,3/2/2021,mg,antineoplastic,5/8/2020,5/6/2020,Intravenous,paclitaxel,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/22/2015,mg,antineoplastic,9/4/2015,7/29/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/22/2020,mg,antineoplastic,1/17/2020,8/22/2019,Intravenous,pembrolizumab,TRUE
110,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/19/2013,mg,antineoplastic,12/19/2012,2/16/2013,Intravenous,etoposide,FALSE
767.3,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,4/22/2022,mg,antineoplastic,1/5/2022,1/28/2022,Intravenous,carboplatin,FALSE
105,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/12/2022,mg,antineoplastic,12/18/2021,10/26/2021,Intravenous,oxaliplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/20/2025,mg,antineoplastic,9/5/2024,4/27/2024,Intravenous,pembrolizumab,TRUE
347,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,3/20/2015,mg,antineoplastic,12/17/2014,12/16/2014,Intravenous,carboplatin,FALSE
200,5,ADVANCED,Administrations,immunotherapy,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/21/2025,mg,antineoplastic,3/18/2025,2/12/2025,Intravenous,pembrolizumab,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/30/2025,mg,antineoplastic,10/16/2024,3/22/2020,Subcutaneous,leuprolide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1GC7BGB8G544,7/21/2020,mg,antineoplastic,6/28/2020,6/5/2020,Intravenous,pembrolizumab,TRUE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/27/2013,mg,antineoplastic,9/5/2013,9/7/2013,Intravenous,paclitaxel,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/10/2023,mg,antineoplastic,5/15/2023,3/26/2023,Intravenous,paclitaxel,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/25/2019,mg,antineoplastic,4/1/2019,9/22/2018,Intravenous,durvalumab,FALSE
1000,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,3/26/2016,mg/m2,antineoplastic,2/24/2016,12/30/2015,Oral,capecitabine,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G262FC43B61CF,10/2/2019,,antineoplastic,7/11/2019,5/21/2019,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1EE49EC392G6,5/12/2024,mg,antineoplastic,5/3/2023,5/14/2023,Intravenous,pembrolizumab,FALSE
207,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,12/20/2021,mg,antineoplastic,11/23/2021,10/30/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/20/2025,,antineoplastic,8/5/2024,2/9/2023,,clinical study drug,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/16/2024,mg,antineoplastic,1/27/2024,1/16/2024,Intravenous,carboplatin,FALSE
1850,2,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,4/14/2025,mg,antineoplastic,1/10/2025,12/8/2024,Intravenous,gemcitabine,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/6/2020,mg,antineoplastic,2/12/2020,2/21/2019,Subcutaneous,bortezomib,FALSE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/25/2019,mg,antineoplastic,9/19/2019,7/11/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,6/4/2024,,antineoplastic,3/13/2024,3/25/2024,Intravenous,cisplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/27/2021,mg/m2,antineoplastic,2/16/2020,11/27/2018,Intravenous,pemetrexed,TRUE
30,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/25/2021,mg,antineoplastic,10/15/2021,10/27/2021,Intravenous,carboplatin,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,2/3/2025,,,9/1/2024,7/9/2024,Oral,dabrafenib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,12/22/2016,mg,antineoplastic,8/30/2016,9/5/2016,Intravenous,pembrolizumab,FALSE
771,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,10/30/2013,mg,antineoplastic,8/20/2013,6/12/2013,Intravenous,bevacizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/6/2025,mg,antineoplastic,5/10/2025,4/16/2023,Intravenous,pembrolizumab,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/3/2018,mg/m2,antineoplastic,7/26/2018,7/2/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2C4G1G76816F,3/23/2025,,antineoplastic,11/15/2017,10/1/2017,Intravenous,clinical study drug,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/27/2024,mg,antineoplastic,6/27/2024,3/12/2024,Intravenous,gemcitabine,FALSE
616,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,3/15/2022,mg,antineoplastic,11/1/2021,11/22/2021,Intravenous,carboplatin,FALSE
1800,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5722GECG4G16,6/6/2024,mg,antineoplastic,3/22/2024,4/7/2024,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/26/2025,mg,antineoplastic,1/21/2020,5/13/2018,Intravenous,pembrolizumab,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/2/2015,mg,antineoplastic,10/10/2014,8/24/2014,Intravenous,carboplatin,FALSE
560,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/12/2023,mg,antineoplastic,6/20/2023,2/25/2023,Intravenous,carboplatin,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/8/2019,mg,antineoplastic,7/6/2019,9/13/2018,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/13/2020,mg,antineoplastic,8/17/2017,2/11/2016,Intravenous,bevacizumab,TRUE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,3/24/2018,,antineoplastic,1/30/2018,7/1/2017,,clinical study drug,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/28/2015,mg,antineoplastic,10/21/2014,8/30/2014,Intravenous,paclitaxel protein-bound,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/20/2016,mg,antineoplastic,11/28/2015,5/23/2015,Intravenous,gemcitabine,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/7/2018,mg,antineoplastic,7/11/2018,6/17/2018,Intravenous,paclitaxel,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,3/6/2012,mg,antineoplastic,2/5/2012,1/9/2012,Subcutaneous,amifostine,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/16/2020,mg,antineoplastic,12/1/2020,8/29/2020,Oral,bicalutamide,FALSE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/21/2017,mg,antineoplastic,6/3/2017,4/15/2017,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,3/28/2025,mg,antineoplastic,8/19/2022,8/2/2022,Intravenous,pembrolizumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/17/2019,AUC,antineoplastic,3/6/2019,12/24/2018,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/2/2024,mg/m2,antineoplastic,11/14/2023,11/14/2023,Intravenous,paclitaxel,FALSE
2500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/6/2013,mg,antineoplastic,2/5/2013,12/22/2012,Intravenous,ifosfamide,FALSE
125,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G31G19E54FC:B,8/16/2020,mg,antineoplastic,3/4/2020,4/10/2020,Intravenous,cisplatin,FALSE
290,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15F6:966BBB3,8/18/2016,mg,antineoplastic,7/29/2016,6/13/2016,Intravenous,carboplatin,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/11/2016,mg,antineoplastic,3/20/2016,12/2/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,10/31/2023,,antineoplastic,4/26/2023,12/17/2022,,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/14/2025,mg,antineoplastic,8/15/2022,2/18/2019,Intravenous,pemetrexed,FALSE
248,,NEOADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,5/11/2014,mg,antineoplastic,3/27/2014,5/2/2014,Intravenous,ado-trastuzumab emtansine,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/22/2018,mg,antineoplastic,4/21/2018,4/13/2018,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,6/11/2021,,antineoplastic,6/19/2021,5/21/2021,Oral,hydroxyurea,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/29/2019,mg,antineoplastic,6/20/2018,5/24/2018,Intravenous,fluorouracil,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,7/21/2020,mg,antineoplastic,10/30/2019,2/4/2019,Intravenous,nivolumab,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B71GB3997CF,5/7/2023,mg,antineoplastic,4/19/2023,3/25/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,7/26/2017,,antineoplastic,5/1/2017,12/21/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/21/2019,mg,antineoplastic,3/5/2019,1/8/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/1/2024,mg,antineoplastic,12/21/2023,5/30/2020,Intravenous,pembrolizumab,TRUE
1075,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,12/13/2018,mg,antineoplastic,9/8/2018,8/9/2018,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/12/2024,,antineoplastic,1/2/2024,10/13/2023,,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G13D3F29D3FFF,3/7/2014,mg,antineoplastic,12/30/2013,10/25/2013,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G1441B4DG:6FF,4/20/2025,,antineoplastic,12/19/2024,7/26/2024,Intravenous,durvalumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/24/2018,mg,antineoplastic,8/11/2018,6/10/2018,Intravenous,paclitaxel protein-bound,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/18/2025,mg,antineoplastic,11/27/2024,5/15/2024,Intravenous,pemetrexed,TRUE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/11/2016,mg,antineoplastic,6/19/2015,9/27/2014,Intravenous,pemetrexed,TRUE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/18/2013,mg/m2,antineoplastic,9/5/2012,7/13/2012,Intravenous,docetaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1169816459CC,4/15/2025,,,9/1/2018,7/23/2018,Oral,osimertinib,FALSE
1150,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/6/2016,mg,antineoplastic,8/23/2015,6/22/2015,Intravenous,bevacizumab,FALSE
28,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/26/2015,mg,antineoplastic,4/20/2015,3/21/2015,Intravenous,docetaxel,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,7/11/2017,mg,antineoplastic,7/30/2017,6/17/2017,Intravenous,pemetrexed,FALSE
45,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1B7793:6:9E1,11/23/2014,mg/m2,antineoplastic,1/22/2014,1/15/2014,Intravenous,paclitaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/7/2025,mg,antineoplastic,11/7/2019,2/10/2019,Intravenous,pemetrexed,TRUE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/27/2025,mg,antineoplastic,12/28/2024,5/14/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/24/2021,mg,antineoplastic,9/8/2021,6/30/2021,Intravenous,pembrolizumab,FALSE
1200,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,1/10/2023,mg,antineoplastic,11/14/2022,10/2/2022,Intravenous,cyclophosphamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/12/2021,mg,antineoplastic,8/26/2021,7/28/2021,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,antiemetic,Clinical Study Drug,G2C233C2:5B1:,5/3/2025,,antiemetic,12/15/2024,11/8/2024,,clinical study drug,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/7/2022,mg,antineoplastic,1/22/2022,8/17/2021,Intravenous,amivantamab-vmjw,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/7/2025,mg,antineoplastic,4/18/2024,3/19/2024,Intravenous,pemetrexed,TRUE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,7/14/2021,mg,antineoplastic,2/25/2020,11/24/2019,Intravenous,durvalumab,TRUE
342,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,7/13/2016,mg,antineoplastic,7/16/2016,4/12/2016,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,10/13/2019,,antineoplastic,9/22/2019,8/26/2019,,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/8/2023,mg,antineoplastic,11/26/2022,12/18/2022,Intravenous,bevacizumab-awwb,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,4/13/2025,,antineoplastic,2/9/2025,12/8/2024,Intravenous,clinical study drug,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/24/2023,,antineoplastic,10/9/2022,10/3/2022,Intravenous,bevacizumab-awwb,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/8/2022,mg,antineoplastic,8/13/2022,6/28/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,8/26/2022,mg,antineoplastic,6/29/2022,6/16/2022,Intravenous,pembrolizumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,3/16/2025,mg,antineoplastic,10/22/2024,10/25/2024,Intravenous,etoposide,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,8/29/2024,mg,antineoplastic,7/24/2024,7/19/2024,Intravenous,pembrolizumab,FALSE
190.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/9/2015,mg,antineoplastic,1/27/2015,2/27/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G54B7:9:4B62G,1/4/2025,,,2/16/2025,2/6/2024,Oral,osimertinib,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,3/23/2016,mg,antineoplastic,4/18/2014,3/15/2014,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/3/2020,mg,antineoplastic,10/4/2017,8/2/2017,Intravenous,pemetrexed,TRUE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,6/23/2021,mg,antineoplastic,4/16/2021,10/24/2020,Intravenous,durvalumab,FALSE
318.2,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/22/2019,mg,antineoplastic,5/6/2019,12/12/2018,Intravenous,carboplatin,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/7/2015,mg,antineoplastic,9/4/2014,9/22/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,Letrozole,G29D9FB:D1D6B,9/23/2018,,antineoplastic,8/25/2018,9/23/2018,,letrozole,FALSE
,3,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3EC5EB18C676,7/31/2018,,antineoplastic,3/19/2018,1/11/2018,,clinical study drug,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/17/2018,mg,antineoplastic,4/12/2018,11/17/2017,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/8/2019,mg,antineoplastic,6/9/2018,4/5/2016,Intravenous,nivolumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/27/2025,mg,antineoplastic,1/4/2024,6/19/2023,Intravenous,pembrolizumab,TRUE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,5/18/2025,mg,antineoplastic,4/2/2025,12/13/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/25/2023,mg,antineoplastic,7/2/2023,5/3/2023,Subcutaneous,azacitidine,FALSE
202,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/6/2022,mg,antineoplastic,5/20/2022,4/13/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G16:GC1C87FG:,6/18/2017,,,4/29/2017,6/2/2017,Oral,afatinib,FALSE
200,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/25/2021,mg,antineoplastic,8/18/2021,4/3/2021,Intravenous,pembrolizumab,FALSE
93,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,12/16/2023,mg,antineoplastic,11/2/2023,9/14/2023,Intravenous,etoposide,FALSE
179,3,ADVANCED,Administrations,chemotherapy,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/20/2021,mg,antineoplastic,8/7/2020,7/5/2020,Intravenous,doxorubicin,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Docetaxel",G3D59288727DB,5/20/2019,mL,solution-fluid,3/30/2019,2/3/2019,Intravenous,docetaxel,FALSE
480,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/7/2022,mg,antineoplastic,6/20/2019,4/8/2017,Intravenous,nivolumab,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/19/2022,mg,antineoplastic,10/15/2021,6/27/2021,Intravenous,leucovorin,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/21/2020,mg,antineoplastic,12/9/2019,10/7/2019,Intravenous,durvalumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/26/2025,mg,antineoplastic,1/31/2022,1/16/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/13/2021,mg,antineoplastic,7/11/2021,7/3/2021,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Crizotinib,G234FGBCGD51F,10/16/2015,,,2/2/2015,2/21/2015,Oral,crizotinib,FALSE
262,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,7/5/2015,mg,antineoplastic,6/4/2015,6/26/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/22/2017,,solution-fluid,2/23/2016,2/16/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1C3CCC:C44GD,7/13/2022,mg,antineoplastic,10/10/2021,9/8/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/11/2025,,antineoplastic,11/25/2024,3/6/2024,Intravenous,clinical study drug,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,7/1/2015,mg/m2,antineoplastic,2/12/2015,10/2/2014,Intravenous,etoposide,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,7/6/2024,mL,solution-fluid,12/14/2023,12/5/2023,Intravenous,pemetrexed,FALSE
3,3,ADVANCED,Orders,immunotherapy,Nivolumab,G14F3GC2D5E43,9/11/2019,mg/kg,antineoplastic,7/29/2019,6/11/2019,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/29/2025,mg,antineoplastic,5/20/2019,1/31/2019,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/14/2022,mg,antineoplastic,10/13/2021,3/15/2021,Intravenous,pembrolizumab,TRUE
490,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/4/2024,mg,antineoplastic,9/13/2024,8/19/2024,Intravenous,carboplatin,FALSE
131,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/29/2018,mg,antineoplastic,11/12/2018,10/17/2018,Intravenous,carboplatin,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,2/25/2013,mg,antineoplastic,6/2/2012,3/25/2012,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,6/30/2016,mg,antineoplastic,4/21/2016,3/29/2016,Intravenous,paclitaxel,FALSE
289,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/20/2024,mg,antineoplastic,5/19/2024,6/10/2024,Intravenous,carboplatin,FALSE
1075,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G221C:3FD2EGB,4/3/2019,mg,antineoplastic,1/28/2019,3/4/2019,Intravenous,pemetrexed,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/19/2019,mg,antineoplastic,4/14/2013,2/1/2013,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,5/24/2024,mL,solution-fluid,5/19/2024,4/9/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/25/2025,mg,antineoplastic,2/13/2021,3/14/2020,Intravenous,pembrolizumab,FALSE
76,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/9/2020,mg,antineoplastic,5/28/2014,2/25/2014,Intravenous,doxorubicin,FALSE
901,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/11/2023,mg,antineoplastic,3/29/2023,11/20/2022,Intravenous,fluorouracil,FALSE
240,1,ADVANCED,Orders,immunotherapy,Nivolumab,G1G618861EGD9,4/1/2019,mg,antineoplastic,3/11/2018,7/5/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/5/2024,mg,antineoplastic,5/22/2023,11/24/2022,Intravenous,nivolumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,5/27/2022,mg,antineoplastic,6/6/2022,4/18/2022,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/22/2020,mg,antineoplastic,6/23/2016,1/20/2016,Intravenous,bevacizumab,TRUE
,5,ADVANCED,Orders,immunotherapy,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/8/2025,,antineoplastic,2/27/2025,1/22/2025,,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G76D1E7GG61,2/12/2015,,antineoplastic,1/2/2015,12/20/2014,,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166FBC749F7D,5/4/2013,mg,antineoplastic,3/14/2013,4/25/2013,Intravenous,paclitaxel,FALSE
115,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,6/4/2015,mg,antineoplastic,4/16/2015,4/8/2015,Intravenous,paclitaxel protein-bound,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/30/2019,mg/kg,antineoplastic,3/10/2019,7/26/2018,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,12/3/2022,mg,antineoplastic,3/17/2022,10/8/2021,Intravenous,durvalumab,TRUE
,1,ADVANCED,Unstructured,,Erlotinib,G2E1F163ECG9B,10/15/2013,,,9/16/2013,9/16/2013,Oral,erlotinib,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,7/7/2015,mg,antineoplastic,10/3/2013,7/4/2013,Intravenous,paclitaxel,FALSE
1600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/22/2013,mg,antineoplastic,6/24/2013,12/22/2012,Intravenous,gemcitabine,FALSE
36,4,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/15/2019,mg/m2,antineoplastic,3/6/2019,3/10/2019,Intravenous,docetaxel,FALSE
500,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/25/2015,mg,antineoplastic,3/4/2015,10/15/2014,Intravenous,carboplatin,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,4/1/2015,mg,antineoplastic,6/3/2014,2/6/2014,Intravenous,paclitaxel,FALSE
290,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/3/2016,mg,antineoplastic,11/25/2015,10/19/2015,Intravenous,paclitaxel protein-bound,FALSE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,9/26/2016,mg,antineoplastic,2/16/2016,12/4/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/14/2020,mg,antineoplastic,7/2/2019,1/13/2019,Intravenous,pembrolizumab,FALSE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,10/23/2015,mg,antineoplastic,8/24/2015,6/9/2015,Intravenous,docetaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/6/2025,mg,antineoplastic,9/29/2023,2/11/2020,Intravenous,pemetrexed,TRUE
146.9,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,7/7/2013,mg,antineoplastic,5/17/2013,4/19/2013,Intravenous,carboplatin,FALSE
2637,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,6/13/2022,mg,antineoplastic,3/5/2022,9/7/2021,Intravenous,gemcitabine,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,5/16/2024,mg,antineoplastic,5/15/2024,9/11/2023,Intravenous,amivantamab-vmjw,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,12/9/2021,mg,antineoplastic,10/24/2021,8/25/2021,Intravenous,paclitaxel,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,4/4/2020,mg,antineoplastic,2/13/2020,1/8/2020,Intravenous,pemetrexed,FALSE
750,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/16/2024,mg,antineoplastic,12/3/2023,1/5/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,1/2/2025,mg,antineoplastic,12/30/2024,9/16/2024,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,2/1/2025,mg,antineoplastic,4/19/2024,5/11/2024,Intravenous,pembrolizumab,FALSE
17.1,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/4/2013,mL,antineoplastic,6/19/2013,6/23/2013,Intravenous,vinorelbine,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/8/2025,mg,antineoplastic,11/16/2024,9/17/2022,Oral,anastrozole,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/27/2019,mg,antineoplastic,1/31/2018,9/17/2017,Intravenous,atezolizumab,FALSE
152.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,8/31/2015,mg,antineoplastic,8/11/2015,3/21/2015,Intravenous,carboplatin,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,2/3/2014,mg,antineoplastic,11/8/2013,11/11/2013,Intravenous,gemcitabine,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,7/12/2012,mg,antineoplastic,4/3/2012,4/5/2012,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,1/25/2022,mg,antineoplastic,11/4/2021,8/22/2021,Intravenous,bevacizumab-awwb,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/17/2022,mg,antineoplastic,11/24/2021,12/29/2021,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,10/21/2021,mg,antineoplastic,3/12/2021,1/29/2021,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/6/2014,mg,antineoplastic,6/10/2014,3/4/2014,Intravenous,paclitaxel protein-bound,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,4/22/2024,mg,antineoplastic,12/15/2023,10/7/2023,Intravenous,nivolumab,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/8/2019,mg,antineoplastic,12/27/2018,6/21/2018,Intravenous,levoleucovorin,FALSE
93,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,12/28/2023,mg,antineoplastic,11/11/2023,9/30/2023,Intravenous,etoposide,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,11/23/2019,mg/m2,antineoplastic,9/26/2019,7/28/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/6/2025,mg,antineoplastic,3/2/2023,9/9/2022,Intravenous,pembrolizumab,TRUE
144,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,11/2/2014,mg,antineoplastic,9/25/2014,9/29/2014,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3EC5EB18C676,8/3/2018,,antineoplastic,3/1/2018,2/20/2018,,clinical study drug,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/19/2024,mg,antineoplastic,5/28/2023,5/4/2023,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G193F989CDC3D,12/2/2017,,,11/30/2017,5/3/2016,Oral,erlotinib,FALSE
1200,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/7/2022,mg/m2,antineoplastic,10/29/2021,10/20/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/20/2020,mg,antineoplastic,7/9/2019,10/25/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,5/14/2025,mg,antineoplastic,3/24/2025,4/5/2025,Intravenous,pembrolizumab,FALSE
1000,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,9/8/2013,mg,antineoplastic,8/18/2013,7/7/2013,Intravenous,gemcitabine,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/17/2022,mL,solution-fluid,12/6/2022,11/11/2022,Intravenous,cisplatin,FALSE
749,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/27/2021,mg,antineoplastic,1/8/2022,10/26/2021,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/24/2025,mg,antineoplastic,8/17/2024,12/27/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G15B:95:E93C7,4/11/2015,,,2/15/2015,2/8/2015,Oral,erlotinib,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G131CBG478:94,3/24/2012,mg,antineoplastic,2/23/2012,1/5/2012,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,1/29/2019,mg,antineoplastic,11/7/2018,3/6/2018,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3G18F3E9E3C8,6/13/2024,mg,antineoplastic,4/18/2024,3/31/2024,Intravenous,nivolumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,2/11/2019,mg,antineoplastic,11/12/2017,10/30/2017,Intravenous,pembrolizumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/27/2017,mg,antineoplastic,1/28/2016,7/6/2015,Intravenous,nivolumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14216G12B:E7,10/25/2019,mg,antineoplastic,8/18/2019,7/29/2019,Intravenous,carboplatin,FALSE
100,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/15/2013,mg/m2,antineoplastic,3/16/2013,2/19/2013,Intravenous,etoposide,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/28/2016,mg,antineoplastic,1/14/2016,11/25/2015,Intravenous,paclitaxel,FALSE
209.1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,2/1/2014,mg,antineoplastic,1/3/2014,1/30/2014,Intravenous,carboplatin,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,10/16/2012,mg/m2,antineoplastic,7/12/2012,6/5/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,5/12/2018,,antineoplastic,9/17/2017,5/4/2017,Intravenous,clinical study drug,FALSE
,1,LOCOREGIONAL,Orders,targeted/non-biologic,Imatinib,G251214GDF65B,12/2/2016,,antineoplastic,10/9/2016,9/1/2016,Oral,imatinib,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/24/2025,mg/m2,antineoplastic,6/21/2019,2/13/2019,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Orders,targeted/non-biologic,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,3/7/2019,,antineoplastic,6/10/2018,3/27/2018,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/22/2024,mg,antineoplastic,1/6/2024,7/7/2023,Intravenous,pembrolizumab,TRUE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/13/2012,mg,antineoplastic,9/10/2012,3/24/2012,Intravenous,docetaxel,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/14/2024,mg,antineoplastic,12/7/2023,7/18/2023,Intravenous,paclitaxel protein-bound,FALSE
160,1,ADVANCED,Orders,targeted/non-biologic,Zanubrutinib,G2D7F77586F3B,10/6/2023,mg,antineoplastic,8/3/2023,1/22/2023,Oral,zanubrutinib,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,6/29/2019,mg,antineoplastic,3/8/2019,2/18/2019,Intravenous,durvalumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/15/2019,mg,antineoplastic,2/12/2019,12/15/2018,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/7/2024,mg,antineoplastic,8/10/2024,12/25/2023,Intravenous,durvalumab,FALSE
,3,ADVANCED,Unstructured,,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/3/2016,,,1/6/2016,12/4/2015,Oral,vemurafenib,FALSE
600,3,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/20/2019,mg,antineoplastic,8/28/2019,6/21/2019,Intravenous,fluorouracil,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,7/13/2023,mg,antineoplastic,10/21/2022,7/17/2022,Intravenous,durvalumab,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/29/2025,mg,antineoplastic,1/2/2025,7/13/2024,Intravenous,durvalumab,FALSE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/18/2011,mg,antineoplastic,8/8/2011,8/21/2011,Intravenous,cisplatin,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/24/2020,mg/kg,antineoplastic,4/13/2020,3/1/2020,Intravenous,ramucirumab,FALSE
800,,CONCURRENT,Administrations,chemotherapy,Pemetrexed,G289C6438E26:,3/18/2013,mg,antineoplastic,4/29/2013,3/26/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/5/2022,mg,antineoplastic,10/5/2021,3/30/2021,Intravenous,pembrolizumab,TRUE
482,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,8/18/2013,mg,antineoplastic,1/29/2013,2/20/2013,Intravenous,carboplatin,FALSE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,1/17/2012,mg,antineoplastic,9/14/2011,9/15/2011,Intravenous,cisplatin,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/12/2020,mg,antineoplastic,1/20/2020,9/12/2019,Intravenous,gemcitabine,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,4/4/2012,mg,antineoplastic,4/16/2012,2/28/2012,Intravenous,carboplatin,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/18/2024,mg,antineoplastic,12/19/2023,9/26/2023,Intravenous,paclitaxel,FALSE
275,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/18/2022,mg,antineoplastic,12/31/2021,9/19/2021,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/27/2016,,antineoplastic,4/22/2016,5/5/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/4/2022,,antineoplastic,4/25/2020,5/25/2017,Oral,nilotinib,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,3/4/2025,,,7/5/2024,8/4/2024,Oral,osimertinib,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/27/2019,mg,antineoplastic,11/12/2018,6/3/2018,Intravenous,trastuzumab,FALSE
151,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/2/2024,mg,antineoplastic,1/11/2024,12/15/2023,Intravenous,carboplatin,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/28/2019,mg/m2,antineoplastic,5/20/2019,4/2/2019,Intravenous,etoposide,FALSE
295.4,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,3/2/2019,mg,antineoplastic,10/20/2018,8/20/2018,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,4/15/2022,,antineoplastic,5/10/2021,6/15/2021,,niraparib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,2/15/2023,mg,antineoplastic,9/12/2022,5/25/2022,Intravenous,durvalumab,FALSE
680,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3E76E32E795:,6/1/2020,mg,antineoplastic,7/2/2020,3/15/2020,Intravenous,ramucirumab,FALSE
167.2,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/3/2015,mg,antineoplastic,10/8/2014,10/6/2014,Intravenous,paclitaxel,FALSE
1500,3,ADVANCED,Administrations,immunotherapy,"Anastrozole,Durvalumab",G1885B3G8447B,2/21/2025,mg,antineoplastic,9/30/2022,9/1/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/18/2022,mg,antineoplastic,7/29/2022,7/29/2022,Intravenous,pembrolizumab,FALSE
438,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/27/2025,mg,antineoplastic,12/10/2024,10/21/2024,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/14/2017,mg,antineoplastic,2/28/2015,11/13/2014,Intravenous,gemcitabine,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/18/2022,mg,antineoplastic,7/10/2020,4/6/2020,Intravenous,durvalumab,TRUE
800,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,8/14/2018,mg,antineoplastic,7/10/2018,4/22/2018,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/19/2025,mg,antineoplastic,8/5/2018,1/12/2017,Intravenous,pembrolizumab,FALSE
230,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,7/28/2013,mg,antineoplastic,7/17/2013,5/8/2013,Intravenous,carboplatin,FALSE
50,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,11/23/2014,mg/m2,antineoplastic,10/21/2014,8/21/2014,Intravenous,paclitaxel,FALSE
900,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,3/31/2020,mg,antineoplastic,2/22/2020,3/19/2020,Intravenous,leucovorin,FALSE
860,5,ADVANCED,Administrations,chemotherapy,Pemetrexed,G166B735:96D2,11/2/2013,mg,antineoplastic,10/4/2013,11/2/2013,Intravenous,pemetrexed,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,6/30/2016,mg,antineoplastic,3/31/2016,2/21/2016,Intravenous,etoposide,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/22/2024,mg,antineoplastic,11/9/2023,9/18/2023,Intravenous,durvalumab,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3C:F1C:2BF6C,11/2/2014,mg,antineoplastic,10/2/2014,9/8/2014,Intravenous,docetaxel,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,7/17/2023,mg,antineoplastic,5/22/2023,5/25/2023,Intravenous,paclitaxel,FALSE
346,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,4/22/2024,mg,antineoplastic,3/28/2024,2/20/2024,Intravenous,paclitaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,12/31/2024,mg,antineoplastic,11/18/2024,9/7/2024,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,4/29/2018,,antineoplastic,2/14/2018,1/9/2018,Intravenous,clinical study drug,FALSE
647,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5::D4E74F959,10/23/2013,mg,antineoplastic,8/3/2013,5/7/2013,Intravenous,carboplatin,FALSE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/15/2022,mg,antineoplastic,8/12/2022,7/21/2022,Intravenous,paclitaxel,FALSE
157,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,1/12/2017,mg,antineoplastic,12/24/2016,11/9/2016,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,5/29/2020,mg,antineoplastic,5/18/2020,3/27/2020,Intravenous,carboplatin,FALSE
200,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,4/25/2019,mg,antineoplastic,4/5/2019,1/28/2019,Intravenous,pembrolizumab,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,1/29/2021,mg,antineoplastic,9/14/2020,10/3/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,5/2/2025,mg,antineoplastic,1/1/2024,9/26/2023,Intravenous,pembrolizumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/30/2014,mg,antineoplastic,8/13/2014,5/26/2014,Intravenous,vinorelbine,FALSE
1480,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,6/7/2021,mg,antineoplastic,2/11/2021,12/2/2020,Intravenous,gemcitabine,FALSE
743,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G392GC5134FFG,9/7/2020,mg,antineoplastic,6/22/2020,8/17/2020,Intravenous,durvalumab,TRUE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/18/2022,mg,antineoplastic,6/30/2021,6/30/2021,Intravenous,bevacizumab-bvzr,FALSE
117,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,10/27/2022,mg,antineoplastic,9/15/2022,8/16/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/2/2025,mg,antineoplastic,8/21/2022,8/21/2022,Intravenous,pembrolizumab,TRUE
1250,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,4/25/2013,mg,antineoplastic,1/22/2013,1/26/2013,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/31/2022,mg,antineoplastic,10/7/2021,8/30/2021,Intravenous,pembrolizumab,FALSE
371,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/26/2016,mg,antineoplastic,8/8/2015,7/18/2015,Intravenous,paclitaxel,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/1/2013,mg,antineoplastic,1/6/2013,3/17/2012,Intravenous,pemetrexed,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,8/4/2015,mg,antineoplastic,8/26/2014,7/8/2014,Intravenous,pemetrexed,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/8/2022,mg,antineoplastic,9/7/2021,5/5/2021,Intravenous,vinorelbine,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,2/26/2022,mg,antineoplastic,2/16/2022,10/18/2021,Intravenous,leucovorin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/8/2023,mg,antineoplastic,2/16/2023,11/4/2022,Intravenous,pembrolizumab,FALSE
388,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,3/6/2019,mg,antineoplastic,1/18/2019,11/29/2018,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,10/26/2015,mg,antineoplastic,8/17/2015,1/28/2015,Intravenous,paclitaxel protein-bound,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,7/26/2015,mg,antineoplastic,8/4/2015,5/2/2015,Intravenous,carboplatin,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/17/2014,mg,antineoplastic,6/6/2014,4/9/2014,Intravenous,pemetrexed,FALSE
63,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/17/2021,mg,antineoplastic,4/17/2021,12/21/2020,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/16/2025,,antineoplastic,3/13/2022,11/9/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,4/5/2025,mg,antineoplastic,10/9/2024,9/1/2024,Intravenous,pembrolizumab,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,3/11/2016,mg,antineoplastic,9/14/2015,6/12/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,6/28/2017,,antineoplastic,1/7/2017,12/22/2016,Intravenous,clinical study drug,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/11/2019,mg/kg,antineoplastic,11/29/2018,8/30/2018,Intravenous,durvalumab,FALSE
166.4,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,2/4/2015,mg,antineoplastic,12/8/2014,10/14/2014,Intravenous,paclitaxel,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,11/14/2014,mg,antineoplastic,8/30/2014,9/2/2014,Intravenous,paclitaxel,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/25/2017,mg,antineoplastic,8/4/2017,6/4/2017,Intravenous,carboplatin,FALSE
803,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/26/2025,mg,antineoplastic,10/7/2023,2/8/2023,Intravenous,pemetrexed,FALSE
198,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/3/2022,mg,antineoplastic,8/22/2022,8/1/2022,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/10/2024,mg,antineoplastic,10/25/2023,2/23/2023,Intravenous,atezolizumab,TRUE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G128:92:3BD3D,12/5/2021,,antiemetic,6/20/2021,4/16/2021,Intravenous,clinical study drug,FALSE
80,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,8/14/2022,mg,antineoplastic,5/26/2022,3/20/2022,Intravenous,ipilimumab,FALSE
1000,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19D32D1B89D8,6/24/2017,mg,antineoplastic,4/22/2017,4/23/2017,Intravenous,pemetrexed,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/18/2011,mg,antineoplastic,7/27/2011,6/7/2011,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G42B4F:55::6F,8/23/2020,mg,antineoplastic,7/9/2020,8/27/2020,Intravenous,pembrolizumab,FALSE
42.5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/22/2021,mg/m2,antineoplastic,5/31/2021,3/2/2021,Intravenous,oxaliplatin,FALSE
765,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,3/11/2016,mg,antineoplastic,7/27/2015,6/21/2015,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/3/2025,mg,antineoplastic,4/21/2025,2/16/2023,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/1/2019,mg,antineoplastic,12/22/2018,5/4/2018,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,5/22/2025,AUC,antineoplastic,12/7/2024,12/13/2024,Intravenous,carboplatin,FALSE
342,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,6/7/2019,mg,antineoplastic,10/18/2018,10/1/2018,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G175D3C95:34G,7/15/2019,,,7/16/2019,4/29/2019,Oral,osimertinib,FALSE
109,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/16/2023,mg,antineoplastic,2/7/2023,2/23/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG899C7446,1/9/2025,mg,antineoplastic,11/27/2024,1/12/2025,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,8/28/2024,AUC,antineoplastic,9/12/2024,7/20/2024,Intravenous,carboplatin,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/6/2024,mg,antineoplastic,10/2/2023,10/16/2023,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/13/2016,,antineoplastic,4/13/2016,4/4/2016,Intravenous,paclitaxel,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/13/2022,mg,antineoplastic,11/3/2022,10/14/2022,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G579E53D92:75,10/28/2011,,hematological agent,11/26/2011,8/25/2011,Subcutaneous,clinical study drug,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/28/2023,mg,antineoplastic,5/29/2023,4/8/2023,Subcutaneous,azacitidine,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/23/2015,mg,antineoplastic,9/4/2014,9/21/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/29/2022,mg,antineoplastic,12/10/2020,6/4/2020,Intravenous,pembrolizumab,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/16/2024,mg,antineoplastic,7/28/2023,7/27/2023,Intravenous,paclitaxel protein-bound,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/26/2020,mg,antineoplastic,12/15/2018,11/15/2015,Intravenous,nivolumab,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,11/15/2022,mg,antineoplastic,8/17/2022,10/12/2022,Intravenous,pemetrexed,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,4/21/2019,mg,antineoplastic,3/18/2019,3/7/2019,Intravenous,gemcitabine,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B913698546B,6/22/2017,mg,antineoplastic,5/11/2017,6/30/2017,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,10/7/2018,mg,antineoplastic,7/6/2018,3/25/2018,Intravenous,pembrolizumab,FALSE
535,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,6/17/2020,mg,antineoplastic,2/4/2020,1/16/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/4/2020,mg,antineoplastic,5/21/2019,12/8/2018,Intravenous,pembrolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,7/22/2023,mg,antineoplastic,4/15/2023,2/25/2023,Intravenous,pembrolizumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G31:9DD57G8:5,2/28/2013,mg,antineoplastic,2/1/2013,2/7/2013,Intravenous,paclitaxel,FALSE
183,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/4/2020,mg,antineoplastic,6/8/2020,5/11/2020,Intravenous,carboplatin,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/19/2023,mg,antineoplastic,3/16/2023,12/29/2022,Intravenous,pemetrexed,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/6/2023,mg,antineoplastic,5/19/2023,3/25/2023,Intravenous,carboplatin,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,11/2/2012,mg/m2,antineoplastic,10/4/2012,5/3/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G149B7C41:236,6/13/2023,,antineoplastic,6/11/2023,5/8/2023,Intravenous,pembrolizumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,6/7/2013,mg,antineoplastic,10/20/2012,6/18/2012,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/2/2023,mg,antineoplastic,9/21/2022,9/2/2022,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/30/2024,,antineoplastic,5/28/2024,4/8/2024,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/29/2019,mg,antineoplastic,11/4/2018,6/16/2018,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,4/21/2024,mg,antineoplastic,4/8/2024,4/2/2024,Intravenous,carboplatin,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,2/25/2014,mg,antineoplastic,11/22/2013,12/3/2013,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/26/2013,mg,antineoplastic,12/23/2012,12/12/2011,Intravenous,etoposide,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,9/8/2019,mg,antineoplastic,7/7/2019,7/16/2019,Intravenous,paclitaxel,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,1/13/2014,mg/m2,antineoplastic,11/4/2013,11/7/2013,Intravenous,paclitaxel,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/7/2019,mg,antineoplastic,5/2/2019,10/11/2018,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,3/24/2018,,antineoplastic,12/24/2017,6/1/2017,,clinical study drug,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,4/8/2024,mg,antineoplastic,3/8/2024,5/7/2023,Intravenous,atezolizumab,FALSE
648.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G266C31886:66,3/26/2015,AUC,antineoplastic,4/29/2015,4/1/2015,Intravenous,carboplatin,FALSE
121,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/30/2020,mg,antineoplastic,3/7/2020,2/22/2020,Intravenous,docetaxel,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/21/2022,mg,antineoplastic,3/28/2022,10/6/2021,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/30/2018,mg,antineoplastic,9/11/2018,8/7/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,12/2/2017,mg,antineoplastic,10/21/2017,4/11/2017,Intravenous,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G157317FG3387,10/29/2024,mg,antineoplastic,9/20/2024,5/22/2024,Intravenous,durvalumab,TRUE
20,,ADJUVANT,Orders,chemotherapy,Decitabine,G1F5415D1B672,12/13/2018,mg/m2,antineoplastic,9/19/2018,9/17/2018,Intravenous,decitabine,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,1/18/2025,mg,antineoplastic,4/17/2023,3/26/2023,Intravenous,paclitaxel protein-bound,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,4/23/2019,mg/m2,antineoplastic,9/29/2017,7/26/2017,Intravenous,docetaxel,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G2FF5BBF:G7GF,10/20/2023,,,6/1/2020,6/23/2020,Oral,osimertinib,FALSE
853.3,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/12/2016,mg,antineoplastic,6/6/2015,6/23/2015,Intravenous,carboplatin,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/6/2025,mg,antineoplastic,8/24/2024,9/15/2024,Intravenous,durvalumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,9/5/2012,mg,antineoplastic,6/18/2012,4/15/2012,Intravenous,pemetrexed,FALSE
298,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,4/1/2024,mg,antineoplastic,10/3/2023,11/6/2023,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/31/2019,mg,antineoplastic,7/6/2018,3/17/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G1969F536B2DD,10/25/2011,,steroid,8/9/2011,7/14/2011,Intravenous,clinical study drug,FALSE
66,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,3/28/2014,mg,antineoplastic,3/5/2014,2/13/2014,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/20/2025,mg,antineoplastic,6/21/2018,1/20/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1D:61B997689,9/24/2018,,,9/14/2018,9/3/2018,Oral,osimertinib,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/28/2013,mg,antineoplastic,3/10/2013,3/2/2013,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/23/2022,mg,antineoplastic,11/16/2021,8/31/2021,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/14/2016,mg,antineoplastic,4/11/2016,2/26/2016,Intravenous,etoposide,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G41DE1E3BE99:,4/22/2022,,antineoplastic,4/20/2022,5/12/2022,Oral,hydroxyurea,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35B956BB:BG8,2/10/2022,mg,antineoplastic,11/9/2021,10/19/2021,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,9/12/2019,mg,antineoplastic,7/31/2019,5/21/2019,Intravenous,carboplatin,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/30/2011,mg,antineoplastic,11/2/2011,9/8/2011,Intravenous,cisplatin,FALSE
119,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,1/1/2021,mg,antineoplastic,8/25/2020,3/26/2020,Intravenous,docetaxel,FALSE
127,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/9/2021,mg,antineoplastic,7/3/2021,6/16/2020,Intravenous,docetaxel,FALSE
75,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/25/2023,mg,antineoplastic,7/4/2023,5/13/2023,Intravenous,tremelimumab-actl,FALSE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,10/27/2024,mg,antineoplastic,9/15/2024,7/12/2024,Intravenous,paclitaxel,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G517B45372B5D,6/18/2020,mg,antineoplastic,4/20/2020,4/1/2020,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,11/28/2016,mg,antineoplastic,5/2/2015,11/29/2014,Intravenous,gemcitabine,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/5/2025,mg,antineoplastic,3/22/2023,2/6/2023,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G147D:E6:68B1,11/14/2024,mg,antineoplastic,10/22/2024,7/5/2024,Intravenous,durvalumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/15/2024,mg,antineoplastic,5/11/2022,12/29/2021,Intravenous,durvalumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/26/2016,mg,antineoplastic,2/25/2016,11/3/2014,Intravenous,bevacizumab,TRUE
674,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,4/26/2023,mg,antineoplastic,2/1/2023,12/26/2022,Intravenous,carboplatin,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/27/2019,mg,antineoplastic,4/19/2018,2/22/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,6/25/2017,,antineoplastic,11/21/2016,8/16/2016,Intravenous,nivolumab,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/2/2022,mg,antineoplastic,3/1/2020,4/20/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/31/2024,mg,antineoplastic,3/25/2024,12/24/2023,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,6/2/2024,mg,antineoplastic,1/27/2022,11/11/2021,Intravenous,pembrolizumab,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/13/2020,mg,antineoplastic,4/12/2019,12/20/2018,Intravenous,pemetrexed,FALSE
533,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2628C28G7613,5/10/2016,mg,antineoplastic,12/26/2015,10/15/2015,Intravenous,ramucirumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,7/8/2024,mg,antineoplastic,5/20/2024,3/30/2024,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/30/2025,mg,antineoplastic,11/18/2019,3/13/2019,Intravenous,pemetrexed,FALSE
306,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,12/1/2024,mg,antineoplastic,8/19/2024,6/15/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,9/6/2022,mg,antineoplastic,5/16/2022,5/10/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G257459B7FF:E,10/4/2019,,,2/12/2018,2/11/2018,Oral,osimertinib,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/5/2024,mg,antineoplastic,5/13/2022,12/8/2021,Intravenous,nivolumab,TRUE
280,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G22D6BD662E16,2/10/2019,mg,antineoplastic,1/9/2019,11/7/2018,Intravenous,carboplatin,FALSE
84,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,5/5/2022,mg,antineoplastic,3/29/2022,3/27/2022,Intravenous,paclitaxel,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/29/2013,mg,antineoplastic,2/1/2013,10/27/2012,Intravenous,vinorelbine,FALSE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G3:67CF8FF:28,10/26/2021,,,11/6/2021,4/1/2020,Oral,osimertinib,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,11/29/2024,,antineoplastic,8/23/2024,7/27/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,5/17/2019,,antineoplastic,3/27/2019,3/6/2019,,docetaxel,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G19GDC129D136,7/17/2018,mg,antineoplastic,8/3/2017,7/15/2017,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G41G38G7991D4,5/20/2025,,,2/27/2025,12/25/2024,Oral,trametinib,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/2/2025,mg,antineoplastic,4/3/2019,3/27/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G26F5C48G8168,5/11/2025,,,5/10/2024,5/8/2024,Oral,alectinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/29/2019,mg,antineoplastic,5/6/2019,4/2/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,4/20/2012,,antineoplastic,3/4/2012,6/14/2011,Intravenous,clinical study drug,FALSE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G1D41F368EE:G,3/12/2020,mg,antineoplastic,1/17/2020,11/27/2019,Subcutaneous,leuprolide,FALSE
755,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14ECFDEBG33C,6/9/2014,mg,antineoplastic,4/16/2014,12/5/2013,Intravenous,pemetrexed,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/28/2025,mg,antineoplastic,1/1/2025,3/15/2024,Intravenous,pemetrexed,TRUE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,7/12/2021,mg,antineoplastic,5/26/2021,4/21/2021,Intravenous,paclitaxel protein-bound,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,1/24/2024,mg,antineoplastic,10/13/2023,9/29/2023,Intravenous,paclitaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,2/26/2023,mg,antineoplastic,2/17/2023,5/29/2022,Intravenous,atezolizumab,FALSE
92,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,3/28/2025,mg,antineoplastic,3/8/2025,2/10/2025,Intravenous,paclitaxel,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1C9B158617B6,3/24/2014,AUC,antineoplastic,12/10/2011,12/20/2011,Intravenous,carboplatin,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,3/3/2020,mg,antineoplastic,7/3/2019,5/27/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/4/2021,,antineoplastic,1/11/2021,12/12/2020,Intravenous,carboplatin,FALSE
757,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,12/13/2019,mg,antineoplastic,10/1/2019,8/22/2019,Intravenous,durvalumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/28/2021,mg,antineoplastic,7/4/2021,6/8/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/1/2025,,antineoplastic,2/22/2019,1/11/2019,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G1G7:9D7EC1EC,9/5/2021,,antineoplastic,7/3/2021,8/4/2021,,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/9/2025,mg,antineoplastic,11/1/2017,12/6/2016,Intravenous,nivolumab,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/4/2021,mg/kg,antineoplastic,3/19/2021,3/4/2021,Intravenous,bevacizumab-awwb,FALSE
,2,ADVANCED,Unstructured,,Crizotinib,G3E12EBD52F4D,5/7/2018,,,2/28/2018,2/25/2018,Oral,crizotinib,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,10/5/2022,mg,antineoplastic,6/23/2022,7/9/2022,Intravenous,pemetrexed,TRUE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,12/19/2019,mg,antineoplastic,9/27/2019,5/4/2019,Intravenous,ramucirumab,FALSE
200,4,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,4/9/2024,mg,antineoplastic,4/2/2024,3/17/2024,Intravenous,pembrolizumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,6/23/2021,mg,antineoplastic,8/13/2020,12/7/2019,Intravenous,durvalumab,TRUE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,11/22/2024,mg,antineoplastic,6/12/2022,4/24/2022,Intravenous,cisplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,3/31/2017,,solution-fluid,10/20/2016,3/8/2016,Intravenous,clinical study drug,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/20/2014,mg,antineoplastic,3/28/2013,9/15/2012,Intravenous,carboplatin,FALSE
950,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/26/2024,mg,antineoplastic,2/14/2024,10/20/2023,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,1/27/2025,,antineoplastic,4/3/2024,5/26/2024,Intravenous,carboplatin,FALSE
145,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G18:439734B::,9/29/2015,mg,antineoplastic,9/27/2015,8/12/2015,Intravenous,docetaxel,FALSE
,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,4/8/2025,,antineoplastic,1/19/2025,1/8/2025,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/25/2021,mg,antineoplastic,5/3/2019,1/5/2019,Intravenous,pembrolizumab,TRUE
489,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G2CCC3642E:67,2/29/2020,mg,antineoplastic,2/12/2020,2/8/2020,Intravenous,ramucirumab,FALSE
83,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/28/2016,mg,antineoplastic,6/9/2016,7/1/2016,Intravenous,paclitaxel,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/13/2016,mg,antineoplastic,8/25/2016,7/10/2016,Intravenous,necitumumab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/9/2025,,antineoplastic,7/6/2024,4/18/2020,Oral,enzalutamide,FALSE
130,1,ADVANCED,Administrations,chemotherapy,Docetaxel,G3::D515D6ED6,4/5/2012,mg,antineoplastic,3/18/2012,2/24/2012,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/30/2023,mg,antineoplastic,6/24/2023,5/30/2023,Intravenous,carboplatin,FALSE
317.5,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/4/2016,mg,antineoplastic,9/3/2016,8/4/2016,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/4/2022,mg,antineoplastic,4/3/2016,2/6/2016,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,6/18/2017,,antineoplastic,12/4/2016,12/7/2016,,clinical study drug,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,6/14/2021,mg,antineoplastic,1/2/2021,10/6/2020,Intravenous,gemcitabine,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G419EE8F1F59D,7/28/2023,mg,antineoplastic,5/13/2023,4/2/2023,Intravenous,pemetrexed,FALSE
165,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/31/2025,mg,antineoplastic,11/20/2024,9/27/2024,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/2/2023,mg,antineoplastic,10/28/2017,11/17/2017,Intravenous,nivolumab,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/10/2019,mg/m2,antineoplastic,11/14/2018,11/18/2018,Intravenous,vinorelbine,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G184:C43CDE:B,7/31/2017,mg,antineoplastic,7/27/2017,6/23/2017,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/29/2025,mg,antineoplastic,9/15/2023,3/9/2019,Intravenous,pemetrexed,FALSE
2,,ADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,5/5/2013,mg,antineoplastic,3/31/2013,12/3/2012,Intravenous,vincristine,FALSE
288,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,2/28/2013,mg,antineoplastic,11/2/2012,11/13/2012,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/13/2025,mg,antineoplastic,7/24/2024,6/20/2022,Intravenous,pembrolizumab,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,2/28/2013,mg/m2,antineoplastic,1/5/2013,11/25/2012,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,9/4/2018,mg,antineoplastic,6/8/2018,8/13/2017,Intravenous,atezolizumab,FALSE
405,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,3/17/2025,mg,antineoplastic,12/7/2024,11/8/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/24/2022,mg,antineoplastic,10/5/2019,12/27/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,3/10/2022,mg,antineoplastic,10/29/2021,11/13/2021,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/10/2018,mg,antineoplastic,7/7/2018,6/24/2018,Intravenous,paclitaxel protein-bound,FALSE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/14/2015,mg,antineoplastic,2/2/2015,2/23/2015,Intravenous,paclitaxel,FALSE
527.6,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/22/2025,mg,antineoplastic,7/15/2019,3/11/2019,Intravenous,carboplatin,FALSE
501.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/11/2018,mg,antineoplastic,8/26/2018,8/18/2018,Intravenous,carboplatin,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,2/11/2014,AUC,antineoplastic,12/12/2013,12/18/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,4/7/2021,mg,antineoplastic,4/17/2021,10/2/2020,Intravenous,pembrolizumab,TRUE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,4/15/2016,mg,antineoplastic,5/7/2016,2/9/2016,Intravenous,nivolumab,FALSE
118,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2518G1D763FB,4/2/2024,mg,antineoplastic,3/5/2024,3/6/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/2/2025,,antineoplastic,7/21/2024,3/12/2023,Intravenous,pemetrexed,FALSE
156,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,2/25/2024,mg,antineoplastic,11/4/2023,11/19/2023,Intravenous,carboplatin,FALSE
66.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,3/10/2023,mg,antineoplastic,12/29/2022,10/25/2022,Intravenous,paclitaxel,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/1/2011,mg,antineoplastic,9/26/2011,9/5/2011,Intravenous,cisplatin,FALSE
1610,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,5/9/2015,mg,antineoplastic,1/5/2015,12/12/2014,Intravenous,gemcitabine,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,12/30/2011,mg,antineoplastic,11/19/2011,9/16/2011,Intravenous,cisplatin,FALSE
625,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,5/27/2022,mg,antineoplastic,3/3/2022,3/8/2022,Intravenous,carboplatin,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,7/27/2024,mg,antineoplastic,7/5/2024,3/16/2024,Intravenous,amivantamab-vmjw,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,6/16/2019,mg,antineoplastic,3/17/2019,2/28/2019,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,5/25/2020,mg,antineoplastic,12/19/2019,8/1/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/10/2025,,antineoplastic,4/14/2023,2/10/2023,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/20/2018,mg,antineoplastic,6/20/2017,4/4/2017,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/6/2025,mg,antineoplastic,2/10/2025,6/20/2024,Intravenous,carboplatin,FALSE
438,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/7/2020,mg,antineoplastic,5/21/2020,2/8/2020,Intravenous,carboplatin,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,10/16/2019,mg,antineoplastic,9/14/2019,9/2/2019,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/1/2016,mg,antineoplastic,12/15/2015,5/24/2015,Intravenous,carboplatin,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,9/1/2020,mg,antineoplastic,5/10/2020,2/4/2020,Intravenous,carboplatin,FALSE
551,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,2/6/2023,mg,antineoplastic,5/26/2022,5/20/2022,Intravenous,carboplatin,FALSE
78,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,10/28/2024,mg,antineoplastic,4/22/2024,5/25/2024,Intravenous,ipilimumab,FALSE
1100,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,7/10/2017,mg,antineoplastic,5/30/2017,5/31/2017,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,5/14/2025,mg,antineoplastic,4/13/2025,2/23/2025,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Durvalumab,G392GC5134FFG,9/24/2020,,antineoplastic,8/14/2020,8/15/2020,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21953622CB66,8/18/2019,mg,antineoplastic,4/13/2019,2/24/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Tepotinib,G211B9B8E3:3E,4/5/2025,,,4/26/2025,2/27/2025,Oral,tepotinib,FALSE
322.4,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,2/7/2016,mg,antineoplastic,8/21/2015,7/6/2015,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,4/27/2025,mg,antineoplastic,10/26/2024,9/24/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/27/2014,mg,antineoplastic,5/18/2014,3/1/2014,Intravenous,carboplatin,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,10/3/2016,mg,antineoplastic,7/28/2016,6/15/2016,Intravenous,paclitaxel,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/23/2019,mg,antineoplastic,7/3/2016,3/23/2016,Intravenous,nivolumab,FALSE
295,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Capecitabine",G5724:G6:4ED5,3/26/2025,mg,antineoplastic,3/27/2025,4/1/2025,Intravenous,bevacizumab-bvzr,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3G3424ECF92G,3/30/2025,mg,antineoplastic,2/13/2025,3/6/2025,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,5/7/2020,mg,antineoplastic,12/16/2019,1/2/2020,Intravenous,pemetrexed,FALSE
1300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/30/2013,mg,antineoplastic,12/4/2012,8/16/2012,Intravenous,gemcitabine,FALSE
392,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,5/11/2025,mg,antineoplastic,3/16/2025,3/11/2025,Intravenous,carboplatin,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G244773::F9D1,12/31/2017,mg,antineoplastic,9/27/2017,9/23/2017,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Unstructured,,"Carboplatin,Crizotinib,Pemetrexed",G1D4DE:C3C41C,4/15/2025,,,3/17/2025,1/9/2024,Oral,crizotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/26/2024,mg,antineoplastic,11/11/2024,10/13/2024,Intravenous,pembrolizumab,TRUE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/20/2025,mg,antineoplastic,6/19/2024,3/14/2020,Subcutaneous,leuprolide,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/25/2019,mL,solution-fluid,10/30/2017,8/13/2017,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,12/21/2016,mg,antineoplastic,9/23/2016,8/30/2016,Intravenous,pembrolizumab,FALSE
581,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,9/6/2024,mg,antineoplastic,6/29/2024,5/21/2024,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/19/2025,mg,antineoplastic,12/13/2023,8/8/2022,Intravenous,pembrolizumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/27/2022,mg,antineoplastic,4/5/2018,5/1/2017,Intravenous,nivolumab,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/16/2022,mg,antineoplastic,7/12/2014,7/4/2014,Intravenous,paclitaxel,FALSE
162,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/20/2019,mg,antineoplastic,12/21/2018,11/2/2018,Intravenous,carboplatin,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/30/2020,mg,antineoplastic,8/26/2020,5/25/2020,Intravenous,paclitaxel,FALSE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,1/16/2017,mg,antineoplastic,1/14/2017,11/14/2016,Intravenous,gemcitabine,FALSE
1055,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,4/13/2025,mg,antineoplastic,1/10/2025,12/28/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1E1BE62:E61G,2/11/2020,mg,antineoplastic,12/31/2019,1/21/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/28/2025,mg,antineoplastic,5/13/2024,5/11/2022,Intravenous,pembrolizumab,FALSE
263,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G557E997E81G5,11/23/2023,mg,antineoplastic,9/14/2023,10/24/2023,Intravenous,carboplatin,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/17/2022,mg,antineoplastic,11/14/2021,9/6/2021,Intravenous,carboplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/19/2024,mg,antineoplastic,6/23/2021,7/3/2020,Intravenous,nivolumab,FALSE
357,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,12/21/2019,mg,antineoplastic,6/3/2013,2/17/2013,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/7/2020,mg,antineoplastic,11/2/2019,1/26/2019,Subcutaneous,bortezomib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/10/2025,mg,antineoplastic,9/6/2021,12/18/2016,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,Alectinib,G53C61B2GG71F,6/6/2016,,,4/16/2016,4/9/2016,Oral,alectinib,FALSE
300,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,9/25/2024,mg,antineoplastic,2/10/2024,2/5/2024,Intravenous,carboplatin,FALSE
1020,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,2/18/2023,mg,antineoplastic,2/4/2023,1/31/2023,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/3/2022,,antineoplastic,4/6/2022,2/27/2022,,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/28/2025,mg,antineoplastic,8/1/2024,9/4/2021,Intravenous,atezolizumab,TRUE
780,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11D1:8:62429,10/31/2015,mg,antineoplastic,10/19/2015,10/21/2015,Intravenous,ramucirumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/2/2025,mg,antineoplastic,3/24/2025,2/29/2024,Intravenous,durvalumab,TRUE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/21/2023,mg,antineoplastic,10/31/2023,1/2/2023,Intravenous,pemetrexed,FALSE
130,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,5/7/2025,mg,antineoplastic,8/25/2024,8/5/2024,Intravenous,paclitaxel,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,8/24/2019,mg,antineoplastic,8/22/2019,6/26/2019,Intravenous,paclitaxel,FALSE
740,1,ADVANCED,Administrations,targeted/biologic,Nivolumab,G21BD9C1D75:6,1/9/2019,mg,antineoplastic,5/27/2018,7/10/2018,Intravenous,bevacizumab,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/5/2022,mg,antineoplastic,2/3/2021,3/22/2020,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/21/2025,mg,antineoplastic,12/27/2023,9/7/2022,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,Erlotinib,G1CGCC1C6CF35,8/29/2013,,,6/25/2013,6/29/2013,Oral,erlotinib,FALSE
,4,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,6/10/2023,,antineoplastic,2/19/2023,1/31/2023,Intravenous,bevacizumab-awwb,FALSE
180,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,3/31/2020,mg,antineoplastic,2/25/2020,3/30/2020,Intravenous,oxaliplatin,FALSE
2425,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G177G4:B9E394,4/9/2025,mg,antineoplastic,3/5/2025,1/30/2025,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/30/2018,mg,antineoplastic,9/26/2017,9/10/2017,Intravenous,pembrolizumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/9/2023,mg,antineoplastic,7/13/2023,6/8/2023,Intravenous,paclitaxel,FALSE
463,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/2/2022,mg,antineoplastic,11/20/2022,8/29/2022,Intravenous,carboplatin,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,3/21/2020,mg,antineoplastic,2/22/2020,12/26/2019,Intravenous,carboplatin,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/10/2023,mg,antineoplastic,11/13/2022,10/13/2022,Intravenous,durvalumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/25/2019,mg,antineoplastic,11/5/2018,1/23/2018,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/11/2020,mg,antineoplastic,2/2/2018,6/30/2016,Intravenous,nivolumab,FALSE
162,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,5/7/2016,mg,antineoplastic,2/20/2016,1/10/2016,Intravenous,carboplatin,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,4/1/2025,mg,antineoplastic,6/26/2024,12/17/2022,Intravenous,cisplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G369D5G3B91:2,11/8/2024,mg,antineoplastic,7/19/2024,7/15/2024,Intramuscular,leuprolide,FALSE
790,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,7/4/2014,mg,antineoplastic,4/26/2014,2/22/2014,Intravenous,bevacizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/1/2022,mg,antineoplastic,7/2/2018,1/9/2016,Intravenous,pemetrexed,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/11/2019,mg,antineoplastic,9/21/2019,9/17/2019,Intravenous,paclitaxel protein-bound,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,8/6/2015,mg,antineoplastic,6/25/2014,6/6/2014,Intravenous,carboplatin,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,9/14/2024,mg,antineoplastic,6/21/2024,4/18/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,"Erlotinib,Osimertinib",G263B3:534B15,5/5/2018,,,4/19/2018,10/13/2016,Oral,osimertinib,FALSE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/28/2013,mg,antineoplastic,1/14/2013,12/30/2012,Intravenous,gemcitabine,FALSE
1500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,12/22/2017,mg,antineoplastic,12/28/2017,11/4/2017,Intravenous,gemcitabine,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/16/2021,mg,antineoplastic,11/14/2021,9/27/2021,Intravenous,paclitaxel,FALSE
1100,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3FE:CB6:EG58,5/22/2024,mg,antineoplastic,4/15/2024,2/29/2024,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,3/3/2019,mg,antineoplastic,7/8/2018,3/14/2018,Intravenous,nivolumab,FALSE
47,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3ED9686E8628,7/7/2014,mg,antineoplastic,3/19/2014,2/27/2014,Intravenous,vinorelbine,FALSE
17.5,2,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,11/17/2013,mg/m2,antineoplastic,11/1/2013,9/19/2013,Intravenous,vinorelbine,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,1/27/2015,mg,antineoplastic,11/24/2014,11/6/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/23/2025,mg,antineoplastic,1/7/2023,3/10/2020,Intravenous,pembrolizumab,FALSE
511,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,5/7/2022,mg,antineoplastic,12/25/2021,11/28/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1DD111EC2E4G,6/13/2021,,antineoplastic,3/19/2021,3/25/2021,,carboplatin,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,3/30/2020,mg,antineoplastic,2/1/2020,1/7/2020,Intravenous,carboplatin,FALSE
600,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/18/2017,mg,antineoplastic,8/31/2017,5/13/2017,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,3/29/2019,mg,antineoplastic,1/7/2018,6/29/2017,Intravenous,nivolumab,FALSE
185,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/25/2022,mg,antineoplastic,3/1/2022,2/20/2022,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/27/2019,mg,antineoplastic,9/24/2017,3/29/2016,Intravenous,nivolumab,FALSE
413,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/20/2023,mg,antineoplastic,2/20/2023,10/30/2022,Intravenous,bevacizumab-bvzr,FALSE
590,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/18/2025,mg,antineoplastic,4/15/2019,4/7/2019,Intravenous,carboplatin,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/4/2016,mg,antineoplastic,7/27/2016,2/25/2016,Intravenous,bevacizumab,TRUE
0,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,10/21/2013,mg/kg,antineoplastic,9/15/2013,7/29/2013,Intravenous,bevacizumab,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,12/5/2024,mg,antineoplastic,11/7/2024,8/22/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G4GE2958C:E1C,4/29/2012,,steroid,11/1/2011,8/7/2011,Intrajejunal,clinical study drug,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/30/2024,mg,antineoplastic,7/31/2024,8/10/2024,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G1188466C5727,1/22/2015,,,4/30/2014,5/8/2014,Oral,erlotinib,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/11/2025,AUC,antineoplastic,12/13/2024,11/27/2024,Intravenous,carboplatin,FALSE
4000,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,2/5/2021,mg,antineoplastic,11/9/2020,10/18/2020,Intravenous,fluorouracil,FALSE
350,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/24/2023,mg,antineoplastic,4/9/2020,1/28/2020,Intravenous,carboplatin,FALSE
765,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/31/2021,mg,antineoplastic,10/21/2021,8/18/2021,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/7/2023,mg,antineoplastic,12/13/2022,8/28/2022,Subcutaneous,azacitidine,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/23/2024,mg,antineoplastic,10/6/2023,12/18/2021,Intravenous,nivolumab,TRUE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G128:92:3BD3D,11/17/2021,,hematological agent,6/5/2021,5/24/2021,Subcutaneous,clinical study drug,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G2D284G82G31F,5/1/2025,,,12/17/2024,12/14/2024,Oral,osimertinib,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/22/2011,mg,antineoplastic,8/19/2011,5/17/2011,Intravenous,carboplatin,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,8/3/2017,,antineoplastic,12/11/2016,11/18/2016,Oral,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,9/7/2017,mg,antineoplastic,5/18/2017,6/26/2017,Intravenous,pembrolizumab,FALSE
1500,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/15/2013,mg,antineoplastic,10/6/2012,5/22/2012,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1F482136BDE5,4/7/2017,,antiemetic,2/14/2017,2/13/2017,Intravenous,clinical study drug,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/10/2016,mg,antineoplastic,4/30/2016,5/7/2016,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G547F143D3DEG,1/20/2025,,,9/14/2024,10/1/2024,Oral,dabrafenib,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/11/2022,,antineoplastic,2/8/2022,1/8/2022,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/27/2020,mg,antineoplastic,5/24/2017,6/22/2016,Intravenous,nivolumab,FALSE
672,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/8/2025,mg,antineoplastic,3/30/2023,2/11/2023,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/12/2023,mg,antineoplastic,10/28/2021,12/31/2019,Intravenous,pembrolizumab,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/30/2013,mg,antineoplastic,6/23/2013,12/1/2012,Intravenous,vinorelbine,FALSE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/6/2015,mg,antineoplastic,2/19/2015,2/15/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G2EF5C6677DE:,7/22/2013,,antineoplastic,6/23/2013,5/19/2013,Intravenous,pemetrexed,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/9/2017,mg,antineoplastic,9/16/2016,11/5/2016,Intravenous,cisplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/14/2025,mg/m2,antineoplastic,8/1/2020,3/21/2019,Intravenous,pemetrexed,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/22/2020,mg,antineoplastic,4/17/2019,1/24/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,2/25/2025,mg,antineoplastic,7/11/2024,6/28/2023,Intravenous,pembrolizumab,TRUE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/24/2025,mg,antineoplastic,12/8/2024,10/1/2024,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/5/2025,mg,antineoplastic,12/20/2018,2/10/2017,Intravenous,pembrolizumab,FALSE
1200,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18E7528ED97:,10/28/2013,mg,antineoplastic,9/22/2013,7/18/2013,Intravenous,gemcitabine,FALSE
258.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,1/24/2020,mg,antineoplastic,10/10/2019,10/21/2019,Intravenous,carboplatin,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,11/28/2019,mg,antineoplastic,9/6/2019,8/13/2019,Intravenous,carboplatin,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/25/2025,mg,antineoplastic,12/2/2024,11/16/2022,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/5/2025,mg,antineoplastic,10/13/2024,6/29/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,10/13/2019,mg,antineoplastic,9/1/2019,8/1/2019,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G445F26762F72,4/18/2024,mg,antineoplastic,1/25/2024,2/19/2024,Intravenous,durvalumab,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/3/2019,mg,antineoplastic,11/13/2018,7/17/2018,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/19/2022,mg,antineoplastic,2/27/2018,5/20/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,8/22/2018,mg,antineoplastic,7/2/2018,3/26/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/28/2024,mg,antineoplastic,9/25/2022,4/30/2020,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,chemotherapy,Pemetrexed,G26G426GG3C8F,1/19/2020,,antineoplastic,4/14/2019,8/11/2017,Intravenous,pemetrexed,TRUE
140,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,1/2/2020,mg,antineoplastic,8/6/2019,8/8/2019,Intravenous,docetaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/16/2016,mg,antineoplastic,1/17/2016,6/23/2015,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G171879EG:3B:,12/15/2017,,antineoplastic,1/10/2018,1/9/2018,Intravenous,durvalumab,FALSE
2637,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,5/30/2022,mg,antineoplastic,2/1/2022,8/24/2021,Intravenous,gemcitabine,FALSE
706,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,11/25/2014,mg,antineoplastic,10/22/2014,10/11/2014,Intravenous,carboplatin,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,1/31/2020,mg,antineoplastic,11/19/2017,8/17/2017,Intravenous,pemetrexed,TRUE
385,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,2/23/2023,mg,antineoplastic,12/14/2022,11/28/2022,Intravenous,paclitaxel,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1B982CB17239,3/2/2019,mg,antineoplastic,1/24/2019,2/1/2019,Intravenous,carboplatin,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/15/2014,AUC,antineoplastic,1/2/2014,11/15/2013,Intravenous,carboplatin,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,2/1/2023,mg,antineoplastic,11/11/2022,7/12/2022,Intravenous,durvalumab,TRUE
489.6,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/9/2022,mg,antineoplastic,11/24/2021,11/14/2021,Intravenous,leucovorin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,4/14/2012,,solution-fluid,10/24/2011,9/5/2011,Intravenous,clinical study drug,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,5/4/2019,mg,antineoplastic,3/14/2019,2/19/2019,Intravenous,pemetrexed,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/26/2020,mg,antineoplastic,3/14/2020,9/22/2019,Intravenous,durvalumab,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/24/2025,mg,antineoplastic,10/26/2024,10/11/2024,Intravenous,durvalumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/3/2017,mL,solution-fluid,8/3/2017,6/21/2017,Intravenous,carboplatin,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/28/2022,mg,antineoplastic,1/10/2022,6/29/2021,Intravenous,bevacizumab-bvzr,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,4/1/2024,mg,antineoplastic,11/10/2020,5/28/2020,Intravenous,pembrolizumab,TRUE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G58FCD4G:G6DF,9/18/2017,mg,antineoplastic,8/11/2017,6/17/2017,Intravenous,carboplatin,FALSE
78,,ADJUVANT,Administrations,chemotherapy,Cisplatin,G2G88EE8653C2,7/19/2020,mg,antineoplastic,6/10/2020,6/3/2020,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3E76E32E795:,3/12/2020,mg,antineoplastic,1/26/2020,1/8/2020,Intravenous,pembrolizumab,TRUE
32,,ADJUVANT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,2/4/2014,mg,antineoplastic,2/9/2014,1/26/2014,Intravenous,vinorelbine,FALSE
2600,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,6/11/2022,mg,antineoplastic,1/2/2022,7/28/2021,Intravenous,gemcitabine,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/15/2018,mg,antineoplastic,8/3/2016,8/18/2015,Intravenous,nivolumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/28/2018,mL,solution-fluid,2/25/2018,12/20/2017,Intravenous,carboplatin,FALSE
62.1,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/8/2021,mg,antineoplastic,6/3/2021,11/26/2020,Intravenous,vinorelbine,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,4/2/2015,mg,antineoplastic,2/10/2015,12/10/2014,Intravenous,paclitaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27456:36F5D8,7/21/2019,mg,antineoplastic,6/21/2019,7/19/2019,Intravenous,pemetrexed,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/6/2022,mg,antineoplastic,2/28/2022,2/5/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/22/2025,,antineoplastic,5/19/2024,3/10/2023,,clinical study drug,FALSE
1010,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,10/2/2021,mg,antineoplastic,10/21/2021,9/5/2021,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,2/1/2015,mg,antineoplastic,1/2/2015,10/28/2014,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/27/2018,mg,antineoplastic,2/13/2018,4/23/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,7/9/2024,mg,antineoplastic,3/29/2024,2/1/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/21/2023,mg,antineoplastic,4/24/2023,4/1/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,12/5/2024,,antineoplastic,11/20/2024,9/2/2024,Intravenous,carboplatin,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/17/2018,mg,antineoplastic,1/9/2018,12/18/2017,Intravenous,carboplatin,FALSE
100,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,3/4/2013,mg/m2,antineoplastic,2/24/2013,1/21/2013,Intravenous,etoposide,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3B26D:2G114C,3/19/2018,,antineoplastic,1/30/2018,12/22/2017,Intravenous,clinical study drug,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/13/2024,mg,antineoplastic,3/29/2021,7/31/2020,Intravenous,nivolumab,FALSE
432.4,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/12/2013,mg,antineoplastic,5/23/2012,3/12/2012,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,4/14/2025,mg,antineoplastic,12/22/2024,9/25/2024,Intravenous,pembrolizumab,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/30/2020,mg,antineoplastic,3/2/2020,9/3/2019,Intravenous,durvalumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/4/2025,mg,antineoplastic,10/24/2019,2/12/2019,Intravenous,pemetrexed,FALSE
710,2,ADVANCED,Administrations,targeted/biologic,"Anastrozole,Ramucirumab",G1GFD92F489E7,11/4/2023,mg,antineoplastic,11/8/2023,10/1/2023,Intravenous,ramucirumab,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/24/2015,mg,antineoplastic,2/23/2014,1/10/2014,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/31/2025,mg,antineoplastic,2/11/2020,1/11/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/21/2018,mg,antineoplastic,2/5/2018,4/10/2017,Intravenous,pembrolizumab,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/2/2017,mg,antineoplastic,2/22/2017,1/6/2017,Intravenous,nivolumab,FALSE
825,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,3/23/2017,mg,antineoplastic,3/8/2017,1/7/2017,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G555D3D316568,8/31/2018,mg,antineoplastic,9/22/2018,7/30/2018,Intravenous,nivolumab,FALSE
230,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,6/5/2022,mg,antineoplastic,4/20/2022,3/24/2022,Intravenous,carboplatin,FALSE
2550,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,5/27/2022,mg,antineoplastic,9/27/2021,8/4/2021,Intravenous,gemcitabine,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/19/2020,mg,antineoplastic,10/4/2019,12/20/2018,Intravenous,durvalumab,TRUE
99.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/29/2021,mg,antineoplastic,5/10/2021,3/14/2021,Intravenous,paclitaxel,FALSE
1020,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1B8EF2645E7F,4/9/2015,mg,antineoplastic,4/18/2015,4/5/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/17/2022,mg,antineoplastic,2/26/2018,1/21/2018,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,3/3/2019,mg,antineoplastic,2/26/2018,9/13/2017,Intravenous,atezolizumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,12/8/2013,mg,antineoplastic,11/11/2013,8/14/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4725296E3CE4,11/21/2022,,,3/28/2022,3/10/2022,Oral,osimertinib,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,9/13/2021,AUC,antineoplastic,9/27/2021,8/30/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/27/2017,,solution-fluid,6/17/2016,3/7/2016,Intravenous,clinical study drug,FALSE
173,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,1/6/2022,mg,antineoplastic,12/11/2021,11/4/2021,Intravenous,carboplatin,FALSE
176,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/3/2012,mg,antineoplastic,3/8/2012,2/22/2012,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/20/2022,mg,antineoplastic,7/16/2021,6/17/2021,Intravenous,bevacizumab-bvzr,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,4/11/2019,mg,antineoplastic,4/8/2019,2/23/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/24/2025,mg,antineoplastic,7/8/2024,7/5/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,6/3/2024,mg,antineoplastic,12/15/2021,11/19/2021,Intravenous,pembrolizumab,FALSE
420,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3642135:5B4C,1/23/2019,mg,antineoplastic,2/8/2019,12/30/2018,Intravenous,durvalumab,FALSE
210,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,4/10/2025,mg,antineoplastic,3/14/2025,2/18/2025,Intravenous,carboplatin,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G3:G28F:1562B,9/2/2017,mg,antineoplastic,8/4/2017,7/23/2017,Intravenous,etoposide,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/10/2022,mg,antineoplastic,8/20/2021,6/21/2021,Intravenous,fluorouracil,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/3/2024,mg,antineoplastic,3/6/2024,1/3/2024,Intravenous,cisplatin,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/11/2023,mg,antineoplastic,6/11/2023,11/25/2022,Intravenous,durvalumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/29/2024,mg,antineoplastic,2/11/2024,12/16/2023,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/12/2021,mg,antineoplastic,12/7/2020,10/21/2020,Intravenous,pemetrexed,FALSE
400,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,2/3/2021,mg,antineoplastic,10/17/2020,11/15/2020,Intravenous,fluorouracil,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G547F143D3DEG,1/25/2025,,,2/28/2025,10/6/2024,Oral,trametinib,FALSE
372,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/15/2022,mg,antineoplastic,5/4/2022,4/22/2022,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/18/2023,mg,antineoplastic,8/26/2023,5/2/2023,Intravenous,durvalumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/4/2022,mg,antineoplastic,5/2/2016,2/3/2016,Intravenous,pemetrexed,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,3/13/2014,mg,antineoplastic,1/11/2014,9/21/2013,Intravenous,gemcitabine,FALSE
1000,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,4/27/2024,mg,antineoplastic,3/26/2024,3/1/2024,Intravenous,pemetrexed,FALSE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,1/28/2025,mg,antineoplastic,7/3/2024,6/3/2024,Intravenous,durvalumab,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/30/2020,mg,antineoplastic,7/25/2020,10/10/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/9/2025,mg,antineoplastic,3/22/2025,8/17/2024,Intravenous,pembrolizumab,TRUE
1070,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1D:B49GGG719,11/21/2016,mg,antineoplastic,7/21/2016,7/30/2016,Intravenous,pemetrexed,TRUE
472,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,4/26/2015,mg,antineoplastic,11/5/2014,10/14/2014,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,antibody-conjugate,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,5/5/2025,mg,antineoplastic,1/29/2025,11/20/2024,Intravenous,fam-trastuzumab deruxtecan-nxki,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/4/2018,mg,antineoplastic,12/23/2017,9/2/2017,Intravenous,atezolizumab,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/16/2020,mg,antineoplastic,1/15/2020,1/21/2020,Intravenous,gemcitabine,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/24/2025,mg,antineoplastic,12/3/2022,1/26/2022,Intravenous,atezolizumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,12/9/2016,mg,antineoplastic,8/23/2016,7/1/2016,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/29/2025,mg,antineoplastic,1/1/2022,7/18/2021,Intravenous,atezolizumab,TRUE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,8/14/2014,mg,antineoplastic,4/9/2014,3/13/2014,Intravenous,paclitaxel protein-bound,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,12/12/2024,mg,antineoplastic,6/21/2024,11/18/2023,Intravenous,durvalumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/18/2023,mg,antineoplastic,9/29/2023,10/3/2023,Intravenous,carboplatin,FALSE
160,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/4/2017,mg,antineoplastic,10/15/2016,5/24/2015,Intravenous,nivolumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/6/2013,mg,antineoplastic,11/6/2012,12/19/2011,Intravenous,etoposide,FALSE
200,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,11/2/2018,mg,antineoplastic,10/22/2018,8/9/2018,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Unstructured,,Osimertinib,G1G9455D2D9G7,1/16/2024,,,1/22/2024,10/12/2023,Oral,osimertinib,FALSE
,4,ADVANCED,Orders,solution-fluid,Clinical Study Drug,G177G4:B9E394,4/17/2025,,solution-fluid,4/18/2025,4/7/2025,,clinical study drug,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,9/25/2024,mg,antineoplastic,7/29/2024,7/22/2024,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,4/8/2020,mg,antineoplastic,6/16/2018,8/4/2018,Intravenous,durvalumab,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/15/2022,mg,antineoplastic,8/6/2021,6/3/2021,Intravenous,leucovorin,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,3/16/2024,mg,antineoplastic,5/19/2023,5/13/2023,Intravenous,atezolizumab,FALSE
810,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,2/26/2025,mg,antineoplastic,9/16/2024,3/26/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/20/2024,mg,antineoplastic,7/3/2020,5/30/2020,Intravenous,pembrolizumab,TRUE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,1/21/2016,mg,antineoplastic,12/30/2015,11/22/2015,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/12/2020,mg,antineoplastic,11/28/2017,12/27/2016,Intravenous,nivolumab,FALSE
457,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/19/2024,mg,antineoplastic,3/4/2024,1/11/2024,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Pemetrexed,G49E3CE9E292G,2/28/2023,mL,solution-fluid,6/4/2020,5/30/2020,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Unstructured,,Afatinib,G1B56G7791723,2/11/2022,,,2/28/2022,9/4/2021,Oral,afatinib,FALSE
725,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,10/23/2021,mg,antineoplastic,10/3/2021,8/13/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/23/2018,,antineoplastic,11/3/2017,5/11/2017,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/14/2020,mg,antineoplastic,2/24/2019,12/8/2018,Intravenous,pembrolizumab,TRUE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/25/2020,mg,antineoplastic,1/24/2019,1/29/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/3/2025,,antineoplastic,8/28/2024,3/16/2023,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Osimertinib",G3BBG95F1669C,10/28/2022,,,1/12/2022,12/30/2021,Oral,alectinib,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/9/2024,mg,antineoplastic,8/27/2023,5/11/2023,Intravenous,carboplatin,FALSE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/9/2015,mg,antineoplastic,4/25/2015,3/7/2015,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/22/2023,mg,antineoplastic,7/2/2023,3/24/2023,Subcutaneous,azacitidine,FALSE
,6,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,7/8/2024,,antineoplastic,2/29/2024,4/30/2023,Oral,niraparib,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/7/2023,mL,solution-fluid,12/24/2022,1/2/2023,Intravenous,pemetrexed,FALSE
118,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,9/8/2019,mg,antineoplastic,9/24/2019,8/12/2019,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,7/22/2017,,antineoplastic,11/8/2016,11/9/2016,,clinical study drug,FALSE
100,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,1/22/2020,mg,antineoplastic,12/25/2019,9/28/2019,Intravenous,paclitaxel,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/7/2019,mg,antineoplastic,5/18/2019,10/3/2018,Intravenous,durvalumab,FALSE
2563,5,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,6/1/2022,mg,antineoplastic,9/28/2021,8/26/2021,Intravenous,gemcitabine,FALSE
269,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/19/2024,mg,antineoplastic,9/29/2023,10/20/2023,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/17/2021,mg/kg,antineoplastic,9/7/2021,4/2/2021,Intravenous,bevacizumab-awwb,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/16/2022,mg,antineoplastic,2/10/2022,2/23/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/30/2025,,antineoplastic,3/19/2023,2/26/2023,,clinical study drug,FALSE
,2,ADVANCED,Unstructured,,Sotorasib,G4253CG56F6FC,5/26/2023,,,3/29/2023,3/20/2023,Oral,sotorasib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/7/2025,mg,antineoplastic,7/1/2023,2/10/2017,Intravenous,pembrolizumab,FALSE
600,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/25/2019,mg,antineoplastic,1/23/2019,8/28/2018,Intravenous,durvalumab,FALSE
460,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/3/2025,mg,antineoplastic,5/18/2016,12/31/2015,Intravenous,carboplatin,FALSE
180.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,4/13/2014,mg,antineoplastic,3/24/2014,2/20/2014,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/31/2015,mg,antineoplastic,9/25/2014,6/5/2014,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,2/26/2023,mg,antineoplastic,12/23/2022,11/21/2022,Intravenous,bevacizumab-awwb,FALSE
114,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/27/2016,mg,antineoplastic,6/23/2016,6/4/2016,Intravenous,paclitaxel,FALSE
735,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,1/8/2024,mg,antineoplastic,9/17/2023,8/29/2023,Intravenous,pemetrexed,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/22/2013,AUC,antineoplastic,7/24/2013,9/5/2013,Intravenous,carboplatin,FALSE
637.3,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/27/2018,mg,antineoplastic,9/1/2018,5/24/2018,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/18/2024,mg,antineoplastic,4/1/2024,3/17/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/6/2022,mg,antineoplastic,8/15/2022,4/24/2022,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/23/2022,mg,antineoplastic,3/8/2022,12/31/2015,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/20/2025,mg,antineoplastic,2/20/2017,1/21/2017,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/22/2025,mg,antineoplastic,3/30/2019,2/10/2017,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/25/2021,mg,antineoplastic,7/23/2020,12/11/2018,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/29/2018,mg,antineoplastic,2/24/2018,7/8/2017,Intravenous,pembrolizumab,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/8/2014,mL,solution-fluid,2/18/2014,12/10/2013,Intravenous,cisplatin,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G15517:BF5DE4,7/30/2023,mg,antineoplastic,2/2/2023,12/30/2022,Intravenous,durvalumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G147D:E6:68B1,10/7/2024,mg,antineoplastic,7/28/2024,6/30/2024,Intravenous,durvalumab,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,8/25/2013,mg,antineoplastic,5/27/2013,1/11/2013,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/20/2023,,antineoplastic,10/6/2022,11/8/2022,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G126FD37CD5C9,7/28/2024,mg,antineoplastic,5/31/2024,3/18/2024,Intravenous,pembrolizumab,FALSE
102,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/21/2018,mg,antineoplastic,8/24/2018,4/29/2018,Intravenous,docetaxel,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/12/2019,mg,antineoplastic,5/2/2019,1/17/2018,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Unstructured,,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/14/2024,,,5/31/2024,5/14/2024,Oral,osimertinib,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/10/2020,mg,antineoplastic,4/4/2019,1/20/2019,Subcutaneous,bortezomib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,4/25/2025,mg,antineoplastic,4/12/2025,5/22/2023,Intravenous,pembrolizumab,FALSE
500,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,3/25/2015,mg,antineoplastic,3/8/2015,3/6/2015,Intravenous,carboplatin,FALSE
973,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/15/2017,mg,antineoplastic,3/6/2017,1/18/2017,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,7/4/2024,,antineoplastic,1/7/2024,11/24/2023,,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11G8BG6E719B,3/24/2025,mg,antineoplastic,2/17/2025,12/5/2024,Intravenous,pembrolizumab,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/17/2021,mg,antineoplastic,4/24/2021,4/6/2021,Intravenous,pemetrexed,FALSE
204,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,1/3/2021,mg,antineoplastic,8/4/2017,3/2/2017,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,10/13/2024,mg,antineoplastic,1/30/2024,12/16/2022,Intravenous,nivolumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14EB8:1:D44G,10/3/2019,mg,antineoplastic,9/8/2019,7/25/2019,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,9/26/2012,mg,antineoplastic,9/9/2012,7/9/2012,Intravenous,carboplatin,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,4/2/2019,mg,antineoplastic,12/17/2018,11/11/2018,Intravenous,carboplatin,FALSE
174,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/2/2012,mg,antineoplastic,10/5/2012,3/13/2012,Intravenous,carboplatin,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,1/14/2017,mg,antineoplastic,9/20/2016,6/25/2016,Intravenous,necitumumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/16/2019,mg,antineoplastic,8/15/2019,7/1/2019,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/27/2025,mg,antineoplastic,12/6/2021,8/13/2021,Intravenous,atezolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/19/2018,mg,antineoplastic,3/6/2018,3/16/2017,Intravenous,pembrolizumab,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/31/2016,mg,antineoplastic,9/20/2016,8/2/2016,Intravenous,bevacizumab,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/12/2016,mg,antineoplastic,5/20/2014,5/13/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G14955945B53:,6/5/2023,mg,antineoplastic,4/26/2023,3/28/2023,Intravenous,pembrolizumab,TRUE
75,1,LOCOREGIONAL,Orders,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/8/2024,mg/m2,antineoplastic,3/11/2024,3/10/2024,Intravenous,cisplatin,FALSE
28,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/12/2013,mg,antineoplastic,8/16/2013,6/27/2013,Intravenous,vinorelbine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,5/17/2018,mg,antineoplastic,4/4/2018,2/14/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G4GF74CE8E4:6,7/1/2023,,,6/15/2023,6/17/2023,Oral,afatinib,FALSE
350,3,ADVANCED,Administrations,immunotherapy,Cemiplimab,G252328CFG4E1,4/15/2024,mg,antineoplastic,2/23/2024,1/7/2024,Intravenous,cemiplimab,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,12/30/2018,mL,solution-fluid,10/17/2017,9/13/2017,Intravenous,cisplatin,FALSE
75,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,7/17/2017,mg/m2,antineoplastic,4/19/2017,4/24/2017,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/13/2020,mg,antineoplastic,2/23/2018,1/1/2017,Intravenous,nivolumab,FALSE
10,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/8/2017,mg/kg,antineoplastic,11/13/2016,9/28/2016,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,10/13/2018,mg,antineoplastic,5/1/2018,3/15/2018,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/17/2020,mg,antineoplastic,11/15/2020,11/11/2020,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/29/2025,mg,antineoplastic,4/25/2025,5/7/2024,Intravenous,pemetrexed,FALSE
1500,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G2141CBEF3GD3,11/16/2022,mg,antineoplastic,11/9/2022,12/19/2022,Intravenous,durvalumab,TRUE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/2/2019,mg/m2,antineoplastic,1/3/2019,10/12/2018,Intravenous,vinorelbine,FALSE
167,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,4/28/2022,mg,antineoplastic,1/10/2022,1/31/2022,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/8/2022,mg,antineoplastic,1/25/2022,12/14/2021,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,4/15/2025,mg,antineoplastic,4/21/2024,8/26/2021,Intravenous,atezolizumab,TRUE
640,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,1/13/2016,mg,antineoplastic,11/19/2015,8/28/2015,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Orders,hormone,Abiraterone,G53D3D6874EB3,3/2/2023,,antineoplastic,12/26/2022,12/30/2022,Oral,abiraterone,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/23/2025,mg,antineoplastic,8/11/2024,5/21/2024,Intravenous,pembrolizumab,FALSE
368,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,6/19/2021,mg,antineoplastic,4/7/2021,4/3/2021,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/8/2020,mg,antineoplastic,6/6/2020,9/4/2019,Intravenous,durvalumab,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,11/24/2011,mg,antineoplastic,8/26/2011,10/9/2011,Intravenous,cisplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,4/16/2025,mg,antineoplastic,9/6/2022,2/1/2022,Intravenous,pembrolizumab,TRUE
1850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,9/1/2018,mg,antineoplastic,5/23/2018,4/16/2018,Intravenous,gemcitabine,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,3/31/2025,mg,antineoplastic,2/25/2025,9/10/2024,Intravenous,nivolumab,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,12/8/2018,mg,antineoplastic,6/25/2018,5/15/2018,Intravenous,carboplatin,FALSE
50,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:D1D2EG5C21,2/11/2015,mg,antineoplastic,12/25/2014,11/18/2014,Intravenous,vinorelbine,FALSE
159.3,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,9/16/2015,mg,antineoplastic,5/10/2015,6/6/2015,Intravenous,nivolumab,FALSE
112,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G21953622CB66,3/16/2020,mg,antineoplastic,1/15/2020,7/25/2019,Intravenous,docetaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/22/2011,mg,antineoplastic,6/30/2011,6/17/2011,Intravenous,etoposide,FALSE
260,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,1/31/2015,mg,antineoplastic,11/4/2014,8/22/2014,Intravenous,paclitaxel,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,10/2/2018,mg,antineoplastic,7/31/2018,4/20/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/13/2023,mg,antineoplastic,10/14/2021,9/26/2021,Intravenous,pembrolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G4D2G1D2:G:5D,8/31/2019,mg/kg,antineoplastic,6/30/2019,6/12/2019,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,solution-fluid,Clinical Study Drug,G14E7662::61C,5/8/2017,,solution-fluid,2/20/2016,2/24/2016,,clinical study drug,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/8/2023,,antineoplastic,1/2/2023,10/25/2022,Intravenous,bevacizumab-awwb,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/19/2023,mg,antineoplastic,7/30/2022,8/24/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/24/2024,mg,antineoplastic,3/10/2023,2/23/2023,Intravenous,atezolizumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,2/7/2017,mg,antineoplastic,2/9/2014,1/15/2014,Intravenous,cisplatin,FALSE
70,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G161:GEG632G8,11/19/2019,mg,antineoplastic,10/24/2019,7/6/2019,Intravenous,docetaxel,FALSE
810,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/29/2025,mg,antineoplastic,8/9/2024,3/14/2024,Intravenous,durvalumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/25/2014,mg,antineoplastic,8/24/2013,7/2/2013,Intravenous,pemetrexed,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/15/2015,mg,antineoplastic,4/30/2015,8/13/2014,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CG8EF93777D,12/30/2021,mg,antineoplastic,10/9/2020,8/3/2020,Intravenous,nivolumab,FALSE
,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4989E69:D856,11/11/2024,,antineoplastic,10/30/2024,11/8/2024,Intravenous,pemetrexed,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/4/2016,mg,antineoplastic,6/12/2016,5/2/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,4/18/2025,mg,antineoplastic,1/10/2025,7/26/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/30/2025,mg,antineoplastic,8/28/2023,6/20/2022,Intravenous,pembrolizumab,FALSE
2450,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5792EBE:8EB3,11/15/2012,mg,antineoplastic,9/4/2012,9/26/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/12/2024,mg,antineoplastic,11/23/2023,5/8/2020,Intravenous,pembrolizumab,TRUE
2450,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G3B26D:2G114C,3/5/2019,mg,antineoplastic,3/17/2019,1/25/2019,Intravenous,gemcitabine,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,3/22/2018,mg,antineoplastic,1/7/2018,11/19/2017,Intravenous,pemetrexed,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/2/2011,mg,antineoplastic,6/29/2011,3/24/2011,Intravenous,carboplatin,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/26/2022,mg,antineoplastic,9/24/2021,7/12/2021,Intravenous,bevacizumab-bvzr,FALSE
575,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/30/2019,mg,antineoplastic,10/10/2019,8/18/2019,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,4/4/2025,mg,antineoplastic,2/14/2025,5/22/2024,Intravenous,pemetrexed,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/9/2022,mg,antineoplastic,12/28/2021,4/2/2021,Intravenous,vinorelbine,FALSE
28,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/5/2013,mg,antineoplastic,10/15/2013,6/19/2013,Intravenous,vinorelbine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Docetaxel",G3D59288727DB,4/21/2019,,antineoplastic,2/13/2019,1/26/2019,,docetaxel,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/26/2015,mg,antineoplastic,3/18/2014,2/9/2014,Intravenous,carboplatin,FALSE
195,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,7/4/2016,mg,antineoplastic,5/5/2016,3/16/2016,Intravenous,carboplatin,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Pemetrexed,Sotorasib",G2C38B34G8794,2/9/2023,mg/m2,antineoplastic,9/29/2022,11/16/2022,Intravenous,pemetrexed,FALSE
660,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,5/26/2022,mg,antineoplastic,2/27/2022,12/27/2021,Intravenous,bevacizumab-bvzr,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/7/2025,mg,antineoplastic,12/28/2024,11/10/2024,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,9/28/2016,mg,antineoplastic,8/12/2016,6/25/2016,Intravenous,carboplatin,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/8/2022,mg,antineoplastic,6/19/2021,6/7/2021,Intravenous,leucovorin,FALSE
,,NEOADJUVANT,Orders,cytoprotective,Clinical Study Drug,G1DCDG73E53FF,7/19/2024,,cytoprotective,4/24/2024,5/27/2024,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G5344:8G5698G,4/11/2025,mg,antineoplastic,1/23/2025,2/15/2025,Intravenous,pembrolizumab,TRUE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,3/15/2020,mg,antineoplastic,1/7/2020,9/22/2019,Intravenous,carboplatin,FALSE
239,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,12/11/2022,mg,antineoplastic,12/12/2022,10/3/2022,Intravenous,carboplatin,FALSE
55,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1594:E29D2D9,5/10/2022,mg,antineoplastic,3/25/2022,3/29/2022,Intravenous,ipilimumab,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,3/30/2021,mg,antineoplastic,2/23/2021,1/10/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,9/20/2019,mg,antineoplastic,7/26/2019,4/1/2019,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/8/2020,mg,antineoplastic,3/29/2016,1/23/2016,Intravenous,bevacizumab,TRUE
153,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,4/22/2018,mg,antineoplastic,4/24/2018,3/19/2018,Intravenous,paclitaxel,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/18/2018,mg,antineoplastic,7/28/2018,7/7/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,10/5/2023,mg,antineoplastic,7/13/2023,7/22/2023,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,11/18/2021,mL,solution-fluid,3/14/2018,3/23/2018,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,targeted/non-biologic,"Azacitidine,Venetoclax",G13F761779185,9/11/2023,,antineoplastic,7/14/2023,4/11/2023,Oral,venetoclax,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,3/15/2023,mg,antineoplastic,11/22/2022,4/23/2022,Intravenous,atezolizumab,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/18/2018,mg,antineoplastic,10/9/2018,7/20/2018,Intravenous,cisplatin,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/17/2024,mg,antineoplastic,7/31/2024,5/6/2024,Intravenous,cemiplimab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,8/9/2024,,antineoplastic,5/26/2024,3/27/2024,,pemetrexed,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,4/1/2024,mg,antineoplastic,1/7/2024,1/24/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/26/2020,mg,antineoplastic,1/7/2020,1/19/2018,Intravenous,pembrolizumab,TRUE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/2/2022,mg,antineoplastic,2/26/2018,5/28/2017,Oral,dasatinib,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/19/2016,mg,antineoplastic,2/17/2016,11/23/2015,Intravenous,paclitaxel,FALSE
66,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,1/26/2025,mg,antineoplastic,10/15/2024,11/8/2024,Intravenous,paclitaxel,FALSE
175,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3GB7EGGB7:9D,3/16/2020,mg,antineoplastic,3/14/2020,1/30/2020,Intravenous,paclitaxel protein-bound,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,9/3/2019,mg/kg,antineoplastic,1/7/2019,9/5/2018,Intravenous,durvalumab,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Osimertinib",G3BBG95F1669C,10/13/2022,,,8/28/2022,12/27/2021,Oral,alectinib,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G1B8G131F6FC6,11/9/2019,,,2/21/2018,2/18/2018,Oral,osimertinib,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,4/24/2025,mg,antineoplastic,4/20/2025,7/7/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/28/2025,mg,antineoplastic,8/29/2019,1/26/2019,Intravenous,pembrolizumab,TRUE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/14/2023,mg,antineoplastic,10/5/2022,8/17/2022,Subcutaneous,azacitidine,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/8/2012,mg,antineoplastic,6/23/2012,1/18/2012,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,"Erlotinib,Osimertinib",G263B3:534B15,4/30/2018,,,5/20/2018,10/17/2016,Oral,erlotinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,6/30/2024,mg,antineoplastic,9/22/2023,6/27/2023,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2177D1::DG1E,6/5/2012,mg,antineoplastic,5/8/2012,4/14/2012,Intravenous,gemcitabine,FALSE
259,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/22/2016,mg,antineoplastic,3/25/2016,11/22/2015,Intravenous,carboplatin,FALSE
815,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3E76E32E795:,4/14/2020,mg,antineoplastic,12/23/2019,12/3/2019,Intravenous,pemetrexed,TRUE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/9/2023,mg,antineoplastic,7/2/2023,9/14/2022,Intravenous,durvalumab,FALSE
165,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11:F93GC6851,6/11/2021,mg,antineoplastic,4/28/2021,4/20/2021,Intravenous,paclitaxel protein-bound,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G2D5B71G65F2G,4/16/2016,mg,antineoplastic,7/2/2015,8/7/2015,Intravenous,docetaxel,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/28/2024,mg,antineoplastic,6/13/2024,5/20/2023,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,5/24/2019,4/5/2017,Intravenous,nivolumab,FALSE
399,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,7/19/2024,mg,antineoplastic,4/22/2024,3/20/2024,Intravenous,paclitaxel,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/21/2016,mg,antineoplastic,4/14/2016,9/20/2014,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,5/13/2019,mg,antineoplastic,2/19/2019,3/2/2019,Intravenous,pembrolizumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/9/2017,mL,solution-fluid,9/7/2017,7/28/2017,Intravenous,carboplatin,FALSE
64,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,8/3/2023,mg,antineoplastic,6/3/2023,6/17/2023,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,4/12/2023,,antineoplastic,12/6/2022,12/5/2022,Intravenous,pemetrexed,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,3/16/2013,mg,antineoplastic,1/23/2013,1/14/2013,Intravenous,paclitaxel,FALSE
118,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/29/2017,mg,antineoplastic,8/1/2017,7/24/2017,Intravenous,cisplatin,FALSE
1700,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G11:F93GC6851,5/13/2021,mg,antineoplastic,2/7/2021,1/4/2021,Intravenous,gemcitabine,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G3:G28F:1562B,8/19/2017,mg,antineoplastic,7/14/2017,8/2/2017,Intravenous,etoposide,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,8/2/2023,mg,antineoplastic,3/20/2023,1/5/2023,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,11/2/2024,mg,antineoplastic,9/21/2024,7/15/2024,Intravenous,carboplatin,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/4/2018,mg,antineoplastic,11/23/2017,11/6/2017,Intravenous,bevacizumab,FALSE
129,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G355524112BFE,4/30/2017,mg,antineoplastic,6/25/2017,6/7/2017,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,9/23/2022,mg,antineoplastic,7/5/2022,6/1/2022,Intravenous,bevacizumab-awwb,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,2/6/2018,mg,antineoplastic,9/12/2017,6/16/2017,Intravenous,nivolumab,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/19/2017,mg,antineoplastic,8/17/2015,4/20/2015,Intravenous,bevacizumab,TRUE
600,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,10/26/2023,mg,antineoplastic,8/25/2023,5/2/2023,Intravenous,pemetrexed,TRUE
2,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,1/4/2020,AUC,antineoplastic,12/5/2019,10/4/2019,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,5/8/2014,mg,antineoplastic,4/17/2014,1/25/2014,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/22/2019,mg,antineoplastic,10/19/2017,3/16/2016,Intravenous,nivolumab,FALSE
469,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/12/2016,mg,antineoplastic,8/11/2016,7/31/2016,Intravenous,carboplatin,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,12/8/2018,mg,antineoplastic,6/24/2018,5/11/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/4/2024,mg,antineoplastic,10/8/2021,5/1/2020,Intravenous,pembrolizumab,TRUE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/23/2022,mL,solution-fluid,1/31/2022,2/15/2022,Intravenous,carboplatin,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/13/2020,mg,antineoplastic,9/6/2019,9/6/2019,Intravenous,durvalumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/6/2025,mg,antineoplastic,7/9/2024,4/10/2024,Intravenous,durvalumab,TRUE
846,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3C:F1C:2BF6C,11/14/2014,mg,antineoplastic,11/1/2014,9/7/2014,Intravenous,carboplatin,FALSE
123,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/5/2024,mg,antineoplastic,9/6/2024,8/10/2024,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,11/27/2018,mg,antineoplastic,12/9/2018,12/14/2018,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G11:E1E83E6:D,5/21/2019,mg,antineoplastic,4/26/2019,3/31/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,9/7/2022,mg,antineoplastic,5/7/2022,2/25/2022,Intravenous,pembrolizumab,FALSE
240,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,5/30/2023,mg,antineoplastic,5/28/2023,3/7/2023,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/2/2025,mg,antineoplastic,3/22/2025,5/18/2024,Intravenous,pemetrexed,TRUE
361,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,12/27/2013,mg,antineoplastic,12/17/2013,11/29/2013,Intravenous,paclitaxel,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,4/17/2021,mg,antineoplastic,2/10/2021,1/22/2021,Intravenous,carboplatin,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/8/2022,mg,antineoplastic,11/20/2021,3/27/2021,Intravenous,bevacizumab-awwb,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,12/8/2019,mg,antineoplastic,11/8/2019,9/4/2019,Intravenous,etoposide,FALSE
180,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/28/2018,mg,antineoplastic,6/2/2018,3/10/2018,Intravenous,carboplatin,FALSE
4,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,2/22/2013,AUC,antineoplastic,1/17/2013,2/9/2013,Intravenous,carboplatin,FALSE
675,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,4/20/2025,mg,antineoplastic,2/14/2025,2/26/2025,Intravenous,pemetrexed,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,3/6/2020,mg,antineoplastic,10/10/2019,12/16/2018,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/19/2019,mg,antineoplastic,6/1/2018,10/17/2017,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G2141CBEF3GD3,11/10/2022,,antineoplastic,10/23/2022,10/31/2022,,durvalumab,TRUE
185,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,7/1/2023,mg,antineoplastic,5/24/2023,6/17/2023,Intravenous,carboplatin,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,3/12/2017,mg,antineoplastic,3/3/2017,11/14/2016,Intravenous,docetaxel,FALSE
109,7,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3:C9BECD3F55,4/20/2022,mg,antineoplastic,2/13/2022,12/30/2021,Intravenous,ipilimumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G445F26762F72,5/18/2024,mg,antineoplastic,2/8/2024,2/15/2024,Intravenous,durvalumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,2/28/2025,,solution-fluid,1/22/2018,10/25/2017,Intravenous,clinical study drug,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/5/2025,mg,antineoplastic,6/27/2019,1/9/2017,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,8/21/2019,mg,antineoplastic,9/20/2018,8/28/2018,Intravenous,nivolumab,FALSE
225,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/8/2014,mg,antineoplastic,5/11/2013,3/26/2013,Intravenous,carboplatin,FALSE
197,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/21/2016,mg,antineoplastic,6/12/2015,4/28/2015,Intravenous,cisplatin,FALSE
75,2,ADVANCED,Orders,chemotherapy,Docetaxel,G2D5B71G65F2G,3/21/2016,mg/m2,antineoplastic,12/15/2015,7/14/2015,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/23/2025,mg,antineoplastic,10/9/2020,2/7/2018,Intravenous,nivolumab,FALSE
1970,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,8/28/2018,mg,antineoplastic,3/28/2018,4/21/2018,Intravenous,gemcitabine,FALSE
196,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,9/17/2019,mg,antineoplastic,7/27/2019,5/12/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/28/2019,mg,antineoplastic,7/2/2019,5/31/2018,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/23/2018,mg,antineoplastic,7/10/2018,6/3/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/16/2025,mg,antineoplastic,4/22/2019,2/20/2019,Intravenous,pembrolizumab,TRUE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,2/4/2023,mg,antineoplastic,12/7/2022,7/26/2022,Intravenous,durvalumab,TRUE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,6/16/2013,mg,antineoplastic,6/14/2013,3/9/2013,Intravenous,gemcitabine,FALSE
105,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,8/27/2022,mg,antineoplastic,5/29/2022,5/28/2022,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/4/2018,mg,antineoplastic,3/22/2018,3/14/2017,Intravenous,pembrolizumab,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/20/2022,mg,antineoplastic,7/1/2021,7/5/2021,Intravenous,leucovorin,FALSE
100,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,4/10/2013,mg,antineoplastic,3/8/2013,2/25/2013,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/2/2025,mg,antineoplastic,4/23/2020,1/21/2019,Intravenous,pemetrexed,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,4/22/2012,mg,antineoplastic,2/11/2012,2/25/2012,Intravenous,carboplatin,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/22/2014,mg,antineoplastic,2/25/2014,10/26/2013,Intravenous,paclitaxel,FALSE
940,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G24167D1DD5FG,1/17/2025,mg,antineoplastic,12/11/2024,10/12/2024,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/8/2020,mg,antineoplastic,9/11/2018,11/17/2015,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4CG4:632GG8E,9/22/2021,,,4/28/2021,5/18/2021,Oral,osimertinib,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/25/2017,,antineoplastic,3/16/2016,1/24/2016,Intravenous,clinical study drug,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/7/2016,mg,antineoplastic,11/23/2014,10/18/2014,Intravenous,pemetrexed,TRUE
25,3,ADVANCED,Orders,chemotherapy,Vinorelbine,G3:D1D2EG5C21,1/23/2015,mg/m2,antineoplastic,2/5/2015,11/3/2014,Intravenous,vinorelbine,FALSE
84,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/5/2021,mg,antineoplastic,11/11/2021,9/13/2021,Intravenous,paclitaxel,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/3/2015,mg,antineoplastic,3/28/2014,1/11/2014,Intravenous,paclitaxel,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1978F5FFE:43,7/31/2014,mg,antineoplastic,7/9/2014,6/27/2014,Intravenous,pemetrexed,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/14/2022,,antineoplastic,1/24/2022,1/13/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G38G2BBE55G71,2/7/2025,,,4/10/2018,5/20/2018,Oral,alectinib,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/6/2013,mg,antineoplastic,6/21/2012,4/30/2012,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,9/11/2012,mg,antineoplastic,5/20/2012,3/3/2012,Intravenous,paclitaxel protein-bound,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/8/2025,mg,antineoplastic,4/10/2024,3/19/2024,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/18/2016,mg,antineoplastic,12/7/2015,5/21/2015,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,10/29/2015,AUC,antineoplastic,11/5/2015,9/15/2015,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/7/2018,mg,antineoplastic,11/22/2018,7/13/2018,Intravenous,paclitaxel,FALSE
683,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/16/2015,mg,antineoplastic,5/16/2015,4/6/2015,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G157317FG3387,10/8/2024,mg,antineoplastic,6/27/2024,5/23/2024,Intravenous,durvalumab,TRUE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/21/2021,mg,antineoplastic,7/3/2018,3/26/2018,Intravenous,durvalumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/17/2018,mg,antineoplastic,7/25/2017,9/28/2015,Intravenous,nivolumab,FALSE
,2,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,4/29/2025,,,6/30/2024,6/4/2024,Oral,osimertinib,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/21/2016,mg,antineoplastic,8/26/2016,7/30/2016,Intravenous,carboplatin,FALSE
41,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/2/2023,mg,antineoplastic,4/24/2023,11/20/2022,Intravenous,leucovorin,FALSE
672,,ADJUVANT,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,4/1/2025,mg,antineoplastic,1/11/2025,12/28/2024,Intravenous,leucovorin,FALSE
60,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,8/14/2018,mg,antineoplastic,7/2/2018,5/30/2018,Intravenous,cisplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,11/28/2017,mL,solution-fluid,10/4/2017,7/2/2017,Intravenous,paclitaxel,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/18/2015,mg,antineoplastic,3/7/2015,2/5/2015,Intravenous,carboplatin,FALSE
430,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/26/2016,mg,antineoplastic,8/16/2016,7/23/2016,Intravenous,carboplatin,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,10/11/2019,mg,antineoplastic,7/3/2019,4/29/2019,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/10/2022,mg,antineoplastic,8/1/2022,7/9/2022,Intravenous,paclitaxel,FALSE
15,1,ADVANCED,Orders,targeted/biologic,Bevacizumab,G247F67418GGD,3/12/2012,mg/kg,antineoplastic,9/15/2011,4/9/2011,Intravenous,bevacizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,2/9/2020,mg,antineoplastic,4/11/2019,11/28/2018,Intravenous,pemetrexed,TRUE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/28/2025,mg,antineoplastic,1/20/2018,8/8/2016,Intravenous,pembrolizumab,FALSE
1640,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G43D:C17:25FG,10/4/2015,mg,antineoplastic,4/14/2015,2/12/2015,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/28/2020,mg,antineoplastic,1/29/2017,6/25/2016,Intravenous,nivolumab,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,8/15/2014,mg,antineoplastic,8/24/2013,7/30/2013,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/3/2025,mg,antineoplastic,8/15/2017,9/2/2016,Intravenous,pembrolizumab,FALSE
740,,ADJUVANT,Administrations,targeted/biologic,Rituximab-Arrx,G2GDF48F:5EGB,11/1/2024,mg,antineoplastic,11/11/2024,9/18/2024,Intravenous,rituximab-arrx,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,8/1/2020,,antineoplastic,12/6/2019,1/10/2020,Oral,pazopanib,FALSE
156,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/20/2016,mg,antineoplastic,9/11/2015,9/27/2015,Intravenous,etoposide,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,10/3/2017,mg,antineoplastic,7/14/2017,8/10/2017,Intravenous,etoposide,FALSE
412,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,3/1/2023,mg,antineoplastic,12/22/2022,11/30/2022,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/29/2019,mg,antineoplastic,5/17/2018,10/19/2017,Intravenous,pembrolizumab,FALSE
1075,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:3B43D3B55G,2/20/2024,mg,antineoplastic,9/18/2023,11/6/2023,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Administrations,growth factor,Clinical Study Drug,G1DCDG73E53FF,7/22/2024,,hematological agent,5/24/2024,4/19/2024,Subcutaneous,clinical study drug,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/19/2018,mg,antineoplastic,8/4/2018,6/24/2018,Intravenous,etoposide,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,8/9/2013,mg,antineoplastic,4/30/2013,3/15/2013,Intravenous,pemetrexed,FALSE
722,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G28G5D2B769B5,12/7/2014,mg,antineoplastic,9/19/2014,8/27/2014,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,10/10/2016,mg,antineoplastic,9/21/2016,7/22/2016,Intravenous,pemetrexed,FALSE
375,,ADJUVANT,Orders,targeted/biologic,Rituximab,G5545136B977G,11/26/2019,mg/m2,antineoplastic,11/17/2019,10/4/2019,Intravenous,rituximab,FALSE
1120,1,LOCOREGIONAL,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,11/11/2016,mg,antineoplastic,8/1/2016,8/24/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,3/22/2025,mg,antineoplastic,6/18/2024,5/4/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,2/18/2015,,antineoplastic,8/30/2014,7/27/2014,,clinical study drug,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,9/21/2024,mg,antineoplastic,7/19/2024,9/19/2023,Intravenous,durvalumab,TRUE
172.5,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G45C13CFDDB84,6/23/2017,mg,antineoplastic,2/22/2016,12/17/2015,Intravenous,nivolumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G7B3CB6D5C4,4/7/2013,mg,antineoplastic,2/27/2013,1/19/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/8/2023,mg,antineoplastic,12/7/2022,8/20/2022,Intravenous,pembrolizumab,TRUE
415,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,12/3/2016,mg,antineoplastic,10/31/2016,6/29/2016,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/20/2017,mg,antineoplastic,3/3/2017,4/26/2016,Intravenous,nivolumab,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,5/5/2022,mg/kg,antineoplastic,10/28/2021,3/14/2021,Intravenous,durvalumab,FALSE
388,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,2/14/2019,mg,antineoplastic,1/17/2019,12/11/2018,Intravenous,carboplatin,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,3/28/2024,mg,antineoplastic,12/25/2023,11/30/2023,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/16/2025,mg,antineoplastic,4/4/2019,2/22/2018,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,4/9/2022,,antineoplastic,8/7/2021,8/26/2021,Intravenous,amivantamab-vmjw,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/8/2023,mg,antineoplastic,5/7/2023,5/16/2023,Subcutaneous,azacitidine,FALSE
1000,2,ADVANCED,Orders,chemotherapy,Capecitabine,G16GE86G42194,4/20/2016,mg/m2,antineoplastic,1/19/2016,11/27/2015,Oral,capecitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,Carboplatin,G3GB8B495B6:3,1/30/2017,,antineoplastic,11/27/2016,12/19/2016,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/24/2025,mg,antineoplastic,7/13/2020,1/26/2017,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/16/2011,mg,antineoplastic,6/16/2011,6/15/2011,Intravenous,etoposide,FALSE
750,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/23/2024,mg,antineoplastic,12/21/2023,2/22/2023,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/20/2017,mg,antineoplastic,9/9/2016,8/13/2016,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/11/2025,mg,antineoplastic,2/22/2021,5/1/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/5/2020,mg,antineoplastic,1/25/2019,1/30/2019,Intravenous,pembrolizumab,FALSE
1580,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/4/2014,mg,antineoplastic,3/6/2014,2/1/2014,Intravenous,gemcitabine,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E589EBD8F93,11/9/2013,mg,antineoplastic,9/20/2013,5/2/2013,Intravenous,bevacizumab,FALSE
66,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/15/2015,mg,antineoplastic,5/12/2015,3/15/2015,Intravenous,cisplatin,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/17/2024,mg,antineoplastic,3/30/2024,1/10/2022,Intravenous,nivolumab,TRUE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/10/2020,mg,antineoplastic,10/31/2019,1/10/2019,Subcutaneous,bortezomib,FALSE
121,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,4/9/2023,mg,antineoplastic,1/18/2023,11/14/2022,Intravenous,carboplatin,FALSE
460,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,7/17/2023,mg,antineoplastic,11/16/2022,10/18/2022,Intravenous,carboplatin,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,5/7/2025,mg,antineoplastic,10/25/2022,3/16/2020,Intravenous,pemetrexed,TRUE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/19/2015,mg,antineoplastic,5/27/2015,5/10/2015,Intravenous,cisplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/29/2022,,antineoplastic,3/24/2022,3/1/2022,,carboplatin,FALSE
99.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/18/2021,mg,antineoplastic,5/8/2021,2/28/2021,Intravenous,paclitaxel,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,5/15/2023,mg,antineoplastic,4/14/2023,2/25/2023,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,10/12/2021,,antineoplastic,8/3/2021,7/9/2021,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/8/2024,mg,antineoplastic,4/16/2024,5/20/2023,Intravenous,carboplatin,FALSE
726,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,12/4/2011,mg,antineoplastic,7/31/2011,7/16/2011,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G2D168F99BCD4,2/24/2023,mg,antineoplastic,12/15/2022,8/31/2022,Intravenous,pembrolizumab,TRUE
160,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,4/17/2018,mg,antineoplastic,4/19/2018,4/7/2018,Intravenous,carboplatin,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/16/2016,mg,antineoplastic,10/25/2015,10/24/2014,Intravenous,bevacizumab,TRUE
600,3,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/2/2019,mg,antineoplastic,6/8/2019,7/9/2019,Intravenous,leucovorin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Ibrutinib,G24:9:84DG17:,11/27/2015,,antineoplastic,9/9/2015,5/26/2015,Oral,ibrutinib,FALSE
177,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,12/23/2018,mg,antineoplastic,6/12/2018,3/18/2018,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/10/2018,mg,antineoplastic,5/13/2018,8/31/2015,Intravenous,nivolumab,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/9/2015,mg,antineoplastic,5/11/2015,1/29/2015,Intravenous,paclitaxel protein-bound,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,10/16/2015,mg,antineoplastic,8/21/2015,7/21/2015,Intravenous,paclitaxel protein-bound,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/17/2017,mg,antineoplastic,4/8/2015,3/26/2015,Intravenous,bevacizumab,TRUE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/13/2024,mg,antineoplastic,11/2/2024,9/28/2024,Intravenous,temsirolimus,FALSE
191.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/3/2018,mg,antineoplastic,5/17/2018,4/4/2018,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Nintedanib,G2848BE3831EF,12/21/2022,,antineoplastic,11/24/2022,12/13/2022,Oral,nintedanib,FALSE
860,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,4/12/2021,mg,antineoplastic,8/24/2019,9/3/2019,Intravenous,pemetrexed,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,12/21/2021,mg,antineoplastic,12/29/2021,10/10/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/14/2017,,solution-fluid,12/24/2016,2/29/2016,Intravenous,clinical study drug,FALSE
36,4,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/9/2019,mg/m2,antineoplastic,3/9/2019,3/24/2019,Intravenous,docetaxel,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,11/27/2015,mg,antineoplastic,9/4/2015,8/20/2015,Intravenous,paclitaxel,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/27/2013,mg,antineoplastic,4/17/2013,6/14/2012,Intravenous,pemetrexed,FALSE
630,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,4/1/2015,mg,antineoplastic,1/15/2015,12/7/2014,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,12/16/2016,mg/m2,antineoplastic,9/23/2016,3/10/2016,Intravenous,pemetrexed,TRUE
1500,,ADJUVANT,Orders,immunotherapy,Durvalumab,G147D:E6:68B1,10/4/2024,mg,antineoplastic,9/20/2024,7/30/2024,Intravenous,durvalumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/13/2022,,antineoplastic,3/20/2022,1/16/2022,Intravenous,paclitaxel,FALSE
268,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,5/24/2021,mg,antineoplastic,4/1/2021,10/17/2020,Intravenous,nivolumab,FALSE
142,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,12/22/2016,mg,antineoplastic,12/28/2016,11/26/2016,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18DFE96F9:2G,6/17/2024,mg,antineoplastic,5/26/2024,4/29/2024,Intravenous,pemetrexed,FALSE
163,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,4/11/2025,mg,antineoplastic,10/10/2024,9/28/2024,Intravenous,nivolumab,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/29/2025,mg,antineoplastic,5/10/2020,3/6/2019,Intravenous,pemetrexed,FALSE
1910,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,3/4/2025,mg,antineoplastic,2/6/2025,11/25/2024,Intravenous,gemcitabine,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/2/2022,mg,antineoplastic,9/28/2020,3/21/2020,Intravenous,pemetrexed,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1BGE419C:CE7,5/7/2025,mg,antineoplastic,1/21/2025,5/4/2024,Intravenous,durvalumab,TRUE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/5/2020,mg,antineoplastic,5/1/2019,2/11/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/2/2025,,antineoplastic,11/1/2024,3/8/2023,,clinical study drug,FALSE
1229,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/28/2015,mg,antineoplastic,10/6/2014,9/8/2014,Intravenous,bevacizumab,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G128:92:3BD3D,12/7/2021,,steroid,4/11/2021,4/30/2021,Intravenous,clinical study drug,FALSE
183,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/4/2023,mg,antineoplastic,4/28/2022,2/21/2022,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/30/2022,mg,antineoplastic,8/9/2019,4/24/2017,Intravenous,nivolumab,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/6/2019,mg,antineoplastic,4/5/2019,11/13/2018,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/11/2025,mg,antineoplastic,12/25/2024,3/17/2024,Intravenous,amivantamab-vmjw,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/26/2019,mg,antineoplastic,11/6/2019,10/4/2019,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/16/2020,mg,antineoplastic,9/28/2019,1/17/2019,Intravenous,pembrolizumab,FALSE
175,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,6/17/2020,mg,antineoplastic,4/26/2020,2/17/2020,Intravenous,paclitaxel,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/5/2020,mg,antineoplastic,12/10/2019,12/17/2018,Intravenous,pemetrexed,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,4/3/2023,mg,antineoplastic,4/17/2020,2/29/2020,Intravenous,docetaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/22/2022,mg,antineoplastic,10/23/2021,6/4/2021,Intravenous,pembrolizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,2/12/2016,mg/m2,antineoplastic,3/14/2016,7/3/2015,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G1542E4F46G4B,7/29/2021,,,7/6/2020,4/12/2020,Oral,osimertinib,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/14/2016,mg,antineoplastic,1/5/2016,11/28/2015,Intravenous,docetaxel,FALSE
5,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/29/2019,AUC,antineoplastic,2/18/2019,12/18/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/15/2014,mg/m2,antineoplastic,5/26/2014,3/15/2014,Intravenous,paclitaxel,FALSE
745,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:B8CFFD1931,3/8/2015,mg,antineoplastic,11/23/2014,9/2/2014,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G164G31958638,8/13/2024,mg,antineoplastic,10/1/2023,6/10/2023,Intravenous,pembrolizumab,TRUE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/17/2016,mg,antineoplastic,2/3/2015,10/3/2014,Intravenous,bevacizumab,TRUE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/26/2014,mg,antineoplastic,12/9/2013,11/14/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/26/2012,,antineoplastic,10/31/2011,8/3/2011,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,6/29/2017,mg,antineoplastic,12/3/2016,10/7/2016,Intravenous,nivolumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/10/2023,mg,antineoplastic,5/20/2023,5/11/2023,Subcutaneous,azacitidine,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G47DB481E783:,2/13/2025,mg,antineoplastic,11/17/2024,9/27/2024,Intravenous,nivolumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/2/2025,mg,antineoplastic,1/1/2017,11/29/2016,Intravenous,nivolumab,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/8/2025,mg,antineoplastic,7/24/2024,7/27/2024,Intravenous,durvalumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/15/2023,mL,solution-fluid,12/14/2022,12/10/2022,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/8/2024,mg,antineoplastic,8/4/2024,7/2/2024,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/28/2021,mg,antineoplastic,9/19/2021,8/3/2021,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,10/24/2024,,antineoplastic,9/28/2024,8/12/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Alectinib,G3BBG95F1669C,11/24/2021,,,12/8/2021,10/3/2021,Oral,alectinib,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/4/2019,mg,antineoplastic,5/15/2018,9/17/2017,Intravenous,atezolizumab,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,8/15/2018,mg,antineoplastic,11/10/2017,9/19/2017,Intravenous,atezolizumab,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/14/2019,mg,antineoplastic,2/22/2019,11/23/2018,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,5/31/2018,mL,solution-fluid,8/4/2015,6/29/2015,Intravenous,carboplatin,FALSE
428,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,4/17/2022,mg,antineoplastic,1/8/2022,12/8/2021,Intravenous,carboplatin,FALSE
1025,1,LOCOREGIONAL,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G13B9C4:GD648,9/11/2012,mg,antineoplastic,5/26/2012,3/24/2012,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Orders,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/19/2022,mg,antineoplastic,10/12/2019,5/16/2017,Intravenous,nivolumab,FALSE
375,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/30/2022,mg,antineoplastic,7/14/2022,4/6/2022,Intravenous,carboplatin,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/17/2016,mg,antineoplastic,8/1/2014,5/28/2014,Intravenous,pemetrexed,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,11/18/2024,mg,antineoplastic,10/4/2024,8/10/2024,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/19/2011,mg,antineoplastic,7/3/2011,4/5/2011,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G3B1F6B561ED5,4/11/2021,,hematological agent,11/12/2020,2/13/2020,Subcutaneous,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/16/2023,mg,antineoplastic,1/1/2023,4/17/2020,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,4/28/2024,,antineoplastic,3/20/2024,4/21/2024,,pembrolizumab,FALSE
1343,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G1B8EF2645E7F,4/5/2015,mg,antineoplastic,4/27/2015,4/20/2015,Intravenous,bevacizumab,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/19/2019,mg,antineoplastic,12/27/2018,12/21/2018,Intravenous,paclitaxel,FALSE
571,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/10/2020,mg,antineoplastic,4/4/2017,4/10/2017,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/7/2023,mg,antineoplastic,6/26/2023,4/30/2023,Subcutaneous,azacitidine,FALSE
245.7,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,6/2/2016,mg,antineoplastic,2/19/2016,12/25/2015,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/24/2025,mg,antineoplastic,11/27/2023,8/28/2022,Intravenous,pembrolizumab,TRUE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/16/2023,mg,antineoplastic,1/28/2021,12/2/2019,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,1/31/2025,mg,antineoplastic,7/6/2017,1/3/2017,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/19/2020,mg,antineoplastic,12/11/2015,11/4/2015,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/9/2025,mg,antineoplastic,7/28/2017,1/10/2017,Intravenous,pembrolizumab,FALSE
772,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,4/5/2023,mg,antineoplastic,11/5/2022,11/16/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,10/23/2019,mg,antineoplastic,10/16/2019,8/28/2019,Intravenous,pembrolizumab,FALSE
950,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G47DB481E783:,5/12/2025,mg,antineoplastic,3/26/2025,2/13/2025,Intravenous,pemetrexed,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/1/2015,mg,antineoplastic,3/8/2015,2/18/2015,Intravenous,pemetrexed,FALSE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,12/31/2023,mg,antineoplastic,10/21/2023,6/9/2023,Intravenous,nivolumab,FALSE
458,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/13/2015,mg,antineoplastic,1/9/2015,10/1/2014,Intravenous,carboplatin,FALSE
540,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,9/28/2018,mg,antineoplastic,3/17/2014,2/10/2014,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/23/2024,mg,antineoplastic,5/17/2024,6/7/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G22FG21G231E9,6/2/2023,,,6/27/2023,6/23/2022,Oral,osimertinib,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/12/2025,mg,antineoplastic,8/3/2020,1/29/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/20/2025,mg,antineoplastic,5/22/2024,8/31/2022,Intravenous,pembrolizumab,TRUE
245.7,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/23/2016,mg,antineoplastic,4/19/2016,12/12/2015,Intravenous,nivolumab,FALSE
204,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/7/2020,mg,antineoplastic,7/6/2017,4/9/2017,Intravenous,paclitaxel,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,4/23/2020,mg,antineoplastic,3/13/2020,12/29/2019,Intravenous,paclitaxel,FALSE
610,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,8/8/2014,mg,antineoplastic,7/22/2013,6/12/2013,Intravenous,carboplatin,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/8/2019,mg,antineoplastic,7/1/2019,2/3/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,9/6/2024,mg,antineoplastic,8/15/2024,6/21/2024,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/12/2024,,antineoplastic,11/5/2023,12/4/2023,,pemetrexed,FALSE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,11/6/2015,mg,antineoplastic,3/16/2015,2/25/2015,Intravenous,paclitaxel,FALSE
500,,CONCURRENT,Administrations,cytoprotective,"Amifostine,Vinorelbine",G58E8F29:9:45,4/1/2012,mg,antineoplastic,2/17/2012,1/4/2012,Subcutaneous,amifostine,FALSE
542,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/14/2021,mg,antineoplastic,9/26/2021,7/11/2021,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,4/4/2025,mg,antineoplastic,11/9/2022,9/27/2022,Oral,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21881333DGG2,5/4/2021,mg,antineoplastic,9/23/2020,9/27/2020,Intravenous,pembrolizumab,TRUE
22.5,,ADJUVANT,Administrations,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/10/2025,mg,antineoplastic,9/17/2024,4/6/2024,Intramuscular,leuprolide,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/2/2019,mg/m2,antineoplastic,11/26/2018,11/6/2018,Intravenous,gemcitabine,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/25/2015,mg,antineoplastic,2/12/2015,8/31/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,8/2/2017,,antineoplastic,3/6/2017,11/24/2016,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G17BG4264193F,3/12/2025,mg,antineoplastic,5/22/2020,3/8/2020,Intravenous,pembrolizumab,FALSE
225,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,5/28/2013,mg,antineoplastic,11/15/2012,7/27/2012,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/17/2014,mL,solution-fluid,12/24/2013,11/5/2013,Intravenous,cisplatin,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,12/9/2019,mg,antineoplastic,8/2/2019,3/31/2019,Intravenous,ramucirumab,FALSE
,,ADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G128:92:3BD3D,11/17/2021,,steroid,5/7/2021,5/4/2021,Intravenous,clinical study drug,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/13/2019,mg,antineoplastic,7/18/2019,8/28/2017,Oral,anastrozole,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,2/8/2025,AUC,antineoplastic,11/11/2024,10/23/2024,Intravenous,carboplatin,FALSE
775,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3G18F3E9E3C8,4/20/2025,mg,antineoplastic,1/24/2025,2/18/2025,Intravenous,pemetrexed,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/23/2018,mg,antineoplastic,7/6/2018,5/8/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2:5874817G9C,7/17/2024,mg,antineoplastic,6/23/2024,5/28/2024,Intravenous,pembrolizumab,TRUE
396,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,1/27/2023,mg,antineoplastic,1/2/2023,10/25/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,4/15/2019,mg,antineoplastic,12/30/2018,9/16/2018,Intravenous,pembrolizumab,TRUE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,12/31/2019,mg,antineoplastic,10/2/2019,2/13/2019,Intravenous,durvalumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,9/28/2023,mg,antineoplastic,7/21/2023,5/16/2023,Subcutaneous,azacitidine,FALSE
521,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,12/12/2024,mg,antineoplastic,10/20/2024,7/28/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,8/8/2023,,antineoplastic,4/6/2023,4/13/2023,,anastrozole,FALSE
950,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,12/9/2018,mg,antineoplastic,11/10/2018,9/7/2018,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/28/2024,mg,antineoplastic,8/28/2023,5/20/2023,Intravenous,pembrolizumab,FALSE
915,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,9/4/2019,mg,antineoplastic,5/18/2019,5/10/2019,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G14G5B9C531F6,1/24/2018,mg,antineoplastic,8/31/2017,7/3/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G3GB6D5C:448G,3/28/2018,,antineoplastic,12/19/2017,6/23/2017,Intravenous,clinical study drug,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/21/2012,mg,antineoplastic,4/18/2012,2/17/2012,Intravenous,docetaxel,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,4/2/2012,,antineoplastic,10/16/2011,6/16/2011,Intravenous,clinical study drug,FALSE
108,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/13/2017,mg,antineoplastic,6/26/2016,6/24/2016,Intravenous,paclitaxel,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/27/2020,mg,antineoplastic,5/26/2020,1/29/2020,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G24C:63G27686,1/31/2014,,antineoplastic,11/19/2013,11/23/2013,,clinical study drug,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/11/2025,mg,antineoplastic,3/20/2024,3/1/2023,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/4/2013,mg/m2,antineoplastic,9/30/2013,9/1/2013,Intravenous,etoposide,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/18/2018,mg,antineoplastic,6/25/2018,7/2/2018,Intravenous,paclitaxel protein-bound,FALSE
870,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/5/2023,mg,antineoplastic,12/3/2022,11/14/2022,Intravenous,pemetrexed,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/30/2024,mg,antineoplastic,10/25/2023,10/1/2023,Intravenous,nivolumab,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/6/2024,mg,antineoplastic,9/14/2024,10/17/2023,Intravenous,durvalumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/19/2024,mg,antineoplastic,6/8/2024,6/15/2024,Intravenous,carboplatin,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/25/2013,mg,antineoplastic,4/12/2012,4/4/2012,Intravenous,pemetrexed,FALSE
2,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/13/2021,AUC,antineoplastic,5/11/2021,3/6/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,6/13/2019,mg,antineoplastic,11/30/2018,12/5/2018,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Unstructured,,"Osimertinib,Trametinib",G31C:9::5EG5D,7/6/2024,,,7/6/2024,5/31/2024,Oral,trametinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,3/28/2025,mg,antineoplastic,5/17/2023,8/3/2022,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Unstructured,,Osimertinib,G4C:6:784E1GF,2/16/2018,,,10/22/2017,9/5/2017,Oral,osimertinib,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2177D1::DG1E,11/18/2011,mg,antineoplastic,9/30/2011,7/23/2011,Intravenous,pemetrexed,FALSE
1400,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1665E:E6:E1:,12/6/2013,mg,antineoplastic,2/14/2013,3/3/2013,Intravenous,gemcitabine,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,7/17/2020,mg,antineoplastic,3/21/2020,2/13/2020,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,10/25/2020,mg,antineoplastic,11/12/2019,8/27/2019,Intravenous,durvalumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/15/2017,,solution-fluid,2/8/2017,3/7/2016,Intravenous,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/25/2023,mg,antineoplastic,12/31/2022,8/22/2022,Intravenous,pembrolizumab,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/17/2021,mg,antineoplastic,4/14/2021,5/10/2020,Intravenous,gemcitabine,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/1/2025,mg,antineoplastic,4/26/2024,10/5/2022,Intravenous,pemetrexed,TRUE
975,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G56B4BCB27428,2/10/2012,mg,antineoplastic,2/19/2012,1/19/2012,Intravenous,pemetrexed,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/23/2024,mg,antineoplastic,5/17/2024,6/1/2024,Intravenous,nivolumab,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,10/31/2014,mg,antineoplastic,8/17/2014,5/29/2014,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,3/4/2019,mg,antineoplastic,6/13/2018,7/20/2018,Intravenous,pembrolizumab,FALSE
1137.5,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/26/2015,mg,antineoplastic,1/9/2015,9/16/2014,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,1/7/2025,mg/m2,antineoplastic,10/25/2024,7/19/2024,Intravenous,gemcitabine,FALSE
1095,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,4/14/2025,mg,antineoplastic,3/29/2025,4/7/2025,Intravenous,pemetrexed,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/22/2015,mg,antineoplastic,6/25/2015,3/11/2015,Intravenous,paclitaxel protein-bound,FALSE
695,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/2/2023,mg,antineoplastic,10/14/2022,7/23/2022,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G2C4G1G76816F,3/29/2025,,steroid,11/9/2017,10/15/2017,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,10/7/2020,mg,antineoplastic,8/28/2020,8/3/2020,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D5BG82C889G,6/20/2021,mg,antineoplastic,6/14/2021,4/30/2021,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/16/2016,mg,antineoplastic,7/18/2015,4/20/2015,Intravenous,nivolumab,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,9/28/2013,mg,antineoplastic,7/18/2013,6/24/2013,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Unstructured,,Afatinib,G3::1:B4F:3D4,2/18/2016,,,3/19/2016,12/9/2015,Oral,afatinib,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/11/2025,mg,antineoplastic,7/16/2024,7/14/2024,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/28/2023,mg,antineoplastic,7/29/2023,3/29/2023,Subcutaneous,azacitidine,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1F482136BDE5,9/12/2024,,antineoplastic,7/28/2024,6/12/2024,Oral,anastrozole,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/17/2023,mg,antineoplastic,6/23/2020,5/10/2020,Intravenous,pemetrexed,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/28/2013,mg,antineoplastic,2/23/2013,9/23/2012,Intravenous,gemcitabine,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,4/4/2021,mg,antineoplastic,4/5/2021,10/1/2020,Intravenous,nivolumab,FALSE
66,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,6/5/2015,mg,antineoplastic,4/2/2015,3/7/2015,Intravenous,cisplatin,FALSE
91,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,12/16/2017,mg,antineoplastic,9/27/2017,8/18/2017,Intravenous,paclitaxel,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/3/2014,mg/kg,antineoplastic,12/30/2013,11/8/2013,Intravenous,bevacizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2F23BB58DF:9,4/12/2015,mg,antineoplastic,3/28/2015,4/18/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3E76E32E795:,4/4/2020,mg,antineoplastic,12/18/2019,12/18/2019,Intravenous,pembrolizumab,TRUE
640,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/19/2017,mg,antineoplastic,10/27/2016,10/29/2016,Intravenous,bevacizumab,FALSE
93,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,2/13/2014,mg,antineoplastic,2/19/2014,12/17/2013,Intravenous,paclitaxel,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,12/5/2017,mg,antineoplastic,6/14/2017,5/17/2017,Intravenous,gemcitabine,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/21/2015,mg,antineoplastic,2/25/2015,2/4/2015,Intravenous,carboplatin,FALSE
170,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B11153DEF52,7/21/2021,mg,antineoplastic,6/19/2021,6/24/2021,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/11/2025,mg,antineoplastic,5/17/2024,3/29/2024,Intravenous,pembrolizumab,TRUE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/30/2017,mL,solution-fluid,8/17/2017,8/14/2017,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/3/2022,mg,antineoplastic,11/3/2020,5/24/2017,Intravenous,nivolumab,FALSE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/10/2015,mg,antineoplastic,3/24/2015,3/30/2015,Intravenous,gemcitabine,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/29/2017,mg,antineoplastic,10/16/2017,9/9/2017,Intravenous,paclitaxel,FALSE
54,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,4/29/2025,mg,antineoplastic,1/29/2025,11/27/2024,Intravenous,ipilimumab,FALSE
787,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,10/12/2020,mg,antineoplastic,9/20/2020,7/19/2020,Intravenous,carboplatin,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG9D112D:6F,7/23/2017,mg,antineoplastic,7/29/2017,5/16/2017,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4EF93:EF39:7,5/14/2021,mg/m2,antineoplastic,4/10/2021,4/20/2021,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,6/9/2022,,antineoplastic,6/30/2022,7/22/2022,Oral,anastrozole,FALSE
636,,ADJUVANT,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/23/2025,mg,antineoplastic,1/6/2025,11/15/2024,Intravenous,leucovorin,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/3/2018,mg/m2,antineoplastic,10/22/2018,8/9/2018,Intravenous,pemetrexed,TRUE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,11/5/2024,mg,antineoplastic,9/23/2024,8/17/2024,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/5/2017,mg,antineoplastic,7/23/2017,6/27/2017,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,1/9/2024,mg,antineoplastic,1/4/2024,11/9/2023,Oral,anastrozole,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/3/2024,mL,solution-fluid,2/26/2024,12/27/2023,Intravenous,cisplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,5/1/2025,mg,antineoplastic,3/19/2025,9/19/2024,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/18/2019,mg,antineoplastic,12/18/2018,2/23/2018,Intravenous,nivolumab,FALSE
63.9,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/12/2021,mg,antineoplastic,4/19/2021,11/17/2020,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/12/2020,mg,antineoplastic,3/30/2020,2/25/2020,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/21/2013,mg/m2,antineoplastic,12/22/2012,10/13/2012,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G58FCD4G:G6DF,8/30/2018,mg,antineoplastic,5/8/2018,3/17/2018,Intravenous,nivolumab,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,5/17/2019,mg/m2,antineoplastic,9/18/2017,7/23/2017,Intravenous,docetaxel,FALSE
362,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,2/18/2014,mg,antineoplastic,1/4/2014,11/19/2013,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/11/2025,mg,antineoplastic,4/1/2024,9/1/2022,Oral,anastrozole,FALSE
,2,ADVANCED,Unstructured,,"Pemetrexed,Sotorasib",G2C38B34G8794,2/1/2023,,,3/13/2023,9/22/2022,Oral,sotorasib,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/25/2025,,antineoplastic,8/5/2021,5/8/2020,Oral,enzalutamide,FALSE
197,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,9/13/2019,mg,antineoplastic,6/22/2019,6/16/2019,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/26/2013,,antineoplastic,2/15/2013,3/15/2013,Intravenous,cisplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/19/2023,,antineoplastic,8/10/2023,11/14/2022,,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,2/18/2023,mg,antineoplastic,1/25/2023,4/17/2022,Intravenous,atezolizumab,FALSE
650.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,5/2/2017,mg,antineoplastic,1/14/2017,12/25/2016,Intravenous,carboplatin,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/15/2016,mg,antineoplastic,6/6/2016,10/6/2014,Intravenous,pemetrexed,TRUE
,3,ADVANCED,Unstructured,,Erlotinib,G166B735:96D2,8/3/2013,,,9/5/2013,8/6/2013,Oral,erlotinib,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,11/10/2018,mg,antineoplastic,11/17/2018,6/19/2018,Intravenous,carboplatin,FALSE
67.5,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,9/10/2024,mg,antineoplastic,9/21/2024,7/26/2024,Intravenous,cisplatin,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/17/2014,mg,antineoplastic,11/19/2014,5/17/2014,Intravenous,vinorelbine,FALSE
490,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,9/13/2024,mg,antineoplastic,8/21/2024,6/29/2024,Intravenous,carboplatin,FALSE
330,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,12/15/2023,mg,antineoplastic,10/22/2023,9/8/2023,Intravenous,carboplatin,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/20/2021,mg,antineoplastic,7/22/2021,6/22/2021,Intravenous,paclitaxel,FALSE
658,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,5/4/2024,mg,antineoplastic,2/26/2024,12/13/2023,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/22/2016,AUC,antineoplastic,11/19/2014,5/27/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/21/2018,mg,antineoplastic,8/27/2017,3/29/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1C3CCC:C44GD,7/22/2022,mg,antineoplastic,12/3/2021,10/12/2021,Intravenous,pembrolizumab,TRUE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,1/7/2024,mg,antineoplastic,7/11/2022,11/16/2021,Intravenous,durvalumab,FALSE
689,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,9/12/2015,mg,antineoplastic,4/27/2015,4/15/2015,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/11/2019,mg,antineoplastic,2/9/2018,3/10/2016,Intravenous,nivolumab,FALSE
235.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/28/2023,mg,antineoplastic,6/3/2023,5/8/2023,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,8/30/2022,mg,antineoplastic,7/8/2022,6/25/2022,Intravenous,pemetrexed,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/5/2025,mg,antineoplastic,12/10/2022,1/29/2020,Intravenous,pemetrexed,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,4/7/2021,AUC,antineoplastic,11/23/2019,9/29/2019,Intravenous,carboplatin,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,8/19/2014,mg,antineoplastic,7/2/2014,4/29/2014,Intravenous,carboplatin,FALSE
634,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,3/23/2021,mg,antineoplastic,3/12/2021,1/28/2021,Intravenous,pemetrexed,FALSE
296,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/9/2019,mg,antineoplastic,6/21/2019,7/19/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,3/23/2015,,solution-fluid,8/21/2014,9/1/2014,Intravenous,clinical study drug,FALSE
45,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,12/28/2013,mg,antineoplastic,12/19/2013,9/19/2013,Intravenous,vinorelbine,FALSE
130,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/21/2013,mg,antineoplastic,12/7/2011,12/7/2011,Intravenous,etoposide,FALSE
98,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide,Pemetrexed",G2799FBE7D4B8,6/23/2015,mg,antineoplastic,7/7/2015,6/5/2015,Intravenous,etoposide,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/31/2025,mg,antineoplastic,2/23/2019,3/17/2018,Intravenous,nivolumab,FALSE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,3/10/2025,mg,antineoplastic,8/1/2024,4/18/2024,Intravenous,durvalumab,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/26/2024,mg,antineoplastic,3/13/2024,9/17/2023,Intravenous,amivantamab-vmjw,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/25/2016,mg,antineoplastic,2/26/2016,12/2/2015,Intravenous,paclitaxel,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/7/2016,mg,antineoplastic,9/6/2015,5/8/2015,Intravenous,gemcitabine,FALSE
885,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,8/14/2022,mg,antineoplastic,6/9/2022,6/25/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/1/2024,mg,antineoplastic,6/16/2023,6/28/2023,Intravenous,pembrolizumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,7/7/2022,mg,antineoplastic,5/20/2022,5/2/2022,Intravenous,paclitaxel,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/28/2023,mg,antineoplastic,9/11/2023,8/20/2022,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Unstructured,,Erlotinib,G3::1:B4F:3D4,8/16/2015,,,6/9/2014,5/6/2014,Oral,erlotinib,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/22/2022,mg,antineoplastic,4/8/2022,12/31/2017,Intravenous,pembrolizumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/2/2017,mg,antineoplastic,11/13/2016,10/1/2016,Intravenous,paclitaxel protein-bound,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/10/2018,mg,antineoplastic,1/25/2018,11/23/2017,Oral,anastrozole,FALSE
600,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/9/2024,mg,antineoplastic,4/9/2024,7/8/2023,Intravenous,pemetrexed,FALSE
78,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/16/2024,mg,antineoplastic,8/6/2024,4/20/2024,Intravenous,ipilimumab,FALSE
,4,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,5/27/2023,,antineoplastic,3/23/2023,2/7/2023,Intravenous,pemetrexed,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,10/15/2012,mg,antineoplastic,7/24/2012,5/7/2012,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/7/2023,,antineoplastic,3/27/2023,12/23/2022,,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/10/2017,,antineoplastic,9/20/2017,8/12/2017,,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/30/2020,mg,antineoplastic,9/22/2020,8/29/2019,Intravenous,pembrolizumab,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,3/22/2025,mg,antineoplastic,8/24/2024,3/31/2024,Intravenous,pembrolizumab,FALSE
366,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/8/2016,mg,antineoplastic,8/7/2016,5/20/2016,Intravenous,paclitaxel,FALSE
1137,,ADJUVANT,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,6/25/2023,mg,antineoplastic,5/31/2023,4/6/2023,Intravenous,bevacizumab-bvzr,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,7/22/2012,mg,antineoplastic,7/6/2012,2/12/2012,Intravenous,paclitaxel protein-bound,FALSE
295,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Capecitabine",G5724:G6:4ED5,4/21/2025,mg,antineoplastic,3/27/2025,2/6/2025,Intravenous,bevacizumab-bvzr,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/7/2025,mg,antineoplastic,12/2/2017,2/3/2017,Intravenous,pembrolizumab,FALSE
771,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,11/6/2013,mg,antineoplastic,10/22/2013,8/4/2013,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/12/2025,,antineoplastic,10/3/2023,2/21/2023,,clinical study drug,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/13/2013,mg,antineoplastic,6/23/2013,7/19/2013,Intravenous,etoposide,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/20/2019,mg,antineoplastic,3/8/2019,3/17/2019,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G2D2EC6C91F3C,8/23/2018,,,7/21/2018,3/28/2018,Oral,erlotinib,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G22C39:D1E249,3/2/2025,,antineoplastic,5/23/2024,4/20/2024,Intravenous,carboplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/28/2019,mg/kg,antineoplastic,6/25/2019,8/28/2018,Intravenous,durvalumab,FALSE
710,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/22/2024,mg,antineoplastic,3/1/2023,1/27/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,2/19/2025,mg,antineoplastic,6/23/2018,4/8/2018,Intravenous,pembrolizumab,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/25/2024,mL,solution-fluid,1/13/2024,10/22/2023,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/15/2015,mg,antineoplastic,3/19/2015,2/21/2015,Intravenous,paclitaxel protein-bound,FALSE
620,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/8/2022,mg,antineoplastic,9/10/2021,9/4/2021,Intravenous,carboplatin,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,5/25/2025,mg,antineoplastic,12/12/2022,9/28/2022,Intravenous,pemetrexed,TRUE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,11/3/2018,mg,antineoplastic,6/30/2018,6/11/2018,Intravenous,etoposide,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/1/2020,mg,antineoplastic,6/17/2019,2/24/2019,Intravenous,nivolumab,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/1/2022,mg,antineoplastic,2/19/2022,1/31/2022,Intravenous,paclitaxel,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,4/27/2018,mg,antineoplastic,9/26/2014,8/14/2014,Intravenous,paclitaxel,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2D3FB2DD2C:1,8/6/2014,mg/m2,antineoplastic,7/16/2014,8/18/2014,Intravenous,cisplatin,FALSE
104,3,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G332GBGFG7416,5/8/2021,mg,antineoplastic,12/3/2020,1/3/2021,Intravenous,cisplatin,FALSE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,1/22/2025,mg,antineoplastic,8/22/2024,5/22/2024,Intravenous,durvalumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,11/8/2022,mg,antineoplastic,11/29/2021,10/8/2021,Intravenous,durvalumab,TRUE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,4/25/2024,,antineoplastic,6/15/2023,5/9/2023,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/2/2021,,antineoplastic,3/29/2020,1/19/2020,Intravenous,clinical study drug,FALSE
513,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/6/2019,mg,antineoplastic,3/12/2019,1/18/2019,Intravenous,carboplatin,FALSE
75,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G225D72BD2FD7,7/22/2017,mg/m2,antineoplastic,5/28/2017,4/26/2017,Intravenous,cisplatin,FALSE
768,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,10/29/2021,mg,antineoplastic,8/20/2021,8/12/2021,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,9/22/2020,mg,antineoplastic,3/16/2020,9/12/2019,Intravenous,pembrolizumab,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/19/2021,mg,antineoplastic,9/25/2021,9/7/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/13/2022,mg,antineoplastic,4/26/2022,7/28/2020,Intravenous,pembrolizumab,TRUE
166,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/4/2024,mg,antineoplastic,1/18/2024,10/23/2023,Intravenous,carboplatin,FALSE
234.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,9/8/2017,mg,antineoplastic,8/16/2017,9/21/2017,Intravenous,carboplatin,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/10/2012,mg,antineoplastic,10/1/2012,4/25/2012,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G118F63B281FD,5/8/2011,,antineoplastic,5/11/2011,6/9/2011,,clinical study drug,FALSE
494,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,1/11/2016,mg,antineoplastic,9/18/2015,11/6/2015,Intravenous,carboplatin,FALSE
695,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/16/2023,mg,antineoplastic,8/18/2022,7/31/2022,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/6/2025,,antineoplastic,3/8/2023,2/16/2023,,clinical study drug,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4F354B:F341F,7/16/2017,,antineoplastic,9/27/2016,8/30/2016,Intravenous,nivolumab,FALSE
310,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/1/2012,mg,antineoplastic,8/12/2012,5/19/2012,Intravenous,paclitaxel,FALSE
285,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/26/2013,mg,antineoplastic,1/29/2013,8/8/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G172GFE717:24,4/16/2020,mg,antineoplastic,3/19/2020,2/11/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,6/24/2015,mg,antineoplastic,9/20/2014,10/13/2014,Intravenous,paclitaxel protein-bound,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,,antineoplastic,8/24/2019,3/30/2017,Oral,nilotinib,FALSE
75,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/9/2025,mg,antineoplastic,1/3/2016,1/1/2016,Intravenous,paclitaxel,FALSE
300,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G259:1C2D4D19,3/13/2013,mg,antineoplastic,2/11/2013,1/16/2013,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,1/6/2024,mg,antineoplastic,1/19/2024,12/11/2023,Oral,anastrozole,FALSE
360,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/19/2016,mg,antineoplastic,6/8/2016,6/14/2016,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/17/2022,mg,antineoplastic,3/5/2022,5/8/2017,Intravenous,nivolumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/3/2011,mg,antineoplastic,5/26/2011,5/22/2011,Intravenous,etoposide,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,11/28/2018,mg/m2,antineoplastic,8/25/2018,6/28/2018,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/11/2020,mg,antineoplastic,6/28/2018,1/6/2018,Intravenous,pembrolizumab,TRUE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/4/2023,mg,antineoplastic,2/12/2018,12/2/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/15/2021,mg,antineoplastic,5/8/2021,3/13/2021,Intravenous,pembrolizumab,FALSE
120,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G24C:63G27686,2/25/2014,mg,antineoplastic,3/7/2014,2/12/2014,Intravenous,paclitaxel protein-bound,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,1/3/2024,mg,antineoplastic,3/23/2023,1/27/2023,Intravenous,doxorubicin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/13/2025,mg,antineoplastic,3/24/2022,2/1/2017,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/6/2025,mL,solution-fluid,6/28/2024,4/6/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,12/28/2019,mg,antineoplastic,1/9/2020,10/12/2019,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/21/2020,,antineoplastic,11/15/2019,2/24/2019,Subcutaneous,bortezomib,FALSE
163.2,6,ADVANCED,Administrations,immunotherapy,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,11/19/2016,mg,antineoplastic,9/16/2016,10/9/2016,Intravenous,pembrolizumab,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,8/29/2022,mg,antineoplastic,7/18/2022,6/19/2022,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/18/2025,mg,antineoplastic,10/25/2020,2/10/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/2/2020,mg,antineoplastic,10/23/2019,6/20/2019,Intravenous,pembrolizumab,TRUE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21G114D2C:9D,10/16/2014,mg,antineoplastic,8/19/2014,9/17/2014,Intravenous,paclitaxel,FALSE
1320,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G46:87GF7FGC9,8/18/2015,mg,antineoplastic,6/2/2015,4/26/2015,Intravenous,bevacizumab,TRUE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/28/2012,mg,antineoplastic,3/6/2012,3/15/2012,Intravenous,docetaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/17/2022,,antineoplastic,3/7/2022,3/13/2022,,nivolumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,2/1/2019,mg,antineoplastic,2/21/2018,4/22/2017,Intravenous,pemetrexed,TRUE
60,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1B59D86EEB5E,6/26/2018,mg,antineoplastic,5/23/2018,5/23/2018,Intravenous,cisplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/19/2019,mg,antineoplastic,4/10/2018,9/8/2017,Oral,anastrozole,FALSE
,1,ADVANCED,Administrations,targeted/biologic,Clinical Study Drug,G1:78734BCEDB,8/19/2014,,antineoplastic,5/13/2014,3/29/2014,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/6/2023,mg,antineoplastic,1/20/2023,11/9/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/2/2025,mg,antineoplastic,2/20/2025,4/25/2024,Intravenous,pembrolizumab,TRUE
212.8,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/9/2012,mg,antineoplastic,3/16/2012,4/12/2012,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/1/2015,,antineoplastic,3/14/2015,3/10/2015,,pemetrexed,FALSE
,4,ADVANCED,Unstructured,,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,3/26/2022,,,12/30/2021,12/20/2021,Oral,osimertinib,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/17/2019,mg,antineoplastic,3/7/2019,11/21/2016,Intramuscular,fulvestrant,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,11/29/2014,mg,antineoplastic,5/19/2014,3/10/2014,Intravenous,paclitaxel,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,7/16/2015,mg,antineoplastic,8/13/2013,7/20/2013,Intravenous,paclitaxel,FALSE
620,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,2/21/2022,mg,antineoplastic,10/28/2021,10/4/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/20/2025,mg,antineoplastic,4/17/2022,2/6/2019,Intravenous,pembrolizumab,TRUE
97.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G135BB2F5GCDF,6/20/2018,mg,antineoplastic,2/17/2018,3/6/2018,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G49E3CE9E292G,4/25/2020,mg,antineoplastic,11/5/2019,11/21/2019,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/5/2020,,antineoplastic,8/1/2019,1/13/2019,Subcutaneous,bortezomib,FALSE
137,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G38E7C386CF5C,5/19/2019,mg,antineoplastic,4/22/2019,1/31/2019,Intravenous,paclitaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G21:2B8189648,6/7/2019,mg,antineoplastic,5/12/2019,5/13/2019,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,1/27/2015,mg,antineoplastic,11/6/2014,9/20/2014,Intravenous,pemetrexed,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/30/2015,mg,antineoplastic,4/19/2015,1/29/2015,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B63:1C9D452,7/23/2016,,antineoplastic,2/5/2016,12/23/2015,Intravenous,carboplatin,FALSE
119,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/26/2020,mg,antineoplastic,5/14/2020,2/14/2020,Intravenous,docetaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,1/22/2025,mg,antineoplastic,4/27/2024,3/24/2024,Intravenous,carboplatin,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/9/2018,mg,antineoplastic,11/14/2015,10/5/2015,Intravenous,nivolumab,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/25/2025,mg,antineoplastic,3/22/2025,10/17/2024,Intravenous,durvalumab,FALSE
539,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1D14:53C99:F,4/18/2023,mg,antineoplastic,2/22/2023,3/1/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4C3G28CF33,1/30/2022,mg,antineoplastic,10/21/2021,12/7/2021,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,5/5/2022,mg,antineoplastic,5/25/2022,11/23/2021,Intravenous,pemetrexed,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,8/24/2019,mg,antineoplastic,8/11/2019,1/26/2019,Intravenous,pemetrexed,TRUE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/30/2016,mg,antineoplastic,4/5/2016,3/23/2016,Intravenous,etoposide,FALSE
1000,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,12/27/2021,mg,antineoplastic,12/3/2021,3/9/2021,Intravenous,bevacizumab-awwb,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,1/22/2015,mg,antineoplastic,11/9/2014,10/14/2014,Intravenous,docetaxel,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G15517:BF5DE4,7/25/2023,mg,antineoplastic,1/7/2023,12/19/2022,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/17/2020,,antineoplastic,7/27/2019,1/9/2019,Subcutaneous,bortezomib,FALSE
760,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/29/2013,mg,antineoplastic,7/8/2012,6/14/2012,Intravenous,pemetrexed,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,12/14/2021,mg,antineoplastic,7/5/2021,4/19/2021,Intravenous,vinorelbine,FALSE
590,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,5/21/2021,mg,antineoplastic,3/15/2021,5/3/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/26/2019,mg,antineoplastic,5/29/2019,4/26/2019,Intravenous,pembrolizumab,FALSE
5,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,2/1/2022,mg/kg,antineoplastic,11/27/2021,10/9/2021,Intravenous,bevacizumab-awwb,FALSE
89.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/21/2024,mg,antineoplastic,10/24/2023,8/24/2023,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/18/2022,mg,antineoplastic,2/3/2018,2/8/2016,Intravenous,pemetrexed,FALSE
1310,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,3/11/2015,mg,antineoplastic,3/1/2015,10/28/2014,Intravenous,gemcitabine,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,3/8/2023,mg,antineoplastic,8/12/2022,8/20/2022,Intravenous,durvalumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/4/2024,mg,antineoplastic,7/27/2024,6/9/2024,Intravenous,pembrolizumab,FALSE
72,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,1/24/2024,mg,antineoplastic,11/8/2023,11/10/2023,Intravenous,paclitaxel,FALSE
570,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/11/2024,mg,antineoplastic,12/31/2023,10/15/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/30/2015,,antineoplastic,3/20/2015,2/23/2015,,pemetrexed,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/2/2023,mg,antineoplastic,3/15/2023,8/25/2022,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/17/2021,mg,antineoplastic,8/7/2019,11/8/2018,Intravenous,pembrolizumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,5/31/2016,mg,antineoplastic,9/3/2014,9/25/2014,Intravenous,etoposide,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,12/13/2011,mg,antineoplastic,8/18/2011,8/30/2011,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,7/29/2015,mg,antineoplastic,11/29/2014,9/8/2014,Intravenous,paclitaxel protein-bound,FALSE
84.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,5/10/2018,mg,antineoplastic,9/18/2014,8/24/2014,Intravenous,paclitaxel,FALSE
630,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G11F2659368B9,12/24/2023,mg,antineoplastic,12/4/2023,8/30/2023,Intravenous,carboplatin,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/7/2019,mg,antineoplastic,7/27/2019,7/8/2019,Intravenous,pemetrexed,FALSE
1281,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/19/2015,mg,antineoplastic,12/4/2014,11/4/2014,Intravenous,bevacizumab,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/9/2017,mg/m2,antineoplastic,7/15/2017,6/16/2017,Intravenous,pemetrexed,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/16/2025,mg,antineoplastic,1/21/2024,1/31/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1E71G:B6G198,3/14/2025,,,8/16/2024,8/16/2024,Oral,osimertinib,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,5/5/2014,mg,antineoplastic,4/5/2014,3/26/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/3/2023,,antineoplastic,9/2/2023,12/27/2022,,pemetrexed,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/21/2025,mg,antineoplastic,7/20/2023,10/12/2022,Intravenous,pemetrexed,TRUE
,,NEOADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G3B698C119:F8,7/6/2012,,antineoplastic,5/19/2012,6/2/2012,Intravenous,clinical study drug,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,8/18/2019,mg,antineoplastic,6/18/2019,5/11/2019,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/26/2018,mg,antineoplastic,12/19/2017,10/24/2017,Intravenous,pemetrexed,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/22/2022,mg,antineoplastic,10/8/2021,2/17/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/1/2023,mg,antineoplastic,9/1/2023,2/10/2022,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/24/2025,,antineoplastic,11/15/2024,11/14/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,4/29/2024,,antineoplastic,5/5/2023,6/18/2023,Intravenous,clinical study drug,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,6/2/2013,mg/m2,antineoplastic,8/2/2012,7/13/2012,Intravenous,docetaxel,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,5/9/2023,mg,antineoplastic,3/10/2023,3/6/2023,Intravenous,gemcitabine,FALSE
124,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G15DCCD:D9154,8/2/2023,mg,antineoplastic,6/24/2023,6/16/2023,Intravenous,cisplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/22/2025,mg,antineoplastic,8/25/2024,3/10/2024,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/4/2022,,antineoplastic,5/10/2020,5/11/2017,Oral,nilotinib,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Docetaxel",G3D59288727DB,4/16/2019,mL,solution-fluid,1/31/2019,2/7/2019,Intravenous,docetaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/8/2019,mg,antineoplastic,1/22/2019,6/5/2018,Intravenous,nivolumab,FALSE
174,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/4/2019,mg,antineoplastic,2/22/2018,4/8/2018,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,1/2/2017,mg,antineoplastic,7/2/2015,12/21/2014,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,10/1/2017,mg,antineoplastic,11/29/2016,9/7/2016,Intravenous,nivolumab,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/15/2018,mg,antineoplastic,6/27/2018,5/20/2018,Intravenous,etoposide,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,4/22/2025,mg,antineoplastic,5/22/2022,2/5/2022,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/9/2023,,antineoplastic,4/23/2023,1/14/2023,,clinical study drug,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/12/2024,,antineoplastic,11/8/2023,11/23/2023,,pemetrexed,FALSE
45,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,7/31/2015,mg/m2,antineoplastic,6/8/2015,7/8/2015,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/24/2025,mg,antineoplastic,2/19/2024,1/12/2024,Intravenous,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G157317FG3387,9/21/2024,mg,antineoplastic,7/10/2024,6/16/2024,Intravenous,durvalumab,TRUE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/25/2017,mg,antineoplastic,6/10/2015,3/11/2015,Intravenous,bevacizumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/27/2024,mg,antineoplastic,6/14/2023,3/26/2022,Intravenous,durvalumab,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/6/2022,mg,antineoplastic,9/5/2019,4/23/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,4/27/2025,mg,antineoplastic,6/23/2024,9/15/2022,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,2/10/2024,mg,antineoplastic,10/17/2023,2/22/2023,Intravenous,atezolizumab,TRUE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/9/2015,mL,solution-fluid,3/20/2015,2/1/2015,Intravenous,pemetrexed,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/1/2024,mg,antineoplastic,10/14/2020,7/7/2020,Intravenous,ipilimumab,FALSE
360,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,10/9/2023,mg,antineoplastic,8/21/2023,5/12/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G45B53B:15E3F,8/26/2018,mg,antineoplastic,8/23/2018,3/10/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21953622CB66,7/22/2019,mg,antineoplastic,2/19/2019,2/26/2019,Intravenous,pembrolizumab,FALSE
77,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,3/25/2019,mg,antineoplastic,3/27/2019,3/28/2019,Intravenous,paclitaxel,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/22/2025,mg,antineoplastic,7/2/2024,3/18/2024,Intravenous,durvalumab,TRUE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/3/2023,mL,solution-fluid,1/4/2023,12/11/2022,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/16/2025,,antineoplastic,11/24/2024,11/24/2024,Intravenous,pembrolizumab,FALSE
1780,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,1/10/2025,mg,antineoplastic,1/19/2025,12/3/2024,Intravenous,gemcitabine,FALSE
336.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,1/14/2020,mg,antineoplastic,9/30/2019,8/25/2019,Intravenous,carboplatin,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G22D6BD662E16,3/16/2019,mL,solution-fluid,12/12/2018,12/28/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G3DG:CFF4F7:G,7/29/2017,,,7/7/2017,6/3/2017,Oral,erlotinib,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/27/2020,mg,antineoplastic,3/14/2020,2/25/2019,Subcutaneous,bortezomib,FALSE
,,ADJUVANT,Administrations,immunotherapy,Clinical Study Drug,G128:92:3BD3D,11/13/2021,,antineoplastic,11/27/2021,4/27/2021,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/11/2025,mg,antineoplastic,6/18/2021,3/6/2019,Intravenous,pemetrexed,FALSE
519,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/14/2019,mg,antineoplastic,2/18/2019,1/15/2019,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,12/30/2012,mg,antineoplastic,3/31/2012,12/7/2011,Intravenous,carboplatin,FALSE
356,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,7/28/2018,mg,antineoplastic,5/4/2018,4/27/2018,Intravenous,carboplatin,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/28/2024,mg,antineoplastic,6/16/2024,9/13/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/10/2022,mg,antineoplastic,1/16/2022,9/28/2021,Intravenous,pembrolizumab,FALSE
125,,ADJUVANT,Administrations,chemotherapy,"Docetaxel,Leuprolide",G53D3D6874EB3,11/11/2023,mg,antineoplastic,7/28/2023,7/11/2023,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,5/7/2025,mg,antineoplastic,3/26/2023,8/27/2021,Intravenous,atezolizumab,TRUE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,4/21/2025,mg,antineoplastic,5/2/2018,2/2/2018,Intravenous,nivolumab,FALSE
1230,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G1:641727397B,4/16/2017,mg,antineoplastic,1/24/2017,1/3/2017,Intravenous,gemcitabine,FALSE
105,5,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/18/2020,mg,antineoplastic,8/2/2019,8/27/2019,Intravenous,docetaxel,FALSE
116,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/2/2021,mg,antineoplastic,7/12/2021,5/23/2021,Intravenous,cisplatin,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/31/2020,mg,antineoplastic,10/6/2018,2/25/2017,Intravenous,bevacizumab,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,3/20/2025,,antiemetic,3/13/2025,11/12/2024,Intravenous,clinical study drug,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/13/2024,mg,antineoplastic,6/6/2024,7/4/2024,Intravenous,paclitaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/28/2024,mg,antineoplastic,11/28/2021,12/21/2021,Intravenous,nivolumab,TRUE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,11/23/2015,mg,antineoplastic,8/4/2015,6/25/2015,Intravenous,paclitaxel protein-bound,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G15517:BF5DE4,11/28/2022,mg,antineoplastic,10/12/2022,9/8/2022,Intravenous,pemetrexed,FALSE
81,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,1/8/2015,mg,antineoplastic,11/11/2014,7/21/2014,Intravenous,paclitaxel,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,8/7/2021,mg,antineoplastic,3/2/2021,3/8/2021,Intravenous,pemetrexed,TRUE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/10/2021,mg,antineoplastic,11/14/2020,9/4/2020,Oral,bicalutamide,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/5/2019,mg,antineoplastic,8/25/2018,6/10/2018,Other/Miscellaneous,fluorouracil,FALSE
370.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45388C4DCEFB,5/27/2012,mg,antineoplastic,5/9/2012,5/10/2012,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/24/2025,mg,antineoplastic,4/6/2025,1/20/2023,Intravenous,pembrolizumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/5/2020,mg,antineoplastic,4/12/2019,3/6/2019,Intravenous,durvalumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/20/2011,mg,antineoplastic,9/17/2011,6/4/2011,Intravenous,etoposide,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/8/2024,mg,antineoplastic,1/5/2023,11/16/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E69F659F391,4/19/2025,mg,antineoplastic,9/23/2024,8/14/2024,Intravenous,pembrolizumab,TRUE
,2,ADVANCED,Orders,glucocorticoid,Clinical Study Drug,G3B1F6B561ED5,4/15/2021,,steroid,2/13/2020,2/25/2020,,clinical study drug,FALSE
713,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G137D67:GFD9F,11/22/2016,mg,antineoplastic,9/10/2016,7/28/2016,Intravenous,carboplatin,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/24/2015,mg,antineoplastic,2/11/2015,10/24/2014,Intravenous,paclitaxel protein-bound,FALSE
75,3,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1CD225858D1:,4/11/2019,mg/m2,antineoplastic,10/9/2017,6/20/2017,Intravenous,docetaxel,FALSE
585,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,10/29/2015,mg,antineoplastic,7/15/2015,8/8/2015,Intravenous,carboplatin,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,2/19/2013,AUC,antineoplastic,12/5/2012,1/13/2013,Intravenous,carboplatin,FALSE
594.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/10/2022,mg,antineoplastic,8/11/2014,5/26/2014,Intravenous,carboplatin,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/5/2024,mg,antineoplastic,9/26/2023,8/28/2023,Intravenous,durvalumab,FALSE
166.4,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/8/2015,mg,antineoplastic,12/13/2014,10/7/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/16/2020,mg,antineoplastic,2/18/2020,1/27/2019,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/14/2022,mg,antineoplastic,10/5/2017,1/16/2016,Intravenous,pemetrexed,FALSE
1700,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,3/14/2023,mg,antineoplastic,1/1/2023,11/11/2022,Intravenous,bevacizumab-bvzr,FALSE
825,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,1/4/2025,mg,antineoplastic,8/31/2024,7/22/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,10/23/2018,mg,antineoplastic,6/17/2018,5/17/2018,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,1/24/2019,mg,antineoplastic,3/19/2018,9/19/2017,Intravenous,atezolizumab,FALSE
373,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/31/2022,mg,antineoplastic,7/8/2022,4/28/2022,Intravenous,carboplatin,FALSE
1700,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G21C61GC:BF54,3/18/2014,mg,antineoplastic,11/11/2013,11/5/2013,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/9/2025,mg,antineoplastic,7/17/2022,2/6/2019,Intravenous,pembrolizumab,TRUE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,5/26/2025,,antineoplastic,12/5/2024,9/6/2024,Intravenous,durvalumab,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,3/14/2020,mg,antineoplastic,7/31/2017,7/18/2017,Intravenous,pemetrexed,TRUE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CG8EF93777D,11/28/2019,mg,antineoplastic,8/29/2019,9/3/2019,Intravenous,paclitaxel,FALSE
175,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4::3E61CFBB9,2/22/2021,mg/m2,antineoplastic,9/27/2020,10/9/2020,Intravenous,paclitaxel,FALSE
370,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,2/4/2024,mg,antineoplastic,10/26/2023,10/19/2023,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,8/9/2019,mg,antineoplastic,12/1/2018,7/31/2018,Intravenous,nivolumab,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/22/2017,mg,antineoplastic,2/24/2014,11/27/2013,Intravenous,etoposide,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,2/20/2019,mL,solution-fluid,11/14/2017,8/10/2017,Intravenous,etoposide,FALSE
,3,ADVANCED,Unstructured,,Adagrasib,G43E:81EC19B6,4/6/2025,,,4/29/2025,6/24/2023,Oral,adagrasib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,1/2/2019,mg,antineoplastic,3/21/2018,4/22/2017,Intravenous,pembrolizumab,FALSE
178,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/20/2013,mg,antineoplastic,10/20/2012,10/18/2012,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Orders,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/12/2025,mg,antineoplastic,2/19/2025,3/18/2024,Intravenous,pembrolizumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/9/2017,mg,antineoplastic,7/6/2015,5/12/2015,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,4/24/2017,mg,antineoplastic,3/4/2017,12/10/2016,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Orders,glucocorticoid,Clinical Study Drug,G485C85BECGC4,4/1/2022,,steroid,12/17/2021,12/10/2021,,clinical study drug,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Crizotinib,Pemetrexed",G1D4DE:C3C41C,5/3/2025,,antineoplastic,3/16/2024,1/19/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/12/2019,mg,antineoplastic,8/6/2018,12/6/2017,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,11/17/2012,mg,antineoplastic,10/9/2012,10/6/2012,Intravenous,gemcitabine,FALSE
112,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/7/2019,mg,antineoplastic,9/27/2017,8/8/2017,Intravenous,cisplatin,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,9/30/2014,mg,antineoplastic,8/4/2014,7/26/2014,Intravenous,pemetrexed,FALSE
366,3,ADVANCED,Administrations,chemotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/5/2016,mg,antineoplastic,10/15/2016,7/8/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/2/2023,,antineoplastic,9/26/2023,1/21/2023,,clinical study drug,FALSE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4989E69:D856,11/5/2024,mg/m2,antineoplastic,11/25/2024,10/7/2024,Intravenous,pemetrexed,FALSE
800,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G221C:3FD2EGB,4/1/2019,mg,antineoplastic,3/10/2019,2/11/2019,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G167G71733G69,10/22/2016,,antineoplastic,11/3/2016,3/26/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,11/28/2022,mg,antineoplastic,3/28/2022,5/13/2021,Intravenous,pembrolizumab,TRUE
10,1,ADVANCED,Orders,immunotherapy,Durvalumab,G11F85:F1CG29,1/9/2022,mg/kg,antineoplastic,10/21/2021,7/26/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/16/2023,mg,antineoplastic,8/5/2022,4/16/2020,Intravenous,pembrolizumab,TRUE
442,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,1/17/2016,mg,antineoplastic,11/10/2015,9/25/2015,Intravenous,paclitaxel,FALSE
390,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,4/5/2016,mg,antineoplastic,3/14/2016,3/12/2016,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G157317FG3387,9/4/2024,mg,antineoplastic,9/9/2024,5/22/2024,Intravenous,durvalumab,TRUE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/25/2024,mg,antineoplastic,5/14/2023,3/26/2022,Intravenous,durvalumab,FALSE
844,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/16/2024,mg,antineoplastic,11/4/2023,10/14/2023,Intravenous,durvalumab,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/23/2023,mg,antineoplastic,8/23/2023,2/25/2023,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/14/2022,,antineoplastic,3/25/2021,4/10/2017,Oral,nilotinib,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Crizotinib,Pemetrexed",G1D4DE:C3C41C,3/15/2025,,antineoplastic,2/2/2024,2/1/2024,Intravenous,carboplatin,FALSE
250.2,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,6/8/2016,mg,antineoplastic,2/12/2016,12/1/2015,Intravenous,nivolumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/28/2014,mg,antineoplastic,1/31/2014,12/26/2013,Intravenous,carboplatin,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/20/2024,mg,antineoplastic,10/1/2022,4/19/2022,Intravenous,durvalumab,TRUE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/25/2013,mg,antineoplastic,3/29/2012,12/2/2011,Intravenous,etoposide,FALSE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,4/14/2024,mg,antineoplastic,11/25/2023,10/28/2023,Oral,ivosidenib,FALSE
,1,ADVANCED,Orders,chemotherapy,Capecitabine,G23G4C57:DEB5,9/27/2020,,antineoplastic,9/15/2020,9/29/2020,Oral,capecitabine,FALSE
44,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,4/14/2014,mg,antineoplastic,2/25/2014,3/4/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Orders,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/11/2023,,antineoplastic,3/2/2023,12/24/2022,,pemetrexed,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/12/2012,mg,antineoplastic,6/16/2012,4/13/2012,Intravenous,docetaxel,FALSE
567,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,5/24/2024,mg,antineoplastic,4/7/2024,2/21/2024,Intravenous,carboplatin,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/14/2025,mg,antineoplastic,2/15/2024,2/15/2023,Intravenous,pembrolizumab,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,2/3/2025,,,12/9/2024,6/28/2024,Oral,osimertinib,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/25/2019,mg,antineoplastic,11/26/2018,11/6/2018,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,1/30/2019,mg,antineoplastic,11/24/2018,6/8/2018,Intravenous,pembrolizumab,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,3/27/2018,mg/m2,antineoplastic,10/15/2014,9/16/2014,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/20/2022,,antineoplastic,3/14/2022,1/18/2022,Intravenous,paclitaxel,FALSE
152.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G462G467E1BF1,3/15/2019,mg,antineoplastic,11/10/2018,12/8/2018,Intravenous,carboplatin,FALSE
1224,4,ADVANCED,Administrations,chemotherapy,"Ipilimumab,Nivolumab",G54F545489E59,4/29/2024,mg,antineoplastic,11/25/2023,11/24/2023,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,11/24/2018,mg,antineoplastic,9/13/2018,9/4/2018,Intravenous,pembrolizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/24/2025,mg,antineoplastic,3/18/2024,4/3/2024,Intravenous,pemetrexed,FALSE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/7/2016,mg,antineoplastic,7/24/2016,5/2/2016,Intravenous,paclitaxel,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/20/2020,mg,antineoplastic,2/2/2020,2/23/2019,Subcutaneous,bortezomib,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,5/19/2023,mg,antineoplastic,11/27/2022,9/12/2022,Subcutaneous,azacitidine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1DCDG73E53FF,4/1/2025,mg,antineoplastic,2/8/2025,11/8/2024,Intravenous,pembrolizumab,FALSE
975,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B26D:2G114C,1/13/2018,mg,antineoplastic,10/8/2016,6/16/2016,Intravenous,pemetrexed,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/12/2023,mg,antineoplastic,3/15/2023,1/14/2023,Intravenous,gemcitabine,FALSE
96,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,2/16/2023,mg,antineoplastic,6/6/2022,6/3/2022,Intravenous,docetaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/9/2022,mg,antineoplastic,10/22/2021,3/3/2021,Intravenous,durvalumab,FALSE
830,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,6/20/2013,mg,antineoplastic,11/9/2012,4/5/2012,Intravenous,pemetrexed,FALSE
209.1,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,2/4/2014,mg,antineoplastic,12/20/2013,2/1/2014,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G54F545489E59,4/10/2023,mg,antineoplastic,2/7/2023,6/27/2022,Intravenous,docetaxel,FALSE
345,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,3/28/2012,mg,antineoplastic,4/1/2012,12/25/2011,Intravenous,paclitaxel,FALSE
99.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/3/2021,mg,antineoplastic,5/11/2021,4/19/2021,Intravenous,paclitaxel,FALSE
973,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,5/2/2017,mg,antineoplastic,12/14/2016,12/19/2016,Intravenous,bevacizumab,FALSE
415,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,2/17/2023,mg,antineoplastic,11/2/2022,10/21/2022,Intravenous,carboplatin,FALSE
190.5,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G26EFGF738125,8/12/2018,mg,antineoplastic,8/1/2018,7/24/2018,Intravenous,carboplatin,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2D5B71G65F2G,8/10/2015,mg,antineoplastic,6/17/2014,6/23/2014,Intravenous,carboplatin,FALSE
336,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/26/2023,mg,antineoplastic,12/14/2022,10/22/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,3/26/2019,mg,antineoplastic,11/20/2018,9/12/2018,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,9/27/2021,mg,antineoplastic,11/15/2020,10/31/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/28/2020,AUC,antineoplastic,3/17/2019,2/21/2019,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/27/2018,mL,solution-fluid,7/15/2015,6/18/2015,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,10/10/2021,,antineoplastic,8/3/2018,3/30/2018,,durvalumab,TRUE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/12/2014,mg,antineoplastic,7/19/2014,3/24/2014,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,2/2/2017,mg,antineoplastic,11/20/2016,11/29/2016,Intravenous,gemcitabine,FALSE
1025,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/15/2016,mg,antineoplastic,9/29/2015,7/2/2015,Intravenous,pemetrexed,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Osimertinib,Paclitaxel",G1594:E29D2D9,3/30/2022,mg,antineoplastic,3/26/2022,1/26/2022,Intravenous,paclitaxel,FALSE
688,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,11/3/2017,mg,antineoplastic,7/8/2017,6/10/2017,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,7/20/2017,,antineoplastic,4/7/2017,12/29/2016,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,1/28/2019,mg,antineoplastic,9/20/2018,3/4/2018,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/10/2025,mg,antineoplastic,7/12/2017,9/2/2016,Intravenous,pembrolizumab,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/27/2016,mg,antineoplastic,12/30/2014,12/1/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/13/2020,mg,antineoplastic,4/5/2019,1/29/2018,Intravenous,pembrolizumab,TRUE
305,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22FG21G231E9,11/4/2021,mg,antineoplastic,11/26/2021,10/14/2021,Intravenous,carboplatin,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/13/2023,mg,antineoplastic,1/12/2021,4/27/2020,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/25/2019,mg,antineoplastic,11/11/2018,5/6/2018,Intravenous,nivolumab,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1CFE2442E26G,12/4/2013,mg,antineoplastic,12/27/2013,11/6/2013,Intravenous,bevacizumab,TRUE
25,1,ADVANCED,Orders,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/16/2015,mg/m2,antineoplastic,11/24/2014,4/23/2014,Intravenous,vinorelbine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/4/2020,mg,antineoplastic,3/4/2018,6/20/2016,Intravenous,nivolumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,12/1/2013,mg,antineoplastic,9/25/2013,10/2/2013,Intravenous,paclitaxel,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/2/2020,mg,antineoplastic,3/24/2020,2/2/2020,Intravenous,bevacizumab,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/16/2021,mg,antineoplastic,8/1/2021,5/30/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/2/2025,mg,antineoplastic,1/10/2025,1/13/2019,Intravenous,pembrolizumab,TRUE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,4/21/2017,mg,antineoplastic,12/21/2016,11/3/2016,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/30/2020,,antineoplastic,11/11/2019,11/27/2019,Intravenous,clinical study drug,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/11/2020,mg/kg,antineoplastic,6/15/2020,3/4/2020,Intravenous,ramucirumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,7/20/2014,mg/m2,antineoplastic,5/4/2014,4/25/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/6/2022,mg,antineoplastic,4/29/2022,5/24/2022,Intravenous,pembrolizumab,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/25/2016,mg,antineoplastic,1/13/2015,12/4/2014,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G46:87GF7FGC9,12/1/2015,,steroid,8/11/2015,8/20/2015,Intrajejunal,clinical study drug,FALSE
80,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/30/2018,mg/m2,antineoplastic,6/20/2018,4/26/2018,Intravenous,paclitaxel,FALSE
1010,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/16/2025,mg,antineoplastic,3/22/2022,11/9/2021,Intravenous,pemetrexed,TRUE
255,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,6/14/2021,mg,antineoplastic,1/8/2017,12/11/2016,Intravenous,carboplatin,FALSE
76,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/11/2014,mg,antineoplastic,9/14/2014,6/25/2014,Intravenous,cisplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/28/2024,mg,antineoplastic,6/14/2024,5/31/2024,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/15/2025,mg,antineoplastic,7/2/2024,4/17/2024,Intravenous,pembrolizumab,FALSE
131,2,ADVANCED,Administrations,chemotherapy,Docetaxel,G1D894G21GC1E,4/7/2025,mg,antineoplastic,2/4/2025,11/3/2024,Intravenous,docetaxel,FALSE
65.4,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/25/2021,mg,antineoplastic,1/1/2021,1/3/2021,Intravenous,vinorelbine,FALSE
510,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/5/2023,mg,antineoplastic,4/8/2023,3/29/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/11/2020,mg,antineoplastic,4/28/2020,7/1/2019,Intravenous,pembrolizumab,TRUE
762,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/11/2020,mg,antineoplastic,8/26/2017,2/24/2017,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/15/2025,,antineoplastic,9/16/2024,1/31/2023,,clinical study drug,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/7/2025,mg,antineoplastic,1/18/2025,5/15/2022,Intravenous,pembrolizumab,FALSE
400,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,12/17/2021,mg,antineoplastic,2/26/2021,2/14/2021,Intravenous,pembrolizumab,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/4/2016,mg,antineoplastic,7/6/2015,10/17/2014,Intravenous,bevacizumab,TRUE
975,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/30/2016,mg,antineoplastic,1/1/2016,7/10/2015,Intravenous,pemetrexed,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,11/30/2013,mg,antineoplastic,6/18/2013,9/2/2012,Intravenous,gemcitabine,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/9/2023,mg,antineoplastic,4/22/2023,10/8/2022,Intravenous,durvalumab,FALSE
740,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,12/4/2024,mg,antineoplastic,10/26/2024,9/29/2024,Intravenous,carboplatin,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/18/2016,mg,antineoplastic,7/12/2015,5/22/2015,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/4/2025,mg,antineoplastic,1/4/2021,1/29/2018,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/6/2023,mg,antineoplastic,3/22/2023,11/10/2021,Intravenous,pembrolizumab,TRUE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/10/2019,mg,antineoplastic,5/15/2018,4/1/2018,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/21/2020,mg,antineoplastic,4/11/2016,3/13/2016,Intravenous,bevacizumab,TRUE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/15/2016,mg,antineoplastic,6/30/2016,6/26/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G15GFGE5:BDC9,3/29/2019,mg,antineoplastic,3/11/2019,10/2/2018,Intravenous,pembrolizumab,TRUE
2052,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G51:G:C712CC6,12/1/2019,mg,antineoplastic,11/9/2019,11/12/2019,Intravenous,gemcitabine,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/23/2022,mg,antineoplastic,7/25/2020,4/14/2020,Intravenous,durvalumab,TRUE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/8/2014,mg,antineoplastic,10/4/2014,6/11/2014,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/13/2020,,antineoplastic,5/15/2020,5/14/2020,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G26B488B88188,11/11/2022,mg,antineoplastic,10/8/2022,9/19/2022,Intravenous,paclitaxel,FALSE
741,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/18/2021,mg,antineoplastic,11/5/2021,11/4/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G38F772G48B9C,2/20/2025,,antineoplastic,4/1/2023,2/26/2022,Intravenous,pembrolizumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,11/28/2015,mg,antineoplastic,6/6/2015,2/9/2015,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,1/29/2024,mg,antineoplastic,10/13/2023,7/1/2023,Intravenous,pembrolizumab,FALSE
230,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G911BEC5817,8/4/2013,mg,antineoplastic,8/17/2013,6/30/2013,Intravenous,carboplatin,FALSE
500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G227FDC93E654,10/25/2013,mg,antineoplastic,8/24/2013,7/29/2013,Intravenous,carboplatin,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,10/24/2022,mg,antineoplastic,8/30/2022,8/26/2022,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/9/2014,mg,antineoplastic,1/29/2014,11/16/2013,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/12/2022,mg,antineoplastic,8/7/2022,12/20/2017,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/26/2020,mg,antineoplastic,12/22/2016,12/10/2016,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/8/2018,mg,antineoplastic,10/15/2017,6/22/2017,Intravenous,pembrolizumab,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/7/2020,mg,antineoplastic,6/4/2020,5/10/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/23/2013,mg,antineoplastic,1/24/2013,11/17/2012,Intravenous,carboplatin,FALSE
534,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/21/2025,mg,antineoplastic,7/20/2024,7/22/2024,Intravenous,carboplatin,FALSE
370,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/26/2020,mg,antineoplastic,12/5/2020,10/28/2020,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G2E42F615FFFC,11/6/2024,mg,antineoplastic,12/22/2024,12/25/2024,Intravenous,pembrolizumab,FALSE
68,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24C:63G27686,5/11/2013,mg,antineoplastic,5/28/2013,5/7/2013,Intravenous,paclitaxel,FALSE
1325,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Erlotinib,Pemetrexed",G1188466C5727,8/31/2015,mg,antineoplastic,1/9/2015,12/11/2014,Intravenous,bevacizumab,FALSE
519,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,10/3/2021,mg,antineoplastic,8/6/2021,8/2/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,9/13/2023,mg,antineoplastic,12/11/2022,7/10/2022,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/19/2022,mg,antineoplastic,10/12/2021,7/20/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/31/2024,mg,antineoplastic,1/29/2023,5/28/2020,Intravenous,pembrolizumab,TRUE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/25/2018,mg,antineoplastic,7/14/2016,9/22/2015,Intravenous,nivolumab,FALSE
172,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,8/28/2024,mg,antineoplastic,7/25/2024,7/22/2024,Intravenous,carboplatin,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/4/2020,mg,antineoplastic,7/4/2019,6/7/2019,Intravenous,pemetrexed,TRUE
225,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C65C839C5CC,7/13/2021,mg,antineoplastic,12/21/2016,12/19/2016,Intravenous,carboplatin,FALSE
140,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,11/14/2023,mg,antineoplastic,10/24/2023,10/14/2023,Intravenous,carboplatin,FALSE
1000,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G163D9B593927,11/6/2017,mg,antineoplastic,6/3/2017,6/4/2017,Intravenous,gemcitabine,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,12/12/2023,mg,antineoplastic,1/12/2023,10/25/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/2/2023,mg,antineoplastic,8/15/2022,2/10/2022,Intravenous,pembrolizumab,TRUE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/20/2025,mL,solution-fluid,6/26/2024,6/12/2024,Intravenous,paclitaxel,FALSE
200,,NEOADJUVANT,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/10/2019,mg,antineoplastic,1/18/2019,12/24/2018,Intravenous,pembrolizumab,FALSE
413,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/19/2023,mg,antineoplastic,3/9/2023,11/13/2022,Intravenous,bevacizumab-bvzr,FALSE
1.6793,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/9/2012,AUC,antineoplastic,3/3/2012,3/3/2012,Intravenous,carboplatin,FALSE
420,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3642135:5B4C,2/17/2019,mg,antineoplastic,11/21/2018,12/2/2018,Intravenous,durvalumab,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/19/2014,mg,antineoplastic,1/17/2014,1/16/2014,Intravenous,pemetrexed,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,12/29/2021,4/24/2017,Oral,nilotinib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,5/23/2025,mg,antineoplastic,11/6/2024,7/27/2024,Intravenous,durvalumab,FALSE
480,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G53233CD43C,10/10/2024,mg,antineoplastic,9/23/2024,7/17/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/25/2018,mg,antineoplastic,5/30/2018,7/27/2017,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/11/2016,mg,antineoplastic,5/18/2016,6/8/2016,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/18/2025,mg,antineoplastic,8/11/2019,2/5/2017,Intravenous,pembrolizumab,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1B3558DGF36B,11/15/2019,mg,antineoplastic,9/10/2019,8/5/2019,Intravenous,cisplatin,FALSE
770,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/16/2020,mg,antineoplastic,5/18/2019,12/1/2018,Intravenous,pemetrexed,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/15/2019,mg,antineoplastic,9/15/2018,6/9/2018,Other/Miscellaneous,fluorouracil,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,6/26/2021,mg,antineoplastic,7/5/2021,9/18/2020,Intravenous,durvalumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/17/2013,mg/m2,antineoplastic,7/28/2013,8/1/2013,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,8/9/2017,,antineoplastic,6/28/2017,3/14/2017,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,10/15/2013,mg,antineoplastic,8/7/2013,9/4/2013,Intravenous,carboplatin,FALSE
795,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,2/21/2020,mg,antineoplastic,11/14/2018,1/5/2019,Intravenous,pemetrexed,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/8/2024,mg,antineoplastic,11/6/2023,12/4/2022,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,6/18/2022,mg,antineoplastic,4/24/2022,1/12/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,9/1/2024,mg,antineoplastic,7/11/2024,6/7/2024,Intravenous,pembrolizumab,FALSE
340,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,3/24/2013,mg,antineoplastic,3/6/2013,2/26/2013,Intravenous,carboplatin,FALSE
860,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,1/31/2013,mg,antineoplastic,12/19/2012,10/16/2012,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,8/5/2019,mg,antineoplastic,5/15/2019,2/7/2019,Intravenous,nivolumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,4/26/2025,mg,antineoplastic,6/20/2024,1/9/2023,Intravenous,pembrolizumab,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,4/27/2016,mg,antineoplastic,9/3/2014,8/19/2014,Intravenous,etoposide,FALSE
860,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,1/22/2013,mg,antineoplastic,11/13/2012,11/28/2012,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,1/17/2016,mg,antineoplastic,8/10/2015,7/30/2015,Intravenous,pemetrexed,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/5/2022,mg,antineoplastic,11/5/2021,11/23/2021,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G2CG3EF9E5:2B,6/17/2021,,,6/24/2021,5/19/2021,Oral,alectinib,FALSE
388,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/17/2020,mg,antineoplastic,9/18/2020,10/22/2020,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/7/2023,mg,antineoplastic,10/16/2021,5/5/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/7/2019,mg,antineoplastic,1/18/2019,1/13/2019,Intravenous,paclitaxel protein-bound,FALSE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/12/2024,mg,antineoplastic,12/9/2023,12/9/2023,Intravenous,paclitaxel,FALSE
229,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,2/19/2022,mg,antineoplastic,10/27/2021,9/13/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,4/12/2016,,antineoplastic,5/18/2016,3/21/2016,Intravenous,pemetrexed,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/30/2015,mg,antineoplastic,4/4/2015,8/19/2014,Intravenous,paclitaxel,FALSE
119,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4B9:3796F753,10/20/2014,mg,antineoplastic,4/6/2014,4/23/2014,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/12/2023,mg,antineoplastic,1/16/2023,11/12/2022,Intravenous,bevacizumab-awwb,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/14/2019,mg,antineoplastic,9/1/2019,8/31/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/11/2025,,antineoplastic,8/9/2023,2/19/2023,Intravenous,pemetrexed,FALSE
1710,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,6/20/2013,mg,antineoplastic,9/5/2012,7/8/2012,Intravenous,gemcitabine,FALSE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/23/2014,mg,antineoplastic,12/15/2013,1/31/2014,Intravenous,pemetrexed,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,2/27/2014,mg,antineoplastic,7/15/2013,7/12/2013,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G177G4:B9E394,3/31/2025,,antiemetic,4/9/2025,4/22/2025,Intravenous,clinical study drug,FALSE
470,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,5/2/2019,mg,antineoplastic,4/3/2019,4/14/2019,Intravenous,carboplatin,FALSE
95,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2364B7D68FE2,10/10/2015,mg,antineoplastic,9/20/2015,7/8/2015,Intravenous,paclitaxel,FALSE
279,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D:B49GGG719,5/5/2017,mg,antineoplastic,1/7/2017,11/12/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2763DEB9848B,5/9/2020,mg,antineoplastic,5/6/2020,4/19/2020,Intravenous,pembrolizumab,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,2/25/2022,mg,antineoplastic,11/4/2021,10/23/2021,Intravenous,pemetrexed,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/19/2013,AUC,antineoplastic,11/27/2012,7/14/2012,Intravenous,carboplatin,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/21/2023,mg,antineoplastic,2/20/2023,1/21/2023,Intravenous,nivolumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,9/19/2021,AUC,antineoplastic,9/27/2021,8/14/2021,Intravenous,carboplatin,FALSE
,5,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G4826CB54C27:,3/23/2025,,,4/8/2025,12/14/2024,Oral,osimertinib,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G7B3CB6D5C4,4/12/2013,mg,antineoplastic,3/25/2013,2/25/2013,Intravenous,carboplatin,FALSE
170,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,4/5/2021,mg,antineoplastic,1/5/2021,1/10/2021,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Orders,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/22/2025,,steroid,12/25/2024,11/8/2024,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/4/2024,mg,antineoplastic,9/23/2022,9/28/2022,Intravenous,pembrolizumab,TRUE
93,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/8/2024,mg,antineoplastic,8/19/2024,8/5/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/7/2022,mg,antineoplastic,7/14/2022,1/25/2018,Intravenous,pembrolizumab,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,11/5/2019,mg,antineoplastic,10/17/2019,10/16/2019,Intravenous,pemetrexed,FALSE
420,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3642135:5B4C,1/23/2019,mg,antineoplastic,12/24/2018,11/13/2018,Intravenous,durvalumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,5/14/2025,mg,antineoplastic,5/15/2024,4/19/2023,Intravenous,pembrolizumab,FALSE
449,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,10/13/2024,mg,antineoplastic,8/10/2024,6/25/2024,Intravenous,carboplatin,FALSE
675,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/28/2016,mg,antineoplastic,10/6/2016,8/2/2016,Intravenous,gemcitabine,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,7/1/2023,mg,antineoplastic,4/22/2023,4/24/2023,Intravenous,paclitaxel,FALSE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,5/6/2012,mg,antineoplastic,6/21/2011,5/7/2011,Intravenous,bevacizumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G36CD19:738D6,11/27/2021,AUC,antineoplastic,10/12/2021,10/25/2021,Intravenous,carboplatin,FALSE
226,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G18:439734B::,1/17/2016,mg,antineoplastic,11/19/2015,10/22/2015,Intravenous,nivolumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/25/2025,mg,antineoplastic,11/1/2022,12/23/2016,Intravenous,pembrolizumab,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,11/2/2020,mg,antineoplastic,10/17/2019,9/27/2019,Intravenous,durvalumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,4/6/2018,mg/m2,antineoplastic,11/27/2017,8/31/2017,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/30/2013,AUC,antineoplastic,9/19/2013,9/5/2012,Intravenous,carboplatin,FALSE
28,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/6/2015,mg,antineoplastic,3/18/2015,3/10/2015,Intravenous,docetaxel,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/3/2023,mg,antineoplastic,4/10/2023,7/4/2022,Intravenous,durvalumab,FALSE
115,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11D1:8:62429,12/4/2015,mg,antineoplastic,10/31/2015,10/15/2015,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/7/2024,,antineoplastic,10/8/2023,3/29/2023,Intravenous,atezolizumab,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1FD6C9677C56,11/2/2017,mg/m2,antineoplastic,10/12/2017,11/18/2017,Intravenous,paclitaxel,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,3/12/2020,mg,antineoplastic,2/22/2020,1/15/2020,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,8/1/2023,mg,antineoplastic,6/23/2022,7/5/2022,Intravenous,pembrolizumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,3/15/2018,AUC,antineoplastic,11/10/2017,9/1/2017,Intravenous,carboplatin,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11E:D3E21E6:,3/15/2025,mg,antineoplastic,5/3/2025,11/19/2024,Intravenous,durvalumab,FALSE
2725,,NEOADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,10/12/2024,mg,antineoplastic,8/15/2024,6/15/2024,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G4GE2958C:E1C,3/21/2012,,antiemetic,11/12/2011,7/21/2011,Oral,clinical study drug,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,4/5/2025,mg,antineoplastic,12/31/2024,12/21/2024,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/8/2013,mg,antineoplastic,7/10/2013,4/26/2013,Intravenous,bevacizumab,FALSE
816,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,5/4/2025,mg,antineoplastic,3/26/2025,2/8/2025,Intravenous,pemetrexed,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,10/4/2024,mg,antineoplastic,6/20/2024,4/22/2024,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,11/27/2016,mg,antineoplastic,11/30/2016,9/7/2016,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,9/30/2015,,antineoplastic,4/17/2015,2/26/2015,,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/2/2025,mg,antineoplastic,6/29/2019,2/4/2019,Intravenous,pemetrexed,TRUE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,7/28/2017,mg,antineoplastic,9/20/2015,5/17/2015,Intravenous,nivolumab,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/3/2024,mg,antineoplastic,5/1/2022,7/13/2020,Intravenous,ipilimumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/19/2025,mg,antineoplastic,2/12/2025,7/7/2024,Intravenous,pembrolizumab,FALSE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,3/12/2013,mg,antineoplastic,3/20/2013,11/24/2012,Intravenous,gemcitabine,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/15/2020,mg,antineoplastic,6/29/2019,8/20/2017,Intravenous,pemetrexed,TRUE
30,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/18/2018,mg/m2,antineoplastic,11/3/2017,9/29/2017,Intravenous,paclitaxel,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,4/25/2024,mg,antineoplastic,2/4/2024,10/27/2023,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Orders,cytoprotective,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,1/3/2022,mg/m2,antineoplastic,10/13/2021,10/4/2021,Intravenous,leucovorin,FALSE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,1/21/2020,mg,antineoplastic,12/4/2019,9/5/2019,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/19/2024,mg,antineoplastic,5/25/2024,5/20/2024,Intravenous,paclitaxel,FALSE
560,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/30/2023,mg,antineoplastic,2/25/2023,4/12/2023,Intravenous,carboplatin,FALSE
388.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,2/7/2013,mg,antineoplastic,11/27/2012,12/4/2012,Intravenous,carboplatin,FALSE
957,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/26/2025,mg,antineoplastic,4/14/2025,10/3/2024,Intravenous,durvalumab,TRUE
148,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/18/2013,mg,antineoplastic,5/7/2012,5/3/2012,Intravenous,carboplatin,FALSE
541,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G54F545489E59,11/12/2023,mg,antineoplastic,4/5/2023,4/9/2023,Intravenous,ramucirumab,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,10/11/2018,mg,antineoplastic,6/4/2018,5/17/2018,Intravenous,carboplatin,FALSE
476,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,3/21/2025,mg,antineoplastic,9/14/2024,6/24/2024,Intravenous,carboplatin,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,12/1/2016,mg,antineoplastic,10/8/2016,6/25/2016,Intravenous,necitumumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/7/2025,mL,solution-fluid,6/7/2024,5/10/2024,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/4/2015,mg,antineoplastic,9/12/2014,9/11/2014,Intravenous,cisplatin,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/4/2024,mg,antineoplastic,3/18/2022,7/29/2020,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/17/2025,mg,antineoplastic,10/27/2016,9/9/2016,Intravenous,pembrolizumab,FALSE
100,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G5817G:99GE51,5/28/2016,mg,antineoplastic,5/4/2016,1/31/2016,Intravenous,etoposide,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/9/2021,mg,antineoplastic,9/2/2018,2/16/2018,Intravenous,durvalumab,TRUE
,1,ADVANCED,Unstructured,,Alectinib,G1:641727397B,5/7/2025,,,2/19/2024,1/18/2024,Oral,alectinib,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G431ECG92273D,12/31/2018,,,11/27/2018,11/21/2018,Oral,afatinib,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/22/2019,mg,antineoplastic,9/10/2019,6/14/2019,Intravenous,paclitaxel,FALSE
600,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/11/2017,mg,antineoplastic,8/3/2017,5/22/2017,Intravenous,trastuzumab,FALSE
63.9,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1BB2C23:5573,8/21/2021,mg,antineoplastic,4/3/2021,12/5/2020,Intravenous,vinorelbine,FALSE
500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G358C8DCE9BD5,9/23/2020,mg,antineoplastic,8/10/2020,10/11/2019,Intravenous,durvalumab,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GEF44EBD419,3/1/2024,mg,antineoplastic,12/1/2023,10/20/2023,Intravenous,paclitaxel,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/6/2016,mg,antineoplastic,8/7/2014,6/28/2014,Intravenous,bevacizumab,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/17/2018,mg,antineoplastic,12/18/2017,10/17/2017,Oral,anastrozole,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/21/2022,mg,antineoplastic,6/23/2018,1/25/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,4/11/2018,,antineoplastic,10/10/2017,6/28/2017,,clinical study drug,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/30/2023,mg,antineoplastic,12/31/2023,11/17/2022,Intravenous,durvalumab,FALSE
260,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1185:32426FB,2/9/2017,mg,antineoplastic,7/15/2016,6/10/2016,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/18/2023,mg,antineoplastic,3/19/2021,4/25/2020,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/24/2024,mg,antineoplastic,9/23/2023,4/8/2023,Intravenous,bevacizumab-awwb,TRUE
178,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/29/2012,mg,antineoplastic,5/30/2012,3/13/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Orders,chemotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,9/6/2021,,antineoplastic,3/9/2021,3/1/2021,Oral,capecitabine,FALSE
22.5,,ADJUVANT,Administrations,hormone,Leuprolide,G369D5G3B91:2,3/8/2024,mg,antineoplastic,3/30/2024,4/2/2024,Intramuscular,leuprolide,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,10/18/2023,mg,antineoplastic,10/20/2023,11/22/2022,Intravenous,atezolizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/27/2025,mg,antineoplastic,7/15/2024,2/12/2024,Intravenous,amivantamab-vmjw,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,8/26/2019,mg,antineoplastic,1/28/2019,7/29/2018,Intravenous,nivolumab,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,1/13/2016,mg,antineoplastic,1/9/2016,10/16/2015,Intravenous,bevacizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/2/2020,mg,antineoplastic,4/30/2018,7/3/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,1/12/2020,mg,antineoplastic,6/20/2019,4/8/2019,Intravenous,pembrolizumab,TRUE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/2/2025,mg,antineoplastic,7/13/2021,3/25/2020,Intravenous,pemetrexed,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/30/2025,mg,antineoplastic,11/3/2017,1/27/2017,Intravenous,pembrolizumab,FALSE
371,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,7/8/2022,mg,antineoplastic,11/16/2021,12/22/2021,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/4/2022,mg,antineoplastic,2/13/2019,4/20/2017,Intravenous,nivolumab,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G116C37BB:EB1,5/1/2025,mg,antineoplastic,12/14/2024,9/16/2024,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/7/2019,mg,antineoplastic,3/5/2019,12/27/2018,Intravenous,paclitaxel protein-bound,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/18/2024,mg,antineoplastic,5/1/2024,4/23/2024,Intravenous,paclitaxel,FALSE
500,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,9/25/2015,mL,solution-fluid,3/27/2015,3/2/2015,Intravenous,carboplatin,FALSE
800,,CONCURRENT,Administrations,chemotherapy,Pemetrexed,G289C6438E26:,4/1/2013,mg,antineoplastic,4/15/2013,3/23/2013,Intravenous,pemetrexed,FALSE
170,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,4/21/2021,mg,antineoplastic,1/12/2021,1/22/2021,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/27/2019,mL,solution-fluid,8/8/2019,7/20/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Clinical Study Drug",G1F9CDC2FCB:5,2/12/2025,,,2/24/2025,1/29/2022,Oral,alectinib,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/22/2022,mg,antineoplastic,4/23/2019,5/9/2017,Oral,nilotinib,FALSE
1035,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/28/2018,mg,antineoplastic,7/17/2018,7/13/2018,Intravenous,pemetrexed,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/27/2020,mg,antineoplastic,2/21/2018,7/19/2017,Intravenous,pemetrexed,TRUE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,1/16/2015,,antineoplastic,11/5/2014,9/2/2014,Intravenous,clinical study drug,FALSE
100,2,ADVANCED,Administrations,solution-fluid,Nivolumab,G22D6BD662E16,8/12/2020,mL,solution-fluid,8/29/2019,3/13/2019,Intravenous,nivolumab,FALSE
609,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G517B45372B5D,5/18/2020,mg,antineoplastic,5/15/2020,3/15/2020,Intravenous,carboplatin,FALSE
147,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,9/15/2024,mg,antineoplastic,7/10/2024,5/17/2024,Intravenous,carboplatin,FALSE
232,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/4/2016,mg,antineoplastic,3/31/2016,12/23/2015,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,3/10/2014,mg,antineoplastic,12/1/2013,11/2/2013,Intravenous,carboplatin,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/3/2022,mg,antineoplastic,5/14/2022,4/21/2022,Intravenous,carboplatin,FALSE
392,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,2/21/2024,mg,antineoplastic,1/6/2024,10/14/2023,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/3/2020,mg,antineoplastic,3/14/2018,1/19/2018,Intravenous,pemetrexed,TRUE
555,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1532797B869C,8/20/2023,mg,antineoplastic,8/20/2023,7/13/2023,Intravenous,ramucirumab,FALSE
400,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,4/3/2022,mg,antineoplastic,3/2/2022,12/1/2021,Intravenous,pembrolizumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,5/28/2020,mg,antineoplastic,2/1/2020,2/5/2019,Subcutaneous,bortezomib,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,3/2/2019,mg,antineoplastic,1/9/2019,11/25/2018,Intravenous,paclitaxel,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,4/29/2022,mg,antineoplastic,4/20/2022,4/11/2022,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/10/2013,mg,antineoplastic,1/24/2012,12/14/2011,Intravenous,etoposide,FALSE
925,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G135B:GEC35G4,4/8/2025,mg,antineoplastic,4/19/2025,3/1/2025,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/16/2025,mg,antineoplastic,7/30/2023,7/16/2021,Intravenous,atezolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G21953622CB66,7/16/2019,mg,antineoplastic,5/22/2019,3/5/2019,Intravenous,pembrolizumab,FALSE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G1GFD92F489E7,4/15/2023,mg,antineoplastic,3/8/2023,2/10/2023,Oral,anastrozole,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/31/2014,mg,antineoplastic,12/1/2014,9/6/2014,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/27/2016,mg,antineoplastic,4/24/2016,2/14/2016,Intravenous,nivolumab,FALSE
77,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G434GE998725C,10/4/2021,mg,antineoplastic,8/28/2021,8/2/2021,Intravenous,cisplatin,FALSE
,4,ADVANCED,Unstructured,,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,7/11/2023,,,1/12/2023,1/30/2023,Oral,capmatinib,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,11/27/2019,mg,antineoplastic,5/26/2019,4/29/2019,Intravenous,ramucirumab,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,6/17/2012,mg,antineoplastic,3/25/2012,2/13/2012,Intravenous,paclitaxel,FALSE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,9/30/2024,mg,antineoplastic,8/21/2024,7/17/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G13GE1E25174F,9/22/2022,mg,antineoplastic,7/31/2022,6/20/2022,Intravenous,pembrolizumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/20/2014,AUC,antineoplastic,6/17/2013,9/3/2012,Intravenous,carboplatin,FALSE
690,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/28/2018,mg,antineoplastic,6/11/2017,7/27/2017,Intravenous,pemetrexed,FALSE
232,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,10/7/2016,mg,antineoplastic,6/16/2016,12/3/2015,Intravenous,nivolumab,FALSE
140,4,ADVANCED,Administrations,chemotherapy,Etoposide,G3:D1D2EG5C21,5/27/2015,mg,antineoplastic,3/17/2015,1/30/2015,Intravenous,etoposide,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,12/17/2022,mg,antineoplastic,10/28/2022,6/27/2021,Intravenous,pembrolizumab,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,7/21/2019,mg/kg,antineoplastic,4/10/2019,8/28/2018,Intravenous,durvalumab,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/12/2023,mL,solution-fluid,10/13/2023,11/10/2022,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/6/2023,mg,antineoplastic,7/29/2023,4/26/2023,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G3EC5EB18C676,1/10/2018,mg,antineoplastic,10/14/2017,6/15/2017,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/18/2025,mg,antineoplastic,4/18/2020,2/8/2019,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/4/2013,mg/m2,antineoplastic,9/4/2013,10/17/2012,Intravenous,gemcitabine,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,11/18/2018,mg,antineoplastic,4/11/2018,12/3/2017,Intravenous,cisplatin,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G1968F::311C2,6/25/2018,,,8/28/2013,7/28/2013,Oral,erlotinib,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/26/2022,mg,antineoplastic,5/15/2017,5/1/2017,Oral,dasatinib,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G3FG621769317,10/19/2024,,antineoplastic,8/16/2024,6/8/2024,Intravenous,carboplatin,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,5/18/2015,mg,antineoplastic,2/13/2015,2/10/2015,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/7/2020,mg,antineoplastic,3/23/2019,10/23/2018,Intravenous,pembrolizumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,10/20/2022,mg,antineoplastic,2/24/2022,10/12/2021,Intravenous,durvalumab,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/26/2025,,antineoplastic,5/28/2024,3/17/2023,,clinical study drug,FALSE
500,,ADJUVANT,Orders,chemotherapy,Pemetrexed,G35146C5E4B61,12/29/2015,mg/m2,antineoplastic,5/21/2015,4/18/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/7/2021,mg,antineoplastic,7/10/2021,3/27/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,3/31/2012,,antiemetic,10/4/2011,9/12/2011,Intravenous,clinical study drug,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,5/2/2025,mg,antineoplastic,2/8/2024,9/17/2023,Intravenous,atezolizumab,FALSE
418,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39GB9B7D:9:C,1/21/2016,mg,antineoplastic,10/21/2015,10/13/2015,Intravenous,carboplatin,FALSE
1,,ADJUVANT,Orders,hormone,Anastrozole,G1FE2:9777177,6/28/2020,mg,antineoplastic,5/13/2020,5/25/2020,Oral,anastrozole,FALSE
1,1,ADVANCED,Orders,hormone,Anastrozole,G175D38G17E84,6/18/2017,mg,antineoplastic,7/7/2016,1/26/2016,Oral,anastrozole,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/8/2019,mg,antineoplastic,2/19/2018,1/12/2018,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G1:D34FC71922,5/11/2015,,antineoplastic,3/21/2015,2/9/2015,,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/20/2025,,antineoplastic,9/4/2023,1/26/2023,Intravenous,pemetrexed,FALSE
1760,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/25/2024,mg,antineoplastic,12/3/2023,7/1/2023,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,9/23/2021,mg,antineoplastic,9/8/2021,6/17/2021,Intravenous,carboplatin,FALSE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/11/2019,mg/m2,antineoplastic,5/13/2019,4/4/2019,Intravenous,cisplatin,FALSE
503,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,2/4/2025,mg,antineoplastic,12/24/2024,11/7/2024,Intravenous,carboplatin,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/8/2025,mg,antineoplastic,3/16/2025,7/15/2024,Intravenous,durvalumab,FALSE
225,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/23/2021,mg,antineoplastic,12/21/2020,12/19/2020,Intravenous,carboplatin,FALSE
70,6,ADVANCED,Administrations,chemotherapy,Vinorelbine,G3:C9BECD3F55,1/19/2022,mg,antineoplastic,8/3/2021,5/6/2021,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G57G45B:D1F17,2/13/2025,,antineoplastic,1/22/2018,10/29/2017,Intravenous,clinical study drug,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/7/2018,AUC,antineoplastic,6/20/2018,4/13/2018,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,6/22/2023,,antineoplastic,1/25/2023,2/11/2023,Intravenous,nivolumab,FALSE
2052,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G51:G:C712CC6,12/22/2019,mg,antineoplastic,11/13/2019,10/27/2019,Intravenous,gemcitabine,FALSE
105,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,3/6/2022,mg,antineoplastic,11/20/2021,9/26/2021,Intravenous,oxaliplatin,FALSE
375.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G33E77:6CF7F3,1/28/2013,mg,antineoplastic,2/1/2013,1/2/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/13/2025,mg,antineoplastic,1/8/2022,10/3/2021,Intravenous,pembrolizumab,TRUE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/1/2018,mL,solution-fluid,3/16/2018,12/24/2017,Intravenous,carboplatin,FALSE
40,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,8/16/2024,mg/m2,antineoplastic,9/20/2024,7/3/2024,Intravenous,paclitaxel protein-bound,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,12/4/2023,mg,antineoplastic,7/25/2023,4/14/2023,Intravenous,gemcitabine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/14/2023,,antineoplastic,8/14/2023,4/1/2023,,azacitidine,FALSE
1050,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,2/4/2024,mg,antineoplastic,11/25/2023,11/29/2023,Intravenous,pemetrexed,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,7/10/2014,mg,antineoplastic,1/14/2014,12/6/2013,Intravenous,bevacizumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/10/2020,mg,antineoplastic,5/24/2019,1/9/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/18/2019,mg,antineoplastic,8/6/2019,8/27/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/11/2017,,antineoplastic,4/17/2017,3/2/2017,Intravenous,pemetrexed,FALSE
142,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G25B:66F61266,2/18/2025,mg,antineoplastic,11/26/2024,10/4/2024,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/1/2018,mg,antineoplastic,3/31/2017,8/26/2015,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G499EB:16:7F3,9/24/2018,mg,antineoplastic,8/26/2018,4/22/2018,Intravenous,carboplatin,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/30/2015,mg,antineoplastic,11/27/2014,11/9/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,4/27/2017,,antineoplastic,7/13/2016,2/7/2016,Intravenous,clinical study drug,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/8/2016,mg,antineoplastic,10/4/2015,5/10/2015,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/27/2024,,,11/24/2023,10/20/2023,Oral,osimertinib,FALSE
168.4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,7/14/2018,mg,antineoplastic,5/17/2018,5/24/2018,Intravenous,carboplatin,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,11/25/2021,mg,antineoplastic,9/14/2021,9/13/2021,Intravenous,paclitaxel protein-bound,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,5/16/2022,mg,antineoplastic,5/2/2022,11/8/2021,Intravenous,pemetrexed,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,4/22/2014,mg,antineoplastic,2/22/2014,1/28/2014,Intravenous,eribulin,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/12/2022,mg,antineoplastic,6/14/2022,6/11/2021,Intravenous,bevacizumab-bvzr,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,5/20/2025,mg,antineoplastic,7/22/2024,3/19/2024,Oral,abiraterone,FALSE
865,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38D11EG5F826,1/29/2020,mg,antineoplastic,2/11/2016,2/24/2016,Intravenous,pemetrexed,TRUE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,4/13/2016,mg,antineoplastic,11/10/2015,11/22/2015,Intravenous,bevacizumab,FALSE
1300,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,7/25/2022,mg,antineoplastic,5/22/2022,6/8/2021,Intravenous,bevacizumab-bvzr,FALSE
1090,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/24/2020,mg,antineoplastic,3/4/2020,11/22/2019,Intravenous,pemetrexed,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/11/2020,mg,antineoplastic,5/3/2020,1/14/2020,Intravenous,gemcitabine,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/27/2015,mg,antineoplastic,11/24/2014,5/30/2014,Intravenous,pemetrexed,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/14/2020,mg,antineoplastic,3/1/2018,3/13/2017,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/20/2025,mg,antineoplastic,5/10/2022,3/1/2020,Intravenous,pembrolizumab,FALSE
200,5,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3:C9BECD3F55,5/2/2021,mg,antineoplastic,3/15/2021,2/18/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/2/2025,mg,antineoplastic,11/6/2021,10/21/2021,Intravenous,pembrolizumab,TRUE
360,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G2DC29B:962F1,1/11/2024,mg,antineoplastic,6/1/2023,7/20/2023,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,4/23/2024,mg,antineoplastic,4/11/2024,4/9/2024,Intravenous,pembrolizumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,10/13/2021,mg,antineoplastic,7/22/2021,8/15/2021,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,antiemetic,Clinical Study Drug,G579E53D92:75,10/23/2011,,antiemetic,10/27/2011,8/2/2011,Intravenous,clinical study drug,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G266E6248F531,8/15/2018,mg,antineoplastic,6/3/2018,3/26/2018,Intravenous,pemetrexed,TRUE
6,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/5/2022,AUC,antineoplastic,9/3/2021,10/14/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G44B44661:316,4/10/2016,,antineoplastic,3/15/2016,2/23/2016,,nivolumab,FALSE
,3,ADVANCED,Orders,targeted/biologic,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,2/20/2023,,antineoplastic,12/30/2022,9/12/2022,Intravenous,bevacizumab-awwb,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,5/29/2024,mg,antineoplastic,5/20/2024,7/19/2023,Intravenous,pembrolizumab,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/20/2019,mg,antineoplastic,8/23/2019,9/2/2018,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/28/2025,mg,antineoplastic,7/13/2019,2/13/2018,Intravenous,nivolumab,FALSE
288,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G493:D:293BE2,1/29/2013,mg,antineoplastic,11/12/2012,10/27/2012,Intravenous,paclitaxel,FALSE
1093,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1G194ECBE647,2/21/2020,mg,antineoplastic,3/5/2020,1/27/2020,Intravenous,durvalumab,TRUE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/13/2015,mg,antineoplastic,8/8/2014,8/20/2014,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,12/30/2017,mg,antineoplastic,11/16/2017,9/23/2017,Intravenous,nivolumab,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/24/2023,mg,antineoplastic,7/29/2023,12/8/2022,Intravenous,pemetrexed,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/25/2014,mg,antineoplastic,5/7/2013,10/1/2012,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,9/27/2022,mg,antineoplastic,5/20/2022,4/30/2022,Intravenous,pembrolizumab,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/28/2023,mg,antineoplastic,7/15/2022,11/14/2021,Intravenous,durvalumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,1/24/2024,mg,antineoplastic,6/11/2023,12/30/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,9/1/2023,mg,antineoplastic,7/21/2023,7/1/2023,Intravenous,carboplatin,FALSE
43,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/30/2023,mg,antineoplastic,12/4/2022,10/7/2022,Intravenous,leucovorin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/25/2025,mg,antineoplastic,8/16/2019,1/9/2017,Intravenous,pembrolizumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/3/2011,mg,antineoplastic,9/6/2011,3/1/2011,Intravenous,paclitaxel,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/23/2013,mg,antineoplastic,6/13/2013,5/15/2013,Intravenous,pemetrexed,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Paclitaxel",G147ED4GE76EE,11/22/2019,mg/m2,antineoplastic,11/17/2019,12/7/2019,Intravenous,cisplatin,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,7/25/2021,mg,antineoplastic,3/13/2021,3/31/2021,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/17/2017,mg,antineoplastic,4/4/2017,12/8/2016,Intravenous,paclitaxel protein-bound,FALSE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,1/29/2015,,antineoplastic,1/7/2015,10/2/2014,Intravenous,clinical study drug,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,10/5/2015,mg,antineoplastic,7/2/2015,6/28/2015,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G166B735:96D2,7/27/2013,mg,antineoplastic,5/2/2013,1/15/2013,Intravenous,bevacizumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/18/2023,mg,antineoplastic,1/4/2023,12/10/2019,Intravenous,pembrolizumab,FALSE
514,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,12/8/2013,mg,antineoplastic,1/9/2014,9/18/2013,Intravenous,carboplatin,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/17/2019,mg/m2,antineoplastic,1/4/2019,11/29/2018,Intravenous,vinorelbine,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G23G4C57:DEB5,7/8/2021,mg,antineoplastic,2/17/2021,10/4/2020,Intravenous,gemcitabine,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,7/30/2015,mg,antineoplastic,8/12/2013,7/22/2013,Intravenous,paclitaxel,FALSE
1250,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,5/10/2013,mg,antineoplastic,3/19/2013,1/11/2013,Intravenous,gemcitabine,FALSE
375,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1658GGG424E:,1/16/2017,mg,antineoplastic,12/16/2016,11/30/2016,Intravenous,carboplatin,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,12/10/2021,mg,antineoplastic,2/7/2021,2/23/2021,Intravenous,durvalumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,12/18/2016,mg,antineoplastic,6/14/2016,7/20/2016,Intravenous,nivolumab,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/3/2025,mg,antineoplastic,3/23/2016,11/26/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G1542E4F46G4B,7/27/2021,,,4/13/2020,3/15/2020,Oral,afatinib,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/9/2019,mg,antineoplastic,7/4/2019,8/22/2018,Intravenous,durvalumab,FALSE
564.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,12/28/2018,mg,antineoplastic,11/12/2018,10/8/2018,Intravenous,carboplatin,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G1D26B928965F,3/12/2015,mg,antineoplastic,2/22/2015,2/20/2015,Intravenous,etoposide,FALSE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,4/21/2025,mg,antineoplastic,10/25/2024,8/27/2024,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/15/2025,mg/m2,antineoplastic,11/16/2024,10/29/2024,Intravenous,etoposide,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/26/2020,mg,antineoplastic,5/30/2020,12/16/2019,Intravenous,gemcitabine,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/1/2019,mg/m2,antineoplastic,1/17/2019,12/7/2018,Intravenous,gemcitabine,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,9/2/2017,mg,antineoplastic,7/7/2016,5/24/2016,Intravenous,paclitaxel protein-bound,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/11/2013,mg/m2,antineoplastic,10/20/2013,7/17/2013,Intravenous,gemcitabine,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,6/11/2013,mg,antineoplastic,1/5/2013,6/26/2012,Intravenous,pemetrexed,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,3/26/2022,mg,antineoplastic,2/13/2022,1/30/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,3/11/2020,mg,antineoplastic,6/12/2019,10/27/2018,Intravenous,pembrolizumab,TRUE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,11/28/2019,mg,antineoplastic,6/28/2019,8/28/2018,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,7/4/2024,mg,antineoplastic,4/10/2024,7/1/2023,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/9/2014,mg/m2,antineoplastic,2/10/2013,9/26/2012,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,5/12/2025,mg,antineoplastic,11/26/2024,1/6/2025,Intravenous,nivolumab,FALSE
189.7,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/31/2022,mg,antineoplastic,6/25/2014,6/16/2014,Intravenous,carboplatin,FALSE
850,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,2/21/2024,mg,antineoplastic,1/28/2024,11/6/2023,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/23/2023,mg,antineoplastic,10/7/2021,4/1/2020,Intravenous,pembrolizumab,TRUE
234,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/12/2022,mg,antineoplastic,10/12/2021,9/15/2021,Intravenous,carboplatin,FALSE
152,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/16/2024,mg,antineoplastic,1/4/2024,11/14/2023,Intravenous,carboplatin,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/19/2018,mg,antineoplastic,1/29/2018,1/20/2018,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G2CG3EF9E5:2B,6/7/2021,,,5/11/2021,6/3/2021,Oral,lorlatinib,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/16/2021,mg,antineoplastic,7/2/2021,9/3/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,3/1/2021,mg,antineoplastic,12/29/2019,9/25/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/19/2019,mg,antineoplastic,12/6/2017,5/10/2017,Intravenous,nivolumab,FALSE
895,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/18/2019,mg,antineoplastic,2/17/2019,1/3/2019,Intravenous,pemetrexed,FALSE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,1/16/2015,,antineoplastic,11/27/2014,9/23/2014,Intravenous,clinical study drug,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/9/2016,mg,antineoplastic,7/6/2015,7/6/2015,Intravenous,pemetrexed,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/24/2023,mg,antineoplastic,4/13/2023,12/14/2022,Intravenous,pemetrexed,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1D4BED:EE889,5/23/2023,mg,antineoplastic,4/10/2023,3/16/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/31/2022,mg,antineoplastic,11/25/2021,6/29/2020,Intravenous,pembrolizumab,TRUE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,7/2/2013,mg,antineoplastic,1/5/2013,1/20/2013,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,7/17/2016,mg,antineoplastic,4/19/2016,3/23/2016,Intravenous,paclitaxel,FALSE
800,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,7/14/2019,mg,antineoplastic,4/22/2019,4/11/2019,Intravenous,ramucirumab,FALSE
1176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,11/26/2023,mg,antineoplastic,9/21/2023,9/17/2023,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G3B1F6B561ED5,3/1/2021,,antineoplastic,4/27/2020,2/28/2020,Intravenous,clinical study drug,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,5/15/2019,mg,antineoplastic,5/14/2019,3/20/2019,Intravenous,paclitaxel,FALSE
100,5,ADVANCED,Administrations,solution-fluid,"Leuprolide,Pembrolizumab",G17G71B51EFE2,3/25/2025,mL,solution-fluid,3/25/2025,2/10/2025,Intravenous,pembrolizumab,FALSE
719,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1B3558DGF36B,8/4/2021,mg,antineoplastic,5/12/2020,12/11/2019,Intravenous,durvalumab,TRUE
,1,ADVANCED,Unstructured,,Crizotinib,G234FGBCGD51F,10/22/2015,,,10/18/2015,1/18/2015,Oral,crizotinib,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/17/2013,mg,antineoplastic,7/7/2013,5/9/2013,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/11/2025,mg,antineoplastic,12/11/2017,12/15/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/25/2025,mg,antineoplastic,8/16/2024,3/13/2024,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/23/2019,mg,antineoplastic,8/22/2018,2/23/2016,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/6/2022,mg,antineoplastic,2/18/2022,9/13/2021,Intravenous,pemetrexed,TRUE
575,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,7/20/2024,mg,antineoplastic,6/13/2024,4/19/2024,Intravenous,carboplatin,FALSE
400,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4936::B67G17,3/25/2022,mg,antineoplastic,4/15/2022,3/2/2022,Intravenous,pembrolizumab,FALSE
251,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,4/2/2021,mg,antineoplastic,12/29/2020,11/30/2020,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,12/9/2015,mg,antineoplastic,12/12/2015,4/8/2015,Intravenous,pemetrexed,TRUE
530,3,ADVANCED,Administrations,immunotherapy,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,11/30/2016,mg,antineoplastic,9/10/2016,5/24/2016,Intravenous,nivolumab,FALSE
516,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2263646BG1E5,8/14/2012,mg,antineoplastic,8/6/2012,8/26/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,2/2/2025,mg,antineoplastic,11/17/2024,11/1/2024,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/13/2014,mg/m2,antineoplastic,11/29/2013,12/28/2013,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,4/12/2025,mg,antineoplastic,8/18/2020,3/19/2018,Intravenous,nivolumab,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/23/2017,mg,antineoplastic,9/29/2015,3/19/2015,Intravenous,bevacizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,8/11/2022,mg,antineoplastic,6/29/2022,6/30/2022,Intravenous,pembrolizumab,FALSE
495,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/14/2021,mg,antineoplastic,7/1/2021,7/18/2021,Intravenous,carboplatin,FALSE
724,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,8/21/2024,mg,antineoplastic,5/28/2024,9/5/2023,Intravenous,durvalumab,TRUE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,6/30/2023,mg,antineoplastic,4/26/2023,2/5/2023,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/2/2019,mg,antineoplastic,3/29/2019,2/3/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/15/2018,mg,antineoplastic,8/31/2017,3/12/2017,Intravenous,pembrolizumab,FALSE
90,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,4/30/2022,mg,antineoplastic,5/26/2022,3/14/2022,Intravenous,paclitaxel,FALSE
800,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G445B:B:15B5F,11/7/2014,mg/m2,antineoplastic,11/14/2014,9/16/2014,Intravenous,gemcitabine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/22/2016,mg,antineoplastic,1/15/2015,11/28/2014,Intravenous,gemcitabine,FALSE
123,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/27/2022,mg,antineoplastic,8/2/2022,7/26/2022,Intravenous,carboplatin,FALSE
117,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,10/2/2020,mg,antineoplastic,9/24/2020,5/26/2020,Subcutaneous,azacitidine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39F5FGEFFD67,10/10/2018,mg,antineoplastic,7/10/2018,6/12/2018,Intravenous,pembrolizumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/7/2025,mg,antineoplastic,12/26/2020,1/24/2019,Intravenous,pemetrexed,FALSE
770,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1G:1C482FFGC,4/21/2013,mg,antineoplastic,3/8/2013,2/24/2013,Intravenous,pemetrexed,FALSE
168,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,4/17/2014,mg,antineoplastic,3/14/2014,2/3/2014,Intravenous,carboplatin,FALSE
300,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2262335C:D62,3/12/2025,mg,antineoplastic,1/7/2025,11/19/2024,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/5/2025,mg,antineoplastic,5/28/2024,9/29/2022,Oral,anastrozole,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/3/2015,mg,antineoplastic,3/21/2015,2/12/2015,Intravenous,paclitaxel protein-bound,FALSE
478,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/9/2025,mg,antineoplastic,4/20/2024,10/24/2022,Intravenous,pemetrexed,TRUE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/21/2019,mg,antineoplastic,4/2/2019,1/1/2018,Intravenous,pemetrexed,FALSE
359,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,1/10/2014,mg,antineoplastic,1/4/2014,12/5/2013,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,4/13/2023,,antineoplastic,1/25/2023,4/27/2022,Intravenous,durvalumab,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/12/2021,mg,antineoplastic,9/26/2021,10/11/2021,Intravenous,carboplatin,FALSE
398,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,11/7/2021,mg,antineoplastic,12/28/2020,1/9/2021,Intravenous,carboplatin,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/29/2021,mg,antineoplastic,9/7/2021,6/29/2021,Intravenous,pemetrexed,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,12/21/2024,mg,antineoplastic,8/13/2024,10/15/2023,Intravenous,durvalumab,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/4/2021,mg/kg,antineoplastic,8/21/2021,3/26/2021,Intravenous,bevacizumab-awwb,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/23/2013,mg,antineoplastic,5/15/2013,10/3/2012,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,Sotorasib,G1G:1C482FFGC,5/19/2025,,,1/24/2025,2/3/2025,Oral,sotorasib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/30/2025,mg,antineoplastic,6/24/2021,12/27/2016,Intravenous,pembrolizumab,FALSE
1110,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/17/2016,mg,antineoplastic,5/29/2015,11/10/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/26/2022,mg,antineoplastic,10/24/2022,10/24/2022,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Orders,targeted/biologic,"Cetuximab,Irinotecan",G1D61871659DG,8/10/2012,mg/m2,antineoplastic,8/12/2012,6/25/2012,Intravenous,cetuximab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/17/2018,mg,antineoplastic,4/13/2018,7/14/2017,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,7/28/2012,,antineoplastic,4/9/2012,4/16/2012,,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/21/2025,,antineoplastic,2/17/2024,3/19/2023,Intravenous,pemetrexed,FALSE
585,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/3/2017,mg,antineoplastic,2/2/2017,10/30/2016,Intravenous,bevacizumab,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/5/2021,mg,antineoplastic,11/7/2020,10/21/2020,Intravenous,bevacizumab,FALSE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/5/2020,mg,antineoplastic,7/1/2020,2/2/2020,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G2D3FB2DD2C:1,8/28/2014,mg/m2,antineoplastic,8/25/2014,7/22/2014,Intravenous,pemetrexed,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/15/2023,mg,antineoplastic,4/16/2023,6/7/2022,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/10/2022,,antineoplastic,10/10/2021,5/8/2017,Oral,nilotinib,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/14/2016,mg,antineoplastic,8/20/2016,6/9/2016,Intravenous,carboplatin,FALSE
480.4,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,5/12/2016,mg,antineoplastic,1/16/2015,2/9/2015,Intravenous,carboplatin,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/10/2025,mg,antineoplastic,12/3/2024,9/16/2024,Intravenous,durvalumab,FALSE
775,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G199G4682G18:,4/2/2024,mg,antineoplastic,1/19/2024,12/23/2023,Intravenous,pemetrexed,FALSE
263,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FE1DBD491BE,9/22/2017,mg,antineoplastic,9/12/2017,8/4/2017,Intravenous,paclitaxel,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G1DCDG73E53FF,6/15/2024,,steroid,5/29/2024,5/25/2024,Intravenous,clinical study drug,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/1/2015,mg,antineoplastic,2/1/2015,8/24/2014,Intravenous,paclitaxel,FALSE
150,5,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G1468E9F5C9CG,8/8/2013,mg,antineoplastic,6/16/2013,4/22/2013,Intravenous,paclitaxel protein-bound,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/29/2019,mg,antineoplastic,5/13/2019,4/26/2019,Intravenous,paclitaxel,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/23/2020,mg,antineoplastic,8/9/2018,8/18/2017,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,4/9/2024,mg,antineoplastic,9/30/2022,10/11/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,6/26/2022,mg,antineoplastic,2/20/2021,7/27/2020,Intravenous,pembrolizumab,TRUE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/4/2023,mg,antineoplastic,4/26/2023,6/11/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/11/2022,mg,antineoplastic,4/1/2022,1/16/2018,Intravenous,pembrolizumab,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,5/14/2025,mg,antineoplastic,2/25/2022,1/9/2022,Intravenous,atezolizumab,FALSE
860,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,4/14/2017,mg,antineoplastic,1/17/2016,4/19/2015,Intravenous,bevacizumab,TRUE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G439D41E1E1FB,11/29/2022,mg,antineoplastic,1/31/2022,10/5/2021,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,10/26/2013,mg,antineoplastic,4/1/2013,11/17/2012,Intravenous,carboplatin,FALSE
579,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,2/15/2015,mg,antineoplastic,1/1/2015,10/17/2014,Intravenous,carboplatin,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1B7793:6:9E1,11/20/2014,mg,antineoplastic,12/6/2014,12/2/2014,Intravenous,etoposide,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,2/8/2024,mg,antineoplastic,9/2/2022,11/21/2021,Intravenous,durvalumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G419EE8F1F59D,5/30/2024,mg,antineoplastic,3/10/2024,7/17/2023,Intravenous,atezolizumab,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G217694659D6F,10/3/2022,,,6/23/2022,6/19/2022,Oral,lorlatinib,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/16/2020,mg,antineoplastic,8/18/2018,6/27/2016,Intravenous,nivolumab,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/3/2025,mg,antineoplastic,2/29/2020,3/19/2020,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/9/2025,,antineoplastic,10/16/2023,2/25/2023,,clinical study drug,FALSE
643,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/18/2022,mg,antineoplastic,5/1/2022,4/25/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,8/29/2022,mg,antineoplastic,5/28/2022,2/27/2022,Intravenous,pembrolizumab,FALSE
538,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,5/23/2016,mg,antineoplastic,4/4/2016,3/10/2016,Intravenous,carboplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,7/30/2021,mg,antineoplastic,5/30/2021,5/13/2021,Intravenous,carboplatin,FALSE
960,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,3/13/2024,mg,antineoplastic,1/13/2024,1/1/2024,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G132B61FB651B,1/11/2016,,antiemetic,10/26/2015,10/20/2015,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/31/2021,mg,antineoplastic,7/3/2021,5/27/2021,Intravenous,etoposide,FALSE
106,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,9/15/2019,mg,antineoplastic,7/19/2019,5/27/2019,Intravenous,paclitaxel,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/25/2023,mg,antineoplastic,6/27/2020,3/3/2020,Intravenous,gemcitabine,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G52B74F86723D,7/2/2020,mg,antineoplastic,5/29/2020,4/20/2020,Intravenous,cisplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G43D:C17:25FG,3/7/2015,mg,antineoplastic,1/10/2015,6/3/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,3/1/2025,mg,antineoplastic,12/11/2024,11/26/2024,Intravenous,pembrolizumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/26/2024,mg,antineoplastic,3/21/2023,4/26/2022,Intravenous,durvalumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,8/8/2022,mg,antineoplastic,9/8/2021,7/24/2021,Intravenous,durvalumab,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,11/12/2013,mg,antineoplastic,8/27/2013,6/16/2013,Intravenous,pemetrexed,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/8/2019,mg,antineoplastic,8/27/2018,6/29/2018,Intravenous,irinotecan,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/7/2014,mg/kg,antineoplastic,6/14/2014,12/8/2013,Intravenous,bevacizumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,11/17/2019,mg,antineoplastic,8/21/2019,6/19/2019,Intravenous,paclitaxel,FALSE
2125,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G53C52948773G,3/25/2024,mg,antineoplastic,3/21/2024,3/9/2024,Intravenous,gemcitabine,FALSE
547,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/23/2021,mg,antineoplastic,7/2/2021,5/26/2021,Intravenous,carboplatin,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/29/2019,mg,antineoplastic,6/29/2019,6/17/2019,Intravenous,paclitaxel protein-bound,FALSE
1900,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,7/1/2024,mg,antineoplastic,5/28/2024,4/29/2024,Intravenous,gemcitabine,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,12/28/2020,mg,antineoplastic,10/19/2020,9/5/2020,Oral,bicalutamide,FALSE
400,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D:2:59GC48E,11/30/2021,mg,antineoplastic,6/1/2021,3/13/2021,Intravenous,pembrolizumab,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,12/8/2020,mg,antineoplastic,7/18/2020,4/22/2020,Intravenous,paclitaxel protein-bound,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,9/3/2018,mg,antineoplastic,2/23/2018,10/1/2017,Intravenous,atezolizumab,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G1DCDG73E53FF,5/29/2024,,steroid,6/9/2024,5/30/2024,Intravenous,clinical study drug,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,2/25/2022,,antineoplastic,8/17/2021,8/26/2021,Intravenous,amivantamab-vmjw,FALSE
900,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2C38B34G8794,10/12/2022,mg,antineoplastic,7/18/2022,9/30/2021,Intravenous,pemetrexed,TRUE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/11/2024,mg,antineoplastic,1/2/2024,1/5/2024,Intravenous,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22B:E513F46B,4/19/2017,mg,antineoplastic,4/24/2017,4/14/2017,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/2/2021,mg,antineoplastic,9/18/2021,4/16/2021,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/6/2022,,antineoplastic,4/3/2022,4/23/2017,Oral,nilotinib,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,12/6/2023,mg,antineoplastic,9/14/2023,3/26/2023,Intravenous,gemcitabine,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/16/2018,mg,antineoplastic,1/12/2018,12/3/2017,Intravenous,bevacizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,12/7/2019,AUC,antineoplastic,10/16/2019,8/13/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/26/2025,mg,antineoplastic,2/15/2025,11/28/2024,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/20/2021,mg,antineoplastic,6/8/2021,5/9/2021,Intravenous,pembrolizumab,FALSE
275.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,1/3/2024,mg,antineoplastic,1/18/2024,10/2/2023,Intravenous,paclitaxel,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/12/2019,mg,antineoplastic,4/17/2019,9/14/2018,Intravenous,durvalumab,FALSE
1050,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G49E3CE9E292G,4/9/2023,mg,antineoplastic,6/5/2020,5/20/2020,Intravenous,pemetrexed,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/11/2021,mg,antineoplastic,1/25/2019,3/31/2018,Intravenous,durvalumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,5/23/2019,AUC,antineoplastic,3/14/2019,2/5/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,2/11/2024,mg,antineoplastic,7/29/2023,7/5/2023,Intravenous,pembrolizumab,FALSE
41,3,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/28/2023,mg,antineoplastic,2/16/2023,11/14/2022,Intravenous,leucovorin,FALSE
50,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,2/23/2013,mg,antineoplastic,8/3/2012,5/12/2012,Intravenous,docetaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/3/2025,mg,antineoplastic,11/4/2020,1/28/2019,Intravenous,pemetrexed,FALSE
245.7,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,5/13/2016,mg,antineoplastic,5/1/2016,1/21/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/12/2023,mg,antineoplastic,2/17/2022,3/18/2020,Intravenous,pembrolizumab,TRUE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/5/2025,mg,antineoplastic,4/16/2024,3/22/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G194ECBE647,1/24/2020,mg,antineoplastic,9/9/2019,9/5/2019,Intravenous,carboplatin,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,8/9/2024,mg,antineoplastic,6/29/2024,9/25/2023,Intravenous,durvalumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G21744:G47B22,11/12/2014,mg,antineoplastic,10/9/2014,8/26/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/9/2019,,antineoplastic,9/1/2019,7/21/2019,,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/12/2022,,antineoplastic,6/15/2021,5/17/2017,Oral,nilotinib,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,3/13/2023,mg,antineoplastic,1/5/2023,1/12/2023,Intravenous,pemetrexed,FALSE
1005,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,10/11/2021,mg,antineoplastic,6/27/2021,4/30/2021,Intravenous,pemetrexed,FALSE
93,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1185:32426FB,3/13/2014,mg,antineoplastic,1/17/2014,1/18/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G53D3D6874EB3,7/15/2023,,antineoplastic,4/30/2023,4/22/2023,Oral,enzalutamide,FALSE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,10/31/2015,mg,antineoplastic,9/9/2015,2/6/2015,Intravenous,pemetrexed,TRUE
800,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,4/20/2022,mg,antineoplastic,12/2/2021,12/1/2021,Intravenous,pemetrexed,FALSE
386,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/26/2022,mg,antineoplastic,2/9/2022,11/12/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G4C:6:784E1GF,10/24/2017,,,9/15/2016,10/8/2016,Oral,erlotinib,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/9/2023,mg,antineoplastic,7/20/2023,6/28/2023,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,5/27/2017,,solution-fluid,8/5/2016,2/3/2016,Intravenous,clinical study drug,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/19/2014,AUC,antineoplastic,4/10/2014,4/18/2014,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,8/12/2022,AUC,antineoplastic,6/11/2022,6/5/2022,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,8/19/2018,mg,antineoplastic,2/5/2018,9/16/2017,Intravenous,atezolizumab,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,10/25/2020,mg,antineoplastic,10/19/2018,12/26/2015,Intravenous,nivolumab,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/6/2023,mg,antineoplastic,6/20/2020,1/23/2020,Intravenous,gemcitabine,FALSE
1200,,NEOADJUVANT,Administrations,chemotherapy,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,12/19/2022,mg,antineoplastic,1/15/2023,10/12/2022,Intravenous,cyclophosphamide,FALSE
350,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,5/23/2025,mg,antineoplastic,7/1/2024,6/3/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G46:87GF7FGC9,11/26/2015,,hematological agent,11/24/2015,8/17/2015,Subcutaneous,clinical study drug,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,10/17/2021,mg,antineoplastic,5/27/2021,4/7/2021,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,cytoprotective,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,9/1/2012,,cytoprotective,3/7/2012,3/27/2012,Intramuscular,clinical study drug,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,3/2/2022,mg,antineoplastic,6/30/2021,1/28/2020,Intravenous,nivolumab,FALSE
260,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,1/23/2015,mg,antineoplastic,2/7/2015,10/14/2014,Intravenous,paclitaxel,FALSE
80,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,2/15/2021,mg,antineoplastic,10/30/2020,7/7/2020,Intravenous,docetaxel,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,1/28/2022,mg,antineoplastic,11/3/2021,9/15/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,4/23/2012,,steroid,2/19/2012,10/8/2011,Intravenous,clinical study drug,FALSE
740,,ADJUVANT,Administrations,targeted/biologic,Rituximab-Arrx,G2GDF48F:5EGB,10/3/2024,mg,antineoplastic,10/17/2024,10/11/2024,Intravenous,rituximab-arrx,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,9/28/2022,mg,antineoplastic,9/3/2021,5/12/2021,Intravenous,leucovorin,FALSE
50,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/13/2013,mg/m2,antineoplastic,7/12/2013,7/16/2013,Intravenous,etoposide,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,11/10/2019,mg,antineoplastic,8/17/2019,7/9/2019,Intravenous,pembrolizumab,FALSE
1170,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G254712FF2998,10/4/2015,mg,antineoplastic,8/8/2014,7/2/2014,Intravenous,bevacizumab,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/7/2017,,antineoplastic,12/14/2016,10/22/2016,Oral,clinical study drug,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/29/2025,mg,antineoplastic,5/15/2024,3/24/2024,Intravenous,durvalumab,TRUE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,12/6/2021,,antineoplastic,5/25/2018,3/4/2018,,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,7/7/2020,mg,antineoplastic,4/26/2020,3/10/2020,Intravenous,pembrolizumab,FALSE
75,3,ADVANCED,Orders,chemotherapy,Docetaxel,G1C32G396:F7G,8/19/2014,mg/m2,antineoplastic,6/30/2014,4/22/2014,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3E12EBD52F4D,4/8/2018,mg,antineoplastic,2/11/2018,3/12/2018,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,Hydroxyurea,G3487E:C:CDC6,7/24/2018,,antineoplastic,7/24/2018,5/16/2018,Oral,hydroxyurea,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/16/2025,mg,antineoplastic,10/30/2021,3/10/2020,Intravenous,pembrolizumab,FALSE
456,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/8/2025,mg,antineoplastic,8/26/2024,7/12/2024,Intravenous,carboplatin,FALSE
1105,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/21/2015,mg,antineoplastic,5/11/2015,9/2/2014,Intravenous,bevacizumab,FALSE
30,,CONCURRENT,Administrations,chemotherapy,"Amifostine,Vinorelbine",G58E8F29:9:45,4/20/2012,mg,antineoplastic,2/19/2012,2/27/2012,Intravenous,vinorelbine,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/25/2022,,antineoplastic,2/28/2022,10/6/2021,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/30/2023,mg,antineoplastic,10/5/2022,9/11/2022,Subcutaneous,azacitidine,FALSE
95.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,3/8/2019,mg,antineoplastic,10/20/2018,9/6/2018,Intravenous,paclitaxel,FALSE
1100,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G17235672EDGF,2/8/2025,mg,antineoplastic,11/26/2024,8/26/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/26/2022,mg,antineoplastic,3/22/2019,12/15/2017,Intravenous,pembrolizumab,FALSE
1800,,NEOADJUVANT,Orders,targeted/biologic,Daratumumab/Hyaluronidase-Fihj,G17DB15D8C7CG,10/9/2024,mg,antineoplastic,8/9/2024,9/11/2024,Subcutaneous,daratumumab/hyaluronidase-fihj,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Palbociclib,G286G2E848134,10/4/2016,,antineoplastic,8/23/2016,9/12/2016,Oral,palbociclib,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,3/11/2022,mg,antineoplastic,11/9/2021,2/17/2021,Intravenous,durvalumab,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,5/7/2022,mg,antineoplastic,7/26/2020,4/3/2020,Intravenous,durvalumab,TRUE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,10/25/2017,mg,antineoplastic,7/10/2017,5/24/2017,Intravenous,trastuzumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,4/18/2025,mg,antineoplastic,1/18/2025,11/26/2024,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,8/2/2023,mg,antineoplastic,10/25/2022,10/18/2022,Intravenous,pembrolizumab,FALSE
244,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:C59D3F54:2,8/30/2021,mg,antineoplastic,6/3/2021,4/20/2021,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,9/5/2019,mg,antineoplastic,8/27/2019,6/23/2019,Intravenous,carboplatin,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,4/13/2019,mg,antineoplastic,7/8/2018,6/7/2018,Intravenous,trastuzumab,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/20/2020,mg,antineoplastic,9/29/2019,3/24/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G4GE2958C:E1C,4/17/2012,,antiemetic,10/7/2011,7/13/2011,Intravenous,clinical study drug,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/7/2022,,antineoplastic,3/14/2022,2/10/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/11/2020,mg,antineoplastic,7/24/2019,2/5/2019,Intravenous,pembrolizumab,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/28/2022,mg,antineoplastic,11/19/2017,4/21/2017,Oral,dasatinib,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,8/16/2021,mL,solution-fluid,4/3/2021,5/14/2021,Intravenous,cisplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G22D6BD662E16,8/1/2020,mg,antineoplastic,6/9/2019,3/1/2019,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,5/4/2025,mg,antineoplastic,4/1/2025,7/23/2024,Intravenous,durvalumab,FALSE
137,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,2/24/2024,mg,antineoplastic,12/24/2023,12/14/2023,Intravenous,carboplatin,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/28/2016,mg,antineoplastic,1/5/2016,11/20/2015,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G29C71B44G:B6,6/15/2013,mg/m2,antineoplastic,6/16/2013,5/21/2013,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Administrations,antineoplastic,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,3/6/2021,,antineoplastic,10/2/2020,7/22/2020,,clinical study drug,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,3/19/2020,mg,antineoplastic,7/25/2018,2/2/2018,Intravenous,pemetrexed,TRUE
353,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,7/31/2018,mg,antineoplastic,6/28/2018,4/17/2018,Intravenous,carboplatin,FALSE
675,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,8/4/2024,mg,antineoplastic,8/14/2024,4/30/2024,Intravenous,pemetrexed,FALSE
1666,,CONCURRENT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,3/9/2013,mg/m2,antineoplastic,2/20/2013,2/14/2013,Intravenous,mesna,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,9/19/2014,mg,antineoplastic,6/19/2014,4/18/2014,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1185:32426FB,5/29/2016,mg,antineoplastic,4/21/2015,1/29/2015,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,3/14/2025,mg,antineoplastic,11/23/2024,12/9/2024,Intravenous,paclitaxel protein-bound,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G485C85BECGC4,5/2/2022,,antineoplastic,3/16/2022,12/10/2021,Intravenous,clinical study drug,FALSE
166.4,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,3/5/2015,mg,antineoplastic,2/8/2015,10/31/2014,Intravenous,paclitaxel,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/2/2016,mg,antineoplastic,9/8/2015,5/30/2015,Intravenous,paclitaxel protein-bound,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/14/2025,mg,antineoplastic,5/6/2022,1/23/2017,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/22/2025,,antineoplastic,12/3/2023,9/22/2022,Oral,anastrozole,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,6/5/2022,mg,antineoplastic,6/13/2022,5/7/2022,Intravenous,carboplatin,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Decitabine,Venetoclax",G41DE1E3BE99:,7/9/2024,mg,antineoplastic,7/18/2024,6/12/2024,Intravenous,decitabine,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/18/2024,mg,antineoplastic,10/3/2020,7/24/2020,Intravenous,nivolumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/12/2011,mg,antineoplastic,7/10/2011,6/18/2011,Intravenous,carboplatin,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/8/2014,mg,antineoplastic,6/5/2013,10/18/2012,Intravenous,gemcitabine,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,12/1/2014,mg,antineoplastic,11/19/2014,7/8/2014,Intravenous,vinorelbine,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/3/2014,mg,antineoplastic,7/25/2014,3/1/2014,Intravenous,paclitaxel protein-bound,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/3/2020,mg,antineoplastic,5/3/2020,5/30/2020,Intravenous,paclitaxel,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5266FE:EBE18,6/28/2015,mg,antineoplastic,5/19/2015,6/5/2015,Intravenous,pemetrexed,FALSE
825,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,3/29/2021,mg,antineoplastic,4/23/2021,12/24/2020,Intravenous,pemetrexed,FALSE
89,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1:EE91B54:7C,6/17/2021,mg,antineoplastic,5/11/2021,11/5/2020,Intravenous,ipilimumab,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/6/2025,mg,antineoplastic,9/26/2022,3/4/2019,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,5/10/2025,mg,antineoplastic,5/4/2025,2/24/2025,Intravenous,pembrolizumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G27D282B7225B,12/29/2021,mg,antineoplastic,10/7/2021,7/13/2021,Intravenous,pemetrexed,TRUE
132,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,12/19/2014,mg,antineoplastic,3/31/2014,1/22/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G29C71B44G:B6,10/2/2013,,,9/6/2013,7/29/2013,Oral,erlotinib,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,1/16/2020,mg,antineoplastic,4/17/2019,12/8/2018,Intravenous,pemetrexed,TRUE
1010,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4484725BB423,10/11/2021,mg,antineoplastic,11/22/2021,8/5/2021,Intravenous,pemetrexed,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/30/2018,mg,antineoplastic,7/16/2015,7/5/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Pemetrexed",G44B44661:316,2/18/2016,,antineoplastic,2/26/2015,3/4/2015,,pemetrexed,FALSE
136,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,11/24/2021,mg,antineoplastic,8/10/2021,4/12/2021,Intravenous,paclitaxel protein-bound,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G247F67418GGD,7/26/2013,mg,antineoplastic,8/7/2012,4/20/2012,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/10/2020,mg,antineoplastic,5/18/2018,2/23/2016,Intravenous,bevacizumab,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/11/2025,mg,antineoplastic,1/24/2025,6/27/2024,Intravenous,pemetrexed,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/19/2014,mg/m2,antineoplastic,4/25/2014,4/12/2014,Intravenous,paclitaxel,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/6/2025,mg,antineoplastic,4/11/2023,2/24/2020,Intravenous,pemetrexed,TRUE
1042.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,3/5/2014,mg,antineoplastic,11/11/2013,12/15/2013,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1EFD1E1::C6E,3/19/2025,mg,antineoplastic,4/27/2025,1/28/2024,Intravenous,pembrolizumab,FALSE
15,3,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,11/11/2014,mg/kg,antineoplastic,11/29/2014,9/22/2014,Intravenous,bevacizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G24167D1DD5FG,5/9/2025,mg,antineoplastic,2/10/2025,2/27/2025,Intravenous,durvalumab,TRUE
610,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/20/2014,mg,antineoplastic,9/7/2013,7/6/2013,Intravenous,carboplatin,FALSE
320,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,4/22/2025,mg,antineoplastic,10/20/2024,8/24/2024,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/7/2015,mg,antineoplastic,3/12/2015,3/14/2015,Intravenous,paclitaxel protein-bound,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/20/2024,mg,antineoplastic,1/21/2024,12/28/2023,Intravenous,pemetrexed,FALSE
,,NEOADJUVANT,Administrations,hematological agent,Clinical Study Drug,G3B698C119:F8,7/16/2012,,hematological agent,6/24/2012,5/19/2012,Intrajejunal,clinical study drug,FALSE
89.5,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/5/2018,mg,antineoplastic,9/28/2017,9/12/2017,Intravenous,paclitaxel,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,3/27/2015,mg,antineoplastic,4/13/2015,2/23/2015,Intravenous,carboplatin,FALSE
134,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,2/2/2017,mg,antineoplastic,12/24/2016,11/8/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G353EE82411C:,4/3/2024,mg,antineoplastic,3/7/2024,2/27/2024,Intravenous,pembrolizumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,4/11/2025,mg,antineoplastic,7/17/2022,12/3/2021,Intravenous,pembrolizumab,TRUE
162,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/20/2024,mg,antineoplastic,5/28/2024,6/15/2024,Intravenous,carboplatin,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18DFE96F9:2G,6/3/2024,mg,antineoplastic,6/5/2024,4/17/2024,Intravenous,carboplatin,FALSE
245,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/8/2014,mg,antineoplastic,4/6/2014,3/31/2014,Intravenous,carboplatin,FALSE
32,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,11/29/2014,mg,antineoplastic,1/27/2014,1/11/2014,Intravenous,cisplatin,FALSE
,4,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G177G4:B9E394,5/7/2025,,steroid,4/28/2025,4/11/2025,Intravenous,clinical study drug,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/3/2019,mg,antineoplastic,7/23/2019,7/10/2019,Intravenous,paclitaxel protein-bound,FALSE
360,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G54F545489E59,5/8/2024,mg,antineoplastic,4/15/2024,11/24/2023,Intravenous,nivolumab,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,11/19/2024,mg,antineoplastic,10/14/2024,5/10/2024,Intravenous,nivolumab,FALSE
386,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/19/2022,mg,antineoplastic,10/27/2021,11/22/2021,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,3/31/2025,mg,antineoplastic,1/3/2025,1/28/2024,Intravenous,pembrolizumab,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,11/28/2014,AUC,antineoplastic,11/19/2014,10/3/2014,Intravenous,carboplatin,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/21/2023,mg,antineoplastic,7/16/2021,12/31/2019,Intravenous,pembrolizumab,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,11/11/2011,mg,antineoplastic,9/17/2011,7/9/2011,Intravenous,carboplatin,FALSE
590,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,1/12/2021,mg,antineoplastic,9/17/2020,6/12/2020,Intravenous,ramucirumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/24/2024,mg,antineoplastic,4/25/2023,2/19/2023,Intravenous,atezolizumab,TRUE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/14/2017,mg,antineoplastic,3/23/2016,5/11/2015,Intravenous,nivolumab,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,7/31/2021,mg,antineoplastic,5/28/2021,5/14/2021,Intravenous,pemetrexed,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/14/2021,mg,antineoplastic,2/16/2021,12/30/2020,Intravenous,carboplatin,FALSE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,9/28/2016,mg,antineoplastic,9/23/2016,6/7/2016,Intravenous,paclitaxel,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,6/3/2023,mg,antineoplastic,5/10/2023,5/18/2023,Intravenous,paclitaxel,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/4/2013,mg,antineoplastic,2/28/2013,10/25/2012,Intravenous,gemcitabine,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,4/7/2013,mg,antineoplastic,3/20/2013,1/30/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,5/1/2025,mg,antineoplastic,1/18/2024,9/20/2023,Intravenous,pembrolizumab,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,1/28/2016,mg/kg,antineoplastic,12/5/2015,9/11/2015,Intravenous,bevacizumab,FALSE
540,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/6/2023,mg,antineoplastic,9/24/2020,4/17/2020,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G12DD1599F4EF,4/15/2025,mg,antineoplastic,10/10/2024,10/8/2024,Intravenous,pembrolizumab,FALSE
197.76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G147B:8F3B:52,11/19/2021,mg,antineoplastic,10/23/2021,10/10/2021,Intravenous,carboplatin,FALSE
169,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,5/9/2015,mg,antineoplastic,4/13/2015,3/14/2015,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/18/2018,mg,antineoplastic,3/25/2018,11/19/2017,Intravenous,pemetrexed,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,12/21/2023,mg,antineoplastic,12/22/2023,11/18/2023,Intravenous,carboplatin,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,1/5/2017,mg,antineoplastic,3/9/2014,12/1/2013,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,3/27/2021,mg,antineoplastic,4/21/2021,1/28/2021,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G344BC2:6BGE1,4/8/2012,,antineoplastic,1/20/2012,10/1/2011,Intravenous,clinical study drug,FALSE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/3/2018,mg,antineoplastic,6/18/2018,4/19/2018,Intravenous,paclitaxel,FALSE
85,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,10/17/2015,mg,antineoplastic,9/6/2015,8/2/2015,Intravenous,paclitaxel,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,3/18/2025,mg,antineoplastic,2/3/2025,5/3/2024,Intravenous,pemetrexed,TRUE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1E2B6::D8477,4/27/2025,mg,antineoplastic,11/17/2024,5/8/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,8/14/2017,,antineoplastic,5/14/2017,3/6/2017,Intravenous,carboplatin,FALSE
1,1,ADVANCED,Orders,hormone,Anastrozole,G175D38G17E84,6/11/2017,mg,antineoplastic,1/28/2016,1/22/2016,Oral,anastrozole,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/8/2018,mg,antineoplastic,9/14/2018,7/11/2018,Intravenous,cisplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/16/2021,mg,antineoplastic,3/19/2021,1/3/2019,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G36G688G4EBD6,12/9/2023,mg,antineoplastic,12/23/2023,8/30/2023,Intravenous,pembrolizumab,TRUE
75,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G4ECBF26D2579,8/29/2014,mg/m2,antineoplastic,4/18/2014,5/20/2014,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,9/22/2022,AUC,antineoplastic,3/18/2022,3/24/2022,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,11/20/2022,,antineoplastic,10/13/2022,11/2/2022,Oral,imatinib,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G31G19E54FC:B,10/31/2020,,,10/1/2020,8/25/2020,Oral,osimertinib,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/15/2024,,antineoplastic,11/20/2023,3/21/2023,Intravenous,atezolizumab,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,2/2/2014,mg/m2,antineoplastic,12/16/2013,11/5/2013,Intravenous,paclitaxel,FALSE
410,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/28/2017,mg,antineoplastic,3/30/2017,3/25/2017,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/9/2022,,antineoplastic,8/3/2021,8/21/2021,Intravenous,amivantamab-vmjw,FALSE
1353,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/3/2016,mg,antineoplastic,2/5/2015,1/21/2015,Intravenous,bevacizumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/22/2016,mg,antineoplastic,4/17/2015,5/3/2014,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/8/2024,mg,antineoplastic,11/30/2023,7/5/2023,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,12/22/2013,mg,antineoplastic,11/23/2013,10/11/2013,Intravenous,bevacizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3EG8DGC9B:1E,6/30/2020,mg,antineoplastic,1/10/2020,7/10/2019,Intravenous,pembrolizumab,FALSE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/7/2018,mg,antineoplastic,8/25/2018,4/20/2018,Intravenous,carboplatin,FALSE
727,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,5/16/2019,mg,antineoplastic,3/31/2019,3/5/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G2GB:GBC6G568,5/5/2025,,,4/14/2025,8/27/2023,Oral,osimertinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/28/2025,mg,antineoplastic,9/8/2021,1/28/2017,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/13/2025,mg,antineoplastic,8/29/2024,9/16/2022,Oral,anastrozole,FALSE
161,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,12/26/2012,mg,antineoplastic,11/9/2012,10/16/2012,Intravenous,cisplatin,FALSE
128,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CCC3642E:67,5/16/2019,mg,antineoplastic,4/5/2019,3/4/2019,Intravenous,carboplatin,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,6/6/2024,mg,antineoplastic,10/31/2023,10/20/2023,Intravenous,amivantamab-vmjw,FALSE
313,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,7/20/2023,mg,antineoplastic,5/1/2023,3/1/2023,Intravenous,paclitaxel,FALSE
600,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/23/2015,mg,antineoplastic,7/22/2015,6/5/2015,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,3/29/2020,mg,antineoplastic,2/4/2020,12/25/2019,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,9/4/2024,mg,antineoplastic,7/15/2024,6/2/2024,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/3/2023,mg,antineoplastic,5/26/2023,4/15/2023,Intravenous,paclitaxel,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/12/2020,mg,antineoplastic,6/23/2019,2/17/2019,Intravenous,durvalumab,FALSE
97,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/13/2024,mg,antineoplastic,7/21/2024,5/17/2024,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,12/30/2013,,antineoplastic,10/25/2013,11/7/2013,Intravenous,clinical study drug,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/23/2018,AUC,antineoplastic,10/22/2017,9/1/2017,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/23/2022,mg,antineoplastic,8/28/2020,3/19/2020,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/6/2016,mg,antineoplastic,11/29/2015,6/29/2015,Intravenous,pemetrexed,FALSE
517,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/11/2016,mg,antineoplastic,7/27/2016,5/5/2016,Intravenous,carboplatin,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/24/2022,mg,antineoplastic,8/22/2021,9/29/2021,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/26/2013,mg/m2,antineoplastic,6/7/2013,9/15/2012,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/21/2025,,antineoplastic,10/27/2024,4/6/2024,Intravenous,clinical study drug,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/22/2022,mg,antineoplastic,7/12/2020,3/23/2020,Intravenous,durvalumab,TRUE
120,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,12/5/2024,mg,antineoplastic,8/8/2024,8/20/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,12/16/2022,mg,antineoplastic,5/12/2022,12/28/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,11/8/2024,mg,antineoplastic,10/16/2024,9/28/2024,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Unstructured,,"Afatinib,Osimertinib",G4GF74CE8E4:6,7/26/2023,,,5/14/2023,6/25/2023,Oral,afatinib,FALSE
705,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,6/22/2022,mg,antineoplastic,4/1/2022,12/23/2021,Intravenous,pemetrexed,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/18/2021,mg,antineoplastic,6/21/2021,5/16/2020,Intravenous,gemcitabine,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15F6:966BBB3,8/9/2016,mg,antineoplastic,8/13/2016,4/29/2016,Intravenous,paclitaxel,FALSE
280,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G242B854DCE96,3/31/2016,mg,antineoplastic,1/20/2016,12/11/2015,Intravenous,nivolumab,FALSE
238,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/25/2021,mg,antineoplastic,7/19/2021,7/18/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,5/18/2012,,solution-fluid,2/27/2012,10/11/2011,Intravenous,clinical study drug,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/22/2024,mg,antineoplastic,7/4/2020,6/5/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/25/2023,mg,antineoplastic,6/2/2022,4/1/2022,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,3/25/2021,,antiemetic,4/23/2020,2/12/2020,Intravenous,clinical study drug,FALSE
250,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,9/24/2024,mg,antineoplastic,5/13/2024,5/6/2024,Intravenous,carboplatin,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/7/2020,mg,antineoplastic,4/30/2019,11/10/2018,Intravenous,durvalumab,TRUE
230,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G46:87GF7FGC9,8/23/2016,mg,antineoplastic,8/16/2016,11/1/2015,Intravenous,nivolumab,FALSE
250,1,LOCOREGIONAL,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/7/2018,mL,solution-fluid,1/21/2018,12/22/2017,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,11/3/2016,mg,antineoplastic,4/26/2015,6/20/2015,Intravenous,pemetrexed,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/19/2020,mg,antineoplastic,4/28/2017,1/18/2016,Intravenous,bevacizumab,TRUE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45388C4DCEFB,7/9/2012,mg,antineoplastic,5/19/2012,5/12/2012,Intravenous,paclitaxel,FALSE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G25BG745::8GE,3/24/2025,,,4/20/2025,6/25/2024,Oral,osimertinib,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/16/2017,mg,antineoplastic,12/31/2016,11/4/2016,Intravenous,carboplatin,FALSE
634,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G252328CFG4E1,6/25/2024,mg,antineoplastic,4/4/2024,5/28/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/3/2022,,antineoplastic,11/8/2021,5/22/2017,Oral,nilotinib,FALSE
3,1,ADVANCED,Orders,immunotherapy,Nivolumab,G33E77:6CF7F3,9/23/2017,mg/kg,antineoplastic,4/6/2017,8/15/2016,Intravenous,nivolumab,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/9/2020,mg,antineoplastic,10/10/2020,11/1/2020,Intravenous,paclitaxel protein-bound,FALSE
540,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/15/2016,mg,antineoplastic,8/16/2016,4/27/2016,Intravenous,bevacizumab,FALSE
1100,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/3/2022,mg,antineoplastic,6/21/2021,3/20/2021,Intravenous,bevacizumab-awwb,FALSE
345,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,3/20/2022,mg,antineoplastic,2/23/2022,12/1/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3B:GGE2C4G47,3/25/2019,mg,antineoplastic,2/18/2019,12/13/2017,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,9/17/2022,AUC,antineoplastic,7/9/2022,7/10/2022,Intravenous,carboplatin,FALSE
101,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/9/2021,mg,antineoplastic,9/26/2021,10/17/2021,Intravenous,paclitaxel,FALSE
160,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G163D9B593927,10/9/2016,mg,antineoplastic,6/29/2016,6/23/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G17EC67:48631,4/3/2025,mg,antineoplastic,4/29/2025,5/4/2024,Intravenous,pembrolizumab,TRUE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/8/2015,mg,antineoplastic,5/17/2015,1/31/2015,Intravenous,paclitaxel protein-bound,FALSE
357,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24G:14D89BD9,1/27/2020,mg,antineoplastic,5/10/2013,2/13/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1:79593262B6,11/16/2022,mg,antineoplastic,8/8/2018,12/18/2017,Intravenous,pembrolizumab,FALSE
190,2,LOCOREGIONAL,Administrations,chemotherapy,Osimertinib,G3:67CF8FF:28,11/22/2021,mg,antineoplastic,4/23/2020,4/17/2020,Intravenous,carboplatin,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/15/2022,mg,antineoplastic,7/24/2022,8/6/2022,Intravenous,paclitaxel,FALSE
1062.5,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,1/4/2016,mg,antineoplastic,11/25/2015,2/3/2015,Intravenous,bevacizumab,FALSE
1055,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G14E999899EFC,4/28/2025,mg,antineoplastic,2/4/2025,12/30/2024,Intravenous,pemetrexed,FALSE
175,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,3/15/2018,mg/m2,antineoplastic,12/24/2017,10/23/2017,Intravenous,paclitaxel,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,2/4/2023,mg,antineoplastic,1/25/2023,12/2/2022,Intravenous,nivolumab,TRUE
120,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,1/2/2023,mg,antineoplastic,10/28/2021,9/23/2021,Intravenous,bendamustine,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/4/2022,mg,antineoplastic,2/6/2022,2/22/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/9/2020,mg,antineoplastic,7/25/2020,6/16/2019,Intravenous,pembrolizumab,TRUE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/23/2013,mg,antineoplastic,3/29/2013,5/27/2012,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G27D282B7225B,11/14/2021,,antineoplastic,7/25/2021,6/18/2021,Intravenous,pemetrexed,TRUE
500,,NEOADJUVANT,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,3/15/2019,mg/m2,antineoplastic,4/7/2019,12/22/2018,Intravenous,pemetrexed,FALSE
1170,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G254712FF2998,8/27/2015,mg,antineoplastic,9/10/2014,8/3/2014,Intravenous,bevacizumab,FALSE
600,1,ADVANCED,Administrations,targeted/biologic,"Erlotinib,Ramucirumab",G4725296E3CE4,9/2/2021,mg,antineoplastic,10/15/2021,8/3/2021,Intravenous,ramucirumab,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,10/1/2013,mg,antineoplastic,4/27/2013,4/6/2013,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/6/2016,,antineoplastic,8/26/2016,4/28/2016,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/23/2015,,antineoplastic,3/18/2015,2/24/2015,,carboplatin,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,10/4/2011,mg,antineoplastic,9/9/2011,6/25/2011,Intravenous,etoposide,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/6/2020,mg,antineoplastic,3/25/2020,9/30/2019,Intravenous,durvalumab,FALSE
268,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,11/22/2020,mg,antineoplastic,3/17/2020,1/27/2020,Intravenous,carboplatin,FALSE
516,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1532797B869C,7/12/2023,mg,antineoplastic,5/21/2023,3/12/2023,Intravenous,durvalumab,TRUE
1060,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,6/12/2014,mg,antineoplastic,3/6/2014,12/14/2013,Intravenous,pemetrexed,FALSE
85,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B2G711:7F8:,5/9/2015,mg,antineoplastic,5/14/2015,5/2/2015,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G242GD729:FB:,5/14/2024,mg,antineoplastic,4/17/2024,3/22/2024,Intravenous,pembrolizumab,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,8/17/2020,mg,antineoplastic,7/15/2020,6/19/2020,Subcutaneous,azacitidine,FALSE
2.4,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/5/2020,mg,antineoplastic,5/24/2020,1/26/2019,Subcutaneous,bortezomib,FALSE
1200,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,2/7/2016,mg,antineoplastic,9/29/2015,9/11/2015,Intravenous,bevacizumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/28/2025,mg,antineoplastic,4/13/2018,8/4/2016,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/9/2024,mg,antineoplastic,6/10/2024,3/17/2023,Intravenous,nivolumab,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,12/1/2023,mg,antineoplastic,10/26/2023,10/8/2023,Intravenous,paclitaxel,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/15/2024,mg,antineoplastic,6/2/2022,4/3/2022,Intravenous,durvalumab,TRUE
84,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1:B8CFFD1931,12/12/2015,mg,antineoplastic,6/1/2015,5/13/2015,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,5/9/2025,mg,antineoplastic,10/19/2022,8/20/2022,Intravenous,pembrolizumab,TRUE
750,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/5/2025,mg,antineoplastic,6/28/2024,2/16/2024,Intravenous,amivantamab-vmjw,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/9/2015,mg,antineoplastic,9/16/2015,1/30/2015,Intravenous,paclitaxel protein-bound,FALSE
156,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G1:F129FBCE3F,10/2/2020,mg,antineoplastic,7/23/2020,7/1/2020,Subcutaneous,azacitidine,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,4/24/2023,,antineoplastic,12/23/2022,10/17/2022,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/17/2011,mg,antineoplastic,9/20/2011,3/17/2011,Intravenous,paclitaxel,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/14/2013,AUC,antineoplastic,9/27/2012,7/16/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,5/13/2013,mg,antineoplastic,12/21/2012,12/26/2012,Intravenous,paclitaxel protein-bound,FALSE
1599,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,4/3/2020,mg,antineoplastic,2/9/2020,1/1/2020,Intravenous,bevacizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/23/2021,mg,antineoplastic,4/16/2019,12/27/2018,Intravenous,pemetrexed,TRUE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/4/2023,mg,antineoplastic,7/29/2020,5/12/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/4/2025,mg,antineoplastic,6/28/2023,10/12/2022,Intravenous,pembrolizumab,TRUE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1CD225858D1:,4/16/2019,mg/kg,antineoplastic,7/12/2017,6/24/2017,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28F814933C3F,1/18/2025,mg,antineoplastic,9/22/2024,8/14/2024,Intravenous,pembrolizumab,TRUE
192,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4C88CEG2:289,12/13/2024,mg,antineoplastic,11/10/2024,11/12/2024,Intravenous,carboplatin,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/19/2022,mg,antineoplastic,6/27/2021,5/26/2021,Intravenous,fluorouracil,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/23/2023,mg,antineoplastic,2/9/2023,8/27/2022,Intravenous,pemetrexed,TRUE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,9/2/2013,mg,antineoplastic,9/3/2013,7/15/2013,Intravenous,cisplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G11:E1E83E6:D,5/4/2019,mg,antineoplastic,5/11/2019,5/24/2019,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/8/2022,mg,antineoplastic,10/17/2018,1/16/2016,Intravenous,pemetrexed,FALSE
304,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G35DB7G1CE73D,7/9/2015,mg,antineoplastic,6/8/2015,6/5/2015,Intravenous,paclitaxel,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,8/24/2013,mg,antineoplastic,5/25/2013,5/23/2013,Intravenous,paclitaxel,FALSE
485,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,7/31/2016,mg,antineoplastic,7/12/2016,5/1/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3EC2153F:341,5/17/2020,mg,antineoplastic,6/16/2020,5/8/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/12/2025,mg,antineoplastic,11/8/2023,5/2/2022,Intravenous,pembrolizumab,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,11/13/2011,mg,antineoplastic,9/26/2011,6/11/2011,Intravenous,etoposide,FALSE
424,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,10/19/2020,mg,antineoplastic,6/16/2020,5/19/2020,Intravenous,carboplatin,FALSE
248,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/27/2016,mg,antineoplastic,10/27/2015,7/24/2015,Intravenous,carboplatin,FALSE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,8/20/2016,mg,antineoplastic,8/12/2015,10/26/2014,Intravenous,bevacizumab,TRUE
636,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/25/2025,mg,antineoplastic,2/2/2025,1/8/2025,Intravenous,fluorouracil,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/19/2021,mg,antineoplastic,8/20/2021,6/30/2021,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3951BC5GBE44,4/19/2025,mg,antineoplastic,12/30/2024,11/21/2024,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G41G38G7991D4,4/21/2025,,,1/13/2025,11/22/2024,Oral,dabrafenib,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/14/2013,mg,antineoplastic,8/3/2013,2/3/2013,Intravenous,paclitaxel protein-bound,FALSE
20,,ADJUVANT,Orders,chemotherapy,Decitabine,G1F5415D1B672,11/21/2018,mg/m2,antineoplastic,8/21/2018,8/19/2018,Intravenous,decitabine,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/20/2020,mg,antineoplastic,6/24/2020,4/25/2020,Intravenous,paclitaxel protein-bound,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,9/3/2020,mg,antineoplastic,8/31/2020,9/19/2019,Intravenous,durvalumab,FALSE
37,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1:B8CFFD1931,6/28/2015,mg,antineoplastic,5/4/2015,2/28/2015,Intravenous,vinorelbine,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,5/15/2018,mg,antineoplastic,3/9/2018,3/14/2018,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/21/2019,mg,antineoplastic,3/30/2018,3/19/2018,Intravenous,nivolumab,FALSE
35,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,1/16/2024,mg/m2,antineoplastic,11/21/2023,11/2/2023,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,2/11/2020,mg,antineoplastic,11/27/2019,12/20/2019,Intravenous,pembrolizumab,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,12/9/2017,mg,antineoplastic,6/12/2017,5/25/2017,Intravenous,paclitaxel,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,10/17/2024,mg,antineoplastic,9/3/2024,8/15/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/5/2023,mg,antineoplastic,3/25/2022,1/28/2022,Intravenous,pembrolizumab,TRUE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/8/2024,mg,antineoplastic,3/22/2024,3/25/2024,Intravenous,carboplatin,FALSE
1025,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,7/23/2020,mg,antineoplastic,6/27/2020,4/13/2020,Intravenous,pemetrexed,FALSE
34,,CONCURRENT,Administrations,chemotherapy,Vinorelbine,G13F669ED2119,5/23/2013,mg,antineoplastic,4/20/2013,12/10/2012,Intravenous,vinorelbine,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,9/18/2023,mg,antineoplastic,6/26/2023,8/11/2022,Intravenous,pemetrexed,TRUE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FF2946:4C6F,11/3/2017,mg,antineoplastic,8/21/2017,5/28/2017,Intravenous,carboplatin,FALSE
251.6,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,11/25/2014,mg,antineoplastic,12/7/2014,8/5/2014,Intravenous,carboplatin,FALSE
93,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G3E76E32E795:,7/14/2020,mg,antineoplastic,5/28/2020,4/15/2020,Intravenous,docetaxel,FALSE
1070,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1D:B49GGG719,11/16/2016,mg,antineoplastic,7/18/2016,7/30/2016,Intravenous,pemetrexed,TRUE
520,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2G6E1E144F8E,5/31/2024,mg,antineoplastic,5/23/2024,3/22/2024,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/1/2023,mL,solution-fluid,9/20/2023,12/7/2022,Intravenous,pemetrexed,FALSE
465,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,6/13/2014,mg,antineoplastic,5/24/2014,4/19/2014,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/14/2025,mg,antineoplastic,10/1/2021,8/26/2021,Intravenous,atezolizumab,TRUE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/28/2020,mg,antineoplastic,6/8/2020,2/16/2020,Intravenous,bevacizumab,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/9/2021,mg,antineoplastic,4/1/2021,9/21/2020,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,3/25/2025,mg,antineoplastic,3/5/2025,5/6/2024,Intravenous,pembrolizumab,FALSE
925,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G135B:GEC35G4,5/23/2025,mg,antineoplastic,4/10/2025,4/8/2025,Intravenous,pemetrexed,FALSE
835,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/10/2021,mg,antineoplastic,6/22/2021,4/5/2021,Intravenous,pemetrexed,TRUE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G24C:63G27686,2/17/2014,,antineoplastic,12/9/2013,10/30/2013,,clinical study drug,FALSE
181,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/8/2023,mg,antineoplastic,4/29/2022,3/10/2022,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/10/2025,mg/m2,antineoplastic,8/10/2024,8/10/2024,Intravenous,gemcitabine,FALSE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/22/2021,mg,antineoplastic,12/9/2018,2/12/2018,Intravenous,durvalumab,TRUE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/20/2022,mg,antineoplastic,5/9/2017,4/18/2017,Oral,dasatinib,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,4/25/2025,mg,antineoplastic,3/8/2025,12/9/2024,Intravenous,pembrolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/12/2019,mg,antineoplastic,10/29/2019,7/10/2018,Intravenous,pembrolizumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/19/2025,mg,antineoplastic,2/5/2025,2/27/2023,Intravenous,pembrolizumab,FALSE
252,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445B:B:15B5F,11/7/2014,mg,antineoplastic,9/26/2014,9/6/2014,Intravenous,carboplatin,FALSE
1700,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G11:F93GC6851,4/15/2021,mg,antineoplastic,3/28/2021,2/6/2021,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/16/2025,,antineoplastic,7/24/2024,3/25/2024,Intravenous,clinical study drug,FALSE
1910,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,1/22/2025,mg,antineoplastic,12/24/2024,1/12/2025,Intravenous,gemcitabine,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/19/2018,mg,antineoplastic,12/19/2017,7/13/2017,Intravenous,pembrolizumab,FALSE
176,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,8/7/2024,mg,antineoplastic,3/23/2024,4/12/2024,Intravenous,cisplatin,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5:9BFG41:736,8/29/2016,mg,antineoplastic,8/27/2016,9/16/2016,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/25/2022,,antineoplastic,10/20/2020,4/16/2017,Oral,nilotinib,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G3EC5EB18C676,2/8/2018,mg,antineoplastic,12/19/2017,6/5/2017,Intravenous,nivolumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,6/10/2018,mg,antineoplastic,12/21/2017,8/23/2015,Intravenous,nivolumab,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/18/2017,mg,antineoplastic,5/19/2016,4/19/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4F354B:F341F,6/30/2017,,antineoplastic,10/8/2016,9/28/2016,Intravenous,nivolumab,FALSE
590,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,1/19/2015,mg,antineoplastic,11/18/2014,10/11/2014,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G1DCDG73E53FF,7/7/2024,,antineoplastic,6/19/2024,4/7/2024,Intravenous,clinical study drug,FALSE
104,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,12/11/2011,mg,antineoplastic,9/14/2011,10/6/2011,Intravenous,etoposide,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G358C8DCE9BD5,9/23/2019,mg,antineoplastic,5/21/2019,5/2/2019,Intravenous,carboplatin,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/2/2023,mg,antineoplastic,7/6/2023,7/7/2023,Intravenous,paclitaxel,FALSE
154,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,11/12/2015,mg,antineoplastic,6/30/2015,7/23/2015,Intravenous,paclitaxel protein-bound,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/21/2022,mg,antineoplastic,5/22/2016,1/10/2016,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Administrations,targeted/biologic,Clinical Study Drug,G579E53D92:75,11/4/2011,,antineoplastic,10/2/2011,8/14/2011,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/3/2025,mg,antineoplastic,8/3/2023,6/2/2023,Intravenous,pembrolizumab,TRUE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,10/17/2021,mg,antineoplastic,5/8/2021,4/21/2021,Intravenous,pemetrexed,FALSE
72,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/20/2024,mg,antineoplastic,9/8/2024,9/6/2024,Intravenous,paclitaxel,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,2/24/2017,mg,antineoplastic,11/26/2015,3/14/2015,Intravenous,bevacizumab,TRUE
620,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1FG3GD3:9D:3,5/11/2025,mg,antineoplastic,11/8/2024,7/14/2024,Intravenous,durvalumab,FALSE
97,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/14/2024,mg,antineoplastic,7/16/2024,6/15/2024,Intravenous,paclitaxel,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,3/8/2019,mg,antineoplastic,3/18/2019,11/15/2018,Intravenous,carboplatin,FALSE
1125,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:78734BCEDB,1/29/2015,mg,antineoplastic,9/28/2014,7/5/2014,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,4/19/2024,mg,antineoplastic,12/22/2021,12/5/2021,Intravenous,pembrolizumab,FALSE
500,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,6/1/2024,mL,solution-fluid,1/10/2024,11/14/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,2/23/2024,mg,antineoplastic,9/13/2023,4/29/2020,Intravenous,pembrolizumab,TRUE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/4/2016,mg,antineoplastic,11/25/2014,11/2/2014,Intravenous,gemcitabine,FALSE
860,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B2469295BGE,1/11/2014,mg,antineoplastic,1/20/2014,11/2/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,6/26/2019,mg,antineoplastic,11/30/2018,12/24/2018,Intravenous,pembrolizumab,FALSE
1666,,CONCURRENT,Orders,cytoprotective,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,3/3/2013,mg/m2,antineoplastic,2/7/2013,3/5/2013,Intravenous,mesna,FALSE
565,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G287777772FGE,12/26/2022,mg,antineoplastic,12/29/2022,12/29/2022,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/8/2013,mg,antineoplastic,6/22/2012,12/18/2011,Intravenous,carboplatin,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G25273E3EC7E1,4/2/2020,mg,antineoplastic,2/28/2020,1/11/2020,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/7/2025,,antineoplastic,3/3/2024,1/25/2023,,clinical study drug,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G45DDGFC1G86F,6/10/2016,mg,antineoplastic,3/16/2016,3/22/2016,Intravenous,nivolumab,FALSE
205,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11:82999D55C,3/14/2017,mg,antineoplastic,2/8/2017,1/18/2017,Intravenous,carboplatin,FALSE
462,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,3/23/2024,mg,antineoplastic,2/29/2024,12/21/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G1CD225858D1:,8/8/2017,,antineoplastic,4/9/2017,1/4/2017,Intravenous,clinical study drug,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/5/2019,mg,antineoplastic,11/15/2016,3/27/2016,Intravenous,nivolumab,FALSE
,,ADJUVANT,Administrations,growth factor,Clinical Study Drug,G128:92:3BD3D,1/2/2022,,hematological agent,5/24/2021,4/8/2021,Subcutaneous,clinical study drug,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/15/2023,mg,antineoplastic,10/24/2022,6/17/2022,Intravenous,durvalumab,FALSE
1570,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,6/13/2014,mg,antineoplastic,2/11/2014,2/16/2014,Intravenous,gemcitabine,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,2/5/2015,mg,antineoplastic,12/17/2014,10/30/2014,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G57G45B:D1F17,1/10/2025,,solution-fluid,7/10/2018,10/25/2017,Intravenous,clinical study drug,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,3/3/2015,mg,antineoplastic,11/20/2014,10/19/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,8/31/2022,mg,antineoplastic,5/13/2022,6/22/2022,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,8/7/2022,mg,antineoplastic,7/16/2022,7/7/2021,Intravenous,bevacizumab-bvzr,FALSE
,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G535BE993E221,9/10/2023,,antineoplastic,6/18/2023,7/11/2023,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,4/30/2024,,antineoplastic,4/24/2024,4/16/2024,Oral,hydroxyurea,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G147ED4GE76EE,2/22/2020,,,1/1/2020,11/25/2019,Oral,afatinib,FALSE
1000,3,ADVANCED,Administrations,immunotherapy,Durvalumab,G1:64BD9C5919,12/28/2023,mg,antineoplastic,12/31/2021,11/20/2021,Intravenous,durvalumab,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1DB5D1BG667E,11/15/2015,mg/m2,antineoplastic,10/28/2015,10/11/2015,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G2E1F163ECG9B,9/12/2013,,,10/2/2013,8/30/2013,Oral,erlotinib,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/20/2019,mg,antineoplastic,5/13/2017,3/26/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,12/4/2023,,solution-fluid,6/28/2023,1/18/2023,Intravenous,clinical study drug,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G1:C9B9B392:C,4/26/2015,mg/m2,antineoplastic,4/12/2015,3/30/2015,Intravenous,gemcitabine,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C8BC23336FC,6/26/2018,mg,antineoplastic,3/27/2018,5/21/2018,Intravenous,carboplatin,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Etoposide",G18G1G58:1447,1/15/2019,mL,solution-fluid,10/2/2017,10/1/2017,Intravenous,etoposide,FALSE
636,,ADJUVANT,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,3/17/2025,mg,antineoplastic,2/9/2025,11/12/2024,Intravenous,leucovorin,FALSE
99,4,ADVANCED,Administrations,chemotherapy,Docetaxel,G3EC5EB18C676,8/27/2019,mg,antineoplastic,12/5/2018,8/1/2018,Intravenous,docetaxel,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,1/4/2021,mg,antineoplastic,8/22/2018,4/1/2017,Intravenous,bevacizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/22/2019,mg,antineoplastic,7/9/2017,3/9/2016,Intravenous,nivolumab,FALSE
4,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/23/2013,AUC,antineoplastic,12/6/2012,7/16/2012,Intravenous,carboplatin,FALSE
205,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,5/21/2016,mg,antineoplastic,3/30/2016,3/23/2016,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,11/3/2021,,antineoplastic,1/14/2019,3/21/2018,,durvalumab,TRUE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,9/4/2024,mg,antineoplastic,9/22/2024,7/9/2024,Intravenous,pemetrexed,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,2/9/2017,mg,antineoplastic,12/28/2013,12/29/2013,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G56EBB:DF7644,3/26/2023,mg,antineoplastic,4/17/2022,3/24/2022,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,Selpercatinib,G145E1G:C6189,5/25/2021,,,6/3/2021,12/21/2020,Oral,selpercatinib,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,3/31/2016,mg,antineoplastic,4/26/2014,4/6/2014,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/8/2025,,antineoplastic,2/19/2022,3/25/2020,Oral,enzalutamide,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/9/2025,mg,antineoplastic,6/3/2021,3/6/2019,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,10/16/2023,,antineoplastic,5/27/2023,5/4/2023,,azacitidine,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,9/10/2016,mg,antineoplastic,8/29/2016,6/18/2016,Intravenous,paclitaxel,FALSE
50,,ADJUVANT,Administrations,hormone,Bicalutamide,G4992B5EB431G,1/13/2021,mg,antineoplastic,11/6/2020,10/3/2020,Oral,bicalutamide,FALSE
360,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1E2B6::D8477,3/28/2024,mg,antineoplastic,5/17/2023,5/14/2023,Intravenous,nivolumab,TRUE
100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/10/2020,mg,antineoplastic,5/17/2020,2/14/2020,Intravenous,paclitaxel,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/9/2023,mg,antineoplastic,6/26/2023,5/23/2023,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G38F772G48B9C,3/20/2025,mg,antineoplastic,10/23/2022,3/18/2022,Intravenous,pembrolizumab,TRUE
297,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/13/2023,mg,antineoplastic,11/21/2022,12/6/2022,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Unstructured,,Afatinib,G133G3GCBGE3D,3/31/2014,,,2/12/2014,2/10/2014,Oral,afatinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/20/2025,mg,antineoplastic,1/1/2020,12/28/2018,Intravenous,pembrolizumab,TRUE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/8/2018,mg,antineoplastic,7/15/2018,5/7/2018,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,4/30/2023,,antineoplastic,11/16/2022,11/13/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,7/11/2020,mg,antineoplastic,3/17/2020,2/16/2020,Intravenous,paclitaxel,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,4/3/2018,mg,antineoplastic,1/1/2018,12/29/2017,Intravenous,paclitaxel,FALSE
1509,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1D:B49GGG719,12/11/2016,mg,antineoplastic,11/7/2016,7/18/2016,Intravenous,bevacizumab,TRUE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/21/2025,mg,antineoplastic,10/4/2024,9/21/2024,Intravenous,carboplatin,FALSE
757,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,9/19/2019,mg,antineoplastic,4/23/2019,2/25/2019,Intravenous,durvalumab,TRUE
96,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,10/10/2014,mg,antineoplastic,8/26/2014,8/22/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/2/2024,mg,antineoplastic,2/15/2023,5/30/2020,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/24/2025,mg,antineoplastic,6/1/2018,12/20/2016,Intravenous,pembrolizumab,FALSE
73,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,5/2/2022,mg,antineoplastic,2/26/2022,1/13/2022,Intravenous,paclitaxel,FALSE
77,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,1/23/2019,mg,antineoplastic,7/22/2018,3/27/2018,Intravenous,paclitaxel,FALSE
1850,1,LOCOREGIONAL,Administrations,chemotherapy,Gemcitabine,G51CG28FB981G,12/10/2024,mg,antineoplastic,6/16/2024,5/21/2024,Intravenous,gemcitabine,FALSE
773,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,3/2/2023,mg,antineoplastic,12/26/2022,12/9/2022,Intravenous,carboplatin,FALSE
516,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G1E2B6::D8477,5/9/2023,mg,antineoplastic,2/8/2023,1/24/2023,Intravenous,carboplatin,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G289C6438E26:,3/6/2013,AUC,antineoplastic,2/7/2013,1/7/2013,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G2262335C:D62,10/11/2024,mg,antineoplastic,1/16/2024,9/20/2023,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,immunotherapy,Pembrolizumab,G199G4682G18:,3/23/2025,,antineoplastic,2/8/2025,3/19/2024,,pembrolizumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G5722GECG4G16,3/19/2024,mg,antineoplastic,12/10/2023,10/7/2023,Intravenous,durvalumab,TRUE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/22/2022,,antineoplastic,4/13/2022,3/4/2022,,ipilimumab,FALSE
5000,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,4/4/2020,mg,antineoplastic,3/7/2020,3/19/2020,Intravenous,fluorouracil,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,7/28/2018,mg,antineoplastic,6/30/2017,5/12/2017,Intravenous,vinorelbine,FALSE
579,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/17/2025,mg,antineoplastic,4/26/2024,3/4/2024,Intravenous,carboplatin,FALSE
717,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,12/16/2023,mg,antineoplastic,11/30/2023,9/8/2023,Intravenous,carboplatin,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,5/1/2020,mg,antineoplastic,5/7/2019,3/15/2019,Intravenous,pemetrexed,FALSE
45,2,ADVANCED,Administrations,cytoprotective,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,11/15/2022,mg,antineoplastic,5/9/2021,6/14/2021,Intravenous,leucovorin,FALSE
,,ADJUVANT,Unstructured,,Erlotinib,G2E99628474:8,10/3/2018,,,8/30/2017,9/25/2017,Oral,erlotinib,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,4/17/2016,mg,antineoplastic,1/14/2016,12/19/2015,Intravenous,paclitaxel,FALSE
600,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,12/20/2020,mg,antineoplastic,11/29/2020,10/15/2020,Intravenous,leucovorin,FALSE
570,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:D34FC71922,10/17/2016,mg,antineoplastic,5/13/2015,5/28/2015,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/18/2025,,antiemetic,1/18/2025,12/6/2024,Intravenous,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/6/2022,mg,antineoplastic,1/30/2016,1/19/2016,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,11/19/2021,mg,antineoplastic,8/1/2019,6/21/2019,Intravenous,nivolumab,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/15/2017,mL,solution-fluid,7/31/2017,7/24/2017,Intravenous,paclitaxel,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/16/2016,mg,antineoplastic,2/23/2016,4/12/2015,Intravenous,nivolumab,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/4/2020,mg,antineoplastic,2/6/2020,1/18/2019,Intravenous,durvalumab,FALSE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,6/7/2024,,antineoplastic,7/17/2020,8/3/2020,,nivolumab,FALSE
1630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,1/10/2014,mg,antineoplastic,11/30/2012,9/29/2012,Intravenous,gemcitabine,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,4/6/2025,mg,antineoplastic,4/20/2025,3/31/2025,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,3/20/2024,mg,antineoplastic,1/10/2024,11/10/2023,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,3/9/2019,mg/m2,antineoplastic,1/24/2019,2/10/2019,Intravenous,gemcitabine,FALSE
815,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/20/2024,mg,antineoplastic,1/8/2024,10/31/2023,Intravenous,pemetrexed,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/7/2020,mg,antineoplastic,6/3/2020,2/22/2020,Intravenous,docetaxel,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/5/2013,mg,antineoplastic,7/27/2013,7/21/2013,Intravenous,vinorelbine,FALSE
36,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,3/30/2016,mg,antineoplastic,4/4/2016,4/6/2016,Intravenous,cisplatin,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,3/16/2020,mg,antineoplastic,12/6/2019,11/27/2019,Intravenous,durvalumab,FALSE
400,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G11:F93GC6851,2/11/2021,mg,antineoplastic,12/5/2020,6/30/2020,Intravenous,ramucirumab,FALSE
,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/5/2014,,solution-fluid,11/23/2013,10/24/2013,Intravenous,clinical study drug,FALSE
97,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,7/24/2024,mg,antineoplastic,6/11/2024,6/26/2024,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56ED712FC18F,5/31/2019,mg,antineoplastic,4/27/2019,4/20/2019,Intravenous,paclitaxel,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,3/15/2014,mg,antineoplastic,8/17/2013,7/19/2013,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,5/4/2025,mg,antineoplastic,8/4/2024,1/5/2017,Intravenous,pembrolizumab,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/24/2024,mg,antineoplastic,11/25/2020,7/1/2020,Intravenous,ipilimumab,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/11/2015,mg,antineoplastic,8/30/2014,9/27/2014,Intravenous,cisplatin,FALSE
5,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/20/2013,AUC,antineoplastic,11/5/2013,9/13/2013,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,7/12/2018,mg,antineoplastic,6/22/2017,6/27/2017,Intravenous,pembrolizumab,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/17/2017,mg,antineoplastic,2/2/2016,6/21/2015,Intravenous,nivolumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/30/2022,mg,antineoplastic,9/27/2020,1/26/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/2/2025,mg,antineoplastic,11/19/2024,10/27/2022,Intravenous,pembrolizumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/7/2020,mg,antineoplastic,11/3/2017,8/9/2016,Intravenous,nivolumab,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G2G22BF9DCG81,4/4/2025,mg,antineoplastic,4/6/2024,9/28/2023,Intravenous,atezolizumab,FALSE
910,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/13/2012,mg,antineoplastic,6/4/2012,4/12/2012,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/6/2013,mg/m2,antineoplastic,10/10/2013,9/7/2013,Intravenous,etoposide,FALSE
25,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide,Rituximab",G48842BBE3634,6/14/2013,mg/m2/day,antineoplastic,6/9/2013,6/11/2013,Other/Miscellaneous,cisplatin,FALSE
64,3,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D:B49GGG719,8/29/2018,mg,antineoplastic,6/19/2017,6/19/2017,Intravenous,vinorelbine,FALSE
251,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/29/2015,mg,antineoplastic,7/22/2015,7/2/2015,Intravenous,carboplatin,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,1/11/2015,mg,antineoplastic,11/29/2014,11/21/2014,Intravenous,pemetrexed,FALSE
182,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F4G973F319F,3/25/2013,mg,antineoplastic,6/11/2012,4/4/2012,Intravenous,carboplatin,FALSE
360,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,3/8/2024,mg,antineoplastic,2/2/2024,10/2/2023,Intravenous,nivolumab,FALSE
271,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,12/30/2021,mg,antineoplastic,8/25/2019,6/11/2019,Intravenous,carboplatin,FALSE
603,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G119DBG986C45,11/9/2023,mg,antineoplastic,4/25/2023,11/1/2022,Intravenous,durvalumab,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/18/2024,mg,antineoplastic,5/10/2024,5/18/2024,Intravenous,etoposide,FALSE
800,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/18/2020,mg,antineoplastic,4/22/2020,2/26/2019,Intravenous,durvalumab,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G55D67392F8:9,11/2/2023,mg,antineoplastic,10/25/2023,9/21/2023,Intravenous,paclitaxel,FALSE
260,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/16/2014,mg,antineoplastic,3/25/2013,4/7/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1GC7B8314B6D,7/13/2023,,,11/9/2020,12/6/2020,Oral,osimertinib,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/5/2019,mg,antineoplastic,7/7/2017,10/22/2016,Intramuscular,fulvestrant,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,6/14/2012,mg,antineoplastic,5/1/2012,4/20/2012,Intravenous,carboplatin,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/13/2022,mg,antineoplastic,12/2/2021,10/1/2021,Intravenous,pemetrexed,FALSE
519,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,11/29/2020,mg,antineoplastic,8/5/2019,5/16/2019,Intravenous,pemetrexed,TRUE
1010,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/7/2025,mg,antineoplastic,11/24/2021,11/3/2021,Intravenous,pemetrexed,TRUE
1015,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,6/29/2023,mg,antineoplastic,12/25/2022,10/31/2022,Intravenous,pemetrexed,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3C98:B743F7B,7/11/2014,AUC,antineoplastic,8/7/2013,6/30/2013,Intravenous,carboplatin,FALSE
1990,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G4C4:64E35941,4/27/2023,mg,antineoplastic,4/24/2023,2/9/2023,Intravenous,gemcitabine,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/28/2025,mg,antineoplastic,11/10/2020,5/15/2018,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/22/2019,mg,antineoplastic,1/1/2019,3/21/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/10/2019,mg,antineoplastic,8/27/2019,7/14/2018,Intravenous,pembrolizumab,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,Pemetrexed,G591:2784957C,11/12/2013,mg/m2,antineoplastic,11/1/2013,10/30/2013,Intravenous,pemetrexed,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,10/3/2024,mg,antineoplastic,1/26/2024,8/18/2023,Intravenous,durvalumab,FALSE
875,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,5/2/2025,mg,antineoplastic,5/10/2025,2/16/2025,Intravenous,amivantamab-vmjw,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,5/26/2025,,antineoplastic,10/27/2024,11/17/2024,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/23/2023,mg,antineoplastic,7/31/2020,6/14/2020,Intravenous,pembrolizumab,FALSE
739,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,10/15/2018,mg,antineoplastic,9/4/2018,7/10/2018,Intravenous,carboplatin,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/3/2025,mg,antineoplastic,7/9/2018,1/8/2017,Intravenous,nivolumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,3/4/2022,mg,antineoplastic,12/12/2021,11/18/2021,Intravenous,paclitaxel,FALSE
38,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G4891G553:D48,11/12/2014,mg,antineoplastic,8/28/2014,6/20/2014,Intravenous,vinorelbine,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/4/2013,mg,antineoplastic,8/29/2013,8/23/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G2C4G1G76816F,4/24/2025,,antineoplastic,10/26/2017,10/17/2017,,clinical study drug,FALSE
412,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/13/2025,mg,antineoplastic,7/5/2020,3/12/2019,Intravenous,carboplatin,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56CF8BF38D:7,11/2/2013,mg,antineoplastic,10/12/2013,9/4/2013,Intravenous,carboplatin,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,12/13/2015,mg,antineoplastic,7/31/2015,4/23/2015,Intravenous,pemetrexed,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/15/2017,mg,antineoplastic,2/10/2017,5/2/2016,Intravenous,nivolumab,FALSE
85,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,3/29/2016,mg,antineoplastic,2/3/2016,1/2/2016,Intravenous,paclitaxel,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18:439734B::,8/1/2015,mg,antineoplastic,6/10/2015,4/18/2015,Intravenous,pemetrexed,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/13/2016,mg,antineoplastic,2/8/2016,11/24/2015,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/12/2022,mg,antineoplastic,5/9/2019,1/12/2018,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,1/18/2018,,antineoplastic,11/5/2017,8/28/2017,Intravenous,carboplatin,FALSE
845,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,2/19/2017,mg,antineoplastic,1/29/2017,11/29/2016,Intravenous,pemetrexed,FALSE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,9/5/2016,mg,antineoplastic,6/17/2016,3/30/2016,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G54368FF4E2E3,6/16/2011,AUC,antineoplastic,6/5/2011,4/28/2011,Intravenous,carboplatin,FALSE
,3,ADVANCED,Unstructured,,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/29/2025,,,10/16/2024,5/29/2023,Oral,sotorasib,FALSE
,1,LOCOREGIONAL,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2141CBEF3GD3,12/6/2022,,antineoplastic,9/10/2022,9/9/2022,,paclitaxel,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G56D5:EDD9C68,4/2/2024,mg,antineoplastic,2/25/2024,12/27/2023,Intravenous,pemetrexed,FALSE
174,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11B743:8G337,1/13/2017,mg,antineoplastic,6/18/2016,5/28/2016,Intravenous,nivolumab,FALSE
40,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G4G98:8D426E2,4/3/2012,mg,antineoplastic,3/31/2012,2/22/2012,Intravenous,docetaxel,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,12/8/2024,mg,antineoplastic,9/9/2023,12/22/2021,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/2/2025,mg,antineoplastic,6/9/2024,8/9/2022,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/25/2022,mg,antineoplastic,6/12/2021,4/7/2021,Intravenous,pembrolizumab,TRUE
165,3,ADVANCED,Administrations,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/13/2016,mg,antineoplastic,6/13/2016,4/24/2016,Intravenous,paclitaxel,FALSE
28,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,4/5/2015,mg,antineoplastic,3/26/2015,4/3/2015,Intravenous,docetaxel,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,10/21/2018,mg,antineoplastic,5/17/2018,6/3/2018,Intravenous,carboplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/8/2022,mg,antineoplastic,2/6/2020,5/21/2017,Oral,nilotinib,FALSE
155,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1968F::311C2,10/16/2018,mg,antineoplastic,8/31/2018,5/10/2018,Intravenous,etoposide,FALSE
955,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,5/3/2015,mg,antineoplastic,1/10/2015,2/12/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,6/3/2018,,antineoplastic,8/24/2015,7/24/2015,,paclitaxel,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D6CD2B8C5FD,12/1/2013,mg,antineoplastic,11/2/2013,10/19/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,2/9/2022,,antineoplastic,9/26/2021,10/15/2021,Intravenous,carboplatin,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G35EFEEBCDBDC,6/13/2018,mg,antineoplastic,3/9/2017,2/12/2017,Intravenous,pembrolizumab,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,9/29/2019,mg,antineoplastic,7/16/2019,7/23/2019,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,11/14/2019,mg,antineoplastic,8/21/2019,6/27/2019,Intravenous,pembrolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/29/2016,mg,antineoplastic,6/7/2016,5/21/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G54F545489E59,7/17/2022,mg,antineoplastic,4/10/2022,11/9/2021,Intravenous,pembrolizumab,FALSE
800,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,4/21/2025,mg,antineoplastic,10/2/2024,8/25/2024,Intravenous,bevacizumab-bvzr,FALSE
226,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,1/4/2015,mg,antineoplastic,8/8/2014,7/26/2014,Intravenous,carboplatin,FALSE
452.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,7/30/2022,mg,antineoplastic,8/6/2022,5/17/2022,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/15/2025,mg,antineoplastic,12/10/2018,5/22/2018,Intravenous,pembrolizumab,FALSE
80,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,1/31/2021,mg,antineoplastic,12/23/2020,7/30/2020,Intravenous,docetaxel,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,8/27/2024,mg,antineoplastic,8/25/2024,7/9/2024,Intravenous,paclitaxel protein-bound,FALSE
84.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G474E:6F:6:B1,9/21/2013,mg,antineoplastic,5/11/2013,5/6/2013,Intravenous,paclitaxel,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/17/2014,mg,antineoplastic,11/28/2013,11/20/2013,Intravenous,carboplatin,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,2/10/2024,,antineoplastic,1/14/2024,10/23/2023,Intravenous,carboplatin,FALSE
148,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,10/23/2012,mg,antineoplastic,8/4/2012,2/22/2012,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/12/2025,mg,antineoplastic,5/23/2019,2/16/2018,Intravenous,nivolumab,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/26/2021,mg,antineoplastic,4/26/2018,3/18/2018,Intravenous,durvalumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/25/2022,mg,antineoplastic,3/27/2021,1/25/2018,Intravenous,pembrolizumab,FALSE
340,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,2/7/2023,mg,antineoplastic,11/7/2022,10/28/2022,Intravenous,carboplatin,FALSE
329,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,11/2/2018,mg,antineoplastic,10/24/2018,10/18/2018,Intravenous,carboplatin,FALSE
130,4,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1G54G4GB8B24,10/4/2023,mg,antineoplastic,8/4/2022,9/9/2022,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,3/29/2019,mg,antineoplastic,3/20/2019,1/6/2019,Intravenous,paclitaxel protein-bound,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/18/2025,mg,antineoplastic,5/21/2023,12/27/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/27/2025,mg,antineoplastic,5/31/2024,4/27/2022,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/1/2013,mg/m2,antineoplastic,11/7/2013,10/10/2013,Intravenous,etoposide,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/11/2023,mg,antineoplastic,4/22/2023,5/12/2022,Intravenous,durvalumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1B278956E5G4,4/24/2025,mg,antineoplastic,3/8/2025,11/6/2024,Intravenous,pemetrexed,TRUE
,,ADJUVANT,Orders,hormone,Anastrozole,G1B8G131F6FC6,5/12/2017,,antineoplastic,6/10/2017,5/3/2017,Oral,anastrozole,FALSE
149,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1BGE419C:CE7,5/27/2024,mg,antineoplastic,2/6/2024,3/6/2024,Intravenous,carboplatin,FALSE
486,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,5/27/2024,mg,antineoplastic,4/22/2024,3/10/2024,Intravenous,paclitaxel,FALSE
1680,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G49E8CFG53::D,6/16/2013,mg,antineoplastic,6/6/2013,2/17/2013,Intravenous,gemcitabine,FALSE
1350,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1E1C181843G1,4/5/2015,mg,antineoplastic,5/9/2015,4/8/2015,Intravenous,bevacizumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35CFEB37C9D3,9/10/2012,mg,antineoplastic,8/29/2012,8/26/2012,Intravenous,paclitaxel,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/25/2019,mg,antineoplastic,7/22/2019,6/5/2019,Intravenous,carboplatin,FALSE
420,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/21/2020,mg,antineoplastic,10/3/2020,11/1/2020,Intravenous,carboplatin,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/12/2022,mg,antineoplastic,12/28/2016,2/6/2016,Intravenous,pemetrexed,FALSE
930,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26EF86FE2766,9/13/2014,mg,antineoplastic,7/7/2014,7/16/2014,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G437:CB1EF9DB,7/1/2023,mg,antineoplastic,4/22/2023,11/9/2022,Intravenous,pembrolizumab,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G266E6248F531,7/13/2018,mg,antineoplastic,4/30/2018,3/4/2018,Intravenous,bevacizumab,TRUE
620,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,11/1/2021,mg,antineoplastic,7/22/2021,7/8/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,8/31/2023,mg,antineoplastic,5/31/2023,8/1/2022,Intravenous,pembrolizumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G4B1F584CB682,11/10/2015,mg,antineoplastic,2/21/2015,3/2/2015,Intravenous,pemetrexed,TRUE
1000,1,ADVANCED,Orders,chemotherapy,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,4/11/2019,mg/m2,antineoplastic,3/6/2019,1/29/2019,Intravenous,gemcitabine,FALSE
450,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,1/22/2024,mg,antineoplastic,1/7/2024,12/18/2023,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1G:94B69FD31,5/7/2025,mg,antineoplastic,3/2/2025,8/18/2024,Intravenous,pembrolizumab,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,2/14/2019,mg/m2,antineoplastic,11/23/2018,10/12/2018,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/21/2025,mg,antineoplastic,12/1/2022,8/11/2022,Intravenous,pembrolizumab,TRUE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/16/2021,mg,antineoplastic,4/7/2021,9/14/2020,Intravenous,ipilimumab,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,6/12/2022,mg,antineoplastic,9/6/2020,4/1/2020,Intravenous,durvalumab,TRUE
1630,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2:5874817G9C,9/4/2024,mg,antineoplastic,5/30/2024,7/22/2024,Intravenous,gemcitabine,FALSE
970,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,6/26/2023,mg,antineoplastic,5/15/2023,4/30/2023,Intravenous,pemetrexed,FALSE
350,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,3/28/2024,mg,antineoplastic,2/1/2024,1/3/2024,Intravenous,cemiplimab,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/14/2025,,antineoplastic,10/17/2021,4/28/2020,Oral,enzalutamide,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/6/2022,mg,antineoplastic,9/3/2016,1/19/2016,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,11/22/2016,mg/m2,antineoplastic,9/10/2016,7/16/2016,Intravenous,gemcitabine,FALSE
606,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G135B:GEC35G4,5/11/2025,mg,antineoplastic,4/30/2025,4/11/2025,Intravenous,carboplatin,FALSE
585,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,7/26/2024,mg,antineoplastic,8/20/2024,8/5/2024,Intravenous,carboplatin,FALSE
245,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,4/11/2016,mg,antineoplastic,1/2/2016,12/5/2015,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G261CF698E543,2/27/2015,,antineoplastic,10/28/2014,9/9/2014,,clinical study drug,FALSE
247,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G148327249BD9,5/9/2025,mg,antineoplastic,5/6/2025,5/4/2025,Intravenous,paclitaxel protein-bound,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1441B4DG:6FF,4/28/2025,mg,antineoplastic,2/19/2025,7/31/2024,Intravenous,durvalumab,FALSE
2070,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/18/2013,mg,antineoplastic,5/16/2013,12/1/2012,Intravenous,gemcitabine,FALSE
69,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G287777772FGE,1/1/2023,mg,antineoplastic,1/6/2023,12/8/2022,Intravenous,ipilimumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/16/2024,mg,antineoplastic,5/1/2024,6/2/2024,Intravenous,etoposide,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G3B76E8182:B:,12/23/2024,mg,antineoplastic,7/15/2024,5/8/2024,Intravenous,durvalumab,TRUE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/13/2025,mg,antineoplastic,7/23/2019,4/15/2019,Intravenous,pemetrexed,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/27/2020,mg,antineoplastic,11/22/2019,10/8/2019,Intravenous,durvalumab,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G264B2D11BG13,10/12/2016,mg,antineoplastic,10/29/2016,10/24/2016,Intravenous,paclitaxel,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,1/1/2025,mL,solution-fluid,10/30/2024,5/29/2024,Intravenous,pembrolizumab,FALSE
580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1E35BD845958,12/18/2014,mg,antineoplastic,7/24/2014,9/2/2014,Intravenous,carboplatin,FALSE
342,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/20/2019,mg,antineoplastic,10/29/2018,11/22/2018,Intravenous,paclitaxel,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,4/23/2025,mg,antineoplastic,6/4/2022,11/4/2021,Intravenous,pembrolizumab,TRUE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/21/2024,mg,antineoplastic,12/22/2023,2/26/2022,Intravenous,durvalumab,FALSE
281,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,10/30/2014,mg,antineoplastic,9/26/2014,8/5/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,5/6/2025,mg,antineoplastic,12/20/2022,5/14/2022,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/7/2021,mg,antineoplastic,4/19/2020,10/23/2019,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,9/12/2021,mg,antineoplastic,9/25/2021,9/22/2021,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,1/7/2022,mg,antineoplastic,12/16/2021,2/4/2021,Intravenous,bevacizumab-awwb,FALSE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,11/27/2023,mg,antineoplastic,8/7/2023,5/11/2023,Intravenous,carboplatin,FALSE
1238,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,11/18/2023,mg,antineoplastic,8/4/2023,4/4/2023,Intravenous,gemcitabine,FALSE
360,1,LOCOREGIONAL,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G1G5G15146B3D,3/2/2023,mg,antineoplastic,11/10/2022,11/29/2022,Intravenous,nivolumab,TRUE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/5/2022,mg,antineoplastic,6/2/2018,4/10/2017,Intravenous,nivolumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G29C71B44G:B6,8/9/2013,AUC,antineoplastic,6/7/2013,5/22/2013,Intravenous,carboplatin,FALSE
1400,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/7/2016,mg,antineoplastic,7/8/2015,7/12/2015,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,10/1/2021,mg,antineoplastic,12/10/2020,10/22/2019,Intravenous,pembrolizumab,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,5/14/2015,mg,antineoplastic,3/1/2015,12/14/2014,Intravenous,gemcitabine,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,11/17/2017,,antineoplastic,9/19/2016,6/3/2016,Intramuscular,fulvestrant,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,12/20/2021,mg,antineoplastic,8/15/2021,2/5/2021,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/3/2023,mg,antineoplastic,6/7/2023,3/13/2023,Intravenous,pembrolizumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2FF2946:4C6F,5/2/2018,mg,antineoplastic,11/30/2017,11/5/2017,Intravenous,nivolumab,FALSE
97,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1441B4DG:6FF,8/10/2024,mg,antineoplastic,6/24/2024,6/2/2024,Intravenous,paclitaxel,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G13GE1E25174F,5/9/2022,mg,antineoplastic,5/30/2022,3/24/2022,Intravenous,pemetrexed,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G12998681218G,12/28/2021,mg,antineoplastic,10/21/2021,2/18/2021,Intravenous,durvalumab,FALSE
552,1,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G53C52948773G,3/20/2024,mg,antineoplastic,12/18/2023,12/17/2023,Intravenous,ramucirumab,FALSE
240,,ADJUVANT,Administrations,immunotherapy,Nivolumab,G264B2D11BG13,7/2/2018,mg,antineoplastic,6/2/2018,12/2/2017,Intravenous,nivolumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,5/11/2015,mg,antineoplastic,1/3/2015,11/20/2014,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/25/2019,mg,antineoplastic,2/20/2019,10/3/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,9/8/2018,mg,antineoplastic,3/10/2018,6/17/2017,Intravenous,pembrolizumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/18/2025,mg/m2,antineoplastic,3/21/2024,3/4/2019,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,solution-fluid,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/22/2024,mL,solution-fluid,11/1/2024,6/19/2024,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/21/2020,mg,antineoplastic,7/5/2019,1/5/2018,Intravenous,pembrolizumab,TRUE
350,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/14/2021,mg,antineoplastic,1/1/2022,9/26/2021,Intravenous,paclitaxel,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/16/2025,mg,antineoplastic,11/13/2024,3/29/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Unstructured,,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,2/26/2025,,,4/1/2025,11/3/2022,Oral,osimertinib,FALSE
426,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2CC42E:::G72,7/3/2019,mg,antineoplastic,2/15/2019,2/27/2019,Intravenous,durvalumab,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/12/2014,mg,antineoplastic,7/20/2014,6/11/2014,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G26C72D6F6G:5,10/10/2020,mg,antineoplastic,9/14/2020,8/6/2020,Intravenous,nivolumab,FALSE
380,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,4/13/2020,mg,antineoplastic,3/13/2020,12/20/2019,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G11B743:8G337,7/9/2016,mg,antineoplastic,5/9/2015,3/20/2015,Intravenous,bevacizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/24/2025,mg,antineoplastic,9/17/2021,7/13/2021,Intravenous,atezolizumab,TRUE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34927D694398,5/20/2018,mg,antineoplastic,4/13/2018,4/4/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/9/2022,mg,antineoplastic,5/16/2022,5/8/2022,Intravenous,pembrolizumab,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,3/5/2015,mg,antineoplastic,11/12/2014,10/27/2014,Intravenous,docetaxel,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G1E589EBD8F93,9/26/2013,mg,antineoplastic,5/17/2013,4/5/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,3/20/2025,mg,antineoplastic,5/9/2022,4/15/2020,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/19/2022,,antineoplastic,3/27/2022,5/9/2017,Oral,nilotinib,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,11/22/2021,,antineoplastic,11/4/2018,3/14/2018,,durvalumab,TRUE
551,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1:F21E8E2D45,5/20/2023,mg,antineoplastic,4/8/2023,3/26/2023,Intravenous,pemetrexed,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,5/25/2016,,antineoplastic,5/3/2016,4/7/2016,Intravenous,pemetrexed,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/21/2024,mg,antineoplastic,12/15/2021,7/11/2020,Intravenous,nivolumab,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/21/2021,mg,antineoplastic,1/8/2021,6/11/2020,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,7/2/2024,,antineoplastic,5/14/2024,4/23/2024,,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/21/2022,mg,antineoplastic,5/13/2022,5/17/2022,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G13C2:FDBFBC2,5/6/2025,,,8/30/2024,8/6/2024,Oral,osimertinib,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,12/29/2019,mg,antineoplastic,9/4/2019,2/23/2019,Intravenous,durvalumab,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,8/18/2024,mg,antineoplastic,12/27/2022,4/6/2022,Intravenous,durvalumab,TRUE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1651E65B5E88,2/4/2018,mg,antineoplastic,1/18/2018,12/21/2017,Intravenous,pemetrexed,FALSE
1200,2,ADVANCED,Administrations,immunotherapy,Atezolizumab,G337BE1E83:B7,5/16/2025,mg,antineoplastic,7/4/2022,2/16/2022,Intravenous,atezolizumab,FALSE
,,ADJUVANT,Orders,hormone,"Letrozole,Osimertinib",G31G19E54FC:B,10/4/2023,,antineoplastic,10/14/2020,10/20/2020,Oral,letrozole,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2G47CG7D:EEG,5/27/2018,mg/m2,antineoplastic,6/12/2018,5/21/2018,Intravenous,pemetrexed,FALSE
181,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/19/2013,mg,antineoplastic,10/2/2012,9/30/2012,Intravenous,carboplatin,FALSE
686,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,7/5/2012,mg,antineoplastic,6/16/2012,4/19/2012,Intravenous,carboplatin,FALSE
1275,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/24/2015,mg,antineoplastic,10/11/2015,9/10/2015,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,5/4/2024,,antineoplastic,5/27/2023,6/3/2023,Intravenous,clinical study drug,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/28/2019,mL,solution-fluid,9/28/2019,9/6/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G3GF88F:7::4:,3/19/2024,,antineoplastic,6/26/2023,6/28/2023,Intravenous,clinical study drug,FALSE
810,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,7/14/2020,mg,antineoplastic,5/18/2020,3/20/2019,Intravenous,durvalumab,FALSE
65,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G344BC2:6BGE1,1/21/2013,mg,antineoplastic,5/23/2012,5/22/2012,Intravenous,docetaxel,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,8/29/2024,mg,antineoplastic,1/22/2024,2/2/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,3/25/2025,mg,antineoplastic,9/30/2022,9/21/2022,Intravenous,pembrolizumab,TRUE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/17/2015,mg,antineoplastic,3/17/2014,12/29/2013,Intravenous,paclitaxel,FALSE
675,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G163D9B593927,6/7/2017,mg,antineoplastic,11/24/2016,9/30/2016,Intravenous,pemetrexed,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/1/2025,AUC,antineoplastic,7/9/2019,3/8/2019,Intravenous,carboplatin,FALSE
147,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC97BGC25B3,3/31/2023,mg,antineoplastic,2/13/2023,1/26/2023,Intravenous,carboplatin,FALSE
446.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,4/28/2020,mg,antineoplastic,3/26/2020,3/2/2020,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,Nivolumab,G1E2B6::D8477,3/29/2024,,antineoplastic,6/11/2023,5/17/2023,Intravenous,nivolumab,TRUE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,4/9/2016,mg,antineoplastic,11/13/2015,6/1/2015,Intravenous,carboplatin,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,3/2/2025,mg,antineoplastic,12/27/2024,10/22/2024,Intravenous,etoposide,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,9/5/2016,mg,antineoplastic,7/25/2016,4/2/2016,Intravenous,carboplatin,FALSE
76,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G392GC5134FFG,8/4/2020,mg,antineoplastic,6/16/2020,5/19/2020,Intravenous,paclitaxel,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/9/2019,mg,antineoplastic,6/22/2016,4/22/2016,Intravenous,nivolumab,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,7/26/2021,mg,antineoplastic,2/1/2021,6/12/2020,Intravenous,docetaxel,FALSE
1990,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G19937F58E541,11/17/2013,mg,antineoplastic,5/9/2013,12/28/2012,Intravenous,gemcitabine,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,5/11/2019,mg,antineoplastic,9/12/2018,6/26/2018,Intravenous,nivolumab,FALSE
206.8,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,8/9/2016,mg,antineoplastic,12/14/2015,11/10/2015,Intravenous,carboplatin,FALSE
879,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,10/14/2020,mg,antineoplastic,12/30/2019,10/6/2019,Intravenous,durvalumab,FALSE
1700,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G11:F93GC6851,4/27/2021,mg,antineoplastic,3/15/2021,1/4/2021,Intravenous,gemcitabine,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,12/2/2017,mg,antineoplastic,6/18/2016,4/5/2016,Intravenous,nivolumab,FALSE
170,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,3/8/2018,mg,antineoplastic,2/12/2018,1/3/2018,Intravenous,carboplatin,FALSE
95,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17177B5C7D7F,2/26/2021,mg,antineoplastic,1/19/2021,12/6/2020,Intravenous,paclitaxel,FALSE
1075,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5545136B977G,1/14/2013,mg,antineoplastic,11/15/2012,10/29/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,4/12/2025,mg,antineoplastic,1/26/2025,2/23/2025,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/24/2025,mg,antineoplastic,12/9/2019,12/29/2018,Intravenous,pembrolizumab,TRUE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FFB5516FEDF,2/2/2014,mg,antineoplastic,11/19/2013,10/29/2013,Intravenous,carboplatin,FALSE
650,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,4/4/2020,mg,antineoplastic,3/4/2020,4/19/2020,Intravenous,fluorouracil,FALSE
,4,ADVANCED,Unstructured,,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,7/18/2016,,,9/6/2016,4/25/2016,Oral,vemurafenib,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,11/26/2020,mg,antineoplastic,10/23/2020,9/14/2020,Intravenous,paclitaxel protein-bound,FALSE
110,1,ADVANCED,Administrations,chemotherapy,Nivolumab,G21BD9C1D75:6,1/22/2019,mg,antineoplastic,7/18/2018,6/16/2018,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,6/13/2020,mg,antineoplastic,4/26/2020,4/13/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,3/5/2020,mg,antineoplastic,9/20/2019,11/1/2019,Intravenous,pembrolizumab,TRUE
1,,ADJUVANT,Administrations,hormone,Anastrozole,G432E:9E:21DC,7/15/2022,mg,antineoplastic,7/6/2022,6/14/2022,Oral,anastrozole,FALSE
317,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G437:CB1EF9DB,5/6/2025,mg,antineoplastic,8/8/2024,8/22/2024,Intravenous,carboplatin,FALSE
312,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1445DG1:E6:D,12/3/2022,mg,antineoplastic,9/21/2022,8/30/2022,Intravenous,carboplatin,FALSE
122,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G19B:27:ECB43,8/1/2021,mg,antineoplastic,5/4/2021,3/20/2021,Intravenous,carboplatin,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/6/2019,mg,antineoplastic,7/6/2018,6/22/2018,Intravenous,fluorouracil,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/20/2016,mg,antineoplastic,12/25/2015,12/19/2015,Intravenous,docetaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/11/2022,mg,antineoplastic,5/22/2021,2/15/2016,Intravenous,pemetrexed,FALSE
186,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14FD45889171,3/28/2014,mg,antineoplastic,3/29/2014,3/10/2014,Intravenous,carboplatin,FALSE
166,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G43E:81EC19B6,10/14/2022,mg,antineoplastic,9/3/2022,8/10/2022,Intravenous,carboplatin,FALSE
400,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,4/6/2025,mg,antineoplastic,2/6/2025,12/17/2024,Intravenous,paclitaxel,FALSE
396,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1117E45EE891,7/7/2014,mg,antineoplastic,3/20/2014,2/3/2014,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/5/2024,mg,antineoplastic,2/24/2023,12/1/2022,Intravenous,nivolumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/13/2023,mg,antineoplastic,5/1/2022,12/16/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,4/7/2024,,pain agent,7/15/2023,7/2/2023,Oral,clinical study drug,FALSE
472,3,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,6/24/2023,mg,antineoplastic,1/30/2023,10/24/2022,Intravenous,bevacizumab-bvzr,FALSE
210,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,3/1/2025,mg,antineoplastic,3/30/2025,2/23/2025,Intravenous,carboplatin,FALSE
200,4,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D168F99BCD4,11/27/2023,mg,antineoplastic,11/1/2023,10/19/2023,Intravenous,pembrolizumab,FALSE
140,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Nivolumab",G2C38B34G8794,9/13/2024,mg,antineoplastic,5/2/2023,4/1/2023,Intravenous,docetaxel,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,5/17/2025,,antineoplastic,8/7/2024,2/29/2024,Intravenous,clinical study drug,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1ED5EF238G3C,8/4/2024,mg,antineoplastic,6/9/2024,7/26/2024,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Sotorasib",G4253CG56F6FC,3/28/2025,mg,antineoplastic,2/9/2024,5/27/2023,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/4/2022,mg,antineoplastic,7/15/2017,2/1/2016,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,7/26/2021,mg,antineoplastic,5/25/2021,5/22/2021,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,5/8/2025,mg,antineoplastic,2/4/2025,3/14/2024,Intravenous,pembrolizumab,TRUE
154,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/11/2015,mg,antineoplastic,9/17/2014,9/1/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G55CDGC1298EB,6/6/2021,mg,antineoplastic,2/26/2019,9/28/2018,Intravenous,pembrolizumab,FALSE
1400,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/13/2025,mg,antineoplastic,4/19/2024,2/21/2024,Intravenous,amivantamab-vmjw,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/8/2022,mg,antineoplastic,4/3/2021,1/9/2018,Intravenous,pembrolizumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,7/12/2024,mg,antineoplastic,1/29/2024,2/3/2024,Intravenous,carboplatin,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/15/2020,mg,antineoplastic,5/6/2020,12/25/2019,Intravenous,gemcitabine,FALSE
1382,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,12/17/2012,mg,antineoplastic,1/9/2013,12/3/2012,Intravenous,bevacizumab,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,10/14/2017,mg,antineoplastic,9/27/2017,7/26/2017,Intravenous,docetaxel,FALSE
6,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G325B2E578F89,2/6/2015,AUC,antineoplastic,1/23/2015,10/13/2014,Intravenous,carboplatin,FALSE
1250,4,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1468E9F5C9CG,5/21/2013,mg,antineoplastic,3/5/2013,2/14/2013,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/11/2025,mg,antineoplastic,2/29/2024,12/8/2023,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,7/9/2020,mg,antineoplastic,6/4/2019,1/15/2019,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G21BD9C1D75:6,7/2/2019,,,2/16/2019,2/1/2019,Oral,afatinib,FALSE
832,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,11/2/2020,mg,antineoplastic,9/18/2020,11/2/2019,Intravenous,durvalumab,FALSE
,5,ADVANCED,Unstructured,,Sotorasib,G56B4BCB27428,10/6/2023,,,9/21/2023,9/23/2023,Oral,sotorasib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27868:751BDF,11/25/2024,mg,antineoplastic,7/1/2024,7/18/2024,Intravenous,pembrolizumab,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Osimertinib,Pembrolizumab",G4826CB54C27:,6/10/2024,mg,antineoplastic,1/10/2022,11/18/2021,Intravenous,pembrolizumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/29/2025,mg,antineoplastic,6/26/2024,3/3/2024,Intravenous,amivantamab-vmjw,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/16/2025,mg,antineoplastic,1/5/2017,8/16/2016,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G56CF8BF38D:7,1/4/2015,,antineoplastic,11/21/2014,10/5/2014,Intravenous,clinical study drug,FALSE
48,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17171D313CCE,6/19/2018,mg,antineoplastic,2/27/2018,3/18/2018,Intravenous,docetaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/17/2025,mg,antineoplastic,6/27/2024,7/24/2023,Intravenous,pembrolizumab,TRUE
220,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2::9G57327G:,12/1/2014,mg,antineoplastic,10/4/2014,8/8/2014,Intravenous,carboplatin,FALSE
1509,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G1D:B49GGG719,1/5/2017,mg,antineoplastic,8/2/2016,8/20/2016,Intravenous,bevacizumab,TRUE
240,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,9/15/2023,mg,antineoplastic,7/18/2023,5/11/2023,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/9/2019,,antineoplastic,11/15/2017,8/24/2017,,cisplatin,FALSE
554,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/11/2025,mg,antineoplastic,4/5/2024,2/20/2024,Intravenous,carboplatin,FALSE
825,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,1/29/2025,mg,antineoplastic,10/18/2024,7/19/2024,Intravenous,pemetrexed,FALSE
1100,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G193F989CDC3D,3/24/2016,mg,antineoplastic,1/21/2016,3/2/2016,Intravenous,bevacizumab,TRUE
176.5,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,2/11/2017,mg,antineoplastic,11/23/2016,9/29/2016,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/19/2022,mg,antineoplastic,1/20/2019,4/22/2017,Intravenous,nivolumab,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5177EGEDDF9F,1/25/2015,mg,antineoplastic,10/5/2014,10/2/2014,Intravenous,paclitaxel,FALSE
126,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G24365CF6:6G7,4/30/2014,mg,antineoplastic,4/20/2014,3/10/2014,Intravenous,cisplatin,FALSE
689,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G24632:D18158,1/3/2020,mg,antineoplastic,5/1/2019,5/19/2019,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/14/2025,mg,antineoplastic,4/6/2024,11/5/2023,Intravenous,pembrolizumab,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,9/22/2016,mg,antineoplastic,6/4/2016,4/18/2016,Intravenous,carboplatin,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,10/1/2022,mg,antineoplastic,8/24/2022,7/12/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,hormone,Clinical Study Drug,G118F63B281FD,5/19/2011,,antineoplastic,5/22/2011,6/14/2011,Intramuscular,clinical study drug,FALSE
90,2,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,1/15/2022,mg/m2,antineoplastic,12/22/2021,11/16/2021,Intravenous,irinotecan,FALSE
555,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1532797B869C,7/24/2023,mg,antineoplastic,9/7/2023,6/25/2023,Intravenous,ramucirumab,FALSE
,2,ADVANCED,Unstructured,,Erlotinib,G15B:95:E93C7,2/17/2015,,,4/5/2015,3/12/2015,Oral,erlotinib,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/7/2025,mg,antineoplastic,10/3/2020,4/20/2018,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,7/6/2023,mg,antineoplastic,7/11/2023,3/31/2023,Intravenous,pembrolizumab,FALSE
225,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/26/2019,mg,antineoplastic,12/7/2018,10/23/2018,Intravenous,carboplatin,FALSE
160,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G167G71733G69,11/11/2016,mg,antineoplastic,8/8/2016,3/17/2016,Intravenous,nivolumab,FALSE
185,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,11/15/2015,mg,antineoplastic,8/29/2015,7/10/2015,Intravenous,carboplatin,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G337BE1E83:B7,2/10/2022,mg,antineoplastic,12/10/2021,10/13/2021,Intravenous,carboplatin,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,5/4/2024,mg,antineoplastic,6/5/2023,5/14/2023,Intravenous,atezolizumab,FALSE
952,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G128:92:3BD3D,3/3/2023,mg,antineoplastic,9/19/2022,7/21/2022,Intravenous,durvalumab,TRUE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,3/19/2016,mg,antineoplastic,11/25/2015,7/28/2015,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G365D2:FDG53F,3/29/2025,mg,antineoplastic,2/11/2025,2/25/2025,Intravenous,pembrolizumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,9/16/2015,mg,antineoplastic,5/22/2015,3/6/2015,Intravenous,paclitaxel protein-bound,FALSE
380.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,4/1/2020,mg,antineoplastic,1/28/2020,12/15/2019,Intravenous,carboplatin,FALSE
663,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,4/6/2024,mg,antineoplastic,3/14/2024,2/5/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,3/29/2023,mg,antineoplastic,9/10/2022,5/28/2022,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/7/2022,mg,antineoplastic,6/30/2017,5/5/2017,Intravenous,nivolumab,FALSE
1400,3,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,4/26/2024,mg,antineoplastic,2/29/2024,10/30/2023,Intravenous,amivantamab-vmjw,FALSE
102,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,10/14/2024,mg,antineoplastic,2/19/2024,2/9/2024,Intravenous,paclitaxel,FALSE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,6/24/2014,mg,antineoplastic,6/27/2013,7/20/2013,Intravenous,pemetrexed,FALSE
25,3,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/19/2019,mg/m2,antineoplastic,1/3/2019,11/28/2018,Intravenous,vinorelbine,FALSE
221,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,10/15/2019,mg,antineoplastic,8/22/2019,6/16/2019,Intravenous,paclitaxel protein-bound,FALSE
,,CONCURRENT,Orders,hormone,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/2/2025,,antineoplastic,12/3/2024,10/5/2024,Oral,anastrozole,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/31/2013,AUC,antineoplastic,6/20/2013,5/20/2013,Intravenous,carboplatin,FALSE
371,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/21/2016,mg,antineoplastic,8/7/2015,7/15/2015,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Administrations,targeted/biologic,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,1/28/2014,,antineoplastic,12/12/2013,11/22/2013,Intravenous,clinical study drug,FALSE
386,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,11/5/2015,mg,antineoplastic,8/29/2015,5/26/2015,Intravenous,ramucirumab,FALSE
,,ADJUVANT,Unstructured,,Osimertinib,G59G454E1B6B3,10/19/2024,,,10/26/2024,6/26/2018,Oral,osimertinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/7/2020,mg,antineoplastic,9/12/2019,9/3/2019,Intravenous,pembrolizumab,FALSE
810,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,6/15/2020,mg,antineoplastic,3/8/2020,2/9/2019,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,10/1/2022,mg,antineoplastic,4/10/2022,3/1/2022,Intravenous,pembrolizumab,FALSE
775,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,5/20/2025,mg,antineoplastic,2/14/2025,7/24/2024,Intravenous,pemetrexed,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/6/2025,mg,antineoplastic,2/7/2022,2/17/2019,Intravenous,pembrolizumab,TRUE
668,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,10/31/2019,mg,antineoplastic,10/16/2019,9/29/2019,Intravenous,pemetrexed,FALSE
800,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/5/2017,mg,antineoplastic,1/13/2017,10/28/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,3/28/2012,,antineoplastic,12/7/2011,8/10/2011,Intravenous,clinical study drug,FALSE
1170,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,7/18/2024,mg,antineoplastic,5/13/2024,4/11/2024,Intravenous,pemetrexed,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/30/2024,mg,antineoplastic,8/10/2024,7/9/2024,Intravenous,paclitaxel,FALSE
2250,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G535G:C261F1E,10/2/2024,mg,antineoplastic,6/28/2024,7/28/2024,Intravenous,gemcitabine,FALSE
348,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,7/13/2013,mg,antineoplastic,3/3/2013,2/2/2013,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,12/16/2022,mg,antineoplastic,10/31/2022,9/10/2022,Intravenous,pembrolizumab,FALSE
699,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,6/4/2024,mg,antineoplastic,3/1/2024,3/12/2024,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/24/2019,mg,antineoplastic,7/7/2019,4/20/2016,Intravenous,nivolumab,FALSE
830,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/20/2018,mg,antineoplastic,10/31/2018,6/14/2018,Intravenous,pemetrexed,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/1/2012,mg,antineoplastic,9/17/2011,9/1/2011,Intravenous,cisplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,1/27/2018,AUC,antineoplastic,12/25/2017,10/2/2017,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,6/9/2023,mg,antineoplastic,4/8/2023,6/29/2022,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,10/30/2022,Ea,antineoplastic,4/7/2020,1/4/2018,Intravenous,pembrolizumab,FALSE
975,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/5/2023,mg,antineoplastic,1/24/2023,12/8/2022,Intravenous,pemetrexed,FALSE
230,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,6/10/2022,mg,antineoplastic,3/17/2022,3/19/2022,Intravenous,carboplatin,FALSE
825,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,9/19/2019,mg,antineoplastic,10/4/2019,7/7/2019,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/12/2020,mg,antineoplastic,4/11/2016,11/16/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/21/2025,,antineoplastic,3/8/2023,2/18/2023,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,4/30/2020,mg,antineoplastic,2/9/2020,1/30/2020,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,11/11/2023,,solution-fluid,7/5/2023,1/2/2023,Intravenous,clinical study drug,FALSE
336,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,10/20/2024,mg,antineoplastic,9/21/2024,7/27/2024,Intravenous,paclitaxel,FALSE
320,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G56BF:5789F3D,4/30/2015,mg,antineoplastic,11/23/2014,12/16/2014,Intravenous,paclitaxel,FALSE
1102,4,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/16/2020,mg,antineoplastic,9/26/2019,9/2/2019,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G545:2F182DD:,10/27/2017,,solution-fluid,7/28/2017,8/16/2017,Intravenous,clinical study drug,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,12/22/2024,mg/m2,antineoplastic,11/10/2024,9/3/2024,Intravenous,pemetrexed,TRUE
973,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/21/2017,mg,antineoplastic,3/14/2017,2/5/2017,Intravenous,bevacizumab,FALSE
1020,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/17/2020,mg,antineoplastic,1/4/2019,12/13/2018,Intravenous,durvalumab,TRUE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,5/16/2025,mg,antineoplastic,11/12/2024,6/29/2023,Intravenous,pembrolizumab,TRUE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,10/2/2016,mg,antineoplastic,3/31/2016,4/29/2016,Intravenous,carboplatin,FALSE
366,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,11/22/2021,mg,antineoplastic,9/28/2021,8/4/2021,Intravenous,paclitaxel,FALSE
514,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,11/22/2013,mg,antineoplastic,10/29/2013,9/22/2013,Intravenous,carboplatin,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,9/10/2018,mg,antineoplastic,3/17/2013,3/1/2013,Intravenous,paclitaxel,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G44785496DGE9,8/18/2024,mg,antineoplastic,4/14/2024,5/18/2024,Intravenous,paclitaxel,FALSE
121,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/11/2020,mg,antineoplastic,9/18/2020,4/8/2020,Intravenous,docetaxel,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/29/2015,mg,antineoplastic,5/14/2015,1/21/2015,Intravenous,paclitaxel protein-bound,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/29/2014,mg/m2,antineoplastic,7/8/2014,12/18/2013,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G44785496DGE9,5/1/2025,,,8/6/2024,8/19/2024,Oral,osimertinib,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,6/15/2023,mg,antineoplastic,7/27/2023,2/18/2023,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4EF93:EF39:7,3/9/2020,,antineoplastic,3/19/2020,3/11/2020,Intravenous,durvalumab,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3951BC5GBE44,1/10/2025,mg,antineoplastic,9/14/2024,10/1/2024,Intravenous,pemetrexed,FALSE
930,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3DG:2D1DGE8B,6/12/2015,mg,antineoplastic,10/18/2014,8/19/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,8/14/2013,mg,antineoplastic,3/19/2013,3/1/2013,Intravenous,paclitaxel protein-bound,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/13/2025,mg,antineoplastic,1/18/2025,4/4/2024,Intramuscular,leuprolide,FALSE
1075,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G2DCF3C5B462B,12/8/2022,mg,antineoplastic,10/24/2022,11/19/2022,Intravenous,pemetrexed,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/18/2024,mg,antineoplastic,11/21/2020,7/2/2020,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/9/2015,mg,antineoplastic,11/29/2014,10/9/2014,Intravenous,etoposide,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/28/2025,mg,antineoplastic,9/22/2016,8/8/2016,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,2/5/2025,mg,antineoplastic,12/28/2024,11/4/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,3/27/2025,,antineoplastic,5/11/2024,2/26/2024,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,2/25/2025,mg,antineoplastic,9/12/2020,2/1/2018,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/7/2019,mg,antineoplastic,2/13/2017,3/4/2016,Intravenous,nivolumab,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/9/2020,mg,antineoplastic,2/18/2020,2/16/2019,Subcutaneous,bortezomib,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G45DDGFC1G86F,5/22/2016,mg,antineoplastic,3/15/2016,4/9/2016,Intravenous,nivolumab,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,11/14/2024,mg,antineoplastic,10/13/2024,8/7/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/12/2023,mg,antineoplastic,1/2/2022,10/19/2021,Intravenous,pembrolizumab,TRUE
773,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,5/4/2023,mg,antineoplastic,3/24/2023,12/10/2022,Intravenous,carboplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3C98:B743F7B,6/9/2013,mg,antineoplastic,3/16/2013,12/13/2012,Intravenous,carboplatin,FALSE
880,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,1/5/2018,mg,antineoplastic,8/10/2017,9/19/2017,Intravenous,pemetrexed,FALSE
710,1,ADVANCED,Administrations,targeted/biologic,Ramucirumab,G1GFD92F489E7,10/13/2023,mg,antineoplastic,7/20/2023,9/2/2023,Intravenous,ramucirumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,6/23/2021,mg,antineoplastic,5/15/2021,3/3/2021,Intravenous,pembrolizumab,TRUE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/4/2016,mg,antineoplastic,4/1/2015,10/15/2014,Intravenous,bevacizumab,TRUE
939,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,5/17/2023,mg,antineoplastic,1/5/2023,11/5/2022,Intravenous,fluorouracil,FALSE
500,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,12/15/2020,mg/m2,antineoplastic,1/23/2021,9/21/2020,Intravenous,pemetrexed,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/29/2020,mg,antineoplastic,11/17/2019,11/27/2019,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,10/10/2019,mg,antineoplastic,8/9/2019,7/28/2019,Intravenous,paclitaxel,FALSE
1140,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5995:57EB51E,6/10/2012,mg,antineoplastic,6/13/2012,4/25/2012,Intravenous,pemetrexed,FALSE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G3::1:B4F:3D4,11/20/2015,mg,antineoplastic,9/20/2015,10/27/2015,Intravenous,nivolumab,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/9/2019,mg,antineoplastic,11/8/2018,12/1/2018,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/29/2022,mg,antineoplastic,4/27/2018,4/27/2017,Intravenous,nivolumab,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/22/2022,mg,antineoplastic,11/27/2021,10/7/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/17/2024,mg,antineoplastic,8/18/2022,6/5/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/27/2024,mg,antineoplastic,1/11/2023,9/30/2022,Intravenous,pembrolizumab,TRUE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,8/11/2013,mg,antineoplastic,9/13/2013,4/7/2013,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/9/2023,mg,antineoplastic,2/27/2023,9/12/2022,Subcutaneous,azacitidine,FALSE
789,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/25/2020,mg,antineoplastic,8/8/2017,2/28/2017,Intravenous,bevacizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,8/6/2021,,antineoplastic,6/7/2021,5/24/2021,,pemetrexed,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/7/2019,mg,antineoplastic,11/20/2016,12/6/2016,Intramuscular,fulvestrant,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19237511G1:D,9/9/2022,mg,antineoplastic,8/31/2022,10/4/2022,Intravenous,pembrolizumab,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/26/2025,mg,antineoplastic,2/9/2017,8/30/2016,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21C1861C3393,2/15/2019,mg,antineoplastic,9/25/2018,8/5/2018,Intravenous,carboplatin,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,4/19/2024,mg,antineoplastic,11/20/2022,3/28/2022,Intravenous,durvalumab,FALSE
1240,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G38GE:9D51587,12/10/2012,mg,antineoplastic,10/8/2012,8/15/2012,Intravenous,gemcitabine,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/8/2021,mg,antineoplastic,7/10/2020,5/26/2020,Intravenous,docetaxel,FALSE
100,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/22/2022,mg,antineoplastic,7/19/2017,4/29/2017,Oral,dasatinib,FALSE
1335,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G46:87GF7FGC9,7/15/2015,mg,antineoplastic,4/19/2015,3/10/2015,Intravenous,bevacizumab,TRUE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,10/10/2016,mg,antineoplastic,6/25/2016,6/5/2016,Intravenous,paclitaxel,FALSE
366,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G4BC1:B::63,12/25/2021,mg,antineoplastic,8/20/2021,8/17/2021,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/24/2025,mg,antineoplastic,12/12/2023,4/28/2022,Intravenous,pembrolizumab,FALSE
460,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/25/2016,mg,antineoplastic,12/15/2015,4/15/2015,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/6/2024,mg,antineoplastic,12/2/2023,10/12/2023,Intravenous,pembrolizumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1C9B158617B6,3/8/2014,AUC,antineoplastic,12/6/2011,12/30/2011,Intravenous,carboplatin,FALSE
501,1,ADVANCED,Administrations,chemotherapy,Osimertinib,G4::3E61CFBB9,2/28/2025,mg,antineoplastic,11/14/2024,10/31/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G132B61FB651B,11/25/2015,,antineoplastic,11/16/2015,10/11/2015,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,3/29/2022,mg,antineoplastic,3/3/2022,12/19/2021,Intravenous,pembrolizumab,FALSE
5,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/12/2014,AUC,antineoplastic,6/18/2014,11/23/2013,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G5:9BFG41:736,9/6/2016,mg,antineoplastic,8/22/2016,10/8/2016,Intravenous,carboplatin,FALSE
234,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G11D1:8:62429,11/9/2015,mg,antineoplastic,9/19/2015,8/13/2015,Intravenous,nivolumab,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,4/25/2022,,antineoplastic,2/12/2022,1/23/2022,Intravenous,paclitaxel,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/25/2023,mg,antineoplastic,9/10/2022,8/3/2022,Subcutaneous,azacitidine,FALSE
1000,,ADJUVANT,Orders,hormone,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,4/13/2024,mg,antineoplastic,3/15/2024,12/8/2023,Oral,abiraterone,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/31/2022,mg,antineoplastic,12/27/2019,5/19/2017,Intravenous,nivolumab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,3/10/2017,mg,antineoplastic,11/6/2016,10/12/2016,Intravenous,paclitaxel protein-bound,FALSE
417,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,4/21/2023,mg,antineoplastic,3/10/2023,3/11/2023,Intravenous,carboplatin,FALSE
1176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2B71GB3997CF,11/20/2023,mg,antineoplastic,8/27/2023,9/23/2023,Intravenous,gemcitabine,FALSE
434,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/24/2013,mg,antineoplastic,2/19/2013,1/5/2013,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,11/18/2011,mg,antineoplastic,4/28/2011,3/26/2011,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/29/2025,mg,antineoplastic,2/12/2024,9/20/2022,Intravenous,pembrolizumab,TRUE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/6/2020,mg,antineoplastic,5/26/2020,5/10/2020,Intravenous,paclitaxel protein-bound,FALSE
1500,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G1G4BC1:B::63,4/30/2022,mg,antineoplastic,3/3/2022,1/7/2022,Intravenous,durvalumab,TRUE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/21/2017,,antineoplastic,9/20/2016,6/3/2016,Intramuscular,fulvestrant,FALSE
420,1,ADVANCED,Administrations,targeted/biologic,"Cetuximab,Irinotecan",G1D61871659DG,8/3/2012,mg,antineoplastic,8/5/2012,8/4/2012,Intravenous,cetuximab,FALSE
1490,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,2/22/2013,mg,antineoplastic,3/10/2013,1/15/2013,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1CD225858D1:,11/26/2016,mg,antineoplastic,10/24/2016,7/1/2016,Intravenous,nivolumab,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,3/25/2018,AUC,antineoplastic,9/25/2014,9/2/2014,Intravenous,carboplatin,FALSE
760,3,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,10/3/2013,mg,antineoplastic,7/7/2013,7/11/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,2/2/2018,mg,antineoplastic,8/24/2017,9/12/2017,Intravenous,pembrolizumab,FALSE
1680,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1D14:53C99:F,3/20/2024,mg,antineoplastic,8/29/2023,4/27/2023,Intravenous,atezolizumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/7/2025,mg,antineoplastic,2/25/2019,1/10/2019,Intravenous,pemetrexed,TRUE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G325B2E578F89,3/14/2016,mg,antineoplastic,10/13/2015,9/24/2015,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/29/2020,mg,antineoplastic,8/7/2017,11/6/2015,Intravenous,nivolumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1C49C5CC7:F7,3/17/2017,mg,antineoplastic,2/27/2017,2/22/2017,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/20/2020,mg,antineoplastic,10/6/2020,5/12/2020,Intravenous,carboplatin,FALSE
760,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/11/2025,mg,antineoplastic,1/12/2021,1/28/2020,Intravenous,pemetrexed,TRUE
128,1,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G53C52948773G,3/3/2024,mg,antineoplastic,11/17/2023,12/17/2023,Intravenous,docetaxel,FALSE
100,5,ADVANCED,Administrations,solution-fluid,"Leuprolide,Pembrolizumab",G17G71B51EFE2,4/8/2025,mL,solution-fluid,3/22/2025,1/12/2025,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,10/7/2024,mg,antineoplastic,8/7/2024,5/26/2024,Intravenous,ipilimumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,"Azacitidine,Venetoclax",G13F761779185,11/4/2023,mg,antineoplastic,6/15/2023,5/15/2023,Subcutaneous,azacitidine,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/3/2022,mg,antineoplastic,11/6/2021,8/21/2021,Intravenous,carboplatin,FALSE
400,4,ADVANCED,Orders,targeted/non-biologic,"Hydroxyurea,Imatinib",G14E7662::61C,12/25/2022,mg,antineoplastic,12/21/2022,10/19/2022,Oral,imatinib,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,3/15/2020,mg,antineoplastic,11/4/2019,11/8/2019,Intravenous,durvalumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,2/26/2022,mg,antineoplastic,10/21/2021,7/1/2021,Intravenous,amivantamab-vmjw,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,12/6/2015,mg,antineoplastic,9/2/2015,10/6/2015,Intravenous,carboplatin,FALSE
649,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G58C6E1DD1D13,12/18/2022,mg,antineoplastic,12/23/2022,12/20/2022,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G579E53D92:75,11/20/2011,,antineoplastic,9/13/2011,8/13/2011,Intravenous,clinical study drug,FALSE
60,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,11/23/2023,mg,antineoplastic,11/5/2023,8/23/2023,Intravenous,paclitaxel,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/22/2025,mg,antineoplastic,3/14/2024,9/21/2022,Oral,anastrozole,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,1/1/2014,AUC,antineoplastic,12/19/2013,12/14/2013,Intravenous,carboplatin,FALSE
2130,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/14/2021,mg,antineoplastic,4/14/2021,5/5/2020,Intravenous,gemcitabine,FALSE
81,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,11/13/2019,mg,antineoplastic,8/24/2019,8/25/2019,Intravenous,paclitaxel,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G32:::74B314F,2/11/2013,AUC,antineoplastic,12/30/2012,1/4/2013,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G3:D1D2EG5C21,11/23/2014,,antineoplastic,8/19/2014,9/18/2014,,clinical study drug,FALSE
218.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24GEG2:6C23D,12/1/2021,mg,antineoplastic,9/13/2021,10/3/2021,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/17/2019,mg,antineoplastic,1/30/2017,2/28/2016,Intravenous,nivolumab,FALSE
610,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,9/3/2020,mg,antineoplastic,2/21/2020,3/3/2020,Intravenous,bevacizumab,FALSE
120,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G24C:63G27686,3/26/2014,mg,antineoplastic,2/8/2014,12/29/2013,Intravenous,paclitaxel protein-bound,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,10/5/2016,mg,antineoplastic,7/21/2016,5/6/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,6/12/2020,mg,antineoplastic,2/16/2020,2/13/2020,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/8/2021,mg/m2,antineoplastic,9/14/2021,3/18/2021,Intravenous,fluorouracil,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G128:92:3BD3D,12/8/2021,,antineoplastic,5/14/2021,4/5/2021,Intravenous,clinical study drug,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,10/30/2014,mg,antineoplastic,8/23/2014,6/26/2014,Intravenous,paclitaxel protein-bound,FALSE
37.5,1,LOCOREGIONAL,Orders,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,11/13/2018,mg/m2,antineoplastic,7/28/2018,8/1/2018,Intravenous,cisplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,9/5/2022,mg,antineoplastic,12/3/2017,5/16/2017,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,5/17/2020,mg,antineoplastic,4/23/2020,2/11/2020,Intravenous,pembrolizumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,5/13/2019,mg,antineoplastic,1/30/2019,1/7/2019,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,8/1/2021,mL,solution-fluid,4/16/2021,4/21/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,8/28/2021,mg,antineoplastic,4/20/2021,2/24/2021,Intravenous,pembrolizumab,FALSE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,7/9/2022,mg,antineoplastic,6/27/2022,3/5/2022,Intravenous,nivolumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/1/2016,AUC,antineoplastic,2/7/2015,6/9/2014,Intravenous,carboplatin,FALSE
469,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G21953622CB66,4/21/2020,mg,antineoplastic,10/27/2019,6/26/2019,Intravenous,ramucirumab,FALSE
550,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,4/13/2014,mg,antineoplastic,12/18/2013,1/1/2014,Intravenous,carboplatin,FALSE
132,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,6/23/2015,mg,antineoplastic,9/9/2013,7/26/2013,Intravenous,paclitaxel,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,4/2/2020,mg,antineoplastic,11/30/2019,10/14/2019,Intravenous,durvalumab,FALSE
600,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/4/2017,mg,antineoplastic,10/23/2016,9/9/2016,Intravenous,bevacizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G2FB35E4B8C3C,2/28/2023,mg,antineoplastic,2/2/2023,10/31/2022,Intravenous,atezolizumab,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,3/26/2025,,steroid,11/21/2024,12/23/2024,Intravenous,clinical study drug,FALSE
149.3,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G171879EG:3B:,11/21/2017,mg,antineoplastic,9/16/2017,9/3/2017,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/7/2025,mg,antineoplastic,1/1/2021,4/21/2018,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,targeted/non-biologic,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,3/8/2019,,antineoplastic,5/18/2018,4/30/2018,,clinical study drug,FALSE
519.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,5/26/2019,mg,antineoplastic,2/21/2019,1/13/2019,Intravenous,carboplatin,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,3/28/2025,mg,antineoplastic,5/16/2017,12/24/2016,Intravenous,pembrolizumab,FALSE
382,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,5/28/2016,mg,antineoplastic,4/12/2016,3/3/2016,Intravenous,carboplatin,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,11/19/2021,mg,antineoplastic,10/1/2021,9/5/2021,Intravenous,carboplatin,FALSE
980,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,8/7/2021,mg,antineoplastic,6/30/2021,2/8/2021,Intravenous,pemetrexed,TRUE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/19/2017,mg,antineoplastic,11/26/2016,11/24/2016,Intravenous,carboplatin,FALSE
151,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/10/2024,mg,antineoplastic,1/20/2024,1/7/2024,Intravenous,carboplatin,FALSE
90,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G24FFF679CFG7,7/26/2013,mg,antineoplastic,6/25/2013,6/28/2013,Intravenous,etoposide,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G253:45FB2F1:,12/23/2018,mg,antineoplastic,7/8/2017,3/16/2017,Intravenous,pemetrexed,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/7/2020,mg,antineoplastic,11/23/2016,7/12/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,5/8/2017,,antineoplastic,1/19/2017,2/21/2016,Intravenous,clinical study drug,FALSE
164,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,6/15/2017,mg,antineoplastic,5/6/2017,5/16/2017,Intravenous,cisplatin,FALSE
410,1,ADVANCED,Administrations,cytoprotective,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/15/2019,mg,antineoplastic,8/22/2018,6/26/2018,Intravenous,levoleucovorin,FALSE
780,,ADJUVANT,Administrations,chemotherapy,Pemetrexed,G35146C5E4B61,12/9/2015,mg,antineoplastic,10/5/2015,4/6/2015,Intravenous,pemetrexed,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/17/2014,mg,antineoplastic,6/23/2014,6/2/2014,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,9/20/2021,mg,antineoplastic,7/14/2021,7/5/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D891287D6B:,11/25/2020,mg,antineoplastic,9/3/2020,7/20/2020,Intravenous,pembrolizumab,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,1/9/2025,mg,antineoplastic,6/2/2022,4/17/2022,Intravenous,cisplatin,FALSE
1580,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/26/2016,mg,antineoplastic,11/30/2015,5/14/2015,Intravenous,gemcitabine,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,2/19/2019,mg,antineoplastic,6/22/2017,11/30/2016,Intramuscular,fulvestrant,FALSE
458,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,2/18/2015,mg,antineoplastic,11/8/2014,10/4/2014,Intravenous,carboplatin,FALSE
390,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/31/2017,mg,antineoplastic,9/30/2017,7/7/2017,Intravenous,carboplatin,FALSE
825,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/22/2023,mg,antineoplastic,5/20/2023,3/7/2023,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,3/21/2025,mg,antineoplastic,4/3/2025,2/6/2025,Intravenous,pembrolizumab,FALSE
820,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G56D5:EDD9C68,3/23/2025,mg,antineoplastic,11/18/2024,4/18/2024,Intravenous,durvalumab,TRUE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Pemetrexed",G53EDE5926292,5/8/2023,,antineoplastic,11/4/2022,11/28/2022,Intravenous,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/24/2023,mL,solution-fluid,5/13/2023,11/19/2022,Intravenous,pemetrexed,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,1/23/2023,,antineoplastic,2/15/2023,9/15/2022,Intravenous,carboplatin,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/4/2025,mg,antineoplastic,10/22/2020,2/22/2019,Intravenous,pemetrexed,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,6/19/2024,mg,antineoplastic,12/9/2023,7/1/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G132B61FB651B,1/17/2016,,antiemetic,12/7/2015,10/16/2015,Intravenous,clinical study drug,FALSE
465,5,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,6/27/2024,mg,antineoplastic,5/10/2024,4/30/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,3/30/2025,,antineoplastic,4/7/2025,10/3/2024,Intravenous,paclitaxel,FALSE
784,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/25/2025,mg,antineoplastic,4/29/2023,9/25/2022,Intravenous,pemetrexed,TRUE
202,,ADJUVANT,Administrations,targeted/biologic,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/22/2017,mg,antineoplastic,4/24/2017,5/21/2017,Intravenous,trastuzumab,FALSE
80,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,2/12/2018,mg/m2,antineoplastic,11/29/2017,9/8/2017,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,6/15/2017,4/14/2017,Intravenous,nivolumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/22/2024,mg,antineoplastic,12/16/2023,3/12/2023,Intravenous,nivolumab,FALSE
500,1,LOCOREGIONAL,Orders,chemotherapy,Pemetrexed,G591:2784957C,12/1/2013,mg/m2,antineoplastic,10/3/2013,9/27/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,12/20/2021,mg,antineoplastic,11/10/2021,11/6/2021,Intravenous,pembrolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D67468:992D,8/30/2016,mg,antineoplastic,3/24/2016,3/17/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,6/8/2021,,antineoplastic,5/16/2021,5/8/2021,,carboplatin,FALSE
88,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G37374D4F9C65,2/25/2023,mg,antineoplastic,10/21/2022,10/25/2022,Intravenous,paclitaxel,FALSE
40,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/25/2015,mg/m2,antineoplastic,2/19/2015,10/8/2014,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,3/15/2025,mg,antineoplastic,4/6/2020,12/30/2018,Intravenous,pembrolizumab,TRUE
145,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G5:D955C88D97,10/27/2022,mg,antineoplastic,4/21/2019,4/28/2019,Intravenous,cisplatin,FALSE
233,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab,Osimertinib",G4826CB54C27:,12/27/2024,mg,antineoplastic,6/6/2024,5/27/2024,Intravenous,nivolumab,FALSE
735,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/5/2024,mg,antineoplastic,6/15/2024,5/30/2024,Intravenous,pemetrexed,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G137D67:GFD9F,5/26/2016,mg,antineoplastic,12/25/2015,11/17/2015,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Bortezomib,G37C2D6679F35,6/19/2020,,antineoplastic,6/30/2019,3/1/2019,Subcutaneous,bortezomib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/19/2025,mg,antineoplastic,3/5/2024,1/21/2017,Intravenous,pembrolizumab,FALSE
41,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/20/2014,mg,antineoplastic,6/26/2014,5/24/2014,Intravenous,vinorelbine,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/28/2024,mg,antineoplastic,3/20/2024,12/3/2022,Intravenous,nivolumab,FALSE
289.3,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,1/19/2016,mg,antineoplastic,9/10/2015,7/5/2015,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3G57E5:BG72C,10/1/2015,mg,antineoplastic,8/25/2015,6/23/2015,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/22/2025,,antineoplastic,3/11/2023,2/6/2023,,clinical study drug,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G2FB35E4B8C3C,7/31/2024,mg,antineoplastic,3/5/2024,3/10/2024,Intravenous,amivantamab-vmjw,FALSE
1045,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/2/2025,mg,antineoplastic,7/14/2024,7/18/2024,Intravenous,pemetrexed,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/14/2023,mg,antineoplastic,8/9/2022,9/9/2022,Subcutaneous,azacitidine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/8/2025,mg,antineoplastic,1/26/2025,7/7/2024,Intravenous,pembrolizumab,FALSE
342,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/1/2017,mg,antineoplastic,6/2/2017,2/22/2017,Intravenous,carboplatin,FALSE
240,4,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,9/11/2023,mg,antineoplastic,7/31/2023,6/27/2023,Intravenous,nivolumab,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,6/8/2024,mg,antineoplastic,6/29/2024,5/3/2024,Intravenous,etoposide,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,5/24/2023,mg,antineoplastic,10/9/2018,10/26/2017,Intravenous,nivolumab,FALSE
15,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/8/2013,mg/kg,antineoplastic,9/22/2012,9/23/2012,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G2FF5BBF:G7GF,10/16/2023,,,10/8/2023,6/20/2020,Oral,osimertinib,FALSE
600,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,11/23/2021,mg,antineoplastic,5/20/2018,3/22/2018,Intravenous,durvalumab,TRUE
64,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14F3GC2D5E43,10/21/2018,mg,antineoplastic,3/8/2018,12/24/2017,Intravenous,cisplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G326EGB36D167,11/20/2019,AUC,antineoplastic,9/4/2019,8/29/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,11/20/2015,AUC,antineoplastic,5/28/2015,3/4/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G545:2F182DD:,10/13/2017,,antineoplastic,9/20/2017,7/25/2017,,clinical study drug,FALSE
195,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,7/31/2015,mg,antineoplastic,6/18/2015,1/21/2015,Intravenous,paclitaxel protein-bound,FALSE
280,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,12/28/2023,mg,antineoplastic,1/2/2024,10/15/2023,Intravenous,carboplatin,FALSE
215,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G4656G51E4EG7,12/18/2018,mg,antineoplastic,11/23/2018,11/18/2018,Intravenous,carboplatin,FALSE
86,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,1/21/2023,mg,antineoplastic,1/4/2023,11/11/2022,Intravenous,paclitaxel,FALSE
4920,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/25/2019,mg,antineoplastic,10/13/2018,7/2/2018,Other/Miscellaneous,fluorouracil,FALSE
178,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/18/2016,mg,antineoplastic,1/23/2016,12/12/2015,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/28/2020,mg,antineoplastic,12/31/2016,11/25/2015,Intravenous,nivolumab,FALSE
485,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15C9CDFE7236,7/24/2016,mg,antineoplastic,8/9/2016,5/25/2016,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/3/2025,mg,antineoplastic,10/30/2024,6/30/2024,Intravenous,pembrolizumab,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/30/2025,mL,solution-fluid,2/15/2025,3/19/2024,Intravenous,pembrolizumab,FALSE
248,,NEOADJUVANT,Administrations,antibody-conjugate,Ado-Trastuzumab Emtansine,G16GE86G42194,4/2/2014,mg,antineoplastic,3/22/2014,3/31/2014,Intravenous,ado-trastuzumab emtansine,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,1/31/2016,mg,antineoplastic,11/8/2015,6/16/2015,Intravenous,pemetrexed,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,1/15/2013,mg,antineoplastic,10/2/2012,10/29/2012,Intravenous,paclitaxel,FALSE
910,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G257459B7FF:E,7/18/2016,mg,antineoplastic,5/31/2016,4/1/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,7/10/2020,,antineoplastic,4/22/2020,12/14/2019,Intravenous,clinical study drug,FALSE
988,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,3/3/2015,mg,antineoplastic,11/21/2014,10/20/2014,Intravenous,bevacizumab,FALSE
127,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,4/3/2016,mg,antineoplastic,3/18/2016,12/27/2015,Intravenous,carboplatin,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1EC14EC2:22:,12/10/2023,mg,antineoplastic,11/18/2023,10/8/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/30/2013,mg/m2,antineoplastic,9/1/2013,8/30/2013,Intravenous,gemcitabine,FALSE
,,NEOADJUVANT,Administrations,glucocorticoid,Clinical Study Drug,G3B698C119:F8,6/19/2012,,steroid,6/16/2012,4/19/2012,Intravenous,clinical study drug,FALSE
940,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G459D:92E2344,12/9/2019,mg,antineoplastic,10/30/2018,9/6/2018,Intravenous,durvalumab,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,6/6/2014,mg,antineoplastic,6/22/2014,5/8/2014,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G3:D1D2EG5C21,9/11/2014,,,1/2/2014,1/19/2014,Oral,erlotinib,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G225D5E995642,5/21/2022,mg,antineoplastic,3/26/2022,2/13/2022,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,10/18/2015,mL,solution-fluid,4/12/2015,2/2/2015,Intravenous,pemetrexed,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/7/2025,mg,antineoplastic,9/5/2021,3/4/2019,Intravenous,pemetrexed,FALSE
60,4,ADVANCED,Administrations,chemotherapy,Doxorubicin Pegylated Liposomal,G19937F58E541,6/3/2014,mg,antineoplastic,5/23/2014,5/16/2014,Intravenous,doxorubicin pegylated liposomal,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/20/2025,mg,antineoplastic,7/12/2024,1/9/2023,Intravenous,pembrolizumab,FALSE
,1,LOCOREGIONAL,Orders,immunotherapy,Durvalumab,G3D1FC341FBF7,10/30/2021,,antineoplastic,12/1/2018,4/3/2018,,durvalumab,TRUE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,2/25/2014,,antineoplastic,11/9/2013,11/15/2013,,cisplatin,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/12/2016,mg,antineoplastic,7/11/2016,6/1/2016,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/17/2023,,antineoplastic,3/22/2023,4/18/2022,Intravenous,durvalumab,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,10/9/2019,mg,antineoplastic,8/17/2019,7/16/2019,Intravenous,carboplatin,FALSE
750,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G211B9B8E3:3E,1/19/2025,mg,antineoplastic,8/31/2024,6/11/2024,Intravenous,durvalumab,FALSE
,4,ADVANCED,Orders,hormone,"Enzalutamide,Pembrolizumab",G17G71B51EFE2,1/16/2025,,antineoplastic,1/30/2025,12/28/2024,,enzalutamide,FALSE
89,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1953CC93B6FB,1/14/2024,mg,antineoplastic,11/18/2023,12/1/2023,Intravenous,paclitaxel,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1CCE24EED8F8,7/18/2022,mg,antineoplastic,7/30/2022,7/8/2022,Intravenous,paclitaxel,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,4/2/2015,mg,antineoplastic,4/12/2014,12/20/2013,Intravenous,carboplatin,FALSE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,3/5/2020,mg,antineoplastic,9/23/2019,9/12/2019,Intravenous,carboplatin,FALSE
100,1,LOCOREGIONAL,Administrations,solution-fluid,Durvalumab,G3D1FC341FBF7,10/8/2021,mL,solution-fluid,7/11/2018,3/26/2018,Intravenous,durvalumab,TRUE
1353,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/24/2016,mg,antineoplastic,4/23/2015,9/24/2014,Intravenous,bevacizumab,TRUE
62,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11E:D3E21E6:,11/19/2024,mg,antineoplastic,8/23/2024,8/21/2024,Intravenous,paclitaxel,FALSE
6,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,3/21/2014,AUC,antineoplastic,11/27/2013,12/14/2013,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,1/9/2016,mg,antineoplastic,6/29/2015,6/20/2015,Intravenous,paclitaxel protein-bound,FALSE
780,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,1/16/2023,mg,antineoplastic,10/15/2020,6/3/2020,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,pain agent,Clinical Study Drug,G3GF88F:7::4:,3/16/2024,,pain agent,10/20/2023,5/12/2023,Oral,clinical study drug,FALSE
36,2,ADVANCED,Administrations,chemotherapy,"Cisplatin,Irinotecan",G325B2E578F89,5/18/2016,mg,antineoplastic,3/30/2016,3/14/2016,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,2/26/2022,mg,antineoplastic,8/7/2021,2/13/2020,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/13/2017,,antineoplastic,7/15/2017,8/1/2017,,carboplatin,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/12/2023,mL,solution-fluid,4/8/2023,11/23/2022,Intravenous,pemetrexed,FALSE
82.2,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,4/27/2015,mg,antineoplastic,3/30/2015,3/30/2015,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,1/16/2022,mg,antineoplastic,10/6/2021,10/24/2021,Intravenous,pemetrexed,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,7/5/2020,mg,antineoplastic,9/19/2017,7/11/2016,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,12/25/2020,mg,antineoplastic,12/9/2019,5/31/2019,Intravenous,pembrolizumab,TRUE
29,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,11/23/2013,mg,antineoplastic,7/26/2013,7/25/2013,Intravenous,vinorelbine,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,4/3/2024,mg,antineoplastic,11/29/2023,2/15/2023,Intravenous,bevacizumab-awwb,TRUE
84,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,5/24/2022,mg,antineoplastic,2/27/2022,3/26/2022,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/14/2022,mg,antineoplastic,3/22/2021,5/5/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G21953622CB66,7/27/2019,mg,antineoplastic,3/6/2019,4/5/2019,Intravenous,pembrolizumab,FALSE
2630,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,3/22/2016,mg,antineoplastic,9/29/2015,4/28/2015,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Unstructured,,Afatinib,G5:7G3C6E4C81,12/9/2018,,,12/11/2018,12/18/2018,Oral,afatinib,FALSE
120,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,11/29/2014,mg,antineoplastic,6/16/2014,7/10/2014,Intravenous,paclitaxel protein-bound,FALSE
617,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,4/1/2025,mg,antineoplastic,4/4/2025,1/21/2025,Intravenous,carboplatin,FALSE
220,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/9/2017,mg,antineoplastic,9/19/2016,4/24/2016,Intravenous,nivolumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G19:83254DDF6,3/6/2023,mg,antineoplastic,12/11/2022,9/12/2022,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/15/2016,AUC,antineoplastic,1/1/2015,6/8/2014,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/21/2019,mg,antineoplastic,8/7/2019,9/3/2019,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,4/4/2024,,antineoplastic,10/13/2023,6/17/2023,Intravenous,clinical study drug,FALSE
226,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G18:439734B::,12/21/2015,mg,antineoplastic,11/4/2015,10/12/2015,Intravenous,nivolumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,7/1/2013,mg,antineoplastic,11/24/2012,5/16/2012,Intravenous,pemetrexed,FALSE
180,3,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G18E7528ED97:,7/25/2012,mg,antineoplastic,6/4/2012,2/27/2012,Intravenous,paclitaxel protein-bound,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G18E7528ED97:,10/17/2011,mg,antineoplastic,9/22/2011,3/7/2011,Intravenous,paclitaxel,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,3/26/2025,mg,antineoplastic,1/29/2024,6/5/2023,Intravenous,pembrolizumab,TRUE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G26D38EC278C1,8/10/2019,mg,antineoplastic,2/26/2019,3/18/2019,Intravenous,atezolizumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G:1C482FFGC,12/15/2016,mg,antineoplastic,4/28/2015,11/9/2014,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G5:3DFC66422C,2/5/2019,mg,antineoplastic,9/5/2018,2/1/2018,Intravenous,nivolumab,FALSE
100,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,11/7/2019,mL,solution-fluid,10/9/2019,8/20/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G12DD1599F4EF,11/14/2024,,antineoplastic,8/16/2024,9/2/2024,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,4/27/2022,,antineoplastic,6/2/2021,7/1/2021,,niraparib,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,3/13/2024,mg,antineoplastic,11/27/2023,3/22/2023,Intravenous,atezolizumab,TRUE
175,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Paclitaxel",G147ED4GE76EE,12/24/2019,mg/m2,antineoplastic,12/26/2019,10/14/2019,Intravenous,paclitaxel,FALSE
288,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,10/14/2023,mg,antineoplastic,8/30/2023,8/1/2023,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3F2D34C5366D,4/27/2022,,antineoplastic,10/1/2021,6/18/2021,,clinical study drug,FALSE
680,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,1/21/2016,mg,antineoplastic,9/29/2015,8/15/2015,Intravenous,carboplatin,FALSE
445,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G242GD729:FB:,3/18/2024,mg,antineoplastic,12/9/2023,12/28/2023,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,chemotherapy,"Capecitabine,Docetaxel",G356E75GB3883,10/15/2017,,antineoplastic,9/6/2017,10/28/2017,Oral,capecitabine,FALSE
411,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,4/18/2025,mg,antineoplastic,2/6/2025,11/14/2024,Intravenous,carboplatin,FALSE
559,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3142D1E86841,5/20/2018,mg,antineoplastic,4/15/2018,2/16/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/20/2025,mg,antineoplastic,4/20/2024,9/16/2022,Intravenous,pembrolizumab,TRUE
350,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,2/8/2025,mg,antineoplastic,2/23/2024,2/23/2024,Intravenous,amivantamab-vmjw,FALSE
64,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,10/24/2024,mg,antineoplastic,5/2/2021,7/3/2020,Intravenous,ipilimumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G2G22BF9DCG81,6/11/2023,mg,antineoplastic,3/8/2023,4/1/2023,Intravenous,pembrolizumab,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,3/7/2016,mg,antineoplastic,12/24/2015,10/29/2015,Intravenous,docetaxel,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G21B7762691EE,8/28/2018,mg,antineoplastic,7/11/2018,8/10/2017,Intravenous,atezolizumab,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,11/23/2019,mg,antineoplastic,9/28/2019,8/19/2019,Intravenous,pemetrexed,FALSE
845,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G18C1EG39143B,9/22/2014,mg,antineoplastic,8/6/2014,9/13/2014,Intravenous,pemetrexed,FALSE
480,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/21/2022,mg,antineoplastic,10/2/2020,5/8/2017,Intravenous,nivolumab,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34BG69F45EE4,10/6/2018,mg,antineoplastic,9/10/2018,7/21/2018,Intravenous,paclitaxel,FALSE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,10/20/2015,mg,antineoplastic,3/13/2015,2/7/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G3B1F6B561ED5,3/17/2021,,hematological agent,10/26/2020,2/8/2020,Subcutaneous,clinical study drug,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1DD111EC2E4G,4/30/2021,,antineoplastic,3/20/2021,4/2/2021,,paclitaxel,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4DE3DE99E:13,1/18/2015,mg,antineoplastic,12/18/2014,9/23/2014,Intravenous,pemetrexed,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G419BEEC19D2C,9/1/2021,mg,antineoplastic,6/22/2021,5/30/2021,Intravenous,carboplatin,FALSE
595,,ADJUVANT,Administrations,targeted/biologic,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,3/21/2018,mg,antineoplastic,2/11/2018,11/2/2017,Intravenous,trastuzumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,1/24/2022,mg,antineoplastic,10/22/2021,9/14/2021,Intravenous,pembrolizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,9/22/2021,mg,antineoplastic,5/27/2021,3/4/2021,Intravenous,pembrolizumab,FALSE
231,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/25/2016,mg,antineoplastic,11/8/2015,7/17/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,12/11/2021,mg,antineoplastic,1/16/2021,1/1/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,2/18/2022,mg,antineoplastic,10/28/2021,9/18/2021,Intravenous,pembrolizumab,TRUE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/4/2017,mg,antineoplastic,7/19/2016,5/16/2015,Intravenous,nivolumab,FALSE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,3/21/2012,mg,antineoplastic,8/4/2011,3/23/2011,Intravenous,bevacizumab,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,6/6/2021,mg,antineoplastic,10/25/2020,11/1/2020,Intravenous,bevacizumab,FALSE
832,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G27B37646G3C2,9/15/2020,mg,antineoplastic,9/9/2020,10/16/2019,Intravenous,durvalumab,FALSE
100,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/23/2015,mg/m2,antineoplastic,3/10/2015,10/6/2014,Intravenous,etoposide,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/18/2019,mg,antineoplastic,4/28/2019,10/4/2018,Intravenous,durvalumab,FALSE
88,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G161297FC6EC1,11/28/2014,mg,antineoplastic,10/6/2014,9/20/2014,Intravenous,paclitaxel,FALSE
386,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1:B8CFFD1931,12/5/2015,mg,antineoplastic,7/2/2015,5/27/2015,Intravenous,ramucirumab,FALSE
1500,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G121:2D8:4E94,7/17/2021,mg,antineoplastic,12/21/2020,10/6/2020,Intravenous,gemcitabine,FALSE
140,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Docetaxel",G3E567F5B3:95,9/4/2017,mg,antineoplastic,8/14/2017,7/4/2017,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G57G45B:D1F17,12/4/2017,mg,antineoplastic,7/20/2017,4/22/2017,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4B1G4D17C4F8,3/4/2023,mg,antineoplastic,6/21/2022,4/5/2022,Intravenous,durvalumab,FALSE
411,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1:B8CFFD1931,9/9/2014,mg,antineoplastic,6/24/2014,7/9/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,6/19/2024,mg,antineoplastic,2/25/2024,11/18/2023,Intravenous,pembrolizumab,FALSE
825,4,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1GC97BGC25B3,10/22/2023,mg,antineoplastic,4/15/2023,4/10/2023,Intravenous,gemcitabine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/2/2025,mg,antineoplastic,2/1/2024,7/21/2023,Intravenous,pembrolizumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,5/12/2025,AUC,antineoplastic,12/28/2024,11/9/2024,Intravenous,carboplatin,FALSE
500,,ADJUVANT,Orders,targeted/non-biologic,Ivosidenib,G13F761779185,4/15/2024,mg,antineoplastic,12/25/2023,9/29/2023,Oral,ivosidenib,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,12/12/2021,mg,antineoplastic,11/3/2021,10/1/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G26G426GG3C8F,7/9/2017,,antineoplastic,6/2/2017,4/4/2017,Intravenous,pemetrexed,FALSE
100,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G4F354B:F341F,10/2/2017,mg,antineoplastic,7/12/2017,6/13/2017,Intravenous,ramucirumab,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/25/2022,mg/kg,antineoplastic,6/8/2021,1/24/2021,Intravenous,durvalumab,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,11/10/2023,mg,antineoplastic,7/21/2023,12/18/2022,Intravenous,pemetrexed,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:46DC16B5B8,5/3/2025,mg,antineoplastic,10/17/2024,9/8/2024,Intravenous,pembrolizumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,8/29/2019,mg,antineoplastic,6/29/2019,5/22/2019,Intravenous,carboplatin,FALSE
250,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/25/2018,mg,antineoplastic,5/31/2018,5/20/2018,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Orders,immunotherapy,Atezolizumab,G26D38EC278C1,7/23/2019,mg,antineoplastic,6/23/2019,4/2/2019,Intravenous,atezolizumab,FALSE
171,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,3/11/2021,mg,antineoplastic,1/21/2021,12/16/2020,Intravenous,carboplatin,FALSE
75,1,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G53C52948773G,4/9/2024,mg/m2,antineoplastic,1/18/2024,12/1/2023,Intravenous,docetaxel,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/26/2019,mg,antineoplastic,11/22/2019,9/16/2019,Intravenous,paclitaxel protein-bound,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G618861EGD9,4/5/2019,mg,antineoplastic,11/15/2017,6/22/2017,Intravenous,nivolumab,FALSE
1500,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G1EC14EC2:22:,3/2/2024,mg,antineoplastic,1/6/2024,12/6/2023,Intravenous,durvalumab,TRUE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G1G78CEE:7E:3,2/14/2018,AUC,antineoplastic,12/6/2017,10/18/2017,Intravenous,carboplatin,FALSE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,3/31/2025,mL,solution-fluid,12/7/2024,4/1/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/28/2020,mg,antineoplastic,6/16/2017,11/10/2015,Intravenous,nivolumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/24/2024,mg,antineoplastic,5/1/2024,5/5/2024,Intravenous,carboplatin,FALSE
90,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,1/8/2021,mg,antineoplastic,9/29/2020,7/16/2020,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,10/25/2020,mg,antineoplastic,8/16/2020,8/30/2019,Intravenous,pembrolizumab,TRUE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,6/7/2019,AUC,antineoplastic,3/27/2019,2/6/2019,Intravenous,carboplatin,FALSE
225,4,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,2/19/2020,mg,antineoplastic,10/7/2019,10/1/2019,Intravenous,carboplatin,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/18/2025,mg,antineoplastic,1/8/2025,9/12/2022,Intravenous,pemetrexed,TRUE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,3/23/2024,mg,antineoplastic,3/4/2024,2/25/2024,Intravenous,pembrolizumab,FALSE
266,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3EC469E475EB,11/10/2018,mg,antineoplastic,12/3/2018,4/26/2018,Intravenous,carboplatin,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,3/2/2023,mg,antineoplastic,1/4/2023,1/5/2023,Intravenous,nivolumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/16/2015,mg,antineoplastic,10/31/2014,8/30/2014,Intravenous,etoposide,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/18/2023,mg,antineoplastic,7/27/2022,5/14/2022,Intravenous,durvalumab,FALSE
960,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/9/2012,mg,antineoplastic,4/21/2012,4/18/2012,Intravenous,bevacizumab,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G2CF99E8E8CF7,9/11/2017,mg,antineoplastic,7/11/2017,8/15/2017,Intravenous,etoposide,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,4/16/2014,mg,antineoplastic,3/16/2014,12/14/2013,Intravenous,docetaxel,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G1B8G131F6FC6,5/12/2017,,antineoplastic,6/14/2017,5/1/2017,,anastrozole,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2777F3E771D8,9/1/2019,mg,antineoplastic,6/11/2019,1/25/2019,Intravenous,pembrolizumab,TRUE
939,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G332GBGFG7416,3/30/2017,mg,antineoplastic,4/4/2015,3/5/2015,Intravenous,bevacizumab,TRUE
925,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/15/2014,mg,antineoplastic,11/7/2013,7/23/2013,Intravenous,pemetrexed,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G24E:FB36:C8B,4/14/2025,mg,antineoplastic,3/1/2016,12/29/2015,Intravenous,paclitaxel,FALSE
29,1,ADVANCED,Administrations,chemotherapy,Cisplatin,G116:6C4GD4D2,11/19/2024,mg,antineoplastic,6/18/2022,4/27/2022,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1C3CCC:C44GD,8/12/2022,mg,antineoplastic,9/16/2021,10/8/2021,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G14E7662::61C,4/1/2017,,solution-fluid,4/4/2017,1/29/2016,Intravenous,clinical study drug,FALSE
1374,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G327B2G171G96,5/31/2022,mg,antineoplastic,5/18/2021,3/17/2020,Intravenous,durvalumab,TRUE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,2/14/2025,mg,antineoplastic,3/8/2023,2/1/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Orders,immunotherapy,Clinical Study Drug,G2DCF3C5B462B,11/7/2023,,antineoplastic,11/20/2023,1/9/2023,,clinical study drug,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/26/2019,mg,antineoplastic,6/1/2019,7/11/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/19/2024,mg,antineoplastic,7/20/2021,6/11/2020,Intravenous,pembrolizumab,TRUE
1000,,NEOADJUVANT,Orders,hormone,"Abiraterone,Leuprolide",G2G419135CEEC,11/8/2023,mg,antineoplastic,10/30/2023,9/1/2023,Oral,abiraterone,FALSE
1313,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,3/18/2015,mg,antineoplastic,11/23/2014,11/7/2014,Intravenous,bevacizumab,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,4/13/2025,mg,antineoplastic,2/27/2025,2/4/2025,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,6/23/2024,,antineoplastic,5/17/2024,5/6/2024,Intravenous,carboplatin,FALSE
725,,NEOADJUVANT,Administrations,chemotherapy,Pemetrexed,G19DB44:G31G8,10/6/2013,mg,antineoplastic,4/27/2013,3/5/2013,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,12/9/2022,,antineoplastic,11/24/2022,11/8/2022,Intravenous,pembrolizumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/12/2024,mg,antineoplastic,6/27/2024,6/3/2024,Intravenous,paclitaxel,FALSE
323,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G776C59C653,12/19/2015,mg,antineoplastic,10/21/2015,10/24/2015,Intravenous,paclitaxel,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/28/2013,AUC,antineoplastic,12/22/2012,10/21/2012,Intravenous,carboplatin,FALSE
235,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,2/25/2016,mg,antineoplastic,7/29/2015,6/7/2015,Intravenous,paclitaxel protein-bound,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,2/15/2019,mg,antineoplastic,12/22/2018,11/10/2018,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/13/2022,mg,antineoplastic,7/15/2018,4/23/2017,Intravenous,nivolumab,FALSE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,11/10/2015,mg,antineoplastic,3/7/2015,1/20/2015,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Capmatinib,G12E5EG31:6:5,9/23/2022,,,10/17/2022,12/13/2021,Oral,capmatinib,FALSE
108,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3GE686D11C25,5/15/2015,mg,antineoplastic,3/29/2015,3/15/2015,Intravenous,paclitaxel,FALSE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G266E6248F531,5/9/2019,mg,antineoplastic,3/6/2019,8/18/2018,Intravenous,nivolumab,FALSE
30,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3:638:2C17ED,7/31/2016,mg,antineoplastic,8/17/2016,8/10/2016,Intravenous,docetaxel,FALSE
230,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G33G487624E32,6/14/2022,mg,antineoplastic,3/4/2022,2/26/2022,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Orders,immunotherapy,Pembrolizumab,G1D3:96CE9334,4/29/2023,mg,antineoplastic,12/16/2019,11/1/2019,Intravenous,pembrolizumab,TRUE
592,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/5/2020,mg,antineoplastic,8/21/2020,6/22/2020,Intravenous,carboplatin,FALSE
226.7,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/30/2014,mg,antineoplastic,12/10/2014,8/7/2014,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,3/30/2025,,antineoplastic,12/14/2020,4/3/2020,Oral,enzalutamide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,5/17/2025,mg,antineoplastic,2/13/2025,4/6/2024,Intravenous,pembrolizumab,FALSE
168,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G43D:C17:25FG,12/26/2015,mg,antineoplastic,10/31/2015,9/11/2015,Intravenous,nivolumab,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G18B63F1G3977,12/9/2017,mg,antineoplastic,12/6/2017,11/11/2017,Intravenous,carboplatin,FALSE
54,4,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,5/8/2025,mg,antineoplastic,10/1/2024,9/30/2024,Intravenous,ipilimumab,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,7/11/2021,mg,antineoplastic,4/16/2021,8/27/2020,Intravenous,durvalumab,FALSE
770,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,12/6/2023,mg,antineoplastic,9/9/2023,9/8/2023,Intravenous,pemetrexed,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/8/2024,mg,antineoplastic,8/25/2023,1/20/2023,Intravenous,durvalumab,FALSE
110,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,9/11/2015,mg,antineoplastic,8/18/2015,9/14/2014,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,9/16/2022,mg,antineoplastic,7/25/2022,6/5/2022,Intravenous,pembrolizumab,FALSE
840,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G153G5833D6D1,5/28/2020,mg,antineoplastic,5/31/2019,3/31/2019,Intravenous,durvalumab,FALSE
855,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,4/1/2017,mg,antineoplastic,1/27/2017,1/18/2017,Intravenous,pemetrexed,FALSE
785,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/12/2021,mg,antineoplastic,8/11/2021,7/6/2021,Intravenous,pemetrexed,FALSE
1075,2,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,4/11/2023,mg,antineoplastic,2/13/2020,12/2/2019,Intravenous,pemetrexed,FALSE
470,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,11/27/2020,mg,antineoplastic,6/14/2017,3/2/2017,Intravenous,carboplatin,FALSE
140,2,ADVANCED,Administrations,chemotherapy,"Paclitaxel Protein-Bound,Pembrolizumab",G5829EBB749DF,4/22/2019,mg,antineoplastic,4/26/2019,4/15/2019,Intravenous,paclitaxel protein-bound,FALSE
500,3,ADVANCED,Orders,chemotherapy,Pemetrexed,G35DE4B3:BCB8,6/2/2019,mg/m2,antineoplastic,5/18/2019,4/24/2019,Intravenous,pemetrexed,FALSE
120,,ADJUVANT,Administrations,chemotherapy,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,12/15/2022,mg,antineoplastic,12/30/2021,9/3/2021,Intravenous,bendamustine,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/7/2025,mg,antineoplastic,10/1/2024,9/18/2022,Intravenous,pemetrexed,TRUE
870,3,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,2/19/2020,mg,antineoplastic,12/27/2019,10/26/2019,Intravenous,pemetrexed,FALSE
523,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,12/6/2020,mg,antineoplastic,4/17/2017,2/23/2017,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,8/17/2017,mg,antineoplastic,9/22/2016,8/13/2016,Intravenous,nivolumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G32:::74B314F,1/17/2013,AUC,antineoplastic,2/1/2013,12/2/2012,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/10/2025,,antineoplastic,6/29/2023,2/2/2023,,clinical study drug,FALSE
186,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,5/16/2023,mg,antineoplastic,6/4/2020,3/13/2020,Intravenous,docetaxel,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G1445DG1:E6:D,9/19/2023,mg,antineoplastic,7/28/2023,12/18/2022,Intravenous,atezolizumab,FALSE
126,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G3848B49CFD:G,11/30/2014,mg,antineoplastic,12/22/2013,2/10/2014,Intravenous,paclitaxel,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/30/2023,mg,antineoplastic,6/22/2022,5/18/2022,Intravenous,durvalumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Vinorelbine",G12F2F77BF3BF,4/16/2013,,antineoplastic,3/26/2013,3/29/2013,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/15/2022,mg,antineoplastic,2/22/2022,4/3/2020,Intravenous,pembrolizumab,TRUE
81,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34:7B13D9C5F,11/8/2015,mg,antineoplastic,3/5/2015,1/31/2015,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/18/2022,,antineoplastic,4/9/2020,4/24/2017,Oral,nilotinib,FALSE
1004,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,4/9/2018,mg,antineoplastic,2/9/2018,12/5/2017,Intravenous,bevacizumab,FALSE
150,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,12/30/2011,mg,antineoplastic,12/19/2011,11/24/2011,Intravenous,carboplatin,FALSE
625,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G2FF1862EC655,1/15/2014,mg,antineoplastic,12/29/2013,11/2/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/13/2024,mg,antineoplastic,6/16/2020,4/22/2020,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,9/1/2024,mg,antineoplastic,10/29/2023,7/9/2023,Intravenous,nivolumab,FALSE
1040,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G17235672EDGF,10/8/2024,mg,antineoplastic,7/3/2024,6/19/2024,Intravenous,pemetrexed,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/13/2022,mg,antineoplastic,10/1/2018,3/30/2017,Intravenous,nivolumab,FALSE
71.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212D32:BD3B6,9/5/2021,mg,antineoplastic,7/11/2021,5/21/2021,Intravenous,paclitaxel,FALSE
,,ADJUVANT,Orders,chemotherapy,"Cisplatin,Pemetrexed",G52:6C556E791,6/22/2024,,antineoplastic,6/7/2024,4/14/2024,,cisplatin,FALSE
745,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G57B5F4B556EG,8/3/2021,mg,antineoplastic,7/31/2021,5/5/2021,Intravenous,pemetrexed,FALSE
160,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,12/6/2012,mg,antineoplastic,5/10/2012,3/10/2012,Intravenous,carboplatin,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,10/22/2024,mg,antineoplastic,8/19/2024,7/2/2024,Intravenous,paclitaxel,FALSE
600,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,12/20/2024,mg,antineoplastic,7/14/2024,4/30/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3GF88F:7::4:,3/13/2024,,antineoplastic,10/25/2023,6/20/2023,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G2GB:GBC6G568,3/16/2025,,,7/25/2023,7/25/2023,Oral,osimertinib,FALSE
1720,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G242B854DCE96,12/19/2015,mg,antineoplastic,11/15/2015,10/29/2015,Intravenous,gemcitabine,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/30/2024,mg,antineoplastic,5/11/2024,7/6/2023,Intravenous,pembrolizumab,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,2/25/2020,mg,antineoplastic,12/31/2017,2/5/2016,Intravenous,bevacizumab,TRUE
350,2,ADVANCED,Administrations,immunotherapy,Cemiplimab,G2262335C:D62,11/5/2024,mg,antineoplastic,11/9/2024,9/1/2024,Intravenous,cemiplimab,FALSE
70,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119DBG986C45,9/14/2022,mg,antineoplastic,8/8/2022,8/20/2022,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G4GE2958C:E1C,3/26/2012,,antineoplastic,8/3/2011,7/14/2011,Intravenous,clinical study drug,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/2/2020,mg,antineoplastic,1/4/2020,8/30/2019,Intravenous,durvalumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/17/2025,mg,antineoplastic,8/28/2024,3/31/2024,Intravenous,pemetrexed,FALSE
413,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,4/6/2025,mg,antineoplastic,1/10/2025,12/20/2024,Intravenous,carboplatin,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,5/1/2025,mg,antineoplastic,2/20/2022,12/20/2021,Intravenous,pembrolizumab,TRUE
1750,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Gemcitabine",G24:75F1:6CB3,5/11/2015,mg,antineoplastic,5/31/2015,3/6/2015,Intravenous,gemcitabine,FALSE
462,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G11F85:F1CG29,8/2/2021,mg,antineoplastic,1/23/2021,9/20/2020,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/24/2022,mg,antineoplastic,6/20/2021,3/15/2021,Intravenous,pembrolizumab,TRUE
582,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,8/17/2024,mg,antineoplastic,3/24/2024,4/21/2024,Intravenous,paclitaxel,FALSE
780,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/3/2025,mg,antineoplastic,7/5/2023,6/30/2023,Intravenous,pemetrexed,TRUE
,1,LOCOREGIONAL,Orders,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/18/2025,,antiemetic,12/15/2024,1/5/2025,,clinical study drug,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,9/11/2020,mg,antineoplastic,6/4/2020,6/19/2020,Intravenous,paclitaxel,FALSE
960,2,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G17177B5C7D7F,5/12/2022,mg,antineoplastic,2/9/2021,3/18/2021,Intravenous,ramucirumab,FALSE
500,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,9/29/2014,mg/m2,antineoplastic,9/5/2014,11/20/2013,Intravenous,pemetrexed,FALSE
35,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G22GF5E64E49D,9/23/2024,mg,antineoplastic,8/7/2024,5/20/2024,Intravenous,vinorelbine,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/24/2020,mg,antineoplastic,1/27/2020,2/2/2019,Subcutaneous,bortezomib,FALSE
950,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G47DB481E783:,4/2/2025,mg,antineoplastic,3/2/2025,3/5/2025,Intravenous,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,1/11/2012,mg,antineoplastic,1/4/2012,11/22/2011,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/3/2025,mg,antineoplastic,11/11/2024,9/1/2022,Oral,anastrozole,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,12/14/2024,mg,antineoplastic,9/27/2024,7/21/2024,Intravenous,pembrolizumab,FALSE
1890,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,8/8/2024,mg,antineoplastic,4/30/2024,3/10/2024,Intravenous,gemcitabine,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,1/6/2023,mg,antineoplastic,6/14/2020,3/19/2020,Intravenous,pemetrexed,TRUE
50,,NEOADJUVANT,Orders,chemotherapy,"Cisplatin,Etoposide",G122G2D35B8CE,6/6/2019,mg/m2,antineoplastic,6/15/2019,5/13/2019,Intravenous,cisplatin,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,7/27/2019,mg,antineoplastic,3/16/2019,2/3/2018,Intravenous,pemetrexed,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,9/27/2012,AUC,antineoplastic,9/20/2012,5/13/2012,Intravenous,carboplatin,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,8/15/2024,mL,solution-fluid,7/15/2024,8/18/2024,Intravenous,gemcitabine,FALSE
125,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G22:2G6GDG986,2/3/2017,mg,antineoplastic,3/17/2014,12/15/2013,Intravenous,etoposide,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,1/8/2019,mg,antineoplastic,10/9/2018,9/25/2017,Intravenous,pembrolizumab,FALSE
250,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,9/26/2024,mg,antineoplastic,5/3/2024,4/23/2024,Intravenous,paclitaxel protein-bound,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/4/2022,mg,antineoplastic,7/15/2020,3/13/2020,Intravenous,pemetrexed,TRUE
83,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,8/15/2015,mg,antineoplastic,7/8/2015,7/21/2015,Intravenous,paclitaxel,FALSE
491,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/8/2025,mg,antineoplastic,12/12/2020,3/27/2019,Intravenous,carboplatin,FALSE
,4,ADVANCED,Unstructured,,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,3/10/2022,,,2/14/2022,12/28/2021,Oral,osimertinib,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/11/2025,mg,antineoplastic,1/23/2023,2/8/2017,Intravenous,pembrolizumab,FALSE
183,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G13FC564CF8GF,8/16/2023,mg,antineoplastic,5/16/2023,5/27/2023,Intravenous,carboplatin,FALSE
193.4,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,12/12/2018,mg,antineoplastic,9/29/2018,8/14/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,3/24/2025,mg,antineoplastic,7/19/2024,6/5/2022,Intravenous,pembrolizumab,FALSE
,4,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G5762B778F:95,7/1/2017,,antineoplastic,10/20/2016,12/3/2016,Oral,clinical study drug,FALSE
95,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Vinorelbine",G11D1:8:62429,12/26/2013,mg,antineoplastic,12/19/2013,9/26/2013,Intravenous,cisplatin,FALSE
273,1,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,10/21/2016,mg,antineoplastic,11/12/2016,7/5/2016,Intravenous,trastuzumab,FALSE
96,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/9/2022,mg,antineoplastic,12/29/2021,9/4/2021,Intravenous,paclitaxel,FALSE
170,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,3/21/2016,mg,antineoplastic,2/26/2016,11/8/2015,Intravenous,paclitaxel protein-bound,FALSE
87,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Etoposide",G42734BB63:32,8/10/2015,mg,antineoplastic,6/30/2015,5/5/2015,Intravenous,cisplatin,FALSE
550,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,5/21/2016,mg,antineoplastic,4/29/2016,4/3/2016,Intravenous,bevacizumab,FALSE
35,2,ADVANCED,Orders,chemotherapy,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,2/1/2024,mg/m2,antineoplastic,10/25/2023,9/15/2023,Intravenous,docetaxel,FALSE
544,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3951BC5GBE44,9/2/2024,mg,antineoplastic,4/2/2024,8/8/2023,Intravenous,durvalumab,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,12/6/2019,mg,antineoplastic,9/25/2019,7/20/2019,Intravenous,paclitaxel protein-bound,FALSE
46,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,12/25/2019,mg,antineoplastic,10/7/2019,9/26/2019,Intravenous,docetaxel,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,1/15/2024,mg,antineoplastic,11/4/2023,11/22/2022,Intravenous,durvalumab,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,4/11/2013,mg,antineoplastic,2/24/2013,2/6/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,4/9/2025,mg,antineoplastic,1/22/2025,12/3/2024,Intravenous,pembrolizumab,TRUE
1050,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,4/29/2025,mg,antineoplastic,2/6/2025,1/21/2025,Intravenous,amivantamab-vmjw,FALSE
170,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G4F354B:F341F,9/12/2017,mg,antineoplastic,8/1/2017,6/3/2017,Intravenous,docetaxel,FALSE
182,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G23BB82DB453D,6/22/2014,mg,antineoplastic,5/1/2014,3/14/2014,Intravenous,cisplatin,FALSE
,4,ADVANCED,Unstructured,,Erlotinib,G18E7528ED97:,8/9/2013,,,2/2/2013,9/18/2012,Oral,erlotinib,FALSE
750,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3EC5EB18C676,3/22/2015,mg,antineoplastic,2/7/2015,1/23/2015,Intravenous,carboplatin,FALSE
2500,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,1/23/2013,mg,antineoplastic,1/21/2013,1/25/2013,Intravenous,ifosfamide,FALSE
725,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3EG8DGC9B:1E,8/4/2019,mg,antineoplastic,12/9/2018,1/27/2018,Intravenous,pemetrexed,FALSE
170,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G2F:C3344EG8G,5/9/2024,mg,antineoplastic,6/3/2024,6/5/2024,Intravenous,etoposide,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,1/17/2013,mg,antineoplastic,2/11/2012,12/13/2011,Intravenous,etoposide,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/19/2013,mg,antineoplastic,6/3/2013,4/20/2013,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,11/5/2021,mg/m2,antineoplastic,4/22/2021,3/30/2021,Intravenous,fluorouracil,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/26/2025,mg/m2,antineoplastic,12/30/2024,10/5/2024,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,3/8/2021,,antiemetic,8/31/2020,2/14/2020,Intravenous,clinical study drug,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/4/2019,mg,antineoplastic,5/29/2016,4/16/2016,Intravenous,nivolumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G376E97C95:G:,7/21/2022,mg,antineoplastic,4/27/2022,9/6/2021,Intravenous,durvalumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,10/22/2017,mg,antineoplastic,1/24/2017,4/21/2016,Intravenous,nivolumab,FALSE
68.9,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/17/2021,mg,antineoplastic,12/16/2020,10/12/2020,Intravenous,ipilimumab,FALSE
2.9,2,ADVANCED,Administrations,chemotherapy,Eribulin,G19937F58E541,1/11/2014,mg,antineoplastic,12/17/2013,10/20/2013,Intravenous,eribulin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,2/14/2020,mg,antineoplastic,1/7/2020,1/13/2020,Intravenous,carboplatin,FALSE
198.9,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,3/24/2017,mg,antineoplastic,9/29/2016,10/17/2016,Intravenous,carboplatin,FALSE
164,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,12/29/2023,mg,antineoplastic,1/9/2024,10/22/2023,Intravenous,carboplatin,FALSE
374,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D6CD2B8C5FD,11/27/2013,mg,antineoplastic,9/24/2013,10/23/2013,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G59243DC543:8,9/19/2024,,,7/11/2024,7/12/2024,Oral,lorlatinib,FALSE
1,,ADJUVANT,Orders,hormone,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,4/30/2018,mg,antineoplastic,4/22/2018,10/19/2017,Oral,anastrozole,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/23/2021,mg,antineoplastic,1/22/2021,10/20/2020,Intravenous,nivolumab,FALSE
79,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G42D:4D9G6157,8/16/2023,mg,antineoplastic,6/7/2023,5/23/2023,Intravenous,paclitaxel,FALSE
5,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/17/2013,AUC,antineoplastic,12/17/2013,10/25/2013,Intravenous,carboplatin,FALSE
222,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/8/2018,mg,antineoplastic,9/4/2015,9/21/2015,Intravenous,nivolumab,FALSE
1005,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,9/2/2021,mg,antineoplastic,9/16/2021,4/25/2021,Intravenous,pemetrexed,FALSE
939,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,3/4/2015,mg,antineoplastic,12/12/2014,12/13/2014,Intravenous,bevacizumab,FALSE
,2,ADVANCED,Unstructured,,Afatinib,G26534:GEG3:6,11/23/2015,,,12/6/2015,8/11/2014,Oral,afatinib,FALSE
80,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4BC1B:E45B69,8/13/2016,mg,antineoplastic,3/29/2016,3/21/2016,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/18/2022,mg,antineoplastic,9/18/2018,5/8/2017,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,immunotherapy,Atezolizumab,G53EDE5926292,2/16/2024,,antineoplastic,4/23/2023,3/19/2023,Intravenous,atezolizumab,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,1/31/2025,mg,antineoplastic,3/23/2023,3/7/2023,Intravenous,paclitaxel protein-bound,FALSE
497,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G3BCC2GG732G:,2/17/2012,mg,antineoplastic,11/29/2011,12/25/2011,Intravenous,carboplatin,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/24/2021,mg,antineoplastic,11/27/2020,5/27/2020,Intravenous,gemcitabine,FALSE
143,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G44DBB13D9C9:,2/1/2019,mg,antineoplastic,11/27/2018,11/14/2018,Intravenous,carboplatin,FALSE
78,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,9/8/2021,mg,antineoplastic,6/5/2021,7/9/2021,Intravenous,paclitaxel,FALSE
369,1,ADVANCED,Administrations,chemotherapy,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/20/2019,mg,antineoplastic,7/16/2018,6/13/2018,Intravenous,irinotecan,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4GE2BD8C57D9,12/28/2018,mg,antineoplastic,6/19/2018,10/28/2017,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,chemotherapy,Gemcitabine,G4:9C89B3B891,1/29/2017,mg,antineoplastic,1/23/2017,12/4/2016,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/7/2025,mg,antineoplastic,3/26/2023,2/24/2020,Intravenous,pembrolizumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/4/2015,mg,antineoplastic,6/18/2015,2/3/2015,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,10/21/2015,mg,antineoplastic,7/2/2015,2/14/2015,Intravenous,paclitaxel protein-bound,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/2/2020,mg,antineoplastic,9/18/2017,11/30/2015,Intravenous,nivolumab,FALSE
1630,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1D84CDE8:C5E,4/29/2015,mg,antineoplastic,3/25/2015,1/10/2015,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,3/17/2025,mg,antineoplastic,11/10/2023,11/9/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,pain agent,Clinical Study Drug,G1CD225858D1:,6/21/2017,,pain agent,11/11/2016,12/20/2016,,clinical study drug,FALSE
134,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/4/2012,mg,antineoplastic,5/25/2012,2/29/2012,Intravenous,carboplatin,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/24/2025,mg,antineoplastic,4/15/2025,8/9/2024,Intravenous,atezolizumab,TRUE
288,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,10/6/2023,mg,antineoplastic,8/17/2023,7/25/2023,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/7/2024,mg,antineoplastic,5/15/2022,4/24/2020,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/27/2025,mg,antineoplastic,11/3/2022,2/27/2020,Intravenous,pembrolizumab,FALSE
70,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G253D7G:9C8CE,6/7/2014,mg,antineoplastic,2/20/2014,1/12/2014,Intravenous,cisplatin,FALSE
262,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1GC444DCD149,9/1/2015,mg,antineoplastic,7/16/2015,7/19/2015,Intravenous,carboplatin,FALSE
15,2,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,10/19/2014,mg/kg,antineoplastic,7/9/2014,11/10/2013,Intravenous,bevacizumab,FALSE
98,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,1/2/2012,mg,antineoplastic,10/19/2011,8/16/2011,Intravenous,paclitaxel,FALSE
334,1,ADVANCED,Administrations,targeted/biologic,"Fluorouracil,Irinotecan,Levoleucovorin,Trastuzumab",G1B3G6DD8B333,3/12/2019,mg,antineoplastic,12/2/2018,6/27/2018,Intravenous,trastuzumab,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,2/26/2024,mg,antineoplastic,12/20/2023,10/24/2023,Intravenous,pembrolizumab,FALSE
169.8,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G45EC515283,7/26/2020,mg,antineoplastic,3/12/2020,2/19/2020,Intravenous,carboplatin,FALSE
535,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FE1DBD491BE,11/5/2017,mg,antineoplastic,10/29/2017,9/30/2017,Intravenous,carboplatin,FALSE
350,2,ADVANCED,Administrations,immunotherapy,Cemiplimab,G2262335C:D62,10/31/2024,mg,antineoplastic,10/2/2024,10/6/2024,Intravenous,cemiplimab,FALSE
326.2,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,4/27/2019,mg,antineoplastic,4/24/2019,3/16/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/22/2019,mg,antineoplastic,7/20/2019,6/22/2018,Intravenous,pembrolizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,8/31/2024,mg,antineoplastic,11/17/2021,6/4/2020,Intravenous,nivolumab,FALSE
1000,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,1/14/2013,mg,antineoplastic,1/10/2013,11/6/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/9/2025,mg,antineoplastic,2/9/2020,4/12/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,10/14/2017,mg,antineoplastic,7/27/2017,6/29/2017,Intravenous,pembrolizumab,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G21BD9C1D75:6,1/30/2019,mg,antineoplastic,9/27/2018,5/25/2018,Intravenous,nivolumab,FALSE
495.6,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G193F52G:DDG7,6/28/2024,mg,antineoplastic,6/2/2024,5/18/2024,Intravenous,carboplatin,FALSE
735,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G12184C2C1CC4,12/20/2023,mg,antineoplastic,12/16/2023,9/10/2023,Intravenous,pemetrexed,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,3/26/2025,mg,antineoplastic,5/4/2022,11/21/2021,Intravenous,pembrolizumab,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/20/2019,mg,antineoplastic,1/8/2018,2/26/2016,Intravenous,nivolumab,FALSE
3629,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/3/2025,mg,antineoplastic,1/6/2025,1/3/2025,Other/Miscellaneous,fluorouracil,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/1/2020,mg,antineoplastic,11/8/2019,2/13/2019,Subcutaneous,bortezomib,FALSE
1130,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/12/2020,mg,antineoplastic,4/16/2014,2/27/2014,Intravenous,cyclophosphamide,FALSE
,1,ADVANCED,Unstructured,,Erlotinib,G25C3661FG6B9,3/26/2015,,,7/17/2014,8/16/2014,Oral,erlotinib,FALSE
1690,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,7/20/2013,mg,antineoplastic,1/11/2013,8/5/2012,Intravenous,gemcitabine,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,6/4/2020,mg,antineoplastic,11/10/2017,11/15/2016,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/10/2025,mg,antineoplastic,9/13/2019,2/6/2019,Intravenous,pemetrexed,TRUE
68,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G213:1B:7D2CF,3/9/2024,mg,antineoplastic,12/3/2023,11/23/2023,Intravenous,paclitaxel,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G261CF698E543,10/20/2015,mL,solution-fluid,2/15/2015,3/7/2015,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G17BG4264193F,4/20/2025,mg,antineoplastic,9/5/2024,4/3/2020,Intravenous,pembrolizumab,FALSE
1,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4464DBGC:5B4,2/3/2018,AUC,antineoplastic,10/25/2017,9/29/2017,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,5/9/2025,mg,antineoplastic,8/31/2024,7/5/2024,Intravenous,pembrolizumab,FALSE
646,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,12/25/2023,mg,antineoplastic,11/9/2023,11/3/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/2/2025,,antineoplastic,10/22/2023,2/13/2023,Intravenous,pemetrexed,FALSE
1100,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,5/8/2017,mg,antineoplastic,5/12/2017,10/25/2016,Intravenous,pemetrexed,FALSE
985,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,3/20/2016,mg,antineoplastic,8/1/2014,5/3/2014,Intravenous,pemetrexed,FALSE
274,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G449FD416E3D5,10/14/2022,mg,antineoplastic,7/31/2022,7/19/2022,Intravenous,carboplatin,FALSE
250,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,9/8/2024,mg,antineoplastic,5/30/2024,4/16/2024,Intravenous,carboplatin,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,11/27/2021,mg,antineoplastic,8/6/2021,10/5/2020,Intravenous,nivolumab,FALSE
100,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/10/2013,mg,antineoplastic,2/9/2012,1/9/2012,Intravenous,etoposide,FALSE
720,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G287777772FGE,1/23/2023,mg,antineoplastic,9/30/2022,3/8/2022,Intravenous,durvalumab,TRUE
500,1,ADVANCED,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G17:EF9E52451,8/4/2021,mL,solution-fluid,7/4/2021,5/2/2021,Intravenous,cisplatin,FALSE
75,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,3/20/2020,mg,antineoplastic,2/15/2020,12/30/2019,Intravenous,paclitaxel,FALSE
1229,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,8/26/2015,mg,antineoplastic,11/16/2014,9/16/2014,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Unstructured,,"Osimertinib,Pembrolizumab",G4826CB54C27:,6/13/2024,,,12/27/2021,11/9/2021,Oral,osimertinib,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/13/2025,mg,antineoplastic,9/16/2023,9/9/2022,Oral,anastrozole,FALSE
137,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/21/2020,mg,antineoplastic,5/5/2020,12/31/2019,Intravenous,docetaxel,FALSE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/30/2022,mg,antineoplastic,9/6/2022,7/19/2021,Intravenous,pembrolizumab,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,5/23/2025,mg,antineoplastic,7/9/2024,7/14/2024,Intravenous,pemetrexed,FALSE
2,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,4/14/2024,AUC,antineoplastic,4/28/2024,2/27/2024,Intravenous,carboplatin,FALSE
40,1,LOCOREGIONAL,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G548B2:G6G6D:,12/28/2018,mg,antineoplastic,9/27/2018,7/1/2018,Intravenous,cisplatin,FALSE
67,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B11FE17FE99,3/26/2023,mg,antineoplastic,3/17/2023,1/24/2023,Intravenous,paclitaxel,FALSE
113,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3642135:5B4C,12/23/2018,mg,antineoplastic,9/23/2018,10/17/2018,Intravenous,carboplatin,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,5/19/2023,mg,antineoplastic,11/24/2022,6/24/2022,Intravenous,durvalumab,FALSE
1000,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G548B2:G6G6D:,1/25/2020,mg,antineoplastic,8/13/2019,1/2/2019,Intravenous,durvalumab,TRUE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1F:9CFGFGFC1,5/1/2020,mg,antineoplastic,8/14/2017,12/4/2016,Intravenous,nivolumab,FALSE
160,2,ADVANCED,Administrations,chemotherapy,Paclitaxel,G3ED9686E8628,1/22/2014,mg,antineoplastic,8/26/2013,7/14/2013,Intravenous,paclitaxel,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G14G5B9C531F6,2/5/2017,mg,antineoplastic,12/25/2016,12/20/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4GE2958C:E1C,4/15/2012,,antineoplastic,8/25/2011,7/8/2011,Intravenous,clinical study drug,FALSE
210,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G14F1:C3:EB31,4/26/2016,mg,antineoplastic,4/16/2014,4/2/2014,Intravenous,carboplatin,FALSE
490,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/22/2025,mg,antineoplastic,8/20/2023,10/24/2022,Intravenous,pemetrexed,TRUE
92,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4DD6CBGD124F,4/22/2025,mg,antineoplastic,4/4/2025,3/29/2025,Intravenous,paclitaxel,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4EF93:EF39:7,3/17/2020,mg,antineoplastic,1/30/2020,11/26/2019,Intravenous,paclitaxel,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/15/2023,mg,antineoplastic,8/11/2023,1/3/2023,Intravenous,pemetrexed,FALSE
1200,,ADJUVANT,Administrations,immunotherapy,Atezolizumab,G32B1E29263BG,4/8/2023,mg,antineoplastic,5/10/2022,5/30/2022,Intravenous,atezolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2E14C6F:EG9B,8/28/2020,mg,antineoplastic,1/29/2019,12/28/2018,Intravenous,pembrolizumab,FALSE
628,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G27:46:6B7F9E,4/18/2025,mg,antineoplastic,10/14/2021,1/30/2020,Intravenous,pemetrexed,TRUE
500,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G2D168F99BCD4,3/4/2023,mg/m2,antineoplastic,2/6/2023,1/30/2023,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Pemetrexed",G49E3CE9E292G,11/1/2019,mL,solution-fluid,8/27/2019,7/17/2019,Intravenous,carboplatin,FALSE
165,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,2/14/2024,mg,antineoplastic,10/10/2023,10/8/2023,Intravenous,carboplatin,FALSE
134,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,2/24/2015,mg,antineoplastic,3/19/2014,12/25/2013,Intravenous,carboplatin,FALSE
1242,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/16/2016,mg,antineoplastic,6/30/2014,6/11/2014,Intravenous,bevacizumab,FALSE
500,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/4/2022,mg,antineoplastic,10/1/2021,6/17/2021,Intravenous,bevacizumab-bvzr,FALSE
154,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G147D:E6:68B1,6/18/2024,mg,antineoplastic,4/22/2024,4/25/2024,Intravenous,carboplatin,FALSE
548,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G445F26762F72,2/19/2024,mg,antineoplastic,1/22/2024,10/20/2023,Intravenous,carboplatin,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,4/5/2023,mg,antineoplastic,10/21/2022,10/24/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,4/13/2025,mg,antineoplastic,8/17/2024,5/31/2024,Intravenous,pembrolizumab,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/13/2023,mg,antineoplastic,3/6/2023,9/29/2022,Subcutaneous,azacitidine,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,8/16/2015,mg,antineoplastic,2/23/2015,3/8/2015,Intravenous,paclitaxel protein-bound,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,3/30/2025,mg/m2,antineoplastic,6/1/2024,12/3/2022,Intravenous,pemetrexed,FALSE
115,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1G3399F19C56,12/14/2016,mg,antineoplastic,1/3/2017,12/7/2016,Intravenous,carboplatin,FALSE
2.7,,ADJUVANT,Administrations,targeted/non-biologic,Bortezomib,G37C2D6679F35,7/1/2020,mg,antineoplastic,1/21/2020,1/30/2019,Subcutaneous,bortezomib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,7/14/2021,mg,antineoplastic,6/23/2021,12/14/2018,Intravenous,pembrolizumab,TRUE
430.8,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,1/28/2015,mg,antineoplastic,9/28/2014,9/17/2014,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1G9455D2D9G7,4/20/2025,,,3/8/2025,2/13/2024,Oral,osimertinib,FALSE
598,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G2GD72:FBC5FG,3/26/2024,mg,antineoplastic,12/15/2022,4/18/2022,Intravenous,durvalumab,FALSE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,8/3/2020,mg,antineoplastic,3/8/2020,1/16/2020,Intravenous,gemcitabine,FALSE
820,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,5/4/2017,mg,antineoplastic,2/7/2017,1/16/2017,Intravenous,pemetrexed,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,12/14/2021,mg,antineoplastic,3/9/2021,10/8/2020,Intravenous,nivolumab,FALSE
356,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/6/2023,mg,antineoplastic,3/16/2023,3/15/2023,Intravenous,carboplatin,FALSE
595,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/16/2021,mg,antineoplastic,6/22/2018,2/18/2018,Intravenous,durvalumab,TRUE
616,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,1/20/2025,mg,antineoplastic,2/29/2024,2/20/2024,Intravenous,carboplatin,FALSE
570,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G16D13269DE9G,12/1/2023,mg,antineoplastic,9/23/2023,10/11/2022,Intravenous,durvalumab,FALSE
176,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,4/11/2022,mg,antineoplastic,2/6/2022,1/22/2022,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G499EB:16:7F3,8/25/2019,mg,antineoplastic,12/16/2018,8/8/2018,Intravenous,nivolumab,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,3/10/2016,mg,antineoplastic,8/17/2015,6/18/2015,Intravenous,carboplatin,FALSE
,2,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,9/2/2020,,antineoplastic,9/17/2019,1/19/2019,,nivolumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/5/2025,,antineoplastic,3/4/2023,2/11/2023,Intravenous,carboplatin,FALSE
1000,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,12/27/2013,mg/m2,antineoplastic,8/21/2013,7/16/2013,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,6/28/2021,mg,antineoplastic,2/6/2020,12/6/2018,Intravenous,pembrolizumab,TRUE
225,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/22/2014,mg,antineoplastic,3/21/2013,3/31/2013,Intravenous,carboplatin,FALSE
138,,ADJUVANT,Administrations,chemotherapy,Azacitidine,G13F761779185,4/9/2023,mg,antineoplastic,11/15/2022,9/29/2022,Subcutaneous,azacitidine,FALSE
250,,ADJUVANT,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2514B78G7G83,10/30/2017,mL,solution-fluid,8/8/2017,7/7/2017,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G26FC954B79DD,4/25/2025,mg,antineoplastic,3/13/2025,1/8/2025,Intravenous,pembrolizumab,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,10/29/2023,mg,antineoplastic,6/24/2023,12/28/2022,Intravenous,pemetrexed,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G376E97C95:G:,8/26/2021,mg,antineoplastic,5/6/2021,5/12/2021,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G26C72D6F6G:5,10/4/2020,mg,antineoplastic,7/25/2020,6/17/2020,Intravenous,nivolumab,FALSE
915,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1E35BD845958,5/2/2015,mg,antineoplastic,1/1/2015,11/22/2014,Intravenous,pemetrexed,TRUE
480,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,2/14/2025,mg,antineoplastic,4/1/2019,12/26/2016,Intravenous,nivolumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G22CF9C794236,3/16/2025,mg,antineoplastic,4/4/2025,12/18/2024,Intravenous,pembrolizumab,FALSE
300,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G119F2D14F4C3,10/13/2016,mg,antineoplastic,7/16/2016,6/10/2016,Intravenous,carboplatin,FALSE
2190,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G1BB2C23:5573,3/20/2020,mg,antineoplastic,12/30/2019,10/17/2019,Intravenous,gemcitabine,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,9/12/2024,mg,antineoplastic,7/21/2024,6/30/2024,Intravenous,paclitaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G55D67392F8:9,11/23/2024,mg,antineoplastic,6/18/2024,11/5/2023,Intravenous,durvalumab,FALSE
,1,LOCOREGIONAL,Administrations,antineoplastic,Clinical Study Drug,G2C233C2:5B1:,5/5/2025,,antineoplastic,12/25/2024,12/10/2024,Intravenous,clinical study drug,FALSE
540,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G48FCG1D:D6C5,9/9/2024,mg,antineoplastic,12/10/2022,5/4/2022,Intravenous,durvalumab,TRUE
2.9,2,ADVANCED,Administrations,chemotherapy,Eribulin,G19937F58E541,12/5/2013,mg,antineoplastic,10/7/2013,11/15/2013,Intravenous,eribulin,FALSE
80,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G11:F93GC6851,2/23/2021,mg,antineoplastic,11/30/2020,8/11/2020,Intravenous,docetaxel,FALSE
560,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G377GC8D648E:,6/22/2024,mg,antineoplastic,5/20/2024,2/20/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/5/2022,mg,antineoplastic,10/30/2021,12/12/2021,Intravenous,pembrolizumab,FALSE
5,1,ADVANCED,Orders,targeted/biologic,"Bevacizumab-Awwb,Fluorouracil,Leucovorin,Oxaliplatin",G1G75:D51G1E5,10/22/2021,mg/kg,antineoplastic,5/13/2021,4/8/2021,Intravenous,bevacizumab-awwb,FALSE
890,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,4/12/2023,mg,antineoplastic,12/24/2022,11/9/2022,Intravenous,pemetrexed,FALSE
80,,CONCURRENT,Administrations,chemotherapy,Cisplatin,G13D3F29D3FFF,2/23/2014,mg,antineoplastic,1/10/2014,12/8/2013,Intravenous,cisplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,Nintedanib,G2848BE3831EF,11/17/2023,,antineoplastic,10/8/2023,10/8/2023,Oral,nintedanib,FALSE
840,2,ADVANCED,Administrations,targeted/biologic,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,5/14/2025,mg,antineoplastic,3/28/2025,3/16/2025,Intravenous,amivantamab-vmjw,FALSE
245.7,3,ADVANCED,Administrations,immunotherapy,"Nivolumab,Vemurafenib",G4C53C5GC48E:,4/21/2016,mg,antineoplastic,5/24/2016,1/13/2016,Intravenous,nivolumab,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/26/2019,mg,antineoplastic,12/17/2018,11/22/2018,Intravenous,pemetrexed,FALSE
467,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,1/14/2025,mg,antineoplastic,1/1/2025,11/23/2024,Intravenous,carboplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G3B8B956G8339,4/10/2025,mg/kg,antineoplastic,1/5/2025,9/27/2024,Intravenous,durvalumab,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3:C9BECD3F55,2/4/2021,,antineoplastic,1/4/2021,11/28/2020,,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G44DDC8341D18,3/24/2025,mg,antineoplastic,11/15/2024,6/11/2023,Intravenous,pembrolizumab,TRUE
757,1,ADVANCED,Administrations,immunotherapy,Durvalumab,G58E33F7EG254,8/24/2019,mg,antineoplastic,4/22/2019,3/7/2019,Intravenous,durvalumab,TRUE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/3/2015,,antineoplastic,5/24/2015,2/3/2015,,pemetrexed,FALSE
153,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/5/2018,mg,antineoplastic,5/22/2018,5/1/2018,Intravenous,paclitaxel,FALSE
17.1,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G19BD1725:45F,10/29/2013,mL,antineoplastic,9/1/2013,7/9/2013,Intravenous,vinorelbine,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/21/2025,mg,antineoplastic,1/11/2025,6/10/2024,Intravenous,carboplatin,FALSE
318,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,10/31/2016,mg,antineoplastic,7/22/2016,5/6/2016,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G14FD45889171,10/3/2015,mg,antineoplastic,3/19/2015,3/8/2015,Intravenous,paclitaxel protein-bound,FALSE
83,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11F85:F1CG29,10/21/2020,mg,antineoplastic,7/16/2020,6/26/2020,Intravenous,paclitaxel,FALSE
126,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G34927D694398,4/5/2018,mg,antineoplastic,3/11/2018,4/26/2018,Intravenous,paclitaxel,FALSE
130,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,12/3/2018,mg,antineoplastic,10/17/2018,9/4/2018,Intravenous,carboplatin,FALSE
,2,ADVANCED,Administrations,growth factor,Clinical Study Drug,G46:87GF7FGC9,11/15/2015,,hematological agent,10/22/2015,7/27/2015,Subcutaneous,clinical study drug,FALSE
,3,ADVANCED,Orders,chemotherapy,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,12/28/2022,,antineoplastic,12/13/2022,10/15/2022,Intravenous,carboplatin,FALSE
445,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/21/2016,mg,antineoplastic,9/23/2014,5/11/2014,Intravenous,carboplatin,FALSE
120,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G1BB2C23:5573,11/20/2020,mg,antineoplastic,4/18/2020,3/18/2020,Intravenous,docetaxel,FALSE
500,,ADJUVANT,Administrations,solution-fluid,"Cisplatin,Pemetrexed",G199G4682G18:,4/12/2024,mL,solution-fluid,1/4/2024,1/2/2024,Intravenous,cisplatin,FALSE
700,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2471D2GFG2E4,8/22/2016,mg,antineoplastic,4/7/2016,4/11/2016,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G41G38G7991D4,5/24/2025,,,4/1/2025,1/6/2025,Oral,dabrafenib,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,8/5/2020,mg,antineoplastic,6/30/2020,3/25/2020,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/13/2020,mg,antineoplastic,4/11/2016,11/7/2015,Intravenous,nivolumab,FALSE
840,4,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,11/19/2021,mg,antineoplastic,10/2/2021,10/26/2021,Intravenous,atezolizumab,FALSE
958,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,11/14/2016,mg,antineoplastic,10/22/2016,2/25/2016,Intravenous,bevacizumab,TRUE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G499EB:16:7F3,11/2/2020,mg,antineoplastic,11/4/2020,9/4/2019,Intravenous,pembrolizumab,FALSE
664,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,4/16/2020,mg,antineoplastic,5/16/2019,1/30/2019,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G1594:E29D2D9,9/1/2021,,,11/1/2020,10/13/2020,Oral,osimertinib,FALSE
622,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,8/13/2017,mg,antineoplastic,5/16/2017,4/23/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,7/31/2022,mg,antineoplastic,7/9/2021,8/21/2020,Intravenous,pembrolizumab,TRUE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,2/17/2020,mg,antineoplastic,8/1/2019,2/17/2019,Intravenous,durvalumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3B43D3B55G,2/26/2025,mg,antineoplastic,4/10/2024,2/16/2024,Intravenous,pembrolizumab,FALSE
78,1,ADVANCED,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,7/14/2022,mg,antineoplastic,6/2/2022,4/30/2022,Intravenous,paclitaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,11/10/2017,mg,antineoplastic,6/12/2017,4/12/2016,Intravenous,nivolumab,FALSE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/28/2017,mg,antineoplastic,8/3/2016,6/7/2016,Intravenous,paclitaxel protein-bound,FALSE
218,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B8B956G8339,9/4/2024,mg,antineoplastic,7/12/2024,8/25/2024,Intravenous,carboplatin,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4826CB54C27:,11/21/2021,,,11/16/2021,4/20/2020,Oral,osimertinib,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G1DD638:C:184,4/18/2025,mg,antineoplastic,5/7/2023,5/28/2022,Intravenous,pembrolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4FG6E1D:B1B7,4/5/2025,mg,antineoplastic,5/1/2025,5/12/2025,Intravenous,carboplatin,FALSE
550,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,12/18/2018,mg,antineoplastic,8/28/2018,8/4/2018,Intravenous,pemetrexed,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,9/21/2021,mg,antineoplastic,8/7/2021,4/13/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C4FFC35G979,4/9/2025,mg,antineoplastic,3/13/2023,10/3/2022,Intravenous,pembrolizumab,TRUE
103,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,6/16/2020,mg,antineoplastic,7/1/2020,12/3/2019,Intravenous,docetaxel,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,9/26/2021,,antineoplastic,6/1/2021,6/17/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,4/12/2020,mg,antineoplastic,3/1/2020,12/31/2017,Intravenous,pembrolizumab,TRUE
,3,ADVANCED,Orders,immunotherapy,Nivolumab,G22D6BD662E16,5/30/2024,,antineoplastic,9/28/2020,9/12/2020,,nivolumab,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,2/17/2021,mg,antineoplastic,1/16/2021,12/15/2020,Intravenous,paclitaxel,FALSE
206.7,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/14/2022,mg,antineoplastic,9/18/2021,9/9/2020,Intravenous,nivolumab,FALSE
145,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/13/2020,mg,antineoplastic,7/31/2020,6/3/2020,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/31/2022,,antineoplastic,12/12/2021,9/1/2021,Intravenous,paclitaxel,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G157317FG3387,6/12/2024,mg,antineoplastic,4/16/2024,5/17/2024,Intravenous,carboplatin,FALSE
622,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,6/8/2023,mg,antineoplastic,10/22/2022,4/22/2022,Intravenous,durvalumab,FALSE
969,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,10/1/2022,mg,antineoplastic,10/11/2021,6/1/2021,Intravenous,fluorouracil,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G33E55:63F87C,4/14/2025,,,4/15/2024,4/21/2024,Oral,osimertinib,FALSE
988,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,2/1/2015,mg,antineoplastic,12/24/2014,11/11/2014,Intravenous,bevacizumab,FALSE
556,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G3642135:5B4C,11/13/2021,mg,antineoplastic,7/28/2021,3/26/2021,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,2/18/2023,mg/m2,antineoplastic,1/14/2023,11/21/2022,Intravenous,pemetrexed,FALSE
591.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,3/11/2021,mg,antineoplastic,11/7/2020,12/9/2020,Intravenous,carboplatin,FALSE
148,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/3/2021,mg,antineoplastic,11/7/2020,5/15/2020,Intravenous,docetaxel,FALSE
832,1,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G247F67418GGD,4/17/2012,mg,antineoplastic,11/1/2011,3/10/2011,Intravenous,bevacizumab,FALSE
192,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3E76E32E795:,9/11/2024,mg,antineoplastic,7/5/2022,6/11/2020,Intravenous,nivolumab,FALSE
,4,ADVANCED,Orders,hormone,"Capecitabine,Fulvestrant",G272F2D3BB8C2,10/11/2017,,antineoplastic,10/13/2016,6/22/2016,Intramuscular,fulvestrant,FALSE
2425,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G177G4:B9E394,4/4/2025,mg,antineoplastic,2/1/2025,3/13/2025,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,9/16/2020,mg,antineoplastic,9/5/2020,6/25/2020,Intravenous,paclitaxel protein-bound,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/2/2022,mg,antineoplastic,11/20/2021,10/16/2021,Intravenous,pemetrexed,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/13/2015,mg,antineoplastic,1/15/2015,5/21/2014,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4CCEFF5GB86F,3/23/2024,mg,antineoplastic,10/25/2022,9/16/2022,Intravenous,pembrolizumab,TRUE
90,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Ramucirumab",G54F545489E59,11/6/2023,mg,antineoplastic,7/4/2023,4/12/2023,Intravenous,docetaxel,FALSE
478,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/3/2025,mg,antineoplastic,3/31/2020,4/4/2019,Intravenous,carboplatin,FALSE
,,NEOADJUVANT,Administrations,antiemetic,Clinical Study Drug,G1DCDG73E53FF,6/29/2024,,antiemetic,5/24/2024,5/20/2024,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,4/25/2024,mg,antineoplastic,3/11/2024,1/24/2024,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/11/2012,,antineoplastic,8/1/2012,4/4/2012,,clinical study drug,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,2/6/2015,,solution-fluid,9/1/2014,8/7/2014,Intravenous,clinical study drug,FALSE
,,ADJUVANT,Administrations,chemotherapy,Clinical Study Drug,G579E53D92:75,11/11/2011,,antineoplastic,10/4/2011,8/12/2011,Intravenous,clinical study drug,FALSE
250,1,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel",G2FGG8E7B7G6B,7/26/2018,mL,solution-fluid,6/12/2015,7/3/2015,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G212CFB5F9B91,4/7/2025,mg,antineoplastic,3/24/2023,12/23/2016,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,10/22/2023,mg,antineoplastic,4/6/2023,7/27/2022,Intravenous,pembrolizumab,TRUE
200,,CONCURRENT,Administrations,immunotherapy,Pembrolizumab,G38C61:99G266,11/13/2022,mg,antineoplastic,9/13/2022,6/5/2021,Intravenous,pembrolizumab,FALSE
160,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/13/2015,mg,antineoplastic,10/23/2014,10/1/2014,Intravenous,etoposide,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,12/29/2023,mg,antineoplastic,12/10/2023,11/13/2023,Oral,anastrozole,FALSE
30.4,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G13F669ED2119,11/11/2012,mg,antineoplastic,6/11/2012,3/23/2012,Intravenous,docetaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G114FBBG316GG,12/27/2022,mg,antineoplastic,8/22/2021,3/26/2021,Intravenous,pembrolizumab,TRUE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,11/17/2021,mg,antineoplastic,11/27/2021,9/8/2021,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/25/2023,mg,antineoplastic,5/1/2022,11/1/2021,Intravenous,pembrolizumab,TRUE
610,1,LOCOREGIONAL,Administrations,immunotherapy,Durvalumab,G3D1FC341FBF7,10/17/2021,mg,antineoplastic,10/8/2018,3/26/2018,Intravenous,durvalumab,TRUE
,2,ADVANCED,Orders,chemotherapy,Pemetrexed,G49E3CE9E292G,4/16/2023,,antineoplastic,7/12/2020,4/22/2020,,pemetrexed,FALSE
150,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G59G63545722G,4/13/2014,mg,antineoplastic,12/24/2013,12/18/2013,Intravenous,docetaxel,FALSE
10,3,ADVANCED,Orders,targeted/biologic,"Docetaxel,Ramucirumab",G1BB2C23:5573,12/7/2020,mg/kg,antineoplastic,10/19/2020,3/11/2020,Intravenous,ramucirumab,FALSE
226,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/31/2024,mg,antineoplastic,6/26/2024,5/24/2024,Intravenous,etoposide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G275592:9ED79,11/7/2021,mg,antineoplastic,10/31/2020,11/4/2019,Intravenous,pembrolizumab,FALSE
1381.5,2,ADVANCED,Administrations,targeted/biologic,"Afatinib,Bevacizumab",G4C53C5GC48E:,12/8/2015,mg,antineoplastic,5/27/2015,2/17/2015,Intravenous,bevacizumab,FALSE
276,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2G1CF3FED3DG,2/10/2018,mg,antineoplastic,1/21/2018,12/11/2017,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,9/24/2021,mg,antineoplastic,6/14/2021,3/27/2021,Intravenous,pembrolizumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,3/26/2025,mg,antineoplastic,3/20/2025,3/26/2024,Intravenous,pembrolizumab,TRUE
572.9,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,4/21/2024,mg,antineoplastic,3/12/2024,3/1/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1D75:47CG6C7,9/28/2024,mg,antineoplastic,11/18/2023,1/11/2023,Intravenous,nivolumab,FALSE
,2,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G2DCF3C5B462B,12/19/2023,,solution-fluid,4/10/2023,1/11/2023,Intravenous,clinical study drug,FALSE
950,3,ADVANCED,Administrations,chemotherapy,Pemetrexed,G47DB481E783:,4/5/2025,mg,antineoplastic,3/29/2025,4/3/2025,Intravenous,pemetrexed,FALSE
220,3,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,5/24/2024,mg,antineoplastic,8/19/2023,7/9/2023,Intravenous,paclitaxel protein-bound,FALSE
250,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G21:3143F86E6,2/21/2015,mg,antineoplastic,1/2/2015,11/29/2014,Intravenous,carboplatin,FALSE
129,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G16D13269DE9G,11/4/2022,mg,antineoplastic,9/5/2022,7/28/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/20/2025,,antineoplastic,5/12/2022,10/22/2021,Intravenous,pembrolizumab,TRUE
716.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G125C8D8E:C:C,5/16/2013,mg,antineoplastic,1/9/2013,1/7/2013,Intravenous,carboplatin,FALSE
,1,ADVANCED,Unstructured,,"Crizotinib,Lorlatinib",G24G49:3G:B1G,2/14/2025,,,10/7/2024,10/16/2024,Oral,crizotinib,FALSE
975,,ADJUVANT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Pemetrexed",G1GFD92F489E7,7/7/2023,mg,antineoplastic,6/3/2023,3/27/2023,Intravenous,pemetrexed,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,3/15/2017,mg,antineoplastic,3/3/2017,12/27/2016,Intravenous,carboplatin,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,4/12/2016,AUC,antineoplastic,4/5/2015,5/4/2014,Intravenous,carboplatin,FALSE
400,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G1:3BC3:FEF23,5/10/2024,mg,antineoplastic,8/5/2023,5/3/2023,Intravenous,pembrolizumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G517B45372B5D,1/15/2021,mg,antineoplastic,8/7/2020,4/27/2020,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1934B71378C6,12/18/2022,mg,antineoplastic,1/10/2022,4/27/2020,Intravenous,pembrolizumab,TRUE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/26/2016,mg,antineoplastic,9/10/2015,7/9/2015,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/27/2024,mg,antineoplastic,9/4/2020,5/22/2020,Intravenous,pembrolizumab,TRUE
520,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,9/11/2024,mg,antineoplastic,5/23/2024,5/23/2024,Intravenous,carboplatin,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,3/24/2025,mg,antineoplastic,10/23/2024,8/5/2024,Intravenous,durvalumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/3/2022,,antineoplastic,5/5/2017,4/11/2017,Oral,nilotinib,FALSE
98,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2GC:751BF4B8,12/4/2018,mg,antineoplastic,10/5/2016,9/1/2016,Intravenous,paclitaxel,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G213:1B:7D2CF,4/16/2025,mg,antineoplastic,9/15/2024,2/9/2024,Intravenous,durvalumab,FALSE
690,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,10/9/2013,mg,antineoplastic,10/17/2013,8/1/2013,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G2B3::97221CC,5/9/2013,mg/m2,antineoplastic,4/22/2013,12/23/2012,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,4/9/2019,mg,antineoplastic,7/30/2018,5/29/2018,Intravenous,nivolumab,FALSE
955,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,11/9/2016,mg,antineoplastic,8/1/2016,7/29/2016,Intravenous,pemetrexed,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,4/23/2024,mg,antineoplastic,2/28/2024,1/15/2024,Intravenous,paclitaxel protein-bound,FALSE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,2/3/2024,mg,antineoplastic,12/10/2023,11/28/2023,Intravenous,paclitaxel,FALSE
,2,ADVANCED,Unstructured,,Tepotinib,G211B9B8E3:3E,5/4/2025,,,2/2/2025,2/8/2025,Oral,tepotinib,FALSE
200,1,ADVANCED,Orders,immunotherapy,Pembrolizumab,G2D168F99BCD4,1/25/2023,mg,antineoplastic,11/18/2022,8/21/2022,Intravenous,pembrolizumab,TRUE
535.8,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,4/14/2019,mg,antineoplastic,2/28/2019,2/13/2019,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/23/2022,mg,antineoplastic,5/24/2017,5/13/2017,Intravenous,nivolumab,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/13/2025,mg,antineoplastic,12/29/2022,9/14/2022,Oral,anastrozole,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G344BC2:6BGE1,5/23/2012,,steroid,12/30/2011,10/17/2011,Intravenous,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/20/2019,mg,antineoplastic,3/19/2018,10/13/2017,Intravenous,atezolizumab,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,4/15/2025,mg,antineoplastic,11/20/2024,2/29/2024,Intravenous,pembrolizumab,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,4/30/2022,mg,antineoplastic,9/8/2019,1/16/2016,Intravenous,pemetrexed,FALSE
360,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,6/25/2022,mg,antineoplastic,3/14/2022,2/2/2022,Intravenous,nivolumab,FALSE
44,2,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G1C32G396:F7G,4/15/2014,mg,antineoplastic,5/2/2014,3/17/2014,Intravenous,vinorelbine,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,12/6/2014,mg,antineoplastic,11/19/2014,4/28/2014,Intravenous,vinorelbine,FALSE
,2,ADVANCED,Unstructured,,"Alectinib,Lorlatinib",G217694659D6F,9/21/2022,,,10/16/2022,8/9/2022,Oral,alectinib,FALSE
,3,ADVANCED,Unstructured,,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,12/11/2016,,,7/4/2016,6/30/2016,Oral,afatinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,11/15/2018,mg,antineoplastic,8/4/2017,3/5/2017,Intravenous,pembrolizumab,FALSE
144,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,1/23/2024,mg,antineoplastic,1/12/2024,11/11/2023,Intravenous,paclitaxel,FALSE
168.7,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G346FFEC8FE4C,8/26/2019,mg,antineoplastic,7/27/2019,5/24/2019,Intravenous,carboplatin,FALSE
176,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35DGE621BE1E,10/31/2023,mg,antineoplastic,9/3/2023,9/3/2023,Intravenous,carboplatin,FALSE
718,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,9/27/2014,mg,antineoplastic,8/26/2014,7/4/2014,Intravenous,carboplatin,FALSE
1090,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28G5D2B769B5,3/17/2016,mg,antineoplastic,1/4/2016,11/7/2014,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G3642135:5B4C,5/15/2021,mg,antineoplastic,12/19/2020,10/12/2020,Intravenous,nivolumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,3/6/2023,mg,antineoplastic,1/7/2023,12/4/2022,Intravenous,pembrolizumab,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/29/2013,mg/m2,antineoplastic,9/10/2012,6/29/2012,Intravenous,docetaxel,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,8/10/2019,mg,antineoplastic,12/20/2016,3/2/2016,Intravenous,nivolumab,FALSE
1150,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,2/19/2025,mg,antineoplastic,12/24/2024,11/11/2024,Intravenous,pemetrexed,TRUE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4464DBGC:5B4,3/17/2025,mg,antineoplastic,5/31/2020,2/23/2018,Intravenous,nivolumab,FALSE
351,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,7/15/2019,mg,antineoplastic,6/20/2016,3/28/2016,Intravenous,nivolumab,FALSE
80,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G3BCC2GG732G:,6/27/2015,mg,antineoplastic,11/15/2014,8/31/2014,Intravenous,cisplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/13/2020,mg,antineoplastic,5/31/2017,8/13/2016,Intravenous,nivolumab,FALSE
499,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,4/22/2025,mg,antineoplastic,7/28/2024,6/26/2024,Intravenous,carboplatin,FALSE
,,ADJUVANT,Orders,targeted/non-biologic,"Fulvestrant,Palbociclib",G286G2E848134,1/22/2019,,antineoplastic,11/8/2016,10/20/2016,Oral,palbociclib,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,3/4/2023,mg,antineoplastic,7/16/2022,1/30/2020,Intravenous,pembrolizumab,FALSE
444,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/18/2019,mg,antineoplastic,5/31/2018,5/31/2018,Intravenous,carboplatin,FALSE
186,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G3GB8B495B6:3,12/21/2016,mg,antineoplastic,2/17/2017,11/18/2016,Intravenous,carboplatin,FALSE
4,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1E3BGE6C42B6,11/16/2024,mg,antineoplastic,10/20/2024,10/19/2024,Intravenous,paclitaxel,FALSE
135,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G15B:95:E93C7,3/14/2015,mg,antineoplastic,5/2/2014,12/22/2013,Intravenous,carboplatin,FALSE
1015,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G4G:96542E2BG,6/10/2018,mg,antineoplastic,3/29/2018,2/13/2018,Intravenous,pemetrexed,FALSE
130,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G1468E9F5C9CG,2/13/2013,mg,antineoplastic,12/22/2011,12/15/2011,Intravenous,etoposide,FALSE
1600,3,ADVANCED,Administrations,chemotherapy,Gemcitabine,G4ED3922EEE48,11/3/2022,mg,antineoplastic,10/27/2022,10/13/2022,Intravenous,gemcitabine,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/12/2020,mg,antineoplastic,9/3/2019,3/28/2019,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G261CF698E543,2/21/2015,,solution-fluid,11/2/2014,8/31/2014,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/9/2017,mg,antineoplastic,5/31/2017,9/9/2016,Intravenous,nivolumab,FALSE
533,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2G1D1B:745EG,7/2/2019,mg,antineoplastic,3/2/2019,3/2/2019,Intravenous,carboplatin,FALSE
400,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,4/3/2025,mg,antineoplastic,2/28/2025,2/8/2025,Intravenous,carboplatin,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,12/17/2022,mg,antineoplastic,11/14/2022,9/26/2022,Intravenous,nivolumab,FALSE
297.9,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G212CFB5F9B91,1/24/2017,mg,antineoplastic,5/6/2016,5/19/2016,Intravenous,carboplatin,FALSE
,1,LOCOREGIONAL,Administrations,glucocorticoid,Clinical Study Drug,G2C233C2:5B1:,4/24/2025,,steroid,2/21/2025,1/6/2025,Intravenous,clinical study drug,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,12/21/2022,mg,antineoplastic,1/17/2021,4/16/2020,Intravenous,pembrolizumab,FALSE
88,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19D32D1B89D8,10/10/2017,mg,antineoplastic,8/29/2017,8/28/2017,Intravenous,paclitaxel,FALSE
463,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46:6C69:D9:C,6/15/2024,mg,antineoplastic,5/27/2024,6/8/2024,Intravenous,carboplatin,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G39183B93EFDG,2/4/2020,mg,antineoplastic,7/31/2019,6/2/2019,Intravenous,carboplatin,FALSE
795,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G131892E39563,1/14/2020,mg,antineoplastic,3/15/2019,12/12/2018,Intravenous,pemetrexed,FALSE
5,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,11/22/2013,AUC,antineoplastic,10/25/2013,9/9/2013,Intravenous,carboplatin,FALSE
166,,ADJUVANT,Administrations,chemotherapy,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,11/23/2017,mg,antineoplastic,8/4/2017,5/20/2017,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,6/29/2023,mg,antineoplastic,5/12/2023,3/2/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Etoposide",G18G1G58:1447,1/3/2019,,antineoplastic,10/24/2017,8/25/2017,,etoposide,FALSE
,2,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G3867F7D51E3D,3/20/2025,,antineoplastic,3/23/2025,3/13/2025,Intravenous,clinical study drug,FALSE
304.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G116C37BB:EB1,10/11/2024,mg,antineoplastic,8/22/2024,5/23/2024,Intravenous,paclitaxel,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/16/2020,mg,antineoplastic,2/2/2019,7/5/2016,Intravenous,nivolumab,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,2/8/2025,mg,antineoplastic,10/29/2024,10/3/2024,Intravenous,carboplatin,FALSE
195,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,6/30/2016,mg,antineoplastic,4/9/2016,4/3/2016,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,9/2/2018,mg,antineoplastic,6/20/2018,6/25/2017,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G3B1F6B561ED5,4/14/2021,,antiemetic,6/18/2020,2/26/2020,Intravenous,clinical study drug,FALSE
360,,NEOADJUVANT,Administrations,immunotherapy,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,1/31/2023,mg,antineoplastic,2/11/2023,12/25/2022,Intravenous,nivolumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,8/23/2016,,antineoplastic,5/21/2016,3/28/2016,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,10/6/2024,mg,antineoplastic,7/24/2024,6/1/2024,Intravenous,pembrolizumab,FALSE
220,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G35DE4B3:BCB8,10/24/2016,mg,antineoplastic,10/16/2016,8/8/2016,Intravenous,nivolumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,12/5/2024,,antineoplastic,6/11/2024,6/17/2024,,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/11/2025,mg,antineoplastic,5/1/2020,5/31/2018,Intravenous,pembrolizumab,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/14/2025,mg,antineoplastic,12/22/2023,4/10/2020,Subcutaneous,leuprolide,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,9/24/2023,mg,antineoplastic,12/18/2022,10/22/2021,Intravenous,pembrolizumab,TRUE
286,,ADJUVANT,Administrations,targeted/biologic,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,2/28/2025,mg,antineoplastic,2/21/2025,12/20/2024,Intravenous,bevacizumab-bvzr,FALSE
636,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G26G426GG3C8F,2/16/2020,mg,antineoplastic,10/26/2019,7/5/2017,Intravenous,pemetrexed,TRUE
179,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G128:92:3BD3D,7/26/2022,mg,antineoplastic,6/14/2022,5/2/2022,Intravenous,carboplatin,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G42D:4D9G6157,12/30/2023,mg/kg,antineoplastic,8/9/2023,8/1/2023,Intravenous,durvalumab,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,4/1/2024,mg,antineoplastic,2/11/2024,2/4/2024,Intravenous,paclitaxel protein-bound,FALSE
300,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1:64BD9C5919,12/21/2021,mg,antineoplastic,9/10/2021,9/20/2021,Intravenous,carboplatin,FALSE
700,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1B2469295BGE,2/4/2014,mg,antineoplastic,2/4/2014,2/27/2014,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,9/2/2017,mg,antineoplastic,10/9/2015,7/4/2015,Intravenous,nivolumab,FALSE
125,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,12/18/2021,mg,antineoplastic,8/26/2021,8/26/2021,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,antiemetic,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/12/2012,,antiemetic,4/6/2012,4/15/2012,,clinical study drug,FALSE
103,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G219998331789,6/13/2020,mg,antineoplastic,5/14/2020,5/11/2020,Intravenous,paclitaxel,FALSE
,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,5/29/2022,,antineoplastic,2/28/2022,1/31/2022,Intravenous,carboplatin,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,9/28/2020,mg,antineoplastic,7/21/2016,12/27/2015,Intravenous,nivolumab,FALSE
780,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G35DGE621BE1E,11/7/2024,mg,antineoplastic,11/28/2024,11/2/2023,Intravenous,durvalumab,FALSE
400,1,ADVANCED,Orders,targeted/non-biologic,"Decitabine,Venetoclax",G41DE1E3BE99:,7/21/2024,mg,antineoplastic,6/19/2024,6/4/2024,Oral,venetoclax,FALSE
190,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,4/29/2022,mg,antineoplastic,2/12/2022,2/17/2022,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/17/2023,mg,antineoplastic,2/16/2022,6/4/2020,Intravenous,pembrolizumab,FALSE
1500,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4D62843::5E1,2/16/2022,mg,antineoplastic,9/22/2021,2/15/2021,Intravenous,durvalumab,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G22F:D77B6329,3/15/2018,mg,antineoplastic,2/16/2018,2/6/2018,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Orders,chemotherapy,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,9/14/2019,,antineoplastic,9/11/2019,7/18/2019,Intravenous,irinotecan,FALSE
840,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,7/29/2017,mg,antineoplastic,7/5/2017,5/23/2017,Intravenous,pemetrexed,FALSE
448,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/9/2025,mg,antineoplastic,1/2/2020,4/19/2019,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,9/7/2022,mg,antineoplastic,8/26/2022,6/1/2022,Intravenous,pembrolizumab,FALSE
440,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,10/29/2019,mg,antineoplastic,9/29/2019,7/30/2019,Intravenous,carboplatin,FALSE
140,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/8/2019,mg,antineoplastic,4/15/2019,2/5/2019,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G1GC97BGC25B3,4/13/2022,mg,antineoplastic,8/25/2020,1/19/2020,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G344BC2:6BGE1,5/15/2012,,antiemetic,9/17/2011,10/25/2011,Intravenous,clinical study drug,FALSE
1050,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G21C1861C3393,1/18/2020,mg,antineoplastic,11/23/2019,3/4/2019,Intravenous,durvalumab,FALSE
129,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Docetaxel",G225477:C1158,11/24/2019,mg,antineoplastic,11/13/2019,9/11/2019,Intravenous,carboplatin,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/23/2013,mg,antineoplastic,5/20/2013,4/10/2013,Intravenous,pemetrexed,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,12/6/2014,mg,antineoplastic,10/1/2014,9/5/2014,Intravenous,paclitaxel,FALSE
392,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,1/23/2024,mg,antineoplastic,12/11/2023,9/11/2023,Intravenous,paclitaxel,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/9/2022,mg,antineoplastic,10/4/2020,1/26/2016,Intravenous,pemetrexed,FALSE
125,2,ADVANCED,Orders,chemotherapy,Paclitaxel Protein-Bound,G564F8B8:FB1E,2/8/2023,mg/m2,antineoplastic,12/20/2022,12/26/2022,Intravenous,paclitaxel protein-bound,FALSE
1075,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,2/7/2016,mg,antineoplastic,10/16/2015,9/17/2015,Intravenous,bevacizumab,FALSE
1165,2,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,3/4/2016,mg,antineoplastic,2/22/2016,12/21/2015,Intravenous,bevacizumab,FALSE
565,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,4/11/2024,mg,antineoplastic,2/12/2024,3/19/2024,Intravenous,carboplatin,FALSE
263,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1FE1DBD491BE,9/22/2017,mg,antineoplastic,9/5/2017,8/24/2017,Intravenous,paclitaxel,FALSE
270,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,12/4/2018,mg,antineoplastic,11/4/2018,6/27/2018,Intravenous,carboplatin,FALSE
168,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/30/2024,mg,antineoplastic,3/16/2024,4/7/2024,Intravenous,carboplatin,FALSE
130,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,2/22/2025,mg,antineoplastic,12/4/2024,10/12/2024,Intravenous,etoposide,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Osimertinib,Pemetrexed",G31C:9::5EG5D,12/7/2023,mg,antineoplastic,4/2/2023,12/2/2022,Intravenous,pemetrexed,FALSE
5,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,8/15/2022,AUC,antineoplastic,5/25/2022,6/6/2022,Intravenous,carboplatin,FALSE
712,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,9/6/2024,mg,antineoplastic,9/3/2024,7/11/2024,Intravenous,pemetrexed,FALSE
238,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,7/27/2021,mg,antineoplastic,8/13/2021,5/29/2021,Intravenous,carboplatin,FALSE
921,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G34BG69F45EE4,9/6/2019,mg,antineoplastic,6/23/2019,9/20/2018,Intravenous,durvalumab,FALSE
60,2,ADVANCED,Orders,chemotherapy,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,6/24/2017,mg/m2,antineoplastic,11/13/2016,11/1/2016,Intravenous,cisplatin,FALSE
180,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G4B1F584CB682,1/24/2016,mg,antineoplastic,12/28/2015,11/24/2015,Intravenous,nivolumab,FALSE
1000,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G33G487624E32,7/15/2023,mg,antineoplastic,7/19/2022,6/30/2022,Intravenous,durvalumab,FALSE
72,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3D1FC341FBF7,2/17/2018,mg,antineoplastic,2/17/2018,1/1/2018,Intravenous,paclitaxel,FALSE
835,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1CG8EF93777D,4/8/2020,mg,antineoplastic,1/27/2020,10/22/2019,Intravenous,durvalumab,FALSE
744,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,3/3/2025,mg,antineoplastic,11/11/2020,2/25/2019,Intravenous,pemetrexed,FALSE
,2,ADVANCED,Unstructured,,Osimertinib,G4ED3922EEE48,10/26/2022,,,5/24/2019,4/21/2019,Oral,osimertinib,FALSE
9.6717,,ADJUVANT,Orders,immunotherapy,Durvalumab,G4::3E61CFBB9,4/19/2022,mg/kg,antineoplastic,4/5/2022,3/3/2021,Intravenous,durvalumab,FALSE
400,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1653:4:85F6:,4/11/2025,mg,antineoplastic,11/28/2022,12/17/2021,Intravenous,pembrolizumab,TRUE
564.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/14/2019,mg,antineoplastic,11/20/2018,11/28/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,3/3/2025,mg,antineoplastic,2/1/2025,7/23/2024,Intravenous,pembrolizumab,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G58E8F29:9:45,8/28/2012,,antineoplastic,9/29/2012,8/22/2012,Oral,anastrozole,FALSE
107,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D62843::5E1,4/7/2021,mg,antineoplastic,12/4/2020,1/18/2021,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,glucocorticoid,Clinical Study Drug,G1969F536B2DD,10/31/2011,,steroid,8/11/2011,7/14/2011,Intravenous,clinical study drug,FALSE
325,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,5/16/2019,mg,antineoplastic,3/16/2019,1/22/2019,Intravenous,paclitaxel,FALSE
268,3,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G131892E39563,12/28/2020,mg,antineoplastic,4/28/2020,1/22/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G252C2C21CF9:,8/16/2022,mg,antineoplastic,3/22/2021,8/7/2020,Intravenous,pembrolizumab,TRUE
49,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Paclitaxel",G56B4BCB27428,1/5/2012,mg,antineoplastic,11/3/2011,9/18/2011,Intravenous,cisplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/25/2018,mg,antineoplastic,3/10/2018,4/18/2017,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3D741EB4:B76,5/20/2025,mg,antineoplastic,11/26/2024,9/13/2022,Intravenous,pembrolizumab,TRUE
,,ADJUVANT,Orders,hormone,Tamoxifen,G1B:584419G11,10/9/2012,,antineoplastic,11/13/2012,10/25/2012,Oral,tamoxifen,FALSE
230,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,9/30/2019,mg,antineoplastic,8/2/2019,7/18/2019,Intravenous,carboplatin,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,10/2/2019,mg,antineoplastic,6/18/2018,6/20/2018,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/9/2024,mg,antineoplastic,11/17/2023,6/2/2023,Intravenous,pembrolizumab,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,11/25/2024,mg,antineoplastic,8/17/2022,12/12/2021,Intravenous,nivolumab,TRUE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,11/4/2020,mg,antineoplastic,3/20/2020,9/14/2019,Intravenous,pembrolizumab,TRUE
320,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17816EGGD:2:,8/23/2018,mg,antineoplastic,8/11/2018,5/13/2018,Intravenous,carboplatin,FALSE
1,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,2/18/2025,mg,antineoplastic,1/14/2023,8/12/2022,Oral,anastrozole,FALSE
,1,ADVANCED,Administrations,solution-fluid,Clinical Study Drug,G344BC2:6BGE1,4/11/2012,,solution-fluid,11/16/2011,9/30/2011,Intravenous,clinical study drug,FALSE
757,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,10/26/2014,mg,antineoplastic,6/16/2014,8/9/2014,Intravenous,carboplatin,FALSE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G5762B778F:95,6/14/2017,,antineoplastic,11/8/2016,11/8/2016,,clinical study drug,FALSE
200,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/2/2024,mg,antineoplastic,5/20/2024,7/9/2023,Intravenous,carboplatin,FALSE
84,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,9/1/2016,mg,antineoplastic,6/29/2016,7/21/2016,Intravenous,paclitaxel,FALSE
198,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G53C52948773G,5/30/2022,mg,antineoplastic,4/16/2022,2/15/2022,Intravenous,carboplatin,FALSE
69,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G215817D1B289,2/25/2021,mg,antineoplastic,1/14/2021,2/7/2021,Intravenous,ipilimumab,FALSE
541,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G54F545489E59,10/24/2023,mg,antineoplastic,5/4/2023,3/5/2023,Intravenous,ramucirumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/18/2022,,antineoplastic,4/25/2019,3/29/2017,Oral,nilotinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3E1::7EC84D4,9/10/2023,mg,antineoplastic,3/5/2023,8/10/2022,Intravenous,pembrolizumab,FALSE
870,3,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,12/27/2019,mg,antineoplastic,11/24/2019,11/11/2019,Intravenous,pemetrexed,FALSE
850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,8/26/2012,mg,antineoplastic,6/28/2012,3/24/2012,Intravenous,pemetrexed,FALSE
40,4,ADVANCED,Administrations,chemotherapy,Vinorelbine,G557E997E81G5,10/15/2023,mg,antineoplastic,6/23/2023,7/10/2023,Intravenous,vinorelbine,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/3/2022,mg,antineoplastic,10/15/2021,8/13/2021,Intravenous,amivantamab-vmjw,FALSE
480,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G56B4BCB27428,6/1/2023,mg,antineoplastic,8/31/2018,12/5/2017,Intravenous,nivolumab,FALSE
,1,ADVANCED,Unstructured,,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,6/21/2014,,,5/30/2014,3/16/2014,Oral,erlotinib,FALSE
200,,CONCURRENT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G3F13DFD1C:33,5/22/2025,mg,antineoplastic,9/3/2024,1/30/2023,Intravenous,pembrolizumab,FALSE
1100,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,9/29/2013,mg,antineoplastic,6/30/2013,3/20/2013,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,8/15/2021,mg,antineoplastic,6/12/2021,6/8/2021,Intravenous,etoposide,FALSE
1800,2,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5722GECG4G16,5/30/2024,mg,antineoplastic,3/20/2024,2/26/2024,Intravenous,gemcitabine,FALSE
,1,ADVANCED,Unstructured,,Osimertinib,G13C2:FDBFBC2,3/27/2025,,,3/24/2025,8/29/2024,Oral,osimertinib,FALSE
100,2,ADVANCED,Administrations,solution-fluid,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,6/11/2024,mL,solution-fluid,5/26/2024,3/23/2024,Intravenous,pembrolizumab,FALSE
1,3,ADVANCED,Administrations,hormone,"Anastrozole,Atezolizumab",G1GFD92F489E7,12/19/2023,mg,antineoplastic,12/8/2023,11/19/2023,Oral,anastrozole,FALSE
300,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,3/16/2015,mg,antineoplastic,1/13/2015,10/28/2014,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,8/5/2020,mg,antineoplastic,8/8/2016,7/13/2016,Intravenous,nivolumab,FALSE
223,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,5/27/2018,mg,antineoplastic,9/30/2016,8/9/2015,Intravenous,nivolumab,FALSE
,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/6/2017,,antineoplastic,7/12/2017,7/21/2017,,carboplatin,FALSE
2.9,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,6/8/2014,mg,antineoplastic,2/2/2014,12/22/2013,Intravenous,eribulin,FALSE
246,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,11/24/2016,mg,antineoplastic,10/11/2016,7/25/2016,Intravenous,paclitaxel,FALSE
86,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G45GCCC8711F:,1/31/2022,mg,antineoplastic,7/12/2014,6/16/2014,Intravenous,paclitaxel,FALSE
570,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,11/25/2012,mg,antineoplastic,9/15/2012,5/8/2012,Intravenous,carboplatin,FALSE
800,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G19511695D78G,4/12/2025,mg,antineoplastic,4/1/2025,5/27/2025,Intravenous,pemetrexed,FALSE
102,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,1/30/2016,mg,antineoplastic,9/27/2015,6/17/2015,Intravenous,paclitaxel,FALSE
1000,2,ADVANCED,Administrations,chemotherapy,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,3/16/2025,mg,antineoplastic,5/25/2024,2/8/2024,Intravenous,pemetrexed,FALSE
620,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G53C52948773G,5/20/2023,mg,antineoplastic,5/5/2023,5/2/2022,Intravenous,durvalumab,FALSE
25,5,ADVANCED,Administrations,targeted/non-biologic,Temsirolimus,G22GF5E64E49D,12/9/2024,mg,antineoplastic,8/30/2024,8/19/2024,Intravenous,temsirolimus,FALSE
140,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,6/14/2023,mg,antineoplastic,6/5/2023,4/21/2023,Intravenous,paclitaxel protein-bound,FALSE
,1,ADVANCED,Orders,targeted/biologic,Ramucirumab,G1GFD92F489E7,11/1/2023,,antineoplastic,10/4/2023,8/25/2023,Intravenous,ramucirumab,FALSE
42,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,1/14/2015,mg,antineoplastic,11/23/2014,11/10/2014,Intravenous,vinorelbine,FALSE
230,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,12/26/2019,mg,antineoplastic,10/7/2019,9/20/2019,Intravenous,paclitaxel protein-bound,FALSE
114,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G327B2G171G96,4/3/2020,mg,antineoplastic,11/16/2019,12/3/2019,Intravenous,paclitaxel,FALSE
125,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G38D11EG5F826,8/17/2020,mg,antineoplastic,3/15/2020,3/5/2020,Intravenous,carboplatin,FALSE
,5,ADVANCED,Unstructured,,Sotorasib,G56B4BCB27428,10/14/2023,,,9/14/2023,9/3/2023,Oral,sotorasib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Docetaxel,Ipilimumab,Nivolumab",G1C679D8145C1,4/17/2022,,antineoplastic,6/11/2022,5/12/2022,Intravenous,ipilimumab,FALSE
700,2,ADVANCED,Administrations,targeted/biologic,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,11/25/2020,mg,antineoplastic,8/16/2014,3/24/2014,Intravenous,rituximab,FALSE
178.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G166G5:E8CEDF,11/1/2016,mg,antineoplastic,4/30/2016,4/9/2016,Intravenous,carboplatin,FALSE
148,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G257D9:2573CF,12/13/2024,mg,antineoplastic,10/2/2024,7/23/2024,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,3/6/2022,,antineoplastic,12/23/2021,10/7/2021,Intravenous,carboplatin,FALSE
501,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G46:6C69:D9:C,6/15/2024,mg,antineoplastic,5/2/2024,5/13/2024,Intravenous,carboplatin,FALSE
135,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G35:D379:C56C,1/27/2022,mg,antineoplastic,10/9/2021,9/2/2021,Intravenous,carboplatin,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/27/2025,mg/m2,antineoplastic,1/16/2025,11/2/2024,Intravenous,paclitaxel,FALSE
900,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/11/2025,mg,antineoplastic,12/27/2020,3/8/2019,Intravenous,pemetrexed,FALSE
150,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G14GFF41D::2B,8/18/2012,mg,antineoplastic,7/30/2012,7/7/2012,Intravenous,cisplatin,FALSE
745,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1:B8CFFD1931,3/28/2015,mg,antineoplastic,9/30/2014,9/25/2014,Intravenous,pemetrexed,TRUE
2052,2,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,7/17/2020,mg,antineoplastic,3/22/2020,1/12/2020,Intravenous,gemcitabine,FALSE
292,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,12/3/2020,mg,antineoplastic,10/22/2020,6/1/2020,Intravenous,paclitaxel,FALSE
1600,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,5/27/2014,mg,antineoplastic,5/2/2014,2/19/2014,Intravenous,gemcitabine,FALSE
250,,ADJUVANT,Administrations,hormone,"Fulvestrant,Palbociclib",G286G2E848134,3/5/2019,mg,antineoplastic,3/2/2017,11/22/2016,Intramuscular,fulvestrant,FALSE
2270,3,ADVANCED,Administrations,chemotherapy,"Docetaxel,Gemcitabine",G3D:24E398DDF,8/7/2021,mg,antineoplastic,11/11/2020,5/7/2020,Intravenous,gemcitabine,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G199G4682G18:,4/25/2025,mg,antineoplastic,12/17/2024,3/31/2024,Intravenous,pembrolizumab,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G26534:GEG3:6,8/28/2020,mg,antineoplastic,11/18/2016,11/8/2015,Intravenous,nivolumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1CGF44F849F1,5/4/2024,mg,antineoplastic,2/5/2024,3/15/2024,Intravenous,nivolumab,FALSE
200,2,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,2/25/2023,mg,antineoplastic,3/14/2020,12/12/2019,Intravenous,pembrolizumab,FALSE
392,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,12/8/2023,mg,antineoplastic,10/17/2023,9/21/2023,Intravenous,paclitaxel,FALSE
15,4,ADVANCED,Orders,targeted/biologic,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,2/2/2015,mg/kg,antineoplastic,12/3/2014,12/8/2014,Intravenous,bevacizumab,FALSE
535,2,ADVANCED,Administrations,targeted/biologic,Bevacizumab,G4C915B9CFD61,5/17/2021,mg,antineoplastic,12/17/2020,11/1/2020,Intravenous,bevacizumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G1:79593262B6,11/12/2022,mg,antineoplastic,12/5/2020,1/25/2018,Intravenous,pembrolizumab,FALSE
80,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,9/4/2024,mg,antineoplastic,8/31/2024,7/23/2024,Intravenous,paclitaxel protein-bound,FALSE
950,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G261CF698E543,10/5/2015,mg,antineoplastic,5/3/2015,2/19/2015,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,11/27/2024,,antineoplastic,9/24/2024,8/30/2024,Intravenous,paclitaxel,FALSE
1000,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/7/2020,mg,antineoplastic,10/7/2018,1/22/2016,Intravenous,bevacizumab,TRUE
100,,ADJUVANT,Administrations,solution-fluid,Pembrolizumab,G199G4682G18:,4/1/2025,mL,solution-fluid,12/6/2024,4/24/2024,Intravenous,pembrolizumab,FALSE
260,1,ADVANCED,Administrations,chemotherapy,Carboplatin,G1E1C181843G1,10/9/2014,mg,antineoplastic,3/5/2013,3/21/2013,Intravenous,carboplatin,FALSE
1680,3,ADVANCED,Administrations,immunotherapy,"Anastrozole,Atezolizumab",G1GFD92F489E7,11/28/2023,mg,antineoplastic,12/24/2023,12/4/2023,Intravenous,atezolizumab,FALSE
50,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,1/6/2012,mg,antineoplastic,12/17/2011,9/5/2011,Intravenous,vinorelbine,FALSE
500,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G32B1E29263BG,5/10/2022,mg,antineoplastic,2/2/2022,2/24/2022,Intravenous,carboplatin,FALSE
,1,ADVANCED,Orders,chemotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,4/15/2025,,antineoplastic,4/21/2022,9/18/2021,Intravenous,pemetrexed,TRUE
155,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,8/26/2017,mg,antineoplastic,8/22/2016,6/11/2016,Intravenous,paclitaxel protein-bound,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G4E4734258BE1,10/23/2022,mg,antineoplastic,5/28/2022,4/7/2022,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4D:183G813CB,10/4/2018,mg,antineoplastic,3/19/2013,2/2/2013,Intravenous,carboplatin,FALSE
1075,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,1/20/2016,mg,antineoplastic,12/20/2015,10/31/2015,Intravenous,bevacizumab,FALSE
700,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G4CF4FFFDGB63,2/20/2024,mg,antineoplastic,2/24/2023,1/24/2023,Intravenous,durvalumab,FALSE
740,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,12/11/2024,mg,antineoplastic,11/15/2024,10/29/2024,Intravenous,carboplatin,FALSE
300,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,7/20/2022,mg,antineoplastic,6/20/2022,5/5/2017,Oral,nilotinib,FALSE
,1,ADVANCED,Orders,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,1/30/2025,,antineoplastic,6/9/2019,1/16/2019,Intravenous,pembrolizumab,TRUE
171,,CONCURRENT,Administrations,chemotherapy,Carboplatin,G2G9:BE:3D8C1,3/22/2021,mg,antineoplastic,2/5/2021,12/25/2020,Intravenous,carboplatin,FALSE
475,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,4/1/2019,mg,antineoplastic,3/26/2019,1/30/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14::E36GD8C6,5/24/2019,AUC,antineoplastic,5/23/2019,4/11/2019,Intravenous,carboplatin,FALSE
651,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GF73E51BG1F,10/28/2016,mg,antineoplastic,8/25/2016,6/20/2016,Intravenous,carboplatin,FALSE
638,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,2/11/2025,mg,antineoplastic,12/29/2024,9/26/2024,Intravenous,carboplatin,FALSE
865,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,7/19/2023,mg,antineoplastic,5/11/2023,4/27/2023,Intravenous,pemetrexed,FALSE
304,1,ADVANCED,Administrations,chemotherapy,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,8/7/2024,mg,antineoplastic,5/23/2024,5/7/2024,Intravenous,carboplatin,FALSE
160,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G16:GC1C87FG:,5/8/2017,mg,antineoplastic,2/19/2017,10/18/2016,Intravenous,paclitaxel protein-bound,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G11:F93GC6851,6/12/2020,mg,antineoplastic,12/13/2019,7/29/2016,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,targeted/non-biologic,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,8/16/2022,,antineoplastic,3/30/2019,4/27/2017,Oral,nilotinib,FALSE
65,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,11/27/2020,mg,antineoplastic,9/27/2020,4/11/2020,Intravenous,paclitaxel,FALSE
306,,ADJUVANT,Administrations,cytoprotective,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/5/2022,mg,antineoplastic,2/14/2022,11/4/2021,Intravenous,leucovorin,FALSE
1920,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G1G913:D125BD,5/15/2019,mg,antineoplastic,2/18/2019,2/16/2019,Intravenous,gemcitabine,FALSE
,2,ADVANCED,Orders,chemotherapy,Gemcitabine,G3G18F3E9E3C8,2/18/2025,mg/m2,antineoplastic,12/3/2024,7/6/2024,Intravenous,gemcitabine,FALSE
250,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G269235FC:5C7,1/8/2015,mg,antineoplastic,9/16/2014,9/20/2014,Intravenous,carboplatin,FALSE
396,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,6/18/2020,mg,antineoplastic,6/4/2020,4/13/2020,Intravenous,paclitaxel,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G475BB:CGC731,3/18/2025,mg,antineoplastic,10/22/2024,8/24/2021,Intravenous,atezolizumab,TRUE
100,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Etoposide",G2BE13CEFB231,12/21/2013,mg/m2,antineoplastic,11/10/2013,10/7/2013,Intravenous,etoposide,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/18/2016,mg,antineoplastic,1/11/2016,5/19/2015,Intravenous,carboplatin,FALSE
64,5,ADVANCED,Administrations,immunotherapy,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,2/29/2024,mg,antineoplastic,1/13/2024,10/5/2023,Intravenous,ipilimumab,FALSE
610,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,5/28/2022,mg,antineoplastic,6/7/2022,4/7/2022,Intravenous,carboplatin,FALSE
340,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G2216DG74F41B,3/28/2024,mg,antineoplastic,3/23/2024,3/15/2024,Intravenous,paclitaxel,FALSE
200,3,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,3/4/2020,mg,antineoplastic,7/15/2019,2/4/2019,Intravenous,pembrolizumab,FALSE
,3,ADVANCED,Unstructured,,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,5/19/2024,,,5/29/2024,10/29/2023,Oral,osimertinib,FALSE
154,,ADJUVANT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G574795::16B2,12/23/2020,mg,antineoplastic,9/14/2020,10/23/2020,Intravenous,cisplatin,FALSE
219,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1532797B869C,2/24/2023,mg,antineoplastic,12/1/2022,10/16/2022,Intravenous,paclitaxel,FALSE
,4,ADVANCED,Unstructured,,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,3/31/2025,,,4/19/2025,5/9/2024,Oral,osimertinib,FALSE
117,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2B:D6686421C,8/14/2013,mg,antineoplastic,6/8/2013,4/22/2013,Intravenous,carboplatin,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,4/18/2025,mg,antineoplastic,10/30/2017,7/13/2016,Intravenous,pembrolizumab,FALSE
780,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G45C13CFDDB84,11/25/2015,mg,antineoplastic,5/30/2015,4/19/2015,Intravenous,pemetrexed,TRUE
60,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,1/14/2024,mg,antineoplastic,12/5/2023,10/14/2023,Intravenous,paclitaxel,FALSE
1075,2,ADVANCED,Administrations,chemotherapy,"Nivolumab,Pemetrexed",G5:3DFC66422C,9/3/2019,mg,antineoplastic,2/16/2019,3/5/2019,Intravenous,pemetrexed,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/10/2022,mg,antineoplastic,9/22/2018,2/26/2016,Intravenous,pemetrexed,FALSE
584.5,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,2/26/2021,mg,antineoplastic,11/7/2020,11/4/2020,Intravenous,carboplatin,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,11/29/2013,mg,antineoplastic,5/14/2013,10/22/2012,Intravenous,carboplatin,FALSE
541,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1::2C155D:6E,10/14/2021,mg,antineoplastic,8/28/2021,7/26/2021,Intravenous,carboplatin,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,7/24/2014,mg,antineoplastic,3/22/2014,4/11/2014,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G3G51E516C136,3/11/2024,mg,antineoplastic,1/4/2024,6/20/2023,Intravenous,pembrolizumab,FALSE
450,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,10/11/2023,mg,antineoplastic,5/23/2023,5/6/2023,Intravenous,carboplatin,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G4G3G:984BG53,12/29/2016,,antineoplastic,6/7/2016,3/11/2016,Intravenous,clinical study drug,FALSE
78,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1366655F1B29,2/3/2019,mg,antineoplastic,4/6/2018,3/4/2018,Intravenous,paclitaxel,FALSE
890,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G28EFBDGDC712,4/11/2025,mg,antineoplastic,6/13/2019,3/16/2019,Intravenous,pemetrexed,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,9/18/2016,mg,antineoplastic,5/20/2015,9/28/2014,Intravenous,pemetrexed,TRUE
1200,2,ADVANCED,Administrations,immunotherapy,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,2/21/2022,mg,antineoplastic,12/2/2021,3/4/2021,Intravenous,atezolizumab,FALSE
,1,ADVANCED,Administrations,antineoplastic,Clinical Study Drug,G14E7662::61C,3/28/2017,,antineoplastic,2/7/2017,3/21/2016,Intravenous,clinical study drug,FALSE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/6/2025,,antineoplastic,11/30/2023,2/9/2023,,clinical study drug,FALSE
252,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G3::1:B4F:3D4,12/2/2015,mg,antineoplastic,10/22/2015,10/7/2015,Intravenous,nivolumab,FALSE
2.28,3,ADVANCED,Administrations,chemotherapy,"Eribulin,Exemestane",G19937F58E541,5/25/2014,mg,antineoplastic,4/12/2014,1/18/2014,Intravenous,eribulin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G33E77:6CF7F3,8/29/2017,mg,antineoplastic,12/2/2016,9/22/2016,Intravenous,nivolumab,FALSE
990,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G55D6D2EG3F64,4/27/2016,mg,antineoplastic,2/19/2016,3/29/2016,Intravenous,pemetrexed,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G26EF86FE2766,7/21/2018,mg,antineoplastic,4/18/2017,8/24/2015,Intravenous,nivolumab,FALSE
210,3,LOCOREGIONAL,Administrations,chemotherapy,Paclitaxel Protein-Bound,G548B2:G6G6D:,1/10/2025,mg,antineoplastic,3/23/2023,4/11/2023,Intravenous,paclitaxel protein-bound,FALSE
240,2,ADVANCED,Orders,immunotherapy,Nivolumab,G4464DBGC:5B4,3/31/2025,mg,antineoplastic,10/28/2018,3/20/2018,Intravenous,nivolumab,FALSE
340,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G148327249BD9,4/7/2025,mg,antineoplastic,4/27/2025,4/5/2025,Intravenous,carboplatin,FALSE
735,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G3B8B956G8339,5/16/2025,mg,antineoplastic,1/25/2025,10/5/2024,Intravenous,durvalumab,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4C915B9CFD61,9/27/2020,mg,antineoplastic,10/7/2019,9/2/2019,Intravenous,pembrolizumab,TRUE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21B7762691EE,4/20/2012,mg,antineoplastic,1/23/2012,12/5/2011,Intravenous,paclitaxel,FALSE
1000,4,ADVANCED,Orders,chemotherapy,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,3/29/2019,mg/m2,antineoplastic,3/24/2019,2/18/2019,Intravenous,gemcitabine,FALSE
225,,ADJUVANT,Administrations,chemotherapy,Carboplatin,G2342EB991FC8,3/15/2020,mg,antineoplastic,2/6/2020,1/28/2020,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G11D8D2G1D8CD,3/7/2025,mg,antineoplastic,5/21/2018,5/29/2018,Intravenous,pembrolizumab,FALSE
1050,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,4/30/2015,mg,antineoplastic,10/30/2014,11/24/2014,Intravenous,pemetrexed,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G48::2:98C2EE,4/21/2025,mg,antineoplastic,12/18/2024,8/18/2024,Intravenous,atezolizumab,TRUE
219,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/16/2020,mg,antineoplastic,9/27/2019,10/4/2019,Intravenous,carboplatin,FALSE
484,4,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G1G54G4GB8B24,10/19/2023,mg,antineoplastic,11/15/2022,7/24/2022,Intravenous,ramucirumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Cisplatin,Pemetrexed",G17:EF9E52451,9/1/2021,,antineoplastic,6/21/2021,5/2/2021,,pemetrexed,FALSE
900,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/1/2025,mg,antineoplastic,10/6/2024,4/5/2024,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,1/19/2022,mg,antineoplastic,1/24/2022,10/2/2021,Intravenous,pembrolizumab,TRUE
169,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G264:CC4B7D1:,9/15/2018,mg,antineoplastic,2/23/2014,3/16/2014,Intravenous,docetaxel,FALSE
500,1,ADVANCED,Orders,chemotherapy,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G38C61:99G266,3/28/2023,mg/m2,antineoplastic,12/5/2022,12/3/2022,Intravenous,pemetrexed,FALSE
1666,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,2/8/2013,mg/m2,antineoplastic,2/8/2013,2/26/2013,Intravenous,ifosfamide,FALSE
480,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4G88:D789F74,10/26/2024,mg,antineoplastic,9/2/2022,1/1/2022,Intravenous,nivolumab,TRUE
1195,1,ADVANCED,Administrations,chemotherapy,Gemcitabine,G5:7591G6FGGG,6/16/2014,mg,antineoplastic,5/6/2014,6/5/2014,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,5/2/2020,mg,antineoplastic,2/19/2020,2/7/2020,Intravenous,pembrolizumab,FALSE
528,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,4/26/2025,mg,antineoplastic,10/5/2019,3/23/2019,Intravenous,carboplatin,FALSE
2,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G17BB6EDG:98F,6/2/2019,AUC,antineoplastic,4/7/2019,2/21/2019,Intravenous,carboplatin,FALSE
190,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,7/2/2015,mg,antineoplastic,6/16/2015,2/22/2015,Intravenous,paclitaxel protein-bound,FALSE
61,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2CC42E:::G72,11/15/2018,mg,antineoplastic,11/7/2018,10/21/2018,Intravenous,paclitaxel,FALSE
790,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G38D11EG5F826,3/17/2020,mg,antineoplastic,4/20/2016,2/2/2016,Intravenous,pemetrexed,TRUE
,4,ADVANCED,Orders,antineoplastic,Clinical Study Drug,G3:C9BECD3F55,2/18/2021,,antineoplastic,12/28/2020,12/18/2020,,clinical study drug,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G221C:3FD2EGB,2/5/2019,mg,antineoplastic,1/12/2018,9/30/2017,Intravenous,atezolizumab,FALSE
180,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,12/19/2013,mg,antineoplastic,5/8/2013,10/5/2012,Intravenous,carboplatin,FALSE
1336,1,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Vinorelbine",G14FD45889171,2/4/2015,mg,antineoplastic,12/9/2014,12/6/2014,Intravenous,gemcitabine,FALSE
10,,ADJUVANT,Orders,immunotherapy,Durvalumab,G14361:3FBBE:,8/16/2019,mg/kg,antineoplastic,11/26/2018,9/15/2018,Intravenous,durvalumab,FALSE
750,2,ADVANCED,Orders,chemotherapy,"Gemcitabine,Vinorelbine",G131EFCB91:B2,10/8/2013,mg/m2,antineoplastic,9/27/2013,9/8/2013,Intravenous,gemcitabine,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2F23BB58DF:9,6/30/2019,mg,antineoplastic,2/2/2017,4/20/2016,Intravenous,nivolumab,FALSE
45,,CONCURRENT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G25F9:26DFGE7,3/20/2025,mg/m2,antineoplastic,12/4/2024,10/20/2024,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G4G88:D789F74,1/14/2022,mg,antineoplastic,9/19/2021,8/28/2020,Intravenous,nivolumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/11/2025,,antineoplastic,1/1/2025,3/1/2023,,clinical study drug,FALSE
990,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G45311117177E,4/2/2025,mg,antineoplastic,12/16/2024,4/15/2024,Intravenous,pemetrexed,TRUE
73,1,ADVANCED,Administrations,chemotherapy,Erlotinib,G455E1367:DG4,6/27/2016,mg,antineoplastic,12/10/2015,10/27/2015,Intravenous,paclitaxel,FALSE
136,,ADJUVANT,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,10/16/2015,mg,antineoplastic,9/5/2014,9/21/2014,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,1/17/2025,mg,antineoplastic,7/11/2024,8/16/2024,Intravenous,pembrolizumab,FALSE
732,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,5/11/2025,mg,antineoplastic,3/12/2025,1/22/2025,Intravenous,pemetrexed,FALSE
500,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G22B:E513F46B,5/18/2017,mg,antineoplastic,4/4/2017,3/10/2017,Intravenous,carboplatin,FALSE
2940,,ADJUVANT,Administrations,chemotherapy,"Fluorouracil,Leucovorin,Oxaliplatin",G197EF388:C98,4/14/2022,mg,antineoplastic,3/10/2022,10/11/2021,Intravenous,fluorouracil,FALSE
100,1,ADVANCED,Administrations,chemotherapy,"Cisplatin,Etoposide",G212CFB5F9B91,6/10/2016,mg,antineoplastic,10/16/2014,7/30/2014,Intravenous,etoposide,FALSE
,,ADJUVANT,Orders,hormone,Anastrozole,G432E:9E:21DC,10/5/2023,,antineoplastic,9/16/2023,10/20/2023,Oral,anastrozole,FALSE
200,3,ADVANCED,Orders,immunotherapy,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,1/6/2022,mg,antineoplastic,11/29/2021,10/4/2021,Intravenous,pembrolizumab,FALSE
179.2,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,4/1/2016,mg,antineoplastic,2/9/2016,1/25/2016,Intravenous,carboplatin,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:1C482FFGC,3/7/2025,mg,antineoplastic,8/27/2017,1/10/2017,Intravenous,nivolumab,FALSE
,2,ADVANCED,Orders,immunotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,4/1/2025,,antineoplastic,2/2/2025,10/20/2024,Intravenous,pembrolizumab,FALSE
150,2,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,7/23/2019,mg,antineoplastic,5/17/2019,11/2/2018,Intravenous,paclitaxel,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G172GFE717:24,4/1/2020,mg,antineoplastic,3/26/2020,2/12/2020,Intravenous,pembrolizumab,FALSE
170,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G156F22D:3335,5/31/2024,mg,antineoplastic,4/26/2024,2/25/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G27:4356GC7E5,3/23/2024,mg,antineoplastic,4/17/2022,5/7/2020,Intravenous,pembrolizumab,TRUE
985,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,5/4/2016,mg,antineoplastic,6/24/2014,5/29/2014,Intravenous,pemetrexed,FALSE
33,1,ADVANCED,Administrations,chemotherapy,Vinorelbine,G1D84CDE8:C5E,1/26/2015,mg,antineoplastic,11/28/2014,5/14/2014,Intravenous,vinorelbine,FALSE
200,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,2/28/2025,mg,antineoplastic,2/6/2025,7/28/2024,Intravenous,pembrolizumab,FALSE
810,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,2/22/2022,mg,antineoplastic,11/15/2021,10/17/2021,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,2/27/2025,mg,antineoplastic,9/24/2019,12/31/2018,Intravenous,pembrolizumab,TRUE
100,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,1/20/2025,mg/m2,antineoplastic,11/6/2024,10/31/2024,Intravenous,etoposide,FALSE
,1,ADVANCED,Orders,targeted/non-biologic,Clinical Study Drug,G3GB6D5C:448G,5/8/2018,,antineoplastic,2/27/2018,7/1/2017,,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/16/2022,mg,antineoplastic,7/22/2018,1/14/2016,Intravenous,pemetrexed,FALSE
1230,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,7/9/2014,mg,antineoplastic,9/23/2013,6/30/2013,Intravenous,bevacizumab,FALSE
1100,3,ADVANCED,Administrations,targeted/biologic,"Docetaxel,Ramucirumab",G3:C9BECD3F55,11/24/2020,mg,antineoplastic,9/4/2020,10/5/2020,Intravenous,ramucirumab,FALSE
713,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,11/27/2018,mg,antineoplastic,11/4/2018,10/6/2018,Intravenous,pemetrexed,FALSE
87,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G58E33F7EG254,4/2/2019,mg,antineoplastic,12/26/2018,12/14/2018,Intravenous,paclitaxel,FALSE
135,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G39262EDCDG7B,3/27/2025,mg,antineoplastic,3/19/2017,7/29/2016,Intravenous,pembrolizumab,FALSE
855,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3FGEBG3CG127,3/25/2025,mg,antineoplastic,1/18/2025,12/29/2024,Intravenous,pemetrexed,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G2471D2GFG2E4,7/28/2017,mg,antineoplastic,7/31/2016,8/18/2016,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,4/7/2025,,antineoplastic,3/20/2025,3/12/2024,Intravenous,clinical study drug,FALSE
,1,LOCOREGIONAL,Administrations,antiemetic,Clinical Study Drug,G2C233C2:5B1:,4/9/2025,,antiemetic,12/25/2024,11/14/2024,Intravenous,clinical study drug,FALSE
90,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,2/20/2016,mg,antineoplastic,11/13/2015,5/10/2015,Intravenous,carboplatin,FALSE
100,3,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G17177B5C7D7F,10/29/2022,mg,antineoplastic,8/23/2022,4/20/2022,Intravenous,ipilimumab,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G28E1765:691E,3/29/2023,mg,antineoplastic,4/9/2023,5/3/2022,Intravenous,nivolumab,FALSE
770,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,7/4/2015,mg,antineoplastic,7/15/2015,6/27/2015,Intravenous,bevacizumab,FALSE
,3,ADVANCED,Orders,immunotherapy,Durvalumab,G3FG621769317,4/29/2025,,antineoplastic,1/6/2025,9/25/2024,Intravenous,durvalumab,FALSE
725,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G2G251E378FE8,4/10/2020,mg,antineoplastic,12/3/2019,9/25/2019,Intravenous,pemetrexed,TRUE
125,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G4DE3DE99E:13,11/3/2015,mg,antineoplastic,11/29/2015,10/10/2015,Intravenous,pembrolizumab,FALSE
50,,ADJUVANT,Orders,chemotherapy,"Carboplatin,Paclitaxel",G134249173C:9,12/12/2015,mg/m2,antineoplastic,9/21/2015,7/11/2015,Intravenous,paclitaxel,FALSE
,5,ADVANCED,Unstructured,,"Dabrafenib,Trametinib",G2D168F99BCD4,12/3/2024,,,11/10/2024,1/16/2024,Oral,trametinib,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G52FEFD8:E24C,8/2/2023,mg,antineoplastic,4/26/2022,2/5/2022,Intravenous,pembrolizumab,TRUE
45,2,ADVANCED,Administrations,chemotherapy,Vinorelbine,G393CEF118B21,1/29/2014,mg,antineoplastic,8/23/2013,10/14/2013,Intravenous,vinorelbine,FALSE
400,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,1/22/2025,mg,antineoplastic,11/7/2024,10/13/2024,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2G38:E36D42B,10/29/2024,mg,antineoplastic,7/31/2024,6/25/2024,Intravenous,carboplatin,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,7/17/2024,mg,antineoplastic,7/27/2023,6/27/2023,Intravenous,pembrolizumab,FALSE
,2,ADVANCED,Orders,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,2/10/2023,mg/m2,antineoplastic,11/26/2020,6/5/2020,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G42C2G1176C76,2/7/2024,mg,antineoplastic,1/23/2024,6/28/2023,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,antineoplastic,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/12/2025,,antineoplastic,3/17/2024,2/6/2023,,clinical study drug,FALSE
644,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G1F23G9736:B3,5/12/2025,mg,antineoplastic,12/15/2024,6/24/2024,Intravenous,durvalumab,FALSE
60,,ADJUVANT,Administrations,chemotherapy,Paclitaxel,G2G22BF9DCG81,9/24/2023,mg,antineoplastic,7/24/2023,6/24/2023,Intravenous,paclitaxel,FALSE
228,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Etoposide",G33:335715B9G,1/26/2025,mg,antineoplastic,1/23/2025,10/15/2024,Intravenous,etoposide,FALSE
160,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G459D:92E2344,9/3/2018,mg,antineoplastic,3/23/2018,4/4/2018,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,4/8/2025,mg,antineoplastic,2/24/2025,1/25/2025,Intravenous,pembrolizumab,FALSE
485,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,10/13/2018,mg,antineoplastic,4/10/2018,5/27/2018,Intravenous,carboplatin,FALSE
750,,NEOADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3:G31857DB4:,12/10/2011,mg,antineoplastic,10/2/2011,7/13/2011,Intravenous,carboplatin,FALSE
90,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G218159B8:4F6,11/22/2019,mg,antineoplastic,9/9/2019,8/2/2019,Intravenous,paclitaxel,FALSE
560.1,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G253:45FB2F1:,3/9/2017,mg,antineoplastic,1/31/2017,1/9/2017,Intravenous,carboplatin,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G13ED3F1277G4,8/10/2017,mg,antineoplastic,6/29/2017,4/19/2017,Intravenous,carboplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G46E218G4252C,11/18/2016,mg,antineoplastic,12/23/2016,8/11/2016,Intravenous,pembrolizumab,FALSE
,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,4/22/2025,,antineoplastic,12/8/2024,2/19/2023,Intravenous,pemetrexed,FALSE
240,3,ADVANCED,Administrations,immunotherapy,Nivolumab,G19:83254DDF6,9/1/2024,mg,antineoplastic,8/14/2023,4/5/2023,Intravenous,nivolumab,FALSE
,5,ADVANCED,Orders,targeted/non-biologic,Niraparib,G38D11EG5F826,5/12/2023,,antineoplastic,5/14/2022,5/16/2022,,niraparib,FALSE
191.8,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G59G454E1B6B3,6/11/2018,mg,antineoplastic,5/17/2018,4/22/2018,Intravenous,carboplatin,FALSE
525,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G51F25:3GF134,11/27/2015,mg,antineoplastic,10/6/2015,9/6/2015,Intravenous,carboplatin,FALSE
78,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2514B78G7G83,11/20/2017,mg,antineoplastic,9/4/2017,6/27/2017,Intravenous,paclitaxel,FALSE
,3,ADVANCED,Orders,chemotherapy,"Nivolumab,Paclitaxel",G242B854DCE96,10/12/2016,,antineoplastic,7/29/2016,4/12/2016,Intravenous,paclitaxel,FALSE
1950,6,ADVANCED,Administrations,chemotherapy,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,10/11/2016,mg,antineoplastic,10/3/2016,8/21/2016,Intravenous,gemcitabine,FALSE
220,1,ADVANCED,Administrations,chemotherapy,Paclitaxel Protein-Bound,G2F23BB58DF:9,2/26/2016,mg,antineoplastic,2/3/2016,12/16/2015,Intravenous,paclitaxel protein-bound,FALSE
228.1,,ADJUVANT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G19E:848FD3G5,12/23/2014,mg,antineoplastic,11/19/2014,8/31/2014,Intravenous,carboplatin,FALSE
249,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4989E69:D856,5/16/2025,mg,antineoplastic,1/30/2025,11/8/2024,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G2D75DGG3E33:,7/27/2021,mg,antineoplastic,3/19/2021,2/17/2021,Intravenous,pembrolizumab,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G222C:17:12DD,6/9/2019,mg,antineoplastic,4/20/2019,1/24/2019,Intravenous,carboplatin,FALSE
720,,ADJUVANT,Administrations,immunotherapy,Durvalumab,G346FFEC8FE4C,8/3/2020,mg,antineoplastic,9/28/2019,8/23/2019,Intravenous,durvalumab,FALSE
650,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,10/4/2013,mg,antineoplastic,3/30/2013,3/19/2013,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Pembrolizumab,Pemetrexed",G3:35C52691D:,5/17/2025,mg,antineoplastic,6/2/2022,9/19/2021,Intravenous,pembrolizumab,TRUE
,3,ADVANCED,Orders,hormone,"Anastrozole,Durvalumab",G1885B3G8447B,3/31/2025,,antineoplastic,6/24/2023,9/7/2022,Oral,anastrozole,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,6/9/2022,mg,antineoplastic,7/26/2017,2/1/2016,Intravenous,pemetrexed,FALSE
,1,ADVANCED,Administrations,chemotherapy,Clinical Study Drug,G1:78734BCEDB,8/16/2014,,antineoplastic,3/29/2014,3/24/2014,Intravenous,clinical study drug,FALSE
110,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,7/5/2012,mg,antineoplastic,3/10/2012,1/22/2012,Intravenous,paclitaxel,FALSE
335,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,10/7/2019,mg,antineoplastic,8/25/2019,8/14/2019,Intravenous,carboplatin,FALSE
792,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,1/4/2019,mg,antineoplastic,9/30/2018,8/13/2018,Intravenous,pemetrexed,FALSE
1500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G4G84CDE8:3F:,8/2/2023,mg,antineoplastic,2/1/2023,1/5/2023,Intravenous,durvalumab,FALSE
750,2,ADVANCED,Administrations,chemotherapy,Pemetrexed,G1EEBCF2E91G2,6/7/2013,mg,antineoplastic,7/4/2013,6/17/2012,Intravenous,pemetrexed,FALSE
200,1,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,7/2/2020,mg,antineoplastic,7/2/2020,4/17/2020,Intravenous,pembrolizumab,FALSE
1850,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Gemcitabine",G3E567F5B3:95,8/15/2018,mg,antineoplastic,7/23/2018,5/16/2018,Intravenous,gemcitabine,FALSE
2,1,ADVANCED,Orders,chemotherapy,Carboplatin,G44DBB13D9C9:,3/1/2019,AUC,antineoplastic,1/15/2019,11/13/2018,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,9/28/2014,mg,antineoplastic,3/31/2014,4/18/2014,Intravenous,carboplatin,FALSE
216,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,6/29/2020,mg,antineoplastic,10/20/2019,9/9/2019,Intravenous,carboplatin,FALSE
308,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,6/14/2023,mg,antineoplastic,2/19/2023,10/7/2022,Intravenous,carboplatin,FALSE
240,1,ADVANCED,Administrations,immunotherapy,Nivolumab,G4C2EB36BG3:G,3/7/2019,mg,antineoplastic,5/9/2018,5/22/2018,Intravenous,nivolumab,FALSE
,1,ADVANCED,Administrations,immunotherapy,Clinical Study Drug,G2C4G1G76816F,4/2/2025,,antineoplastic,9/3/2017,9/8/2017,Intravenous,clinical study drug,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G554292GGE7B7,4/24/2025,mg,antineoplastic,10/24/2024,11/8/2023,Intravenous,pembrolizumab,FALSE
165,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,6/15/2021,mg,antineoplastic,4/5/2021,4/25/2021,Intravenous,paclitaxel protein-bound,FALSE
158,1,ADVANCED,Administrations,chemotherapy,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,12/30/2011,mg,antineoplastic,10/3/2011,10/7/2011,Intravenous,cisplatin,FALSE
200,2,ADVANCED,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,8/2/2018,mg,antineoplastic,5/15/2018,7/13/2017,Intravenous,pembrolizumab,FALSE
1200,1,ADVANCED,Administrations,immunotherapy,Atezolizumab,G21B7762691EE,9/10/2018,mg,antineoplastic,4/5/2018,9/18/2017,Intravenous,atezolizumab,FALSE
600,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,2/21/2022,mg,antineoplastic,1/12/2022,12/11/2021,Intravenous,carboplatin,FALSE
935,2,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,3/24/2025,mg,antineoplastic,4/20/2019,4/19/2019,Intravenous,pemetrexed,FALSE
535.8,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,5/17/2019,mg,antineoplastic,2/8/2019,2/26/2019,Intravenous,carboplatin,FALSE
22.5,,ADJUVANT,Administrations,hormone,"Enzalutamide,Leuprolide",G1D41F368EE:G,4/1/2025,mg,antineoplastic,4/12/2024,4/3/2020,Subcutaneous,leuprolide,FALSE
84,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G439D41E1E1FB,10/19/2021,mg,antineoplastic,8/26/2021,7/21/2021,Intravenous,paclitaxel,FALSE
472.5,1,ADVANCED,Administrations,chemotherapy,"Pembrolizumab,Pemetrexed",G4E4734258BE1,4/1/2025,mg,antineoplastic,4/6/2025,8/30/2022,Intravenous,pemetrexed,TRUE
257.6,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5:919981B622,7/9/2023,mg,antineoplastic,6/6/2023,4/3/2023,Intravenous,carboplatin,FALSE
,,ADJUVANT,Administrations,targeted/biologic,Clinical Study Drug,G579E53D92:75,11/26/2011,,antineoplastic,8/6/2011,8/15/2011,Intravenous,clinical study drug,FALSE
180,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G4ED3922EEE48,8/29/2016,mg,antineoplastic,7/10/2016,7/11/2016,Intravenous,carboplatin,FALSE
48,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G21F65359GC46,10/12/2024,mg,antineoplastic,9/16/2024,8/11/2024,Intravenous,paclitaxel,FALSE
,1,ADVANCED,Administrations,antiemetic,Clinical Study Drug,G1969F536B2DD,10/10/2011,,antiemetic,8/6/2011,7/3/2011,Intravenous,clinical study drug,FALSE
240,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G15517:BF5DE4,8/28/2024,mg,antineoplastic,12/13/2023,7/6/2023,Intravenous,nivolumab,FALSE
956,1,ADVANCED,Administrations,targeted/biologic,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,3/10/2015,mg,antineoplastic,10/6/2014,10/17/2014,Intravenous,bevacizumab,FALSE
,2,LOCOREGIONAL,Unstructured,,Osimertinib,G19B:27:ECB43,1/9/2025,,,8/7/2024,7/27/2021,Oral,osimertinib,FALSE
200,,ADJUVANT,Administrations,immunotherapy,Pembrolizumab,G12184C2C1CC4,2/15/2025,mg,antineoplastic,4/30/2024,12/17/2023,Intravenous,pembrolizumab,FALSE
6,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Paclitaxel",G14D44F4B44F2,9/30/2012,AUC,antineoplastic,5/29/2012,4/30/2012,Intravenous,carboplatin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Osimertinib,G1169816459CC,4/6/2025,mg,antineoplastic,9/5/2018,8/28/2018,Intravenous,pembrolizumab,FALSE
1050,2,ADVANCED,Administrations,targeted/biologic,Amivantamab-Vmjw,G57B5F4B556EG,3/11/2022,mg,antineoplastic,7/23/2021,8/14/2021,Intravenous,amivantamab-vmjw,FALSE
372,1,LOCOREGIONAL,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G5395BFB17GD:,4/6/2024,mg,antineoplastic,1/10/2024,10/24/2023,Intravenous,paclitaxel,FALSE
50,1,ADVANCED,Orders,chemotherapy,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,12/8/2023,mg/m2,antineoplastic,1/12/2023,3/3/2023,Intravenous,doxorubicin,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G131892E39563,12/15/2018,mg,antineoplastic,11/30/2017,4/19/2017,Intravenous,pembrolizumab,FALSE
200,1,LOCOREGIONAL,Administrations,immunotherapy,Pembrolizumab,G16DE246787:5,4/10/2025,mg,antineoplastic,8/22/2023,5/31/2023,Intravenous,pembrolizumab,TRUE
,1,ADVANCED,Orders,immunotherapy,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,5/13/2025,,antineoplastic,7/3/2023,2/10/2023,,clinical study drug,FALSE
845,1,ADVANCED,Administrations,chemotherapy,Pemetrexed,G28E1765:691E,5/16/2022,mg,antineoplastic,10/26/2016,1/2/2016,Intravenous,pemetrexed,FALSE
1080,1,ADVANCED,Administrations,chemotherapy,"Bevacizumab,Pemetrexed",G4F354B:F341F,10/3/2016,mg,antineoplastic,2/8/2015,10/20/2014,Intravenous,pemetrexed,TRUE
500,2,ADVANCED,Administrations,immunotherapy,Durvalumab,G17171D313CCE,2/25/2020,mg,antineoplastic,7/18/2018,8/8/2018,Intravenous,durvalumab,FALSE
91,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G287777772FGE,3/3/2022,mg,antineoplastic,10/26/2021,10/20/2021,Intravenous,paclitaxel,FALSE
194,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Docetaxel",G17171D313CCE,7/11/2018,mg,antineoplastic,4/9/2018,3/1/2018,Intravenous,carboplatin,FALSE
875,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Pemetrexed",G2C38B34G8794,10/23/2021,mg,antineoplastic,5/3/2021,5/16/2021,Intravenous,pemetrexed,FALSE
274,,CONCURRENT,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,7/29/2014,mg,antineoplastic,6/4/2014,6/8/2014,Intravenous,carboplatin,FALSE
248,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G11545861:F9G,2/26/2016,mg,antineoplastic,10/25/2015,7/10/2015,Intravenous,carboplatin,FALSE
20,1,ADVANCED,Orders,chemotherapy,"Carboplatin,Docetaxel",G133G3GCBGE3D,5/28/2013,mg/m2,antineoplastic,12/18/2012,8/15/2012,Intravenous,docetaxel,FALSE
775,,CONCURRENT,Administrations,chemotherapy,"Cisplatin,Pemetrexed",G3951BC5GBE44,9/28/2023,mg,antineoplastic,7/30/2023,6/27/2023,Intravenous,pemetrexed,FALSE
200,,ADJUVANT,Administrations,immunotherapy,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,11/17/2019,mg,antineoplastic,10/27/2019,5/29/2018,Intravenous,pembrolizumab,FALSE
360,1,ADVANCED,Administrations,immunotherapy,"Ipilimumab,Nivolumab",G3G18F3E9E3C8,6/13/2024,mg,antineoplastic,5/7/2024,5/5/2024,Intravenous,nivolumab,TRUE
151,1,ADVANCED,Administrations,chemotherapy,"Carboplatin,Paclitaxel",G3B76E8182:B:,6/7/2024,mg,antineoplastic,2/24/2024,1/31/2024,Intravenous,carboplatin,FALSE
179,2,ADVANCED,Administrations,immunotherapy,Nivolumab,G1G:548DD7228,8/14/2017,mg,antineoplastic,8/28/2015,6/12/2015,Intravenous,nivolumab,FALSE
1000,3,ADVANCED,Orders,chemotherapy,"Carboplatin,Gemcitabine,Pembrolizumab",G26EFGF738125,10/30/2018,mg/m2,antineoplastic,10/4/2018,8/23/2018,Intravenous,gemcitabine,FALSE
200,1,ADVANCED,Administrations,immunotherapy,Pembrolizumab,G28EFBDGDC712,1/31/2019,mg,antineoplastic,8/24/2018,6/17/2018,Intravenous,pembrolizumab,FALSE
